PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Miljkovic-Licina, M; Hammel, P; Garrido-Urbani, S; Bradfield, PF; Szepetowski, P; Imhof, BA				Miljkovic-Licina, Marijana; Hammel, Philippe; Garrido-Urbani, Sarah; Bradfield, Paul F.; Szepetowski, Pierre; Imhof, Beat A.			Sushi repeat protein X-linked 2, a novel mediator of angiogenesis	FASEB JOURNAL			English	Article						endothelial remodeling; migration; sprouting; uPAR	ENDOTHELIAL-CELL MIGRATION; ACTIVATOR RECEPTOR UPAR; FOCAL ADHESION KINASE; UROKINASE RECEPTOR; IN-VIVO; SRPX2; MORPHOGENESIS; DISORDERS; INTEGRIN; DISEASE	On appropriate stimuli, quiescent endothelial cells start to proliferate and form de novo blood vessels through angiogenesis. To further define molecular mechanisms accompanying the activation of endothelial cells during angiogenesis, we identified genes that were differentially regulated during this process using microarray analyses. In this work, we established a regulatory role for Sushi repeat protein X-linked 2 (Srpx2) in endothelial cell remodeling during angiogenesis. In particular, silencing of Srpx2 using small interfering RNAs (siRNAs) specifically attenuated endothelial cell migration and delayed angiogenic sprout formation. In vivo, Srpx2 expression was detected in de novo formation of blood vessels in angiogenic tissues by in situ mRNA hybridization and immunostaining. Pull-down experiments identified Srpx2 as a ligand for vascular uPAR, a key molecule involved in invasive migration of angiogenic endothelium. Immunostaining revealed coexpression of the Srpx2 and uPAR on vascular endothelium. These findings suggest that Srpx2 regulates endothelial cell migration and tube formation and provides a new target for modulating angiogenesis.-Miljkovic-Licina, M., Hammel, P., Garrido-Urbani, S., Bradfield, P. F., Szepetowski, P., Imhof, B. A. Sushi repeat protein Xlinked 2, a novel mediator, of angiogenesis. FASEB J. 23, 4105-4116 (2009). www.fasebj.org	[Miljkovic-Licina, Marijana; Hammel, Philippe; Garrido-Urbani, Sarah; Bradfield, Paul F.; Imhof, Beat A.] Univ Geneva, CMU, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Szepetowski, Pierre] Univ Mediterranee, INSERM, UMR 901, Marseille, France; [Szepetowski, Pierre] Univ Mediterranee, UMR 910, Marseille, France	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Imhof, BA (corresponding author), Univ Geneva, CMU, Dept Pathol & Immunol, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	beat.imhof@unige.ch		Garrido-Urbani, Sarah/0000-0002-7309-0137; Miljkovic-Licina, Marijana/0000-0001-9023-2208; Hammel, Pascal/0000-0002-4630-4996				Adachi Y, 2001, J BIOL CHEM, V276, P47171, DOI 10.1074/jbc.M104334200; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ashraf S, 2008, CURR OPIN RHEUMATOL, V20, P573, DOI 10.1097/BOR.0b013e3283103d12; Aurrand-Lions M, 2004, J PATHOL, V203, P700, DOI 10.1002/path.1571; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; Cherqui S, 2007, MOL THER, V15, P1264, DOI 10.1038/sj.mt.6300183; Colman RW, 2006, CURR PHARM DESIGN, V12, P2599, DOI 10.2174/138161206777698710; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Egami K, 2006, J LEUKOCYTE BIOL, V79, P971, DOI 10.1189/jlb.0805448; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Hoshino M, 1996, DEVELOPMENT, V122, P589; Jones CA, 2007, CURR OPIN GENET DEV, V17, P332, DOI 10.1016/j.gde.2007.07.004; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; Kurosawa H, 1999, BLOOD, V93, P321, DOI 10.1182/blood.V93.1.321.401k05_321_332; Lakka SS, 2005, BRAIN PATHOL, V15, P327; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; O'Leary JM, 2004, PROTEIN SCI, V13, P1238, DOI 10.1110/ps.03582704; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Oliveira-Ferrer L, 2004, CANCER RES, V64, P8932, DOI 10.1158/0008-5472.CAN-04-0505; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Pepper MS, 1996, ENZYME PROTEIN, V49, P138, DOI 10.1159/000468622; PIALI L, 1993, EUR J IMMUNOL, V23, P2464, DOI 10.1002/eji.1830231013; Prager GW, 2004, CIRC RES, V94, P1562, DOI 10.1161/01.RES.0000131498.36194.6b; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Royer B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-72; Royer-Zemmour B, 2008, HUM MOL GENET, V17, P3617, DOI 10.1093/hmg/ddn256; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Suchting S, 2006, EXP CELL RES, V312, P668, DOI 10.1016/j.yexcr.2005.11.009; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tanaka K, 2009, INT J CANCER, V124, P1072, DOI 10.1002/ijc.24065; Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	52	32	41	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4105	4116		10.1096/fj.09-135202	http://dx.doi.org/10.1096/fj.09-135202			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19667118				2022-12-25	WOS:000272193700007
J	Endo, A; Kitamura, N; Komada, M				Endo, Akinori; Kitamura, Naomi; Komada, Masayuki			Nucleophosmin/B23 Regulates Ubiquitin Dynamics in Nucleoli by Recruiting Deubiquitylating Enzyme USP36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARF TUMOR-SUPPRESSOR; PROTEIN B23; RIBOSOME BIOGENESIS; RNA; LOCALIZATION; DEGRADATION; CHAPERONE; SIGNAL; SENP3	The nucleolus is a subnuclear compartment with multiple cellular functions, including ribosome biogenesis. USP36 is a deubiquitylating enzyme that localizes to nucleoli and plays an essential role in regulating the structure and function of the organelle. However, how the localization of USP36 is regulated remains unknown. Here, we identified a short stretch of basic amino acids (RGKEKKIKKFKREKRR) that resides in the C-terminal region of USP36 and serves as a nucleolar localization signal for the protein. We found that this motif interacts with a central acidic region of nucleophosmin/B23, a major nucleolar protein involved in various nucleolar functions. Knockdown of nucleophosmin/B23 resulted in a significant reduction in the amount of USP36 in nucleoli, without affecting the cellular USP36 level. This was associated with elevated ubiquitylation levels of fibrillarin, a USP36 substrate protein in nucleoli. We conclude that nucleophosmin/B23 recruits USP36 to nucleoli, thereby serving as a platform for the regulation of nucleolar protein functions through ubiquitylation/deubiquitylation.	[Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Komada, M (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B16 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	makomada@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [19570178]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid 19570178 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. K.).	ADACHI Y, 1993, J BIOL CHEM, V268, P13930; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chen M, 2002, MOL BIOL CELL, V13, P3576, DOI 10.1091/mbc.02-05-0083; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; Szebeni A, 1999, PROTEIN SCI, V8, P905; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185	23	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27918	27923		10.1074/jbc.M109.037218	http://dx.doi.org/10.1074/jbc.M109.037218			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679658	Green Published, hybrid			2022-12-25	WOS:000270676300019
J	Yokooji, Y; Tomita, H; Atomi, H; Imanaka, T				Yokooji, Yuusuke; Tomita, Hiroya; Atomi, Haruyuki; Imanaka, Tadayuki			Pantoate Kinase and Phosphopantothenate Synthetase, Two Novel Enzymes Necessary for CoA Biosynthesis in the Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A BIOSYNTHESIS; THERMOCOCCUS-KODAKARAENSIS KOD1; PANTOTHENATE KINASE; FEEDBACK-REGULATION; ESCHERICHIA-COLI; PATHWAY; FRUCTOSE-1,6-BISPHOSPHATASE; 4'-PHOSPHOPANTETHEINE; NEURODEGENERATION; GALACTOKINASE	Bacteria/eukaryotes share a common pathway for coenzyme A (CoA) biosynthesis. Although archaeal genomes harbor homologs for most of these enzymes, homologs of bacterial/eukaryotic pantothenate synthetase (PS) and pantothenate kinase (PanK) are missing. PS catalyzes the ATP-dependent condensation of pantoate and beta-alanine to produce pantothenate, whereas PanK catalyzes the ATP-dependent phosphorylation of pantothenate to produce 4'-phosphopantothenate. When we examined the cell-free extracts of the hyperthermophilic archaeon Thermococcus kodakaraensis, PanK activity could not be detected. A search for putative kinase-encoding genes widely distributed in Archaea, but not present in bacteria/eukaryotes, led to four candidate genes. Among these genes, TK2141 encoded a protein with relatively low PanK activity. However, higher levels of activity were observed when pantothenate was replaced with pantoate. V-max values were 7-fold higher toward pantoate, indicating that TK2141 encoded a novel enzyme, pantoate kinase (PoK). A search for genes with a distribution similar to TK2141 led to the identification of TK1686. The protein product catalyzed the ATP-dependent conversion of phosphopantoate and beta-alanine to produce 4'-phosphopantothenate and did not exhibit PS activity, indicating that TK1686 also encoded a novel enzyme, phosphopantothenate synthetase (PPS). Although the classic PS/PanK system performs condensation with beta-alanine prior to phosphorylation, the PoK/PPS system performs condensation after phosphorylation of pantoate. Gene disruption of TK2141 and TK1686 led to CoA auxotrophy, indicating that both genes are necessary for CoA biosynthesis in T. kodakaraensis. Homologs of both genes are widely distributed among the Archaea, suggesting that the PoK/PPS system represents the pathway for 4'-phosphopantothenate biosynthesis in the Archaea.	[Imanaka, Tadayuki] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Noji Higashi, Kusatsu 5258577, Japan; [Yokooji, Yuusuke; Tomita, Hiroya; Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan	Ritsumeikan University; Kyoto University	Imanaka, T (corresponding author), Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Noji Higashi, Kusatsu 5258577, Japan.	imanaka@sk.ritsumei.ac.jp	Zhang, Ning/F-1387-2014; Tomita, Hiroya/GQY-9725-2022	Atomi, Haruyuki/0000-0001-9687-6426	Japan Society for the Promotion of Science [18GS0421];  [19310126]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported in part by the Japan Society for the Promotion of Science under a grant-in-aid for Creative Scientific Research (project 18GS0421 to T.I.) and by a grant-in-aid for Scientific Research (B) (19310126 to H. A.).	Armengaud J, 2003, J BIOL CHEM, V278, P31078, DOI 10.1074/jbc.M301891200; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; BORK P, 1993, PROTEIN SCI, V2, P31; Brand LA, 2005, J BIOL CHEM, V280, P20185, DOI 10.1074/jbc.C500044200; Calder RB, 1999, J BIOL CHEM, V274, P2014, DOI 10.1074/jbc.274.4.2014; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Genschel U, 2004, MOL BIOL EVOL, V21, P1242, DOI 10.1093/molbev/msh119; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kupke T, 2006, J BIOL CHEM, V281, P5435, DOI 10.1074/jbc.M510056200; Kupke T, 2003, J BIOL CHEM, V278, P38229, DOI 10.1074/jbc.M306321200; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Neuwald AF, 1999, GENOME RES, V9, P27; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Robb Frank T., 1995, P167; Rock CO, 2003, J BACTERIOL, V185, P3410, DOI 10.1128/JB.185.11.3410-3415.2003; Rock CO, 2002, GENE, V291, P35, DOI 10.1016/S0378-1119(02)00564-4; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Ronconi S, 2008, FEBS J, V275, P2754, DOI 10.1111/j.1742-4658.2008.06416.x; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; SONG WJ, 1994, J BIOL CHEM, V269, P27051; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yang D, 2002, J BIOL CHEM, V277, P9462, DOI 10.1074/jbc.M110787200; Yang K, 2006, J BACTERIOL, V188, P5532, DOI 10.1128/JB.00469-06	35	63	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28137	28145		10.1074/jbc.M109.009696	http://dx.doi.org/10.1074/jbc.M109.009696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666462	hybrid, Green Published			2022-12-25	WOS:000270676300040
J	Edreira, MM; Li, S; Hochbaum, D; Wong, S; Gorfe, AA; Ribeiro-Neto, F; Woods, VL; Altschuler, DL				Edreira, Martin M.; Li, Sheng; Hochbaum, Daniel; Wong, Sergio; Gorfe, Alemayehu A.; Ribeiro-Neto, Fernando; Woods, Virgil L., Jr.; Altschuler, Daniel L.			Phosphorylation-induced Conformational Changes in Rap1b ALLOSTERIC EFFECTS ON SWITCH DOMAINS AND EFFECTOR LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; H-RAS; BINDING PROTEIN; CELL-GROWTH; K-RAS; INHIBITION; ACTIVATION; NUCLEOTIDE; DYNAMICS; PKA	Rap1b has been implicated in the transduction of the cAMP mitogenic response. Agonists that increase intracellular cAMP rapidly activate (i.e. GTP binding) and phosphorylate Rap1b on Ser(179) at its C terminus. cAMP-dependent protein kinase (PKA)-mediated phosphorylation of Rap1b is required for cAMP-dependent mitogenesis, tumorigenesis, and inhibition of AKT activity. However, the role of phosphorylation still remains unknown. In this study, we utilized amide hydrogen/deuterium exchange mass spectroscopy (DXMS) to assess potential conformational changes and/or mobility induced by phosphorylation. We report here DXMS data comparing exchange rates for PKA phosphorylated (Rap1-P) and S179D phosphomimetic (Rap1-D) Rap1b proteins. Rap1-P and Rap1-D behaved exactly the same, revealing an increased exchange rate in discrete regions along the protein; these regions include a domain around the phosphorylation site and unexpectedly the two switch loops. Thus, local effects induced by Ser(179) phosphorylation communicate allosterically with distal domains involved in effector interaction. These results provide a mechanistic explanation for the differential effects of Rap1 phosphorylation by PKA on effector protein interaction.	[Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Wong, Sergio; Gorfe, Alemayehu A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wong, Sergio; Gorfe, Alemayehu A.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Edreira, Martin M.; Hochbaum, Daniel; Ribeiro-Neto, Fernando; Altschuler, Daniel L.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Woods, VL (corresponding author), Univ Calif San Diego, Dept Med, 9500 Hillman Dr, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; altschul@pitt.edu	Edreira, Martin/AAE-7816-2020	Edreira, Martin/0000-0002-9120-2649; Hochbaum, Daniel/0000-0001-6387-7529	National Institutes of Health [R01 CA071649, DK063069, AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, GM066170]; Innovative Technologies for the Molecular Analysis of Cancer (IMAT) Program [CA099835, CA118595]; University of California IUCRP Program; NATIONAL CANCER INSTITUTE [R33CA099835, R01CA071649, R21CA099835, R21CA118595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961, P01AI068730, R01AI081982, R01AI072106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, F32GM020501, R01GM020501, R01GM037684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Technologies for the Molecular Analysis of Cancer (IMAT) Program; University of California IUCRP Program(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA071649 and DK063069 (to D. L. A.); Innovative Technologies for the Molecular Analysis of Cancer (IMAT) Program Grants CA099835 and CA118595 (to V. L. W.); National Institutes of Health Grants AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, and GM066170 (to V. L. W.); and Discovery Grant UC10591 from the University of California IUCRP Program, BiogenIDEC corporate sponsor (to V. L. W.).	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Arai Y, 2006, BIOCHEM BIOPH RES CO, V343, P809, DOI 10.1016/j.bbrc.2006.03.031; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Gallicchio E, 2002, J COMPUT CHEM, V23, P517, DOI 10.1002/jcc.10045; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Harding A, 2008, CELL CYCLE, V7, P127, DOI 10.4161/cc.7.2.5237; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Schmitt JM, 2001, MOL CELL BIOL, V21, P3671, DOI 10.1128/MCB.21.11.3671-3683.2001; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tsutsui Y, 2007, CURR MED CHEM, V14, P2344, DOI 10.2174/092986707781745596	38	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27480	27486		10.1074/jbc.M109.011312	http://dx.doi.org/10.1074/jbc.M109.011312			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651783	Green Published, hybrid			2022-12-25	WOS:000270232300050
J	Yuan, BZ; Chapman, J; Reynolds, SH				Yuan, B-Z; Chapman, J.; Reynolds, S. H.			Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage	ONCOGENE			English	Article						proteasome inhibitor; non-small cell lung carcinoma; apoptosis; Mcl-1; positive feedback mechanism; protein cleavage	TRAIL; SENSITIZE; EPIDEMIOLOGY; ACTIVATION; BORTEZOMIB; FLICE; NOXA	Proteasome inhibitors (PIs) are promising new therapeutic agents for treating non-small cell lung carcinoma (NSCLC). To investigate the mechanisms of action of PIs, we analyzed the proapoptotic activities of PIs (MG132 or Bortezomib) in NSCLC cells. We found that both MG132 (>1 mu M) and Bortezomib (>0.025 mu M) induced a significant apoptosis in NCI-H1703, a PI-sensitive NSCLC cell line, through initially activating the intrinsic apoptosis pathway, leading to the activation of a positive feedback mechanism (PFM), which then conveyed apoptosis signaling from the intrinsic pathway to the extrinsic pathway with formation of a signaling loop for maximal caspase activation. Mcl-1 and Noxa were identified to be the major anti-apoptotic and proapoptotic proteins, respectively, in PI-induced apoptosis and mutually exclusive in protein stability. Although the Mcl-1 protein was upregulated by proteasome inhibition, it was also subjected to caspase 3-dependent cleavage governed by the PFM. Moreover, it was revealed that Mcl-1 protein cleavage contributed to PFM-governed apoptosis in following inter-related ways: reducing the anti-apoptotic Mcl-1; generating the truncated proapoptotic Mcl-1(S); and inducing a shift of balance between Mcl-1 and Noxa. It was further manifested that tumor necrosis factor-related apoptosis-inducing ligand boosted MG132's proapoptotic activity through strengthening the PFM in both NCI-H1703 and NCI-H358, a PI-resistant NSCLC cell line. Therefore, this study provides a basis for enhancing the efficacy of PIs in treating NSCLC. Oncogene (2009) 28, 3775-3786; doi:10.1038/onc.2009.240; published online 17 August 2009	[Yuan, B-Z; Chapman, J.; Reynolds, S. H.] NIOSH, Mol Genet Lab, Toxicol & Mol Biol Branch, CDC, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Yuan, BZ (corresponding author), NIOSH, Mol Genet Lab, Toxicol & Mol Biol Branch, CDC, 1095 Willowdale Rd,M-S L-3014, Morgantown, WV 26505 USA.	bby1@cdc.gov						Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Das T, 1999, BIOCHEM BIOPH RES CO, V260, P105, DOI 10.1006/bbrc.1999.0712; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Green DR, 2006, CANCER CELL, V9, P328, DOI 10.1016/j.ccr.2006.05.004; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Hassan M, 2008, ONCOGENE, V27, P4557, DOI 10.1038/onc.2008.90; Henderson CJ, 2005, CELL DEATH DIFFER, V12, P1240, DOI 10.1038/sj.cdd.4401729; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Kruyt FAE, 2008, CANCER LETT, V263, P14, DOI 10.1016/j.canlet.2008.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Milhas D, 2005, J BIOL CHEM, V280, P19836, DOI 10.1074/jbc.M414358200; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagy K, 2006, PATHOL ONCOL RES, V12, P133, DOI 10.1007/BF02893359; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saulle E, 2007, APOPTOSIS, V12, P635, DOI 10.1007/s10495-006-0025-9; Steenland K, 1996, AM J IND MED, V30, P495, DOI 10.1002/(SICI)1097-0274(199610)30:4<495::AID-AJIM16>3.3.CO;2-I; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Voortman J, 2007, MOL CANCER THER, V6, P1046, DOI 10.1158/1535-7163.MCT-06-0577; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Willison HJ, 2005, NAT CLIN PRACT NEURO, V1, P2, DOI 10.1038/ncpneuro0001; Yuan BZ, 2007, EXP CELL RES, V313, P3868, DOI 10.1016/j.yexcr.2007.08.009; Yuan BZ, 2008, TRANSL ONCOL, V1, P129, DOI 10.1593/tlo.08133; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373	34	24	25	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	43					3775	3786		10.1038/onc.2009.240	http://dx.doi.org/10.1038/onc.2009.240			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	512KT	19684616				2022-12-25	WOS:000271248400002
J	Wan, M; Qin, J; Songyang, Z; Liu, D				Wan, Ma; Qin, Jun; Songyang, Zhou; Liu, Dan			OB Fold-containing Protein 1 (OBFC1), a Human Homolog of Yeast Stn1, Associates with TPP1 and Is Implicated in Telomere Length Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME END-PROTECTION; COMPLEX; DNA; POT1; CELLS; REPLICATION; INTERACTS; CDC13; TRF1	The telosome/shelterin, a six-protein complex formed by TRF1, TRF2, RAP1, TIN2, POT1, and TPP1, functions as the core of the telomere interactome, acting as the molecular platform for the assembly of higher order complexes and coordinating cross-talks between various protein subcomplexes. Within the telosome, there are two oligonucleotide-or oligosaccharide-binding ( OB) fold-containing proteins, TPP1 and POT1. They can form heterodimers that bind to the telomeric single-stranded DNA, an activity that is central for telomere end capping and telomerase recruitment. Through proteomic analyses, we found that in addition to POT1, TPP1 can associate with another OB fold-containing protein, OBFC1/AAF44. The yeast homolog of OBFC1 is Stn1, which plays a critical role in telomere regulation. We show here that OBFC1/AAF44 can localize to telomeres in human cells and bind to telomeric single-stranded DNA in vitro. Furthermore, overexpression of an OBFC1 mutant resulted in elongated telomeres in human cells, implicating OBFC1/AAF4 in telomere length regulation. Taken together, our studies suggest that OBFC1/AAF44 represents a new player in the telomere interactome for telomere maintenance.	[Wan, Ma; Qin, Jun; Songyang, Zhou; Liu, Dan] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Liu, Dan] Baylor Coll Med, Cell Based Assay Screening Serv Core, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Songyang, Z (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	songyang@bcm.edu; danl@bcm.edu			National Institutes of Health; American Heart Association; American Cancer Society; Welch Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); Welch Foundation(The Welch Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grant. This work was also supported by grants from the American Heart Association, the American Cancer Society, and the Welch Foundation.	Bailey SM, 2004, CYTOGENET GENOME RES, V104, P109, DOI 10.1159/000077474; BLACKBURN EH, 1991, TRENDS BIOCHEM SCI, V16, P378, DOI 10.1016/0968-0004(91)90155-O; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Granger MP, 2002, CRIT REV ONCOL HEMAT, V41, P29, DOI 10.1016/S1040-8428(01)00188-3; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Hanaoka S, 2005, PROTEIN SCI, V14, P119, DOI 10.1110/ps.04983705; Harrington L, 2002, ONCOGENE, V21, P592, DOI 10.1038/sj.onc.1205084; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Song XY, 2008, P NATL ACAD SCI USA, V105, P19815, DOI 10.1073/pnas.0807867105; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wei C, 2003, CELL MOL LIFE SCI, V60, P2283, DOI 10.1007/s00018-003-3244-z; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhou SY, 2006, CRIT REV EUKAR GENE, V16, P103, DOI 10.1615/CritRevEukarGeneExpr.v16.i2.10	35	99	106	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26725	26731		10.1074/jbc.M109.021105	http://dx.doi.org/10.1074/jbc.M109.021105			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648609	Green Published, hybrid			2022-12-25	WOS:000269969600053
J	Galligan, CL; Siebert, JC; Siminovitch, KA; Keystone, EC; Bykerk, V; Perez, OD; Fish, EN				Galligan, Carole L.; Siebert, Janet C.; Siminovitch, Katherine A.; Keystone, Edward C.; Bykerk, Vivian; Perez, Omar D.; Fish, Eleanor N.			Multiparameter Phospho-Flow Analysis of Lymphocytes in Early Rheumatoid Arthritis: Implications for Diagnosis and Monitoring Drug Therapy	PLOS ONE			English	Article								Background: The precise mechanisms involved in the initiation and progression of rheumatoid arthritis (RA) are not known. Early stages of RA often have non-specific symptoms, delaying diagnosis and therapy. Additionally, there are currently no established means to predict clinical responsiveness to therapy. Immune cell activation is a critical component therefore we examined the cellular activation of peripheral blood mononuclear cells (PBMCs) in the early stages of RA, in order to develop a novel diagnostic modality. Methods and Findings: PBMCs were isolated from individuals diagnosed with early RA (ERA) (n = 38), longstanding RA (n = 10), osteoarthritis (OA) (n = 19) and from healthy individuals (n = 10). PBMCs were examined for activation of 15 signaling effectors, using phosphorylation status as a measure of activation in immunophenotyped cells, by flow cytometry (phospho-flow). CD3+CD4+, CD3+CD8+ and CD20+ cells isolated from patients with ERA, RA and OA exhibited activation of multiple phospho-epitopes. ERA patient PBMCs showed a bias towards phosphorylation-activation in the CD4+ and CD20+ compartments compared to OA PBMCs, where phospho-activation was primarily observed in CD8+ cells. The ratio of phospho (p)-AKT/p-p38 was significantly elevated in patients with ERA and may have diagnostic potential. The mean fluorescent intensity (MFI) levels for p-AKT and p-H3 in CD4+, CD8+ and CD20+ T cells correlated directly with physician global assessment scores (MDGA) and DAS (disease activity score). Stratification by medications revealed that patients receiving leflunomide, systemic steroids or anti-TNF therapy had significant reductions in phospho-specific activation compared with patients not receiving these therapies. Correlative trends between medication-associated reductions in the levels of phosphorylation of specific signaling effectors and lower disease activity were observed. Conclusions: Phospho-flow analysis identified phosphorylation-activation of specific signaling effectors in the PB from patients with ERA. Notably, phosphorylation of these signaling effectors did not distinguish ERA from late RA, suggesting that the activation status of discrete cell populations is already established early in disease. However, when the ratio of MFI values for p-AKT and p-p38 is > 1.5, there is a high likelihood of having a diagnosis of RA. Our results suggest that longitudinal sampling of patients undergoing therapy may result in phospho-signatures that are predictive of drug responsiveness.			Galligan, CL (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	en.fish@utoronto.ca	Siminovitch, Katherine/K-1475-2013		NHLBI NIH HHS [N01-HV-281831, N01HV28183] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028183] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arvidson NG, 1997, ANN RHEUM DIS, V56, P27, DOI 10.1136/ard.56.1.27; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BANAL F, 2008, ANN RHEUM DIS; BANERJEE S, 1992, CELL IMMUNOL, V144, P347, DOI 10.1016/0008-8749(92)90250-S; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Berglin E, 2003, RHEUMATOLOGY, V42, P268, DOI 10.1093/rheumatology/keg077; Bingham CO, 2008, BULL HOSP JT DIS, V66, P210; Bowes J, 2008, RHEUMATOLOGY, V47, P399, DOI 10.1093/rheumatology/ken005; Buch MH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2416; Burger D, 2003, RHEUMATOLOGY, V42, P89, DOI 10.1093/rheumatology/keg038; CHERWINSKI HM, 1995, J PHARMACOL EXP THER, V275, P1043; CHONG ASF, 1993, TRANSPLANTATION, V55, P1361, DOI 10.1097/00007890-199306000-00028; Chong ASF, 1996, TRANSPLANTATION, V61, P140, DOI 10.1097/00007890-199601150-00026; COPE AP, 1994, J CLIN INVEST, V94, P749, DOI 10.1172/JCI117394; Cush JJ, 2007, J RHEUMATOL, V34, P1; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Elkayam O, 2003, ANN RHEUM DIS, V62, P440, DOI 10.1136/ard.62.5.440; Firestein GS, 2005, JCR-J CLIN RHEUMATOL, V11, pS39, DOI 10.1097/01.rhu.0000166673.34461.33; FIRESTEIN GS, 1995, J CLIN INVEST, V96, P1631, DOI 10.1172/JCI118202; Forslind K, 2004, ANN RHEUM DIS, V63, P1090, DOI 10.1136/ard.2003.014233; Gabriel SE, 2001, RHEUM DIS CLIN N AM, V27, P269, DOI 10.1016/S0889-857X(05)70201-5; Garnero P, 2002, ARTHRITIS RHEUM, V46, P2847, DOI 10.1002/art.10616; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gerber LH, 2003, CLIN EXP RHEUMATOL, V21, pS65; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gonzalez-Alvaro I, 2008, ANN RHEUM DIS; Hildner KM, 2007, J IMMUNOL, V178, P3427, DOI 10.4049/jimmunol.178.6.3427; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2007, BLOOD, V109, P2589, DOI 10.1182/blood-2006-02-004234; Klimiuk PA, 2009, CLIN RHEUMATOL, V28, P17, DOI 10.1007/s10067-008-0974-1; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; KURIYA B, 2008, ANN RHEUM DIS; Kuuliala A, 2005, CLIN EXP RHEUMATOL, V23, P243; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Lubberts Erik, 2003, Curr Opin Investig Drugs, V4, P572; Makrygiannakis D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2582; Manna SK, 1999, J IMMUNOL, V162, P2095; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; Meyer O, 2003, ANN RHEUM DIS, V62, P120, DOI 10.1136/ard.62.2.120; Mikuls TR, 2000, ARTHRITIS RHEUM, V43, P464, DOI 10.1002/1529-0131(200002)43:2<464::AID-ANR30>3.0.CO;2-U; Muller-Ladner U, 2000, J IMMUNOL, V164, P3894, DOI 10.4049/jimmunol.164.7.3894; Mustelin T, 2004, MOL IMMUNOL, V41, P687, DOI 10.1016/j.molimm.2004.04.015; Nielen MMJ, 2005, ANN RHEUM DIS, V64, P1199, DOI 10.1136/ard.2004.029389; PALMER DG, 1995, BRIT MED BULL, V51, P286, DOI 10.1093/oxfordjournals.bmb.a072961; Perez Omar D, 2004, Methods Mol Biol, V263, P67; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Santos LL, 2008, CLIN EXP IMMUNOL, V152, P372, DOI 10.1111/j.1365-2249.2008.03639.x; Schett G, 2000, ARTHRITIS RHEUM, V43, P2501, DOI 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K; Schuerwegh AJ, 2001, J RHEUMATOL, V28, P1793; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Siemasko K, 1998, J IMMUNOL, V160, P1581; Siemasko KF, 1996, TRANSPLANTATION, V61, P635, DOI 10.1097/00007890-199602270-00020; Singh R, 2007, J RHEUMATOL, V34, P2285; Stanton RJ, 2007, J VIROL, V81, P7860, DOI 10.1128/JVI.02247-06; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Tian HH, 2007, BULL HOSP JT DIS, V65, P168; Urushibara M, 2004, ARTHRITIS RHEUM-US, V50, P794, DOI 10.1002/art.20206; van der Helm-van Mil AH, 2008, ARTHRITIS RHEUM-US, V58, P2241, DOI 10.1002/art.23681; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; van Venrooij WJ, 2008, ANN NY ACAD SCI, V1143, P268, DOI 10.1196/annals.1443.013; Verstappen SMM, 2005, ANN RHEUM DIS, V64, P38, DOI 10.1136/ard.2003.014928; Walker JG, 2006, ANN RHEUM DIS, V65, P1558, DOI 10.1136/ard.2005.050385; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Yu CR, 2008, J IMMUNOL, V181, P1190, DOI 10.4049/jimmunol.181.2.1190; LANCET, V352, P1498	73	28	28	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6703	10.1371/journal.pone.0006703	http://dx.doi.org/10.1371/journal.pone.0006703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693272	gold, Green Published, Green Submitted			2022-12-25	WOS:000269267400011
J	Ahmad, S; Ramsay, T; Huebsch, L; Flanagan, S; McDiarmid, S; Batkin, I; McIntyre, L; Sundaresan, SR; Maziak, DE; Shamji, FM; Hebert, P; Fergusson, D; Tinmouth, A; Seely, AJE				Ahmad, Saif; Ramsay, Tim; Huebsch, Lothar; Flanagan, Sarah; McDiarmid, Sheryl; Batkin, Izmail; McIntyre, Lauralyn; Sundaresan, Sudhir R.; Maziak, Donna E.; Shamji, Farid M.; Hebert, Paul; Fergusson, Dean; Tinmouth, Alan; Seely, Andrew J. E.			Continuous Multi-Parameter Heart Rate Variability Analysis Heralds Onset of Sepsis in Adults	PLOS ONE			English	Article							ORGAN DYSFUNCTION SYNDROME; GOAL-DIRECTED THERAPY; SPECTRAL-ANALYSIS; SEPTIC SHOCK; NEUTROPENIA; INFECTION	Background: Early diagnosis of sepsis enables timely resuscitation and antibiotics and prevents subsequent morbidity and mortality. Clinical approaches relying on point-in-time analysis of vital signs or lab values are often insensitive, non-specific and late diagnostic markers of sepsis. Exploring otherwise hidden information within intervals-in-time, heart rate variability (HRV) has been documented to be both altered in the presence of sepsis, and correlated with its severity. We hypothesized that by continuously tracking individual patient HRV over time in patients as they develop sepsis, we would demonstrate reduced HRV in association with the onset of sepsis. Methodology/Principal Findings: We monitored heart rate continuously in adult bone marrow transplant (BMT) patients (n = 21) beginning a day before their BMT and continuing until recovery or withdrawal (1264 days). We characterized HRV continuously over time with a panel of time, frequency, complexity, and scale-invariant domain techniques. We defined baseline HRV as mean variability for the first 24 h of monitoring and studied individual and population average percentage change (from baseline) over time in diverse HRV metrics, in comparison with the time of clinical diagnosis and treatment of sepsis (defined as systemic inflammatory response syndrome along with clinically suspected infection requiring treatment). Of the 21 patients enrolled, 4 patients withdrew, leaving 17 patients who completed the study. Fourteen patients developed sepsis requiring antibiotic therapy, whereas 3 did not. On average, for 12 out of 14 infected patients, a significant (25%) reduction prior to the clinical diagnosis and treatment of sepsis was observed in standard deviation, root mean square successive difference, sample and multiscale entropy, fast Fourier transform, detrended fluctuation analysis, and wavelet variability metrics. For infected patients (n = 14), wavelet HRV demonstrated a 25% drop from baseline 35 h prior to sepsis on average. For 3 out of 3 non-infected patients, all measures, except root mean square successive difference and entropy, showed no significant reduction. Significant correlation was present amongst these HRV metrics for the entire population. Conclusions/Significance: Continuous HRV monitoring is feasible in ambulatory patients, demonstrates significant HRV alteration in individual patients in association with, and prior to clinical diagnosis and treatment of sepsis, and merits further investigation as a means of providing early warning of sepsis.	[Ahmad, Saif; Ramsay, Tim; Flanagan, Sarah; Batkin, Izmail; McIntyre, Lauralyn; Hebert, Paul; Fergusson, Dean; Tinmouth, Alan; Seely, Andrew J. E.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Sundaresan, Sudhir R.; Maziak, Donna E.; Shamji, Farid M.; Seely, Andrew J. E.] Univ Ottawa, Div Thorac Surg, Ottawa, ON, Canada; [Huebsch, Lothar; McDiarmid, Sheryl; Tinmouth, Alan] Univ Ottawa, Dept Clin Hematol, Ottawa, ON, Canada; [McIntyre, Lauralyn; Hebert, Paul; Seely, Andrew J. E.] Univ Ottawa, Dept Crit Care Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Ahmad, S (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	aseely@ottawahospital.on.ca	McIntyre, Lauralyn/AAR-7710-2021	McIntyre, Lauralyn/0000-0001-7421-1407; Ramsay, Tim/0000-0001-8478-8170; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research (CIHR); Ottawa Hospital Research Institute (OHRI); University of Ottawa Department of Critical Care	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ottawa Hospital Research Institute (OHRI); University of Ottawa Department of Critical Care	We gratefully acknowledge support from the Canadian Institutes of Health Research (CIHR), the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa Department of Critical Care for their support of this research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Barnaby D, 2002, ACAD EMERG MED, V9, P661, DOI 10.1111/j.1553-2712.2002.tb02143.x; Cao HQ, 2004, ANN BIOMED ENG, V32, P233, DOI 10.1023/B:ABME.0000012743.81754.0b; Celebi H, 2000, BONE MARROW TRANSPL, V26, P211, DOI 10.1038/sj.bmt.1702503; Chen WL, 2008, AM J EMERG MED, V26, P395, DOI 10.1016/j.ajem.2007.06.016; Clifford G, 2006, ADV METHODS TOOLS EC; Ellenby MS, 2001, SHOCK, V16, P274, DOI 10.1097/00024382-200116040-00007; Garrard C S, 1993, Clin Auton Res, V3, P5, DOI 10.1007/BF01819137; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Griffin MP, 2005, PEDIATRICS, V116, P1070, DOI 10.1542/peds.2004-2461; Korach M, 2001, CRIT CARE MED, V29, P1380, DOI 10.1097/00003246-200107000-00013; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lalami Y, 2006, ANN ONCOL, V17, P507, DOI 10.1093/annonc/mdj092; Lin MT, 2006, J CRIT CARE, V21, P280, DOI 10.1016/j.jcrc.2006.02.005; Low PA, 2004, DIABETES CARE, V27, P2942, DOI 10.2337/diacare.27.12.2942; Marik PE, 2001, DM-DIS MON, V47, P465, DOI 10.1067/mda.2001.119745; Neth OW, 2005, BRIT J HAEMATOL, V129, P713, DOI 10.1111/j.1365-2141.2005.05462.x; Otero RM, 2006, CHEST, V130, P1579, DOI 10.1378/chest.130.5.1579; PIEPOLI M, 1995, INTENS CARE MED, V21, P112, DOI 10.1007/BF01726532; Pontet J, 2003, J CRIT CARE, V18, P156, DOI 10.1016/j.jcrc.2003.08.005; Regazzoni CJ, 2003, INTENS CARE MED, V29, P135, DOI 10.1007/s00134-002-1560-7; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Seely AJE, 2000, CRIT CARE MED, V28, P2193, DOI 10.1097/00003246-200007000-00003; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Toyry JP, 1997, CIRCULATION, V96, P1185, DOI 10.1161/01.CIR.96.4.1185	27	143	147	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6642	10.1371/journal.pone.0006642	http://dx.doi.org/10.1371/journal.pone.0006642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680545	Green Submitted, Green Published, gold			2022-12-25	WOS:000268936200008
J	Feng, Y; Johansson, J; Shao, RJ; Manneras, L; Fernandez-Rodriguez, J; Billig, H; Stener-Victorin, E				Feng, Yi; Johansson, Julia; Shao, Ruijin; Manneras, Louise; Fernandez-Rodriguez, Julia; Billig, Hakan; Stener-Victorin, Elisabet			Hypothalamic Neuroendocrine Functions in Rats with Dihydrotestosterone-Induced Polycystic Ovary Syndrome: Effects of Low-Frequency Electro-Acupuncture	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; CORTICOTROPIN-RELEASING-FACTOR; BLOOD-FLOW RESPONSES; ANDROGEN REGULATION; GENE-EXPRESSION; ADIPOSE-TISSUE; HORMONE; ACUPUNCTURE; NEURONS; STIMULATION	Adult female rats continuously exposed to androgens from prepuberty have reproductive and metabolic features of polycystic ovary syndrome (PCOS). We investigated whether such exposure adversely affects estrous cyclicity and the expression and distribution of gonadotropin-releasing hormone (GnRH), GnRH receptors, and corticotrophin-releasing hormone (CRH) in the hypothalamus and whether the effects are mediated by the androgen receptor (AR). We also assessed the effect of low-frequency electro-acupuncture (EA) on those variables. At 21 days of age, rats were randomly divided into three groups (control, PCOS, and PCOS EA; n = 12/group) and implanted subcutaneously with 90-day continuous-release pellets containing vehicle or 5 alpha-dihydrostestosterone (DHT). From age 70 days, PCOS EA rats received 2-Hz EA (evoking muscle twitches) five times/week for 4-5 weeks. Hypothalamic protein expression was measured by immunohistochemistry and western blot. DHT-treated rats were acyclic, but controls had regular estrous cycles. In PCOS rats, hypothalamic medial preoptic AR protein expression and the number of AR- and GnRH-immunoreactive cells were increased, but CRH was not affected; however, GnRH receptor expression was decreased in both the pituitary and hypothalamus. Low-frequency EA restored estrous cyclicity within 1 week and reduced the elevated hypothalamic GnRH and AR expression levels. EA did not affect GnRH receptor or CRH expression. Interestingly, nuclear AR co-localized with GnRH in the hypothalamus. Thus, rats with DHT-induced PCOS have disrupted estrous cyclicity and an increased number of hypothalamic cells expressing GnRH, most likely mediated by AR activation. Repeated low-frequency EA normalized estrous cyclicity and restored GnRH and AR protein expression. These results may help explain the beneficial neuroendocrine effects of low-frequency EA in women with PCOS.	[Feng, Yi; Johansson, Julia; Shao, Ruijin; Manneras, Louise; Billig, Hakan; Stener-Victorin, Elisabet] Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Feng, Yi] Fudan Univ, Dept Neurobiol & Integrat Med, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Fernandez-Rodriguez, Julia] Univ Gothenburg, Ctr Cellular Imaging, Core Facil, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Fudan University; University of Gothenburg	Feng, Y (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	elisabet.stener-victorin@neuro.gu.se	Shao, Linus R/M-3134-2019; Billig, Hakan/E-8891-2011; Stener-Victorin, Elisabet/W-6322-2018; Shao, Linus R/M-3059-2019	Shao, Linus R/0000-0002-1339-9570; Billig, Hakan/0000-0001-6140-9182; Stener-Victorin, Elisabet/0000-0002-3424-1502; Shao, Linus R/0000-0002-1339-9570; Fernandez-Rodriguez, Julia/0000-0003-4522-0966; Feng, Yi/0000-0002-7156-6023	Swedish Medical Research Council [2008-72VP-15445-01A]; Novo Nordisk Foundation; Wilhelm and Martina Lundgren's Science Fund; Hjalmar Svensson Foundation; Tore Nilson Foundation; Ake Wiberg Foundation; Adlerbert Research Foundation; Ekhaga Foundation; Swedish federal government [ALFFGBG-10984]; Regional Research and Development agreement [VGFOUREG-5171, VGFOUREG-11296, VGFOUREG-7861]; Chinese Special Fund for Postdoctorial studies [200801170]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Wilhelm and Martina Lundgren's Science Fund; Hjalmar Svensson Foundation; Tore Nilson Foundation; Ake Wiberg Foundation; Adlerbert Research Foundation; Ekhaga Foundation; Swedish federal government; Regional Research and Development agreement; Chinese Special Fund for Postdoctorial studies	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by grants from the Swedish Medical Research Council (Project No. 2008-72VP-15445-01A); Novo Nordisk Foundation; Wilhelm and Martina Lundgren's Science Fund; Hjalmar Svensson Foundation; Tore Nilson Foundation; Ake Wiberg Foundation; Adlerbert Research Foundation; Ekhaga Foundation; Swedish federal government under the letters of understanding agreement of Medical Education (ALFFGBG-10984) and Regional Research and Development agreement (VGFOUREG-5171, 11296 and 7861), and Chinese Special Fund for Postdoctorial studies (No. 200801170).	Ahmed MI, 2008, HUM REPROD, V23, P2564, DOI 10.1093/humrep/den273; Azziz R, 1998, J CLIN ENDOCR METAB, V83, P2317, DOI 10.1210/jc.83.7.2317; Barontini M, 2001, ARCH MED RES, V32, P544, DOI 10.1016/S0188-4409(01)00325-3; Blank SK, 2006, HUM REPROD UPDATE, V12, P351, DOI 10.1093/humupd/dml017; CHEN BY, 1992, ACUPUNCTURE ELECTRO, V17, P15, DOI 10.3727/036012992816357846; CUMMING DC, 1984, CLIN ENDOCRINOL, V20, P643, DOI 10.1111/j.1365-2265.1984.tb00114.x; Dronavalli S, 2007, CLIN OBSTET GYNECOL, V50, P244, DOI 10.1097/GRF.0b013e31802f35a0; Foecking EM, 2008, HORM BEHAV, V53, P673, DOI 10.1016/j.yhbeh.2007.12.013; Foecking EM, 2005, BIOL REPROD, V72, P1475, DOI 10.1095/biolreprod.105.039800; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Handa RJ, 2008, HORM BEHAV, V53, P741, DOI 10.1016/j.yhbeh.2007.09.012; Hayes FJ, 1998, J CLIN ENDOCR METAB, V83, P2343, DOI 10.1210/jc.83.7.2343; HERBISON AE, 1992, NEUROSCIENCE, V50, P283, DOI 10.1016/0306-4522(92)90423-Y; HERBISON AE, 1995, NEUROENDOCRINOLOGY, V61, P1, DOI 10.1159/000126810; Hu YC, 2004, P NATL ACAD SCI USA, V101, P11209, DOI 10.1073/pnas.0404372101; Kagitani F, 2005, JPN J PHYSIOL, V55, P149, DOI 10.2170/jjphysiol.R2120; Kallo I, 2001, J NEUROENDOCRINOL, V13, P741, DOI 10.1046/j.1365-2826.2001.00708.x; LANZONE A, 1995, FERTIL STERIL, V63, P1195, DOI 10.1016/S0015-0282(16)57596-7; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; MANN JJ, 2005, INT J NEUROPSYCHOPH, V21, P1; Manneras L, 2008, ENDOCRINOLOGY, V149, P3559, DOI 10.1210/en.2008-0053; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Manneras L, 2009, AM J PHYSIOL-REG I, V296, pR1124, DOI 10.1152/ajpregu.90947.2008; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Naftolin F, 2007, REPROD SCI, V14, P101, DOI 10.1177/1933719107301059; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Patisaul HB, 1999, MOL BRAIN RES, V67, P165, DOI 10.1016/S0169-328X(99)00058-3; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; RIVEST S, 1995, ENDOCR REV, V16, P177, DOI 10.1210/er.16.2.177; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Shao RJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE604, DOI 10.1152/ajpendo.00350.2006; Shao RJ, 2006, J ENDOCRINOL, V190, P857, DOI 10.1677/joe.1.06896; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHIVERS BD, 1983, NATURE, V304, P345, DOI 10.1038/304345a0; Shughrue PJ, 1996, STEROIDS, V61, P678, DOI 10.1016/S0039-128X(96)00222-X; Silverman Ann-Judith, 1994, P1683; Skynner MJ, 1999, ENDOCRINOLOGY, V140, P5195, DOI 10.1210/en.140.11.5195; Steckler TL, 2009, ENDOCRINOLOGY, V150, P1456, DOI 10.1210/en.2008-1256; Stener-Victorin E, 2008, J NEUROENDOCRINOL, V20, P290, DOI 10.1111/j.1365-2826.2007.01634.x; Stener-Victorin E, 2000, BIOL REPROD, V63, P1497, DOI 10.1095/biolreprod63.5.1497; Stener-Victorin E, 2004, BIOL REPROD, V70, P329, DOI 10.1095/biolreprod.103.022368; Stener-Victorin E, 2003, AUTON NEUROSCI-BASIC, V108, P50, DOI 10.1016/j.autneu.2003.08.006; Stener-Victorin E, 2000, ACTA OBSTET GYN SCAN, V79, P180, DOI 10.1034/j.1600-0412.2000.079003180.x; Stener-Victorin E, 2001, NEUROPEPTIDES, V35, P227, DOI 10.1054/npep.2002.0878; Stener-Victorin E, 2006, J APPL PHYSIOL, V101, P84, DOI 10.1152/japplphysiol.01593.2005; Stener-Victorin Elisabet, 2003, Reprod Biol Endocrinol, V1, P33, DOI 10.1186/1477-7827-1-33; Stengl V, 2004, CENT EUR J CHEM, V2, P16, DOI 10.2478/BF02476182; Walters KA, 2008, BIOL REPROD, V78, P380, DOI 10.1095/biolreprod.107.064089; Witkin JW, 1999, MICROSC RES TECHNIQ, V44, P11, DOI 10.1002/(SICI)1097-0029(19990101)44:1<11::AID-JEMT3>3.0.CO;2-W; Wu TJ, 1997, J NEUROBIOL, V33, P983, DOI 10.1002/(SICI)1097-4695(199712)33:7<983::AID-NEU9>3.0.CO;2-4	50	43	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6638	10.1371/journal.pone.0006638	http://dx.doi.org/10.1371/journal.pone.0006638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680559	gold, Green Published, Green Submitted			2022-12-25	WOS:000268936200005
J	Ritsema, T; Brodmann, D; Diks, SH; Bos, CL; Nagaraj, V; Pieterse, CMJ; Boller, T; Wiemken, A; Peppelenbosch, MP				Ritsema, Tita; Brodmann, David; Diks, Sander H.; Bos, Carina L.; Nagaraj, Vinay; Pieterse, Corne M. J.; Boller, Thomas; Wiemken, Andres; Peppelenbosch, Maikel P.			Are Small GTPases Signal Hubs in Sugar-Mediated Induction of Fructan Biosynthesis?	PLOS ONE			English	Article							SERINE/THREONINE/TYROSINE PROTEIN-KINASE; SUCROSE-BINDING BOX; ARABIDOPSIS-THALIANA; BARLEY LEAVES; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; PHORBOL ESTERS; CELL-CYCLE; PLANTS; LIGHT	External sugar initiates biosynthesis of the reserve carbohydrate fructan, but the molecular processes mediating this response remain obscure. Previously it was shown that a phosphatase and a general kinase inhibitor hamper fructan accumulation. We use various phosphorylation inhibitors both in barley and in Arabidopsis and show that the expression of fructan biosynthetic genes is dependent on PP2A and different kinases such as Tyr-kinases and PI3-kinases. To further characterize the phosphorylation events involved, comprehensive analysis of kinase activities in the cell was performed using a PepChip, an array of >1000 kinase consensus substrate peptide substrates spotted on a chip. Comparison of kinase activities in sugar-stimulated and mock(sorbitol)-treated Arabidopsis demonstrates the altered phosphorylation of many consensus substrates and documents the differences in plant kinase activity upon sucrose feeding. The different phosphorylation profiles obtained are consistent with sugar-mediated alterations in Tyr phosphorylation, cell cycling, and phosphoinositide signaling, and indicate cytoskeletal rearrangements. The results lead us to infer a central role for small GTPases in sugar signaling.	[Ritsema, Tita; Brodmann, David; Nagaraj, Vinay; Boller, Thomas; Wiemken, Andres] Univ Basel, Inst Bot, Zurich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; [Ritsema, Tita; Pieterse, Corne M. J.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Diks, Sander H.; Bos, Carina L.; Peppelenbosch, Maikel P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands	University of Basel; Utrecht University; University of Groningen	Ritsema, T (corresponding author), Univ Basel, Inst Bot, Zurich Basel Plant Sci Ctr, Hebelstr 1, CH-4056 Basel, Switzerland.	M.P.Peppelenbosch@med.umcg.nl	Pieterse, Corné/A-9326-2011; Boller, Thomas/G-3500-2012	Pieterse, Corné/0000-0002-5473-4646; Boller, Thomas/0000-0001-6768-7503; Peppelenbosch, Maikel/0000-0001-9112-6028	Swiss Science Foundation; Top Institute Pharma [3.3]	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Top Institute Pharma	The authors are grateful for the support of the Swiss Science Foundation (TR, DB, VN), NWO VICI (CMJP, TR) and the Top Institute Pharma grant 3.3 (MPP, TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	ALI N, 1994, J BIOL CHEM, V269, P31626; Allada R, 2005, MOL CELL BIOCHEM, V274, P141, DOI 10.1007/s11010-005-2943-1; Barizza E, 1999, FEBS LETT, V447, P191, DOI 10.1016/S0014-5793(99)00272-0; Berken A, 2005, NATURE, V436, P1176, DOI 10.1038/nature03883; Bloch D, 2005, MOL BIOL CELL, V16, P1913, DOI 10.1091/mbc.E04-07-0562; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Diks SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000777; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Forsberg J, 2001, PHOTOSYNTH RES, V68, P71, DOI 10.1023/A:1011891017067; Francis D, 2006, PLANT MOL BIOL, V60, P981, DOI 10.1007/s11103-005-5749-3; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Habas R, 2007, CURR BIOL, V17, pR474, DOI 10.1016/j.cub.2007.04.020; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Homma MK, 2005, MOL CELL BIOCHEM, V274, P47, DOI 10.1007/s11010-005-3111-3; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Kelly-Skupek MN, 2006, PLANT PHYSIOL BIOCH, V44, P132, DOI 10.1016/j.plaphy.2006.03.004; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; Kudinov Y, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-4; Li X, 2006, ENDOCRINOLOGY, V147, P5236, DOI 10.1210/en.2006-0779; MacRobbie EAC, 2002, P NATL ACAD SCI USA, V99, P11963, DOI 10.1073/pnas.172360399; Martinez-Noel G, 2007, PLANT PHYSIOL BIOCH, V45, P410, DOI 10.1016/j.plaphy.2007.03.004; Martinez-Noel G, 2006, PLANTA, V225, P183, DOI 10.1007/s00425-006-0339-4; Mayrose M, 2004, J BIOL CHEM, V279, P14819, DOI 10.1074/jbc.M313388200; Menges M, 2006, PLANT CELL, V18, P893, DOI 10.1105/tpc.105.039636; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Muller J, 2000, PLANT PHYSIOL, V123, P265, DOI 10.1104/pp.123.1.265; Nagaraj VJ, 2001, J PLANT PHYSIOL, V158, P1601, DOI 10.1078/0176-1617-00592; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Noel GM, 2001, PLANTA, V213, P640, DOI 10.1007/s004250100550; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Parikh Kaushal, 2009, V527, P269, DOI 10.1007/978-1-60327-834-8_20; Peppelenbosch MP, 1996, J BIOL CHEM, V271, P7883, DOI 10.1074/jbc.271.14.7883; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Reddy MM, 2007, ARCH BIOCHEM BIOPHYS, V460, P122, DOI 10.1016/j.abb.2007.01.003; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riou-Khamlichi C, 2000, MOL CELL BIOL, V20, P4513, DOI 10.1128/MCB.20.13.4513-4521.2000; Ritsema T, 2005, PLANT MOL BIOL, V58, P597, DOI 10.1007/s11103-005-6504-5; Ritsema T, 2003, J PLANT PHYSIOL, V160, P811, DOI 10.1078/0176-1617-01029; Ritsema T, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-3; Ritsema T, 2006, PLANT J, V48, P228, DOI 10.1111/j.1365-313X.2006.02862.x; Rudrabhatla P, 2004, BIOCHEMISTRY-US, V43, P12123, DOI 10.1021/bi0497042; Rudrabhatla P, 2002, PLANT PHYSIOL, V130, P380, DOI 10.1104/pp.005173; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Shichrur K, 2006, TRENDS PLANT SCI, V11, P57, DOI 10.1016/j.tplants.2005.12.001; Shimotohno A, 2006, PLANT J, V47, P701, DOI 10.1111/j.1365-313X.2006.02820.x; SIMMEN U, 1993, PLANT PHYSIOL, V101, P459, DOI 10.1104/pp.101.2.459; Turck F, 2004, PLANT PHYSIOL, V134, P1527, DOI 10.1104/pp.103.035873; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang CW, 2000, PLANTA, V211, P701, DOI 10.1007/s004250000335; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wei JZ, 2002, J PLANT PHYSIOL, V159, P705, DOI 10.1078/0176-1617-0781; Weyens G, 2004, PLANT BIOTECHNOL J, V2, P321, DOI 10.1111/j.1467-7652.2004.00074.x; WOLF M, 1988, BIOCHEM BIOPH RES CO, V154, P1273, DOI 10.1016/0006-291X(88)90277-X; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; YANAGIHARA N, 1991, J NEUROCHEM, V56, P294, DOI 10.1111/j.1471-4159.1991.tb02595.x; Ying G, 2004, CURR OPIN PLANT BIOL, V7, P527, DOI 10.1016/j.pbi.2004.07.006	63	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6605	10.1371/journal.pone.0006605	http://dx.doi.org/10.1371/journal.pone.0006605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672308	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900016
J	Palsgaard, J; Brons, C; Friedrichsen, M; Dominguez, H; Jensen, M; Storgaard, H; Spohr, C; Torp-Pedersen, C; Borup, R; De Meyts, P; Vaag, A				Palsgaard, Jane; Brons, Charlotte; Friedrichsen, Martin; Dominguez, Helena; Jensen, Maja; Storgaard, Heidi; Spohr, Camilla; Torp-Pedersen, Christian; Borup, Rehannah; De Meyts, Pierre; Vaag, Allan			Gene Expression in Skeletal Muscle Biopsies from People with Type 2 Diabetes and Relatives: Differential Regulation of Insulin Signaling Pathways	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; 1ST-DEGREE RELATIVES; HEXOKINASE II; DEFECTS; TRANSDUCTION; RESISTANCE; TRANSPORT; PROFILE; LOCI	Background: Gene expression alterations have previously been associated with type 2 diabetes, however whether these changes are primary causes or secondary effects of type 2 diabetes is not known. As healthy first degree relatives of people with type 2 diabetes have an increased risk of developing type 2 diabetes, they provide a good model in the search for primary causes of the disease. Methods/Principal Findings: We determined gene expression profiles in skeletal muscle biopsies from Caucasian males with type 2 diabetes, healthy first degree relatives, and healthy controls. Gene expression was measured using Affymetrix Human Genome U133 Plus 2.0 Arrays covering the entire human genome. These arrays have not previously been used for this type of study. We show for the first time that genes involved in insulin signaling are significantly upregulated in first degree relatives and significantly downregulated in people with type 2 diabetes. On the individual gene level, 11 genes showed altered expression levels in first degree relatives compared to controls, among others KIF1B and GDF8 ( myostatin). LDHB was found to have a decreased expression in both groups compared to controls. Conclusions/Significance: We hypothesize that increased expression of insulin signaling molecules in first degree relatives of people with type 2 diabetes, work in concert with increased levels of insulin as a compensatory mechanism, counteracting otherwise reduced insulin signaling activity, protecting these individuals from severe insulin resistance. This compensation is lost in people with type 2 diabetes where expression of insulin signaling molecules is reduced.	[Palsgaard, Jane; Jensen, Maja; De Meyts, Pierre] Novo Nordisk AS, Receptor Syst Biol Lab, Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Brons, Charlotte; Friedrichsen, Martin; Dominguez, Helena; Storgaard, Heidi; Spohr, Camilla; Torp-Pedersen, Christian; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Borup, Rehannah] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; Rigshospitalet; University of Copenhagen	Palsgaard, J (corresponding author), Novo Nordisk AS, Receptor Syst Biol Lab, Hagedorn Res Inst, DK-2820 Gentofte, Denmark.	JPAG@novonordisk.com	Torp-Pedersen, Christian/E-5931-2013; Friedrichsen, Martin/A-3638-2015; DOMINGUEZ, Helena/ABC-1905-2021	Friedrichsen, Martin/0000-0003-3383-9593; DOMINGUEZ, Helena/0000-0002-7089-2636; Storgaard, Heidi/0000-0003-1177-2658; Brons, Charlotte/0000-0002-6653-9020; De Meyts, Pierre/0000-0001-6214-0824; Vaag, Allan Arthur/0000-0002-3690-2191	Danish Diabetesforeningen; Danish Ministry of Science, Technology, and Innovation	Danish Diabetesforeningen; Danish Ministry of Science, Technology, and Innovation	This project was supported by a grant from the Danish Diabetesforeningen (Diabetes Association) to Pierre De Meyts. Jane Palsgaard was the recipient of an Industrial PhD scholarship from the Danish Ministry of Science, Technology, and Innovation. The Hagedorn Research Institute is an independent research component of Novo Nordisk A/S. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding does not alter adherence to all PLoSONE policies on sharing data and materials.	Barazzoni R, 2004, CLIN NUTR, V23, P1413, DOI 10.1016/j.clnu.2004.06.007; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; DEMEYTS P, 1993, ADV EXP MED BIOL, V334, P89; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Elbein S C, 2000, Diabetes Technol Ther, V2, P391, DOI 10.1089/15209150050194260; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gray ST, 2005, DIABETES-METAB RES, V21, P416, DOI 10.1002/dmrr.559; Hansen L, 2004, BIOCHEM BIOPH RES CO, V323, P685, DOI 10.1016/j.bbrc.2004.08.146; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson S, 2000, DIABETES, V49, P1169, DOI 10.2337/diabetes.49.7.1169; JAFARMOHAMMADI B, 2007, ANN MED, V1; Joulia-Ekaza D, 2007, CURR OPIN PHARMACOL, V7, P310, DOI 10.1016/j.coph.2006.11.011; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; McIntyre EA, 2002, CLIN ENDOCRINOL, V57, P303, DOI 10.1046/j.1365-2265.2002.01610.x; Mercado Maria M, 2002, Curr Diab Rep, V2, P83, DOI 10.1007/s11892-002-0063-9; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pendergrass M, 1998, DIABETES, V47, P387, DOI 10.2337/diabetes.47.3.387; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Thompson DB, 1996, J CLIN INVEST, V98, P2346, DOI 10.1172/JCI119046; Tsuchida Kunihiro, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P157, DOI 10.2174/1568008043339901; VAAG A, 1992, J CLIN INVEST, V89, P782, DOI 10.1172/JCI115656; Vestergaard H, 1995, J CLIN INVEST, V96, P2639, DOI 10.1172/JCI118329; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zierath JR, 2002, ANN NY ACAD SCI, V967, P120	36	72	75	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6575	10.1371/journal.pone.0006575	http://dx.doi.org/10.1371/journal.pone.0006575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668377	Green Submitted, Green Published, gold			2022-12-25	WOS:000268935600005
J	Houben, ML; Nikkels, PGJ; van Bleek, GM; Visser, GHA; Rovers, MM; Kessel, H; de Waal, WJ; Schuijff, L; Evers, A; Kimpen, JLL; Bont, L				Houben, Michiel L.; Nikkels, Peter G. J.; van Bleek, Grada M.; Visser, Gerard H. A.; Rovers, Maroeska M.; Kessel, Hilda; de Waal, Wouter J.; Schuijff, Leontine; Evers, Annemiek; Kimpen, Jan L. L.; Bont, Louis			The Association between Intrauterine Inflammation and Spontaneous Vaginal Delivery at Term: A Cross-Sectional Study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; AMNIOTIC-FLUID; MICROBIAL INVASION; PRETERM DELIVERY; LUNG-FUNCTION; LABOR; INFECTION; CYTOKINES; PREVALENCE; VILLITIS	Background: Different factors contribute to the onset of labor at term. In animal models onset of labor is characterized by an inflammatory response. The role of intrauterine inflammation, although implicated in preterm birth, is not yet established in human term labor. We hypothesized that intrauterine inflammation at term is associated with spontaneous onset of labor. Methods/Results: In two large urban hospitals in the Netherlands, a cross-sectional study of spontaneous onset term vaginal deliveries and elective caesarean sections (CS), without signs of labor, was carried out. Placentas and amniotic fluid samples were collected during labor and/or at delivery. Histological signs of placenta inflammation were determined. Amniotic fluid proinflammatory cytokine concentrations were measured using ELISA. A total of 375 women were included. In term vaginal deliveries, more signs of intrauterine inflammation were found than in elective CS: the prevalence of chorioamnionitis was higher (18 vs 4%, p = 0.02) and amniotic fluid concentration of IL-6 was higher (3.1 vs 0.37 ng/mL, p<0.001). Similar results were obtained for IL-8 (10.93 vs 0.96 ng/mL, p<0.001) and percentage of detectable TNF-alpha (50 vs 4%, p<0.001). Conclusions: This large cross-sectional study shows that spontaneous term delivery is characterized by histopathological signs of placenta inflammation and increased amniotic fluid proinflammatory cytokines.			Houben, ML (corresponding author), Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands.	L.J.Bont@umcutrecht.nl	Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X				Becroft DM, 2005, AM J OBSTET GYNECOL, V192, P264, DOI 10.1016/j.ajog.2004.06.062; Boog G, 2008, EUR J OBSTET GYN R B, V136, P9, DOI 10.1016/j.ejogrb.2007.06.018; BRY K, 1993, AM J OBSTET GYNECOL, V168, P1318, DOI 10.1016/0002-9378(93)90388-Y; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; de Laat MWM, 2007, PEDIATR DEVEL PATHOL, V10, P293, DOI 10.2350/06-01-0015.1; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Hitti J, 2001, OBSTET GYNECOL, V98, P1080, DOI 10.1016/S0029-7844(01)01567-8; Holst RM, 2007, J MATERN-FETAL NEO M, V20, P885, DOI 10.1080/14767050701752601; Keelan JA, 1999, AM J OBSTET GYNECOL, V181, P1530, DOI 10.1016/S0002-9378(99)70400-X; LIGGINS GC, 1989, BIOL NEONATE, V55, P366, DOI 10.1159/000242940; Lopez R, 2003, MANUSCRIPTA MATH, V110, P45, DOI 10.1007/s00229-002-0302-z; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; MacKenzie IZ, 2006, REPRODUCTION, V131, P989, DOI 10.1530/rep.1.00709; MARTINEZ FD, 1988, NEW ENGL J MED, V319, P1112, DOI 10.1056/NEJM198810273191702; Maul H, 2006, CLIN OBSTET GYNECOL, V49, P551, DOI 10.1097/00003081-200609000-00015; Maxwell NC, 2006, CURR OPIN INFECT DIS, V19, P253, DOI 10.1097/01.qco.0000224819.42729.2e; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508; Redline RW, 2007, HUM PATHOL, V38, P1439, DOI 10.1016/j.humpath.2007.05.025; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P129, DOI 10.1016/0002-9378(92)91845-2; ROMERO R, 1993, J REPROD MED, V38, P543; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P969, DOI 10.1016/0002-9378(91)90450-6; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Rusconi F, 2007, AM J RESP CRIT CARE, V175, P16, DOI 10.1164/rccm.200512-1978OC; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Schmidt B, 2001, AM J OBSTET GYNECOL, V185, P173, DOI 10.1067/mob.2001.13321; Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Waldorf KMA, 2008, REPROD SCI, V15, P121, DOI 10.1177/1933719107310992; Winkler M, 2003, BJOG-INT J OBSTET GY, V110, P118, DOI 10.1016/S1470-0328(03)00062-4; Yoon B H, 2003, J Matern Fetal Neonatal Med, V13, P32, DOI 10.1080/jmf.13.1.32.38; Zeitlin J, 2007, BJOG-INT J OBSTET GY, V114, P1097, DOI 10.1111/j.1471-0528.2007.01328.x	39	55	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6572	10.1371/journal.pone.0006572	http://dx.doi.org/10.1371/journal.pone.0006572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668329	Green Published, gold, Green Submitted			2022-12-25	WOS:000268773300013
J	Prakash, H; Becker, D; Bohme, L; Albert, L; Witzenrath, M; Rosseau, S; Meyer, TF; Rudel, T				Prakash, Hridayesh; Becker, Daniel; Boehme, Linda; Albert, Lori; Witzenrath, Martin; Rosseau, Simone; Meyer, Thomas F.; Rudel, Thomas			cIAP-1 Controls Innate Immunity to C. pneumoniae Pulmonary Infection	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED CELL-DEATH; CHLAMYDIA-PNEUMONIAE; NITRIC-OXIDE; CHLAMYDOPHILA-PNEUMONIAE; ALVEOLAR MACROPHAGES; APOPTOSIS PROTEINS; ENDOTHELIAL-CELLS; INHIBITOR; NECROSIS	The resistance of epithelial cells infected with Chlamydophila pneumoniae for apoptosis has been attributed to the induced expression and increased stability of anti-apoptotic proteins called inhibitor of apoptosis proteins (IAPs). The significance of cellular inhibitor of apoptosis protein-1 (cIAP-1) in C. pneumoniae pulmonary infection and innate immune response was investigated in cIAP-1 knockout (KO) mice using a novel non-invasive intra-tracheal infection method. In contrast to wildtype, cIAP-1 knockout mice failed to clear the infection from their lungs. Wildtype mice responded to infection with a strong inflammatory response in the lung. In contrast, the recruitment of macrophages was reduced in cIAP-1 KO mice compared to wildtype mice. The concentration of Interferon gamma (IFN-gamma) was increased whereas that of Tumor Necrosis Factor (TNF-alpha) was reduced in the lungs of infected cIAP-1 KO mice compared to infected wildtype mice. Ex vivo experiments on mouse peritoneal macrophages and splenocytes revealed that cIAP-1 is required for innate immune responses of these cells. Our findings thus suggest a new immunoregulatory role of cIAP-1 in the course of bacterial infection.			Prakash, H (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Charitepl 1, Berlin, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Rosseau, Simone/AAO-1201-2020; Hridayesh, Prakash/W-9478-2019; Meyer, Thomas F. F/J-2485-2013	Hridayesh, Prakash/0000-0001-5269-2481; Meyer, Thomas F. F/0000-0002-6120-8679				AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Airenne S, 1999, INFECT IMMUN, V67, P1445, DOI 10.1128/IAI.67.3.1445-1449.1999; Appelberg R, 2006, J LEUKOCYTE BIOL, V79, P1117, DOI 10.1189/jlb.0206079; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boise LH, 2001, TRENDS MICROBIOL, V9, P64, DOI 10.1016/S0966-842X(00)01937-5; Carratelli CR, 2005, CAN J MICROBIOL, V51, P941, DOI 10.1139/w05-080; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chen BJ, 1996, FEMS IMMUNOL MED MIC, V14, P109, DOI 10.1016/0928-8244(96)00018-1; CHEN WJ, 1980, AM J PATHOL, V100, P365; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Cochrane M, 2005, PATHOLOGY, V37, P69, DOI 10.1080/00313020400011284; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Currier AR, 2000, J INTERF CYTOK RES, V20, P369, DOI 10.1089/107999000312306; da Costa CP, 2002, EUR J IMMUNOL, V32, P2460, DOI 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dockrell DH, 2003, J IMMUNOL, V171, P5380, DOI 10.4049/jimmunol.171.10.5380; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Feihl F, 2001, PHARMACOL THERAPEUT, V91, P179, DOI 10.1016/S0163-7258(01)00155-3; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Gaydos CA, 1996, INFECT IMMUN, V64, P1614, DOI 10.1128/IAI.64.5.1614-1620.1996; Haranaga S, 2003, J INFECT DIS, V187, P1107, DOI 10.1086/368168; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Heinemann M, 1996, INFECT IMMUN, V64, P4872, DOI 10.1128/IAI.64.11.4872-4875.1996; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KAMIJO R, 1993, P NATL ACAD SCI USA, V90, P6626, DOI 10.1073/pnas.90.14.6626; KILBOURN RG, 1990, P NATL ACAD SCI USA, V87, P3629, DOI 10.1073/pnas.87.9.3629; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; LY IA, 1974, J IMMUNOL METHODS, V5, P239, DOI 10.1016/0022-1759(74)90108-2; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Molestina RE, 1999, INFECT IMMUN, V67, P1323, DOI 10.1128/IAI.67.3.1323-1330.1999; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; Paland N, 2008, J BIOL CHEM, V283, P6438, DOI 10.1074/jbc.M708422200; Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Redecke V, 1998, AM J RESP CELL MOL, V19, P721, DOI 10.1165/ajrcmb.19.5.3072; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Thiemermann C, 2001, CRIT CARE MED, V29, P223, DOI 10.1097/00003246-200101000-00055; Topley N, 1996, IMMUNOBIOLOGY, V195, P563, DOI 10.1016/S0171-2985(96)80022-2; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030	52	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6519	10.1371/journal.pone.0006519	http://dx.doi.org/10.1371/journal.pone.0006519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657383	gold, Green Published, Green Submitted			2022-12-25	WOS:000268739300001
J	Vudattu, NK; Kuhlmann-Berenzon, S; Khademi, M; Seyfert, V; Olsson, T; Maeurer, MJ				Vudattu, Nalini Kumar; Kuhlmann-Berenzon, Sharon; Khademi, Mohsen; Seyfert, Vicki; Olsson, Thomas; Maeurer, Markus J.			Increased Numbers of IL-7 Receptor Molecules on CD4+CD25-CD107a+T-Cells in Patients with Autoimmune Diseases Affecting the Central Nervous System	PLOS ONE			English	Article								Background: High content immune profiling in peripheral blood may reflect immune aberrations associated with inflammation in multiple sclerosis (MS) and other autoimmune diseases affecting the central nervous system. Methods and Findings: Peripheral blood mononuclear cells from 46 patients with multiple sclerosis (MS), 9 patients diagnosed with relapsing remitting MS (RRMS), 13 with secondary progressive multiple sclerosis (SPMS), 9 with other neurological diseases (OND) and well as 15 healthy donors (HD) were analyzed by 12 color flow cytometry (TCR alpha beta, TCR gamma delta, CD4, CD8 alpha, CD8 beta, CD45RA, CCR7, CD27, CD28, CD107a, CD127, CD14) in a cross-sectional study to identify variables significantly different between controls (HD) and patients (OND, RRMS, SPMS). We analyzed 187 individual immune cell subsets (percentages) and the density of the IL-7 receptor alpha chain (CD127) on 59 individual immune phenotypes using a monoclonal anti-IL-7R antibody (clone R34.34) coupled to a single APC molecule in combination with an APC-bead array. A non-parametric analysis of variance (Kruskal-Wallis test) was conducted in order to test for differences among the groups in each of the variables. To correct for the multiplicity problem, the FDR correction was applied on the p-values. We identified 19 variables for immune cell subsets (percentages) which allowed to segregate healthy individuals and individuals with CNS disorders. We did not observe differences in the relative percentage of IL-7R-positive immune cells in PBMCs. In contrast, we identified significant differences in IL-7 density, measured on a single cell level, in 2/59 variables: increased numbers of CD127 molecules on TCR alpha beta+CD4+CD25 (intermed) T-cells and on TCR alpha beta+CD4+CD25-CD107a+ T-cells (mean: 28376 Il-7R binding sites on cells from HD, 48515 in patients with RRMS, 38195 in patients with SPMS and 33692 IL-7 receptor binding sites on cells from patients with OND). Conclusion: These data show that immunophenotyping represents a powerful tool to differentiate healthy individuals from individuals suffering from neurological diseases and that the number of IL-7 receptor molecules on differentiated TCR alpha beta+CD4+CD25-CD107a+ T-cells, but not the percentage of IL-7R-positive cells, segregates healthy individuals from patients with neurological disorders.			Vudattu, NK (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	markus.maeurer@ki.se	Kühlmann-Berenzon, Sharon/J-1554-2019; Vudattu, Nalini/L-1779-2014	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Maeurer, Markus/0000-0002-8436-8077; Khademi, Mohsen/0000-0003-0801-1444; Vudattu, Nalini/0000-0001-6705-3332; Olsson, Tomas/0000-0002-2938-1877				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bielekova B, 1999, J NEUROIMMUNOL, V100, P115, DOI 10.1016/S0165-5728(99)00200-3; Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; DEJAGER PL, 2008, BRAIN; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Johnson AJ, 2007, INT REV NEUROBIOL, V79, P73, DOI 10.1016/S0074-7742(07)79004-9; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lundmark F, 2007, J NEUROIMMUNOL, V192, P171, DOI 10.1016/j.jneuroim.2007.08.015; Mackall CL, 2001, BLOOD, V97, P1491, DOI 10.1182/blood.V97.5.1491; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; Magalhaes I, 2008, J IMMUNOTHER, V31, P840, DOI 10.1097/CJI.0b013e31818883a1; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; REINHERZ EL, 1980, NEW ENGL J MED, V303, P125, DOI 10.1056/NEJM198007173030303; Rinaldi L, 2006, BRAIN, V129, P1993, DOI 10.1093/brain/awl179; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; SELMAJ K, 1991, P NATL ACAD SCI USA, V88, P6452, DOI 10.1073/pnas.88.15.6452; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Venigalla RKC, 2008, ARTHRITIS RHEUM-US, V58, P2120, DOI 10.1002/art.23556; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vudattu NK, 2007, INT J CANCER, V121, P1512, DOI 10.1002/ijc.22854; Zhang B, 2008, ANN RHEUM DIS, V67, P1037, DOI 10.1136/ard.2007.083543	31	9	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6534	10.1371/journal.pone.0006534	http://dx.doi.org/10.1371/journal.pone.0006534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657390	gold, Green Published, Green Submitted			2022-12-25	WOS:000268739300005
J	Schloegl, C; Dierks, A; Gajdon, GK; Huber, L; Kotrschal, K; Bugnyar, T				Schloegl, Christian; Dierks, Anneke; Gajdon, Gyula K.; Huber, Ludwig; Kotrschal, Kurt; Bugnyar, Thomas			What You See Is What You Get? Exclusion Performances in Ravens and Keas	PLOS ONE			English	Article							TRIAL ASSOCIATIVE MEMORY; MONKEYS CEBUS-APELLA; CORVUS-CORAX; COMMON RAVENS; SPATIAL MEMORY; CHOICE TASK; FOOD; INFERENCES; EVOLUTION; COGNITION	Background: Among birds, corvids and parrots are prime candidates for advanced cognitive abilities. Still, hardly anything is known about cognitive similarities and dissimilarities between them. Recently, exclusion has gained increasing interest in comparative cognition. To select the correct option in an exclusion task, one option has to be rejected (or excluded) and the correct option may be inferred, which raises the possibility that causal understanding is involved. However, little is yet known about its evolutionary history, as only few species, and mainly mammals, have been studied. Methodology/Principal Findings: We tested ravens and keas in a choice task requiring the search for food in two differently shaped tubes. We provided the birds with partial information about the content of one of the two tubes and asked whether they could use this information to infer the location of the hidden food and adjust their searching behaviour accordingly. Additionally, this setup allowed us to investigate whether the birds would appreciate the impact of the shape of the tubes on the visibility of food. The keas chose the baited tube more often than the ravens. However, the ravens applied the more efficient strategy, choosing by exclusion more frequently than the keas. An additional experiment confirmed this, indicating that ravens and keas either differ in their cognitive skills or that they apply them differently. Conclusion: To our knowledge, this is the first study to demonstrate that corvids and parrots may perform differently in cognitive tasks, highlighting the potential impact of different selection pressures on the cognitive evolution of these large-brained birds.			Schloegl, C (corresponding author), Konrad Lorenz Forsch Ethol, Grunau Im Almtal, Austria.	chris_schloegl@web.de		Huber, Ludwig/0000-0002-0217-136X	Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish; Austrian Science Fund FWF [Y 366] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		Aust U, 2008, ANIM COGN, V11, P587, DOI 10.1007/s10071-008-0149-0; Bakeman R., 1997, OBSERVING INTERACTIO; BALDA RP, 1989, ANIM BEHAV, V38, P486, DOI 10.1016/S0003-3472(89)80041-7; Beran MJ, 2002, J EXP ANAL BEHAV, V78, P497, DOI 10.1901/jeab.2002.78-497; Boesch C, 2008, J COMP PSYCHOL, V122, P453, DOI 10.1037/0735-7036.122.4.453; Bolhuis JJ, 2001, TRENDS COGN SCI, V5, P426, DOI 10.1016/S1364-6613(00)01753-8; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; BRODBECK DR, 1994, ANIM LEARN BEHAV, V22, P119, DOI 10.3758/BF03199912; Bugnyar T, 2005, P ROY SOC B-BIOL SCI, V272, P1641, DOI 10.1098/rspb.2005.3144; Bugnyar T, 2004, P ROY SOC B-BIOL SCI, V271, P1331, DOI 10.1098/rspb.2004.2738; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Bugnyar T, 2004, ANIM COGN, V7, P69, DOI 10.1007/s10071-003-0189-4; Bugnyar T, 2006, ANIM COGN, V9, P369, DOI 10.1007/s10071-006-0035-6; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Call J., 2001, ANIM COGN, V3, P207, DOI [10.1007/s100710100078, DOI 10.1007/S100710100078]; Call J, 2006, ANIM COGN, V9, P393, DOI 10.1007/s10071-006-0037-4; Carruthers P, 2008, MIND LANG, V23, P58, DOI 10.1111/j.1468-0017.2007.00329.x; CLAYTON NS, 1994, J COMP PHYSIOL A, V174, P371; CLAYTON NS, 1994, ANIM LEARN BEHAV, V22, P366, DOI 10.3758/BF03209155; CLAYTON NS, 1993, J COMP PHYSIOL A, V171, P807, DOI 10.1007/BF00213077; Clement TS, 2003, PSYCHON B REV, V10, P959, DOI 10.3758/BF03196558; de Kort S.R., 2006, P602; Diamond J, 2004, BEHAVIOUR, V141, P777, DOI 10.1163/1568539042265680; Diamond J., 1999, KEA BIRD PARADOX EVO; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; FLAVELL JH, 1991, BRIT J DEV PSYCHOL, V9, P73, DOI 10.1111/j.2044-835X.1991.tb00863.x; Gajdon GK, 2004, LEARN BEHAV, V32, P62; Gajdon GK, 2006, ANIM COGN, V9, P173, DOI 10.1007/s10071-006-0018-7; Hampton RR, 2004, ANIM COGN, V7, P239, DOI 10.1007/s10071-004-0215-1; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Heinrich B, 1998, ANIM BEHAV, V56, P1083, DOI 10.1006/anbe.1998.0906; Heinrich B, 1995, AUK, V112, P994, DOI 10.2307/4089030; Heinrich B., 1989, RAVENS WINTER; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; HUBER L, ORIGINS SOC IN PRESS; HUBER L, 2008, ORIGINS SOCIAL MIND, P97; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; HUGHES M, 1979, EDUC REV, V31, P133, DOI 10.1080/0013191790310207; ITO K, 1969, P INT S MULT AN NEW, P87; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; KAMIL AC, 1988, NEBR SYM MOTIV, V35, P257; KAMIL AC, 1994, J COMP PSYCHOL, V108, P385, DOI 10.1037/0735-7036.108.4.385; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kastak CR, 2002, J EXP ANAL BEHAV, V78, P449, DOI 10.1901/jeab.2002.78-449; KREBS JR, 1990, ANIM BEHAV, V39, P1127, DOI 10.1016/S0003-3472(05)80785-7; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; OLSON DJ, 1995, J COMP PSYCHOL, V109, P173, DOI 10.1037/0735-7036.109.2.173; Paukner A, 2006, ANIM COGN, V9, P110, DOI 10.1007/s10071-005-0007-2; Paukner A, 2009, J COMP PSYCHOL, V123, P26, DOI 10.1037/a0013128; Pepperberg IM, 2004, ANIM COGN, V7, P263, DOI 10.1007/s10071-004-0218-y; Pepperberg IM, 2006, J COMP PSYCHOL, V120, P205, DOI 10.1037/0735-7036.120.3.205; Petit O., 2005, PRIMATE REP, V72, P76; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; PREMACK D, 1994, COGNITION, V50, P347, DOI 10.1016/0010-0277(94)90035-3; Rasch D., 2004, PSYCHOL SCI, V46, P175; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Sabbatini G, 2008, J COMP PSYCHOL, V122, P156, DOI 10.1037/0735-7036.122.2.156; Scheid C, 2008, ANIM COGN, V11, P691, DOI 10.1007/s10071-008-0160-5; Schloegl C, 2009, RATIONAL ANIMALS IRR, P217; Schloegl C, 2008, ANIM COGN, V11, P231, DOI 10.1007/s10071-007-0105-4; Schloegl C, 2008, BEHAV PROCESS, V77, P61, DOI 10.1016/j.beproc.2007.06.002; Schloegl C, 2007, ANIM BEHAV, V74, P769, DOI 10.1016/j.anbehav.2006.08.017; SCHUSTERMAN RJ, 1993, LANG COMMUN, P502; Seed AM, 2006, CURR BIOL, V16, P697, DOI 10.1016/j.cub.2006.02.066; Shettleworth Sara J., 2006, RATIONAL ANIMALS, P235; Shettleworth SJ, 2002, COGNITIVE ANIMAL, P123; Shettleworth SJ, 2003, BRAIN BEHAV EVOLUT, V62, P108, DOI 10.1159/000072441; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; TAYLOR AH, 2008, P ROY SOC B, V276, P247; Tebbich S, 2004, ANIM BEHAV, V67, P689, DOI 10.1016/j.anbehav.2003.08.003; Tebbich S, 1996, ANIM BEHAV, V52, P1, DOI 10.1006/anbe.1996.0147; TOMONAGA M, 1991, PSYCHOL REP, V68, P51, DOI 10.2466/PR0.68.1.51-60; TOMONAGA M, 1993, J EXP ANAL BEHAV, V59, P215, DOI 10.1901/jeab.1993.59-215; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018	79	63	64	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6368	10.1371/journal.pone.0006368	http://dx.doi.org/10.1371/journal.pone.0006368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480MN	19654864	Green Submitted, Green Published, gold			2022-12-25	WOS:000268739100001
J	Stylianou, IM; Svenson, KL; VanOrman, SK; Langle, Y; Millar, JS; Paigen, B; Rader, DJ				Stylianou, Ioannis M.; Svenson, Karen L.; VanOrman, Sara K.; Langle, Yanina; Millar, John S.; Paigen, Beverly; Rader, Daniel J.			Novel ENU-Induced Point Mutation in Scavenger Receptor Class B, Member 1, Results in Liver Specific Loss of SCARB1 Protein	PLOS ONE			English	Article								Cardiovascular disease (CVD) is the largest cause of premature death in human populations throughout the world. Circulating plasma lipid levels, specifically high levels of LDL or low levels of HDL, are predictive of susceptibility to CVD. The scavenger receptor class B member 1 (SCARB1) is the primary receptor for the selective uptake of HDL cholesterol by liver and steroidogenic tissues. Hepatic SCARB1 influences plasma HDL-cholesterol levels and is vital for reverse cholesterol transport. Here we describe the mapping of a novel N-ethyl-N-nitrosourea (ENU) induced point mutation in the Scarb1 gene identified in a C57BL/6J background. The mutation is located in a highly conserved amino acid in the extracellular loop and leads to the conversion of an isoleucine to an asparagine (I179N). Homozygous mutant mice express normal Scarb1 mRNA levels and are fertile. SCARB1 protein levels are markedly reduced in liver (similar to 90%), but not in steroidogenic tissues. This leads to similar to 70% increased plasma HDL levels due to reduced HDL cholesteryl ester selective uptake. Pdzk1 knockout mice have liver-specific reduction of SCARB1 protein as does this mutant; however, in vitro analysis of the mutation indicates that the regulation of SCARB1 protein in this mutant is independent of PDZK1. This new Scarb1 model may help further our understanding of post-translational and tissue-specific regulation of SCARB1 that may aid the important clinical goal of raising functional HDL.			Stylianou, IM (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	ist@mail.med.upenn.edu	Stylianou, Ioannis/C-6061-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633, R01HL055323, R01HL077796, U01HL066611, R37HL077796] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL055323, 2-R01-HL055323, P01 HL022633, P01-HL022633, R01 HL077796, R37 HL055323, HL66611, R37 HL077796, HL77796, U01 HL066611] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Balling R, 2001, ANNU REV GENOM HUM G, V2, P463, DOI 10.1146/annurev.genom.2.1.463; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Gee SH, 1998, J BIOL CHEM, V273, P21980, DOI 10.1074/jbc.273.34.21980; Gu XJ, 2000, J BIOL CHEM, V275, P9120, DOI 10.1074/jbc.275.13.9120; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ishimori N, 2004, ARTERIOSCL THROM VAS, V24, P161, DOI 10.1161/01.ATV.0000104027.52895.D7; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lahjouji K, 2002, MOL GENET METAB, V76, P76, DOI 10.1016/S1096-7192(02)00017-3; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Mardones P, 2001, J LIPID RES, V42, P170; NISHINA PM, 1993, J LIPID RES, V34, P1413; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Rollins J, 2006, TRENDS CARDIOVAS MED, V16, P220, DOI 10.1016/j.tcm.2006.04.003; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Stylianou IM, 2005, PHYSIOL GENOMICS, V20, P224, DOI 10.1152/physiolgenomics.00183.2004; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; SU Z, 2009, J LIPID RES; SU Z, 2008, J LIPID RES; Sugiura T, 2008, DRUG METAB DISPOS, V36, P1181, DOI 10.1124/dmd.107.020321; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Wang DQH, 2002, BBA-MOL CELL BIOL L, V1583, P141, DOI 10.1016/S1388-1981(02)00194-4; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5	53	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6521	10.1371/journal.pone.0006521	http://dx.doi.org/10.1371/journal.pone.0006521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654867	gold, Green Submitted, Green Published			2022-12-25	WOS:000268739100015
J	Gutkin, M; Shamir, R; Dror, G				Gutkin, Michael; Shamir, Ron; Dror, Gideon			SlimPLS: A Method for Feature Selection in Gene Expression-Based Disease Classification	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; BREAST-CANCER; MOLECULAR CLASSIFICATION; LINEAR-REGRESSION; MICROARRAY; PATTERNS; PREDICTION; BIOMARKERS; PROFILES; SURVIVAL	A major challenge in biomedical studies in recent years has been the classification of gene expression profiles into categories, such as cases and controls. This is done by first training a classifier by using a labeled training set containing labeled samples from the two populations, and then using that classifier to predict the labels of new samples. Such predictions have recently been shown to improve the diagnosis and treatment selection practices for several diseases. This procedure is complicated, however, by the high dimensionality if the data. While microarrays can measure the levels of thousands of genes per sample, case-control microarray studies usually involve no more than several dozen samples. Standard classifiers do not work well in these situations where the number of features ( gene expression levels measured in these microarrays) far exceeds the number of samples. Selecting only the features that are most relevant for discriminating between the two categories can help construct better classifiers, in terms of both accuracy and efficiency. In this work we developed a novel method for multivariate feature selection based on the Partial Least Squares algorithm. We compared the method's variants with common feature selection techniques across a large number of real case-control datasets, using several classifiers. We demonstrate the advantages of the method and the preferable combinations of classifier and feature selection technique.			Gutkin, M (corresponding author), Tel Aviv Univ, Blavatn Sch Comp Sci, IL-69978 Tel Aviv, Israel.	rshamir@tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870				Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; [Anonymous], COMPREHENSIVE R ARCH; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., RANDOM FORESTS; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chowdary D, 2006, J MOL DIAGN, V8, P31, DOI 10.2353/jmoldx.2006.050056; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; DING B, 2004, CLASSIFICATION USING; Everitt B. S., 2006, HDB STAT ANAL USING; FISHER R, 1948, AM STAT, V2; Fort G, 2005, BIOINFORMATICS, V21, P1104, DOI 10.1093/bioinformatics/bti114; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gruvberger S, 2001, CANCER RES, V61, P5979; GUTKIN M, 2008, FEATURE SELECTION ME; Hamming RW., 1980, CODING INFORM THEORY; Hanczar B, 2007, BIOINFORMATICS, V23, P2866, DOI 10.1093/bioinformatics/btm429; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Huang XH, 2005, COMPUT BIOL CHEM, V29, P204, DOI 10.1016/j.compbiolchem.2005.04.002; Huang XH, 2003, BIOINFORMATICS, V19, P2072, DOI 10.1093/bioinformatics/btg283; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Martens H., 1989, MULTIVARIATE CALIBRA; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Momma M, 2003, LECT NOTES ARTIF INT, V2777, P216, DOI 10.1007/978-3-540-45167-9_17; Nguyen DV, 2002, BIOINFORMATICS, V18, P1216, DOI 10.1093/bioinformatics/18.9.1216; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Okada T, 2003, FEBS LETT, V555, P583, DOI 10.1016/S0014-5793(03)01345-0; *R PROJ, R PROJ STAT COMP; ROSIPAL R, 2001, J MACHINE LEARNING R, V2, P97; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; ROSIPOL R, 2003, 20 INT C MACH LEARN; Russell S.J., 2016, ARTIF INTELL; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Song L, 2007, BIOINFORMATICS, V23, pI490, DOI 10.1093/bioinformatics/btm216; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Venables W.N., 2002, MODERN APPL STAT S; Webb A. R., 2003, STAT PATTERN RECOGNI; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wold H., 1985, ENCY STAT SCI, P581, DOI DOI 10.1002/0471667196; Wold H., 1982, SYSTEMS INDIRECT OBS, P1; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	51	36	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6416	10.1371/journal.pone.0006416	http://dx.doi.org/10.1371/journal.pone.0006416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19649265	Green Published, gold			2022-12-25	WOS:000268494500017
J	Melo, KM; Carvalho, KI; Bruno, FR; Ndhlovu, LC; Ballan, WM; Nixon, DF; Kallas, EG; Costa-Carvalho, BT				Melo, Karina M.; Carvalho, Karina I.; Bruno, Fernanda R.; Ndhlovu, Lishomwa C.; Ballan, Wassim M.; Nixon, Douglas F.; Kallas, Esper G.; Costa-Carvalho, Beatriz T.			A Decreased Frequency of Regulatory T Cells in Patients with Common Variable Immunodeficiency	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; IMMUNOLOGICAL-TOLERANCE; IMMUNE-DEFICIENCY; FOXP3; EXPRESSION; DISEASE; ABNORMALITIES; LYMPHOCYTES; SUBGROUPS; MOLECULES	Introduction: Common variable immunodeficiency disorder (CVID) is a heterogeneous syndrome, characterized by deficient antibody production and recurrent bacterial infections in addition abnormalities in T cells. CD4(+)CD25(high) regulatory T cells (Treg) are essential modulators of immune responses, including down-modulation of immune response to pathogens, allergens, cancer cells and self-antigens. Objective: In this study we set out to investigate the frequency of Treg cells in CVID patients and correlate with their immune activation status. Materials and Methods: Sixteen patients (6 males and 10 females) with CVID who had been treated with regular intravenous immunoglobulin and 14 controls were enrolled. Quantitative analyses of peripheral blood mononuclear cells (PBMC) were performed by multiparametric flow cytometry using the following cell markers: CD38, HLA-DR, CCR5 ( immune activation); CD4, CD25, FOXP3, CD127, and OX40 (Treg cells); Ki-67 and IFN-gamma (intracellular cytokine). Results: A significantly lower proportion of CD4(+)CD25(high) FOXP3 T cells was observed in CVID patients compared with healthy controls (P<0.05). In addition to a higher proportion of CD8(+) T cells from CVID patients expressing the activation markers, CD38(+) and HLA-DR+ (P<0.05), we observed no significant correlation between Tregs and immune activation. Conclusion: Our results demonstrate that a reduction in Treg cells could have impaired immune function in CVID patients.			Melo, KM (corresponding author), Univ Fed Sao Paulo, Sao Paulo, Brazil.	beacarvalho@terra.com.br	Kallas, Esper G/C-9539-2012; Carvalho, Karina IL/J-6789-2012; n, l/AAX-3992-2020; Ballan, Wassim/GXG-8204-2022; Nixon, Douglas/AAU-5734-2020	Carvalho, Karina IL/0000-0002-7763-8139; Nixon, Douglas/0000-0002-2801-1786; Kallas, Esper/0000-0003-2026-6925; Ndhlovu, Lishomwa/0000-0001-5427-4187	FIC NIH HHS [#D43 TW00003, D43 TW000003] Funding Source: Medline; NIAID NIH HHS [R01 AI052731, R01 AI060379, AI60379, R21 AI060379, R01-AI52731] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI060379, R01AI052731, R01AI060379] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Blanco-Quiros A, 2006, Allergol Immunopathol (Madr), V34, P263; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Carbone J, 2006, Allergol Immunopathol (Madr), V34, P131, DOI 10.1157/13091037; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Cunningham-Rundies C, 2007, IMMUNOL RES, V38, P78, DOI 10.1007/s12026-007-0024-0; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Cunningham-Rundles C, 2001, Curr Allergy Asthma Rep, V1, P421, DOI 10.1007/s11882-001-0027-1; de Vries E, 2006, CLIN EXP IMMUNOL, V145, P204, DOI 10.1111/j.1365-2249.2006.03138.x; Di Renzo M, 2004, CLIN EXP MED, V3, P211, DOI 10.1007/s10238-004-0027-2; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; FARRINGTON M, 1994, P NATL ACAD SCI USA, V91, P1099, DOI 10.1073/pnas.91.3.1099; FERRER JM, 1995, CLIN EXP IMMUNOL, V102, P286; Fevang B, 2007, CLIN EXP IMMUNOL, V147, P521, DOI 10.1111/j.1365-2249.2006.03314.x; FISCHER MB, 1994, BRIT J HAEMATOL, V88, P520, DOI 10.1111/j.1365-2141.1994.tb05068.x; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; Glocker E, 2007, CURR OPIN PEDIATR, V19, P685, DOI 10.1097/MOP.0b013e3282f1ddd5; Haymore BR, 2008, AUTOIMMUN REV, V7, P309, DOI 10.1016/j.autrev.2007.11.024; Holm AM, 2005, BLOOD, V105, P2887, DOI 10.1182/blood-2004-06-2423; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Kondratenko I, 1997, CLIN EXP IMMUNOL, V108, P9, DOI 10.1046/j.1365-2249.1997.d01-993.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Lopes-da-Silva S, 2008, J CLIN IMMUNOL, V28, pS46, DOI 10.1007/s10875-008-9172-9; Michaelsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-41; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nordoy I, 1998, CLIN EXP IMMUNOL, V114, P258; North ME, 1998, CLIN EXP IMMUNOL, V111, P70; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Pons J, 2006, SCAND J IMMUNOL, V63, P383, DOI 10.1111/j.1365-3083.2006.01753.x; Pozzi N, 2001, CLIN EXP IMMUNOL, V123, P99, DOI 10.1046/j.1365-2249.2001.01413.x; Quinti I, 2007, J CLIN IMMUNOL, V27, P308, DOI 10.1007/s10875-007-9075-1; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Salzer U, 2006, SEMIN IMMUNOL, V18, P337, DOI 10.1016/j.smim.2006.07.004; Serrano D, 2000, CLIN IMMUNOL, V97, P248, DOI 10.1006/clim.2000.4941; Sewell WAC, 1999, CLIN EXP IMMUNOL, V116, P509; Taams LS, 2006, IMMUNOLOGY, V118, P1, DOI 10.1111/j.1365-2567.2006.02348.x; Vialle R, 2006, CLIN ANAT, V19, P51, DOI 10.1002/ca.20148; Waldmann H, 2006, SEMIN IMMUNOL, V18, P111, DOI 10.1016/j.smim.2006.01.010; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yu GP, 2009, CLIN IMMUNOL, V131, P240, DOI 10.1016/j.clim.2008.12.006; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001	49	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6269	10.1371/journal.pone.0006269	http://dx.doi.org/10.1371/journal.pone.0006269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19649263	Green Submitted, Green Published, gold			2022-12-25	WOS:000268494500002
J	Fan, HC; Zhang, XM; McNaughton, PA				Fan, Hueng-Chuen; Zhang, Xuming; McNaughton, Peter A.			Activation of the TRPV4 Ion Channel Is Enhanced by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CAPSAICIN RECEPTOR VR1; HEAT-EVOKED ACTIVATION; CATION CHANNEL; NOCICEPTIVE NEURONS; SIGNALING PATHWAYS; INFLAMMATORY PAIN; HYPERALGESIA; SENSITIZATION; MODULATION	The TRPV4 (transient receptor potential vanilloid 4) ion channel, a member of the vanilloid subfamily of the transient receptor potential channels, is activated by membrane stretch, by non-noxious warm temperatures, and by a range of chemical activators. In the present study we examined the role of phosphorylation in modulating the activation of TRPV4. We expressed TRPV4 in HEK293 cells and activated the channel by cell swelling in a hypotonic solution. TRPV4 channel activation and serine phosphorylation were enhanced by exposure to the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate or by application of bradykinin, which activates PKC via a G-protein-coupled mechanism. The enhancement was inhibited by the PKC inhibitors staurosporine, bisindolylmaleimide I, and rottlerin or by mutation of the serine/threonine residues Ser(162), Thr(175), and Ser(189). The adenylate cyclase activator forskolin also enhanced activation of TRPV4, and the enhancement was antagonized by the selective cyclic AMP-dependent protein kinase (PKA) inhibitor H89 or by mutation of serine residue Ser(824). Sensitization of TRPV4 by both PKC and PKA depended on the scaffolding protein AKAP79, because channel activation and phosphorylation were enhanced by co-transfection of AKAP79 and were antagonized by removal of AKAP79 using small interfering RNA. We conclude that the serine/threonine kinases PKC and PKA enhance activation of the TRPV4 ion channel by phosphorylation at specific sites and that phosphorylation depends on assembly of PKC and PKA by AKAP79 into a signaling complex with TRPV4.	[Fan, Hueng-Chuen; Zhang, Xuming; McNaughton, Peter A.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Fan, Hueng-Chuen] Tri Serv Gen Hosp, Dept Pediat, Taipei 11490, Taiwan; [Fan, Hueng-Chuen] Natl Def Med Ctr, Taipei 11490, Taiwan	University of Cambridge; Tri-Service General Hospital; National Defense Medical Center	McNaughton, PA (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	pam42@cam.ac.uk		McNaughton, Peter/0000-0003-1946-9610; Zhang, Xuming/0000-0002-5331-8675	Biotechnology and Biological Sciences Research Council [BB/F003072/1, BB/C003217/1] Funding Source: Medline; BBSRC [BB/F003072/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Aley KO, 1999, J NEUROSCI, V19, P2181; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Birder L, 2007, J PHARMACOL EXP THER, V323, P227, DOI 10.1124/jpet.107.125435; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Cunha FQ, 1999, BRIT J PHARMACOL, V127, P671, DOI 10.1038/sj.bjp.0702601; Delany NS, 2001, PHYSIOL GENOMICS, V4, P165, DOI 10.1152/physiolgenomics.2001.4.3.165; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Guler AD, 2002, J NEUROSCI, V22, P6408; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	47	132	134	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27884	27891		10.1074/jbc.M109.028803	http://dx.doi.org/10.1074/jbc.M109.028803			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19661060	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000270676300015
J	Huet, G; Constant, P; Malaga, W; Laneelle, MA; Kremer, K; Van Soolingen, D; Daffe, M; Guilhot, C				Huet, Gaelle; Constant, Patricia; Malaga, Wladimir; Laneelle, Marie-Antoinette; Kremer, Kristin; Van Soolingen, Dick; Daffe, Mamadou; Guilhot, Christophe			A Lipid Profile Typifies the Beijing Strains of Mycobacterium tuberculosis IDENTIFICATION OF A MUTATION RESPONSIBLE FOR A MODIFICATION OF THE STRUCTURES OF PHTHIOCEROL DIMYCOCEROSATES AND PHENOLIC GLYCOLIPIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DISSECTION; IMMUNE-RESPONSE; PHTHIOCEROL; VIRULENCE; COMPLEX; GENOTYPE; LINEAGE; PHENOLGLYCOLIPIDS; BIOSYNTHESIS; PERMEABILITY	The Mycobacterium tuberculosis Beijing strains are a family highly prevalent in Asia and have recently spread worldwide, causing a number of epidemics, suggesting that they express virulence factors not found in other M. tuberculosis strains. Accordingly, we looked for putative characteristic compounds by comparing the lipid profiles of several Beijing and non-Beijing strains. All the Beijing strains analyzed were found to synthesize structural variants of two well known characteristic lipids of the tubercle bacillus, namely phthiocerol dimycocerosates (DIM) and eventually phenolglycolipids (PGL). These variants were not found in non-Beijing M. tuberculosis isolates. Structural elucidation of these variants showed that they consist of phthiotriol and glycosylated phenolphthiotriol dimycocerosates, eventually acylated with 1 mol of palmitic acid, in addition to the conventional acylation of the beta-diol by mycocerosic acids. We demonstrated that this unusual lipid profile resulted from a single point mutation in the Rv2952 gene, which encodes the S-adenosylmethionine-dependent methyltransferase participating to the O-methylation of the third hydroxyl of the phthiotriol and phenolphthiotriol in the biosynthetic pathway of DIM and PGL. Consistently, the mutated enzyme exhibited in vitro a much lower O-methyltransferase activity than did the wild-type Rv2952. We finally demonstrated that the structural variants of DIM and PGL fulfill the same function in the cell envelope and virulence than their conventional counterparts.	[Huet, Gaelle; Constant, Patricia; Malaga, Wladimir; Laneelle, Marie-Antoinette; Daffe, Mamadou; Guilhot, Christophe] IPBS, CNRS, F-31077 Toulouse 4, France; [Huet, Gaelle; Constant, Patricia; Malaga, Wladimir; Laneelle, Marie-Antoinette; Daffe, Mamadou; Guilhot, Christophe] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Kremer, Kristin; Van Soolingen, Dick] Natl Inst Publ Hlth & Environm, Natl Mycobacteria Reference Lab, NL-3720 BA Bilthoven, Netherlands	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Netherlands National Institute for Public Health & the Environment	Guilhot, C (corresponding author), IPBS, CNRS, 205 Route Narbonne, F-31077 Toulouse 4, France.	Christophe.Guilhot@ipbs.fr			Agence Nationale de la Recherche [06 MIME 037 01]; CNRS [MIE 2006]	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported in part by Agence Nationale de la Recherche Grant 06 MIME 037 01 and CNRS Grant MIE 2006.	Barczak AK, 2005, J INFECT DIS, V192, P600, DOI 10.1086/432006; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DAFFE M, 1987, EUR J BIOCHEM, V167, P155, DOI 10.1111/j.1432-1033.1987.tb13317.x; DAFFE M, 1988, J GEN MICROBIOL, V134, P2049; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Guilhot C, 2008, MYCOBACTERIAL CELL ENVELOPE, P273; Kong Y, 2007, J CLIN MICROBIOL, V45, P409, DOI 10.1128/JCM.01459-06; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Malaga W, 2008, J BIOL CHEM, V283, P15177, DOI 10.1074/jbc.M710275200; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Perez E, 2004, J BIOL CHEM, V279, P42584, DOI 10.1074/jbc.M406134200; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Simeone R, 2007, FEBS J, V274, P1957, DOI 10.1111/j.1742-4658.2007.05740.x; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; 2006, EMERG INF DIS, V12, P736	34	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27101	27113		10.1074/jbc.M109.041939	http://dx.doi.org/10.1074/jbc.M109.041939			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648652	Green Published, hybrid			2022-12-25	WOS:000270232300011
J	Mascarenhas, JB; Young, KP; Littlejohn, EL; Yoo, BK; Salgia, R; Lang, D				Mascarenhas, Joseph B.; Young, Kacey P.; Littlejohn, Erica L.; Yoo, Brian K.; Salgia, Ravi; Lang, Deborah			PAX6 Is Expressed in Pancreatic Cancer and Actively Participates in Cancer Progression through Activation of the MET Tyrosine Kinase Receptor Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; PAIRED DOMAIN; UP-REGULATION; TRANSCRIPTIONAL ACTIVATION; GLIOBLASTOMA CELLS; INVASIVE GROWTH; IDENTIFICATION; PROTOONCOGENE; SUPPRESSES	Tumors of the exocrine pancreas have a poor prognosis. Several proteins are overexpressed in this cancer type, including the MET tyrosine kinase receptor and the transcription factor PAX6. In this report, we find that PAX6(5a), an alternately spliced variant form of PAX6, is expressed in pancreatic carcinoma cell lines at higher levels than the canonical PAX6 protein. Both protein forms of PAX6 bind directly to an enhancer element in the MET promoter and activate the expression of the MET gene. In addition, inhibition of PAX6 transcripts leads to a decline in cell growth and survival, differentiation, and a concurrent reduction of MET protein expression. These data support a model for a neoplastic pathway, where expression of a transcription factor from development activates the MET receptor, a protein that has been directly linked to protumorigenic processes of resisting apoptosis, tumor growth, invasion, and metastasis.	[Mascarenhas, Joseph B.; Young, Kacey P.; Littlejohn, Erica L.; Yoo, Brian K.; Salgia, Ravi; Lang, Deborah] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Lang, D (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 5067, Chicago, IL 60637 USA.	dlang@medicine.bsd.uchicago.edu		Lang, Deborah/0000-0003-1057-0923; LITTLEJOHN, ERICA/0000-0003-3255-8546; Mascarenhas, Joseph B/0000-0002-4735-3140	National Institutes of Health [R01CA130202, R01CA100750, R01CA125541, R21CA140003]; Schweppe Foundation; University of Chicago Cancer Center Pilot Program [P30 CA014599]; NATIONAL CANCER INSTITUTE [P30CA014599, R01CA125541, R01CA100750, R01CA130202, R21CA140003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schweppe Foundation; University of Chicago Cancer Center Pilot Program(University of Chicago); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA130202, R01CA100750, R01CA125541, and R21CA140003. This work was also supported by the Schweppe Foundation and the University of Chicago Cancer Center Pilot Program, Grant P30 CA014599.	Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Beuret L, 2007, J BIOL CHEM, V282, P14140, DOI 10.1074/jbc.M611563200; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chauhan BK, 2004, INVEST OPHTH VIS SCI, V45, P385, DOI 10.1167/iovs.03-0968; DIRENZO MF, 1995, CANCER RES, V55, P1129; Duncan MK, 2000, J CELL SCI, V113, P3173; EBERT M, 1994, CANCER RES, V54, P5775; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; FURUKAWA T, 1995, AM J PATHOL, V147, P889; GAMBAROTTA G, 1994, J BIOL CHEM, V269, P12852; Gambarotta G, 1996, ONCOGENE, V13, P1911; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Jaworski C, 1997, BIOCHEM BIOPH RES CO, V240, P196, DOI 10.1006/bbrc.1997.7623; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Lang D, 2008, MOL CARCINOGEN, V47, P148, DOI 10.1002/mc.20375; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Oshima Y, 2007, GASTROENTEROLOGY, V132, P720, DOI 10.1053/j.gastro.2006.11.027; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pinson J, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-13; Pinto GR, 2007, GENET MOL RES, V6, P1019; Qian LW, 2003, INT J CANCER, V104, P542, DOI 10.1002/ijc.10997; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Salem CE, 2000, INT J CANCER, V87, P179, DOI 10.1002/1097-0215(20000715)87:2<179::AID-IJC4>3.0.CO;2-X; Schag K, 2004, CLIN CANCER RES, V10, P3658, DOI 10.1158/1078-0432.CCR-03-0640; Seol DW, 1999, J BIOL CHEM, V274, P3565, DOI 10.1074/jbc.274.6.3565; Seol DW, 2000, ONCOGENE, V19, P1132, DOI 10.1038/sj.onc.1203404; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Stanescu D, 2007, EYE, V21, P90, DOI 10.1038/sj.eye.6702166; Stella MC, 2005, MOL CELL BIOL, V25, P3982, DOI 10.1128/MCB.25.10.3982-3996.2005; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Tsuda M, 2007, CANCER RES, V67, P919, DOI 10.1158/0008-5472.CAN-06-2855; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF1216, DOI 10.1152/ajprenal.00426.2002; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880; Zhou YH, 2005, J NEURO-ONCOL, V71, P223, DOI 10.1007/s11060-004-1720-4; Zhou YH, 2003, CLIN CANCER RES, V9, P3369	45	40	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27524	27532		10.1074/jbc.M109.047209	http://dx.doi.org/10.1074/jbc.M109.047209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651775	Green Published, hybrid			2022-12-25	WOS:000270232300054
J	Wong, SW; Kwon, MJ; Choi, AMK; Kim, HP; Nakahira, K; Hwang, DH				Wong, Scott W.; Kwon, Myung-Ja; Choi, Augustine M. K.; Kim, Hong-Pyo; Nakahira, Kiichi; Hwang, Daniel H.			Fatty Acids Modulate Toll-like Receptor 4 Activation through Regulation of Receptor Dimerization and Recruitment into Lipid Rafts in a Reactive Oxygen Species-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; CUTTING EDGE; INNATE IMMUNITY; DIFFERENTIAL MODULATION; MICROBIAL LIPOPROTEINS; INSULIN-RESISTANCE; PLASMA-MEMBRANE; TOLL-LIKE-RECEPTOR-4; MACROPHAGES	The saturated fatty acids acylated on Lipid A of lipopolysaccharide (LPS) or bacterial lipoproteins play critical roles in ligand recognition and receptor activation for Toll-like Receptor 4 (TLR4) and TLR2. The results from our previous studies demonstrated that saturated and polyunsaturated fatty acids reciprocally modulate the activation of TLR4. However, the underlying mechanism has not been understood. Here, we report for the first time that the saturated fatty acid lauric acid induced dimerization and recruitment of TLR4 into lipid rafts, however, dimerization was not observed in non-lipid raft fractions. Similarly, LPS and lauric acid enhanced the association of TLR4 with MD-2 and downstream adaptor molecules, TRIF and MyD88, into lipid rafts leading to the activation of downstream signaling pathways and target gene expression. However, docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, inhibited LPS- or lauric acid-induced dimerization and recruitment of TLR4 into lipid raft fractions. Together, these results demonstrate that lauric acid and DHA reciprocally modulate TLR4 activation by regulation of the dimerization and recruitment of TLR4 into lipid rafts. In addition, we showed that TLR4 recruitment to lipid rafts and dimerization were coupled events mediated at least in part by NADPH oxidase-dependent reactive oxygen species generation. These results provide a new insight in understanding the mechanism by which fatty acids differentially modulate TLR4-mediated signaling pathway and consequent inflammatory responses which are implicated in the development and progression of many chronic diseases.	[Wong, Scott W.; Kwon, Myung-Ja; Hwang, Daniel H.] USDA ARS, Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Wong, Scott W.; Kwon, Myung-Ja; Hwang, Daniel H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Choi, Augustine M. K.; Kim, Hong-Pyo; Nakahira, Kiichi] Harvard Univ, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; Harvard University; Harvard Medical School	Hwang, DH (corresponding author), USDA ARS, Western Human Nutr Res Ctr, 430 W Hlth Sci Dr, Davis, CA 95616 USA.	daniel.hwang@ars.usda.gov			National Institutes of Health [DK064007, DK41868, CA75613, HL079904, HL55330, HL6234]; United States Dept. of Agriculture (USDA) [2001-35200-10721]; American Institutes for Cancer Research [01A095Rev]; Western Human Nutrition Research Center/ARS/USDA; National Center for Research Resources, NIH [C06 RR17348-01, C06 RR12088-01]; NATIONAL CANCER INSTITUTE [R01CA075613] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017348, C06RR012088] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL055330, R01HL055330, R01HL079904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041868, R01DK064007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Agriculture (USDA)(United States Department of Agriculture (USDA)); American Institutes for Cancer Research; Western Human Nutrition Research Center/ARS/USDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK064007, DK41868, and CA75613. This work was also supported by Grant 2001-35200-10721 from the United States Dept. of Agriculture (USDA), Grant 01A095Rev from the American Institutes for Cancer Research, and program funds from the Western Human Nutrition Research Center/ARS/USDA (to D. H. H.) and by NIH Grants HL079904, HL55330, and HL6234 (to A. M. K. C.). This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grants C06 RR17348-01 and C06 RR12088-01 from the National Center for Research Resources, NIH.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brunn GJ, 2005, FASEB J, V19, P872, DOI 10.1096/fj.04-3211fje; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Fan YY, 2004, J IMMUNOL, V173, P6151, DOI 10.4049/jimmunol.173.10.6151; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; KRAUSS JH, 1989, EUR J BIOCHEM, V180, P519, DOI 10.1111/j.1432-1033.1989.tb14677.x; Kwon MJ, 2006, J IMMUNOL, V177, P950, DOI 10.4049/jimmunol.177.2.950; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lee JY, 2005, BIOCHEM PHARMACOL, V70, P1231, DOI 10.1016/j.bcp.2005.07.020; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; MIDDLEBROOK JL, 1984, MICROBIOL REV, V48, P199, DOI 10.1128/MMBR.48.3.199-221.1984; MUNFORD RS, 1986, SCIENCE, V234, P203, DOI 10.1126/science.3529396; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; QURESHI N, 1991, INFECT IMMUN, V59, P441, DOI 10.1128/IAI.59.1.441-444.1991; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Saitoh SI, 2006, CHEM REC, V6, P311, DOI 10.1002/tcr.20093; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Triantafilou M, 2002, J CELL SCI, V115, P2603; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; UHL B, 1992, EUR J CELL BIOL, V58, P90; WOLF B, 1989, IMMUNOL LETT, V20, P121, DOI 10.1016/0165-2478(89)90096-5; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4; Zhao L, 2007, J BIOL CHEM, V282, P11618, DOI 10.1074/jbc.M608644200	52	380	393	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27384	27392		10.1074/jbc.M109.044065	http://dx.doi.org/10.1074/jbc.M109.044065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648648	Green Published, hybrid			2022-12-25	WOS:000270232300040
J	Ling, C; Groop, L; Del Guerra, S; Lupi, R				Ling, Charlotte; Groop, Leif; Del Guerra, Silvia; Lupi, Roberto			Calpain-10 Expression Is Elevated in Pancreatic Islets from Patients with Type 2 Diabetes	PLOS ONE			English	Article								Background: Calpain-10 was the first gene to be identified influencing the risk of type 2 diabetes (T2D) by positioning cloning. Studies in beta-cell lines and rodent islets suggest that calpain-10 may act as a regulator of insulin secretion. However, its role in human pancreatic islets remains unclear. The aim of this study was to examine if calpain-10 expression is altered in islets from patients with T2D and if the transcript level correlates with insulin release. We also tested if polymorphisms in the CAPN10 gene are associated with gene expression and insulin secretion in vitro. Methodology/Principal Findings: Calpain-10 mRNA expression was analysed in human pancreatic islets from 34 nondiabetic and 10 T2D multi-organ donors. CAPN10 SNP-43 and SNP-44 were genotyped and related to gene expression and insulin release in response to glucose, arginine and glibenclamide. The mRNA level of calpain-10 was elevated by 64% in pancreatic islets from patients with T2D compared with non-diabetic donors (P = 0.01). Moreover, the calpain-10 expression correlated positively with arginine-stimulated insulin release in islets from non-diabetic donors (r = 0.45, P = 0.015). However, this correlation was lost in islets from patients with T2D (r = 0.09; P = 0.8). The G/G variant of SNP-43 was associated with reduced insulin release in response to glucose (P <= 0.04) in non-diabetic donors. Conclusions: While calpain-10 expression correlates with insulin release in non-diabetic human islets, this correlation is lost in T2D suggesting that a stimulatory effect of calpain-10 could be lost in patients with T2D.			Ling, C (corresponding author), Lund Univ, Clin Res Ctr, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden.	charlotte.ling@med.lu.se	Ling, Charlotte/Q-2432-2015	Ling, Charlotte/0000-0003-0587-7154				Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Carlsson E, 2005, DIABETES, V54, P3015, DOI 10.2337/diabetes.54.10.3015; Carlsson E, 2004, J CLIN ENDOCR METAB, V89, P3601, DOI 10.1210/jc.2003-032105; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Ling C, 2008, DIABETOLOGIA; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; Parnaud G, 2005, AM J PHYSIOL-ENDOC M, V289, pE313, DOI 10.1152/ajpendo.00006.2005; Rasmussen SK, 2002, DIABETES, V51, P3561, DOI 10.2337/diabetes.51.12.3561; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Stumvoll M, 2001, DIABETES, V50, P2161, DOI 10.2337/diabetes.50.9.2161; Tripathy D, 2004, DIABETOLOGIA, V47, P782, DOI 10.1007/s00125-004-1393-8; Tsuchiya T, 2006, MOL GENET METAB, V89, P174, DOI 10.1016/j.ymgme.2006.05.013; Turner MD, 2007, BIOCHEM BIOPH RES CO, V352, P650, DOI 10.1016/j.bbrc.2006.11.077; Zhou YP, 2003, METABOLISM, V52, P528, DOI 10.1053/meta.2003.50091	22	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6558	10.1371/journal.pone.0006558	http://dx.doi.org/10.1371/journal.pone.0006558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688040	Green Published, gold			2022-12-25	WOS:000269075800002
J	Czaran, T; Hoekstra, RF				Czaran, Tamas; Hoekstra, Rolf F.			Microbial Communication, Cooperation and Cheating: Quorum Sensing Drives the Evolution of Cooperation in Bacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SOCIAL EVOLUTION; VIRULENCE; BEHAVIOR	An increasing body of empirical evidence suggests that cooperation among clone-mates is common in bacteria. Bacterial cooperation may take the form of the excretion of "public goods": exoproducts such as virulence factors, exoenzymes or components of the matrix in biofilms, to yield significant benefit for individuals joining in the common effort of producing them. Supposedly in order to spare unnecessary costs when the population is too sparse to supply the sufficient exoproduct level, many bacteria have evolved a simple chemical communication system called quorum sensing (QS), to "measure" the population density of clone-mates in their close neighborhood. Cooperation genes are expressed only above a threshold rate of QS signal molecule re-capture, i.e., above the local quorum of cooperators. The cooperative population is exposed to exploitation by cheaters, i.e., mutants who contribute less or nil to the effort but fully enjoy the benefits of cooperation. The communication system is also vulnerable to a different type of cheaters ("Liars") who may produce the QS signal but not the exoproduct, thus ruining the reliability of the signal. Since there is no reason to assume that such cheaters cannot evolve and invade the populations of honestly signaling cooperators, the empirical fact of the existence of both bacterial cooperation and the associated QS communication system seems puzzling. Using a stochastic cellular automaton approach and allowing mutations in an initially non-cooperating, non-communicating strain we show that both cooperation and the associated communication system can evolve, spread and remain persistent. The QS genes help cooperative behavior to invade the population, and vice versa; cooperation and communication might have evolved synergistically in bacteria. Moreover, in good agreement with the empirical data recently available, this synergism opens up a remarkably rich repertoire of social interactions in which cheating and exploitation are commonplace.			Czaran, T (corresponding author), Hungarian Acad Sci, Ecol & Theoret Biol Res Grp, Budapest, Hungary.	czaran@ludens.elte.hu	Czárán, Tamás/A-1169-2008; Czárán, Tamás/P-4297-2019	Czárán, Tamás/0000-0002-2722-6208; Czárán, Tamás/0000-0002-2722-6208				Brookfield JEY, 1998, EVOLUTION, V52, P1263, DOI 10.1111/j.1558-5646.1998.tb02007.x; Brown SP, 2001, P ROY SOC B-BIOL SCI, V268, P961, DOI 10.1098/rspb.2001.1609; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Chatterjee S, 2008, P NATL ACAD SCI USA, V105, P2670, DOI 10.1073/pnas.0712236105; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Czaran T, 2007, BEHAV ECOL, V18, P866, DOI 10.1093/beheco/arm061; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Denervaud V, 2004, J CLIN MICROBIOL, V42, P554, DOI 10.1128/JCM.42.2.554-562.2004; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; FLETCHER JA, 2008, PROCEEDINGS; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Maynard Smith J., 1982, pi; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; QUELLER DC, 1992, AM NAT, V139, P540, DOI 10.1086/285343; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schaber JA, 2004, J MED MICROBIOL, V53, P841, DOI 10.1099/jmm.0.45617-0; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Toffoli T, 1987, CELLULAR AUTOMATA MA; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039	33	95	100	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6655	10.1371/journal.pone.0006655	http://dx.doi.org/10.1371/journal.pone.0006655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684853	gold, Green Published, Green Submitted			2022-12-25	WOS:000269075600004
J	Hinkal, G; Parikh, N; Donehower, LA				Hinkal, George; Parikh, Neha; Donehower, Lawrence A.			Timed Somatic Deletion of p53 in Mice Reveals Age-Associated Differences in Tumor Progression	PLOS ONE			English	Article							MUTANT MICE; P53-DEFICIENT MICE; TRANSGENIC MICE; MOUSE MODELS; DNA-DAMAGE; CANCER; TUMORIGENESIS; GENERATION; SUPPRESSION; INSTABILITY	Inactivating mutations in the p53 tumor suppressor gene occur often in the progression of human cancers. p53 inhibits the outgrowth of nascent cancer cells through anti-proliferative actions (including induction of apoptosis or senescence). To test p53 tumor suppressor functions in a novel experimental context, we somatically deleted both p53 alleles in multiple tissues of mice at various ages. Mice homozygously deleted for p53 at 3 months of age showed a longer tumor latency compared to mice deleted for p53 at 6 and 12 months of age. These results are consistent with a model in which tissues accumulate oncogenically activated cells with age and these are held in check by wildtype p53. We also deleted p53 before, concurrent with, and after treatment of mice with ionizing radiation (IR). The absence or presence of p53 during IR treatment had no effect on radiation-induced lymphoma latency, confirming that the immediate p53 damage response was irrelevant for cancer prevention. Even the presence of wildtype p53 for up to four weeks post-IR provided no protection against early lymphoma incidence, indicating that long term maintenance of functional p53 is critical for preventing the emergence of a cancer. These experiments indicate that sustained p53 anti-oncogenic function acts as a final or near final line of defense preventing progression of oncogenically activated cells to malignant tumors.	[Hinkal, George; Parikh, Neha; Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Hinkal, George; Donehower, Lawrence A.] Baylor Coll Med, Interdepartmental Program Cell & Mol Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Hinkal, G (corresponding author), Ctr Leon Berard, Unite Oncol Mol, F-69373 Lyon, France.	larryd@bcm.tmc.edu			National Institute for Aging (NIA); Ellison Medical Foundation; AFAR/Ellison Medical Foundation	National Institute for Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported by grants from the National Institute for Aging (NIA) and from the Ellison Medical Foundation to L. A. D. G. H. was supported by an NIA training grant. N.P. was supported by a postdoctoral fellowship from AFAR/Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardi LD, 2005, MUTAT RES-FUND MOL M, V576, P4, DOI 10.1016/j.mrfmmm.2004.08.022; BLONDAL JA, 1994, SEMIN CANCER BIOL, V5, P177; BOUFFLER SD, 1995, CANCER RES, V55, P3883; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; de Boer JG, 1998, MUTAGENESIS, V13, P109; de Magalhaes JP, 2005, GENETICS, V169, P265, DOI 10.1534/genetics.104.032292; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Dumble Melissa L, 2003, Methods Mol Biol, V234, P29; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 1997, ONCOGENE, V15, P1295, DOI 10.1038/sj.onc.1201482; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hinkal GW, 2009, MECH AGEING DEV, V130, P262, DOI 10.1016/j.mad.2009.01.001; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; Macleod K, 2000, CURR OPIN GENET DEV, V10, P81, DOI 10.1016/S0959-437X(99)00041-6; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Mao JH, 1998, BRIT J CANCER, V77, P243, DOI 10.1038/bjc.1998.40; Marino S, 2000, GENE DEV, V14, P994; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Olivier M, 2005, 25 YEARS OF P53 RESEARCH, P321, DOI 10.1007/1-4020-2922-5_14; Phillips DH, 2001, CARCINOGENESIS, V22, P839, DOI 10.1093/carcin/22.6.839; PURDIE CA, 1994, ONCOGENE, V9, P603; Sansom OJ, 2000, MUTAT RES-FUND MOL M, V452, P149, DOI 10.1016/S0027-5107(00)00089-0; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Venkatachalam S, 2001, TOXICOL PATHOL, V29, P147, DOI 10.1080/019262301753178555; VENKATACHALAM S, 2001, CANCER RES, V55, P3883	37	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6654	10.1371/journal.pone.0006654	http://dx.doi.org/10.1371/journal.pone.0006654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680549	Green Published, gold, Green Submitted			2022-12-25	WOS:000268936200018
J	Mravinac, B; Sullivan, LL; Reeves, JW; Yan, CM; Kopf, KS; Farr, CJ; Schueler, MG; Sullivan, BA				Mravinac, Brankica; Sullivan, Lori L.; Reeves, Jason W.; Yan, Christopher M.; Kopf, Kristen S.; Farr, Christine J.; Schueler, Mary G.; Sullivan, Beth A.			Histone Modifications within the Human X Centromere Region	PLOS ONE			English	Article							ALPHA-SATELLITE DNA; CHROMOSOME CENTROMERE; HUMAN CANCER; DROSOPHILA CENTROMERE; METHYLATION STATES; HETEROCHROMATIN; CHROMATIN; KINETOCHORE; CELLS; MINICHROMOSOME	Human centromeres are multi-megabase regions of highly ordered arrays of alpha satellite DNA that are separated from chromosome arms by unordered alpha satellite monomers and other repetitive elements. Complexities in assembling such large repetitive regions have limited detailed studies of centromeric chromatin organization. However, a genomic map of the human X centromere has provided new opportunities to explore genomic architecture of a complex locus. We used ChIP to examine the distribution of modified histones within centromere regions of multiple X chromosomes. Methylation of H3 at lysine 4 coincided with DXZ1 higher order alpha satellite, the site of CENP-A localization. Heterochromatic histone modifications were distributed across the 400-500 kb pericentromeric regions. The large arrays of alpha satellite and gamma satellite DNA were enriched for both euchromatic and heterochromatic modifications, implying that some pericentromeric repeats have multiple chromatin characteristics. Partial truncation of the X centromere resulted in reduction in the size of the CENP-A/Cenp-A domain and increased heterochromatic modifications in the flanking pericentromere. Although the deletion removed similar to 1/3 of centromeric DNA, the ratio of CENP-A to alpha satellite array size was maintained in the same proportion, suggesting that a limited, but defined linear region of the centromeric DNA is necessary for kinetochore assembly. Our results indicate that the human X centromere contains multiple types of chromatin, is organized similarly to smaller eukaryotic centromeres, and responds to structural changes by expanding or contracting domains.	[Mravinac, Brankica; Sullivan, Lori L.; Reeves, Jason W.; Yan, Christopher M.; Kopf, Kristen S.; Sullivan, Beth A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Reeves, Jason W.] Duke Univ, Univ Program Genet & Genom, Durham, NC USA; [Farr, Christine J.; Schueler, Mary G.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; NHGRI, NIH, Bethesda, MD 20892 USA; [Yan, Christopher M.; Sullivan, Beth A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; Duke University; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Duke University	Mravinac, B (corresponding author), Rudjer Boskovic Inst, Zagreb, Croatia.	beth.sullivan@duke.edu	Sullivan, Beth A/Q-3456-2017	Sullivan, Beth A/0000-0001-5216-4603; Farr, Christine/0000-0002-5357-5962	NIH NIGMS [R01 GM069514]; March of Dimes Research Foundation [1-FY06-377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069514] Funding Source: NIH RePORTER	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes Research Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH NIGMS R01 GM069514 and March of Dimes Research Foundation grant #1-FY06-377 (both to B.A.S). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; BLOWER MD, 2002, DEV CELL, V3, P1; BROWN CJ, 1989, AM J HUM GENET, V45, P592; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; DORMAN BP, 1978, P NATL ACAD SCI USA, V75, P2363, DOI 10.1073/pnas.75.5.2363; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fraga MF, 2005, CELL CYCLE, V4, P1377, DOI 10.4161/cc.4.10.2113; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Grunau C, 2006, GENOME RES, V16, P1198, DOI 10.1101/gr.5440306; Hansen RS, 1998, P NATL ACAD SCI USA, V95, P5133, DOI 10.1073/pnas.95.9.5133; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Jin WW, 2005, PLANT CELL, V17, P1412, DOI 10.1105/tpc.104.030643; KIM JH, 2009, GENOME RES; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lopez JM, 2000, CURR BIOL, V10, P997, DOI 10.1016/S0960-9822(00)00650-3; MAHTANI MM, 1990, GENOMICS, V7, P607, DOI 10.1016/0888-7543(90)90206-A; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mills W, 1999, HUM MOL GENET, V8, P751, DOI 10.1093/hmg/8.5.751; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Partridge JF, 2000, GENE DEV, V14, P783; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rudd MK, 2004, TRENDS GENET, V20, P529, DOI 10.1016/j.tig.2004.08.008; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Schueler MG, 2005, P NATL ACAD SCI USA, V102, P10563, DOI 10.1073/pnas.0503346102; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Spence JM, 2006, CHROMOSOMA, V115, P60, DOI 10.1007/s00412-005-0032-6; Spence JM, 2002, EMBO J, V21, P5269, DOI 10.1093/emboj/cdf511; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Wakimoto B, 1997, TRENDS GENET, V13, P349, DOI 10.1016/S0168-9525(97)01243-2; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yan HH, 2005, PLANT CELL, V17, P3227, DOI 10.1105/tpc.105.037945	44	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6602	10.1371/journal.pone.0006602	http://dx.doi.org/10.1371/journal.pone.0006602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672304	gold, Green Published			2022-12-25	WOS:000268935900015
J	Schuch, R; Fischetti, VA				Schuch, Raymond; Fischetti, Vincent A.			The Secret Life of the Anthrax Agent Bacillus anthracis: Bacteriophage-Mediated Ecological Adaptations	PLOS ONE			English	Article							ETOSHA-NATIONAL-PARK; GENOME SEQUENCE; CEREUS GROUP; INHALATIONAL ANTHRAX; SERRATIA-MARCESCENS; NORTHERN CANADA; GENE-EXPRESSION; THURINGIENSIS; VIRULENCE; SPORES	Ecological and genetic factors that govern the occurrence and persistence of anthrax reservoirs in the environment are obscure. A central tenet, based on limited and often conflicting studies, has long held that growing or vegetative forms of Bacillus anthracis survive poorly outside the mammalian host and must sporulate to survive in the environment. Here, we present evidence of a more dynamic lifecycle, whereby interactions with bacterial viruses, or bacteriophages, elicit phenotypic alterations in B. anthracis and the emergence of infected derivatives, or lysogens, with dramatically altered survival capabilities. Using both laboratory and environmental B. anthracis strains, we show that lysogeny can block or promote sporulation depending on the phage, induce exopolysaccharide expression and biofilm formation, and enable the long-term colonization of both an artificial soil environment and the intestinal tract of the invertebrate redworm, Eisenia fetida. All of the B. anthracis lysogens existed in a pseudolysogenic-like state in both the soil and worm gut, shedding phages that could in turn infect non-lysogenic B. anthracis recipients and confer survival phenotypes in those environments. Finally, the mechanism behind several phenotypic changes was found to require phage-encoded bacterial sigma factors and the expression of at least one host-encoded protein predicted to be involved in the colonization of invertebrate intestines. The results here demonstrate that during its environmental phase, bacteriophages provide B. anthracis with alternatives to sporulation that involve the activation of soil-survival and endosymbiotic capabilities.	[Schuch, Raymond; Fischetti, Vincent A.] Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Schuch, R (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	schuchr@rockefeller.edu			USPHS [AI057472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057472] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was carried out with the financial support of USPHS grant AI057472. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN HW, 1978, CAN J MICROBIOL, V24, P818, DOI 10.1139/m78-137; BEAMAN TC, 1972, J BACTERIOL, V109, P1198, DOI 10.1128/JB.109.3.1198-1209.1972; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Bouzianas DG, 2007, EXPERT REV ANTI-INFE, V5, P665, DOI 10.1586/14787210.5.4.665; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Brown George G., 2004, P213; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; BUCK CA, 1963, J BACTERIOL, V85, P1423, DOI 10.1128/JB.85.6.1423-1430.1963; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; COLE HB, 1984, J CLIN MICROBIOL, V19, P48, DOI 10.1128/JCM.19.1.48-53.1984; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Daane LL, 1996, APPL ENVIRON MICROB, V62, P515, DOI 10.1128/AEM.62.2.515-521.1996; Day WA, 2007, J BACTERIOL, V189, P3296, DOI 10.1128/JB.01860-06; Debre P., 1998, L PASTEUR; DRAGON DC, 1995, CAN VET J, V36, P295; Dragon DC, 2005, APPL ENVIRON MICROB, V71, P1610, DOI 10.1128/AEM.71.3.1610-1615.2005; Dragon DC, 2001, J APPL MICROBIOL, V91, P435, DOI 10.1046/j.1365-2672.2001.01389.x; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Fedhila S, 2002, J BACTERIOL, V184, P3296, DOI 10.1128/JB.184.12.3296-3304.2002; Feinberg L, 1999, SYMBIOSIS, V27, P109; Ferrer S, 1996, J BACTERIOL, V178, P951, DOI 10.1128/jb.178.4.951-960.1996; Fouet A, 2006, CURR OPIN MICROBIOL, V9, P160, DOI 10.1016/j.mib.2006.02.009; GAINER RS, 1989, CAN VET J, V30, P953; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hajaij-Ellouze M, 2006, FEMS MICROBIOL LETT, V260, P9, DOI 10.1111/j.1574-6968.2006.00289.x; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Helgason E, 2000, J CLIN MICROBIOL, V38, P1615, DOI 10.1128/JCM.38.4.1615-1622.2000; Hendriksen NB, 2002, CAN J MICROBIOL, V48, P256, DOI [10.1139/w02-009, 10.1139/W02-009]; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Hill KK, 2004, APPL ENVIRON MICROB, V70, P1068, DOI 10.1128/AEM.70.2.1068-1080.2004; Inal JM, 1996, CURR MICROBIOL, V32, P171, DOI 10.1007/s002849900030; Ishii S, 2004, APPL ENVIRON MICROB, V70, P5026, DOI 10.1128/AEM.70.8.5026-5029.2004; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Jin S, 1996, J MOL BIOL, V256, P264, DOI 10.1006/jmbi.1996.0084; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kiel JL, 2008, FOLIA MICROBIOL, V53, P472, DOI 10.1007/s12223-008-0074-2; Le Fleche P, 2001, BMC Microbiol, V1, P2; Lee K, 2007, MICROBIOL-SGM, V153, P1693, DOI 10.1099/mic.0.2006/003376-0; Leffers GG, 1998, J BACTERIOL, V180, P1573, DOI 10.1128/JB.180.6.1573-1577.1998; LEIGHTON TJ, 1971, J BIOL CHEM, V246, P3189; Li XZ, 1997, INT J SYST BACTERIOL, V47, P443, DOI 10.1099/00207713-47-2-443; LINDEQUE PM, 1994, ONDERSTEPOORT J VET, V61, P71; LOCHHEAD AG, 1952, J BACTERIOL, V63, P219, DOI 10.1128/JB.63.2.219-226.1952; MALIK S, 1988, J BIOL CHEM, V263, P1174; MANCHEE RJ, 1981, NATURE, V294, P254, DOI 10.1038/294254a0; Margulis L, 1998, P NATL ACAD SCI USA, V95, P1236, DOI 10.1073/pnas.95.3.1236; MCCLOY E, 1951, J GEN MICROBIOL, V5, pR14; McKenzie GJ, 2001, CURR OPIN MICROBIOL, V4, P586, DOI 10.1016/S1369-5274(00)00255-1; Mignot T, 2001, MOL MICROBIOL, V42, P1189, DOI 10.1046/j.1365-2958.2001.02692.x; Minakhin L, 2005, J MOL BIOL, V354, P1, DOI 10.1016/j.jmb.2005.09.052; Minett F. C., 1941, INDIAN JOUR VET SCI AND ANIMAL HUSBANDRY, V11, P308; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; NAGY E, 1976, J GEN VIROL, V32, P129, DOI 10.1099/0022-1317-32-1-129; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; ODENDAAL MW, 1991, ONDERSTEPOORT J VET, V58, P21; Passalacqua KD, 2006, FUTURE MICROBIOL, V1, P397, DOI 10.2217/17460913.1.4.397; Patra G, 1998, J CLIN MICROBIOL, V36, P3412, DOI 10.1128/JCM.36.11.3412-3414.1998; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pepper IL, 2002, SOIL SCI, V167, P627, DOI 10.1097/00010694-200210000-00001; Radnedge L, 2003, APPL ENVIRON MICROB, V69, P2755, DOI 10.1128/AEM.69.5.2755-2764.2003; Ramisse V, 1999, J APPL MICROBIOL, V87, P224, DOI 10.1046/j.1365-2672.1999.00874.x; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Redmond C., 1996, SALISBURY MED B SP S, V87, P60; Reyes-Ramirez A, 2005, APPL ENVIRON MICROB, V71, P1346, DOI 10.1128/AEM.71.3.1346-1355.2005; Ripp S, 1997, MICROBIOL-UK, V143, P2065, DOI 10.1099/00221287-143-6-2065; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; Schmitz JE, 2008, APPL ENVIRON MICROB, V74, P1649, DOI 10.1128/AEM.01864-07; Schuch R, 2006, J BACTERIOL, V188, P3037, DOI 10.1128/JB.188.8.3037-3051.2006; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Shafazand S, 1999, CHEST, V116, P1369, DOI 10.1378/chest.116.5.1369; Sozhamannan S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-34; Stanley NR, 2004, MOL MICROBIOL, V52, P917, DOI 10.1111/j.1365-2958.2004.04036.x; Stromsten NJ, 2003, J BACTERIOL, V185, P6985, DOI 10.1128/JB.185.23.6985-6989.2003; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; THORNE CB, 1968, BACTERIOL REV, V32, P358, DOI 10.1128/MMBR.32.4_Pt_1.358-361.1968; Turnbull P., 1996, Environmental Health, V104, P171; TURNBULL P C B, 1986, Madoqua, V14, P321; TURNBULL P C B, 1989, Madoqua, V16, P93; Turnbull PCB, 1998, J APPL MICROBIOL, V84, P667, DOI 10.1046/j.1365-2672.1998.00394.x; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; TURNBULL PCB, 1992, J APPL BACTERIOL, V72, P21; Turner S, 1996, J PETROL, V37, P45, DOI 10.1093/petrology/37.1.45; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Velloso LM, 2008, EMBO REP, V9, P199, DOI 10.1038/sj.embor.7401154; VERA T, 1968, AM J VET RES, V29, P1059; Verheust C, 2005, J BACTERIOL, V187, P1966, DOI 10.1128/JB.187.6.1966-1973.2005; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; Walter MH, 2003, CURR MICROBIOL, V47, P55, DOI 10.1007/s00284-002-3899-y; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; White AK, 2006, J BACTERIOL, V188, P6354, DOI 10.1128/JB.00656-06; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Williamson SJ, 2001, APPL ENVIRON MICROB, V67, P1682, DOI 10.1128/AEM.67.4.1682-1688.2001; Worsham PL, 1999, CAN J MICROBIOL, V45, P1, DOI 10.1139/cjm-45-1-1; ICTVDB UNIVERSAL VIR	102	115	121	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6532	10.1371/journal.pone.0006532	http://dx.doi.org/10.1371/journal.pone.0006532			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672290	Green Published, gold, Green Submitted			2022-12-25	WOS:000268935900002
J	Gurven, M; Kaplan, H; Winking, J; Rodriguez, DE; Vasunilashorn, S; Kim, JK; Finch, C; Crimmins, E				Gurven, Michael; Kaplan, Hillard; Winking, Jeffrey; Rodriguez, Daniel Eid; Vasunilashorn, Sarinnapha; Kim, Jung Ki; Finch, Caleb; Crimmins, Eileen			Inflammation and Infection Do Not Promote Arterial Aging and Cardiovascular Disease Risk Factors among Lean Horticulturalists	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ANKLE-BRACHIAL INDEX; LOW-DENSITY-LIPOPROTEIN; AMERICAN-INDIANS; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; PREVALENCE; GENE; POPULATION; ATHEROSCLEROSIS	Background: Arterial aging is well characterized in industrial populations, but scantly described in populations with little access to modern medicine. Here we characterize health and aging among the Tsimane, Amazonian forager-horticulturalists with short life expectancy, high infectious loads and inflammation, but low adiposity and robust physical fitness. Inflammation has been implicated in all stages of arterial aging, atherogenesis and hypertension, and so we test whether greater inflammation associates with atherosclerosis and CVD risk. In contrast, moderate to vigorous daily activity, minimal obesity, and low fat intake predict minimal CVD risk among older Tsimane. Methods and Findings: Peripheral arterial disease (PAD), based on the Ankle-Brachial Index (ABI), and hypertension were measured in Tsimane adults, and compared with rates from industrialized populations. No cases of PAD were found among Tsimane and hypertension was comparatively low (prevalence: 3.5%, 40+; 23%, 70+). Markers of infection and inflammation were much higher among Tsimane than among U. S. adults, whereas HDL was substantially lower. Regression models examine associations of ABI and BP with biomarkers of energy balance and metabolism and of inflammation and infection. Among Tsimane, obesity, blood lipids, and disease history were not significantly associated with ABI. Unlike the Tsimane case, higher cholesterol, C-reactive protein, leukocytes, cigarette smoking and systolic pressure among North Americans are all significantly associated with lower ABI. Conclusions: Inflammation may not always be a risk factor for arterial degeneration and CVD, but instead may be offset by other factors: healthy metabolism, active lifestyle, favorable body mass, lean diet, low blood lipids and cardiorespiratory health. Other possibilities, including genetic susceptibility and the role of helminth infections, are discussed. The absence of PAD and CVD among Tsimane parallels anecdotal reports from other small-scale subsistence populations and suggests that chronic vascular disease had little impact on adult mortality throughout most of human evolutionary history.	[Gurven, Michael] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Kaplan, Hillard] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Winking, Jeffrey] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Rodriguez, Daniel Eid] Univ Mayor de San Simon, Dept Med, Cochabamba, Bolivia; [Vasunilashorn, Sarinnapha; Kim, Jung Ki; Finch, Caleb; Crimmins, Eileen] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA	University of California System; University of California Santa Barbara; University of New Mexico; Texas A&M University System; Texas A&M University College Station; University of Southern California	Gurven, M (corresponding author), Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA.	gurven@anth.ucsb.edu	Finch, Caleb/AAA-7250-2022	Gurven, Michael/0000-0002-5661-527X; Winking, Jeffrey/0000-0002-2298-3680; Kaplan, Hillard/0000-0002-7398-7358	National Science Foundation [BCS-0422690]; National Institute on Aging [R01AG024119-01, P30AG17265, R21AG031988, T32AG0037]; Ziegler Fund; NATIONAL INSTITUTE ON AGING [P30AG017265, T32AG000037, R01AG024119, R21AG031988] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ziegler Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research was supported by the National Science Foundation (BCS-0422690), the National Institute on Aging (R01AG024119-01, P30AG17265, R21AG031988, T32AG0037) and the Ziegler Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, CIRCULATION, V105, P2595, DOI 10.1161/01.CIR.0000017493.03108.1C; Bansal Devendra, 2005, Lipids Health Dis, V4, P10, DOI 10.1186/1476-511X-4-10; Barbieri M, 2003, AM J HYPERTENS, V16, P537, DOI 10.1016/S0895-7061(03)00861-6; Berger P, 2002, CYTOKINE, V17, P171, DOI 10.1006/cyto.2001.0974; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Best LG, 2004, CIRCULATION, V109, P471, DOI 10.1161/01.CIR.0000109757.95461.10; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Bjerregaard P, 2003, ATHEROSCLEROSIS, V166, P351, DOI 10.1016/S0021-9150(02)00364-7; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Buitron-Granados LV, 2004, ANGIOLOGY, V55, P43, DOI 10.1177/000331970405500107; Carbayo JA, 2007, NUTR METAB CARDIOVAS, V17, P41, DOI 10.1016/j.numecd.2005.08.009; *CDC, 2006, HLTH BEH AD US 2002; Costa DL, 2007, P NATL ACAD SCI USA, V104, P13219, DOI 10.1073/pnas.0611077104; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Andrade FM, 2000, ANN HUM BIOL, V27, P29, DOI 10.1080/030144600282352; DEVEREUX RB, 2000, IMPACT DIABETES CARD, P2271; EATON SB, 1988, AM J MED, V84, P739, DOI 10.1016/0002-9343(88)90113-1; Eldrup N, 2006, EUR HEART J, V27, P316, DOI 10.1093/eurheartj/ehi644; Fabsitz RR, 1999, AM J EPIDEMIOL, V149, P330; Feringa HHH, 2006, ARCH INTERN MED, V166, P529, DOI 10.1001/archinte.166.5.529; Finch CE, 2007, BIOL HUMAN LONGEVITY; FLEMINGMORAN M, 1990, SOC SCI MED, V31, P593, DOI 10.1016/0277-9536(90)90095-A; Fowkes FGR, 2006, EUR J CARDIOV PREV R, V13, P964, DOI 10.1097/01.hjr.0000201511.28590.9f; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; He Y, 2006, J VASC SURG, V44, P333, DOI 10.1016/j.jvs.2006.03.032; Heald CL, 2006, ATHEROSCLEROSIS, V189, P61, DOI 10.1016/j.atherosclerosis.2006.03.011; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; Howell N., 1979, DEMOGRAPHY DOBE KUNG; Hubacek JA, 1999, CIRCULATION, V99, P3218, DOI 10.1161/01.CIR.99.25.3218; KIECHL S, 2002, TOLL LIKE RECEPTOR 4, P185; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Magen E, 2005, MED HYPOTHESES, V64, P904, DOI 10.1016/j.mehy.2004.09.028; Matsuzawa Y, 1997, DIABETES METAB REV, V13, P3, DOI 10.1002/(SICI)1099-0895(199703)13:1&lt;3::AID-DMR178&gt;3.0.CO;2-N; McDade TW, 2008, J NUTR, V138, P2442, DOI 10.3945/jn.108.092700; McGill HC, 2000, AM J CLIN NUTR, V72, p1307S, DOI 10.1093/ajcn/72.5.1307s; Medina-Lezama J, 2005, AM HEART J, V149, pE13, DOI 10.1016/j.ahj.2004.09.002; O'Connor S, 2001, EMERG INFECT DIS, V7, P780; O'DEA K, 1991, Ethnicity and Disease, V1, P171; O'Donovan G, 2005, INT J OBESITY, V29, P1063, DOI 10.1038/sj.ijo.0803004; O'Keefe JH, 2004, J AM COLL CARDIOL, V43, P2142, DOI 10.1016/j.jacc.2004.03.046; Oguma Y, 2004, AM J PREV MED, V26, P407, DOI 10.1016/j.amepre.2004.02.007; Osterud B, 1997, THROMB RES, V85, P1, DOI 10.1016/S0049-3848(96)00205-8; Pearce-Duvet JMC, 2006, BIOL REV, V81, P369, DOI 10.1017/S1464793106007020; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sacks David, 2003, J Vasc Interv Radiol, V14, pS389; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shah P K, 1998, Vasc Med, V3, P199, DOI 10.1177/1358836X9800300304; Slatkin M, 2000, GENETICS, V156, P2119; Sritara P, 2007, ANGIOLOGY, V58, P572, DOI 10.1177/0003319707303652; Steffen PR, 2006, PSYCHOSOM MED, V68, P386, DOI 10.1097/01.psy.0000221255.48190.32; Tall AR, 2004, NEW ENGL J MED, V350, P1450, DOI 10.1056/NEJMe048020; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Vasse M, 1996, BRIT J HAEMATOL, V93, P955, DOI 10.1046/j.1365-2141.1996.d01-1731.x; VASUNILASHORN S, BLOOD LIPIDS I UNPUB; Vickers MA, 2002, CARDIOVASC RES, V53, P1029, DOI 10.1016/S0008-6363(01)00534-X; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wild SH, 2006, DIABETES CARE, V29, P637, DOI 10.2337/diacare.29.03.06.dc05-1637; World Health Organization (CH), 1985, WHO TECHN REP SER; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; [No title captured]	70	71	74	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6590	10.1371/journal.pone.0006590	http://dx.doi.org/10.1371/journal.pone.0006590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668697	Green Published, gold			2022-12-25	WOS:000268935600016
J	Wood, JN				Wood, Justin N.			Spatiotemporal Correlations between Blood-Brain Barrier Permeability and Apparent Diffusion Coefficient in a Rat Model of Ischemic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; GD-DTPA MRI; TRANSFER CONSTANTS; EMBOLIC STROKE; QUANTITATIVE-EVALUATION; GRAPHICAL EVALUATION; TEMPORAL EVOLUTION; REPERFUSION; DISRUPTION; PERFUSION	Variations in apparent diffusion coefficient of water (ADC) and blood-brain barrier (BBB) permeability after ischemia have been suggested, though the correlation between ADC alterations and BBB opening remains to be studied. We hypothesized that there are correlations between the alteration of ADC and BBB permeability. Rats were subjected to 2 h of transient middle cerebral artery occlusion and studied at 3 and 48 h of reperfusion, which are crucial times of BBB opening. BBB permeability and ADC values were measured by dynamic contrast-enhanced MRI and diffusion-weighted imaging, respectively. Temporal and spatial analyses of the evolution of BBB permeability and ADC alteration in cortical and subcortical regions were conducted along with the correlation between ADC and BBB permeability data. We found significant increases in BBB leakage and reduction in ADC values between 3 and 48 h of reperfusion. We identified three MR tissue signature models: high K-i and low ADC, high K-i and normal ADC, and normal K-i and low ADC. Over time, areas with normal K-i and low ADC transformed into areas with high K-i. We observed a pattern of lesion evolution where the extent of initial ischemic injury reflected by ADC abnormalities determines vascular integrity. Our results suggest that regions with vasogenic edema alone are not likely to develop low ADC by 48 h and may undergo recovery.	Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	University of Southern California	Wood, JN (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	justin.wood@usc.edu		Candelario-Jalil, Eduardo/0000-0003-3631-1989	National Institutes of Health (NIH) [R01 NS045847, R01 NS052305]; American Heart Association (AHA) [0720160Z]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association)	This work was supported by grants from the National Institutes of Health (NIH) to GAR (R01 NS045847 and R01 NS052305). ECJ was supported by a research grant from the American Heart Association (AHA, 0720160Z, Pacific Mountain Affiliate). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABORAMADAN U, 2009, EXP NEUROL IN PRESS; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Candelario-Jalil E, 2007, J NEUROCHEM, V100, P1108, DOI 10.1111/j.1471-4159.2006.04280.x; Carano RAD, 2000, J MAGN RESON IMAGING, V12, P842, DOI 10.1002/1522-2586(200012)12:6<842::AID-JMRI7>3.0.CO;2-5; Dijkhuizen RM, 2002, STROKE, V33, P2100, DOI 10.1161/01.STR.0000023534.37670.F7; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Engelhorn T, 1999, STROKE, V30, P1456, DOI 10.1161/01.STR.30.7.1456; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; HOEHNBERLAGE M, 1995, J CEREBR BLOOD F MET, V15, P1002, DOI 10.1038/jcbfm.1995.126; Jiang Q, 2005, J CEREBR BLOOD F MET, V25, P583, DOI 10.1038/sj.jcbfm.9600053; Jiang Q, 1998, J CEREBR BLOOD F MET, V18, P758, DOI 10.1097/00004647-199807000-00007; Knight RA, 2005, MAGNET RESON MED, V54, P813, DOI 10.1002/mrm.20629; Lansberg MG, 2008, STROKE, V39, P2491, DOI 10.1161/STROKEAHA.107.508572; LARSSON HBW, 1990, MAGNET RESON MED, V16, P117, DOI 10.1002/mrm.1910160111; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Li FH, 2000, NEUROLOGY, V54, P689, DOI 10.1212/WNL.54.3.689; Liu KF, 2001, STROKE, V32, P1897, DOI 10.1161/01.STR.32.8.1897; Marks MP, 1999, NEUROLOGY, V52, P1792, DOI 10.1212/WNL.52.9.1792; McCullagh P, 1989, GEN LINEAR MODELS; Mitsias PD, 2002, STROKE, V33, P2839, DOI 10.1161/01.STR.0000043072.76353.7C; Nagaraja TN, 2008, STROKE, V39, P427, DOI 10.1161/STROKEAHA.107.496059; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Nicoli F, 2003, STROKE, V34, pE82, DOI 10.1161/01.STR.0000078659.43423.0A; Olah L, 2000, J CEREBR BLOOD F MET, V20, P1474, DOI 10.1097/00004647-200010000-00009; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Plaschke K, 2006, EXP BRAIN RES, V169, P361, DOI 10.1007/s00221-005-0146-3; *R PROJ, 2007, R PROJ STAT COMP; Ringer TM, 2001, STROKE, V32, P2362, DOI 10.1161/hs1001.096058; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sood RR, 2008, J CEREBR BLOOD F MET, V28, P431, DOI 10.1038/sj.jcbfm.9600534; Tofts PS, 1996, MAGN RESON IMAGING, V14, P373, DOI 10.1016/0730-725X(96)00023-9; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Wu O, 2001, STROKE, V32, P933, DOI 10.1161/01.STR.32.4.933; Yang Q, 1999, STROKE, V30, P2382, DOI 10.1161/01.STR.30.11.2382; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375	38	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6597	10.1371/journal.pone.0006597	http://dx.doi.org/10.1371/journal.pone.0006597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668371	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935600018
J	McCoy, MW; Allen, AP; Gillooly, JF				McCoy, Michael W.; Allen, Andrew P.; Gillooly, James F.			The Random Nature of Genome Architecture: Predicting Open Reading Frame Distributions	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; NUCLEAR GENOME; SIZE; EVOLUTION; GENES; DNA; SELECTION; ORIGINS	Background: A better understanding of the size and abundance of open reading frames (ORFS) in whole genomes may shed light on the factors that control genome complexity. Here we examine the statistical distributions of open reading frames (i.e. distribution of start and stop codons) in the fully sequenced genomes of 297 prokaryotes, and 14 eukaryotes. Methodology/Principal Findings: By fitting mixture models to data from whole genome sequences we show that the size-frequency distributions for ORFS are strikingly similar across prokaryotic and eukaryotic genomes. Moreover, we show that i) a large fraction (60-80%) of ORF size-frequency distributions can be predicted a priori with a stochastic assembly model based on GC content, and that (ii) size-frequency distributions of the remaining "non-random'' ORFs are well-fitted by log-normal or gamma distributions, and similar to the size distributions of annotated proteins. Conclusions/Significance: Our findings suggest stochastic processes have played a primary role in the evolution of genome complexity, and that common processes govern the conservation and loss of functional genomics units in both prokaryotes and eukaryotes.			McCoy, MW (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	mwmccoy@bu.edu	Allen, Andrew/B-8045-2011	Allen, Andrew/0000-0003-0304-7544; McCoy, Michael/0000-0002-7993-6236				Barlow R. E., 1965, MATH THEORY RELIABIL; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; BERNARDI G, 1990, J MOL EVOL, V31, P265, DOI 10.1007/BF02101122; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker B. M., 2008, BBMLE TOOLS GEN MAXI; Burnham KP, 2001, MODEL SELECTION MULT; Carpena P, 2002, GENE, V300, P97, DOI 10.1016/S0378-1119(02)01041-7; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cavalier-Smith T., 1985, EVOLUTION GENOME SIZ, P104; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; COTTRET L, 2008, GENER R GENES SEQUEN; Daubin V, 2004, SCIENCE, V306; Engen S, 1996, J THEOR BIOL, V178, P325, DOI 10.1006/jtbi.1996.0028; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Loewe L, 2006, BIOL LETTERS, V2, P426, DOI 10.1098/rsbl.2006.0481; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Lynch M, 2007, ORIGINS GENOME ARCHI; Lynch M, 2004, SCIENCE, V306, P978, DOI DOI 10.1126/SCIENCE.1100559; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; PAGEL M, 1992, P ROY SOC B-BIOL SCI, V249, P119, DOI 10.1098/rspb.1992.0093; SENAPATHY P, 1986, P NATL ACAD SCI USA, V83, P2133, DOI 10.1073/pnas.83.7.2133; Siew N, 2004, NUCLEIC ACIDS RES, V32, pD281, DOI 10.1093/nar/gkh116; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Team. RDC, 2007, R LANG ENV STAT COMP; Todinov MT, 2005, RELIABILITY AND RISK MODELS: SETTING RELIABILITY REQUIREMENTS, P1, DOI 10.1002/0470094907; Vinogradov AE, 2004, CURR OPIN GENET DEV, V14, P620, DOI 10.1016/j.gde.2004.09.007; Vinogradov AE, 2004, SCIENCE, V304, P389; VINOGRADOV AE, 1994, CYTOMETRY, V16, P34, DOI 10.1002/cyto.990160106; Vinogradov AE, 1998, J THEOR BIOL, V193, P197, DOI 10.1006/jtbi.1997.0629; Wessler SR, 2006, P NATL ACAD SCI USA, V103, P17600, DOI 10.1073/pnas.0607612103; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yi S, 2005, TRENDS GENET, V21, P643, DOI 10.1016/j.tig.2005.09.003; Yi SV, 2006, BIOESSAYS, V28, P979, DOI 10.1002/bies.20478; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6456	10.1371/journal.pone.0006456	http://dx.doi.org/10.1371/journal.pone.0006456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649247	gold, Green Submitted, Green Published			2022-12-25	WOS:000268494600019
J	van Beek, EM; de Vries, TJ; Mulder, L; Schoenmaker, T; Hoeben, KA; Matozaki, T; Langenbach, GEJ; Kraal, G; Everts, V; van den Berg, TK				van Beek, Ellen M.; de Vries, Teun J.; Mulder, Lars; Schoenmaker, Ton; Hoeben, Kees A.; Matozaki, Takashi; Langenbach, Geerling E. J.; Kraal, Georg; Everts, Vincent; van den Berg, Timo K.			Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha	FASEB JOURNAL			English	Article						immunoreceptor; actin ring; osteoclast function; osteoclastogenesis	TYROSINE-PHOSPHATASE SHP-1; IN-VITRO; C-SRC; RECEPTOR; SHPS-1; INTEGRIN; FUSION; LIGAND; CELLS; DIFFERENTIATION	Osteoclasts mediate bone resorption, which is critical for bone development, maintenance, and repair. Proper control of osteoclast development and function is important and deregulation of these processes may lead to bone disease, such as osteoporosis. Previous studies have shown that the cytosolic protein tyrosine phosphatase SHP-1 acts as a suppressor of osteoclast differentiation and function, but putative inhibitory receptors that mediate recruitment and activation of SHP-1 in osteoclasts have remained unknown. In the present study, we identify the SHP-1-recruiting inhibitory immunoreceptor signal regulatory protein (SIRP) alpha as a negative regulator of osteoclast activity. SIRP alpha is expressed by osteoclasts, and osteoclasts from mice lacking the SIRP alpha cytoplasmic tail and signaling capacity display enhanced bone resorption in vitro. Consequently, SIRP alpha-mutant mice have a significantly reduced cortical bone mass. Furthermore, osteoclasts from SIRP alpha-mutant mice show an enhanced formation of actin rings, known to be instrumental in bone resorption. SIRP alpha mutation did not significantly affect osteoclast formation, implying that the role of SIRP alpha was limited to the regulation of mature osteoclast function. This identifies SIRP alpha as a bona fide inhibitory receptor that regulates the bone-resorption activity and supports a concept in which osteoclast function is balanced by the signaling activities of activating and inhibitory immunoreceptors.-Van Beek, E. M., de Vries, T. J., Mulder, L., Schoenmaker, T., Hoeben, K. A., Matozaki, T., Langenbach, G. E. J., Kraal, G., Everts, V., van den Berg, T. K. Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha. FASEB J. 23, 4081-4090 (2009). www.fasebj.org	[van den Berg, Timo K.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Phagocyte Lab, NL-1066 CX Amsterdam, Netherlands; [Hoeben, Kees A.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1066 CX Amsterdam, Netherlands; [de Vries, Teun J.; Schoenmaker, Ton; Everts, Vincent] Univ Amsterdam, MOVE Res Inst, Acad Ctr Dent Amsterdam, Dept Periodontol & Oral Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Langenbach, Geerling E. J.] Univ Amsterdam, MOVE Res Inst, Acad Ctr Dent Amsterdam, Dept Funct Anat, NL-1066 CX Amsterdam, Netherlands; [Kraal, Georg] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Mulder, Lars] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Matozaki, Takashi] Gunma Univ, Lab Biosignal Sci, Inst Mol & Cellular Regulat, Gunma, Japan	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Eindhoven University of Technology; Gunma University	van den Berg, TK (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Phagocyte Lab, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	t.k.vandenberg@sanquin.nl	van den Berg, Timo K/AAC-2479-2022	Schoenmaker, Ton/0000-0001-6649-374X; de Vries, Teun/0000-0001-6464-5172				Adams S, 1998, J IMMUNOL, V161, P1853; Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; CHUANG W, 1990, DEV BIOL, V137, P219, DOI 10.1016/0012-1606(90)90249-I; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; de Vries TJ, 2006, J CELL BIOCHEM, V98, P370, DOI 10.1002/jcb.20795; de Vries TJ, 2005, J CELL BIOCHEM, V94, P954, DOI 10.1002/jcb.20326; de Vries TJ, 1999, BRIT J CANCER, V80, P883, DOI 10.1038/sj.bjc.6690436; Everts V, 1999, FASEB J, V13, P1219, DOI 10.1096/fasebj.13.10.1219; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Fukunaga A, 2004, J IMMUNOL, V172, P4091, DOI 10.4049/jimmunol.172.7.4091; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Johansson MK, 2007, BLOOD, V109, P5178, DOI 10.1182/blood-2006-12-061382; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Manolagas SC, 2000, J BONE MINER RES, V15, P1001, DOI 10.1359/jbmr.2000.15.6.1001; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mulder L, 2004, ACTA RADIOL, V45, P769, DOI 10.1080/02841850410008171; Nikolic T, 2003, INT IMMUNOL, V15, P515, DOI 10.1093/intimm/dxg050; Nordahl J, 1998, CALCIFIED TISSUE INT, V63, P401, DOI 10.1007/s002239900548; Perez-Amodio S, 2004, J BONE MINER RES, V19, P1722, DOI 10.1359/JBMR.040509; Saginario C, 1995, P NATL ACAD SCI USA, V92, P12210, DOI 10.1073/pnas.92.26.12210; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; TEITELBAUM SL, 1993, J BONE MINER RES, V8, pS523; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Umeda S, 1999, AM J PATHOL, V155, P223, DOI 10.1016/S0002-9440(10)65116-4; van den Berg TK, 2004, TRENDS IMMUNOL, V25, P11, DOI 10.1016/j.it.2003.11.006; van den Nieuwenhof IM, 2001, J CELL SCI, V114, P1321; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Zenger S, 2007, BONE, V41, P820, DOI 10.1016/j.bone.2007.07.010; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	50	26	26	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4081	4090		10.1096/fj.09-131557	http://dx.doi.org/10.1096/fj.09-131557			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19667119				2022-12-25	WOS:000272193700005
J	Oudhoff, MJ; Kroeze, KL; Nazmi, K; van den Keijbus, PAM; van't Hof, W; Fernandez-Borja, M; Hordijk, PL; Gibbs, S; Bolscher, JGM; Veerman, ECI				Oudhoff, Menno J.; Kroeze, Kim L.; Nazmi, Kamran; van den Keijbus, Petra A. M.; van't Hof, Wim; Fernandez-Borja, Mar; Hordijk, Peter L.; Gibbs, Susan; Bolscher, Jan G. M.; Veerman, Enno C. I.			Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1000-fold	FASEB JOURNAL			English	Article						antimicrobial peptides; cell migration; cyclic peptide; domain mapping; reepithelialization	EPIDERMAL-GROWTH-FACTOR; ANTIMICROBIAL PEPTIDES; KERATINOCYTE MIGRATION; CYCLIC-PEPTIDES; TRANSACTIVATION; DEFENSINS; RECEPTOR; CYTOKINES; MUCOSAL; BINDING	Wounds in the mouth heal faster and with less scarification and inflammation than those in the skin. Saliva is thought to be essential for the superior oral wound healing, but the involved mechanism is still unclear. We have previously discovered that a human-specific peptide, histatin, might be implicated in the wound-healing properties of saliva. Here we report that histatin enhances reepithelialization in a human full-skin wound model closely resembling normal skin. The peptide does not stimulate proliferation but induces cell spreading and migration, two key initiating steps in reepithelialization. Activation of cells by histatin requires a G-protein-coupled receptor that activates the ERK1/2 pathway. Using a stepwise-truncation method, we determined the minimal domain (SHREFPFYGDYGS) of the 38-mer-parent peptide that is required for activity. Strikingly, N- to C-terminal cyclization of histatin-1 potentiates the molar activity similar to 1000-fold, indicating that the recognition of histatin by its cognate receptor requires a specific spatial conformation of the peptide. Our results emphasize the importance of histatin in human saliva for tissue protection and recovery and establish the experimental basis for the development of synthetic histatins as novel skin wound-healing agents.-Oudhoff, M. J., Kroeze, K. L., Nazmi, K., van den Keijbus, P. A. M., van 't Hof, W., Fernandez-Borja, M., Hordijk, P. L., Gibbs, S., Bolscher, J. G. M., Veerman, E. C. I. Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1000-fold. FASEB J. 23, 3928-3935 (2009). www.fasebj.org	[Oudhoff, Menno J.; Nazmi, Kamran; van den Keijbus, Petra A. M.; van't Hof, Wim; Bolscher, Jan G. M.; Veerman, Enno C. I.] Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam, NL-1081 BT Amsterdam, Netherlands; [Oudhoff, Menno J.; Nazmi, Kamran; van den Keijbus, Petra A. M.; van't Hof, Wim; Bolscher, Jan G. M.; Veerman, Enno C. I.] Vrije Univ Amsterdam, NL-1081 BT Amsterdam, Netherlands; [Kroeze, Kim L.; Gibbs, Susan] Vrije Univ Amsterdam, Med Ctr, Dept Dermatol, Amsterdam, Netherlands; [Fernandez-Borja, Mar; Hordijk, Peter L.] Univ Amsterdam, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Acad Med Ctr, NL-1081 BT Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Oudhoff, MJ (corresponding author), Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam ACTA, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	mj.oudhoff@vumc.nl	Bolscher, Jan/ABF-6102-2021	Bolscher, Jan/0000-0001-5669-6164; Oudhoff, Menno/0000-0002-1180-8975; Hordijk, Peter/0000-0002-3348-078X	Skeletal Tissue Engineering Group Amsterdam (STEGA)	Skeletal Tissue Engineering Group Amsterdam (STEGA)	We thank Hakan Kalay (VU Medical Center, Amsterdam) for determining the mass of the peptides by mass spectrometry. E. C. I. V. gratefully acknowledges the support from the Skeletal Tissue Engineering Group Amsterdam (STEGA).	Aarbiou J, 2006, INFLAMM RES, V55, P119, DOI 10.1007/s00011-005-0062-9; ABRAMOFF MD, 2004, BIOPHOTON INT, V11, P26; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BAUM BJ, 1976, ARCH BIOCHEM BIOPHYS, V177, P427, DOI 10.1016/0003-9861(76)90455-0; Breetveld M, 2006, J INVEST DERMATOL, V126, P1918, DOI 10.1038/sj.jid.5700330; Brennand DM, 1997, FEBS LETT, V413, P70, DOI 10.1016/S0014-5793(97)00885-5; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Engeland CG, 2006, ARCH SURG-CHICAGO, V141, P1193, DOI 10.1001/archsurg.141.12.1193; FISHER DA, 1990, ENDOCR REV, V11, P418, DOI 10.1210/edrv-11-3-418; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Gibbs S, 2006, BRIT J DERMATOL, V155, P267, DOI 10.1111/j.1365-2133.2006.07266.x; Huang RP, 1996, J CELL BIOL, V133, P211, DOI 10.1083/jcb.133.1.211; HUTSON JM, 1979, NATURE, V279, P793, DOI 10.1038/279793a0; JACKSON S, 1994, J AM CHEM SOC, V116, P3220, DOI 10.1021/ja00087a007; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; KONTUREK SJ, 1988, GASTROENTEROLOGY, V94, P1300, DOI 10.1016/0016-5085(88)90667-1; Lorenowicz MJ, 2007, AM J PHYSIOL-LUNG C, V293, pL1321, DOI 10.1152/ajplung.00443.2006; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; MURPHY RA, 1980, J HISTOCHEM CYTOCHEM, V28, P890, DOI 10.1177/28.8.6969274; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Occleston NL, 2008, DRUG DISCOV TODAY, V13, P973, DOI 10.1016/j.drudis.2008.08.009; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; PONEC M, 1981, J INVEST DERMATOL, V76, P211, DOI 10.1111/1523-1747.ep12525761; Ruissen ALA, 2002, PEPTIDES, V23, P1391, DOI 10.1016/S0196-9781(02)00076-1; Stawikowski M, 2006, TETRAHEDRON LETT, V47, P8587, DOI 10.1016/j.tetlet.2006.09.116; Sun X, 2009, FASEB J, V23; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; VanWetering S, 1997, J LEUKOCYTE BIOL, V62, P217, DOI 10.1002/jlb.62.2.217; Veerman ECI, 2007, J BIOL CHEM, V282, P18831, DOI 10.1074/jbc.M610555200; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P636, DOI 10.1167/iovs.06-0203; Yokoyama F, 2004, BIOCHEMISTRY-US, V43, P13590, DOI 10.1021/bi049009u; Zhou NM, 2002, J BIOL CHEM, V277, P17476, DOI 10.1074/jbc.M202063200; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	40	69	75	3	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3928	3935		10.1096/fj.09-137588	http://dx.doi.org/10.1096/fj.09-137588			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19652025				2022-12-25	WOS:000271272500028
J	Breitinger, HG; Villmann, C; Melzer, N; Rennert, J; Breitinger, U; Schwarzinger, S; Becker, CM				Breitinger, Hans-Georg; Villmann, Carmen; Melzer, Nima; Rennert, Janine; Breitinger, Ulrike; Schwarzinger, Stephan; Becker, Cord-Michael			Novel Regulatory Site within the TM3-4 Loop of Human Recombinant alpha 3 Glycine Receptors Determines Channel Gating and Domain Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; NICOTINIC ACETYLCHOLINE-RECEPTOR; 5-HT3A RECEPTOR; LIGAND-BINDING; HYPEREKPLEXIA; SUBUNIT; MUTATION; DESENSITIZATION; ASSOCIATION; SELECTIVITY	Glycine receptors are Cys loop ligand-gated ion channels that mediate fast inhibitory synaptic transmission in the mammalian central nervous system. The functionally distinct splice variants alpha 3L and alpha 3K of the human glycine receptor differ by a 15-amino acid insert within the long intracellular TM3-4 loop, a region of high intersubunit diversity. In a mutational study, effects of the insert on ion channel function and secondary structure of the TM3-4 loop were investigated. Whole cell current responses and protein surface expression data indicated that the major effect of mutations within the insert was on channel gating. Changes in channel gating correlated with the distribution of charged residues about the splice region. Analysis of complex molecular weight indicated that recombinant TM3-4 loops of alpha 3L and alpha 3K associated into oligomers of different stoichiometry. Secondary structure analysis suggested that the insert stabilized the overall fold of the large cytoplasmic domain of alpha 3L subunits. The absence of the insert resulted in a channel that was still functional, but the TM3-4 cytoplasmic domain appeared not stably folded. Thus, our data identified the spliced insert within the large TM 3-4 loop of alpha 3 Gly receptors as a novel regulatory motif that serves a 2-fold role: (i) the presence of the insert stabilizes the overall spatial structure of the domain, and (ii) the insert presents a control unit that regulates gating of the receptor ion channel.	[Breitinger, Hans-Georg; Villmann, Carmen; Melzer, Nima; Rennert, Janine; Breitinger, Ulrike; Becker, Cord-Michael] Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Schwarzinger, Stephan] Univ Bayreuth, Lehrstuhl Biopolymere, D-95440 Bayreuth, Germany	University of Erlangen Nuremberg; University of Bayreuth	Becker, CM (corresponding author), Fahrstr 17, D-91054 Erlangen, Germany.	cmb@biochem.uni-erlangen.de	Breitinger, Hans-Georg/ABD-3247-2021; Schwarzinger, Stephan/O-4318-2014; Schwarzinger, Stephan/GWV-5819-2022	Breitinger, Hans-Georg/0000-0003-0111-3528; Schwarzinger, Stephan/0000-0002-0894-5290	Deutsche Forschungsgemeinschaft [SFB 359-A13]; Fonds der Chemischen Industrie [SPG 1026, BR 1507/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 359-A13 (to H.-G. B. and C.-M. B.), SPG 1026, and BR 1507/4 and by the Fonds der Chemischen Industrie.	Becker C. M., 1995, NEUROSCIENTIST, V1, P130; BECKER CM, 1989, J NEUROCHEM, V53, P124, DOI 10.1111/j.1471-4159.1989.tb07303.x; Becker K, 2000, CHANNELOPATHIES - COMMON MECHANISMS IN AURA, ARRHYTHMIA AND ALKALOSIS, P199, DOI 10.1016/B978-044450489-0/50010-0; Betz H, 1999, ANN NY ACAD SCI, V868, P667, DOI 10.1111/j.1749-6632.1999.tb11343.x; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Breitinger HG, 2002, J NEUROCHEM, V83, P30, DOI 10.1046/j.1471-4159.2002.01109.x; Breitinger HG, 2001, J BIOL CHEM, V276, P29657, DOI 10.1074/jbc.M100446200; Breitinger U, 2004, J BIOL CHEM, V279, P1627, DOI 10.1074/jbc.M303811200; Brune W, 1996, AM J HUM GENET, V58, P989; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P339; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Gee VJ, 2007, BRIT J PHARMACOL, V152, P501, DOI 10.1038/sj.bjp.0707429; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; HANNAPPEL E, 1988, ARCH BIOCHEM BIOPHYS, V260, P546, DOI 10.1016/0003-9861(88)90480-8; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; HESS GP, 1993, BIOCHEMISTRY-US, V32, P989, DOI 10.1021/bi00055a001; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kukhtina V, 2006, J NEUROCHEM, V97, P63, DOI 10.1111/j.1471-4159.2005.03468.x; Lee DJS, 2003, NEUROSCI LETT, V351, P196, DOI 10.1016/j.neulet.2003.08.005; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Moorhouse AJ, 1999, MOL PHARMACOL, V55, P386, DOI 10.1124/mol.55.2.386; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Saul B, 1999, J NEUROSCI, V19, P869; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Sreerama N, 1999, PROTEIN SCI, V8, P370; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wotring VE, 2003, J PHYSIOL-LONDON, V548, P527, DOI 10.1113/jphysiol.2002.032045	42	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28624	28633		10.1074/jbc.M109.043174	http://dx.doi.org/10.1074/jbc.M109.043174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19661067	hybrid, Green Published			2022-12-25	WOS:000270678900017
J	Liu, HL; Shim, AHR; He, XL				Liu, Heli; Shim, Ann H. R.; He, Xiaolin			Structural Characterization of the Ectodomain of a Disintegrin and Metalloproteinase-22 (ADAM22), a Neural Adhesion Receptor Instead of Metalloproteinase INSIGHTS ON ADAM FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; CRYSTAL-STRUCTURES; FAMILY; PROTEINS; ARCHITECTURE; PRODOMAIN; REVEAL; INFLAMMATION; PROTEASE; LGI1	ADAMs (a disintegrin and metalloproteinases) are a family of multidomain transmembrane glycoproteins with diverse roles in physiology and diseases, with several members being drug targets for cancer and inflammation therapies. The spatial organization of the ADAM extracellular segment and its influence on the function of ADAMs have been unclear. Although most members of the ADAM family are active zinc metalloproteinases, 8 of 21 ADAMs lack functional metalloproteinase domains and are implicated in protein-protein interactions instead of membrane protein ectodomain shedding. One of such non-proteinase ADAMs, ADAM22, acts as a receptor on the surface of the postsynaptic neuron to regulate synaptic signal transmission. The crystal structure of the full ectodomain of mature human ADAM22 shows that it is a compact four-leaf clover with the metalloproteinase-like domain held in the concave face of a rigid module formed by the disintegrin, cysteine-rich, and epidermal growth factor-like domains. The loss of metalloproteinase activity is ensured by the absence of critical catalytic residues, the filling of the substrate groove, and the steric hindrance by the cysteine-rich domain. The structure, combined with calorimetric experiments, suggests distinct roles of three putative calcium ions bound to ADAM22, with one in the metalloproteinase-like domain being regulatory and two in the disintegrin domain being structural. The metalloproteinase-like domain contacts the rest of ADAM22 with discontinuous, hydrophilic, and poorly complemented interactions, suggesting the possibility of modular movement of ADAM22 and other ADAMs. The ADAM22 structure provides a framework for understanding how different ADAMs exert their adhesive function and shedding activities.	[Liu, Heli; Shim, Ann H. R.; He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	He, XL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Searle 8-417,303 E Chicago Ave, Chicago, IL 60611 USA.	x-he@northwestern.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Duffy MJ, 2003, THROMB HAEMOSTASIS, V89, P622; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Gerhardt S, 2007, J MOL BIOL, V373, P891, DOI 10.1016/j.jmb.2007.07.047; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Lu X., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P29; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moss ML, 2004, BIOCHEMISTRY-US, V43, P7227, DOI 10.1021/bi049677f; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Novak U, 2004, J CLIN NEUROSCI, V11, P227, DOI 10.1016/j.jocn.2003.10.006; Orth P, 2004, J MOL BIOL, V335, P129, DOI 10.1016/j.jmb.2003.10.037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Sagane K, 1999, GENE, V236, P79, DOI 10.1016/S0378-1119(99)00253-X; Sagane K, 2008, INT J BIOL SCI, V4, P387; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shieh HS, 2008, J BIOL CHEM, V283, P1501, DOI 10.1074/jbc.M705879200; Sorensen HP, 2008, PROTEIN EXPRES PURIF, V61, P175, DOI 10.1016/j.pep.2008.05.020; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200	44	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29077	29086		10.1074/jbc.M109.014258	http://dx.doi.org/10.1074/jbc.M109.014258			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692335	hybrid, Green Published			2022-12-25	WOS:000270678900064
J	Friedman, MJ; Li, SH; Li, XJ				Friedman, Meyer J.; Li, Shihua; Li, Xiao-Jiang			Activation of Gene Transcription by Heat Shock Protein 27 May Contribute to Its Neuronal Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT CEREBELLAR-ATAXIA; TATA-BINDING PROTEIN; HUNTINGTONS-DISEASE; MOLECULAR CHAPERONES; MOUSE MODEL; ANDROGEN RECEPTOR; IN-VITRO; HSP27; POLYGLUTAMINE; EXPRESSION	Heat shock proteins are up-regulated as a physiological response to stressful stimuli and generally function as molecular chaperones for improperly folded protein substrates. The small heat shock protein HSP27 (or HSPB1) has multiple cytoplasmic roles. HSP27 also can translocate to the nucleus in response to stress, but the functional significance of this nuclear distribution has not been elucidated. We have previously implicated HSP27 as a genetic modifier of spinocerebellar ataxia 17 (SCA17), a neurological disease caused by a polyglutamine expansion in the TATA-binding protein (T]BP). Altered expression of HSP27 is also found in cell models of other polyglutamine diseases, including Huntington disease as well as SCA3 and SCA7. Here, we show that Hsp27, unlike Hsp70, is not detected in mutant TBP aggregates in primary cerebellar granule neurons from transgenic SCA17 mice. Although HSP27 overexpression does not reduce the aggregation of cotransfected mutant TBP containing 105 glutamines, it potentiates activated transcription from both TATA-containing and TATA-lacking promoters. Neither HSP40 nor HSP70 elicits the same transcriptional effect. Moreover, HSP27 interacts with the transcription factor SP1, and coexpression of SP1 and nuclear localization signal-tagged HSP27 synergistically activates reporter constructs for the SP1-responsive neurotrophic receptor genes Ngfr(p75) and TRKA. Overexpression of nuclear localization signal-tagged HSP27 also rescues mutant TBP-mediated down-regulation of TrkA in a PC12 cell model of SCA17. These results indicate that nuclear HSP27 can modulate SP1-dependent transcriptional activity to promote neuronal protection.	[Friedman, Meyer J.; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Friedman, Meyer J.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Emory University; University of California System; University of California San Diego	Li, SH (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	sli@emory.edu; xli2@emory.edu			National Institutes of Health [NS0465016, NS041669]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS045016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS0465016 (to S. L.) and NS041669 (to X.-J. L.).	Adhikari AS, 2004, EXP CELL RES, V299, P393, DOI 10.1016/j.yexcr.2004.05.032; Armstrong CL, 2001, J COMP NEUROL, V434, P262, DOI 10.1002/cne.1176; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Bryantsev AL, 2007, BIOCHEM J, V407, P407, DOI 10.1042/BJ20070195; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Chai YH, 1999, J NEUROSCI, V19, P10338; COLGAN J, 1992, GENE DEV, V6, P304, DOI 10.1101/gad.6.2.304; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Evert BO, 2003, J NEUROPATH EXP NEUR, V62, P1006, DOI 10.1093/jnen/62.10.1006; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fontaine JM, 2006, FASEB J, V20, P2168, DOI 10.1096/fj.06-5911fje; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Friedman MJ, 2008, J BIOL CHEM, V283, P8283, DOI 10.1074/jbc.M709674200; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Fujigasaki H, 2001, BRAIN, V124, P1939, DOI 10.1093/brain/124.10.1939; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Georget V, 2002, BIOCHEMISTRY-US, V41, P11824, DOI 10.1021/bi0259150; Geum D, 2002, J BIOL CHEM, V277, P19913, DOI 10.1074/jbc.M104396200; HAINAUT P, 1992, EMBO J, V11, P3513, DOI 10.1002/j.1460-2075.1992.tb05434.x; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Helmlinger D, 2002, HUM MOL GENET, V11, P3351, DOI 10.1093/hmg/11.26.3351; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Latchman DS, 2005, INT J HYPERTHER, V21, P393, DOI 10.1080/02656730400023664; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; MCCLAREN M, 1994, J INVEST DERMATOL, V102, P375, DOI 10.1111/1523-1747.ep12371798; Merienne K, 2003, J BIOL CHEM, V278, P16957, DOI 10.1074/jbc.M212049200; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Oesterreich S, 1996, BIOCHEM BIOPH RES CO, V222, P155, DOI 10.1006/bbrc.1996.0714; Orr AL, 2008, J BIOL CHEM, V283, P16027, DOI 10.1074/jbc.M710606200; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Quraishe S, 2008, NEUROSCIENCE, V153, P483, DOI 10.1016/j.neuroscience.2008.01.058; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Seo HR, 2006, J BIOL CHEM, V281, P17220, DOI 10.1074/jbc.M600062200; SHAH AG, 2009, HUM MOL GEN IN PRESS; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Tsai HF, 2005, BIOCHEM BIOPH RES CO, V334, P1279, DOI 10.1016/j.bbrc.2005.06.207; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Williams KL, 2006, J NEUROSCI RES, V84, P716, DOI 10.1002/jnr.20983; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057; Zourlidou A, 2007, HUM MOL GENET, V16, P1078, DOI 10.1093/hmg/ddm057	47	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27944	27951		10.1074/jbc.M109.037937	http://dx.doi.org/10.1074/jbc.M109.037937			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19656944	hybrid, Green Published			2022-12-25	WOS:000270676300022
J	Guo, P; Dong, XY; Zhao, KW; Sun, XD; Li, QN; Dong, JT				Guo, Peng; Dong, Xue-Yuan; Zhao, Kewen; Sun, Xiaodong; Li, Qunna; Dong, Jin-Tang			Opposing Effects of KLF5 on the Transcription of MYC in Epithelial Proliferation in the Context of Transforming Growth Factor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-5; HUMAN-BREAST-CANCER; CDK INHIBITOR P15(INK4B); HUMAN PROSTATE-CANCER; EMBRYONIC STEM-CELLS; C-MYC; TGF-BETA; SELF-RENEWAL; MEDIATED INDUCTION; TUMOR PROGRESSION	The proto-oncogene MYC plays a critical role in cell proliferation and tumorigenesis, and its down-regulation by transforming growth factor beta (TGF beta) signaling is necessary for TGF beta to inhibit cell proliferation. KLF5, on the other hand, is a pro-proliferative basic transcription factor that reverses function to become an anti-proliferative TGF beta cofactor upon TGF beta stimulation in epithelial homeostasis. In this study we investigated whether KLF5 directly regulates MYC transcription in epithelial cells in the context of TGF beta Knockdown of KLF5 significantly reduced MYC expression in the HaCaT epidermal epithelial cells. When TGF beta was applied, however, whereas MYC expression was significantly inhibited, knockdown of KLF5 increased MYC expression. Furthermore, re-expression of KLF5 restored the inhibitory effect of TGF beta on MYC expression in two cancer cell lines. Chromatin immunoprecipitation and oligo pulldown experiments demonstrated that whereas binding of KLF5 to both KLF5 binding element (KBE) and TGF beta inhibitory element (TIE) DNA elements was necessary for MYC transcription, binding to KBE was decreased by TGF beta and binding to TIE was increased by TGF beta These results suggest that KLF5 is not only essential for MYC transcription in proliferating epithelial cells but also mediates the inhibitory effect of TGF beta on MYC transcription. Furthermore, different binding sites mediate different effects of KLF5 in the context of TGF beta.	[Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Dong, JT (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, 1365-C Clifton Rd, Atlanta, GA 30322 USA.	jdong2@emory.edu	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019	Guo, Peng/0000-0002-4575-8443; Dong, Jin-Tang/0000-0003-2349-5782				Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; DUBIK D, 1988, J BIOL CHEM, V263, P12705; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Park BJ, 2000, CANCER RES, V60, P3031; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Sur I, 2002, EUR J CELL BIOL, V81, P323, DOI 10.1078/0171-9335-00257; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Waikel RL, 1999, ONCOGENE, V18, P4870, DOI 10.1038/sj.onc.1203040; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; WATSON PH, 1991, CANCER RES, V51, P3996; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200	47	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28243	28252		10.1074/jbc.M109.036160	http://dx.doi.org/10.1074/jbc.M109.036160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684017	Green Published, hybrid			2022-12-25	WOS:000270676300052
J	Liu, Y; Prasad, R; Beard, WA; Hou, EW; Horton, JK; McMurray, CT; Wilson, SH				Liu, Yuan; Prasad, Rajendra; Beard, William A.; Hou, Esther W.; Horton, Julie K.; McMurray, Cynthia T.; Wilson, Samuel H.			Coordination between Polymerase beta and FEN1 Can Modulate CAG Repeat Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; HUMAN FLAP ENDONUCLEASE-1; DNA SECONDARY STRUCTURE; TRANSGENIC MOUSE MODEL; PROTEIN CROSS-LINKS; HUMAN-DISEASE; TRINUCLEOTIDE REPEATS; MYOTONIC-DYSTROPHY; TRIPLET REPEATS; IN-VITRO	The oxidized DNA base 8-oxoguanine (8-oxoG) is implicated in neuronal CAG repeat expansion associated with Huntington disease, yet it is unclear how such a DNA base lesion and its repair might cause the expansion. Here, we discovered size-limited expansion of CAG repeats during repair of 8-oxoG in a wildtype mouse cell extract. This expansion was deficient in extracts from cells lacking pol beta and HMGB1. We demonstrate that expansion is mediated through pol beta multinucleotide gap-filling DNA synthesis during long-patch base excision repair. Unexpectedly, FEN1 promotes expansion by facilitating ligation of hairpins formed by strand slippage. This alternate role of FEN1 and the polymerase beta (pol beta) multinucleotide gap-filling synthesis is the result of uncoupling of the usual coordination between pol beta and FEN1. HMGB1 probably promotes expansion by stimulating APEI and FEN1 in forming single strand breaks and ligatable nicks, respectively. This is the first report illustrating that disruption of pol beta and FEN1 coordination during long-patch BER results in CAG repeat expansion.	[Liu, Yuan; Prasad, Rajendra; Beard, William A.; Hou, Esther W.; Horton, Julie K.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [McMurray, Cynthia T.] Mayo Clin & Mayo Fdn, Dept Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Mayo Clinic	Wilson, SH (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Classen, Scott/AAY-8176-2020; Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	NIEHS Intramural Research Program [Z01-ES050158, Z01-ES050159];  [GM066359];  [CA092584]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102546, ZIAES050158, ZIAES050159] Funding Source: NIH RePORTER	NIEHS Intramural Research Program; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Research Projects Z01-ES050158 and Z01-ES050159 from the NIEHS Intramural Research Program and Grants GM066359 and CA092584 (to C. T. M.).	Andersson P, 2006, EUR J CANCER, V42, P2833, DOI 10.1016/j.ejca.2006.06.030; ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Brosh RM, 2001, EMBO J, V20, P5791; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Cardozo-Pelaez F, 1999, MOVEMENT DISORD, V14, P972, DOI 10.1002/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; Delagoutte E, 2008, J BIOL CHEM, V283, P13341, DOI 10.1074/jbc.M800153200; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gacy AM, 1998, BIOCHEMISTRY-US, V37, P9426, DOI 10.1021/bi980157s; GACY AM, 1995, CELL, V81, P533; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hartenstine MJ, 2002, J BIOL CHEM, V277, P41379, DOI 10.1074/jbc.M207013200; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Henricksen LA, 2002, J BIOL CHEM, V277, P22361, DOI 10.1074/jbc.M201765200; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539; KOVLUN IV, 2001, NAT GENET, V27, P407; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Lia AS, 1998, HUM MOL GENET, V7, P1285, DOI 10.1093/hmg/7.8.1285; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu Y, 2004, MOL CELL BIOL, V24, P4049, DOI 10.1128/MCB.24.9.4049-4064.2004; Liu Y, 2003, J BIOL CHEM, V278, P13728, DOI 10.1074/jbc.M212061200; LIU Y, 2006, GENETIC INSTABILITIE, P667; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; Meservy JL, 2003, MOL CELL BIOL, V23, P3152, DOI 10.1128/MCB.23.9.3152-3162.2003; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Parniewski P, 1999, NUCLEIC ACIDS RES, V27, P616, DOI 10.1093/nar/27.2.616; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Richard GF, 2000, EMBO J, V19, P2381, DOI 10.1093/emboj/19.10.2381; Ruggiero BL, 2004, J BIOL CHEM, V279, P23088, DOI 10.1074/jbc.M313170200; Schildkraut JM, 2007, CANCER EPIDEM BIOMAR, V16, P473, DOI 10.1158/1055-9965.EPI-06-0868; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Spiro C, 2003, MOL CELL BIOL, V23, P6063, DOI 10.1128/MCB.23.17.6063-6074.2003; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Sung JS, 2005, J BIOL CHEM, V280, P39095, DOI 10.1074/jbc.M506480200; Sung JS, 2006, METHOD ENZYMOL, V408, P48, DOI 10.1016/S0076-6879(06)08004-9; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; WANG TSF, 1985, P NATL ACAD SCI USA, V82, P5270, DOI 10.1073/pnas.82.16.5270; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; White PJ, 1999, MOL CELL BIOL, V19, P5675; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson SH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P693; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001	68	93	95	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28352	28366		10.1074/jbc.M109.050286	http://dx.doi.org/10.1074/jbc.M109.050286			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674974	hybrid, Green Published			2022-12-25	WOS:000270676300061
J	Sabbadin, F; Jackson, R; Haider, K; Tampi, G; Turkenburg, JP; Hart, S; Bruce, NC; Grogan, G				Sabbadin, Federico; Jackson, Rosamond; Haider, Kamran; Tampi, Girish; Turkenburg, Johan P.; Hart, Sam; Bruce, Neil C.; Grogan, Gideon			The 1.5-angstrom Structure of XplA-heme, an Unusual Cytochrome P450 Heme Domain That Catalyzes Reductive Biotransformation of Royal Demolition Explosive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; CRYSTAL-STRUCTURES; DIOXYGEN COMPLEX; WILD-TYPE; SYSTEM; DEGRADATION; DENITRATION; METABOLISM; MECHANISMS; REVEALS	XplA is a cytochrome P450 of unique structural organization, consisting of a heme- domain that is C-terminally fused to its native flavodoxin redox partner. XplA, along with flavodoxin reductase XplB, has been shown to catalyze the breakdown of the nitramine explosive and pollutant hexahydro-1,3,5-trinitro-1,3,5-triazine (royal demolition explosive) by reductive denitration. The structure of the heme domain of XplA (XplA-heme) has been solved in two crystal forms: as a dimer in space group P2(1) to a resolution of 1.9 angstrom and as a monomer in space group P2(1)2(1)2 to a resolution of 1.5 angstrom, with the ligand imidazole bound at the heme iron. Although it shares the overall fold of cytochromes P450 of known structure, XplA-heme is unusual in that the kinked I-helix that traverses the distal face of the heme is broken by Met-394 and Ala-395 in place of the well conserved Asp/Glu plus Thr/Ser, important in oxidative P450s for the scission of the dioxygen bond prior to substrate oxygenation. The heme environment of XplA-heme is hydrophobic, featuring a cluster of three methionines above the heme, including Met-394. Imidazole was observed bound to the heme iron and is in close proximity to the side chain of Gln-438, which is situated over the distal face of the heme. Imidazole is also hydrogen-bonded to a water molecule that sits in place of the threonine side-chain hydroxyl exemplified by Thr-252 in Cyt-P450cam. Both Gln-438 -> Ala and Ala-395 -> Thr mutants of XplA-heme displayed markedly reduced activity compared with the wild type for royal demolition explosive degradation when combined with surrogate electron donors.	[Sabbadin, Federico; Haider, Kamran; Turkenburg, Johan P.; Hart, Sam; Grogan, Gideon] Univ York, Dept Biol, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Sabbadin, Federico; Jackson, Rosamond; Tampi, Girish; Bruce, Neil C.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5YW, N Yorkshire, England	University of York - UK; University of York - UK	Grogan, G (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England.	grogan@ysbl.york.ac.uk		Hart, Sam/0000-0002-3542-1126; Bruce, Neil Charles/0000-0003-0398-2997; Turkenburg, Johan/0000-0001-6992-6838	Strategic and Environmental Research and Development Program of the U.S. Dept. of Defense; Biotechnology and Biological Sciences Research Council; Centre of Excellence for Biocatalysis, Biotransformation, and Biomanufacture; Biotechnology and Biological Sciences Research Council [BB/E000576/1] Funding Source: researchfish; Medical Research Council [G0500367] Funding Source: researchfish; BBSRC [BB/E000576/1] Funding Source: UKRI; MRC [G0500367] Funding Source: UKRI	Strategic and Environmental Research and Development Program of the U.S. Dept. of Defense; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Centre of Excellence for Biocatalysis, Biotransformation, and Biomanufacture; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Strategic and Environmental Research and Development Program of the U.S. Dept. of Defense, by the Biotechnology and Biological Sciences Research Council, and by a studentship from the Centre of Excellence for Biocatalysis, Biotransformation, and Biomanufacture (to F. S.).	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; ALSTON TA, 1980, BIOCHEM BIOPH RES CO, V97, P294, DOI 10.1016/S0006-291X(80)80167-7; Andeer PF, 2009, APPL ENVIRON MICROB, V75, P3258, DOI 10.1128/AEM.02396-08; Atkin KE, 2008, J MOL BIOL, V384, P1218, DOI 10.1016/j.jmb.2008.09.090; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003; BINKS PR, 1995, APPL ENVIRON MICROB, V61, P1318, DOI 10.1128/AEM.61.4.1318-1322.1995; Bonsor D, 2006, ORG BIOMOL CHEM, V4, P1252, DOI 10.1039/b517338h; Boopathy R, 1998, CURR MICROBIOL, V37, P127, DOI 10.1007/s002849900350; Buzukov AA, 1996, CHEM-BIOL INTERACT, V100, P113, DOI 10.1016/0009-2797(96)03694-0; Clarke TA, 2008, BIOCHEMISTRY-US, V47, P3789, DOI 10.1021/bi702175w; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Cupp-Vickery JR, 2001, J MOL BIOL, V311, P101, DOI 10.1006/jmbi.2001.4803; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; HOFFSOMMER JC, 1977, J PHYS CHEM-US, V81, P380, DOI 10.1021/j100520a003; Jackson RG, 2007, P NATL ACAD SCI USA, V104, P16822, DOI 10.1073/pnas.0705110104; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; LOCKHART RW, 1976, J CHEM SOC CHEM COMM, P52; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; Meharenna YT, 2008, J BIOL CHEM, V283, P10804, DOI 10.1074/jbc.M709722200; Mellado E, 2004, ANTIMICROB AGENTS CH, V48, P2747, DOI 10.1128/AAC.48.7.2747-2750.2004; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; Obayashi E, 2000, J INORG BIOCHEM, V82, P103, DOI 10.1016/S0162-0134(00)00161-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson JA, 1998, STRUCTURE, V6, P1079, DOI 10.1016/S0969-2126(98)00109-9; POULOS TL, 1985, J BIOL CHEM, V260, P6122; Rylott EL, 2006, NAT BIOTECHNOL, V24, P216, DOI 10.1038/nbt1184; Santarelli LC, 2006, J PHYSIOL-LONDON, V571, P329, DOI 10.1113/jphysiol.2005.101089; SERVENT D, 1989, BIOCHEM BIOPH RES CO, V163, P1210, DOI 10.1016/0006-291X(89)91106-6; Seth-Smith HMB, 2008, APPL ENVIRON MICROB, V74, P4550, DOI 10.1128/AEM.00391-08; Seth-Smith HMB, 2002, APPL ENVIRON MICROB, V68, P4764, DOI 10.1128/AEM.68.10.4764-4771.2002; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Xiang H, 2000, J BIOL CHEM, V275, P35999, DOI 10.1074/jbc.M005811200; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; ZHAO JS, 2006, FEMS MICROBIOL ECOL, V39, P349	46	24	25	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28467	28475		10.1074/jbc.M109.031559	http://dx.doi.org/10.1074/jbc.M109.031559			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19692330	hybrid, Green Published			2022-12-25	WOS:000270676300071
J	Sturla, L; Fresia, C; Guida, L; Bruzzone, S; Scarfi, S; Usai, C; Fruscione, F; Magnone, M; Millo, E; Basile, G; Grozio, A; Jacchetti, E; Allegretti, M; De Flora, A; Zocchi, E				Sturla, Laura; Fresia, Chiara; Guida, Lucrezia; Bruzzone, Santina; Scarfi, Sonia; Usai, Cesare; Fruscione, Floriana; Magnone, Mirko; Millo, Enrico; Basile, Giovanna; Grozio, Alessia; Jacchetti, Emanuela; Allegretti, Marcello; De Flora, Antonio; Zocchi, Elena			LANCL2 Is Necessary for Abscisic Acid Binding and Signaling in Human Granulocytes and in Rat Insulinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; CELLULAR-SENSITIVITY; G-PROTEINS; RECEPTOR; INFLAMMATION; EXPRESSION; GPCR; 2ND-MESSENGER; BIOSYNTHESIS; ACTIVATION	Abscisic acid (ABA) is a plant hormone regulating fundamental physiological functions in plants, such as response to abiotic stress. Recently, ABA was shown to be produced and released by human granulocytes, by insulin-producing rat insulinoma cells, and by human and murine pancreatic beta cells. ABA autocrinally stimulates the functional activities specific for each cell type through a receptor-operated signal transduction pathway, sequentially involving a pertussis toxin-sensitive receptor/G-protein complex, cAMP, CD38-produced cADP-ribose and intracellular calcium. Here we show that the lanthionine synthetase C-like protein LANCL2 is required for ABA binding on the membrane of human granulocytes and that LANCL2 is necessary for transduction of the ABA signal into the cell-specific functional responses in granulocytes and in rat insulinoma cells. Co-expression of LANCL2 and CD38 in the human HeLa cell line reproduces the ABA-signaling pathway. Results obtained with granulocytes and CD38(+)/LANCL2(+) HeLa transfected with a chimeric G-protein (G alpha(q/i)) suggest that the pertussis toxin-sensitive G-protein coupled to LANCL2 is a G(i). Identification of LANCL2 as a critical component of the ABA-sensing protein complex will enable the screening of synthetic ABA antagonists as prospective new anti-inflammatory and anti-diabetic agents.	[Sturla, Laura; Fresia, Chiara; Guida, Lucrezia; Bruzzone, Santina; Scarfi, Sonia; Magnone, Mirko; Millo, Enrico; Basile, Giovanna; Grozio, Alessia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Sturla, Laura; Fresia, Chiara; Guida, Lucrezia; Bruzzone, Santina; Scarfi, Sonia; Magnone, Mirko; Millo, Enrico; Basile, Giovanna; Grozio, Alessia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Scarfi, Sonia; Fruscione, Floriana; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Usai, Cesare; Jacchetti, Emanuela] CNR, Inst Biophys, I-16149 Genoa, Italy; [Allegretti, Marcello] Dompe Pharma, I-67100 Laquila, Italy	University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Dompe	De Flora, A (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto XV 1, I-16132 Genoa, Italy.	toninodf@unige.it; ezocchi@unige.it	Millo, Enrico/K-3218-2018; fruscione, floriana/AAA-8747-2020; JACCHETTI, Emanuela/AAP-2453-2021; Scarfi, Sonia/AAJ-2387-2020; Bruzzone, Santina/A-4264-2015	Millo, Enrico/0000-0002-4019-0051; JACCHETTI, Emanuela/0000-0001-5990-001X; Scarfi, Sonia/0000-0002-7079-6919; Bruzzone, Santina/0000-0003-2034-3716; Usai, Cesare/0000-0001-8863-7759; fruscione, floriana/0000-0002-4054-645X; FRESIA, CHIARA MARTA/0000-0002-9177-4655	Regione Liguria; Ministero dell'Istruzione; dell'Universita e della Ricerca; University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia	Regione Liguria(Regione Liguria); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia	This work was supported by grants from Regione Liguria, Ministero dell'Istruzione, dell'Universita e della Ricerca, the University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia.	Bauer H, 2000, BIOCHEM BIOPH RES CO, V275, P69, DOI 10.1006/bbrc.2000.3260; Bodrato N, 2009, J BIOL CHEM, V284, P14777, DOI 10.1074/jbc.M802604200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Dorn GW, 1997, BIOCHEMISTRY-US, V36, P6415, DOI 10.1021/bi970080s; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; GUIDA L, 1995, FEBS LETT, V368, P481, DOI 10.1016/0014-5793(95)00715-L; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Illingworth CJR, 2008, BIOPHYS CHEM, V133, P28, DOI 10.1016/j.bpc.2007.11.004; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Katoh M, 2003, INT J MOL MED, V12, P399; Kim K, 2008, ARCH PHARM RES, V31, P310, DOI 10.1007/s12272-001-1157-x; Landlinger C, 2006, BBA-BIOMEMBRANES, V1758, P1759, DOI 10.1016/j.bbamem.2006.07.018; LeBrasseur N, 2007, J CELL BIOL, V179, P174, DOI 10.1083/jcb.1792pi; LEE HC, 2002, CYCLIC ADP RIBOSE NA, P23; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Mayer H, 1998, BBA-GENE STRUCT EXPR, V1395, P301, DOI 10.1016/S0167-4781(97)00178-4; Mayer H, 2001, CYTOGENET CELL GENET, V93, P100, DOI 10.1159/000056958; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park S, 2003, CANCER RES, V63, P723; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; SIMCHOWITZ L, 1980, J IMMUNOL, V124, P1482; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; Tsu RC, 1996, J NEUROSCI, V16, P1317; Utsumi T, 2005, FEBS J, V272, P472, DOI 10.1111/j.1742-4658.2004.04487.x; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	43	88	100	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28045	28057		10.1074/jbc.M109.035329	http://dx.doi.org/10.1074/jbc.M109.035329			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19667068	Green Published, hybrid			2022-12-25	WOS:000270676300032
J	Chen, L; Zhang, JJ; Rafii, S; Huang, XY				Chen, Lin; Zhang, J. Jillian; Rafii, Shahin; Huang, Xin-Yun			Suppression of Tumor Angiogenesis by G alpha(13) Haploinsufficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; BONE-MARROW; G-PROTEINS; NEOVASCULARIZATION; METASTASIS; MIGRATION; RECRUITMENT; SWITCH	Heterotrimeric G proteins are critical transducers of cellular signaling. Of the four families of G proteins, the physiological function of G alpha(13) is less well understood. G alpha(13) gene-deleted mice die at embryonic day similar to 9.5. Here, we show that heterozygous G alpha(+/-)(13) mice display defects in adult angiogenesis. Female G alpha(+/-)(13) mice showed a higher number of immature follicles and a lower density of blood vessels in the mature corpus luteum compared with G alpha(+/-)(13) mice. Furthermore, implanted tumors grew slower in G alpha(+/-)(13) host mice. These tumor tissues had many fewer blood vessels compared with those from G alpha(+/+)(13) host mice. Moreover, bone marrow-derived progenitor cells from G alpha(+/+)(13) mice rescued the failed growth of allografted tumors when reconstituted into irradiated G alpha(+/-)(13) mice. Hence, G alpha(13) is haploinsufficient for adult angiogenesis in both the female reproductive system and tumor angiogenesis.	[Chen, Lin; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Dept Physiol, New York, NY 10065 USA; [Rafii, Shahin] Cornell Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Rafii, Shahin] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10065 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University	Huang, XY (corresponding author), Cornell Univ, Dept Physiol, New York, NY 10065 USA.	xyhuang@med.cornell.edu			National Institutes of Health [HL91525]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL91525.	Adams GB, 2009, NATURE, V459, P103, DOI 10.1038/nature07859; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fraser HM, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-18; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Rafii S, 2008, SCIENCE, V319, P163, DOI 10.1126/science.1153615; Redmer D A, 1996, Rev Reprod, V1, P182; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Seandel M, 2008, CANCER CELL, V13, P181, DOI 10.1016/j.ccr.2008.02.016; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; VRCIC H, 1992, GYNECOL OBSTET INVES, V33, P69; Wang DW, 2006, J BIOL CHEM, V281, P32660, DOI 10.1074/jbc.M604588200; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200	31	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27409	27415		10.1074/jbc.M109.025460	http://dx.doi.org/10.1074/jbc.M109.025460			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654325	hybrid, Green Published			2022-12-25	WOS:000270232300043
J	Narasimhachar, Y; Coue, M				Narasimhachar, Yadushyla; Coue, Martine			Geminin Stabilizes Cdt1 during Meiosis in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK-DEPENDENT UBIQUITINATION; LICENSING FACTOR CDT1; CELL-CYCLE REGULATION; DNA-REPLICATION; EGG EXTRACTS; S-PHASE; PREVENTS REREPLICATION; TRANSLATIONAL CONTROL; RE-REPLICATION; NUCLEAR IMPORT	During the mitotic cell cycle, Geminin can act both as a promoter and inhibitor of initiation of DNA replication. As a promoter, Geminin stabilizes Cdt1 and facilitates its accumulation leading to the assembly of the pre-replication complex on DNA. As an inhibitor, Geminin prevents Cdt1 from loading the minichromosome maintenance complex onto pre-replication complexes in late S, G(2), and M phases. Here we show that during meiosis Geminin functions as a stabilizer of Cdt1 promoting its accumulation for the early division cycles of the embryo. Depletion of Geminin in Xenopus immature oocytes leads to a decrease of Cdt1 protein levels during maturation and after activation of these oocytes. Injection of exogenous recombinant Geminin into the depleted oocytes rescues Cdt1 levels demonstrating that Geminin stabilizes Cdt1 during meiosis and after fertilization. Furthermore, Geminin-depleted oocytes did not replicate their DNA after meiosis I indicating that Geminin does not act as an inhibitor of initiation of DNA replication between meiosis I and meiosis II.	[Narasimhachar, Yadushyla; Coue, Martine] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Narasimhachar, Y (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA.	yadushyla.narasimhachar@ttuhsc.edu; martine.coue@ttuhsc.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health grant (to M. C.).	Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Auziol C, 2007, BIOCHEM BIOPH RES CO, V361, P276, DOI 10.1016/j.bbrc.2007.06.117; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Chang HY, 2004, J CELL SCI, V117, P6289, DOI 10.1242/jcs.01567; Coue M, 1996, EMBO J, V15, P1085, DOI 10.1002/j.1460-2075.1996.tb00446.x; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; Gopalakrishnan V, 2001, P NATL ACAD SCI USA, V98, P13114, DOI 10.1073/pnas.221467598; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hochegger H, 2001, DEVELOPMENT, V128, P3795; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Lemaitre JM, 2002, NATURE, V419, P718, DOI 10.1038/nature01046; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li A, 2004, CELL CYCLE, V3, P443; Li A, 2004, NAT CELL BIOL, V6, P260, DOI 10.1038/ncb1100; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Lutzmann M, 2008, MOL CELL, V31, P190, DOI 10.1016/j.molcel.2008.07.001; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Lygerou Z, 2000, SCIENCE, V290, P2271; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Madine M, 2001, NAT CELL BIOL, V3, pE49, DOI 10.1038/35055158; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, CELL CYCLE, V3, P1002; Nakajo N, 2000, GENE DEV, V14, P328; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; OHSUMI K, 1994, J CELL SCI, V107, P3005; Papin C, 2004, DEV BIOL, V272, P66, DOI 10.1016/j.ydbio.2004.04.018; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Saxena S, 2003, CELL CYCLE, V2, P283, DOI 10.4161/cc.2.4.443; Setoyama D, 2007, P NATL ACAD SCI USA, V104, P18001, DOI 10.1073/pnas.0706952104; Sugimoto N, 2008, MOL BIOL CELL, V19, P1007, DOI 10.1091/mbc.E07-09-0859; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Whitmire E, 2002, NATURE, V419, P722, DOI 10.1038/nature01032; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025; Yanagi K, 2005, J BIOL CHEM, V280, P19689, DOI 10.1074/jbc.C500070200; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; Yoshida K, 2005, GENES CELLS, V10, P63, DOI 10.1111/j.1365-2443.2005.00815.x; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhou Y, 2002, BIOCHEM BIOPH RES CO, V294, P120, DOI 10.1016/S0006-291X(02)00447-3; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559	58	9	11	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27235	27242		10.1074/jbc.M109.008854	http://dx.doi.org/10.1074/jbc.M109.008854			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656945	Green Published, hybrid			2022-12-25	WOS:000270232300024
J	Miller, M; Cook, HA; Furuya, EY; Bhat, M; Lee, MH; Vavagiakis, P; Visintainer, P; Vasquez, G; Larson, E; Lowy, FD				Miller, Maureen; Cook, Heather A.; Furuya, E. Yoko; Bhat, Meera; Lee, Mei-Ho; Vavagiakis, Peter; Visintainer, Paul; Vasquez, Glenny; Larson, Elaine; Lowy, Franklin D.			Staphylococcus aureus in the Community: Colonization Versus Infection	PLOS ONE			English	Article								Background: Antibiotic-resistant Staphylococcus aureus infections have increased dramatically in the community, yet S. aureus nasal colonization has remained stable. The objectives of this study were to determine if S. aureus colonization is a useful proxy measure to study disease transmission and infection in community settings, and to identify potential community reservoirs. Methodology/Principal Findings: Randomly selected households in Northern Manhattan, completed a structured social network questionnaire and provided nasal swabs that were typed by pulsed field gel electrophoresis to identify S. aureus colonizing strains. The main outcome measures were: 1) colonization with S. aureus; and 2) recent serious skin infection. Risk factor analyses were conducted at both the individual and the household levels; logistic regression models identified independent risks for household colonization and infection. Results: 321 surveyed households contained 914 members. The S. aureus prevalence was 25% and MRSA was 0.4%. More than 40% of households were colonized. Recent antibiotic use was the only significant correlate for household colonization (p = .002). Seventy-eight (24%) households reported serious skin infection. In contrast with colonization, five of the six risk factors that increased the risk of skin infection in the household at the univariate level remained independently significant in multivariable analysis: international travel, sports participation, surgery, antibiotic use and towel sharing. S. aureus colonization was not significantly associated with serious skin infection in any analysis. Among multiperson households with more than one person colonized, 50% carried the same strain. Conclusions/Significance: The lack of association between S. aureus nasal colonization and serious skin infection underscores the need to explore alternative venues or body sites that may be crucial to transmission. Moreover, the magnitude of colonization and infection within the household suggests that households are an underappreciated and substantial community reservoir.			Miller, M (corresponding author), New York Med Coll, Dept Epidemiol & Biostat, Sch Publ Hlth, Valhalla, NY 10595 USA.	fl189@columbia.edu	Lee, Mei-Ho/ABA-1514-2021	Lee, Mei-Ho/0000-0001-9206-6805; Visintainer, Paul/0000-0002-2491-1242	PHS HHS [CCR223380] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; Cook HA, 2007, CLIN INFECT DIS, V44, P410, DOI 10.1086/510681; DIEP BA, 2008, ANN INTERN MED; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Friedman SR, 1997, AM J PUBLIC HEALTH, V87, P1289, DOI 10.2105/AJPH.87.8.1289; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Keene A, 2005, INFECT CONT HOSP EP, V26, P622, DOI 10.1086/502591; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Miller M, 2007, CLIN INFECT DIS, V45, P343, DOI 10.1086/519429; Moran GJ, 2005, ANN EMERG MED, V45, P321, DOI 10.1016/j.annemergmed.2004.11.007; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Reischl U, 2000, J CLIN MICROBIOL, V38, P2429; ROODYN LEONARD, 1960, JOUR HYG, V58, P1; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; WEINSTEIN HJ, 1959, NEW ENGL J MED, V260, P1303, DOI 10.1056/NEJM195906252602601; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	26	62	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6708	10.1371/journal.pone.0006708	http://dx.doi.org/10.1371/journal.pone.0006708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693269	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267400015
J	Li, D; Raza, A; DeJong, J				Li, Dan; Raza, Abbas; DeJong, Jeff			Regulation of ALF Promoter Activity in Xenopus Oocytes	PLOS ONE			English	Article								Background: In this report we evaluate the use of Xenopus laevis oocytes as a matched germ cell system for characterizing the organization and transcriptional activity of a germ cell-specific X. laevis promoter. Principal Findings: The promoter from the ALF transcription factor gene was cloned from X. laevis genomic DNA using a PCR-based genomic walking approach. The endogenous ALF gene was characterized by RACE and RT-PCR for transcription start site usage, and by sodium bisulfite sequencing to determine its methylation status in somatic and oocyte tissues. Homology between the X. laevis ALF promoter sequence and those from human, chimpanzee, macaque, mouse, rat, cow, pig, horse, dog, chicken and X. tropicalis was relatively low, making it difficult to use such comparisons to identify putative regulatory elements. However, microinjected promoter constructs were very active in oocytes and the minimal promoter could be narrowed by PCR-mediated deletion to a region as short as 63 base pairs. Additional experiments using a series of site-specific promoter mutants identified two cis-elements within the 63 base pair minimal promoter that were critical for activity. Both elements (A and B) were specifically recognized by proteins present in crude oocyte extracts based on oligonucleotide competition assays. The activity of promoter constructs in oocytes and in transfected somatic Xenopus XLK-WG kidney epithelial cells was quite different, indicating that the two cell types are not functionally equivalent and are not interchangeable as assay systems. Conclusions: Overall the results provide the first detailed characterization of the organization of a germ cell-specific Xenopus promoter and demonstrate the feasibility of using immature frog oocytes as an assay system for dissecting the biochemistry of germ cell gene regulation.			Li, D (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA.	dejong@utdallas.edu		Li, Dan/0000-0002-8841-8991				Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Brown DD, 2004, J BIOL CHEM, V279, P45291, DOI 10.1074/jbc.X400008200; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DeJong J, 2006, GENE, V366, P39, DOI 10.1016/j.gene.2005.10.012; EISENBERG SP, 1985, MOL CELL BIOL, V5, P1940, DOI 10.1128/MCB.5.8.1940; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Freiman RN, 2009, BBA-GENE REGUL MECH, V1789, P161, DOI 10.1016/j.bbagrm.2009.01.005; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Han SY, 2004, BIOL REPROD, V71, P933, DOI 10.1095/biolreprod.104.030247; Han SY, 2003, J BIOL CHEM, V278, P45586, DOI 10.1074/jbc.M302884200; Han SY, 2001, BIOL REPROD, V64, P507, DOI 10.1095/biolreprod64.2.507; Hellsten U, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-31; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Jallow Z, 2004, P NATL ACAD SCI USA, V101, P13525, DOI 10.1073/pnas.0405536101; Kim M, 2006, J BIOL CHEM, V281, P34288, DOI 10.1074/jbc.M607168200; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Ozer J, 2000, J BIOL CHEM, V275, P122, DOI 10.1074/jbc.275.1.122; Song JL, 2005, DIFFERENTIATION, V73, P1, DOI 10.1111/j.1432-0436.2005.07301005.x; TOYODA T, 1992, DEV BIOL, V153, P150, DOI 10.1016/0012-1606(92)90099-3; Trasler JM, 1998, SEMIN CELL DEV BIOL, V9, P467, DOI 10.1006/scdb.1998.0225; Upadhyaya AB, 1999, J BIOL CHEM, V274, P18040, DOI 10.1074/jbc.274.25.18040; Upadhyaya AB, 2002, J BIOL CHEM, V277, P34208, DOI 10.1074/jbc.M204808200; Xiao LJ, 2006, GENE EXPR PATTERNS, V6, P409, DOI 10.1016/j.modgep.2005.09.005; Xie WS, 2002, J BIOL CHEM, V277, P17765, DOI 10.1074/jbc.M200954200; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6664	10.1371/journal.pone.0006664	http://dx.doi.org/10.1371/journal.pone.0006664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684851	Green Submitted, Green Published, gold			2022-12-25	WOS:000269075600001
J	Santamaria, B; Benito-Martin, A; Ucero, AC; Aroeira, LS; Reyero, A; Vicent, MJ; Orzaez, M; Celdran, A; Esteban, J; Selgas, R; Ruiz-Ortega, M; Cabrera, ML; Egido, J; Perez-Paya, E; Ortiz, A				Santamaria, Beatriz; Benito-Martin, Alberto; Conrado Ucero, Alvaro; Stark Aroeira, Luiz; Reyero, Ana; Jesus Vicent, Maria; Orzaez, Mar; Celdran, Angel; Esteban, Jaime; Selgas, Rafael; Ruiz-Ortega, Marta; Lopez Cabrera, Manuel; Egido, Jesus; Perez-Paya, Enrique; Ortiz, Alberto			A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IN-VITRO MODEL; PERITONEAL-DIALYSIS; INDUCED APOPTOSIS; REGULATORY PROTEINS; TUBULAR EPITHELIUM; CYTOCHROME-C; DEATH; ACTIVATION; RECEPTOR	Background: Inflammation may lead to tissue injury. We have studied the modulation of inflammatory milieu-induced tissue injury, as exemplified by the mesothelium. Peritoneal dialysis is complicated by peritonitis episodes that cause loss of mesothelium. Proinflammatory cytokines are increased in the peritoneal cavity during peritonitis episodes. However there is scarce information on the modulation of cell death by combinations of cytokines and on the therapeutic targets to prevent desmesothelization. Methodology: Human mesothelial cells were cultured from effluents of stable peritoneal dialysis patients and from omentum of non-dialysis patients. Mesothelial cell death was studied in mice with S. aureus peritonitis and in mice injected with tumor necrosis factor alpha and interferon gamma. Tumor necrosis factor alpha and interferon gamma alone do not induce apoptosis in cultured mesothelial cells. By contrast, the cytokine combination increased the rate of apoptosis 2 to 3-fold over control. Cell death was associated with the activation of caspases and a pancaspase inhibitor prevented apoptosis. Specific caspase-8 and caspase-3 inhibitors were similarly effective. Co-incubation with both cytokines also impaired mesothelial wound healing in an in vitro model. However, inhibition of caspases did not improve wound healing and even impaired the long-term recovery from injury. By contrast, a polymeric nanoconjugate Apaf-1 inhibitor protected from apoptosis and allowed wound healing and long-term recovery. The Apaf-1 inhibitor also protected mesothelial cells from inflammation-induced injury in vivo in mice. Conclusion: Cooperation between tumor necrosis factor alpha and interferon gamma contributes to mesothelial injury and impairs the regenerative capacity of the monolayer. Caspase inhibition attenuates mesothelial cell apoptosis but does not facilitate regeneration. A drug targeting Apaf-1 allows protection from apoptosis as well as regeneration in the course of inflammation-induced tissue injury.	[Santamaria, Beatriz; Benito-Martin, Alberto; Conrado Ucero, Alvaro; Reyero, Ana; Celdran, Angel; Ortiz, Alberto] Univ Autonoma Madrid, Fdn Jimenez Diaz, Dialysis Unit, Inst Reina Sofia Invest Nefrol, Madrid, Spain; [Stark Aroeira, Luiz; Selgas, Rafael] Hosp Univ La Paz, Serv Nefrol, Madrid, Spain; [Jesus Vicent, Maria] Ctr Invest Principe Felipe, Dept Med Chem, Polymer Therapeut Lab, Valencia, Spain; [Ruiz-Ortega, Marta; Egido, Jesus] Univ Autonoma Madrid, Lab Renal & Vasc Res, Madrid, Spain; [Lopez Cabrera, Manuel] Hosp Univ Princesa, Dept Mol Biol, Madrid, Spain; [Orzaez, Mar; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Dept Med Chem, Peptide & Prot Lab, Valencia, Spain; [Perez-Paya, Enrique] CSIC, Inst Biomed Valencia, Valencia, Spain; [Esteban, Jaime] Fdn Jimenez Diaz, Microbiol Serv, E-28040 Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Prince Felipe Research Center; Autonomous University of Madrid; Hospital de La Princesa; Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Santamaria, B (corresponding author), Univ Autonoma Madrid, Fdn Jimenez Diaz, Dialysis Unit, Inst Reina Sofia Invest Nefrol, Madrid, Spain.	aortiz@fjd.es	Vicent, Maria J./O-3664-2019; Aroeira, Luiz Stark/D-7558-2014; Ucero, Alvaro C/C-8437-2013; Ortega, Marta Ruiz/AAN-2136-2020; Ruiz-Ortega, Marta/D-3584-2012; Santamaria, Beatriz/B-3469-2015; Benito-Martin, Alberto/GLU-6164-2022; Esteban, Jaime/S-6554-2018; ortiz, alberto/Y-7582-2018; Esteban, Jaime/W-2049-2019; Orzaez, Mar/B-4992-2014; Ucero, Alvaro Conrado/AGQ-2114-2022; Vicent, Maria J. J/A-9690-2014; ruiz-ortega, marta/D-3584-2012	Vicent, Maria J./0000-0001-7771-3373; Aroeira, Luiz Stark/0000-0001-9391-1409; Ucero, Alvaro C/0000-0002-5575-0808; Ortega, Marta Ruiz/0000-0002-1495-6535; Ruiz-Ortega, Marta/0000-0002-1495-6535; Santamaria, Beatriz/0000-0002-1990-2106; Benito-Martin, Alberto/0000-0002-0700-3891; Esteban, Jaime/0000-0002-8971-3167; ortiz, alberto/0000-0002-9805-9523; Orzaez, Mar/0000-0003-3231-5835; Ucero, Alvaro Conrado/0000-0002-5575-0808; Vicent, Maria J. J/0000-0001-7771-3373; Lopez Cabrera, Manuel/0000-0002-0976-9719; ruiz-ortega, marta/0000-0002-1403-2690	ISCIII [01/0199, 06/0046]; ISCIII-RETIC [REDinREN/RD06/0016]; Comunidad de Madrid [FRACM/S-BIO0283/2006]; Sociedad Espanola de Nefrologi-a; Fresenius Medical Care, Programa Intensificacion Actividad Investigadora Sistema Nacional de Salud ISCIII/CM; MEC [BIO2004-998, BIO2007-60066, CTQ2007-60601]; GVA [GV07/070]; Fundacion Conchita Rabago; Fondo de Investigaciones Sanitarias (FIS)	ISCIII(Instituto de Salud Carlos III); ISCIII-RETIC(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Sociedad Espanola de Nefrologi-a; Fresenius Medical Care, Programa Intensificacion Actividad Investigadora Sistema Nacional de Salud ISCIII/CM; MEC(European Commission); GVA; Fundacion Conchita Rabago; Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III)	Grant support: ISCIII (01/0199, 06/0046, ISCIII-RETIC REDinREN/RD06/0016, Comunidad de Madrid/FRACM/S-BIO0283/2006, Sociedad Espanola de Nefrologi-a, and Fresenius Medical Care, Programa Intensificacion Actividad Investigadora Sistema Nacional de Salud ISCIII/CM to AO, MEC (BIO2004-998 and BIO2007-60066) to EPP, MEC (CTQ2007-60601) and GVA (GV07/070) to MJV. BS and ACU were supported by Fundacion Conchita Rabago and AB by Fondo de Investigaciones Sanitarias (FIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BAKER AJ, 1994, J CLIN INVEST, V94, P2105, DOI 10.1172/JCI117565; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; BEN MT, 2007, HEPATOLOGY, V45, P1014; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; Brauner A, 1996, AM J KIDNEY DIS, V27, P402, DOI 10.1016/S0272-6386(96)90364-9; Broaddus VC, 1996, J CLIN INVEST, V98, P2050, DOI 10.1172/JCI119010; Catalan MP, 2003, KIDNEY INT, V64, P321, DOI 10.1046/j.1523-1755.2003.00062.x; Catalan MP, 2003, PERITON DIALYSIS INT, V23, P123; Catalan MP, 2001, J AM SOC NEPHROL, V12, P2442, DOI 10.1681/ASN.V12112442; Catalan MPE, 2005, KIDNEY INT, V68, P1303; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chen JY, 2003, NEPHROL DIAL TRANSPL, V18, P1741, DOI 10.1093/ndt/gfg275; Chen XY, 2007, MOL CELL BIOL, V27, P541, DOI 10.1128/MCB.01166-06; Crum NF, 2005, MEDICINE, V84, P291, DOI 10.1097/01.md.0000180044.19285.9a; DASGUPTA MK, 1994, KIDNEY INT, V46, P475, DOI 10.1038/ki.1994.297; DI PN, 2000, PERITON DIAL INT S3, V20, pS5; Diaz C, 1998, ADV PERIT D, V14, P19; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Gastaldello K, 2008, PERITON DIALYSIS INT, V28, P655; Gdynia G, 2007, MOL CANCER RES, V5, P1232, DOI 10.1158/1541-7786.MCR-07-0343; Guillermet J, 2003, P NATL ACAD SCI USA, V100, P155, DOI 10.1073/pnas.0136771100; Haider AS, 2003, CYTOM PART A, V53A, P1, DOI 10.1002/cyto.a.10032; Haslinger-Loffler B, 2006, KIDNEY INT, V70, P1089, DOI 10.1038/sj.ki.5001710; Heath RM, 2004, BRIT J CANCER, V90, P1437, DOI 10.1038/sj.bjc.6601635; HEIMBURGER O, 2007, HDB DIALYSIS, P339; Hill Michelle M, 2003, Mol Interv, V3, P19, DOI 10.1124/mi.3.1.19; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jimenez LA, 1997, AM J PHYSIOL-LUNG C, V273, pL1029, DOI 10.1152/ajplung.1997.273.5.L1029; Justo P, 2006, KIDNEY INT, V69, P2205, DOI 10.1038/sj.ki.5000444; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; Justo P, 2003, J AM SOC NEPHROL, V14, P3072, DOI 10.1097/01.ASN.0000099383.57934.0E; Kondo S, 2006, MOL CELL BIOL, V26, P7258, DOI 10.1128/MCB.00183-06; Lee DH, 2009, PERITON DIALYSIS INT, V29, P44; Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lorz C, 2000, J AM SOC NEPHROL, V11, P1266, DOI 10.1681/ASN.V1171266; Lorz C, 2004, J AM SOC NEPHROL, V15, P380, DOI 10.1097/01.ASN.0000111289.91206.B0; Malet G, 2006, CELL DEATH DIFFER, V13, P1523, DOI 10.1038/sj.cdd.4401828; Marchi E, 2000, AM J PHYSIOL-LUNG C, V278, pL528, DOI 10.1152/ajplung.2000.278.3.L528; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Mondragon L, 2009, APOPTOSIS, V14, P182, DOI 10.1007/s10495-008-0310-x; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; Ortiz A, 2000, KIDNEY INT, V58, P467, DOI 10.1046/j.1523-1755.2000.00188.x; Ortiz A, 2004, PERITON DIALYSIS INT, V24, P105; Ortiz A, 1998, KIDNEY INT, V54, pS25, DOI 10.1046/j.1523-1755.1998.06808.x; Pei YH, 2007, APOPTOSIS, V12, P1681, DOI 10.1007/s10495-007-0091-7; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; Polverino AJ, 1997, J BIOL CHEM, V272, P7013, DOI 10.1074/jbc.272.11.7013; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Saliu OY, 2006, J INFECT DIS, V194, P486, DOI 10.1086/505430; Santamaria B, 2008, NEPHROL DIAL TRANSPL, V23, P3307, DOI 10.1093/ndt/gfn273; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Szeto CC, 2006, NEPHRON EXP NEPHROL, V103, pE166, DOI 10.1159/000092907; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; VERGER C, 1983, KIDNEY INT, V23, P823, DOI 10.1038/ki.1983.101; Vicent MJ, 2006, J MED CHEM, V49, P3763, DOI 10.1021/jm060458x; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Webber EM, 1998, HEPATOLOGY, V28, P1226, DOI 10.1002/hep.510280509; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yung S, 1998, KIDNEY INT, V54, P2160, DOI 10.1046/j.1523-1755.1998.00177.x; ZEMEL D, 1994, KIDNEY INT, V46, P1422, DOI 10.1038/ki.1994.414; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	74	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6634	10.1371/journal.pone.0006634	http://dx.doi.org/10.1371/journal.pone.0006634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675677	Green Published, gold			2022-12-25	WOS:000268936100009
J	Hara, Y; Mohamed, R; Nathan, S				Hara, Yuka; Mohamed, Rahmah; Nathan, Sheila			Immunogenic Burkholderia pseudomallei Outer Membrane Proteins as Potential Candidate Vaccine Targets	PLOS ONE			English	Article							ESCHERICHIA-COLI; A OMPA; POLYSACCHARIDE; IMMUNIZATION; MELIOIDOSIS; INTERFERON; PROTECTION; CHALLENGE; INFECTION; RESPONSES	Background: Burkholderia pseudomallei is the causative agent of melioidosis, a disease of significant morbidity and mortality in both human and animals in endemic areas. There is no vaccine towards the bacterium available in the market, and the efficacy of many of the bacterium's surface and secreted proteins are currently being evaluated as vaccine candidates. Methodology/Principal Findings: With the availability of the B. pseudomallei whole genome sequence, we undertook to identify genes encoding the known immunogenic outer membrane protein A (OmpA). Twelve OmpA domains were identified and ORFs containing these domains were fully annotated. Of the 12 ORFs, two of these OmpAs, Omp3 and Omp7, were successfully cloned, expressed as soluble protein and purified. Both proteins were recognised by antibodies in melioidosis patients' sera by Western blot analysis. Purified soluble fractions of Omp3 and Omp7 were assessed for their ability to protect BALB/c mice against B. pseudomallei infection. Mice were immunised with either Omp3 or Omp7, subsequently challenged with 1*10(6) colony forming units (cfu) of B. pseudomallei via the intraperitoneal route, and examined daily for 21 days post-challenge. This pilot study has demonstrated that whilst all control unimmunised mice died by day 9 post-challenge, two mice (out of 4) from both immunised groups survived beyond 21 days post-infection. Conclusions/Significance: We have demonstrated that B. pseudomallei OmpA proteins are immunogenic in mice as well as melioidosis patients and should be further assessed as potential vaccine candidates against B. pseudomallei infection.			Hara, Y (corresponding author), Univ Kebangsaan Malaysia MTDC Smart Technol Ctr, Malaysia Genome Inst, Bangi, Selangor, Malaysia.	sheila@ukm.my	Nathan, Sheila/C-1182-2011	Nathan, Sheila/0000-0002-2132-2346				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brett PJ, 1996, INFECT IMMUN, V64, P2824, DOI 10.1128/IAI.64.7.2824-2828.1996; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; Chen YL, 2003, INFECT IMMUN, V71, P1155, DOI 10.1128/IAI.71.3.1155-1160.2003; Chen YS, 2006, VACCINE, V24, P750, DOI 10.1016/j.vaccine.2005.08.069; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chin CY, 2007, ENZYME MICROB TECH, V40, P370, DOI 10.1016/j.enzmictec.2006.09.014; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DANCE DA, 2002, CURR OPIN INFECT DIS, V96, P72; Das M, 1998, FEMS IMMUNOL MED MIC, V22, P303, DOI 10.1111/j.1574-695X.1998.tb01219.x; Elvin SJ, 2006, INFECT IMMUN, V74, P1706, DOI 10.1128/IAI.74.3.1706-1711.2006; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Haque A, 2006, J INFECT DIS, V194, P1241, DOI 10.1086/508217; Healey GD, 2005, INFECT IMMUN, V73, P5945, DOI 10.1128/IAI.73.9.5945-5951.2005; Jeannin P, 2002, VACCINE, V20, pA23, DOI 10.1016/S0264-410X(02)00383-3; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kim SK, 2000, J IMMUNOL, V165, P7285, DOI 10.4049/jimmunol.165.12.7285; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SH, 2007, DIAGN MICR INFEC DIS, V58, P263, DOI 10.1016/j.diagmicrobio.2007.01.002; Leelarasamee A, 2004, CURR OPIN INFECT DIS, V17, P131, DOI 10.1097/00001432-200404000-00011; Lertpatanasuwan N, 1999, CLIN INFECT DIS, V28, P927, DOI 10.1086/517253; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Poolman J T, 1996, Adv Exp Med Biol, V397, P73; PUOHINIEMI R, 1990, INFECT IMMUN, V58, P1691, DOI 10.1128/IAI.58.6.1691-1696.1990; Ross BC, 2004, ORAL MICROBIOL IMMUN, V19, P6, DOI 10.1046/j.0902-0055.2003.00096.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J, 2001, MOL CLONING LAB MANU; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Subramaniam S, 2000, CLIN DIAGN LAB IMMUN, V7, P168, DOI 10.1128/CDLI.7.2.168-174.2000; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ulett GC, 2005, MICROBES INFECT, V7, P1263, DOI 10.1016/j.micinf.2005.04.013; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991	38	68	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6496	10.1371/journal.pone.0006496	http://dx.doi.org/10.1371/journal.pone.0006496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654871	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739100005
J	Quaia, C; Ying, HS; Optican, LM				Quaia, Christian; Ying, Howard S.; Optican, Lance M.			The Viscoelastic Properties of Passive Eye Muscle in Primates. II: Testing the Quasi-Linear Theory	PLOS ONE			English	Article								We have extensively investigated the mechanical properties of passive eye muscles, in vivo, in anesthetized and paralyzed monkeys. The complexity inherent in rheological measurements makes it desirable to present the results in terms of a mathematical model. Because Fung's quasi-linear viscoelastic (QLV) model has been particularly successful in capturing the viscoelastic properties of passive biological tissues, here we analyze this dataset within the framework of Fung's theory. We found that the basic properties assumed under the QLV theory ( separability and superposition) are not typical of passive eye muscles. We show that some recent extensions of Fung's model can deal successfully with the lack of separability, but fail to reproduce the deviation from superposition. While appealing for their elegance, the QLV model and its descendants are not able to capture the complex mechanical properties of passive eye muscles. In particular, our measurements suggest that in a passive extraocular muscle the force does not depend on the entire length history, but to a great extent is only a function of the last elongation to which it has been subjected. It is currently unknown whether other passive biological tissues behave similarly.			Quaia, C (corresponding author), NEI, Sensorimotor Res Lab, Bldg 10, Bethesda, MD 20892 USA.	quaiac@nei.nih.gov			NEI NIH HHS [K12 EY015025, EY15025, R01 EY019347, EY19347] Funding Source: Medline; NATIONAL EYE INSTITUTE [K12EY015025, ZIAEY000302, R01EY019347] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abramowitch SD, 2004, J BIOMECH ENG-T ASME, V126, P92, DOI 10.1115/1.1645528; BAGLEY RL, 1983, AIAA J, V21, P741, DOI 10.2514/3.8142; BAGNI MA, 1992, BIOPHYS J, V63, P1412, DOI 10.1016/S0006-3495(92)81718-6; BAGNI MA, 1995, J PHYSIOL-LONDON, V482, P391, DOI 10.1113/jphysiol.1995.sp020526; Bagni MA, 1999, J ELECTROMYOGR KINES, V9, P77, DOI 10.1016/S1050-6411(98)00039-X; BEST TM, 1994, J BIOMECH, V27, P413, DOI 10.1016/0021-9290(94)90017-5; BEST TM, 1995, J BIOMECH ENG-T ASME, V117, P262, DOI 10.1115/1.2794179; Buchthal F., 1951, DAN VIDENS SELS BIOL, V21, P1; Carew EO, 1999, J BIOMECH ENG-T ASME, V121, P386, DOI 10.1115/1.2798335; DeFrate LE, 2007, BIOMECH MODEL MECHAN, V6, P245, DOI 10.1007/s10237-006-0056-8; Doehring TC, 2004, ANN BIOMED ENG, V32, P223, DOI 10.1023/B:ABME.0000012742.01261.b0; Elliott DM, 2003, ANN BIOMED ENG, V31, P599, DOI 10.1114/1.1567282; EMRI I, 1994, RHEOL ACTA, V33, P60, DOI 10.1007/BF00453464; EMRI I, 1993, RHEOL ACTA, V32, P311, DOI 10.1007/BF00434195; EMRI I, 1995, INT J SOLIDS STRUCT, V32, P817, DOI 10.1016/0020-7683(94)00162-P; Fung Y.-C., 2004, BIOMECHANICS MECH PR; Fung Y.C.B, 1971, BIOMECHANICS ITS FDN, P181; Funk JR, 2000, J BIOMECH ENG-T ASME, V122, P15, DOI 10.1115/1.429623; Huang CY, 2001, J BIOMECH ENG-T ASME, V123, P410, DOI 10.1115/1.1392316; HUYGHE JM, 1991, J BIOMECH, V24, P841, DOI 10.1016/0021-9290(91)90309-B; Iatridis JC, 1997, J BIOMECH, V30, P1005, DOI 10.1016/S0021-9290(97)00069-9; JOHNSON GA, 1994, J ORTHOPAED RES, V12, P796, DOI 10.1002/jor.1100120607; Kim SM, 1999, DYSPHAGIA, V14, P8, DOI 10.1007/PL00009584; Kohandel M, 2008, MATH COMPUT MODEL, V47, P266, DOI 10.1016/j.mcm.2007.04.006; KORENBERG MJ, 1990, ANN BIOMED ENG, V18, P629, DOI 10.1007/BF02368452; Korenberg MJ, 1996, ANN BIOMED ENG, V24, P250, DOI 10.1007/BF02667354; KWAN MK, 1993, J BIOMECH, V26, P447, DOI 10.1016/0021-9290(93)90008-3; LIN HC, 1987, P ASME ADV BIOENG, V5, P47; Malkin AY, 2006, POLYM SCI SER A+, V48, P39, DOI 10.1134/S0965545X06010068; Marmarelis P.Z., 1978, ANAL PHYSL SYSTEMS W; Mutungi G, 1996, J PHYSIOL-LONDON, V496, P827, DOI 10.1113/jphysiol.1996.sp021730; Mutungi G, 1996, J MUSCLE RES CELL M, V17, P357; Mutungi G, 1996, BIOPHYS J, V70, P1432, DOI 10.1016/S0006-3495(96)79702-3; Mutungi G, 1998, J PHYSIOL-LONDON, V508, P253, DOI 10.1111/j.1469-7793.1998.253br.x; Nekouzadeh A, 2007, J BIOMECH, V40, P3070, DOI 10.1016/j.jbiomech.2007.03.019; Nelles O, 2001, NONLINEAR SYSTEM IDE; NIGUL I, 1987, J BIOMECH, V20, P343, DOI 10.1016/0021-9290(87)90042-X; PINTO JA, 1973, J BIOMECH, V6, P596; Pioletti DP, 2000, J BIOMECH, V33, P1729, DOI 10.1016/S0021-9290(00)00128-7; PIPKIN AC, 1968, J MECH PHYS SOLIDS, V16, P59, DOI 10.1016/0022-5096(68)90016-1; Provenzano P, 2001, ANN BIOMED ENG, V29, P908, DOI 10.1114/1.1408926; Provenzano PP, 2002, BIOMECH MODEL MECHAN, V1, P45, DOI 10.1007/s10237-002-0004-1; Pryse KM, 2003, ANN BIOMED ENG, V31, P1287, DOI 10.1114/1.1615571; Quaia C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004850; Ramirez LES, 2007, ANN PHYS-BERLIN, V16, P543, DOI 10.1002/andp.200710246; Ranatunga KW, 2001, J MUSCLE RES CELL M, V22, P399, DOI 10.1023/A:1014502610259; ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9; RUGH WJ, 1981, NONLINEAR SYSTEM THE; Thornton GM, 1997, J ORTHOPAED RES, V15, P652, DOI 10.1002/jor.1100150504; Toms SR, 2002, J BIOMECH, V35, P1411, DOI 10.1016/S0021-9290(02)00166-5; TSCHOEGL NW, 1993, RHEOL ACTA, V32, P322, DOI 10.1007/BF00434196; WOO SLY, 1982, BIORHEOLOGY, V19, P385; WOO SLY, 1980, J BIOMECH ENG-T ASME, V102, P85, DOI 10.1115/1.3138220; WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P293, DOI 10.1115/1.3138295	54	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6480	10.1371/journal.pone.0006480	http://dx.doi.org/10.1371/journal.pone.0006480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649257	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637700006
J	Vaudano, AE; Laufs, H; Kiebel, SJ; Carmichael, DW; Hamandi, K; Guye, M; Thornton, R; Rodionov, R; Friston, KJ; Duncan, JS; Lemieux, L				Vaudano, Anna E.; Laufs, Helmut; Kiebel, Stefan J.; Carmichael, David W.; Hamandi, Khalid; Guye, Maxime; Thornton, Rachel; Rodionov, Roman; Friston, Karl J.; Duncan, John S.; Lemieux, Louis			Causal Hierarchy within the Thalamo-Cortical Network in Spike and Wave Discharges	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; CONSCIOUS RESTING STATE; DEFAULT MODE; EEG-FMRI; GENERALIZED SPIKE; ABSENCE SEIZURES; BRAIN ACTIVITY; FRONTAL-CORTEX; EPILEPSY; CINGULATE	Background: Generalised spike wave (GSW) discharges are the electroencephalographic ( EEG) hallmark of absence seizures, clinically characterised by a transitory interruption of ongoing activities and impaired consciousness, occurring during states of reduced awareness. Several theories have been proposed to explain the pathophysiology of GSW discharges and the role of thalamus and cortex as generators. In this work we extend the existing theories by hypothesizing a role for the precuneus, a brain region neglected in previous works on GSW generation but already known to be linked to consciousness and awareness. We analysed fMRI data using dynamic causal modelling (DCM) to investigate the effective connectivity between precuneus, thalamus and prefrontal cortex in patients with GSW discharges. Methodology and Principal Findings: We analysed fMRI data from seven patients affected by Idiopathic Generalized Epilepsy (IGE) with frequent GSW discharges and significant GSW-correlated haemodynamic signal changes in the thalamus, the prefrontal cortex and the precuneus. Using DCM we assessed their effective connectivity, i.e. which region drives another region. Three dynamic causal models were constructed: GSW was modelled as autonomous input to the thalamus (model A), ventromedial prefrontal cortex (model B), and precuneus (model C). Bayesian model comparison revealed Model C (GSW as autonomous input to precuneus), to be the best in 5 patients while model A prevailed in two cases. At the group level model C dominated and at the population-level the p value of model C was -1. Conclusion: Our results provide strong evidence that activity in the precuneus gates GSW discharges in the thalamo(fronto) cortical network. This study is the first demonstration of a causal link between haemodynamic changes in the precuneus - an index of awareness - and the occurrence of pathological discharges in epilepsy.			Vaudano, AE (corresponding author), Univ Roma La Sapienza, Policlin Umberto I, Dept Neurol, Rome, Italy.	l.lemieux@ion.ucl.ac.uk	Laufs, Helmut/I-8562-2014; Kiebel, Stefan J/B-1551-2009; Carmichael, David/A-5391-2009; Friston, Karl/D-9230-2011; hamandi, khalid/G-4333-2011; Vaudano, Anna Elisabetta AE/O-2653-2015	Laufs, Helmut/0000-0003-0030-2781; Kiebel, Stefan J/0000-0002-5052-1117; Carmichael, David/0000-0001-9972-0718; Friston, Karl/0000-0001-7984-8909; Vaudano, Anna Elisabetta AE/0000-0002-6280-7526; Hamandi, Khalid/0000-0001-7116-262X; Duncan, John S/0000-0002-1373-0681; Lemieux, Louis/0000-0003-3036-7412	MRC [G0301067] Funding Source: UKRI; Medical Research Council [G0200216, G0301067] Funding Source: Medline; Wellcome Trust [067176, 088130, 056750] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health		Aghakhani Y, 2004, BRAIN, V127, P1127, DOI 10.1093/brain/awh136; Amor F, 2009, NEUROIMAGE, V45, P950, DOI 10.1016/j.neuroimage.2008.12.011; Anderer P, 2001, NEUROSCIENCE, V103, P581, DOI 10.1016/S0306-4522(01)00028-8; Andermann F, 2001, EPILEPSIA, V42, P317, DOI 10.1046/j.1528-1157.2001.36400.x; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; [Anonymous], 1981, Epilepsia, V22, P489; Archer JS, 2003, NEUROIMAGE, V20, P1915, DOI 10.1016/S1053-8119(03)00294-5; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Brazdil M, 2007, NEUROIMAGE, V35, P827, DOI 10.1016/j.neuroimage.2006.12.020; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Clemens B, 2007, EPILEPSIA, V48, P941, DOI 10.1111/j.1528-1167.2007.01030.x; Craiu D, 2006, EPILEPSY RES, V70, pS141, DOI 10.1016/j.eplepsyres.2005.11.018; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; De Tiege X, 2007, EPILEPSY BEHAV, V11, P460, DOI 10.1016/j.yebeh.2007.06.001; Faymonville ME, 2006, J PHYSIOL-PARIS, V99, P463, DOI 10.1016/j.jphysparis.2006.03.018; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; FRISTON K, 2009, PLOS BIOL, V7; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; GLOOR A, 1990, GEN EPILEPSY NEUROBI, P190; GLOOR P, 1978, ELECTROEN CLIN NEURO, V34, pS245; GLOOR P, 1982, H GASTAUT MARSEILLES, P45; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; GUEY J, 1969, EPILEPSIA, V10, P441, DOI 10.1111/j.1528-1157.1969.tb06140.x; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamandi K, 2008, J NEUROL NEUROSUR PS, V79, P594, DOI 10.1136/jnnp.2007.125401; Hamandi K, 2008, NEUROIMAGE, V39, P608, DOI 10.1016/j.neuroimage.2007.07.009; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; Hill RA, 1999, EPILEPSIA, V40, P912, DOI 10.1111/j.1528-1157.1999.tb00798.x; Holmes MD, 2004, EPILEPSIA, V45, P1568, DOI 10.1111/j.0013-9580.2004.23204.x; JASPER HH, 1947, RES PUBL ASS NERV ME, V26, P272; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kiebel SJ, 2008, COGN NEURODYNAMICS, V2, P121, DOI 10.1007/s11571-008-9038-0; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Kostopoulos GK, 2000, CLIN NEUROPHYSIOL, V111, pS27, DOI 10.1016/S1388-2457(00)00399-0; Krakow K, 2000, Adv Neurol, V83, P187; Labate A, 2005, EPILEPTIC DISORD, V7, P373; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Laufs H, 2007, CURR OPIN NEUROL, V20, P417, DOI 10.1097/WCO.0b013e3282202b92; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lemieux L, 2007, MAGN RESON IMAGING, V25, P894, DOI 10.1016/j.mri.2007.03.009; Liston AD, 2006, NEUROIMAGE, V30, P827, DOI 10.1016/j.neuroimage.2005.10.025; MARCUS EM, 1968, EPILEPSIA, V9, P233, DOI 10.1111/j.1528-1157.1968.tb04623.x; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McGuire PK, 1996, NEUROREPORT, V7, P2095; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; NIEDERMEYER E., 1966, EPILEPSIA, V7, P23, DOI 10.1111/j.1528-1157.1966.tb03367.x; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salek-Haddadi A, 2003, ANN NEUROL, V53, P663, DOI 10.1002/ana.10586; Salek-Haddadi A, 2006, BRAIN RES, V1088, P148, DOI 10.1016/j.brainres.2006.02.098; SCHMAHMANN JD, 1990, J COMP NEUROL, V295, P299, DOI 10.1002/cne.902950212; Stephan KE, 2007, J BIOSCIENCES, V32, P129, DOI 10.1007/s12038-007-0012-5; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Tucker DM, 2007, EPILEPSY BEHAV, V11, P546, DOI 10.1016/j.yebeh.2007.04.023; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; VANGELDER NM, 1983, EPILEPSIA, V24, P200; VANHOESEN GW, 1993, NEUROBIOLOGY CINGULA, P345; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; YETERIAN EH, 1985, J COMP NEUROL, V237, P408, DOI 10.1002/cne.902370309	73	104	106	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6475	10.1371/journal.pone.0006475	http://dx.doi.org/10.1371/journal.pone.0006475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649252	Green Published, gold, Green Submitted			2022-12-25	WOS:000268637700002
J	D'Anastasio, R; Zipfel, B; Moggi-Cecchi, J; Stanyon, R; Capasso, L				D'Anastasio, Ruggero; Zipfel, Bernhard; Moggi-Cecchi, Jacopo; Stanyon, Roscoe; Capasso, Luigi			Possible Brucellosis in an Early Hominin Skeleton from Sterkfontein, South Africa	PLOS ONE			English	Article							ISOTOPIC EVIDENCE; LIMBUS VERTEBRA; NATIONAL-PARK; KOOBI-FORA; MEAT; STRATEGIES	We report on the paleopathological analysis of the partial skeleton of the late Pliocene hominin species Australopithecus africanus Stw 431 from Sterkfontein, South Africa. A previous study noted the presence of lesions on vertebral bodies diagnosed as spondylosis deformans due to trauma. Instead, we suggest that these lesions are pathological changes due to the initial phases of an infectious disease, brucellosis. The macroscopic, microscopic and radiological appearance of the lytic lesions of the lumbar vertebrae is consistent with brucellosis. The hypothesis of brucellosis (most often associated with the consumption of animal proteins) in a 2.4 to 2.8 million year old hominid has a host of important implications for human evolution. The consumption of meat has been regarded an important factor in supporting, directing or altering human evolution. Perhaps the earliest (up to 2.5 million years ago) paleontological evidence for meat eating consists of cut marks on animal remains and stone tools that could have made these marks. Now with the hypothesis of brucellosis in A. africanus, we may have evidence of occasional meat eating directly linked to a fossil hominin.			D'Anastasio, R (corresponding author), State Univ G dAnnunzio, Dept Human Movement Sci, Sect Anthropol, Chieti, Italy.	r.danastasio@unich.it		Stanyon, Roscoe/0000-0002-7229-1092; MOGGI CECCHI, IACOPO/0000-0001-5055-8369; Zipfel, Bernhard/0000-0002-4251-884X				ALBEROLA I, 1986, REV SANITARIA SERVIC, P38; BAHAR RH, 1988, CLIN NUCL MED, V13, P102, DOI 10.1097/00003072-198802000-00008; Becker M., 2001, J ROMAN STUD, V93, P404; Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; BUNN HT, 1994, J HUM EVOL, V27, P247, DOI 10.1006/jhev.1994.1045; Capasso L, 1999, INT J OSTEOARCHAEOL, V9, P277, DOI 10.1002/(SICI)1099-1212(199909/10)9:5<277::AID-OA489>3.3.CO;2-S; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; COOK DC, 1983, AM J PHYS ANTHROPOL, V60, P83, DOI 10.1002/ajpa.1330600113; CORDERO M, 1991, J BONE JOINT SURG BR, V73, P100, DOI 10.1302/0301-620X.73B1.1991738; Curate F, 2006, INT J OSTEOARCHAEOL, V16, P453, DOI 10.1002/oa.843; Delson E., 1988, P317; ELDESOUKI M, 1991, RADIOLOGY, V181, P415, DOI 10.1148/radiology.181.2.1924782; Etxeberria F., 1994, J PALEOPATHOL, V6, P41; Fisk G.R., 1992, International Journal of Osteoarchaeology, V2, P325, DOI 10.1002/oa.1390020408; GANADO W, 1958, J BONE JOINT SURG AM, V40, P1380, DOI 10.2106/00004623-195840060-00014; Geyik MF, 2002, SWISS MED WKLY, V132, P98, DOI 10.57187/smw.2002.09900; GHELMAN B, 1976, AM J ROENTGENOL, V127, P854, DOI 10.2214/ajr.127.5.854; GIRDLESTONE GR, 1965, TUBERCULOSIS BONE JO; GLASGOW MMS, 1976, BRIT J SURG, V63, P283, DOI 10.1002/bjs.1800630408; Godfroid J, 2002, REV SCI TECH OIE, V21, P277, DOI 10.20506/rst.21.2.1333; HENALES V, 1993, PEDIATR RADIOL, V23, P608, DOI 10.1007/BF02014980; Jaffe H., 1972, METABOLIC DEGENERATI; KELLY PJ, 1960, JAMA-J AM MED ASSOC, V174, P347, DOI 10.1001/jama.1960.03030040001001; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; LOVELL NC, 1991, YEARB PHYS ANTHROPOL, V34, P117; LOWBEER L, 1948, AM J PATHOL, V24, P723; LOWBEER L, 1949, Proc Staff Meet Tulsa Okla Hillcrest Meml Hosp, V6, P1; MADKOUR MM, 1988, AM J ROENTGENOL, V150, P1101, DOI 10.2214/ajr.150.5.1101; Mays SA, 2007, INT J OSTEOARCHAEOL, V17, P107, DOI 10.1002/oa.903; MCKEE JK, 1995, AM J PHYS ANTHROPOL, V96, P235, DOI 10.1002/ajpa.1330960303; MIKOLICH DJ, 1989, PRINCIPLES PRACTICE, P1735; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; MOUSA ARM, 1987, REV INFECT DIS, V9, P531; Mupparapu M, 2002, DENTOMAXILLOFAC RAD, V31, P328, DOI 10.1038/sj.dmfr.4600698; NORDEN C, 1994, INFECT BONES JOINTS; ORTNER JO, 2003, IDENTIFICATION PATHO; Ozgocmen S, 2001, JOINT BONE SPINE, V68, P521, DOI 10.1016/S1297-319X(01)00319-0; Pedro-Pons A., 1944, BRUCELOSIS HUMANA; Pfeiffer John E., 1969, EMERGENCE MAN; Pobiner BL, 2008, J HUM EVOL, V55, P103, DOI 10.1016/j.jhevol.2008.02.001; RAJAPAKSE CNA, 1995, BAILLIERE CLIN RHEUM, V9, P161, DOI 10.1016/S0950-3579(05)80153-0; Rashidi JS, 2001, AM J PHYS ANTHROPOL, P122; Reinhart M., 1932, BEITRAGE KLIN TUBERK, V79, P745; RHINE RJ, 1986, AM J PHYS ANTHROPOL, V70, P105, DOI 10.1002/ajpa.1330700115; Rose L, 1996, CURR ANTHROPOL, V37, P307, DOI 10.1086/204494; Schlabritz-Loutsevitch NE, 2009, J MED PRIMATOL, V38, P70, DOI 10.1111/j.1600-0684.2008.00314.x; SHIPMAN P, 1986, J HUM EVOL, V15, P691, DOI 10.1016/S0047-2484(86)80005-7; SPETH JD, 1989, J HUM EVOL, V18, P329, DOI 10.1016/0047-2484(89)90035-3; Spink WW, 1956, NATURE BRUCELLOSIS; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; STANFORD CB, 1994, AM J PHYS ANTHROPOL, V94, P213, DOI 10.1002/ajpa.1330940206; STANFORD CB, 1994, BEHAVIOUR, V131, P1, DOI 10.1163/156853994X00181; Stanford CB, 1999, CURR ANTHROPOL, V40, P726, DOI 10.1086/300092; Stanford CB, 2001, MEAT EATING HUMAN EV; Staps D, 2002, AM J PHYS ANTHROPOL, P146; Tobias P. V, 1994, J PALEOPATHOLOGY, V6, P125; Tobias PV, 1974, LEECH, V44, P119; Toussaint M, 2003, S AFR J SCI, V99, P215; TRINKAUS E, 1982, AM J PHYS ANTHROPOL, V57, P61, DOI 10.1002/ajpa.1330570108; Ungar P.S, 2007, EVOLUTION HUMAN DIET; UNGAR S., 2007, EVOLUTION HUMAN DIET; Vrba E.S., 1985, P195	64	39	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6439	10.1371/journal.pone.0006439	http://dx.doi.org/10.1371/journal.pone.0006439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CG	19649274	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494600009
J	Mamelli, L; Petit, S; Chevalier, J; Giglione, C; Lieutaud, A; Meinnel, T; Artaud, I; Pages, JM				Mamelli, Laurent; Petit, Sylvain; Chevalier, Jacqueline; Giglione, Carmela; Lieutaud, Aurelie; Meinnel, Thierry; Artaud, Isabelle; Pages, Jean-Marie			New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors	PLOS ONE			English	Article								Background Multi-drug resistant (MDR) bacteria have become a major concern in hospitals worldwide and urgently require the development of new antibacterial molecules. Peptide deformylase is an intracellular target now well-recognized for the design of new antibiotics. The bacterial susceptibility to such a cytoplasmic target primarily depends on the capacity of the compound to reach and accumulate in the cytosol. Methodology/Principal Findings: To determine the respective involvement of penetration (influx) and pumping out (efflux) mechanisms to peptide deformylase inhibitors (PDF-I) activity, the potency of various series was determined using various genetic contexts (efflux overproducers or efflux-deleted strains) and membrane permeabilizers. Depending on the structure of the tested molecules, two behaviors could be observed: (i) for actinonin the first PDF-I characterized, the AcrAB efflux system was the main parameter involved in the bacterial susceptibility, and (ii), for the lastest PDF-Is such as the derivatives of 2-(5-bromo-1H-indol-3-yl)-N-hydroxyacetamide, the penetration through the membrane was a important limiting step. Conclusions/Significance: Our results clearly show that the bacterial membrane plays a key role in modulating the antibacterial activity of PDF-Is. The bacterial susceptibility for these new antibacterial molecules can be improved by two unrelated ways in MDR strains: by collapsing the Acr efflux activity or by increasing the uptake rate through the bacterial membrane. The efficiency of the second method is associated with the nature of the compound.			Mamelli, L (corresponding author), Univ Aix Marseille 2, UMR MD1, Fac Med & Pharm, IFR 88, Marseille, France.	Jean-Marie.PAGES@univmed.fr	Meinnel, Thierry/B-9813-2016; PAGES, jean-marie/F-2555-2013	PAGES, jean-marie/0000-0001-7092-7977; Meinnel, Thierry/0000-0001-5642-8637; Giglione, Carmela/0000-0002-7475-1558				Blot S, 2007, CURR OPIN INFECT DIS, V20, P391, DOI 10.1097/QCO.0b013e32818be6f7; Boularot A, 2007, J MED CHEM, V50, P10, DOI 10.1021/jm060910c; Boularot Adrien, 2004, Curr Opin Investig Drugs, V5, P809; Cavallo J.D., 2008, COMITE ANTIBIOGRAMME; Chen DZ, 2000, BIOCHEMISTRY-US, V39, P1256, DOI 10.1021/bi992245y; Chevalier J, 2000, BIOCHEM BIOPH RES CO, V274, P496, DOI 10.1006/bbrc.2000.3159; Chevalier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003203; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P3621, DOI 10.1128/AAC.48.9.3621-3624.2004; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Dean CR, 2007, ANTIMICROB AGENTS CH, V51, P1004, DOI 10.1128/AAC.01103-06; Dean CR, 2005, ANTIMICROB AGENTS CH, V49, P3129, DOI 10.1128/AAC.49.8.3129-3135.2005; Duroc Y, 2009, ANTIMICROB AGENTS CH, V53, P1673, DOI 10.1128/AAC.01340-08; Elkins CA, 2007, ANTIMICROB AGENTS CH, V51, P923, DOI 10.1128/AAC.01048-06; Falagas ME, 2008, EXPERT OPIN INV DRUG, V17, P973, DOI 10.1517/13543784.17.7.973 ; Fieulaine S, 2005, J BIOL CHEM, V280, P42315, DOI 10.1074/jbc.M507155200; Fritsche TR, 2005, ANTIMICROB AGENTS CH, V49, P1468, DOI 10.1128/AAC.49.4.1468-1476.2005; Jain R, 2005, CURR MED CHEM, V12, P1607, DOI 10.2174/0929867054367194; Johnson K. W., 2005, Current Drug Targets - Infectious Disorders, V5, P39, DOI 10.2174/1568005053174618; Landman D, 2008, CLIN MICROBIOL REV, V21, P449, DOI 10.1128/CMR.00006-08; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; Margolis PS, 2000, ANTIMICROB AGENTS CH, V44, P1825, DOI 10.1128/AAC.44.7.1825-1831.2000; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; O'Neill A, 2008, EXPERT OPIN INV DRUG, V17, P297, DOI 10.1517/13543784.17.3.297 ; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pankuch GA, 2008, ANTIMICROB AGENTS CH, V52, P333, DOI 10.1128/AAC.00689-07; Paterson DL, 2008, CLIN INFECT DIS, V47, pS14, DOI 10.1086/590062; Petit S, 2009, CHEMMEDCHEM, V4, P261, DOI 10.1002/cmdc.200800251; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Rice Louis B, 2007, Cleve Clin J Med, V74 Suppl 4, pS12; Sahalan AZ, 2008, INT J ANTIMICROB AG, V31, P224, DOI 10.1016/j.ijantimicag.2007.10.005; Salmi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002765; Su CC, 2007, FEBS LETT, V581, P4972, DOI 10.1016/j.febslet.2007.09.035; Viveiros M, 2005, ANTIMICROB AGENTS CH, V49, P3578, DOI 10.1128/AAC.49.8.3578-3582.2005; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Yuan ZY, 2006, BIOCHEM PHARMACOL, V71, P1042, DOI 10.1016/j.bcp.2005.10.015	44	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6443	10.1371/journal.pone.0006443	http://dx.doi.org/10.1371/journal.pone.0006443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649280	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494600013
J	Yang, XM; Li, HC; Liu, XS; Deng, AP; Liu, XQ				Yang, Xiaoming; Li, Hongchang; Liu, X. Shawn; Deng, Anping; Liu, Xiaoqi			Cdc2-mediated Phosphorylation of CLIP-170 Is Essential for Its Inhibition of Centrosome Reduplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; MICROTUBULES; LOCALIZATION; DUPLICATION; PROTEINS; DYNAMICS; BINDING; KINASES; TUBULIN	CLIP-170, the founding member of microtubule "plus ends tracking" proteins, is involved in many critical microtubule-related functions, including recruitment of dynactin to the microtubule plus ends and formation of kinetochore-microtubule attachments during metaphase. Although it has been reported that CLIP-170 is a phosphoprotein, neither have individual phosphorylation sites been identified nor have the associated kinases been extensively studied. Herein, we identify Cdc2 as a kinase that phosphorylates CLIP-170. We show that Cdc2 interacts with CLIP-170 mediating its phosphorylation on Thr(287) in vivo. Significantly, expression of CLIP-170 with a threonine 287 to alanine substitution (T287A) results in its mislocalization, accumulation of Plk1 and cyclin B, and block of the G2/M transition. Finally, we found that depletion of CLIP-170 leads to centrosome reduplication and that Cdc2 phosphorylation of CLIP-170 is required for the process. These results demonstrate that Cdc2-mediated phosphorylation of CLIP-170 is essential for the normal function of this protein during cell cycle progression.	[Yang, Xiaoming; Li, Hongchang; Liu, X. Shawn; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Sichuan University	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	liu, shawn/J-3969-2016; Li, Hongchang/GQO-9662-2022		National Institutes of Health Howard Temin Award, NCI [K01 CA114401]; China Scholarship Council; NATIONAL CANCER INSTITUTE [K01CA114401] Funding Source: NIH RePORTER	National Institutes of Health Howard Temin Award, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Howard Temin Award K01 CA114401 from the NCI (to X. L.). This work was also supported by the China Scholarship Council (to X. Y.).	Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Choi JH, 2002, EMBO REP, V3, P988, DOI 10.1093/embo-reports/kvf197; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Mimori-Kiyosue Yuko, 2006, Tanpakushitsu Kakusan Koso, V51, P543; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; RICKARD JE, 1991, J BIOL CHEM, V266, P17597; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Tanenbaum ME, 2006, EMBO J, V25, P45, DOI 10.1038/sj.emboj.7600916; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	22	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28775	28782		10.1074/jbc.M109.017681	http://dx.doi.org/10.1074/jbc.M109.017681			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19687009	Green Published, hybrid			2022-12-25	WOS:000270678900034
J	Kobayashi, H; Utsunomiya, H; Yamanaka, H; Sei, Y; Katunuma, N; Okamoto, K; Tsuge, H				Kobayashi, Hidetomo; Utsunomiya, Hiroko; Yamanaka, Hiroyasu; Sei, Yoshihisa; Katunuma, Nobuhiko; Okamoto, Keinosuke; Tsuge, Hideaki			Structural Basis for the Kexin-like Serine Protease from Aeromonas sobria as Sepsis-causing Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCESSING ENZYME; SECRETORY PATHWAY; CRYSTAL-STRUCTURE; GENE-PRODUCT; 3' END; FURIN; SPECIFICITY; CLEAVAGE; CONVERTASES; PROTEINASE	The anaerobic bacterium Aeromonas sobria is known to cause potentially lethal septic shock. We recently proposed that A. sobria serine protease (ASP) is a sepsis-related factor that induces vascular leakage, reductions in blood pressure via kinin release, and clotting via activation of prothrombin. ASP preferentially cleaves peptide bonds that follow dibasic amino acid residues, as do Kex2 (Saccharomyces cerevisiae serine protease) and furin, which are representative kexin family proteases. Here, we revealed the crystal structure of ASP at 1.65 angstrom resolution using the multiple isomorphous replacement method with anomalous scattering. Although the overall structure of ASP resembles that of Kex2, it has a unique extra occluding region close to its active site. Moreover, we found that a nicked ASP variant is cleaved within the occluding region. Nicked ASP shows a greater ability to cleave small peptide substrates than the native enzyme. On the other hand, the cleavage pattern for prekallikrein differs from that of ASP, suggesting the occluding region is important for substrate recognition. The extra occluding region of ASP is unique and could serve as a useful target to facilitate development of novel antisepsis drugs.	[Utsunomiya, Hiroko; Katunuma, Nobuhiko; Tsuge, Hideaki] Tokushima Bunri Univ, Inst Hlth Sci, Yamashiro, Tokushima 7708514, Japan; [Kobayashi, Hidetomo; Yamanaka, Hiroyasu] Hiroshima Int Univ, Lab Mol Microbiol Sci, Fac Pharmaceut Sci, Hiroshima 7370112, Japan; [Sei, Yoshihisa] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Kagawa 7692193, Japan; [Okamoto, Keinosuke] Okayama Univ, Fac Pharmaceut Sci, Okayama 7008530, Japan	Tokushima Bunri University; Tokushima Bunri University; Okayama University	Tsuge, H (corresponding author), Tokushima Bunri Univ, Inst Hlth Sci, 180 Yamashiro Cho, Yamashiro, Tokushima 7708514, Japan.	tsuge@tokushima.bunri-u.ac.jp	Yamanaka, Hiroyasu/AAG-7880-2021; OKAMOTO, Keinosuke/B-2257-2011; Tsuge, Hideaki/ABF-6424-2021	Tsuge, Hideaki/0000-0003-0166-9163; Kobayashi, Hidetomo/0000-0002-5918-4268	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by the Academic Frontier Promotion Program of MEXT of Japan.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brink AJ, 1998, S AFR MED J, V88, P1011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chuang YC, 1997, MICROBIOL-SGM, V143, P803, DOI 10.1099/00221287-143-3-803; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii Y, 1998, MICROBIOL IMMUNOL, V42, P703, DOI 10.1111/j.1348-0421.1998.tb02343.x; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Galindo CL, 2004, J BIOL CHEM, V279, P37597, DOI 10.1074/jbc.M404641200; GLUSCHANKOF P, 1994, EMBO J, V13, P2280, DOI 10.1002/j.1460-2075.1994.tb06510.x; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2004, BIOCHEMISTRY-US, V43, P2412, DOI 10.1021/bi035849h; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Imamura T, 2006, J IMMUNOL, V177, P8723, DOI 10.4049/jimmunol.177.12.8723; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JANDA JM, 1987, J INFECT DIS, V155, P589, DOI 10.1093/infdis/155.3.589; JONES BL, 1995, J ANTIMICROB CHEMOTH, V35, P453, DOI 10.1093/jac/35.4.453; Kobayashi H, 2006, FEMS MICROBIOL LETT, V256, P165, DOI 10.1111/j.1574-6968.2006.00134.x; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; LEIBOWITZ MJ, 1976, P NATL ACAD SCI USA, V73, P2061, DOI 10.1073/pnas.73.6.2061; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MOSES AE, 1995, EUR J CLIN MICROBIOL, V14, P237, DOI 10.1007/BF02310364; Nitta H, 2008, J IMMUNOL, V181, P3602, DOI 10.4049/jimmunol.181.5.3602; Nitta H, 2007, FEBS LETT, V581, P5935, DOI 10.1016/j.febslet.2007.11.076; Nomura T, 2002, J BACTERIOL, V184, P7058, DOI 10.1128/JB.184.24.7058-7061.2002; Nomura T, 1999, MICROBIOL IMMUNOL, V43, P29, DOI 10.1111/j.1348-0421.1999.tb02369.x; Okamoto K, 2000, MICROBIOL IMMUNOL, V44, P787, DOI 10.1111/j.1348-0421.2000.tb02565.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; ROEBROEK AJM, 1986, MOL BIOL REP, V11, P117, DOI 10.1007/BF00364823; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANDEVEN WJM, 1991, ENZYME, V45, P257, DOI 10.1159/000468900; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamada S, 1997, EPIDEMIOL INFECT, V119, P121, DOI 10.1017/S0950268897007942; Zhou A, 1998, J BIOL CHEM, V273, P11107, DOI 10.1074/jbc.273.18.11107	41	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27655	27663		10.1074/jbc.M109.006114	http://dx.doi.org/10.1074/jbc.M109.006114			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654332	Green Published, hybrid			2022-12-25	WOS:000270232300067
J	Nakamura, S; Kuroki, K; Ohki, I; Sasaki, K; Kajikawa, M; Maruyama, T; Ito, M; Kameda, Y; Ikura, M; Yamamoto, K; Matsumoto, N; Maenaka, K				Nakamura, Seiko; Kuroki, Kimiko; Ohki, Izuru; Sasaki, Kaori; Kajikawa, Mizuho; Maruyama, Takuma; Ito, Masayuki; Kameda, Yosuke; Ikura, Mitsuhiko; Yamamoto, Kazuo; Matsumoto, Naoki; Maenaka, Katsumi			Molecular Basis for E-cadherin Recognition by Killer Cell Lectin-like Receptor G1 (KLRG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTTING EDGE; ADHESION; BINDING; MECHANISM; INTEGRIN; INSIGHTS; COMPLEX; LIGAND; DOMAIN	The killer cell lectin-like receptor G1, KLRG1, is a cell surface receptor expressed on subsets of natural killer (NK) cells and T cells. KLRG1 was recently found to recognize E-cadherin and thus inhibit immune responses by regulating the effector function and the developmental processes of NK and T cells. E-cadherin is expressed on epithelial cells and exhibits Ca2+-dependent homophilic interactions that contribute to cell-cell junctions. However, the mechanism underlying the molecular recognition of KLRG1 by E-cadherin remains unclear. Here, we report structural, binding, and functional analyses of this interaction using multiple methods. Surface plasmon resonance demonstrated that KLRG1 binds the E-cadherin N-terminal domains 1 and 2 with low affinity (K-d similar to 7-12 mu M), typical of cell-cell recognition receptors. NMR binding studies showed that only a limited N-terminal region of E-cadherin, comprising the homodimer interface, exhibited spectrum perturbation upon KLRG1 complex formation. It was confirmed by binding studies using a series of E-cadherin mutants. Furthermore, killing assays using KLRG1(+)NK cells and reporter cell assays demonstrated the functional significance of the N-terminal region of E-cadherin. These results suggest that KLRG1 recognizes the N-terminal homodimeric interface of domain 1 of E-cadherin and binds only the monomeric form of E-cadherin to inhibit the immune response. This raises the possibility that KLRG1 detects monomeric E-cadherin at exposed cell surfaces to control the activation threshold of NK and T cells.	[Nakamura, Seiko; Kuroki, Kimiko; Ohki, Izuru; Sasaki, Kaori; Kajikawa, Mizuho; Maenaka, Katsumi] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Maruyama, Takuma; Ito, Masayuki; Kameda, Yosuke; Yamamoto, Kazuo; Matsumoto, Naoki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 2M9, Canada; [Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	Kyushu University; University of Tokyo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Maenaka, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kmaenaka-umin@umin.net	Ohki, Izuru/C-7883-2013; Ohki, Izuru/O-4816-2019; Kuroki, Kimiko/F-6906-2012	Ohki, Izuru/0000-0002-0667-5936; Ikura, Mitsuhiko/0000-0002-9524-1303	Ministry of Education, Culture, Sports, Science and Technology; Japan Bio-oriented Technology Research Advancement Institute (BRAIN)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Bio-oriented Technology Research Advancement Institute (BRAIN)	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology and the Japan Bio-oriented Technology Research Advancement Institute (BRAIN).	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Colonna M, 2006, J EXP MED, V203, P261, DOI 10.1084/jem.20052559; Gooding JM, 2004, BIOESSAYS, V26, P497, DOI 10.1002/bies.20033; Grundemann C, 2006, J IMMUNOL, V176, P1311, DOI 10.4049/jimmunol.176.3.1311; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Matsumoto N, 2001, J EXP MED, V193, P147, DOI 10.1084/jem.193.2.147; Moretta L, 2004, CURR OPIN IMMUNOL, V16, P626, DOI 10.1016/j.coi.2004.07.010; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Ohki I, 1999, EMBO J, V18, P6653, DOI 10.1093/emboj/18.23.6653; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Parisini E, 2007, J MOL BIOL, V373, P401, DOI 10.1016/j.jmb.2007.08.011; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Robbins SH, 2002, J IMMUNOL, V168, P2585, DOI 10.4049/jimmunol.168.6.2585; Rosshart S, 2008, EUR J IMMUNOL, V38, P3354, DOI 10.1002/eji.200838690; Schwartzkopff S, 2007, J IMMUNOL, V179, P1022, DOI 10.4049/jimmunol.179.2.1022; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Yokoyama WM, 1998, CURR OPIN IMMUNOL, V10, P298, DOI 10.1016/S0952-7915(98)80168-4	27	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27327	27335		10.1074/jbc.M109.038802	http://dx.doi.org/10.1074/jbc.M109.038802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654330	Green Published, hybrid			2022-12-25	WOS:000270232300033
J	Wang, XX; Zhao, Q; Matta, R; Meng, XM; Liu, XP; Liu, CG; Nelin, LD; Liu, YS				Wang, Xianxi; Zhao, Qun; Matta, Ranyia; Meng, Xiaomei; Liu, Xiuping; Liu, Chang-Gong; Nelin, Leif D.; Liu, Yusen			Inducible Nitric-oxide Synthase Expression Is Regulated by Mitogen-activated Protein Kinase Phosphatase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; PROINFLAMMATORY CYTOKINE BIOSYNTHESIS; FACTOR-KAPPA-B; IFN-GAMMA; MESSENGER-RNA; INTERFERON-GAMMA; UNITED-STATES; MACROPHAGES; LIPOPOLYSACCHARIDE; MKP-1	Inducible nitric-oxide (NO) synthase (iNOS) plays a critical role in the eradication of intracellular pathogens. However, the excessive production of NO by iNOS has also been implicated in the pathogenesis of septic shock syndrome. Previously, we have demonstrated that mice deficient in mitogen-activated protein kinase phosphatase-1 (MKP-1) exhibit exaggerated inflammatory responses and rapidly succumb to lipopolysaccharide (LPS). In response to LPS, MKP-1(-/-) mice produce greater amounts of inflammatory cytokines and NO than do wild-type mice, and the MKP-1(-/-) mice exhibit severe hypotension. To understand the molecular basis for the increase in NO production, we studied the role of MKP-1 in the regulation of iNOS expression. We found that LPS challenge elicited a stronger iNOS induction in MKP-1 knock-out mice than in wild-type mice. Likewise, LPS treatment also resulted in greater iNOS expression in macrophages from MKP-1(-/-) mice than in macrophages from wild-type mice. Both accelerated gene transcription and enhanced mRNA stability contribute to the increases in iNOS expression in LPS-stimulated MKP-1(-/-) macrophages. We found that STAT-1, a transcription factor known to mediate iNOS induction by interferon-gamma, was more potently activated by LPS in MKP-1(-/-) macrophages than in wild-type cells. MicroRNA array analysis indicated that microRNA (miR)-155 expression was increased in MKP-1-deficient macrophages compared with wild-type macrophages. Transfection of miR-155 attenuated the expression of Suppressor of Cytokine Signal (SOCS)-1 and enhanced the expression of iNOS. Our results suggest that MKP-1 may negatively regulate iNOS expression by controlling the expression of miR-155 and consequently the STAT pathway via SOCS-1.	[Wang, Xianxi; Zhao, Qun; Meng, Xiaomei; Nelin, Leif D.; Liu, Yusen] Ohio State Univ, Ctr Perinatal Res, Res Inst, Nationwide Childrens Hosp,Dept Pediat,Coll Med, Columbus, OH 43205 USA; [Matta, Ranyia; Nelin, Leif D.; Liu, Yusen] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Liu, Yusen] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Liu, Xiuping; Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Liu, YS (corresponding author), Ohio State Univ, Ctr Perinatal Res, Res Inst, Nationwide Childrens Hosp,Dept Pediat,Coll Med, 700 Childrens Dr, Columbus, OH 43205 USA.	yusen.liu@nationwidechildrens.org	Liu, Yusen/E-3527-2011; Nelin, Leif/AAC-8475-2020; Nelin, Leif/E-3747-2011	Liu, Yusen/0000-0002-0994-0109	National Institutes of Health [AI 57798, AI 68956, HL 75261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057798, R01AI068956, R21AI057798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 57798 and AI 68956 (to Y.L.) and HL 75261 (to L.D.N.).	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Calvert TJ, 2008, AM J PHYSIOL-HEART C, V294, pH1621, DOI 10.1152/ajpheart.01008.2007; CHARLES CH, 1992, ONCOGENE, V7, P187; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen W, 1998, MOL CELL BIOL, V18, P5178, DOI 10.1128/MCB.18.9.5178; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; COLLART MA, 1986, J EXP MED, V164, P2113, DOI 10.1084/jem.164.6.2113; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Dorfman K, 1996, ONCOGENE, V13, P925; Fechir M, 2005, MOL PHARMACOL, V67, P2148, DOI 10.1124/mol.104.008763; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Gavrilescu LC, 2004, INFECT IMMUN, V72, P1257, DOI 10.1128/IAI.72.3.1257-1264.2004; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; Hecker M, 1996, BRIT J PHARMACOL, V118, P2178, DOI 10.1111/j.1476-5381.1996.tb15660.x; Heitmeier MR, 1999, J BIOL CHEM, V274, P29266, DOI 10.1074/jbc.274.41.29266; Hoefig KP, 2008, CURR OPIN IMMUNOL, V20, P281, DOI 10.1016/j.coi.2008.05.005; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; JANEWAY CA, 2005, IMMUNOBIOLOGY, P37; JUN CD, 1994, J IMMUNOL, V153, P3684; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Malu S, 2003, J IMMUNOL METHODS, V272, P55, DOI 10.1016/S0022-1759(02)00424-6; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Parrillo J E, 1993, N Engl J Med, V328, P1471; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Salkowski CA, 1997, J IMMUNOL, V158, P905; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Taylor LS, 1997, CANCER RES, V57, P2468; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Zhang YH, 2005, CELL IMMUNOL, V234, P16, DOI 10.1016/j.cellimm.2005.04.004; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	51	47	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27123	27134		10.1074/jbc.M109.051235	http://dx.doi.org/10.1074/jbc.M109.051235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651781	Green Published, hybrid			2022-12-25	WOS:000270232300013
J	Levy, J; Pernet, C; Treserras, S; Boulanouar, K; Aubry, F; Demonet, JF; Celsis, P				Levy, Jonathan; Pernet, Cyril; Treserras, Sebastien; Boulanouar, Kader; Aubry, Florent; Demonet, Jean-Francois; Celsis, Pierre			Testing for the Dual-Route Cascade Reading Model in the Brain: An fMRI Effective Connectivity Account of an Efficient Reading Style	PLOS ONE			English	Article							WORD RECOGNITION; INDIVIDUAL-DIFFERENCES; CORTICAL REGIONS; SINGLE LETTERS; VISUAL-CORTEX; LANGUAGE; OBJECT; ACTIVATION; ANATOMY; NETWORK	Neuropsychological data about the forms of acquired reading impairment provide a strong basis for the theoretical framework of the dual-route cascade (DRC) model which is predictive of reading performance. However, lesions are often extensive and heterogeneous, thus making it difficult to establish precise functional anatomical correlates. Here, we provide a connective neural account in the aim of accommodating the main principles of the DRC framework and to make predictions on reading skill. We located prominent reading areas using fMRI and applied structural equation modeling to pinpoint distinct neural pathways. Functionality of regions together with neural network dissociations between words and pseudowords corroborate the existing neuroanatomical view on the DRC and provide a novel outlook on the sub-regions involved. In a similar vein, congruent (or incongruent) reliance of pathways, that is reliance on the word (or pseudoword) pathway during word reading and on the pseudoword (or word) pathway during pseudoword reading predicted good (or poor) reading performance as assessed by out-of-magnet reading tests. Finally, inter-individual analysis unraveled an efficient reading style mirroring pathway reliance as a function of the fingerprint of the stimulus to be read, suggesting an optimal pattern of cerebral information trafficking which leads to high reading performance.			Levy, J (corresponding author), CHU Purpan, INSERM, Imagerie Cerebrale & Handicaps Neurol UMR 825, Toulouse, France.	yoni.levy@fcdonders.ru.nl	Demonet, Jean-Francois/E-6725-2010; Pernet, Cyril R./A-9237-2008	Pernet, Cyril R./0000-0003-4010-4632				Aparicio M, 2007, NEUROIMAGE, V35, P1303, DOI 10.1016/j.neuroimage.2006.12.046; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; BARON J, 1976, J EXP PSYCHOL HUMAN, V2, P386, DOI 10.1037/0096-1523.2.3.386; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Bitan T, 2005, J NEUROSCI, V25, P5397, DOI 10.1523/JNEUROSCI.0864-05.2005; Booth JR, 2008, BRAIN RES, V1189, P78, DOI 10.1016/j.brainres.2007.10.080; Booth JR, 2002, NEUROIMAGE, V16, P7, DOI 10.1006/nimg.2002.1081; Bruno JL, 2008, NEUROIMAGE, V39, P1988, DOI 10.1016/j.neuroimage.2007.10.044; Cao F, 2008, BRAIN LANG, V107, P91, DOI 10.1016/j.bandl.2007.12.009; Castles A, 2006, APHASIOLOGY, V20, P871, DOI 10.1080/02687030600738952; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Coltheart M, 2006, J RES READ, V29, P124, DOI 10.1111/j.1467-9817.2006.00296.x; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Connor CM, 2007, SCIENCE, V315, P464, DOI 10.1126/science.1134513; de Marco G, 2009, MAGN RESON IMAGING, V27, P1, DOI 10.1016/j.mri.2008.05.003; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Dietz NAE, 2005, HUM BRAIN MAPP, V26, P81, DOI 10.1002/hbm.20122; Dufor O, 2007, NEUROIMAGE, V34, P1692, DOI 10.1016/j.neuroimage.2006.10.034; Dufor O, 2009, NEUROIMAGE, V46, P241, DOI 10.1016/j.neuroimage.2009.01.035; FUNNELL E, 1983, BRIT J PSYCHOL, V74, P159, DOI 10.1111/j.2044-8295.1983.tb01851.x; Henry ML, 2007, BRAIN LANG, V100, P44, DOI 10.1016/j.bandl.2006.06.011; Hodges JR, 2007, LANCET NEUROL, V6, P1004, DOI 10.1016/S1474-4422(07)70266-1; J/reskog K.G., 1988, LISREL 7 GUIDE PROGR; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Joseph JE, 2006, NEUROIMAGE, V32, P806, DOI 10.1016/j.neuroimage.2006.04.175; Joseph JE, 2003, COGN AFFECT BEHAV NE, V3, P1, DOI 10.3758/CABN.3.1.1; Joseph JE, 2003, COGNITIVE BRAIN RES, V17, P56, DOI 10.1016/S0926-6410(03)00080-6; Kronbichler M, 2007, J COGNITIVE NEUROSCI, V19, P1584, DOI 10.1162/jocn.2007.19.10.1584; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; Lefavrais P., 2006, ALOUETTE R TEST ANAL; Levy J, 2008, NEUROIMAGE, V43, P581, DOI 10.1016/j.neuroimage.2008.08.008; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; MCCARTHY R, 1986, CORTEX, V22, P359, DOI 10.1016/S0010-9452(86)80002-8; Mechelli A, 2005, J COGNITIVE NEUROSCI, V17, P1753, DOI 10.1162/089892905774589190; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Mechelli A, 2000, J COGNITIVE NEUROSCI, V12, P145, DOI 10.1162/089892900564000; Meyler A, 2007, CEREB CORTEX, V17, P2780, DOI 10.1093/cercor/bhm006; Moore CJ, 1999, NEUROIMAGE, V10, P181, DOI 10.1006/nimg.1999.0450; Nakamura K, 2007, P NATL ACAD SCI USA, V104, P19643, DOI 10.1073/pnas.0704487104; Nakamura K, 2006, NEURON, V52, P557, DOI 10.1016/j.neuron.2006.09.030; PATTERSON K, 1992, NEUROPSYCHOLOGIA, V30, P1025, DOI 10.1016/0028-3932(92)90096-5; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pernet C, 2004, NEUROIMAGE, V22, P1563, DOI 10.1016/j.neuroimage.2004.03.044; PERNET C, 2009, HUM BRAIN M IN PRESS; Pernet C, 2007, NEUROIMAGE, V35, P991, DOI 10.1016/j.neuroimage.2007.01.017; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 2003, BRAIN LANG, V86, P272, DOI 10.1016/S0093-934X(02)00544-8; Price CJ, 1999, NEUROIMAGE, V10, P36, DOI 10.1006/nimg.1999.0447; Price CJ, 2005, CURR OPIN NEUROBIOL, V15, P231, DOI 10.1016/j.conb.2005.03.003; Puce A, 1996, J NEUROSCI, V16, P5205; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; Rapcsak SZ, 2004, NEUROLOGY, V62, P2221, DOI 10.1212/01.WNL.0000130169.60752.C5; Ratcliff R, 2004, PSYCHOL REV, V111, P159, DOI 10.1037/0033-295X.111.1.159; Reinke K, 2008, BRAIN LANG, V104, P180, DOI 10.1016/j.bandl.2007.04.006; Salmelin R, 2007, CLIN NEUROPHYSIOL, V118, P237, DOI 10.1016/j.clinph.2006.07.316; Seghier ML, 2008, NEUROIMAGE, V42, P1226, DOI 10.1016/j.neuroimage.2008.05.029; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Starrfelt R, 2007, NEUROIMAGE, V35, P334, DOI 10.1016/j.neuroimage.2006.12.003; TREIMAN R, 1984, J EXP CHILD PSYCHOL, V37, P463, DOI 10.1016/0022-0965(84)90071-7; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Wilson TW, 2007, EXP BRAIN RES, V180, P247, DOI 10.1007/s00221-007-0852-0; Wilson TW, 2005, EXP BRAIN RES, V167, P141, DOI 10.1007/s00221-005-0011-4; Zevin JD, 2000, J EXP PSYCHOL LEARN, V26, P121, DOI 10.1037/0278-7393.26.1.121; Ziegler JC, 2008, COGNITION, V107, P151, DOI 10.1016/j.cognition.2007.09.004	70	79	82	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6675	10.1371/journal.pone.0006675	http://dx.doi.org/10.1371/journal.pone.0006675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688099	gold, Green Published			2022-12-25	WOS:000269075800010
J	Marsollier, N; Kassis, N; Mezghenna, K; Soty, M; Fioramonti, X; Lacombe, A; Joly, A; Pillot, B; Zitoun, C; Vilar, J; Mithieux, G; Gross, R; Lajoix, AD; Routh, V; Magnan, C; Cruciani-Guglielmacci, C				Marsollier, Nicolas; Kassis, Nadim; Mezghenna, Karima; Soty, Maud; Fioramonti, Xavier; Lacombe, Amelie; Joly, Aurelie; Pillot, Bruno; Zitoun, Carine; Vilar, Jose; Mithieux, Gilles; Gross, Rene; Lajoix, Anne-Dominique; Routh, Vanessa; Magnan, Christophe; Cruciani-Guglielmacci, Celine			Deregulation of Hepatic Insulin Sensitivity Induced by Central Lipid Infusion in Rats Is Mediated by Nitric Oxide	PLOS ONE			English	Article							GLUCOSE-INHIBITED NEURONS; FATTY-ACIDS; PARAVENTRICULAR NUCLEUS; DIABETES-MELLITUS; IMPAIRS GLUCOSE; FOOD-INTAKE; BETA-CELL; SYNTHASE; BRAIN; LIVER	Background: Deregulation of hypothalamic fatty acid sensing lead to hepatic insulin-resistance which may partly contribute to further impairment of glucose homeostasis. Methodology: We investigated here whether hypothalamic nitric oxide (NO) could mediate deleterious peripheral effect of central lipid overload. Thus we infused rats for 24 hours into carotid artery towards brain, either with heparinized triglyceride emulsion (Intralipid, IL) or heparinized saline (control rats). Principal Findings: Lipids infusion led to hepatic insulin-resistance partly related to a decreased parasympathetic activity in the liver assessed by an increased acetylcholinesterase activity. Hypothalamic nitric oxide synthases (NOS) activities were significantly increased in IL rats, as the catalytically active neuronal NOS (nNOS) dimers compared to controls. This was related to a decrease in expression of protein inhibitor of nNOS (PIN). Effect of IL infusion on deregulated hepatic insulin-sensitivity was reversed by carotid injection of non selective NOS inhibitor NG-monomethyl-L-arginine (L-NMMA) and also by a selective inhibitor of the nNOS isoform, 7-Nitro-Indazole (7-Ni). In addition, NO donor injection (L-arginine and SNP) within carotid in control rats mimicked lipid effects onto impaired hepatic insulin sensitivity. In parallel we showed that cultured VMH neurons produce NO in response to fatty acid (oleic acid). Conclusions/Significance: We conclude that cerebral fatty acid overload induces an enhancement of nNOS activity within hypothalamus which is, at least in part, responsible fatty acid increased hepatic glucose production.	[Marsollier, Nicolas; Kassis, Nadim; Lacombe, Amelie; Joly, Aurelie; Magnan, Christophe; Cruciani-Guglielmacci, Celine] Univ Paris Diderot, CNRS, Paris, France; [Mezghenna, Karima; Gross, Rene; Lajoix, Anne-Dominique] Fac Pharm Montpellier, CNRS, UMR 5232, F-34060 Montpellier, France; [Soty, Maud; Pillot, Bruno; Zitoun, Carine; Mithieux, Gilles] INSERM, U855, Lyon, France; [Soty, Maud; Pillot, Bruno; Zitoun, Carine; Mithieux, Gilles] Univ Lyon, U1235, Lyon, France; [Soty, Maud; Pillot, Bruno; Zitoun, Carine; Mithieux, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; [Fioramonti, Xavier; Routh, Vanessa] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Vilar, Jose] Hop Lariboisiere, INSERM, U689, F-75475 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Rutgers State University New Brunswick; Rutgers State University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Marsollier, N (corresponding author), Univ Paris Diderot, CNRS, Paris, France.	nicolas.marsollier@univ-paris-diderot.fr	magnan, christophe/AAJ-7622-2021; Pillot, Bruno/D-5448-2015	magnan, christophe/0000-0002-7044-2571; Pillot, Bruno/0000-0002-1499-3299; Gross, Rene/0000-0001-5884-3607; Gilles, Mithieux/0000-0003-3579-8529; Cruciani-Guglielmacci, Celine/0000-0002-2562-5360; Vilar, Jose/0000-0002-9136-7726; Fioramonti, Xavier/0000-0003-1713-4817	ANR (Agence Nationale de la Recherche) [ANR-05-PNRA-004-05, 2006]; ALFEDIAM-Becton-Dickinson; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081538] Funding Source: NIH RePORTER	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); ALFEDIAM-Becton-Dickinson; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ANR (Agence Nationale de la Recherche) grant N degrees ANR-05-PNRA-004-05, 2006 ALFEDIAM-Becton-Dickinson grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaraviciene SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002182; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; BECKER K, 1995, EUR J BIOCHEM, V234, P472, DOI 10.1111/j.1432-1033.1995.472_b.x; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Cailotto C, 2008, ENDOCRINOLOGY, V149, P1914, DOI 10.1210/en.2007-0816; Canabal DD, 2007, AM J PHYSIOL-REG I, V293, pR592, DOI 10.1152/ajpregu.00207.2007; Canabal DD, 2007, AM J PHYSIOL-REG I, V292, pR1418, DOI 10.1152/ajpregu.00216.2006; Chang YWE, 2000, MOL CELL BIOL, V20, P8571, DOI 10.1128/MCB.20.22.8571-8579.2000; Clement L, 2002, PFLUG ARCH EUR J PHY, V445, P375, DOI 10.1007/s00424-002-0937-3; Conti A, 2007, BRAIN RES REV, V54, P205, DOI 10.1016/j.brainresrev.2007.01.013; Cruciani-Guglielmacci C, 2004, DIABETOLOGIA, V47, P2032, DOI 10.1007/s00125-004-1569-2; Das UN, 2002, NUTRITION, V18, P667, DOI 10.1016/S0899-9007(02)00746-3; De Vente J, 1998, NEUROSCIENCE, V87, P207, DOI 10.1016/S0306-4522(98)00171-7; Dunlap ME, 2003, AM J PHYSIOL-HEART C, V285, pH1632, DOI 10.1152/ajpheart.01051.2002; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Elmquist JK, 2003, NAT MED, V9, P645, DOI 10.1038/nm0603-645; Gilbert M, 2003, DIABETES, V52, P277, DOI 10.2337/diabetes.52.2.277; Greenwood MT, 1997, BIOCHEM BIOPH RES CO, V238, P617, DOI 10.1006/bbrc.1997.7361; Horn TFW, 2002, FASEB J, V16, P1611, DOI 10.1096/fj.02-0126com; JOBGEN WS, 2006, J NUTR BIOCH; JOMAINBAUM M, 1978, J BIOL CHEM, V253, P3648; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lajoix AD, 2004, DIABETES, V53, P1467, DOI 10.2337/diabetes.53.6.1467; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; LANG G, 1974, METHOD ENZYMAT AN, V6, P1238; LEFOLL C, 2009, AM J PHYSL REGUL INT; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Levin BE, 2005, AM J PHYSIOL-REG I, V289, pR704, DOI 10.1152/ajpregu.00216.2005; LEVIN BE, 1995, AM J PHYSIOL-REG I, V268, pR389, DOI 10.1152/ajpregu.1995.268.2.R389; Magnan C, 1998, DIABETES METAB, V24, P46; Magnan C, 1996, LIPIDS, V31, P1141, DOI 10.1007/BF02524288; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Migrenne S, 2006, DIABETES, V55, pS139, DOI 10.2337/db06-S017; Miguel TT, 2008, BRAIN RES, V1240, P39, DOI 10.1016/j.brainres.2008.08.068; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mithieux G, 2002, DIABETES, V51, P139, DOI 10.2337/diabetes.51.1.139; Norsted E, 2008, J CHEM NEUROANAT, V36, P107, DOI 10.1016/j.jchemneu.2008.06.002; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; PARDRIDGE WM, 1980, J NEUROCHEM, V34, P463, DOI 10.1111/j.1471-4159.1980.tb06621.x; Penicaud L, 2006, CURR OPIN CLIN NUTR, V9, P458, DOI 10.1097/01.mco.0000232908.84483.e0; ROEHRIG KL, 1974, ANAL BIOCHEM, V58, P414, DOI 10.1016/0003-2697(74)90210-3; Routh Vanessa H, 2004, Diabetes Technol Ther, V6, P413, DOI 10.1089/152091504774198133; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Shimazu T, 1996, NUTRITION, V12, P65; Stern JE, 2003, ACTA PHYSIOL SCAND, V177, P37, DOI 10.1046/j.1365-201X.2003.01045.x; Tataranni PA, 1997, OBES RES, V5, P341, DOI 10.1002/j.1550-8528.1997.tb00562.x; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu GY, 2002, ANNU REV NUTR, V22, P61, DOI 10.1146/annurev.nutr.22.110901.145329; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xu HY, 2006, BIOCHEM BIOPH RES CO, V349, P439, DOI 10.1016/j.bbrc.2006.08.071; Xue CR, 2000, J SURG RES, V90, P19, DOI 10.1006/jsre.2000.5820; Yang ES, 2002, FREE RADICAL BIO MED, V33, P927, DOI 10.1016/S0891-5849(02)00981-4; Zhang K, 1998, AM J PHYSIOL-REG I, V275, pR728, DOI 10.1152/ajpregu.1998.275.3.R728	58	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6649	10.1371/journal.pone.0006649	http://dx.doi.org/10.1371/journal.pone.0006649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680547	gold, Green Submitted, Green Published			2022-12-25	WOS:000268936200014
J	Aguas, R; Lourenco, JML; Gomes, MGM; White, LJ				Aguas, Ricardo; Lourenco, Jose M. L.; Gomes, M. Gabriela M.; White, Lisa J.			The Impact of IPTi and IPTc Interventions on Malaria Clinical Burden - In Silico Perspectives	PLOS ONE			English	Article							INTERMITTENT PREVENTIVE TREATMENT; PLASMODIUM-FALCIPARUM MALARIA; PLACEBO-CONTROLLED TRIAL; SULFADOXINE-PYRIMETHAMINE; DOUBLE-BLIND; PLACENTAL MALARIA; SEVERE ANEMIA; TRANSMISSION; CHILDREN; PREGNANCY	Background: Clinical management of malaria is a major health issue in sub-Saharan Africa. New strategies based on intermittent preventive treatment (IPT) can tackle disease burden by simultaneously reducing frequency of infections and life-threatening illness in infants (IPTi) and children (IPTc), while allowing for immunity to build up. However, concerns as to whether immunity develops efficiently in treated individuals, and whether there is a rebound effect after treatment is halted, have made it imperative to define the effects that IPTi and IPTc exert on the clinical malaria scenario. Methods and Findings: Here, we simulate several schemes of intervention under different transmission settings, while varying immunity build up assumptions. Our model predicts that infection risk and effectiveness of acquisition of clinical immunity under prophylactic effect are associated to intervention impact during treatment and follow-up periods. These effects vary across regions of different endemicity and are highly correlated with the interplay between the timing of interventions in age and the age dependent risk of acquiring an infection. However, even when significant rebound effects are predicted to occur, the overall intervention impact is positive. Conclusions: IPTi is predicted to have minimal impact on the acquisition of clinical immunity, since it does not interfere with the occurrence of mild infections, thus failing to reduce the underlying force of infection. On the contrary, IPTc has a significant potential to reduce transmission, specifically in areas where it is already low to moderate.	[Aguas, Ricardo; Lourenco, Jose M. L.; Gomes, M. Gabriela M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Gomes, M. Gabriela M.] Univ Lisbon, Ctr Matemat & Aplicacoes Fundamentais, P-1699 Lisbon, Portugal; [White, Lisa J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Aguas, R (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	ricaguas@igc.gulbenkian.pt	White, Lisa/AAC-9396-2020; Gomes, Gabriela/H-7218-2014	White, Lisa/0000-0002-6523-185X; Gomes, Gabriela/0000-0002-1454-4979; Lourenco, Jose/0000-0002-9318-2581	Portuguese Research Council (FCT); European Commission [MEXT-CT-2004-14338]; Wellcome Trust of Great Britain	Portuguese Research Council (FCT)(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust of Great Britain(Wellcome Trust)	This work was supported by the Portuguese Research Council (FCT), by the European Commission Grant MEXT-CT-2004-14338, and the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Alexander N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-9; Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Cisse B, 2007, TROP MED INT HEALTH, V12, P46; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; *COMM PERSP ROL IN, 2008, ASS ROL INT PREV TRE; DEROOS AM, 1992, AM NAT, V139, P123, DOI 10.1086/285316; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Faiz MA, 2005, LANCET, V366, P717; Falade CO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-88; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Greenwood B, 2004, AM J TROP MED HYG, V70, P1; Hommerich L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-144; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Myint HY, 2004, T ROY SOC TROP MED H, V98, P73, DOI 10.1016/S0035-9203(03)00014-2; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2006, PLOS MED, V3, P633, DOI 10.1371/journal.pmed.0030141; O'Meara Wendy Prudhomme, 2005, Malar J, V4, P33, DOI 10.1186/1475-2875-4-33; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Ross A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002661; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Schellenberg D, 2006, TRENDS PARASITOL, V22, P296, DOI 10.1016/j.pt.2006.05.006; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SNOW RW, 1999, B WHO, V77; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Sowunmi A, 2007, AM J TROP MED HYG, V77, P235, DOI 10.4269/ajtmh.2007.77.235; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; *WHO, 2005, GIVSGLOBAL IMM VIS S	42	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6627	10.1371/journal.pone.0006627	http://dx.doi.org/10.1371/journal.pone.0006627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675675	Green Published, Green Submitted, gold			2022-12-25	WOS:000268936100006
J	Qian, BZ; Deng, Y; Im, JH; Muschel, RJ; Zou, YY; Li, JF; Lang, RA; Pollard, JW				Qian, Binzhi; Deng, Yan; Im, Jae Hong; Muschel, Ruth J.; Zou, Yiyu; Li, Jiufeng; Lang, Richard A.; Pollard, Jeffrey W.			A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth	PLOS ONE			English	Article								Background: The stromal microenvironment and particularly the macrophage component of primary tumors influence their malignant potential. However, at the metastatic site the role of these cells and their mechanism of actions for establishment and growth of metastases remain largely unknown. Methodology/Principal Findings: Using animal models of breast cancer metastasis, we show that a population of host macrophages displaying a distinct phenotype is recruited to extravasating pulmonary metastatic cells regardless of species of origin. Ablation of this macrophage population through three independent means (genetic and chemical) showed that these macrophages are required for efficient metastatic seeding and growth. Importantly, even after metastatic growth is established, ablation of this macrophage population inhibited subsequent growth. Furthermore, imaging of intact lungs revealed that macrophages are required for efficient tumor cell extravasation. Conclusion/Significance: These data indicate a direct enhancement of metastatic growth by macrophages through their effects on tumor cell extravasation, survival and subsequent growth and identifies these cells as a new therapeutic target for treatment of metastatic disease.			Qian, BZ (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	pollard@aecom.yu.edu	Lang, Richard/E-5578-2011	IM, JAE HONG/0000-0002-0316-4372; Lang, Richard/0000-0002-5212-254X	NATIONAL CANCER INSTITUTE [P01CA100324, P30CA013330, R01CA094173] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 94173, P30 CA 13330, P01 CA100324, P30 CA013330, P01 CA 100324, R01 CA094173] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; BUTLER TP, 1975, CANCER RES, V35, P512; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; FIDLER IJ, 1982, CANCER RES, V42, P496; FOKAS E, 2007, CANC METASTASIS REV; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GORELIK E, 1982, INT J CANCER, V29, P575, DOI 10.1002/ijc.2910290514; Gouon-Evans V, 2002, BREAST CANCER RES, V4, P155, DOI 10.1186/bcr441; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; HERNANDEZ L, 2009, CANC RES IN PRESS, V69; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; HO MK, 1983, J BIOL CHEM, V258, P636; Hu HY, 1998, PROTEIN ENG, V11, P811, DOI 10.1093/protein/11.9.811; HUME DA, 1983, J EXP MED, V157, P1704, DOI 10.1084/jem.157.5.1704; Ito T, 2004, J IMMUNOL, V172, P3628, DOI 10.4049/jimmunol.172.6.3628; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim JW, 2004, CANCER LETT, V213, P203, DOI 10.1016/j.canlet.2004.03.042; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Leek RD, 1996, CANCER RES, V56, P4625; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; McDermott RS, 2002, EUR CYTOKINE NETW, V13, P121; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; OJALVO L, 2009, AM J PATHOLOGY; Piris A, 2007, CANCER TREAT RES, P119; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pollard JW, 1997, BIOL REPROD, V56, P1290, DOI 10.1095/biolreprod56.5.1290; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shibata Y, 2001, BLOOD, V98, P2845, DOI 10.1182/blood.V98.9.2845; SMITH HO, 1995, CLIN CANCER RES, V1, P313; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; VANNETTEN JP, 1993, J LEUKOCYTE BIOL, V54, P360, DOI 10.1002/jlb.54.4.360; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Varghese HJ, 2002, CANCER RES, V62, P887; WELCH DR, 1989, P NATL ACAD SCI USA, V86, P5859, DOI 10.1073/pnas.86.15.5859; WIKTORJEDRZEJCZAK W, 1991, P NATL ACAD SCI USA, V88, P5937; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wong CW, 2001, CANCER RES, V61, P333; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	67	470	480	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6562	10.1371/journal.pone.0006562	http://dx.doi.org/10.1371/journal.pone.0006562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668347	Green Submitted, gold, Green Published			2022-12-25	WOS:000268773300004
J	Eivers, E; Fuentealba, LC; Sander, V; Clemens, JC; Hartnett, L; Robertis, EM				Eivers, Edward; Fuentealba, Luis C.; Sander, Veronika; Clemens, James C.; Hartnett, Lori; De Robertis, E. M.			Mad Is Required for Wingless Signaling in Wing Development and Segment Patterning in Drosophila	PLOS ONE			English	Article							BETA; BMP; FAMILY; WNT; MECHANISMS; EXPRESSION; POLARITY; PROTEIN; SMAD1; DPP	A key question in developmental biology is how growth factor signals are integrated to generate pattern. In this study we investigated the integration of the Drosophila BMP and Wingless/GSK3 signaling pathways via phosphorylations of the transcription factor Mad. Wingless was found to regulate the phosphorylation of Mad by GSK3 in vivo. In epistatic experiments, the effects of Wingless on wing disc molecular markers (senseless, distalless and vestigial) were suppressed by depletion of Mad with RNAi. Wingless overexpression phenotypes, such as formation of ectopic wing margins, were induced by Mad GSK3 phosphorylation-resistant mutant protein. Unexpectedly, we found that Mad phosphorylation by GSK3 and MAPK occurred in segmental patterns. Mad depletion or overexpression produced Wingless-like embryonic segmentation phenotypes. In Xenopus embryos, segmental border formation was disrupted by Smad8 depletion. The results show that Mad is required for Wingless signaling and for the integration of gradients of positional information.			Eivers, E (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90024 USA.	ederobertis@mednet.ucla.edu	Sander, Veronika/R-5190-2019	Sander, Veronika/0000-0002-2918-833X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502, R01HD021502] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [R01 HD021502-23, R01 HD021502, HD21502-23, R37 HD021502] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; Baena-Lopez LA, 2006, P NATL ACAD SCI USA, V103, P13734, DOI 10.1073/pnas.0606092103; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; COUSO JP, 1994, DEVELOPMENT, V120, P621; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; Damen WGM, 2007, DEV DYNAM, V236, P1379, DOI 10.1002/dvdy.21157; De Robertis EM, 2008, P NATL ACAD SCI USA, V105, P16411, DOI 10.1073/pnas.0808774105; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; Eivers E, 2008, CURR OPIN GENET DEV, V18, P304, DOI 10.1016/j.gde.2008.06.001; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gabay L, 1997, DEVELOPMENT, V124, P3535; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; LaLonde M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-60; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marquez RM, 2001, GENETICS, V157, P1639; Miyanaga Y, 2002, MOL CELL BIOL, V22, P1317, DOI 10.1128/MCB.22.5.1317-1328.2002; Mizutani CM, 2008, NAT REV GENET, V9, P663, DOI 10.1038/nrg2417; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pueyo JI, 2008, P NATL ACAD SCI USA, V105, P16614, DOI 10.1073/pnas.0804093105; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; SCHWYTER DH, 1995, MOL CELL BIOL, V15, P3960; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Struhl G, 1997, DEVELOPMENT, V124, P2155; Szuts D, 1997, DEVELOPMENT, V124, P3209; Takaesu NT, 2008, DEV BIOL, V313, P829, DOI 10.1016/j.ydbio.2007.10.021; Takaesu NT, 2005, DEVELOPMENT, V132, P4883, DOI 10.1242/dev.02048; WIESCHAUS E, 2003, DROSOPHILA, P179; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zeng YA, 2007, DEVELOPMENT, V134, P2061, DOI 10.1242/dev.02853; Zeng YA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003893	57	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6543	10.1371/journal.pone.0006543	http://dx.doi.org/10.1371/journal.pone.0006543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657393	Green Published, gold			2022-12-25	WOS:000268739300014
J	Nabet, B; Tsai, A; Tobias, JW; Carstens, RP				Nabet, Behnam; Tsai, Arthur; Tobias, John W.; Carstens, Russ P.			Identification of a Putative Network of Actin-Associated Cytoskeletal Proteins in Glomerular Podocytes Defined by Co-Purified mRNAs	PLOS ONE			English	Article								The glomerular podocyte is a highly specialized and polarized kidney cell type that contains major processes and foot processes that extend from the cell body. Foot processes from adjacent podocytes form interdigitations with those of adjacent cells, thereby creating an essential intercellular junctional domain of the renal filtration barrier known as the slit diaphragm. Interesting parallels have been drawn between the slit diaphragm and other sites of cell-cell contact by polarized cells. Notably mutations in several genes encoding proteins localized to the foot processes can lead to proteinuria and kidney failure. Mutations in the Wilm's tumor gene (WT1) can also lead to kidney disease and one isoform of WT1, WT1(+KTS), has been proposed to regulate gene expression post-transcriptionally. We originally sought to identify mRNAs associated with WT1(+KTS) through an RNA immunoprecipitation and microarray approach, hypothesizing that the proteins encoded by these mRNAs might be important for podocyte morphology and function. We identified a subset of mRNAs that were remarkably enriched for transcripts encoding actin-binding proteins and other cytoskeletal proteins including several that are localized at or near the slit diaphragm. Interestingly, these mRNAs included those of alpha-actinin-4 and nonmuscle myosin IIA that are mutated in genetic forms of kidney disease. However, isolation of the mRNAs occurred independently of the expression of WT1, suggesting that the identified mRNAs were serendipitously co-purified on the basis of co-association in a common subcellular fraction. Mass spectroscopy revealed that other components of the actin cytoskeleton co-purified with these mRNAs, namely actin, tubulin, and elongation factor 1 alpha. We propose that these mRNAs encode a number of proteins that comprise a highly specialized protein interactome underlying the slit diaphragm. Collectively, these gene products and their interactions may prove to be important for the structural integrity of the actin cytoskeleton in podocytes as well as other polarized cell types.			Nabet, B (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	russcars@upenn.edu	Nabet, Behnam/AAZ-4987-2020	Nabet, Behnam/0000-0002-6738-4200	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK064660] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK064660] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arrondel C, 2002, J AM SOC NEPHROL, V13, P65, DOI 10.1681/ASN.V13165; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Barnes AP, 2004, MOL BRAIN RES, V124, P105, DOI 10.1016/j.molbrainres.2003.12.020; Baroni Timothy E., 2008, V419, P93, DOI 10.1007/978-1-59745-033-1_6; Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chen Y, 2003, J BIOL CHEM, V278, P46094, DOI 10.1074/jbc.M305311200; Collier LS, 2006, CURR OPIN GENET DEV, V16, P23, DOI 10.1016/j.gde.2005.11.001; Condeelis J, 2005, BIOL CELL, V97, P97; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; D'Atri F, 2001, FEBS LETT, V507, P21, DOI 10.1016/S0014-5793(01)02936-2; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Garg P, 2007, NEPHRON EXP NEPHROL, V106, pE67, DOI 10.1159/000101795; Gelot A, 1996, NEUROREPORT, V8, P113, DOI 10.1097/00001756-199612200-00023; Geng J, 2006, PROTEIN EXPRES PURIF, V48, P142, DOI 10.1016/j.pep.2006.01.021; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Goel M, 2005, PFLUG ARCH EUR J PHY, V451, P87, DOI 10.1007/s00424-005-1454-y; Goriounov D, 2003, J CELL SCI, V116, P1045, DOI 10.1242/jcs.00272; Gramolini AO, 2001, J CELL BIOL, V154, P1173, DOI 10.1083/jcb.200101108; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hara T, 2007, MOL CELL PROTEOMICS, V6, P479, DOI 10.1074/mcp.M600129-MCP200; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hiroi J, 1996, KIDNEY INT, V49, P1231, DOI 10.1038/ki.1996.177; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; Jia ZJ, 2005, J BIOL CHEM, V280, P30564, DOI 10.1074/jbc.M501754200; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; Matsumoto M, 2007, NEUROSCI RES, V57, P411, DOI 10.1016/j.neures.2006.11.015; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Meng XB, 2005, J PROTEOME RES, V4, P2081, DOI 10.1021/pr0502121; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Morrison AA, 2006, BIOCHEM CELL BIOL, V84, P789, DOI 10.1139/O06-065; Morrison AA, 2008, BBA-REV CANCER, V1785, P55, DOI 10.1016/j.bbcan.2007.10.002; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Niessen P, 2004, EXP CELL RES, V292, P170, DOI 10.1016/j.yexcr.2003.09.005; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Ooshio T, 2004, J BIOL CHEM, V279, P31365, DOI 10.1074/jbc.M401957200; Peitsch WK, 2003, J AM SOC NEPHROL, V14, P1452, DOI 10.1097/01.ASN.0000069222.63700.DE; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Raats CJI, 2000, AM J PATHOL, V156, P1749, DOI 10.1016/S0002-9440(10)65046-8; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Ronco P, 2007, J CLIN INVEST, V117, P2079, DOI 10.1172/JCI32966; RUPPERT C, 1995, J CELL SCI, V108, P3775; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Suzuki T, 2007, NEUROSCI RES, V57, P61, DOI 10.1016/j.neures.2006.09.009; Takahashi H, 2003, J NEUROSCI, V23, P6586; Tandon R, 2007, AM J PHYSIOL-RENAL, V292, pF701, DOI 10.1152/ajprenal.00246.2006; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; WINDER SJ, 1995, J CELL SCI, V108, P63; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	90	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6491	10.1371/journal.pone.0006491	http://dx.doi.org/10.1371/journal.pone.0006491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652713	gold, Green Published, Green Submitted			2022-12-25	WOS:000268637800005
J	Talamini, LM; Meeter, M				Talamini, Lucia M.; Meeter, Martijn			Dominance of Objects over Context in a Mediotemporal Lobe Model of Schizophrenia	PLOS ONE			English	Article							SEMANTIC MEMORY RETRIEVAL; EVENT-RELATED POTENTIALS; HIPPOCAMPAL-FORMATION; COGNITIVE DEFICITS; ENTORHINAL CORTEX; PARAHIPPOCAMPAL CORTICES; RECOGNITION MEMORY; THOUGHT-DISORDER; SPATIAL CONTEXT; EPISODIC MEMORY	Background: A large body of evidence suggests impaired context processing in schizophrenia. Here we propose that this impairment arises from defective integration of mediotemporal 'what' and 'where' routes, carrying object and spatial information to the hippocampus. Methodology and Findings: We have previously shown, in a mediotemporal lobe (MTL) model, that the abnormal connectivity between MTL regions observed in schizophrenia can explain the episodic memory deficits associated with the disorder. Here we show that the same neuropathology leads to several context processing deficits observed in patients with schizophrenia: 1) failure to choose subordinate stimuli over dominant ones when the former fit the context, 2) decreased contextual constraints in memory retrieval, as reflected in increased false alarm rates and 3) impaired retrieval of contextual information in source monitoring. Model analyses show that these deficits occur because the 'schizophrenic MTL' forms fragmented episodic representations, in which objects are overrepresented at the expense of spatial contextual information. Conclusions and Significance: These findings highlight the importance of MTL neuropathology in schizophrenia, demonstrating that it may underlie a broad spectrum of deficits, including context processing and memory impairments. It is argued that these processing deficits may contribute to central schizophrenia symptoms such as contextually inappropriate behavior, associative abnormalities, conversational drift, concreteness and delusions.			Talamini, LM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	L.M.Talamini@uva.nl	Meeter, Martijn/A-2926-2009	Meeter, Martijn/0000-0002-5112-6717				Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aleman A, 2005, J PSYCHIATR NEUROSCI, V30, P53; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Arnold SE, 2000, ANN NY ACAD SCI, V911, P275; Bachevalier J, 2008, HIPPOCAMPUS, V18, P64, DOI 10.1002/hipo.20369; Bartha L, 2003, COGNITIVE BRAIN RES, V17, P339, DOI 10.1016/S0926-6410(03)00135-6; Bazin N, 2000, SCHIZOPHR RES, V45, P93, DOI 10.1016/S0920-9964(99)00167-X; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Brebion G, 1997, J NERV MENT DIS, V185, P247, DOI 10.1097/00005053-199704000-00005; Brebion G, 1999, PSYCHIAT RES, V88, P15, DOI 10.1016/S0165-1781(99)00076-1; Brebion G, 2004, J CLIN EXP NEUROPSYC, V26, P1093, DOI 10.1080/13803390490515513; Brebion G, 1997, PSYCHOL MED, V27, P383, DOI 10.1017/S0033291796004448; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P35, DOI 10.1037/0021-843X.85.1.35; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Danion JM, 1999, ARCH GEN PSYCHIAT, V56, P639, DOI 10.1001/archpsyc.56.7.639; Diaz-Asper C, 2008, PSYCHIAT RES, V159, P259, DOI 10.1016/j.psychres.2007.02.018; Elvevag B, 2000, PSYCHOL MED, V30, P885, DOI 10.1017/S003329179900255X; Elvevag B, 2004, NEUROPSYCHOLOGIA, V42, P546, DOI 10.1016/j.neuropsychologia.2003.08.013; Ergorul C, 2006, J NEUROSCI, V26, P4111, DOI 10.1523/JNEUROSCI.0441-06.2006; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRASER WI, 1986, BRIT J PSYCHIAT, V148, P275, DOI 10.1192/bjp.148.3.275; Frost JA, 1999, BRAIN, V122, P199, DOI 10.1093/brain/122.2.199; Gold JM, 2000, J ABNORM PSYCHOL, V109, P534, DOI 10.1037//0021-843X.109.3.534; GOLD JM, 1992, J ABNORM PSYCHOL, V101, P487, DOI 10.1037/0021-843X.101.3.487; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; HARVEY PD, 1990, SCHIZOPHRENIA BULL, V16, P147, DOI 10.1093/schbul/16.1.147; HARVEY PD, 1988, SCHIZOPHRENIA BULL, V14, P57, DOI 10.1093/schbul/14.1.57; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Hemby SE, 2002, ARCH GEN PSYCHIAT, V59, P631, DOI 10.1001/archpsyc.59.7.631; HEMSLEY DR, 1992, PSYCHOL MED, V22, P839, DOI 10.1017/S003329170003840X; Hoenig K, 2005, HIPPOCAMPUS, V15, P597, DOI 10.1002/hipo.20080; HOFFMAN RE, 1999, PROG BRAIN RES, V21, P311; Iakimova G, 2006, PSYCHOPATHOLOGY, V39, P277, DOI 10.1159/000095732; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Keefe RSE, 1999, PSYCHOL MED, V29, P903, DOI 10.1017/S0033291799008673; Kent G.H., 1910, AM J INSANITY, V67, P37; LACKNER JR, 1974, NEUROPSYCHOLOGIA, V12, P199, DOI 10.1016/0028-3932(74)90005-0; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; LUBOW RE, 1987, B PSYCHONOMIC SOC, V25, P464; MacKay DG, 2006, HIPPOCAMPUS, V16, P491, DOI 10.1002/hipo.20176; MacKay DG, 1998, J COGNITIVE NEUROSCI, V10, P377, DOI 10.1162/089892998562807; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; Moritz S, 2003, PSYCHOL MED, V33, P131, DOI 10.1017/S0033291702006852; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Paulsen J S, 1995, J Int Neuropsychol Soc, V1, P88; Rizzo L, 1996, NEUROPSYCHOLOGY, V10, P376, DOI 10.1037/0894-4105.10.3.376; Rolls ET, 2005, J NEUROPHYSIOL, V94, P833, DOI 10.1152/jn.01063.2004; Ruppin E, 1996, SCHIZOPHRENIA BULL, V22, P105, DOI 10.1093/schbul/22.1.105; Rushe TM, 1999, SCHIZOPHR RES, V35, P85, DOI 10.1016/S0920-9964(98)00117-0; Ryan L, 2008, NEUROPSYCHOLOGIA, V46, P2109, DOI 10.1016/j.neuropsychologia.2008.02.030; Salisbury DF, 2000, PSYCHOPHYSIOLOGY, V37, P456, DOI 10.1017/S0048577200980028; Salisbury DF, 2002, CLIN NEUROPHYSIOL, V113, P383, DOI 10.1016/S1388-2457(02)00003-2; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Schmolck H, 2000, HIPPOCAMPUS, V10, P759, DOI 10.1002/1098-1063(2000)10:6<759::AID-HIPO1013>3.0.CO;2-A; Schmolck H, 2002, HIPPOCAMPUS, V12, P520, DOI 10.1002/hipo.10039; SCHWARTZ S, 1992, BEHAV BRAIN SCI, V5, P579; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Siekmeier PJ, 2007, SCHIZOPHR RES, V89, P177, DOI 10.1016/j.schres.2006.08.007; Siekmeier PJ, 2002, BRIT J PSYCHIAT, V180, P345, DOI 10.1192/bjp.180.4.345; Sitnikova T, 2002, PSYCHOPHYSIOLOGY, V39, P851, DOI 10.1111/1469-8986.3960851; Springer JA, 1999, BRAIN, V122, P2033, DOI 10.1093/brain/122.11.2033; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Talamini LM, 2005, ARCH GEN PSYCHIAT, V62, P485, DOI 10.1001/archpsyc.62.5.485; Tek C, 2002, ARCH GEN PSYCHIAT, V59, P146, DOI 10.1001/archpsyc.59.2.146; THOMAS P, 1990, BRIT J PSYCHIAT, V156, P204, DOI 10.1192/bjp.156.2.204; Titone D, 2000, J ABNORM PSYCHOL, V109, P761, DOI 10.1037/0021-843X.109.4.761; Vann SD, 2000, J NEUROSCI, V20, P2711; Vinogradov S, 1997, AM J PSYCHIAT, V154, P1530, DOI 10.1176/ajp.154.11.1530; Waters FAV, 2004, SCHIZOPHR RES, V68, P119, DOI 10.1016/S0920-9964(03)00221-4; Whatmough C, 2007, BEHAV BRAIN RES, V181, P262, DOI 10.1016/j.bbr.2007.04.017; WHITNEY C, 2008, J COGN NEUROSCI; WIDLOCHER D, 1989, CAH PSYCHOL COGN, V9, P583; ZAIDEL DW, 1995, LANCET, V345, P656, DOI 10.1016/S0140-6736(95)90562-6	81	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6505	10.1371/journal.pone.0006505	http://dx.doi.org/10.1371/journal.pone.0006505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479CW	19652706	gold, Green Published, Green Submitted			2022-12-25	WOS:000268637800014
J	vanEngelsdorp, D; Evans, JD; Saegerman, C; Mullin, C; Haubruge, E; Nguyen, BK; Frazier, M; Frazier, J; Cox-Foster, D; Chen, YP; Underwood, R; Tarpy, DR; Pettis, JS				vanEngelsdorp, Dennis; Evans, Jay D.; Saegerman, Claude; Mullin, Chris; Haubruge, Eric; Nguyen, Bach Kim; Frazier, Maryann; Frazier, Jim; Cox-Foster, Diana; Chen, Yanping; Underwood, Robyn; Tarpy, David R.; Pettis, Jeffery S.			Colony Collapse Disorder: A Descriptive Study	PLOS ONE			English	Article							HONEY-BEE HYMENOPTERA; APIS-MELLIFERA L.; VARROA-DESTRUCTOR ACARI; DIVISION-OF-LABOR; FLUCTUATING ASYMMETRY; NOSEMA-CERANAE; POLLEN AVAILABILITY; ECTOPARASITIC MITE; ACARAPIS-WOODI; APIDAE	Background: Over the last two winters, there have been large-scale, unexplained losses of managed honey bee (Apis mellifera L.) colonies in the United States. In the absence of a known cause, this syndrome was named Colony Collapse Disorder (CCD) because the main trait was a rapid loss of adult worker bees. We initiated a descriptive epizootiological study in order to better characterize CCD and compare risk factor exposure between populations afflicted by and not afflicted by CCD. Methods and Principal Findings: Of 61 quantified variables (including adult bee physiology, pathogen loads, and pesticide levels), no single measure emerged as a most-likely cause of CCD. Bees in CCD colonies had higher pathogen loads and were co-infected with a greater number of pathogens than control populations, suggesting either an increased exposure to pathogens or a reduced resistance of bees toward pathogens. Levels of the synthetic acaricide coumaphos (used by beekeepers to control the parasitic mite Varroa destructor) were higher in control colonies than CCD-affected colonies. Conclusions/Significance: This is the first comprehensive survey of CCD-affected bee populations that suggests CCD involves an interaction between pathogens and other stress factors. We present evidence that this condition is contagious or the result of exposure to a common risk factor. Potentially important areas for future hypothesis-driven research, including the possible legacy effect of mite parasitism and the role of honey bee resistance to pesticides, are highlighted.			vanEngelsdorp, D (corresponding author), Penn Dept Agr, Harrisburg, PA USA.	Jeffery.Pettis@ars.usda.gov	Evans, Jay D/C-8408-2012; vanEngelsdorp, Dennis/E-7934-2010	Evans, Jay D/0000-0002-0036-4651; Saegerman, Claude/0000-0001-9087-7436; Haubruge, Eric/0000-0002-8138-0476				AIKIN RC, 1897, GLNGS BEE CULT, V25, P479; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; [Anonymous], 2006, STAT VET ANIMAL SCI; BAILEY L, 1958, PARASITOLOGY, V48, P493, DOI 10.1017/S0031182000021430; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; CANTWELL G E, 1970, American Bee Journal, V110, P222; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Clarke Geoffrey M., 1992, Acta Zoologica Fennica, V191, P31; Clarke KE, 2001, MOL ECOL, V10, P1347, DOI 10.1046/j.1365-294X.2001.01274.x; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Contzen C, 2004, THERMOCHIM ACTA, V415, P115, DOI 10.1016/j.tca.2003.06.006; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DEGRANDIHOFFMAN G, 2008, J APICULT RES, V4, P126; DELFINADOBAKER M, 1984, AM BEE J, V124, P805; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DICKER RC, 2002, FIELD EPIDEMIOLOGY, P117; Dryden I., 1998, STAT ANAL SHAPE; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; *EXT TOX NETW, 1994, ESF; Farrar CL, 1936, AM BEE J, V76, P452; Franck P, 2000, MOL ECOL, V9, P907, DOI 10.1046/j.1365-294x.2000.00945.x; Frazier MT, 2000, J ECON ENTOMOL, V93, P551, DOI 10.1603/0022-0493-93.3.551; FRIEDMAN GD, 1987, PRIMER EPIDEMIOLOGY, P401; GOODMAN RA, 2002, FIELD EPIDEMIOLOGY, P3; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Hendrickx F, 2003, J EVOLUTION BIOL, V16, P1270, DOI 10.1046/j.1420-9101.2003.00633.x; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; HYMANS KC, 1998, EPIDEMIOL REV, V20, P148; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Keller I, 2005, BEE WORLD, V86, P27, DOI 10.1080/0005772X.2005.11099650; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; Lehotay SJ, 2005, J AOAC INT, V88, P615; Leung B, 1997, OIKOS, V78, P397, DOI 10.2307/3546309; MARGOLIS L, 1982, J PARASITOL, V68, P131, DOI 10.2307/3281335; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Mattila HR, 2006, APIDOLOGIE, V37, P533, DOI 10.1051/apido:2006037; Mattila HR, 2006, J ECON ENTOMOL, V99, P604, DOI 10.1603/0022-0493-99.3.604; Mattila HR, 2006, ENVIRON ENTOMOL, V35, P708, DOI 10.1603/0046-225X-35.3.708; Milani N, 1999, APIDOLOGIE, V30, P229, DOI 10.1051/apido:19990211; Moller AP, 2003, VET J, V166, P19, DOI 10.1016/S1090-0233(02)00262-9; MULLIN CA, 2009, PESTICIDES HON UNPUB; *NAT RES COUNC COM, 2006, STAT POLL N AM; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Nielsen DI, 2000, ANN ENTOMOL SOC AM, V93, P1, DOI 10.1603/0013-8746(2000)093[0001:IPCRBM]2.0.CO;2; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Pettis JS, 2004, J ECON ENTOMOL, V97, P171, DOI 10.1603/0022-0493-97.2.171; Pettis JS, 2004, APIDOLOGIE, V35, P91, DOI 10.1051/apido:2003060; Rinderer T, 2004, AM BEE J, V144, P560; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Saegerman C, 2004, J CLIN MICROBIOL, V42, P172, DOI 10.1128/JCM.42.1.172-178.2004; Sagili RR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1471, DOI 10.1007/s00265-007-0379-1; Sagili RR, 2005, J INSECT PHYSIOL, V51, P953, DOI 10.1016/j.jinsphys.2005.04.003; *SAS I INC, 2002, SAS COMP PROGR VERS; *SAS I INC, 2007, JMP COMP PROGR VERS; Scharlaken B, 2007, ARCH INSECT BIOCHEM, V65, P223, DOI 10.1002/arch.20179; Schneider SS, 2003, EVOLUTION, V57, P2350, DOI 10.1111/j.0014-3820.2003.tb00247.x; Shimanuki H, 2000, DIAGNOSIS HONEY BEE; SOMERVILLE DC, 2001, 176 NSW AGR RUR IND; STONER A, 1985, AM BEE J, V125, P513; Trotta V, 2005, EUR J ENTOMOL, V102, P195, DOI 10.14411/eje.2005.031; Tuyttens FAM, 2003, ANIM WELFARE, V12, P535; Underwood R., 2007, BEE CULTURE, V35, P13; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanengelsdorp D, 2008, J ECON ENTOMOL, V101, P256, DOI 10.1603/0022-0493(2008)101[256:SFOHBH]2.0.CO;2; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; VANVALEN L, 1962, EVOLUTION, V16, P125; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Zander E., 1909, M NCH BIENENZ, V31, P196, DOI DOI 10.1016/J.BBAGEN.2015.01.008	85	829	867	20	923	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6481	10.1371/journal.pone.0006481	http://dx.doi.org/10.1371/journal.pone.0006481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649264	Green Submitted, gold, Green Published			2022-12-25	WOS:000268637700007
J	Nomikou, K; Dovas, CI; Maan, S; Anthony, SJ; Samuel, AR; Papanastassopoulou, M; Maan, NS; Mangana, O; Mertens, PPC				Nomikou, Kyriaki; Dovas, Chrysostomos I.; Maan, Sushila; Anthony, Simon J.; Samuel, Alan R.; Papanastassopoulou, Maria; Maan, Narender S.; Mangana, Olga; Mertens, Peter P. C.			Evolution and Phylogenetic Analysis of Full-Length VP3 Genes of Eastern Mediterranean Bluetongue Virus Isolates	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; COMPLETE NUCLEOTIDE-SEQUENCE; UNITED-STATES; MOLECULAR EPIDEMIOLOGY; MESSENGER-RNA; PROTEIN; GENOME; STRAINS; IDENTIFICATION; VACCINE	Bluetongue virus (BTV) is the 'type' species of the genus Orbivirus within the family Reoviridae. The BTV genome is composed of ten linear segments of double-stranded RNA (dsRNA), each of which codes for one of ten distinct viral proteins. Previous phylogenetic comparisons have evaluated variations in genome segment 3 (Seg-3) nucleotide sequence as way to identify the geographical origin (different topotypes) of BTV isolates. The full-length nucleotide sequence of genome Seg-3 was determined for thirty BTV isolates recovered in the eastern Mediterranean region, the Balkans and other geographic areas (Spain, India, Malaysia and Africa). These data were compared, based on molecular variability, positive-selection-analysis and maximum-likelihood phylogenetic reconstructions (using appropriate substitution models) to 24 previously published sequences, revealing their evolutionary relationships. These analyses indicate that negative selection is a major force in the evolution of BTV, restricting nucleotide variability, reducing the evolutionary rate of Seg-3 and potentially of other regions of the BTV genome. Phylogenetic analysis of the BTV-4 strains isolated over a relatively long time interval (1979-2000), in a single geographic area (Greece), showed a low level of nucleotide diversity, indicating that the virus can circulate almost unchanged for many years. These analyses also show that the recent incursions into south-eastern Europe were caused by BTV strains belonging to two different major-lineages: representing an 'eastern' (BTV-9, -16 and -1) and a 'western' (BTV-4) group/topotype. Epidemiological and phylogenetic analyses indicate that these viruses originated from a geographic area to the east and southeast of Greece (including Cyprus and the Middle East), which appears to represent an important ecological niche for the virus that is likely to represent a continuing source of future BTV incursions into Europe.			Nomikou, K (corresponding author), AFRC, Inst Anim Hlth, Pirbright Lab, Arbovirus Mol Res Grp,Dept Vector Borne Dis, Woking GU24 0NF, Surrey, England.	peter.mertens@bbsrc.ac.uk	Nomikou, Kyriaki/P-1840-2018; Nomikou, Kyriaki/Q-5555-2016; Dovas, Chrysostomos/AAF-9663-2019	Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Dovas, Chrysostomos/0000-0003-2947-1765; Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AFSHAR A, 1994, COMP IMMUNOL MICROB, V17, P221, DOI 10.1016/0147-9571(94)90045-0; Anisimova M, 2003, GENETICS, V164, P1229; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Balasuriya UBR, 2008, VET MICROBIOL, V126, P91, DOI 10.1016/j.vetmic.2007.07.006; Barros SC, 2007, VET MICROBIOL, V124, P25, DOI 10.1016/j.vetmic.2007.04.014; Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; Bernard KA, 1997, INTERVIROLOGY, V40, P226, DOI 10.1159/000150551; Bonneau KR, 2000, ARCH VIROL, V145, P1163, DOI 10.1007/s007050070116; Bonneau KR, 1999, VIRUS RES, V61, P153, DOI 10.1016/S0168-1702(99)00034-9; Bonneau KR, 2001, J VIROL, V75, P8298, DOI 10.1128/JVI.75.17.8298-8305.2001; Breard E, 2007, VIRUS RES, V125, P191, DOI 10.1016/j.virusres.2007.01.002; Clavijo A, 2000, J VIROL METHODS, V87, P13, DOI 10.1016/S0166-0934(00)00150-6; DECLERCQ K, 2009, TRANSBOUNDARY UNPUB; DEMATTOS CA, 1994, VIRUS RES, V31, P67, DOI 10.1016/0168-1702(94)90072-8; DeMattos CC, 1996, J VIROL, V70, P5735, DOI 10.1128/JVI.70.8.5735-5739.1996; DEMATTOS CCP, 1994, VIROLOGY, V201, P173, DOI 10.1006/viro.1994.1281; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Dungu B, 2004, DEV BIOLOGICALS, V119, P463; GHIASI H, 1985, VIRUS RES, V3, P181, DOI 10.1016/0168-1702(85)90007-3; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; GOULD AR, 1987, VIRUS RES, V7, P169, DOI 10.1016/0168-1702(87)90078-5; GOULD AR, 1990, VIRUS RES, V17, P31, DOI 10.1016/0168-1702(90)90078-P; Grimes JM, 1997, STRUCTURE, V5, P885, DOI 10.1016/S0969-2126(97)00243-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOWELL P G, 1970, Journal of the South African Veterinary Medical Association, V41, P215; HWANG GY, 1994, VIRUS RES, V32, P381, DOI 10.1016/0168-1702(94)90086-8; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kar AK, 2004, VIROLOGY, V324, P387, DOI 10.1016/j.virol.2004.04.018; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lymperopoulos K, 2003, J BIOL CHEM, V278, P31722, DOI 10.1074/jbc.M301072200; Lymperopoulos K, 2006, VIROLOGY, V353, P17, DOI 10.1016/j.virol.2006.04.022; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Markotter W, 2004, VIRUS RES, V105, P1, DOI 10.1016/j.virusres.2004.04.005; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; Mertens P.P.C., 2004, VIRUS TAXONOMY, P447; Mertens PPC, 2004, VIRUS RES, V101, P29, DOI 10.1016/j.virusres.2003.12.004; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, PROMED ARCH; Nason EL, 2004, J VIROL, V78, P8059, DOI 10.1128/JVI.78.15.8059-8067.2004; Nei M., 1987, MOL EVOLUTIONARY GEN; Nikolakaki SV, 2005, VIRUS RES, V114, P6, DOI 10.1016/j.virusres.2005.05.004; Nomikou K, 2004, VETER ITAL SER, V40, P108; OIE, 2004, MAN DIAGN TESTS VACC; OIE, 2022, NUMB NEW H5 OUTBR; PARKER J, 1975, VET REC, V96, P284, DOI 10.1136/vr.96.13.284; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Potgieter AC, 2005, J VET MED B, V52, P372, DOI 10.1111/j.1439-0450.2005.00883.x; Pritchard LI, 1995, VIRUS RES, V39, P207, DOI 10.1016/0168-1702(95)00094-1; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Pritchard LI, 2004, VIRUS RES, V101, P193, DOI 10.1016/j.virusres.2004.01.004; PURDY M, 1984, J VIROL, V51, P754, DOI 10.1128/JVI.51.3.754-759.1984; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2006, NAT REV MICROBIOL, V4, DOI 10.1038/nrmicro1366; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Ramadevi N, 1998, P NATL ACAD SCI USA, V95, P13537, DOI 10.1073/pnas.95.23.13537; RAO CD, 1983, J VIROL, V46, P378, DOI 10.1128/JVI.46.2.378-383.1983; ROY P, 1989, VIRUS RES, V13, P179, DOI 10.1016/0168-1702(89)90015-4; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shimshony A, 2004, VETER ITAL SER, V40, P116; SINGH KP, 2005, VET ITAL, V40, P479; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; TANAKA S, 1994, J VIROL, V68, P2795, DOI 10.1128/JVI.68.5.2795-2802.1994; TAYLOR WP, 1994, EPIDEMIOL INFECT, V112, P623, DOI 10.1017/S0950268800051323; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ting LJ, 2005, VET REC, V156, P52, DOI 10.1136/vr.156.2.52; Toussaint JF, 2007, EMERG INFECT DIS, V13, P614, DOI 10.3201/eid1304.061136; Vassalos M., 1980, Bulletin de l'Office International des Epizooties, V92, P547; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; White DM, 2006, VIRUS RES, V118, P39, DOI 10.1016/j.virusres.2005.11.008; Wilson WC, 2000, VIRUS RES, V67, P141, DOI 10.1016/S0168-1702(00)00138-6	82	31	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6437	10.1371/journal.pone.0006437	http://dx.doi.org/10.1371/journal.pone.0006437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649272	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000268494600007
J	Guignabert, C; Tu, L; Izikki, M; Dewachter, L; Zadigue, P; Humbert, M; Adnot, S; Fadel, E; Eddahibi, S				Guignabert, Christophe; Tu, Ly; Izikki, Mohamed; Dewachter, Laurence; Zadigue, Patricia; Humbert, Marc; Adnot, Serge; Fadel, Elie; Eddahibi, Saadia			Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22 alpha-targeted overexpression of the serotonin transporter	FASEB JOURNAL			English	Article						pulmonary vascular remodeling; serotonin pathway; NFAT/Kv1.5 axis; PDK inhibitor; Bcl-2/Bax ratio	SMOOTH-MUSCLE-CELLS; GATED K+ CURRENTS; ARTERIAL-HYPERTENSION; KINASE ACTIVATION; APOPTOSIS; CHANNELS; GENE; 5-HYDROXYTRYPTAMINE; EXPRESSION; PREVENTS	Voltage-gated potassium (Kv)1.5 is decreased in pulmonary arteries (PAs) of patients with idiopathic pulmonary arterial hypertension (IPAH) and in experimental models including mice with SM22 alpha-targeted overexpression of the serotonin transporter (5-HTT). The mechanisms underlying these abnormalities, however, remain unknown. Dichloroacetate (DCA) inhibits chronic hypoxia-or monocrotaline-induced PAH by inhibiting nuclear factor of activated T-cells (NFAT) c2 and increasing Kv1.5. Therefore, we hypothesized that DCA could regress established PAH in SM22-5-HTT+ mice. We evaluated pulmonary hemodynamics, vascular remodeling, NFATc2, and Kv1.5 protein in 20-wk-old SM22-5-HTT+ or wild-type mice treated for 1, 7, and 21 d with DCA, cyclosporine-A (NFAT inhibitor), or vehicle. DCA partially reversed PAH in SM22-5-HTT+ mice by decreasing proliferation and increasing apoptosis in muscularized PAs. Furthermore, serotonin (10(-8)-10(-6) M) dose-dependently increased PA-smooth muscle cell (PA-SMC) proliferation in culture (EC50 = 0.97 x 10(-7) M) and DCA (5 x 10(-4) M) vs. PBS markedly reduced the growth of PA-SMC from IPAH and control patients treated with the highest dose of serotonin by 50 and 30%, respectively. Finally, although serotonin induces NFATc2 activation in PA-SMCs, inhibition of NFATc2 alone with cyclosporine-A was not sufficient for reversing PAH in this model. Our results support the possibility that DCA may be an interesting agent for investigation in patients with PAH.-Guignabert, C., Tu, L., Izikki, M., Dewachter, L., Zadigue, P., Humbert, M., Adnot, S., Fadel, E., Eddahibi, S. Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22 alpha-targeted overexpression of the serotonin transporter. FASEB J. 23, 4135-4147 (2009). www.fasebj.org	[Guignabert, Christophe; Tu, Ly; Izikki, Mohamed; Dewachter, Laurence; Humbert, Marc; Fadel, Elie; Eddahibi, Saadia] Univ Paris 11, Ctr Chirurg Marie Lannelongue, INSERM Unity Pulm Hypertens Pathophysiol & Innova, F-92350 Le Plessis Robinson, France; [Guignabert, Christophe; Tu, Ly; Izikki, Mohamed; Zadigue, Patricia; Adnot, Serge; Eddahibi, Saadia] Inst Mondor Rech Biomed, INSERM, U955, Creteil, France; [Fadel, Elie] Ctr Chirurg Marie Lannelongue, UPRES, EA2705, Le Plessis Robinson, France; [Humbert, Marc] Hop Antoine Beclere, INSERM, U764, AP HP, Clamart, France	Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Marie Lannelongue; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Guignabert, C (corresponding author), Univ Paris 11, Ctr Chirurg Marie Lannelongue, INSERM Unity Pulm Hypertens Pathophysiol & Innova, 133 Ave Resistance, F-92350 Le Plessis Robinson, France.	christophe.guignabert@inserm.fr	GUIGNABERT, Christophe/G-3873-2013; Humbert, Marc/ABD-5112-2021; GUIGNABERT, Christophe/AGI-2488-2022; TU, Ly/G-4035-2013; TU, Ly/AAK-4996-2020	GUIGNABERT, Christophe/0000-0002-8545-4452; GUIGNABERT, Christophe/0000-0002-8545-4452; TU, Ly/0000-0003-2336-5099; TU, Ly/0000-0003-2336-5099; Humbert, Marc/0000-0003-0703-2892	French National Institute for Health and Medical Research (IN-SERM); Ministere de la Recherche	French National Institute for Health and Medical Research (IN-SERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	The authors thank Michel Hamon for helpful discussions. This research was supported by grants from the French National Institute for Health and Medical Research (IN-SERM), the Ministere de la Recherche.	Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Bush E, 2004, P NATL ACAD SCI USA, V101, P2870, DOI 10.1073/pnas.0308723101; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; de Caestecker M, 2006, CIRC RES, V98, P1229, DOI 10.1161/01.RES.0000225927.04710.33; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Evans AM, 1996, J PHYSIOL-LONDON, V496, P407, DOI 10.1113/jphysiol.1996.sp021694; Guignabert C, 2005, CIRCULATION, V111, P2812, DOI 10.1161/CIRCULATIONAHA.104.524926; Guignabert C, 2006, CIRC RES, V98, P1323, DOI 10.1161/01.RES.0000222546.45372.a0; Guilluy C, 2009, AM J RESP CRIT CARE, V179, P1151, DOI 10.1164/rccm.200805-691OC; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lee SL, 2001, AM J PHYSIOL-LUNG C, V281, pL646, DOI 10.1152/ajplung.2001.281.3.L646; Lee SL, 1998, FREE RADICAL BIO MED, V24, P855, DOI 10.1016/S0891-5849(97)00359-6; Lee SL, 1997, AM J PHYSIOL-CELL PH, V272, pC223, DOI 10.1152/ajpcell.1997.272.1.C223; Liu YL, 2004, CIRC RES, V95, P579, DOI 10.1161/01.RES.0000141428.53262.a4; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; MacLean MR, 2000, BRIT J PHARMACOL, V131, P161, DOI 10.1038/sj.bjp.0703570; Marcos E, 2003, AM J RESP CRIT CARE, V168, P487, DOI 10.1164/rccm.200210-1212OC; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974; Michelakis ED, 2008, CIRCULATION, V118, P1486, DOI 10.1161/CIRCULATIONAHA.106.673988; Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; POST JM, 1995, CIRC RES, V77, P131, DOI 10.1161/01.RES.77.1.131; Pozeg ZI, 2003, CIRCULATION, V107, P2037, DOI 10.1161/01.CIR.0000062688.76508.B3; Reeve HL, 2001, J APPL PHYSIOL, V90, P2249, DOI 10.1152/jappl.2001.90.6.2249; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Voelkel NF, 1998, CHEST, V114, p225S, DOI 10.1378/chest.114.3_Supplement.225S; Walczak-Drzewiecka A, 2008, J IMMUNOL, V181, P1665, DOI 10.4049/jimmunol.181.3.1665; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Young KA, 2006, AM J PHYSIOL-LUNG C, V290, pL841, DOI 10.1152/ajplung.00158.2005; Yu Y, 2001, CIRCULATION, V104, P1557, DOI 10.1161/hc3801.095662; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400; YUAN XJ, 1995, CIRC RES, V77, P370, DOI 10.1161/01.RES.77.2.370; Yuan XJ, 1998, LANCET, V351, P726, DOI 10.1016/S0140-6736(05)78495-6; ZHAI FG, 2009, CLIN EXP PHARM PHYSL	46	66	72	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4135	4147		10.1096/fj.09-131664	http://dx.doi.org/10.1096/fj.09-131664			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19679640				2022-12-25	WOS:000272193700010
J	Henes, J; Schmit, MA; Morote-Garcia, JC; Mirakaj, V; Kohler, D; Glover, L; Eldh, T; Walter, U; Karhausen, J; Colgan, SP; Rosenberger, P				Henes, Janek; Schmit, Marthe A.; Morote-Garcia, Julio C.; Mirakaj, Valbona; Koehler, David; Glover, Louise; Eldh, Therese; Walter, Ulrich; Karhausen, Joern; Colgan, Sean P.; Rosenberger, Peter			Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury	FASEB JOURNAL			English	Article						cytoskeleton; ALI; ventilator-induced lung injury; pulmonary inflammation; actin	GAP FORMATION; PERMEABILITY; ADENOSINE; HYPOXIA; KINASE; INCREASE; IDENTIFICATION; REGENERATION; ENDOTHELIUM; ACTIVATION	Acute lung injury (ALI) is an inflammatory disorder associated with reduced alveolar-capillary barrier function, increased pulmonary vascular permeability, and infiltration of leukocytes into the alveolar space. Pulmonary function might be compromised, its most severe form being the acute respiratory distress syndrome. A protein central to physiological barrier properties is vasodilator-stimulated phosphoprotein (VASP). Given the fact that VASP expression is reduced during periods of cellular hypoxia, we investigated the role of VASP during ALI. Initial studies revealed reduced VASP expressional levels through cytokines in vitro. Studies in the putative human VASP promoter identified NF-kappa B as a key regulator of VASP transcription. This VASP repression results in increased paracellular permeability and migration of neutrophils in vitro. In a model of LPS-induced ALI, VASP(-/-) mice demonstrated increased pulmonary damage compared with wild-type animals. These findings were confirmed in a second model of ventilator-induced lung injury. Studies employing bone marrow chimeric animals identified tissue-specific repression of VASP as the underlying cause of decreased barrier properties of the alveolar-capillary barrier during ALI. Taken together these studies identify tissue-specific VASP as a central protein in the control of the alveolar-capillary barrier properties during ALI.-Henes, J., Schmit, M. A., Morote-Garcia, J. C., Mirakaj, V., Kohler, D., Glover, L., Eldh, T., Walter, U., Karhausen, J., Colgan, S. P., Rosenberger, P. Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury. FASEB J. 23, 4244-4255 (2009). www.fasebj.org	[Henes, Janek; Schmit, Marthe A.; Morote-Garcia, Julio C.; Mirakaj, Valbona; Koehler, David; Karhausen, Joern; Rosenberger, Peter] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, D-72076 Tubingen, Germany; [Eldh, Therese] Univ Tubingen Hosp, Dept Radiat Oncol, D-72076 Tubingen, Germany; [Schmit, Marthe A.] Univ Munich, Tieraerztl Fak, Munich, Germany; [Glover, Louise; Colgan, Sean P.] Univ Colorado, Hlth Sci Ctr, Mucosal Inflammat Program, Denver, CO USA; [Walter, Ulrich] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; [Walter, Ulrich] Univ Wurzburg, Div Lab Med, IKBZ, Wurzburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Wurzburg; University of Wurzburg	Rosenberger, P (corresponding author), Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	peter.rosenberger@medizin.uni-tuebingen.de	Walter, ulrich/W-2478-2017; karhausen, jorn/X-8813-2019	Walter, ulrich/0000-0001-6784-2307; karhausen, jorn/0000-0002-4240-229X; Mirakaj, Valbona/0000-0002-6907-6455; Glover, Louise/0000-0001-9056-1810	Deutsche Forschungsgemeinschaft [DFG RO 3671/4-1]; Tuebingen University Fortuene [IZKF 1639-0]; European Society of Anesthesiology; Karl-Kuhn Foundation for Cardiovascular Research; Ministere de la Culture; de l'Enseignement Superieur et de la Recherche; Grand-Duche de Luxembourg; U. S. National Institutes of Health [NIH DK50189]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050189, R01DK050189, R29DK050189] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University Fortuene; European Society of Anesthesiology; Karl-Kuhn Foundation for Cardiovascular Research; Ministere de la Culture; de l'Enseignement Superieur et de la Recherche; Grand-Duche de Luxembourg; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Marion Faigle and Stephanie Zug for help with immunhistochemistry and CHIP assay and Stefanie Laucher for help with the performance of animal experiments. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG RO 3671/4-1), a Tuebingen University Fortuene grant (IZKF 1639-0), a research grant of the European Society of Anesthesiology, and the Karl-Kuhn Foundation for Cardiovascular Research grant (all to P. R.); a grant from the Ministere de la Culture, de l'Enseignement Superieur et de la Recherche, Grand-Duche de Luxembourg to M. A. S; and a grant by the U. S. National Institutes of Health (NIH DK50189) to S. P. C. J. H., M. S., J. C. M.-G., V. M., D. K., and L. G. performed experiments and analyzed data.; T. E. performed bone marrow transplantation; U. W. designed research and helped with manuscript writing; J. K. designed research and analyzed data; and S. P. C. and P. R. designed research and wrote the manuscript.	Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Barone G W, 1989, J Card Surg, V4, P140, DOI 10.1111/j.1540-8191.1989.tb00270.x; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Bouvry D, 2006, AM J RESP CELL MOL, V35, P519, DOI 10.1165/rcmb.2005-0478OC; Chin AC, 2007, ANNU REV PATHOL-MECH, V2, P111, DOI 10.1146/annurev.pathol.2.010506.091944; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Eckle T, 2008, AM J PHYSIOL-LUNG C, V295, pL718, DOI 10.1152/ajplung.90298.2008; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; FASANO A, 1995, J CLIN INVEST, V96, P710, DOI 10.1172/JCI118114; Furman C, 2007, J CELL BIOL, V179, P761, DOI 10.1083/jcb.200705002; GARCIA JGN, 1986, J CELL PHYSIOL, V128, P96, DOI 10.1002/jcp.1041280115; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia JGN, 1999, AM J PHYSIOL-LUNG C, V276, pL989, DOI 10.1152/ajplung.1999.276.6.L989; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Hohenstein B, 2005, J AM SOC NEPHROL, V16, P986, DOI 10.1681/ASN.2004070591; Holtzman MJ, 2002, PHYSIOL REV, V82, P19, DOI 10.1152/physrev.00020.2001; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Lawrence DW, 2002, AM J PHYSIOL-CELL PH, V282, pC1235, DOI 10.1152/ajpcell.00288.2001; Lennon PF, 1998, J EXP MED, V188, P1433, DOI 10.1084/jem.188.8.1433; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; Minamino T, 2006, J CLIN INVEST, V116, P2316, DOI 10.1172/JCI29637; MIZUNOYAGYU Y, 1987, BIOCHEM PHARMACOL, V36, P3809; MOLITORIS BA, 1991, AM J PHYSIOL, V260, pF769; Petrache I, 2001, AM J PHYSIOL-LUNG C, V280, pL1168, DOI 10.1152/ajplung.2001.280.6.L1168; Price CJ, 2000, ARTERIOSCL THROM VAS, V20, P2051, DOI 10.1161/01.ATV.20.9.2051; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schlegel N, 2008, AM J PHYSIOL-CELL PH, V294, pC178, DOI 10.1152/ajpcell.00273.2007; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wojciak-Stothard B, 2006, AM J PHYSIOL-LUNG C, V290, pL1173, DOI 10.1152/ajplung.00309.2005; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; WU NZ, 1992, AM J PHYSIOL, V262, pH1238; Yamashita R, 2006, NUCLEIC ACIDS RES, V34, pD86, DOI 10.1093/nar/gkj129	44	34	36	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4244	4255		10.1096/fj.09-138693	http://dx.doi.org/10.1096/fj.09-138693			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19690214	Green Published			2022-12-25	WOS:000272193700019
J	Huang, SK; White, ES; Wettlaufer, SH; Grifka, H; Hogaboam, CM; Thannickal, VJ; Horowitz, JC; Peters-Golden, M				Huang, Steven K.; White, Eric S.; Wettlaufer, Scott H.; Grifka, Heather; Hogaboam, Cory M.; Thannickal, Victor J.; Horowitz, Jeffrey C.; Peters-Golden, Marc			Prostaglandin E-2 induces fibroblast apoptosis by modulating multiple survival pathways	FASEB JOURNAL			English	Article						PTEN; survivin; Fas; Akt; idiopathic pulmonary fibrosis	IDIOPATHIC PULMONARY-FIBROSIS; FIBROTIC LUNG FIBROBLASTS; GROWTH-FACTOR-BETA; INHIBITS FIBROBLAST; CELL-DEATH; E-PROSTANOID-2 RECEPTOR; CASPASE INHIBITORS; MESENCHYMAL CELLS; EPITHELIAL-CELLS; ACTIVATION	Although the lipid mediator prostaglandin E-2 (PGE(2)) exerts antifibrotic effects by inhibiting multiple fibroblast functions, its ability to regulate fibroblast survival is unknown. Here, we examined the effects of this prostanoid on apoptosis and apoptosis pathways in normal and fibrotic lung fibroblasts. As compared to medium alone, 24 h of treatment with PGE(2) increased apoptosis of normal lung fibroblasts in a dose-dependent manner (EC50 similar to 50 nM), as measured by annexin V staining, caspase 3 activity, cleavage of poly-ADP-ribose polymerase, and single-stranded DNA levels. PGE(2) also potentiated apoptosis elicited by Fas ligand plus cycloheximide. These proapoptotic actions were dependent on signaling through the EP2/EP4 receptors and by downstream activation of both caspases 8 and 9. Silencing and gene deletion of PTEN demonstrated that the effects of PGE(2) involved decreased activity of the prosurvival molecule Akt. PGE(2) also down-regulated expression of survivin, an inhibitor of apoptosis, and increased expression of Fas. Fibroblasts from patients with pulmonary fibrosis exhibited resistance to the apoptotic effects of PGE(2). These findings show for the first time that, in contrast to its effects on many other cell types, PGE(2) promotes apoptosis in lung fibroblasts through diverse pathways. They provide another dimension by which PGE(2) may inhibit, and perhaps even reverse, fibrogenesis in patients with interstitial lung disease.-Huang, S. K., White, E. S., Wettlaufer, S. H., Grifka, H., Hogaboam, C. M., Thannickal, V. J., Horowitz, J. C., Peters-Golden, M. Prostaglandin E-2 induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J. 23, 4317-4326 (2009). www.fasebj.org	[Huang, Steven K.; White, Eric S.; Wettlaufer, Scott H.; Grifka, Heather; Thannickal, Victor J.; Horowitz, Jeffrey C.; Peters-Golden, Marc] Univ Michigan, Div Pulm & Crit Care Med, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Hogaboam, Cory M.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Peters-Golden, M (corresponding author), Univ Michigan, Div Pulm & Crit Care Med, Dept Internal Med, Sch Med, 6301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	Hogaboam, Cory M./AAI-1433-2021; Horowitz, Jeffrey/AAY-7238-2021; hogaboam, cory/M-3578-2014	Hogaboam, Cory M./0000-0003-3366-4850; Horowitz, Jeffrey/0000-0002-1505-2837; White, Eric/0000-0003-4060-8443	U.S. National Institutes of Health [P50 HL56402]; Parker B. Francis Fellowship; American Thoracic Society Fellows Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749, P50HL056402, R01HL085083] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship; American Thoracic Society Fellows Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Rommel Sagana for providing assistance with the PTEN siRNA experiments. This work was supported by U.S. National Institutes of Health grant P50 HL56402 from the National Heart, Lung, and Blood Institute. S. K. H. was supported by a Parker B. Francis Fellowship and an American Thoracic Society Fellows Career Development Award.	Barbas-Filho JV, 2001, J CLIN PATHOL, V54, P132, DOI 10.1136/jcp.54.2.132; BITTERMAN PB, 1986, J CLIN INVEST, V77, P700, DOI 10.1172/JCI112364; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buhling F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-37; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CHAUNCEY JB, 1988, LAB INVEST, V58, P133; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; ELIAS JA, 1985, AM REV RESPIR DIS, V131, P94; Falleni M, 2003, J PATHOL, V200, P620, DOI 10.1002/path.1388; FINE A, 1989, J BIOL CHEM, V264, P16988; Hawcroft G, 2007, ONCOGENE, V26, P3006, DOI 10.1038/sj.onc.1210113; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Hogaboam CM, 2005, METH MOLEC MED, V117, P209; Horowitz JC, 2006, AM J PHYSIOL-LUNG C, V290, pL415, DOI 10.1152/ajplung.00276.2005; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2008, AM J RESP CRIT CARE, V177, P66, DOI 10.1164/rccm.200706-963OC; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kawasaki H, 1998, CANCER RES, V58, P5071; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Krysan K, 2004, FASEB J, V18, P205, DOI 10.1096/fj.03-0369fje; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Laurent Geoffrey J, 2008, Proc Am Thorac Soc, V5, P311, DOI 10.1513/pats.200710-159DR; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lin J, 2005, BIOCHEM PHARMACOL, V70, P658, DOI 10.1016/j.bcp.2005.05.028; LIPCHIK RJ, 1990, AM J PHYSIOL, V259, pL73, DOI 10.1152/ajplung.1990.259.2.L73; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Moodley YP, 2004, J PATHOL, V202, P486, DOI 10.1002/path.1531; Moore BB, 2000, J IMMUNOL, V165, P4032, DOI 10.4049/jimmunol.165.7.4032; Moore BB, 2005, J IMMUNOL, V174, P5644, DOI 10.4049/jimmunol.174.9.5644; Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100; Nishimura K, 2006, BIOSCI BIOTECH BIOCH, V70, P2145, DOI 10.1271/bbb.60106; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Plataki M, 2005, CHEST, V127, P266, DOI 10.1378/chest.127.1.266; Porter BO, 1999, EUR J IMMUNOL, V29, P2360, DOI 10.1002/(SICI)1521-4141(199907)29:07<2360::AID-IMMU2360>3.0.CO;2-A; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; Sauerwald TM, 2003, BIOTECHNOL BIOENG, V81, P329, DOI 10.1002/bit.10473; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sheng HM, 1998, CANCER RES, V58, P362; Sugiura H, 2007, J CELL PHYSIOL, V210, P99, DOI 10.1002/jcp.20825; Sweeney EA, 1998, FEBS LETT, V425, P61, DOI 10.1016/S0014-5793(98)00198-7; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uhal BD, 1998, AM J PHYSIOL-LUNG C, V275, pL1192, DOI 10.1152/ajplung.1998.275.6.L1192; Weinlich R, 2008, CELL DEATH DIFFER, V15, P1901, DOI 10.1038/cdd.2008.128; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045	57	113	114	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4317	4326		10.1096/fj.08-128801	http://dx.doi.org/10.1096/fj.08-128801			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19671668	Green Published, Green Submitted			2022-12-25	WOS:000272193700026
J	Leivonen, SK; Makela, R; Ostling, P; Kohonen, P; Haapa-Paananen, S; Kleivi, K; Enerly, E; Aakula, A; Hellstrom, K; Sahlberg, N; Kristensen, VN; Borresen-Dale, AL; Saviranta, P; Perala, M; Kallioniemi, O				Leivonen, S-K; Makela, R.; Ostling, P.; Kohonen, P.; Haapa-Paananen, S.; Kleivi, K.; Enerly, E.; Aakula, A.; Hellstrom, K.; Sahlberg, N.; Kristensen, V. N.; Borresen-Dale, A-L; Saviranta, P.; Perala, M.; Kallioniemi, O.			Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines	ONCOGENE			English	Article						breast cancer; estrogen receptor; miRNA; protein lysate microarray; screening	CYCLE PROGRESSION; MESSENGER-RNAS; EXPRESSION; ALPHA; TARGETS; RESISTANCE; GENES	Predicting the impact of microRNAs (miRNAs) on target proteins is challenging because of their different regulatory effects at the transcriptional and translational levels. In this study, we applied a novel protein lysate microarray (LMA) technology to systematically monitor for target protein levels after high-throughput transfections of 319 pre-miRs into breast cancer cells. We identified 21 miRNAs that downregulated the estrogen receptor-alpha (ER alpha), as validated by western blotting and quantitative real time-PCR, and by demonstrating the inhibition of estrogen-stimulated cell growth. Five potent ER alpha-regulating miRNAs, miR-18a, miR-18b, miR-193b, miR-206 and miR-302c, were confirmed to directly target ER alpha in 3'-untranslated region reporter assays. The gene expression signature that they repressed highly overlapped with that of a small interfering RNA against ER alpha, and across all the signatures tested, was most closely associated with the repression of known estrogen-induced genes. Furthermore, miR-18a and miR-18b showed higher levels of expression in ER alpha-negative as compared with ER alpha-positive clinical tumors. In summary, we present systematic and direct functional evidence of miRNAs inhibiting ER alpha signaling in breast cancer, and demonstrate the high-throughput LMA technology as a novel, powerful technique in determining the relative impact of various miRNAs on key target proteins and associated cellular processes and pathways. Oncogene (2009) 28, 3926-3936; doi:10.1038/onc.2009.241; published online 17 August 2009	[Leivonen, S-K] VTT Tech Res Ctr Finland, VTT Med Biotechnol, FI-20521 Turku, Finland; [Leivonen, S-K; Makela, R.; Ostling, P.; Kohonen, P.; Haapa-Paananen, S.; Kleivi, K.; Aakula, A.; Hellstrom, K.; Sahlberg, N.; Saviranta, P.; Perala, M.; Kallioniemi, O.] Univ Turku, Ctr Biotechnol, Turku, Finland; [Kleivi, K.; Enerly, E.; Kristensen, V. N.; Borresen-Dale, A-L] Univ Hosp, Rikshosp, Norwegian Radiumhosp, Dept Genet,Inst Canc Res, Oslo, Norway; [Enerly, E.; Borresen-Dale, A-L] Univ Oslo, Fac Med, Div Norwegian Radiumhosp, Oslo, Norway; [Kristensen, V. N.] Univ Oslo, Fac Med, Div AHUS, Oslo, Norway; [Kallioniemi, O.] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland	VTT Technical Research Center Finland; University of Turku; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Helsinki	Leivonen, SK (corresponding author), VTT Tech Res Ctr Finland, VTT Med Biotechnol, Itainen Pitkakatu 4C,POB 106, FI-20521 Turku, Finland.	suvi-katri.leivonen@vtt.fi	Haapa-Paananen, Saija/D-3075-2012; Leivonen, Suvi-Katri/AAK-3096-2021; Kohonen, Pekka/F-9596-2011; Kallioniemi, Olli P/H-5111-2011; Enerly, Espen/P-4666-2019	Kohonen, Pekka/0000-0002-7845-3611; Kallioniemi, Olli P/0000-0002-3231-0332; Enerly, Espen/0000-0002-2974-2273; Saviranta, Petri/0000-0002-3289-0621; Ostling, Paivi/0000-0001-5501-466X; Leivonen, Suvi-Katri/0000-0003-3224-0757; Kleivi Sahlberg, Kristine/0000-0002-7281-2759	Academy of Finland Centre of Excellence on Translational Genome-Scale Biology; Academy of Finland postdoctoral researcher's grant; Sigrid Juselius Foundation; Finnish Cancer Society; EU-FP6 [LSHB-CT-2004-005276, LSHG-CT-2004-5033155]; EU-FP7 [HEALTH-F2-2007-201438]	Academy of Finland Centre of Excellence on Translational Genome-Scale Biology(Academy of Finland); Academy of Finland postdoctoral researcher's grant(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Society; EU-FP6(European Commission); EU-FP7(European Commission)	The technical assistance of Pauliina Toivonen is gratefully acknowledged. We thank Agilent Technologies for their support on the miRNA expression arrays, and Hilde Johnsen (Department of Genetics, Norwegian Radium Hospital) for laboratory handling of miRNA expression arrays on tumors. We are grateful to the Department of Pathology, Norwegian Radium Hospital, for providing ER-IHC. This study was supported by the Academy of Finland Centre of Excellence on Translational Genome-Scale Biology, Academy of Finland postdoctoral researcher's grant (to SKL), Sigrid Juselius Foundation, Finnish Cancer Society, EU-FP6 projects RIGHT (LSHB-CT-2004-005276) and Moltools (LSHG-CT-2004-5033155), and EU-FP7 project ProspeR (HEALTH-F2-2007-201438).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Kenealy MR, 2000, ENDOCRINOLOGY, V141, P2805, DOI 10.1210/en.141.8.2805; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Milano A, 2006, EUR J CANCER, V42, P2692, DOI 10.1016/j.ejca.2006.06.022; Naume B, 2001, CLIN CANCER RES, V7, P4122; Reid G, 2002, CELL MOL LIFE SCI, V59, P821, DOI 10.1007/s00018-002-8470-2; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Verghese ET, 2008, J PATHOL, V215, P214, DOI 10.1002/path.2359; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	31	185	194	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2009	28	44					3926	3936		10.1038/onc.2009.241	http://dx.doi.org/10.1038/onc.2009.241			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	515LJ	19684618				2022-12-25	WOS:000271471900007
J	Singh, P; Marikkannu, R; Bitomsky, N; Klempnauer, KH				Singh, P.; Marikkannu, R.; Bitomsky, N.; Klempnauer, K-H			Disruption of the Pdcd4 tumor suppressor gene in chicken DT40 cells reveals its role in the DNA-damage response	ONCOGENE			English	Article						Pdcd4; DT40; DNA damage; UV; tumor suppressor	PROTEIN PDCD4; TRANSLATION INITIATION; EUKARYOTIC TRANSLATION; STRUCTURAL BASIS; EXPRESSION; TRANSFORMATION; BINDING; MA-3; TRANSCRIPTION; INHIBITION	The programmed cell death gene 4 (Pdcd4) gene has been implicated as a new tumor suppressor gene in the development of several types of human cancer. Pdcd4 interacts with the translation initiation factor, eIF4A, and is thought to act as a translation inhibitor. Here, we have used the chicken B-cell line DT40 to disrupt the Pdcd4 gene by homologous recombination. Our study shows that cells lacking a functional Pdcd4 gene are viable and have no obvious defects when cultivated under normal growth conditions. However, Pdcd4 knockout cells show an increased sensitivity to agents that cause DNA damage, such as UV light, etoposide or ethyl-methanesulfonate. In summary, our findings show that Pdcd4 has an important function in the cellular response to DNA damage. Low Pdcd4 expression, which is frequently observed in tumor cells, might therefore contribute to tumorigenesis by disturbing the cellular DNA-damage response. Oncogene (2009) 28, 3758-3764; doi: 10.1038/onc.2009.239; published online 17 August 2009	[Singh, P.; Marikkannu, R.; Bitomsky, N.; Klempnauer, K-H] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de	Singh, Priyanka/GRF-6098-2022; Singh, Priyanka/N-1372-2018	Singh, Priyanka/0000-0003-0841-1544; Singh, Priyanka/0000-0002-5928-6280	Deutsche Krebshilfe [10-1716]; Graduate School of Chemistry (GSC-MS) at the University of Munster	Deutsche Krebshilfe(Deutsche Krebshilfe); Graduate School of Chemistry (GSC-MS) at the University of Munster	We thank B Berkenfeld for excellent technical assistance. This study was supported by grants from the Deutsche Krebshilfe (10-1716) and the Wilhelm-Sander-Stiftung (2004.088.1). PS and RM were supported by fellowships from the Graduate School of Chemistry (GSC-MS) at the University of Munster.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Schlichter U, 2001, BBA-GENE STRUCT EXPR, V1520, P99, DOI 10.1016/S0167-4781(01)00252-4; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Takao N, 1999, ONCOGENE, V18, P7002, DOI 10.1038/sj.onc.1203172; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634	32	21	21	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2009	28	42					3758	3764		10.1038/onc.2009.239	http://dx.doi.org/10.1038/onc.2009.239			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	509MY	19684621				2022-12-25	WOS:000271023200008
J	Antonczak, AK; Simova, Z; Tippmann, EM				Antonczak, Alicja K.; Simova, Zuzana; Tippmann, Eric M.			A Critical Examination of Escherichia coli Esterase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; EARTHWORM LUMBRICUS-TERRESTRIS; SITE-SPECIFIC INCORPORATION; BINDING LECTIN EW29; GENETIC-CODE; STRUCTURAL BASIS; N-ACETYLGLUCOSAMINE; DIRECTED EVOLUTION; L-PHENYLALANINE; EXPRESSION	The ability of Escherichia coli to grow on a series of acetylated and glycosylated compounds has been investigated. It is surmised that E. coli maintains low levels of nonspecific esterase activity. This observation may have ramifications for previous reports that relied on nonspecific esterases from E. coli to genetically encode nonnatural amino acids. It had been reported that nonspecific esterases from E. coli deacetylate tri-acetyl O-linked glycosylated serine and threonine in vivo. The glycosylated amino acids were reported to have been genetically encoded into proteins in response to the amber stop codon. However, it is our contention that such amino acids are not utilized in this manner within E. coli. The current results report in vitro analysis of the original enzyme and an in vivo analysis of a glycosylated amino acid. It is concluded that the amber suppression method with nonnatural amino acids may require a caveat for use in certain instances.	[Antonczak, Alicja K.; Simova, Zuzana; Tippmann, Eric M.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales	Cardiff University	Tippmann, EM (corresponding author), Main Bldg,Pk Pl, Cardiff CF10 3AT, S Glam, Wales.	tippmann@cardiff.ac.uk			Engineering and Physical Sciences Research Council [EP/D001641]; EPSRC [EP/D001641/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D001641/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council Grant EP/D001641.	Alvarez-Anorve LI, 2005, J BACTERIOL, V187, P2974, DOI 10.1128/JB.187.9.2974-2982.2005; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Baldwin AJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn358; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOOS W, 1974, ANNU REV BIOCHEM, V43, P123, DOI 10.1146/annurev.bi.43.070174.001011; Carinato ME, 1998, J BACTERIOL, V180, P3517, DOI 10.1128/JB.180.14.3517-3521.1998; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Hasona A, 2002, APPL ENVIRON MICROB, V68, P2651, DOI 10.1128/AEM.68.6.2651-2659.2002; ISENBERG S, 1974, J BACTERIOL, V118, P53, DOI 10.1128/JB.118.1.53-58.1974; Kanaya S, 1998, BIOCHEM J, V332, P75, DOI 10.1042/bj3320075; Kiick KL, 2001, FEBS LETT, V502, P25, DOI 10.1016/S0014-5793(01)02657-6; Kim HE, 2003, CURR MICROBIOL, V46, P291, DOI 10.1007/s00284-002-3886-3; Kobayashi T, 2003, NAT STRUCT BIOL, V10, P425, DOI 10.1038/nsb934; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; LAWRENCE RC, 1967, NATURE, V213, P1264, DOI 10.1038/2131264a0; Liu H, 2003, CHEMBIOCHEM, V4, P603, DOI 10.1002/cbic.200300557; Liu WS, 2007, ANGEW CHEM INT EDIT, V46, P6073, DOI 10.1002/anie.200701990; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; MOUREY A, 1976, J APPL BACTERIOL, V40, P47, DOI 10.1111/j.1365-2672.1976.tb00589.x; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Peist R, 1997, J BACTERIOL, V179, P7679, DOI 10.1128/jb.179.24.7679-7686.1997; Plumbridge J, 1999, J BACTERIOL, V181, P47, DOI 10.1128/JB.181.1.47-54.1999; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; REDDY PG, 1989, GENE, V76, P145, DOI 10.1016/0378-1119(89)90016-4; Rodriguez S, 2000, J ORG CHEM, V65, P2586, DOI 10.1021/jo9917036; Roh C, 2008, J APPL MICROBIOL, V105, P116, DOI 10.1111/j.1365-2672.2007.03717.x; Samain E, 1999, J BIOTECHNOL, V72, P33, DOI 10.1016/S0168-1656(99)00048-6; Santoro SW, 2002, NAT BIOTECHNOL, V20, P1044, DOI 10.1038/nbt742; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; STOOPS JK, 1969, BIOCHEMISTRY-US, V8, P2026, DOI 10.1021/bi00833a037; Suzuki R, 2004, ACTA CRYSTALLOGR D, V60, P1895, DOI 10.1107/S0907444904018979; Suzuki R, 2009, ACTA CRYSTALLOGR D, V65, P49, DOI 10.1107/S0907444908037451; TOONE EJ, 1990, J AM CHEM SOC, V112, P4946, DOI 10.1021/ja00168a047; Turner JM, 2006, P NATL ACAD SCI USA, V103, P6483, DOI 10.1073/pnas.0601756103; Turner JM, 2005, J AM CHEM SOC, V127, P14976, DOI 10.1021/ja0549042; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; WANG HY, 1993, J BACTERIOL, V175, P1665, DOI 10.1128/JB.175.6.1665-1673.1993; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wells HG, 1912, J INFECT DIS, V11, P388, DOI 10.1093/infdis/11.3.388; WOLF RE, 1979, J BACTERIOL, V139, P1093, DOI 10.1128/JB.139.3.1093-1096.1979; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xie JM, 2004, NAT BIOTECHNOL, V22, P1297, DOI 10.1038/nbt1013; Xu R, 2004, J AM CHEM SOC, V126, P15654, DOI 10.1021/ja044711z; Zhang Y, 2005, PROTEIN SCI, V14, P1340, DOI 10.1110/ps.041239305; Zhang ZW, 2004, SCIENCE, V303, P371, DOI 10.1126/science.1089509	49	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28795	28800		10.1074/jbc.M109.027409	http://dx.doi.org/10.1074/jbc.M109.027409			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19666472	hybrid, Green Published			2022-12-25	WOS:000270678900036
J	Sirianni, R; Chimento, A; De Luca, A; Zolea, F; Carpino, A; Rago, V; Maggiolini, M; Ando, S; Pezzi, V				Sirianni, Rosa; Chimento, Adele; De Luca, Arianna; Zolea, Fabiana; Carpino, Amalia; Rago, Vittoria; Maggiolini, Marcello; Ando, Sebastiano; Pezzi, Vincenzo			Inhibition of Cyclooxygenase-2 Down-regulates Aromatase Activity and Decreases Proliferation of Leydig Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; CONTROL BRAIN AROMATASE; CONSTITUTIVE EXPRESSION; BINDING-PROTEIN; GENE-EXPRESSION; RAT TESTIS; FACTOR-I; ESTROGEN; RECEPTOR; CARCINOMA	Our recent studies have revealed that estrogens stimulate an autocrine mechanism determining Leydig tumor cell proliferation. Estrogen overproduction is due to an elevated steroidogenic factor-1 (SF-1) expression and cAMP-response element-binding protein (CREB) phosphorylation, both inducing aromatase overexpression. Although we have shown that increased SF-1 expression depends mainly on higher local insulin-like growth factor I production, the mechanisms and factors determining increased CREB activation in Leydig tumor cells are not completely understood. In this study, we investigated the role of cyclooxygenase-2 (COX-2) in CREB dependent- aromatase expression in Leydig tumor cells. We found that COX-2 is expressed in rat and human Leydigiomas as well as in the rat Leydig tumor cell line R2C, but not in normal testis. Our data indicate that in R2C cells the COX-2-derived prostaglandin E2 (PGE2) binds the PGE2 receptor EP4 and activates protein kinase A (PKA) and ultimately CREB. Inhibitors for COX-2 (NS398), EP4 (AH23848), and PKA (H89) decreased aromatase expression and activity as a consequence of a decreased phosphorylated CREB recruitment to the PII promoter of the aromatase gene. The COX-2/PGE2/PKA pathway also seems to be involved in aromatase post-translational activation, an observation that requires further studies. The reduction in aromatase activity was responsible for a drop in estrogen production and subsequent reduction in cyclin E expression resulting in a decrease in tumor Leydig cell proliferation. Furthermore, COX-2 silencing caused a significant decrease in CREB phosphorylation, aromatase expression, and R2C cell proliferation. These novel findings clarify the mechanisms involved in the growth of Leydig cell tumors and should be taken into account in determining new therapeutic approaches.	[Maggiolini, Marcello; Pezzi, Vincenzo] Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, CS, Italy; [Carpino, Amalia; Rago, Vittoria; Ando, Sebastiano] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, CS, Italy	University of Calabria; University of Calabria	Pezzi, V (corresponding author), Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, CS, Italy.	v.pezzi@unical.it	Pezzi, Vincenzo/AAL-4017-2020; Maggiolini, Marcello/Z-4729-2019; Rago, Vittoria/AAE-5924-2020	Rago, Vittoria/0000-0003-3971-7378; pezzi, Vincenzo/0000-0003-2311-2286; SIRIANNI, Rosa/0000-0002-8966-350X; De Luca, Arianna/0000-0003-2388-6564; Carpino, Amalia/0000-0002-5006-3216; Maggiolini, Marcello/0000-0002-7485-854X	Progetti di Ricerca di Interesse Nazionale (PRIN) del Ministero dell'Universita e della Ricerca (MIUR); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Progetti di Ricerca di Interesse Nazionale (PRIN) del Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Progetti di Ricerca di Interesse Nazionale (PRIN) del Ministero dell'Universita e della Ricerca (MIUR) and by grants from the Associazione Italiana per la Ricerca sul Cancro.	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Alshafie GA, 2000, ONCOL REP, V7, P1377; Ascoli M, 2007, MOL CELL ENDOCRINOL, V260, P244, DOI 10.1016/j.mce.2005.09.016; Balthazart J, 2003, J STEROID BIOCHEM, V86, P367, DOI 10.1016/S0960-0760(03)00346-7; Balthazart J, 2003, EUR J NEUROSCI, V17, P1591, DOI 10.1046/j.1460-9568.2003.02598.x; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Brueggemeier RW, 1999, CANCER LETT, V140, P27, DOI 10.1016/S0304-3835(99)00050-6; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; Carpino A, 2007, EUR J ENDOCRINOL, V157, P239, DOI 10.1530/EJE-07-0029; Chandras C, 2007, J ENDOCRINOL, V194, P595, DOI 10.1677/JOE-07-0128; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Chen HL, 2007, ENDOCRINOLOGY, V148, P735, DOI 10.1210/en.2006-0925; COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258; COLEMAN RA, 1995, ADV PROSTAG THROMB L, V23, P283; Davis TL, 2000, BRIT J PHARMACOL, V130, P1919, DOI 10.1038/sj.bjp.0703525; Diaz-Cruz ES, 2005, J CLIN ENDOCR METAB, V90, P2563, DOI 10.1210/jc.2004-2029; DUFAU ML, 1984, J STEROID BIOCHEM, V20, P161, DOI 10.1016/0022-4731(84)90203-6; Farley JH, 2006, GYNECOL ONCOL, V103, P425, DOI 10.1016/j.ygyno.2006.03.036; Fowler KA, 2000, AM J PATHOL, V156, P347, DOI 10.1016/S0002-9440(10)64736-0; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; FULTON AM, 1991, CANCER RES, V51, P2047; Gobbetti A, 2002, J EXP ZOOL, V293, P73, DOI 10.1002/jez.10100; Harada N, 1997, J STEROID BIOCHEM, V61, P175; Hase T, 2003, EUR J CANCER, V39, P2043, DOI 10.1016/S0959-8049(03)00485-4; Hawkins C, 1996, Oncol Nurs Forum, V23, P1203; Hida T, 1998, CANCER RES, V58, P3761; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Inoue H, 1999, J ENDOCRINOL, V161, P231, DOI 10.1677/joe.0.1610231; Jo Y, 2005, BIOL REPROD, V73, P244, DOI 10.1095/biolreprod.104.037721; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; Pan MR, 2008, CELL SIGNAL, V20, P1134, DOI 10.1016/j.cellsig.2008.02.004; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; Pezzi V, 2004, ENDOCRINOLOGY, V145, P2186, DOI 10.1210/en.2003-1366; Prosperi JR, 2006, PROSTAG OTH LIPID M, V81, P55, DOI 10.1016/j.prostaglandins.2006.07.003; RICHARDS JA, 2003, J CLIN ENDOCR METAB, V88, P2010; Ristimaki A, 1997, CANCER RES, V57, P1276; Ristimaki A, 2002, CANCER RES, V62, P632; Salhab M, 2007, J SURG ONCOL, V96, P424, DOI 10.1002/jso.20740; SANO H, 1995, CANCER RES, V55, P3785; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Sirianni R, 2007, CANCER RES, V67, P8368, DOI 10.1158/0008-5472.CAN-06-4064; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Su B, 2008, STEROIDS, V73, P104, DOI 10.1016/j.steroids.2007.09.011; Tsuji S, 2001, J EXP CLIN CANC RES, V20, P117; Tucker ON, 1999, CANCER RES, V59, P987; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900; Winnall WR, 2007, BIOL REPROD, V76, P759, DOI 10.1095/biolreprod.106.053124; WOODWARD DF, 1995, BIOCHEM PHARMACOL, V50, P1731, DOI 10.1016/0006-2952(95)02035-7; Young M, 1998, ENDOCRINOLOGY, V139, P5082, DOI 10.1210/en.139.12.5082; Young M, 1997, J STEROID BIOCHEM, V63, P37, DOI 10.1016/S0960-0760(97)00069-1; Yue W, 2003, J STEROID BIOCHEM, V86, P265, DOI 10.1016/S0960-0760(03)00366-2; Zhao Y, 1996, ENDOCRINOLOGY, V137, P5739, DOI 10.1210/en.137.12.5739; Zimmermann KC, 1999, CANCER RES, V59, P198	61	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28905	28916		10.1074/jbc.M109.041020	http://dx.doi.org/10.1074/jbc.M109.041020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679653	hybrid, Green Published			2022-12-25	WOS:000270678900047
J	Xie, YB; Park, JH; Kim, DK; Hwang, JH; Oh, S; Park, SB; Shong, M; Lee, IK; Choi, HS				Xie, Yuan-Bin; Park, Jeong-Hoh; Kim, Don-Kyu; Hwang, Jung Hwan; Oh, Sangmi; Park, Seung Bum; Shong, Minho; Lee, In-Kyu; Choi, Hueng-Sik			Transcriptional Corepressor SMILE Recruits SIRT1 to Inhibit Nuclear Receptor Estrogen Receptor-related Receptor gamma Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-HETERODIMER-PARTNER; PROMOTES CELL-SURVIVAL; GENE-EXPRESSION; ERR-GAMMA; INTERACTING PROTEIN; RESPONSE ELEMENT; BINDING PROTEIN; MOLECULAR-BASIS; ALPHA; DEACETYLASE	SMILE (small heterodimer partner interacting leucine zipper protein) has been identified as a corepressor of the glucocorticoid receptor, constitutive androstane receptor, and hepatocyte nuclear factor 4 alpha. Here we show that SMILE also represses estrogen receptor-related receptor gamma (ERR gamma) transactivation. Knockdown of SMILE gene expression increases ERR gamma activity. SMILE directly interacts with ERR gamma in vitro and in vivo. Domain mapping analysis showed that SMILE binds to the AF2 domain of ERR gamma. SMILE represses ERR gamma transactivation partially through competition with coactivators PGC-1 alpha, PGC-1 beta, and GRIP1. Interestingly, the repression of SMILE on ERR gamma is released by SIRT1 inhibitors, a catalytically inactive SIRT1 mutant, and SIRT1 small interfering RNA but not by histone protein deacetylase inhibitor. In vivo glutathione S-transferase pulldown and coimmunoprecipitation assays validated that SMILE physically interacts with SIRT1. Furthermore, the ERR gamma inverse agonist GSK5182 enhances the interaction of SMILE with ERR gamma and SMILE-mediated repression. Knockdown of SMILE or SIRT1 blocks the repressive effect of GSK5182. Moreover, chromatin immunoprecipitation assays revealed that GSK5182 augments the association of SMILE and SIRT1 on the promoter of the ERR gamma target PDK4. GSK5182 and adenoviral overexpression of SMILE cooperate to repress ERR gamma-induced PDK4 gene expression, and this repression is released by overexpression of a catalytically defective SIRT1 mutant. Finally, we demonstrated that ERR gamma regulates SMILE gene expression, which in turn inhibits ERR gamma. Overall, these findings implicate SMILE as a novel corepressor of ERR gamma and recruitment of SIRT1 as a novel repressive mechanism for SMILE and ERR gamma inverse agonist.	[Xie, Yuan-Bin; Park, Jeong-Hoh; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Hwang, Jung Hwan; Shong, Minho] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon 301721, South Korea; [Oh, Sangmi; Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151747, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu 700721, South Korea	Chonnam National University; Chungnam National University; Seoul National University (SNU); Kyungpook National University	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	/H-7803-2012; Park, Seung Bum/N-1901-2014; Lee, In-Kyu/AAR-6374-2021	Park, Seung Bum/0000-0003-1753-1433; Oh, Sangmi/0000-0003-0895-1110; shong, minho/0000-0002-0247-7115	National Research Laboratory [ROA-2005-00010047-0]; Korea Research Foundation [KRF-2006-005-J03003]	National Research Laboratory(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by National Research Laboratory Grant ROA-2005-00010047-0 and the Korea Research Foundation Grant KRF-2006-005-J03003.	Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Heery DM, 2001, J BIOL CHEM, V276, P6695, DOI 10.1074/jbc.M009404200; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Hogan MR, 2006, FEBS LETT, V580, P58, DOI 10.1016/j.febslet.2005.11.046; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Lee CH, 1999, J BIOL CHEM, V274, P31320, DOI 10.1074/jbc.274.44.31320; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Misra V, 2005, J BIOL CHEM, V280, P15257, DOI 10.1074/jbc.M500728200; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ruse MD, 2002, MOL CELL BIOL, V22, P1626, DOI 10.1128/MCB.22.6.1626-1638.2002; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tremblay GB, 2001, ENDOCRINOLOGY, V142, P4572, DOI 10.1210/en.142.10.4572; Wang JJ, 2009, FEBS LETT, V583, P643, DOI 10.1016/j.febslet.2009.01.030; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhang ZP, 2007, MOL CELL ENDOCRINOL, V264, P128, DOI 10.1016/j.mce.2006.11.002; Zhou DJ, 2006, NUCLEIC ACIDS RES, V34, P5974, DOI 10.1093/nar/gkl764	52	53	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28762	28774		10.1074/jbc.M109.034165	http://dx.doi.org/10.1074/jbc.M109.034165			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690166	hybrid, Green Published			2022-12-25	WOS:000270678900033
J	Cui, GL; Qin, X; Zhang, YB; Gong, ZW; Ge, BX; Zang, YQ				Cui, Guoliang; Qin, Xia; Zhang, Yuebo; Gong, Zhenwei; Ge, Baoxue; Zang, Ying Qin			Berberine Differentially Modulates the Activities of ERK, p38 MAPK, and JNK to Suppress Th17 and Th1 T Cell Differentiation in Type 1 Diabetic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ARYL-HYDROCARBON RECEPTOR; NEUTRAL SULFATE BERBERINE; ACTIVATED PROTEIN-KINASE; IFN-GAMMA; SIGNALING PATHWAY; 3T3-L1 ADIPOCYTE; HELPER-CELLS; NOD MOUSE; ROR-GAMMA	Berberine, an alkaloid derivative from Berberis vulgaris L., has been used extensively in traditional Chinese medicine to treat diarrhea and diabetes, but the underlying mechanisms for treating diabetes are not fully understood. Recent studies suggested that berberine has many beneficial biological effects, including anti-inflammation. Because type 1 diabetes is caused by T cell-mediated destruction of beta cells and severe islet inflammation, we hypothesized that berberine could ameliorate type 1 diabetes through its immune regulation properties. Here we reported that 2 weeks of oral administration of berberine prevented the progression of type I diabetes in half of the NOD mice and decreased Th17 and Th1 cytokine secretion. Berberine suppressed Th17 and Th1 differentiation by reducing the expression of lineage markers. We found that berberine inhibited Th17 differentiation by activating ERK1/2 and inhibited Th1 differentiation by inhibiting p38 MAPK and JNK activation. Berberine down-regulated the activity of STAT1 and STAT4 through the suppression of p38 MAPK and JNK activation, and it controlled the stability of STAT4 through the ubiquitin-proteasome pathway. Our findings indicate that berberine targets MAPK to suppress Th17 and Th1 differentiation in type 1 diabetic NOD mice. This study revealed a novel role of ERK in Th17 differentiation through down-regulation of STAT3 phosphorylation and ROR gamma t expression.	[Cui, Guoliang; Zhang, Yuebo; Gong, Zhenwei; Zang, Ying Qin] Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China; [Ge, Baoxue] Chinese Acad Sci, Inst Hlth Sci, Key Lab Nutr & Metab, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China; [Qin, Xia] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Zang, YQ (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai Inst Biol Sci,Grad Sch, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	yqin@sibs.ac.cn	Gong, Zhenwei/G-2435-2012	Cui, Guoliang/0000-0001-5559-7957	Hundred Talent Project; Chinese Academy of Sciences [KSCX2-YW-R-116, KSCX1-YW-R-44]; Ministry of Science and Technology of China [2009CB919000, STCSM 07JC14011]	Hundred Talent Project(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported in part by grants from the Hundred Talent Project, Chinese Academy of Sciences Grants KSCX2-YW-R-116 and KSCX1-YW-R-44, and Ministry of Science and Technology of China Grants 2009CB919000 and STCSM 07JC14011.	Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Choi BH, 2006, EXP MOL MED, V38, P599, DOI 10.1038/emm.2006.71; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Ellison CA, 1998, J IMMUNOL, V161, P631; Enk R, 2007, J ETHNOPHARMACOL, V109, P170, DOI 10.1016/j.jep.2006.07.013; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higaki Shuichi, 1995, Journal of Dermatology (Tokyo), V22, P4, DOI 10.1111/j.1346-8138.1995.tb03332.x; Hsiang CY, 2005, J BIOMED SCI, V12, P791, DOI 10.1007/s11373-005-9003-4; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Hultgren B, 1996, DIABETES, V45, P812, DOI 10.2337/diabetes.45.6.812; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jain R, 2008, J EXP MED, V205, P207, DOI 10.1084/jem.20071878; Kang BY, 2002, BIOCHEM PHARMACOL, V63, P1901, DOI 10.1016/S0006-2952(02)00982-6; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lee S, 2007, BIOCHEM BIOPH RES CO, V362, P853, DOI 10.1016/j.bbrc.2007.08.060; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li F, 2006, ACTA PHARMACOL SIN, V27, P1199, DOI 10.1111/j.1745-7254.2006.00368.x; Lin SK, 2004, MOL PHARMACOL, V66, P612; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Mensah-Brown EPK, 2006, EUR J IMMUNOL, V36, P216, DOI 10.1002/eji.200535325; Miljkovic D, 2005, CELL MOL LIFE SCI, V62, P2658, DOI 10.1007/s00018-005-5259-0; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NISHINO H, 1986, ONCOLOGY, V43, P131, DOI 10.1159/000226349; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pandey MK, 2008, CANCER RES, V68, P5370, DOI 10.1158/0008-5472.CAN-08-0511; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ren YP, 2008, J IMMUNOL, V181, P1491, DOI 10.4049/jimmunol.181.2.1491; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Srinivasan S, 2008, DIABETES, V57, P484, DOI 10.2337/db07-0855; Stojanovic I, 2009, IMMUNOLOGY, V126, P74, DOI 10.1111/j.1365-2567.2008.02879.x; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vukkadapu SS, 2005, PHYSIOL GENOMICS, V21, P201, DOI 10.1152/physiolgenomics.00173.2004; Wang B, 1997, P NATL ACAD SCI USA, V94, P13844, DOI 10.1073/pnas.94.25.13844; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang J, 2006, ACTA PHARMACOL SIN, V27, P173, DOI 10.1111/j.1745-7254.2006.00257.x; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yu HH, 2005, J MED FOOD, V8, P454, DOI 10.1089/jmf.2005.8.454	46	154	161	5	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28420	28429		10.1074/jbc.M109.012674	http://dx.doi.org/10.1074/jbc.M109.012674			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19661066	Green Published, hybrid			2022-12-25	WOS:000270676300067
J	Lvov, A; Greitzer, D; Berlin, S; Chikvashvili, D; Tsuk, S; Lotan, I; Michaelevski, I				Lvov, Anatoli; Greitzer, Dafna; Berlin, Shai; Chikvashvili, Dodo; Tsuk, Sharon; Lotan, Ilana; Michaelevski, Izhak			Rearrangements in the Relative Orientation of Cytoplasmic Domains Induced by a Membrane-anchored Protein Mediate Modulations in Kv Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; RESONANCE ENERGY-TRANSFER; KV2.1 POTASSIUM CHANNEL; C-TERMINAL DOMAINS; K+ CHANNEL; SNARE COMPLEX; TARGETING SIGNAL; BETA-SUBUNIT; SYNTAXIN 1A; LIVE CELLS	Interdomain interactions between intracellular N and C termini have been described for various K+ channels, including the voltage-gated Kv2.1, and suggested to affect channel gating. However, no channel regulatory protein directly affecting N/C interactions has been demonstrated. Most Kv2.1 channel interactions with regulatory factors occur at its C terminus. The vesicular SNARE that is also present at a high concentration in the neuronal plasma membrane, VAMP2, is the only protein documented to affect Kv2.1 gating by binding to its N terminus. As its binding target has been mapped near a site implicated in Kv2.1 N/C interactions, we hypothesized that VAMP2 binding to the N terminus requires concomitant conformational. changes in the C terminus, which wraps around the N terminus from the outside, to give VAMP2 access. Here, we first determined that the Kv2.1 N terminus, although crucial, is not sufficient to convey functional interaction with VAMP2, and that, concomitant to its binding to the "docking loop" at the Kv2.1 N terminus, VAMP2 binds to the proximal part of the Kv2.1 C terminus, C1a. Next, using computational biology approaches (ab initio modeling, docking, and molecular dynamics simulations) supported by molecular biology, biochemical, electrophysiological, and fluorescence resonance energy transfer analyses, we mapped the interaction sites on both VAMP2 and Kv2.1 and found that this interaction is accompanied by rearrangements in the relative orientation of Kv2.1 cytoplasmic domains. We propose that VAMP2 modulates Kv2.1 inactivation by interfering with the interaction between the docking loop and C1a, a mechanism for gating regulation that may pertain also to other Kv channels.	[Greitzer, Dafna; Berlin, Shai; Chikvashvili, Dodo; Tsuk, Sharon; Lotan, Ilana] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel; [Lvov, Anatoli] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Michaelevski, Izhak] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; University of Massachusetts System; University of Massachusetts Worcester; Weizmann Institute of Science	Lotan, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel.	ilotan@post.tau.ac.il; izhak.michaelevski@weizmann.ac.il	Michaelevski, Izhak/G-8940-2018	Michaelevski, Izhak/0000-0002-0783-1443; Berlin, shai/0000-0002-5153-4876	Public Committee for Allocation of Estate Funds [3-4181]; Ministry of Justice, Israel	Public Committee for Allocation of Estate Funds; Ministry of Justice, Israel	This work was supported by Grant 3-4181 from the Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel (to I. L.).	Adair B, 2008, BIOPHYS J, V94, P2106, DOI 10.1529/biophysj.107.118562; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Frei E, 2006, CELL PHYSIOL BIOCHEM, V18, P165, DOI 10.1159/000097665; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kammer B, 2003, MOL CELL NEUROSCI, V23, P333, DOI 10.1016/S1044-7431(03)00064-2; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kobrinsky E, 2006, J BIOL CHEM, V281, P19233, DOI 10.1074/jbc.M601231200; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Leng Q, 2006, P NATL ACAD SCI USA, V103, P1982, DOI 10.1073/pnas.0510610103; LEVIN G, 1995, J BIOL CHEM, V270, P14611, DOI 10.1074/jbc.270.24.14611; Levin G, 1996, J BIOL CHEM, V271, P29321, DOI 10.1074/jbc.271.46.29321; LEVITT M, 1981, J MOL BIOL, V145, P251, DOI 10.1016/0022-2836(81)90342-9; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Pedretti A, 2003, THEOR CHEM ACC, V109, P229, DOI 10.1007/s00214-002-0402-6; Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qu ZQ, 2000, J BIOL CHEM, V275, P31573, DOI 10.1074/jbc.M003473200; Ritchie DW, 1999, J COMPUT CHEM, V20, P383, DOI 10.1002/(SICI)1096-987X(199903)20:4<383::AID-JCC1>3.0.CO;2-M; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Scholle A, 2004, BIOPHYS J, V87, P873, DOI 10.1529/biophysj.104.040550; Sobko A, 1998, EMBO J, V17, P4723, DOI 10.1093/emboj/17.16.4723; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tsien RY, 1998, SCIENCE, V280, P1954, DOI 10.1126/science.280.5371.1954; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsuboi T, 2004, P NATL ACAD SCI USA, V101, P76, DOI 10.1073/pnas.0306347101; Tsuk S, 2005, MOL PHARMACOL, V67, P480, DOI 10.1124/mol.104.005314; Tsuk S, 2008, BIOCHEMISTRY-US, V47, P8342, DOI 10.1021/bi800512p; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Wolf-Goldberg T, 2006, MOL PHARMACOL, V70, P818, DOI 10.1124/mol.105.021717; Zhang Y, 2003, BBA-BIOMEMBRANES, V1614, P182, DOI 10.1016/S0005-2736(03)00177-9; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1	51	7	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28276	28291		10.1074/jbc.M109.028761	http://dx.doi.org/10.1074/jbc.M109.028761			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690160	hybrid, Green Published			2022-12-25	WOS:000270676300055
J	Ra, HJ; Harju-Baker, S; Zhang, FM; Linhardt, RJ; Wilson, CL; Parks, WC				Ra, Hyun-Jeong; Harju-Baker, Susanna; Zhang, Fuming; Linhardt, Robert J.; Wilson, Carole L.; Parks, William C.			Control of Promatrilysin (MMP7) Activation and Substrate-specific Activity by Sulfated Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; E-CADHERIN; PERICELLULAR ACTIVATION; CHOLESTEROL SULFATE; SECRETORY GRANULE; PROGELATINASE-A; ALPHA-DEFENSINS; HOST-DEFENSE; CANCER CELLS; FAS LIGAND	Matrix metalloproteinases are maintained in an inactive state by a bond between the thiol of a conserved cysteine in the prodomain and a zinc atom in the catalytic domain. Once this bond is disrupted, MMPs become active proteinases and can act on a variety of extracellular protein substrates. In vivo, matrilysin (MMP7) activates pro-alpha-defensins (procryptdins), but in vitro, processing of these peptides is slow, with about 50% conversion in 8-12 h. Similarly, autolytic activation of promatrilysin in vitro can take up to 12-24 It for 50% conversion. These inefficient reactions suggest that natural cofactors enhance the activation and activity of matrilysin. We determined that highly sulfated glycosaminoglycans (GAG), such as heparin, chondroitin-4,6-sulfate (CS-E), and dermatan sulfate, markedly enhanced (> 50-fold) the intermolecular autolytic activation of promatrilysin and the activity of fully active matrilysin to cleave specific physiologic substrates. In contrast, heparan sulfate and less sulfated forms of chondroitin sulfate did not augment matrilysin activation or activity. Chondroitin-2,6-sulfate (CS-D) also did not enhance matrilysin activity, suggesting that the presentation of sulfates is more important than the overall degree of sulfation. Surface plasmon resonance demonstrated that promatrilysin bound heparin (K-D, 400 nM) and CS-E (K-D, 630 nM). Active matrilysin bound heparin (K-D, 150 nM) but less so to CS-E (K-D, 60 mu M). Neither form bound heparan sulfate. These observations demonstrate that sulfated GAGs regulate matrilysin activation and its activity against specific substrates.	[Ra, Hyun-Jeong; Harju-Baker, Susanna; Parks, William C.] Univ Washington, Ctr Lung Biol, Seattle, WA 98109 USA; [Wilson, Carole L.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol & Chem Engn, Troy, NY 12180 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Parks, WC (corresponding author), Univ Washington, Ctr Lung Biol, 815 Mercer St, Seattle, WA 98109 USA.	parksw@u.washington.edu	Parks, William C./AAH-6786-2021	Kosamo, Susanna/0000-0001-5151-9361	National Institutes of Health [HL029594, GM038060, F32-HL083665]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594, F32HL083665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL029594 (to W. C. P.), GM038060 (to R. J. L.), and F32-HL083665 (to S. H. B.).	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P14419, DOI 10.1021/bi00252a007; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; Davies G, 2001, CLIN CANCER RES, V7, P3289; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Filippov S, 2003, J EXP MED, V198, P925, DOI 10.1084/jem.20030626; Fujita Y, 2006, ARTHRITIS RHEUM-US, V54, P3233, DOI 10.1002/art.22140; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; Higashi S, 2008, J BIOL CHEM, V283, P35735, DOI 10.1074/jbc.M806285200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Itoh F, 1996, CANCER, V77, P1717; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Mitsiades N, 2001, CANCER RES, V61, P577; Noe V, 2001, J CELL SCI, V114, P111; Ouellette AJ, 1996, FASEB J, V10, P1280, DOI 10.1096/fasebj.10.11.8836041; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; SCHICK BP, 1995, J CELL PHYSIOL, V165, P96, DOI 10.1002/jcp.1041650113; Shiomi T, 2005, LAB INVEST, V85, P1489, DOI 10.1038/labinvest.3700351; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Stricker TP, 2001, J BIOL CHEM, V276, P29375, DOI 10.1074/jbc.M102217200; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; VONBREDOW DC, 1995, EXP CELL RES, V221, P83, DOI 10.1006/excr.1995.1355; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yamamoto K, 2006, J BIOL CHEM, V281, P9170, DOI 10.1074/jbc.M510377200; Yu Q, 2000, GENE DEV, V14, P163; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200	46	53	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27924	27932		10.1074/jbc.M109.035147	http://dx.doi.org/10.1074/jbc.M109.035147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654318	Green Published, hybrid			2022-12-25	WOS:000270676300020
J	Scharl, M; Paul, G; Barrett, KE; McCole, DF				Scharl, Michael; Paul, Gisela; Barrett, Kim E.; McCole, Declan F.			AMP-activated Protein Kinase Mediates the Interferon-gamma-induced Decrease in Intestinal Epithelial Barrier Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; LIGHT-CHAIN KINASE; PANCREATIC BETA-CELLS; CROHNS-DISEASE; TIGHT JUNCTION; ULCERATIVE-COLITIS; CHLORIDE SECRETION; IFN-GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE	Impaired epithelial barrier function plays a crucial role in the pathogenesis of inflammatory bowel disease. Elevated levels of the pro-inflammatory cytokine, interferon-gamma (IFN gamma), are believed to be prominently involved in the pathogenesis of Crohn disease. Treatment of T-84 intestinal epithelial cells with IFN gamma severely impairs their barrier properties measured as transepithelial electrical resistance (TER) or permeability and reduces the expression of tight junction proteins such as occludin and zonula occludens-1 (ZO-1). However, little is known about the signaling events that are involved. The cellular energy sensor, AMP-activated protein kinase (AMPK), is activated in response to cellular stress, as occurs during inflammation. The aim of this study was to investigate a possible role for AMPK in mediating IFN gamma-induced effects on the intestinal epithelial barrier. We found that IFN gamma activates AMPK by phosphorylation, independent of intracellular energy levels. Inhibition of AMPK prevents, at least in part, the IFN gamma-induced decrease in TER. Furthermore, AMPK knockdown prevented the increased epithelial permeability, the decreased TER, and the decrease in occludin and ZO-1 caused by IFN gamma treatment of T-84 cells. However, AMPK activity alone was not sufficient to cause alterations in epithelial barrier function. These data show a novel role for AMPK, in concert with other signals induced by IFN gamma, in mediating reduced epithelial barrier function in a cell model of chronic intestinal inflammation. These findings may implicate AMPK in the pathogenesis of chronic intestinal inflammatory conditions, such as inflammatory bowel disease.	[McCole, Declan F.] Univ Calif San Diego, Div Gastroenterol, Dept Med, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McCole, DF (corresponding author), Univ Calif San Diego, Div Gastroenterol, Dept Med, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dmccole@ucsd.edu	McCole, Declan/AAL-2454-2020; Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019	Barrett, Kim Elaine/0000-0002-6704-998X; Scharl, Michael/0000-0002-6729-1469	National Institutes of Health [DK080506]; Crohn's and Colitis Foundation of America; German Research Foundation (Deutsche Forschungsgemeinschaft); UCSD Digestive Diseases Research Development Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); UCSD Digestive Diseases Research Development Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080506. This work was also supported by a Career Development Award and a Senior Research Award from the Crohn's and Colitis Foundation of America (to D. F. M.), scholarships from the German Research Foundation (Deutsche Forschungsgemeinschaft) (to M. S. and G. P.), and by the UCSD Digestive Diseases Research Development Center.	Amasheh S, 2004, GASTROENTEROLOGY, V126, P1711, DOI 10.1053/j.gastro.2004.03.010; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Bertelsen LS, 2004, AM J PHYSIOL-GASTR L, V286, pG157, DOI 10.1152/ajpgi.00227.2003; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; CARTWRIGHT CA, 1985, J CLIN INVEST, V76, P1837, DOI 10.1172/JCI112176; Cheng PY, 2007, BIOCHEM PHARMACOL, V74, P1758, DOI 10.1016/j.bcp.2007.08.004; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Clayburgh DR, 2004, J BIOL CHEM, V279, P55506, DOI 10.1074/jbc.M408822200; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Duvall MD, 1998, AM J PHYSIOL-CELL PH, V275, pC1313, DOI 10.1152/ajpcell.1998.275.5.C1313; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Fish SM, 1999, GUT, V45, P191, DOI 10.1136/gut.45.2.191; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fryer LGD, 2000, DIABETES, V49, P1978, DOI 10.2337/diabetes.49.12.1978; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Greig ER, 2004, J PATHOL, V204, P84, DOI 10.1002/path.1613; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Horman S, 2008, J BIOL CHEM, V283, P18505, DOI 10.1074/jbc.M802053200; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; MADARA JL, 1985, J CELL BIOL, V101, P2124, DOI 10.1083/jcb.101.6.2124; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; MARIN ML, 1983, AM J GASTROENTEROL, V78, P355; MARIN ML, 1983, AM J GASTROENTEROL, V78, P537; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; McKay DM, 2007, J PHARMACOL EXP THER, V320, P1013, DOI 10.1124/jpet.106.113639; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; SASAKI T, 1992, GASTROENTEROL JPN, V27, P29; Schmitz H, 2000, ANN NY ACAD SCI, V915, P312; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Taylor CT, 1998, GASTROENTEROLOGY, V114, P657, DOI 10.1016/S0016-5085(98)70579-7; Tuzun A, 2002, CLIN BIOCHEM, V35, P569, DOI 10.1016/S0009-9120(02)00361-2; Uribe JM, 1996, J BIOL CHEM, V271, P26588, DOI 10.1074/jbc.271.43.26588; Uribe JM, 2002, AM J PHYSIOL-GASTR L, V283, pG923, DOI 10.1152/ajpgi.00237.2002; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Vucicevic L, 2009, BIOCHEM PHARMACOL, V77, P1684, DOI 10.1016/j.bcp.2009.03.005; Walker J, 2003, AM J PHYSIOL-GASTR L, V285, pG850, DOI 10.1152/ajpgi.00077.2003; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Watson JL, 2004, AM J PHYSIOL-GASTR L, V287, pG954, DOI 10.1152/ajpgi.00302.2003; Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Woollhead AM, 2006, J BIOL CHEM, V281, P5158, DOI 10.1074/jbc.M509947200; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	66	79	82	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27952	27963		10.1074/jbc.M109.046292	http://dx.doi.org/10.1074/jbc.M109.046292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654324	hybrid, Green Published			2022-12-25	WOS:000270676300023
J	Hansen, C; Howlin, J; Tengholm, A; Dyachok, O; Vogel, WF; Nairn, AC; Greengard, P; Andersson, T				Hansen, Christian; Howlin, Jillian; Tengholm, Anders; Dyachok, Oleg; Vogel, Wolfgang F.; Nairn, Angus C.; Greengard, Paul; Andersson, Tommy			Wnt-5a-induced Phosphorylation of DARPP-32 Inhibits Breast Cancer Cell Migration in a CREB-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED NEURONAL PHOSPHOPROTEIN; PROTEIN PHOSPHATASE 1; TYROSINE KINASE DDR1; GLYCOGEN-SYNTHASE; TUMOR-SUPPRESSOR; CYCLIC-AMP; DOPAMINE; WNT-5A; WNT5A; CAMP	Tumor cell migration plays a central role in the process of cancer metastasis. We recently identified dopamine and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) as an antimigratory phosphoprotein in breast cancer cells. Here we link this effect of DARPP-32 to Wnt-5a signaling by demonstrating that recombinant Wnt-5a triggers cAMP elevation at the plasma membrane and Thr34-DARPP-32 phosphorylation in MCF-7 cells. In agreement, both protein kinase A (PKA) inhibitors and siRNA-mediated knockdown of Frizzled-3 receptor or G alpha(s) expression abolished Wnt-5a-induced phosphorylation of DARPP-32. Furthermore, Wnt-5a induced DARPP-32-dependent inhibition of MCF-7 cell migration. Phospho-Thr-34-DARPP-32 interacted with protein phosphatase-1 (PP1) and potentiated the Wnt-5a-mediated phosphorylation of CREB, a well-known PP1 substrate, but had no effect on CREB phosphorylation by itself. Moreover, inhibition of the Wnt-5a/DARPP-32/CREB pathway, by expression of dominant negative CREB (DN-CREB), diminished the antimigratory effect of Wnt-5a-induced phospho-Thr-34-DARPP-32. Phalloidin-staining revealed that that the presence of phospho-Thr-34-DARPP-32 in MCF-7 cells results in reduced filopodia formation. In accordance, the activity of the Rho GTPase Cdc42, known to be crucial for filopodia formation, was reduced in MCF-7 cells expressing phospho-Thr-34-DARPP- 32. The effects of DARPP-32 on cell migration and filopodia formation could be reversed in T47D breast cancer cells that were depleted of their endogenous DARPP-32 by siRNA targeting. Consequently, Wnt-5a activates a Frizzled-3/G alpha(s)/cAMP/PKA signaling pathway that triggers a DARPP-32- and CREB-dependent antimigratory response in breast cancer cells, representing a novel mechanism whereby Wnt-5a can inhibit breast cancer cell migration.	[Hansen, Christian; Howlin, Jillian; Andersson, Tommy] Lund Univ, Dept Lab Med, CRC, S-20502 Malmo, Sweden; [Tengholm, Anders; Dyachok, Oleg] Uppsala Univ, Dept Med Cell Biol, BMC, SE-75123 Uppsala, Sweden; [Vogel, Wolfgang F.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Lund University; Uppsala University; University of Toronto; Yale University; Rockefeller University	Andersson, T (corresponding author), Lund Univ, Dept Lab Med, CRC, S-20502 Malmo, Sweden.	tommy.andersson@med.lu.se	Dyachok, Oleg/B-5935-2017; Howlin, Jill/G-9665-2011	Howlin, Jill/0000-0002-2766-3002; Nairn, Angus/0000-0002-7075-0195; Andersson, Tommy/0000-0003-4032-5769	Swedish Cancer Foundation; Swedish Research Council; U-MAS Research Foundations; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society in Lund; Magnus Bergvall's Foundation; Canada Research Chair Program; National Institutes of Health [MH074866]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); U-MAS Research Foundations; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society in Lund; Magnus Bergvall's Foundation; Canada Research Chair Program(Canada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Swedish Cancer Foundation (to T. A.), the Swedish Research Council (to T. A. and A. T.), the U-MAS Research Foundations (to T. A.), the Gunnar Nilsson's Cancer Foundation (to T. A.), the Royal Physiographic Society in Lund (to C. H.), Magnus Bergvall's Foundation (to A. T.), the Canada Research Chair Program (to W. V.), and in part, by National Institutes of Health Grant MH074866 (to A. N. and P. G.).	APERIA A, 1990, AM J HYPERTENS, V3, pS11, DOI 10.1093/ajh/3.6.11S; Beckler A, 2003, CANCER, V98, P1547, DOI 10.1002/cncr.11654; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Brady MJ, 1997, J BIOL CHEM, V272, P29698, DOI 10.1074/jbc.272.47.29698; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Ebihara Y, 2004, BRIT J CANCER, V91, P119, DOI 10.1038/sj.bjc.6601899; El-Rifai W, 2002, CANCER RES, V62, P4061; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Garcia-Jimenez C, 2005, MOL ENDOCRINOL, V19, P3060, DOI 10.1210/me.2005-0129; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Han JZ, 2007, J CELL BIOL, V176, P101, DOI 10.1083/jcb.200607128; Hansen C, 2006, EXP CELL RES, V312, P4011, DOI 10.1016/j.yexcr.2006.09.003; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Huang HB, 1999, J BIOL CHEM, V274, P7870, DOI 10.1074/jbc.274.12.7870; Jalvy S, 2007, CARDIOVASC RES, V75, P738, DOI 10.1016/j.cardiores.2007.05.019; Jansson M, 2001, J CELL SCI, V114, P2043; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jonsson M, 2002, CANCER RES, V62, P409; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li L, 2006, WORLD J SURG, V30, P1672, DOI 10.1007/s00268-006-0035-3; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Lilja L, 2005, BIOCHEM BIOPH RES CO, V329, P673, DOI 10.1016/j.bbrc.2005.02.017; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Mayerhofer A, 2004, EXP CLIN ENDOCR DIAB, V112, P451, DOI 10.1055/s-2004-821205; MEISTER B, 1991, J ENDOCRINOL INVEST, V14, P655, DOI 10.1007/BF03347888; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; WALAAS SI, 1983, J NEUROSCI, V3, P291; WALAAS SI, 1983, NATURE, V301, P69; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	43	61	65	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27533	27543		10.1074/jbc.M109.048884	http://dx.doi.org/10.1074/jbc.M109.048884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651774	hybrid, Green Published			2022-12-25	WOS:000270232300055
J	Hoshino, D; Tomari, T; Nagano, M; Koshikawa, N; Seiki, M				Hoshino, Daisuke; Tomari, Taizo; Nagano, Makoto; Koshikawa, Naohiko; Seiki, Motoharu			A Novel Protein Associated with Membrane-type 1 Matrix Metalloproteinase Binds p27(kip1) and Regulates RhoA Activation, Actin Remodeling, and Matrigel Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CELL-MIGRATION; CANCER; INVADOPODIA; GTPASES; INHIBITION; MOTILITY; DOMAIN; ROCK; PODOSOMES; MT1-MMP	Pericellular proteolysis by membrane-type 1 matrix metalloproteinase (MT1-MMP) plays a pivotal role in tumor cell invasion. Localization of MT1-MMP at the invasion front of cells, e. g. on lamellipodia and invadopodia, has to be regulated in coordination with reorganization of the actin cytoskeleton. However, little is known about how such invasion-related actin structures are regulated at the sites where MT1-MMP localizes. During analysis of MT1-MMP-associated proteins, we identified a heretofore uncharacterized protein. This protein, which we call p27RF-Rho, enhances activation of RhoA by releasing it from inhibition by p27(kip1) and thereby regulates actin structures. p27(kip1) is a well known cell cycle regulator in the nucleus. In contrast, cytoplasmic p27(kip1) has been demonstrated to bind GDP-RhoA and inhibit GDP-GTP exchange mediated by guanine nucleotide exchange factors. p27RF-Rho binds p27(kip1) and prevents p27(kip1) from binding to RhoA, thereby freeing the latter for activation. Knockdown of p27RF-Rho expression renders cells resistant to RhoA activation stimuli, whereas overexpression of p27RF-Rho sensitizes cells to such stimulation. p27RF-Rho exhibits a punctate distribution in invasive human tumor cell lines. Stimulation of the cells with lysophosphatidic acid induces activation of RhoA and induces the formation of punctate actin structures within foci of p27RF-Rho localization. Some of the punctate actin structures co-localize with MT1-MMP and cortactin. Down-regulation of p27RF-Rho prevents both redistribution of actin into the punctate structures and tumor cell invasion. Thus, p27RF-Rho is a new potential target for cancer therapy development.	[Hoshino, Daisuke; Tomari, Taizo; Nagano, Makoto; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Koshikawa, Naohiko/S-7306-2017; Seiki, Motoharu/K-9443-2015; Nagano, Makoto/J-7050-2015	Koshikawa, Naohiko/0000-0002-4539-888X; Nagano, Makoto/0000-0002-1948-1591	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Specific Coordination Fund for Promoting Science (to D. H.), a grant-in-aid for Scientific Research on Priority Areas, "Integrative Research toward the Conquest of Cancer," and the Global COE Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. S.).	Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; MONSKY WL, 1993, CANCER RES, V53, P3159; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Weaver AM, 2008, CURR BIOL, V18, pR362, DOI 10.1016/j.cub.2008.02.028; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304	34	53	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27315	27326		10.1074/jbc.M109.041400	http://dx.doi.org/10.1074/jbc.M109.041400			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654316	Green Published, hybrid			2022-12-25	WOS:000270232300032
J	Nelsen, SM; Christian, JL				Nelsen, Sylvia M.; Christian, Jan L.			Site-specific Cleavage of BMP4 by Furin, PC6, and PC7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-4; VERTEBRATE EMBRYONIC-DEVELOPMENT; PROPROTEIN CONVERTASE; XENOPUS DEVELOPMENT; PRODOMAIN; MOUSE; ALPHA(1)-ANTITRYPSIN; EMBRYOGENESIS; EXPRESSION; MESODERM	Bone morphogenetic proteins (BMPs) require proteolytic activation by members of the proprotein convertase (PC) family. Pro-BMP4 is initially cleaved at a site adjacent to the mature ligand domain (S1) and then at an upstream site (S2) within the prodomain. Cleavage at the S2 site, which appears to occur in a tissue-specific fashion, regulates the activity and signaling range of mature BMP4. To test the hypothesis that tissue-specific cleavage of pro-BMP4 is regulated by differential expression of a site-specific protease, we identified the PCs that cleave each site in vivo. In Xenopus oocytes, furin and PC6 function redundantly to cleave both the S1 and S2 sites of pro-BMP4, as evidenced by the results of antisense-mediated gene knockdown and the use of the furin-and PC6-selective inhibitor alpha(1)-PDX. By contrast, alpha(1)-PDX blocked cleavage of the S2 but not the S1 site of pro-BMP4 in embryos, suggesting the existence of a developmentally regulated S1 site-specific convertase. This protease is likely to be PC7 based on knowledge of its required substrate cleavage motif and resistance to alpha(1)-PDX. Consistent with this prediction, an alpha(1)-PDX variant engineered to target PC7, in addition to furin and PC6, completely inhibited cleavage of BMP4 in oocytes and embryos. Further studies showed that pc7 transcripts are expressed and polyadenylated, and that the PC7 precursor protein undergoes efficient autocatalytic activation in both oocytes and embryos. These results suggest that PC7, or a convertase with similar substrate specificity, functions to selectively cleave the S1 site of pro-BMP4 in a developmentally regulated fashion.	[Christian, Jan L.] Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Nelsen, Sylvia M.] Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Christian, JL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	christia@ohsu.edu	Nelsen, Sylvia/AAD-6878-2022	Nelsen, Sylvia/0000-0002-3770-4728	National Institutes of Health [RO1HD037976]; Shriners Hospitals for Children [8530]; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037976] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HD037976 (to J.L.C.). This work was also supported by the Shriners Hospitals for Children Grant 8530 and by a predoctoral fellowship from the American Heart Association (to S.M.N.).	ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Birsoy B, 2005, DEVELOPMENT, V132, P591, DOI 10.1242/dev.01599; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Constam DB, 2000, GENE DEV, V14, P1146; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cui YZ, 2001, GENE DEV, V15, P2797; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Dufour EK, 2001, J BIOL CHEM, V276, P38971, DOI 10.1074/jbc.M102959200; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Goldman DC, 2009, MECH DEVELOP, V126, P117, DOI 10.1016/j.mod.2008.11.008; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Moon R. T., 1989, TECHNIQUE, V1, P76; Nelsen S, 2005, DEV DYNAM, V233, P1038, DOI 10.1002/dvdy.20378; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Salles FJ, 1999, METH MOL B, V118, P441; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tian Q, 1999, DEVELOPMENT, V126, P3371; Tsuji A, 1999, J BIOCHEM, V126, P591, DOI 10.1093/oxfordjournals.jbchem.a022491; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257	43	55	56	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27157	27166		10.1074/jbc.M109.028506	http://dx.doi.org/10.1074/jbc.M109.028506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651771	Green Published, hybrid			2022-12-25	WOS:000270232300016
J	Sonoda, A; Iwamoto, T; Nakamura, T; Fukumoto, E; Yoshizaki, K; Yamada, A; Arakaki, M; Harada, H; Nonaka, K; Nakamura, S; Yamada, Y; Fukumoto, S				Sonoda, Akira; Iwamoto, Tsutomu; Nakamura, Takashi; Fukumoto, Emiko; Yoshizaki, Keigo; Yamada, Aya; Arakaki, Makiko; Harada, Hidemitsu; Nonaka, Kazuaki; Nakamura, Seiji; Yamada, Yoshihiko; Fukumoto, Satoshi			Critical Role of Heparin Binding Domains of Ameloblastin for Dental Epithelium Cell Adhesion and Ameloblastoma Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMININ ALPHA-1 CHAIN; ODONTOGENIC-TUMORS; ENAMEL PROTEINS; IMMUNOHISTOCHEMICAL-DEMONSTRATION; TOOTH DEVELOPMENT; CALCIUM-BINDING; ROOT SHEATH; GENE; DIFFERENTIATION; EXPRESSION	AMBN (ameloblastin) is an enamel matrix protein that regulates cell adhesion, proliferation, and differentiation of ameloblasts. In AMBN-deficient mice, ameloblasts are detached from the enamel matrix, continue to proliferate, and form a multiple cell layer; often, odontogenic tumors develop in the maxilla with age. However, the mechanism of AMBN functions in these biological processes remains unclear. By using recombinant AMBN proteins, we found that AMBN had heparin binding domains at the C-terminal half and that these domains were critical for AMBN binding to dental epithelial cells. Overexpression of full-length AMBN protein inhibited proliferation of human ameloblastoma AM-1 cells, but overexpression of heparin binding domain-deficient AMBN protein had no inhibitory effect. In full-length AMBN-overexpressing AM-1 cells, the expression of Msx2, which is involved in the dental epithelial progenitor phenotype, was decreased, whereas the expression of cell proliferation inhibitors p21 and p27 was increased. We also found that the expression of enamelin, a marker of differentiated ameloblasts, was induced, suggesting that AMBN promotes odontogenic tumor differentiation. Thus, our results suggest that AMBN promotes cell binding through the heparin binding sites and plays an important role in preventing odontogenic tumor development by suppressing cell proliferation and maintaining differentiation phenotype through Msx2, p21, and p27.	[Sonoda, Akira; Yoshizaki, Keigo; Nonaka, Kazuaki; Fukumoto, Satoshi] Kyushu Univ, Sect Pediat Dent, Div Oral Hlth Growth & Dev, Fukuoka 8128582, Japan; [Sonoda, Akira; Nakamura, Seiji] Kyushu Univ, Dept Oral & Maxillofacial Surg 1, Fac Dent Sci, Fukuoka 8128582, Japan; [Iwamoto, Tsutomu; Nakamura, Takashi; Fukumoto, Emiko; Yamada, Aya; Arakaki, Makiko; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [Nakamura, Takashi; Yamada, Yoshihiko] NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; [Harada, Hidemitsu] Iwate Med Coll, Sch Dent, Dept Oral Anat 2, Morioka, Iwate 0208505, Japan	Kyushu University; Kyushu University; Tohoku University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Iwate Medical University	Fukumoto, S (corresponding author), Kyushu Univ, Sect Pediat Dent, Div Oral Hlth Growth & Dev, Fukuoka 8128582, Japan.	fukumoto@mail.tains.tohoku.ac.jp	Iwamoto, Tsutomu/AAA-6597-2019; Iwamoto, Tsutomu/AAI-8952-2021; Nakamura, Takashi/P-7796-2016; Harada, Hidemitsu/P-5692-2017; Nakamura, Takashi/A-8931-2012	Iwamoto, Tsutomu/0000-0001-8472-605X; Nakamura, Takashi/0000-0001-9904-1037; Harada, Hidemitsu/0000-0002-9724-8568; Nakamura, Takashi/0000-0001-9904-1037; Fukumoto, Satoshi/0000-0002-5046-6891; Yoshizaki, Keigo/0000-0002-0598-5879	Intramural Program of the National Institutes of Health, NIDCR; Ministry of Education, Science and Culture of Japan [17689058]; Japan Society for the Promotion of Science [20679006]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000720] Funding Source: NIH RePORTER	Intramural Program of the National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the Intramural Program of the National Institutes of Health, NIDCR (to Y.Y.). This work was also supported in part by Ministry of Education, Science and Culture of Japan Grants-in-aid for Research Fellows of the Japan Society for the Promotion of Science 17689058 and 20679006 (to S. F.).	Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Cerny R, 1996, J BONE MINER RES, V11, P883; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200; Fong CD, 1996, J BONE MINER RES, V11, P892; Fukae M, 1987, Adv Dent Res, V1, P261; Fukumoto S, 2005, CELLS TISSUES ORGANS, V181, P189, DOI 10.1159/000091380; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; GOLDBLATT LI, 1982, ORAL SURG ORAL MED O, V54, P187, DOI 10.1016/0030-4220(82)90216-X; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Kobayashi C, 2006, BIOPHYS J, V90, P3043, DOI 10.1529/biophysj.105.078071; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; MacDougall M, 2000, EUR J ORAL SCI, V108, P303, DOI 10.1034/j.1600-0722.2000.108004303.x; Melrose RJ, 1999, SEMIN DIAGN PATHOL, V16, P271; Nagano T, 2003, J DENT RES, V82, P982, DOI 10.1177/154405910308201209; Nakamura Y, 2006, CALCIFIED TISSUE INT, V78, P278, DOI 10.1007/s00223-005-0144-2; Nanci A, 1998, J HISTOCHEM CYTOCHEM, V46, P911, DOI 10.1177/002215549804600806; NEWMAN L, 1995, BRIT J ORAL MAX SURG, V33, P47, DOI 10.1016/0266-4356(95)90087-X; Nishiguchi M, 2007, ARCH ORAL BIOL, V52, P237, DOI 10.1016/j.archoralbio.2006.09.016; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200; Perdigao PF, 2004, ORAL ONCOL, V40, P841, DOI 10.1016/j.oraloncology.2004.03.004; RAMADAS K, 1990, CANCER, V66, P1475, DOI 10.1002/1097-0142(19901001)66:7<1475::AID-CNCR2820660707>3.0.CO;2-D; Ravindranath HH, 2004, BIOCHEM BIOPH RES CO, V323, P1075, DOI 10.1016/j.bbrc.2004.08.207; Ravindranath RMH, 2007, J BIOL CHEM, V282, P36370, DOI 10.1074/jbc.M704731200; Rincon JC, 2006, J PERIODONTAL RES, V41, P245, DOI 10.1111/j.1600-0765.2006.00880.x; SAKU T, 1992, J ORAL PATHOL MED, V21, P113, DOI 10.1111/j.1600-0714.1992.tb00993.x; Shinmura Y, 2008, J CELL PHYSIOL, V217, P728, DOI 10.1002/jcp.21546; Takata T, 2000, VIRCHOWS ARCH, V436, P324, DOI 10.1007/s004280050454; Toyosawa S, 2000, GENE, V256, P1, DOI 10.1016/S0378-1119(00)00379-6; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L; Yamakoshi Y, 2001, ARCH ORAL BIOL, V46, P1005, DOI 10.1016/S0003-9969(01)00070-X; Yuasa K, 2004, J BIOL CHEM, V279, P10286, DOI 10.1074/jbc.M310013200; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404; Zeichner-David M, 2006, EUR J ORAL SCI, V114, P244, DOI 10.1111/j.1600-0722.2006.00322.x	45	47	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27176	27184		10.1074/jbc.M109.033464	http://dx.doi.org/10.1074/jbc.M109.033464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648121	Green Published, hybrid			2022-12-25	WOS:000270232300018
J	Xu, JD; Litterst, C; Georgakopoulos, A; Zaganas, I; Robakis, NK				Xu, Jindong; Litterst, Claudia; Georgakopoulos, Anastasios; Zaganas, Ioannis; Robakis, Nikolaos K.			Peptide EphB2/CTF2 Generated by the gamma-Secretase Processing of EphB2 Receptor Promotes Tyrosine Phosphorylation and Cell Surface Localization of N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; NMDA-RECEPTORS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; CALCIUM INFLUX; EXPRESSION; NR2B; TRAFFICKING; MUTATIONS; RETENTION	Presenilin 1, a protein involved in the development of familial Alzheimer disease, is an important functional component of the gamma-secretase complex that processes many cell surface receptors including the EphB2 tyrosine kinase receptors (Litterst, C., Georgakopoulos, A., Shioi, J., Ghersi, E., Wisniewski, T., Wang, R., Ludwig, A., and Robakis, N. K. (2007) J. Biol. Chem. 282, 16155-16163). Recent evidence reveals that cytosolic peptides produced by the combined metalloproteinase/gamma-secretase processing of cell surface proteins function in signal transduction and protein phosphorylation. Here we show that peptide EphB2/CTF2 released to the cytosol by the gamma-secretase processing of EphB2 receptor, has tyrosine kinase activity, and directly phosphorylates the N-methyl-D-aspartate receptor (NMDAR) subunits in both cell lines and primary neuronal cultures. This phosphorylation occurs in the absence of Src kinases and is resistant to Src inhibitors revealing a novel pathway of NMDAR tyrosine phosphorylation independent of Src activity. EphB2/CTF2, but not a kinase-deficient mutant of EphB2/CTF2, promotes the cell surface expression of NMDAR. Because NMDAR plays central roles in synaptic plasticity and function, our results provide a potential link between the gamma-secretase function of presenilin 1 and learning and memory.	[Robakis, Nikolaos K.] Mt Sinai Sch Med, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Sch Med, Ctr Mol Biol & Genet Neurodegenerat, Dept Neurosci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Robakis, NK (corresponding author), Mt Sinai Sch Med, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, 1 Gustave Levy Pl,Box 1229, New York, NY 10029 USA.	nikos.robakis@mssm.edu	Robakis, Nikolaos/AAA-1838-2021; Zaganas, Ioannis/AAE-5441-2020	Zaganas, Ioannis/0000-0002-0774-5772	National Institutes of Health [AG-17926, AG-08200, AG-05138]; NATIONAL INSTITUTE ON AGING [R01AG017926, P50AG005138, R01AG008200, R37AG017926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG-17926, AG-08200, and AG-05138.	Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DE SB, 1999, NATURE, V398, P518; Elder GA, 1996, J NEUROSCI RES, V45, P308; Ellis C, 1996, ONCOGENE, V12, P1727; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Kalo MS, 1999, BIOCHEMISTRY-US, V38, P14396, DOI 10.1021/bi991628t; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Okabe S, 1999, J NEUROSCI, V19, P7781; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slack S, 2008, NEUROSCIENCE, V156, P175, DOI 10.1016/j.neuroscience.2008.07.023; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823	39	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27220	27228		10.1074/jbc.M109.048728	http://dx.doi.org/10.1074/jbc.M109.048728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661068	hybrid, Green Published			2022-12-25	WOS:000270232300022
J	Dissanayeke, SR; Levin, S; Pienaar, S; Wood, K; Eley, B; Beatty, D; Henderson, H; Anderson, S; Levin, M				Dissanayeke, Shobana Rebecca; Levin, Samuel; Pienaar, Sandra; Wood, Kathryn; Eley, Brian; Beatty, David; Henderson, Howard; Anderson, Suzanne; Levin, Michael			Polymorphic Variation in TIRAP Is Not Associated with Susceptibility to Childhood TB but May Determine Susceptibility to TBM in Some Ethnic Groups	PLOS ONE			English	Article							RECEPTOR 1 DEFICIENCY; TOLL-LIKE RECEPTORS; INTERFERON-GAMMA; IFN-GAMMA; TUBERCULOSIS; LIPOPOLYSACCHARIDE; RECOGNITION; MUTATION; SILENCE; PROTEIN	Host recognition of mycobacterial surface molecules occurs through toll like receptors (TLR) 2 and 6. The adaptor protein TIRAP mediates down stream signalling of TLR2 and 4, and polymorphisms in the TIRAP gene (TIRAP) have been associated with susceptibility and resistance to tuberculosis (TB) in adults. In order to investigate the role of polymorphic variation in TIRAP in childhood TB in South Africa, which has one of the highest TB incidence rates in the world, we screened the entire open reading frame of TIRAP for sequence variation in two cohorts of childhood TB from different ethnic groups (Xhosa and mixed ancestry). We identified 13 SNPs, including seven previously unreported, in the two cohorts, and found significant differences in frequency of the variants between the two ethnic groups. No differences in frequency between individual SNPs or combinations were found between TB cases and controls in either cohort. However the 558C -> T SNP previously associated with TB meningitis (TBM) in a Vietnamese population was found to be associated with TBM in the mixed ancestry group. Polymorphisms in TIRAP do not appear to be involved in childhood TB susceptibility in South Africa, but may play a role in determining occurrence of TBM.			Dissanayeke, SR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat Infect Dis, London, England.	m.levin@imperial.ac.uk		Levin, Michael/0000-0003-2767-6919	Wellcome Trust [059141/Z/99] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; CASTIBLANCO J, 2008, INFECT GENET EVOL; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Crepin M, 2003, ELECTROPHORESIS, V24, P26, DOI 10.1002/elps.200390023; Daun JM, 2000, J INTERF CYTOK RES, V20, P843, DOI 10.1089/10799900050163217; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Jouanguy E, 2000, J CLIN INVEST, V105, P1429, DOI 10.1172/JCI9166; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Lobato MN, 1998, PEDIATR INFECT DIS J, V17, P407, DOI 10.1097/00006454-199805000-00012; Means TK, 1999, J IMMUNOL, V163, P3920; Means TK, 1999, J IMMUNOL, V163, P6748; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nejentsev S, 2008, NAT GENET, V40, P261, DOI 10.1038/ng0308-261; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; NICKERSON DA, 2003, HL66682 NHLBI; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Parmley JL, 2007, MOL BIOL EVOL, V24, P1600, DOI 10.1093/molbev/msm104; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; SCHEPERHUGHES N, 2006, ETHNIC IDENTITY PROB, P346; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; van Rie A, 1999, ARCH DIS CHILD, V80, P433, DOI 10.1136/adc.80.5.433; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; World Health Organization, 2009, GLOB TUB CONTR EP ST	34	28	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6698	10.1371/journal.pone.0006698	http://dx.doi.org/10.1371/journal.pone.0006698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693265	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267400007
J	Ramadan, W; Eschenko, O; Sara, SJ				Ramadan, Wiam; Eschenko, Oxana; Sara, Susan J.			Hippocampal Sharp Wave/Ripples during Sleep for Consolidation of Associative Memory	PLOS ONE			English	Article								The beneficial effect of sleep on memory has been well-established by extensive research on humans, but the neurophysiological mechanisms remain a matter of speculation. This study addresses the hypothesis that the fast oscillations known as ripples recorded in the CA1 region of the hippocampus during slow wave sleep (SWS) may provide a physiological substrate for long term memory consolidation. We trained rats in a spatial discrimination task to retrieve palatable reward in three fixed locations. Hippocampal local field potentials and cortical EEG were recorded for 2 h after each daily training session. There was an increase in ripple density during SWS after early training sessions, in both trained rats and in rats randomly rewarded for exploring the maze. In rats learning the place -reward association, there was a striking further significant increase in ripple density correlated with subsequent improvements in behavioral performance as the rat learned the spatial discrimination aspect of the task. The results corroborate others showing an experience-dependent increase in ripple activity and associated ensemble replay after exploratory activity, but in addition, for the first time, reveal a clear further increase in ripple activity related to associative learning based on spatial discrimination.			Ramadan, W (corresponding author), Univ Libaniase, Lab Physiol Gen, Fac Sci, Sect 5,Rue Nabih Berri, Nabatiyeh, Lebanon.	susan.sara@college-de-france.fr	Eschenko, Oxana/N-7335-2013; Sara, Susan/AEX-0016-2022	Eschenko, Oxana/0000-0001-7482-5628; Sara, Susan J./0000-0003-4537-7971				Bjorvatn B, 1998, PHYSIOL BEHAV, V63, P413, DOI 10.1016/S0031-9384(97)00460-5; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bouret S, 2002, EUR J NEUROSCI, V16, P2371, DOI 10.1046/j.1460-9568.2002.02413.x; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; ESCHENKO O, 2008, CEREBRAL CORTEX; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Fogel SM, 2006, J SLEEP RES, V15, P250, DOI 10.1111/j.1365-2869.2006.00522.x; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MAQUET P, 2003, REV NEUROL, V159; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Schall KP, 2008, J NEUROPHYSIOL, V99, P888, DOI 10.1152/jn.00915.2007; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Skaggs WE, 1998, J NEUROSCI, V18, P8455; SQUIRE LR, 1994, INT REV NEUROBIOL, V37, P243; SUZUKI SS, 1985, EXP NEUROL, V89, P71, DOI 10.1016/0014-4886(85)90266-3; WANG Z, 1993, J NEUROSCI, V13, P2199; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006	42	104	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6697	10.1371/journal.pone.0006697	http://dx.doi.org/10.1371/journal.pone.0006697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693273	gold, Green Published			2022-12-25	WOS:000269267400006
J	Rohila, JS; Chen, M; Chen, S; Chen, J; Cerny, RL; Dardick, C; Canlas, P; Fujii, H; Gribskov, M; Kanrar, S; Knoflicek, L; Stevenson, B; Xie, MT; Xu, X; Zheng, XW; Zhu, JK; Ronald, P; Fromm, ME				Rohila, Jai S.; Chen, Mei; Chen, Shuo; Chen, Johann; Cerny, Ronald L.; Dardick, Christopher; Canlas, Patrick; Fujii, Hiroaki; Gribskov, Michael; Kanrar, Siddhartha; Knoflicek, Lucas; Stevenson, Becky; Xie, Mingtang; Xu, Xia; Zheng, Xianwu; Zhu, Jian-Kang; Ronald, Pamela; Fromm, Michael E.			Protein-Protein Interactions of Tandem Affinity Purified Protein Kinases from Rice	PLOS ONE			English	Article								Eighty-eight rice (Oryza sativa) cDNAs encoding rice leaf expressed protein kinases (PKs) were fused to a Tandem Affinity Purification tag (TAP-tag) and expressed in transgenic rice plants. The TAP-tagged PKs and interacting proteins were purified from the T1 progeny of the transgenic rice plants and identified by tandem mass spectrometry. Forty-five TAP-tagged PKs were recovered in this study and thirteen of these were found to interact with other rice proteins with a high probability score. In vivo phosphorylated sites were found for three of the PKs. A comparison of the TAP-tagged data from a combined analysis of 129 TAP-tagged rice protein kinases with a concurrent screen using yeast two hybrid methods identified an evolutionarily new rice protein that interacts with the well conserved cell division cycle 2 (CDC2) protein complex.			Rohila, JS (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	jai.rohila@sdstate.edu; mfromm@unlnotes.unl.edu	Rohila, Jai Singh/A-2175-2013; Zhu, Jian-Kang/F-7658-2011; Gribskov, Michael/AAH-5905-2021; Ronald, Pamela/AAK-7664-2020	Rohila, Jai Singh/0000-0002-4041-5804; Zhu, Jian-Kang/0000-0001-5134-731X; Xie, Mingtang/0000-0002-2797-0598; Fujii, Hiroaki/0000-0002-0013-5891; Gribskov, Michael/0000-0002-1718-0242	NCI NIH HHS [P30 CA36727, P30 CA036727] Funding Source: Medline; NCRR NIH HHS [P20 RR15635, P20 RR015635] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bouly JP, 1999, PLANT J, V18, P541, DOI 10.1046/j.1365-313X.1999.00476.x; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Ding XD, 2009, PLANT PHYSIOL, V149, P1478, DOI 10.1104/pp.108.128298; Etheridge Naomi, 2005, Briefings in Functional Genomics & Proteomics, V3, P372, DOI 10.1093/bfgp/3.4.372; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; Ferrando A, 2001, NUCLEIC ACIDS RES, V29, P3685, DOI 10.1093/nar/29.17.3685; Forler D, 2003, NAT BIOTECHNOL, V21, P89, DOI 10.1038/nbt773; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gingras AC, 2005, J PHYSIOL-LONDON, V563, P11, DOI 10.1113/jphysiol.2004.080440; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Inze D, 2005, EMBO J, V24, P657, DOI 10.1038/sj.emboj.7600561; Kayser J P, 2004, J Biomol Tech, V15, P285; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Koroleva OA, 2004, PLANT CELL, V16, P2364, DOI 10.1105/tpc.104.023754; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Lumbreras V, 2001, EMBO REP, V2, P55, DOI 10.1093/embo-reports/kve001; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Peck SC, 2005, PLANT PHYSIOL, V138, P591, DOI 10.1104/pp.105.060285; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rensink WA, 2004, PLANT PHYSIOL, V135, P622, DOI 10.1104/pp.104.040170; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rohila JS, 2006, PLANT J, V46, P1, DOI 10.1111/j.1365-313X.2006.02671.x; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Rolland F, 2005, BIOCHEM SOC T, V33, P269, DOI 10.1042/BST0330269; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Somerville C, 2001, SCIENCE, V292, P2217, DOI 10.1126/science.292.5525.2217; Steen H, 2006, MOL CELL PROTEOMICS, V5, P172, DOI 10.1074/mcp.M500135-MCP200; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Taylor GK, 2005, RAPID COMMUN MASS SP, V19, P3420, DOI 10.1002/rcm.2225; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Van Leene J, 2007, MOL CELL PROTEOMICS, V6, P1226, DOI 10.1074/mcp.M700078-MCP200; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; [No title captured]	43	32	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6685	10.1371/journal.pone.0006685	http://dx.doi.org/10.1371/journal.pone.0006685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690613	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267300006
J	Emmert-Streib, F; Dehmer, M				Emmert-Streib, Frank; Dehmer, Matthias			Predicting Cell Cycle Regulated Genes by Causal Interactions	PLOS ONE			English	Article							MICROARRAY DATA; GENOMIC ANALYSIS; IDENTIFICATION	The fundamental difference between classic and modern biology is that technological innovations allow to generate high-throughput data to get insights into molecular interactions on a genomic scale. These high-throughput data can be used to infer gene networks, e. g., the transcriptional regulatory or signaling network, representing a blue print of the current dynamical state of the cellular system. However, gene networks do not provide direct answers to biological questions, instead, they need to be analyzed to reveal functional information of molecular working mechanisms. In this paper we propose a new approach to analyze the transcriptional regulatory network of yeast to predict cell cycle regulated genes. The novelty of our approach is that, in contrast to all other approaches aiming to predict cell cycle regulated genes, we do not use time series data but base our analysis on the prior information of causal interactions among genes. The major purpose of the present paper is to predict cell cycle regulated genes in S. cerevisiae. Our analysis is based on the transcriptional regulatory network, representing causal interactions between genes, and a list of known periodic genes. No further data are used. Our approach utilizes the causal membership of genes and the hierarchical organization of the transcriptional regulatory network leading to two groups of periodic genes with a well defined direction of information flow. We predict genes as periodic if they appear on unique shortest paths connecting two periodic genes from different hierarchy levels. Our results demonstrate that a classical problem as the prediction of cell cycle regulated genes can be seen in a new light if the concept of a causal membership of a gene is applied consequently. This also shows that there is a wealth of information buried in the transcriptional regulatory network whose unraveling may require more elaborate concepts than it might seem at first.			Emmert-Streib, F (corresponding author), Queens Univ Belfast, Sch Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641				Ahnert SE, 2006, BIOINFORMATICS, V22, P1471, DOI 10.1093/bioinformatics/btl121; Alon U., 2006, INTRO SYSTEMS BIOL D; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bornholdt S, 2003, HDB GRAPHS NETWORKS; Cheng C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-116; Csardi G, 2008, IGRAPH PACKAGE; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Dorogovtesev S, 2003, EVOLUTION NETWORKS B; Emmert-Streib F, 2007, J COMPUT BIOL, V14, P961, DOI 10.1089/cmb.2007.0041; Emmert-Streib F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-76; Emmert-Streib F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-237; EmmertStreib F, 2008, ANALYSIS OF MICROARRAY DATA: A NETWORK-BASED APPROACH, P1; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Johansson D, 2003, BIOINFORMATICS, V19, P467, DOI 10.1093/bioinformatics/btg017; KITANO H, 2001, FDN SYSTEMS BIOL, P4; Luan Y, 2004, BIOINFORMATICS, V20, P332, DOI 10.1093/bioinformatics/btg413; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Palsson B O, 2006, SYSTEMS BIOL; PAPIN J, 2005, NAT REV MOL CELL BIO; R Core Team, 2022, R LANG ENV STAT COMP; Rahman SA, 2006, BIOINFORMATICS, V22, P1767, DOI 10.1093/bioinformatics/btl181; Rue H, 2005, G MARKOV RANDOM FIEL; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Shmulevich I., 2007, GENOMIC SIGNAL PROCE; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Von Bertalanffy L, 1968, GEN SYSTEM THEORY FD; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Willbrand K, 2005, BIOINFORMATICS, V21, P3859, DOI 10.1093/bioinformatics/bti549; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zhao LP, 2001, P NATL ACAD SCI USA, V98, P5631, DOI 10.1073/pnas.101013198; Zhu DX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-8	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6633	10.1371/journal.pone.0006633	http://dx.doi.org/10.1371/journal.pone.0006633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688096	Green Submitted, Green Published, gold			2022-12-25	WOS:000269075800003
J	van Gemert, AMC; van der Laan, AMA; Pilgram, GSK; Fradkin, LG; Noordermeer, JN; Tanke, HJ; Jost, CR				van Gemert, Alice M. C.; van der Laan, Annelies M. A.; Pilgram, Gonneke S. K.; Fradkin, Lee G.; Noordermeer, Jasprina N.; Tanke, Hans J.; Jost, Carolina R.			In Vivo Monitoring of mRNA Movement in Drosophila Body Wall Muscle Cells Reveals the Presence of Myofiber Domains	PLOS ONE			English	Article							FLUORESCENCE RECOVERY; UNTRANSLATED REGION; GENE-EXPRESSION; LOCALIZATION; DYSTROPHIN; BINDING; FRAP; CHROMATIN; DYNAMICS; MYOSIN	Background: In skeletal muscle each muscle cell, commonly called myofiber, is actually a large syncytium containing numerous nuclei. Experiments in fixed myofibers show that mRNAs remain localized around the nuclei in which they are produced. Methodology/Principal Findings: In this study we generated transgenic flies that allowed us to investigate the movement of mRNAs in body wall myofibers of living Drosophila embryos. We determined the dynamic properties of GFP-tagged mRNAs using in vivo confocal imaging and photobleaching techniques and found that the GFP-tagged mRNAs are not free to move throughout myofibers. The restricted movement indicated that body wall myofibers consist of three domains. The exchange of mRNAs between the domains is relatively slow, but the GFP-tagged mRNAs move rapidly within these domains. One domain is located at the centre of the cell and is surrounded by nuclei while the other two domains are located at either end of the fiber. To move between these domains mRNAs have to travel past centrally located nuclei. Conclusions/Significance: These data suggest that the domains made visible in our experiments result from prolonged interactions with as yet undefined structures close to the nuclei that prevent GFP-tagged mRNAs from rapidly moving between the domains. This could be of significant importance for the treatment of myopathies using regenerative cell-based therapies.			van Gemert, AMC (corresponding author), Leiden Univ Med C, Dept Mol Cell Biol, Lab Gene Express & Imaging, Leiden, Netherlands.	c.r.jost@lumc.nl						ALLEN DL, 1990, MYONUCLEAR DOMAINS M; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Braga J, 2007, BIOPHYS J, V92, P2694, DOI 10.1529/biophysj.106.096693; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1993, J NEUROSCI, V13, P144; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Chretien F, 2005, AM J PATHOL, V166, P1741, DOI 10.1016/S0002-9440(10)62484-4; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; Crawford JM, 1998, DEV BIOL, V204, P151, DOI 10.1006/dbio.1998.9061; Frescas D, 2006, J CELL BIOL, V173, P219, DOI 10.1083/jcb.200601156; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gramolini AO, 2001, J CELL BIOL, V154, P1173, DOI 10.1083/jcb.200101108; Grieder NC, 2000, DEVELOPMENT, V127, P4253; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; HORNE Z, 1990, BIOCHEM J, V268, P231, DOI 10.1042/bj2680231; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jaramillo AM, 2008, J CELL SCI, V121, P887, DOI 10.1242/jcs.019091; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Kinoshita I, 1998, MUSCLE NERVE, V21, P91, DOI 10.1002/(SICI)1097-4598(199801)21:1<91::AID-MUS12>3.0.CO;2-3; Li Q, 2006, CHEM BIOL, V13, P615, DOI 10.1016/j.chembiol.2006.04.007; LOWARY PT, 1987, NUCLEIC ACIDS RES, V15, P10483, DOI 10.1093/nar/15.24.10483; Mavrakis M., 2008, CURR PROTOC CELL BIO; Metzstein MM, 2006, PLOS GENET, V2, P2143, DOI 10.1371/journal.pgen.0020180; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PAVLATH GK, 1989, NATURE, V337, P570, DOI 10.1038/337570a0; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; RALSTON E, 1992, J CELL BIOL, V119, P1063, DOI 10.1083/jcb.119.5.1063; Ralston E, 1997, EXP CELL RES, V236, P453, DOI 10.1006/excr.1997.3753; Ravel-Chapuis A, 2007, EMBO J, V26, P1117, DOI 10.1038/sj.emboj.7601572; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stavreva DA, 2004, METHOD ENZYMOL, V375, P443; Tanke HJ, 1999, EUR J HUM GENET, V7, P2, DOI 10.1038/sj.ejhg.5200265; van der Plas MC, 2007, MECH DEVELOP, V124, P617, DOI 10.1016/j.mod.2007.04.003; Wieschaus E., 1986, DROSOPHILA PRACTICAL; Yu JH, 2006, DEV BIOL, V289, P336, DOI 10.1016/j.ydbio.2005.10.027; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6663	10.1371/journal.pone.0006663	http://dx.doi.org/10.1371/journal.pone.0006663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684860	Green Published, Green Submitted, gold			2022-12-25	WOS:000269075600011
J	Halaschek-Wiener, J; Amirabbasi-Beik, M; Monfared, N; Pieczyk, M; Sailer, C; Kollar, A; Thomas, R; Agalaridis, G; Yamada, S; Oliveira, L; Collins, JA; Meneilly, G; Marra, MA; Madden, KM; Le, ND; Connors, JM; Brooks-Wilson, AR				Halaschek-Wiener, Julius; Amirabbasi-Beik, Mahsa; Monfared, Nasim; Pieczyk, Markus; Sailer, Christian; Kollar, Anita; Thomas, Ruth; Agalaridis, Georgios; Yamada, So; Oliveira, Lisa; Collins, Jennifer A.; Meneilly, Graydon; Marra, Marco A.; Madden, Kenneth M.; Le, Nhu D.; Connors, Joseph M.; Brooks-Wilson, Angela R.			Genetic Variation in Healthy Oldest-Old	PLOS ONE			English	Article							CALORIE RESTRICTION; LIFE-SPAN; OXIDATIVE STRESS; HUMAN LONGEVITY; CANCER; LONG; POLYMORPHISMS; ASSOCIATION; LIVE; CENTENARIANS	Individuals who live to 85 and beyond without developing major age-related diseases may achieve this, in part, by lacking disease susceptibility factors, or by possessing resistance factors that enhance their ability to avoid disease and prolong lifespan. Healthy aging is a complex phenotype likely to be affected by both genetic and environmental factors. We sequenced 24 candidate healthy aging genes in DNA samples from 47 healthy individuals aged eighty-five years or older (the 'oldest-old'), to characterize genetic variation that is present in this exceptional group. These healthy seniors were never diagnosed with cancer, cardiovascular disease, pulmonary disease, diabetes, or Alzheimer disease. We re-sequenced all exons, intron-exon boundaries and selected conserved non-coding sequences of candidate genes involved in aging-related processes, including dietary restriction (PPARG, PPARGC1A, SIRT1, SIRT3, UCP2, UCP3), metabolism (IGF1R, APOB, SCD), autophagy (BECN1, FRAP1), stem cell activation (NOTCH1, DLL1), tumor suppression (TP53, CDKN2A, ING1), DNA methylation (TRDMT1, DNMT3A, DNMT3B) Progeria syndromes (LMNA, ZMPSTE24, KL) and stress response (CRYAB, HSPB2). We detected 935 variants, including 848 single nucleotide polymorphisms (SNPs) and 87 insertion or deletions; 41% (385) were not recorded in dbSNP. This study is the first to present a comprehensive analysis of genetic variation in aging-related candidate genes in healthy oldest-old. These variants and especially our novel polymorphisms are valuable resources to test for genetic association in models of disease susceptibility or resistance. In addition, we propose an innovative tagSNP selection strategy that combines variants identified through gene re-sequencing- and HapMap-derived SNPs.	[Halaschek-Wiener, Julius; Amirabbasi-Beik, Mahsa; Monfared, Nasim; Pieczyk, Markus; Sailer, Christian; Kollar, Anita; Thomas, Ruth; Agalaridis, Georgios; Yamada, So; Oliveira, Lisa; Collins, Jennifer A.; Marra, Marco A.; Brooks-Wilson, Angela R.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Sailer, Christian] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Meneilly, Graydon; Madden, Kenneth M.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Connors, Joseph M.] British Columbia Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of Zurich; University of British Columbia; British Columbia Cancer Agency; Simon Fraser University	Halaschek-Wiener, J (corresponding author), British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada.	abrooks-wilson@bcgsc.ca	Connors, Joseph/AAF-5284-2019; Brooks-Wilson, Angela/E-9399-2012; Collins, Jennifer/AAE-1895-2020; Sailer, Christian/AAE-7281-2019; Marra, Marco A/B-5987-2008	Connors, Joseph/0000-0002-1361-7531; Brooks-Wilson, Angela/0000-0003-1009-6408; Sailer, Christian/0000-0003-0070-0317; Marra, Marco A/0000-0001-7146-7175	Canadian Institutes of Health Research (CIHR); Austrian Science Foundation (FWF)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF))	This work was funded by a New Emerging Team Grant from the Canadian Institutes of Health Research (CIHR). JH-W was supported in part by an Erwin-Schrodinger Fellowship from the Austrian Science Foundation (FWF). ARB-W is a Michael Smith Foundation for Health Research Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ARIAS E, 2004, NATL VITAL STAT REPO, V63; Atwood Craig S., 2003, Experimental Gerontology, V38, P1217, DOI 10.1016/j.exger.2003.08.005; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bonafe M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Campisi J, 2004, NAT MED, V10, P231, DOI 10.1038/nm0304-231; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cellini E, 2005, MECH AGEING DEV, V126, P826, DOI 10.1016/j.mad.2005.01.009; Christiansen L, 2004, MECH AGEING DEV, V125, P391, DOI 10.1016/j.mad.2004.03.004; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cournil A, 2001, TRENDS GENET, V17, P233, DOI 10.1016/S0168-9525(01)02306-X; Cuervo AM, 2008, J GERONTOL A-BIOL, V63, P547, DOI 10.1093/gerona/63.6.547; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ebert TA, 2003, FISH B-NOAA, V101, P915; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Gami MS, 2006, AGING CELL, V5, P31, DOI 10.1111/j.1474-9726.2006.00188.x; Geesaman BJ, 2003, P NATL ACAD SCI USA, V100, P14115, DOI 10.1073/pnas.1936249100; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3; HISAMA F.M., 2003, CHROMOSOMAL INSTABIL; HOLIDAY R, 2007, AGING PARADOX LIFE, P132; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Lio D, 2002, GENES IMMUN, V3, P30, DOI 10.1038/sj.gene.6363827; Lio D, 2003, J MED GENET, V40, P296, DOI 10.1136/jmg.40.4.296; Liu BH, 2008, HISTOL HISTOPATHOL, V23, P747, DOI 10.14670/HH-23.747; LOUHIJA J, 1994, ARTERIOSCLER THROMB, V14, P1084, DOI 10.1161/01.ATV.14.7.1084; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; MARTIN S, 2002, CMAJ, V167, P1456; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Munk Kristen M., 2001, Alaska Fishery Research Bulletin, V8, P12; Perls TT, 1998, LANCET, V351, P1560, DOI 10.1016/S0140-6736(05)61126-9; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rea IM, 2004, EXP GERONTOL, V39, P629, DOI 10.1016/j.exger.2003.11.019; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Schrauwen P, 2002, J EXP BIOL, V205, P2275; Seripa D, 2006, J GERONTOL A-BIOL, V61, P918, DOI 10.1093/gerona/61.9.918; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wolkow CA, 2006, AGEING RES REV, V5, P196, DOI 10.1016/j.arr.2006.03.007; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	63	39	40	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6641	10.1371/journal.pone.0006641	http://dx.doi.org/10.1371/journal.pone.0006641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680556	Green Published, Green Submitted, gold			2022-12-25	WOS:000268936200007
J	Kang, H; Jung, JW; Kim, MK; Chung, JH				Kang, Hyeog; Jung, Jae-Won; Kim, Myung K.; Chung, Jay H.			CK2 Is the Regulator of SIRT1 Substrate-Binding Affinity, Deacetylase Activity and Cellular Response to DNA-Damage	PLOS ONE			English	Article							PROTEIN-KINASE CK2; DEPENDENT HISTONE DEACETYLASE; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; GAMMA-RADIATION; P53; PHOSPHORYLATION; SURVIVAL; NAD; TUMORIGENESIS	SIRT1, an NAD(+) (nicotinamide adenine dinucleotide)-dependent deacetylase, protects cells from stress-induced apoptosis, and its orthologues delay aging in lower eukaryotes. SIRT1 increases survival in response to stress such as DNA damage by deacetylating a number of substrates including pro-apoptotic protein p53. The molecular mechanism by which DNA-damage activates SIRT1 is not known. By screening a kinase inhibitor library, we identified CK2 as a SIRT1 kinase. CK2 is a pleiotropic kinase with more than 300 substrates and well-known anti-apoptotic and pro-growth activities. We find that CK2 is recruited to SIRT1 after ionizing radiation (IR) and phosphorylates conserved residues Ser 154, 649, 651 and 683 in the Nand C-terminal domains of mouse SIRT1. Phosphorylation of SIRT1 increases its deacetylation rate but not if the four Ser residues are mutated. In addition, phosphorylation of SIRT1 increases its substrate-binding affinity. CK2-mediated phosphorylation increases the ability of SIRT1 to deacetylate p53 and protect cells from apoptosis after DNA damage. Based on these findings, we propose that CK2 protects against IR-induced apoptosis partly by phosphorylating and activating SIRT1. Thus, this work suggests that SIRT1 is a component of the expansive anti-apoptotic network controlled by CK2. Since expression of both CK2 and SIRT1 is upregulated with tumorigenesis and downregulated with senescence, the CK2-SIRT1 link sheds new light on how CK2 may regulate cancer development and aging.	[Kang, Hyeog; Jung, Jae-Won; Kim, Myung K.; Chung, Jay H.] NHLBI, Lab Biochem Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kang, H (corresponding author), NHLBI, Lab Biochem Genet, NIH, Bldg 10, Bethesda, MD 20892 USA.	chungj@nhlbi.nih.gov		kang, hyeog/0000-0001-8935-1103; Jung, Jae-Won/0000-0002-9081-685X	National Heart Lung and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002243, ZIAHL002243] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program, National Heart Lung and Blood Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN P, 1990, P NATL ACAD SCI USA, V87, P821, DOI 10.1073/pnas.87.2.821; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; CARROLL D, 1989, J BIOL CHEM, V264, P7345; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; RINE J, 1987, GENETICS, V116, P9; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryu SW, 2006, FEBS LETT, V580, P988, DOI 10.1016/j.febslet.2006.01.028; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vilk G, 1999, J BIOL CHEM, V274, P14406, DOI 10.1074/jbc.274.20.14406; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	50	102	104	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6611	10.1371/journal.pone.0006611	http://dx.doi.org/10.1371/journal.pone.0006611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680552	Green Submitted, Green Published, gold			2022-12-25	WOS:000268936200001
J	Wilking, H; Ziller, M; Staubach, C; Globig, A; Harder, TC; Conraths, FJ				Wilking, Hendrik; Ziller, Mario; Staubach, Christoph; Globig, Anja; Harder, Timm C.; Conraths, Franz J.			Chances and Limitations of Wild Bird Monitoring for the Avian Influenza Virus H5N1-Detection of Pathogens Highly Mobile in Time and Space	PLOS ONE			English	Article							H5N1; SURVEILLANCE; PATTERNS; GERMANY; PERSISTENCE; OUTBREAKS; SPREAD; WATER	Highly pathogenic influenza virus (HPAIV) H5N1 proved to be remarkably mobile in migratory bird populations where it has led to extensive outbreaks for which the true number of affected birds usually cannot be determined. For the evaluation of avian influenza monitoring and HPAIV early warning systems, we propose a time-series analysis that includes the estimation of confidence intervals for (i) the prevalence in outbreak situations or (ii) in the apparent absence of disease in time intervals for specified regional units. For the German outbreak regions in 2006 and 2007, the upper 95% confidence limit allowed the detection of prevalences below 1% only for certain time intervals. Although more than 25,000 birds were sampled in Germany per year, the upper 95% confidence limit did not fall below 5% in the outbreak regions for most of the time. The proposed analysis can be used to monitor water bodies and high risk areas, also as part of an early-warning system. Chances for an improved targeting of the monitoring system as part of a risk-based approach are discussed with the perspective of reducing sample sizes.	[Wilking, Hendrik; Ziller, Mario; Staubach, Christoph; Conraths, Franz J.] Friedrich Loeffler Inst, Inst Epidemiol, Fed Res Inst Anim Hlth, Wusterhausen, Germany; [Globig, Anja] Friedrich Loeffler Inst, Inst Diagnost Virol, Fed Res Inst Anim Hlth, Greifswald, Germany; [Harder, Timm C.] Friedrich Loeffler Inst, Inst Diagnost Virol, Fed Res Inst Anim Hlth, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Wilking, H (corresponding author), Friedrich Loeffler Inst, Inst Epidemiol, Fed Res Inst Anim Hlth, Wusterhausen, Germany.	franz.conraths@fli.bund.de	Harder, Timm/AAE-2932-2019	Harder, Timm/0000-0003-2387-378X; Conraths, Franz/0000-0002-7400-9409; Wilking, Hendrik/0000-0002-8574-5831	German Federal Ministry of Food, Agriculture and Consumer [FSI 3.2]	German Federal Ministry of Food, Agriculture and Consumer	The project was partially financed by the German Federal Ministry of Food, Agriculture and Consumer protection (FSI 3.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; CANNON RM, LIVESTOCK DIS SURVEY; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Happold JR, 2008, AVIAN DIS, V52, P100, DOI 10.1637/8021-051407-Reg; Harder TC, 2009, EMERG INFECT DIS, V15, P272, DOI 10.3201/eid1502.080949; Hoffmann B, 2007, J CLIN MICROBIOL, V45, P600, DOI 10.1128/JCM.01681-06; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2008, ECOL SOC, V13; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; *R, 2008, R PROJ STAT COMP; Salman M.D., 2003, ANIMAL DIS SURVEILLA, V1st; SINNECKER H, 1982, ZBL BAKT-INT J MED M, V253, P297; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Teifke JP, 2007, VET PATHOL, V44, P137, DOI 10.1354/vp.44-2-137; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Unger F, 2008, TIERAERZTL PRAX G N, V36, P5, DOI 10.1055/s-0037-1621523; *US GEOL SURV, 2008, LIST SPEC AFF H5N1 A; Veen J., 2007, ORNITHOLOGICAL DATA	25	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6639	10.1371/journal.pone.0006639	http://dx.doi.org/10.1371/journal.pone.0006639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680560	gold, Green Submitted, Green Published			2022-12-25	WOS:000268936200006
J	Hazledine, S; Sun, J; Wysham, D; Downie, JA; Oldroyd, GED; Morris, RJ				Hazledine, Saul; Sun, Jongho; Wysham, Derin; Downie, J. Allan; Oldroyd, Giles E. D.; Morris, Richard J.			Nonlinear Time Series Analysis of Nodulation Factor Induced Calcium Oscillations: Evidence for Deterministic Chaos?	PLOS ONE			English	Article							INTRACELLULAR CA2+; HEPATOCYTES; BEHAVIOR; LEGUMES; LENGTH; NOISE	Legume plants form beneficial symbiotic interactions with nitrogen fixing bacteria (called rhizobia), with the rhizobia being accommodated in unique structures on the roots of the host plant. The legume/rhizobial symbiosis is responsible for a significant proportion of the global biologically available nitrogen. The initiation of this symbiosis is governed by a characteristic calcium oscillation within the plant root hair cells and this signal is activated by the rhizobia. Recent analyses on calcium time series data have suggested that stochastic effects have a large role to play in defining the nature of the oscillations. The use of multiple nonlinear time series techniques, however, suggests an alternative interpretation, namely deterministic chaos. We provide an extensive, nonlinear time series analysis on the nature of this calcium oscillation response. We build up evidence through a series of techniques that test for determinism, quantify linear and nonlinear components, and measure the local divergence of the system. Chaos is common in nature and it seems plausible that properties of chaotic dynamics might be exploited by biological systems to control processes within the cell. Systems possessing chaotic control mechanisms are more robust in the sense that the enhanced flexibility allows more rapid response to environmental changes with less energetic costs. The desired behaviour could be most efficiently targeted in this manner, supporting some intriguing speculations about nonlinear mechanisms in biological signaling.	[Hazledine, Saul; Downie, J. Allan] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Hazledine, S (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England.	richard.morris@bbsrc.ac.uk	Oldroyd, Giles/ABA-7501-2020; Sun, Jongho/G-5235-2016; Oldroyd, Giles/ABD-8143-2021; Downie, Allan/I-3487-2012; Sun, Jongho/AAL-6673-2020	Sun, Jongho/0000-0002-3705-3072; Oldroyd, Giles/0000-0002-5245-6355; Sun, Jongho/0000-0002-3705-3072; Downie, Allan/0000-0003-1011-4960; Morris, Richard/0000-0003-3080-2613	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council David Phillips Fellowship; Royal Society Wolfson Research Merit award; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000611] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Wolfson Research Merit award(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	S. H. was funded by a PhD studentship from the Biotechnology and Biological Sciences Research Council. This work was supported by a Biotechnology and Biological Sciences Research Council David Phillips Fellowship and a Royal Society Wolfson Research Merit award to G.O., and a grant in aid from the Biotechnology and Biological Sciences Research Council to G.O., J. A. D., and R. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio T, 2008, J ECON BEHAV ORGAN, V65, P768, DOI 10.1016/j.jebo.2006.03.005; Bien H, 2006, BIOPHYS J, V90, P2628, DOI 10.1529/biophysj.105.063321; Borghans JAM, 1997, BIOPHYS CHEM, V66, P25, DOI 10.1016/S0301-4622(97)00010-0; Brockwell P. J., 2002, INTRO TIME SERIES FO; CAPIOD T, 1991, BIOCHEM J, V275, P277, DOI 10.1042/bj2750277; DIXON CJ, 1990, BIOCHEM J, V269, P499, DOI 10.1042/bj2690499; Ellner S., 1992, I STAT MIMEO SERIES; Falcke M, 2003, BIOPHYS J, V84, P42, DOI 10.1016/S0006-3495(03)74831-0; Gaspard P., 2005, CHAOS SCATTERING STA; GREEN AK, 1993, FEBS LETT, V322, P197, DOI 10.1016/0014-5793(93)81567-J; Haberichter T, 2001, BIOPHYS CHEM, V90, P17, DOI 10.1016/S0301-4622(01)00127-2; HAYES S, 1994, PHYS REV LETT, V73, P1781, DOI 10.1103/PhysRevLett.73.1781; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kantz H., 1997, NONLINEAR TIME SERIE; KAPLAN DT, 1993, PHYSICA D, V64, P431, DOI 10.1016/0167-2789(93)90054-5; KAPLAN DT, 1992, PHYS REV LETT, V68, P427, DOI 10.1103/PhysRevLett.68.427; Kennel MB, 1997, PHYS REV E, V56, P316, DOI 10.1103/PhysRevE.56.316; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Kugiumtzis D, 1996, PHYSICA D, V95, P13, DOI 10.1016/0167-2789(96)00054-1; Kummer U, 2005, BIOPHYS J, V89, P1603, DOI 10.1529/biophysj.104.057216; Kummer U, 2000, BIOPHYS J, V79, P1188, DOI 10.1016/S0006-3495(00)76373-9; LAI YC, 1995, PHYS LETT A, V200, P418, DOI 10.1016/0375-9601(95)00224-Q; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Nagata T, 2004, MOL BIOL EVOL, V21, P1855, DOI 10.1093/molbev/msh197; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2006, CURR OPIN PLANT BIOL, V9, P351, DOI 10.1016/j.pbi.2006.05.003; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; Perc M, 2003, BIOPHYS CHEM, V104, P509, DOI 10.1016/S0301-4622(03)00038-3; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; Poon CS, 2001, P NATL ACAD SCI USA, V98, P7107, DOI 10.1073/pnas.131173198; R Development Core Team, 2006, R LANG ENV STAT COMP; RILLING PFG, 2003, EMPIRICAL MODE DECOM; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; SCHREIBER T, 1993, PHYS REV E, V47, P2401, DOI 10.1103/PhysRevE.47.2401; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Schreiber T, 1997, PHYS REV E, V55, P5443, DOI 10.1103/PhysRevE.55.5443; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; SHINBROT T, 1993, NATURE, V363, P411, DOI 10.1038/363411a0; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Sneyd J, 2004, P NATL ACAD SCI USA, V101, P1392, DOI 10.1073/pnas.0303472101; Sun JH, 2006, PLANT J, V46, P961, DOI 10.1111/j.1365-313X.2006.02751.x; Wais RJ, 2002, MOL PLANT MICROBE IN, V15, P1245, DOI 10.1094/MPMI.2002.15.12.1245; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104	45	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6637	10.1371/journal.pone.0006637	http://dx.doi.org/10.1371/journal.pone.0006637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675679	Green Published, Green Submitted, gold			2022-12-25	WOS:000268936100012
J	Hu, D; Bi, XL; Fang, WF; Han, AJ; Yang, WC				Hu, Dong; Bi, Xiuli; Fang, Wenfeng; Han, Anjia; Yang, Wancai			GSK3 beta Is Involved in JNK2-Mediated beta-Catenin Inhibition	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTION; GLYCOGEN-SYNTHASE KINASE-3; JUN NH2-TERMINAL KINASE; C-JUN; SIGNAL-TRANSDUCTION; PATHWAY; INACTIVATION; PHOSPHORYLATION; SUPPRESSION; ACTIVATION	Background: We have recently reported that mitogen-activated protein kinase(MAPK) JNK1 downregulates beta-catenin signaling and plays a critical role in regulating intestinal homeostasis and in suppressing tumor formation. This study was designed to determine whether JNK2, another MAPK, has similar and/or different functions in the regulation of beta-catenin signaling. Methodology and Principal Findings: We used an in vitro system with manipulation of JNK2 and beta-catenin expression and found that activated JNK2 increased GSK3 beta activity and inhibited beta-catenin expression and transcriptional activity. However, JNK2-mediated downregulation of beta-catenin was blocked by the proteasome inhibitor MG132 and GSK3 beta inhibitor lithium chloride. Moreover, targeted mutations at GSK3 beta phosphorylation sites(Ser33 and Ser37) of beta-catenin abrogated JNK2-mediated suppression of beta-catenin. In vivo studies further revealed that JNK2 deficiency led to upregulation of beta-catenin and increase of GSK3-beta phosphorylation in JNK2-/- mouse intestinal epithelial cells. Additionally, physical interaction and co-localization among JNK2, beta-catenin and GSK3 beta were observed by immunoprecipitation, mammalian two-hybridization assay and confocal microscopy, respectively. Conclusion and Significance: In general, our data suggested that JNK2, like JNK1, interacts with and suppresses beta-catenin signaling in vitro and in vivo, in which GSK3 beta plays a key role, although previous studies have shown distinct functions of JNK1 and JNK2. Our study also provides a novel insight into the crosstalk between Wnt/beta-catenin and MAPK JNKs signaling.	[Hu, Dong; Bi, Xiuli; Fang, Wenfeng; Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL 60680 USA; [Han, Anjia] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Han, Anjia] Affiliated Hosp 1, Dept Pathol, Guangzhou, Guangdong, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sun Yat Sen University	Hu, D (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60680 USA.	wyang06@uic.edu	Yang, Wancai/O-7655-2019; Yang, Wancai/G-3750-2010; hu, dong/F-8812-2011	Yang, Wancai/0000-0001-7437-9197; 	National Institutes of Health [CA112081]; NATIONAL CANCER INSTITUTE [R01CA112081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant (CA112081). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chen NY, 2001, CANCER RES, V61, P3908; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davies G, 2001, INT J ONCOL, V18, P843; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Han AJ, 2008, CANCER BIOL THER, V7, P454, DOI 10.4161/cbt.7.3.5455; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Provost E, 2005, ONCOGENE, V24, P2667, DOI 10.1038/sj.onc.1208346; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; She QB, 2002, CANCER RES, V62, P1343; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	27	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6640	10.1371/journal.pone.0006640	http://dx.doi.org/10.1371/journal.pone.0006640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675674	Green Published, gold, Green Submitted			2022-12-25	WOS:000268936100013
J	Wang, IC; Meliton, L; Ren, XM; Zhang, YF; Balli, D; Snyder, J; Whitsett, JA; Kalinichenko, VV; Kalin, TV				Wang, I-Ching; Meliton, Lucille; Ren, Xiaomeng; Zhang, Yufang; Balli, David; Snyder, Jonathan; Whitsett, Jeffrey A.; Kalinichenko, Vladimir V.; Kalin, Tanya V.			Deletion of Forkhead Box M1 Transcription Factor from Respiratory Epithelial Cells Inhibits Pulmonary Tumorigenesis	PLOS ONE			English	Article							DNA TOPOISOMERASE-II; EXPRESSION; FOXM1; GROWTH; ROLES; PROGRESSION; CARCINOMAS; PATHWAYS; GENES	The Forkhead Box m1 (Foxm1) protein is induced in a majority of human non-small cell lung cancers and its expression is associated with poor prognosis. However, specific requirements for the Foxm1 in each cell type of the cancer lesion remain unknown. The present study provides the first genetic evidence that the Foxm1 expression in respiratory epithelial cells is essential for lung tumorigenesis. Using transgenic mice, we demonstrated that conditional deletion of Foxm1 from lung epithelial cells (epFoxm1(-/-) mice) prior to tumor initiation caused a striking reduction in the number and size of lung tumors, induced by either urethane or 3-methylcholanthrene (MCA)/butylated hydroxytoluene (BHT). Decreased lung tumorigenesis in epFoxm1(-/-) mice was associated with diminished proliferation of tumor cells and reduced expression of Topoisomerase-2 alpha (TOPO-2 alpha), a critical regulator of tumor cell proliferation. Depletion of Foxm1 mRNA in cultured lung adenocarcinoma cells significantly decreased TOPO-2 alpha mRNA and protein levels. Moreover, Foxm1 directly bound to and induced transcription of the mouse TOPO-2 alpha promoter region, indicating that TOPO-2 alpha is a direct target of Foxm1 in lung tumor cells. Finally, we demonstrated that a conditional deletion of Foxm1 in pre-existing lung tumors dramatically reduced tumor growth in the lung. Expression of Foxm1 in respiratory epithelial cells is critical for lung cancer formation and TOPO-2 alpha expression in vivo, suggesting that Foxm1 is a promising target for anti-tumor therapy.	[Wang, I-Ching; Ren, Xiaomeng; Zhang, Yufang; Balli, David; Snyder, Jonathan; Whitsett, Jeffrey A.; Kalinichenko, Vladimir V.; Kalin, Tanya V.] Cincinnati Childrens Hosp, Res Fdn, Div Pulm Biol, Cincinnati, OH USA; [Wang, I-Ching; Ren, Xiaomeng; Zhang, Yufang; Balli, David; Snyder, Jonathan; Whitsett, Jeffrey A.; Kalinichenko, Vladimir V.; Kalin, Tanya V.] Cincinnati Childrens Hosp, Res Fdn, Perinatal Inst, Cincinnati, OH USA; [Meliton, Lucille] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Chicago	Wang, IC (corresponding author), Cincinnati Childrens Hosp, Res Fdn, Div Pulm Biol, Cincinnati, OH USA.	Vladimir.Kalinichenko@cchmc.org; kal4ti@cchmc.org	Ren, Xiaomeng/U-1751-2019	Wang, I-Ching/0000-0003-4398-2975	American Cancer Society, Ohio Division; Concern Foundation [84794]; US Public Health Service [HL 84151-01]; National Lung Cancer Partnership; American Cancer Society, National office [RSG-06-187-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151] Funding Source: NIH RePORTER	American Cancer Society, Ohio Division(American Cancer Society); Concern Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Lung Cancer Partnership; American Cancer Society, National office(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Research Grant from the American Cancer Society, Ohio Division (TVK), the Grant from Concern Foundation 84794 (TVK), US Public Health Service Grant HL 84151-01 (VVK), Career Development Award from National Lung Cancer Partnership (ICW) and Research Scholar Grant RSG-06-187-01 from the American Cancer Society, National office (VVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Blaine SA, 2005, CARCINOGENESIS, V26, P209, DOI 10.1093/carcin/bgh302; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Giaccone G, 1996, CHEST, V109, pS130, DOI 10.1378/chest.109.5_Supplement.130S; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; KIMURA K, 1994, J BIOL CHEM, V269, P1173; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Malkinson AM, 1998, EXP LUNG RES, V24, P541, DOI 10.3109/01902149809087385; Malkinson AM, 1997, CANCER RES, V57, P2832; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Mitsuuchi Y, 2002, AM J MED GENET, V115, P183, DOI 10.1002/ajmg.10692; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Takashima K, 2008, J OCCUP HEALTH, V50, P169, DOI 10.1539/joh.L7105; Toloza EM, 2006, J CELL BIOCHEM, V99, P1, DOI 10.1002/jcb.20851; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036	37	52	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6609	10.1371/journal.pone.0006609	http://dx.doi.org/10.1371/journal.pone.0006609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672312	Green Submitted, Green Published, gold			2022-12-25	WOS:000268935900020
J	Kim, JK; Klinger, M; Benjamin, J; Xiao, YY; Erle, DJ; Littman, DR; Killeen, N				Kim, Joong Kyu; Klinger, Mark; Benjamin, Jonathan; Xiao, Yuanyuan; Erle, David J.; Littman, Dan R.; Killeen, Nigel			Impact of the TCR Signal on Regulatory T Cell Homeostasis, Function, and Trafficking	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; THYMIC STROMAL LYMPHOPOIETIN; IN-VIVO; ALPHA-BETA; AUTOIMMUNE OOPHORITIS; TYROSINE KINASE; CD4 ENDOCYTOSIS; GENE-EXPRESSION; MICROARRAY DATA; EFFECTOR-CELLS	Signaling through the T cell antigen receptor (TCR) is important for the homeostasis of naive and memory CD4(+) T cells. The significance of TCR signaling in regulatory T (Treg) cells has not been systematically addressed. Using an Ox40-cre allele that is prominently expressed in Treg cells, and a conditional null allele of the gene encoding p56(Lck), we have examined the importance of TCR signaling in Treg cells. Inactivation of p56(Lck) resulted in abnormal Treg homeostasis characterized by impaired turnover, preferential redistribution to the lymph nodes, loss of suppressive function, and striking changes in gene expression. Abnormal Treg cell homeostasis and function did not reflect the involvement of p56(Lck) in CD4 function because these effects were not observed when CD4 expression was inactivated by Ox40-cre. The results make clear multiple aspects of Treg cell homeostasis and phenotype that are dependent on a sustained capacity to signal through the TCR.	[Kim, Joong Kyu; Klinger, Mark; Killeen, Nigel] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Benjamin, Jonathan; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY USA; [Benjamin, Jonathan; Littman, Dan R.] NYU, Sch Med, Dept Microbiol, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Benjamin, Jonathan; Littman, Dan R.] NYU, Sch Med, Dept Pathol, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY USA; [Xiao, Yuanyuan; Erle, David J.] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; New York University; New York University; New York University; University of California System; University of California San Francisco	Kim, JK (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	nigel.killeen@ucsf.edu		Erle, David/0000-0002-2171-0648; Benjamin, Jonathan/0000-0002-6078-616X	National Institutes of Health [AI39506]; Leukemia and Lymphoma Society; HHMI; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039506, R21AI039506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); HHMI(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (AI39506). NK was supported by a Scholar Award from the Leukemia and Lymphoma Society, DRL was supported by the HHMI, and MK was supported by a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 2005, IMMUNOLOGY, V115, P179, DOI 10.1111/j.1365-2567.2005.02146.x; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Latour RP, 2006, BLOOD, V108, P2300, DOI 10.1182/blood-2006-04-017947; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; Filby A, 2007, J IMMUNOL, V179, P4635, DOI 10.4049/jimmunol.179.7.4635; Firan M, 2006, BLOOD, V107, P619, DOI 10.1182/blood-2005-06-2277; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Grandjean I, 2003, J EXP MED, V198, P1089, DOI 10.1084/jem.20030963; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Hanninen A, 1997, P NATL ACAD SCI USA, V94, P6898, DOI 10.1073/pnas.94.13.6898; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KILLEEN N, 1993, PHILOS T ROY SOC B, V342, P25, DOI 10.1098/rstb.1993.0131; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonnstedt I, 2002, STAT SINICA, V12, P31; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; Martin B, 2006, BLOOD, V108, P270, DOI 10.1182/blood-2006-01-0017; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; PENHALE WJ, 1976, CLIN EXP IMMUNOL, V25, P6; Pippig SD, 1999, J IMMUNOL, V163, P6520; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; POWRIE F, 1990, J EXP MED, V172, P1701, DOI 10.1084/jem.172.6.1701; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; SAKAGUCHI S, 1982, J EXP MED, V156, P1565, DOI 10.1084/jem.156.6.1565; SAKAGUCHI S, 1982, J EXP MED, V156, P1577, DOI 10.1084/jem.156.6.1577; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Varona R, 2006, LEUKEMIA LYMPHOMA, V47, P1469, DOI 10.1080/10428190500513819; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Wang Q, 2001, J EXP MED, V194, P1721, DOI 10.1084/jem.194.12.1721; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282	82	37	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6580	10.1371/journal.pone.0006580	http://dx.doi.org/10.1371/journal.pone.0006580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668367	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935600009
J	de Sio, FRS; Trono, D				de Sio, Francesca R. Santoni; Trono, Didier			APOBEC3G-Depleted Resting CD4(+) T Cells Remain Refractory to HIV1	PLOS ONE			English	Article								Background: CD4+ T lymphocytes are the primary targets of HIV1 but cannot be infected when fully quiescent, due to a post-entry block preventing the completion of reverse transcription. Chiu et al. recently proposed that this restriction reflects the action of APOBEC3G (A3G). They further suggested that T cell activation abrogates the A3G-mediated block by directing this protein to a high molecular mass complex. Methodology/Principal Findings: In the present work, we sought to explore further this model. However, we found that effective suppression of A3G by combined RNA interference and expression of HIV1 Vif does not relieve the restrictive phenotype of post-activation resting T cells. We also failed to find a correlation between HIV resistance and the presence of A3G in a low molecular complex in primary T cells. Conclusions/Significance: We conclude that A3G is unlikely to play a role in the HIV restrictive phenotype of quiescent T lymphocytes.			de Sio, FRS (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Frontiers Genet Natl Ctr Competence Res, Lausanne, Switzerland.	didier.trono@epfl.ch	de Sio, Francesca Santoni/AAF-3432-2020	Santoni de Sio, Francesca Romana/0000-0002-6522-0499				Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Jost S, 2007, J VIROL, V81, P10588, DOI 10.1128/JVI.02489-06; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Korin YD, 1999, J VIROL, V73, P6526, DOI 10.1128/JVI.73.8.6526-6532.1999; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	22	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6571	10.1371/journal.pone.0006571	http://dx.doi.org/10.1371/journal.pone.0006571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668336	Green Published, gold, Green Submitted			2022-12-25	WOS:000268773300012
J	Gunnersen, JM; Kuek, A; Phipps, JA; Hammond, VE; Puthussery, T; Fletcher, EL; Tan, SS				Gunnersen, Jenny M.; Kuek, Annabel; Phipps, Joanna A.; Hammond, Vicki E.; Puthussery, Theresa; Fletcher, Erica L.; Tan, Seong-Seng			Seizure-Related Gene 6 (Sez-6) in Amacrine Cells of the Rodent Retina and the Consequence of Gene Deletion	PLOS ONE			English	Article							EXPRESSION; PATTERNS; DYSFUNCTION; CLONING; RATS	Background: Seizure-related gene 6 (Sez-6) is expressed in neurons of the mouse brain, retina and spinal cord. In the cortex, Sez-6 plays a role in specifying dendritic branching patterns and excitatory synapse numbers during development. Methodology/Principal Findings: The distribution pattern of Sez-6 in the retina was studied using a polyclonal antibody that detects the multiple isoforms of Sez-6. Prominent immunostaining was detected in GABAergic, but not in All glycinergic, amacrine cell subpopulations of the rat and mouse retina. Amacrine cell somata displayed a distinct staining pattern with the Sez-6 antibody: a discrete, often roughly triangular-shaped bright spot positioned between the nucleus and the apical dendrite superimposed over weaker general cytoplasmic staining. Displaced amacrines in the ganglion cell layer were also positive for Sez-6 and weaker staining was occasionally observed in neurons with the morphology of alpha ganglion cells. Two distinct Sez-6 positive strata were present in the inner plexiform layer in addition to generalized punctate staining. Certain inner nuclear layer cells, including bipolar cells, stained more weakly and diffusely than amacrine cells, although some bipolar cells exhibited a perinuclear "bright spot'' similar to amacrine cells. In order to assess the role of Sez-6 in the retina, we analyzed the morphology of the Sez-6 knockout mouse retina with immunohistochemical markers and compared ganglion cell dendritic arbor patterning in Sez-6 null retinae with controls. The functional importance of Sez-6 was assessed by dark-adapted paired-flash electroretinography (ERG). Conclusions: In summary, we have reported the detailed expression pattern of a novel retinal marker with broad cell specificity, useful for retinal characterization in rodent experimental models. Retinal morphology, ganglion cell dendritic branching and ERG waveforms appeared normal in the Sez-6 knockout mouse suggesting that, in spite of widespread expression of Sez-6, retinal function in the absence of Sez-6 is not affected.			Gunnersen, JM (corresponding author), Univ Melbourne, Howard Florey Inst, Parkville, Vic 3052, Australia.	jenny.gunnersen@florey.edu.au	Fletcher, Erica/E-6364-2012	Fletcher, Erica/0000-0001-9412-9523; Gunnersen, Jenny/0000-0002-6310-7724; Puthussery, Teresa/0000-0002-9188-6067				Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bui Bang Viet, 2002, Documenta Ophthalmologica, V104, P17, DOI 10.1023/A:1014401502915; Bui BV, 2001, EXP EYE RES, V73, P651, DOI 10.1006/exer.2001.1070; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018; Gunnersen JM, 2002, MOL CELL NEUROSCI, V19, P560, DOI 10.1006/mcne.2001.1098; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Havik B, 2007, NEUROSCIENCE, V148, P925, DOI 10.1016/j.neuroscience.2007.07.024; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; Kim MH, 2002, MECH DEVELOP, V118, P171, DOI 10.1016/S0925-4773(02)00238-1; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Lu C, 2001, NEUROSCIENCE, V107, P35, DOI 10.1016/S0306-4522(01)00337-2; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; Morgans C, 2000, NEUROREPORT, V11, P85, DOI 10.1097/00001756-200001170-00017; Mumm JS, 2005, PROG BRAIN RES, V147, P155, DOI 10.1016/S0079-6123(04)47012-5; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakazawa T, 2005, MOL BRAIN RES, V135, P58, DOI 10.1016/j.molbrainres.2004.12.006; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Phipps JA, 2007, INVEST OPHTH VIS SCI, V48, P927, DOI 10.1167/iovs.06-0892; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; SHIMIZUNISHIKAWA K, 1995, BIOCHEM BIOPH RES CO, V216, P382, DOI 10.1006/bbrc.1995.2635; SHIMIZUNISHIKAWA K, 1995, MOL BRAIN RES, V28, P201, DOI 10.1016/0169-328X(94)00203-Q; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tunggal J, 2003, J CELL SCI, V116, P803, DOI 10.1242/jcs.00293; WASSLE H, 1993, J COMP NEUROL, V332, P407; Wong WT, 2000, J NEUROSCI, V20, P5024	29	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6546	10.1371/journal.pone.0006546	http://dx.doi.org/10.1371/journal.pone.0006546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662096	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739600005
J	Wardrope, L; Okely, E; Leach, D				Wardrope, Laura; Okely, Ewa; Leach, David			Resolution of Joint Molecules by RuvABC and RecG Following Cleavage of the Escherichia coli Chromosome by EcoKI	PLOS ONE			English	Article								DNA double-strand breaks can be repaired by homologous recombination involving the formation and resolution of Holliday junctions. In Escherichia coli, the RuvABC resolvasome and the RecG branch-migration enzyme have been proposed to act in alternative pathways for the resolution of Holliday junctions. Here, we have studied the requirements for RuvABC and RecG in DNA double-strand break repair after cleavage of the E. coli chromosome by the EcoKI restriction enzyme. We show an asymmetry in the ability of RuvABC and RecG to deal with joint molecules in vivo. We detect linear DNA products compatible with the cleavage-ligation of Holliday junctions by the RuvABC pathway but not by the RecG pathway. Nevertheless we show that the XerCD-mediated pathway of chromosome dimer resolution is required for survival regardless of whether the RuvABC or the RecG pathway is active, suggesting that crossing-over is a common outcome irrespective of the pathway utilised. This poses a problem. How can cells resolve joint molecules, such as Holliday junctions, to generate crossover products without cleavage-ligation? We suggest that the mechanism of bacterial DNA replication provides an answer to this question and that RecG can facilitate replication through Holliday junctions.			Wardrope, L (corresponding author), Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland.	D.Leach@ed.ac.uk	Leach, David R/H-7159-2012	Leach, David R/0000-0003-4964-6913	MRC [G0401313] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0401313] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arber WEL, 1983, EXPT METHODS USE LAM; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Blakely GW, 2006, MOL MICROBIOL, V60, P883, DOI 10.1111/j.1365-2958.2006.05144.x; Cromie GA, 2000, MOL CELL, V6, P815, DOI 10.1016/S1097-2765(00)00079-4; Cromie GA, 2003, MOL MICROBIOL, V48, P1427, DOI 10.1046/j.1365-2958.2003.03561.x; Cromie GA, 2001, MOL MICROBIOL, V41, P873, DOI 10.1046/j.1365-2958.2001.02553.x; DAY RS, 1977, J VIROL, V21, P1249, DOI 10.1128/JVI.21.3.1249-1251.1977; EFIMOVA EP, 1988, MOL GEN GENET, V214, P317, DOI 10.1007/BF00337728; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Handa N, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-5; Ishioka K, 1998, GENES CELLS, V3, P209, DOI 10.1046/j.1365-2443.1998.00185.x; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Makovets S, 1998, MOL MICROBIOL, V28, P25, DOI 10.1046/j.1365-2958.1998.00767.x; Makovets S, 1999, P NATL ACAD SCI USA, V96, P9757, DOI 10.1073/pnas.96.17.9757; Meddows TR, 2004, MOL MICROBIOL, V52, P119, DOI 10.1111/j.1365-2958.2003.03970.x; Merlin C, 2002, J BACTERIOL, V184, P4573, DOI 10.1128/JB.184.16.4573-4581.2002; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; SAIN B, 1980, MOL GEN GENET, V180, P35, DOI 10.1007/BF00267350; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; THALER DS, 1987, GENETICS, V116, P501; THOMS B, 1982, MOL GEN GENET, V186, P111, DOI 10.1007/BF00422921; THOMS B, 1984, MOL GEN GENET, V197, P297, DOI 10.1007/BF00330977; Thoms B, 1998, J BACTERIOL, V180, P5639, DOI 10.1128/JB.180.21.5639-5645.1998; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; WILLETTS NS, 1969, J BACTERIOL, V100, P231, DOI 10.1128/JB.100.1.231-239.1969	29	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6542	10.1371/journal.pone.0006542	http://dx.doi.org/10.1371/journal.pone.0006542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657385	Green Published, Green Submitted, gold			2022-12-25	WOS:000268739300013
J	Jailwala, P; Waukau, J; Glisic, S; Jana, S; Ehlenbach, S; Hessner, M; Alemzadeh, R; Matsuyama, S; Laud, P; Wang, XJ; Ghosh, S				Jailwala, Parthav; Waukau, Jill; Glisic, Sanja; Jana, Srikanta; Ehlenbach, Sarah; Hessner, Martin; Alemzadeh, Ramin; Matsuyama, Shigemi; Laud, Purushottam; Wang, Xujing; Ghosh, Soumitra			Apoptosis of CD4(+)CD25(high) T Cells in Type 1 Diabetes May Be Partially Mediated by IL-2 Deprivation	PLOS ONE			English	Article							COMPLEX CLASS-I; INTERLEUKIN-2 PRODUCTION; SUPPRESSOR FUNCTION; REGULATORY CELLS; IAN FAMILY; EXPRESSION; TRANSCRIPTION; FOXP3; GENES; ACTIVATION	Background: Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease targeting the insulin-producing pancreatic beta cells. Naturally occurring FOXP3(+)CD4(+)CD25(high) regulatory T cells (T-regs) play an important role in dominant tolerance, suppressing autoreactive CD4(+) effector T cell activity. Previously, in both recent-onset T1D patients and beta cell antibody-positive at-risk individuals, we observed increased apoptosis and decreased function of polyclonal T-regs in the periphery. Our objective here was to elucidate the genes and signaling pathways triggering apoptosis in T-regs from T1D subjects. Principal Findings: Gene expression profiles of unstimulated T-regs from recent-onset T1D (n=12) and healthy control subjects (n=15) were generated. Statistical analysis was performed using a Bayesian approach that is highly efficient in determining differentially expressed genes with low number of replicate samples in each of the two phenotypic groups. Microarray analysis showed that several cytokine/chemokine receptor genes, HLA genes, GIMAP family genes and cell adhesion genes were downregulated in T-regs from T1D subjects, relative to control subjects. Several downstream target genes of the AKT and p53 pathways were also upregulated in T1D subjects, relative to controls. Further, expression signatures and increased apoptosis in T-regs from T1D subjects partially mirrored the response of healthy T-regs under conditions of IL-2 deprivation. CD4(+) effector T-cells from T1D subjects showed a marked reduction in IL-2 secretion. This could indicate that prior to and during the onset of disease, T-regs in T1D may be caught up in a relatively deficient cytokine milieu. Conclusions: In summary, expression signatures in T-regs from T1D subjects reflect a cellular response that leads to increased sensitivity to apoptosis, partially due to cytokine deprivation. Further characterization of these signaling cascades should enable the detection of genes that can be targeted for restoring T-reg function in subjects predisposed to T1D.			Jailwala, P (corresponding author), Med Coll Wisconsin, Dept Pediat, Max McGee Natl Res Ctr Juvenile Diabet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	sghosh@mcw.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00058, M01 RR000058] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abdul-Rasoul M, 2006, PEDIATR DIABETES, V7, P101, DOI 10.1111/j.1399-543X.2006.00155.x; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Anal O, 1997, J PEDIATR ENDOCR MET, V10, P391; Anderson PO, 2006, EUR J IMMUNOL, V36, P1374, DOI 10.1002/eji.200635883; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Baecher-Allan C, 2004, SEMIN IMMUNOL, V16, P89, DOI 10.1016/j.smim.2003.12.005; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bonfanti R, 1998, ACTA DIABETOL, V35, P91, DOI 10.1007/s005920050110; Bosque A, 2007, MOL IMMUNOL, V44, P1446, DOI 10.1016/j.molimm.2006.04.029; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Dalberg U, 2007, INT IMMUNOL, V19, P447, DOI 10.1093/intimm/dxm009; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Devireddy LR, 2003, MOL CELL BIOL, V23, P4532, DOI 10.1128/MCB.23.13.4532-4541.2003; Dion C, 2005, INT IMMUNOL, V17, P1257, DOI 10.1093/intimm/dxh302; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; EFRON B, 2003, J AM STAT ASSOC, V96, P99; FAUSTMAN D, 1991, SCIENCE, V254, P1756, DOI 10.1126/science.1763324; Fleischer A, 2007, IMMUNOL LETT, V112, P9, DOI 10.1016/j.imlet.2007.06.004; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIORDANO C, 1989, DIABETES, V38, P310, DOI 10.2337/diabetes.38.3.310; Glisic-Milosavljevic S, 2007, CLIN EXP IMMUNOL, V150, P75, DOI 10.1111/j.1365-2249.2007.03475.x; Glisic-Milosavljevic S, 2005, CELL PROLIFERAT, V38, P301, DOI 10.1111/j.1365-2184.2005.00351.x; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Hao W, 1996, J CLIN INVEST, V98, P1613, DOI 10.1172/JCI118955; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hein AMK, 2005, BIOSTATISTICS, V6, P349, DOI 10.1093/biostatistics/kxi016; Hein AMK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-353; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; KAIZER EC, 2007, J CLIN ENDOCRINOL ME; KAYE WA, 1986, NEW ENGL J MED, V315, P920, DOI 10.1056/NEJM198610093151502; Knoechel B, 2006, J IMMUNOL, V176, P6473, DOI 10.4049/jimmunol.176.11.6473; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Kupfer R, 2007, MOL IMMUNOL, V44, P479, DOI 10.1016/j.molimm.2006.02.014; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakamoto Y, 2002, J LEUKOCYTE BIOL, V72, P49; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Orban T, 2007, J AUTOIMMUN, V28, P177, DOI 10.1016/j.jaut.2007.01.002; PALACIOS R, 1982, IMMUNOL REV, V63, P73, DOI 10.1111/j.1600-065X.1982.tb00412.x; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Pfoertner S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r54; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Rabinovitch A, 2007, CELL BIOCHEM BIOPHYS, V48, P159, DOI 10.1007/s12013-007-0029-2; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; TURRO E, 2007, BMC BIOINFO IN PRESS; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Ward SG, 1998, BIOCHEM J, V333, P457, DOI 10.1042/bj3330457; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103	81	64	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6527	10.1371/journal.pone.0006527	http://dx.doi.org/10.1371/journal.pone.0006527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654878	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739100019
J	Yang, HZ; Cui, B; Liu, HZ; Mi, S; Yan, J; Yan, HM; Hua, F; Lin, H; Cai, WF; Xie, WJ; Lv, XX; Wang, XX; Xin, BM; Zhan, QM; Hu, ZW				Yang, Hong-Zhen; Cui, Bing; Liu, Han-Zhi; Mi, Su; Yan, Jun; Yan, Hui-Min; Hua, Fang; Lin, Heng; Cai, Wen-Feng; Xie, Wen-Jie; Lv, Xiao-Xi; Wang, Xiao-Xing; Xin, Bing-Mu; Zhan, Qi-Min; Hu, Zhuo-Wei			Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor	PLOS ONE			English	Article								Background: Metastasis is the most pivotal cause of mortality in cancer patients. Immune tolerance plays a crucial role in tumor progression and metastasis. Methods and Findings: In this study, we investigated the potential roles and mechanisms of TLR2 signaling on tumor metastasis in a mouse model of intravenously injected B16 melanoma cells. Multiple subtypes of TLRs were expressed on B16 cells and several human cancer cell lines; TLR2 mediated the invasive activity of these cells. High metastatic B16 cells released more heat shock protein 60 than poor metastatic B16-F1 cells. Importantly, heat shock protein 60 released by tumor cells caused a persistent activation of TLR2 and was critical in the constitutive activation of transcription factor Stat3, leading to the release of immunosuppressive cytokines and chemokines. Moreover, targeting TLR2 markedly reduced pulmonary metastases and increased the survival of B16-bearing mice by reversing B16 cells induced immunosuppressive microenvironment and restoring tumor-killing cells such as CD8(+) T cells and M1 macrophages. Combining an anti-TLR2 antibody and a cytotoxic agent, gemcitabine, provided a further improvement in the survival of tumor-bearing mice. Conclusions and Significance: Our results demonstrate that TLR2 is an attractive target against metastasis and that targeting immunosuppressive microenvironment using anti-TLR2 antibody is a novel therapeutic strategy for combating a life-threatening metastasis.			Yang, HZ (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Mol Immunol & Pharmacol Lab, Beijing 100050, Peoples R China.	huzhuowei@imm.ac.cn	Cui, Bing/F-3599-2018	Cui, Bing/0000-0001-8374-7801				Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Curtin JF, 2009, PLOS MED, V6, P83, DOI 10.1371/journal.pmed.1000010; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006; Entin I, 2003, CLIN CANCER RES, V9, P3190; Fernandez S, 2004, J IMMUNOL, V172, P2613, DOI 10.4049/jimmunol.172.4.2613; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Garaci E, 2007, ANN NY ACAD SCI, V1112, P225, DOI 10.1196/annals.1415.044; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Huang SC, 2005, BIOCHEM PHARMACOL, V69, P221, DOI 10.1016/j.bcp.2004.09.019; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Knorr C, 2008, BRAIN RES, V1205, P36, DOI 10.1016/j.brainres.2008.02.021; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Kortylewski M, 2007, J IMMUNOTHER, V30, P131, DOI 10.1097/01.cji.0000211327.76266.65; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lian XM, 2005, J IMMUNOL, V174, P7250, DOI 10.4049/jimmunol.174.11.7250; Long EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005601; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; McDuffie Eric, 2006, J Inflamm (Lond), V3, P15, DOI 10.1186/1476-9255-3-15; Medzhitov R, 2007, SEMIN IMMUNOL, V19, P1, DOI 10.1016/j.smim.2007.02.001; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; MULLER AJ, 2006, NAT REV CANCER, V6, P742, DOI DOI 10.1038/NRC1979; Nakamura T, 2007, CANCER SCI, V98, P874, DOI 10.1111/j.1349-7006.2007.00470.x; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Paz K, 2004, ONCOGENE, V23, P8455, DOI 10.1038/sj.onc.1207803; Sharma RK, 2005, MOL IMMUNOL, V42, P695, DOI 10.1016/j.molimm.2004.09.018; Sinha P, 2005, CANCER RES, V65, P11743, DOI 10.1158/0008-5472.CAN-05-0045; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Yang HZ, 2009, J IMMUNOL, V182, P692, DOI 10.4049/jimmunol.182.1.692; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zanin-Zhorov A, 2005, J IMMUNOL, V175, P276, DOI 10.4049/jimmunol.175.1.276; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423	42	82	88	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6520	10.1371/journal.pone.0006520	http://dx.doi.org/10.1371/journal.pone.0006520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654875	Green Submitted, Green Published, gold			2022-12-25	WOS:000268739100014
J	Gorlov, IP; Gallick, GE; Gorlova, OY; Amos, C; Logothetis, CJ				Gorlov, Ivan P.; Gallick, Gary E.; Gorlova, Olga Y.; Amos, Christopher; Logothetis, Christopher J.			GWAS Meets Microarray: Are the Results of Genome-Wide Association Studies and Gene-Expression Profiling Consistent? Prostate Cancer as an Example	PLOS ONE			English	Article								Background: Genome-wide association studies (GWASs) and global profiling of gene expression (microarrays) are two major technological breakthroughs that allow hypothesis-free identification of candidate genes associated with tumorigenesis. It is not obvious whether there is a consistency between the candidate genes identified by GWAS (GWAS genes) and those identified by profiling gene expression (microarray genes). Methodology/Principal Findings: We used the Cancer Genetic Markers Susceptibility database to retrieve single nucleotide polymorphisms from candidate genes for prostate cancer. In addition, we conducted a large meta-analysis of gene expression data in normal prostate and prostate tumor tissue. We identified 13,905 genes that were interrogated by both GWASs and microarrays. On the basis of P values from GWASs, we selected 1,649 most significantly associated genes for functional annotation by the Database for Annotation, Visualization and Integrated Discovery. We also conducted functional annotation analysis using same number of the top genes identified in the meta-analysis of the gene expression data. We found that genes involved in cell adhesion were overrepresented among both the GWAS and microarray genes. Conclusions/Significance: We conclude that the results of these analyses suggest that combining GWAS and microarray data would be a more effective approach than analyzing individual datasets and can help to refine the identification of candidate genes and functions associated with tumor development.			Gorlov, IP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	ipgorlov@mdanderson.org			NATIONAL CANCER INSTITUTE [T32CA096520, R01CA121197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055258] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA096520, R01 CA121197, R01 CA121197-01A2] Funding Source: Medline; NIAMS NIH HHS [AR055258, R01 AR055258] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bao Ting, 2008, Adv Surg, V42, P249, DOI 10.1016/j.yasu.2008.03.002; Bazas' V. M., 2008, Experimental Oncology, V30, P235; Brown MC, 1998, MOL BIOL CELL, V9, P1803, DOI 10.1091/mbc.9.7.1803; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; GORLOV IP, 2009, BMC CANC IN PRESS; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hansen MDH, 2006, J BIOL CHEM, V281, P16178, DOI 10.1074/jbc.M512771200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; Lacroix L, 2008, EXPERT REV MOL DIAGN, V8, P167, DOI 10.1586/14737159.8.2.167; Mason MD, 2002, CRIT REV ONCOL HEMAT, V41, P11, DOI 10.1016/S1040-8428(01)00171-8; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moschos Stergios J, 2007, Oncology (Williston Park), V21, P13; Nam RK, 2008, PROSTATE CANCER P D, V11, P241, DOI 10.1038/sj.pcan.4501010; Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492; Piao M, 2006, ENDOTHELIUM-J ENDOTH, V13, P249, DOI 10.1080/10623320600903940; Ramjaun AR, 2009, INT J BIOCHEM CELL B, V41, P521, DOI 10.1016/j.biocel.2008.05.030; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Takkunen M, 2008, HISTOCHEM CELL BIOL, V130, P509, DOI 10.1007/s00418-008-0443-6; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91	28	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6511	10.1371/journal.pone.0006511	http://dx.doi.org/10.1371/journal.pone.0006511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652704	Green Submitted, gold, Green Published			2022-12-25	WOS:000268637800017
J	Jaramillo, J; Chabi-Olaye, A; Kamonjo, C; Jaramillo, A; Vega, FE; Poehling, HM; Borgemeister, C				Jaramillo, Juliana; Chabi-Olaye, Adenirin; Kamonjo, Charles; Jaramillo, Alvaro; Vega, Fernando E.; Poehling, Hans-Michael; Borgemeister, Christian			Thermal Tolerance of the Coffee Berry Borer Hypothenemus hampei: Predictions of Climate Change Impact on a Tropical Insect Pest	PLOS ONE			English	Article							LIFE-HISTORY; AGROFORESTRY MANAGEMENT; GEOGRAPHICAL RANGE; BUGS HETEROPTERA; TEMPERATURE; COLEOPTERA; CURCULIONIDAE; POPULATION; BIODIVERSITY; ACCLIMATION	Coffee is predicted to be severely affected by climate change. We determined the thermal tolerance of the coffee berry borer, Hypothenemus hampei, the most devastating pest of coffee worldwide, and make inferences on the possible effects of climate change using climatic data from Colombia, Kenya, Tanzania, and Ethiopia. For this, the effect of eight temperature regimes (15, 20, 23, 25, 27, 30, 33 and 35 degrees C) on the bionomics of H. hampei was studied. Successful egg to adult development occurred between 20-30 degrees C. Using linear regression and a modified Logan model, the lower and upper thresholds for development were estimated at 14.9 and 32 degrees C, respectively. In Kenya and Colombia, the number of pest generations per year was considerably and positively correlated with the warming tolerance. Analysing 32 years of climatic data from Jimma (Ethiopia) revealed that before 1984 it was too cold for H. hampei to complete even one generation per year, but thereafter, because of rising temperatures in the area, 1-2 generations per year/coffee season could be completed. Calculated data on warming tolerance and thermal safety margins of H. hampei for the three East African locations showed considerably high variability compared to the Colombian site. The model indicates that for every 1 degrees C rise in thermal optimum (T-opt), the maximum intrinsic rate of increase (r(max)) will increase by an average of 8.5%. The effects of climate change on the further range of H. hampei distribution and possible adaption strategies are discussed. Abstracts in Spanish and French are provided as supplementary material Abstract S1 and Abstract S2.			Jaramillo, J (corresponding author), Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, Hannover, Germany.	jjaramillo@icipe.org	Vega, Fernando E./AAM-5536-2021	Vega, Fernando E./0000-0001-8103-5640				ADDOBEDIAKO A, 2000, P ROY SOC LOND B BIO, V267, P735; ALEGRE G., 1959, Agron. trop., V14, P23; ARCILA J, 1993, 193 CENICAFE; Assad ED, 2004, PESQUI AGROPECU BRAS, V39, P1057, DOI 10.1590/S0100-204X2004001100001; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Baker P. S., 1984, FOLIA ENTOMOL MEX, V61, P9; BAKER PS, 1992, J APPL ECOL, V29, P656, DOI 10.2307/2404473; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BARRADAS VL, 1986, AGR FOREST METEOROL, V38, P101, DOI 10.1016/0168-1923(86)90052-3; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; Benavides P, 2005, ANN ENTOMOL SOC AM, V98, P359, DOI 10.1603/0013-8746(2005)098[0359:BABOAI]2.0.CO;2; Bergamin J., 1943, ARQ INST BIOL [SAO PAULO], V14, P31; Borbon-Martinez MO, 1989, THESIS U P SABATIER; BUSTILLO AE, 1998, INTEGRATED PEST MANA; Calosi P, 2008, J BIOGEOGR, V35, P295, DOI 10.1111/j.1365-2699.2007.01787.x; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; COSTE R, 1993, COFFEE PLANT PRODUCT; Crnokrak P, 2000, J EVOLUTION BIOL, V13, P396, DOI 10.1046/j.1420-9101.2000.00188.x; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; DAVIDSON A, 1967, Cafe (Lima), V8, P1; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; DEALVIM PT, 1960, SCIENCE, V132, P3423; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dingemanse NJ, 2008, ECOL ENTOMOL, V33, P394, DOI 10.1111/j.1365-2311.2007.00982.x; do Amaral JAT, 2006, PESQUI AGROPECU BRAS, V41, P377, DOI 10.1590/S0100-204X2006000300002; Fernández Silvestre, 2007, Bioagro, V19, P35; Forkner RE, 2008, ECOL ENTOMOL, V33, P276, DOI 10.1111/j.1365-2311.2007.00976.x; Gaston KJ, 1999, OIKOS, V86, P584, DOI 10.2307/3546663; Gay C, 2006, CLIMATIC CHANGE, V79, P259, DOI 10.1007/s10584-006-9066-x; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Gordon C, 2007, AGR ECOSYST ENVIRON, V118, P256, DOI 10.1016/j.agee.2006.05.023; *GRID, 2002, VIT CLIM GRAPH AFR G; Hodkinson ID, 1999, J ANIM ECOL, V68, P1259, DOI 10.1046/j.1365-2656.1999.00372.x; Hodkinson ID, 1999, FUNCT ECOL, V13, P83, DOI 10.1046/j.1365-2435.1999.00011.x; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; HULTING FL, 1990, FLA ENTOMOL, V73, P601, DOI 10.2307/3495274; *INT COFF ORG, 2008, LETT EX DIR COFF MAR; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIMATE CHANGE 2007, P9; Jaramillo A., 2005, ANDEAN CLIMATE COFFE; Jaramillo J, 2006, B ENTOMOL RES, V96, P223, DOI 10.1079/BER2006434; Jaramillo J, 2009, ENTOMOL EXP APPL, V130, P275, DOI 10.1111/j.1570-7458.2008.00820.x; Jaramillo R. A., 2005, REV ACAD COLOMB CIEN, V29, P371; Karban R, 2004, ECOL ENTOMOL, V29, P251, DOI 10.1111/j.1365-2311.2004.00576.x; Kiritani K, 2007, GLOBAL CHANGE BIOL, V13, P1586, DOI 10.1111/j.1365-2486.2007.01397.x; Kiritani K, 2006, POPUL ECOL, V48, P5, DOI 10.1007/s10144-005-0225-0; KIRKPATRICK TW, 1935, CLIMATE ECOCLIMATES; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; LEPELLEY RH, 1968, PESTS COFFEE; Lin BB, 2007, AGR FOREST METEOROL, V144, P85, DOI 10.1016/j.agrformet.2006.12.009; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Mendesil E., 2003, ETHIOPIAN J BIOL SCI, V2, P61; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; Muschler RG, 2001, AGROFOREST SYST, V51, P131, DOI 10.1023/A:1010603320653; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; Neuvonen Seppo, 1999, Ecological Bulletins, V47, P63; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Perez J, 2005, ANN ENTOMOL SOC AM, V98, P483, DOI 10.1603/0013-8746(2005)098[0483:DTCBBC]2.0.CO;2; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Pinto HS, 2001, REV BRASILEIRA AGROM, V9, P495; ROMERO JV, 2004, REV CENICAF, V55, P221; RUIZ CR, 1996, THESIS U CALDAS COLO; SALAZAR MR, 1993, COLOMBIA REV CENICAF, V45, P41; SAS Institute, 1999, SAS STAT US GUID; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Teodoro A, 2008, AGR ECOSYST ENVIRON, V125, P120, DOI 10.1016/j.agee.2007.12.004; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; Terblanche JS, 2005, J INSECT PHYSIOL, V51, P1013, DOI 10.1016/j.jinsphys.2005.04.016; TICHELER J. H. G., 1961, MEDEDEL LANDBOUWHOGESCH TE WAGENINGEN, V61, P1; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Vaast P, 2006, J SCI FOOD AGR, V86, P197, DOI 10.1002/jsfa.2338; van der Putten WH, 2004, BASIC APPL ECOL, V5, P487, DOI 10.1016/j.baae.2004.09.003; Vega F.E., 2004, ENCY ENTOMOLOGY, V1, P575; Vega FE, 2003, NATURE, V425, P343, DOI 10.1038/425343a; Vega FE, 2003, ENTOMOL EXP APPL, V107, P19, DOI 10.1046/j.1570-7458.2003.00034.x; Vega FE, 2008, AM SCI, V96, P138, DOI 10.1511/2008.70.138; Vega FE, 2008, PL BRED RE, V30, P415; Romero JV, 2007, REV COLOMB ENTOMOL, V33, P10; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Wellman, 1961, COFFEE BOT CULTIVATI; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9	85	107	112	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6487	10.1371/journal.pone.0006487	http://dx.doi.org/10.1371/journal.pone.0006487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649255	Green Published, gold			2022-12-25	WOS:000268637700012
J	Kang, HW; Walvick, R; Bogdanov, A				Kang, Hye-Won; Walvick, Ronn; Bogdanov, Alexei, Jr.			In vitro and In vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cells	FASEB JOURNAL			English	Article						HUVEC; BMP; MRI; PGC	BONE MORPHOGENETIC PROTEIN; SIGNAL-TRANSDUCTION; ADOPTIVE TRANSFER; STEM-CELLS; BMP; DIFFERENTIATION; ANGIOGENESIS; ADHESION; MICE	Noggin protein is a potent bone morphogenetic protein (BMP) antagonist capable of inhibiting vasculogenesis even in the presence of provasculogenic VEGF and FGF-2. We found that human umbilical vein endothelial cells (HUVECs) do not express Noggin in culture and used these cells for modeling of antivasculogenesis. We hypothesized that high-efficiency transduction of HUVECs with bicistronic lentiviral vector encoding Noggin and enhanced green fluorescent protein (EGFP) enables direct visualization of Noggin effects in homogenous primary cell populations in vitro and in vivo. By comparing HUVECs transduced with a control GFP and GFP/Noggin expression cassettes, we showed that constitutive and orthotopic Noggin protein expression did not influence cell proliferation, down-regulated BMP-2 expression, and showed no effect on BMP receptor transcripts. We demonstrated that in contrast to GFP-only control, Noggin expression in endothelial cells abrogated endothelial migration in response to monolayer injury, blocked endothelial transmigration, and caused abrogation of cord formation in vitro. Adding exogenous BMP-4 restored the formation of cords. Imaging experiments in vivo investigated vessel formation in Matrigel implants in athymic mice by utilizing GFP imaging or magnetic resonance imaging of perfusion in the implants. Both approaches demonstrated the lack of functional vessel formation after the adoptive transfer of GFP/Noggin-expressing human endothelial cells in mice.-Kang, H.-W., Walvick, R., Bogdanov, A. In vitro and in vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cells. FASEB J. 23, 4126-4134 (2009). www.fasebj.org	[Kang, Hye-Won; Bogdanov, Alexei, Jr.] Univ Massachusetts, Sch Med, Dept Radiol, Worcester, MA 01655 USA; [Walvick, Ronn] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA	University of Massachusetts System; University of Massachusetts Worcester; Worcester Polytechnic Institute	Bogdanov, A (corresponding author), Univ Massachusetts, Sch Med, Dept Radiol, 55 Lake Ave N, Worcester, MA 01655 USA.	alexei.bogdanov@umassmed.edu	Bogdanov, Alexei A/K-4946-2017	Bogdanov, Alexei A/0000-0003-4806-5869	U. S. National Institutes of Health [RO1-EB000858]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034901] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by U. S. National Institutes of Health grant RO1-EB000858 (A. B.). The authors are grateful to Dr. Miguel Sena-Esteves (Department of Neurology, Massachusetts General Hospital, Boston, MA, USA) for providing hightiter lentiviral vectors, Dr. Marian Nakada (Centocor, Malvern, PA, USA) for supplying anti-human CD31 monoclonal antibody, and Bill Luscinskas (Brigham and Women's Hospital, Boston, MA, USA) for providing HUVECs.	Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bogdanov AA, 2007, PHARM RES-DORDR, V24, P1186, DOI 10.1007/s11095-006-9219-7; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Boyd NL, 2007, EXP BIOL MED, V232, P833; Bressan M, 2009, DEV BIOL, V326, P101, DOI 10.1016/j.ydbio.2008.10.045; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; Chang K, 2007, CIRCULATION, V116, P1258, DOI 10.1161/CIRCULATIONAHA.106.683227; Chiba S, 2008, STEM CELLS, V26, P2810, DOI 10.1634/stemcells.2008-0085; Dai JL, 2004, CANCER RES, V64, P994, DOI 10.1158/0008-5472.CAN-03-1382; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hotfilder M, 1997, KLIN PADIATR, V209, P265, DOI 10.1055/s-2008-1043960; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kang HW, 2002, BIOCONJUGATE CHEM, V13, P122, DOI 10.1021/bc0155521; Kang HW, 2006, LAB INVEST, V86, P599, DOI 10.1038/labinvest.3700421; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kelly MA, 2009, ARTERIOSCL THROM VAS, V29, P718, DOI 10.1161/ATVBAHA.109.184200; Kim YR, 2005, CANCER RES, V65, P9253, DOI 10.1158/0008-5472.CAN-03-2619; Kiyono M, 2003, MOL CELL BIOL, V23, P4627, DOI 10.1128/MCB.23.13.4627-4636.2003; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lewin M, 1999, INT J CANCER, V83, P798, DOI 10.1002/(SICI)1097-0215(19991210)83:6<798::AID-IJC16>3.0.CO;2-W; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Nakada MT, 2000, J IMMUNOL, V164, P452, DOI 10.4049/jimmunol.164.1.452; Nimmagadda S, 2005, DEV BIOL, V280, P100, DOI 10.1016/j.ydbio.2005.01.005; Reese DE, 2004, DEV CELL, V6, P699, DOI 10.1016/S1534-5807(04)00127-3; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Skovseth DK, 2002, AM J PATHOL, V160, P1629, DOI 10.1016/S0002-9440(10)61110-8; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347	31	9	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4126	4134		10.1096/fj.08-127795	http://dx.doi.org/10.1096/fj.08-127795			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19692649	Green Published			2022-12-25	WOS:000272193700009
J	Zhao, YH; Zhou, M; Liu, H; Ding, Y; Khong, HT; Yu, D; Fodstad, O; Tan, M				Zhao, Y. H.; Zhou, M.; Liu, H.; Ding, Y.; Khong, H. T.; Yu, D.; Fodstad, O.; Tan, M.			Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth	ONCOGENE			English	Article						ErbB2; HSF1; LDH-A; glycolysis; Warburg effect; breast cancer	DNA-BINDING; FACTOR-I; ACTIVATION; METABOLISM; EXPRESSION; TRANSCRIPTION; WARBURG; HYPOXIA; OVEREXPRESSION; DEREGULATION	ErbB2 has been shown to activate signaling molecules that may regulate glucose metabolism. However, there is no evidence reported to directly link ErbB2 to glycolysis, and the mechanism underlying ErbB2-enhanced glycolysis is poorly understood. In this study, we investigated the role and mechanism of ErbB2 in regulating glycolysis. We found that ErbB2-overexpressing cells possessed a significantly higher level of glycolysis when compared to the ErbB2-low-expressing cells, and the downregulation of ErbB2 markedly decreased glycolysis. Overexpression of ErbB2 increased the expression of glycolysis-regulating molecules lactate dehydrogenase A (LDH-A) and heat shock factor 1 (HSF1). ErbB2 activated HSF1, indicated by the increased HSF1 trimer formation, and promoted HSF1 protein synthesis. HSF1 bound to LDH-A promoter and the downregulation of HSF1 reduced the expression of LDH-A and subsequently decreased cancer cell glycolysis and growth. Moreover, the glycolysis inhibitors, 2-deoxyglucose and oxamate, selectively inhibited the growth of ErbB2-overexpressing cells. Taken together, this study shows that in human breast cancer cells, ErbB2 promotes glycolysis at least partially through the HSF1-mediated upregulation of LDH-A. This pathway may have a major role in regulating glucose metabolism in breast cancer cells. These novel findings have important implications for the design of new approaches to target ErbB2-overexpressing breast cancers. Oncogene (2009) 28, 3689-3701; doi: 10.1038/onc.2009.229; published online 10 August 2009	[Tan, M.] Univ S Alabama, Mitchell Canc Inst, Ctr Basic & Translat Canc Res, Mobile, AL 36604 USA; [Zhao, Y. H.] Sichuan Univ, W China Med Ctr, Dept Biochem & Mol Biol, Chengdu 610064, Peoples R China; [Yu, D.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Fodstad, O.] Univ Oslo, Norwegian Radium Hosp, Inst Canc Res, Oslo, Norway; [Tan, M.] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36604 USA	University of South Alabama; Sichuan University; University of Texas System; UTMD Anderson Cancer Center; University of Oslo; University of South Alabama	Tan, M (corresponding author), Univ S Alabama, Mitchell Canc Inst, Ctr Basic & Translat Canc Res, 1660 Spring Hill Ave, Mobile, AL 36604 USA.	mtan@usouthal.edu	Zhao, Yuhua/H-3210-2013; Tan, Ming/ABD-5847-2021	Zhao, Yuhua/0000-0002-4060-631X; Tan, Ming/0000-0003-2007-9898; Yu, Dihua/0000-0001-6231-9381	Jr. Cancer Research Foundation (M Tan) [334003]	Jr. Cancer Research Foundation (M Tan)	We thank Dr Ivor Benjamin for the HSF1 MEFs; Dr Jianrong Lu, Dr Adam Riker and Dr Laurie Owen for reading the article; Ms Amy Brown for editorial assistance; Dr June Ayling, Dr Robert Laush and Ms Judy Miller for assistance with equipments. We are grateful for the support from The Vincent F Kilborn, Jr. Cancer Research Foundation (M Tan) and from the Radiumhospitalets Legater Award Project 334003 (M Tan and O Fodstad).	BALINSKY D, 1983, CANCER RES, V43, P5895; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Liu HY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-111; Lu J, 2009, CLIN CANCER RES, V15, P1326, DOI 10.1158/1078-0432.CCR-08-0954; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Tan M, 2006, CANCER RES, V66, P3764, DOI 10.1158/0008-5472.CAN-05-2747; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Tan M, 1997, CANCER RES, V57, P1199; Wadekar SA, 2004, MOL ENDOCRINOL, V18, P500, DOI 10.1210/me.2003-0215; WARBURG O, 1956, SCIENCE, V124, P269; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	39	182	195	5	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2009	28	42					3689	3701		10.1038/onc.2009.229	http://dx.doi.org/10.1038/onc.2009.229			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	509MY	19668225				2022-12-25	WOS:000271023200002
J	Jama, AM; Fenton, J; Robertson, SD; Torok, K				Jama, Abdirahman M.; Fenton, Jon; Robertson, Saralili D.; Torok, Katalin			Time-dependent Autoinactivation of Phospho-Thr(286)-alpha Ca2+/Calmodulin-dependent Protein Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; ALPHA-CAMKII; CALMODULIN; AUTOPHOSPHORYLATION; ACTIVATION; CALCIUM; INACTIVATION; MEMORY; CA2+/CALMODULIN	Ca2+/calmodulin-dependent protein kinase II (alpha CaMKII) is thought to exert its role in memory formation by autonomous Ca2+-independent persistent activity conferred by Thr(286) autophosphorylation, allowing the enzyme to remain active even when intracellular [Ca2+] has returned to resting levels. Ca2+ sequestration-induced inhibition, caused by a burst of Thr(305/306) autophosphorylation via calmodulin (CaM) dissociation from the Thr(305/306) sites, is in conflict with this view. The processes of CaM binding, autophosphorylation, and inactivation are dissected to resolve this conflict. Upon Ca2+ withdrawal, CaM sequential domain dissociation is observed, starting with the rapid release of the first (presumed N-terminal) CaM lobe, thought to be bound at the Thr(305/306) sites. The time courses of Thr(305/306) autophosphorylation and inactivation, however, correlate with the slow dissociation of the second (presumed C-terminal) CaM lobe. Exposure of the Thr(305/306) sites is thus not sufficient for their autophosphorylation. Moreover, Thr(305/306) autophosphorylation and autoinactivation are shown to occur in the continuous presence of Ca2+ and bound Ca2+/CaM by time courses similar to those seen following Ca2+ sequestration. Our investigation of the activity and mechanisms of phospho-Thr(286)-alpha CaMKII thus shows time-dependent autoinactivation, irrespective of the continued presence of Ca2+ and CaM, allowing a very short, if any, time window for Ca2+/CaM-free phospho-Thr(286)-alpha CaMKII activity. Physiologically, the time-dependent autoinactivation mechanisms of phospho-Thr(286)-alpha CaMKII (t(1/2) of similar to 50 s at 37 degrees C) suggest a transient kinase activity of similar to 1 min duration in the induction of long term potentiation and thus memory formation.	[Jama, Abdirahman M.; Fenton, Jon; Robertson, Saralili D.; Torok, Katalin] Univ London, Div Basic Med Sci, London SW17 0RE, England	University of London	Torok, K (corresponding author), Univ London, Div Basic Med Sci, London SW17 0RE, England.	k.torok@sgul.ac.uk		Torok, Katalin/0000-0002-3107-4534	Wellcome Trust Project [075931]	Wellcome Trust Project(Wellcome Trust)	This work was supported by Wellcome Trust Project Grant 075931 (to K.T.).	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Fukunaga K, 1999, JPN J PHARMACOL, V79, P7, DOI 10.1254/jjp.79.7; Grant PAA, 2008, CELL CALCIUM, V44, P465, DOI 10.1016/j.ceca.2008.03.003; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Ishida A, 1996, BBA-MOL CELL RES, V1311, P211, DOI 10.1016/0167-4889(95)00197-2; ISHIDA A, 1995, J BIOL CHEM, V270, P2163, DOI 10.1074/jbc.270.5.2163; Johnson LN, 2001, E SCHERING RES FDN W, V34, P47; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lengyel I, 2004, EUR J NEUROSCI, V20, P3063, DOI 10.1111/j.1460-9568.2004.03748.x; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; MUKHERJI S, 1995, J BIOL CHEM, V270, P14062, DOI 10.1074/jbc.270.23.14062; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Roberts LA, 1998, MOL BRAIN RES, V56, P38, DOI 10.1016/S0169-328X(98)00026-6; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; SCHULMAN H, 1989, TRENDS BIOCHEM SCI, V14, P62, DOI 10.1016/0968-0004(89)90045-5; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; SMITH GL, 1985, BIOCHIM BIOPHYS ACTA, V839, P287, DOI 10.1016/0304-4165(85)90011-X; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Torok K, 1998, CURR BIOL, V8, P692, DOI 10.1016/S0960-9822(98)70275-1; Tse JKY, 2007, BIOCHEMISTRY-US, V46, P4017, DOI 10.1021/bi700013y; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064; Wang ZW, 2008, MOL NEUROBIOL, V38, P153, DOI 10.1007/s12035-008-8039-7	36	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28146	28155		10.1074/jbc.M109.005900	http://dx.doi.org/10.1074/jbc.M109.005900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654320	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000270676300041
J	Mima, J; Wickner, W				Mima, Joji; Wickner, William			Complex Lipid Requirements for SNARE- and SNARE Chaperone-dependent Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOTYPIC VACUOLE FUSION; VERTEX RING DOMAIN; YEAST VACUOLE; T-SNARE; PLASMA-MEMBRANE; VESICLE FUSION; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR MEMBRANES; REGULATORY LIPIDS; PHOSPHOLIPASE-C	Membrane fusion without lysis has been reconstituted with purified yeast vacuolar SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors), the SNARE chaperones Sec17p/Sec18p and the multifunctional HOPS complex, which includes a subunit of the SNARE-interactive Sec1-Munc18 family, and vacuolar lipids: phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidic acid (PA), cardiolipin (CL), ergosterol (ERG), diacylglycerol (DAG), and phosphatidylinositol 3-phosphate (PI3P). We now report that many of these lipids are required for rapid and efficient fusion of the reconstituted SNARE proteoliposomes in the presence of SNARE chaperones. Omission of either PE, PA, or PI3P from the complete set of lipids strongly reduces fusion, and PC, PE, PA, and PI3P constitute a minimal set of lipids for fusion. PA could neither be replaced by other lipids with small headgroups such as DAG or ERG nor by the acidic lipids PS or PI. PA is needed for full association of HOPS and Sec18p with proteoliposomes having a minimal set of lipids. Strikingly, PA and PE are as essential for SNARE complex assembly as for fusion, suggesting that these lipids facilitate functional interactions among SNAREs and SNARE chaperones.	[Mima, Joji; Wickner, William] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wickner, W (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg,Rm 425 Remsen, Hanover, NH 03755 USA.	Bill.Wickner@dartmouth.edu			National Institutes of Health [R01-GM23377]; TOYOBO BIO Foundation; Osaka University Life Science Young Independent Researcher Support Program (Japan Science and Technology Agency); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TOYOBO BIO Foundation; Osaka University Life Science Young Independent Researcher Support Program (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM23377.; Supported by TOYOBO BIO Foundation long-term research grants and the Osaka University Life Science Young Independent Researcher Support Program (Japan Science and Technology Agency). Current address: Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan.	ALLAN D, 1978, NATURE, V276, P289, DOI 10.1038/276289a0; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; BURGESS SW, 1992, BIOCHEMISTRY-US, V31, P2653, DOI 10.1021/bi00125a004; Chang JY, 2009, BIOPHYS J, V96, P1839, DOI 10.1016/j.bpj.2008.11.033; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; INGOLIA TD, 1978, J BIOL CHEM, V253, P3821; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lau WL, 2004, BIOPHYS J, V86, P272, DOI 10.1016/S0006-3495(04)74103-X; Liu S, 2007, TRAFFIC, V8, P1630, DOI 10.1111/j.1600-0854.2007.00628.x; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Meers P, 2000, BBA-BIOMEMBRANES, V1467, P227, DOI 10.1016/S0005-2736(00)00224-8; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nakanishi H, 2006, J CELL SCI, V119, P1406, DOI 10.1242/jcs.02841; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; SANCHEZMIGALLON MP, 1995, BIOPHYS J, V68, P558, DOI 10.1016/S0006-3495(95)80217-1; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tong JS, 2009, P NATL ACAD SCI USA, V106, P5141, DOI 10.1073/pnas.0813138106; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Villar AV, 2000, BIOCHEMISTRY-US, V39, P14012, DOI 10.1021/bi992515c; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	59	49	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27114	27122		10.1074/jbc.M109.010223	http://dx.doi.org/10.1074/jbc.M109.010223			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654322	Green Published, hybrid			2022-12-25	WOS:000270232300012
J	Nakano, T; Katafuchi, A; Matsubara, M; Terato, H; Tsuboi, T; Masuda, T; Tatsumoto, T; Pack, SP; Makino, K; Croteau, DL; Van Houten, B; Iijima, K; Tauchi, H; Ide, H				Nakano, Toshiaki; Katafuchi, Atsushi; Matsubara, Mayumi; Terato, Hiroaki; Tsuboi, Tomohiro; Masuda, Tasuku; Tatsumoto, Takahiro; Pack, Seung Pil; Makino, Keisuke; Croteau, Deborah L.; Van Houten, Bennett; Iijima, Kenta; Tauchi, Hiroshi; Ide, Hiroshi			Homologous Recombination but Not Nucleotide Excision Repair Plays a Pivotal Role in Tolerance of DNA-Protein Cross-links in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE LESIONS; UVRABC NUCLEASE; IN-VIVO; DAMAGE; METHYLTRANSFERASE; PATHWAY; 5-AZA-2'-DEOXYCYTIDINE; FORMALDEHYDE; INHIBITION; ACTIVATION	DNA-protein cross-links (DPCs) are unique among DNA lesions in their unusually bulky nature. The steric hindrance imposed by cross-linked proteins (CLPs) will hamper DNA transactions, such as replication and transcription, posing an enormous threat to cells. In bacteria, DPCs with small CLPs are eliminated by nucleotide excision repair (NER), whereas oversized DPCs are processed exclusively by RecBCD-dependent homologous recombination (HR). Here we have assessed the roles of NER and HR for DPCs in mammalian cells. We show that the upper size limit of CLPs amenable to mammalian NER is relatively small (8-10 kDa) so that NER cannot participate in the repair of chromosomal DPCs in mammalian cells. Moreover, CLPs are not polyubiquitinated and hence are not subjected to proteasomal degradation prior to NER. In contrast, HR constitutes the major pathway in tolerance of DPCs as judged from cell survival and RAD51 and gamma-H2AX nuclear foci formation. Induction of DPCs results in the accumulation of DNA double strand breaks in HR-deficient but not HR-proficient cells, suggesting that fork breakage at the DPC site initiates HR and reactivates the stalled fork. DPCs activate both ATR and ATM damage response pathways, but there is a time lag between two responses. These results highlight the differential involvement of NER in the repair of DPCs in bacterial and mammalian cells and demonstrate the versatile and conserved role of HR in tolerance of DPCs among species.	[Nakano, Toshiaki; Katafuchi, Atsushi; Matsubara, Mayumi; Terato, Hiroaki; Tsuboi, Tomohiro; Masuda, Tasuku; Tatsumoto, Takahiro; Ide, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Pack, Seung Pil] Korea Univ, Dept Biotechnol & Bioinformat, Jochiwon 339700, Chungnam, South Korea; [Makino, Keisuke] Kyoto Univ, Inst Adv Energy, Uji 6110011, Japan; [Croteau, Deborah L.; Van Houten, Bennett] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Iijima, Kenta; Tauchi, Hiroshi] Ibaraki Univ, Fac Sci, Dept Environm Sci, Mito, Ibaraki 3108512, Japan	Hiroshima University; Korea University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Ibaraki University	Ide, H (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.	ideh@hiroshima-u.ac.jp	Ide, Hiroshi/G-9042-2019; Croteau, Deb/AAP-5933-2020; Van Houten, Bennett/K-2284-2019	Terato, Hiroaki/0000-0002-7070-5263; Croteau, Deborah/0000-0002-6094-4084; Nakano, Toshiaki/0000-0002-5274-2909	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (to T. N., H. T., and H. I.) and by a Grant-in-aid for the Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (to H. I.).	Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Bergstralh DT, 2008, TRENDS GENET, V24, P70, DOI 10.1016/j.tig.2007.11.003; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gowher H, 2004, CANCER BIOL THER, V3, P1062, DOI 10.4161/cbt.3.11.1308; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; Kiziltepe T, 2007, MOL CANCER THER, V6, P1718, DOI 10.1158/1535-7163.MCT-07-0010; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Minko IG, 2005, BIOCHEMISTRY-US, V44, P3000, DOI 10.1021/bi0478805; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Morishima K, 2007, BIOCHEM BIOPH RES CO, V362, P872, DOI 10.1016/j.bbrc.2007.08.086; Nakano T, 2005, NUCLEIC ACIDS RES, V33, P2181, DOI 10.1093/nar/gki513; Nakano T, 2005, MUTAGENESIS, V20, P209, DOI 10.1093/mutage/gei027; Nakano T, 2003, J BIOL CHEM, V278, P25264, DOI 10.1074/jbc.M212847200; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Schneider-Stock R, 2005, J PHARMACOL EXP THER, V312, P525, DOI 10.1124/jpet.104.074195; Skorvaga M, 2002, J BIOL CHEM, V277, P1553, DOI 10.1074/jbc.M108847200; Speit G, 2007, MUTAGENESIS, V22, P387, DOI 10.1093/mutage/gem031; Speit Gunter, 2006, Methods Mol Biol, V314, P275; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Truglio JJ, 2004, EMBO J, V23, P2498, DOI 10.1038/sj.emboj.7600263; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	41	88	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27065	27076		10.1074/jbc.M109.019174	http://dx.doi.org/10.1074/jbc.M109.019174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19674975	Green Published, hybrid			2022-12-25	WOS:000270232300008
J	Lafferty-Whyte, K; Cairney, CJ; Will, MB; Serakinci, N; Daidone, MG; Zaffaroni, N; Bilsland, A; Keith, WN				Lafferty-Whyte, K.; Cairney, C. J.; Will, M. B.; Serakinci, N.; Daidone, M-G; Zaffaroni, N.; Bilsland, A.; Keith, W. N.			A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT	ONCOGENE			English	Article						telomerase; ALT; mesenchymal; microarray; signalling; c-Myc	MAINTENANCE MECHANISMS; IN-VITRO; TRANSFORMATION; SARCOMAS; TUMORS; LIPOSARCOMAS; ASSOCIATION; PROGNOSIS; CULTURE; HTR	Telomere length is maintained by two known mechanisms, the activation of telomerase or alternative lengthening of telomeres (ALT). The molecular mechanisms regulating the ALT phenotype are poorly understood and it is unknown how the decision of which pathway to activate is made at the cellular level. We have shown earlier that active repression of telomerase gene expression by chromatin remodelling of the promoters is one mechanism of regulation; however, other genes and signalling networks are likely to be required to regulate telomerase and maintain the ALT phenotype. Using gene expression profiling, we have uncovered a signature of 1305 genes to distinguish telomerase-positive and ALT cell lines. By combining this with the gene expression profiles of liposarcoma tissue samples, we refined this signature to 297 genes. A network analysis of known interactions between genes within this signature revealed a regulatory signalling network consistent with a model of human telomerase reverse transcriptase (hTERT) repression in ALT cell lines and liposarcomas. This network expands on our existing knowledge of hTERT regulation and provides a platform to understand differential regulation of hTERT in different tumour types and normal tissues. We also show evidence to suggest a novel mesenchymal stem cell origin for ALT immortalization in cell lines and mesenchymal tissues. Oncogene (2009) 28, 3765-3774; doi:10.1038/onc.2009.238; published online 17 August 2009	[Lafferty-Whyte, K.; Cairney, C. J.; Will, M. B.; Bilsland, A.; Keith, W. N.] Univ Glasgow, Ctr Oncol & Appl Pharmacol, Canc Res UK Beatson Labs, Glasgow G61 1BD, Lanark, Scotland; [Serakinci, N.] So Denmark Univ, Inst Reg Hlth Serv, Telomere & Aging Grp, Vejle, Denmark; [Daidone, M-G; Zaffaroni, N.] Ist Nazl Tumori, Unit 10, Dept Expt Oncol & Labs, Fdn IRCCS, I-20133 Milan, Italy	Beatson Institute; University of Glasgow; University of Southern Denmark; Fondazione IRCCS Istituto Nazionale Tumori Milan	Keith, WN (corresponding author), Univ Glasgow, Ctr Oncol & Appl Pharmacol, Canc Res UK Beatson Labs, Alexander Stone Bldg,Garscube Estate,Switchback R, Glasgow G61 1BD, Lanark, Scotland.	n.keith@beatson.gla.ac.uk	Zaffaroni, Nadia/J-8178-2016; Cairney, Claire/H-6989-2012; Daidone, Maria Grazia/E-9232-2017; Bilsland, Alan/G-2629-2010; Keith, Nicol/D-3325-2009	Zaffaroni, Nadia/0000-0002-4669-0890; Daidone, Maria Grazia/0000-0002-4786-1321; Keith, Nicol/0000-0001-7862-3580; Cairney, Claire/0000-0001-6531-245X; Bilsland, Alan/0000-0003-0957-3908; SERAKINCI, Nedime/0000-0002-1884-0839	Cancer Research UK; European Community [LSHC-CT-2004-502943, LSHC-CT-2005-0018806]; Glasgow University [Health-F2-2007-200950]; Italian Association for Cancer Research	Cancer Research UK(Cancer Research UK); European Community(European Commission); Glasgow University; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Cancer Research UK, European Community Grants LSHC-CT-2004-502943, LSHC-CT-2005-0018806 and Health-F2-2007-200950 Glasgow University and Italian Association for Cancer Research.	Atkinson SP, 2005, CANCER RES, V65, P7585, DOI 10.1158/0008-5472.CAN-05-1715; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cairney CJ, 2008, BRIT J CANCER, V98, P1467, DOI 10.1038/sj.bjc.6604328; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Chen YJ, 2006, CANCER RES, V66, P6473, DOI 10.1158/0008-5472.CAN-06-0910; Costa A, 2006, CANCER RES, V66, P8918, DOI 10.1158/0008-5472.CAN-06-0273; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Hakin-Smith V, 2003, LANCET, V361, P836, DOI 10.1016/S0140-6736(03)12681-5; Hao Huang, 2008, J Exp Clin Cancer Res, V27, P27, DOI 10.1186/1756-9966-27-27; Henson JD, 2005, CLIN CANCER RES, V11, P217; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Huang PR, 2008, BBA-MOL CELL RES, V1783, P193, DOI 10.1016/j.bbamcr.2007.08.006; Jiang WQ, 2007, ONCOGENE, V26, P4635, DOI 10.1038/sj.onc.1210260; Johnson JE, 2005, CLIN CANCER RES, V11, P5347, DOI 10.1158/1078-0432.CCR-05-0684; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Mehle C, 1996, ONCOGENE, V13, P161; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Serakinci N, 2006, REGEN MED, V1, P125, DOI 10.2217/17460751.1.1.125; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Ulaner GA, 2004, GENE CHROMOSOME CANC, V41, P155, DOI 10.1002/gcc.20074; Ulaner GA, 2003, CANCER RES, V63, P1759; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Yeager TR, 1999, CANCER RES, V59, P4175; Zhao YM, 2008, BIOCHEM BIOPH RES CO, V369, P1114, DOI 10.1016/j.bbrc.2008.03.011; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200; Zhou YF, 2006, CANCER RES, V66, P10849, DOI 10.1158/0008-5472.CAN-06-2146; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	32	47	50	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	43					3765	3774		10.1038/onc.2009.238	http://dx.doi.org/10.1038/onc.2009.238			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	512KT	19684619	Green Accepted			2022-12-25	WOS:000271248400001
J	Mastroeni, D; McKee, A; Grover, A; Rogers, J; Coleman, PD				Mastroeni, Diego; McKee, Ann; Grover, Andrew; Rogers, Joseph; Coleman, Paul D.			Epigenetic Differences in Cortical Neurons from a Pair of Monozygotic Twins Discordant for Alzheimer's Disease	PLOS ONE			English	Article							PRECURSOR PROTEIN GENE; IN-VITRO; EXPRESSION; BRAIN; AGE; HOMOCYSTEINE; INFLAMMATION; METABOLISM; DEMENTIA; TAU	DNA methylation [1,2] is capable of modulating coordinate expression of large numbers of genes across many different pathways, and may therefore warrant investigation for their potential role between genes and disease phenotype. In a rare set of monozygotic twins discordant for Alzheimer's disease (AD), significantly reduced levels of DNA methylation were observed in temporal neocortex neuronal nuclei of the AD twin. These findings are consistent with the hypothesis that epigenetic mechanisms may mediate at the molecular level the effects of life events on AD risk, and provide, for the first time, a potential explanation for AD discordance despite genetic similarities.	[Mastroeni, Diego; Grover, Andrew; Rogers, Joseph; Coleman, Paul D.] Sun Hlth Res Inst, LJ Roberts Ctr Alzheimers Res, Sun City, AZ USA; [McKee, Ann] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [McKee, Ann] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Boston University; Boston University	Mastroeni, D (corresponding author), Sun Hlth Res Inst, LJ Roberts Ctr Alzheimers Res, Sun City, AZ USA.	paul.coleman@sunhealth.org			NIA [AG30429, AGO7364]; Arizona Alzheimer's Research Consortium; NATIONAL INSTITUTE ON AGING [R21AG030429, R01AG036400] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Alzheimer's Research Consortium; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by NIA AG30429, NIA AGO7364 and by the Arizona Alzheimer's Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alonso AD, 2001, J BIOL CHEM, V276, P37967; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Caballero R, 2007, J CELL SCI, V120, P2619, DOI 10.1242/jcs.007344; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Chapman G, 2003, EXP NEUROL, V184, P715, DOI 10.1016/S0014-4886(03)00337-6; Espada J, 2004, J BIOL CHEM, V279, P37175, DOI 10.1074/jbc.M404842200; Jungling K, 2003, FASEB J, V17, P2100, DOI 10.1096/fj.03-0118fje; KOVACS EJ, 1987, J LEUKOCYTE BIOL, V41, P40, DOI 10.1002/jlb.41.1.40; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Luchsinger JA, 2008, J NUTR HEALTH AGING, V12, P127, DOI 10.1007/BF02982565; Maki WC, 2008, BIOSENS BIOELECTRON, V23, P780, DOI 10.1016/j.bios.2007.08.017; MANNOJI H, 1986, ACTA NEUROPATHOL, V71, P341, DOI 10.1007/BF00688060; MASTROENI D, 2008, NEUROBIOL AGING; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Sato TA, 2006, AM J PHYSIOL-ENDOC M, V290, pE490, DOI 10.1152/ajpendo.00406.2005; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tohgi H, 1999, MOL BRAIN RES, V70, P288, DOI 10.1016/S0169-328X(99)00163-1; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; West RL, 1995, J MOL NEUROSCI, V6, P141, DOI 10.1007/BF02736773	25	207	218	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6617	10.1371/journal.pone.0006617	http://dx.doi.org/10.1371/journal.pone.0006617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672297	Green Published, gold			2022-12-25	WOS:000268935900026
J	Yoshizawa, K; Jelezcova, E; Brown, AR; Foley, JF; Nyska, A; Cui, XL; Hofseth, LJ; Maronpot, RM; Wilson, SH; Sepulveda, AR; Sobol, RW				Yoshizawa, Katsuhiko; Jelezcova, Elena; Brown, Ashley R.; Foley, Julie F.; Nyska, Abraham; Cui, Xiangli; Hofseth, Lorne J.; Maronpot, Robert M.; Wilson, Samuel H.; Sepulveda, Antonia R.; Sobol, Robert W.			Gastrointestinal Hyperplasia with Altered Expression of DNA Polymerase beta	PLOS ONE			English	Article							BASE EXCISION-REPAIR; MICROSATELLITE INSTABILITY; ENHANCED EXPRESSION; GENE POLYMORPHISMS; CANCER; PROTEIN; DAMAGE; CELLS; MICE; DEFICIENCY	Background: Altered expression of DNA polymerase beta (Pol beta) has been documented in a large percentage of human tumors. However, tumor prevalence or predisposition resulting from Pol beta over-expression has not yet been evaluated in a mouse model. Methodology/Principal Findings: We have recently developed a novel transgenic mouse model that over-expresses Pol beta. These mice present with an elevated incidence of spontaneous histologic lesions, including cataracts, hyperplasia of Brunner's gland and mucosal hyperplasia in the duodenum. In addition, osteogenic tumors in mice tails, such as osteoma and osteosarcoma were detected. This is the first report of elevated tumor incidence in a mouse model of Pol beta overexpression. These findings prompted an evaluation of human gastrointestinal tumors with regard to Pol beta expression. We observed elevated expression of Pol beta in stomach adenomas and thyroid follicular carcinomas, but reduced Pol beta expression in esophageal adenocarcinomas and squamous carcinomas. Conclusions/Significance: These data support the hypothesis that balanced and proficient base excision repair protein expression and base excision repair capacity is required for genome stability and protection from hyperplasia and tumor formation.			Yoshizawa, K (corresponding author), NIEHS, Cellular & Mol Pathol Branch, POB 12233, Res Triangle Pk, NC 27709 USA.	rws9@pitt.edu	Sobol, Robert W./E-4125-2013; Wilson, Samuel H/E-6644-2019	Sobol, Robert W./0000-0001-7385-3563; Wilson, Samuel H/0000-0002-1702-5293	Intramural NIH HHS [Z01 ES050158, Z01 ES050159] Funding Source: Medline; NCI NIH HHS [P50 CA097190, P20 CA132385, 1 P20 CA132385-01, 1P50 CA 097190 01A1, P20 CA103730] Funding Source: Medline; NIA NIH HHS [R01 AG024364, 1 R01 AG24364-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA097190, P20CA103730, P20CA132385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, ZIGES102505, Z01ES050158, ZIAES050159, Z01ES050159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024364] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Allen D, 2008, BIOL REPROD, V79, P824, DOI 10.1095/biolreprod.108.069104; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; [Anonymous], GUIDE CARE USE LAB A; Bergoglio V, 2004, FEBS LETT, V566, P147, DOI 10.1016/j.febslet.2004.04.020; Bergoglio V, 2002, CANCER RES, V62, P3511; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; Bhattacharyya N, 1997, P NATL ACAD SCI USA, V94, P10324, DOI 10.1073/pnas.94.19.10324; Boivin GP, 1996, LAB INVEST, V74, P513; Boorman GA, 1990, PATHOLOGY FISHER RAT; Bu DW, 2004, J INVEST SURG, V17, P327, DOI 10.1080/08941930490524372; Cabelof DC, 2003, CANCER RES, V63, P5799; Cabelof DC, 2006, CANCER RES, V66, P7460, DOI 10.1158/0008-5472.CAN-06-1177; Canitrot Y, 2006, ANTICANCER RES, V26, P523; COCKMANTHOMAS RA, 1994, LAB ANIM SCI, V44, P531; Denkert C, 2006, MODERN PATHOL, V19, P1261, DOI 10.1038/modpathol.3800645; Dong ZM, 2006, DIS ESOPHAGUS, V19, P172, DOI 10.1111/j.1442-2050.2006.00560.x; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; El-Andaloussi N, 2007, FASEB J, V21, P26, DOI 10.1096/fj.06-6194com; Erianne GS, 2000, LEUKEMIA RES, V24, P705, DOI 10.1016/S0145-2126(00)00027-8; Esposito I, 2001, LANGENBECK ARCH SURG, V386, P163, DOI 10.1007/s004230100232; Fan R, 2004, CANCER RES, V64, P8526, DOI 10.1158/0008-5472.CAN-04-1601; Faumont N, 2009, CANCER RES, V69, P5177, DOI 10.1158/0008-5472.CAN-08-2866; Feng YQ, 2001, MOL CELL BIOL, V21, P298, DOI 10.1128/MCB.21.1.298-309.2001; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Fischer HP, 2003, PATHOLOGE, V24, P196, DOI 10.1007/s00292-003-0617-x; Fotiadou P, 2004, CANCER RES, V64, P3830, DOI 10.1158/0008-5472.CAN-04-0136; FRITH CH, 1983, LAB ANIM SCI, V33, P273; Gao Q, 2007, STEM CELLS, V25, P3085, DOI 10.1634/stemcells.2007-0478; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; HO SB, 1995, CANCER LETT, V91, P177, DOI 10.1016/0304-3835(95)03748-L; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Horton JK, 2002, DNA REPAIR, V1, P317, DOI 10.1016/S1568-7864(02)00008-3; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; Jean Michael, 2003, Curr Gastroenterol Rep, V5, P171, DOI 10.1007/s11894-003-0088-5; Kimura S, 1999, CARCINOGENESIS, V20, P1825, DOI 10.1093/carcin/20.9.1825; Kimura W, 2004, J HEPATO-BILIARY-PAN, V11, P223, DOI 10.1007/s00534-004-0894-7; Kruman II, 2004, J BIOL CHEM, V279, P43952, DOI 10.1074/jbc.M408025200; Li DH, 2007, INT J CANCER, V120, P1748, DOI 10.1002/ijc.22301; Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607; Liu Song-nian, 2008, Chinese Medical Sciences Journal, V23, P108; LUZ A, 1991, MONOGRAPHS PATHOLOGY; MADI K, 1990, EXP PATHOL-JENA, V38, P129, DOI 10.1016/S0232-1513(11)80248-3; Mahler M, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P269; Maronpot RR, 1999, PATHOLOGY MOUSE REFE; McNees CJ, 2005, EMBO J, V24, P2447, DOI 10.1038/sj.emboj.7600704; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Michiels S, 2009, CARCINOGENESIS, V30, P763, DOI 10.1093/carcin/bgp046; MIZUTANI T, 1984, CANCER LETT, V25, P19, DOI 10.1016/S0304-3835(84)80021-X; Niimi N, 2006, MUTAGENESIS, V21, P55, DOI 10.1093/mutage/gei074; Ochs K, 2002, CANCER RES, V62, P1524; Oka H, 2008, BIOCHEM BIOPH RES CO, V371, P225, DOI 10.1016/j.bbrc.2008.04.052; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Pascucci B, 2005, NUCLEIC ACIDS RES, V33, P280, DOI 10.1093/nar/gki168; Patel AC, 2000, CARCINOGENESIS, V21, P1691, DOI 10.1093/carcin/21.9.1691; Rime M, 2004, MOL CANCER THER, V3, P955; ROWLATT C, 1969, JNCI-J NATL CANCER I, V43, P1353; RUBEN Z, 1986, J COMP PATHOL, V96, P89, DOI 10.1016/0021-9975(86)90025-3; Servant L, 2002, J MOL BIOL, V315, P1039, DOI 10.1006/jmbi.2001.5307; Sobol RW, 2008, MOL CELL, V29, P413, DOI 10.1016/j.molcel.2008.02.004; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Sobol RW, 2003, DNA REPAIR, V2, P609, DOI 10.1016/S1568-7864(03)00026-0; Sobol RW, 2002, P NATL ACAD SCI USA, V99, P6860, DOI 10.1073/pnas.092662499; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1999, CARCINOGENESIS, V20, P1049, DOI 10.1093/carcin/20.6.1049; Starcevic D, 2004, CELL CYCLE, V3, P998; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sugo N, 2004, MOL CELL BIOL, V24, P9470, DOI 10.1128/MCB.24.21.9470-9477.2004; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Takaku K, 1999, CANCER RES, V59, P6113; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; WADSWORTH PF, 1989, LAB ANIM, V23, P324, DOI 10.1258/002367789780745971; Wang LM, 2007, CARCINOGENESIS, V28, P1356, DOI 10.1093/carcin/bgl239; Wang LM, 2004, CANCER RES, V64, P7673, DOI 10.1158/0008-5472.CAN-04-2801; WANG LM, 1992, CANCER RES, V52, P4824; WARD JM, 1975, CANCER RES, V35, P1938; Ward JM, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P161; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yamada NA, 2002, CANCER RES, V62, P6061; Yang K, 1997, J EXP ZOOL, V277, P245, DOI 10.1002/(SICI)1097-010X(19970215)277:3<245::AID-JEZ5>3.3.CO;2-N; Yu JS, 2006, CLIN CANCER RES, V12, P5104, DOI 10.1158/1078-0432.CCR-06-0547	87	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6493	10.1371/journal.pone.0006493	http://dx.doi.org/10.1371/journal.pone.0006493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654874	Green Published, Green Accepted, gold			2022-12-25	WOS:000268739100004
J	Alsop, D; Ings, JS; Vijayan, MM				Alsop, Derek; Ings, Jennifer S.; Vijayan, Mathilakath M.			Adrenocorticotropic Hormone Suppresses Gonadotropin-Stimulated Estradiol Release from Zebrafish Ovarian Follicles	PLOS ONE			English	Article							MELANOCORTIN-2 RECEPTOR; GLUCOCORTICOID-RECEPTOR; TELEOST FISH; HPA AXIS; EXPRESSION; CORTISOL; STRESS; REPRODUCTION; BIOSYNTHESIS; MECHANISMS	While stress is known to impact reproductive performance, the pathways involved are not entirely understood. Corticosteroid effects on the functioning of the hypothalamus-pituitary-gonadal axis are thought to be a key aspect of stress-mediated reproductive dysfunction. A vital component of the stress response is the pituitary secretion of adrenocorticotropic hormone (ACTH), which binds to the melanocortin 2 receptor (MC2R) in the adrenal glands and activates cortisol biosynthesis. We recently reported MC2R mRNA abundance in fish gonads leading to the hypothesis that ACTH may be directly involved in gonadal steroid modulation. Using zebrafish (Danio rerio) ovarian follicles, we tested the hypothesis that acute ACTH stimulation modulates cortisol and estradiol (E-2) secretion. ACTH neither affected cortisol nor unstimulated E-2 release from ovarian follicles. However, ACTH suppressed human chorionic gonadotropin (hCG)-stimulated E-2 secretion in a dose-related manner, with a maximum decrease of 62% observed at 1 I.U. ACTH mL(-1). This effect of ACTH on E-2 release was not observed in the presence of either 8-bromo-cAMP or forskolin, suggesting that the mechanism(s) involved in steroid attenuation was upstream of adenylyl cyclase activation. Overall, our results suggest that a stress-induced rise in plasma ACTH levels may initiate a rapid down-regulation of acute stimulated E-2 biosynthesis in the zebrafish ovary, underscoring a novel physiological role for this pituitary peptide in modulating reproductive activity.			Alsop, D (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	mvijayan@uwaterloo.ca	Vijayan, Mathilakath/F-6756-2012; Vijayan, Mathilakath/AAC-2190-2020					Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Aluru N, 2008, ENDOCRINOLOGY, V149, P4577, DOI 10.1210/en.2008-0435; Aluru N, 2007, PHYSIOL GENOMICS, V31, P483, DOI 10.1152/physiolgenomics.00118.2007; Aluru N, 2006, AQUAT TOXICOL, V77, P291, DOI 10.1016/j.aquatox.2005.12.010; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Boston BA, 1999, ANN NY ACAD SCI, V885, P75; Breen KM, 2006, FRONT NEUROENDOCRIN, V27, P233, DOI 10.1016/j.yfrne.2006.03.335; CARRAGHER JF, 1989, GEN COMP ENDOCR, V76, P310, DOI 10.1016/0016-6480(89)90163-9; Chen CC, 2008, GEN COMP ENDOCR, V157, P148, DOI 10.1016/j.ygcen.2008.04.003; Erden HF, 1998, J CLIN ENDOCR METAB, V83, P448, DOI 10.1210/jc.83.2.448; Ghizzoni L, 1997, ENDOCRINOLOGY, V138, P4806, DOI 10.1210/en.138.11.4806; Gonsten D, 2002, BIOL REPROD, V66, P106, DOI 10.1095/biolreprod66.1.106; Hontela A, 2009, TARG ORG T, V26, P233; Hu GX, 2008, STEROIDS, V73, P1018, DOI 10.1016/j.steroids.2007.12.020; Ings JS, 2006, MOL REPROD DEV, V73, P943, DOI 10.1002/mrd.20490; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Jalabert B, 2005, REPROD NUTR DEV, V45, P261, DOI 10.1051/rnd:2005019; Johnston H, 2007, REPRODUCTION, V133, P1181, DOI 10.1530/REP-06-0359; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; Lethimonier C, 2000, BIOL REPROD, V62, P1763, DOI 10.1095/biolreprod62.6.1763; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; NIKOLARAKIS KE, 1986, BRAIN RES, V377, P388, DOI 10.1016/0006-8993(86)90887-5; O'Shaughnessy PJ, 2003, ENDOCRINOLOGY, V144, P3279, DOI 10.1210/en.2003-0277; Oakley AE, 2009, ENDOCRINOLOGY, V150, P341, DOI 10.1210/en.2008-0587; PANKHURST NW, 1995, GEN COMP ENDOCR, V99, P249, DOI 10.1006/gcen.1995.1108; Rae MT, 2005, TRENDS ENDOCRIN MET, V16, P327, DOI 10.1016/j.tem.2005.07.002; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Simpson ER, 2005, ENDOCR REV, V26, P322, DOI 10.1210/er.2004-0020; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Taniguchi F, 2007, FASEB J, V21, P586, DOI 10.1096/fj.06-6681com; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/revreprod/5.2.105; Yong PYK, 2000, J CLIN ENDOCR METAB, V85, P4728, DOI 10.1210/jc.85.12.4728; Zmijewski MA, 2007, J ENDOCRINOL, V193, P157, DOI 10.1677/joe.1.06927	35	34	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6463	10.1371/journal.pone.0006463	http://dx.doi.org/10.1371/journal.pone.0006463			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649243	gold, Green Published, Green Submitted			2022-12-25	WOS:000268637600011
J	Sundriyal, A; Roberts, AK; Shone, CC; Acharya, KR				Sundriyal, Amit; Roberts, April K.; Shone, Clifford C.; Acharya, K. Ravi			Structural Basis for Substrate Recognition in the Enzymatic Component of ADP-ribosyltransferase Toxin CDTa from Clostridium difficile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS-IOTA-TOXIN; RIBOSYLATING TOXINS; ACTIN; BOTULINUM; MECHANISM; PROTEINS; DISEASE; SITE	ADP-ribosylation is one of the favored modes of cell intoxication employed by several bacteria. Clostridium difficile is recognized to be an important nosocomial pathogen associated with considerable morbidity and attributable mortality. Along with its two well known toxins, Toxin A and Toxin B, it produces an ADP-ribosylating toxin that targets monomeric actin of the target cell. Like other Clostridial actin ADP-ribosylating toxins, this binary toxin, known as C. difficile toxin (CDT), is composed of two subunits, CDTa and CDTb. In this study, we present high resolution crystal structures of CDTa in its native form (at pH 4.0, 8.5, and 9.0) and in complex with ADP-ribose donors, NAD and NADPH (at pH 9.0). The crystal structures of the native protein show "pronounced conformational flexibility" confined to the active site region of the protein and "enhanced" disorder at low pH, whereas the complex structures highlight significant differences in "ligand specificity" compared with the enzymatic subunit of a close homologue, Clostridium perfringens iota toxin. Specifically in CDTa, two of the suggested catalytically important residues (Glu-385 and Glu-387) seem to play no role or a less important role in ligand binding. These structural data provide the first detailed information on protein-donor substrate complex stabilization in CDTa, which may have implications in understanding CDT recognition.	[Sundriyal, Amit; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Sundriyal, Amit; Roberts, April K.; Shone, Clifford C.] Hlth Protect Agcy, Res Dept, Salisbury SP4 0JG, Wilts, England	University of Bath; Health Protection Agency	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk	Roberts, April/AAD-7330-2019	Acharya, K. Ravi/0000-0002-3009-4058	Health Protection Agency and Biotechnology and Biological Sciences Research Council (United Kingdom); Royal Society (United Kingdom) Industry Fellowship	Health Protection Agency and Biotechnology and Biological Sciences Research Council (United Kingdom); Royal Society (United Kingdom) Industry Fellowship(Royal Society of London)	Supported by a joint postgraduate studentship from the Health Protection Agency and Biotechnology and Biological Sciences Research Council (United Kingdom).; Supported by a Royal Society (United Kingdom) Industry Fellowship.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KNOOP FC, 1993, CLIN MICROBIOL REV, V6, P251, DOI 10.1128/CMR.6.3.251-265.1993; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MAUSS S, 1990, EUR J BIOCHEM, V194, P237, DOI 10.1111/j.1432-1033.1990.tb19448.x; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCFARLAND LV, 1986, AM J INFECT CONTROL, V14, P99, DOI 10.1016/0196-6553(86)90018-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; OHISHI I, 1983, INFECT IMMUN, V40, P336, DOI 10.1128/IAI.40.1.336-339.1983; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; REUNER KH, 1987, EUR J CELL BIOL, V43, P134; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SIMPSON LL, 1982, J PHARMACOL EXP THER, V223, P695; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; vanDamme J, 1996, FEBS LETT, V380, P291, DOI 10.1016/0014-5793(96)00052-X; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	32	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28713	28719		10.1074/jbc.M109.043018	http://dx.doi.org/10.1074/jbc.M109.043018			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692332	Green Published, hybrid			2022-12-25	WOS:000270678900027
J	Mahimainathan, L; Ghosh-Choudhury, N; Venkatesan, B; Das, F; Mandal, CC; Dey, N; Habib, SL; Kasinath, BS; Abboud, HE; Choudhury, GG				Mahimainathan, Lenin; Ghosh-Choudhury, Nandini; Venkatesan, Balachandar; Das, Falguni; Mandal, Chandi C.; Dey, Nirmalya; Habib, Samy L.; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh			TSC2 Deficiency Increases PTEN via H1F1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; TUMOR-SUPPRESSOR GENE; INDUCIBLE FACTOR-I; CELL-SURVIVAL; RENAL ANGIOMYOLIPOMAS; 3-KINASE/AKT PATHWAY; SIGNALING PATHWAY; MESANGIAL CELLS; DOWN-REGULATION; S6 KINASE	Substantial evidence suggests roles of TSC2 and PTEN in the development of cancer predisposition syndromes. Loss of TSC2 results in benign tumors, neurological disorders, and angiomyolipomas. We found that PTEN mRNA and protein levels are elevated in Tsc2(-/-) mouse embryo fibroblasts with concomitant reduction in Akt phosphorylation. Reconstitution of TSC2 in Tsc2(-/-) mouse embryo fibroblasts decreases PTEN levels. Interestingly, increased HIF1 alpha activity present in Tsc2 null cells is required for PTEN transcription and protein expression. We identified a canonical hypoxia-responsive element in the PTEN promoter, which regulates the transcription of this tumor suppressor protein in a TSC2-dependent manner. Finally, we demonstrate a positive correlation between expression of HIF1 alpha and PTEN in renal angiomyolipomas from TSC patients. Our results reveal a unique function of HIF1 alpha in up-regulation of PTEN and provide a new mechanism of reduced Akt phosphorylation in Tsc2 null cells. These data suggest that PTEN may safeguard against developing malignant tumors in patients with TSC deficiency.	[Mahimainathan, Lenin; Venkatesan, Balachandar; Das, Falguni; Dey, Nirmalya; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Mandal, Chandi C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Habib, Samy L.; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA; [Habib, Samy L.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Mail Code 7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu	Chen, Lingxin/H-5761-2019	Chen, Lingxin/0000-0002-3764-3515; /0000-0001-5077-3552; Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RC1 DIK50190]; Juvenile Diabetes Research Foundation; Veterans Affairs Research Service Merit Review Grants; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078971, R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs Research Service Merit Review Grants(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RC1 DIK50190. This work was also supported by the Juvenile Diabetes Research Foundation and Veterans Affairs Research Service Merit Review Grants (to G. G. C.).	Arbiser JL, 2002, J AM ACAD DERMATOL, V46, P376, DOI 10.1067/mjd.2002.120530; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Choi JW, 2004, CANCER RES, V64, P35, DOI 10.1158/0008-5472.CAN-03-0145; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Habib SL, 2008, AM J PHYSIOL-RENAL, V294, pF281, DOI 10.1152/ajprenal.00370.2007; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; HENSKE EP, 1995, GENE CHROMOSOME CANC, V13, P295, DOI 10.1002/gcc.2870130411; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Karbowniczek M, 2003, AM J PATHOL, V162, P491, DOI 10.1016/S0002-9440(10)63843-6; Kenerson HL, 2002, CANCER RES, V62, P5645; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Mahimainathan L, 2005, AM J PHYSIOL-RENAL, V289, pF72, DOI 10.1152/ajprenal.00277.2004; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martignoni G, 1998, AM J SURG PATHOL, V22, P663, DOI 10.1097/00000478-199806000-00003; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nguyen-Vu PA, 2001, J CUTAN PATHOL, V28, P470, DOI 10.1034/j.1600-0560.2001.028009470.x; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shin DH, 2007, CANCER LETT, V255, P107, DOI 10.1016/j.canlet.2007.03.026; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Venkatesan B, 2007, J CELL PHYSIOL, V211, P457, DOI 10.1002/jcp.20953; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhou YD, 2005, J NAT PROD, V68, P947, DOI 10.1021/np050029m	60	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27790	27798		10.1074/jbc.M109.028860	http://dx.doi.org/10.1074/jbc.M109.028860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19648120	hybrid, Green Published			2022-12-25	WOS:000270676300005
J	Nejak-Bowen, KN; Zeng, G; Tan, XP; Cieply, B; Monga, SP				Nejak-Bowen, Kari N.; Zeng, Gang; Tan, Xinping; Cieply, Benjamin; Monga, Satdarshan P.			beta-Catenin Regulates Vitamin C Biosynthesis and Cell Survival in Murine Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENESCENCE MARKER PROTEIN-30; DEOXYRIBONUCLEIC-ACID SYNTHESIS; REGUCALCIN MESSENGER-RNA; HEPATOCYTE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; BINDING PROTEIN; RAT-LIVER; ENDOGENOUS REGUCALCIN; MOUSE HEPATOCYTES; SIGNALING PATHWAY	Because the Wnt/beta-catenin pathway plays multiple roles in liver pathobiology, it is critical to identify gene targets that mediate such diverse effects. Here we report a novel role of, beta-catenin in controlling ascorbic acid biosynthesis in murine liver through regulation of expression of regucalcin or senescence marker protein 30 and L-gulonolactone oxidase. Reverse transcription-PCR, Western blotting, and immunohistochemistry demonstrate decreased regucalcin expression in beta-catenin-null livers and greater expression in beta-catenin overexpressing transgenic livers, HepG2 hepatoma cells (contain constitutively active beta-catenin), regenerating livers, and in hepatocellular cancer tissues that exhibit beta-catenin activation. Interestingly, coprecipitation and immunofluorescence studies also demonstrate an association of beta-catenin and regucalcin. Luciferase reporter and chromatin immunoprecipitation assays verified a functional TCF-4-binding site located between -163 and -157 (CTTTGCA) on the regucalcin promoter to be critical for regulation by beta-catenin. Significantly lower serum ascorbate levels were observed in beta-catenin knockout mice secondary to decreased expression of regucalcin and also Of L-gulonolactone oxidase, the penultimate and last (also rate-limiting) steps in the synthesis of ascorbic acid, respectively. These mice also show enhanced basal hepatocyte apoptosis. To test if ascorbate deficiency secondary to beta-catenin loss and regucalcin decrease was contributing to apoptosis, beta-catenin-null hepatocytes or regucalcin small interfering RNA-transfected HepG2 cells were cultured, which exhibited significant apoptosis that was alleviated by the addition of ascorbic acid. Thus, through regucalcin and L-gulonolactone oxidase expression, beta-catenin regulates vitamin C biosynthesis in murine liver, which in turn may be one of the mechanisms contributing to the role of beta-catenin in cell survival.	[Monga, Satdarshan P.] Univ Pittsburgh, Dept Pathol, Div Expt Pathol, Sch Med, Pittsburgh, PA 15216 USA; [Monga, Satdarshan P.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15216 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monga, SP (corresponding author), Univ Pittsburgh, Dept Pathol, Div Expt Pathol, Sch Med, 200 Lothrop St,S-421 BST, Pittsburgh, PA 15216 USA.	smonga@pitt.edu	Zeng, Gang G/J-9995-2018	Zeng, Gang G/0000-0002-2954-9051; Monga, Satdarshan/0000-0002-8437-3378; Nejak-Bowen, Kari/0000-0001-6051-5338	National Institutes of Health [1R01 DK62277, 1R01 CA1 24414]; Rango's Fund for the Enhancement of Pathology Research; NATIONAL CANCER INSTITUTE [R01CA124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rango's Fund for the Enhancement of Pathology Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01 DK62277 and 1R01 CA1 24414 (to S. P. S. M.). This work was also supported by Rango's Fund for the Enhancement of Pathology Research.	Apte U, 2006, HEPATOLOGY, V44, P992, DOI 10.1002/hep.21317; Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151; Barroso MP, 1997, ARCH BIOCHEM BIOPHYS, V343, P243, DOI 10.1006/abbi.1997.0170; Behari J, 2007, J HEPATOL, V46, P849, DOI 10.1016/j.jhep.2006.11.017; Bell AW, 2006, HEPATOLOGY, V44, P186, DOI 10.1002/hep.21234; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Cieply B, 2009, HEPATOLOGY, V49, P821, DOI 10.1002/hep.22695; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Devereux TR, 1999, ONCOGENE, V18, P4726, DOI 10.1038/sj.onc.1202858; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Elchuri S, 2007, PROTEOMICS, V7, P2121, DOI 10.1002/pmic.200601011; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841; Fujita T, 1998, J GASTROEN HEPATOL, V13, pS124; Graveel CR, 2001, ONCOGENE, V20, P2704, DOI 10.1038/sj.onc.1204391; Hanada S, 2008, HEPATOLOGY, V48, P943, DOI 10.1002/hep.22436; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Izumi T, 2004, J CELL BIOCHEM, V92, P296, DOI 10.1002/jcb.20056; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Lee HS, 2007, LIFE SCI, V80, P690, DOI 10.1016/j.lfs.2006.10.024; LIDA M, 2003, CARCINOGENESIS, V24, P757; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Majer BJ, 2004, MUTAT RES-FUND MOL M, V551, P153, DOI 10.1016/j.mrfmmm.2004.02.022; Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161; Michalopoulos GK, 2001, AM J PATHOL, V159, P1877, DOI 10.1016/S0002-9440(10)63034-9; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Murata T, 1998, BIOCHEM J, V329, P157, DOI 10.1042/bj3290157; Murata T, 1997, MOL CELL BIOCHEM, V175, P163, DOI 10.1023/A:1006844815743; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Ray R, 2003, CANCER RES, V63, P8085; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005; Takahasi H, 1996, MOL CELL BIOCHEM, V162, P133; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Tsurusaki Y, 2004, INT J MOL MED, V14, P277; Tsurusaki Y, 2002, J CELL BIOCHEM, V85, P516, DOI 10.1002/jcb.10153; Tsurusaki Y, 2000, INT J MOL MED, V6, P295; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Yamaguchi M, 2005, INT J MOL MED, V15, P371; Yamaguchi M, 2002, MOL CELL BIOCHEM, V241, P61, DOI 10.1023/A:1020822610085; Yamaguchi M, 2000, BIOCHEM BIOPH RES CO, V276, P1, DOI 10.1006/bbrc.2000.3359; YAMAGUCHI M, 1995, J CELL BIOCHEM, V57, P185, DOI 10.1002/jcb.240570203; Yamaguchi M, 1996, MOL CELL BIOCHEM, V162, P121; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang JW, 2001, HEPATOLOGY, V33, P848, DOI 10.1053/jhep.2001.23438; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zeng G, 2007, HEPATOLOGY, V45, P195, DOI 10.1002/hep.21473; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	65	32	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28115	28127		10.1074/jbc.M109.047258	http://dx.doi.org/10.1074/jbc.M109.047258			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690176	hybrid, Green Published			2022-12-25	WOS:000270676300038
J	Jha, AN; Ananthasuresh, GK; Vishveshwara, S				Jha, Anupam Nath; Ananthasuresh, G. K.; Vishveshwara, Saraswathi			A Search for Energy Minimized Sequences of Proteins	PLOS ONE			English	Article								In this paper, we present numerical evidence that supports the notion of minimization in the sequence space of proteins for a target conformation. We use the conformations of the real proteins in the Protein Data Bank (PDB) and present computationally efficient methods to identify the sequences with minimum energy. We use edge-weighted connectivity graph for ranking the residue sites with reduced amino acid alphabet and then use continuous optimization to obtain the energy-minimizing sequences. Our methods enable the computation of a lower bound as well as a tight upper bound for the energy of a given conformation. We validate our results by using three different inter-residue energy matrices for five proteins from protein data bank (PDB), and by comparing our energy-minimizing sequences with 80 million diverse sequences that are generated based on different considerations in each case. When we submitted some of our chosen energy-minimizing sequences to Basic Local Alignment Search Tool (BLAST), we obtained some sequences from non-redundant protein sequence database that are similar to ours with an E-value of the order of 10(-7). In summary, we conclude that proteins show a trend towards minimizing energy in the sequence space but do not seem to adopt the global energy-minimizing sequence. The reason for this could be either that the existing energy matrices are not able to accurately represent the inter-residue interactions in the context of the protein environment or that Nature does not push the optimization in the sequence space, once it is able to perform the function.			Jha, AN (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	suresh@mecheng.iisc.ernet.in; sv@mbu.iisc.ernet.in	JHA, ANUPAM/AAF-4384-2020	JHA, ANUPAM/0000-0003-2304-2468				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Butterfoss GL, 2006, ANNU REV BIOPH BIOM, V35, P49, DOI 10.1146/annurev.biophys.35.040405.102046; Dahiyat BI, 1997, J MOL BIOL, V273, P789, DOI 10.1006/jmbi.1997.1341; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Farinas E, 1998, PROTEIN SCI, V7, P1939, DOI 10.1002/pro.5560070909; Floudas CA, 2006, CHEM ENG SCI, V61, P966, DOI 10.1016/j.ces.2005.04.009; Fung HK, 2008, BIOPHYS J, V94, P584, DOI 10.1529/biophysj.107.110627; Gillespie B, 2003, J MOL BIOL, V330, P813, DOI 10.1016/S0022-2836(03)00616-8; HELLINGA HW, 1994, P NATL ACAD SCI USA, V91, P5803, DOI 10.1073/pnas.91.13.5803; HINDS DA, 1994, J MOL BIOL, V243, P668, DOI 10.1016/0022-2836(94)90040-X; Jha AN, 2007, J THEOR BIOL, V248, P81, DOI 10.1016/j.jtbi.2007.04.018; Klepeis JL, 2003, J AM CHEM SOC, V125, P8422, DOI 10.1021/ja034846p; Koehl P, 1999, J MOL BIOL, V293, P1183, DOI 10.1006/jmbi.1999.3212; Koehl P, 1999, J MOL BIOL, V293, P1161, DOI 10.1006/jmbi.1999.3211; Koehl P, 2002, P NATL ACAD SCI USA, V99, P691, DOI 10.1073/pnas.022408799; Koehl P, 2002, P NATL ACAD SCI USA, V99, P1280, DOI 10.1073/pnas.032405199; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Koh SK, 2005, J MECH DESIGN, V127, P728, DOI 10.1115/1.1901705; Koh SK, 2005, INT J ROBOT RES, V24, P109, DOI 10.1177/0278364905050354; KOLINSKI A, 1993, J CHEM PHYS, V98, P7420, DOI 10.1063/1.464706; Kono H, 2001, J MOL BIOL, V306, P607, DOI 10.1006/jmbi.2000.4422; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; LEE C, 1994, J MOL BIOL, V236, P918, DOI 10.1006/jmbi.1994.1198; Looger LL, 2001, J MOL BIOL, V307, P429, DOI 10.1006/jmbi.2000.4424; Luthra A, 2007, J BIOSCIENCES, V32, P883, DOI 10.1007/s12038-007-0088-y; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Pokala N, 2001, J STRUCT BIOL, V134, P269, DOI 10.1006/jsbi.2001.4349; Rakshit S, 2008, J THEOR BIOL, V250, P291, DOI 10.1016/j.jtbi.2007.09.032; Saven JG, 2003, J CHEM PHYS, V118, P6133, DOI 10.1063/1.1565995; Saven JG, 2002, CURR OPIN STRUC BIOL, V12, P453, DOI 10.1016/S0959-440X(02)00347-0; Saven JG, 2001, CHEM REV, V101, P3113, DOI 10.1021/cr000058w; Street AG, 1999, STRUCTURE, V7, pR105, DOI 10.1016/S0969-2126(99)80062-8; SVANBERG K, 1987, INT J NUMER METH ENG, V24, P359, DOI 10.1002/nme.1620240207; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; YUE K, 1992, P NATL ACAD SCI USA, V89, P4163, DOI 10.1073/pnas.89.9.4163	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6684	10.1371/journal.pone.0006684	http://dx.doi.org/10.1371/journal.pone.0006684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690619	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000269267300005
J	Radonjic, M; de Haan, JR; van Erk, MJ; van Dijk, KW; van den Berg, SAA; de Groot, PJ; Muller, M; van Ommen, B				Radonjic, Marijana; de Haan, Jorn R.; van Erk, Marjan J.; van Dijk, Ko Willems; van den Berg, Sjoerd A. A.; de Groot, Philip J.; Muller, Michael; van Ommen, Ben			Genome-Wide mRNA Expression Analysis of Hepatic Adaptation to High-Fat Diets Reveals Switch from an Inflammatory to Steatotic Transcriptional Program	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; PPAR-GAMMA; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); APOE-ASTERISK-3LEIDEN MICE; INSULIN-RESISTANCE; LIVER STEATOSIS; TRANSGENIC MICE; OBESITY; ATHEROSCLEROSIS	Background: Excessive exposure to dietary fats is an important factor in the initiation of obesity and metabolic syndrome associated pathologies. The cellular processes associated with the onset and progression of diet-induced metabolic syndrome are insufficiently understood. Principal Findings: To identify the mechanisms underlying the pathological changes associated with short and long-term exposure to excess dietary fat, hepatic gene expression of ApoE3Leiden mice fed chow and two types of high-fat (HF) diets was monitored using microarrays during a 16-week period. A functional characterization of 1663 HF-responsive genes reveals perturbations in lipid, cholesterol and oxidative metabolism, immune and inflammatory responses and stress-related pathways. The major changes in gene expression take place during the early (day 3) and late (week 12) phases of HF feeding. This is also associated with characteristic opposite regulation of many HF-affected pathways between these two phases. The most prominent switch occurs in the expression of inflammatory/immune pathways (early activation, late repression) and lipogenic/adipogenic pathways (early repression, late activation). Transcriptional network analysis identifies NF-kappa B, NEMO, Akt, PPARc and SREBP1 as the key controllers of these processes and suggests that direct regulatory interactions between these factors may govern the transition from early (stressed, inflammatory) to late (pathological, steatotic) hepatic adaptation to HF feeding. This transition observed by hepatic gene expression analysis is confirmed by expression of inflammatory proteins in plasma and the late increase in hepatic triglyceride content. In addition, the genes most predictive of fat accumulation in liver during 16-week high-fat feeding period are uncovered by regression analysis of hepatic gene expression and triglyceride levels. Conclusions: The transition from an inflammatory to a steatotic transcriptional program, possibly driven by the reciprocal activation of NF-kB and PPARc regulators, emerges as the principal signature of the hepatic adaptation to excess dietary fat. These findings may be of essential interest for devising new strategies aiming to prevent the progression of high-fat diet induced pathologies.	[Radonjic, Marijana; de Haan, Jorn R.; van Erk, Marjan J.; van Dijk, Ko Willems; van den Berg, Sjoerd A. A.; de Groot, Philip J.; Muller, Michael; van Ommen, Ben] Top Inst Food & Nutr, Nutrigenom Consortium, Wageningen, Netherlands; [Radonjic, Marijana; de Haan, Jorn R.; van Erk, Marjan J.; van Ommen, Ben] BU Biosci, TNO Qual Life, Zeist, Netherlands; [van Dijk, Ko Willems; van den Berg, Sjoerd A. A.] Leiden Univ, Med Ctr, Dept Gen Internal Med, Leiden, Netherlands; [van Dijk, Ko Willems; van den Berg, Sjoerd A. A.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [de Groot, Philip J.; Muller, Michael] Wageningen UR, Dept Human Nutr, Wageningen, Netherlands	Top Institute Food & Nutrition; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research	Radonjic, M (corresponding author), Top Inst Food & Nutr, Nutrigenom Consortium, Wageningen, Netherlands.	marijana.radonjic@tno.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021; van den Berg, Sjoerd AA/B-1994-2009; van den Berg, Sjoerd A/R-9541-2018	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; van den Berg, Sjoerd/0000-0001-5937-7505; van den Berg, Sjoerd/0000-0001-8967-376X	Top Institute Food and Nutrition, The Netherlands [A-006]	Top Institute Food and Nutrition, The Netherlands(Netherlands Government)	This work is financially supported by Top Institute Food and Nutrition, The Netherlands (Nutrigenomics Consortium, project A-006) and the resident institutes of the authors. All authors are member of the Nutrigenomics consortium (www.nutrigenomicsconsortium.nl) and European Nutrigenomics Organisation (www.nugo.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R PROJECT STAT COMPU; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cardona F, 2008, EUR J CLIN INVEST, V38, P510, DOI 10.1111/j.1365-2362.2008.01959.x; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Drew PD, 1995, J NEUROIMMUNOL, V63, P157, DOI 10.1016/0165-5728(95)00140-9; Duivenvoorden I, 2005, J LIPID RES, V46, P988, DOI 10.1194/jlr.M400505-JLR200; Duque N, 1997, J IMMUNOL, V159, P3474; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Gijbels MJJ, 1999, ATHEROSCLEROSIS, V143, P15, DOI 10.1016/S0021-9150(98)00263-9; Gobin SJP, 2003, BLOOD, V101, P3058, DOI 10.1182/blood-2002-09-2924; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Iwasaki T, 2007, INTERNAL MED, V46, P1633, DOI 10.2169/internalmedicine.46.0049; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Kopelman PG, 2004, GUT, V53, P1044, DOI 10.1136/gut.2003.021816; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kreeft AJ, 2005, ATHEROSCLEROSIS, V182, P249, DOI 10.1016/j.atherosclerosis.2005.01.049; Kreeft AJ, 2001, ARTERIOSCL THROM VAS, V21, P1984, DOI 10.1161/hq1201.100265; Kuenzli S, 2003, BRIT J DERMATOL, V149, P229, DOI 10.1046/j.1365-2133.2003.05532.x; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meng FY, 2002, J BIOL CHEM, V277, P29674, DOI 10.1074/jbc.M112464200; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; OLEFSKY J, 1974, J CLIN INVEST, V53, P64, DOI 10.1172/JCI107560; Ouadrhiri Y, 2002, AM J RESP CELL MOL, V26, P315, DOI 10.1165/ajrcmb.26.3.4590; Ozes ON, 1999, NATURE, V401, P82; Pang H, 2006, BIOINFORMATICS, V22, P2028, DOI 10.1093/bioinformatics/btl344; Poole E, 2008, J VIROL, V82, P4250, DOI 10.1128/JVI.02156-07; READ R, 2009, VET PATHOL; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rodriguez JA, 2002, CELL MOL BIOL, V48, P103; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; van der Hoorn JW, 2008, CRIT CARE MED, V36, P2576, DOI 10.1097/CCM.0b013e318183f0fd; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zingarelli B, 2003, J IMMUNOL, V171, P6827, DOI 10.4049/jimmunol.171.12.6827; MANAGEMENT ANAL DATA; ARRAYEXPRESS REPOSIT; NUGO MICROARRAY INFO	81	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6646	10.1371/journal.pone.0006646	http://dx.doi.org/10.1371/journal.pone.0006646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680557	Green Published, gold, Green Submitted			2022-12-25	WOS:000268936200012
J	Calvo, IA; Gabrielli, N; Iglesias-Baena, I; Garcia-Santamarina, S; Hoe, KL; Kim, DU; Sanso, M; Zuin, A; Perez, P; Ayte, J; Hidalgo, E				Calvo, Isabel A.; Gabrielli, Natalia; Iglesias-Baena, Ivan; Garcia-Santamarina, Sarela; Hoe, Kwang-Lae; Kim, Dong Uk; Sanso, Miriam; Zuin, Alice; Perez, Pilar; Ayte, Jose; Hidalgo, Elena			Genome-Wide Screen of Genes Required for Caffeine Tolerance in Fission Yeast	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PAP1; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; MULTIDRUG-RESISTANCE; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; H2O2 LEVELS; DNA-DAMAGE; CELL-CYCLE; PATHWAY	Background: An excess of caffeine is cytotoxic to all eukaryotic cell types. We aim to study how cells become tolerant to a toxic dose of this drug, and the relationship between caffeine and oxidative stress pathways. Methodology/Principal Findings: We searched for Schizosaccharomyces pombe mutants with inhibited growth on caffeine-containing plates. We screened a collection of 2,700 haploid mutant cells, of which 98 were sensitive to caffeine. The genes mutated in these sensitive clones were involved in a number of cellular roles including the H(2)O(2)-induced Pap1 and Sty1 stress pathways, the integrity and calcineurin pathways, cell morphology and chromatin remodeling. We have investigated the role of the oxidative stress pathways in sensing and promoting survival to caffeine. The Pap1 and the Sty1 pathways are both required for normal tolerance to caffeine, but only the Sty1 pathway is activated by the drug. Cells lacking Pap1 are sensitive to caffeine due to the decreased expression of the efflux pump Hba2. Indeed, ?hba2 cells are sensitive to caffeine, and constitutive activation of the Pap1 pathway enhances resistance to caffeine in an Hba2-dependent manner. Conclusions/Significance: With our caffeine-sensitive, genome-wide screen of an S. pombe deletion collection, we have demonstrated the importance of some oxidative stress pathway components on wild-type tolerance to the drug.	[Calvo, Isabel A.; Gabrielli, Natalia; Iglesias-Baena, Ivan; Garcia-Santamarina, Sarela; Sanso, Miriam; Zuin, Alice; Ayte, Jose; Hidalgo, Elena] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona, Spain; [Perez, Pilar] CSIC, Inst Microbiol Bioquim, Salamanca, Spain; [Hoe, Kwang-Lae; Kim, Dong Uk] KRIBB, Pombe Delet Project, Taejon, South Korea	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Calvo, IA (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona, Spain.	elena.hidalgo@upf.edu	Santamarina, Sarela Garcia/AAA-2261-2021; Hidalgo, Elena/K-2919-2014; Perez, Pilar/B-4948-2010; Garcia Santamarina, Sarela/O-4477-2017; Ayte, Jose/L-5217-2014; Sanso, Miriam/F-3282-2016	Santamarina, Sarela Garcia/0000-0002-0611-7918; Hidalgo, Elena/0000-0002-3768-6785; Perez, Pilar/0000-0003-3557-2247; Garcia Santamarina, Sarela/0000-0002-0611-7918; Ayte, Jose/0000-0002-6354-0536; Sanso, Miriam/0000-0001-7155-4041; Calvo Arnedo, Isabel/0000-0001-6619-4571; Hoe, Kwang Lae/0000-0002-3943-4549	Direccion General de Investigacion of Spain [BFU2006-02610]; Spanish program Consolider-Ingenio [CSD 2007-0020]	Direccion General de Investigacion of Spain(Spanish Government); Spanish program Consolider-Ingenio	This work was supported by Direccion General de Investigacion of Spain Grant BFU2006-02610, and by the Spanish program Consolider-Ingenio 2010 Grant CSD 2007-0020, to E. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alfa C, 1993, EXPT FISSION YEAST L; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; Bandyopadhyay A, 2002, J BIOL CHEM, V277, P2360, DOI 10.1074/jbc.M107790200; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Benko Z, 1997, CURR GENET, V31, P481, DOI 10.1007/s002940050233; Benko Z, 2004, MOL GENET GENOMICS, V271, P161, DOI 10.1007/s00438-003-0967-3; Benko Z, 1998, MOL GEN GENET, V260, P434, DOI 10.1007/s004380050914; BENKO Z, 1993, CAN J MICROBIOL, V39, P551, DOI 10.1139/m93-079; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; Castillo EA, 2003, J BIOL CHEM, V278, P40565, DOI 10.1074/jbc.M305859200; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162, DOI 10.1128/MCB.12.3.1162; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; FABRE F, 1972, MOL GEN GENET, V117, P153, DOI 10.1007/BF00267612; GENTNER NE, 1975, MOL GEN GENET, V142, P171, DOI 10.1007/BF00425643; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Jacoby JJ, 1998, MOL GEN GENET, V258, P148, DOI 10.1007/s004380050717; Jungwirth H, 2000, EUR J BIOCHEM, V267, P4809, DOI 10.1046/j.1432-1327.2000.01537.x; Katayama S, 2002, MOL BIOL CELL, V13, P211, DOI 10.1091/mbc.01-07-0333; Keppler D, 1999, FREE RADICAL BIO MED, V27, P985, DOI 10.1016/S0891-5849(99)00171-9; Kucharczyk R, 1999, YEAST, V15, P987, DOI 10.1002/(SICI)1097-0061(199907)15:10B<987::AID-YEA403>3.0.CO;2-5; Kumada K, 1996, MOL GEN GENET, V250, P59, DOI 10.1007/s004380050051; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Loewith R, 2000, J CELL SCI, V113, P153; LOPRIENO N, 1974, MUTAT RES, V26, P83, DOI 10.1016/S0027-5107(74)80038-2; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; NOJIMA H, 1994, NUCLEIC ACIDS RES, V22, P5279, DOI 10.1093/nar/22.24.5279; Osman F, 1998, MOL GEN GENET, V260, P319, DOI 10.1007/s004380050901; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; SANSO M, 2008, EUKARYOT CELL; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; Toone WM, 1998, GENE DEV, V12, P2650; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; WU AL, 1993, J BIOL CHEM, V268, P18850; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	53	58	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6619	10.1371/journal.pone.0006619	http://dx.doi.org/10.1371/journal.pone.0006619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672306	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900028
J	Huang, YY; Tschopp, M; Neuhauss, SCF				Huang, Ying-Yu; Tschopp, Markus; Neuhauss, Stephan C. F.			Illusionary Self-Motion Perception in Zebrafish	PLOS ONE			English	Article							EYE-MOVEMENTS; CONGENITAL NYSTAGMUS; OPTOKINETIC RESPONSE; SPASMUS-NUTANS; HUMAN ALBINOS; OPTIC CHIASM; BEHAVIOR; COORDINATION; VERTEBRATE; BALANCE	Zebrafish mutant belladonna (bel) carries a mutation in the lhx2 gene (encoding a Lim domain homeobox transcription factor) that results in a defect in retinotectal axon pathfinding, which can lead to uncrossed optic nerves failing to form an optic chiasm. Here, we report on a novel swimming behavior of the bel mutants, best described as looping. Together with two previously reported oculomotor instabilities that have been related to achiasmatic bel mutants, reversed optokinetic response (OKR) and congenital nystagmus (CN, involuntary conjugate oscillations of both eyes), looping opens a door to study the influence of visual input and eye movements on postural balance. Our result shows that looping correlates perfectly with reversed OKR and CN and is vision-dependent and contrast sensitive. CN precedes looping and the direction of the CN slow phase is predictive of the looping direction, but is absent during looping. Therefore, looping may be triggered by CN in bel. Moreover, looping in wild- type fish can also be evoked by whole-field motion, suggesting that looping in a bel mutant larvae is a result of self-motion perception. In contrary to previous hypotheses, our findings indicate that postural control in vertebrates relies on both direct visual input (afference signal) and eye-movement-related signals (efference copy or reafference signal).	[Huang, Ying-Yu] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Huang, Ying-Yu; Tschopp, Markus; Neuhauss, Stephan C. F.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Huang, Ying-Yu; Tschopp, Markus; Neuhauss, Stephan C. F.] Univ Zurich, Inst Zool, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Huang, YY (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.	stephan.neuhauss@zool.uzh.ch	Neuhauss, Stephan/AAX-9915-2020	Neuhauss, Stephan/0000-0002-9615-480X; Tschopp, Markus/0000-0001-6684-7325; Huang, Melody Ying-Yu/0000-0003-4368-9648	Swiss National Science Foundation [PP00A-68868/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Swiss National Science Foundation (PP00A-68868/1) to SCFN and Novartis Research Foundation to MT. The funders had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Biega TJ, 2007, AM J NEURORADIOL, V28, P392; COLLEWIJN H, 1985, BRAIN, V108, P1, DOI 10.1093/brain/108.1.1; EASTER SS, 1977, J NEUROPHYSIOL, V40, P1245, DOI 10.1152/jn.1977.40.6.1245; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Fushiki H, 2005, ACTA OTO-LARYNGOL, V125, P60, DOI 10.1080/00016480410015794; Glasauer S, 2005, NEUROLOGY, V65, P1291, DOI 10.1212/01.wnl.0000175132.01370.fc; GOTTLOB I, 1992, OPHTHALMOLOGY, V99, P1024; GOTTLOB I, 1995, INVEST OPHTH VIS SCI, V36, P2768; GRESTY M, 1981, ANN NY ACAD SCI, V374, P614, DOI 10.1111/j.1749-6632.1981.tb30905.x; GRUSSER OJ, 1986, ACTA PSYCHOL, V63, P3, DOI 10.1016/0001-6918(86)90039-9; Haffter P, 1996, DEVELOPMENT, V123, P1; HIBBARD E, 1967, EXP NEUROL, V19, P350, DOI 10.1016/0014-4886(67)90031-3; Huang YY, 2008, FRONT BIOSCI-LANDMRK, V13, P1899, DOI 10.2741/2810; Huang YY, 2006, J NEUROSCI, V26, P9873, DOI 10.1523/JNEUROSCI.2886-06.2006; Jahn K, 2002, BRAIN, V125, P2005, DOI 10.1093/brain/awf204; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; MCCARTY JW, 1992, AM J OPHTHALMOL, V113, P86, DOI 10.1016/S0002-9394(14)75759-9; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Rice AN, 2005, J EXP BIOL, V208, P3503, DOI 10.1242/jeb.01779; Rick JM, 2000, CURR BIOL, V10, P595, DOI 10.1016/S0960-9822(00)00495-4; Rinner O, 2005, INVEST OPHTH VIS SCI, V46, P137, DOI 10.1167/iovs.04-0682; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; SPERRY RW, 1945, J NEUROPHYSIOL, V8, P15, DOI 10.1152/jn.1945.8.1.15; Sperry RW, 1943, J EXP ZOOL, V92, P263, DOI 10.1002/jez.1400920303; STJOHN R, 1984, AM J OPTOM PHYS OPT, V61, P377; Strupp M, 2003, ANN NY ACAD SCI, V1004, P352, DOI 10.1196/annals.1303.033	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6550	10.1371/journal.pone.0006550	http://dx.doi.org/10.1371/journal.pone.0006550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672291	Green Published, gold			2022-12-25	WOS:000268935900003
J	Lin, BY; Wang, J; Hong, X; Yan, XW; Hwang, D; Cho, JH; Yi, D; Utleg, AG; Fang, XF; Schones, DE; Zhao, KJ; Omenn, GS; Hood, L				Lin, Biaoyang; Wang, Jun; Hong, Xu; Yan, Xiaowei; Hwang, Daehee; Cho, Ji-Hoon; Yi, Danielle; Utleg, Angelita G.; Fang, Xuefeng; Schones, Dustin E.; Zhao, Keji; Omenn, Gilbert S.; Hood, Leroy			Integrated Expression Profiling and ChIP-seq Analyses of the Growth Inhibition Response Program of the Androgen Receptor	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; TUMOR-SUPPRESSOR; TARGET GENES; LINE; AMPLIFICATION; PROMOTER; ELEMENTS; GENOME; IDENTIFICATION; COREGULATORS	Background: The androgen receptor (AR) plays important roles in the development of male phenotype and in different human diseases including prostate cancers. The AR can act either as a promoter or a tumor suppressor depending on cell types. The AR proliferative response program has been well studied, but its prohibitive response program has not yet been thoroughly studied. Methodology/Principal Findings: Previous studies found that PC3 cells expressing the wild-type AR inhibit growth and suppress invasion. We applied expression profiling to identify the response program of PC3 cells expressing the AR (PC3-AR) under different growth conditions (i.e. with or without androgens and at different concentration of androgens) and then applied the newly developed ChIP-seq technology to identify the AR binding regions in the PC3 cancer genome. A surprising finding was that the comparison of MOCK-transfected PC3 cells with AR-transfected cells identified 3,452 differentially expressed genes (two fold cutoff) even without the addition of androgens (i.e. in ethanol control), suggesting that a ligand independent activation or extremely low-level androgen activation of the AR. ChIP-Seq analysis revealed 6,629 AR binding regions in the cancer genome of PC3 cells with an FDR (false discovery rate) cut off of 0.05. About 22.4% (638 of 2,849) can be mapped to within 2 kb of the transcription start site (TSS). Three novel AR binding motifs were identified in the AR binding regions of PC3-AR cells, and two of them share a core consensus sequence CGAGCTCTTC, which together mapped to 27.3% of AR binding regions (1,808/ 6,629). In contrast, only about 2.9% (190/ 6,629) of AR binding sites contains the canonical AR matrix M00481, M00447 and M00962 (from the Transfac database), which is derived mostly from AR proliferative responsive genes in androgen dependent cells. In addition, we identified four top ranking co-occupancy transcription factors in the AR binding regions, which include TEF1 (Transcriptional enhancer factor), GATA (GATA transcription factors), OCT (octamer transcription factors) and PU1 (PU.1 transcription factor). Conclusions/Significance: Our data provide a valuable data set in understanding the molecular basis for growth inhibition response program of the AR in prostate cancer cells, which can be exploited for developing novel prostate cancer therapeutic strategies.	[Lin, Biaoyang; Fang, Xuefeng] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Lin, Biaoyang; Wang, Jun; Hong, Xu] Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Biaoyang] Swedish Med Ctr, Seattle, WA USA; [Yan, Xiaowei; Yi, Danielle; Utleg, Angelita G.; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Hwang, Daehee; Cho, Ji-Hoon] Pohang Univ Sci & Technol, Bio Program 1, Pohang, Kyungbuk, South Korea; [Hwang, Daehee; Cho, Ji-Hoon] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang, Kyungbuk, South Korea; [Schones, Dustin E.; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Omenn, Gilbert S.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; Zhejiang University; Swedish Medical Center; Institute for Systems Biology (ISB); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Michigan System; University of Michigan	Lin, BY (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98195 USA.	biaoylin@gmail.com	Lin, Biaoyang/AAA-1258-2020; Thomson, Axel/A-7893-2013	Lin, Biaoyang/0000-0002-2189-0407; Omenn, Gilbert S./0000-0002-8976-6074	MOST, China [2006AA02A303, 2006AA02Z4A2, 2006DFA32950, 2007DFC30360]; NIH, USA [5P50GM076547, 5U54CA119347, U54DA021519]; Korean Ministry of Education, Science and Technology (MEST), Korea [M1AN29-2007-03990, FPR08A1-050]; NATIONAL CANCER INSTITUTE [U54CA119347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	MOST, China(Ministry of Science and Technology, China); NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants 2006AA02A303, 2006AA02Z4A2, 2006DFA32950 and 2007DFC30360 from the MOST (http://www.most.gov.cn/eng/), China, and grants 5P50GM076547, 5U54CA119347, U54DA021519 from NIH (www.nih.gov/), USA, and grants M1AN29-2007-03990 and FPR08A1-050 from the Korean Ministry of Education, Science and Technology (MEST) (http://www.mest.go.kr/), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuwaijri S, 2007, ASIAN J ANDROL, V9, P181, DOI 10.1111/j.1745-7262.2007.00258.x; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bebermeier JH, 2006, J MOL MED, V84, P919, DOI 10.1007/s00109-006-0081-1; Bevan CL, 2005, TRENDS ENDOCRIN MET, V16, P395, DOI 10.1016/j.tem.2005.09.006; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bishop C.M., 2006, PATTERN RECOGNITION; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; CULIG Z, 1994, CANCER RES, V54, P5474; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; DePrimo SE, 2002, GENOME BIOL, V3; Haendler B, 2001, MOL CELL ENDOCRINOL, V173, P63, DOI 10.1016/S0303-7207(00)00434-2; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Jariwala U, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-39; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; KAIGHN ME, 1979, INVEST UROL, V17, P16; Knight JF, 2008, BRIT J CANCER, V99, P1849, DOI 10.1038/sj.bjc.6604774; Koivisto P, 1997, CANCER RES, V57, P314; Lin BY, 2005, CANCER RES, V65, P3081, DOI 10.1158/0008-5472.CAN-04-3218; Linja MJ, 2001, CANCER RES, V61, P3550; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; MURTHA P, 1993, BIOCHEMISTRY-US, V32, P6459, DOI 10.1021/bi00076a020; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; RAY D, 1990, ONCOGENE, V5, P663; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921, DOI 10.1210/mend-5-12-1921; ROBERTSON G, 2007, NAT METHODS; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shen RQ, 2000, ENDOCRINOLOGY, V141, P1699, DOI 10.1210/en.141.5.1699; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; YUAN SX, 1993, CANCER RES, V53, P1304; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287	50	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6589	10.1371/journal.pone.0006589	http://dx.doi.org/10.1371/journal.pone.0006589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668381	Green Published, gold, Green Submitted			2022-12-25	WOS:000268935600015
J	Jiang, G; Shi, M; Conteh, S; Richie, N; Banania, G; Geneshan, H; Valencia, A; Singh, P; Aguiar, J; Limbach, K; Kamrud, KI; Rayner, J; Smith, J; Bruder, JT; King, CR; Tsuboi, T; Takeo, S; Endo, Y; Doolan, DL; Richie, TL; Weiss, WR				Jiang, George; Shi, Meng; Conteh, Solomon; Richie, Nancy; Banania, Glenna; Geneshan, Harini; Valencia, Anais; Singh, Priti; Aguiar, Joao; Limbach, Keith; Kamrud, Kurt I.; Rayner, Jonathan; Smith, Jonathan; Bruder, Joseph T.; King, C. Richter; Tsuboi, Takafumi; Takeo, Satoru; Endo, Yaeta; Doolan, Denise L.; Richie, Thomas L.; Weiss, Walter R.			Sterile Protection against Plasmodium knowlesi in Rhesus Monkeys from a Malaria Vaccine: Comparison of Heterologous Prime Boost Strategies	PLOS ONE			English	Article								Using newer vaccine platforms which have been effective against malaria in rodent models, we tested five immunization regimens against Plasmodium knowlesi in rhesus monkeys. All vaccines included the same four P. knowlesi antigens: the pre-erythrocytic antigens CSP, SSP2, and erythrocytic antigens AMA1, MSP1. We used four vaccine platforms for prime or boost vaccinations: plasmids (DNA), alphavirus replicons (VRP), attenuated adenovirus serotype 5 (Ad), or attenuated poxvirus (Pox). These four platforms combined to produce five different prime/boost vaccine regimens: Pox alone, VRP/Pox, VRP/Ad, Ad/Pox, and DNA/Pox. Five rhesus monkeys were immunized with each regimen, and five Control monkeys received a mock vaccination. The time to complete vaccinations was 420 days. All monkeys were challenged twice with 100 P. knowlesi sporozoites given IV. The first challenge was given 12 days after the last vaccination, and the monkeys receiving the DNA/Pox vaccine were the best protected, with 3/5 monkeys sterilely protected and 1/5 monkeys that self-cured its parasitemia. There was no protection in monkeys that received Pox malaria vaccine alone without previous priming. The second sporozoite challenge was given 4 months after the first. All 4 monkeys that were protected in the first challenge developed malaria in the second challenge. DNA, VRP and Ad5 vaccines all primed monkeys for strong immune responses after the Pox boost. We discuss the high level but short duration of protection in this experiment and the possible benefits of the long interval between prime and boost.			Jiang, G (corresponding author), USN, Med Res Ctr, Malaria Program, Silver Spring, MD USA.	walter.weiss@verizon.net	Doolan, Denise L/F-1969-2015; Tsuboi, Takafumi/AAK-6145-2021	Doolan, Denise/0000-0001-7354-8817; Rayner, Jonathan/0000-0002-2091-7604; Richie, Thomas/0000-0002-2946-5456; Tsuboi, Takafumi/0000-0002-7415-1325				BARNWELL JW, 1983, INFECT IMMUN, V40, P985, DOI 10.1128/IAI.40.3.985-994.1983; Bojang KA, 2006, EXPERT REV VACCINES, V5, P611, DOI 10.1586/14760584.5.5.611; Brice GT, 2007, MICROBES INFECT, V9, P1439, DOI 10.1016/j.micinf.2007.07.009; CHAROENVIT Y, 1987, INFECT IMMUN, V55, P604, DOI 10.1128/IAI.55.3.604-608.1987; COATNEY WEC, 1971, PRIMATE MALARIAS; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Druilhe P, 2007, CURR OPIN MICROBIOL, V10, P371, DOI 10.1016/j.mib.2007.07.009; EARLE WC, 1932, J LAB CLIN MED, V17, P1124; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hubby B, 2007, VACCINE, V25, P8180, DOI 10.1016/j.vaccine.2007.09.038; Jiang G, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-135; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Krzych U, 2005, CURR TOP MICROBIOL, V297, P1; Kumar A, 2001, J IMMUNOL METHODS, V247, P49, DOI 10.1016/S0022-1759(00)00310-0; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Li SQ, 2007, VACCINE, V25, P2567, DOI 10.1016/j.vaccine.2006.07.035; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; Perlaza BL, 2003, EUR J IMMUNOL, V33, P1321, DOI 10.1002/eji.200323339; Perlaza BL, 2008, EUR J IMMUNOL, V38, P2610, DOI 10.1002/eji.200738055; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Rayner JO, 2002, REV MED VIROL, V12, P279, DOI 10.1002/rmv.360; Rogers WO, 2002, INFECT IMMUN, V70, P4329, DOI 10.1128/IAI.70.8.4329-4335.2002; Rogers WO, 2001, INFECT IMMUN, V69, P5565, DOI 10.1128/IAI.69.9.5565-5572.2001; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Sawasaki T, 2005, METH MOL B, V310, P131; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Stahl-Hennig C, 2007, J MED PRIMATOL, V36, P195, DOI 10.1111/j.1600-0684.2007.00237.x; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; VOLLER A, 1969, T ROY SOC TROP MED H, V63, P507, DOI 10.1016/0035-9203(69)90040-6; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Wille-Reece U, 2005, J IMMUNOL, V174, P7676, DOI 10.4049/jimmunol.174.12.7676; World Health Organization, 2008, WORLD MAL REP; Wykes M, 2007, INT J PARASITOL, V37, P705, DOI 10.1016/j.ijpara.2007.02.007; Zapata JC, 2002, J PARASITOL, V88, P723, DOI 10.1645/0022-3395(2002)088[0723:RIOIAL]2.0.CO;2	39	42	43	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6559	10.1371/journal.pone.0006559	http://dx.doi.org/10.1371/journal.pone.0006559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668343	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000268773300001
J	Glaser, BT; Bergendahl, V; Anthony, LC; Olson, B; Burgess, RR				Glaser, Bryan T.; Bergendahl, Veit; Anthony, Larry C.; Olson, Brian; Burgess, Richard R.			Studying the Salt Dependence of the Binding of sigma 70 and sigma 32 to Core RNA Polymerase Using Luminescence Resonance Energy Transfer	PLOS ONE			English	Article								The study of protein-protein interactions is becoming increasingly important for understanding the regulation of many cellular processes. The ability to quantify the strength with which two binding partners interact is desirable but the accurate determination of equilibrium binding constants is a difficult process. The use of Luminescence Resonance Energy Transfer (LRET) provides a homogeneous binding assay that can be used for the detection of protein-protein interactions. Previously, we developed an LRET assay to screen for small molecule inhibitors of the interaction of sigma 70 with the beta' coiled-coil fragment (amino acids 100-309). Here we describe an LRET binding assay used to monitor the interaction of E. coli sigma 70 and sigma 32 with core RNA polymerase along with the controls to verify the system. This approach generates fluorescently labeled proteins through the random labeling of lysine residues which enables the use of the LRET assay for proteins for which the creation of single cysteine mutants is not feasible. With the LRET binding assay, we are able to show that the interaction of sigma 70 with core RNAP is much more sensitive to NaCl than to potassium glutamate (KGlu), whereas the sigma 32 interaction with core RNAP is insensitive to both salts even at concentrations >500 mM. We also find that the interaction of sigma 32 with core RNAP is stronger than sigma 70 with core RNAP, under all conditions tested. This work establishes a consistent set of conditions for the comparison of the binding affinities of the E. coli sigma factors with core RNA polymerase. The examination of the importance of salt conditions in the binding of these proteins could have implications in both in vitro assay conditions and in vivo function.			Glaser, BT (corresponding author), SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	burgess@oncology.wisc.edu		Burgess, Richard/0000-0001-9545-3165	NIGMS NIH HHS [R01 GM028575, R01 GM28575] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028575] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andre E, 2004, ASSAY DRUG DEV TECHN, V2, P629, DOI 10.1089/adt.2004.2.629; Anthony LC, 2003, METHOD ENZYMOL, V370, P181; Bergendahl V, 2003, METHOD ENZYMOL, V370, P192; Bergendahl V, 2003, J IMMUNOL METHODS, V277, P117, DOI 10.1016/S0022-1759(03)00183-2; Bergendahl V, 2003, APPL ENVIRON MICROB, V69, P1492, DOI 10.1128/AEM.69.3.1492-1498.2003; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Ferguson AL, 2000, FEBS LETT, V481, P281, DOI 10.1016/S0014-5793(00)02028-7; FORSTER T, 1965, DELOCALIZED EXCITATI, P93; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; Glaser BT, 2007, ASSAY DRUG DEV TECHN, V5, P759, DOI 10.1089/adt.2007.095; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; Gross CA, 1996, PHILOS T R SOC B, V351, P475, DOI 10.1098/rstb.1996.0045; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Heyduk T, 2001, BIOPOLYMERS, V61, P201; Heyduk T, 2001, METHODS, V25, P44, DOI 10.1006/meth.2001.1214; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Joo DM, 1997, P NATL ACAD SCI USA, V94, P4907, DOI 10.1073/pnas.94.10.4907; JOVANOVICH SB, 1988, J BACTERIOL, V170, P534, DOI 10.1128/jb.170.2.534-539.1988; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Mooney RA, 2003, GENE DEV, V17, P2839, DOI 10.1101/gad.1142203; Riddle SM, 2006, ANAL BIOCHEM, V356, P108, DOI 10.1016/j.ab.2006.05.017; Selvin P.R., 1999, APPL FLUORESCENCE CH, P457; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shaner S L, 1983, Cold Spring Harb Symp Quant Biol, V47 Pt 1, P463; SHANER SL, 1982, BIOCHEMISTRY-US, V21, P5539, DOI 10.1021/bi00265a025; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; WU FYH, 1976, BIOCHEMISTRY-US, V15, P3254, DOI 10.1021/bi00660a014	35	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6490	10.1371/journal.pone.0006490	http://dx.doi.org/10.1371/journal.pone.0006490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649256	Green Submitted, Green Published, gold			2022-12-25	WOS:000268637700014
J	Hooven, LA; Sherman, KA; Butcher, S; Giebultowicz, JM				Hooven, Louisa A.; Sherman, Katherine A.; Butcher, Shawn; Giebultowicz, Jadwiga M.			Does the Clock Make the Poison? Circadian Variation in Response to Pesticides	PLOS ONE			English	Article								Background: Circadian clocks govern daily physiological and molecular rhythms, and putative rhythms in expression of xenobiotic metabolizing (XM) genes have been described in both insects and mammals. Such rhythms could have important consequences for outcomes of chemical exposures at different times of day. To determine whether reported XM gene expression rhythms result in functional rhythms, we examined daily profiles of enzyme activity and dose responses to the pesticides propoxur, deltamethrin, fipronil, and malathion. Methodology/Principal Findings: Published microarray expression data were examined for temporal patterns. Male Drosophila were collected for ethoxycoumarin-O-deethylase (ECOD), esterase, glutathione-S-transferase (GST), and, and uridine 59-diphosphoglucosyltransferase (UGT) enzyme activity assays, or subjected to dose-response tests at four hour intervals throughout the day in both light/dark and constant light conditions. Peak expression of several XM genes cluster in late afternoon. Significant diurnal variation was observed in ECOD and UGT enzyme activity, however, no significant daily variation was observed in esterase or GST activity. Daily profiles of susceptibility to lethality after acute exposure to propoxur and fipronil showed significantly increased resistance in midday, while susceptibility to deltamethrin and malathion varied little. In constant light, which interferes with clock function, the daily variation in susceptibility to propoxur and in ECOD and UGT enzyme activity was depressed. Conclusions/Significance: Expression and activities of specific XM enzymes fluctuate during the day, and for specific insecticides, the concentration resulting in 50% mortality varies significantly during the day. Time of day of chemical exposure should be an important consideration in experimental design, use of pesticides, and human risk assessment.			Hooven, LA (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	hoovenl@onid.orst.edu			NIEHS NIH HHS [5F32ES014994-02, F32 ES014994] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES014994] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alavanja MCR, 2004, ANNU REV PUBL HEALTH, V25, P155, DOI 10.1146/annurev.publhealth.25.101802.123020; Baraldo M, 2008, EXPERT OPIN DRUG MET, V4, P175, DOI 10.1517/17425255.4.2.175; Bibi Z, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-27; Boobis AR, 2008, TOXICOL LETT, V180, P137, DOI 10.1016/j.toxlet.2008.06.004; Brown RP, 2005, GENE, V358, P39, DOI 10.1016/j.gene.2005.05.026; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Collier AC, 2000, DRUG METAB DISPOS, V28, P1184; DESOUSA G, 1995, ANAL BIOCHEM, V229, P86, DOI 10.1006/abio.1995.1382; EESA NM, 1995, J ISLAMIC ACAD SCI, V8; FATRANSKA M, 1978, CHRONOBIOLOGIA, V5, P39; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gordon CJ, 2001, TOXICOLOGY, V169, P93, DOI 10.1016/S0300-483X(01)00496-6; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hanukoglu I, 2006, DRUG METAB REV, V38, P171, DOI 10.1080/03602530600570040; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Jeibmann A, 2009, INT J MOL SCI, V10, P407, DOI 10.3390/ijms10020407; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Lemmer B, 2007, ADV DRUG DELIVER REV, V59, P825, DOI 10.1016/j.addr.2007.08.001; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Maroni M, 2006, Med Lav, V97, P430; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Nicolau G Y, 1982, Endocrinologie, V20, P73; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Pszczolkowski MA, 1999, PHYTOPARASITICA, V27, P19, DOI 10.1007/BF02980723; QU X, 2008, TOXICOL APPL PHARM; Qu XY, 2007, MOL PHARMACOL, V72, P1349, DOI 10.1124/mol.107.039305; Qu XY, 2009, TOXICOL APPL PHARM, V234, P370, DOI 10.1016/j.taap.2008.10.016; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2003, J BIOL RHYTHM, V18, P96, DOI 10.1177/0748730403252245; SAUNDERS DS, 2002, INSECT CLOCKS, P560; Scharf ME, 2000, PEST MANAG SCI, V56, P757, DOI 10.1002/1526-4998(200009)56:9<757::AID-PS197>3.0.CO;2-W; Schneider D, 2000, NAT REV GENET, V1, P218, DOI 10.1038/35042080; Shea SA, 2005, J CLIN ENDOCR METAB, V90, P2537, DOI 10.1210/jc.2004-2232; Simon N, 2003, CHRONOBIOL INT, V20, P451, DOI 10.1081/CBI-120021385; SULLIVAN WN, 1970, J ECON ENTOMOL, V63, P159, DOI 10.1093/jee/63.1.159; TEBOUL M, 2008, NUCL HORMONE RECEPTO; TONG J, 1990, PROG CLIN BIOL RES, V341, P503; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang SZ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r247; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; Zhang YKJ, 2009, DRUG METAB DISPOS, V37, P106, DOI 10.1124/dmd.108.024174	52	64	67	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6469	10.1371/journal.pone.0006469	http://dx.doi.org/10.1371/journal.pone.0006469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649249	Green Published, gold, Green Submitted			2022-12-25	WOS:000268637600017
J	Pasquariello, N; Catanzaro, G; Marzano, V; Amadio, D; Barcaroli, D; Oddi, S; Federici, G; Urbani, A; Agro, AF; Maccarrone, M				Pasquariello, Nicoletta; Catanzaro, Giuseppina; Marzano, Valeria; Amadio, Daniele; Barcaroli, Daniela; Oddi, Sergio; Federici, Giorgio; Urbani, Andrea; Agro, Alessandro Finazzi; Maccarrone, Mauro			Characterization of the Endocannabinoid System in Human Neuronal Cells and Proteomic Analysis of Anandamide-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; NEUROBLASTOMA SH-SY5Y CELLS; CANNABINOID RECEPTOR CB1; HEAT-SHOCK PROTEINS; UP-REGULATION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; TRIOSEPHOSPHATE ISOMERASE	Anandamide (AEA) is an endogenous agonist of type 1 cannabinoid receptors (CB1R) that, along with metabolic enzymes of AEA and congeners, compose the "endocannabinoid system." Here we report the biochemical, morphological, and functional characterization of the endocannabinoid system in human neuroblastoma SH-SY5Y cells that are an experimental model for neuronal cell damage and death, as well as for major human neurodegenerative disorders. We also show that AEA dose-dependently induced apoptosis of SH-SY5Y cells. Through proteomic analysis, we further demonstrate that AEA-induced apoptosis was paralleled by an similar to 3 to similar to 5-fold up-regulation or down-regulation of five genes; IgG heavy chain-binding protein, stress-induced phosphoprotein-1, and triose-phosphate isomerase-1, which were up-regulated, are known to act as antiapoptotic agents; actin-related protein 2/3 complex subunit 5 and peptidylprolyl isomerase-like protein 3 isoform PPIL3b were down-regulated, and the first is required for actin network formation whereas the second is still function-orphan. Interestingly, only the effect of AEA on BiP was reversed by the CB1R antagonist SR141716, in SH-SY5Y cells as well as in human neuroblastoma LAN-5 cells (that express a functional CB1R) but not in SK-NBE cells (which do not express CB1R). Silencing or overexpression of BiP increased or reduced, respectively, AEA-induced apoptosis of SH-SY5Y cells. In addition, the expression of BiP and of the BiP-related apoptotic markers p53 and PUMA was increased by AEA through a CB1R-dependent pathway that engages p38 and p42/44 mitogen-activated protein kinases. Consistently, this effect of AEA was minimized by SR141716. In conclusion, we identified BiP as a key protein in neuronal apoptosis induced by AEA.	[Pasquariello, Nicoletta; Catanzaro, Giuseppina; Oddi, Sergio; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, I-64100 Teramo, Italy; [Pasquariello, Nicoletta; Catanzaro, Giuseppina; Marzano, Valeria; Amadio, Daniele; Oddi, Sergio; Federici, Giorgio; Urbani, Andrea; Maccarrone, Mauro] Fdn Santa Lucia, Ctr Europeo Ric Cervello, I-00143 Rome, Italy; [Marzano, Valeria; Federici, Giorgio] Univ Roma Tor Vergata, Dipartimento Med Interna, I-00133 Rome, Italy; [Urbani, Andrea] Fdn G DAnnunzio, Ctr Studi Invecchiamento, I-66013 Chieti, Italy; [Urbani, Andrea] Univ G DAnnunzio, Dipartimento Sci Biomed, I-66013 Chieti, Italy; [Amadio, Daniele; Barcaroli, Daniela; Agro, Alessandro Finazzi] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Sci Biochim, I-00133 Rome, Italy	University of Teramo; IRCCS Santa Lucia; University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Rome Tor Vergata	Maccarrone, M (corresponding author), Univ Teramo, Dept Biomed Sci, Piazza A Moro 45, I-64100 Teramo, Italy.	a.urbani@unich.it; mmaccarrone@unite.it	Oddi, Sergio/B-6668-2009; Urbani, Andrea/B-2953-2012; catanzaro, giuseppina/AGZ-8080-2022; Maccarrone, Mauro/K-5398-2012; Urbani, Andrea/AAD-1675-2022; Marzano, Valeria/K-5770-2016	Oddi, Sergio/0000-0002-6217-698X; catanzaro, giuseppina/0000-0001-8427-9691; Maccarrone, Mauro/0000-0002-3990-2963; Marzano, Valeria/0000-0001-6364-2121	Fondazione Cassa di Risparmio di Teramo [Tercas 2004, 2005]; Agenzia Spaziale Italiana Disturbi del Controllo Motorio e Cardiorespiratorio Project [2006]; Ministero dell'Istruzione; dell'Universita e della Ricerca Progretto di Ricerca di Interesse Nazionale; Fondo per gli Investimenti della Ricerca di Base Projects [2006]	Fondazione Cassa di Risparmio di Teramo; Agenzia Spaziale Italiana Disturbi del Controllo Motorio e Cardiorespiratorio Project; Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca Progretto di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondo per gli Investimenti della Ricerca di Base Projects	This work was supported in part by Fondazione Cassa di Risparmio di Teramo Grants Tercas 2004 and 2005, Agenzia Spaziale Italiana Disturbi del Controllo Motorio e Cardiorespiratorio Project 2006, and Ministero dell'Istruzione, dell'Universita e della Ricerca Progretto di Ricerca di Interesse Nazionale, and Fondo per gli Investimenti della Ricerca di Base Projects 2006 (to M. M.).	Aguado T, 2007, J BIOL CHEM, V282, P6854, DOI 10.1074/jbc.M608900200; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bifulco M, 2002, NAT MED, V8, P547, DOI 10.1038/nm0602-547; Birse-Archbold JLA, 2005, J CEREBR BLOOD F MET, V25, P1356, DOI 10.1038/sj.jcbfm.9600133; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Biswas KK, 2003, HEPATOLOGY, V38, P1167, DOI 10.1053/jhep.2003.50459; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Bouaboula M, 1999, FEBS LETT, V449, P61, DOI 10.1016/S0014-5793(99)00395-6; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Colombo G, 2009, J MOL NEUROSCI, V37, P111, DOI 10.1007/s12031-008-9114-2; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Di Marzo V, 2007, CHEM BIOL, V14, P741, DOI 10.1016/j.chembiol.2007.05.014; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Fang F, 2008, ACTA PHARMACOL SIN, V29, P152, DOI 10.1111/j.1745-7254.2008.00714.x; Feng Z, 2004, J PINEAL RES, V37, P257, DOI 10.1111/j.1600-079X.2004.00164.x; Fezza F, 2005, ANAL BIOCHEM, V339, P113, DOI 10.1016/j.ab.2004.12.005; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Gasperi V, 2007, CELL MOL LIFE SCI, V64, P219, DOI 10.1007/s00018-006-6445-4; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Gomez C, 2001, J NEUROSCI RES, V63, P421, DOI 10.1002/1097-4547(20010301)63:5<421::AID-JNR1037>3.0.CO;2-4; Gomez-Santos C, 2002, BRAIN RES, V935, P32, DOI 10.1016/S0006-8993(02)02422-8; GRACY RW, 1982, ISOZYMES-CURR T BIOL, V6, P169; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Huo DH, 2008, BIOCHEM BIOPH RES CO, V372, P14, DOI 10.1016/j.bbrc.2008.04.178; Jacobsson SOP, 2001, J PHARMACOL EXP THER, V299, P951; Jayachandran S., 2008, MOL PSYCHIATR, P1; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; Kaneda A, 2004, CANCER LETT, V212, P203, DOI 10.1016/j.canlet.2004.03.020; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; Kerr LE, 2007, ONCOGENE, V26, P2554, DOI 10.1038/sj.onc.1210044; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Lacour P, 2007, J NEUROSCI METH, V166, P24, DOI 10.1016/j.jneumeth.2007.06.019; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Maccarrone M, 2006, ENDOCANNABINOIDS: THE BRAIN AND BODY'S MARIJUANA AND BEYOND, P451; Maccarrone M, 2007, PROG NEUROBIOL, V81, P349, DOI 10.1016/j.pneurobio.2006.11.006; Massi P, 2004, J PHARMACOL EXP THER, V308, P838, DOI 10.1124/jpet.103.061002; Massi P, 2008, CURR PHARM DESIGN, V14, P2289, DOI 10.2174/138161208785740135; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Peng Y, 2008, NEUROSCI LETT, V434, P224, DOI 10.1016/j.neulet.2008.01.080; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pettifer KM, 2007, PURINERG SIGNAL, V3, P399, DOI 10.1007/s11302-007-9073-z; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Qi ZY, 2005, CHINESE MED J-PEKING, V118, P799; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Sheline CT, 1998, NEUROBIOL DIS, V5, P47, DOI 10.1006/nbdi.1998.0177; Short DM, 2007, PROTEOMICS, V7, P3085, DOI 10.1002/pmic.200600964; Shu CV, 2008, J CELL PHYSIOL, V215, P627, DOI 10.1002/jcp.21340; Siegmund SV, 2006, J BIOL CHEM, V281, P10431, DOI 10.1074/jbc.M509706200; SMYTH JD, 1989, PHYSL BIOCH CESTODES, P77; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Urbani A, 2005, PROTEOMICS, V5, P796, DOI 10.1002/pmic.200401147; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Wang SF, 2008, TOXICOLOGY, V246, P234, DOI 10.1016/j.tox.2008.01.020; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Wu CW, 2007, TOXICOL APPL PHARM, V220, P243, DOI 10.1016/j.taap.2007.01.011; Yamaji R, 2004, ARCH BIOCHEM BIOPHYS, V423, P332, DOI 10.1016/j.abb.2004.01.003; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu JH, 2008, INT J BIOCHEM CELL B, V40, P503, DOI 10.1016/j.biocel.2007.09.001; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Yuste VJ, 2002, J NEUROCHEM, V80, P126, DOI 10.1046/j.0022-3042.2001.00695.x; Zhou Z, 2001, CYTOGENET CELL GENET, V92, P231, DOI 10.1159/000056909	72	52	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29413	29426		10.1074/jbc.M109.044412	http://dx.doi.org/10.1074/jbc.M109.044412			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19690173	Green Published, hybrid			2022-12-25	WOS:000270896800023
J	Link, W; Oyarzabal, J; Serelde, BG; Albarran, MI; Rabal, O; Cebria, A; Alfonso, P; Fominaya, J; Renner, O; Peregrina, S; Soilan, D; Ceballos, PA; Hernandez, AI; Lorenzo, M; Pevarello, P; Granda, TG; Kurz, G; Carnero, A; Bischoff, JR				Link, Wolfgang; Oyarzabal, Julen; Serelde, Beatriz G.; Isabel Albarran, Maria; Rabal, Obdulia; Cebria, Antonio; Alfonso, Patricia; Fominaya, Jesus; Renner, Oliver; Peregrina, Sandra; Soilan, David; Ceballos, Placido A.; Hernandez, Ana-Isabel; Lorenzo, Milagros; Pevarello, Paolo; Granda, Teresa G.; Kurz, Guido; Carnero, Amancio; Bischoff, James R.			Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; SIGNALING PATHWAY; CELL-SURVIVAL; CANCER; EXPORT; TRANSFORMATION; ACTIVATION; SCREEN; PTEN; P110-ALPHA	Activation of the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway is one the most frequent genetic events in human cancer. A cell-based imaging assay that monitored the translocation of the Akt effector protein, Forkhead box O (FOXO), from the cytoplasm to the nucleus was employed to screen a collection of 33,992 small molecules. The positive compounds were used to screen kinases known to be involved in FOXO translocation. Pyrazolopyrimidine derivatives were found to be potent FOXO relocators as well as biochemical inhibitors of PI3K alpha. A combination of virtual screening and molecular modeling led to the development of a structure-activity relationship, which indicated the preferred substituents on the pyrazolopyrimidine scaffold. This leads to the synthesis of ETP-45658, which is a potent and selective inhibitor of phosphoinositide 3-kinases and demonstrates mechanism of action in tumor cell lines and in vivo in treated mice.	[Link, Wolfgang; Oyarzabal, Julen; Serelde, Beatriz G.; Isabel Albarran, Maria; Rabal, Obdulia; Cebria, Antonio; Alfonso, Patricia; Fominaya, Jesus; Renner, Oliver; Peregrina, Sandra; Soilan, David; Ceballos, Placido A.; Hernandez, Ana-Isabel; Lorenzo, Milagros; Pevarello, Paolo; Granda, Teresa G.; Kurz, Guido; Carnero, Amancio; Bischoff, James R.] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Bischoff, JR (corresponding author), Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	jrbischoff@cnio.es	Higueras, Ana Isabel Hernandez/F-9372-2016; Albarrán, M Isabel M.I.Albarrán/F-3898-2016; IBIS, CANCER/P-3323-2015; Link, Wolfgang/F-4435-2012; Cebriá, Antonio/F-3757-2016; Cebriá, Antonio/AGE-3432-2022; Oyarzabal, Julen/K-7393-2017; Renner, Oliver/M-7002-2015; Rabal, Obdulia/D-3076-2017	Higueras, Ana Isabel Hernandez/0000-0003-2310-3718; Albarrán, M Isabel M.I.Albarrán/0000-0003-0750-3869; Link, Wolfgang/0000-0002-3340-5165; Cebriá, Antonio/0000-0001-8222-0848; Cebriá, Antonio/0000-0001-8222-0848; Oyarzabal, Julen/0000-0003-1941-7255; Renner, Oliver/0000-0002-4046-0517; Rabal, Obdulia/0000-0002-3224-0987; Carnero, Amancio/0000-0003-4357-3979; Granda, Teresa/0000-0002-7490-5932	Spanish Ministerio de Ciencias e Innovacion [BIO2006-02432]	Spanish Ministerio de Ciencias e Innovacion	This work was supported by funding from the Spanish Ministerio de Ciencias e Innovacion (Project BIO2006-02432).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; DiMauro EF, 2006, J MED CHEM, V49, P5671, DOI 10.1021/jm0605482; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; KAROBATH M, 1974, P NATL ACAD SCI USA, V71, P2915, DOI 10.1073/pnas.71.7.2915; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Medvedev AE, 1998, J CHEM INF COMP SCI, V38, P1137, DOI 10.1021/ci9802068; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Renner O, 2008, CANCER RES, V68, P9643, DOI 10.1158/0008-5472.CAN-08-1539; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Turner JG, 2008, CURR MED CHEM, V15, P2648, DOI 10.2174/092986708786242859; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yang J, 2007, CHEM BIOL, V14, P371, DOI 10.1016/j.chembiol.2007.02.004; Zanella F, 2008, CHEMBIOCHEM, V9, P2229, DOI 10.1002/cbic.200800255; Zanella F, 2007, ASSAY DRUG DEV TECHN, V5, P333, DOI 10.1089/adt.2007.058; Zanella F, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-14; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	34	73	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28392	28400		10.1074/jbc.M109.038984	http://dx.doi.org/10.1074/jbc.M109.038984			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690175	Green Published, hybrid			2022-12-25	WOS:000270676300064
J	Fu, J; Zhang, JR; Jin, F; Patchefsky, J; Braunewell, KH; Klein-Szanto, AJ				Fu, Jian; Zhang, Jirong; Jin, Fang; Patchefsky, Jamie; Braunewell, Karl-Heinz; Klein-Szanto, Andres J.			Promoter Regulation of the Visinin-like Subfamily of Neuronal Calcium Sensor Proteins by Nuclear Respiratory Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; CA2+-SENSOR PROTEINS; MAMMALIAN-CELLS; BINDING PROTEIN; FMR1 PROMOTER; FACTOR-A; VILIP-1; BIOGENESIS	VILIP-1 (gene name VSNL1), a member of the neuronal Ca2+ sensor protein family, acts as a tumor suppressor gene by inhibiting cell proliferation, adhesion, and invasiveness. VILIP-1 expression is down-regulated in several types of human cancer. In human non-small cell lung cancer, we found that down-regulation was due to epigenetic changes. Consequently, in this study we analyzed the VSNL1 promoter and its regulation. Serial truncation of the proximal 2-kb VSNL1 promoter (VP-1998) from its 5' terminus disclosed that the last 3' terminal 100-bp promoter fragment maintained similar promoter activity as compared with VP-1998 and therefore was referred to as VSNL1 minimal promoter. When the 5' terminal 50 bp were deleted from the minimal promoter, the activity was dramatically decreased, suggesting that the deleted 50 bp contained a potential cis-acting element crucial for promoter activity. Deletion and site-directed mutagenesis combined with in silico transcription factor binding analysis of VSNL1 promoter identified nuclear respiratory factor (NRF)-1/alpha-PAL as a major player in regulating VSNL1 minimal promoter activity. The function of NRF-1 was further confirmed using dominant-negative NRF-1 overexpression and NRF-1 small interfering RNA knockdown. Electrophoretic mobility shift assay and chromatin immunoprecipitation provided evidence for direct NRF-1 binding to the VSNL1 promoter. Methylation of the NRF-1-binding site was found to be able to regulate VSNL1 promoter activity. Our results further indicated that NRF-1 could be a regulatory factor for gene expression of the other visinin-like subfamily members including HPCAL4, HPCAL1, HPCA, and NCALD.	[Fu, Jian; Zhang, Jirong; Jin, Fang; Patchefsky, Jamie; Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Fu, Jian; Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Canc Genet & Signaling Program, Philadelphia, PA 19111 USA; [Braunewell, Karl-Heinz] So Res Inst, Birmingham, AL 35205 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Klein-Szanto, AJ (corresponding author), Fox Chase Canc Ctr, Dept Pathol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	aj_klein-szanto@fccc.edu			National Institutes of Health [CA107257, CA06927]; Commonwealth of Pennsylvania; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA107257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA107257 and CA06927. This work was also supported by an appropriation from the Commonwealth of Pennsylvania and by a grant from the Pennsylvania Department of Health.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Asangani IA, 2008, GENE, V410, P197, DOI 10.1016/j.gene.2007.12.009; Becker TS, 1998, DEVELOPMENT, V125, P4369; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Blesa JR, 2008, BIOCHEM CELL BIOL, V86, P46, DOI [10.1139/O07-151, 10.1139/o07-151]; Blesa JR, 2007, GENE, V391, P198, DOI 10.1016/j.gene.2006.12.024; Brackmann M, 2004, BIOCHEM BIOPH RES CO, V322, P1073, DOI 10.1016/j.bbrc.2004.08.028; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Braunewell KH, 2003, NEUROPHARMACOLOGY, V44, P707, DOI 10.1016/S0028-3908(03)00051-0; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Chang WT, 2004, J BIOL CHEM, V279, P14542, DOI 10.1074/jbc.M309825200; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Dai FHF, 2006, J BIOL CHEM, V281, P21942, DOI 10.1074/jbc.M512924200; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; DESIMONE SM, 1993, MOL CELL BIOL, V13, P3641, DOI 10.1128/MCB.13.6.3641; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Fu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001698; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gierke P, 2004, BIOCHEM BIOPH RES CO, V323, P38, DOI 10.1016/j.bbrc.2004.08.055; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Guerrico AMG, 2005, ONCOGENE, V24, P2307, DOI 10.1038/sj.onc.1208476; Haussmann IU, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r73; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Izumi H, 2003, BIOCHEM J, V373, P713, DOI 10.1042/BJ20021902; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kherrouche Z, 2004, BIOCHEM J, V383, P529, DOI 10.1042/BJ20040935; Kobayashi M, 2005, NEUROSCIENCE, V133, P471, DOI 10.1016/j.neuroscience.2005.02.034; Kumari D, 2001, J BIOL CHEM, V276, P4357, DOI 10.1074/jbc.M009629200; KUZMIN I, 1995, ONCOGENE, V10, P2185; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Mahloogi H, 2003, CANCER RES, V63, P4997; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Myers SJ, 1998, J NEUROSCI, V18, P6723; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200; Rozenberg JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-67; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Smith KT, 2004, HUM MOL GENET, V13, P1611, DOI 10.1093/hmg/ddh172; Spilker C, 2002, BBA-PROTEINS PROTEOM, V1600, P118, DOI 10.1016/S1570-9639(02)00452-1; Takahashi Y, 2002, BBA-GENE STRUCT EXPR, V1574, P359, DOI 10.1016/S0167-4781(01)00374-8; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wickborn C, 2006, MOL CARCINOGEN, V45, P572, DOI 10.1002/mc.20201; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yu ZY, 2004, J BIOL CHEM, V279, P46954, DOI 10.1074/jbc.M407192200	53	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27577	27586		10.1074/jbc.M109.049361	http://dx.doi.org/10.1074/jbc.M109.049361			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19674972	Green Published, hybrid			2022-12-25	WOS:000270232300059
J	Solt, LA; Madge, LA; May, MJ				Solt, Laura A.; Madge, Lisa A.; May, Michael J.			NEMO-binding Domains of Both IKK alpha and IKK beta Regulate I kappa B Kinase Complex Assembly and Classical NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; DEPENDENT GENE-EXPRESSION; SEVERE LIVER DEGENERATION; PROTEIN PHOSPHATASE 2A; ESSENTIAL MODULATOR; GENOTOXIC STIMULI; P65 SUBUNIT; PHOSPHORYLATION; GAMMA; TRANSCRIPTION	Proinflammatory NF-kappa B activation requires the I kappa B (inhibitor of NF-kappa B) kinase (IKK) complex that contains two catalytic subunits named IKK alpha and IKK beta and a regulatory subunit named NF-kappa B essential modulator (NEMO). NEMO and IKK beta are essential for tumor necrosis factor (TNF)-induced NF-kappa B activation, and we recently demonstrated that NEMO and IKK alpha are sufficient for interleukin (IL)-1-induced signaling. IKK alpha and IKK beta both contain a functional NEMO-binding domain (NBD); however, the role of NEMO association with each kinase in NF-kappa B signaling and IKK complex formation remains unclear. To address this question, we stably reconstituted IKK alpha(-/-) and IKK beta(-/-) murine embryonic fibroblasts (MEFs) with wild-type (WT) or NBD-deficient (Delta NBD) versions of IKK alpha and IKK beta, respectively. TNF-induced classical NF-kappa B activation in IKK beta(-/-) MEFs was rescued by IKK beta(WT) but not IKK beta(Delta NBD), whereas neither IKK beta(WT) nor IKK beta(Delta NBD) affected IL-1-induced NF-kappa B signaling. As previously described, classical NF-kappa B transcriptional activity was absent in IKK alpha(-/-) cells. Reconstitution with either IKK alpha(WT) or IKK alpha(Delta NBD) rescued both IL-1 and TNF-induced transcription, demonstrating that NEMO association is not required for IKK alpha-dependent regulation of NF-kappa B-dependent transcription. Stably expressed IKK alpha(WT) or IKK beta(WT) associated with endogenous IKKs and NEMO in IKK alpha(-/-) or IKK beta(-/-) MEFs, respectively, resulting in formation of the heterotrimeric IKK alpha-IKK beta-NEMO complex. In contrast, although the IKK alpha(Delta NBD) and IKK beta(Delta NBD) mutants associated with endogenous IKKs containing an NBD, these dimeric endogenous IKK-IKK Delta NBD complexes did not associate with NEMO. These findings therefore demonstrate that formation of the heterotrimeric IKK alpha-IKK beta-NEMO holocomplex absolutely requires two intact NEMO-binding domains.	[Solt, Laura A.; Madge, Lisa A.; May, Michael J.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [May, Michael J.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	May, MJ (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St,OVH 200E, Philadelphia, PA 19104 USA.	maym@vet.upenn.edu		May, Michael/0000-0002-2485-3716	National Institutes of Health [1RO1-HL-080612, T32-AI-055428-06]; W.W. Smith Charitable Trust [H0703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.W. Smith Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1-HL-080612 and T32-AI-055428-06. This work was also supported by W.W. Smith Charitable Trust Grant H0703.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fontan E, 2007, FEBS J, V274, P2540, DOI 10.1111/j.1742-4658.2007.05788.x; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Higashimoto T, 2008, J BIOL CHEM, V283, P35354, DOI 10.1074/jbc.M806258200; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hong S, 2007, J BIOL CHEM, V282, P12119, DOI 10.1074/jbc.M610392200; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Khoshnan A, 1999, J IMMUNOL, V163, P5444; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Marienfeld RB, 2006, MOL CELL BIOL, V26, P9209, DOI 10.1128/MCB.00478-06; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Orange JS, 2008, CELL MOL LIFE SCI, V65, P3564, DOI 10.1007/s00018-008-8222-z; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Verma UN, 2004, J BIOL CHEM, V279, P3509, DOI 10.1074/jbc.M309300200; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	60	31	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27596	27608		10.1074/jbc.M109.047563	http://dx.doi.org/10.1074/jbc.M109.047563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666475	Green Published, hybrid			2022-12-25	WOS:000270232300061
J	Berger, TG; Schulze-Koops, H; Schafer, M; Muller, E; Lutz, MB				Berger, Thomas G.; Schulze-Koops, Hendrik; Schaefer, Michaela; Mueller, Ester; Lutz, Manfred B.			Immature and Maturation-Resistant Human Dendritic Cells Generated from Bone Marrow Require Two Stimulations to Induce T Cell Anergy In Vitro	PLOS ONE			English	Article							CLONAL ANERGY; IL-12 PRODUCTION; ALLOGRAFT SURVIVAL; LANGERHANS CELLS; GM-CSF; TOLERANCE; CTLA-4; ACTIVATION; INHIBITION; THERAPY	Immature dendritic cells (DC) represent potential clinical tools for tolerogenic cellular immunotherapy in both transplantation and autoimmunity. A major drawback in vivo is their potential to mature during infections or inflammation, which would convert their tolerogenicity into immunogenicity. The generation of immature DC from human bone marrow (BM) by low doses of GM-CSF (lowGM) in the absence of IL-4 under GMP conditions create DC resistant to maturation, detected by surface marker expression and primary stimulation by allogeneic T cells. This resistence could not be observed for BM-derived DC generated with high doses of GM-CSF plus IL-4 (highGM/4), although both DC types induced primary allogeneic T cell anergy in vitro. The estabishment of the anergic state requires two subsequent stimulations by immature DC. Anergy induction was more profound with lowGM-DC due to their maturation resistance. Together, we show the generation of immature, maturation-resistant lowGM-DC for potential clinical use in transplant rejection and propose a two-step-model of T cell anergy induction by immature DC.	[Berger, Thomas G.; Schaefer, Michaela; Mueller, Ester; Lutz, Manfred B.] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany; [Schulze-Koops, Hendrik] Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany; [Lutz, Manfred B.] Univ Wurzburg, Inst Virol & Immunbiol, D-8700 Wurzburg, Germany; [Berger, Thomas G.] Johns Hopkins Med, Tawam Hosp, Div Dermatol, Al Ain, U Arab Emirates; [Schulze-Koops, Hendrik] Univ Munich, Med Poliklin, Div Rheumatol, Munich, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Wurzburg; Johns Hopkins University; Johns Hopkins Medicine; University of Munich	Berger, TG (corresponding author), Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany.	m.lutz@vim.uni-wuerzburg.de		Lutz, Manfred B./0000-0001-9193-1772	Interdisciplinary Center for Clinical Research (IZKF) Erlangen; Marohn-Foundation Erlangen; German Research Foundation [DFG LU851/4-1]; ELAN-Fonds Erlangen	Interdisciplinary Center for Clinical Research (IZKF) Erlangen; Marohn-Foundation Erlangen; German Research Foundation(German Research Foundation (DFG)); ELAN-Fonds Erlangen	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) Erlangen, the Marohn-Foundation Erlangen, and by an individual grant of the German Research Foundation (DFG LU851/4-1) for MBL, and the ELAN-Fonds Erlangen for TGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2009, HUM IMMUNOL, V70, P345, DOI 10.1016/j.humimm.2009.01.016; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berthier-Vergnes O, 2005, FEBS LETT, V579, P3660, DOI 10.1016/j.febslet.2005.04.087; Bluestone JA, 2007, NAT REV IMMUNOL, V7, P650, DOI 10.1038/nri2137; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; DESILVA DR, 1991, J IMMUNOL, V147, P3261; Dietze B, 2008, IMMUNOBIOLOGY, V213, P751, DOI 10.1016/j.imbio.2008.07.024; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Fu FM, 1996, TRANSPLANTATION, V62, P659, DOI 10.1097/00007890-199609150-00021; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Howland KC, 2000, J IMMUNOL, V164, P4465, DOI 10.4049/jimmunol.164.9.4465; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; KAWABE Y, 1990, J EXP MED, V172, P1065, DOI 10.1084/jem.172.4.1065; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lutz M.B., 2006, HDB DENDRITIC CELLS, P517; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Macian F, 2004, CURR OPIN IMMUNOL, V16, P209, DOI 10.1016/j.coi.2004.01.013; McIlroy D, 2001, BLOOD, V97, P3470, DOI 10.1182/blood.V97.11.3470; MELAMED D, 1993, EUR J IMMUNOL, V23, P935, DOI 10.1002/eji.1830230426; Menges M, 2005, J LEUKOCYTE BIOL, V77, P535, DOI 10.1189/jlb.0804473; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Powell JD, 1999, J IMMUNOL, V162, P2775; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; Sato K, 2003, BLOOD, V101, P3581, DOI 10.1182/blood-2002-09-2712; Schneider H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003842; SCHWARTZ RH, 1989, COLD SPRING HARB SYM, V54, P605; SIMON JC, 1991, J IMMUNOL, V146, P485; Sousa CRE, 2001, IMMUNITY, V14, P495; Stax AM, 2008, TRANSPLANTATION, V86, P1275, DOI 10.1097/TP.0b013e31818a6682; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Thomson AW, 2009, TRANSPL P, V41, P537, DOI 10.1016/j.transproceed.2009.01.011; Turnquist HR, 2008, CURR OPIN ORGAN TRAN, V13, P350, DOI 10.1097/MOT.0b013e328306116c; Valk E, 2008, TRENDS IMMUNOL, V29, P272, DOI 10.1016/j.it.2008.02.011; van Kooten Cees, 2009, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-540-71029-5_11; Velasquez-Lopera MM, 2008, CLIN EXP IMMUNOL, V154, P107, DOI 10.1111/j.1365-2249.2008.03734.x; Verdoodt B, 2003, EUR J IMMUNOL, V33, P3154, DOI 10.1002/eji.200323960; Vlad G, 2009, HUM IMMUNOL, V70, P340, DOI 10.1016/j.humimm.2009.03.004; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Woltman AM, 2000, EUR J IMMUNOL, V30, P1807, DOI 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zahorchak AF, 2007, TRANSPLANTATION, V84, P196, DOI 10.1097/01.tp.0000268582.21168.f6	50	25	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6645	10.1371/journal.pone.0006645	http://dx.doi.org/10.1371/journal.pone.0006645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680551	Green Submitted, Green Published, gold			2022-12-25	WOS:000268936200011
J	Nolan, A; Kobayashi, H; Naveed, B; Kelly, A; Hoshino, Y; Hoshino, S; Karulf, MR; Rom, WN; Weiden, MD; Gold, JA				Nolan, Anna; Kobayashi, Hiroshi; Naveed, Bushra; Kelly, Ann; Hoshino, Yoshihiko; Hoshino, Satomi; Karulf, Matthew R.; Rom, William N.; Weiden, Michael D.; Gold, Jeffrey A.			Differential Role for CD80 and CD86 in the Regulation of the Innate Immune Response in Murine Polymicrobial Sepsis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODY; UNITED-STATES; DOUBLE-BLIND; CD28; LETHALITY; TRIAL; CD40; CELL; COSTIMULATION	Background: Inflammation in the early stages of sepsis is governed by the innate immune response. Costimulatory molecules are a receptor/ligand class of molecules capable of regulation of inflammation in innate immunity via macrophage/neutrophil contact. We recently described that CD80/86 ligation is required for maximal macrophage activation and CD80/86(-/-) mice display reduced mortality and inflammatory cytokine production after cecal ligation and puncture (CLP). However, these data also demonstrate differential regulation of CD80 and CD86 expression in sepsis, suggesting a divergent role for these receptors. Therefore, the goal of this study was to determine the individual contribution of CD80/86 family members in regulating inflammation in sepsis. Methodology/Principal Findings: CD80(-/-) mice had improved survival after CLP when compared to WT or CD86(-/-) mice. This was associated with preferential attenuation of inflammatory cytokine production in CD80(-/-) mice. Results were confirmed with pharmacologic blockade, with anti-CD80 mAb rescuing mice when administered before or after CLP. In vitro, activation of macrophages with neutrophil lipid rafts caused selective disassociation of IRAK-M, a negative regulator of NFkB signaling from CD80; providing a mechanism for preferential regulation of cytokine production by CD80. Finally, in humans, upregulation of CD80 and loss of constitutive CD86 expression on monocytes was associated with higher severity of illness and inflammation confirming the findings in our mouse model. Conclusions: In conclusion, our data describe a differential role for CD80 and CD86 in regulation of inflammation in the innate immune response to sepsis. Future therapeutic strategies for blockade of the CD80/86 system in sepsis should focus on direct inhibition of CD80.	[Nolan, Anna; Kobayashi, Hiroshi; Naveed, Bushra; Hoshino, Yoshihiko; Hoshino, Satomi; Rom, William N.; Weiden, Michael D.] NYU, Sch Med, Div Pulm Crit Care, New York, NY 10003 USA; [Kelly, Ann; Karulf, Matthew R.; Gold, Jeffrey A.] Oregon Hlth & Sci Univ, Div Pulm Crit Care, Portland, OR 97201 USA	New York University; Oregon Health & Science University	Nolan, A (corresponding author), NYU, Sch Med, Div Pulm Crit Care, New York, NY 10003 USA.	goldje@ohsu.edu	Nolan, Anna/C-2796-2012; Hoshino, Yoshihiko/B-5159-2019	Nolan, Anna/0000-0002-0631-1171; Hoshino, Yoshihiko/0000-0002-3132-0715; Rom, William/0000-0002-8793-7028; gold, jeffrey/0000-0001-6683-9907	NIH [M01 00096, T32ES007267, K23HL084191, K24A1080298, R01HL057879, R01A1067522]; Stony-Wold Herbert Fund; ECRIP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090316, R01HL057879, K23HL084191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI080298, R01AI067522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony-Wold Herbert Fund; ECRIP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding Sources: NIH M01 00096, T32ES007267, K23HL084191, K24A1080298, R01HL057879, R01A1067522, Stony-Wold Herbert Fund, ECRIP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 1998, LANCET, V351, P929; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Gold JA, 2003, INFECT IMMUN, V71, P3521, DOI 10.1128/IAI.71.6.3521-3528.2003; Gold JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000736; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hager ACM, 2003, SCAND J IMMUNOL, V57, P517, DOI 10.1046/j.1365-3083.2003.01271.x; Hoshino Y, 2007, J INFECT DIS, V195, P1303, DOI 10.1086/513438; Hosiawa KA, 2005, J IMMUNOL, V175, P6197, DOI 10.4049/jimmunol.175.9.6197; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Mandelbrot DA, 2001, J CLIN INVEST, V107, P881, DOI 10.1172/JCI11710; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Newton Sarah, 2004, Surg Infect (Larchmt), V5, P375, DOI 10.1089/sur.2004.5.375; Nolan A, 2008, AM J RESP CRIT CARE, V177, P301, DOI 10.1164/rccm.200703-515OC; Okano M, 2001, AM J RESP CRIT CARE, V164, P1501, DOI 10.1164/ajrccm.164.8.2011072; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; ORABONA C, 2004, NAT IMMUNOL; REMICK D, 1995, SHOCK, V4, P89, DOI 10.1097/00024382-199508000-00002; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Remick DG, 2001, CRIT CARE MED, V29, P473, DOI 10.1097/00003246-200103000-00001; Saha B, 1996, J EXP MED, V183, P2675, DOI 10.1084/jem.183.6.2675; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Schwulst SJ, 2006, J IMMUNOL, V177, P557, DOI 10.4049/jimmunol.177.1.557; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tzianabos AO, 2000, INFECT IMMUN, V68, P6650, DOI 10.1128/IAI.68.12.6650-6655.2000; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Venuprasad K, 2002, J IMMUNOL, V169, P920, DOI 10.4049/jimmunol.169.2.920; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007	32	78	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6600	10.1371/journal.pone.0006600	http://dx.doi.org/10.1371/journal.pone.0006600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672303	gold, Green Submitted, Green Published			2022-12-25	WOS:000268935900014
J	Oliveira, SJ; Pinto, JP; Picarote, G; Costa, VM; Carvalho, F; Rangel, M; de Sousa, M; de Almeida, SF				Oliveira, Susana J.; Pinto, Jorge P.; Picarote, Goncalo; Costa, Vera M.; Carvalho, Felix; Rangel, Maria; de Sousa, Maria; de Almeida, Sergio F.			ER Stress-Inducible Factor CHOP Affects the Expression of Hepcidin by Modulating C/EBPalpha Activity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; IRON-MEDIATED REGULATION; PROTEIN; GENE; BINDING; METABOLISM; REGULATOR; LIVER; HEMOCHROMATOSIS; TRANSCRIPTION	Endoplasmic reticulum (ER) stress induces a complex network of pathways collectively termed the unfolded protein response (UPR). The clarification of these pathways has linked the UPR to the regulation of several physiological processes. However, its crosstalk with cellular iron metabolism remains unclear, which prompted us to examine whether an UPR affects the expression of relevant iron-related genes. For that purpose, the HepG2 cell line was used as model and the UPR was activated by dithiothreitol (DTT) and homocysteine (Hcys). Here, we report that hepcidin, a liver secreted hormone that shepherds iron homeostasis, exhibits a biphasic pattern of expression following UPR activation: its levels decreased in an early stage and increased with the maintenance of the stress response. Furthermore, we show that immediately after stressing the ER, the stress-inducible transcription factor CHOP depletes C/EBP alpha protein pool, which may in turn impact on the activation of hepcidin transcription. In the later period of the UPR, CHOP levels decreased progressively, enhancing C/EBP alpha-binding to the hepcidin promoter. In addition, analysis of ferroportin and ferritin H revealed that the transcript levels of these iron-genes are increased by the UPR signaling pathways. Taken together, our findings suggest that the UPR can have a broad impact on the maintenance of cellular iron homeostasis.	[Oliveira, Susana J.; Pinto, Jorge P.; Picarote, Goncalo; de Sousa, Maria; de Almeida, Sergio F.] Univ Porto, Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Costa, Vera M.; Carvalho, Felix] Univ Porto, Fac Farm, Dept Toxicol, REQUIMTE, P-4100 Oporto, Portugal; [Rangel, Maria] Univ Porto, REQUIMTE, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Oliveira, SJ (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	mdesousa@ibmc.up.pt	de Almeida, Sergio/H-3002-2019; Carvalho, Félix/D-4914-2013; de Almeida, Sergio F/F-9197-2010; Rangel, Maria/B-3732-2012; Costa, Vera Marisa/D-6284-2013; Rangel, Maria/B-3732-2012; Pinto, Jorge/J-7827-2013	de Almeida, Sergio/0000-0002-7774-1355; Carvalho, Félix/0000-0003-3858-3494; de Almeida, Sergio F/0000-0002-7774-1355; Rangel, Maria/0000-0002-0998-1437; Costa, Vera Marisa/0000-0002-0471-2756; de sousa, maria/0000-0002-4552-185X; Oliveira, Susana Joao/0000-0002-6834-8703; Rangel, Maria/0000-0002-2423-3154; Pinto, Jorge/0000-0003-1501-458X	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/BIA-BCM/66818/2006, SFRH/BD/19682/2004]	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This work was financed by the research grant PTDC/BIA-BCM/66818/2006 from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. SJO is recipient of a PhD fellowship funded by FCT: SFRH/BD/19682/2004. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Chua ACG, 2007, CRIT REV CL LAB SCI, V44, P413, DOI 10.1080/10408360701428257; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gleeson F, 2007, BLOOD CELL MOL DIS, V38, P37, DOI 10.1016/j.bcmd.2006.09.008; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Harrison-Findik DD, 2007, HEPATOLOGY, V46, P1979, DOI 10.1002/hep.21895; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Jacolot S, 2008, BLOOD CELL MOL DIS, V41, P100, DOI 10.1016/j.bcmd.2008.01.006; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lymboussaki A, 2003, J HEPATOL, V39, P710, DOI 10.1016/S0168-8278(03)00408-2; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Outinen PA, 1998, BIOCHEM J, V332, P213, DOI 10.1042/bj3320213; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Ruscher K, 2000, J BIOTECHNOL, V78, P163, DOI 10.1016/S0168-1656(00)00207-8; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; RYDEN TA, 1989, MOL CELL BIOL, V9, P1155, DOI 10.1128/MCB.9.3.1155; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; You KR, 2003, HEPATOLOGY, V38, P745, DOI 10.1053/jhep.2003.50367; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zoller H, 2002, BLOOD CELL MOL DIS, V29, P488, DOI 10.1006/bcmd.2002.0587	42	78	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6618	10.1371/journal.pone.0006618	http://dx.doi.org/10.1371/journal.pone.0006618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672300	gold, Green Submitted, Green Published			2022-12-25	WOS:000268935900027
J	Wood, JN				Wood, Justin N.			Distinct Visual Working Memory Systems for View-Dependent and View-Invariant Representation	PLOS ONE			English	Article							SHORT-TERM-MEMORY; LATERAL OCCIPITAL COMPLEX; LANDMARK GUIDANCE; OBJECT SHAPE; CAPACITY; NAVIGATION; RECOGNITION; INFORMATION; STORAGE; NUMBER	Background: How do people sustain a visual representation of the environment? Currently, many researchers argue that a single visual working memory system sustains non-spatial object information such as colors and shapes. However, previous studies tested visual working memory for two-dimensional objects only. In consequence, the nature of visual working memory for three-dimensional (3D) object representation remains unknown. Methodology/Principal Findings: Here, I show that when sustaining information about 3D objects, visual working memory clearly divides into two separate, specialized memory systems, rather than one system, as was previously thought. One memory system gradually accumulates sensory information, forming an increasingly precise view-dependent representation of the scene over the course of several seconds. A second memory system sustains view-invariant representations of 3D objects. The view-dependent memory system has a storage capacity of 3-4 representations and the view-invariant memory system has a storage capacity of 1-2 representations. These systems can operate independently from one another and do not compete for working memory storage resources. Conclusions/Significance: These results provide evidence that visual working memory sustains object information in two separate, specialized memory systems. One memory system sustains view-dependent representations of the scene, akin to the view-specific representations that guide place recognition during navigation in humans, rodents and insects. The second memory system sustains view-invariant representations of 3D objects, akin to the object-based representations that underlie object cognition.	Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	University of Southern California	Wood, JN (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	justin.wood@usc.edu			University of Southern California	University of Southern California	This work was supported by the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Baddeley A., 2007, WORKING MEMORY THOUG; BESNER D, 1981, Q J EXP PSYCHOL-A, V33, P415, DOI 10.1080/14640748108400801; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BRADY T, 2008, P NATL ACAD SCI USA, V38, P1425; Carey S, 2001, J EXP CHILD PSYCHOL, V78, P55, DOI 10.1006/jecp.2000.2603; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; Cheng K, 2008, TRENDS COGN SCI, V12, P355, DOI 10.1016/j.tics.2008.06.004; Collett M, 2000, BIOL CYBERN, V83, P245, DOI 10.1007/s004220000168; Collett TS, 1997, J COMP PHYSIOL A, V181, P47, DOI 10.1007/s003590050092; COLLETT TS, 1993, P ROY SOC B-BIOL SCI, V252, P129, DOI 10.1098/rspb.1993.0056; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Gillner S, 2008, COGNITION, V109, P105, DOI 10.1016/j.cognition.2008.07.018; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Jacobs WJ, 1998, LEARN MOTIV, V29, P288, DOI 10.1006/lmot.1998.1008; Judd SPD, 1998, NATURE, V392, P710, DOI 10.1038/33681; Kallai J, 2007, BEHAV NEUROSCI, V121, P21, DOI 10.1037/0735-7044.121.1.21; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Logie R. H., 1995, VISUAL SPATIAL WORKI; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Morey CC, 2004, PSYCHON B REV, V11, P296, DOI 10.3758/BF03196573; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; SUTHERLAND RJ, 1987, PSYCHOBIOLOGY, V15, P48; Trullier O, 1997, PROG NEUROBIOL, V51, P483, DOI 10.1016/S0301-0082(96)00060-3; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	32	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6601	10.1371/journal.pone.0006601	http://dx.doi.org/10.1371/journal.pone.0006601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	483BA	19668380	Green Published, gold, Green Submitted			2022-12-25	WOS:000268935600019
J	Silkworth, WT; Nardi, IK; Scholl, LM; Cimini, D				Silkworth, William T.; Nardi, Isaac K.; Scholl, Lindsey M.; Cimini, Daniela			Multipolar Spindle Pole Coalescence Is a Major Source of Kinetochore Mis-Attachment and Chromosome Mis-Segregation in Cancer Cells	PLOS ONE			English	Article							CENTROSOME AMPLIFICATION; INSTABILITY; ORIENTATION; ANEUPLOIDY; ANAPHASE; DEFECTS; TUMORIGENESIS; MECHANISMS; STABILITY; BRIDGES	Many cancer cells display a CIN (Chromosome Instability) phenotype, by which they exhibit high rates of chromosome loss or gain at each cell cycle. Over the years, a number of different mechanisms, including mitotic spindle multipolarity, cytokinesis failure, and merotelic kinetochore orientation, have been proposed as causes of CIN. However, a comprehensive theory of how CIN is perpetuated is still lacking. We used CIN colorectal cancer cells as a model system to investigate the possible cellular mechanism(s) underlying CIN. We found that CIN cells frequently assembled multipolar spindles in early mitosis. However, multipolar anaphase cells were very rare, and live-cell experiments showed that almost all CIN cells divided in a bipolar fashion. Moreover, fixed-cell analysis showed high frequencies of merotelically attached lagging chromosomes in bipolar anaphase CIN cells, and higher frequencies of merotelic attachments in multipolar vs. bipolar prometaphases. Finally, we found that multipolar CIN prometaphases typically possessed c-tubulin at all spindle poles, and that a significant fraction of bipolar metaphase/early anaphase CIN cells possessed more than one centrosome at a single spindle pole. Taken together, our data suggest a model by which merotelic kinetochore attachments can easily be established in multipolar prometaphases. Most of these multipolar prometaphase cells would then bi-polarize before anaphase onset, and the residual merotelic attachments would produce chromosome mis-segregation due to anaphase lagging chromosomes. We propose this spindle pole coalescence mechanism as a major contributor to chromosome instability in cancer cells.			Silkworth, WT (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	cimini@vt.edu	Cimini, Daniela/A-3039-2016	Cimini, Daniela/0000-0002-4082-4894				Acilan C, 2008, CELL, V134, P572, DOI 10.1016/j.cell.2008.08.007; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Canman JC, 2002, CELL MOTIL CYTOSKEL, V52, P61, DOI 10.1002/cm.10032; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2002, J CELL SCI, V115, P507; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Cimini D, 2007, CELL CYCLE, V6, P1558, DOI 10.4161/cc.6.13.4452; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; GANEM NJ, 2009, NATURE; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Gisselsson D, 2005, CELL CYCLE, V4, P1007, DOI 10.4161/cc.4.8.1884; Gisselsson D, 2005, GENE CHROMOSOME CANC, V42, P22, DOI 10.1002/gcc.20094; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Jin YS, 2007, CLIN CANCER RES, V13, P1703, DOI 10.1158/1078-0432.CCR-06-2705; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lingle WL, 2005, ADV EXP MED BIOL, V570, P393, DOI 10.1007/1-4020-3764-3_14; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Masuda A, 2002, ONCOGENE, V21, P6884, DOI 10.1038/sj.onc.1205566; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Pellman D, 2001, SCIENCE, V291, P2555, DOI 10.1126/science.1057337; Pihan GA, 2001, CANCER RES, V61, P2212; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Rajagopalan H, 2004, CANCER CHEMOTH PHARM, V54, pS65, DOI 10.1007/s00280-004-0889-8; Reing JE, 2004, CANCER GENET CYTOGEN, V150, P57, DOI 10.1016/j.cancergencyto.2003.08.002; Rieder C.L., 1990, International Review of Cytology, V122, P153, DOI 10.1016/S0074-7696(08)61208-5; Sato N, 2001, CANCER GENET CYTOGEN, V126, P13, DOI 10.1016/S0165-4608(00)00384-8; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Stewenius Y, 2007, CLIN CANCER RES, V13, P6593, DOI 10.1158/1078-0432.CCR-07-1081; Suryawan A, 2009, FASEB J, V23; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tighe A, 2001, EMBO REP, V2, P609, DOI 10.1093/embo-reports/kve127; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wolf KW, 1996, J SUBMICR CYTOL PATH, V28, P369; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yuen KW, 2008, J CELL BIOL, V180, P661, DOI 10.1083/jcb.200801030	47	308	316	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6564	10.1371/journal.pone.0006564	http://dx.doi.org/10.1371/journal.pone.0006564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668340	Green Published, gold, Green Submitted			2022-12-25	WOS:000268773300006
J	Thangaraj, K; Nandan, A; Sharma, V; Sharma, VK; Eaaswarkhanth, M; Patra, PK; Singh, S; Rekha, S; Dua, M; Verma, N; Reddy, AG; Singh, L				Thangaraj, Kumarasamy; Nandan, Amrita; Sharma, Vishwas; Sharma, Varun Kumar; Eaaswarkhanth, Muthukrishnan; Patra, Pradeep Kumar; Singh, Sandhya; Rekha, Sashi; Dua, Monika; Verma, Narendra; Reddy, Alla G.; Singh, Lalji			Deep Rooting In-Situ Expansion of mtDNA Haplogroup R8 in South Asia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; PHYLOGEOGRAPHY; SETTLEMENT; HISTORIES; PHYLOGENY; LINEAGES; SEQUENCE; HERITAGE; INDIA	Background: The phylogeny of the indigenous Indian-specific mitochondrial DNA (mtDNA) haplogroups have been determined and refined in previous reports. Similar to mtDNA superhaplogroups M and N, a profusion of reports are also available for superhaplogroup R. However, there is a dearth of information on South Asian subhaplogroups in particular, including R8. Therefore, we ought to access the genealogy and pre-historic expansion of haplogroup R8 which is considered one of the autochthonous lineages of South Asia. Methodology/Principal Findings: Upon screening the mtDNA of 5,836 individuals belonging to 104 distinct ethnic populations of the Indian subcontinent, we found 54 individuals with the HVS-I motif that defines the R8 haplogroup. Complete mtDNA sequencing of these 54 individuals revealed two deep-rooted subclades: R8a and R8b. Furthermore, these subclades split into several fine subclades. An isofrequency contour map detected the highest frequency of R8 in the state of Orissa. Spearman's rank correlation analysis suggests significant correlation of R8 occurrence with geography. Conclusions/Significance: The coalescent age of newly-characterized subclades of R8, R8a (15.4 +/- 7.2 Kya) and R8b (25.7 +/- 10.2 Kya) indicates that the initial maternal colonization of this haplogroup occurred during the middle and upper Paleolithic period, roughly around 40 to 45 Kya. These results signify that the southern part of Orissa currently inhabited by Munda speakers is likely the origin of these autochthonous maternal deep-rooted haplogroups. Our high-resolution study on the genesis of R8 haplogroup provides ample evidence of its deep-rooted ancestry among the Orissa (Austro-Asiatic) tribes.			Thangaraj, K (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	thangs@ccmb.res.in; lalji@ccmb.res.in	Sharma, Varun Kumar/AAQ-5947-2020; Thangaraj, Kumarasamy/G-5596-2010; Muthukrishnan, Eaaswarkhanth/AAA-7106-2022	Muthukrishnan, Eaaswarkhanth/0000-0001-9631-8555; Thangaraj, Kumarasamy/0000-0002-0075-0106; Sharma, Varun Kumar/0000-0001-8575-6939; Sharma, Vishwas/0000-0002-1345-7873				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barik SS, 2008, AM J PHYS ANTHROPOL, V136, P19, DOI 10.1002/ajpa.20773; Chaubey G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-227; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Delfiner P, 1976, ADV GEOSTATISTICS MI, P49; GADGIL M, 1998, HUMAN HERITAGE, P100; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kumar V, 2003, J BIOSCIENCES, V28, P507, DOI 10.1007/BF02705125; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Reddy BM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001141; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider S., 2000, ARLEQUIN VER 2 000 S; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thangaraj K, 2006, SCIENCE, V311, DOI 10.1126/science.1120670; Thangaraj K, 2005, HUM GENET, V116, P507, DOI 10.1007/s00439-005-1271-6; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151	24	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6545	10.1371/journal.pone.0006545	http://dx.doi.org/10.1371/journal.pone.0006545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662095	Green Submitted, gold, Green Published			2022-12-25	WOS:000268739600004
J	Dutia, BM; Reid, SJ; Drummond, DD; Ligertwood, Y; Bennet, I; Rietberg, W; Silvia, O; Jarvis, MA; Nash, AA				Dutia, Bernadette M.; Reid, Stuart J.; Drummond, Derek D.; Ligertwood, Yvonne; Bennet, Ian; Rietberg, Willard; Silvia, Ondine; Jarvis, Michael A.; Nash, Anthony A.			A Novel Cre Recombinase Imaging System for Tracking Lymphotropic Virus Infection In Vivo	PLOS ONE			English	Article								Background: Detection, isolation, and identification of individual virus infected cells during long term infection are critical to advance our understanding of mechanisms of pathogenesis for latent/persistent viruses. However, current approaches to study these viruses in vivo have been hampered by low sensitivity and effects of cell-type on expression of viral encoded reporter genes. We have designed a novel Cre recombinase (Cre)-based murine system to overcome these problems, and thereby enable tracking and isolation of individual in vivo infected cells. Methodology/Principal findings: Murine gammaherpesvirus 68 (MHV-68) was used as a prototypic persistent model virus. A Cre expressing recombinant virus was constructed and characterised. The virus is attenuated both in lytic virus replication, producing ten-fold lower lung virus titres than wild type virus, and in the establishment of latency. However, despite this limitation, when the sEGFP7 mouse line containing a Cre-activated enhanced green fluorescent protein (EGFP) was infected with the Cre expressing virus, sites of latent and persistent virus infection could be identified within B cells and macrophages of the lymphoid system on the basis of EGFP expression. Importantly, the use of the sEGFP7 mouse line which expresses high levels of EGFP allowed individual virus positive cells to be purified by FACSorting. Virus gene expression could be detected in these cells. Low numbers of EGFP positive cells could also be detected in the bone marrow. Conclusions/Significance: The use of this novel Cre-based virus/mouse system allowed identification of individual latently infected cells in vivo and may be useful for the study and long-term monitoring of other latent/persistent virus infections.			Dutia, BM (corresponding author), Univ Edinburgh, Roslin Inst, Ctr Infect Dis, Summerhall, Edinburgh, Midlothian, Scotland.	B.M.Dutia@ed.ac.uk		Jarvis, Michael A/0000-0002-0124-4061	Biotechnology and Biological Sciences Research Council [S18918] Funding Source: Medline; NIAID NIH HHS [R01 AI021640, AI21640, R37 AI021640] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021640, R37AI021640] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Adler H, 2001, J VIROL, V75, P5692, DOI 10.1128/JVI.75.12.5692-5696.2001; Boldogkoi Z, 1999, LUMINESCENCE, V14, P69, DOI 10.1002/(SICI)1522-7243(199903/04)14:2<69::AID-BIO509>3.3.CO;2-2; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Clambey ET, 2000, J VIROL, V74, P1973, DOI 10.1128/JVI.74.4.1973-1984.2000; Dienglewicz RL, 1999, ACTA VIROL, V43, P106; Dutia BM, 2004, J GEN VIROL, V85, P1393, DOI 10.1099/vir.0.79908-0; Dutia BM, 1997, J VIROL, V71, P4278, DOI 10.1128/JVI.71.6.4278-4283.1997; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; ECOBPRINCE MS, 1995, J GEN VIROL, V76, P1527, DOI 10.1099/0022-1317-76-6-1527; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1365, DOI 10.1099/0022-1317-71-6-1365; Flano E, 2003, J IMMUNOL, V170, P3828, DOI 10.4049/jimmunol.170.7.3828; Flano E, 2002, J EXP MED, V196, P1363, DOI 10.1084/jem.20020890; Gilchrist DS, 2003, GENESIS, V36, P168, DOI 10.1002/gene.10209; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Lachmann RH, 1996, J GEN VIROL, V77, P2575, DOI 10.1099/0022-1317-77-10-2575; Lachmann RH, 1997, J VIROL, V71, P3197, DOI 10.1128/JVI.71.4.3197-3207.1997; LOKENSGARD JR, 1994, J VIROL, V68, P7148, DOI 10.1128/JVI.68.11.7148-7158.1994; Macrae AI, 2001, J VIROL, V75, P5315, DOI 10.1128/JVI.75.11.5315-5327.2001; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Marshall KR, 2000, J VIROL, V74, P956, DOI 10.1128/JVI.74.2.956-964.2000; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; Parcells MS, 1999, J VIROL, V73, P1362, DOI 10.1128/JVI.73.2.1362-1373.1999; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Rue CA, 2004, J VIROL, V78, P12529, DOI 10.1128/JVI.78.22.12529-12536.2004; Sacher T, 2008, CELL HOST MICROBE, V3, P263, DOI 10.1016/j.chom.2008.02.014; Scarpini CG, 2001, GENE THER, V8, P1057, DOI 10.1038/sj.gt.3301497; Shariatmadari R, 2001, BIOTECHNIQUES, V30, P1282, DOI 10.2144/01306st06; Shimeld C, 2001, J VIROL, V75, P5252, DOI 10.1128/JVI.75.11.5252-5262.2001; Skelton D, 2001, GENE THER, V8, P1813, DOI 10.1038/sj.gt.3301586; Smith C, 2000, J GEN VIROL, V81, P649, DOI 10.1099/0022-1317-81-3-649; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Wagner M, 2002, TRENDS MICROBIOL, V10, P318, DOI 10.1016/S0966-842X(02)02394-6; Wakim LM, 2008, IMMUNOL CELL BIOL, V86, P666, DOI 10.1038/icb.2008.47	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6492	10.1371/journal.pone.0006492	http://dx.doi.org/10.1371/journal.pone.0006492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652715	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637800006
J	Faure, B; Jollivet, D; Tanguy, A; Bonhomme, F; Bierne, N				Faure, Baptiste; Jollivet, Didier; Tanguy, Arnaud; Bonhomme, Francois; Bierne, Nicolas			Speciation in the Deep Sea: Multi-Locus Analysis of Divergence and Gene Flow between Two Hybridizing Species of Hydrothermal Vent Mussels	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; SNAKE PIT AREA; DROSOPHILA-PSEUDOOBSCURA; BATHYMODIOLUS BIVALVIA; STATISTICAL PROPERTIES; POPULATION-GENETICS; NEUTRALITY TESTS; LUCKY STRIKE; EVOLUTION; ZONE	Background: Reconstructing the history of divergence and gene flow between closely-related organisms has long been a difficult task of evolutionary genetics. Recently, new approaches based on the coalescence theory have been developed to test the existence of gene flow during the process of divergence. The deep sea is a motivating place to apply these new approaches. Differentiation by adaptation can be driven by the heterogeneity of the hydrothermal environment while populations should not have been strongly perturbed by climatic oscillations, the main cause of geographic isolation at the surface. Methodology/Principal Finding: Samples of DNA sequences were obtained for seven nuclear loci and a mitochondrial locus in order to conduct a multi-locus analysis of divergence and gene flow between two closely related and hybridizing species of hydrothermal vent mussels, Bathymodiolus azoricus and B. puteoserpentis. The analysis revealed that (i) the two species have started to diverge approximately 0.760 million years ago, (ii) the B. azoricus population size was 2 to 5 time greater than the B. puteoserpentis and the ancestral population and (iii) gene flow between the two species occurred over the complete species range and was mainly asymmetric, at least for the chromosomal regions studied. Conclusions/Significance: A long history of gene flow has been detected between the two Bathymodiolus species. However, it proved very difficult to conclusively distinguish secondary introgression from ongoing parapatric differentiation. As powerful as coalescence approaches could be, we are left by the fact that natural populations often deviates from standard assumptions of the underlying model. A more direct observation of the history of recombination at one of the seven loci studied suggests an initial period of allopatric differentiation during which recombination was blocked between lineages. Even in the deep sea, geographic isolation may well be a crucial promoter of speciation.			Faure, B (corresponding author), UPMC, Stn Biol Riscoff, Roscoff, France.	bmf12@psu.edu	Bonhomme, Francois/C-6290-2012; Bonhomme, Francois/AAG-6558-2021	Bonhomme, Francois/0000-0002-8792-9239; Bonhomme, Francois/0000-0002-8792-9239; Bierne, Nicolas/0000-0003-1856-3197				AMOS AF, 1971, DEEP-SEA RES, V18, P145, DOI 10.1016/0011-7471(71)90106-9; Bahlo M, 2000, THEOR POPUL BIOL, V57, P79, DOI 10.1006/tpbi.1999.1447; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1986, HEREDITY, V57, P415, DOI 10.1038/hdy.1986.142; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bierne N, 2007, MOL ECOL NOTES, V7, P562, DOI 10.1111/j.1471-8286.2007.01685.x; BOUGAULT H, 1993, J GEOPHYS RES-SOL EA, V98, P9643, DOI 10.1029/93JB00508; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; CANNAT M, 1995, GEOLOGY, V23, P49, DOI 10.1130/0091-7613(1995)023<0049:TCUEAR>2.3.CO;2; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; Comtet T, 1998, MAR ECOL PROG SER, V163, P165, DOI 10.3354/meps163165; COMTET T, 1998, THESIS U BRETAGNE OC; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L., 2005, ARLEQUIN VERSION 3 0, P47; Faure B, 2007, GENE, V406, P99, DOI 10.1016/j.gene.2007.06.025; Faure MF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-164; Fay JC, 2000, GENETICS, V155, P1405; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; Galtier N, 2000, GENETICS, V155, P981; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P383, DOI 10.1017/S0025315499002088; Genio L, 2008, J SHELLFISH RES, V27, P53, DOI 10.2983/0730-8000(2008)27[53:NROBMC]2.0.CO;2; Geyer CJ, 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; HILTON H, 1994, EVOLUTION, V48, P1900, DOI 10.1111/j.1558-5646.1994.tb02222.x; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; Jollivet D, 1998, CAH BIOL MAR, V39, P359; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Kadar E, 2005, J EXP MAR BIOL ECOL, V318, P99, DOI 10.1016/j.jembe.2004.12.025; KENK VC, 1985, MALACOLOGIA, V26, P253; Lyngso RB, 2005, LECT NOTES COMPUT SC, V3692, P239; MACDONALD KC, 1986, J GEOPHYS RES-SOLID, V91, P3334, DOI 10.1029/JB091iB03p03334; Machado CA, 2003, P ROY SOC B-BIOL SCI, V270, P1193, DOI 10.1098/rspb.2003.2333; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Matabos M, 2008, MAR BIOL, V153, P545, DOI 10.1007/s00227-007-0829-3; NAAR DF, 1991, J GEOPHYS RES-SOLID, V96, P7961, DOI 10.1029/90JB02398; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, GENETICS, V158, P885; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RHOADS DC, 1981, SCIENCE, V214, P911, DOI 10.1126/science.214.4523.911; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J, 2001, MOL CLONING LAB MANU; Schierup MH, 2000, GENETICS, V156, P879; SEGONZAC M, 1992, CR ACAD SCI III-VIE, V314, P593; Stephan W, 1998, P NATL ACAD SCI USA, V95, P5649, DOI 10.1073/pnas.95.10.5649; Stephens JC, 2000, J PHYS OCEANOGR, V30, P622, DOI 10.1175/1520-0485(2000)030<0622:DPOABW>2.0.CO;2; TAJIMA F, 1989, GENETICS, V123, P585; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VanDover CL, 1996, DEEP-SEA RES PT I, V43, P1509; VONCOSEL R, 1994, VELIGER, V37, P374; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Won Y, 2003, MOL ECOL, V12, P3185, DOI 10.1046/j.1365-294X.2003.01974.x; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Won YJ, 2003, APPL ENVIRON MICROB, V69, P6785, DOI 10.1128/AEM.69.11.6785-6792.2003	75	39	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6485	10.1371/journal.pone.0006485	http://dx.doi.org/10.1371/journal.pone.0006485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649261	Green Published, gold			2022-12-25	WOS:000268637700010
J	Eke, I; Leonhardt, F; Storch, K; Hehlgans, S; Cordes, N				Eke, Iris; Leonhardt, Franziska; Storch, Katja; Hehlgans, Stephanie; Cordes, Nils			The Small Molecule Inhibitor QLT0267 Radiosensitizes Squamous Cell Carcinoma Cells of the Head and Neck	PLOS ONE			English	Article								Background: The constant increase of cancer cell resistance to radio-and chemotherapy hampers improvement of patient survival and requires novel targeting approaches. Integrin-Linked Kinase ( ILK) has been postulated as potent druggable cancer target. On the basis of our previous findings clearly showing that ILK transduces antisurvival signals in cells exposed to ionizing radiation, this study evaluated the impact of the small molecule inhibitor QLT0267, reported as putative ILK inhibitor, on the cellular radiation survival response of human head and neck squamous cell carcinoma cells (hHNSCC). Methodology/Principal Findings: Parental FaDu cells and FaDu cells stably transfected with a constitutively active ILK mutant (FaDu-IH) or empty vectors, UTSCC45 cells, ILKfloxed/floxed(fl/fl) and ILK-/- mouse fibroblasts were used. Cells grew either two-dimensionally (2D) on or three-dimensionally (3D) in laminin-rich extracellular matrix. Cells were treated with QLT0267 alone or in combination with irradiation (X-rays, 0-6 Gy single dose). ILK knockdown was achieved by small interfering RNA transfection. ILK kinase activity, clonogenic survival, number of residual DNA double strand breaks (rDSB; cH2AX/53BP1 foci assay), cell cycle distribution, protein expression and phosphorylation (e.g. Akt, p44/42 mitogen-activated protein kinase ( MAPK)) were measured. Data on ILK kinase activity and phosphorylation of Akt and p44/42 MAPK revealed a broad inhibitory spectrum of QLT0267 without specificity for ILK. QLT0267 significantly reduced basal cell survival and enhanced the radiosensitivity of FaDu and UTSCC45 cells in a time- and concentration-dependent manner. QLT0267 exerted differential, cell culture model-dependent effects with regard to radiogenic rDSB and accumulation of cells in the G2 cell cycle phase. Relative to corresponding controls, FaDu-IH and ILKfl/fl fibroblasts showed enhanced radiosensitivity, which failed to be antagonized by QLT0267. A knockdown of ILK revealed no change in clonogenic survival of the tested cell lines as compared to controls. Conclusions/Significance: Our data clearly show that the small molecule inhibitor QLT0267 has potent cytotoxic and radiosensitizing capability in hHNSCC cells. However, QLT0267 is not specific for ILK. Further in vitro and in vivo studies are necessary to clarify the potential of QLT0267 as a targeted therapeutic in the clinic.			Eke, I (corresponding author), Tech Univ Dresden, OncoRay Ctr Radiat Res Oncol, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany.	Nils.Cordes@OncoRay.de	Eke, Iris/B-9251-2016	Eke, Iris/0000-0002-3591-019X; Cordes, Nils/0000-0001-5684-629X				Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bravou V, 2003, BRIT J CANCER, V89, P2340, DOI 10.1038/sj.bjc.6601482; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Chung DH, 1998, VIRCHOWS ARCH, V433, P113, DOI 10.1007/s004280050225; Cordes N, 2004, CANCER RES, V64, P5683, DOI 10.1158/0008-5472.CAN-04-1056; Cordes N, 2003, BRIT J CANCER, V88, P1470, DOI 10.1038/sj.bjc.6600912; Cordes N, 2003, STRAHLENTHER ONKOL, V179, P337, DOI 10.1007/s00066-003-1074-4; Cruet-Hennequart S, 2003, ONCOGENE, V22, P1688, DOI 10.1038/sj.onc.1206347; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Eke I, 2007, INT J RADIAT BIOL, V83, P793, DOI 10.1080/09553000701727549; Eke I, 2006, RADIOTHER ONCOL, V80, P178, DOI 10.1016/j.radonc.2006.07.028; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Haase M, 2008, J HISTOCHEM CYTOCHEM, V56, P819, DOI 10.1369/jhc.2008.951095; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Hehigans S, 2008, RADIOTHER ONCOL, V86, P329, DOI 10.1016/j.radonc.2007.09.007; Hehlgans S, 2007, INT J RADIAT BIOL, V83, P769, DOI 10.1080/09553000701694327; Hess F, 2007, ONCOGENE, V26, P1372, DOI 10.1038/sj.onc.1209947; Huang Y, 1999, INT J MOL MED, V3, P563; Ito R, 2003, VIRCHOWS ARCH, V442, P118, DOI 10.1007/s00428-002-0718-6; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu J, 2006, J THORAC ONCOL, V1, P771, DOI 10.1097/01243894-200610000-00004; Marotta A, 2001, ONCOGENE, V20, P6250, DOI 10.1038/sj.onc.1204791; Olive PL, 1998, RADIAT RES, V150, pS42, DOI 10.2307/3579807; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sandfort V, 2007, INT J RADIAT BIOL, V83, P727, DOI 10.1080/09553000701694335; Takanami I, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-1; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; White DE, 2001, ONCOGENE, V20, P7064, DOI 10.1038/sj.onc.1204910; Yau CYF, 2005, CANCER RES, V65, P1497, DOI 10.1158/0008-5472.CAN-04-2940; Younes MN, 2007, ARCH OTOLARYNGOL, V133, P15, DOI 10.1001/archotol.133.1.15; Younes MN, 2005, MOL CANCER THER, V4, P1146, DOI 10.1158/1535-7163.MCT-05-0078; Yuan HY, 2008, CURR MED CHEM, V15, P470; Zips D, 2008, J PHARM PHARMACOL, V60, P1019, DOI 10.1211/jpp.60.8.0008	46	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6434	10.1371/journal.pone.0006434	http://dx.doi.org/10.1371/journal.pone.0006434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649326	gold, Green Submitted, Green Published			2022-12-25	WOS:000268494600004
J	Rivera, J; Megias, D; Navas, C; Bravo, J				Rivera, Jose; Megias, Diego; Navas, Carolina; Bravo, Jeronimo			Identification of Essential Sequences for Cellular Localization in BRMS1 Metastasis Suppressor	PLOS ONE			English	Article								Background: Breast cancer metastasis suppressor 1 (BRMS1) reduces the number and the size of secondary tumours in a mouse model without affecting the growth of the primary foci upon its re-expression. Knockdown of BRMS1 expression associates with metastasis. The molecular details on BRMS1 mechanism of action include its ability to function as a transcriptional co-repressor and consistently BRMS1 has been described as a predominantly nuclear protein. Since cellular distribution could represent a potential mechanism of regulation, we wanted to characterize BRMS1 sequence motifs that might regulate its cellular distribution. According to its amino acids sequence, BRMS1 contain two putative nuclear localization signals, however none of them has been proved to work so far. Methodology/Principal Findings: By using well known in vivo assays to detect both nuclear import and export signal, we have characterized, in the present study, one functional nuclear localisation signal as necessary and sufficient to promote nuclear transport. Additionally, the outcome of a directed yeast two-hybrid assay identify importin alpha 6 as a specific partner of BRMS1 thus speculating that BRMS1 nuclear import could be specifically mediated by the reported nuclear transporter. Besides, the combination of a computational searching approach along the utilization of a nuclear export assay, identified a functional motif within the BRMS1 sequence responsible for its nuclear export, that resulted not affected by the highly specific CRM1 inhibitor Leptomycin-B. Interspecies heterokaryon assay demonstrate the capability of BRMS1 to shuttle between the nuclear and cytosolic compartments Conclusions/Significance: Our results show for the first time that BRMS1 contains both nuclear import and export signals enabling its nucleo-cytoplasmic shuttling. These findings contributes new data for the understanding of the BRMS1 functions and allow us to speculate that this phenomenon could represent a novel mechanism for regulating the activity of BRMS1 or its associated cytosolic partners			Rivera, J (corresponding author), Ctr Nacl Invest Oncol, Signal Transduct Grp, Madrid, Spain.	jrivera@cnio.es; jbravo@ibv.csic.es	Bravo, Jeronimo/K-9103-2014; Megías, Diego/L-6008-2014; Rivera-Torres, José/P-2793-2015; Navas, Carolina/T-7623-2018	Bravo, Jeronimo/0000-0001-6695-2846; Rivera-Torres, José/0000-0003-0365-9604; Megias, Diego/0000-0003-0755-0518				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; DeWald DB, 2005, CANCER RES, V65, P713; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fahrenkrog B, 2001, CURR TOP MICROBIOL, V259, P95; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod Maarten, 2002, Results Probl Cell Differ, V35, P67; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Harreman MT, 2003, J BIOL CHEM, V278, P21361, DOI 10.1074/jbc.M301114200; Harreman MT, 2003, J BIOL CHEM, V278, P5854, DOI 10.1074/jbc.M210951200; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hurst DR, 2006, BIOCHEM BIOPH RES CO, V348, P1429, DOI 10.1016/j.bbrc.2006.08.005; HURST DR, 2008, J BIOL CHEM; James P, 1996, GENETICS, V144, P1425; Kau TR, 2003, DRUG DISCOV TODAY, V8, P78, DOI 10.1016/S1359-6446(02)02562-X; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kuersten S, 2001, TRENDS CELL BIOL, V11, P497, DOI 10.1016/S0962-8924(01)02144-4; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lischka P, 2003, J VIROL, V77, P3734, DOI 10.1128/JVI.77.6.3734-3748.2003; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Nilsen T, 2007, J BIOL CHEM, V282, P26245, DOI 10.1074/jbc.M611234200; Rinker-Schaeffer CW, 2006, CLIN CANCER RES, V12, P3882, DOI 10.1158/1078-0432.CCR-06-1014; Rivera J, 2007, J PROTEOME RES, V6, P4006, DOI 10.1021/pr0703167; Rivera J, 2007, J VIROL, V81, P2923, DOI 10.1128/JVI.02077-06; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Saunders MM, 2001, CANCER RES, V61, P1765; SCHMIDTZACHMANN MS, 1993, CELL, V74, P493, DOI 10.1016/0092-8674(93)80051-F; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thompson ME, 2005, J BIOL CHEM, V280, P21854, DOI 10.1074/jbc.M502676200; WOLFF B, 1995, EXP CELL RES, V217, P31, DOI 10.1006/excr.1995.1060; Yang JY, 2008, CANCER LETT, V269, P46, DOI 10.1016/j.canlet.2008.04.016	44	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6433	10.1371/journal.pone.0006433	http://dx.doi.org/10.1371/journal.pone.0006433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649328	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494600003
J	Huysseune, S; Kienlen-Campard, P; Hebert, S; Tasiaux, B; Leroy, K; Devuyst, O; Brion, JP; De Strooper, B; Octave, JN				Huysseune, Sandra; Kienlen-Campard, Pascal; Hebert, Sebastien; Tasiaux, Bernadette; Leroy, Karelle; Devuyst, Olivier; Brion, Jean-Pierre; De Strooper, Bart; Octave, Jean-Noel			Epigenetic control of aquaporin 1 expression by the amyloid precursor protein	FASEB JOURNAL			English	Article						AICD; Alzheimer's disease; gene expression; histone acetylation	DEPENDENT TRANSCRIPTIONAL CONTROL; HISTONE DEACETYLASE INHIBITORS; DEGRADING ENZYME NEPRILYSIN; GAMMA-SECRETASE COMPLEXES; GENE-EXPRESSION; INTRACELLULAR DOMAIN; CYTOSKELETAL DYNAMICS; MICE LACKING; PRESENILIN; APP	Cellular processing of the amyloid precursor protein (APP) has been extensively studied, but its precise function remains elusive. The intracellular domain of APP has been proposed to regulate expression of several genes by mechanisms that are largely unknown. We report that APP regulates expression of the aquaporin 1 (AQP1) gene in mouse embryonic fibroblasts and in transgenic mice. AQP1 mRNA and protein were down-regulated in fibroblasts lacking APP or presenilin 2 in which AQP1 expression was restored by stable expression of full-length APP or presenilin 2 but not by APP deleted from its carboxy-terminal domain. The transcriptional activity of the AQP1 gene promoter and the stability of AQP1 mRNA were identical in fibroblasts expressing or not expressing APP. Control of AQP1 expression by APP was sensitive to trichostatin A, an histone deacetylase inhibitor, and histone deacetylase activity coimmunoprecipitated with APP. Altogether, these data show that a presenilin-2-dependent gamma-secretase activity releases the intracellular domain of APP involved in the epigenetic control of AQP1 expression. Since AQP1 is found in astrocytes surrounding senile plaques, this epigenetic control of AQP1 expression could have important implications in Alzheimer disease.-Huysseune, S., Kienlen-Campard, P., Hebert, S., Tasiaux, B., Leroy, K., Devuyst, O., Brion, J.-P., De Strooper, B., Octave, J.-N. Epigenetic control of aquaporin 1 expression by the amyloid precursor protein. FASEB J. 23, 4158-4167 (2009). www.fasebj.org	[Huysseune, Sandra; Kienlen-Campard, Pascal; Tasiaux, Bernadette; Octave, Jean-Noel] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Hebert, Sebastien] CHU Quebec, Ctr Rech, Laurier, PQ, Canada; [Leroy, Karelle; Brion, Jean-Pierre] Univ Libre Bruxelles, Fac Med, Lab Histol Neuroanat & Neuropathol, Brussels, Belgium; [Devuyst, Olivier] Catholic Univ Louvain, Unite Nephrol, B-1200 Brussels, Belgium; [Hebert, Sebastien; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Hebert, Sebastien; De Strooper, Bart] VIB, Dept Mol & Dev Genet, Louvain, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles; Universite Catholique Louvain; KU Leuven; Flanders Institute for Biotechnology (VIB)	Octave, JN (corresponding author), Catholic Univ Louvain, Inst Neurosci, FARL 5410,Ave Hippocrate 54, B-1200 Brussels, Belgium.	jean-noel.octave@uclouvain.be	Brion, Jean-Pierre/C-6467-2009; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	Brion, Jean-Pierre/0000-0002-1917-775X; De Strooper, Bart/0000-0001-5455-5819; Devuyst, Olivier/0000-0003-3744-4767; Leroy, Karelle/0000-0002-8661-5262; Hebert, Sebastien/0000-0002-0391-9325; Kienlen-Campard, Pascal/0000-0003-1086-2942	Belgian Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture; Belgian Fonds National pour la Recherche Scientifique, bourses du Patrimoine; Communaute Francaise de Belgique; Action de Recherche Concertees; Belgian Federal Science Policy Office [P6/43, P6/05]; Belgian Fonds de la Recherche Scientifique Medicale; Alzheimer Belgique; la Fondation pour la Recherche sur la Maladie d'Alzheimer/Stichting voor Alzheimer Onderzoek; Region Walonne; Fondation Alphonse Jean Forton; European Community [GA 201590]; Flemish government; KU Leuven; VIB	Belgian Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS); Belgian Fonds National pour la Recherche Scientifique, bourses du Patrimoine(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique(Australian Research Council); Action de Recherche Concertees; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Alzheimer Belgique; la Fondation pour la Recherche sur la Maladie d'Alzheimer/Stichting voor Alzheimer Onderzoek; Region Walonne(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); Fondation Alphonse Jean Forton; European Community(European Commission); Flemish government(European Commission); KU Leuven(KU Leuven); VIB	We thank Huguette Debaix for technical assistance and Jean-Christophe Renauld and Laurent Knoops for assistance in designing the miccroarray experiments. We thank Belaid Sekkali for discussion in the field of epigenetics. We also thank Wim Annaert (KU Leuven and VIB, Leuven, Belgium) for providing PS2<SUP>-/-</SUP> rescue PS2 MEFs and Alan S. Verkman for providing the Aqp1 mouse. This work was supported by the Belgian Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (to S. H.), the Belgian Fonds National pour la Recherche Scientifique, bourses du Patrimoine (to S. H), the Communaute Francaise de Belgique, the Action de Recherche Concertees, the Interuniversity Attraction Poles (IUAP) Program (P6/43, P6/05) of the Belgian Federal Science Policy Office, the Belgian Fonds de la Recherche Scientifique Medicale, Alzheimer Belgique, la Fondation pour la Recherche sur la Maladie d'Alzheimer/Stichting voor Alzheimer Onderzoek, the Programme d'excellence "Marshall" DIANE convention from the Region Walonne, the Fondation Alphonse & Jean Forton, and the European Network for the Study of Orphan Nephropathies (EUNEFRON) program of the European Community (FP7, GA#201590). Work in the laboratory of B. D. S. was supported by a Methusalem grant of the Flemish government and funding from the KU Leuven and VIB.	Alarcon R, 2005, J BIOL CHEM, V280, P30406, DOI 10.1074/jbc.M414686200; Annaert W, 1999, TRENDS NEUROSCI, V22, P439, DOI 10.1016/S0166-2236(99)01455-1; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Boassa D, 2006, J NEUROSCI, V26, P7811, DOI 10.1523/JNEUROSCI.0525-06.2006; BONDY C, 1993, P NATL ACAD SCI USA, V90, P4500, DOI 10.1073/pnas.90.10.4500; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Carey N, 2006, CURR OPIN PHARMACOL, V6, P369, DOI 10.1016/j.coph.2006.03.010; Chen AC, 2007, NEURON, V53, P479, DOI 10.1016/j.neuron.2007.01.023; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fass DM, 2003, J BIOL CHEM, V278, P43014, DOI 10.1074/jbc.M305905200; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Heber S, 2000, J NEUROSCI, V20, P7951; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Huysseune S, 2007, BIOCHEM BIOPH RES CO, V361, P317, DOI 10.1016/j.bbrc.2007.06.186; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim JG, 2007, J BIOL CHEM, V282, P14923, DOI 10.1074/jbc.M701411200; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Makki MS, 2008, NUCLEIC ACIDS RES, V36, P4067, DOI 10.1093/nar/gkn356; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Misawa T, 2008, ACTA NEUROPATHOL, V116, P247, DOI 10.1007/s00401-008-0387-x; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Perez E, 2007, BRAIN RES, V1128, P164, DOI 10.1016/j.brainres.2006.09.109; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; SALMON P, 2007, CURR PROTOC HUM GENE, V54; Santos SF, 2009, J NEUROSCI, V29, P4708, DOI 10.1523/JNEUROSCI.4917-08.2009; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Sweatt JD, 2007, NATURE, V447, P151, DOI 10.1038/nature05716; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	60	42	42	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4158	4167		10.1096/fj.09-140012	http://dx.doi.org/10.1096/fj.09-140012			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19687153				2022-12-25	WOS:000272193700012
J	Setsuie, R; Suzuki, M; Kabuta, T; Fujita, H; Miura, S; Ichihara, N; Yamada, D; Wang, YL; Ezaki, O; Suzuki, Y; Wada, K				Setsuie, Rieko; Suzuki, Mari; Kabuta, Tomohiro; Fujita, Hiromi; Miura, Shinji; Ichihara, Nobutsune; Yamada, Daisuke; Wang, Yu-Lai; Ezaki, Osamu; Suzuki, Yasuyuki; Wada, Keiji			Ubiquitin C-terminal hydrolase-L3-knockout mice are resistant to diet-induced obesity and show increased activation of AMP-activated protein kinase in skeletal muscle	FASEB JOURNAL			English	Article						energy balance; energy expenditure; deubiquitinating enzyme	ENERGY-EXPENDITURE; SIGNALING PATHWAYS; INSULIN-RESISTANCE; CELL APOPTOSIS; FAT; METABOLISM; GROWTH; FUEL; OVEREXPRESSION; DEGENERATION	Obesity results from the dysregulation of energy balance throughout the entire body. Although the ubiquitin system participates in many cellular processes, its contribution to the balance of energy in the body remains poorly understood. Here, we show that ubiquitin C-terminal hydrolase (UCH)-L3, one of the deubiquitinating enzymes, contributes to the regulation of metabolism. Uchl3(-/-) mice displayed a reduction of adipose tissue mass and were protected against high-fat diet (HFD)-induced obesity and insulin resistance. Uchl3(-/-) mice given both a normal chow and an HFD had an increased whole-body energy expenditure accounting for the reduction of adipose tissue mass. Activation of AMP-activated protein kinase (AMPK) in skeletal muscle has been reported to increase fatty acid beta-oxidation, leading to the elevation of the whole-body energy expenditure. Consistently, increased activation of AMPK and fatty acid beta-oxidation was observed in skeletal muscle of Uchl3(-/-) mice. Mouse embryonic fibroblasts derived from Uchl3(-/-) mice also showed increased activation of AMPK, indicating that UCH-L3 is involved in a cell-autonomous down-regulation of AMPK. These results suggest a role for UCH-L3 in the regulation of AMPK activity and whole-body energy metabolism.-Setsuie, R., Suzuki, M., Kabuta, T., Fujita, H., Miura, S., Ichihara, N., Yamada, D., Wang, Y.-L., Ezaki, O., Suzuki, Y., Wada, K. Ubiquitin C-terminal hydrolase-L3-knockout mice are resistant to diet-induced obesity and show increased activation of AMP-activated protein kinase in skeletal muscle. FASEB J. 23, 4148-4157 (2009). www.fasebj.org	[Setsuie, Rieko; Suzuki, Mari; Kabuta, Tomohiro; Fujita, Hiromi; Yamada, Daisuke; Wang, Yu-Lai; Suzuki, Yasuyuki; Wada, Keiji] Natl Ctr Neurol & Psychiat, Dept Degenerat Neurol Dis, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Miura, Shinji; Ezaki, Osamu] Natl Inst Hlth & Nutr, Nutr Sci Program, Tokyo 162, Japan; [Ichihara, Nobutsune] Azabu Univ, Sch Vet Med, Kanagawa, Japan; [Yamada, Daisuke; Wada, Keiji] Japan Sci & Technol Agcy, Saitama, Japan	National Center for Neurology & Psychiatry - Japan; National Institute of Health & Nutrition - Japan; Azabu University; Japan Science & Technology Agency (JST)	Wada, K (corresponding author), Natl Ctr Neurol & Psychiat, Dept Degenerat Neurol Dis, Natl Inst Neurosci, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	wada@ncnp.go.jp	Miura, Shinji/K-6516-2013; Kabuta, Tomohiro/B-2948-2015	Miura, Shinji/0000-0001-8806-9763; Kabuta, Tomohiro/0000-0002-3058-2596; Yamada, Daisuke/0000-0002-6989-6736	National Institute of Biomedical Innovation of Japan; Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr. Shirley M. Tilghman (Princeton University, Princeton, NJ, USA) for providing the Uchl3<SUP>-/-</SUP> mice. We thank Mr. Miki Tadaishi (National Institute of Health and Nutrition, Tokyo, Japan) for his assistance with the measurement of fatty acid beta-oxidation. We thank Dr. Etsuko Wada (NCNP, Tokyo, Japan) and Ms. Mariko Yamamoto (NCNP) for their assistance with animal care, and Ms. Hisae Kikuchi (NCNP) for her assistance with histological studies. We thank Dr. Yukiko K. Hayashi (NCNP) for technical assistance and discussions concerning muscle analysis and Dr. Hirohiko Hohjoh (NCNP) for providing the homecage monitor. We thank Dr. Sachio Naito (High Energy Accelerator Research Organization, Tsukuba, Japan), Dr. Yoshitaka Nagai (NCNP), Dr. Hitoshi Osaka (Kanagawa Children's Medical Center, Kanagawa, Japan), Dr. Yukihiro Tsuchiya (NCNP), and Dr. Yusuke Tozuka (NCNP) for discussions and comments concerning manuscript preparation. This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan and grants-in-aid for scientific research from the Ministry of Health, Labor, and Welfare of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Brown-Borg HM, 2009, MOL CELL ENDOCRINOL, V299, P64, DOI 10.1016/j.mce.2008.07.001; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koyama S, 2008, J MOL BIOL, V376, P1224, DOI 10.1016/j.jmb.2007.11.049; Kurihara LJ, 2000, MOL CELL BIOL, V20, P2498, DOI 10.1128/MCB.20.7.2498-2504.2000; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Long YC, 2008, AM J PHYSIOL-ENDOC M, V295, pE545, DOI 10.1152/ajpendo.90259.2008; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lucas A, 1998, J NUTR, V128, p401S, DOI 10.1093/jn/128.2.401S; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; McInnes KJ, 2006, ENDOCRINOLOGY, V147, P5907, DOI 10.1210/en.2006-0879; Miura S, 2009, AM J PHYSIOL-ENDOC M, V296, pE47, DOI 10.1152/ajpendo.90690.2008; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Sano Y, 2006, AM J PATHOL, V169, P132, DOI 10.2353/ajpath.2006.060085; Semenova E, 2003, HUM MOL GENET, V12, P1301, DOI 10.1093/hmg/ddg140; Setsuie R, 2007, NEUROCHEM INT, V50, P119, DOI 10.1016/j.neuint.2006.07.015; Simpson ER, 2005, CELL METAB, V2, P346, DOI 10.1016/j.cmet.2005.11.010; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	53	17	17	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4148	4157		10.1096/fj.09-132217	http://dx.doi.org/10.1096/fj.09-132217			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19671667				2022-12-25	WOS:000272193700011
J	Zhang, GQ; Kernan, KA; Thomas, A; Collins, S; Song, YM; Li, L; Zhu, WZ; LeBoeuf, RC; Eddy, AA				Zhang, Guoqiang; Kernan, Kelly A.; Thomas, Alison; Collins, Sarah; Song, Yumei; Li, Ling; Zhu, Weizhong; LeBoeuf, Renee C.; Eddy, Allison A.			A Novel Signaling Pathway FIBROBLAST NICOTINIC RECEPTOR alpha 1 BINDS UROKINASE AND PROMOTES RENAL FIBROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR SYSTEM; MUSCLE-CELLS; ACETYLCHOLINE-RECEPTORS; EXPRESSION; GENE; SUBUNIT; UPA; FIBRINOLYSIS; FIBROGENESIS; CONTRACTION	The nicotinic acetylcholine receptor alpha 1 (nAChR alpha 1) was investigated as a potential fibrogenic molecule in the kidney, given reports that it may be an alternative urokinase (urokinase plasminogen activator; uPA) receptor in addition to the classical receptor uPAR. In a mouse obstructive uropathy model of chronic kidney disease, interstitial fibroblasts were identified as the primary cell type that bears nAChR alpha 1 during fibrogenesis. Silencing of the nAChR alpha 1 gene led to significantly fewer interstitial alpha SMA(+) myofibroblasts (2.8 times decreased), reduced interstitial cell proliferation (2.6 times decreased), better tubular cell preservation (E-cadherin 14 times increased), and reduced fibrosis severity (24% decrease in total collagen). The myofibroblast-inhibiting effect of nAChR alpha 1 silencing in uPA-sufficient mice disappeared in uPA-null mice, suggesting that a uPA-dependent fibroblastic nAChR alpha 1 pathway promotes renal fibrosis. To further establish this possible ligand-receptor relationship and to identify downstream signaling pathways, in vitro studies were performed using primary cultures of renal fibroblasts. S-35-Labeled uPA bound to nAChR alpha 1 with a K-d of 1.6 x 10(-8) M, which was displaced by the specific nAChR alpha 1 inhibitor D-tubocurarine in a dose-dependent manner. Pre-exposure of uPA to the fibroblasts inhibited [H-3] nicotine binding. The uPA binding induced a cellular calcium influx and an inward membrane current that was entirely prevented by D-tubocurarine preincubation or nAChR alpha 1 silencing. By mass spectrometry phosphoproteome analyses, uPA stimulation phosphorylated nAChR alpha 1 and a complex of signaling proteins, including calcium-binding proteins, cytoskeletal proteins, and a nucleoprotein. This signaling pathway appears to regulate the expression of a group of genes that transform renal fibroblasts into more active myofibroblasts characterized by enhanced proliferation and contractility. This new fibrosis-promoting pathway may also be relevant to disorders that extend beyond chronic kidney disease.	[Eddy, Allison A.] Seattle Childrens Hosp, Res Inst, Div Nephrol, Seattle, WA 98101 USA; [Song, Yumei] Seattle Childrens Hosp, Res Inst, Div Immunol, Seattle, WA 98101 USA; [Zhu, Weizhong] Univ Washington, Dept Pathol, Seattle, WA 98105 USA; [LeBoeuf, Renee C.] Univ Washington, Div Endocrine & Metab Dis, Dept Med, Seattle, WA 98105 USA; [Li, Ling] Seattle Biomed Res Inst, Seattle, WA 98101 USA	Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Center for Infectious Disease Research	Zhang, GQ (corresponding author), C9S,1900 9th Ave, Seattle, WA 98101 USA.	guoqiang.zhang@seattlechildrens.org	Zhu, Wei-Zhong/G-4919-2011	Eddy, Allison/0000-0002-3560-7510	National Institutes of Health [DK54500, DK44757]; American Heart Association National Center; Seattle Children's Hospital and Regional Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079382, R01HL055362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK054500, P50DK044757, R01DK054500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Center(American Heart Association); Seattle Children's Hospital and Regional Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54500 and DK44757 (to A. A. E.). This work was also supported by a scientist development grant from the American Heart Association National Center (to G. Z.) and the Young Investigator Award from Seattle Children's Hospital and Regional Medical Center (to G. Z.).	Akk G, 2003, J PHYSIOL-LONDON, V551, P155, DOI 10.1113/jphysiol.2003.043885; Annecke K, 2008, ADV CLIN CHEM, V45, P31, DOI 10.1016/S0065-2423(07)00002-9; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; ASTRUP T, 1955, SCAND J CLIN LAB INV, V7, P239, DOI 10.3109/00365515509134516; BROMMER EJP, 1994, THROMB HAEMOSTASIS, V71, P19; CARLIN BE, 1986, P NATL ACAD SCI USA, V83, P498, DOI 10.1073/pnas.83.2.498; Carlisle DL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-27; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CAULEY K, 1989, J CELL BIOL, V108, P637, DOI 10.1083/jcb.108.2.637; Chaurasia SS, 2009, EXP EYE RES, V89, P133, DOI 10.1016/j.exer.2009.02.022; Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411; Duner E, 1997, HYPERTENSION, V29, P1007, DOI 10.1161/01.HYP.29.4.1007; DuToit PJ, 1997, MED HYPOTHESES, V49, P57, DOI 10.1016/S0306-9877(97)90253-X; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eyden B., 2005, Journal of Submicroscopic Cytology and Pathology, V37, P1; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Gou DM, 2003, FEBS LETT, V548, P113, DOI 10.1016/S0014-5793(03)00630-6; Jin T, 2005, J INFECT DIS, V192, P429, DOI 10.1086/431600; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Killeen S, 2008, DRUG NEWS PERSPECT, V21, P107, DOI 10.1358/dnp.2008.21.2.1188197; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; Koopman JL, 1998, J BIOL CHEM, V273, P33267, DOI 10.1074/jbc.273.50.33267; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Liang OD, 2003, BIOL CHEM, V384, P229, DOI 10.1515/BC.2003.025; Mang GQ, 2004, J AM SOC NEPHROL, V15, P2090, DOI 10.1097/01.ASN.0000135057; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; MILES K, 1994, J NEUROSCI, V14, P3271; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Morgan D, 2001, BIOCHEM PHARMACOL, V61, P733, DOI 10.1016/S0006-2952(00)00587-6; Mukhina S, 2000, J BIOL CHEM, V275, P16450, DOI 10.1074/jbc.M909080199; PANG IH, 1993, INVEST OPHTH VIS SCI, V34, P1876; Pawlak K, 2007, THROMB RES, V120, P871, DOI 10.1016/j.thromres.2007.01.011; Plekhanova OS, 2006, J VASC RES, V43, P437, DOI 10.1159/000094906; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Poliakov AA, 1999, J RECEPT SIGNAL TR R, V19, P939, DOI 10.3109/10799899909038433; Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56; Stempien-Otero A, 2006, J BIOL CHEM, V281, P15345, DOI 10.1074/jbc.M512818200; Strutz F, 2000, KIDNEY INT, V57, P1521, DOI 10.1046/j.1523-1755.2000.00997.x; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; WANG XM, 1990, EMBO J, V9, P783, DOI 10.1002/j.1460-2075.1990.tb08174.x; Yamaguchi I, 2007, AM J PHYSIOL-RENAL, V293, pF12, DOI 10.1152/ajprenal.00380.2006; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1254, DOI 10.1097/01.ASN.0000064292.37793.FB; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1234, DOI 10.1097/01.ASN.0000064701.70231.3F; Zhang GQ, 2008, FRONT BIOSCI-LANDMRK, V13, P5462, DOI 10.2741/3093; Zhang GQ, 2007, J AM SOC NEPHROL, V18, P846, DOI 10.1681/ASN.2006080886	50	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29050	29064		10.1074/jbc.M109.010249	http://dx.doi.org/10.1074/jbc.M109.010249			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690163	Green Published, hybrid			2022-12-25	WOS:000270678900062
J	Tang, FQ; Wang, DS; Duan, CJ; Huang, DM; Wu, Y; Chen, Y; Wang, WW; Xie, CL; Meng, JJ; Wang, L; Wu, B; Liu, SJ; Tian, DF; Zhu, F; He, ZW; Deng, FL; Cao, Y				Tang, Faqing; Wang, Dongsheng; Duan, Chaojun; Huang, Damao; Wu, Yuan; Chen, Yu; Wang, Weiwei; Xie, Chunlei; Meng, Jingjing; Wang, Lei; Wu, Bin; Liu, Shujin; Tian, Daofa; Zhu, Feng; He, Zhiwei; Deng, Fuliang; Cao, Ya			Berberine Inhibits Metastasis of Nasopharyngeal Carcinoma 5-8F Cells by Targeting Rho Kinase-mediated Ezrin Phosphorylation at Threonine 567	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LUNG-CANCER CELLS; ORGANIZER EZRIN; LINKER EZRIN; CYCLE ARREST; ERM PROTEINS; IN-VITRO; EXPRESSION; CYTOSKELETON; INVASION	Ezrin is highly expressed in metastatic tumors and is involved in filopodia formation as well as promotion of tumor metastasis. Thus, Ezrin may serve as a potential target for anti-metastatic therapy. This study demonstrates that berberine reduces filopodia formation of a nasopharyngeal carcinoma (NPC) cell line, 5-8F, at non-cytotoxic concentrations. Furthermore, invasion and motility of 5-8F cells are decreased in a dose-and time-dependent manner, resulting in 73.0% invasion and 67.0% motility inhibition at 20 mu M. The inhibitory effects of berberine on 5-8F cell metastasis were further confirmed in a mouse model of metastasis. Berberine treatment in vivo resulted in a 51.1% inhibition of tumor metastasis to the lymph nodes and decreased Ezrin phosphorylation at threonine 567 in metastatic samples. Berberine suppressed the presence of phosphorylated Ezrin (phospho-Ezrin) in a dose-and time-dependent manner but had no effect on total Ezrin protein expression at non-cytotoxic concentrations. Furthermore, the inhibitory effects of berberine on phospho-Ezrin were dependent on the suppression of Rho kinase activity. Reduction of Ezrin phosphorylation at Thr(567) by berberine was associated with its inhibitory effect on filopodia formation in 5-8F cells. However, berberine did not effectively inhibit the motility and invasion of NPC cells containing Ezrin Thr(567) mutants. These results confirm that berberine inhibits Ezrin phosphorylation at Thr(567). Nonetheless, berberine reduces motility and invasion of cells and inhibits tumor metastasis. The reduction of Rho kinase-mediated Ezrin phosphorylation mediated by berberine may be a novel anti-metastatic pathway in NPC 5-8F cells.			Tang, FQ (corresponding author), Xiangya Hosp, Dept Clin Lab, Xiangya Rd 87th, Changsha 410008, Hunan, Peoples R China.	tangfaqing33@hotmail.com			National Natural Science Foundation of China [30572455]; Program for New Century Excellent Talents in University [NCET-06-0685]; Traditional Chinese Medicine Foundation of Hunan [2008039]; Science and Technology Foundation of Hunan [08FJ3176]; Science Foundation of Central South University [08SDF07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Traditional Chinese Medicine Foundation of Hunan; Science and Technology Foundation of Hunan; Science Foundation of Central South University	This work was supported in part by National Natural Science Foundation of China Grant 30572455, Program for New Century Excellent Talents in University Grant NCET-06-0685, Traditional Chinese Medicine Foundation of Hunan Grant 2008039, Science and Technology Foundation of Hunan Grant 08FJ3176, and Science Foundation of Central South University Grant 08SDF07.	Attiga FA, 2000, CANCER RES, V60, P4629; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; CHEN J, 1995, P NATL ACAD SCI USA, V92, P7495, DOI 10.1073/pnas.92.16.7495; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Deng XY, 2007, CLIN EXP METASTAS, V24, P107, DOI 10.1007/s10585-007-9059-9; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gallo G, 2008, DEV NEUROBIOL, V68, P926, DOI 10.1002/dneu.20631; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; Hwang JM, 2002, ARCH TOXICOL, V76, P664, DOI 10.1007/s00204-002-0351-9; Iizuka N, 2000, CANCER LETT, V148, P19, DOI 10.1016/S0304-3835(99)00264-5; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jimenez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; KOBAYASHI Y, 1995, PLANTA MED, V61, P414, DOI 10.1055/s-2006-958127; Kocher HM, 2009, GUT, V58, P271, DOI 10.1136/gut.2008.159871; Kuo CL, 2005, IN VIVO, V19, P247; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2; Lau CW, 2001, CARDIOVASC DRUG REV, V19, P234; Lee DU, 2003, LIFE SCI, V73, P1401, DOI 10.1016/S0024-3205(03)00435-1; Letasiova S, 2006, CANCER LETT, V239, P254, DOI 10.1016/j.canlet.2005.08.024; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Li Q, 2008, CANCER LETT, V261, P55, DOI 10.1016/j.canlet.2007.11.018; Lin JP, 2006, WORLD J GASTROENTERO, V12, P21, DOI 10.3748/wjg.v12.i1.21; Lin SS, 2005, PHYTOMEDICINE, V12, P351, DOI 10.1016/j.phymed.2003.11.008; Liu SJ, 2008, BRIT J CANCER, V98, P363, DOI 10.1038/sj.bjc.6604167; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mitani N, 2001, CANCER LETT, V165, P35, DOI 10.1016/S0304-3835(00)00710-2; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; PALOU J, 2008, EUR UROL IN PRESS; Park EJ, 2004, J IMMUNOL, V173, P5697, DOI 10.4049/jimmunol.173.9.5697; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Peng SP, 2007, CANCER SCI, V98, P341, DOI 10.1111/j.1349-7006.2007.00410.x; Ridley AJ, 1999, BIOCHEM SOC SYMP, V65, P111; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Slaninova I, 2001, CELL BIOL TOXICOL, V17, P51, DOI 10.1023/A:1010907231602; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Yang XY, 2005, CELL ONCOL, V27, P215; Yonemura S, 2002, J CELL SCI, V115, P2569; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5	52	75	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27456	27466		10.1074/jbc.M109.033795	http://dx.doi.org/10.1074/jbc.M109.033795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651779	Green Published, hybrid			2022-12-25	WOS:000270232300048
J	Harada, Y; Ueda, Y; Kinoh, H; Komaru, A; Fuji-Ogawa, T; Furuya, A; Iida, A; Hasegawa, M; Ichikawa, T; Yonemitsu, Y				Harada, Yui; Ueda, Yasuji; Kinoh, Hiroaki; Komaru, Atsushi; Fuji-Ogawa, Terumi; Furuya, Aki; Iida, Akihiro; Hasegawa, Mamoru; Ichikawa, Tomohiko; Yonemitsu, Yoshikazu			Cytokine-Based Log-Scale Expansion of Functional Murine Dendritic Cells	PLOS ONE			English	Article								Background: Limitations of the clinical efficacy of dendritic cell (DC)-based immunotherapy, as well as difficulties in their industrial production, are largely related to the limited number of autologous DCs from each patient. We here established a possible breakthrough, a simple and cytokine-based culture method to realize a log-scale order of functional murine DCs (>1,000-fold), which cells were used as a model before moving to human studies. Methodology/Principal Findings: Floating cultivation of lineage-negative hematopoietic progenitors from bone marrow in an optimized cytokine cocktail (FLT3-L, IL-3, IL-6, and SCF) led to a stable log-scale proliferation of these cells, and a subsequent differentiation study using IL-4/GM-CSF revealed that 3-weeks of expansion was optimal to produce CD11b+/CD11c+ DC-like cells. The expanded DCs had typical features of conventional myeloid DCs in vitro and in vivo, including identical efficacy as tumor vaccines. Conclusions/Significance: The concept of DC expansion should make a significant contribution to the progress of DC-based immunotherapy.			Harada, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Gene Therapy, Chiba, Japan.	yonemitu@faculty.chiba-u.jp		Kinoh, Hiroaki/0000-0002-5859-0942; KOMARU, ATSUSHI/0000-0002-6350-3436				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; Bontkes HJ, 2002, J LEUKOCYTE BIOL, V72, P321; Feng B, 2000, STEM CELLS, V18, P53, DOI 10.1634/stemcells.18-1-53; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Jacobsen SEW, 1996, BLOOD, V87, P5016, DOI 10.1182/blood.V87.12.5016.bloodjournal87125016; Kato T, 2006, J GENE MED, V8, P1450; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Mohle R, 2007, SEMIN HEMATOL, V44, P193, DOI 10.1053/j.seminhematol.2007.04.006; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Shibata S, 2006, J IMMUNOL, V177, P3564, DOI 10.4049/jimmunol.177.6.3564; Takakura N, 1996, J EXP MED, V184, P2301, DOI 10.1084/jem.184.6.2301; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yonemitsu Y, 2000, NAT BIOTECHNOL, V18, P970, DOI 10.1038/79463; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama Y, 2007, BIOCHEM BIOPH RES CO, V355, P129, DOI 10.1016/j.bbrc.2007.01.132; Yoshida K, 2007, BIOCHEM BIOPH RES CO, V361, P811, DOI 10.1016/j.bbrc.2007.07.111	18	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6674	10.1371/journal.pone.0006674	http://dx.doi.org/10.1371/journal.pone.0006674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688095	Green Published, Green Submitted, gold			2022-12-25	WOS:000269075800009
J	Mason, WJ; Skaar, EP				Mason, William Jeffrey; Skaar, Eric Patrick			Assessing the Contribution of Heme-Iron Acquisition to Staphylococcus aureus Pneumonia Using Computed Tomography	PLOS ONE			English	Article								Background: S. aureus acquires heme-iron using the iron regulated surface determinant (Isd) system and the heme transport system (Hts) with both systems showing critical importance in systemic models of infection. The contribution of heme-iron acquisition to staphylococcal pneumonia has not yet been elucidated. In addition, the use of computed tomography (CT) for the evaluation of staphylococcal pneumonia and its correlation to pathologic examination of infected lung tissue has not been performed to date. We have applied CT-based imaging to a murine model of staphylococcal pneumonia to determine the virulence contribution of heme-iron acquisition through the Hts and Isd systems. Methodology/Principal Findings: Mice were intranasally inoculated with similar to 1.0x10(8) colony forming units (CFU) of S. aureus. Lungs from mice infected with wild type S. aureus or strains deficient in isdB and isdH (Delta isdBH) or htsA and isdE (Delta htsA Delta isdE) were harvested at 24 hours. Histology, radiographic appearance by computed tomography (CT), percent mortality and bacterial burden were evaluated. Infection with S. aureus Delta isdBH and Delta htsA Delta isdE did not result in a statistically significant difference in mortality or bacterial burden as compared to controls. CT imaging of infected mice also did not reveal an appreciable difference between the various strains when compared to wild type, but did correlate with pathologic findings of pneumonia. However, a systemic model of infection using the Delta htsA Delta isdE strain revealed a statistically significant decrease in bacterial burden in the lung, heart and kidneys. Conclusions/Significance: The development of staphylococcal pneumonia in this murine model is not dependent on hemoglobin binding or heme-iron uptake into S. aureus. However, this model does reveal that heme-iron acquisition contributes to the pathogenesis of systemic staphylococcal infections. In addition, CT imaging of murine lungs is an attractive adjunct to histologic analysis for the confirmation and staging of pneumonia.			Mason, WJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Internal Med, Div Infect Dis, Nashville, TN 37212 USA.	eric.skaar@vanderbilt.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007474] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI07474-13, T32 AI007474] Funding Source: Medline; PHS HHS [R01 A1069233] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Armbrust LJ, 2005, AM J VET RES, V66, P835, DOI 10.2460/ajvr.2005.66.835; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Sharma S, 2007, CURR OPIN PULM MED, V13, P159, DOI 10.1097/MCP.0b013e3280f3bff4; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Ventura CL, 2008, INFECT IMMUN, V76, P888, DOI 10.1128/IAI.01301-07; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06	10	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6668	10.1371/journal.pone.0006668	http://dx.doi.org/10.1371/journal.pone.0006668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688098	Green Submitted, Green Published, gold			2022-12-25	WOS:000269075800006
J	Keuling, AM; Felton, KEA; Parker, AAM; Akbari, M; Andrew, SE; Tron, VA				Keuling, Angela M.; Felton, Kathleen E. A.; Parker, Arabesque A. M.; Akbari, Majid; Andrew, Susan E.; Tron, Victor A.			RNA Silencing of Mcl-1 Enhances ABT-737-Mediated Apoptosis in Melanoma: Role for a Caspase-8-Dependent Pathway	PLOS ONE			English	Article								Background: Malignant melanoma is resistant to almost all conventional forms of chemotherapy. Recent evidence suggests that anti-apoptotic proteins of the Bcl-2 family are overexpressed in melanoma and may contribute to melanoma's striking resistance to apoptosis. ABT-737, a small-molecule inhibitor of Bcl-2, Bcl-xl and Bcl-w, has demonstrated efficacy in several forms of leukemia, lymphoma as well as solid tumors. However, overexpression of Mcl-1, a frequent observance in melanoma, is known to confer ABT-737 resistance. Methodology/Principal Findings: Here we report that knockdown of Mcl-1 greatly reduces cell viability in combination with ABT-737 in six different melanoma cell lines. We demonstrate that the cytotoxic effect of this combination treatment is due to apoptotic cell death involving not only caspase-9 activation but also activation of caspase-8, caspase-10 and Bid, which are normally associated with the extrinsic pathway of apoptosis. Caspase-8 (and caspase-10) activation is abrogated by inhibition of caspase-9 but not by inhibitors of the death receptor pathways. Furthermore, while caspase-8/-10 activity is required for the full induction of cell death with treatment, the death receptor pathways are not. Finally, we demonstrate that basal levels of caspase-8 and Bid correlate with treatment sensitivity. Conclusions/Significance: Our findings suggest that the combination of ABT-737 and Mcl-1 knockdown represents a promising, new treatment strategy for malignant melanoma. We also report a death receptor-independent role for extrinsic pathway proteins in treatment response and suggest that caspase-8 and Bid may represent potential markers of treatment sensitivity.			Keuling, AM (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	tronv@kgh.kari.net						Barth A, 1995, J Am Coll Surg, V181, P193; Bush JA, 2003, CLIN EXP METASTAS, V20, P531, DOI 10.1023/A:1025874502181; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; de Vries JF, 2007, APOPTOSIS, V12, P181, DOI 10.1007/s10495-006-0526-6; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Eberle J, 2007, DRUG RESIST UPDATE, V10, P218, DOI 10.1016/j.drup.2007.09.001; Filomenko R, 2006, ONCOGENE, V25, P7635, DOI 10.1038/sj.onc.1209733; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Green MML, 2005, BRIT J CANCER, V92, P449, DOI 10.1038/sj.bjc.6602344; Keogh RJ, 2007, CIRC RES, V100, P834, DOI 10.1161/01.RES.0000261352.81736.37; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kline MP, 2007, LEUKEMIA, V21, P1549, DOI 10.1038/sj.leu.2404719; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; LI C, 2008, HUM MUTAT; Lorigan P, 2008, EXP DERMATOL, V17, P383, DOI 10.1111/j.1600-0625.2007.00673.x; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Milhas D, 2005, J BIOL CHEM, V280, P19836, DOI 10.1074/jbc.M414358200; MILLER LA, 2008, J INVEST DERMATOL; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Stein JA, 2008, J DRUGS DERMATOL, V7, P175; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Sutheesophon K, 2005, J CELL PHYSIOL, V203, P387, DOI 10.1002/jcp.20235; TAGSCHERER KE, 2008, ONCOGENE; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Tang LR, 1998, CLIN CANCER RES, V4, P1865; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wong RPC, 2008, ONCOL REP, V19, P933; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Young LC, 2003, J INVEST DERMATOL, V121, P876, DOI 10.1046/j.1523-1747.2003.12486.x; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750	43	65	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6651	10.1371/journal.pone.0006651	http://dx.doi.org/10.1371/journal.pone.0006651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684859	Green Submitted, Green Published, gold			2022-12-25	WOS:000269075600003
J	Carrol, ED; Mankhambo, LA; Jeffers, G; Parker, D; Guiver, M; Newland, P; Banda, DL; Molyneux, EM; Heyderman, RS; Molyneux, ME; Hart, CA				Carrol, Enitan D.; Mankhambo, Limangeni A.; Jeffers, Graham; Parker, Deborah; Guiver, Malcolm; Newland, Paul; Banda, Daniel L.; Molyneux, Elizabeth M.; Heyderman, Robert S.; Molyneux, Malcolm E.; Hart, C. Anthony		IPD Study Grp	The Diagnostic and Prognostic Accuracy of Five Markers of Serious Bacterial Infection in Malawian Children with Signs of Severe Infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CD163 SERUM-LEVELS; SOLUBLE CD163; PLASMA-CONCENTRATIONS; PROCALCITONIN; BACTEREMIA; MENINGITIS; MORTALITY; SURVIVAL; EFFICACY	Background: Early recognition and prompt and appropriate antibiotic treatment can significantly reduce mortality from serious bacterial infections (SBI). The aim of this study was to evaluate the utility of five markers of infection: C-reactive protein (CRP), procalcitonin (PCT), soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), CD163 and high mobility group box-1 (HMGB1), as markers of SBI in severely ill Malawian children. Methodology and Principal Findings: Children presenting with a signs of meningitis (n = 282) or pneumonia (n = 95), were prospectively recruited. Plasma samples were taken on admission for CRP, PCT, sTREM-1 CD163 and HMGB1 and the performance characteristics of each test to diagnose SBI and to predict mortality were determined. Of 377 children, 279 (74%) had SBI and 83 (22%) died. Plasma CRP, PCT, CD163 and HMGB1 and were higher in HIV-infected children than in HIV-uninfected children (p<0.01). In HIV-infected children, CRP and PCT were higher in children with SBI compared to those with no detectable bacterial infection (p<0.0005), and PCT and CD163 were higher in non-survivors (p = 0.001, p = 0.05 respectively). In HIV-uninfected children, CRP and PCT were also higher in children with SBI compared to those with no detectable bacterial infection (p<0.0005), and CD163 was higher in non-survivors (p = 0.05). The best predictors of SBI were CRP and PCT, and areas under the curve (AUCs) were 0.81 (95% CI 0.73-0.89) and 0.86 (95% CI 0.79-0.92) respectively. The best marker for predicting death was PCT, AUC 0.61 (95% CI 0.50-0.71). Conclusions: Admission PCT and CRP are useful markers of invasive bacterial infection in severely ill African children. The study of these markers using rapid tests in a less selected cohort would be important in this setting.	[Carrol, Enitan D.; Mankhambo, Limangeni A.; Banda, Daniel L.; Heyderman, Robert S.; Molyneux, Malcolm E.; IPD Study Grp] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Mankhambo, Limangeni A.; Molyneux, Elizabeth M.] Univ Malawi, Coll Med, Dept Paediat, Zomba, Malawi; [Parker, Deborah] Glenfield Hosp, Inst Lung Hlth Clin Sci, Leicester, Leics, England; [Guiver, Malcolm] Hlth Protect Agcy, Manchester, Lancs, England; [Newland, Paul] Alder Hey Childrens NHS Fdn Trust, Dept Biochem, Liverpool, Merseyside, England; [Carrol, Enitan D.; Jeffers, Graham] Univ Liverpool, Inst Child Hlth, Alder Hey Childrens NHS Fdn Trust, Div Child Hlth, Liverpool L69 3BX, Merseyside, England; [Carrol, Enitan D.; Hart, C. Anthony] Univ Liverpool, Div Med Microbiol, Liverpool L69 3BX, Merseyside, England	University of Malawi; University of Malawi; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Health Protection Agency; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Liverpool	Carrol, ED (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	edcarrol@liv.ac.uk		Carrol, Enitan/0000-0001-8357-7726	Wellcome Trust [068026]	Wellcome Trust(Wellcome TrustEuropean Commission)	All authors state that they have no competing interests or financial disclosures to declare. Enitan D Carrol was supported by a Wellcome Trust Career Development Fellowship in Clinical Tropical Medicine, Grant No. 068026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Barrow GI, 1993, COWAN STEELES MANUAL; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brunkhorst FM, 1998, INTENS CARE MED, V24, P888, DOI 10.1007/s001340050683; Carcillo Joseph A, 2005, Pediatr Crit Care Med, V6, pS157, DOI 10.1097/01.PCC.0000161574.36857.CA; Carrol ED, 2002, ARCH DIS CHILD, V86, P282, DOI 10.1136/adc.86.4.282; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; Cheung YB, 2008, TROP MED INT HEALTH, V13, P603, DOI 10.1111/j.1365-3156.2008.02050.x; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Gaini S, 2008, CLIN EXP IMMUNOL, V151, P423, DOI 10.1111/j.1365-2249.2007.03586.x; Gaini S, 2006, APMIS, V114, P103, DOI 10.1111/j.1600-0463.2006.apm_341.x; Gaini S, 2007, CRIT CARE, V11, DOI 10.1186/cc5967; Gibot S, 2005, INTENS CARE MED, V31, P594, DOI 10.1007/s00134-005-2572-x; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Gibot S, 2007, SCAND J INFECT DIS, V39, P604, DOI 10.1080/00365540701199832; Gibot S, 2007, INTENS CARE MED, V33, P1347, DOI 10.1007/s00134-007-0691-2; Knudsen TB, 2005, CLIN MICROBIOL INFEC, V11, P730, DOI 10.1111/j.1469-0691.2005.01229.x; Knudsen TB, 2007, SCAND J INFECT DIS, V39, P542, DOI 10.1080/00365540601113685; Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07; Madhi SA, 2005, PLOS MED, V2, P147, DOI 10.1371/journal.pmed.0020038; Meisner M, 2000, CLIN CHEM LAB MED, V38, P989, DOI 10.1515/CCLM.2000.147; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; Palmer A, 2004, ANN TROP PAEDIATR, V24, P205, DOI 10.1179/027249304225018948; Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3; Simon L, 2008, PEDIATR CRIT CARE ME, V9, P407, DOI 10.1097/PCC.0b013e31817285a6; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]	28	60	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6621	10.1371/journal.pone.0006621	http://dx.doi.org/10.1371/journal.pone.0006621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675669	gold, Green Submitted, Green Published			2022-12-25	WOS:000268936100002
J	Regev, N; Degani-Katzav, N; Korngreen, A; Etzioni, A; Siloni, S; Alaimo, A; Chikvashvili, D; Villarroel, A; Attali, B; Lotan, I				Regev, Noa; Degani-Katzav, Nurit; Korngreen, Alon; Etzioni, Adi; Siloni, Sivan; Alaimo, Alessandro; Chikvashvili, Dodo; Villarroel, Alvaro; Attali, Bernard; Lotan, Ilana			Selective Interaction of Syntaxin 1A with KCNQ2: Possible Implications for Specific Modulation of Presynaptic Activity	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; KCNQ2/KCNQ3 K+ CHANNELS; CA1 PYRAMIDAL CELLS; C-TERMINAL DOMAINS; VOLTAGE-GATED K+; POTASSIUM CHANNELS; NEURONAL EXCITABILITY; SURFACE EXPRESSION; OPEN PROBABILITY; XENOPUS-OOCYTES	KCNQ2/KCNQ3 channels are the molecular correlates of the neuronal M-channels, which play a major role in the control of neuronal excitability. Notably, they differ from homomeric KCNQ2 channels in their distribution pattern within neurons, with unique expression of KCNQ2 in axons and nerve terminals. Here, combined reciprocal coimmunoprecipitation and two-electrode voltage clamp analyses in Xenopus oocytes revealed a strong association of syntaxin 1A, a major component of the exocytotic SNARE complex, with KCNQ2 homomeric channels resulting in a similar to 2-fold reduction in macroscopic conductance and similar to 2-fold slower activation kinetics. Remarkably, the interaction of KCNQ2/Q3 heteromeric channels with syntaxin 1A was significantly weaker and KCNQ3 homomeric channels were practically resistant to syntaxin 1A. Analysis of different KCNQ2 and KCNQ3 chimeras and deletion mutants combined with in-vitro binding analysis pinpointed a crucial C-terminal syntaxin 1A-association domain in KCNQ2. Pull-down and coimmunoprecipitation analyses in hippocampal and cortical synaptosomes demonstrated a physical interaction of brain KCNQ2 with syntaxin 1A, and confocal immunofluorescence microscopy showed high colocalization of KCNQ2 and syntaxin 1A at presynaptic varicosities. The selective interaction of syntaxin 1A with KCNQ2, combined with a numerical simulation of syntaxin 1A's impact in a firing-neuron model, suggest that syntaxin 1A's interaction is targeted at regulating KCNQ2 channels to fine-tune presynaptic transmitter release, without interfering with the function of KCNQ2/3 channels in neuronal firing frequency adaptation.	[Regev, Noa; Degani-Katzav, Nurit; Etzioni, Adi; Siloni, Sivan; Chikvashvili, Dodo; Attali, Bernard; Lotan, Ilana] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel; [Korngreen, Alon] Bar Ilan Univ, Mina & Everard Goodman Fac life Sci, Ramat Gan, Israel; [Alaimo, Alessandro; Villarroel, Alvaro] UPV, CSIC, Unidad Biofis, Euskal Herriko Unibersitatea, Leioa, Spain	Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Regev, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel.	ilotan@post.tau.ac.il	Villarroel, Alvaro/H-5580-2015; Alaimo, Alessandro/C-6334-2016	Alaimo, Alessandro/0000-0002-5888-6268; Korngreen, Alon/0000-0002-2036-6160; Regev, Noa/0000-0002-5865-4774	Israeli Science Foundation (ISF) [208/06, 1396/05, 672/05]; The Public Committee for Allocation of Estate Funds [3-4181]; Ministry of Justice, Israel; The Israel Ministry of Science; DFG-DIP; Spanish Ministry of Education [SAF2006-13450, CSD2008-00005]	Israeli Science Foundation (ISF)(Israel Science Foundation); The Public Committee for Allocation of Estate Funds; Ministry of Justice, Israel; The Israel Ministry of Science; DFG-DIP; Spanish Ministry of Education(Spanish Government)	This work was supported by the Israeli Science Foundation (ISF) grants no. 208/06 (I.L.), 1396/05) (I.L.) and 672/05 (B.A.); The Public Committee for Allocation of Estate Funds grant no. 3-4181, Ministry of Justice, Israel (I.L.); The Israel Ministry of Science 'Tashtiot' program and a DFG-DIP grant (B. A.); the Spanish Ministry of Education grant no. SAF2006-13450 (A.V.) and the Consolider project CSD2008-00005 (A.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparan D, 2005, J NEUROCHEM, V92, P349, DOI 10.1111/j.1471-4159.2004.02869.x; BENNETT MK, 1995, CURR OPIN CELL BIOL, V7, P581, DOI 10.1016/0955-0674(95)80016-6; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Colbert CM, 1996, J NEUROSCI, V16, P6676; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; DASCAL N, 1992, J PHYSIOL-LONDON, V450, P469, DOI 10.1113/jphysiol.1992.sp019137; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; DESTEXHE A, 2001, THALAMACORTICAL ASSE; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Frei E, 2006, CELL PHYSIOL BIOCHEM, V18, P165, DOI 10.1159/000097665; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hansen HH, 2006, J PHARMACOL EXP THER, V318, P1006, DOI 10.1124/jpet.106.106757; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; IVANINA T, 1994, BIOCHEMISTRY-US, V33, P8786, DOI 10.1021/bi00195a021; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Ji JZ, 2002, GASTROENTEROLOGY, V122, P994, DOI 10.1053/gast.2002.32412; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jing J, 1999, EMBO J, V18, P1245, DOI 10.1093/emboj/18.5.1245; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kang YH, 2004, J BIOL CHEM, V279, P47125, DOI 10.1074/jbc.M404954200; Kobrinsky E, 2006, J BIOL CHEM, V281, P19233, DOI 10.1074/jbc.M601231200; Lang Thorsten, 2008, V184, P107; Leung YM, 2005, BIOCHEM J, V387, P195, DOI 10.1042/BJ20041625; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; LEVIN G, 1995, J BIOL CHEM, V270, P14611, DOI 10.1074/jbc.270.24.14611; Levin G, 1996, J BIOL CHEM, V271, P29321, DOI 10.1074/jbc.271.46.29321; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Linial M, 1997, J NEUROCHEM, V69, P1781; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Martire M, 2007, J NEUROCHEM, V102, P179, DOI 10.1111/j.1471-4159.2007.04562.x; MICHAELEVSKI I, 2003, J BIOL CHEM; Michaelevski I, 2007, PFLUG ARCH EUR J PHY, V454, P477, DOI 10.1007/s00424-007-0223-5; Michaelevski L, 2002, J BIOL CHEM, V277, P34909, DOI 10.1074/jbc.M203943200; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Scholle A, 2004, BIOPHYS J, V87, P873, DOI 10.1529/biophysj.104.040550; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Singer-Lahat D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001381; Singer-Lahat D, 2007, J NEUROSCI, V27, P1651, DOI 10.1523/JNEUROSCI.4006-06.2007; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tsuk S, 2005, MOL PHARMACOL, V67, P480, DOI 10.1124/mol.104.005314; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Wolf-Goldberg T, 2006, MOL PHARMACOL, V70, P818, DOI 10.1124/mol.105.021717; Yamakawa T, 2007, BIOCHEMISTRY-US, V46, P10942, DOI 10.1021/bi7006806; Yue CY, 2006, J NEUROPHYSIOL, V95, P3480, DOI 10.1152/jn.01333.2005; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zheng Jie, 2006, V337, P65	87	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6586	10.1371/journal.pone.0006586	http://dx.doi.org/10.1371/journal.pone.0006586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675672	Green Submitted, Green Published, gold			2022-12-25	WOS:000268936100001
J	Kim, MS; Louwagie, J; Carvalho, B; Droste, JSTS; Park, HL; Chae, YK; Yamashita, K; Liu, JW; Ostrow, KL; Ling, SZ; Guerrero-Preston, R; Demokan, S; Yalniz, Z; Dalay, N; Meijer, GA; Van Criekinge, W; Sidransky, D				Kim, Myoung Sook; Louwagie, Joost; Carvalho, Beatriz; Droste, Jochim S. Terhaar Sive; Park, Hannah Lui; Chae, Young Kwang; Yamashita, Keishi; Liu, Junwei; Ostrow, Kimberly Laskie; Ling, Shizhang; Guerrero-Preston, Rafael; Demokan, Semra; Yalniz, Zubeyde; Dalay, Nejat; Meijer, Gerrit A.; Van Criekinge, Wim; Sidransky, David			Promoter DNA Methylation of Oncostatin M receptor-beta as a Novel Diagnostic and Therapeutic Marker in Colon Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; GROWTH-REGULATOR; EXPRESSION; GENES; HYPERMETHYLATION; PROFILE; BETA-1,4-GALACTOSYLTRANSFERASE; IDENTIFICATION; CARCINOMA; APOPTOSIS	In addition to genetic changes, the occurrence of epigenetic alterations is associated with accumulation of both genetic and epigenetic events that promote the development and progression of human cancer. Previously, we reported a set of candidate genes that comprise part of the emerging "cancer methylome". In the present study, we first tested 23 candidate genes for promoter methylation in a small number of primary colon tumor tissues and controls. Based on these results, we then examined the methylation frequency of Oncostatin M receptor-beta (OSMR) in a larger number of tissue and stool DNA samples collected from colon cancer patients and controls. We found that OSMR was frequently methylated in primary colon cancer tissues (80%, 80/100), but not in normal tissues (4%, 4/100). Methylation of OSMR was also detected in stool DNA from colorectal cancer patients (38%, 26/69) (cut-off in TaqMan-MSP, 4). Detection of other methylated markers in stool DNA improved sensitivity with little effect on specificity. Promoter methylation mediated silencing of OSMR in cell lines, and CRC cells with low OSMR expression were resistant to growth inhibition by Oncostatin M. Our data provide a biologic rationale for silencing of OSMR in colon cancer progression and highlight a new therapeutic target in this disease. Moreover, detection and quantification of OSMR promoter methylation in fecal DNA is a highly specific diagnostic biomarker for CRC.			Kim, MS (corresponding author), Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21218 USA.	dsidrans@jhmi.edu	Demokan, Semra/AAC-5943-2020; Ling, Shizhang/J-6114-2014	Ling, Shizhang/0000-0002-6856-3577; Guerrero-Preston, Rafael/0000-0002-6639-6488; Meijer, Gerrit/0000-0003-0330-3130	NATIONAL CANCER INSTITUTE [U01CA084986] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA084986] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Deng GR, 2009, CLIN CANCER RES, V15, P1519, DOI 10.1158/1078-0432.CCR-08-1778; Douglas AM, 1997, ONCOGENE, V14, P661, DOI 10.1038/sj.onc.1200882; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ganapathi MK, 1996, CELL GROWTH DIFFER, V7, P923; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; Grant SL, 1999, MOL MED TODAY, V5, P406, DOI 10.1016/S1357-4310(99)01540-3; Herman JG, 1999, SEMIN CANCER BIOL, V9, P359, DOI 10.1006/scbi.1999.0138; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Inoue A, 2002, J MOL ENDOCRINOL, V29, P175, DOI 10.1677/jme.0.0290175; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim MS, 2008, ONCOGENE, V27, P2045, DOI 10.1038/sj.onc.1210842; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lacreusette A, 2007, ONCOGENE, V26, P881, DOI 10.1038/sj.onc.1209844; Li ZJ, 2006, MOL CELL BIOCHEM, V291, P69, DOI 10.1007/s11010-006-9198-3; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Liu JW, 1998, CYTOKINE, V10, P295, DOI 10.1006/cyto.1997.0283; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Ohata Y, 2001, MOL HUM REPROD, V7, P665, DOI 10.1093/molehr/7.7.665; Paz MF, 2003, CANCER RES, V63, P1114; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; Seko A, 1998, FEBS LETT, V440, P307, DOI 10.1016/S0014-5793(98)01458-6; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Underhill-Day N, 2006, CANCER RES, V66, P10891, DOI 10.1158/0008-5472.CAN-06-1766; Uthoff SMS, 2001, MOL CARCINOGEN, V31, P56, DOI 10.1002/mc.1039; Xu XL, 2004, WORLD J GASTROENTERO, V10, P3441; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; Zhang S, 2003, MOL CELL BIOCHEM, V243, P81, DOI 10.1023/A:1021683324548; Zhu XY, 2003, BIOCHEM BIOPH RES CO, V309, P279, DOI 10.1016/j.bbrc.2003.04.001; Zhu XY, 2005, J BIOL CHEM, V280, P12503, DOI 10.1074/jbc.M413631200	41	82	87	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6555	10.1371/journal.pone.0006555	http://dx.doi.org/10.1371/journal.pone.0006555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662090	Green Published, Green Submitted, gold			2022-12-25	WOS:000268739600011
J	Nayak, B; Rout, SN; Kumar, S; Khalil, MS; Fouda, MM; Ahmed, LE; Earhart, KC; Perez, DR; Collins, PL; Samal, SK				Nayak, Baibaswata; Rout, Subrat N.; Kumar, Sachin; Khalil, Mohammed S.; Fouda, Moustafa M.; Ahmed, Luay E.; Earhart, Kenneth C.; Perez, Daniel R.; Collins, Peter L.; Samal, Siba K.			Immunization of Chickens with Newcastle Disease Virus Expressing H5 Hemagglutinin Protects against Highly Pathogenic H5N1 Avian Influenza Viruses	PLOS ONE			English	Article								Background: Highly-pathogenic avian influenza virus (HPAIV) and Newcastle disease virus (NDV) are the two most important poultry viruses in the world. Natural low-virulence NDV strains have been used as vaccines over the past 70 years with proven track records. We have previously developed a reverse genetics system to produce low-virulent NDV vaccine strain LaSota from cloned cDNA. This system allows us to use NDV as a vaccine vector for other avian pathogens. Methodology/Principal Finding: Here, we constructed two recombinant NDVs (rNDVs) each of which expresses the hemagglutinin (HA) gene of HPAIV H5N1strain A/Vietnam/1203/2004 from an added gene. In one, rNDV (rNDV-HA), the open reading frame (ORF) of HA gene was expressed without modification. In the second, rNDV (rNDV-HAF), the ORF was modified so that the transmembrane and cytoplasmic domains of the encoded HA gene were replaced with those of the NDV F protein. The insertion of either version of the HA ORF did not increase the virulence of the rNDV vector. The HA protein was found to be incorporated into the envelopes of both rNDV-HA and rNDV-HAF. However, there was an enhanced incorporation of the HA protein in rNDV-HAF. Chickens immunized with a single dose of either rNDV-HA or rNDV-HAF induced a high titer of HPAIV H5-specific antibodies and were completely protected against challenge with NDV as well as lethal challenges of both homologous and heterologous HPAIV H5N1. Conclusion and Significance: Our results suggest that these chimeric viruses have potential as safe and effective bivalent vaccines against NDV and. HPAIV. These vaccines will be convenient and affordable, which will be highly beneficial to the poultry industry. Furthermore, immunization with these vaccines will permit serological differentiation of vaccinated and avian influenza field virus infected animals.			Nayak, B (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu	Nayak, Baibaswata/L-6156-2016; Perez, Daniel R./D-5044-2016	Perez, Daniel R./0000-0002-6569-5689	Intramural NIH HHS Funding Source: Medline; PHS HHS [N01A060009] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000938, ZIAAI000938] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; BEARD CW, 1991, AVIAN DIS, V35, P356, DOI 10.2307/1591189; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; DiNapoli JM, 2007, J VIROL, V81, P11560, DOI 10.1128/JVI.00713-07; DiNapoli JM, 2007, P NATL ACAD SCI USA, V104, P9788, DOI 10.1073/pnas.0703584104; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Galarza JM, 2005, VIRAL IMMUNOL, V18, P244, DOI 10.1089/vim.2005.18.244; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; HIERHOLZER JC, 1996, UK VIROLOGY METHODS, P25; Huang N, 2004, BIOPROCESS INT, V2, P54; Huang Z, 2003, POULTRY SCI, V82, P899, DOI 10.1093/ps/82.6.899; Huang ZH, 2001, J GEN VIROL, V82, P1729, DOI 10.1099/0022-1317-82-7-1729; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Krishnamurthy S, 2000, VIROLOGY, V278, P168, DOI 10.1006/viro.2000.0618; Luschow D, 2001, VACCINE, V19, P4249, DOI 10.1016/S0264-410X(01)00167-0; Nakaya T, 2001, J VIROL, V75, P11868, DOI 10.1128/JVI.75.23.11868-11873.2001; OIE, 2004, MAN DIAGN TESTS VACC; *OIE, 2009, AV INFL FACTS FIG 62; *OIE FAO, 2005, OIE FAO INT SCI C AV; Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103; ROBINSON HL, 1993, VACCINE, V11, P957, DOI 10.1016/0264-410X(93)90385-B; Rout SN, 2008, J VIROL, V82, P7828, DOI 10.1128/JVI.00578-08; Singh N, 2008, MOL THER, V16, P965, DOI 10.1038/mt.2008.12; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Swayne DE, 2000, VACCINE, V18, P1088, DOI 10.1016/S0264-410X(99)00369-2; TAYLOR J, 1988, VACCINE, V6, P504, DOI 10.1016/0264-410X(88)90101-6; Toro H, 2007, VACCINE, V25, P2886, DOI 10.1016/j.vaccine.2006.09.047; Veits J, 2003, J GEN VIROL, V84, P3343, DOI 10.1099/vir.0.19570-0; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; *WHO, 2009, CUM NUMB CONF HUM CA; Yang DG, 2007, MOL THER, V15, P989, DOI 10.1038/mt.sj.6300131	36	59	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6509	10.1371/journal.pone.0006509	http://dx.doi.org/10.1371/journal.pone.0006509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654873	gold, Green Submitted, Green Published			2022-12-25	WOS:000268739100009
J	Zhao, DX; Chen, S; Cai, J; Guo, YS; Song, ZH; Che, J; Liu, C; Wu, C; Ding, MX; Deng, HK				Zhao, Dongxin; Chen, Song; Cai, Jun; Guo, Yushan; Song, Zhihua; Che, Jie; Liu, Chun; Wu, Chen; Ding, Mingxiao; Deng, Hongkui			Derivation and Characterization of Hepatic Progenitor Cells from Human Embryonic Stem Cells	PLOS ONE			English	Article								The derivation of hepatic progenitor cells from human embryonic stem (hES) cells is of value both in the study of early human liver organogenesis and in the creation of an unlimited source of donor cells for hepatocyte transplantation therapy. Here, we report for the first time the generation of hepatic progenitor cells derived from hES cells. Hepatic endoderm cells were generated by activating FGF and BMP pathways and were then purified by fluorescence activated cell sorting using a newly identified surface marker, N-cadherin. After co-culture with STO feeder cells, these purified hepatic endoderm cells yielded hepatic progenitor colonies, which possessed the proliferation potential to be cultured for an extended period of more than 100 days. With extensive expansion, they co-expressed the hepatic marker AFP and the biliary lineage marker KRT7 and maintained bipotential differentiation capacity. They were able to differentiate into hepatocyte-like cells, which expressed ALB and AAT, and into cholangiocyte-like cells, which formed duct-like cyst structures, expressed KRT19 and KRT7, and acquired epithelial polarity. In conclusion, this is the first report of the generation of proliferative and bipotential hepatic progenitor cells from hES cells. These hES cell-derived hepatic progenitor cells could be effectively used as an in vitro model for studying the mechanisms of hepatic stem/progenitor cell origin, self-renewal and differentiation.			Zhao, DX (corresponding author), Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.	hongkui_deng@pku.edu.cn	Zhao, Dongxin/K-4932-2016; LIU, CHUN/N-6909-2014; Cai, Jun/D-4118-2012	wu, chen/0000-0003-3900-9363; Liu, Chun/0000-0002-8242-3896				Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen Q, 2007, NAT PROTOC, V2, P1197, DOI 10.1038/nprot.2007.118; Chiao E, 2008, STEM CELLS, V26, P2032, DOI 10.1634/stemcells.2007-0964; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Doi Y, 2007, HEPATOL RES, V37, P230, DOI 10.1111/j.1872-034X.2007.00028.x; Drobinskaya I, 2008, STEM CELLS, V26, P2245, DOI 10.1634/stemcells.2008-0387; Gigliozzi A, 2000, GASTROENTEROLOGY, V119, P1113, DOI 10.1053/gast.2000.18156; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Martin MA, 2005, STEM CELLS DEV, V14, P493, DOI 10.1089/scd.2005.14.493; Mosnier JF, 2009, MODERN PATHOL, V22, P182, DOI 10.1038/modpathol.2008.123; Oertel M, 2008, GASTROENTEROLOGY, V134, P823, DOI 10.1053/j.gastro.2008.01.007; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Soto-Gutierrez A, 2006, NAT BIOTECHNOL, V24, P1412, DOI 10.1038/nbt1257; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuchiya A, 2005, GASTROENTEROLOGY, V128, P2089, DOI 10.1053/j.gastro.2005.03.030; Tsuchiya B, 2006, ARCH HISTOL CYTOL, V69, P135, DOI 10.1679/aohc.69.135; Walkup MH, 2006, STEM CELLS, V24, P1833, DOI 10.1634/stemcells.2006-0063; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516	31	77	113	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6468	10.1371/journal.pone.0006468	http://dx.doi.org/10.1371/journal.pone.0006468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649295	Green Submitted, gold, Green Published			2022-12-25	WOS:000268637600016
J	Frese, MA; Milz, F; Dick, M; Lamanna, WC; Dierks, T				Frese, Marc-Andre; Milz, Fabian; Dick, Marina; Lamanna, William C.; Dierks, Thomas			Characterization of the Human Sulfatase Sulf1 and Its High Affinity Heparin/Heparan Sulfate Interaction Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; GROWTH; BINDING; QSULF1; 6-O-ENDOSULFATASES; GENE; PROTEOGLYCANS; DEFICIENCY; PROMOTE	The extracellular sulfartases Sulf1 and Sulf2 remodel the 60-sulfation state of heparan sulfate proteoglycans on the cell surface, thereby modulating growth factor signaling. Different from all other sulfartases, the Sulfs contain a unique, positively charged hydrophilic domain (HD) of about 320 amino acid residues. Using various HD deletion mutants and glutathione S-transferase (GST)-HD fusion proteins, this study demonstrates that the HD is required for enzymatic activity and acts as a high affinity heparin/heparan sulfate interaction domain. Association of the HD with the cell surface is sensitive to heparinase treatment, underlining specificity toward heparan sulfate chains. Correspondingly, isolated GST-HD binds strongly to both heparin and heparan sulfate in vitro and also to living cells. Surface plasmon resonance studies indicate nanomolar affinity of GST-HD toward immobilized heparin. The comparison of different mutants reveals that especially the outer regions of the HD mediate heparan sulfate binding, probably involving "tandem" interactions. Interestingly, binding to heparan sulfate depends on the presence of 60-sulfate substrate groups, suggesting that substrate turnover facilitates release of the enzyme from its substrate. Deletion of the inner, less conserved region of the HD drastically increases Sulf1 secretion without affecting enzymatic activity or substrate specificity, thus providing a tool for the in vitro modulation of HS-dependent signaling as demonstrated here for the signal transduction of fibroblast growth factor 2. Taken together, the present study shows that specific regions of the HD influence different aspects of HS binding, cellular localization, and enzyme function.	[Frese, Marc-Andre; Milz, Fabian; Dick, Marina; Lamanna, William C.; Dierks, Thomas] Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany	University of Bielefeld	Dierks, T (corresponding author), Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Inclustrie; Shire Human Genetic Therapies, Inc. (Cambridge, MA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Inclustrie; Shire Human Genetic Therapies, Inc. (Cambridge, MA)	This work was supported by the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Inclustrie, and Shire Human Genetic Therapies, Inc. (Cambridge, MA).	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Ambasta RK, 2007, J BIOL CHEM, V282, P34492, DOI 10.1074/jbc.M706744200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Dierks T, 2009, BBA-MOL CELL RES, V1793, P710, DOI 10.1016/j.bbamcr.2008.11.015; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Eckert R, 2003, FEBS LETT, V541, P121, DOI 10.1016/S0014-5793(03)00322-3; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Klagsbrun M, 1990, CURR OPIN CELL BIOL, V2, P857, DOI 10.1016/0955-0674(90)90084-R; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; LUNDQUIST P, 1980, CLIN CHEM, V26, P1178; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; SOBEL M, 1992, J BIOL CHEM, V267, P8857; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101	41	56	58	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28033	28044		10.1074/jbc.M109.035808	http://dx.doi.org/10.1074/jbc.M109.035808			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666466	Green Published, hybrid			2022-12-25	WOS:000270676300031
J	Jitkaew, S; Trebinska, A; Grzybowska, E; Carlsson, G; Nordstrom, A; Lehtio, J; Frojmark, AS; Dahl, N; Fadeel, B				Jitkaew, Siriporn; Trebinska, Alicja; Grzybowska, Ewa; Carlsson, Goeran; Nordstrom, Anders; Lehtio, Janne; Frojmark, Anne-Sophie; Dahl, Niklas; Fadeel, Bengt			N-alpha-Tosyl-L-phenylalanine Chloromethyl Ketone Induces Caspase-dependent Apoptosis in Transformed Human B Cell Lines with Transcriptional Down-regulation of Anti-apoptotic HS1-associated Protein X-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE CONGENITAL NEUTROPENIA; MONOCYTIC THP.1 CELLS; CYTOCHROME-C; BCL-2; HAX-1; RELEASE; MITOCHONDRIA; INHIBITION; EXPRESSION; CLEAVAGE	N-alpha-ToSyl-L-phenylalanine chloromethylketone (TPCK) has been widely used to investigate signal transduction pathways that are involved in gene expression and cell survival/cell death. However, contradictory effects of TPCK on apoptosis have been reported, and the underlying signaling events leading to TPCK-induced promotion or prevention of apoptosis are not fully understood. Here, we show that TPCK induces caspase-dependent apoptosis in Epstein-Barr virus (EBV)-transformed human B cell lines with release of pro-apoptotic proteins from mitochondria. TPCK treatment also results in down-regulation of the anti-apoptotic proteins, cIAP1, cIAP2, and HAX-1, and caspase-dependent cleavage of the anti-apoptotic proteins, Bcl-2 and XIAP. Quantitative PCR analysis confirmed that the TPCK-induced down-regulation of HAX-1 occurred at the transcriptional level, and experiments using the specific pharmacological inhibitor, Bay 11-7082, suggested that HAX-1 expression is subject to regulation by the transcription factor, NF-kappa B cell lines derived from patients with homozygous HAX1 mutations were more sensitive to TPCK-induced apoptosis when compared with normal donor cell lines. Furthermore, N-acetylcysteine effectively blocked TPCK-induced apoptosis in EBV-transformed B cell lines and prevented the down-regulation or cleavage of anti-apoptotic proteins. Taken together, our studies demonstrate that TPCK induces apoptosis in human B cell lines and exerts multiple effects on pro- and anti-apoptotic factors.	[Jitkaew, Siriporn; Fadeel, Bengt] Karolinska Univ Hosp, Inst Environm Med, Div Mol Toxicol, S-17176 Stockholm, Sweden; [Carlsson, Goeran] Karolinska Univ Hosp, Childhood Canc Res Unit, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [Nordstrom, Anders; Lehtio, Janne] Karolinska Univ Hosp, Dept Pathol & Oncol, Karolinska Inst, Karolinska Biom Ctr, S-17176 Stockholm, Sweden; [Jitkaew, Siriporn] Mahidol Univ, Siriraj Hosp, Dept Biochem, Fac Med, Bangkok 10700, Thailand; [Jitkaew, Siriporn] Mahidol Univ, Thalassemia Res Ctr, Inst Sci & Technol Res & Dev, Nakhonpothom 73170, Thailand; [Trebinska, Alicja; Grzybowska, Ewa] Maria Sklodowska Curie Mem Canc Ctr, Dept Mol Biol, PL-02781 Warsaw, Poland; [Trebinska, Alicja; Grzybowska, Ewa] Inst Oncol, PL-02781 Warsaw, Poland; [Frojmark, Anne-Sophie; Dahl, Niklas] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Mahidol University; Mahidol University; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Uppsala University	Fadeel, B (corresponding author), Karolinska Univ Hosp, Inst Environm Med, Div Mol Toxicol, S-17176 Stockholm, Sweden.	bengt.fadeel@ki.se	Grzybowska, Ewa/F-2711-2013; Trebinska-Stryjewska, Alicja A/F-3007-2013	Trebinska-Stryjewska, Alicja A/0000-0001-7847-049X; Lehtio, Janne/0000-0002-8100-9562	Swedish Cancer Foundation; Swedish Children's Cancer Foundation; Swedish Research Council; Stockholm County Council; Polish Committee for Scientific Research [N30100432/0437]	Swedish Cancer Foundation; Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Polish Committee for Scientific Research(Polish State Committee for Scientific Research)	This work was supported, in part, by grants from the Swedish Cancer Foundation, Swedish Children's Cancer Foundation, Swedish Research Council, Stockholm County Council, and Polish Committee for Scientific Research (Grant N30100432/0437).	Ballif BA, 2001, J BIOL CHEM, V276, P12466, DOI 10.1074/jbc.M009939200; Carlsson G, 2008, J INTERN MED, V264, P388, DOI 10.1111/j.1365-2796.2008.01982.x; Carlsson G, 2004, BLOOD, V103, P3355, DOI 10.1182/blood-2003-04-1011; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Fadeel B, 1999, LEUKEMIA, V13, P719, DOI 10.1038/sj.leu.2401411; Frydrych I, 2008, J CELL BIOCHEM, V103, P1646, DOI 10.1002/jcb.21550; Grabe Niels, 2002, In Silico Biology, V2, pS1; Grzybowska EA, 2006, GENE, V371, P84, DOI 10.1016/j.gene.2005.11.035; Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5; Heussler VT, 1999, CELL DEATH DIFFER, V6, P342, DOI 10.1038/sj.cdd.4400501; Jones RA, 1998, HEPATOLOGY, V27, P1632, DOI 10.1002/hep.510270624; Kagan VE, 2001, CANCER RES, V61, P7777; Kim K, 2003, BIOCHEM BIOPH RES CO, V306, P954, DOI 10.1016/S0006-291X(03)01088-X; King MA, 2004, CELL CYCLE, V3, P1566, DOI 10.4161/cc.3.12.1276; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lees DM, 2008, J MOL BIOL, V379, P645, DOI 10.1016/j.jmb.2008.04.020; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Rokhlin OW, 2004, CANCER BIOL THER, V3, P761, DOI 10.4161/cbt.3.8.970; SCHOELLMANN G, 1963, BIOCHEMISTRY-US, V2, P252, DOI 10.1021/bi00902a008; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Sun Y, 2005, BLOOD, V105, P4070, DOI 10.1182/blood-2004-10-4075; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wu M, 1996, MOL CELL BIOL, V16, P5015; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Zhu HJ, 1997, CELL DEATH DIFFER, V4, P590, DOI 10.1038/sj.cdd.4400284; Zhuang JG, 1998, CELL DEATH DIFFER, V5, P953, DOI 10.1038/sj.cdd.4400440	32	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27827	27837		10.1074/jbc.M109.027912	http://dx.doi.org/10.1074/jbc.M109.027912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679660	Green Published, hybrid			2022-12-25	WOS:000270676300009
J	Poncet, S; Soret, M; Mervelet, P; Deutscher, J; Noirot, P				Poncet, Sandrine; Soret, Maryline; Mervelet, Peggy; Deutscher, Josef; Noirot, Philippe			Transcriptional Activator YesS Is Stimulated by Histidine-phosphorylated HPr of the Bacillus subtilis Phosphotransferase System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE REPRESSION RESISTANCE; ESCHERICHIA-COLI; PROTEIN-KINASE; INDUCER EXCLUSION; SER/THR/TYR PHOSPHOPROTEOME; PHOSPHOCARRIER PROTEIN; ALLOSTERIC REGULATION; BIFUNCTIONAL ENZYME; GENE; CCPA	In low GC content Gram-positive bacteria, the HPr protein is the master regulator of carbon metabolism. HPr is a key component of the phosphoenolpyruvate (PEP):sugar phosphotransferase system that interacts with and/or phosphorylates proteins relevant to carbon catabolite repression. HPr can be phosphorylated by two distinct kinases as follows: the bifunctional enzyme HPr kinase/Ser(P)-HPr phosphorylase (HprK/P) phosphorylating the serine 46 residue (Ser(P)-HPr) and acting as a phosphorylase on Ser(P)-HPr; and the PEP-requiring enzyme I (EI) generating histidine 15-phosphorylated HPr (His(P)-HPr). The various HPr forms interact with numerous enzymes and modulate their activity. By carrying out a genome-wide yeast two-hybrid screen of a Bacillus subtilis library, we identified a novel HPr-interacting protein, the transcriptional activator YesS, which regulates the expression of pectin/rhamnogalacturonan utilization genes. Remarkably, yeast tri-hybrid assays involving the ATP-dependent HprK/P and the PEP-dependent EI suggested that YesS interacts with HPr and His(P)-HPr but not with Ser(P)-HPr. These findings were confirmed by in vitro interaction assays using the purified HPr-binding domain of the YesS protein. Furthermore, pectin utilization and in vivo YesS-mediated transcriptional activation depended upon the presence of His(P)-HPr, indicating that HPr-mediated YesS regulation serves as a novel type of carbon catabolite repression. In the yeast two-hybrid assays, B. subtilis HprK/P and EI were active and specifically recognized their substrates. Both kinases formed long lived complexes only with the corresponding non-phosphorylatable mutant HPr. These findings suggest that two-hybrid assays can be used for the identification of unknown kinases of phosphorylated bacterial proteins detected in phosphoproteome analyses.	[Poncet, Sandrine; Deutscher, Josef] INRA AgroParisTech CNRS, Lab Microbiol & Genet Mol, F-78850 Thiverval Grignon, France; [Soret, Maryline; Mervelet, Peggy; Noirot, Philippe] INRA, Lab Genet Microbienne, F-78352 Jouy En Josas, France	AgroParisTech; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Deutscher, J (corresponding author), INRA AgroParisTech CNRS, Lab Microbiol & Genet Mol, F-78850 Thiverval Grignon, France.	Josef.Deutscher@grignon.inra.fr; Philippe.Noirot@jouy.inra.fr		PONCET, Sandrine/0000-0002-2813-0793	European BaSysBio [LSHG-CT-2006-037469]; INRA	European BaSysBio; INRA	This work was supported in part by European BaSysBio Project LSHG-CT-2006-037469 (to P. N.) and in part by funding from the INRA Programme Transversalite-AGMIAL (to P. N. and J. D.).	AYMERICH S, 1986, J BACTERIOL, V166, P993, DOI 10.1128/jb.166.3.993-998.1986; Chaptal V, 2007, J BIOL CHEM, V282, P34952, DOI 10.1074/jbc.M705979200; Cochu A, 2005, APPL ENVIRON MICROB, V71, P1364, DOI 10.1128/AEM.71.3.1364-1372.2005; Darbon E, 2002, MOL MICROBIOL, V43, P1039, DOI 10.1046/j.1365-2958.2002.02800.x; Darbon E, 2001, J MOL MICROB BIOTECH, V3, P439; DEUTSCHER J, 1994, J BACTERIOL, V176, P3336, DOI 10.1128/jb.176.11.3336-3344.1994; DEUTSCHER J, 1984, FEMS MICROBIOL LETT, V23, P157; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Eymann C, 2007, PROTEOMICS, V7, P3509, DOI 10.1002/pmic.200700232; Fieulaine S, 2001, EMBO J, V20, P3917, DOI 10.1093/emboj/20.15.3917; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P3; Herro R, 2005, J MOL MICROB BIOTECH, V9, P224, DOI 10.1159/000089650; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; James P, 1996, GENETICS, V144, P1425; Jones BE, 1997, J BIOL CHEM, V272, P26530, DOI 10.1074/jbc.272.42.26530; Joshi MV, 2007, MOL MICROBIOL, V66, P633, DOI 10.1111/j.1365-2958.2007.05942.x; Kolin A, 2008, MOL MICROBIOL, V68, P448, DOI 10.1111/j.1365-2958.2008.06164.x; Kravanja M, 1999, MOL MICROBIOL, V31, P59, DOI 10.1046/j.1365-2958.1999.01146.x; Levine A, 2006, PROTEOMICS, V6, P2157, DOI 10.1002/pmic.200500352; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; Ludwig H, 2002, MOL MICROBIOL, V45, P543, DOI 10.1046/j.1365-2958.2002.03034.x; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Martin-Verstraete I, 1999, J BACTERIOL, V181, P2966, DOI 10.1128/JB.181.9.2966-2969.1999; MIWA Y, 1994, MICROBIOL-UK, V140, P2567, DOI 10.1099/00221287-140-10-2567; Monedero V, 2001, EMBO J, V20, P3928, DOI 10.1093/emboj/20.15.3928; Monedero V, 2008, RES MICROBIOL, V159, P94, DOI 10.1016/j.resmic.2007.10.002; Muller W, 2006, FEBS J, V273, P1251, DOI 10.1111/j.1742-4658.2006.05148.x; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; OGDEN S, 1980, P NATL ACAD SCI-BIOL, V77, P3346, DOI 10.1073/pnas.77.6.3346; Park YH, 2006, J BIOL CHEM, V281, P6448, DOI 10.1074/jbc.M512672200; Plamondon P, 1999, J BACTERIOL, V181, P6914, DOI 10.1128/JB.181.22.6914-6921.1999; PLATT T, 1972, EXPT MOL GENETICS, P352; Pompeo F, 2007, J BACTERIOL, V189, P1154, DOI 10.1128/JB.01575-06; Presecan-Siedel E, 1999, J BACTERIOL, V181, P6889, DOI 10.1128/JB.181.22.6889-6897.1999; REIZER J, 1992, J BIOL CHEM, V267, P9158; Reizer J, 1996, J BACTERIOL, V178, P5480, DOI 10.1128/jb.178.18.5480-5486.1996; Schumacher MA, 2006, J BIOL CHEM, V281, P6793, DOI 10.1074/jbc.M509977200; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; Soufi B, 2008, PROTEOMICS, V8, P3486, DOI 10.1002/pmic.200800069; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Yoshida K, 2001, NUCLEIC ACIDS RES, V29, P683, DOI 10.1093/nar/29.3.683	47	16	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28188	28197		10.1074/jbc.M109.046334	http://dx.doi.org/10.1074/jbc.M109.046334			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19651770	hybrid, Green Published			2022-12-25	WOS:000270676300046
J	Almeida, M; Ambrogini, E; Han, L; Manolagas, SC; Jilka, RL				Almeida, Maria; Ambrogini, Elena; Han, Li; Manolagas, Stavros C.; Jilka, Robert L.			Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-gamma Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; PPAR-GAMMA; BONE LOSS; BETA-CATENIN; OSTEOBLAST DIFFERENTIATION; AORTIC CALCIFICATION; APOLIPOPROTEIN-E; ADVANCED ATHEROSCLEROSIS; OXIDIZED PHOSPHOLIPIDS	Loss of bone mass with advancing age in mice is because of decreased osteoblast number and is associated with increased oxidative stress and decreased canonical Wnt signaling. However, the underlying mechanisms are poorly understood. We report an age-related increase in the lipid oxidation product 4-hydroxynonenal (4-HNE) as well as increased expression of lipoxygenase and peroxisome proliferator-activated receptor-gamma (PPAR gamma) in the murine skeleton. These changes together with decreased Wnt signaling are reproduced in 4-month-old mice bearing a high expressing allele of the lipoxygenase Alox15. The addition of 4-HNE to cultured osteoblastic cells increases oxidative stress, which in turn diverts beta-catenin from T-cell-specific transcription factors to Forkhead box O (FoxO) transcription factors, thereby attenuating the suppressive effect of beta-catenin on PPAR gamma gene expression. Oxidized lipids, acting as ligands of PPAR gamma, promote binding of PPAR gamma 2 to beta-catenin and reduce the levels of the latter, and they attenuate Wnt3a-stimulated proliferation and osteoblast differentiation. Furthermore, oxidized lipids and 4-HNE stimulate apoptosis of osteoblastic cells. In view of the role of oxidized lipids in atherogenesis, the adverse effects of lipoxygenase-mediated lipid oxidation on the differentiation and survival of osteoblasts may provide a mechanistic explanation for the link between atherosclerosis and osteoporosis.	[Almeida, Maria; Ambrogini, Elena; Han, Li; Manolagas, Stavros C.; Jilka, Robert L.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Jilka, RL (corresponding author), 4301 W Markham,Slot 587, Little Rock, AR 72205 USA.	rljilka@uams.edu		Almeida, Maria/0000-0002-6722-9200; Warren, Aaron D./0000-0002-0042-9021	National Institutes of Health [P01-AG13918]; Department of Veterans Affairs; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-AG13918 (to S. C. M.). This work was also supported by the Veterans Affairs merit review grants from the Office of Research and Development of the Department of Veterans Affairs (to R. L. J. and S. C. M.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Brodeur MR, 2008, FREE RADICAL BIO MED, V44, P506, DOI 10.1016/j.freeradbiomed.2007.08.030; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Coleman JD, 2007, FREE RADICAL BIO MED, V42, P1155, DOI 10.1016/j.freeradbiomed.2007.01.003; Cyrus T, 2001, CIRCULATION, V103, P2277; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Duque G, 2009, EXP GERONTOL, V44, P183, DOI 10.1016/j.exger.2008.10.004; Farhat GN, 2006, J BONE MINER RES, V21, P1839, DOI 10.1359/JBMR.060903; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Giaginis C, 2007, FUND CLIN PHARMACOL, V21, P231, DOI 10.1111/j.1472-8206.2007.00486.x; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; Griesser M, 2009, J LIPID RES, V50, P2455, DOI 10.1194/jlr.M900181-JLR200; Hak AE, 2000, ARTERIOSCL THROM VAS, V20, P1926, DOI 10.1161/01.ATV.20.8.1926; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang MS, 2007, J BIOL CHEM, V282, P21237, DOI 10.1074/jbc.M701341200; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; JILKA RL, 2002, BONEKEY OSTEOVISION, DOI DOI 10.1138/2002024; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kiel DP, 2001, CALCIFIED TISSUE INT, V68, P271, DOI 10.1007/BF02390833; Kim SH, 2006, TOXICOL APPL PHARM, V215, P198, DOI 10.1016/j.taap.2006.03.001; Klein BY, 2003, J CELL BIOCHEM, V90, P42, DOI 10.1002/jcb.10603; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kousteni S, 2003, J CLIN INVEST, V111, P1651, DOI 10.1172/JCI200317261; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lee JY, 2006, TOXICOL LETT, V166, P212, DOI 10.1016/j.toxlet.2006.07.305; Limor R, 2008, AM J HYPERTENS, V21, P219, DOI 10.1038/ajh.2007.39; LIPS P, 1978, CALC TISS RES, V26, P13, DOI 10.1007/BF02013227; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Parfitt AM., 1990, BONE TREATISE, VI, P351; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; Perrien DS, 2007, AM J PHYSIOL-REG I, V292, pR988, DOI 10.1152/ajpregu.00302.2006; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Robinson CE, 1998, BIOCHEM BIOPH RES CO, V244, P671, DOI 10.1006/bbrc.1998.8305; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Sampey BP, 2007, MOL PHARMACOL, V71, P871, DOI 10.1124/mol.106.029686; Satoh K, 1999, ANAL BIOCHEM, V270, P323, DOI 10.1006/abio.1999.4073; Schild RL, 2002, J CLIN ENDOCR METAB, V87, P1105, DOI 10.1210/jc.87.3.1105; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226; Sharma A, 2008, ARCH BIOCHEM BIOPHYS, V480, P85, DOI 10.1016/j.abb.2008.09.016; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Soroceanu MA, 2004, J ENDOCRINOL, V183, P203, DOI 10.1677/joe.1.05723; Spiteller G, 2001, EXP GERONTOL, V36, P1425, DOI 10.1016/S0531-5565(01)00131-0; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Tanko LB, 2003, CALCIFIED TISSUE INT, V73, P15, DOI 10.1007/s00223-002-2070-x; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Towler DA, 2008, J AM COLL CARDIOL, V52, P851, DOI 10.1016/j.jacc.2008.05.044; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; VOGT MT, 1992, J CLIN EPIDEMIOL, V45, P529, DOI 10.1016/0895-4356(92)90102-S; Weinstein RS, 2008, J BONE MINER RES, V23, pS70; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083	80	198	214	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27438	27448		10.1074/jbc.M109.023572	http://dx.doi.org/10.1074/jbc.M109.023572			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19657144	hybrid, Green Published			2022-12-25	WOS:000270232300046
J	Katoh, Y; Ritter, B; Gaffry, T; Blondeau, F; Honing, S; McPherson, PS				Katoh, Yohei; Ritter, Brigitte; Gaffry, Thomas; Blondeau, Francois; Hoening, Stefan; McPherson, Peter S.			The Clavesin Family, Neuron-specific Lipid-and Clathrin-binding Sec14 Proteins Regulating Lysosomal Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE MEG2; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; IDENTIFICATION; DISTINCT; CVAK104; COMPLEX; KINASE; VAC14; YEAST; TGN	Clathrin-coated vesicles (CCVs) originating from the trans-Golgi network (TGN) provide a major transport pathway from the secretory system to endosomes/lysosomes. Herein we describe paralogous Sec14 domain-bearing proteins, clavesin 1/CRALBPL and clavesin 2, identified through a proteomic analysis of CCVs. Clavesins are enriched on CCVs and form a complex with clathrin heavy chain (CHC) and adaptor protein-1, major coat components of TGN-derived CCVs. The proteins co-localize with markers of endosomes and the TGN as well as with CHC and adaptor protein-1. A membrane mimic assay using the Sec14 domain of clavesin 1 reveals phosphatidylinositol 3,5-bisphosphate as a specific lipid partner. Phosphatidylinositol 3,5-bisphosphate is localized to late endosomes/lysosomes, and interestingly, isoform-specific knockdown of clavesins in neurons using lentiviral delivery of interfering RNA leads to enlargement of a lysosome-associated membrane protein 1-positive membrane compartment with no obvious influence on the CCV machinery at the TGN. Since clavesins are expressed exclusively in neurons, this new protein family appears to provide a unique neuron-specific regulation of late endosome/lysosome morphology.	[Katoh, Yohei; Ritter, Brigitte; Blondeau, Francois; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	McGill University; University of Cologne; University of Cologne	McPherson, PS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca	Katoh, Yohei/AAA-3378-2020	Katoh, Yohei/0000-0003-1649-4917; Ritter, Brigitte/0000-0002-0094-0460	Canadian Institutes of Health Research (CIHR) [MOP-62684]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-62684 (to P. S. M.).	Au CE, 2007, CURR OPIN CELL BIOL, V19, P376, DOI 10.1016/j.ceb.2007.05.004; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burman JL, 2005, FEBS LETT, V579, P2177, DOI 10.1016/j.febslet.2005.03.008; Conner SD, 2005, J BIOL CHEM, V280, P21539, DOI 10.1074/jbc.M502462200; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; Donaldson JG, 2009, EMBO REP, V10, P132, DOI 10.1038/embor.2008.248; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Duwel M, 2006, MOL BIOL CELL, V17, P4513, DOI 10.1091/mbc.E06-05-0390; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Huynh H, 2003, J IMMUNOL, V171, P6661, DOI 10.4049/jimmunol.171.12.6661; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Kong YH, 2006, BIOTECHNOL LETT, V28, P1327, DOI 10.1007/s10529-006-9096-5; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Kruger JM, 2002, J BIOL CHEM, V277, P2620, DOI 10.1074/jbc.M104550200; Lemaire JF, 2006, FEBS LETT, V580, P6948, DOI 10.1016/j.febslet.2006.11.061; Michell RH, 2009, EMBO J, V28, P86, DOI 10.1038/emboj.2008.270; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Mousley CJ, 2007, BBA-MOL CELL BIOL L, V1771, P727, DOI 10.1016/j.bbalip.2007.04.002; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Phillips SE, 2006, CRIT REV BIOCHEM MOL, V41, P21, DOI 10.1080/10409230500519573; Pivtoraiko VN, 2009, ANTIOXID REDOX SIGN, V11, P481, DOI [10.1089/ars.2008.2263, 10.1089/ARS.2008.2263]; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Ridley SH, 2001, J CELL SCI, V114, P3991; Ritter B, 2004, TOP CURR GENET, V10, P9; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004; Ritter B, 2007, EMBO J, V26, P4066, DOI 10.1038/sj.emboj.7601836; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Thomas S, 2009, J BIOL CHEM, V284, P12410, DOI 10.1074/jbc.M809746200; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	55	29	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27646	27654		10.1074/jbc.M109.034884	http://dx.doi.org/10.1074/jbc.M109.034884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651769	Green Published, hybrid			2022-12-25	WOS:000270232300066
J	Chen, R; Feldstein, AE; McIntyre, TM				Chen, Rui; Feldstein, Ariel E.; McIntyre, Thomas M.			Suppression of Mitochondrial Function by Oxidatively Truncated Phospholipids Is Reversible, Aided by Bid, and Suppressed by Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING-FACTOR-ACETYLHYDROLASE; SMOOTH-MUSCLE-CELLS; PERMEABILITY TRANSITION PORE; OXIDIZED PHOSPHOLIPIDS; LIPID-PEROXIDATION; IN-VIVO; ACID SPHINGOMYELINASE; INDUCED APOPTOSIS; BILAYER PACKING; FREE-RADICALS	Oxidatively truncated phospholipids are present in atherosclerotic lesions, apoptotic cells, and oxidized low density lipoproteins. Some of these lipids rapidly enter cells to induce apoptosis by the intrinsic pathway, but how such lipids initiate this process is unknown. We show the truncated phospholipid hexadecyl azelaoyl glycerophosphocholine (Az-LPAF), derived from the fragmentation of abundant sn-2 linoleoyl residues, depolarized mitochondria of intact cells. Az-LPAF also depolarized isolated mitochondria and allowed NADH loss, but did not directly interfere with complex I function. Cyclosporin A blockade of the mitochondrial permeability transition pore partially prevented the loss of electrochemical potential. Depolarization of isolated mitochondria by the truncated phospholipid was readily reversed by the addition of albumin that sequestered this lipid. Ectopic expression of the anti-apoptotic protein Bcl-XL in HL-60 cells reduced apoptosis by the truncated phospholipid by protecting their mitochondria. Mitochondria isolated from these cells were also protected from Az-LPAF-induced depolarization. Conversely mitochondria isolated from Bid(-/-) animals that lack this pro-apoptotic Bcl-2 family member were resistant to Az-LPAF depolarization. Addition of recombinant full-length Bid, which has phospholipid transfer activity, restored this sensitivity. Thus, phospholipid oxidation products physically interact with mitochondria to continually depolarize this organelle without permanent harm, and Bcl-2 family members modulate this interaction with full-length Bid acting as a cofactor for pro-apoptotic, oxidatively truncated phospholipids.	[McIntyre, Thomas M.] Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	McIntyre, TM (corresponding author), Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org			National Institutes of Health [R01AA017748, R01HL092747, 1R01DK076852]; National Center for Research Resources (Cleveland, OH) [CTSA 1UL1RR024989]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (Cleveland, OH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AA017748, R01HL092747, and 1R01DK076852 and National Center for Research Resources Grant CTSA 1UL1RR024989 (Cleveland, OH).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brookes PS, 2002, PROTEOMICS, V2, P969, DOI 10.1002/1615-9861(200208)2:8<969::AID-PROT969>3.0.CO;2-3; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; Chen X, 2008, J LIPID RES, V49, P832, DOI 10.1194/jlr.M700598-JLR200; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Esposti MD, 2002, BBA-BIOENERGETICS, V1553, P331, DOI 10.1016/S0005-2728(02)00187-1; Fruhwirth GO, 2006, BBA-MOL CELL BIOL L, V1761, P1060, DOI 10.1016/j.bbalip.2006.06.001; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Goonesinghe A, 2005, BIOCHEM J, V387, P109, DOI 10.1042/BJ20041389; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hirashima Y, 2000, BRAIN RES, V885, P128, DOI 10.1016/S0006-8993(00)02852-3; ITABE H, 1988, BIOCHIM BIOPHYS ACTA, V962, P8; Jaburek M, 2004, J BIOL CHEM, V279, P53097, DOI 10.1074/jbc.M405339200; Ji H, 2006, MAGN RESON CHEM, V44, pS101, DOI 10.1002/mrc.1856; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kogure K, 2003, CHEM PHYS LIPIDS, V126, P29, DOI 10.1016/S0009-3084(03)00091-4; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Korge P, 2003, AM J PHYSIOL-HEART C, V285, pH259, DOI 10.1152/ajpheart.01028.2002; Kroemer G, 1999, BIOCHEM SOC SYMP, V66, P1; KUGIYAMA K, 1993, CIRC RES, V73, P335, DOI 10.1161/01.RES.73.2.335; Loidl A, 2003, J BIOL CHEM, V278, P32921, DOI 10.1074/jbc.M306088200; Marathe GK, 2003, J BIOL CHEM, V278, P3937, DOI 10.1074/jbc.M211126200; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Matsuzawa A, 1997, J BIOL CHEM, V272, P32315, DOI 10.1074/jbc.272.51.32315; Mattila JP, 2008, BBA-BIOMEMBRANES, V1778, P2041, DOI 10.1016/j.bbamem.2008.03.020; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Megli FM, 2005, FEBS LETT, V579, P4577, DOI 10.1016/j.febslet.2005.07.022; Megli FM, 2004, FEBS LETT, V573, P68, DOI 10.1016/j.febslet.2004.07.057; Megli FM, 2003, FEBS LETT, V550, P185, DOI 10.1016/S0014-5793(03)00861-5; Megli FA, 2008, BBA-BIOMEMBRANES, V1778, P143, DOI 10.1016/j.bbamem.2007.09.014; Megli FM, 2009, BBA-BIOMEMBRANES, V1788, P371, DOI 10.1016/j.bbamem.2008.10.002; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Moumtzi A, 2007, J LIPID RES, V48, P565, DOI 10.1194/jlr.M600394-JLR200; MULLER E, 1991, BIOCHEM BIOPH RES CO, V181, P1580, DOI 10.1016/0006-291X(91)92119-5; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; PFEIFFER DR, 1995, J BIOL CHEM, V270, P4923, DOI 10.1074/jbc.270.9.4923; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Reis A, 2004, RAPID COMMUN MASS SP, V18, P2849, DOI 10.1002/rcm.1686; Rhode S, 2009, J BIOL CHEM, V284, P2258, DOI 10.1074/jbc.M807591200; Sabatini K, 2006, BIOPHYS J, V90, P4488, DOI 10.1529/biophysj.105.080176; Salomon R G, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P323; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shimizu S, 2000, ONCOGENE, V19, P4309, DOI 10.1038/sj.onc.1203788; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Tokumura A, 1996, LIPIDS, V31, P1251, DOI 10.1007/BF02587909; Umemura K, 2007, STROKE, V38, P1063, DOI 10.1161/01.STR.0000257981.09329.d2; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wieckowski MR, 2000, FEBS LETT, V484, P61, DOI 10.1016/S0014-5793(00)02127-X; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565; YAMASHITA A, 2009, BIOCH BIOPH IN PRESS; Zhai DY, 2001, EUR J BIOCHEM, V268, P48, DOI 10.1046/j.1432-1327.2001.01841.x	63	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26297	26308		10.1074/jbc.M109.018978	http://dx.doi.org/10.1074/jbc.M109.018978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19654426	hybrid, Green Published			2022-12-25	WOS:000269969600009
J	Kim, M; Suh, H; Cho, EJ; Buratowski, S				Kim, Minkyu; Suh, Hyunsuk; Cho, Eun-Jung; Buratowski, Stephen			Phosphorylation of the Yeast Rpb1 C-terminal Domain at Serines 2, 5, and 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; TRANSCRIPTIONAL ELONGATION; SACCHAROMYCES-CEREVISIAE; HISTONE METHYLATION; PROCESSING FACTORS; P-TEFB; CTD; KINASE; TFIIH	The C-terminal domain (CTD) of Rpb1, the largest subunit of RNA polymerase II, acts as a binding platform for various mRNA processing and histone-modifying enzymes that act co-transcriptionally. These factors are targeted to specific phosphorylation states of the CTD that predominate at different stages of transcription. Within the repeating sequence YSPTSPS, serines 2 and 5 are major phosphorylation sites, but serine 7 phosphorylation was recently discovered in mammalian cells. Here we show that CTD serine 7 is also phosphorylated in yeast and that Ser-7(P) chromatin immunoprecipitation patterns resemble those of Ser-5(P). The basal factor TFIIH can phosphorylate Ser-7 in vitro and is necessary for Ser-7(P) in vivo. Interestingly, deletion of the CTD Ser-5(P) phosphatase Rtr1 leads to an increase in Ser-5(P) but not Ser-7(P).	[Kim, Minkyu; Suh, Hyunsuk; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Minkyu] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Cho, Eun-Jung] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea	Harvard University; Harvard Medical School; Seoul National University (SNU); Sungkyunkwan University (SKKU)	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	SteveB@hms.harvard.edu	Cho, Eun-Jung/AAR-1785-2020	Cho, Eun-Jung/0000-0002-6610-5329	National Institutes of Health [GM46498, GM56663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046498, R01GM046498, R01GM056663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM46498 and GM56663 (to S.B.).	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503	34	104	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26421	26426		10.1074/jbc.M109.028993	http://dx.doi.org/10.1074/jbc.M109.028993			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19679665	Green Published, hybrid			2022-12-25	WOS:000269969600023
J	Bhat, UG; Halasi, M; Gartel, AL				Bhat, Uppoor G.; Halasi, Marianna; Gartel, Andrei L.			FoxM1 Is a General Target for Proteasome Inhibitors	PLOS ONE			English	Article							FORKHEAD BOX M1; NF-KAPPA-B; TRANSCRIPTION FACTOR; ANTICANCER DRUGS; INDUCE APOPTOSIS; TUMOR-SUPPRESSOR; CANCER-CELLS; EXPRESSION; IDENTIFICATION; BORTEZOMIB	Proteasome inhibitors are currently in the clinic or in clinical trials, but the mechanism of their anticancer activity is not completely understood. The oncogenic transcription factor FoxM1 is one of the most overexpressed genes in human tumors, while its expression is usually halted in normal non-proliferating cells. Previously, we established that thiazole antibiotics Siomycin A and thiostrepton inhibit FoxM1 and induce apoptosis in human cancer cells. Here, we report that Siomycin A and thiostrepton stabilize the expression of a variety of proteins, such as p21, Mcl-1, p53 and hdm-2 and also act as proteasome inhibitors in vitro. More importantly, we also found that well-known proteasome inhibitors such as MG115, MG132 and bortezomib inhibit FoxM1 transcriptional activity and FoxM1 expression. In addition, overexpression of FoxM1 specifically protects against bortezomib-, but not doxorubicin-induced apoptosis. These data suggest that negative regulation of FoxM1 by proteasome inhibitors is a general feature of these drugs and it may contribute to their anticancer properties.	[Bhat, Uppoor G.; Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60680 USA; [Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Gartel, Andrei L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bhat, UG (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60680 USA.	agartel@uic.edu			NIH [1RO1CA1294414-01A1, 1R21CA134615-01]; NATIONAL CANCER INSTITUTE [R21CA134615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants 1RO1CA1294414-01A1 and 1R21CA134615-01 to ALG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami Guy R, 2007, Future Oncol, V3, P1, DOI 10.2217/14796694.3.1.1; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Gartel AL, 1996, EXP CELL RES, V227, P171, DOI 10.1006/excr.1996.0264; Gartel AL, 2008, EXPERT OPIN THER TAR, V12, P663, DOI 10.1517/14728222.12.6.663 ; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Matta H, 2005, CANCER BIOL THER, V4, P77, DOI 10.4161/cbt.4.1.1379; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Radhakrishnan SK, 2006, CANCER RES, V66, P3264, DOI 10.1158/0008-5472.CAN-05-3940; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; RADHAKRISHNAN SK, 2008, NAT REV CANCER, V8, pE1; RADHAKRISHNAN SK, 2008, NAT REV CANCER, V8, pE2; Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265	25	148	153	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6593	10.1371/journal.pone.0006593	http://dx.doi.org/10.1371/journal.pone.0006593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672316	Green Submitted, Green Published, gold			2022-12-25	WOS:000268935900008
J	McLeod, L; Marshall, DJ				McLeod, Laura; Marshall, Dustin J.			Do Genetic Diversity Effects Drive the Benefits Associated with Multiple Mating? A Test in a Marine Invertebrate	PLOS ONE			English	Article							POLYCHAETE GALEOLARIA-CAESPITOSA; SEXUAL SELECTION; FERTILIZATION SUCCESS; FITNESS CONSEQUENCES; SEA-URCHIN; POLYANDRY; EVOLUTION; INCOMPATIBILITY; COMPETITION; FEMALES	Background: Mothers that mate with multiple males often produce higher quality offspring than mothers that mate with a single male. By engaging in polyandry, mothers may increase their chances of mating with a compatible male or promote sperm competition - both of which act to increase maternal fitness via the biasing of the paternity of offspring. Surprisingly, mating with multiple males, can carry benefits without biasing paternity and may be due simply to differences in genetic diversity between monandrous and polyandrous clutches but role of genetic diversity effects in driving the benefits of polyandry remains poorly tested. Disentangling indirect, genetic benefits from genetic diversity effects is challenging but crucial if we are to understand the selection pressures acting to promote polyandry. Methodology/Principal Findings: Here, we examine the post-fertilisation benefits of accessing the sperm of multiple males in an externally fertilising polychaete worm. Accessing the sperm of multiple males increases offspring performance but this benefit was driven entirely by genetic diversity effects and not by the biasing of paternity at fertilisation. Conclusions/Significance: Previous studies on polyandry should be interpreted cautiously as genetic diversity effects alone can explain the benefits of polyandry yet these diversity effects may be difficult to disentangle from other mechanisms. We suggest that future studies use a modified experimental design in order to discriminate between genetic diversity effects and indirect, genetic benefits.	[McLeod, Laura; Marshall, Dustin J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	University of Queensland	McLeod, L (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	d.marshall1@uq.edu.au	Marshall, Dustin/A-4185-2008; Marshall, Dustin/C-3450-2016	Marshall, Dustin/0000-0001-6651-6219	 [DPO666147]		This work was supported by a Discovery grant to Dr. Dustin Marshall (Grant#:DPO666147). Website: www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNQVIST G, 1989, ANIM BEHAV, V38, P749, DOI 10.1016/S0003-3472(89)80107-1; BARTON NH, 1986, J THEOR BIOL, V120, P381, DOI 10.1016/S0022-5193(86)80033-9; Bilde T, 2007, J EVOLUTION BIOL, V20, P1237, DOI 10.1111/j.1420-9101.2006.01280.x; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Birkhead TR, 1998, SPERM COMPETITION SE; BODE M, 2007, QUICK DEAD SPERM COM; Castilla JC, 2007, P NATL ACAD SCI USA, V104, P18120, DOI 10.1073/pnas.0708233104; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Dunn DW, 2005, BEHAV ECOL SOCIOBIOL, V58, P128, DOI 10.1007/s00265-005-0922-x; Dunn PO, 2009, BEHAV ECOL SOCIOBIOL, V63, P911, DOI 10.1007/s00265-009-0734-5; Dziminski MA, 2008, EVOLUTION, V62, P879, DOI 10.1111/j.1558-5646.2008.00328.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Evans JP, 2007, EVOLUTION, V61, P2832, DOI 10.1111/j.1558-5646.2007.00227.x; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2005, EVOLUTION, V59, P106; Forsman A, 2007, EVOL ECOL RES, V9, P1305; Griffiths SW, 2001, P ROY SOC B-BIOL SCI, V268, P1293, DOI 10.1098/rspb.2001.1660; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Ivy TM, 2007, J EVOLUTION BIOL, V20, P479, DOI 10.1111/j.1420-9101.2006.01269.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Klemme I, 2008, P ROY SOC B-BIOL SCI, V275, P1095, DOI 10.1098/rspb.2008.0038; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; LOMAN J, 1988, OIKOS, V52, P69, DOI 10.2307/3565983; Maklakov AA, 2006, BEHAV ECOL SOCIOBIOL, V61, P31, DOI 10.1007/s00265-006-0234-9; MANAHAN DT, 1990, AM ZOOL, V30, P147; MARSDEN JR, 1981, AUST J MAR FRESH RES, V32, P667; Marshall DJ, 2005, J EVOLUTION BIOL, V18, P1244, DOI 10.1111/j.1420-9101.2005.00947.x; Marshall DJ, 2005, J EVOLUTION BIOL, V18, P735, DOI 10.1111/j.1420-9101.2004.00873.x; Marshall DJ, 2004, MAR ECOL PROG SER, V266, P135, DOI 10.3354/meps266135; Marshall DJ, 2002, MAR ECOL PROG SER, V236, P113, DOI 10.3354/meps236113; Marshall DJ, 2007, BIOLOGY LETT, V3, P685, DOI 10.1098/rsbl.2007.0438; Marshall DJ, 2007, BIOL BULL-US, V212, P6, DOI 10.2307/25066575; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; OLDROYD BP, 1992, ANN ENTOMOL SOC AM, V85, P335, DOI 10.1093/aesa/85.3.335; Pai A, 2007, EVOL ECOL, V21, P687, DOI 10.1007/s10682-006-9146-4; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P537, DOI DOI 10.1017/CBO9780511806384; RIDLEY M, 1993, AM NAT, V142, P893, DOI 10.1086/285579; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Teng ZQ, 2007, EVOLUTION, V61, P470, DOI 10.1111/j.1558-5646.2007.00030.x; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	48	41	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6347	10.1371/journal.pone.0006347	http://dx.doi.org/10.1371/journal.pone.0006347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672289	Green Submitted, Green Published, gold			2022-12-25	WOS:000268935900001
J	Nowbahari, E; Scohier, A; Durand, JL; Hollis, KL				Nowbahari, Elise; Scohier, Alexandra; Durand, Jean-Luc; Hollis, Karen L.			Ants, Cataglyphis cursor, Use Precisely Directed Rescue Behavior to Free Entrapped Relatives	PLOS ONE			English	Article							NIGER HYMENOPTERA; SOCIAL-BEHAVIOR; EVOLUTION; FORMICIDAE	Although helping behavior is ubiquitous throughout the animal kingdom, actual rescue activity is particularly rare. Nonetheless, here we report the first experimental evidence that ants, Cataglyphis cursor, use precisely directed rescue behavior to free entrapped victims; equally important, they carefully discriminate between individuals in distress, offering aid only to nestmates. Our experiments simulate a natural situation, which we often observed in the field when collecting Catagyphis ants, causing sand to collapse in the process. Using a novel experimental technique that binds victims experimentally, we observed the behavior of separate, randomly chosen groups of 5 C. cursor nestmates under one of six conditions. In five of these conditions, a test stimulus (the "victim") was ensnared with nylon thread and held partially beneath the sand. The test stimulus was either (1) an individual from the same colony; (2) an individual from a different colony of C cursor; (3) an ant from a different ant species; (4) a common prey item; or, (5) a motionless (chilled) nestmate. In the final condition, the test stimulus (6) consisted of the empty snare apparatus. Our results demonstrate that ants are able to recognize what, exactly, holds their relative in place and direct their behavior to that object, the snare, in particular. They begin by excavating sand, which exposes the nylon snare, transporting sand away from it, and then biting at the snare itself. Snare biting, a behavior never before reported in the literature, demonstrates that rescue behavior is far more sophisticated, exact and complexly organized than the simple forms of helping behavior already known, namely limb pulling and sand digging. That is, limb pulling and sand digging could be released directly by a chemical call for help and thus result from a very simple mechanism. However, it's difficult to see how this same releasing mechanism could guide rescuers to the precise location of the nylon thread, and enable them to target their bites to the thread itself.	[Nowbahari, Elise; Scohier, Alexandra; Durand, Jean-Luc] Univ Paris 13, Lab Ethol Expt & Comparee, EA 4443, F-93430 Villetaneuse, France; [Hollis, Karen L.] Mt Holyoke Coll, Interdisciplinary Program Neurosci & Behav, S Hadley, MA 01075 USA	Universite Paris 13; Mount Holyoke College	Nowbahari, E (corresponding author), Univ Paris 13, Lab Ethol Expt & Comparee, EA 4443, F-93430 Villetaneuse, France.	Elise.Nowbahari@leec.univ-paris13.fr						Beck Jan, 2007, Myrmecological News, V10, P27; Belt T., 1874, NATURALIST NICARAGUA; BLUM MS, 1966, ANN ENTOMOL SOC AM, V59, P774, DOI 10.1093/aesa/59.4.774; Czechowski W, 2002, ANN ZOOL, V52, P423; Dugatkin L.A., 1997, COOPERATION ANIMALS; Dugatkin L. A., 2009, PRINCIPLES ANIMAL BE; Forrest H. F., 1963, THESIS RUTGERS U; Guillette LM, 2009, BEHAV PROCESS, V80, P224, DOI 10.1016/j.beproc.2008.12.015; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hangartner W., 1969, Psyche, Camb., V76, P58, DOI 10.1155/1969/58428; HOLM S, 1979, SCAND J STAT, V6, P65; Lafleur LJ, 1940, J COMP PSYCHOL, V30, P23, DOI 10.1037/h0056162; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; MAYADE S, 1993, BEHAV PROCESS, V30, P131, DOI 10.1016/0376-6357(93)90003-A; Nowbahari E, 1999, AGGRESSIVE BEHAV, V25, P369, DOI 10.1002/(SICI)1098-2337(1999)25:5<369::AID-AB5>3.0.CO;2-C; Nowbahari E, 2007, LEARN BEHAV, V35, P87, DOI 10.3758/BF03193043; Siebenaler J. B., 1956, Journal of Mammalogy, V37, P126, DOI 10.2307/1375558; SPANGLER HG, 1968, ENTOMOL SOC, V41, P318; Vogel ER, 2006, AM J PRIMATOL, V68, P1012, DOI 10.1002/ajp.20286; WILSON EDWARD O., 1958, PSYCHE, V65, P41, DOI 10.1155/1958/57483	22	70	71	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6573	10.1371/journal.pone.0006573	http://dx.doi.org/10.1371/journal.pone.0006573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672292	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900005
J	Pang, PS; Planet, PJ; Glenn, JS				Pang, Phillip S.; Planet, Paul J.; Glenn, Jeffrey S.			The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; PHYLOGENETIC TREE SELECTION; NONSTRUCTURAL PROTEIN 5A; PEGINTERFERON ALPHA-2B; VIRUS-INFECTION; VIROLOGICAL RESPONSE; HCV GENOTYPE-2; TREATMENT DURATION; ANTIVIRAL THERAPY; INITIAL TREATMENT	Background: Patients chronically infected with hepatitis C virus (HCV) require significantly different durations of therapy and achieve substantially different sustained virologic response rates to interferon-based therapies, depending on the HCV genotype with which they are infected. There currently exists no systematic framework that explains these genotype-specific response rates. Since humans are the only known natural hosts for HCV-a virus that is at least hundreds of years old-one possibility is that over the time frame of this relationship, HCV accumulated adaptive mutations that confer increasing resistance to the human immune system. Given that interferon therapy functions by triggering an immune response, we hypothesized that clinical response rates are a reflection of viral evolutionary adaptations to the immune system. Methods and Findings: We have performed the first phylogenetic analysis to include all available full-length HCV genomic sequences (n = 345). This resulted in a new cladogram of HCV. This tree establishes for the first time the relative evolutionary ages of the major HCV genotypes. The outcome data from prospective clinical trials that studied interferon and ribavirin therapy was then mapped onto this new tree. This mapping revealed a correlation between genotype-specific responses to therapy and respective genotype age. This correlation allows us to predict that genotypes 5 and 6, for which there currently are no published prospective trials, will likely have intermediate response rates, similar to genotype 3. Ancestral protein sequence reconstruction was also performed, which identified the HCV proteins E2 and NS5A as potential determinants of genotype-specific clinical outcome. Biochemical studies have independently identified these same two proteins as having genotype-specific abilities to inhibit the innate immune factor double-stranded RNA-dependent protein kinase (PKR). Conclusion: An evolutionary analysis of all available HCV genomes supports the hypothesis that immune selection was a significant driving force in the divergence of the major HCV genotypes and that viral factors that acquired the ability to inhibit the immune response may play a role in determining genotype-specific response rates to interferon therapy.	[Pang, Phillip S.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Palo Alto, CA 94304 USA; [Planet, Paul J.] Amer Museum Nat Hist, Dept Pediat, Div Infect Dis, Columbia Presbyterian Med Ctr, New York, NY 10024 USA; [Planet, Paul J.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Glenn, Jeffrey S.] Stanford Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; [Glenn, Jeffrey S.] Palo Alto Vet Adm Med Ctr, Palo Alto, CA USA	Stanford University; American Museum of Natural History (AMNH); Columbia University; NewYork-Presbyterian Hospital; American Museum of Natural History (AMNH); Stanford University	Pang, PS (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Palo Alto, CA 94304 USA.	jeffrey.glenn@stanford.edu			Burroughs Wellcome Fund, NIH [RO1 DK064223]; Center for Translational Research in Chronic Viral Infections; Stanford Dean's Fellowship, NIH [T32 AI070502]; NRSA [1F32AI082930]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064223] Funding Source: NIH RePORTER	Burroughs Wellcome Fund, NIH(Burroughs Wellcome FundUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Translational Research in Chronic Viral Infections; Stanford Dean's Fellowship, NIH; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JSG funded by a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, NIH RO1 DK064223, and the Center for Translational Research in Chronic Viral Infections. PSP supported by a Stanford Dean's Fellowship, NIH T32 AI070502, and NRSA 1F32AI082930.	Agosti D, 1996, CLADISTICS, V12, P65; Alfaleh FZ, 2004, LIVER INT, V24, P568, DOI 10.1111/j.1478-3231.2004.0976.x; [Anonymous], 2002, GASTROENTEROLOGY, V123, P2082; Antaki N, 2008, J VIRAL HEPATITIS, V15, P383, DOI 10.1111/j.1365-2893.2007.00946.x; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Bartenschlager R, 2005, P NATL ACAD SCI USA, V102, P9739, DOI 10.1073/pnas.0504296102; Berg T, 2000, HEPATOLOGY, V32, P1386, DOI 10.1053/jhep.2000.20527; Cannon NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002123; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Chevaliez Stephane, 2009, V189, P203, DOI 10.1007/978-3-540-79086-0_8; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Coppola N, 2005, GUT, V54, P1207, DOI 10.1136/gut.2005.070649; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Dal Pero F, 2007, J INFECT DIS, V196, P998, DOI 10.1086/521306; Dalgard O, 2008, HEPATOLOGY, V47, P35, DOI 10.1002/hep.21975; de Rueda PM, 2008, J VIROL, V82, P6644, DOI 10.1128/JVI.02231-07; Derbala M, 2005, J VIRAL HEPATITIS, V12, P380, DOI 10.1111/j.1365-2893.2005.00604.x; DESALLE R, 2002, TECHNIQUES MOL SYSTE, V9; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; El-Zayadi AR, 2005, AM J GASTROENTEROL, V100, P2447, DOI 10.1111/j.1572-0241.2005.00253.x; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; ERIKSSON T, 1997, AUTODECAY; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, PHYLOGENIES COMP MET, P1; Fishman SL, 2008, J INFECT DIS, V197, P597, DOI 10.1086/526519; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Gaudy C, 2005, J CLIN MICROBIOL, V43, P750, DOI 10.1128/JCM.43.2.750-754.2005; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Han JQ, 2004, J INTERF CYTOK RES, V24, P664, DOI 10.1089/1079990042475698; Han JQ, 2002, RNA, V8, P512, DOI 10.1017/S1355838202020617; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hasan F, 2004, AM J GASTROENTEROL, V99, P1733, DOI 10.1111/j.1572-0241.2004.40077.x; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HILLIS DM, 1992, SCIENCE, V255, P589, DOI 10.1126/science.1736360; Hofmann WP, 2008, LIVER INT, V28, P1332, DOI 10.1111/j.1478-3231.2008.01896.x; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Kamal SM, 2007, HEPATOLOGY, V46, P1732, DOI 10.1002/hep.21917; Kamal SM, 2005, GUT, V54, P858, DOI 10.1136/gut.2004.057182; Kamal SM, 2002, GASTROENTEROLOGY, V123, P1070, DOI 10.1053/gast.2002.36045; KAMAL SM, 2007, AM J GASTROENTEROL; Kato Nobuyuki, 2000, Microbial and Comparative Genomics, V5, P129, DOI 10.1089/omi.1.2000.5.129; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Kuntzen T, 2007, J VIROL, V81, P11658, DOI 10.1128/JVI.00995-07; Lloyd AR, 2007, IMMUNOL CELL BIOL, V85, P24, DOI 10.1038/sj.icb.7100010; Maddison WP, 1992, MACCLADE VERSION 3 A; Magiorkinis G, 2007, INFECT GENET EVOL, V7, P354, DOI 10.1016/j.meegid.2006.04.003; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Miyamoto M, 2005, INTERVIROLOGY, V49, P37, DOI 10.1159/000087261; MUERHOFF AS, 1995, J VIROL, V69, P5621, DOI 10.1128/JVI.69.9.5621-5630.1995; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Noguchi T, 2001, MICROBIOL IMMUNOL, V45, P829, DOI 10.1111/j.1348-0421.2001.tb01322.x; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Planet PJ, 2006, J BIOMED INFORM, V39, P86, DOI 10.1016/j.jbi.2005.08.008; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Rubbia-Brandt L, 2004, GUT, V53, P406, DOI 10.1136/gut.2003.018770; Rumi MG, 2005, GUT, V54, P402, DOI 10.1136/gut.2004.048009; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Shiffman Mitchell L, 2006, Curr Gastroenterol Rep, V8, P46, DOI 10.1007/s11894-006-0063-z; Shiffman ML, 2008, CLIN LIVER DIS, V12, P487, DOI 10.1016/j.cld.2008.03.004; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sikes D.S., 2001, PAUPRAT TOOL IMPLEME; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Sklan EH, 2009, NAT REV GASTRO HEPAT, V6, P217, DOI 10.1038/nrgastro.2009.32; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Smith DB, 1997, J GEN VIROL, V78, P1511, DOI 10.1099/0022-1317-78-7-1511; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Szabo G, 2007, HEPATOLOGY, V46, P1279, DOI 10.1002/hep.21938; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; THOMPSON A, 1997, MO S RES EDUC POL, V1, P63; Timm J, 2007, HEPATOLOGY, V46, P339, DOI 10.1002/hep.21702; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; von Wagner M, 2003, J VIRAL HEPATITIS, V10, P413; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Zekry A, 2005, J HEPATOL, V42, P293, DOI 10.1016/j.jhep.2004.12.012; Zeuzem S, 2004, ANN INTERN MED, V140, P370, DOI 10.7326/0003-4819-140-5-200403020-00033; Zwickl D.J., 2006, THESIS U TEXAS AUSTI; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	107	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6579	10.1371/journal.pone.0006579	http://dx.doi.org/10.1371/journal.pone.0006579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668364	gold, Green Published, Green Submitted			2022-12-25	WOS:000268935600008
J	Potkin, SG; Guffanti, G; Lakatos, A; Turner, JA; Kruggel, F; Fallon, JH; Saykin, AJ; Orro, A; Lupoli, S; Salvi, E; Weiner, M; Macciardi, F				Potkin, Steven G.; Guffanti, Guia; Lakatos, Anita; Turner, Jessica A.; Kruggel, Frithjof; Fallon, James H.; Saykin, Andrew J.; Orro, Alessandro; Lupoli, Sara; Salvi, Erika; Weiner, Michael; Macciardi, Fabio		Alzheimers Dis Neuroimaging Initia	Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; UBIQUITIN-PROTEASOME SYSTEM; NEURODEGENERATIVE DISORDERS; CLINICAL STATUS; AXON GUIDANCE; ONSET; MRI; APOPTOSIS; COMPLEX; VOLUME	Background: With the exception of APOE epsilon 4 allele, the common genetic risk factors for sporadic Alzheimer's Disease (AD) are unknown. Methods and Findings: We completed a genome-wide association study on 381 participants in the ADNI (Alzheimer's Disease Neuroimaging Initiative) study. Samples were genotyped using the Illumina Human610-Quad BeadChip. 516,645 unique Single Nucleotide Polymorphisms (SNPs) were included in the analysis following quality control measures. The genotype data and raw genetic data are freely available for download (LONI, http://www.loni.ucla.edu/ADNI/Data/). Two analyses were completed: a standard case-control analysis, and a novel approach using hippocampal atrophy measured on MRI as an objectively defined, quantitative phenotype. A General Linear Model was applied to identify SNPs for which there was an interaction between the genotype and diagnosis on the quantitative trait. The case-control analysis identified APOE and a new risk gene, TOMM40 (translocase of outer mitochondrial membrane 40), at a genome-wide significance level of <= 10(-6) (10(-11) for a haplotype). TOMM40 risk alleles were approximately twice as frequent in AD subjects as controls. The quantitative trait analysis identified 21 genes or chromosomal areas with at least one SNP with a p-value <= 10(-6), which can be considered potential "new'' candidate loci to explore in the etiology of sporadic AD. These candidates included EFNA5, CAND1, MAGI2, ARSB, and PRUNE2, genes involved in the regulation of protein degradation, apoptosis, neuronal loss and neurodevelopment. Thus, we identified common genetic variants associated with the increased risk of developing AD in the ADNI cohort, and present publicly available genome-wide data. Supportive evidence based on case-control studies and biological plausibility by gene annotation is provided. Currently no available sample with both imaging and genetic data is available for replication. Conclusions: Using hippocampal atrophy as a quantitative phenotype in a genome-wide scan, we have identified candidate risk genes for sporadic Alzheimer's disease that merit further investigation.			Potkin, SG (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.	sgpotkin@uci.edu	Turner, Jessica A/N-2228-2017; Potkin, Steven G/A-2021-2013; Macciardi, Fabio/N-3768-2014; Turner, Jessica A/H-7282-2015; Kruggel, Frithjof/M-9201-2016; Masetti, Guia Guffanti/AAQ-7108-2020; Orro, Alessandro/ABA-3542-2020; Salvi, Erika/AAA-1415-2019; Salvi, Erika/C-1033-2015; Scharre, Douglas W/E-4030-2011; Saykin, Andrew/A-1318-2007	Turner, Jessica A/0000-0003-0076-8434; Macciardi, Fabio/0000-0003-0537-4266; Turner, Jessica A/0000-0003-0076-8434; Kruggel, Frithjof/0000-0003-3507-5662; Salvi, Erika/0000-0002-2724-2291; Salvi, Erika/0000-0002-2724-2291; Potkin, Steven/0000-0003-1028-1013; Saykin, Andrew/0000-0002-1376-8532	NCRR NIH HHS [P20 RR020837-01, U24-RR021992, P20 RR020837, U24 RR021992] Funding Source: Medline; NIA NIH HHS [U19 AG010483, U01 AG024904, U01 AG024904-01, 3 U01 AG024904-03S5, U24 AG021886] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021992, P20RR020837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG010483, U01AG024904, U24AG021886] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALMASY L, 2008, AM J PSYCHIAT; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEKRIS LM, 2009, AM J MED GENET B; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bigler ED, 2002, J INT NEUROPSYCH SOC, V8, P925, DOI 10.1017/S1355617702870072; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Camins A, 2008, METHOD FIND EXP CLIN, V30, P43, DOI 10.1358/mf.2008.30.1.1090962; Cataldo AM, 1996, ADV EXP MED BIOL, V389, P271; Chen YZ, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-3; Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501, DOI 10.1093/gerona/63.5.501; Du AT, 2006, NEUROBIOL AGING, V27, P733, DOI 10.1016/j.neurobiolaging.2005.03.021; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ertekin-Taner N, 2007, NEUROL CLIN, V25, P611, DOI 10.1016/j.ncl.2007.03.009; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; GASER C, 2008, VRM TOOLBOX SPM5; GE D, 2007, WGA VIEWER PACKAGE C; Grundman M, 2003, J MOL NEUROSCI, V20, P241, DOI 10.1385/JMN:20:3:241; Grundman M, 2002, J MOL NEUROSCI, V19, P23, DOI 10.1007/s12031-002-0006-6; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Holmans P, 2005, AM J MED GENET B, V135B, P24, DOI 10.1002/ajmg.b.30114; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Irie K, 2007, MINI-REV MED CHEM, V7, P1001, DOI 10.2174/138955707782110187; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Karas G, 2008, AM J NEURORADIOL, V29, P944, DOI 10.3174/ajnr.A0949; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liu B.H., 1997, STAT GENOMICS LINKAG; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Martinez A, 2005, BRAIN RES REV, V49, P211, DOI 10.1016/j.brainresrev.2005.02.001; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mayeux Richard, 2008, Handb Clin Neurol, V89, P195, DOI 10.1016/S0072-9752(07)01218-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mori F, 2005, NEUROPATH APPL NEURO, V31, P53, DOI 10.1111/j.1365-2990.2004.00603.x; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Neale BM, 2008, AM J MED GENET B, V147B, P1288, DOI 10.1002/ajmg.b.30747; Neve RL, 2006, PHARMACOL THERAPEUT, V111, P99, DOI 10.1016/j.pharmthera.2005.09.005; NIXON RA, 1992, ANN NY ACAD SCI, V674, P65; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Orro A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S13; Pallas M, 2006, CURR PHARM DESIGN, V12, P4389, DOI 10.2174/138161206778792967; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; POTKIN S, 2009, COGNITIVE N IN PRESS; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reber M, 2007, ADV EXP MED BIOL, V621, P32, DOI 10.1007/978-0-387-76715-4_3; Rosenberg RN, 2008, ARCH NEUROL-CHICAGO, V65, P307, DOI 10.1001/archneur.65.3.307; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Scott WK, 2003, AM J HUM GENET, V73, P1041, DOI 10.1086/379083; Shimohama S, 2000, APOPTOSIS, V5, P9, DOI 10.1023/A:1009625323388; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; StataCorp, 2007, STAT STAT SOFTW REL; Storandt M, 2002, NEUROLOGY, V59, P1034, DOI 10.1212/WNL.59.7.1034; Takei N, 2009, GENOMICS, V93, P441, DOI 10.1016/j.ygeno.2009.01.003; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Valencia CA, 2007, BIOCHEM BIOPH RES CO, V364, P495, DOI 10.1016/j.bbrc.2007.10.018; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; YOSHIDA M, 1993, J CLIN INVEST, V91, P1099, DOI 10.1172/JCI116268; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	70	261	269	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6501	10.1371/journal.pone.0006501	http://dx.doi.org/10.1371/journal.pone.0006501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19668339	gold, Green Published			2022-12-25	WOS:000268739600001
J	Doncic, A; Ben-Jacob, E; Einav, S; Barkai, N				Doncic, Andreas; Ben-Jacob, Eshel; Einav, Shmuel; Barkai, Naama			Reverse Engineering of the Spindle Assembly Checkpoint	PLOS ONE			English	Article								The Spindle Assembly Checkpoint (SAC) is an intracellular mechanism that ensures proper chromosome segregation. By inhibiting Cdc20, a co-factor of the Anaphase Promoting Complex (APC), the checkpoint arrests the cell cycle until all chromosomes are properly attached to the mitotic spindle. Inhibition of Cdc20 is mediated by a conserved network of interacting proteins. The individual functions of these proteins are well characterized, but understanding of their integrated function is still rudimentary. We here describe our attempts to reverse-engineer the SAC network based on gene deletion phenotypes. We begun by formulating a general model of the SAC which enables us to predict the rate of chromosomal missegregation for any putative set of interactions between the SAC proteins. Next the missegregation rates of seven yeast strains are measured in response to the deletion of one or two checkpoint proteins. Finally, we searched for the set of interactions that correctly predicted the observed missegregation rates of all deletion mutants. Remarkably, although based on only seven phenotypes, the consistent network we obtained successfully reproduces many of the known properties of the SAC. Further insights provided by our analysis are discussed.			Doncic, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	Naama.Barkai@weizmann.ac.il						Burke DJ, 2008, DEV CELL, V14, P474, DOI 10.1016/j.devcel.2008.03.015; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; CHAN CSM, 1993, GENETICS, V135, P677; Chung EN, 2003, NAT CELL BIOL, V5, P748, DOI 10.1038/ncb1022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Doncic A, 2005, P NATL ACAD SCI USA, V102, P6332, DOI 10.1073/pnas.0409142102; Doncic A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100070; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; HOLT LJ, 2008, NATURE; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Ibrahim B, 2008, BIOPHYS CHEM, V134, P93, DOI 10.1016/j.bpc.2008.01.007; Ibrahim B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001555; Kerscher O, 2003, MOL CELL BIOL, V23, P6406, DOI 10.1128/MCB.23.18.6406-6418.2003; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; King EMJ, 2007, GENE DEV, V21, P1163, DOI 10.1101/gad.431507; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Mistry HB, 2008, P NATL ACAD SCI USA, V105, P20215, DOI 10.1073/pnas.0810706106; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Poddar A, 2005, EUKARYOT CELL, V4, P867, DOI 10.1128/EC.4.5.867-878.2005; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sear RP, 2006, P NATL ACAD SCI USA, V103, P16758, DOI 10.1073/pnas.0603174103; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Simonetta M, 2009, PLOS BIOL, V7, P175, DOI 10.1371/journal.pbio.1000010; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Warren CD, 2002, MOL BIOL CELL, V13, P3029, DOI 10.1091/mbc.E02-04-0203; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6495	10.1371/journal.pone.0006495	http://dx.doi.org/10.1371/journal.pone.0006495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652707	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637800008
J	Verduzco-Flores, S; Bodner, M; Ermentrout, B; Fuster, JM; Zhou, YD				Verduzco-Flores, Sergio; Bodner, Mark; Ermentrout, Bard; Fuster, Joaquin M.; Zhou, Yongdi			Working Memory Cells' Behavior May Be Explained by Cross-Regional Networks with Synaptic Facilitation	PLOS ONE			English	Article							CORTICAL SPIKE TRAINS; PREFRONTAL CORTEX; PERSISTENT ACTIVITY; RECURRENT NETWORK; NEURONAL-ACTIVITY; PARIETAL CORTEX; UNIT-ACTIVITY; MODEL; DYNAMICS; RATES	Neurons in the cortex exhibit a number of patterns that correlate with working memory. Specifically, averaged across trials of working memory tasks, neurons exhibit different firing rate patterns during the delay of those tasks. These patterns include: 1) persistent fixed-frequency elevated rates above baseline, 2) elevated rates that decay throughout the tasks memory period, 3) rates that accelerate throughout the delay, and 4) patterns of inhibited firing ( below baseline) analogous to each of the preceding excitatory patterns. Persistent elevated rate patterns are believed to be the neural correlate of working memory retention and preparation for execution of behavioral/ motor responses as required in working memory tasks. Models have proposed that such activity corresponds to stable attractors in cortical neural networks with fixed synaptic weights. However, the variability in patterned behavior and the firing statistics of real neurons across the entire range of those behaviors across and within trials of working memory tasks are typical not reproduced. Here we examine the effect of dynamic synapses and network architectures with multiple cortical areas on the states and dynamics of working memory networks. The analysis indicates that the multiple pattern types exhibited by cells in working memory networks are inherent in networks with dynamic synapses, and that the variability and firing statistics in such networks with distributed architectures agree with that observed in the cortex.			Verduzco-Flores, S (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	mbodner@mindresearch.net	Zhou, Yongdi/GOH-3291-2022	VERDUZCO-FLORES, SERGIO/0000-0002-0712-145X	NINDS NIH HHS [NS-44919, R01 NS044919] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044919] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Amit DJ, 1997, NETWORK-COMP NEURAL, V8, P373, DOI 10.1088/0954-898X/8/4/003; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P275, DOI 10.1088/0954-898X/2/3/004; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; AMIT DJ, 1989, MODELING BRAIN FUNCT, P504; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; Barbieri F, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.005.2007; Bodner M, 2005, EUR J NEUROSCI, V21, P2538, DOI 10.1111/j.1460-9568.2005.04085.x; Bodner M, 1996, NEUROREPORT, V7, P1905, DOI 10.1097/00001756-199608120-00006; Bodner M, 1998, NEUROSCIENCE, V86, P1083, DOI 10.1016/S0306-4522(98)00096-7; Bodner M, 1997, J NEUROPHYSIOL, V77, P2219, DOI 10.1152/jn.1997.77.4.2219; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; CastroAlamancos MA, 1996, P NATL ACAD SCI USA, V93, P1335, DOI 10.1073/pnas.93.3.1335; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Delord B, 1997, NEUROREPORT, V8, P1019, DOI 10.1097/00001756-199703030-00040; Delord B, 2000, J COMPUT NEUROSCI, V8, P251, DOI 10.1023/A:1008902110844; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT B, SIMULATING ANAL ANIM, P290; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; Fuster J M, 2003, CORTEX MIND UNIFYING; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1982, J NEUROSCI, V2, P361; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; FUSTER JM, 1974, BRAIN RES, V81, P393, DOI 10.1016/0006-8993(74)90838-5; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Fuster JM, 1995, MEMORY CEREBRAL CORT; Galarreta M, 2000, J NEUROPHYSIOL, V83, P621, DOI 10.1152/jn.2000.83.1.621; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLOMB D, 1990, PHYS REV A, V41, P1843, DOI 10.1103/PhysRevA.41.1843; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; HOPPENSTEAD F, 2002, BRAIN THEORY NEURAL; Kaas AL, 2007, CEREB CORTEX, V17, P1637, DOI 10.1093/cercor/bhl074; KOCH KW, 1989, EXP BRAIN RES, V76, P292; Ku YX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000771; Laing CR, 2001, NEURAL COMPUT, V13, P1473, DOI 10.1162/089976601750264974; Latham PE, 2004, NEURAL COMPUT, V16, P1385, DOI 10.1162/089976604323057434; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Miller EK, 1996, J NEUROSCI, V16, P5154; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Okamoto H, 2007, J NEUROPHYSIOL, V97, P3859, DOI 10.1152/jn.01100.2006; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Roudi Y, 2007, PLOS COMPUT BIOL, V3, P1679, DOI 10.1371/journal.pcbi.0030141; RUBIN N, 1989, EUROPHYS LETT, V10, P465, DOI 10.1209/0295-5075/10/5/013; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; SHAFI M, 2005, THESIS UCLA; Singh R, 2006, J NEUROSCI, V26, P3667, DOI 10.1523/JNEUROSCI.4864-05.2006; Stoeckel MC, 2003, NEUROIMAGE, V19, P1103, DOI 10.1016/S1053-8119(03)00182-4; TREVES A, 1989, J PHYS A-MATH GEN, V22, P2205, DOI 10.1088/0305-4470/22/12/020; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P10533, DOI 10.1073/pnas.93.19.10533; ZIPSER D, 1993, J NEUROSCI, V13, P3406	65	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6399	10.1371/journal.pone.0006399	http://dx.doi.org/10.1371/journal.pone.0006399			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652716	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000268637800003
J	Kim, J; Swee, M; Parks, WC				Kim, Jaehong; Swee, Mei; Parks, William C.			Cytosolic SYT/SS18 Isoforms Are Actin-Associated Proteins that Function in Matrix-Specific Adhesion	PLOS ONE			English	Article								SYT (SYnovial sarcoma Translocated gene or SS18) is widely produced as two isoforms, SYT/L and SYT/S, that are thought to function in the nucleus as transcriptional coactivators. Using isoform-specific antibodies, we detected a sizable pool of SYT isoforms in the cytosol where the proteins were organized into filamentous arrays. Actin and actin-associated proteins co-immunoprecipitated with SYT isoforms, which also co-sedimented and co-localized with the actin cytoskeleton in cultured cells and tissues. The association of SYT with actin bundles was extensive yet stopped short of the distal ends at focal adhesions. Disruption of the actin cytoskeleton also led to a breakdown of the filamentous organization of SYT isoforms in the cytosol. RNAi ablation of SYT/L alone or both isoforms markedly impaired formation of stress fibers and focal adhesions but did not affect formation of cortical actin bundles. Furthermore, ablation of SYT led to markedly impaired adhesion and spreading on fibronectin and laminin-111 but not on collagen types I or IV. These findings indicate that cytoplasmic SYT isoforms interact with actin filaments and function in the ability cells to bind and react to specific extracellular matrices.			Kim, J (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	parksw@u.washington.edu	Parks, William C./AAH-6786-2021	Kim, Jaehong/0000-0001-5653-1159	NHLBI NIH HHS [R01 HL077555, HL077555, HL029594, P01 HL029594] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594, R01HL077555] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Barco R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005060; Brodin B, 2001, GENE, V268, P173, DOI 10.1016/S0378-1119(01)00412-7; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; de Bruijn DRH, 2006, HUM MOL GENET, V15, P2936, DOI 10.1093/hmg/ddl235; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; de Bruijn DRH, 2001, CYTOGENET CELL GENET, V92, P310, DOI 10.1159/000056920; de Bruijn DRH, 2001, ONCOGENE, V20, P3281, DOI 10.1038/sj.onc.1204419; deBruijn DRH, 1996, ONCOGENE, V13, P643; dos Santos NR, 2000, EXP CELL RES, V256, P192, DOI 10.1006/excr.2000.4813; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ishida M, 2004, GENES CELLS, V9, P419, DOI 10.1111/j.1356-9597.2004.00737.x; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; KIMURA T, 2009, LAB INVEST; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Miao H, 2002, J CELL SCI, V115, P2199; Morimoto Y, 2003, CANCER LETT, V199, P35, DOI 10.1016/S0304-3835(03)00314-8; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nguyen BP, 2001, J BIOL CHEM, V276, P43860, DOI 10.1074/jbc.M103404200; Orr AW, 2007, J CELL BIOL, V176, P719, DOI 10.1083/jcb.200609008; Perani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200; Perani M, 2003, ONCOGENE, V22, P8156, DOI 10.1038/sj.onc.1207031; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Spradling KD, 2001, J BIOL CHEM, V276, P29257, DOI 10.1074/jbc.M101663200; Sudbeck BD, 1997, J BIOL CHEM, V272, P22103, DOI 10.1074/jbc.272.35.22103; Swee M, 2008, J LEUKOCYTE BIOL, V83, P1404, DOI 10.1189/jlb.0108016; SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Van de Walle GR, 2007, BLOOD, V109, P595, DOI 10.1182/blood-2005-11-011775; Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8; Xie YT, 2002, ONCOGENE, V21, P5791, DOI 10.1038/sj.onc.1205700; Zamir E, 2001, J CELL SCI, V114, P3577	42	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6455	10.1371/journal.pone.0006455	http://dx.doi.org/10.1371/journal.pone.0006455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649286	Green Published, gold, Green Submitted			2022-12-25	WOS:000268637600007
J	Price, LB; Liu, CM; Melendez, JH; Frankel, YM; Engelthaler, D; Aziz, M; Bowers, J; Rattray, R; Ravel, J; Kingsley, C; Keim, PS; Lazarus, GS; Zenilman, JM				Price, Lance B.; Liu, Cindy M.; Melendez, Johan H.; Frankel, Yelena M.; Engelthaler, David; Aziz, Maliha; Bowers, Jolene; Rattray, Rogan; Ravel, Jacques; Kingsley, Chris; Keim, Paul S.; Lazarus, Gerald S.; Zenilman, Jonathan M.			Community Analysis of Chronic Wound Bacteria Using 16S rRNA Gene-Based Pyrosequencing: Impact of Diabetes and Antibiotics on Chronic Wound Microbiota	PLOS ONE			English	Article								Background: Bacterial colonization is hypothesized to play a pathogenic role in the non-healing state of chronic wounds. We characterized wound bacteria from a cohort of chronic wound patients using a 16S rRNA gene-based pyrosequencing approach and assessed the impact of diabetes and antibiotics on chronic wound microbiota. Methodology/Principal Findings: We prospectively enrolled 24 patients at a referral wound center in Baltimore, MD; sampled patients' wounds by curette; cultured samples under aerobic and anaerobic conditions; and pyrosequenced the 16S rRNA V3 hypervariable region. The 16S rRNA gene-based analyses revealed an average of 10 different bacterial families in wounds-approximately 4 times more than estimated by culture-based analyses. Fastidious anaerobic bacteria belonging to the Clostridiales family XI were among the most prevalent bacteria identified exclusively by 16S rRNA gene-based analyses. Community-scale analyses showed that wound microbiota from antibiotic treated patients were significantly different from untreated patients (p = 0.007) and were characterized by increased Pseudomonadaceae abundance. These analyses also revealed that antibiotic use was associated with decreased Streptococcaceae among diabetics and that Streptococcaceae was more abundant among diabetics as compared to non-diabetics. Conclusions/Significance: The 16S rRNA gene-based analyses revealed complex bacterial communities including anaerobic bacteria that may play causative roles in the non-healing state of some chronic wounds. Our data suggest that antimicrobial therapy alters community structure-reducing some bacteria while selecting for others.			Price, LB (corresponding author), Translat Genom Res Inst, Flagstaff, AZ USA.	lprice@tgen.org	Ravel, Jacques/D-2530-2009; Liu, Cindy/ABF-7427-2020; Keim, Paul S/A-2269-2010	Ravel, Jacques/0000-0002-0851-2233				Andersen A, 2007, J Wound Care, V16, P171; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Bowler PG, 2002, ANN MED, V34, P419, DOI 10.1080/078538902321012360; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davies CE, 2001, WOUND REPAIR REGEN, V9, P332, DOI 10.1046/j.1524-475x.2001.00332.x; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; Goldstein EJC, 2002, CLIN INFECT DIS, V35, pS119, DOI 10.1086/341932; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Greenhalgh DG, 2003, CLIN PLAST SURG, V30, P37, DOI 10.1016/S0094-1298(02)00066-4; Howell-Jones RS, 2006, WOUND REPAIR REGEN, V14, P387, DOI 10.1111/j.1743-6109.2006.00144.x; Howell-Jones RS, 2005, J ANTIMICROB CHEMOTH, V55, P143, DOI 10.1093/jac/dkh513; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kindt R., 2005, WORLD; Lee S, 2008, KOR J LAB MED, V28, P191, DOI 10.3343/kjlm.2008.28.3.191; Lipsky BA, 2008, DIABETES-METAB RES, V24, pS66, DOI 10.1002/dmrr.828; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; O'Meara S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003557.pub2; O'Meara S, 2000, Health Technol Assess, V4, P1; Oksanen J., 2009, VEGAN COMMUNITY ECOL; R Core Team, 2022, R LANG ENV STAT COMP; Rihl M, 2006, BEST PRACT RES CL RH, V20, P1119, DOI 10.1016/j.berh.2006.08.008; ROBERTS DW, 2007, IABDSV ORDINATION MU; Rocas IN, 2008, J CLIN MICROBIOL, V46, P3599, DOI 10.1128/JCM.00431-08; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Siqueira JF, 2008, J ENDOD, V34; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wysocki Annette B, 2002, AACN Clin Issues, V13, P382, DOI 10.1097/00044067-200208000-00005	40	164	172	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6462	10.1371/journal.pone.0006462	http://dx.doi.org/10.1371/journal.pone.0006462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649281	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637600010
J	Billaud, M; Marthan, R; Savineau, JP; Guibert, C				Billaud, Marie; Marthan, Roger; Savineau, Jean-Pierre; Guibert, Christelle			Vascular Smooth Muscle Modulates Endothelial Control of Vasoreactivity via Reactive Oxygen Species Production through Myoendothelial Communications	PLOS ONE			English	Article							HYPOXIC PULMONARY-HYPERTENSION; RAT INTRAPULMONARY ARTERIES; GAP-JUNCTION FUNCTION; HYPERPOLARIZING FACTOR; NITRIC-OXIDE; MESENTERIC-ARTERIES; MEDIATED RELAXATION; RABBIT ARTERIES; CALCIUM INFLUX; SUPEROXIDE	Background: Endothelial control of vascular smooth muscle plays a major role in the resulting vasoreactivity implicated in physiological or pathological circulatory processes. However, a comprehensive understanding of endothelial (EC)/smooth muscle cells (SMC) crosstalk is far from complete. Here, we have examined the role of gap junctions and reactive oxygen species (ROS) in this crosstalk and we demonstrate an active contribution of SMC to endothelial control of vasomotor tone. Methodology/Principal Findings: In small intrapulmonary arteries, quantitative RT-PCR, Western Blot analyses and immunofluorescent labeling evidenced connexin (Cx) 37, 40 and 43 in EC and/or SMC. Functional experiments showed that the Cx-mimetic peptide targeted against Cx 37 and Cx 43 ((37,43)Gap27) (1) reduced contractile and calcium responses to serotonin (5-HT) simultaneously recorded in pulmonary arteries and (2) abolished the diffusion in SMC of carboxyfluorescein-AM loaded in EC. Similarly, contractile and calcium responses to 5-HT were decreased by superoxide dismutase and catalase which, catabolise superoxide anion and H(2)O(2), respectively. Both Cx- and ROS-mediated effects on the responses to 5-HT were reversed by L-NAME, a NO synthase inhibitor or endothelium removal. Electronic paramagnetic resonance directly demonstrated that 5-HT-induced superoxide anion production originated from the SMC. Finally, whereas 5-HT increased NO production, it also decreased cyclic GMP content in isolated intact arteries. Conclusions/Significance: These data demonstrate that agonist-induced ROS production in SMC targeting EC via myoendothelial gap junctions reduces endothelial NO-dependent control of pulmonary vasoreactivity. Such SMC modulation of endothelial control may represent a signaling pathway controlling vasoreactivity under not only physiological but also pathological conditions that often implicate excessive ROS production.			Billaud, M (corresponding author), INSERM, U885, Lab Physiol Cellulaire Resp, Bordeaux, France.	christelle.guibert@u-bordeaux2.fr	Billaud, Marie/N-7609-2017; , GUIBERT/M-2357-2014	Billaud, Marie/0000-0002-7591-0362; , GUIBERT/0000-0003-3253-5694; Marthan, Roger/0000-0001-5412-5712				BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bonnet S, 2003, P NATL ACAD SCI USA, V100, P9488, DOI 10.1073/pnas.1633724100; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Chaytor AT, 2003, P NATL ACAD SCI USA, V100, P15212, DOI 10.1073/pnas.2435030100; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; Dempsie Y, 2008, BRIT J PHARMACOL, V155, P455, DOI 10.1038/bjp.2008.241; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Figueroa XF, 2004, PHYSIOLOGY, V19, P277, DOI 10.1152/physiol.00008.2004; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Griffith TM, 2002, P NATL ACAD SCI USA, V99, P6392, DOI 10.1073/pnas.092089799; Guibert C, 2005, BRIT J PHARMACOL, V146, P692, DOI 10.1038/sj.bjp.0706379; Guibert C, 2004, AM J PHYSIOL-LUNG C, V286, pL1228, DOI 10.1152/ajplung.00265.2003; ISAKSON BE, 2007, AM J PHYSIOL, V277, pL282; Jahnichen S, 2005, N-S ARCH PHARMACOL, V371, P89, DOI 10.1007/s00210-004-1006-6; Kansui Y, 2008, CELL CALCIUM, V44, P135, DOI 10.1016/j.ceca.2007.11.012; Kleschyov AL, 2000, BIOCHEM BIOPH RES CO, V275, P672, DOI 10.1006/bbrc.2000.3361; Ko YS, 1999, J HISTOCHEM CYTOCHEM, V47, P683, DOI 10.1177/002215549904700510; Lee SL, 2001, AM J PHYSIOL-LUNG C, V281, pL646, DOI 10.1152/ajplung.2001.281.3.L646; Lee SL, 1999, AM J PHYSIOL-LUNG C, V277, pL282, DOI 10.1152/ajplung.1999.277.2.L282; Lee SL, 1998, FREE RADICAL BIO MED, V24, P855, DOI 10.1016/S0891-5849(97)00359-6; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Liu JQ, 2004, AM J PHYSIOL-LUNG C, V287, pL111, DOI 10.1152/ajplung.00006.2004; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Matchkov VV, 2006, AM J PHYSIOL-HEART C, V291, pH357, DOI 10.1152/ajpheart.00681.2005; Meziani F, 2007, AM J PATHOL, V171, P1753, DOI 10.2353/ajpath.2007.070316; MOORE LK, 1995, AM J PHYSIOL-HEART C, V269, pH1481, DOI 10.1152/ajpheart.1995.269.4.H1481; Morio Y, 2003, AM J PHYSIOL-HEART C, V284, pH1762, DOI 10.1152/ajpheart.00831.2002; Nakamura K, 1999, ARCH HISTOL CYTOL, V62, P27, DOI 10.1679/aohc.62.27; Quilley J, 2000, TRENDS PHARMACOL SCI, V21, P121, DOI 10.1016/S0165-6147(00)01445-0; Robert R, 2007, EUR RESPIR J, V30, P857, DOI 10.1183/09031936.00060007; Rocha ML, 2008, CARDIOVASC RES, V80, P123, DOI 10.1093/cvr/cvn178; Rodat L, 2007, PFLUG ARCH EUR J PHY, V454, P41, DOI 10.1007/s00424-006-0178-y; Rummery NM, 2002, ARTERIOSCL THROM VAS, V22, P1427, DOI 10.1161/01.ATV.0000028814.45706.E5; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Schuster A, 2001, AM J PHYSIOL-HEART C, V280, pH1088, DOI 10.1152/ajpheart.2001.280.3.H1088; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watts SW, 1996, HYPERTENSION, V28, P888, DOI 10.1161/01.HYP.28.5.888	39	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6432	10.1371/journal.pone.0006432	http://dx.doi.org/10.1371/journal.pone.0006432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649279	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494600002
J	Thirkettle, HJ; Mills, IG; Whitaker, HC; Neal, DE				Thirkettle, H. J.; Mills, I. G.; Whitaker, H. C.; Neal, D. E.			Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression	ONCOGENE			English	Article						LYRIC/AEG-1; PLZF; transcription; repression; nucleus	ASTROCYTE-ELEVATED GENE-1; PROSTATE-CANCER; PROTEIN PLZF; BREAST-CANCER; C-MYC; IDENTIFICATION; METASTASIS; ACTIVATION; PROGRESSION; EXPRESSION	LYRIC/AEG-1 and its altered expression have been linked to carcinogenesis in prostate, brain and melanoma as well as promoting chemoresistance and metastasis in breast cancer. LYRIC/AEG-1 function remains unclear, although LYRIC/AEG-1 is activated by oncogenic HA-RAS, through binding of c-myc to its promoter, which in turn regulates the key components of the PI3-kinase and nuclear factor-kappa B pathways. We have identified the transcriptional repressor PLZF as an interacting protein of LYRIC/AEG through a yeast two-hybrid screen. PLZF regulates the expression of genes involved in cell growth and apoptosis including c-myc. Coexpression of LYRIC/AEG-1 with PLZF leads to a reduction in PLZF-mediated repression by reducing PLZF binding to promoters. We have confirmed that nuclear LYRIC/AEG-1 and PLZF interact in mammalian cells via the N- and C termini of LYRIC/AEG-1 and a region C terminal to the RD2 domain of PLZF. Both proteins colocalize to nuclear bodies containing histone deacetylases, which are known to promote PLZF-mediated repression. Our data suggest one mechanism for cells with altered LYRIC/AEG-1 expression to evade apoptosis and increase cell growth during tumourigenesis through the regulation of PLZF repression. Oncogene (2009) 28, 3663-3670; doi:10.1038/onc.2009.223; published online 3 August 2009	[Whitaker, H. C.] Canc Res UK Cambridge Res Inst, Urooncol Res Grp, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute	Whitaker, HC (corresponding author), Canc Res UK Cambridge Res Inst, Urooncol Res Grp, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	Hayley.Whitaker@cancer.org.uk	Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; Neal, David/0000-0002-6033-5086	Cancer Research UK; Medical Research Council; Cancer Research UK Cambridge Genomics Core Facility and Microscopy Core Facility; MRC [G0500966] Funding Source: UKRI; Medical Research Council [G0500966] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Cambridge Genomics Core Facility and Microscopy Core Facility(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this study was provided by Cancer Research UK (DEN, HCW, IGM) and the Medical Research Council (HJT). We thank Jonathon D Licht for the PLZF reporter construct 4xIL-3R-tkLUC, Zhou Wang (Chicago) for PLZF expression construct, Krishna Chatterjee (Cambridge) for pEF-BOS-b-gal construct. We also thank Wendy Bickmore for LYRIC/AEG-1 antibodies (Edinburgh) and Maria Carmo-Fonseca (Lisbon) for the anti-coilin antibody. We are very grateful to Antonio Ramos-Montoya (Cambridge) for help and advice with ChIP and qRT -PCR. We acknowledge the support of the Cancer Research UK Cambridge Genomics Core Facility and Microscopy Core Facility, The University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited.	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Ball HJ, 1999, NUCLEIC ACIDS RES, V27, P4106, DOI 10.1093/nar/27.20.4106; Bernardo MV, 2007, BIOCHEM BIOPH RES CO, V359, P317, DOI 10.1016/j.bbrc.2007.05.085; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; Chao TT, 2007, BIOCHEM BIOPH RES CO, V358, P475, DOI 10.1016/j.bbrc.2007.04.157; Chauchereau A, 2004, ONCOGENE, V23, P8777, DOI 10.1038/sj.onc.1208128; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jiang F, 2004, PROSTATE, V59, P426, DOI 10.1002/pros.20000; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kang SI, 2003, J BIOL CHEM, V278, P51479, DOI 10.1074/jbc.M309237200; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kikugawa T, 2006, PROSTATE, V66, P1092, DOI 10.1002/pros.20443; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kwong LN, 2009, CANCER CELL, V15, P1, DOI 10.1016/j.ccr.2008.12.007; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Seeler JS, 1999, CURR OPIN GENET DEV, V9, P362, DOI 10.1016/S0959-437X(99)80054-9; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Thirkettle HJ, 2009, CLIN CANCER RES, V15, P3003, DOI 10.1158/1078-0432.CCR-08-2046; Waghray A, 2001, PROTEOMICS, V1, P1327, DOI 10.1002/1615-9861(200110)1:10<1327::AID-PROT1327>3.3.CO;2-2; Whitaker HC, 2007, PROSTATE, V67, P943, DOI 10.1002/pros.20580	28	56	59	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2009	28	41					3663	3670		10.1038/onc.2009.223	http://dx.doi.org/10.1038/onc.2009.223			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KJ	19648967				2022-12-25	WOS:000270851800007
J	Tsunoyama, Y; Bernat, G; Dyczmons, NG; Schneider, D; Rogner, M				Tsunoyama, Yuichi; Bernat, Gabor; Dyczmons, Nina G.; Schneider, Dirk; Roegner, Matthias			Multiple Rieske Proteins Enable Short- and Long-term Light Adaptation of Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME B(6)F COMPLEX; CYCLIC ELECTRON FLOW; IRON-SULFUR PROTEIN; ALGA CHLAMYDOMONAS-REINHARDTII; STATE TRANSITIONS; PHOTOSYSTEM-I; SP PCC-6803; GREEN-ALGA; SIGNAL-TRANSDUCTION; PLASTOQUINONE POOL	In contrast to eukaryotes, most cyanobacteria contain several isoforms of the Rieske iron-sulfur protein, PetC, resulting in heterogeneity in the composition of the cytochrome b(6)f complexes. Of three isoforms in the mesophilic cyanobacterium Synechocystis PCC 6803, PetC1 is the major Rieske protein in the cytochrome b(6)f complex, whereas the physiological function of PetC2 and PetC3 is still uncertain. Comparison of wild type and various petC-deficient strains under selected light conditions revealed distinct functional differences: high-light exposure of wild type cells resulted in a significantly enhanced petC2 transcript level, whereas a Delta petC1 mutant showed a low cytochrome b(6)f content, low electron flux, and a considerably increased accumulation of cytochrome-bd oxidase. In contrast to wild type and Delta petC1, Delta petC2 and Delta petC3 strains still grew fast under high-light conditions although all three Rieske proteins are required for maximal electron transport rates. Although the presence of PetC3 appears to be required for activation of the cyclic electron transport, state transitions were more effective in the absence of PetC2 and/or PetC3. In summary, our data suggest defined roles of the various PetC proteins in short- and long-term light adaptation.	[Tsunoyama, Yuichi; Bernat, Gabor; Dyczmons, Nina G.; Roegner, Matthias] Ruhr Univ Bochum, Dept Plant Biochem, D-44780 Bochum, Germany; [Tsunoyama, Yuichi] Kyoto Univ, Div Biol, Radioisotope Res Ctr, Sakyo Ku, Kyoto 6068502, Japan; [Schneider, Dirk] Univ Freiburg, ZBMZ, Dept Biochem & Mol Biol, D-79104 Freiburg, Germany	Ruhr University Bochum; Kyoto University; University of Freiburg	Rogner, M (corresponding author), Ruhr Univ Bochum, Dept Plant Biochem, D-44780 Bochum, Germany.	Matthias.Roegner@rub.de	Bernat, Gabor/J-6333-2017	Bernat, Gabor/0000-0001-6147-9391	German Research Foundation Deutsche Forschungsgemeinschaft [SFB 480, SCHN 690/3-1]; Federal Ministry of Education and Research (BMBF) [Bio-H2]; Kyoto University Foundation; EU/NEST	German Research Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Kyoto University Foundation; EU/NEST(European Commission)	This work was supported by German Research Foundation Deutsche Forschungsgemeinschaft Grant SFB 480, project CI (to M. R.) and SCHN 690/3-1 (to D.S.), grants from the Federal Ministry of Education and Research (BMBF) project Bio-H2 (to G. B.), the Kyoto University Foundation (to Y. T.), and the EU/NEST project Solar-H (to M. R.).	Aldridge C, 2008, MOL MICROBIOL, V70, P140, DOI 10.1111/j.1365-2958.2008.06401.x; Alfonso M, 2000, PLANT PHYSIOL, V122, P505, DOI 10.1104/pp.122.2.505; Allen JF, 2004, TRENDS PLANT SCI, V9, P130, DOI 10.1016/j.tplants.2004.01.009; Allen JF, 2003, SCIENCE, V299, P1530, DOI 10.1126/science.1082833; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Bernat G, 2009, PHOTOSYNTH RES, V99, P205, DOI 10.1007/s11120-008-9398-7; Berry S, 2002, BIOCHEMISTRY-US, V41, P3422, DOI 10.1021/bi011683d; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Bukhov N, 2004, PHOTOSYNTH RES, V82, P17, DOI 10.1023/B:PRES.0000040442.59311.72; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cape JL, 2006, TRENDS PLANT SCI, V11, P46, DOI 10.1016/j.tplants.2005.11.007; Cramer W, 2008, PHOTOSYNTHETIC PROTE, P155, DOI [10.1002/9783527623464.ch7, DOI 10.1002/9783527623464.CH7]; Cramer WA, 2006, BBA-BIOENERGETICS, V1757, P339, DOI 10.1016/j.bbabio.2006.04.020; Cramer WA, 2006, ANNU REV BIOCHEM, V75, P769, DOI 10.1146/annurev.biochem.75.103004.142756; de Vitry C, 2004, J BIOL CHEM, V279, P44621, DOI 10.1074/jbc.M406955200; de Vitry C, 1999, PLANT CELL, V11, P2031, DOI 10.1105/tpc.11.10.2031; Finazzi G, 2004, PHOTOSYNTH RES, V82, P327, DOI 10.1007/s11120-004-0359-5; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; FORK DC, 1993, PHOTOSYNTH RES, V36, P149, DOI 10.1007/BF00033035; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Howitt CA, 1998, BIOCHEMISTRY-US, V37, P17944, DOI 10.1021/bi981486n; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; KALLAS T, 1988, J BIOL CHEM, V263, P14334; Kaneko T, 1996, DNA Res, V3, P109; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Mao HB, 2002, FEBS LETT, V519, P82, DOI 10.1016/S0014-5793(02)02715-1; Mogi T, 2009, J BIOCHEM, V145, P395, DOI 10.1093/jb/mvn179; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064; MULLINEAUX CW, 1986, FEBS LETT, V205, P155, DOI 10.1016/0014-5793(86)80885-7; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; MYERS J, 1978, J PHYCOL, V14, P513, DOI 10.1111/j.1529-8817.1978.tb02478.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Schneider D, 2004, J BIOL CHEM, V279, P39383, DOI 10.1074/jbc.M406288200; Schneider D, 2002, J BIOL CHEM, V277, P10949, DOI 10.1074/jbc.M104076200; Schneider D, 2001, J BIOL CHEM, V276, P16780, DOI 10.1074/jbc.M009503200; Schneider D, 2005, BBA-BIOENERGETICS, V1710, P1, DOI 10.1016/j.bbabio.2005.09.003; Schneider D, 2007, RES MICROBIOL, V158, P45, DOI 10.1016/j.resmic.2006.10.002; SCHULTZE M, 2009, BIOCH BIOPH IN PERSS; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; van Thor JJ, 1998, BOT ACTA, V111, P430, DOI 10.1111/j.1438-8677.1998.tb00731.x; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; VENER AV, 1995, J BIOL CHEM, V270, P25225, DOI 10.1074/jbc.270.42.25225; Volkmer T, 2007, J BIOL CHEM, V282, P3730, DOI 10.1074/jbc.M604948200; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Yan JS, 2003, J BIOL CHEM, V278, P20925, DOI 10.1074/jbc.M212616200; Yeremenko N, 2005, PLANT CELL PHYSIOL, V46, P1433, DOI 10.1093/pcp/pci147; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	60	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27875	27883		10.1074/jbc.M109.011189	http://dx.doi.org/10.1074/jbc.M109.011189			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674969	hybrid, Green Published			2022-12-25	WOS:000270676300014
J	Bagci, T; Wu, JK; Pfannl, R; Ilag, LL; Jay, DG				Bagci, T.; Wu, J. K.; Pfannl, R.; Ilag, L. L.; Jay, D. G.			Autocrine semaphorin 3A signaling promotes glioblastoma dispersal	ONCOGENE			English	Article						proteomics; glioma; dispersal; semaphorin; neuropilin	ENDOTHELIAL GROWTH-FACTOR; PANCREATIC-CANCER CELLS; HUMAN GLIOMA-CELLS; CARCINOMA-CELLS; POOR-PROGNOSIS; TUMOR-CELLS; NEUROPILIN-1; MIGRATION; RECEPTOR; EXPRESSION	Glioblastoma multiforme (GBM) is the most malignant glioma type with diffuse borders due to extensive tumor cell infiltration. Therefore, understanding the mechanism of GBM cell dispersal is critical for developing effective therapies to limit infiltration. We identified neuropilin-1 as a mediator of cancer cell invasion by a functional proteomic screen and showed its role in GBM cells. Neuropilin-1 is a receptor for semaphorin3A (Sema3A), a secreted chemo-repellent that facilitates axon guidance during neural development. Although neuropilin-1 expression in GBMs was previously shown, its role as a Sema3A receptor remained elusive. Using fluorophore-assisted light inactivation and RNA interference, we showed that neuropilin-1 is required for GBM cell migration. We also showed that GBM cells secrete Sema3A endogenously, and RNA interference-mediated downregulation of Sema3A inhibits migration and alters cell morphology that is dependent on Rac1 activity. Sema3A depletion also reduces dispersal, which is recovered by supplying Sema3A exogenously. Extracellular application of Sema3A decreases cell-substrate adhesion in a neuropilin-1-dependent manner. Using immunohistochemistry, we showed that Sema3A is overexpressed in a subset of human GBMs compared with the non-neoplastic brain. Together, these findings implicate Sema3A as an autocrine signal for neuropilin-1 to promote GBM dispersal by modulating substrate adhesion and suggest that targeting Sema3A-neuropilin-1 signaling may limit GBM infiltration. Oncogene (2009) 28, 3537-3550; doi: 10.1038/onc.2009.204; published online 17 August 2009	[Jay, D. G.] Tufts Univ, Dept Physiol, Sch Med, Boston, MA 02111 USA; [Bagci, T.; Jay, D. G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Wu, J. K.] Tufts Univ, Sch Med, Dept Neurosurg, Boston, MA 02111 USA; [Pfannl, R.] Tufts Univ, Sch Med, Dept Neuropathol, Boston, MA 02111 USA; [Ilag, L. L.] Bio21 Mol Sci & Biotechnol Inst, Patrys Ltd, Parkville, Vic, Australia	Tufts University; Tufts University; Tufts University; Tufts University	Jay, DG (corresponding author), Tufts Univ, Dept Physiol, Sch Med, 136 Harrison Ave,M&V709, Boston, MA 02111 USA.	daniel.jay@tufts.edu	Onder, Tugba Bagci/AAN-1392-2021	Bagci Onder, Tugba/0000-0003-3646-2613	Goldhirsh Foundation; NIH [RO1 CA 116642]; NATIONAL CANCER INSTITUTE [R01CA116642] Funding Source: NIH RePORTER	Goldhirsh Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Alex Kolodkin (Johns Hopkins School of Medicine) for kindly providing function blocking anti-Nrp-1 antibody; Jean Stewart, Dean Yimlamai and Jennifer Salluzzo for technical help; Sonya Craig for discussions about the adhesion assay; Brenda Eustace for assistance with the invasion screen; Pat Hibberd for help with the statistical analysis; Laura Liscum, Tamer Onder and Jessica McCready for critically reading the paper. This work was supported by the Goldhirsh Foundation and the NIH, RO1 CA 116642.	Bachelder RE, 2001, CANCER RES, V61, P5736; Bachelder RE, 2003, CANCER RES, V63, P5230; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034; Broholm H, 2004, APMIS, V112, P257, DOI 10.1111/j.1600-0463.2004.apm11204-0505.x; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Ding H, 2000, INT J CANCER, V88, P584, DOI 10.1002/1097-0215(20001115)88:4<584::AID-IJC11>3.0.CO;2-T; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fukahi K, 2004, CLIN CANCER RES, V10, P581, DOI 10.1158/1078-0432.CCR-0930-03; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Halloran MC, 2006, CURR OPIN CELL BIOL, V18, P533, DOI 10.1016/j.ceb.2006.08.010; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kreuter M, 2006, LEUKEMIA, V20, P1950, DOI 10.1038/sj.leu.2404384; Lee P, 2002, P NATL ACAD SCI USA, V99, P10470, DOI 10.1073/pnas.162366299; Li M, 2004, CANCER-AM CANCER SOC, V101, P2341, DOI 10.1002/cncr.20634; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Mueller MW, 2007, INT J CANCER, V121, P2421, DOI 10.1002/ijc.22949; Nakada M, 2004, CANCER RES, V64, P3179, DOI 10.1158/0008-5472.CAN-03-3667; Nakada M, 2006, CANCER RES, V66, P8492, DOI 10.1158/0008-5472.CAN-05-4211; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Okada H, 1996, INT J CANCER, V66, P255, DOI 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A; Osada H, 2004, ANTICANCER RES, V24, P547; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rieger J, 2003, GLIA, V42, P379, DOI 10.1002/glia.10210; Roche J, 2002, ADV EXP MED BIOL, V515, P103; Rossignol M, 2000, GENOMICS, V70, P211, DOI 10.1006/geno.2000.6381; Roush W, 1998, SCIENCE, V279, P2042, DOI 10.1126/science.279.5359.2042; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Vales A, 2007, LEUKEMIA LYMPHOMA, V48, P1997, DOI 10.1080/10428190701534424; Vanveldhuizen PJ, 2003, ONCOL REP, V10, P1067; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	57	86	95	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2009	28	40					3537	3550		10.1038/onc.2009.204	http://dx.doi.org/10.1038/onc.2009.204			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KI	19684614				2022-12-25	WOS:000270851700003
J	Rijken, PJ; Houtkooper, RH; Akbari, H; Brouwers, JF; Koorengevel, MC; de Kruijff, B; Frentzen, M; Vaz, FM; de Kroon, AIPM				Rijken, Pieter J.; Houtkooper, Riekelt H.; Akbari, Hana; Brouwers, Jos F.; Koorengevel, Martijn C.; de Kruijff, Ben; Frentzen, Margrit; Vaz, Frederic M.; de Kroon, Anton I. P. M.			Cardiolipin Molecular Species with Shorter Acyl Chains Accumulate in Saccharomyces cerevisiae Mutants Lacking the Acyl Coenzyme A-binding Protein Acb1p NEW INSIGHTS INTO ACYL CHAIN REMODELING OF CARDIOLIPIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER MEMBRANES; BARTH-SYNDROME; PHOSPHOLIPID BIOSYNTHESIS; SUBCELLULAR MEMBRANES; CDP-DIACYLGLYCEROL; INNER MEMBRANE; BOVINE HEART; YEAST; METABOLISM; SYNTHASE	The function of the mitochondrial phospholipid cardiolipin (CL) is thought to depend on its acyl chain composition. The present study aims at a better understanding of the way the CL species profile is established in Saccharomyces cerevisiae by using depletion of the acyl-CoA-binding protein Acb1p as a tool to modulate the cellular acyl chain content. Despite the presence of an intact CL remodeling system, acyl chains shorter than 16 carbon atoms (C16) were found to accumulate in CL in cells lacking Acb1p. Further experiments revealed that Taz1p, a key CL remodeling enzyme, was not responsible for the shortening of CL in the absence of Acb1p. This left de novo CL synthesis as the only possible source of acyl chains shorter than C16 in CL. Experiments in which the substrate specificity of the yeast cardiolipin synthase Crd1p and the acyl chain composition of individual short CL species were investigated, indicated that both CL precursors (i.e. phosphatidylglycerol and CDP-diacylglycerol) contribute to comparable extents to the shorter acyl chains in CL in acb1 mutants. Based on the findings, we conclude that the fatty acid composition of mature CL in yeast is governed by the substrate specificity of the CL-specific lipase Cld1p and the fatty acid composition of the Taz1p substrates.	[Rijken, Pieter J.; Koorengevel, Martijn C.; de Kruijff, Ben; de Kroon, Anton I. P. M.] Univ Utrecht, Dept Membrane Biochem, Bijvoet Inst, NL-3584 CH Utrecht, Netherlands; [Rijken, Pieter J.; Koorengevel, Martijn C.; de Kruijff, Ben; de Kroon, Anton I. P. M.] Univ Utrecht, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands; [Houtkooper, Riekelt H.; Vaz, Frederic M.] Univ Amsterdam, Dept Clin Chem, Lab Genet Metab Dis, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; [Houtkooper, Riekelt H.; Vaz, Frederic M.] Univ Amsterdam, Dept Pediat, Lab Genet Metab Dis, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; [Akbari, Hana; Frentzen, Margrit] Univ Aachen, Unit Bot, Inst Biol 1, Rhein Westfal TH, D-52056 Aachen, Germany; [Brouwers, Jos F.] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, NL-3584 CL Utrecht, Netherlands	Utrecht University; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; RWTH Aachen University; Utrecht University	de Kroon, AIPM (corresponding author), POB 80-053, NL-3508 TB Utrecht, Netherlands.	a.i.p.m.dekroon@uu.nl	Brouwers, Jos F/AAH-1444-2019; Houtkooper, Riekelt/P-5001-2019; de Kroon, Anton I/O-4119-2016; Houtkooper, Riekelt H/E-1602-2011	Brouwers, Jos F/0000-0003-2924-3279; Houtkooper, Riekelt H/0000-0001-9961-0842; de Kroon, Anton/0000-0003-1209-756X; Vaz, Frederic/0000-0002-9048-1041	Dutch Organization for Scientific Research (NWO); Prinses Beatrix Fonds [WAR05-0126]; Barth Syndrome Foundation	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Prinses Beatrix Fonds; Barth Syndrome Foundation	This work was supported by an Earth and Life Sciences (ALW) grant with financial aid from the Dutch Organization for Scientific Research (NWO). This work was also supported by Prinses Beatrix Fonds Grant WAR05-0126 and the Barth Syndrome Foundation (to F. M. V.).	Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Choi JY, 1996, J BIOL CHEM, V271, P3581; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Kroon AIPM, 1999, MOL MEMBR BIOL, V16, P205; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Faergeman NJ, 2004, BIOCHEM J, V380, P907, DOI 10.1042/BJ20031949; Feddersen S, 2007, BIOCHEM J, V407, P219, DOI 10.1042/BJ20070315; FRENTZEN M, 1994, PLANT PHYSIOL, V106, P1527, DOI 10.1104/pp.106.4.1527; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang F, 1999, MOL MICROBIOL, V31, P373, DOI 10.1046/j.1365-2958.1999.01181.x; KLIG LS, 1988, J BACTERIOL, V170, P1878, DOI 10.1128/jb.170.4.1878-1886.1988; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nowicki M, 2005, FEBS LETT, V579, P2161, DOI 10.1016/j.febslet.2005.03.007; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Simockova M, 2008, J BIOL CHEM, V283, P17107, DOI 10.1074/jbc.M800868200; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; VASILENKO I, 1982, BIOCHIM BIOPHYS ACTA, V684, P282, DOI 10.1016/0005-2736(82)90018-9; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Welti R, 2003, ANAL BIOCHEM, V314, P149, DOI 10.1016/S0003-2697(02)00623-1; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	59	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27609	27619		10.1074/jbc.M109.016311	http://dx.doi.org/10.1074/jbc.M109.016311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656950	hybrid, Green Published			2022-12-25	WOS:000270232300062
J	Bohm, M; Locke, WJ; Sutherland, RL; Kench, JG; Henshall, SM				Boehm, M.; Locke, W. J.; Sutherland, R. L.; Kench, J. G.; Henshall, S. M.			A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes	ONCOGENE			English	Article						AR; GATA-2; prostate cancer; progression	LIPID MOBILIZING FACTOR; TRANSCRIPTION FACTORS; RECEPTOR; EXPRESSION; CELLS; ADIPOCYTES; EVOLUTION; PATHWAY; MODEL	GATA-2, a member of the GATA family of transcription factors, is involved in androgen receptor (AR) signaling, however, little is known regarding its role in prostate cancer. Here, we report that GATA-2 is expressed in a substantial proportion of prostate cancers and that high expression of GATA-2 is associated with biochemical recurrence and distant metastatic progression in a validation set of 203 cancers. In vitro data show that GATA-2 is directly recruited to the promoter region of the AR upon androgen stimulation of LNCaP prostate cancer cells with 5 alpha-dihydroxytestosterone (DHT) for 24 h. Ectopic GATA-2 expression causes the induction of AR transcript levels under androgen-depleted conditions (P<0.05). The expression of the AR target gene, AZGP1, is induced upon androgen stimulation and this effect is repressed by GATA-2. In contrast, GATA-2 significantly increases transcript levels of KLK2, which increases further in a time-dependent manner on DHT treatment and in the presence of GATA-2. These results indicate that upregulation of GATA-2 may contribute to the progression to aggressive prostate cancer through modulation of expression of AR and key androgen-regulated genes, one of which, AZGP1, is associated with the progression to metastatic disease. Oncogene (2009) 28, 3847-3856; doi:10.1038/onc.2009.243; published online 17 August 2009	[Boehm, M.; Locke, W. J.; Sutherland, R. L.; Kench, J. G.; Henshall, S. M.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia; [Kench, J. G.] Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of Sydney	Henshall, SM (corresponding author), Garvan Inst Med Res, Canc Res Program, 384 Victoria St, Sydney, NSW 2010, Australia.	s.henshall@garvan.org.au	Locke, Warwick/G-3152-2017; Sutherland, Robert L/A-8378-2008	Locke, Warwick/0000-0002-9281-0363; Kench, James Geoffrey/0000-0001-8687-4988	Cancer Institute NSW; National Health and Medical Research Council; Prostate Cancer Foundation of Australia; RT Hall Trust	Cancer Institute NSW; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation of Australia; RT Hall Trust	This work is supported by grants from the Cancer Institute NSW, the National Health and Medical Research Council, the Prostate Cancer Foundation of Australia and the RT Hall Trust. We thank Professor Liz Musgrove, Dr Ross Laybutt and Dr Liz Caldon for helpful discussion and critical reading of the paper. Furthermore, we thank Ruth PeBenito for technical support.	Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Borgono CA, 2004, MOL CANCER RES, V2, P257; COX DR, 1972, J R STAT SOC B, V187, P220; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Heemers HV, 2009, MOL ENDOCRINOL, V23, P572, DOI 10.1210/me.2008-0363; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Henshall SM, 2003, CANCER RES, V63, P4196; Henshall SM, 2006, J NATL CANCER I, V98, P1420, DOI 10.1093/jnci/djj378; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kato S, 2004, J STEROID BIOCHEM, V89-90, P627, DOI 10.1016/j.jsbmb.2004.03.099; Lin BY, 1999, CANCER RES, V59, P4180; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; Masuda K, 2005, J MOL BIOL, V353, P763, DOI 10.1016/j.jmb.2005.09.009; Matsuyama M, 2008, PPAR RES, V2008, DOI 10.1155/2008/249849; Minegishi N, 2005, GENES CELLS, V10, P693, DOI 10.1111/j.1365-2443.2005.00864.x; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Oren Aharon, 2005, Saline Syst, V1, P2, DOI 10.1186/1746-1448-1-2; Perez-Stable CM, 2000, MOL CELL ENDOCRINOL, V167, P43, DOI 10.1016/S0303-7207(00)00300-2; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921, DOI 10.1210/mend-5-12-1921; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; SIMON MC, 1995, NAT GENET, V11, P9, DOI 10.1038/ng0995-9; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Wang G, 2006, ONCOGENE, V25, P7311, DOI 10.1038/sj.onc.1209715; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Xu Y, 2003, J CELL PHYSIOL, V196, P131, DOI 10.1002/jcp.10281; YOUNG CYF, 1992, BIOCHEMISTRY-US, V31, P818, DOI 10.1021/bi00118a026	38	62	63	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	43					3847	3856		10.1038/onc.2009.243	http://dx.doi.org/10.1038/onc.2009.243			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	512KT	19684615				2022-12-25	WOS:000271248400008
J	Chan, CB; Liu, X; Jang, SW; Hsu, SIH; Williams, I; Kang, S; Chen, J; Ye, K				Chan, C. B.; Liu, X.; Jang, S-W; Hsu, S. I-H; Williams, I.; Kang, S.; Chen, J.; Ye, K.			NGF inhibits human leukemia proliferation by downregulating cyclin A1 expression through promoting acinus/CtBP2 association	ONCOGENE			English	Article						acinus; CtBP2; cyclin A1; gambogic amide; leukemia; NGF	NERVE GROWTH-FACTOR; TERMINAL BINDING-PROTEIN; ACUTE MYELOID-LEUKEMIA; CANCER CELL-LINES; CHROMATIN CONDENSATION; HEMATOPOIETIC-CELLS; COREPRESSOR CTBP; RETINOIC ACID; TRKA RECEPTOR; CO-REPRESSOR	Cyclin A1 is essential for leukemia progression, and its expression is tightly regulated by acinus, a nuclear speckle protein. However, the molecular mechanism of how acinus mediates cyclin A1 expression remains elusive. Here we show that transcription corepressor CtBP2 directly binds acinus, which is regulated by nerve growth factor (NGF), inhibiting its stimulatory effect on cyclin A1, but not cyclin A2, expression in leukemia. NGF, a cognate ligand for the neurotrophic receptor TrkA, promotes the interaction between CtBP2 and acinus through triggering acinus phosphorylation by Akt. Overexpression of CtBP2 diminishes cyclin A1 transcription, whereas depletion of CtBP2 abolishes NGF's suppressive effect on cyclin A1 expression. Strikingly, gambogic amide, a newly identified TrkA agonist, potently represses cyclin A1 expression, thus blocking K562 cell proliferation. Moreover, gambogic amide ameliorates the leukemia progression in K562 cells inoculated nude mice. Hence, NGF downregulates cyclin A1 expression through escalating CtBP2/acinus complex formation, and gambogic amide might be useful for human leukemia treatment. Oncogene (2009) 28, 3825-3836; doi:10.1038/onc.2009.236; published online 10 August 2009	[Chan, C. B.; Liu, X.; Jang, S-W; Williams, I.; Ye, K.] Emory Univ, Dept Pathol & Lab Med, Sch Med, Atlanta, GA 30322 USA; [Hsu, S. I-H] Natl Univ Singapore, Dept Med, Fac Med, Singapore 117548, Singapore; [Kang, S.; Chen, J.] Emory Univ, Winship Canc Inst, Sch Med, Atlanta, GA 30322 USA	Emory University; National University of Singapore; Emory University	Ye, K (corresponding author), Emory Univ, Dept Pathol & Lab Med, Sch Med, Room 145,Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu			NIH [RO1 NS060680]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060680] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by a grant from NIH (RO1 NS060680) to K Ye. We thank Dr G Chinnadurai (Saint Louis University Health Sciences Center) for GST-CtBP1 plasmid.	BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chan CB, 2007, CELL DEATH DIFFER, V14, P1688, DOI 10.1038/sj.cdd.4402179; Chen J, 2008, LIFE SCI, V83, P103, DOI 10.1016/j.lfs.2008.05.003; CHEVALIER S, 1994, BLOOD, V83, P1479; DEWECK Z, 1987, BIOCHEMISTRY-US, V26, P4769, DOI 10.1021/bi00389a026; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Guo QL, 2004, ACTA PHARMACOL SIN, V25, P769; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; JACKSON GR, 1992, BRAIN RES, V592, P239, DOI 10.1016/0006-8993(92)91681-4; Jang SW, 2008, CANCER RES, V68, P4559, DOI 10.1158/0008-5472.CAN-08-0021; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Kaebisch A, 1996, BRIT J HAEMATOL, V95, P102, DOI 10.1046/j.1365-2141.1996.d01-1874.x; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Kramer A, 1998, LEUKEMIA, V12, P893, DOI 10.1038/sj.leu.2401051; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Li ZX, 2009, BLOOD, V113, P2028, DOI 10.1182/blood-2008-05-155200; Liao C, 2001, P NATL ACAD SCI USA, V98, P6853, DOI 10.1073/pnas.121540098; Liu W, 2005, WORLD J GASTROENTERO, V11, P3655, DOI 10.3748/wjg.v11.i24.3655; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; McLure KG, 2004, MOL CELL BIOL, V24, P9958, DOI 10.1128/MCB.24.22.9958-9967.2004; Meyer J, 2007, LEUKEMIA, V21, P2171, DOI 10.1038/sj.leu.2404882; Miller JP, 2007, CELL CYCLE, V6, P2932, DOI 10.4161/cc.6.23.5042; MISSALE C, 1993, P NATL ACAD SCI USA, V90, P7961, DOI 10.1073/pnas.90.17.7961; Missale C, 1998, P NATL ACAD SCI USA, V95, P5366, DOI 10.1073/pnas.95.9.5366; Nardini M, 2006, PROTEIN SCI, V15, P1042, DOI 10.1110/ps.062115406; Pereda MP, 2000, MOL CELL ENDOCRINOL, V167, P99, DOI 10.1016/S0303-7207(00)00286-0; Qiang L, 2008, BIOCHEM PHARMACOL, V75, P1083, DOI 10.1016/j.bcp.2007.10.033; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Schwerk C, 2003, MOL CELL BIOL, V23, P2981, DOI 10.1128/MCB.23.8.2981-2990.2003; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Shu WX, 2008, BASIC CLIN PHARMACOL, V103, P530, DOI 10.1111/j.1742-7843.2008.00292.x; Sigala S, 1999, CLIN CANCER RES, V5, P1211; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tao ZJ, 2007, CANCER BIOL THER, V6, P691, DOI 10.4161/cbt.6.5.3960; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; TRIA MA, 1994, EXP NEUROL, V127, P178, DOI 10.1006/exnr.1994.1093; TSUDA T, 1991, BLOOD, V77, P971; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Vucetic Z, 2008, MOL CELL BIOL, V28, P2549, DOI 10.1128/MCB.01199-07; Wolgemuth DJ, 2004, INT J ANDROL, V27, P192, DOI 10.1111/j.1365-2605.2004.00480.x; Xie P, 2000, LEUKEMIA RES, V24, P751, DOI 10.1016/S0145-2126(00)00044-8; Xie P, 1997, NEUROREPORT, V8, P1067, DOI 10.1097/00001756-199703240-00001; Xu XY, 2009, INT J DERMATOL, V48, P186, DOI 10.1111/j.1365-4632.2009.03946.x; Yang R, 1997, CANCER RES, V57, P913; Yang R, 1999, BLOOD, V93, P2067; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Zhang QH, 2002, SCIENCE, V295, P1895	55	21	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	43					3825	3836		10.1038/onc.2009.236	http://dx.doi.org/10.1038/onc.2009.236			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	512KT	19668232	Green Accepted			2022-12-25	WOS:000271248400006
J	Scholtmeijer, K; de Vocht, ML; Rink, R; Robillard, GT; Wosten, HAB				Scholtmeijer, Karin; de Vocht, Marcel L.; Rink, Rick; Robillard, George T.; Wosten, Han A. B.			Assembly of the Fungal SC3 Hydrophobin into Functional Amyloid Fibrils Depends on Its Concentration and Is Promoted by Cell Wall Polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Class I hydrophobins function in fungal growth and development by self-assembling at hydrophobic-hydrophilic interfaces into amyloid-like fibrils. SC3 of the mushroom-forming fungus Schizophyllum commune is the best studied class I hydrophobin. This protein spontaneously adopts the amyloid state at the water-air interface. In contrast, SC3 is arrested in an intermediate conformation at the interface between water and a hydrophobic solid such as polytetrafluoroethylene (PTFE; Teflon). This finding prompted us to study conditions that promote assembly of SC3 into amyloid fibrils. Here, we show that SC3 adopts the amyloid state at the water-PTFE interface at high concentration (300 mu g ml(-1)) and prolonged incubation (16 h). Moreover, we show that amyloid formation at both the water-air and water-PTFE interfaces is promoted by the cell wall components schizophyllan (beta(1-3), beta(1-6)-glucan) and beta(1-3)-glucan. Hydrophobin concentration and cell wall polysaccharides thus contribute to the role of SC3 in formation of aerial hyphae and in hyphal attachment.	[Scholtmeijer, Karin; Robillard, George T.] Univ Utrecht, Groningen Biomol Sci & Biotechnol Inst, NL-3584 CH Utrecht, Netherlands; [Wosten, Han A. B.] Univ Utrecht, Dept Microbiol, NL-3584 CH Utrecht, Netherlands	University of Groningen; Utrecht University; Utrecht University	Scholtmeijer, K (corresponding author), Univ Utrecht, Groningen Biomol Sci & Biotechnol Inst, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	K.Scholtmeijer@uu.nl	Wösten, Han AB/K-2769-2016	Wösten, Han AB/0000-0002-0399-3648; Scholtmeijer, Karin/0000-0002-8510-1809				Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martin GG, 2000, BIOMACROMOLECULES, V1, P49, DOI 10.1021/bm005505w; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; Teertstra WR, 2009, J BIOL CHEM, V284, P9153, DOI 10.1074/jbc.M900095200	11	39	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26309	26314		10.1074/jbc.M109.005553	http://dx.doi.org/10.1074/jbc.M109.005553			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19654326	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000269969600010
J	Golovaty, I; Jones, L; Gelaye, B; Tilahun, M; Belete, H; Kumie, A; Berhane, Y; Williams, MA				Golovaty, Ilya; Jones, Larissa; Gelaye, Bizu; Tilahun, Melkie; Belete, Habtamu; Kumie, Abera; Berhane, Yemane; Williams, Michelle A.			Access to Water Source, Latrine Facilities and Other Risk Factors of Active Trachoma in Ankober, Ethiopia	PLOS ONE			English	Article								Objective: This study aims to determine the prevalence and correlates of active trachoma in Ankober, Ethiopia. Methods: A cross-sectional community-based study was conducted during July 2007. A total of 507 children (ages 1-9 years), from 232 households were included in the study. All children were examined for trachoma by ophthalmic nurses using the WHO simplified clinical grading system. Interviews and observations were used to assess risk factors. Logistic regression procedures were used to determine associations between potential risk factors and signs of active trachoma. Results: Overall, the prevalence of active trachoma was found to be 53.9% (95% CI 49.6%-58.2%). Presence of fly-eye (fly contact with the eyelid margin during eye examination) (Odds Ratio (OR) = 4.03 95% CI 1.40-11.59), absence of facial cleanliness (OR = 7.59; 95% CI 4.60-12.52), an illiterate mother (OR = 5.88; 95% CI 2.10-15.95), lack of access to piped water (OR = 2.19; 95% CI 1.14-6.08), and lack of access to latrine facilities ( OR = 4.36; 95% CI 1.49-12.74) were statistically significantly associated with increased risk of active trachoma. Conclusion: Active trachoma among children 1-9 years of age in Ankober is highly prevalent and significantly associated with a number of risk factors including access to water and latrine facilities. Trachoma prevention programs that include improved access to water and sanitation, active fly control, and hygiene education are recommended to lower the burden of trachoma in Ankober, Ethiopia.			Golovaty, I (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, Multidisciplinary Int Res Training Program, Seattle, WA 98195 USA.	mirt@u.washington.edu	Kumie, Abera/AAC-8537-2022; Berhane, Yemane/ABB-8154-2020	Gelaye, Bizu/0000-0001-7934-548X	NIMHD NIH HHS [T37 MD001449, T37-MD001449] Funding Source: Medline; National Institute on Minority Health and Health Disparities [T37MD001449] Funding Source: NIH RePORTER	NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Abdou A, 2007, BRIT J OPHTHALMOL, V91, P13, DOI 10.1136/bjo.2006.099507; Alemayehu W, 2005, T ROY SOC TROP MED H, V99, P840, DOI 10.1016/j.trstmh.2005.06.013; Baggaley RF, 2006, TROP MED INT HEALTH, V11, P220, DOI 10.1111/j.1365-3156.2005.01553.x; BAILEY R, 1989, INT J EPIDEMIOL, V18, P944, DOI 10.1093/ije/18.4.944; BAILEY R, 1991, T ROY SOC TROP MED H, V85, P824, DOI 10.1016/0035-9203(91)90470-J; Bejiga A, 2001, Ophthalmic Epidemiol, V8, P119, DOI 10.1076/opep.8.2.119.4168; COURTRIGHT P, 1991, BRIT J OPHTHALMOL, V75, P322, DOI 10.1136/bjo.75.6.322; Cumberland P, 2005, T ROY SOC TROP MED H, V99, P120, DOI 10.1016/j.trstmh.2004.03.011; Edwards T, 2008, TROP MED INT HEALTH, V13, P556, DOI 10.1111/j.1365-3156.2008.02034.x; Emerson PM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000197; Emerson PM, 2001, MED VET ENTOMOL, V15, P314, DOI 10.1046/j.0269-283x.2001.00318.x; Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; Haileselassie Tesfay, 2007, Ethiop Med J, V45, P181; HARDINGESCH EM, 2008, T R SOC TROP MED HYG; *INT DEV RES CTR, 2002, POP HLTH DEV COUNTR; Khandekar R, 2006, OPHTHAL EPIDEMIOL, V13, P43, DOI 10.1080/09286580500477507; Mesfin MM, 2006, OPHTHAL EPIDEMIOL, V13, P173, DOI 10.1080/09286580600611427; Ngondi J, 2008, T ROY SOC TROP MED H, V102, P432, DOI 10.1016/j.trstmh.2008.02.014; O'Loughlin R, 2006, TROP MED INT HEALTH, V11, P1406, DOI 10.1111/j.1365-3156.2006.01689.x; Polack S, 2006, T ROY SOC TROP MED H, V100, P1075, DOI 10.1016/j.trstmh.2005.12.002; Regassa K, 2004, OPHTHAL EPIDEMIOL, V11, P9, DOI 10.1076/opep.11.1.9.26440; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SAHLU T, 1992, J TROP MED HYG, V95, P36; Taye A, 2007, ANN TROP MED PARASIT, V101, P441, DOI 10.1179/136485907X176544; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; TIELSCH JM, 1988, AM J TROP MED HYG, V38, P393, DOI 10.4269/ajtmh.1988.38.393; WEST S, 1989, B WORLD HEALTH ORGAN, V67, P71; *WHO, 2008, TRACH GRAD CARDS SL; World Health Organization, 1997, 1 M WHO ALL GLOB EL; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Yemane Berhane, 2007, Ethiopian Journal of Health Development, V21, P204; Yemane Berhane, 2007, Ethiopian Journal of Health Development, V21, P211; Zack R, 2008, T ROY SOC TROP MED H, V102, P426, DOI 10.1016/j.trstmh.2008.02.001	34	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6702	10.1371/journal.pone.0006702	http://dx.doi.org/10.1371/journal.pone.0006702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693271	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267400010
J	Chandriani, S; Frengen, E; Cowling, VH; Pendergrass, SA; Perou, CM; Whitfield, ML; Cole, MD				Chandriani, Sanjay; Frengen, Eirik; Cowling, Victoria H.; Pendergrass, Sarah A.; Perou, Charles M.; Whitfield, Michael L.; Cole, Michael D.			A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response	PLOS ONE			English	Article								Background: The MYC oncogene contributes to induction and growth of many cancers but the full spectrum of the MYC transcriptional response remains unclear. Methodology/Principal Findings: Using microarrays, we conducted a detailed kinetic study of genes that respond to MYCN or MYCN Delta MBII induction in primary human fibroblasts. In parallel, we determined the response to steady state overexpression of MYCN and MYCN Delta MBII in the same cell type. An overlapping set of 398 genes from the two protocols was designated a 'Core MYC Signature' and used for further analysis. Comparison of the Core MYC Signature to a published study of the genes induced by serum stimulation revealed that only 7.4% of the Core MYC Signature genes are in the Core Serum Response and display similar expression changes to both MYC and serum. Furthermore, more than 50% of the Core MYC Signature genes were not influenced by serum stimulation. In contrast, comparison to a panel of breast cancers revealed a strong concordance in gene expression between the Core MYC Signature and the basal-like breast tumor subtype, which is a subtype with poor prognosis. This concordance was supported by the higher average level of MYC expression in the same tumor samples. Conclusions/Significance: The Core MYC Signature has clinical relevance as this profile can be used to deduce an underlying genetic program that is likely to contribute to a clinical phenotype. Therefore, the presence of the Core MYC Signature may predict clinical responsiveness to therapeutics that are designed to disrupt MYC-mediated phenotypes.			Chandriani, S (corresponding author), Univ Calif San Francisco, George Williams Hooper Res Fdn, San Francisco, CA 94143 USA.	michael.d.cole@dartmouth.edu	Perou, Charles M/H-9934-2014; Whitfield, Michael/AAC-5010-2020	Perou, Charles M/0000-0001-9827-2247; Pendergrass, Rion/0000-0002-0565-6522; Chandriani, Sanjay/0000-0002-8680-7424; Frengen, Eirik/0000-0002-8387-2247; Cowling, Victoria/0000-0001-7638-4870	MRC [G0700240] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA101227, R01CA080320, P30CA023108, P50CA058223] Funding Source: NIH RePORTER; Howard Hughes Medical Institute [76200-560801] Funding Source: Medline; Medical Research Council [G0700240] Funding Source: Medline; NCI NIH HHS [R01-CA-101227-01, R01 CA101227, R01 CA080320, R01-CA-80320, P30 CA023108, P50-CA58223, P50 CA058223] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Alles MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004710; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Cowling VH, 2007, ONCOGENE, V26, P3582, DOI 10.1038/sj.onc.1210132; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; Dang CV, 1999, MOL CELL BIOL, V19, P1; DANG CV, 2005, MYC TARGET GEN UNPUB; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Grushko TA, 2004, CLIN CANCER RES, V10, P499, DOI 10.1158/1078-0432.CCR-0976-03; Guo QM, 2000, CANCER RES, V60, P5922; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; KEATH EJ, 1984, CELL, V39, P339, DOI 10.1016/0092-8674(84)90012-6; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Malynn BA, 2000, GENE DEV, V14, P1390; Mao DYL, 2004, NUCLEIC ACIDS RES, V32, P3462, DOI 10.1093/nar/gkh669; Marinkovic D, 2004, NUCLEIC ACIDS RES, V32, P5368, DOI 10.1093/nar/gkh877; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5054, DOI 10.1128/MCB.22.14.5054-5063.2002; OCONNELL BC, 2003, J BIOL CHEM; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Soucek L, 2002, CANCER CELL, V1, P406, DOI 10.1016/S1535-6108(02)00077-6; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102	68	92	95	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6693	10.1371/journal.pone.0006693	http://dx.doi.org/10.1371/journal.pone.0006693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690609	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267300010
J	Flori, L; Fritz, S; Jaffrezic, F; Boussaha, M; Gut, I; Heath, S; Foulley, JL; Gautier, M				Flori, Laurence; Fritz, Sebastien; Jaffrezic, Florence; Boussaha, Mekki; Gut, Ivo; Heath, Simon; Foulley, Jean-Louis; Gautier, Mathieu			The Genome Response to Artificial Selection: A Case Study in Dairy Cattle	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; AFFECTING MILK-YIELD; MISSENSE MUTATION; GENE; DGAT1; IDENTIFICATION; POLYMORPHISM; NUCLEOTIDE; INFERENCE	Dairy cattle breeds have been subjected over the last fifty years to intense artificial selection towards improvement of milk production traits. In this study, we performed a whole genome scan for differentiation using 42,486 SNPs in the three major French dairy cattle breeds (Holstein, Normande and Montbeliarde) to identify the main physiological pathways and regions which were affected by this selection. After analyzing the population structure, we estimated FST within and across the three breeds for each SNP under a pure drift model. We further considered two different strategies to evaluate the effect of selection at the genome level. First, smoothing FST values over each chromosome with a local variable bandwidth kernel estimator allowed identifying 13 highly significant regions subjected to strong and/or recent positive selection. Some of them contained genes within which causal variants with strong effect on milk production traits (GHR) or coloration (MC1R) have already been reported. To go further in the interpretation of the observed signatures of selection we subsequently concentrated on the annotation of differentiated genes defined according to the FST value of SNPs localized close or within them. To that end we performed a comprehensive network analysis which suggested a central role of somatotropic and gonadotropic axes in the response to selection. Altogether, these observations shed light on the antagonism, at the genome level, between milk production and reproduction traits in highly producing dairy cows.	[Flori, Laurence; Jaffrezic, Florence; Boussaha, Mekki; Foulley, Jean-Louis; Gautier, Mathieu] INRA, UMR Genet Anim & Biol Integrat, Jouy En Josas, France; [Fritz, Sebastien] Union Natl Cooperat Agr Elevage & Inseminat Anim, Paris, France; [Gut, Ivo; Heath, Simon] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, Evry, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Flori, L (corresponding author), INRA, UMR Genet Anim & Biol Integrat, Jouy En Josas, France.	mathieu.gautier@jouy.inra.fr	gautier, mathieu/AAU-8789-2020; Flori, Laurence/H-3683-2013; gautier, mathieu/F-7429-2010; Gut, Ivo/ABF-3188-2020; Heath, Simon C/J-4138-2012	gautier, mathieu/0000-0001-7257-5880; gautier, mathieu/0000-0001-7257-5880; Gut, Ivo/0000-0001-7219-632X; Heath, Simon C/0000-0002-9550-0897; FRITZ, Sebastien/0000-0002-3378-1048; boussaha, mekki/0000-0002-5432-4604	French Ministry of Education and Research	French Ministry of Education and Research	The genotyping was supported in part by the French Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry DP, 2003, J DAIRY SCI, V86, P3704, DOI 10.3168/jds.S0022-0302(03)73976-9; Blott S, 2003, GENETICS, V163, P253; BOICHARD D, 1998, GENETIC EVALUATION F, P103; Brotherstone S, 2005, PHILOS T R SOC B, V360, P1479, DOI 10.1098/rstb.2005.1668; Calafell F, 2008, HUM GENET, V124, P123, DOI 10.1007/s00439-008-0530-8; Callegaro A, 2006, BIOINFORMATICS, V22, P2658, DOI 10.1093/bioinformatics/btl455; Chagas LM, 2007, J DAIRY SCI, V90, P4022, DOI 10.3168/jds.2006-852; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Darwin C., 1859, ORIGIN SPECIES MEANS; de Roos APW, 2008, GENETICS, V179, P1503, DOI 10.1534/genetics.107.084301; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Gautier M, 2007, J DAIRY SCI, V90, P2980, DOI 10.3168/jds.2006-707; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Hayes BJ, 2009, ANIM GENET, V40, P176, DOI 10.1111/j.1365-2052.2008.01815.x; Herrmann E, 1997, J COMPUT GRAPH STAT, V6, P35, DOI 10.2307/1390723; Iolascon Achille, 2003, Rev Clin Exp Hematol, V7, P22; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kong G, 2002, ONCOGENE, V21, P7214, DOI 10.1038/sj.onc.1205895; Li RW, 2008, FUNCT INTEGR GENOMIC, V8, P55, DOI 10.1007/s10142-007-0055-6; Liang LM, 2007, BIOINFORMATICS, V23, P1565, DOI 10.1093/bioinformatics/btm138; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; MATTALIA S, 2006, VARIABILITE GENETIQU, P239; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Maudet C, 2002, J DAIRY SCI, V85, P707, DOI 10.3168/jds.S0022-0302(02)74127-1; McCafferty DM, 2002, J IMMUNOL, V168, P4930, DOI 10.4049/jimmunol.168.10.4930; McCarthy MM, 2008, J NEUROENDOCRINOL, V20, P777, DOI 10.1111/j.1365-2826.2008.01723.x; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Olsen HG, 2008, J DAIRY SCI, V91, P4312, DOI 10.3168/jds.2008-1000; Olsen HG, 2005, GENETICS, V169, P275, DOI 10.1534/genetics.104.031559; Pritchard JK, 2000, GENETICS, V155, P945; Renaville R, 2002, DOMEST ANIM ENDOCRIN, V23, P351, DOI 10.1016/S0739-7240(02)00170-4; Roche JF, 2006, ANIM REPROD SCI, V96, P282, DOI 10.1016/j.anireprosci.2006.08.007; Royal MD, 2002, J DAIRY SCI, V85, P958, DOI 10.3168/jds.S0022-0302(02)74155-6; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Sebastiani P, 2008, AM J HEMATOL, V83, P189, DOI 10.1002/ajh.21048; Seo KS, 2007, VET DERMATOL, V18, P392, DOI 10.1111/j.1365-3164.2007.00634.x; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Weir BS, 1984, EVOLUTION, V19, P395; WELLER JI, 1990, J DAIRY SCI, V73, P2525, DOI 10.3168/jds.S0022-0302(90)78938-2; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Zarzynska J, 2005, J DAIRY RES, V72, P39, DOI 10.1017/S0022029904000639; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3	55	153	166	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6595	10.1371/journal.pone.0006595	http://dx.doi.org/10.1371/journal.pone.0006595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672461	Green Submitted, Green Published, gold			2022-12-25	WOS:000268935900010
J	Sun, XJ; Hoage, T; Bai, P; Ding, YH; Chen, ZY; Zhang, RL; Huang, W; Jahangir, A; Paw, B; Li, YG; Xu, XL				Sun, Xiaojing; Hoage, Tiffany; Bai, Ping; Ding, Yonghe; Chen, Zhenyue; Zhang, Ruilin; Huang, Wei; Jahangir, Ashad; Paw, Barry; Li, Yi-Gang; Xu, Xiaolei			Cardiac Hypertrophy Involves Both Myocyte Hypertrophy and Hyperplasia in Anemic Zebrafish	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARDIOVASCULAR-DISEASE; HEART; SYSTEM; ENERGY; DEATH; CELLS	Background: An adult zebrafish heart possesses a high capacity of regeneration. However, it has been unclear whether and how myocyte hyperplasia contributes to cardiac remodeling in response to biomechanical stress and whether myocyte hypertrophy exists in the zebrafish. To address these questions, we characterized the zebrafish mutant tr265/tr265, whose Band 3 mutation disrupts erythrocyte formation and results in anemia. Although Band 3 does not express and function in the heart, the chronic anemia imposes a sequential biomechanical stress towards the heart. Methodology/Principal Findings: Hearts of the tr265/tr265 Danio rerio mutant become larger than those of the sibling by week 4 post fertilization and gradually exhibit characteristics of human cardiomyopathy, such as muscular disarray, reactivated fetal gene expression, and severe arrhythmia. At the cellular level, we found both increased individual cardiomyocyte size and increased myocyte proliferation can be detected in week 4 to week 12 tr265/tr265 fish. Interestingly, all tr265/tr265 fish that survive after week-12 have many more cardiomyocytes of smaller size than those in the sibling, suggesting that myocyte hyperplasia allows the long-term survival of these fish. We also show the cardiac hypertrophy process can be recapitulated in wild-type fish using the anemia-inducing drug phenylhydrazine (PHZ). Conclusions/Significance: The anemia-induced cardiac hypertrophy models reported here are the first adult zebrafish cardiac hypertrophy models characterized. Unlike mammalian models, both cardiomyocyte hypertrophy and hyperplasia contribute to the cardiac remodeling process in these models, thus allowing the effects of cardiomyocyte hyperplasia on cardiac remodeling to be studied. However, since anemia can induce effects on the heart other than biomechanical, non-anemic zebrafish cardiac hypertrophy models shall be generated and characterized.	[Sun, Xiaojing; Hoage, Tiffany; Ding, Yonghe; Chen, Zhenyue; Zhang, Ruilin; Huang, Wei; Xu, Xiaolei] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Sun, Xiaojing; Hoage, Tiffany; Ding, Yonghe; Chen, Zhenyue; Zhang, Ruilin; Huang, Wei; Jahangir, Ashad; Xu, Xiaolei] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN USA; [Bai, Ping; Li, Yi-Gang] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai 200030, Peoples R China; [Chen, Zhenyue] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China; [Paw, Barry] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Mayo Clinic; Mayo Clinic; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sun, XJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	xu.xiaolei@mayo.edu	zhang, ruilin/J-5074-2013; Jahangir, Arshad/M-7916-2016	zhang, ruilin/0000-0002-0358-8415; Ding, Yonghe/0000-0002-4531-1721; Paw, Barry/0000-0002-0492-1419	Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107304, P01HL032262, R01HL081753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070838] Funding Source: NIH RePORTER	Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Barbosa ME, 2005, METH MOLEC MED, V112, P339; Chen JN, 1996, DEVELOPMENT, V123, P293; Chen ZY, 2008, CARDIOVASC RES, V79, P97, DOI 10.1093/cvr/cvn073; Chico TJA, 2008, TRENDS CARDIOVAS MED, V18, P150, DOI 10.1016/j.tcm.2008.04.002; Clark RJ, 1998, J EXP BIOL, V201, P1541; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; Kagemann L, 2008, MOL VIS, V14, P2157; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lopaschuk GD, 2008, INT J OBESITY, V32, pS29, DOI 10.1038/ijo.2008.120; MAJNO G, 1995, AM J PATHOL, V146, P3; McGrath MF, 2005, TRENDS ENDOCRIN MET, V16, P469, DOI 10.1016/j.tem.2005.10.007; MOLKENTIN JD, 2008, J MOL CELL CARDIOL; NORMAN TD, 1958, CIRC RES, V6, P765, DOI 10.1161/01.RES.6.6.765; Paw BH, 2003, NAT GENET, V34, P59, DOI 10.1038/ng1137; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; Simonot DL, 2007, J EXP BIOL, V210, P2574, DOI 10.1242/jeb.004028; Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Sun L, 2008, IEEE T BIO-MED ENG, V55, P2039, DOI 10.1109/TBME.2008.919110; Vornanen M, 2005, AM J PHYSIOL-REG I, V289, pR1177, DOI 10.1152/ajpregu.00157.2005; Warren KS, 2001, AM J PHYSIOL-HEART C, V281, pH1711, DOI 10.1152/ajpheart.2001.281.4.H1711; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wills AA, 2008, DEVELOPMENT, V135, P183, DOI 10.1242/dev.010363; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	39	57	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6596	10.1371/journal.pone.0006596	http://dx.doi.org/10.1371/journal.pone.0006596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672293	gold, Green Published, Green Submitted			2022-12-25	WOS:000268935900011
J	Focardi, S; Montanaro, P; Pecchioli, E				Focardi, Stefano; Montanaro, Paolo; Pecchioli, Elena			Adaptive Levy Walks in Foraging Fallow Deer	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; MOVEMENT PATTERNS; MARINE PREDATOR; BEHAVIOR; DISTRIBUTIONS; LAWS	Background: Levy flights are random walks, the step lengths of which come from probability distributions with heavy power-law tails, such that clusters of short steps are connected by rare long steps. levy walks maximise search efficiency of mobile foragers. Recently, several studies raised some concerns about the reliability of the statistical analysis used in previous analyses. Further, it is unclear whether levy walks represent adaptive strategies or emergent properties determined by the interaction between foragers and resource distribution. Thus two fundamental questions still need to be addressed: the presence of levy walks in the wild and whether or not they represent a form of adaptive behaviour. Methodology/Principal Findings: We studied 235 paths of solitary and clustered (i.e. foraging in group) fallow deer (Dama dama), exploiting the same pasture. We used maximum likelihood estimation for discriminating between a power-tailed distribution and the exponential alternative and rank/frequency plots to discriminate between levy walks and composite Brownian walks. We showed that solitary deer perform levy searches, while clustered animals did not adopt that strategy. Conclusion/Significance: Our demonstration of the presence of levy walks is, at our knowledge, the first available which adopts up-to-date statistical methodologies in a terrestrial mammal. Comparing solitary and clustered deer, we concluded that the levy walks of solitary deer represent an adaptation maximising encounter rates with forage resources and not an epiphenomenon induced by a peculiar food distribution.	[Focardi, Stefano; Montanaro, Paolo] INFS, ISPRA, Sede Amministrat, Ozzano Dell Emilia, Italy; [Pecchioli, Elena] IASMA Res & Innovat Ctr, Fdn Edmund Mach, Environm & Nat Resources Area, San Michele All Adige, Italy	Italian Institute for Environmental Protection & Research (ISPRA); Fondazione Edmund Mach	Focardi, S (corresponding author), INFS, ISPRA, Sede Amministrat, Ozzano Dell Emilia, Italy.	stefano.focardi@infs.it			INFS	INFS	The study was based on internal funding of the INFS as part of institutional research. No funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Dai XH, 2007, J MAMMAL, V88, P151, DOI 10.1644/06-MAMM-A-035R1.1; de Knegt HJ, 2007, BEHAV ECOL, V18, P1065, DOI 10.1093/beheco/arm080; DILUZIO P, 2005, THESIS U STUDI ROMA; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Focardi S, 1996, J ANIM ECOL, V65, P606, DOI 10.2307/5740; Focardi S, 2005, BEHAV ECOL SOCIOBIOL, V59, P84, DOI 10.1007/s00265-005-0012-0; Fortin D, 2005, OECOLOGIA, V145, P335, DOI 10.1007/s00442-005-0122-4; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Marell A, 2002, CAN J ZOOL, V80, P854, DOI 10.1139/Z02-061; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; REYNOLDS A, 2008, COMMENT ECOLOGY, V89, P2347; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Shlesinger M. F., 1985, GROWTH FORM, P279, DOI DOI 10.1103/PHYSREVLETT.108.230602; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Toivonen R, 2006, PHYSICA A, V371, P851, DOI 10.1016/j.physa.2006.03.050; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	26	36	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6587	10.1371/journal.pone.0006587	http://dx.doi.org/10.1371/journal.pone.0006587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668369	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935600013
J	De Iuliis, GN; Newey, RJ; King, BV; Aitken, RJ				De Iuliis, Geoffry N.; Newey, Rhiannon J.; King, Bruce V.; Aitken, R. John			Mobile Phone Radiation Induces Reactive Oxygen Species Production and DNA Damage in Human Spermatozoa In Vitro	PLOS ONE			English	Article								Background: In recent times there has been some controversy over the impact of electromagnetic radiation on human health. The significance of mobile phone radiation on male reproduction is a key element of this debate since several studies have suggested a relationship between mobile phone use and semen quality. The potential mechanisms involved have not been established, however, human spermatozoa are known to be particularly vulnerable to oxidative stress by virtue of the abundant availability of substrates for free radical attack and the lack of cytoplasmic space to accommodate antioxidant enzymes. Moreover, the induction of oxidative stress in these cells not only perturbs their capacity for fertilization but also contributes to sperm DNA damage. The latter has, in turn, been linked with poor fertility, an increased incidence of miscarriage and morbidity in the offspring, including childhood cancer. In light of these associations, we have analyzed the influence of RF-EMR on the cell biology of human spermatozoa in vitro. Principal Findings: Purified human spermatozoa were exposed to radio-frequency electromagnetic radiation (RF-EMR) tuned to 1.8 GHz and covering a range of specific absorption rates (SAR) from 0.4 W/kg to 27.5 W/kg. In step with increasing SAR, motility and vitality were significantly reduced after RF-EMR exposure, while the mitochondrial generation of reactive oxygen species and DNA fragmentation were significantly elevated (P < 0.001). Furthermore, we also observed highly significant relationships between SAR, the oxidative DNA damage bio-marker, 8-OH-dG, and DNA fragmentation after RF-EMR exposure. Conclusions: RF-EMR in both the power density and frequency range of mobile phones enhances mitochondrial reactive oxygen species generation by human spermatozoa, decreasing the motility and vitality of these cells while stimulating DNA base adduct formation and, ultimately DNA fragmentation. These findings have clear implications for the safety of extensive mobile phone use by males of reproductive age, potentially affecting both their fertility and the health and wellbeing of their offspring.			De Iuliis, GN (corresponding author), ARC Ctr Excellence Biotechnol & Dev, Callaghan, NSW, Australia.	jaitken@mail.newcastle.edu.au	Aitken, Robert John/AAY-8238-2020; De Iuliis, Geoffry N./G-7042-2013	Aitken, Robert John/0000-0002-9152-156X; De Iuliis, Geoffry N./0000-0002-6978-6123; King, Bruce/0000-0003-0877-5866				Agarwal A, 2006, CURR OPIN OBSTET GYN, V18, P325, DOI 10.1097/01.gco.0000193003.58158.4e; AGARWAL A, 2009, FERTIL STERIL; Agarwal A, 2008, FERTIL STERIL, V89, P124, DOI 10.1016/j.fertnstert.2007.01.166; Aitken J, 2007, REPROD BIOMED ONLINE, V14, P727, DOI 10.1016/S1472-6483(10)60676-1; Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Aitken RJ, 2005, INT J ANDROL, V28, P171, DOI 10.1111/j.1365-2605.2005.00531.x; Aitken RJ, 2003, MOL HUM REPROD, V9, P645, DOI 10.1093/molehr/gag086; AITKEN RJ, 1989, BIOL REPROD, V41, P183, DOI 10.1095/biolreprod41.1.183; Aitken RJ, 2008, EXPERT REV OBSTET GY, V3, P267, DOI DOI 10.1586/17474108.3.3.267; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Cui JK, 2000, FASEB J, V14, P955; De Iuliis GN, 2006, J CLIN ENDOCR METAB, V91, P1968, DOI 10.1210/jc.2005-2711; Deepinder F, 2007, REPROD BIOMED ONLINE, V15, P266, DOI 10.1016/S1472-6483(10)60338-0; Esterhuizen AD, 2000, J ASSIST REPROD GEN, V17, P508, DOI 10.1023/A:1009493824953; Evenson D, 2006, REPROD BIOMED ONLINE, V12, P466, DOI 10.1016/S1472-6483(10)62000-7; Fejes I, 2005, ARCH ANDROLOGY, V51, P385, DOI 10.1080/014850190924520; Friedman J, 2007, BIOCHEM J, V405, P559, DOI 10.1042/BJ20061653; Gajda GB, 2002, BIOELECTROMAGNETICS, V23, P592, DOI 10.1002/bem.10055; Hardell L, 2008, BIOMED PHARMACOTHER, V62, P104, DOI 10.1016/j.biopha.2007.12.004; Hoyto A, 2008, RADIAT RES, V170, P235, DOI 10.1667/RR1322.1; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Johnson RD, 2007, ANAL BIOANAL CHEM, V387, P107, DOI 10.1007/s00216-006-0689-6; JONES R, 1979, FERTIL STERIL, V31, P531; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Kundi M, 2004, J TOXICOL ENV HEAL B, V7, P351, DOI 10.1080/10937400490486258; Lewis SEM, 2005, CELL TISSUE RES, V322, P33, DOI 10.1007/s00441-005-1097-5; McLachlan RI, 2001, MED J AUSTRALIA, V174, P116, DOI 10.5694/j.1326-5377.2001.tb143180.x; Oger I, 2003, ZYGOTE, V11, P367, DOI 10.1017/S0967199403002442; Shen HM, 2000, FREE RADICAL BIO MED, V28, P529, DOI 10.1016/S0891-5849(99)00234-8; TURNER TT, 1995, J ANDROL, V16, P292	32	254	263	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6446	10.1371/journal.pone.0006446	http://dx.doi.org/10.1371/journal.pone.0006446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649291	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637600002
J	Nishida, Y; Ito, S; Ohtsuki, S; Yamamoto, N; Takahashi, T; Iwata, N; Jishage, K; Yamada, H; Sasaguri, H; Yokota, S; Piao, WY; Tomimitsu, H; Saido, TC; Yanagisawa, K; Terasaki, T; Mizusawa, H; Yokota, T				Nishida, Yoichiro; Ito, Shingo; Ohtsuki, Sumio; Yamamoto, Naoki; Takahashi, Tsubura; Iwata, Nobuhisa; Jishage, Kou-ichi; Yamada, Hiromi; Sasaguri, Hiroki; Yokota, Shigefumi; Piao, Wenying; Tomimitsu, Hiroyuki; Saido, Takaomi C.; Yanagisawa, Katsuhiko; Terasaki, Tetsuya; Mizusawa, Hidehiro; Yokota, Takanori			Depletion of Vitamin E Increases Amyloid beta Accumulation by Decreasing Its Clearances from Brain and Blood in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-1; OXIDATIVE STRESS; IN-VIVO; TRANSGENIC MICE; PHARMACOKINETIC ANALYSIS; SECRETASE ACTIVITY; ENDOTHELIAL-CELLS; PRECURSOR PROTEIN; PLAQUE-FORMATION; BARRIER	Increased oxidative damage is a prominent and early feature in Alzheimer disease. We previously crossed Alzheimer disease transgenic (APPsw) model mice with alpha-tocopherol transfer protein knock-out (Ttpa(-/-)) mice in which lipid peroxidation in the brain was significantly increased. The resulting double-mutant (Ttpa(-/-) APPsw) mice showed increased amyloid beta (A beta) deposits in the brain, which was ameliorated with alpha-tocopherol supplementation. To investigate the mechanism of the increased A beta accumulation, we here studied generation, degradation, aggregation, and efflux of A beta in the mice. The clearance of intracerebral-microinjected I-125-A beta(1-40) from brain was decreased in Ttpa(-/-) mice to be compared with wildtype mice, whereas the generation of A beta was not increased in Ttpa(-/-) APPsw mice. The activity of an A beta-degrading enzyme, neprilysin, did not decrease, but the expression level of insulin-degrading enzyme was markedly decreased in Ttpa(-/-) mouse brain. In contrast, A beta aggregation was accelerated in Ttpa(-/-) mouse brains compared with wild-type brains, and well known molecules involved in A beta transport from brain to blood, low density lipoprotein receptor-related protein-1 (LRP-1) and p-glycoprotein, were up-regulated in the small vascular fraction of Ttpa(-/-) mouse brains. Moreover, the disappearance of intravenously administered I-125-A beta(1-40) was decreased in Ttpa(-/-) mice with reduced translocation of LRP-1 in the hepatocytes. These results suggest that lipid peroxidation due to depletion of alpha-tocopherol impairs A beta clearances from the brain and from the blood, possibly causing increased A beta accumulation in Ttpa(-/-) APPsw mouse brain and plasma.	[Nishida, Yoichiro; Takahashi, Tsubura; Yamada, Hiromi; Sasaguri, Hiroki; Yokota, Shigefumi; Piao, Wenying; Tomimitsu, Hiroyuki; Mizusawa, Hidehiro; Yokota, Takanori] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Ito, Shingo; Ohtsuki, Sumio; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Mol Biopharm & Genet, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Yamamoto, Naoki; Yanagisawa, Katsuhiko] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Aichi 4748522, Japan; [Iwata, Nobuhisa; Saido, Takaomi C.] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Jishage, Kou-ichi] Chugai Res Inst Med Sci Inc, Shizuoka 4128513, Japan	Tokyo Medical & Dental University (TMDU); Tohoku University; National Center for Geriatrics & Gerontology; RIKEN; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.	Yokota, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	tak-yokota.nuro@tmd.ac.jp	Sado, Takaomi/AAN-2759-2021; Terasaki, Tetsuya/K-6730-2012; Saido, Takaomi C/N-5472-2015; Ohtsuki, Sumio/S-4360-2016	Sado, Takaomi/0000-0003-1970-6903; Terasaki, Tetsuya/0000-0002-6332-7575; Saido, Takaomi C/0000-0003-1970-6903; Ohtsuki, Sumio/0000-0003-4634-7133; Yokota, Takanori/0000-0002-6490-3263	Ministry of Health, Labor, and Welfare of Japan; 21st Century COE Program on Brain Integration and Its Disorders; Ministry of Education, Science, and Culture; Japan Science and Technology Agency	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); 21st Century COE Program on Brain Integration and Its Disorders(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by a grant for Research on Psychiatric and Neurological Disease and Mental Health from the Ministry of Health, Labor, and Welfare of Japan ( to T. Y. and H. M.), a grant from the 21st Century COE Program on Brain Integration and Its Disorders to Tokyo Medical and Dental University ( to Y. N., H. S., and H. M.), a grant from the Ministry of Education, Science, and Culture ( to N. I., H. T., T. Y., and H. T.), and a grant of the SORST of Japan Science and Technology Agency ( to S. O. and T. Terasaki).	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Apelt J, 2004, INT J DEV NEUROSCI, V22, P475, DOI 10.1016/j.ijdevneu.2004.07.006; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; DOWSON JH, 1992, NEUROBIOL AGING, V13, P493, DOI 10.1016/0197-4580(92)90077-B; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200; Ghiso J, 1997, FEBS LETT, V408, P105, DOI 10.1016/S0014-5793(97)00400-6; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hino T, 2006, BIOCHEM BIOPH RES CO, V340, P263, DOI 10.1016/j.bbrc.2005.11.173; Hone E, 2003, J ALZHEIMERS DIS, V5, P1, DOI 10.3233/JAD-2003-5101; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Igbavboa U, 1996, J NEUROCHEM, V66, P1717; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Kakee A, 1996, J PHARMACOL EXP THER, V277, P1550; KANDA T, 1994, J CELL BIOL, V126, P235, DOI 10.1083/jcb.126.1.235; Kandimalla KK, 2005, J PHARMACOL EXP THER, V313, P1370, DOI 10.1124/jpet.104.081901; KATZMAN R, 1991, FASEB J, V5, P278, DOI 10.1096/fasebj.5.3.2001787; Kuo YM, 1999, BIOCHEM BIOPH RES CO, V257, P787, DOI 10.1006/bbrc.1999.0552; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Matsubara E, 2004, NEUROBIOL AGING, V25, P833, DOI 10.1016/j.neurobiolaging.2003.10.004; Matsubara E, 1999, ANN NEUROL, V45, P537, DOI 10.1002/1531-8249(199904)45:4<537::AID-ANA20>3.0.CO;2-2; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Moreira PI, 2005, ANN NY ACAD SCI, V1043, P545, DOI 10.1196/annals.1333.062; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Nishida Y, 2006, BIOCHEM BIOPH RES CO, V350, P530, DOI 10.1016/j.bbrc.2006.09.083; Ogawa T, 2005, J NEUROCHEM, V95, P1156, DOI 10.1111/j.1471-4159.2005.03436.x; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shiiki T, 2004, J NEUROSCI, V24, P9632, DOI 10.1523/JNEUROSCI.2236-04.2004; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tabata K., 1999, XENOBIO METABOL DISP, V14, P286, DOI DOI 10.2133/DMPK.14.286; Tamaki C, 2007, MOL PHARMACOL, V72, P850, DOI 10.1124/mol.107.036913; Tamaki C, 2006, PHARM RES-DORDR, V23, P1407, DOI 10.1007/s11095-006-0208-7; Traber MG, 2004, ANN NY ACAD SCI, V1031, P1, DOI 10.1196/annals.1331.001; Van Uden E, 2002, J NEUROSCI, V22, P9298; Vogelgesang S, 2002, PHARMACOGENETICS, V12, P535, DOI 10.1097/00008571-200210000-00005; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	45	75	79	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33400	33408		10.1074/jbc.M109.054056	http://dx.doi.org/10.1074/jbc.M109.054056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19679659	Green Published, hybrid			2022-12-25	WOS:000272028500046
J	Mishima, Y; Quintin, J; Aimanianda, V; Kellenberger, C; Coste, F; Clavaud, C; Hetru, C; Hoffmann, JA; Latge, JP; Ferrandon, D; Roussel, A				Mishima, Yumiko; Quintin, Jessica; Aimanianda, Vishukumar; Kellenberger, Christine; Coste, Franck; Clavaud, Cecile; Hetru, Charles; Hoffmann, Jules A.; Latge, Jean-Paul; Ferrandon, Dominique; Roussel, Alain			The N-terminal Domain of Drosophila Gram-negative Binding Protein 3 (GNBP3) Defines a Novel Family of Fungal Pattern Recognition Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPHENOLOXIDASE ACTIVATING SYSTEM; LYSINE-TYPE PEPTIDOGLYCAN; BETA-GLUCAN RECEPTOR; INNATE IMMUNITY; CRYSTAL-STRUCTURE; BOMBYX-MORI; POSITIVE BACTERIA; PGRP-SD; BETA-1,3-GLUCAN; TOLL	Gram-negative binding protein 3 (GNBP3), a pattern recognition receptor that circulates in the hemolymph of Drosophila, is responsible for sensing fungal infection and triggering Toll pathway activation. Here, we report that GNBP3 N-terminal domain binds to fungi upon identifying long chains of beta-1,3-glucans in the fungal cell wall as a major ligand. Interestingly, this domain fails to interact strongly with short oligosaccharides. The crystal structure of GNBP3-Nter reveals an immunoglobulin-like fold in which the glucan binding site is masked by a loop that is highly conserved among glucan-binding proteins identified in several insect orders. Structure-based mutagenesis experiments reveal an essential role for this occluding loop in discriminating between short and long polysaccharides. The displacement of the occluding loop is necessary for binding and could explain the specificity of the interaction with long chain structured polysaccharides. This represents a novel mechanism for beta-glucan recognition.	[Mishima, Yumiko; Kellenberger, Christine; Coste, Franck; Roussel, Alain] CNRS, CBM, UPR 4301, F-45071 Orleans 2, France; [Quintin, Jessica; Hetru, Charles; Hoffmann, Jules A.; Ferrandon, Dominique] CNRS, UPR9022, Inst Biol Mole culaire & Cellulaire, F-67084 Strasbourg, France; [Aimanianda, Vishukumar; Clavaud, Cecile; Latge, Jean-Paul] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Roussel, A (corresponding author), CNRS, CBM, UPR 4301, Rue Charles 631-517, F-45071 Orleans 2, France.	roussel@cnrs-orleans.fr	kellenberger, christine/AAV-9304-2020; Aimanianda, Vishukumar/E-9204-2011; Latge, Jean Paul/C-9846-2014; coste, franck/ABC-1407-2020; coste, franck/F-6832-2015	Aimanianda, Vishukumar/0000-0001-5813-7497; coste, franck/0000-0002-7409-0470; coste, franck/0000-0002-7409-0470; FERRANDON, Dominique/0000-0001-7680-7773	National Institutes of Health [PO1 AI44220]; Action Thematique et Incitative sur Programme of the CNRS; Agence Nationale de la Recherche; Ministere de l'Enseignement et de la Recherche; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Action Thematique et Incitative sur Programme of the CNRS; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement et de la Recherche; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AI44220. This work was also supported by an Action Thematique et Incitative sur Programme of the CNRS (2005-2008, to A. R.), by a grant from the Agence Nationale de la Recherche (ANR-MIME, to A. R. and C. H.), by the CNRS, and by a grant from the Ministere de l'Enseignement et de la Recherche ( Programme de Recherche en Microbiologie).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2004, PLOS BIOL, V2, P1293, DOI 10.1371/journal.pbio.0020277; de Pereda JM, 1999, EMBO J, V18, P4087, DOI 10.1093/emboj/18.15.4087; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrick JA, 2004, J BIOL CHEM, V279, P26605, DOI 10.1074/jbc.M403382200; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lee SH, 2006, PROTEIN SCI, V15, P304, DOI 10.1110/ps.051813506; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mishima Y, 2009, ACTA CRYSTALLOGR F, V65, P870, DOI 10.1107/S1744309109014997; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUTA T, 1995, J BIOL CHEM, V270, P892, DOI 10.1074/jbc.270.2.892; OCHIAI M, 1988, J BIOL CHEM, V263, P12056; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Okobira T, 2008, BIOMACROMOLECULES, V9, P783, DOI 10.1021/bm700511d; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Ramirez MG, 2004, J MICROBIOL METH, V56, P213, DOI 10.1016/j.mimet.2003.10.011; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Takaki Y, 2002, J BIOL CHEM, V277, P14281, DOI 10.1074/jbc.M200177200; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; van Bueren AL, 2007, J MOL BIOL, V365, P555, DOI 10.1016/j.jmb.2006.10.018; YOSHIDA H, 1986, BIOCHEM BIOPH RES CO, V141, P1177, DOI 10.1016/S0006-291X(86)80168-1	51	50	55	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28687	28697		10.1074/jbc.M109.034587	http://dx.doi.org/10.1074/jbc.M109.034587			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692333	Green Published, hybrid			2022-12-25	WOS:000270678900024
J	Peiro-Chova, L; Estruch, F				Peiro-Chova, Lorena; Estruch, Francisco			The Yeast RNA Polymerase II-associated Factor Iwr1p Is Involved in the Basal and Regulated Transcription of Specific Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PHO5 PROMOTER; ACID-PHOSPHATASE; FINGER PROTEINS; COMPLEX; NC2; REPRESSION; EXPRESSION	RNA polymerase II (RNA pol II) is a multisubunit enzyme that requires many auxiliary factors for its activity. Over the years, these factors have been identified using both biochemical and genetic approaches. Recently, the systematic characterization of protein complexes by tandem affinity purification and mass spectroscopy has allowed the identification of new components of well established complexes, including the RNA pol II holoenzyme. Using this approach, a novel and highly conserved factor, Iwr1p, that physically interacts with most of the RNA pol II subunits has been described in yeast. Here we show that Iwr1p genetically interacts with components of the basal transcription machinery and plays a role in both basal and regulated transcription. We report that mutation of the IWR1 gene is able to bypass the otherwise essential requirement for the transcriptional regulator negative cofactor 2, which occurs with different components of the basal transcription machinery, including TFIIA and subunits of the mediator complex. Deletion of the IWR1 gene leads to an altered expression of specific genes, including phosphate-responsive genes and SUC2. Our results show that Iwr1p is a nucleocytoplasmic shuttling protein and suggest that Iwr1p acts early in the formation of the pre-initiation complex by mediating the interaction of certain activators with the basal transcription apparatus.	[Peiro-Chova, Lorena; Estruch, Francisco] Univ Valencia, Dept Biochem & Mol Biol, E-46100 Burjassot, Spain	University of Valencia	Estruch, F (corresponding author), Fac Biol, C Dr Moliner 50, Valencia 46100, Spain.	estruch@uv.es	Estruch, Francisco/R-4569-2018		Spanish Ministry of Education and Science [BFU2007-61525, BFU2008-04082-C02-01]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by Spanish Ministry of Education and Science Grants BFU2007-61525 and BFU2008-04082-C02-01 (to F. E.).	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Balciunas D, 1999, P NATL ACAD SCI USA, V96, P376, DOI 10.1073/pnas.96.2.376; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; CRABEEL M, 1995, YEAST, V11, P1367, DOI 10.1002/yea.320111405; CRABEEL M, 1990, MOL CELL BIOL, V10, P1226, DOI 10.1128/MCB.10.3.1226; Dhasarathy A, 2005, MOL CELL BIOL, V25, P2698, DOI 10.1128/MCB.25.7.2698-2707.2005; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; Gligoris T, 2007, MOL CELL BIOL, V27, P4198, DOI 10.1128/MCB.00238-07; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; Goppelt A, 1996, NUCLEIC ACIDS RES, V24, P4450, DOI 10.1093/nar/24.22.4450; Gregory PD, 1999, METHOD ENZYMOL, V304, P365; HAGUENAUERTSAPIS R, 1984, MOL CELL BIOL, V4, P2668, DOI 10.1128/MCB.4.12.2668; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kim S, 2000, MOL CELL BIOL, V20, P2455, DOI 10.1128/MCB.20.7.2455-2465.2000; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lemaire M, 2000, MOL MICROBIOL, V36, P163, DOI 10.1046/j.1365-2958.2000.01839.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magbanua JPV, 1997, J BIOCHEM, V121, P1182; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Peiro-Chova L, 2007, GENETICS, V176, P125, DOI 10.1534/genetics.106.066829; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reinke H, 2004, BBA-GENE STRUCT EXPR, V1677, P24, DOI 10.1016/j.bbaexp.2003.09.014; Riego L, 2002, BIOCHEM BIOPH RES CO, V293, P79, DOI 10.1016/S0006-291X(02)00174-2; SCHMID A, 1992, CELL, V71, P853, DOI 10.1016/0092-8674(92)90560-Y; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; UEDA Y, 1975, J BACTERIOL, V122, P911, DOI 10.1128/JB.122.3.911-922.1975; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Xie J, 2000, EMBO J, V19, P672, DOI 10.1093/emboj/19.4.672; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.biochem.60.1.689	61	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28958	28967		10.1074/jbc.M109.012153	http://dx.doi.org/10.1074/jbc.M109.012153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679657	Green Published, hybrid			2022-12-25	WOS:000270678900053
J	Du, ZY; Fan, MY; Kim, JG; Eckerle, D; Lothstein, L; Wei, L; Pfeffer, LM				Du, Ziyun; Fan, Meiyun; Kim, Jong-Gwan; Eckerle, Dara; Lothstein, Leonard; Wei, Lai; Pfeffer, Lawrence M.			Interferon-resistant Daudi Cell Line with a Stat2 Defect Is Resistant to Apoptosis Induced by Chemotherapeutic Agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-INTERFERON; ANTIPROLIFERATIVE ACTION; PHOSPHATIDYLINOSITOL 3-KINASE; BINDING; TRANSCRIPTION; DNA; RESPONSIVENESS; IDENTIFICATION; TRAFFICKING	Interferon-alpha (IFN alpha) has shown promise in the treatment of various cancers. However, the development of IFN resistance is a significant drawback. Using conditions that mimic in vivo selection of IFN-resistant cells, the RST2 IFN-resistant cell line was isolated from the highly IFN-sensitive Daudi human Burkitt lymphoma cell line. The RST2 cell line was resistant to the antiviral, antiproliferative, and gene-induction actions of IFNa. Although STAT2 mRNA was present, STAT2 protein expression was deficient in RST2 cells. A variant STAT2 mRNA, which resulted from alternative splicing within the intron between exon 19 and 20, was expressed in several human cell lines but at relatively high levels in RST2 cells. Most importantly, the RST2 line showed an intrinsic resistance to apoptosis induced by a number of chemotherapeutic agents (camptothecin, staurosporine, and doxorubicin). Expression of STAT2 in RST2 cells not only rescued their sensitivity to the biological activities of IFNs but also restored sensitivity to apoptosis induced by these chemotherapeutic agents. The intrinsic resistance of the RST2 cells to IFN as well as chemotherapeutic agents adds a new dimension to our knowledge of the role of STAT2 as it relates to not only biological actions of IFN but also resistance to chemotherapy-induced apoptosis.	Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN 38163 USA; Ctr Canc Res, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Pfeffer, LM (corresponding author), 19 S Manassas Ave,Rm 154, Memphis, TN 38163 USA.	lpfeffer@utmem.edu	Wei, Lai/D-1088-2014	Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA73753]; Muirhead Chair Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA073753, R01CA133322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muirhead Chair Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA73753 (to L. M. P.). This work was also supported by funds from the Muirhead Chair Endowment at the University of Tennessee Health Science Center (to L. M. P.).	Banninger G, 2004, J BIOL CHEM, V279, P39199, DOI 10.1074/jbc.M400815200; Binaschi M., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P113, DOI 10.2174/1568011013354723; Brierley MM, 2005, J BIOL CHEM, V280, P13029, DOI 10.1074/jbc.M500426200; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; EISENKRAFT BL, 1991, CANCER RES, V51, P5881; Johnson LR, 1999, AM J PHYSIOL-CELL PH, V276, pC419, DOI 10.1152/ajpcell.1999.276.2.C419; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Kingma PS, 1999, BIOCHEMISTRY-US, V38, P3457, DOI 10.1021/bi982855i; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Mack JT, 2007, CURR DRUG METAB, V8, P47, DOI 10.2174/138920007779315044; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; PFEFFER LM, 1990, CANCER RES, V50, P2654; Pfeffer LM, 1996, J UROLOGY, V156, P1867, DOI 10.1016/S0022-5347(01)65555-1; Pfeffer LM, 1998, CANCER RES, V58, P2489; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Stark G R, 1997, Harvey Lect, V93, P1; Sugiyama T, 1996, FEBS LETT, V381, P191, DOI 10.1016/0014-5793(96)00121-4; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; XU B, 1994, BLOOD, V84, P1942; YAN RQ, 1995, NUCLEIC ACIDS RES, V23, P459, DOI 10.1093/nar/23.3.459; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang J, 2005, CANCER RES, V65, P939; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806	40	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27808	27815		10.1074/jbc.M109.028324	http://dx.doi.org/10.1074/jbc.M109.028324			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19687011	Green Published, hybrid			2022-12-25	WOS:000270676300007
J	Li, LO; Ellis, JM; Paich, HA; Wang, SL; Gong, N; Altshuller, G; Thresher, RJ; Koves, TR; Watkins, SM; Muoio, DM; Cline, GW; Shulman, GI; Coleman, RA				Li, Lei O.; Ellis, Jessica M.; Paich, Heather A.; Wang, Shuli; Gong, Nan; Altshuller, George; Thresher, Randy J.; Koves, Timothy R.; Watkins, Steven M.; Muoio, Deborah M.; Cline, Gary W.; Shulman, Gerald I.; Coleman, Rosalind A.			Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and beta-Oxidation and Alters Phospholipid Fatty Acid Composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC INSULIN-RESISTANCE; RAT-LIVER; MESSENGER-RNA; PHOSPHATIDYLCHOLINE SYNTHESIS; MICROSOMAL-ENZYMES; SELECTIVE CHANGES; KNOCKOUT MICE; EXPRESSION; METABOLISM; PROTEIN	In mammals, a family of five acyl-CoA synthetases (ACSLs), each the product of a separate gene, activates long chain fatty acids to form acyl-CoAs. Because the ACSL isoforms have overlapping preferences for fatty acid chain length and saturation and are expressed in many of the same tissues, the individual function of each isoform has remained uncertain. Thus, we constructed a mouse model with a liver-specific knock-out of ACSL1, a major ACSL isoform in liver. Eliminating ACSL1 in liver resulted in a 50% decrease in total hepatic ACSL activity and a 25-35% decrease in long chain acyl-CoA content. Although the content of triacylglycerol was unchanged in Acsl1(L-/-) liver after mice were fed either low or high fat diets, in isolated primary hepatocytes the absence of ACSL1 diminished the incorporation of [C-14]oleate into triacylglycerol. Further, small but consistent increases were observed in the percentage of 16:0 in phosphatidylcholine and phosphatidylethanolamine and of 18:1 in phosphatidylethanolamine and lysophosphatidylcholine, whereas concomitant decreases were seen in 18:0 in phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and lysophosphatidylcholine. In addition, decreases in long chain acylcarnitine content and diminished production of acid-soluble metabolites from [C-14]oleate suggested that hepatic ACSL1 is important for mitochondrial beta-oxidation of long chain fatty acids. Because the Acsl1(L-/-) mice were not protected from developing either high fat diet-induced hepatic steatosis or insulin resistance, our study suggests that lowering the content of hepatic acyl-CoA without a concomitant decrease in triacylglycerol and other lipid intermediates is insufficient to protect against hepatic insulin resistance.	[Li, Lei O.; Ellis, Jessica M.; Paich, Heather A.; Wang, Shuli; Gong, Nan; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Altshuller, George; Thresher, Randy J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Koves, Timothy R.; Muoio, Deborah M.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Watkins, Steven M.] Lip Technol Inc, W Sacramento, CA 95691 USA; [Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Howard Hughes Med Inst, Dept Internal Med & Cellular & Mol Physiol, New Haven, CT 06510 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Howard Hughes Medical Institute; Yale University	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, CB 7461, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Koves, Tim/I-4806-2012; Shulman, Gerald I./P-7176-2019; Muoio, Debbie Marie/E-1147-2012; Li, Lei/B-5164-2010	Koves, Tim/0000-0001-8763-5866; Shulman, Gerald I./0000-0003-1529-5668; Muoio, Deborah/0000-0003-3760-9277	National Institutes of Health [DK59935, DK40936, U24 DK59635, P30 DK34987]; American Diabetes Association; American Heart Association Mid-Atlantic Region; Precloctoral Training Grant [HL069768, P30 DK034987, P30 DK056350]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, U24DK059635, P30DK034987, P30DK056350, R01DK059935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association Mid-Atlantic Region(American Heart Association); Precloctoral Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59935 (to R. A. Q, DK40936 (to G. 1. S.), U24 DK59635 (to G. 1. S.), P30 DK34987 (to G. 1. S.), a grant from the American Diabetes Association (to D. M. M.), a postdoctoral fellowship from the American Heart Association Mid-Atlantic Region (to L. O. L.), Precloctoral Training Grant HL069768 in Integrative Vascular Biology (to J. M. E.) and P30 DK034987 and P30 DK056350.	Agarwal AK, 2006, ARCH BIOCHEM BIOPHYS, V449, P64, DOI 10.1016/j.abb.2006.03.014; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; COLEMAN RA, 1978, J BIOL CHEM, V253, P7256; COLEMAN RA, 1983, J BIOL CHEM, V258, P450; Distler AM, 2006, ANAL BIOCHEM, V356, P18, DOI 10.1016/j.ab.2006.03.053; Faergeman NJ, 1997, BIOCHEM J, V323, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frederiksen KS, 2004, J LIPID RES, V45, P592, DOI 10.1194/jlr.M300239-JLR200; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; Iijima H, 1996, EUR J BIOCHEM, V242, P186, DOI 10.1111/j.1432-1033.1996.0186r.x; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kos CH, 2004, NUTR REV, V62, P243, DOI 10.1301/nr2004.jun243-246; Kuriyama H, 1998, HEPATOLOGY, V27, P557, DOI 10.1002/hep.510270233; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashek DG, 2004, J LIPID RES, V45, P1958, DOI 10.1194/jlr.E400002-JLR200; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Parkes HA, 2006, AM J PHYSIOL-ENDOC M, V291, pE737, DOI 10.1152/ajpendo.00112.2006; Petrescu AD, 2002, J BIOL CHEM, V277, P23988, DOI 10.1074/jbc.M201241200; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; SCHOONJANS K, 1993, EUR J BIOCHEM, V216, P615, DOI 10.1111/j.1432-1033.1993.tb18181.x; SHIMOMURA I, 1992, BIOCHIM BIOPHYS ACTA, V1124, P112, DOI 10.1016/0005-2760(92)90086-B; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Thompson AL, 2000, DIABETES, V49, P1761, DOI 10.2337/diabetes.49.11.1761; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200	47	155	164	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27816	27826		10.1074/jbc.M109.022467	http://dx.doi.org/10.1074/jbc.M109.022467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19648649	Green Published, hybrid			2022-12-25	WOS:000270676300008
J	Maryon, EB; Zhang, J; Jellison, JW; Kaplan, JH				Maryon, Edward B.; Zhang, Jing; Jellison, John W.; Kaplan, Jack H.			Human Copper Transporter 1 Lacking O-Linked Glycosylation Is Proteolytically Cleaved in a Rab9-positive Endosomal Compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; TRANSFERRIN RECEPTOR; PROTEASE INHIBITOR; SECRETORY PATHWAY; CELLS; HCTR1; MECHANISM; CTR1; ACTIVATION; FURIN	The human copper transporter hCTR1 is a homotrimer composed of a plasma membrane protein of 190 amino acids that contains three transmembrane segments. The extracellular 65-amino acid amino terminus of hCTR1 contains both N-linked (at Asn(15)) and O-linked (at Thr(27)) sites of glycosylation. If O-glycosylation at Thr(27) is prevented, hCTR1 is efficiently cleaved, removing similar to 30 amino acids from the amino terminus. We have now investigated (i) the site of this cleavage, determining which peptide bonds are cleaved, (ii) the mechanism by which glycosylation prevents cleavage, and (iii) where in the cell the proteolytic cleavage takes place. Cleavage occurs in the sequence Ala-Ser-His-Ser-His (residues 29-33), which does not contain previously recognized protease cleavage sites. Using a series of hCTR1 mutants, we show that cleavage occurs preferentially between residues Ala(29)-Ser(30)-His(31). We also show that the O-linked polysaccharide at Thr(27) blocks proteolysis due to its proximity to the cleavage site. Moving the cleavage site away from the Thr(27) polysaccharide by insertion of as few as 5 amino acids allows cleavage to occur in the presence of glycosylation. Imaging studies using immunofluorescence in fixed cells and a functional green fluorescent protein-tagged hCTR1 transporter in live cells showed that the cleaved peptide accumulates in punctate structures in the cytoplasm. These puncta overlap compartments were stained by Rab9, indicating that hCTR1 cleavage occurs in a late endosomal compartment prior to delivery of the transporter to the plasma membrane.	[Maryon, Edward B.; Zhang, Jing; Jellison, John W.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, JH (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	kaplanj@uic.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [P01 GM 067166]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM 067166 (to J. H. K.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Cabrera A, 2008, BIOMETALS, V21, P525, DOI 10.1007/s10534-008-9139-6; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haremaki T, 2007, P NATL ACAD SCI USA, V104, P12029, DOI 10.1073/pnas.0701413104; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Iijima R, 1999, J BIOCHEM-TOKYO, V126, P912, DOI 10.1093/oxfordjournals.jbchem.a022534; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauer-Fields JL, 2007, J BIOL CHEM, V282, P142, DOI 10.1074/jbc.M605236200; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lin KI, 1998, CELL DEATH DIFFER, V5, P577, DOI 10.1038/sj.cdd.4400384; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Matsuo M, 2006, CANCER SCI, V97, P155, DOI 10.1111/j.1349-7006.2006.00152.x; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Momiyama J, 2006, TOHOKU J EXP MED, V209, P89, DOI 10.1620/tjem.209.89; Petris MJ, 2004, PFLUG ARCH EUR J PHY, V447, P752, DOI 10.1007/s00424-003-1092-1; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; RUTLEDGE EA, 1994, BLOOD, V83, P580; RUTLEDGE EA, 1994, J BIOL CHEM, V269, P31864; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; TAUB ME, 1993, J CELL SCI, V106, P1313; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Yamada T, 1996, J IMMUNOL, V157, P901; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481	48	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28104	28114		10.1074/jbc.M109.044925	http://dx.doi.org/10.1074/jbc.M109.044925			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684018	hybrid, Green Published			2022-12-25	WOS:000270676300037
J	Simona, F; Magistrato, A; Dal Peraro, M; Cavalli, A; Vila, AJ; Carloni, P				Simona, Fabio; Magistrato, Alessandra; Dal Peraro, Matteo; Cavalli, Andrea; Vila, Alejandro J.; Carloni, Paolo			Common Mechanistic Features among Metallo-beta-lactamases A COMPUTATIONAL STUDY OF AEROMONAS HYDROPHILA CphA ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; STANDARD NUMBERING SCHEME; DENSITY-FUNCTIONAL THEORY; BACILLUS-CEREUS; SUBSTRATE-BINDING; ANTIBIOTIC-RESISTANCE; BACTEROIDES-FRAGILIS; CATALYTIC MECHANISM; INHIBITOR-RESISTANT; BIOLOGICAL-SYSTEMS	Metallo-beta-lactamases (M beta Ls) constitute an increasingly serious clinical threat by giving rise to beta-lactam antibiotic resistance. They accommodate in their catalytic pocket one or two zinc ions, which are responsible for the hydrolysis of beta-lactams. Recent x-ray studies on a member of the mono-zinc B2 M beta Ls, CphA from Aeromonas hydrophila, have paved the way to mechanistic studies of this important subclass, which is selective for carbapenems. Here we have used hybrid quantum mechanical/molecular mechanical methods to investigate the enzymatic hydrolysis by CphA of the antibiotic biapenem. Our calculations describe the entire reaction and point to a new mechanistic description, which is in agreement with the available experimental evidence. Within our proposal, the zinc ion properly orients the antibiotic while directly activating a second catalytic water molecule for the completion of the hydrolytic cycle. This mechanism provides an explanation for a variety of mutagenesis experiments and points to common functional facets across B2 and B1 M beta Ls.	[Simona, Fabio] Univ Bern, Dept Chem & Biochem, Lab Computat Chem & Biochem, CH-3012 Bern, Switzerland; [Magistrato, Alessandra; Carloni, Paolo] SISSA, I-34014 Trieste, Italy; [Magistrato, Alessandra] CNR INFM Democritos Natl Simulat Ctr, I-34014 Trieste, Italy; [Dal Peraro, Matteo] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Biomol Modeling, CH-1015 Lausanne, Switzerland; [Cavalli, Andrea] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Cavalli, Andrea] Italian Inst Technol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy; [Vila, Alejandro J.] Univ Nacl Rosario, Fac Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina	University of Bern; International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bologna; Istituto Italiano di Tecnologia - IIT; National University of Rosario	Carloni, P (corresponding author), Via Beirut 2-4, I-34014 Trieste, Italy.	carloni@sissa.it	Carloni, Paolo/H-8736-2013; Magistrato, Alessandra/U-9756-2019	CAVALLI, ANDREA/0000-0002-6370-1176; Vila, Alejandro/0000-0002-7978-3233	Distributed European Infrastructure for Supercomputing Applications (DELSA); Consorzio Interuniversitario (CINECA)	Distributed European Infrastructure for Supercomputing Applications (DELSA); Consorzio Interuniversitario (CINECA)	We thank Distributed European Infrastructure for Supercomputing Applications (DELSA) and Consorzio Interuniversitario (CINECA) and its staff for CPU time and support.	Abriata LA, 2008, BIOCHEMISTRY-US, V47, P8590, DOI 10.1021/bi8006912; Babic M, 2006, DRUG RESIST UPDATE, V9, P142, DOI 10.1016/j.drup.2006.05.005; Badarau A, 2008, J BIOL INORG CHEM, V13, P919, DOI 10.1007/s00775-008-0379-2; Bebrone C, 2005, J BIOL CHEM, V280, P28195, DOI 10.1074/jbc.M414052200; Bebrone C, 2008, BIOCHEM J, V414, P151, DOI 10.1042/BJ20080375; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Carloni P, 2002, ACCOUNTS CHEM RES, V35, P455, DOI 10.1021/ar010018u; CASE DA, 2002, AMBER VERSION 9 0; CICCOTTI G, 1989, CHEM PHYS, V129, P241, DOI 10.1016/0301-0104(89)80010-2; Costello AL, 2006, BIOCHEMISTRY-US, V45, P13650, DOI 10.1021/bi061547e; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Dal Peraro M, 2004, J AM CHEM SOC, V126, P12661, DOI 10.1021/ja048071b; Dal Peraro M, 2004, PROTEINS, V54, P412, DOI 10.1002/prot.10554; Dal Peraro M, 2007, CURR OPIN STRUC BIOL, V17, P149, DOI 10.1016/j.sbi.2007.03.018; Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556; Diaz N, 2001, J AM CHEM SOC, V123, P9867, DOI 10.1021/ja0113246; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garau G, 2005, ANTIMICROB AGENTS CH, V49, P2778, DOI 10.1128/AAC.49.7.2778-2784.2005; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Georgopapadakou NH, 2004, EXPERT OPIN INV DRUG, V13, P1307, DOI 10.1517/13543784.13.10.1307; Gonzalez JM, 2007, J MOL BIOL, V373, P1141, DOI 10.1016/j.jmb.2007.08.031; Hata M, 2006, BIOL PHARM BULL, V29, P2151, DOI 10.1248/bpb.29.2151; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Krauss M, 2003, J PHYS CHEM B, V107, P1215, DOI 10.1021/jp027097r; Laio A, 2002, J CHEM PHYS, V116, P6941, DOI 10.1063/1.1462041; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Llarrull LI, 2007, J BIOL CHEM, V282, P18276, DOI 10.1074/jbc.M700742200; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Magistrato A, 2000, INORG CHEM, V39, P5553, DOI 10.1021/ic000754e; Moran-Barrio J, 2007, J BIOL CHEM, V282, P18286, DOI 10.1074/jbc.M700467200; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oelschlaeger P, 2003, PROTEIN ENG, V16, P341, DOI 10.1093/protein/gzg049; Olsen L, 2004, J PHYS CHEM B, V108, P17639, DOI 10.1021/jp0482215; Pagan-Rodriguez D, 2004, J BIOL CHEM, V279, P19494, DOI 10.1074/jbc.M311669200; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Piana S, 2004, J PHYS CHEM B, V108, P11139, DOI 10.1021/jp037651c; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sharma NP, 2006, BIOCHEMISTRY-US, V45, P10729, DOI 10.1021/bi060893t; Simona F, 2007, PROTEINS, V69, P595, DOI 10.1002/prot.21476; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Suarez D, 2002, J COMPUT CHEM, V23, P1587, DOI 10.1002/jcc.10157; Suarez D, 2001, J AM CHEM SOC, V123, P3759, DOI 10.1021/ja003796a; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Tamames B, 2007, PROTEINS, V69, P466, DOI 10.1002/prot.21536; Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Toney Jeffrey H, 2004, Curr Opin Investig Drugs, V5, P823; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Xu DG, 2006, J BIOL CHEM, V281, P8740, DOI 10.1074/jbc.M512517200; Xu DG, 2005, J MED CHEM, V48, P6679, DOI 10.1021/jm0505112	57	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28164	28171		10.1074/jbc.M109.049502	http://dx.doi.org/10.1074/jbc.M109.049502			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19671702	hybrid, Green Published			2022-12-25	WOS:000270676300043
J	Caccamo, A; Majumder, S; Deng, JJ; Bai, YD; Thornton, FB; Oddo, S				Caccamo, Antonella; Majumder, Smita; Deng, Janice J.; Bai, Yidong; Thornton, Fiona B.; Oddo, Salvatore			Rapamycin Rescues TDP-43 Mislocalization and the Associated Low Molecular Mass Neurofilament Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; TAR-DNA-BINDING; MOTOR-NEURON DISEASE; NUCLEAR FACTOR TDP-43; LIFE-SPAN; FUNCTIONAL IMPLICATIONS; PROTEIN-DEGRADATION; ALZHEIMERS-DISEASE; SIGNALING PATHWAY	TDP-43 is a nuclear protein involved in exon skipping and alternative splicing. Recently, TDP-43 has been identified as the pathological signature protein in frontotemporal lobar degeneration with ubiquitin-positive inclusions and in amyotrophic lateral sclerosis. In addition, TDP-43-positive inclusions are present in Parkinson disease, dementia with Lewy bodies, and 30% of Alzheimer disease cases. Pathological TDP-43 is redistributed from the nucleus to the cytoplasm, where it accumulates. An similar to 25-kDa C-terminal fragment of TDP-43 accumulates in affected brain regions, suggesting that it may be involved in the disease pathogenesis. Here, we show that overexpression of the 25-kDa C-terminal fragment is sufficient to cause the mislocalization and cytoplasmic accumulation of endogenous full-length TDP-43 in two different cell lines, thus recapitulating a key biochemical characteristic of TDP-43 proteinopathies. We also found that TDP-43 mislocalization is associated with a reduction in the low molecular mass neurofilament mRNA levels. Notably, we show that the autophagic system plays a role in TDP-43 metabolism. Specifically, we found that autophagy inhibition increases the accumulation of the C-terminal fragments of TDP-43, whereas inhibition of mTOR, a key protein kinase involved in autophagy regulation, reduces the 25-kDa C-terminal fragment accumulation and restores TDP-43 localization. Our results suggest that autophagy induction may be a valid therapeutic target for TDP-43 proteinopathies.	[Caccamo, Antonella; Majumder, Smita; Thornton, Fiona B.; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Deng, Janice J.; Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Oddo, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	oddo@uthscsa.edu	Bai, Yidong/A-4959-2012	Oddo, Salvatore/0000-0001-7304-7430				Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arias-Vasquez A, 2007, NEUROSCI LETT, V424, P1, DOI 10.1016/j.neulet.2007.07.015; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bigio EH, 2008, ACTA NEUROPATHOL, V116, P135, DOI 10.1007/s00401-008-0405-z; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lu A, 2009, J MOL NEUROSCI, V38, P19, DOI 10.1007/s12031-008-9155-6; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Monaco AP, 2009, TRANSPLANTATION, V87, P157, DOI 10.1097/TP.0b013e318193886e; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Seelaar H, 2007, BRAIN, V130, P1375, DOI 10.1093/brain/awm024; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Wali RK, 2008, CURR OPIN ORGAN TRAN, V13, P614, DOI 10.1097/MOT.0b013e3283193bad; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Ward Walter F, 2002, Prog Mol Subcell Biol, V29, P35; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	57	121	138	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27416	27424		10.1074/jbc.M109.031278	http://dx.doi.org/10.1074/jbc.M109.031278			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651785	hybrid, Green Published			2022-12-25	WOS:000270232300044
J	Chamberland, A; Wang, E; Jones, AR; Collins-Racie, LA; LaVallie, ER; Huang, Y; Liu, L; Morris, EA; Flannery, CR; Yang, ZY				Chamberland, Angela; Wang, Eunice; Jones, Aled R.; Collins-Racie, Lisa A.; LaVallie, Edward R.; Huang, Ying; Liu, Lin; Morris, Elisabeth A.; Flannery, Carl R.; Yang, Zhiyong			Identification of a Novel HtrA1-susceptible Cleavage Site in Human Aggrecan EVIDENCE FOR THE INVOLVEMENT OF HtrA1 IN AGGRECAN PROTEOLYSIS IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTRA1 SERINE-PROTEASE; HUMAN SYNOVIAL-FLUID; CARTILAGE; EXPRESSION; QUANTIFICATION; OSTEOARTHRITIS; DEGRADATION; FRAGMENTS; ADAMTS-4; FAMILY	Mass spectrometry-based proteomic analyses performed on cartilage tissue extracts identified the serine protease HtrA1/PRSS11 as a major protein component of human articular cartilage, with elevated levels occurring in association with osteoarthritis. Overexpression of a catalytically active form of HtrA1, but not an active site mutant (S328A), caused a marked reduction in proteoglycan content in chondrocyte-seeded alginate cultures. Aggrecan degradation fragments were detected in conditioned media from the alginate cultures overexpressing active HtrA1. Incubation of native or recombinant aggrecan with wild type HtrA1 resulted in distinct cleavage of these substrates. Cleavage of aggrecan by HtrA1 was strongly enhanced by HtrA1 agonists such as CPII, a C-terminal hexapeptide derived from the C-propeptide of procollagen II alpha 1 (i.e. chondrocalcin). A novel HtrA1-susceptible cleavage site within the interglobular domain (IGD) of aggrecan was identified, and an antibody that specifically recognizes the neoepitope sequence(VQTV(356)) generated at the HtrA1 cleavage site was developed. Western blot analysis demonstrated that HtrA1-generated aggrecan fragments containing the VQTV356 neoepitope were significantly more abundant in osteoarthritic cartilage compared with cartilage from healthy joints, implicating HtrA1 as a critical protease involved in proteoglycan turnover and cartilage degradation during degenerative joint disease.	[Chamberland, Angela; Wang, Eunice; Jones, Aled R.; Morris, Elisabeth A.; Flannery, Carl R.; Yang, Zhiyong] Wyeth Res, Dept Tissue Repair, Cambridge, MA 02140 USA; [Collins-Racie, Lisa A.; LaVallie, Edward R.; Huang, Ying; Liu, Lin] Wyeth Res, Dept Biol Technol, Cambridge, MA 02140 USA	Pfizer; Pfizer	Yang, ZY (corresponding author), Wyeth Res, Dept Tissue Repair, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	ZYyang@wyeth.com						Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; Chelius D, 2003, ANAL CHEM, V75, P6658, DOI 10.1021/ac034607k; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chockalingam PS, 2004, ARTHRITIS RHEUM-US, V50, P2839, DOI 10.1002/art.20496; Chubinskaya S, 2001, J HISTOCHEM CYTOCHEM, V49, P1165, DOI 10.1177/002215540104900910; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; GANU V, 2001, ORTH RES SOC 47 ANN, V26, P266; GOLDBERG R, 2000, ORTH RES SOC 46 ANN, V25, P164; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hou J, 2005, J CELL BIOCHEM, V94, P470, DOI 10.1002/jcb.20328; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Nelson F, 1998, J CLIN INVEST, V102, P2115, DOI 10.1172/JCI4853; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	26	59	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27352	27359		10.1074/jbc.M109.037051	http://dx.doi.org/10.1074/jbc.M109.037051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19657146	hybrid, Green Published			2022-12-25	WOS:000270232300036
J	Fournier, M; Vitte, J; Garrigue, J; Langui, D; Dullin, JP; Saurini, F; Hanoun, N; Perez-Diaz, F; Cornilleau, F; Joubert, C; Ardila-Osorio, H; Traver, S; Duchateau, R; Goujet-Zalc, C; Paleologou, K; Lashuel, HA; Haass, C; Duyckaerts, C; Cohen-Salmon, C; Kahle, PJ; Hamon, M; Brice, A; Corti, O				Fournier, Margot; Vitte, Jeremie; Garrigue, Jerome; Langui, Dominique; Dullin, Jean-Philippe; Saurini, Francoise; Hanoun, Naima; Perez-Diaz, Fernando; Cornilleau, Fabien; Joubert, Chantal; Ardila-Osorio, Hector; Traver, Sabine; Duchateau, Rene; Goujet-Zalc, Cecile; Paleologou, Katerina; Lashuel, Hilal A.; Haass, Christian; Duyckaerts, Charles; Cohen-Salmon, Charles; Kahle, Philipp J.; Hamon, Michel; Brice, Alexis; Corti, Olga			Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; INCLUSION-BODY FORMATION; TRANSGENIC MICE; DROSOPHILA MODEL; LEWY BODIES; CELL-DEATH; RAT MODEL; PHOSPHORYLATION; UBIQUITINATION; PROTEIN	In synucleinopathies, including Parkinson's disease, partially ubiquitylated alpha-synuclein species phosphorylated on serine 129 (P-S129-alpha-synuclein) accumulate abnormally. Parkin, an ubiquitin-protein ligase that is dysfunctional in autosomal recessive parkinsonism, protects against alpha-synuclein-mediated toxicity in various models. We analyzed the effects of Parkin deficiency in a mouse model of synucleinopathy to explore the possibility that Parkin and alpha-synuclein act in the same biochemical pathway. Whether or not Parkin was present, these mice developed an age-dependent neurodegenerative disorder preceded by a progressive decline in performance in tasks predictive of sensorimotor dysfunction. The symptoms were accompanied by the deposition of P-S129-alpha-synuclein but not P-S87-alpha-synuclein in neuronal cell bodies and neuritic processes throughout the brainstem and the spinal cord; activation of caspase 9 was observed in 5% of the P-S129-alpha-synuclein-positive neurons. As in Lewy bodies, ubiquitin-immunoreactivity, albeit less abundant, was invariably co-localized with P-S129-alpha-synuclein. During late disease stages, the disease-specific neuropathological features revealed by ubiquitinand P-S129-alpha-synuclein-specific antibodies were similar in mice with or without Parkin. However, the proportion of P-S129-alpha-synuclein-immunoreactive neuronal cell bodies and neurites co-stained for ubiquitin was lower in the absence than in the presence of Parkin, suggesting less advanced synucleinopathy. Moreover, sensorimotor impairment and manifestation of the neurodegenerative phenotype due to overproduction of human alpha-synuclein were significantly delayed in Parkindeficient mice. These findings raise the possibility that effective compensatory mechanisms modulate the phenotypic expression of disease in parkin-related parkinsonism.	[Fournier, Margot; Vitte, Jeremie; Garrigue, Jerome; Langui, Dominique; Dullin, Jean-Philippe; Perez-Diaz, Fernando; Cornilleau, Fabien; Joubert, Chantal; Ardila-Osorio, Hector; Traver, Sabine; Duyckaerts, Charles; Brice, Alexis; Corti, Olga] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Fournier, Margot; Vitte, Jeremie; Garrigue, Jerome; Langui, Dominique; Dullin, Jean-Philippe; Perez-Diaz, Fernando; Cornilleau, Fabien; Joubert, Chantal; Ardila-Osorio, Hector; Traver, Sabine; Duyckaerts, Charles; Brice, Alexis; Corti, Olga] INSERM, U975, Paris, France; [Fournier, Margot; Vitte, Jeremie; Garrigue, Jerome; Langui, Dominique; Dullin, Jean-Philippe; Perez-Diaz, Fernando; Cornilleau, Fabien; Joubert, Chantal; Ardila-Osorio, Hector; Traver, Sabine; Duyckaerts, Charles; Brice, Alexis; Corti, Olga] CNRS, UMR 7225, Paris, France; [Saurini, Francoise; Hanoun, Naima; Hamon, Michel] Univ Paris 06, CRPN, UMR S894, Paris, France; [Saurini, Francoise; Hanoun, Naima; Hamon, Michel] INSERM, U894, Paris, France; [Duchateau, Rene; Goujet-Zalc, Cecile] CNRS, SEAT, Villejuif, France; [Paleologou, Katerina; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Haass, Christian] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Munich, Germany; [Cohen-Salmon, Charles] INSERM, U676, Paris, France; [Kahle, Philipp J.] Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Brice, Alexis] Grp Hosp Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, F-75634 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Fournier, M (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	olga.corti@upmc.fr	Corti, Olga/I-4981-2016; hanoun, naima NH/M-6408-2014; Vitte, Jeremie/B-9874-2017; brice, alexis/AAE-8275-2019; Lashuel, Hilal/M-3500-2017; Brice, Alexis/A-2170-2009; Corti, Olga/AAC-3160-2019; Langui, Dominique/AAX-7949-2020	Corti, Olga/0000-0003-2093-7389; Vitte, Jeremie/0000-0002-2567-7988; brice, alexis/0000-0002-0941-3990; Fournier, Margot/0000-0001-8906-1907; ARDILA OSORIO, Hector/0000-0002-1198-6843	French Ministry of Research; Fondation pour la Recherche Medicale; Institut National de la Sante et de la Recherche Medicale; EU [LSHM-CT-2003-503330]; Fondation de France [2003 013 796]; Federation pour la Recherche sur le Cerveau	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); EU(European Commission); Fondation de France(Fondation de France); Federation pour la Recherche sur le Cerveau	Margot Fournier was supported by the French Ministry of Research and the Fondation pour la Recherche Medicale. This project was supported by Institut National de la Sante et de la Recherche Medicale, Abnormal proteins in the pathogenesis of neurodegenerative disorders (APOPIS, an integrated project funded by the EU under the Sixth Framework Programme; Priority: Life Science for Health, contract no. LSHM-CT-2003-503330), Fondation de France (2003 013 796), and Federation pour la Recherche sur le Cerveau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Corti O, 2007, DRUG DISCOV TODAY, V4, P121; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; HAMPE C, 2006, HUM MOL GENET; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Haywood AFM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-14; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; KLEIN C, 2008, NEUROLOGY; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lohmann E, 2003, ANN NEUROL, V54, P176, DOI 10.1002/ana.10613; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; PALEOLOGOU KE, 2008, J BIOL CHEM; Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Ren Y, 2003, J NEUROSCI, V23, P3316; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Singleton A, 2004, LANCET, V364, P1105, DOI 10.1016/S0140-6736(04)17117-1; Singleton AB, 2005, TRENDS NEUROSCI, V28, P416, DOI 10.1016/j.tins.2005.05.009; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Tofaris GK, 2005, MOVEMENT DISORD, V20, pS37, DOI 10.1002/mds.20538; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; von Coelln R, 2006, J NEUROSCI, V26, P3685, DOI 10.1523/JNEUROSCI.0414-06.2006; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Zeevalk GD, 2008, BIOMED PHARMACOTHER, V62, P236, DOI 10.1016/j.biopha.2008.01.017	54	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6629	10.1371/journal.pone.0006629	http://dx.doi.org/10.1371/journal.pone.0006629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680561	gold, Green Submitted, Green Published			2022-12-25	WOS:000268936200003
J	Bernier-Latmani, J; Baumer, A; Shaw, P				Bernier-Latmani, Jeremiah; Baumer, Alessandra; Shaw, Phillip			No Evidence for Mutations of CTCFL/BORIS in Silver-Russell Syndrome Patients with IGF2/H19 Imprinting Control Region 1 Hypomethylation	PLOS ONE			English	Article							GENOMIC VARIANTS; DNA METHYLATION; GENE; CTCF; DNMT3A; LOCUS; BORIS	Background: Silver-Russell syndrome (SRS) is a genetically and clinically heterogeneous disease. Although no protein coding gene defects have been reported in SRS patients, approximately 50% of SRS patients carry epimutations (hypomethylation) at the IGF2/H19 imprinting control region 1 (ICR1). Proper methylation at ICR1 is crucial for the imprinted expression of IGF2, a fetal growth factor. CTCFL, a testis-specific protein, has recently been proposed to play a role in the establishment of DNA methylation at the murine equivalent of ICR1. A screen was undertaken to assess whether CTCFL is mutated in SRS patients with hypomethylation, to explore a link between the observed epimutations and a genetic cause of the disease. Methodology/Principal Findings: DNA was obtained from 36 SRS patients with hypomethylation at ICR1. All CTCFL coding exons were sequenced and analyzed for duplications/deletions using both multiplex ligation-dependent probe amplification, with a custom CTCFL probe set, and genomic qPCR. Novel SNP alleles were analyzed for potential differential splicing in vitro utilizing a splicing assay. Neither mutations of CTCFL nor duplications/deletions were observed. Five novel SNPs were identified and have been submitted to dbSNP. In silico splice prediction suggested one novel SNP, IVS2-66A>C, activated a cryptic splice site, resulting in aberrant splicing and premature termination. In vitro splicing assays did not confirm predicted aberrant splicing. Conclusions/Significance: As no mutations were detected at CTCFL in the patients examined, we conclude that genetic alterations of CTCFL are not responsible for the SRS hypomethylation. We suggest that analysis of other genes involved in the establishment of DNA methylation at imprinted genes, such as DNMT3A and DNMT3L, may provide insight into the genetic cause of hypomethylation in SRS patients.	[Bernier-Latmani, Jeremiah; Shaw, Phillip] Univ Lausanne, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland; [Baumer, Alessandra] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland	University of Lausanne; University of Zurich	Bernier-Latmani, J (corresponding author), Univ Lausanne, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland.	phillip.shaw@chuv.ch		Bernier-Latmani, Jeremiah/0000-0002-6407-1049	Swiss National Science Foundation [3100AO_118432]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by Swiss National Science Foundation grant #3100AO_118432 to P. S. (http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Bartholdi D, 2009, J MED GENET, V46, P192, DOI 10.1136/jmg.2008.061820; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bruce S, 2009, J CLIN ENDOCR METAB, V94, P579, DOI 10.1210/jc.2008-1805; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Eggermann T, 2008, TRENDS GENET, V24, P195, DOI 10.1016/j.tig.2008.01.003; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hata K, 2002, DEVELOPMENT, V129, P1983; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kobayashi S, 2001, AM J MED GENET, V104, P225, DOI 10.1002/ajmg.10022.abs; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Martinez MJ, 2001, AM J MED GENET, V99, P335, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1177>3.0.CO;2-Q; Meyer E, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e65; Meyer E, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e44; Prager S, 2003, GENET TEST, V7, P259, DOI 10.1089/109065703322537304; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Riegel M, 2003, CLIN GENET, V64, P252, DOI 10.1034/j.1399-0004.2003.00135.x; Schoherr N, 2008, EUR J MED GENET, V51, P322, DOI 10.1016/j.ejmg.2008.05.001; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Singh G, 2006, BIOTECHNIQUES, V41, P177, DOI 10.2144/000112208; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6631	10.1371/journal.pone.0006631	http://dx.doi.org/10.1371/journal.pone.0006631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675668	Green Submitted, Green Published, gold			2022-12-25	WOS:000268936100008
J	Carr, CE; Mcgee, J				Carr, Christopher E.; Mcgee, Jeremy			The Apollo Number: Space Suits, Self-Support, and the Walk-Run Transition	PLOS ONE			English	Article							SIMULATED REDUCED-GRAVITY; GAITS; BIOENERGETICS; BIOMECHANICS; LOCOMOTION; SPEED	Background: How space suits affect the preferred walk-run transition is an open question with relevance to human biomechanics and planetary extravehicular activity. Walking and running energetics differ; in reduced gravity (<0.5 g), running, unlike on Earth, uses less energy per distance than walking. Methodology/Principal Findings: The walk-run transition (denoted *) correlates with the Froude Number (Fr = v(2)/gL, velocity v, gravitational acceleration g, leg length L). Human unsuited Fr* is relatively constant (similar to 0.5) with gravity but increases substantially with decreasing gravity below similar to 0.4 g, rising to 0.9 in 1/6 g; space suits appear to lower Fr*. Because of pressure forces, space suits partially (1 g) or completely (lunar-g) support their own weight. We define the Apollo Number (Ap = Fr/ M) as an expected invariant of locomotion under manipulations of M, the ratio of human-supported to total transported mass. We hypothesize that for lunar suited conditions Ap* but not Fr* will be near 0.9, because the Apollo Number captures the effect of space suit self-support. We used the Apollo Lunar Surface Journal and other sources to identify 38 gait events during lunar exploration for which we could determine gait type (walk/lope/run) and calculate Ap. We estimated the binary transition between walk/lope (0) and run (1), yielding Fr* (0.36 +/- 0.11, mean +/- 95% CI) and Ap* (0.68 +/- 0.20). Conclusions/Significance: The Apollo Number explains 60% of the difference between suited and unsuited Fr*, appears to capture in large part the effects of space suits on the walk-run transition, and provides several testable predictions for space suit locomotion and, of increasing relevance here on Earth, exoskeleton locomotion. The knowledge of how space suits affect gait transitions can be used to optimize space suits for use on the Moon and Mars.	[Carr, Christopher E.; Mcgee, Jeremy] MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Carr, CE (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chrisc@mit.edu		Carr, Christopher/0000-0002-7946-5622	Leslie C. Patron Fund	Leslie C. Patron Fund	Support for JM was provided in part by the Leslie C. Patron Fund through the MIT Undergraduate Research Opportunities Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1996, MATH GAZ, V80, P262, DOI [10.2307/3619558, DOI 10.2307/3619558]; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Bullimore SR, 2008, J THEOR BIOL, V250, P339, DOI 10.1016/j.jtbi.2007.09.038; CARR CE, 2005, SAE T J AEROSPACE, V114; Carr CE, 2007, AVIAT SPACE ENVIR MD, V78, P1093, DOI 10.3357/ASEM.1953.2007; Carr CE, 2007, AVIAT SPACE ENVIR MD, V78, P1013, DOI 10.3357/ASEM.1952.2007; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; FARLEY CT, 1992, J APPL PHYSIOL, V73, P2709, DOI 10.1152/jappl.1992.73.6.2709; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; HAGAN D, 2006, C9 OTHER MICROGRAVIT, P161; Hesse S, 2003, CURR OPIN NEUROL, V16, P705, DOI 10.1097/00019052-200312000-00010; Johnston R.S., 1975, BIOMEDICAL RESULTS A; JONES EM, 2006, APOLLO LUNAR SURFACE; Kram R, 1997, J EXP BIOL, V200, P821; KUBIS J, APOLLO 16 TIME MOTIO; Kubis J. F., 1972, APOLLO 15 TIME MOTIO; Minetti AE, 2001, NATURE, V409, P467, DOI 10.1038/35054166; Minetti AE, 1998, P ROY SOC B-BIOL SCI, V265, P1227, DOI 10.1098/rspb.1998.0424; MOCHON S, 1980, MATH BIOSCI, V52, P241, DOI 10.1016/0025-5564(80)90070-X; Neptune RR, 2005, J EXP BIOL, V208, P799, DOI 10.1242/jeb.01435; RADER A, 2007, 2007013134 SAE; RAY D, 1994, PARTIAL GRAVITY SIMU; WALSH CJ, 2007, INT J HUMAN IN PRESS	24	14	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6614	10.1371/journal.pone.0006614	http://dx.doi.org/10.1371/journal.pone.0006614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672305	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900023
J	Hammer, A; Kordon, A; Heldmann, M; Zurowski, B; Munte, TF				Hammer, Anke; Kordon, Andreas; Heldmann, Marcus; Zurowski, Bartosz; Muente, Thomas F.			Brain Potentials of Conflict and Error-Likelihood Following Errorful and Errorless Learning in Obsessive-Compulsive Disorder	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FRONTAL-LOBE DYSFUNCTION; MEMORY IMPAIRMENT; COGNITIVE DEFICITS; NEUROPSYCHOLOGICAL PERFORMANCE; SCALP DISTRIBUTIONS; COMPUTATIONAL MODEL; NEURAL SYSTEM; CONFIDENCE; PREDICTION	Background: The anterior cingulate cortex (ACC) is thought to be overacting in patients with Obsessive Compulsive Disorder (OCD) reflecting an enhanced action monitoring system. However, influences of conflict and error-likelihood have not been explored. Here, the error-related negativity (ERN) originating in ACC served as a measure of conflict and error-likelihood during memory recognition following different learning modes. Errorless learning prevents the generation of false memory candidates and has been shown to be superior to trial-and-error-learning. The latter, errorful learning, introduces false memory candidates which interfere with correct information in later recognition leading to enhanced conflict processing. Methodology/Principal Findings: Sixteen OCD patients according to DSM-IV criteria and 16 closely matched healthy controls participated voluntarily in the event-related potential study. Both, OCD- and control group showed enhanced memory performance following errorless compared to errorful learning. Nevertheless, response-locked data showed clear modulations of the ERN amplitude. OCD patients compared to controls showed an increased error-likelihood effect after errorless learning. However, with increased conflict after errorful learning, OCD patients showed a reduced error-likelihood effect in contrast to controls who showed an increase. Conclusion/Significance: The increase of the errorlikelihood effect for OCD patients within low conflict situations (recognition after errorless learning) might be conceptualized as a hyperactive monitoring system. However, within high conflict situations (recognition after EF-learning) the opposite effect was observed: whereas the control group showed an increased error-likelihood effect, the OCD group showed a reduction of the error-likelihood effect based on altered ACC learning rates in response to errors. These findings support theoretical frameworks explaining differences in ACC activity on the basis of conflict and perceived error-likelihood as influenced by individual error learning rate.	[Hammer, Anke; Muente, Thomas F.] Otto VonGuericke Univ Magdegurg, Dept Neuropsychol, D-39016 Magdeburg, Germany; [Kordon, Andreas; Zurowski, Bartosz] Med Univ Lubeck, Dept Psychiat & Psychotherapy, D-23538 Lubeck, Germany; [Heldmann, Marcus] Otto VonGuericke Univ Magdegurg, Dept Neurol, D-39016 Magdeburg, Germany; [Muente, Thomas F.] Ctr Behav Brain Sci, Magdeburg, Germany; [Zurowski, Bartosz] Univ Hamburg, Hamburg, Germany	Otto von Guericke University; University of Lubeck; Otto von Guericke University; University of Hamburg	Hammer, A (corresponding author), Otto VonGuericke Univ Magdegurg, Dept Neuropsychol, D-39016 Magdeburg, Germany.	anke.hammer@ovgu.de	Münte, Thomas/C-2077-2014		DFG; BMBF	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	The work was supported by grants from the DFG and the BMBF to TFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE M, 1995, BRAIN COGNITION, V27, P202, DOI 10.1006/brcg.1995.1017; Abbruzzese M, 1997, NEUROPSYCHOLOGIA, V35, P907, DOI 10.1016/S0028-3932(96)00095-4; ABBRUZZESE M, 1995, PSYCHIAT RES, V58, P37, DOI 10.1016/0165-1781(95)02670-R; American Psychiatric Association, 1994, DSM IV DIAGN STAT MA; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Boone KB, 1991, NEUROPSY NEUROPSY BE, V4, P96; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Brown JW, 2007, COGNITIVE PSYCHOL, V55, P37, DOI 10.1016/j.cogpsych.2006.09.005; Brown JW, 2008, BRAIN RES, V1202, P99, DOI 10.1016/j.brainres.2007.06.080; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Cabrera AR, 2001, PSYCHOL MED, V31, P1089, DOI 10.1017/S0033291701004354; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CHRISTENSEN KJ, 1992, BIOL PSYCHIAT, V31, P4, DOI 10.1016/0006-3223(92)90003-I; Cohen LJ, 1996, J NEUROPSYCH CLIN N, V8, P82; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Deckersbach T, 2000, J INT NEUROPSYCH SOC, V6, P673, DOI 10.1017/S1355617700666055; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DENBRABER A, 2008, FMRI STUDY MONOZYGOT; DIRSON S, 1995, PSYCHOTHER PSYCHOSOM, V63, P22, DOI 10.1159/000288933; Endrass T, 2008, NEUROPSYCHOLOGIA, V46, P1877, DOI 10.1016/j.neuropsychologia.2007.12.001; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Foa EB, 1997, J ANXIETY DISORD, V11, P119, DOI 10.1016/S0887-6185(97)00001-7; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Hajcak G, 2002, PSYCHIAT RES, V110, P63, DOI 10.1016/S0165-1781(02)00034-3; HELDMANN M, 2008, NEUROSCI LETT; Henin A, 2001, AM J PSYCHIAT, V158, P137, DOI 10.1176/appi.ajp.158.1.137; Hermans D, 2008, BEHAV RES THER, V46, P98, DOI 10.1016/j.brat.2007.11.001; Herrmann M, 2001, HUM BRAIN MAPP, V13, P94, DOI 10.1002/hbm.1027; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2003, TRENDS NEUROSCI, V26, P402, DOI 10.1016/S0166-2236(03)00175-9; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Johannes S, 2001, PSYCHIAT RES-NEUROIM, V108, P101, DOI 10.1016/S0925-4927(01)00117-2; Johannes S, 2001, ACTA NEUROL SCAND, V104, P36, DOI 10.1034/j.1600-0404.2001.00308.x; Kopell BH, 2004, J CLIN NEUROPHYSIOL, V21, P51, DOI 10.1097/00004691-200401000-00007; Kuelz AK, 2004, BIOL PSYCHOL, V65, P185, DOI 10.1016/j.biopsycho.2003.07.007; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; MacDonald PA, 1997, BEHAV RES THER, V35, P497, DOI 10.1016/S0005-7967(97)00013-2; Malloy P., 1987, FRONTAL LOBES REVISI, P207; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Munte TF, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.011.2007; Nessler D, 2003, PSYCHOPHYSIOLOGY, V40, P146, DOI 10.1111/1469-8986.00015; Nieuwenhuis S, 2005, PSYCHIAT RES, V134, P111, DOI 10.1016/j.psychres.2005.02.005; Nieuwenhuis S, 2007, CEREB CORTEX, V17, P1570, DOI 10.1093/cercor/bhl068; PITMAN RK, 1987, COMPR PSYCHIAT, V28, P334, DOI 10.1016/0010-440X(87)90070-8; Purcell R, 1998, ARCH GEN PSYCHIAT, V55, P415, DOI 10.1001/archpsyc.55.5.415; Purcell R, 1998, BIOL PSYCHIAT, V43, P348, DOI 10.1016/S0006-3223(97)00201-1; Radomsky AS, 2001, BEHAV RES THER, V39, P813, DOI 10.1016/S0005-7967(00)00079-6; Radomsky AS, 1999, BEHAV RES THER, V37, P605, DOI 10.1016/S0005-7967(98)00151-X; Rauch S L, 2001, Adv Neurol, V85, P207; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rodriguez-Fornells A, 2004, COGNITIVE BRAIN RES, V19, P160, DOI 10.1016/j.cogbrainres.2003.11.009; RUBENSTEIN CS, 1993, BEHAV RES THER, V31, P759, DOI 10.1016/0005-7967(93)90006-G; Santesso DL, 2006, DEV NEUROPSYCHOL, V29, P431, DOI 10.1207/s15326942dn2903_3; Savage CR, 2000, NEUROPSYCHOLOGY, V14, P141, DOI 10.1037/0894-4105.14.1.141; Savage CR, 1999, BIOL PSYCHIAT, V45, P905, DOI 10.1016/S0006-3223(98)00278-9; Savage CR, 2000, AM J PSYCHIAT, V157, P1182, DOI 10.1176/appi.ajp.157.7.1182; Savage CR, 1996, J NEUROPSYCH CLIN N, V8, P99; Stein D J, 2001, Curr Psychiatry Rep, V3, P281, DOI 10.1007/s11920-001-0020-3; Stein D J, 2000, Curr Psychiatry Rep, V2, P341, DOI 10.1007/s11920-000-0079-2; TERRACE HS, 1963, J EXP ANAL BEHAV, V6, P1, DOI 10.1901/jeab.1963.6-1; Tolin DF, 2001, BEHAV RES THER, V39, P913, DOI 10.1016/S0005-7967(00)00064-4; Ullsperger M, 2004, NAT NEUROSCI, V7, P1173, DOI 10.1038/nn1104-1173; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Urbach TP, 2002, PSYCHOPHYSIOLOGY, V39, P791, DOI 10.1111/1469-8986.3960791; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Veale DM, 1996, PSYCHOL MED, V26, P1261, DOI 10.1017/S0033291700035984; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463	71	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6553	10.1371/journal.pone.0006553	http://dx.doi.org/10.1371/journal.pone.0006553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	483BD	19672309	gold, Green Submitted, Green Published			2022-12-25	WOS:000268935900004
J	Sun, Z; Huang, ZP; Zhang, DD				Sun, Zheng; Huang, Zheping; Zhang, Donna D.			Phosphorylation of Nrf2 at Multiple Sites by MAP Kinases Has a Limited Contribution in Modulating the Nrf2-Dependent Antioxidant Response	PLOS ONE			English	Article							SUBSTRATE ADAPTER PROTEIN; TRANSCRIPTION FACTOR NRF2; MAMMARY EPITHELIAL-CELLS; MEDIATED GENE-EXPRESSION; HEME OXYGENASE-1 GENE; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; HEPG2 CELLS; TRANSLATIONAL CONTROL; SIGNALING PATHWAY	The bZIP transcription factor Nrf2 has emerged as a pivotal regulator of intracellular redox homeostasis by controlling the expression of many endogenous antioxidants and phase II detoxification enzymes. Upon oxidative stress, Nrf2 is induced at protein levels through redox-sensitive modifications on cysteine residues of Keap1, a component of the E3 ubiquitin ligase that targets Nrf2 for ubiquitin-dependent degradation. The mitogen activated protein kinases (MAPKs) have previously been proposed to regulate Nrf2 in response to oxidative stress. However, the exact role of MAPKs and the underlying molecular mechanism remain poorly defined. Here we report the first evidence that Nrf2 is phosphorylated in vivo by MAPKs. We have identified multiple serine/threonine residues as major targets of MAPK-mediated phosphorylation. Combined alanine substitution on those residues leads to a moderate decrease in the transcriptional activity of Nrf2, most likely due to a slight reduction in its nuclear accumulation. More importantly, Nrf2 protein stability, primarily controlled by Keap1, is not altered by Nrf2 phosphorylation in vivo. These data indicate that direct phosphorylation of Nrf2 by MAPKs has limited contribution in modulating Nrf2 activity. We suggest that MAPKs regulate the Nrf2 signaling pathway mainly through indirect mechanisms.	[Sun, Zheng; Huang, Zheping; Zhang, Donna D.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Huang, Zheping] Brown Univ, Dept Pediat, Div Biol & Med, Providence, RI 02912 USA	University of Arizona; Brown University	Sun, Z (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	dzhang@pharmacy.arizona.edu	Sun, Zheng/C-1146-2012; Zhang, Donna/B-1015-2012	Sun, Zheng/0000-0002-6858-0633; 	NIEHS [1RO1ES015010]; ACS [RSG-07-154]; SWEHSC [ES006694]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694, R01ES015010] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ACS(American Cancer Society); SWEHSC; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIEHS 1RO1ES015010, ACS RSG-07-154, SWEHSC ES006694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2000, J BIOL CHEM, V275, P27694; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Andreadi CK, 2006, MOL PHARMACOL, V69, P1033, DOI 10.1124/mol.105.018374; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hwang YP, 2008, TOXICOL APPL PHARM, V231, P318, DOI 10.1016/j.taap.2008.04.019; Kang KA, 2007, FEBS LETT, V581, P2000, DOI 10.1016/j.febslet.2007.04.022; Kanwar JR, 2005, CURR MED CHEM, V12, P2947, DOI 10.2174/092986705774462833; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Keum YS, 2003, PHARM RES-DORDR, V20, P1351, DOI 10.1023/A:1025737622815; Kim JW, 2008, BIOCHEM PHARMACOL, V76, P1577, DOI 10.1016/j.bcp.2008.08.007; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kocanova S, 2007, APOPTOSIS, V12, P731, DOI 10.1007/s10495-006-0016-x; Manandhar S, 2007, EUR J PHARMACOL, V577, P17, DOI 10.1016/j.ejphar.2007.08.018; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McMahon M, 2001, CANCER RES, V61, P3299; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Pae HO, 2006, WORLD J GASTROENTERO, V12, P214, DOI 10.3748/wjg.v12.i2.214; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; RAUGHT B, 2007, COLD SPRING HARB SYM, P369; Ruef Johannes, 1999, Thrombosis and Haemostasis, V82, P32; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song HJ, 2008, J ETHNOPHARMACOL, V118, P94, DOI 10.1016/j.jep.2008.03.010; SUN Z, 2009, MOL CELL BIOL; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang XJ, 2008, TOXICOL APPL PHARM, V230, P383, DOI 10.1016/j.taap.2008.03.003; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang XJ, 2007, TOXICOL APPL PHARM, V225, P206, DOI 10.1016/j.taap.2007.07.016; WANG XJ, 2009, ECTODERMAL NEURAL CO; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497; Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381; Yao P, 2007, J HEPATOL, V47, P253, DOI 10.1016/j.jhep.2007.02.008; Yeh CT, 2006, CARCINOGENESIS, V27, P1008, DOI 10.1093/carcin/bgi281; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Yu R, 2000, J BIOL CHEM, V275, P2322, DOI 10.1074/jbc.275.4.2322; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Yuan XL, 2006, MOL CARCINOGEN, V45, P841, DOI 10.1002/mc.20234; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; ZHANG H, 2005, AM J RESP CELL MOL B; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	62	253	261	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6588	10.1371/journal.pone.0006588	http://dx.doi.org/10.1371/journal.pone.0006588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668370	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935600014
J	Wu, JB; Chen, K; Li, YM; Lau, YFC; Shih, JC				Wu, Jason B.; Chen, Kevin; Li, Yunmin; Lau, Yun-Fai Chris; Shih, Jean C.			Regulation of monoamine oxidase A by the SRY gene on the Y chromosome	FASEB JOURNAL			English	Article						sex-determining region Y gene; transcriptional activation; sexual dimorphism; X chromosome gene; promoter regulation; Sp1 coactivation	DEFICIT HYPERACTIVITY DISORDER; TRANSCRIPTION FACTOR SP1; OBSESSIVE-COMPULSIVE DISORDER; SEX-DIFFERENCES; HUMAN BRAIN; B GENES; MAO-A; EMBRYONIC-DEVELOPMENT; ASSOCIATION ANALYSIS; SEROTONIN SYNTHESIS	Monoamine oxidase A (MAO A), encoded by the X chromosome, catalyzes the oxidative deamination of monoamine neurotransmitters, such as serotonin, and plays a critically important role in brain development and functions. Abnormal MAO A activity has been implicated in several neuropsychiatric disorders, such as depression, autism, and attention deficit hyperactivity disorder, which show sexual dimorphism. However, the molecular basis for these disease processes is unclear. Recently, we found that MAO A was a putative target gene directly regulated by a transcription factor encoded by the sex-determining region Y (SRY) gene located on the Y chromosome. We demonstrated that SRY activates both MAO A-promoter and catalytic activities in a human male neuroblastoma BE(2) C cell line. A functional SRY-binding site in the MAO A core promoter was identified and validated by electrophoretic mobility shift and chromatin immunoprecipitation (ChIP) analyses. Coimmunoprecipitation and ChIP assays showed that SRY and Sp1 form a transcriptional complex and synergistically activate MAO A transcription. This is the first study demonstrating that the Y-encoded transcription factor SRY is capable of regulating an X-located gene, suggesting a novel molecular mechanism for sexual dimorphism in neural development, brain functions, and initiation/progression of neural disorders associated with MAO A dysfunction.-Wu, J. B., Chen, K., Li, Y., Lau, Y.-F. C., Shih, J. C. Regulation of monoamine oxidase A by the SRY gene on the Y chromosome. FASEB J. 23, 4029-4038 (2009). www.fasebj.org	[Wu, Jason B.; Chen, Kevin; Shih, Jean C.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Shih, Jean C.] Univ So Calif, Dept Cell & Neurobiol, Keck Sch Med, Los Angeles, CA 90089 USA; [Li, Yunmin; Lau, Yun-Fai Chris] Univ Calif San Francisco, Dept Med, Vet Affairs Med Ctr, San Francisco, CA USA	University of Southern California; University of Southern California; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Shih, JC (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave,PSC 518, Los Angeles, CA 90089 USA.	jcshih@usc.edu	Wu, Jason Boyang/I-5780-2013; Chen, Kevin/GYU-8963-2022; Lau, Yun-Fai C/E-4465-2014	Lau, Yun-Fai C/0000-0002-9119-7050	National Institute of Mental Health [R01MH67968, R01MH39085]; Boyd and Elsie Welin Professorship; U. S. Department of Defense; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067968, R01MH039085] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000865] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Boyd and Elsie Welin Professorship; U. S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institute of Mental Health grants R01MH67968 and R01MH39085 and the Boyd and Elsie Welin Professorship to J. C. S., and by a concept grant from the U. S. Department of Defense Autism Research Program to Y.-F. C. L. Y.-F. C. L. is a Research Career Scientist of the Department of Veterans Affairs. The authors thank Dr. Hans Rotheneder (Department of Medical Biochemistry and Molecular Biology, Medical University of Vienna, Vienna, Austria) for providing HA-Sp1 expression construct. The authors are also grateful to Dr. Marco Bortolato for critical reading of the manuscript.	Alonso-Nanclares L, 2008, P NATL ACAD SCI USA, V105, P14615, DOI 10.1073/pnas.0803652105; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chan Wai-Yee, 2002, Current Molecular Medicine (Hilversum), V2, P25, DOI 10.2174/1566524023363095; Chen K, 2005, J BIOL CHEM, V280, P11552, DOI 10.1074/jbc.M410033200; Chen K, 2004, NEUROTOXICOLOGY, V25, P31, DOI 10.1016/S0161-813X(03)00113-X; Chugani DC, 1998, SYNAPSE, V28, P33, DOI 10.1002/(SICI)1098-2396(199801)28:1<33::AID-SYN5>3.0.CO;2-D; Cohen IL, 2003, CLIN GENET, V64, P190, DOI 10.1034/j.1399-0004.2003.00115.x; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Das M, 2006, AM J MED GENET B, V141B, P637, DOI 10.1002/ajmg.b.30385; Davis LK, 2008, AM J MED GENET B, V147B, P1145, DOI 10.1002/ajmg.b.30738; Dennis C, 2004, NATURE, V427, P390, DOI 10.1038/427390a; Dewing P, 2006, CURR BIOL, V16, P415, DOI 10.1016/j.cub.2006.01.017; Domschke K, 2005, AM J MED GENET B, V134B, P110, DOI 10.1002/ajmg.b.30158; Dulcan M, 1997, J AM ACAD CHILD PSY, V36, pS85, DOI 10.1097/00004583-199710001-00007; GRIMSBY J, 1991, P NATL ACAD SCI USA, V88, P3637, DOI 10.1073/pnas.88.9.3637; Guan L, 2009, MOL PSYCHIATR, V14, P546, DOI 10.1038/sj.mp.4002139; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Hranilovic D, 2008, COLLEGIUM ANTROPOL, V32, P75; Jaisoorya TS, 2009, COMPR PSYCHIAT, V50, P70, DOI 10.1016/j.comppsych.2008.05.003; Jiang HB, 2006, J BIOL CHEM, V281, P8591, DOI 10.1074/jbc.M510926200; Jiang SD, 2001, AM J MED GENET, V105, P783, DOI 10.1002/ajmg.10098; Jonsson EG, 2003, SCHIZOPHR RES, V61, P31, DOI 10.1016/S0920-9964(02)00224-4; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; Knickmeyer RC, 2006, EARLY HUM DEV, V82, P755, DOI 10.1016/j.earlhumdev.2006.09.014; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; LAN NC, 1989, GENOMICS, V4, P552, DOI 10.1016/0888-7543(89)90279-6; Lau YFC, 2009, BIRTH DEFECTS RES C, V87, P114, DOI 10.1002/bdrc.20144; Lawson DC, 2003, AM J MED GENET B, V116B, P84, DOI 10.1002/ajmg.b.10002; Lee TL, 2006, GENOMICS, V88, P18, DOI 10.1016/j.ygeno.2006.03.008; Li YM, 2006, MOL CELL ENDOCRINOL, V257-8, P35, DOI 10.1016/j.mce.2006.06.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Mayer A, 1998, NEUROGENETICS, V1, P281, DOI 10.1007/s100480050042; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Nordquist N, 2006, BIOCHEM BIOPH RES CO, V348, P763, DOI 10.1016/j.bbrc.2006.07.131; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; OSRAN H, 1993, AM J PSYCHIAT, V150, P806; Ou XM, 2006, J BIOL CHEM, V281, P21512, DOI 10.1074/jbc.M600250200; Ozcan ME, 2003, EUR ARCH PSY CLIN N, V253, P193, DOI 10.1007/s00406-003-0424-7; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Pinsonneault JK, 2006, HUM MOL GENET, V15, P2636, DOI 10.1093/hmg/ddl192; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Pooley EC, 2007, MOL PSYCHIATR, V12, P556, DOI 10.1038/sj.mp.4001951; POULAT F, 1995, J CELL BIOL, V128, P737, DOI 10.1083/jcb.128.5.737; Ren B, 2004, METHOD ENZYMOL, V376, P304; Rommelse NNJ, 2008, AM J MED GENET B, V147B, P1524, DOI 10.1002/ajmg.b.30845; Salahpour A, 2007, BIOL PSYCHIAT, V61, P65, DOI 10.1016/j.biopsych.2006.03.020; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; Shih JC, 1995, PROG BRAIN RES, V106, P49; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Strom AC, 1996, NUCLEIC ACIDS RES, V24, P1981, DOI 10.1093/nar/24.11.1981; Sumner BEH, 1997, NEUROSCI LETT, V234, P7, DOI 10.1016/S0304-3940(97)00651-4; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tadic A, 2003, AM J MED GENET B, V117B, P1, DOI 10.1002/ajmg.b.10013; Taketo T, 2005, DEV DYNAM, V233, P612, DOI 10.1002/dvdy.20352; Thevenet L, 2004, EMBO J, V23, P3336, DOI 10.1038/sj.emboj.7600352; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Williams JG, 2008, J AUTISM DEV DISORD, V38, P1731, DOI 10.1007/s10803-008-0558-6; Wilson CA, 2007, REPRODUCTION, V133, P331, DOI 10.1530/REP-06-0078; Wright SL, 2009, DEPRESS ANXIETY, V26, P182, DOI 10.1002/da.20502; Wu JB, 2009, J BIOL CHEM, V284, P16723, DOI 10.1074/jbc.M901779200; Yoo HJ, 2009, NEUROSCI RES, V63, P172, DOI 10.1016/j.neures.2008.11.007; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201; ZHU QS, 1994, J NEUROSCI, V14, P7393; ZHU QS, 1992, J NEUROSCI, V12, P4437	78	87	90	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					4029	4038		10.1096/fj.09-139097	http://dx.doi.org/10.1096/fj.09-139097			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19661285	Green Published			2022-12-25	WOS:000271272500038
J	Ulijasz, AT; Cornilescu, G; von Stetten, D; Cornilescu, C; Escobar, FV; Zhang, JR; Stankey, RJ; Rivera, M; Hildebrandt, P; Vierstra, RD				Ulijasz, Andrew T.; Cornilescu, Gabriel; von Stetten, David; Cornilescu, Claudia; Escobar, Francisco Velazquez; Zhang, Junrui; Stankey, Robert J.; Rivera, Mario; Hildebrandt, Peter; Vierstra, Richard D.			Cyanochromes Are Blue/Green Light Photoreversible Photoreceptors Defined by a Stable Double Cysteine Linkage to a Phycoviolobilin-type Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GAF DOMAIN; BINDING DOMAIN; CYANOBACTERIOCHROME TEPIXJ; LINEAR TETRAPYRROLES; VIBRATIONAL-SPECTRA; HISTIDINE KINASES; CRYSTAL-STRUCTURE; PHYTOCHROME; BACTERIOPHYTOCHROME	Phytochromes are a collection of bilin-containing photoreceptors that regulate a diverse array of processes in microorganisms and plants through photoconversion between two stable states, a red light-absorbing Pr form, and a far red light-absorbing Pfr form. Recently, a novel set of phytochrome-like chromoproteins was discovered in cyanobacteria, designated here as cyanochromes, that instead photoconvert between stable blue and green light-absorbing forms Pb and Pg, respectively. Here, we show that the distinctive absorption properties of cyanochromes are facilitated through the binding of phycocyanobilin via two stable cysteine-based thioether linkages within the cGMP phosphodiesterase/adenyl cyclase/FhlA domain. Absorption, resonance Raman and infrared spectroscopy, and molecular modeling of the Te-PixJ GAF (cGMP phosphodiesterase/adenyl cyclase/FhlA) domain assembled with phycocyanobilin are consistent with attachments to the C3(1) carbon of the ethylidene side chain and the C4 or C5 carbons in the A-B methine bridge to generate a double thioether-linked phycoviolobilin-type chromophore. These spectroscopic methods combined with NMR data show that the bilin is fully protonated in the Pb and Pg states and that numerous conformation changes occur during Pb -> Pg photoconversion. Also identified were a number of photochromically inactive mutants with strong yellow or red fluorescence that may be useful for fluorescence-based cell biological assays. Phylogenetic analyses detected cyanochromes capable of different signaling outputs in a wide range of cyanobacterial species. One unusual case is the Synechocystis cyanochrome Etr1 that also binds ethylene, suggesting that it works as a hybrid receptor to simultaneously integrate light and hormone signals.	[Ulijasz, Andrew T.; Zhang, Junrui; Stankey, Robert J.; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Cornilescu, Gabriel; Cornilescu, Claudia] Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [von Stetten, David; Escobar, Francisco Velazquez; Hildebrandt, Peter] Tech Univ Berlin, D-10623 Berlin, Germany; [Rivera, Mario] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	University of Wisconsin System; University of Wisconsin Madison; Technical University of Berlin; University of Kansas	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, 425-G Henry Mall, Madison, WI 53706 USA.	vierstra@wisc.edu	Cornilescu, Gabriel/H-3113-2011; Zhang, Junrui/J-2684-2012; Hildebrandt, Peter/J-5658-2014; Cornilescu, Claudia/K-1981-2015; Cornilescu, Claudia/H-1959-2012	Cornilescu, Gabriel/0000-0002-1204-8904; Hildebrandt, Peter/0000-0003-1030-5900; Cornilescu, Claudia/0000-0002-2401-7806; Stankey, Robert/0000-0003-1259-2296; von Stetten, David/0000-0001-7906-9788; Ulijasz, Andrew/0000-0003-0739-1297; Velazquez Escobar, Francisco/0000-0003-0365-8118	National Science Foundation [07191530]; Deutsche Forschungsgemeinschaft [SFB498]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002781, S10RR008438, P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB 07191530 (to R. D. V.) and Deutsche Forschungsgemeinschaft Grant SFB498 (to P. H.).	Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Hirose Y, 2008, P NATL ACAD SCI USA, V105, P9528, DOI 10.1073/pnas.0801826105; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2006, PLANT CELL PHYSIOL, V47, P1251, DOI 10.1093/pcp/pcj095; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; Magdo I, 1999, J PHYS CHEM A, V103, P289, DOI 10.1021/jp983101g; Miller AE, 2006, P NATL ACAD SCI USA, V103, P11136, DOI 10.1073/pnas.0604724103; MIZUTANI Y, 1994, BIOCHEMISTRY-US, V33, P153, DOI 10.1021/bi00167a020; Mroginski MA, 2004, J AM CHEM SOC, V126, P16734, DOI 10.1021/ja043959l; Mroginski MA, 2006, J PHYS CHEM A, V110, P10564, DOI 10.1021/jp063128x; Mutsuda M, 2003, J BIOL CHEM, V278, P19102, DOI 10.1074/jbc.M213255200; Nagy F., 2006, PHOTOMORPHOGENESIS P, P65; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Strauss HM, 2005, BIOCHEMISTRY-US, V44, P8244, DOI 10.1021/bi050457r; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Terauchi K, 2004, MOL MICROBIOL, V51, P567, DOI 10.1046/j.1365-2958.2003.03853.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; VIERSTRA RD, 1983, PLANT PHYSIOL, V72, P264, DOI 10.1104/pp.72.1.264; Vierstra RD, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P171, DOI 10.1002/352760510X.ch8; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WILSON DF, 1970, SCIENCE, V168, P1577, DOI 10.1126/science.168.3939.1577; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214; Yoshihara S, 2000, PLANT CELL PHYSIOL, V41, P1299, DOI 10.1093/pcp/pce010; ZHAO KH, 1995, BBA-BIOENERGETICS, V1228, P244, DOI 10.1016/0005-2728(94)00180-D	62	68	71	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29757	29772		10.1074/jbc.M109.038513	http://dx.doi.org/10.1074/jbc.M109.038513			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19671704	Green Published, hybrid			2022-12-25	WOS:000270896800057
J	Atkinson, GP; Nozell, SE; Harrison, DK; Stonecypher, MS; Chen, D; Benveniste, EN				Atkinson, G. P.; Nozell, S. E.; Harrison, D. K.; Stonecypher, M. S.; Chen, D.; Benveniste, E. N.			The prolyl isomerase Pin1 regulates the NF-kappa B signaling pathway and interleukin-8 expression in glioblastoma	ONCOGENE			English	Article						glioblastoma; gene expression; signal transduction; NF-kappa B; Pin1	NECROSIS-FACTOR-ALPHA; TRANSCRIPTIONAL ACTIVITY; CANCER; PHOSPHORYLATION; TARGET; ACTIVATION; APOPTOSIS; TUMORS; GROWTH; STAT3	The brain tumor glioblastoma (GBM) remains one of the most aggressive and devastating tumors despite decades of effort to find more effective treatments. A hallmark of GBM is the constitutive activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) signaling pathway, which regulates cell proliferation, in. ammation, migration and apoptosis. The prolyl isomerase, Pin1, has been found to bind directly to the NF-kappa B protein, p65, and cause increases in NF-kappa B promoter activity in a breast cancer model. We now present evidence that this interaction occurs in GBM and that it has important consequences on NF-kappa B signaling. We demonstrate that Pin1 levels are enhanced in primary GBM tissues compared with controls, and that this difference in Pin1 expression affects the migratory capacity of GBM-derived cells. Pin1 knockdown decreases the amount of activated, phosphorylated p65 in the nucleus, resulting in inhibition of the transcriptional program of the IL-8 gene. Through the use of microarray, we also observed changes in the expression levels of other NF-kappa B regulated genes due to Pin1 knockdown. Taken together, these data suggest that Pin1 is an important regulator of NF-kappa B in GBM, and support the notion of using Pin1 as a therapeutic target in the future. Oncogene (2009) 28, 3735-3745; doi: 10.1038/onc.2009.232; published online 10 August 2009	[Atkinson, G. P.; Nozell, S. E.; Stonecypher, M. S.; Benveniste, E. N.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Harrison, D. K.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Chen, D.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benveniste, EN (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, THT Room 926A,1900 Univ Blvd, Birmingham, AL 35294 USA.	tika@uab.edu			National Institutes of Health [CA97247, NS-54158, IRG-60-001-47]; American Cancer Society [CA-13148-31]; NCI (SEN); UAB Medical Scientist Training Program; NIH [T32AI0705]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA158534, R01CA194414, P50CA097247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000705, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054158, R01NS045290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NCI (SEN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UAB Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Michael Crowley in the UAB Comprehensive Cancer Center Gene Expression Shared Facility for his assistance with microarray processing, and Dr Cheryl Ann Palmer (University of Alabama at Birmingham) for providing the brain tumor resections. We also thank Dr Yancey Gillespie, UAB Brain Tumor Tissue Core, for glioma and control tissue samples, and express our appreciation to the laboratory of Dr Dale Benos for assistance with the scratch assay. Finally, many thanks to Dr Rafal Bartoszewski for assistance with the qPCR and to Dr Gerald Fuller for reading the paper. This work was supported in part by National Institutes of Health grants CA97247 (ENB), NS-54158 (ENB and SEN) and IRG-60-001-47 from the American Cancer Society and CA-13148-31 from the NCI (SEN). GPA was supported by the UAB Medical Scientist Training Program, and is currently supported by NIH T32AI0705.	Afra D, 2002, LANCET, V359, P1011; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ayala G, 2003, CANCER RES, V63, P6244; Baker BJ, 2008, GLIA, V56, P1250, DOI 10.1002/glia.20694; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Brandes AA, 2008, CRIT REV ONCOL HEMAT, V67, P139, DOI 10.1016/j.critrevonc.2008.02.005; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Chandana SR, 2008, AM FAM PHYSICIAN, V77, P1423; Choi C, 2002, MOL CELL BIOL, V22, P724, DOI 10.1128/MCB.22.3.724-736.2002; Choi YH, 2006, P NATL ACAD SCI USA, V103, P18715, DOI 10.1073/pnas.0604800103; Finn G, 2008, CURR CANCER DRUG TAR, V8, P223, DOI 10.2174/156800908784293622; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Harant H, 1996, J BIOL CHEM, V271, P26954, DOI 10.1074/jbc.271.43.26954; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Nagai S, 2002, J NEUROSURG, V96, P909, DOI 10.3171/jns.2002.96.5.0909; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Nozell S, 2006, J IMMUNOL, V177, P822, DOI 10.4049/jimmunol.177.2.822; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Raychaudhuri B, 2007, J NEURO-ONCOL, V85, P39, DOI 10.1007/s11060-007-9390-7; Ryo A, 2005, CLIN CANCER RES, V11, P7523, DOI 10.1158/1078-0432.CCR-05-0457; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Ryo A, 2007, J BIOL CHEM, V282, P36671, DOI 10.1074/jbc.M704145200; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Smith D, 2008, MOL CELL BIOCHEM, V307, P141, DOI 10.1007/s11010-007-9593-4; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Wakabayashi K, 2004, ONCOGENE, V23, P6924, DOI 10.1038/sj.onc.1207778; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Yamamoto M, 2000, ANTICANCER RES, V20, P611; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	54	65	65	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2009	28	42					3735	3745		10.1038/onc.2009.232	http://dx.doi.org/10.1038/onc.2009.232			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	509MY	19668231	Green Accepted			2022-12-25	WOS:000271023200006
J	Angelow, S; Yu, ASL				Angelow, Susanne; Yu, Alan S. L.			Structure-Function Studies of Claudin Extracellular Domains by Cysteine-scanning Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-JUNCTION; PARACELLULAR PORES; SELECTIVE CHANNELS; EPITHELIAL-CELLS; ION; RECEPTOR; EXPRESSION; KIDNEY; IDENTIFICATION; PERMEABILITY	Claudins form size- and charge-selective pores in the tight junction that control the paracellular flux of inorganic ions and small molecules. However, the structural basis for ion selectivity of paracellular pores is poorly understood. Here we applied cysteine scanning to map the paracellular pathway of ion permeation across claudin-2-transfected Madin-Darby canine kidney type I cells. Four potential pore-lining amino acid residues in the first extracellular loop were mutated to cysteine and screened for their accessibility to thiol-reactive reagents. All mutants were functional except D65C, which formed dimers by intermolecular disulfide bonding, leading to a loss of charge and size selectivity. This suggests that claudin-2 pores are multimeric and that Asp(65) lies close to a protein-protein interface. Methanethiosulfonate reagents of different size and charge and the organic mercury derivate, p-(chloromercuri) benzenesulfonic acid, significantly decreased paracellular ion permeation across I66C-transfected cells by a mechanism that suggests steric blocking of the pore. The conductance of wild-type claudin-2 and the other cysteine mutants was only weakly affected. The rate of reaction with I66C decreased dramatically with increasing size of the reagent, suggesting that Ile(66) is buried deep within a narrow segment of the pore with its side group facing into the lumen. Furthermore, labeling with N-biotinoylaminoethyl methanethiosulfonate showed that I66C was weakly reactive, whereas Y35C was strongly reactive, suggesting that Tyr(35) is located at the protein surface outside of the pore.	Univ So Calif, Keck Sch Med, Div Nephrol, Dept Med, Los Angeles, CA 90089 USA; [Yu, Alan S. L.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Yu, ASL (corresponding author), 2025 Zonal Ave,RMR 406, Los Angeles, CA 90089 USA.	alanyu@usc.edu	Yu, Alan/AID-7467-2022	Yu, Alan/0000-0002-1776-2533	National Institutes of Health [DK062283, DK48522]; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522, R01DK062283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062283 (to A. Y.) and DK48522 (to the USC Center for Liver Diseases, for the Confocal Microscopy Sub-Core). This work was also supported by a postdoctoral research grant by the National Kidney Foundation (to S. A.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alexandre MD, 2007, BIOCHEM BIOPH RES CO, V357, P87, DOI 10.1016/j.bbrc.2007.03.078; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Angelow S, 2006, J PHYSIOL-LONDON, V571, P15, DOI 10.1113/jphysiol.2005.099135; Angelow S, 2007, AM J PHYSIOL-RENAL, V293, pF166, DOI 10.1152/ajprenal.00087.2007; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; DIAMOND JM, 1969, ANNU REV PHYSIOL, V31, P581, DOI 10.1146/annurev.ph.31.030169.003053; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; Enck AH, 2001, AM J PHYSIOL-RENAL, V281, pF966, DOI 10.1152/ajprenal.0021.2001; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GREEN WN, 1991, ANNU REV PHYSIOL, V53, P341, DOI 10.1146/annurev.ph.53.030191.002013; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; MORENO JH, 1975, J MEMBRANE BIOL, V21, P197, DOI 10.1007/BF01941070; Nagamori S, 2000, J BIOCHEM-TOKYO, V128, P129, DOI 10.1093/oxfordjournals.jbchem.a022723; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2006, AM J PHYSIOL-RENAL, V291, pF1288, DOI 10.1152/ajprenal.00138.2006; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	34	65	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29205	29217		10.1074/jbc.M109.043752	http://dx.doi.org/10.1074/jbc.M109.043752			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690347	Green Published, hybrid			2022-12-25	WOS:000270678900075
J	Chen, XP; El Gazzar, M; Yoza, BK; McCall, CE				Chen, Xiaoping; El Gazzar, Mohamed; Yoza, Barbara K.; McCall, Charles E.			The NF-kappa B Factor RelB and Histone H3 Lysine Methyltransferase G9a Directly Interact to Generate Epigenetic Silencing in Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CHROMATIN; TRANSCRIPTION; METHYLATION; IL-1-BETA; COMPLEXES; RECRUITS; GENES	The interplay of transcription factors, histone modifiers, and DNA modification can alter chromatin structure that epigenetically controls gene transcription. During severe systemic inflammatory (SSI), the generation of facultative heterochromatin from euchromatin reversibly silences transcription of a set of acute proinflammatory genes. This gene-specific silencing is a salient feature of the endotoxin tolerant phenotype that is found in blood leukocytes of SSI patients and in a human THP-1 cell model of SSL We previously reported that de novo induction of the NF-kappa B transcription factor RelB by endotoxin activation is necessary and sufficient for silencing transcription of acute proinflammatory genes in the endotoxin tolerant SSI phenotype. Here, we examined how RelB silences gene expression and found that RelB induces facultative heterochromatin formation by directly interacting with the histone H3 lysine 9 methyltransferase G9a. We found that heterochromatin protein 1 (HP1) and G9a formed a complex at the interleukin-1 beta promoter that is dependent on the Rel homology domain (RHD) of RelB. RelB knockdown disassociated the complex and reversed transcription silencing. We also observed that whereas RelB chromatin binding was independent of G9a, RelB transcriptional silencing required G9a accumulation at the silenced promoter. Binding between RelB and G9a was confirmed by glutathione S-transferase pulldown in vitro and coimmunoprecipitation in vivo. These data provide novel insight into how RelB is required to initiate silencing in the phenotype associated with severe systemic inflammation in humans, a disease with major morbidity and mortality.	[Chen, Xiaoping; El Gazzar, Mohamed; Yoza, Barbara K.; McCall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Yoza, Barbara K.] Wake Forest Univ, Bowman Gray Sch Med, Dept Gen Surg, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	McCall, CE (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	chmccall@wfubmc.edu			National Institutes of Health [RO1A1-09169, RO1A1-065791]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065791, R01AI009169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1A1-09169 and RO1A1-065791 (to C.E.M.).	Akbarian S, 2009, BIOL PSYCHIAT, V65, P198, DOI 10.1016/j.biopsych.2008.08.015; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen XP, 2009, CLIN VACCINE IMMUNOL, V16, P104, DOI 10.1128/CVI.00320-08; Cobb J P, 2000, Surg Infect (Larchmt), V1, P207, DOI 10.1089/109629600750018132; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Esteve PO, 2005, NUCLEIC ACIDS RES, V33, P3211, DOI 10.1093/nar/gki635; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRUYS V, 1993, J EXP MED, V177, P1383, DOI 10.1084/jem.177.5.1383; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; MILNER CM, 1993, BIOCHEM J, V290, P811, DOI 10.1042/bj2900811; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; RYSECK RP, 1995, MOL CELL BIOL, V15, P3100; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005	35	143	149	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27857	27865		10.1074/jbc.M109.000950	http://dx.doi.org/10.1074/jbc.M109.000950			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690169	Green Published, hybrid			2022-12-25	WOS:000270676300012
J	Crabtree, MJ; Tatham, AL; Hale, AB; Alp, NJ; Channon, KM				Crabtree, Mark J.; Tatham, Amy L.; Hale, Ashley B.; Alp, Nicholas J.; Channon, Keith M.			Critical Role for Tetrahydrobiopterin Recycling by Dihydrofolate Reductase in Regulation of Endothelial Nitric-oxide Synthase Coupling RELATIVE IMPORTANCE OF THE DENOVO BIOPTERIN SYNTHESIS VERSUS SALVAGE PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOHYDROLASE-I EXPRESSION; CELLS; SUPEROXIDE; ATHEROSCLEROSIS; BIOSYNTHESIS; METABOLISM; MICE; ENOS; 7,8-DIHYDROBIOPTERIN; OVEREXPRESSION	Tetrahyrobiopterin (BH4) is a required cofactor for the synthesis of nitric oxide by endothelial nitric-oxide synthase (eNOS), and BH4 bioavailability within the endothelium is a critical factor in regulating the balance between NO and superoxide production by eNOS (eNOS coupling). BH4 levels are determined by the activity of GTP cyclohydrolase I (GTPCH), the rate-limiting enzyme in de novo BH4 biosynthesis. However, BH4 levels may also be influenced by oxidation, forming 7,8-dihydrobiopterin (BH2), which promotes eNOS uncoupling. Conversely, dihydrofolate reductase (DHFR) can regenerate BH4 from BH2, but the functional importance of DHFR in maintaining eNOS coupling remains unclear. We investigated the role of DHFR in regulating BH4 versus BH2 levels in endothelial cells and in cell lines expressing eNOS combined with tet-regulated GTPCH expression in order to compare the effects of low or high levels of de novo BH4 biosynthesis. Pharmacological inhibition of DHFR activity by methotrexate or genetic knockdown of DHFR protein by RNA interference reduced intracellular BH4 and increased BH2 levels resulting in enzymatic uncoupling of eNOS, as indicated by increased eNOS-dependent superoxide but reduced NO production. In contrast to the decreased BH4:BH2 ratio induced by DHFR knockdown, GTPCH knockdown greatly reduced total biopterin levels but with no change in BH4:BH2 ratio. In cells expressing eNOS with low biopterin levels, DHFR inhibition or knockdown further diminished the BH4:BH2 ratio and exacerbated eNOS uncoupling. Taken together, these data reveal a key role for DHFR in eNOS coupling by maintaining the BH4:BH2 ratio, particularly in conditions of low total biopterin availability.	[Crabtree, Mark J.; Tatham, Amy L.; Hale, Ashley B.; Alp, Nicholas J.; Channon, Keith M.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford	Channon, KM (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	keith.channon@cardiov.ox.ac.uk		channon, keith/0000-0002-1043-4342; Crabtree, Mark/0000-0003-3298-2697	British Heart Foundation [PG/05/141/20098, RG/07/003/23133]; Wellcome Trust Clinician Scientist Fellowship [GR074428/Z/04/Z]	British Heart Foundation(British Heart Foundation); Wellcome Trust Clinician Scientist Fellowship(Wellcome Trust)	This work was supported by British Heart Foundation Project Grant PG/05/141/20098, British Heart Foundation Programme Grant RG/07/003/23133, and a Wellcome Trust Clinician Scientist Fellowship GR074428/Z/04/Z.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Brand MP, 1996, J NEUROCHEM, V66, P1150; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; CURTIUS HC, 1985, EUR J BIOCHEM, V148, P413, DOI 10.1111/j.1432-1033.1985.tb08855.x; de Bono JP, 2007, NITRIC OXIDE-BIOL CH, V16, P1, DOI 10.1016/j.niox.2006.03.008; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; HEALES S, 1989, J CHROMATOGR-BIOMED, V494, P77, DOI 10.1016/S0378-4347(00)82658-4; Huang AN, 2005, CIRC RES, V96, P164, DOI 10.1161/01.RES.0000153669.24827.DF; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Ionova IA, 2008, AM J PHYSIOL-HEART C, V295, pH2178, DOI 10.1152/ajpheart.00748.2008; Katusic ZS, 1998, ARTERIOSCL THROM VAS, V18, P27, DOI 10.1161/01.ATV.18.1.27; KAUFMAN S, 1983, ANN NEUROL, V14, P308, DOI 10.1002/ana.410140309; Linscheid P, 1998, CIRCULATION, V98, P1703, DOI 10.1161/01.CIR.98.17.1703; Maetzel A, 2000, RHEUMATOLOGY, V39, P975, DOI 10.1093/rheumatology/39.9.975; McDonald DM, 2004, PHARMACOGENETICS, V14, P831, DOI 10.1097/00008571-200412000-00006; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Newsome Grace, 2002, J Am Acad Nurse Pract, V14, P432; NICHOL CA, 1983, P NATL ACAD SCI-BIOL, V80, P1546, DOI 10.1073/pnas.80.6.1546; Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; Ren J, 2008, AM J PHYSIOL-REG I, V294, pR793, DOI 10.1152/ajpregu.00713.2007; Sawabe K, 2004, J PHARMACOL SCI, V96, P124, DOI 10.1254/jphs.FP0040280; Schmidt PP, 2001, J BIOL INORG CHEM, V6, P151, DOI 10.1007/s007750000185; Sugiyama T, 2009, J BIOL CHEM, V284, P12691, DOI 10.1074/jbc.M809295200; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Vasquez-Vivar J, 2002, ARTERIOSCL THROM VAS, V22, P1655, DOI 10.1161/01.ATV.0000029122.79665.D9; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	35	156	161	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28128	28136		10.1074/jbc.M109.041483	http://dx.doi.org/10.1074/jbc.M109.041483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666465	Green Published, hybrid			2022-12-25	WOS:000270676300039
J	Cushman, I; Casey, PJ				Cushman, Ian; Casey, Patrick J.			Role of Isoprenylcysteine Carboxylmethyltransferase-catalyzed Methylation in Rho Function and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; CARBOXYL METHYLTRANSFERASE; FARNESYLTRANSFERASE INHIBITORS; TRANSFERASE INHIBITORS; CELL-MIGRATION; CANCER-CELLS; K-RAS; PRENYLATION; INVASION; TARGETS	A number of proteins that play key roles in biological regulatory events undergo a process of post-translational modifications termed prenylation. The prenylation pathway consists of three enzymatic steps; the final processed protein is isoprenoid-modified and methylated on the C-terminal cysteine. This protein modification pathway plays a significant role in cancer biology because many oncogenic proteins undergo prenylation. Methylation of the C terminus by isoprenylcysteine carboxylmethyltransferase (Icmt) is the final step in the prenylation pathway. Cysmethynil, a specific Icmt inhibitor discovered in our laboratory, is able to inhibit Ras-mediated signaling, cell growth, and oncogenesis. We sought to examine the role of Icmt-mediated methylation on the behaviors of cancer cells associated with metastatic potential. Our results indicate that inhibition of methylation reduces migration of the highly metastatic MDA-MB-231 breast cancer cell line. In addition, cell adhesion and cell spreading are also significantly impacted by cysmethynil. To examine the mechanism of Icmt-dependent migration we focused on RhoA and Rac1, prenylated proteins that are important mediators of cell migration through their control of the actin cytoskeleton. Inhibition of Icmt significantly decreases the activation of both RhoA and Rac1; an increase in Rho GDP-dissociation inhibitor (RhoGDI) binding in the absence of methylation appears to contribute to this effect. Furthermore, in the absence of Icmt activity the addition of exogenous RhoA or Rac1 is able to partially rescue directed and random migration, respectively. These findings establish a role for Icmt-mediated methylation in cell migration and advance our understanding of the biological consequences of Rho methylation.	[Cushman, Ian; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Cushman, Ian; Casey, Patrick J.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore	Duke University; National University of Singapore	Casey, PJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Res Dr, Durham, NC 27710 USA.	casey006@mc.duke.edu		Casey, Patrick/0000-0002-7366-9309	National Institutes of Health [GM46372]; American Cancer Society Postdoctoral Fellow Award [PF-06-068-01-TBE]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellow Award(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46372 (to P. J. C.) and an American Cancer Society Postdoctoral Fellow Award PF-06-068-01-TBE (to I.C.).	Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200; Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Baron RA, 2007, BIOCHEMISTRY-US, V46, P554, DOI 10.1021/bi060344n; Baron Rudi A., 2004, BMC Biochemistry, V5, P19, DOI 10.1186/1471-2091-5-19; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Clarke S, 2004, J CLIN INVEST, V113, P513, DOI 10.1072/JCI200421059; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Collisson EA, 2003, MOL CANCER THER, V2, P941; Doll RJ, 2004, CURR OPIN DRUG DISC, V7, P478; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Lebowitz PF, 1997, J BIOL CHEM, V272, P16093, DOI 10.1074/jbc.272.26.16093; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Lu Q, 2004, CIRC RES, V94, P306, DOI 10.1161/01.RES.0000113923.85084.C1; Matozaki T, 2000, CELL SIGNAL, V12, P515, DOI 10.1016/S0898-6568(00)00102-9; Mazieres J, 2004, CANCER LETT, V206, P159, DOI 10.1016/j.canlet.2003.08.033; Meigs TE, 2005, J BIOL CHEM, V280, P18049, DOI 10.1074/jbc.M500445200; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Papaharalambus C, 2005, J BIOL CHEM, V280, P18790, DOI 10.1074/jbc.M410081200; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Walker K, 2005, CURR OPIN GENET DEV, V15, P62, DOI 10.1016/j.gde.2004.11.001; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Windler-Hart SL, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-14; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Young S. G., 2001, ENZYMES, V21, P156; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	37	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27964	27973		10.1074/jbc.M109.025296	http://dx.doi.org/10.1074/jbc.M109.025296			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19651782	Green Published, hybrid			2022-12-25	WOS:000270676300024
J	Naismith, TV; Dalal, S; Hanson, PI				Naismith, Teresa V.; Dalal, Seerna; Hanson, Phyllis I.			Interaction of TorsinA with Its Major Binding Partners Is Impaired by the Dystonia-associated Delta GAG Deletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER NUCLEAR-MEMBRANE; AAA PLUS PROTEIN; MUTANT TORSINA; DYT1 DYSTONIA; SECRETORY PATHWAY; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; PC12 CELLS; ENVELOPE; MUTATION	Early onset (DYT1) torsion dystonia is a dominantly inherited movement disorder associated with a three-base pair (Delta GAG) deletion that removes a glutamic acid residue from the protein torsinA. TorsinA is an essential AAA(+) (ATPases associated with a variety of cellular activities) ATPase found in the endoplasmic reticulum and nuclear envelope of higher eukaryotes, but what it does and how changes caused by the Delta GAG deletion lead to dystonia are not known. Here, we asked how the DYT1 mutation affects association of torsinA with interacting proteins. Using immunoprecipitation and mass spectrometry, we first established that the related transmembrane proteins LULL1 and LAP1 are prominent binding partners for torsinA in U2OS cells. Comparative analysis demonstrates that these two proteins are targeted to the endoplasmic reticulum or nuclear envelope by their divergent N-terminal domains. Binding of torsinA to their C-terminal lumenal domains is stabilized when residues in any one of three motifs implicated in ATP hydrolysis (Walker B, sensor 1, and sensor 2) are mutated. Importantly, the Delta GAG deletion does not stabilize this binding. Indeed, deleting the Delta GAG encoded glutamic acid residue from any of the three ATP hydrolysis mutants destabilizes their association with LULL1 and LAP1C, suggesting a possible basis for loss of torsinA function. Impaired interaction of torsinA with LULL1 and/or LAP1 may thus contribute to the development of dystonia.	[Naismith, Teresa V.; Dalal, Seerna; Hanson, Phyllis I.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Hanson, PI (corresponding author), WA Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	phanson22@wustl.edu	Hanson, Phyllis/E-9420-2012		NINDS; National Institutes of Health [R01 NS050717]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050717] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS, National Institutes of Health Grant R01 NS050717 (to P. I. H.).	Bragg DC, 2004, NEUROSCIENCE, V125, P651, DOI 10.1016/j.neuroscience.2004.01.053; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Bressman SB, 2000, NEUROLOGY, V54, P1746, DOI 10.1212/WNL.54.9.1746; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Gordon KL, 2008, NEUROSCIENCE, V157, P588, DOI 10.1016/j.neuroscience.2008.09.028; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett JW, 2008, HUM MOL GENET, V17, P1436, DOI 10.1093/hmg/ddn032; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2004, J NEUROCHEM, V89, P1186, DOI 10.1111/j.1471-4159.2004.02404.x; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Kondo Y, 2002, BIOCHEM BIOPH RES CO, V294, P770, DOI 10.1016/S0006-291X(02)00563-6; Kuner R, 2003, NEUROSCI LETT, V350, P153, DOI 10.1016/S0304-3940(03)00904-2; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Kustedjo K, 2003, BIOCHEMISTRY-US, V42, P15333, DOI 10.1021/bi0349569; Maison C, 1997, EMBO J, V16, P4839, DOI 10.1093/emboj/16.16.4839; MARTIN L, 1995, J BIOL CHEM, V270, P8822, DOI 10.1074/jbc.270.15.8822; Nagy M, 2009, PROTEIN SCI, V18, P287, DOI 10.1002/pro.36; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Vasudevan A, 2006, BRAIN RES, V1073, P139, DOI 10.1016/j.brainres.2005.12.087; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015	42	62	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27866	27874		10.1074/jbc.M109.020164	http://dx.doi.org/10.1074/jbc.M109.020164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19651773	hybrid, Green Published			2022-12-25	WOS:000270676300013
J	Weng, TT; Gao, L; Bhaskaran, M; Guo, YJ; Gou, DM; Narayanaperumal, J; Chintagari, NR; Zhang, KX; Liu, L				Weng, Tingting; Gao, Li; Bhaskaran, Manoj; Guo, Yujie; Gou, Deming; Narayanaperumal, Jeyaparthasarathy; Chintagari, Narendranath Reddy; Zhang, Kexiong; Liu, Lin			Pleiotrophin Regulates Lung Epithelial Cell Proliferation and Differentiation during Fetal Lung Development via beta-Catenin and Dlk1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR PLEIOTROPHIN; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; MYOGENIC DIFFERENTIATION; MESSENGER-RNA; CANCER-CELLS; II CELLS; HB-GAM; WNT; MORPHOGENESIS	The role of pleiotrophin in fetal lung development was investigated. We found that pleiotrophin and its receptor, protein-tyrosine phosphatase receptor beta/zeta, were highly expressed in mesenchymal and epithelial cells of the fetal lungs, respectively. Using isolated fetal alveolar epithelial type II cells, we demonstrated that pleiotrophin promoted fetal type II cell proliferation and arrested type II cell trans-differentiation into alveolar epithelial type I cells. Pleiotrophin also increased wound healing of injured type II cell monolayer. Knockdown of pleiotrophin influenced lung branching morphogenesis in a fetal lung organ culture model. Pleiotrophin increased the tyrosine phosphorylation of beta-catenin, promoted beta-catenin translocation into the nucleus, and activated T cell factor/lymphoid enhancer factor transcription factors. DIU, a membrane ligand that initiates the Notch signaling pathway, was identified as a downstream target of the pleiotrophin/beta-catenin pathway by endogenous dlk1 expression, promoter assay, and chromatin immunoprecipitation. These results provide evidence that pleiotrophin regulates fetal type II cell proliferation and differentiation via integration of multiple signaling pathways including pleiotrophin, beta-catenin, and Notch pathways.	[Weng, Tingting; Gao, Li; Bhaskaran, Manoj; Guo, Yujie; Gou, Deming; Narayanaperumal, Jeyaparthasarathy; Chintagari, Narendranath Reddy; Zhang, Kexiong; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Liu, L (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, 264 McElroy Hall, Stillwater, OK 74078 USA.	lin.liu@okstate.edu		Guo, Yujie/0000-0002-0307-9266; Zhang, Kexiong/0000-0001-9517-8386	National Institutes of Health [R01 HIL-052146, R01 HIL-071628, R01 HL-083188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071628, R01HL083188, R01HL052146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HIL-052146, R01 HIL-071628, and R01 HL-083188 (to L. L.).	Aoyama K, 2007, STEM CELLS, V25, P2488, DOI 10.1634/stemcells.2007-0102; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; BATENBURG JJ, 1988, BIOCHIM BIOPHYS ACTA, V960, P441, DOI 10.1016/0005-2760(88)90053-7; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Cheng P, 2008, IMMUNOL RES, V41, P1, DOI 10.1007/s12026-007-8011-z; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; De Langhe SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001516; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Eberhart CG, 2001, PEDIATR DEVEL PATHOL, V4, P351, DOI 10.1007/s10024001-0037-y; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; FRASLON C, 1991, IN VITRO CELL DEV B, V27, P843; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; Heller H, 2001, J BIOL CHEM, V276, P37307, DOI 10.1074/jbc.M103195200; Herradon G, 2004, BIOCHEM BIOPH RES CO, V324, P1041, DOI 10.1016/j.bbrc.2004.09.161; Hilfer SR, 1996, ANNU REV PHYSIOL, V58, P93, DOI 10.1146/annurev.ph.58.030196.000521; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Jager R, 1997, INT J CANCER, V73, P537; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Perez-Pinera P, 2006, P NATL ACAD SCI USA, V103, P17795, DOI 10.1073/pnas.0607299103; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; SACHS L, 1980, P NATL ACAD SCI-BIOL, V77, P6152, DOI 10.1073/pnas.77.10.6152; Sakural H, 2001, DEVELOPMENT, V128, P3283; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Seykora JT, 2003, AM J DERMATOPATH, V25, P6, DOI 10.1097/00000372-200302000-00002; Shannon JM, 1998, DEV DYNAM, V212, P482, DOI 10.1002/(SICI)1097-0177(199808)212:4<482::AID-AJA2>3.0.CO;2-D; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; SilosSantiago I, 1996, J NEUROBIOL, V31, P283, DOI 10.1002/(SICI)1097-4695(199611)31:3<283::AID-NEU2>3.0.CO;2-6; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; Weng TT, 2006, AM J PHYSIOL-LUNG C, V291, pL1027, DOI 10.1152/ajplung.00435.2005; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yeh HJ, 1998, J NEUROSCI, V18, P3699	49	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28021	28032		10.1074/jbc.M109.052530	http://dx.doi.org/10.1074/jbc.M109.052530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19661059	Green Published, hybrid			2022-12-25	WOS:000270676300030
J	Tsukumo, Y; Tsukahara, S; Saito, S; Tsuruo, T; Tomida, A				Tsukumo, Yoshinori; Tsukahara, Satomi; Saito, Sakae; Tsuruo, Takashi; Tomida, Akihiro			A Novel Endoplasmic Reticulum Export Signal PROLINE AT THE + 2-POSITION FROM THE SIGNAL PEPTIDE CLEAVAGE SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; MULTIPLE EF-HAND; CA2+-BINDING PROTEIN; SECRETORY PATHWAY; BINDING PROTEIN; COATED VESICLES; GOLGI; COPII; ER; NUCLEOBINDIN	NUCB1 (nucleobindin 1) is a Golgi-localized soluble protein with a signal peptide and multiple functional domains. We reported recently that NUCB1 is a negative regulator of the unfolded protein response that activates various endoplasmic reticulum (ER)-originating signaling pathways. In that report, we also showed that Golgi localization of NUCB1 was essential to regulate the unfolded protein response. However, the localization mechanism of NUCB1 is still unknown. Here, we report that the proline residue at the +2-position (Pro(+2)) from the signal peptide cleavage site is the determinant of NUCB1 protein export from the ER and subsequent transport to the Golgi. Fusion of the N-terminal amino acids 1-35 peptide region, including both signal peptide (amino acids 1-26) and Pro(+2), was sufficient for enhanced green fluorescent protein to localize in the Golgi, whereas single amino acid mutation of Pro(+2) resulted in defective export from the ER without affecting the protein maturation process. Furthermore, we demonstrated that Pro(+2) was important for the enhanced green fluorescent protein fusion protein to concentrate at a transport vesicle formation site within the ER, often termed the ER exit site. Interestingly, such a Pro(+2) has also been functionally conserved in other Golgi-localized soluble proteins, Cab45 (Ca2+-binding protein of 45 kDa), reticulocalbin 1, and calumenin. Our findings indicate that Pro(+2) can function as a novel ER export signal of some Golgi proteins.	[Tsukumo, Yoshinori; Tsukahara, Satomi; Saito, Sakae; Tsuruo, Takashi; Tomida, Akihiro] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan	Japanese Foundation for Cancer Research	Tomida, A (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan.	akihiro.tomida@jfcr.or.jp			Ministry of Health, Labour, and Welfare; New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ishizu Scholarship Foundation	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ishizu Scholarship Foundation	This work was supported in part by Grant-in-aid for Cancer Research 21-3-1 from the Ministry of Health, Labour, and Welfare (to A. T.), a Grant-in-aid for scientific research on priority areas for cancer (to T. T. and A. T.), a grant from the New Energy and Industrial Technology Development Organization (NEDO) of Japan, and aid from the Ishizu Scholarship Foundation (to Y.T.).	Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Ballif BA, 1996, P NATL ACAD SCI USA, V93, P5544, DOI 10.1073/pnas.93.11.5544; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Cheung JC, 2008, BIOCHEMISTRY-US, V47, P1465, DOI 10.1021/bi702209s; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; KANAI Y, 1992, IMMUNOL LETT, V32, P43; KANAI Y, 1993, BIOCHEM BIOPH RES CO, V196, P729, DOI 10.1006/bbrc.1993.2310; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Laskowski RA, 2008, NAT REV GENET, V9, P141, DOI 10.1038/nrg2273; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; Miura K, 1996, GENOMICS, V34, P181, DOI 10.1006/geno.1996.0263; MIZUNO M, 1993, P NATL ACAD SCI USA, V90, P5732, DOI 10.1073/pnas.90.12.5732; MOCHIZUKI N, 1995, FEBS LETT, V373, P155, DOI 10.1016/0014-5793(95)01031-9; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195; OZAWA M, 1993, J BIOL CHEM, V268, P699; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Petersson U, 2004, BONE, V34, P949, DOI 10.1016/j.bone.2004.01.019; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257; SHEN LM, 1991, BIOCHEMISTRY-US, V30, P11775, DOI 10.1021/bi00115a006; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; WANG SN, 1994, PATHOL INT, V44, P844, DOI 10.1111/j.1440-1827.1994.tb01682.x; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; WENDEL M, 1995, J BIOL CHEM, V270, P6125, DOI 10.1074/jbc.270.11.6125; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	43	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27500	27510		10.1074/jbc.M109.021592	http://dx.doi.org/10.1074/jbc.M109.021592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656946	Green Published, hybrid			2022-12-25	WOS:000270232300052
J	Fazi, B; Melino, S; De Rubeis, S; Bagni, C; Paci, M; Piacentini, M; Di Sano, F				Fazi, B.; Melino, S.; De Rubeis, S.; Bagni, C.; Paci, M.; Piacentini, M.; Di Sano, F.			Acetylation of RTN-1C regulates the induction of ER stress by the inhibition of HDAC activity in neuroectodermal tumors	ONCOGENE			English	Article						acetylation; ER; RTN-1C; apoptosis	ENDOPLASMIC-RETICULUM; CALRETICULIN EXPOSURE; HISTONE DEACETYLASE; INDUCED APOPTOSIS; CELL-DEATH; PROTEIN; BINDING; FAMILY; CANCER; RNA	Reticulons are a family of highly conserved proteins, localized in the endoplasmic reticulum (ER) and involved in different cellular functions, such as intracellular membrane trafficking, apoptosis and nuclear envelope formation. The reticulon protein family consists of four members, but their specific functions are presently poorly understood. RTN-1C overexpression triggers apoptosis, regulating ER stress versus DNA damage-induced cell death in a mutually exclusive way. The different RTN isoforms share a C-terminal reticulon homology domain containing two hydrophobic segments and a 66-amino acid hydrophilic loop. In the C-terminal region of RTN-1C, a unique consensus sequence (GAKRH) has recently been identified, showing 100% identity with the DNA-binding domain of histone H4. In this study, we show that this sequence is essential for RTN-1C-mediated apoptosis. It is noteworthy that the lysine 204 present in this region is post-translationally modified by acetylation and that this event is associated with a significant decrease in histone deacetylase activity and contributes to RTN-1C binding to DNA. These data demonstrate a molecular mechanism by which RTN-1C controls apoptosis and indicate this protein to be a novel potential target for cancer therapy. Oncogene (2009) 28, 3814-3824; doi:10.1038/onc.2009.233; published online 10 August 2009	[Fazi, B.; De Rubeis, S.; Piacentini, M.; Di Sano, F.] Univ Roma Tor Vergata, Dept Biol, I-133 Rome, Italy; [Melino, S.; Paci, M.] Univ Roma Tor Vergata, Dept Sci & Chem Technol, I-133 Rome, Italy; [De Rubeis, S.; Bagni, C.] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [De Rubeis, S.; Bagni, C.] Flanders Inst Biotechnol VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Bagni, C.] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-133 Rome, Italy; [Piacentini, M.] Natl Inst Infect Dis IRCCS L Spallanzani, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Rome Tor Vergata; IRCCS Lazzaro Spallanzani	Piacentini, M (corresponding author), Univ Roma Tor Vergata, Dept Biol, Viale Ric Sci 1, I-133 Rome, Italy.	mauro.piacentini@uniroma2.it	De Rubeis, Silvia/E-9852-2013; Piacentini, Mauro/I-2411-2016	De Rubeis, Silvia/0000-0001-9383-6883; Piacentini, Mauro/0000-0003-2919-1296; Di Sano, Federica/0000-0002-5048-3966; Bagni, Claudia/0000-0002-4419-210X; MELINO, SONIA/0000-0001-7694-5279	Ricerca Corrente; Ministero della Salute; AIRC; Telethon Foundation; EU; Cofin; FIRB	Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Ministero della Salute(Ministry of Health, Italy); AIRC(Fondazione AIRC per la ricerca sul cancro); Telethon Foundation(Fondazione Telethon); EU(European Commission); Cofin; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was partially supported by grants from Ricerca Corrente and Finalizzata from Ministero della Salute, AIRC, Telethon Foundation, EU integrated project 'Apo-sys' and Cofin 2006 to MP, and from COFIN and FIRB to CB.	Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Di Sano F, 2007, J NEUROCHEM, V102, P345, DOI 10.1111/j.1471-4159.2007.04479.x; Eliseeva ED, 2007, MOL CANCER THER, V6, P2391, DOI 10.1158/1535-7163.MCT-07-0159; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gonzenbach RR, 2008, CELL MOL LIFE SCI, V65, P161, DOI 10.1007/s00018-007-7170-3; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gupta S, 2005, NUCLEIC ACIDS RES, V33, P6972, DOI 10.1093/nar/gki990; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Huber AB, 2002, J NEUROSCI, V22, P3553; Iwahashi J, 2003, Cell Mol Biol (Noisy-le-grand), V49 Online Pub, pOL467; Iwahashi J, 2007, BIOCHEM BIOPH RES CO, V355, P508, DOI 10.1016/j.bbrc.2007.02.001; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kuang E, 2005, J CELL PHYSIOL, V204, P549, DOI 10.1002/jcp.20340; Lin HY, 2006, MED RES REV, V26, P397, DOI 10.1002/med.20056; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Melino S, 2009, BIOCHEMISTRY-US, V48, P242, DOI 10.1021/bi801407w; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oertle T, 2003, J MOL BIOL, V325, P299, DOI 10.1016/S0022-2836(02)01179-8; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; PUIG OM, 1988, BIOCHIM BIOPHYS ACTA, V1397, P79; ROEBROEK AJM, 1993, J BIOL CHEM, V268, P13439; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Steiner P, 2004, J NEUROCHEM, V89, P569, DOI 10.1111/j.1471-4159.2004.02345.x; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Tagami S, 2000, ONCOGENE, V19, P5736, DOI 10.1038/sj.onc.1203948; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	39	29	29	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	43					3814	3824		10.1038/onc.2009.233	http://dx.doi.org/10.1038/onc.2009.233			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	512KT	19668229				2022-12-25	WOS:000271248400005
J	Nepusz, T; Petroczi, A; Naughton, DP				Nepusz, Tamas; Petroczi, Andrea; Naughton, Declan P.			Network Analytical Tool for Monitoring Global Food Safety Highlights China	PLOS ONE			English	Article								Background: The Beijing Declaration on food safety and security was signed by over fifty countries with the aim of developing comprehensive programs for monitoring food safety and security on behalf of their citizens. Currently, comprehensive systems for food safety and security are absent in many countries, and the systems that are in place have been developed on different principles allowing poor opportunities for integration. Methodology/Principal Findings: We have developed a user-friendly analytical tool based on network approaches for instant customized analysis of food alert patterns in the European dataset from the Rapid Alert System for Food and Feed. Data taken from alert logs between January 2003-August 2008 were processed using network analysis to i) capture complexity, ii) analyze trends, and iii) predict possible effects of interventions by identifying patterns of reporting activities between countries. The detector and transgressor relationships are readily identifiable between countries which are ranked using i) Google's PageRank algorithm and ii) the HITS algorithm of Kleinberg. The program identifies Iran, China and Turkey as the transgressors with the largest number of alerts. However, when characterized by impact, counting the transgressor index and the number of countries involved, China predominates as a transgressor country. Conclusions/Significance: This study reports the first development of a network analysis approach to inform countries on their transgressor and detector profiles as a user-friendly aid for the adoption of the Beijing Declaration. The ability to instantly access the country-specific components of the several thousand annual reports will enable each country to identify the major transgressors and detectors within its trading network. Moreover, the tool can be used to monitor trading countries for improved detector/transgressor ratios.			Nepusz, T (corresponding author), Kingston Univ, Sch Life Sci, London, England.	T.Nepusz@kingston.ac.uk	Petroczi, Andrea/ABG-9863-2021	Petroczi, Andrea/0000-0002-8365-6173				Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Kleinberg J.M., 1998, P 9 ANN ACM SIAM S D, P668; Nepusz T, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-308; *RW ROB W JOHNS FD, 2009, KEEP AM FOOD SAF BLU; EU RAPID ALERT SYSTE	5	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6680	10.1371/journal.pone.0006680	http://dx.doi.org/10.1371/journal.pone.0006680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688088	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000269075800015
J	Miller, MEB; Antonopoulos, DA; Rincon, MT; Band, M; Bari, A; Akraiko, T; Hernandez, A; Thimmapuram, J; Henrissat, B; Coutinho, PM; Borovok, I; Jindou, S; Lamed, R; Flint, HJ; Bayer, EA; White, BA				Miller, Margret E. Berg; Antonopoulos, Dionysios A.; Rincon, Marco T.; Band, Mark; Bari, Albert; Akraiko, Tatsiana; Hernandez, Alvaro; Thimmapuram, Jyothi; Henrissat, Bernard; Coutinho, Pedro M.; Borovok, Ilya; Jindou, Sadanari; Lamed, Raphael; Flint, Harry J.; Bayer, Edward A.; White, Bryan A.			Diversity and Strain Specificity of Plant Cell Wall Degrading Enzymes Revealed by the Draft Genome of Ruminococcus flavefaciens FD-1	PLOS ONE			English	Article							MICROBIAL GENE IDENTIFICATION; BETA-GLUCANASE GENE; CLOSTRIDIUM-THERMOCELLUM; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCE; CELLULOSE; PROTEIN; RUMINOCOCCUS-FLAVEFACIENS-17; EXPRESSION	Background: Ruminococcus flavefaciens is a predominant cellulolytic rumen bacterium, which forms a multi-enzyme cellulosome complex that could play an integral role in the ability of this bacterium to degrade plant cell wall polysaccharides. Identifying the major enzyme types involved in plant cell wall degradation is essential for gaining a better understanding of the cellulolytic capabilities of this organism as well as highlighting potential enzymes for application in improvement of livestock nutrition and for conversion of cellulosic biomass to liquid fuels. Methodology/Principal Findings: The R. flavefaciens FD-1 genome was sequenced to 29x-coverage, based on pulsed-field gel electrophoresis estimates (4.4 Mb), and assembled into 119 contigs providing 4,576,399 bp of unique sequence. As much as 87.1% of the genome encodes ORFs, tRNA, rRNAs, or repeats. The GC content was calculated at 45%. A total of 4,339 ORFs was detected with an average gene length of 918 bp. The cellulosome model for R. flavefaciens was further refined by sequence analysis, with at least 225 dockerin-containing ORFs, including previously characterized cohesin-containing scaffoldin molecules. These dockerin-containing ORFs encode a variety of catalytic modules including glycoside hydrolases (GHs), polysaccharide lyases, and carbohydrate esterases. Additionally, 56 ORFs encode proteins that contain carbohydrate-binding modules (CBMs). Functional microarray analysis of the genome revealed that 56 of the cellulosome-associated ORFs were up-regulated, 14 were down-regulated, 135 were unaffected, when R. flavefaciens FD-1 was grown on cellulose versus cellobiose. Three multi-modular xylanases (ORF01222, ORF03896, and ORF01315) exhibited the highest levels of up-regulation. Conclusions/Significance: The genomic evidence indicates that R. flavefaciens FD-1 has the largest known number of fiber-degrading enzymes likely to be arranged in a cellulosome architecture. Functional analysis of the genome has revealed that the growth substrate drives expression of enzymes predicted to be involved in carbohydrate metabolism as well as expression and assembly of key cellulosomal enzyme components.	[Miller, Margret E. Berg; Antonopoulos, Dionysios A.; Band, Mark; Bari, Albert; Akraiko, Tatsiana; Hernandez, Alvaro; Thimmapuram, Jyothi; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Rincon, Marco T.; Flint, Harry J.] Univ Aberdeen, Microbial Ecol Grp, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 1, Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 2, F-13284 Marseille 07, France; [Henrissat, Bernard; Coutinho, Pedro M.] CNRS, Marseille, France; [Borovok, Ilya; Jindou, Sadanari; Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Aberdeen; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Tel Aviv University; Weizmann Institute of Science	Miller, MEB (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	bwhite44@illinois.edu	Henrissat, Bernard/J-2475-2012; Antonopoulos, Dionysios/ABE-6212-2020; Rincon, Marco T/T-4798-2019; BOROVOK, ILYA/ABB-7370-2022	Henrissat, Bernard/0000-0002-3434-8588; Antonopoulos, Dionysios/0000-0002-2238-5031; BOROVOK, ILYA/0000-0003-1602-4499; Berg, Margret/0000-0002-0411-1619	USDA [2002-35206-11634]; Israel Science Foundation [422/05, 159/07, 291/08]; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Initiative for Future Agriculture and Food Systems [2000-52100-9618, 2001-52100-11330]; USDA Cooperative State Research, Education, and Extension Service; Scottish Government Rural Environment Research and Analysis Directorate	USDA(United States Department of Agriculture (USDA)); Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); Initiative for Future Agriculture and Food Systems; USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Scottish Government Rural Environment Research and Analysis Directorate	This work was supported by a USDA grant for Functional Genomics of Ruminococcus flavefaciens FD-1 (Grant No. 2002-35206-11634) and by grants from the Israel Science Foundation (Grant Nos 422/05, 159/07 and 291/08) and the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel. We also thank the The North American Consortium for Genomics of Fibrolytic Ruminal Bacteria which was supported by the Initiative for Future Agriculture and Food Systems, Grant no. 2000-52100-9618 and Grant No 2001-52100-11330, from the USDA Cooperative State Research, Education, and Extension Service's National Research Initiative Competitive Grants Program for support for DA. HJF would like to acknowledge support from the Scottish Government Rural Environment Research and Analysis Directorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON MJ, 1958, SCIENCE, V128, P474, DOI 10.1126/science.128.3322.474; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonopoulos DA, 2004, ENVIRON MICROBIOL, V6, P335, DOI 10.1111/j.1462-2920.2004.00576.x; Antonopoulos DA, 2003, FEMS MICROBIOL LETT, V227, P1, DOI 10.1016/S0378-1097(03)00597-4; Antonopoulos DA, 2003, ARCH MICROBIOL, V179, P184, DOI 10.1007/s00203-002-0513-4; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Aurilia V, 2000, ANAEROBE, V6, P333, DOI 10.1006/anae.2000.0358; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; BAYER EA, 2000, PROKARYOTES EVOLVING; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Bron PA, 2006, J APPL MICROBIOL, V100, P728, DOI 10.1111/j.1365-2672.2006.02891.x; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; BRYANT MP, 1958, J BACTERIOL, V76, P529, DOI 10.1128/JB.76.5.529-537.1958; BRYANT MP, 1953, J DAIRY SCI, V36, P205, DOI 10.3168/jds.S0022-0302(53)91482-9; BRYANT MP, 1961, APPL MICROBIOL, V9, P96, DOI 10.1128/AEM.9.2.96-103.1961; BRYANT MP, 1963, J DAIRY SCI, V46, P150, DOI 10.3168/jds.S0022-0302(63)88991-2; Bryant MP, 1986, BERGEYS MANUAL SYSTE, V2, P1093; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DEHORITY BA, 1967, J DAIRY SCI, V50, P1136, DOI 10.3168/jds.S0022-0302(67)87579-9; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; DOERNER KC, 1990, APPL ENVIRON MICROB, V56, P1844, DOI 10.1128/AEM.56.6.1844-1850.1990; DOERNER KC, 1992, FEMS MICROBIOL LETT, V93, P147; Dror TW, 2003, J BACTERIOL, V185, P3042, DOI 10.1128/JB.185.10.3042-3048.2003; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; FLINT HJ, 1989, APPL ENVIRON MICROB, V55, P1230, DOI 10.1128/AEM.55.5.1230-1233.1989; FLINT HJ, 1993, J BACTERIOL, V175, P2943, DOI 10.1128/JB.175.10.2943-2951.1993; FLINT HJ, 1994, CURR MICROBIOL, V29, P139, DOI 10.1007/BF01570754; GARDNER RM, 1987, J BACTERIOL, V169, P4581, DOI 10.1128/jb.169.10.4581-4588.1987; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HELASZEK CT, 1991, APPL ENVIRON MICROB, V57, P64, DOI 10.1128/AEM.57.1.64-68.1991; HUNGATE RE, 1947, J BACTERIOL, V53, P631, DOI 10.1128/JB.53.5.631-645.1947; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Kirby J, 1997, FEMS MICROBIOL LETT, V149, P213, DOI 10.1111/j.1574-6968.1997.tb10331.x; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Kwinn LA, 2007, J BACTERIOL, V189, P1322, DOI 10.1128/JB.01256-06; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Mongodin E, 2003, J BACTERIOL, V185, P4638, DOI 10.1128/JB.185.15.4638-4643.2003; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; ODENYO AA, 1994, APPL ENVIRON MICROB, V60, P3688, DOI 10.1128/AEM.60.10.3688-3696.1994; Ohara H, 2000, BIOSCI BIOTECH BIOCH, V64, P254, DOI 10.1271/bbb.64.254; Ohara H, 2000, BIOSCI BIOTECH BIOCH, V64, P80, DOI 10.1271/bbb.64.80; Pearson W R, 1994, Methods Mol Biol, V24, P307; PETTIPHER GL, 1979, J GEN MICROBIOL, V110, P21, DOI 10.1099/00221287-110-1-21; RASMUSSEN MA, 1988, APPL ENVIRON MICROB, V54, P890, DOI 10.1128/AEM.54.4.890-897.1988; Reglier-Poupet H, 2003, J BIOL CHEM, V278, P49469, DOI 10.1074/jbc.M307953200; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; Rincon MT, 2001, APPL ENVIRON MICROB, V67, P4426, DOI 10.1128/AEM.67.10.4426-4431.2001; Robert C, 2003, FEMS MICROBIOL ECOL, V46, P81, DOI 10.1016/S0168-6496(03)00207-1; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Salim KY, 2007, INFECT IMMUN, V75, P5011, DOI 10.1128/IAI.01824-06; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Selkov E, 2000, P NATL ACAD SCI USA, V97, P3509, DOI 10.1073/pnas.97.7.3509; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VERCOE PE, 1995, CAN J MICROBIOL, V41, P869, DOI 10.1139/m95-120; VERCOE PE, 1995, CAN J MICROBIOL, V41, P27, DOI 10.1139/m95-004; WANG WY, 1990, MOL GEN GENET, V222, P265, DOI 10.1007/BF00633827; WANG WY, 1993, J GEN MICROBIOL, V139, P1219, DOI 10.1099/00221287-139-6-1219; WHITE BA, 1990, MICROBIAL PLANT OPPU; WOLIN MJ, 1983, FED PROC, V42, P109; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; ZHANG JX, 1992, MOL MICROBIOL, V6, P1013, DOI 10.1111/j.1365-2958.1992.tb02167.x; Zverlov VV, 2005, PROTEOMICS, V5, P3646, DOI 10.1002/pmic.200401199	76	95	101	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6650	10.1371/journal.pone.0006650	http://dx.doi.org/10.1371/journal.pone.0006650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680555	Green Published, Green Submitted, gold			2022-12-25	WOS:000268936200015
J	Santoro, R; Lienemann, P; Fussenegger, M				Santoro, Raffaella; Lienemann, Philipp; Fussenegger, Martin			Epigenetic Engineering of Ribosomal RNA Genes Enhances Protein Production	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; HAMSTER OVARY CELLS; NORC; DNA; METHYLATION; EXPRESSION; BIOGENESIS; PROMOTER; CANCER	Selection of mammalian high-producer cell lines remains a major challenge for the biopharmaceutical manufacturing industry. Ribosomal RNA (rRNA) genes encode the major component of the ribosome but many rRNA gene copies are not transcribed [1-5] due to epigenetic silencing by the nucleolar remodelling complex (NoRC) [6], which may limit the cell's full production capacity. Here we show that the knockdown of TIP5, a subunit of NoRC, decreases the number of silent rRNA genes, upregulates rRNA transcription, enhances ribosome synthesis and increases production of recombinant proteins. However, general enhancement of rRNA transcription rate did not stimulate protein synthesis. Our data demonstrates that the number of transcriptionally competent rRNA genes limits efficient ribosome synthesis. Epigenetic engineering of ribosomal RNA genes offers new possibilities for improving biopharmaceutical manufacturing and provides novel insights into the complex regulatory network which governs the translation machinery in normal cellular processes as well as in pathological conditions like cancer.	[Santoro, Raffaella; Lienemann, Philipp; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Santoro, R (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	raffaella.santoro@bsse.ethz.ch; fussenegger@bsse.ethz.ch	Santoro, Raffaella/L-2637-2013	Lienemann, Philipp/0000-0002-0272-3988	Swiss National Science Foundation (SNF); 7th EC Framework Program (PERSIST)	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); 7th EC Framework Program (PERSIST)	Swiss National Science Foundation (SNF); 7th EC Framework Program (PERSIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Li JW, 2005, EMBO J, V24, P120, DOI 10.1038/sj.emboj.7600492; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; MUSCARELLA DE, 1985, J CELL BIOL, V101, P1749, DOI 10.1083/jcb.101.5.1749; Qu GZ, 1999, CANCER GENET CYTOGEN, V109, P34, DOI 10.1016/S0165-4608(98)00143-5; RIVIN CJ, 1986, GENETICS, V113, P1009; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Santoro R, 2005, CELL MOL LIFE SCI, V62, P2067, DOI 10.1007/s00018-005-5110-7; Schlatter S, 2003, BIOTECHNOL BIOENG, V81, P1, DOI 10.1002/bit.10549; Schlatter S, 2002, GENE, V282, P19, DOI 10.1016/S0378-1119(01)00824-1; Shiraishi M, 1999, BIOL CHEM, V380, P1127, DOI 10.1515/BC.1999.141; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Underhill MF, 2003, BIOTECHNOL PROGR, V19, P121, DOI 10.1021/bp025560b; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	29	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6653	10.1371/journal.pone.0006653	http://dx.doi.org/10.1371/journal.pone.0006653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680546	Green Published, Green Submitted, gold			2022-12-25	WOS:000268936200017
J	Badders, NM; Goel, S; Clark, RJ; Klos, KS; Kim, S; Bafico, A; Lindvall, C; Williams, BO; Alexander, CM				Badders, Nisha M.; Goel, Shruti; Clark, Rod J.; Klos, Kristine S.; Kim, Soyoung; Bafico, Anna; Lindvall, Charlotta; Williams, Bart O.; Alexander, Caroline M.			The Wnt Receptor, Lrp5, Is Expressed by Mouse Mammary Stem Cells and Is Required to Maintain the Basal Lineage	PLOS ONE			English	Article							GENE-EXPRESSION; GLAND DEVELOPMENT; SIGNALING PATHWAYS; CANCER; P63; INTERNALIZATION; PROLIFERATION; ACCUMULATION; PROTEIN; DIFFERENTIATION	Background: Ectopic Wnt signaling induces increased stem/ progenitor cell activity in the mouse mammary gland, followed by tumor development. The Wnt signaling receptors, Lrp5/6, are uniquely required for canonical Wnt activity. Previous data has shown that the absence of Lrp5 confers resistance to Wnt1-induced tumor development. Methodology/Principal Findings: Here, we show that all basal mammary cells express Lrp5, and co-express Lrp6 in a similar fashion. Though Wnt dependent transcription of key target genes is relatively unchanged in mammary epithelial cell cultures, the absence of Lrp5 specifically depletes adult regenerative stem cell activity (to less than 1%). Stem cell activity can be enriched by >200 fold (over 80% of activity), based on high Lrp5 expression alone. Though Lrp5 null glands have apparent normal function, the basal lineage is relatively reduced (from 42% basal/total epithelial cells to 22%) and Lrp5(-/-) mammary epithelial cells show enhanced expression of senescence-associated markers in vitro, as measured by expression of p16(Ink4a) and TA-p63. Conclusions/Significance: This is the first single biomarker that has been demonstrated to be functionally involved in stem cell maintenance. Together, these results demonstrate that Wnt signaling through Lrp5 is an important component of normal mammary stem cell function.	[Badders, Nisha M.; Goel, Shruti; Clark, Rod J.; Klos, Kristine S.; Kim, Soyoung; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Bafico, Anna] Cardiff Univ, Dept Pathol, Cardiff, S Glam, Wales; [Lindvall, Charlotta; Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA	University of Wisconsin System; University of Wisconsin Madison; Cardiff University; Van Andel Institute	Badders, NM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301	American Cancer Society [W81XWH-06-1-0491, PF-07-294-01-CNE]; NATIONAL CANCER INSTITUTE [T32CA157322, R01CA090877] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an Era of Hope Scholars award to CMA (W81XWH-06-1-0491) and a post-doctoral award from the American Cancer Society to NMB (PF-07-294-01-CNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2008, CANCER BIOL THER, V7, P1706, DOI 10.4161/cbt.7.11.6943; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005; Benhaj K, 2006, ONCOL REP, V15, P701; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; Figueroa DJ, 2000, J HISTOCHEM CYTOCHEM, V48, P1357, DOI 10.1177/002215540004801006; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jin T, 2008, DIABETOLOGIA, V51, P1771, DOI 10.1007/s00125-008-1084-y; Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lako M, 2001, MECH DEVELOP, V103, P49, DOI 10.1016/S0925-4773(01)00331-8; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lee YJ, 1999, J BIOL CHEM, V274, P22401, DOI 10.1074/jbc.274.32.22401; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu BY, 2003, ONCOGENE, V22, P9243, DOI 10.1038/sj.onc.1207217; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Mi KH, 2007, J NEUROCHEM, V101, P517, DOI 10.1111/j.1471-4159.2007.04447.x; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Paguirigan A, 2007, CELL PROLIFERAT, V40, P106; Pandur P, 2001, BIOESSAYS, V23, P207, DOI 10.1002/1521-1878(200103)23:3<207::AID-BIES1029>3.0.CO;2-0; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Reya T, 2003, RECENT PROG HORM RES, V58, P283, DOI 10.1210/rp.58.1.283; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Ruzankina Y, 2007, BRIT J CANCER, V97, P1189, DOI 10.1038/sj.bjc.6604029; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shibamoto S, 1998, GENES CELLS, V3, P659; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; van Dam AA, 2002, REV FISH BIOL FISHER, V12, P1, DOI 10.1023/A:1022639805031; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Wu GJ, 2003, CANCER RES, V63, P2351; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	76	100	101	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6594	10.1371/journal.pone.0006594	http://dx.doi.org/10.1371/journal.pone.0006594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672307	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900009
J	Miletic, AV; Graham, DB; Sakata-Sogawa, K; Hiroshima, M; Hamann, MJ; Cemerski, S; Kloeppel, T; Billadeau, DD; Kanagawa, O; Tokunaga, M; Swat, W				Miletic, Ana V.; Graham, Daniel B.; Sakata-Sogawa, Kumiko; Hiroshima, Michio; Hamann, Michael J.; Cemerski, Saso; Kloeppel, Tracie; Billadeau, Daniel D.; Kanagawa, Osami; Tokunaga, Makio; Swat, Wojciech			Vav Links the T Cell Antigen Receptor to the Actin Cytoskeleton and T Cell Activation Independently of Intrinsic Guanine Nucleotide Exchange Activity	PLOS ONE			English	Article							DBL HOMOLOGY DOMAIN; IMMUNOLOGICAL SYNAPSE; TYROSINE PHOSPHORYLATION; PROTOONCOGENE PRODUCT; P21-ACTIVATED KINASES; SIGNAL-TRANSDUCTION; BIOLOGICAL-ACTIVITY; PRESENTING CELLS; SH2 DOMAIN; TCR	Background: T cell receptor (TCR) engagement leads to formation of signaling microclusters and induction of rapid and dynamic changes in the actin cytoskeleton, although the exact mechanism by which the TCR initiates actin polymerization is incompletely understood. The Vav family of guanine nucleotide exchange factors (GEF) has been implicated in generation of TCR signals and immune synapse formation, however, it is currently not known if Vav's GEF activity is required in T cell activation by the TCR in general, and in actin polymerization downstream of the TCR in particular. Methodology/Principal Findings: Here, we report that Vav1 assembles into signaling microclusters at TCR contact sites and is critical for TCR-initiated actin polymerization. Surprisingly, Vav1 functions in TCR signaling and Ca++ mobilization via a mechanism that does not appear to strictly depend on the intrinsic GEF activity. Conclusions/Significance: We propose here a model in which Vav functions primarily as a tyrosine phosphorylated linker-protein for TCR activation of T cells. Our results indicate that, contrary to expectations based on previously published studies including from our own laboratory, pharmacological inhibition of Vav1's intrinsic GEF activity may not be an effective strategy for T cell-directed immunosuppressive therapy.	[Miletic, Ana V.; Graham, Daniel B.; Cemerski, Saso; Kloeppel, Tracie; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Miletic, Ana V.; Graham, Daniel B.; Cemerski, Saso; Kloeppel, Tracie; Swat, Wojciech] Siteman Canc Ctr, St Louis, MO USA; [Sakata-Sogawa, Kumiko; Hiroshima, Michio; Tokunaga, Makio] RIKEN, Ctr Allergy & Immunol, Res Unit Single Mol Immunoimaging, Kanagawa, Japan; [Hamann, Michael J.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA; [Hamann, Michael J.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN USA; [Kanagawa, Osami] RIKEN, Ctr Allergy & Immunol, Lab Autoimmune Regulat, Kanagawa, Japan; [Tokunaga, Makio] Grad Univ Adv Studies, Natl Inst Genet, Struct Biol Ctr, Shizuoka, Japan; [Tokunaga, Makio] Grad Univ Adv Studies, Dept Genet, Shizuoka, Japan	Washington University (WUSTL); Siteman Cancer Center; RIKEN; Mayo Clinic; Mayo Clinic; RIKEN; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Miletic, AV (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	swat@wustl.edu		Tokunaga, Makio/0000-0003-4586-8922	NIH [P30-AR048335, RO1-AI061077, RO1-AI065447]; NEDO; MEXT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061077, R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20114004] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEDO(New Energy and Industrial Technology Development Organization (NEDO)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support by: NIH P30-AR048335 (WS), RO1-AI061077 (WS), RO1-AI065447 (DDB), NEDO (MT), and MEXT Adv.Innov.Res.Program (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Amarasinghe GK, 2005, BIOCHEMISTRY-US, V44, P15257, DOI 10.1021/bi051126h; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Billadeau DD, 2000, J IMMUNOL, V164, P3971, DOI 10.4049/jimmunol.164.8.3971; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Fang N, 1999, J BIOL CHEM, V274, P16206, DOI 10.1074/jbc.274.23.16206; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Fujita Masato, 2003, Memoir of the Fukui Prefectural Dinosaur Museum, V2, P3; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Gomez-Rodriguez J, 2007, IMMUNOL REV, V218, P45, DOI 10.1111/j.1600-065X.2007.00534.x; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huang J, 2000, EUR J IMMUNOL, V30, P50, DOI 10.1002/1521-4141(200001)30:1<50::AID-IMMU50>3.3.CO;2-9; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KATZAV S, 1994, J BIOL CHEM, V269, P32579; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Manser E, 1998, METH MOL B, V84, P295; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Prisco A, 2005, IMMUNITY, V23, P263, DOI 10.1016/j.immuni.2005.07.007; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Schiller MR, 2005, EXP CELL RES, V307, P402, DOI 10.1016/j.yexcr.2005.03.024; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tanaka Y, 2005, BLOOD, V106, P1286, DOI 10.1182/blood-2004-10-4074; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	71	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6599	10.1371/journal.pone.0006599	http://dx.doi.org/10.1371/journal.pone.0006599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672294	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900013
J	Wai, SC; Gerber, SA; Li, R				Wai, Stephanie C.; Gerber, Scott A.; Li, Rong			Multisite Phosphorylation of the Guanine Nucleotide Exchange Factor Cdc24 during Yeast Cell Polarization	PLOS ONE			English	Article								Background: Cell polarization is essential for processes such as cell migration and asymmetric cell division. A common regulator of cell polarization in most eukaryotic cells is the conserved Rho GTPase, Cdc42. In budding yeast, Cdc42 is activated by a single guanine nucleotide exchange factor, Cdc24. The mechanistic details of Cdc24 activation at the onset of yeast cell polarization are unclear. Previous studies have suggested an important role for phosphorylation of Cdc24, which may regulate activity or function of the protein, representing a key step in the symmetry breaking process. Methodology/Principal Findings: Here, we directly ask whether multisite phosphorylation of Cdc24 plays a role in its regulation. We identify through mass spectrometry analysis over thirty putative in vivo phosphorylation sites. We first focus on sites matching consensus sequences for cyclin-dependent and p21-activated kinases, two kinase families that have been previously shown to phosphorylate Cdc24. Through site-directed mutagenesis, yeast genetics, and light and fluorescence microscopy, we show that nonphosphorylatable mutations of these consensus sites do not lead to any detectable consequences on growth rate, morphology, kinetics of polarization, or localization of the mutant protein. We do, however, observe a change in the mobility shift of mutant Cdc24 proteins on SDS-PAGE, suggesting that we have indeed perturbed its phosphorylation. Finally, we show that mutation of all identified phosphorylation sites does not cause observable defects in growth rate or morphology. Conclusions/Significance: We conclude that lack of phosphorylation on Cdc24 has no overt functional consequences in budding yeast. Yeast cell polarization may be more tightly regulated by inactivation of Cdc42 by GTPase activating proteins or by alternative methods of Cdc24 regulation, such as conformational changes or oligomerization.			Wai, SC (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	rli@stowers.org		Gerber, Scott/0000-0002-2964-5051	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057063] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Burke D., 2000, METHODS YEAST GENETI; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; DRUBIN DG, 2000, CELL POLARITY; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Gururaj AE, 2005, BREAST CANCER RES, V7, P5, DOI 10.1186/bcr961; Haas W, 2006, MOL CELL PROTEOMICS; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Michelitch M, 1996, CURR BIOL, V6, P446, DOI 10.1016/S0960-9822(02)00512-2; Mionnet C, 2008, J BIOL CHEM, V283, P17515, DOI 10.1074/jbc.M800305200; MIYAMOTO S, 1991, BIOCHEM BIOPH RES CO, V181, P604, DOI 10.1016/0006-291X(91)91233-3; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Pruyne D, 2000, J CELL SCI, V113, P365; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Shimada Y, 2004, EMBO J, V23, P1051, DOI 10.1038/sj.emboj.7600124; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Toenjes KA, 2004, CURR GENET, V45, P257, DOI 10.1007/s00294-004-0485-9; Toenjes KA, 1999, CURR BIOL, V9, P1183, DOI 10.1016/S0960-9822(00)80022-6; Tuazon PT, 1997, BIOCHEMISTRY-US, V36, P16059, DOI 10.1021/bi9717845; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wootton JC, 1996, METHOD ENZYMOL, V266, P554	55	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6563	10.1371/journal.pone.0006563	http://dx.doi.org/10.1371/journal.pone.0006563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668330	gold, Green Submitted, Green Published			2022-12-25	WOS:000268773300005
J	Petit-Bertron, AF; Machavoine, F; Defresne, MP; Gillard, M; Chatelain, P; Mistry, P; Schneider, E; Dy, M				Petit-Bertron, Anne-France; Machavoine, Francois; Defresne, Marie Paule; Gillard, Michel; Chatelain, Pierre; Mistry, Prakash; Schneider, Elke; Dy, Michel			H4 Histamine Receptors Mediate Cell Cycle Arrest in Growth Factor-Induced Murine and Human Hematopoietic Progenitor Cells	PLOS ONE			English	Article							HIGH-DOSE CYCLOPHOSPHAMIDE; H-4 RECEPTOR; PROLIFERATION; CHEMOTAXIS; EXPRESSION; PROTECTION; AGENTS; MICE; H1	The most recently characterized H4 histamine receptor (H4R) is expressed preferentially in the bone marrow, raising the question of its role during hematopoiesis. Here we show that both murine and human progenitor cell populations express this receptor subtype on transcriptional and protein levels and respond to its agonists by reduced growth factor-induced cell cycle progression that leads to decreased myeloid, erythroid and lymphoid colony formation. H4R activation prevents the induction of cell cycle genes through a cAMP/PKA-dependent pathway that is not associated with apoptosis. It is mediated specifically through H4R signaling since gene silencing or treatment with selective antagonists restores normal cell cycle progression. The arrest of growth factor-induced G1/S transition protects murine and human progenitor cells from the toxicity of the cell cycle-dependent anticancer drug Ara-C in vitro and reduces aplasia in a murine model of chemotherapy. This first evidence for functional H4R expression in hematopoietic progenitors opens new therapeutic perspectives for alleviating hematotoxic side effects of antineoplastic drugs.			Petit-Bertron, AF (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Fac Med, CNRS, UMR8147, Paris, France.	schneider@necker.fr						Bertolini F, 1997, BLOOD, V90, P3027, DOI 10.1182/blood.V90.8.3027; Boer K, 2008, EUR J CELL BIOL, V87, P227, DOI 10.1016/j.ejcb.2007.12.003; BOTNICK LE, 1981, CANCER RES, V41, P2338; Broxmeyer HE, 2006, EXP HEMATOL, V34, P1069, DOI 10.1016/j.exphem.2006.04.007; Buckland KF, 2003, BRIT J PHARMACOL, V140, P1117, DOI 10.1038/sj.bjp.0705530; BYRON JW, 1977, AGENTS ACTIONS, V7, P209, DOI 10.1007/BF01969974; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cianchi F, 2005, CLIN CANCER RES, V11, P6807, DOI 10.1158/1078-0432.CCR-05-0675; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; de Esch IJP, 2005, TRENDS PHARMACOL SCI, V26, P462, DOI 10.1016/j.tips.2005.07.002; Dunford PJ, 2006, J IMMUNOL, V176, P7062, DOI 10.4049/jimmunol.176.11.7062; Dy M, 2004, CYTOKINE GROWTH F R, V15, P393, DOI 10.1016/j.cytogfr.2004.06.003; Gabrilove JL, 2001, SEMIN HEMATOL, V38, P1, DOI 10.1053/shem.2001.27480; Gantner F, 2002, J PHARMACOL EXP THER, V303, P300, DOI 10.1124/jpet.102.036939; Guest I, 2001, EXP HEMATOL, V29, P123, DOI 10.1016/S0301-472X(00)00621-4; Gutzmer R, 2005, J IMMUNOL, V174, P5224, DOI 10.4049/jimmunol.174.9.5224; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; HORNUNG RL, 1992, BLOOD, V80, P77; Hough LB, 2001, MOL PHARMACOL, V59, P415, DOI 10.1124/mol.59.3.415; Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LaBella FS, 2000, SEMIN CANCER BIOL, V10, P47, DOI 10.1006/scbi.2000.0307; Ling P, 2004, BRIT J PHARMACOL, V142, P161, DOI 10.1038/sj.bjp.0705729; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Masse A, 1998, BLOOD, V91, P441, DOI 10.1182/blood.V91.2.441; Medina V, 2008, CANCER BIOL THER, V7, P28, DOI 10.4161/cbt.7.1.5123; Medina V, 2006, CANCER BIOL THER, V5, P1462, DOI 10.4161/cbt.5.11.3273; Miyoshi K, 2006, J PHARMACOL SCI, V101, P3, DOI 10.1254/jphs.FMJ06001X2; MOORE MAS, 1991, BLOOD, V78, P1; MULDER POM, 1989, CANCER RES, V49, P4654; Nagler A, 2004, EXP HEMATOL, V32, P122, DOI 10.1016/j.exphem.2003.09.007; Phillips KA, 1998, J CLIN ONCOL, V16, P3179, DOI 10.1200/JCO.1998.16.9.3179; Rivera ES, 2000, SEMIN CANCER BIOL, V10, P15, DOI 10.1006/scbi.2000.0303; Santini V, 2001, Expert Opin Pharmacother, V2, P479, DOI 10.1517/14656566.2.3.479; Schneider E, 2002, TRENDS IMMUNOL, V23, P255, DOI 10.1016/S1471-4906(02)02215-9; Schneider E, 2005, J EXP MED, V202, P387, DOI 10.1084/jem.20050195; SCHNEIDER E, 1990, J CELL PHYSIOL, V143, P337, DOI 10.1002/jcp.1041430218; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Takeshita K, 2003, J PHARMACOL EXP THER, V307, P1072, DOI 10.1124/jpet.103.057489; Thurmond RL, 2004, J PHARMACOL EXP THER, V309, P404, DOI 10.1124/jpet.103.061754	43	24	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6504	10.1371/journal.pone.0006504	http://dx.doi.org/10.1371/journal.pone.0006504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662098	gold, Green Published, Green Submitted			2022-12-25	WOS:000268739600002
J	Rolland, T; Neuveglise, C; Sacerdot, C; Dujon, B				Rolland, Thomas; Neuveglise, Cecile; Sacerdot, Christine; Dujon, Bernard			Insertion of Horizontally Transferred Genes within Conserved Syntenic Regions of Yeast Genomes	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; NATURAL HYBRIDS; EVOLUTION; BACTERIA; ORIGIN; DNA; INTROGRESSION	Horizontal gene transfer has been occasionally mentioned in eukaryotic genomes, but such events appear much less numerous than in prokaryotes, where they play important functional and evolutionary roles. In yeasts, few independent cases have been described, some of which corresponding to major metabolic functions, but no systematic screening of horizontally transferred genes has been attempted so far. Taking advantage of the synteny conservation among five newly sequenced and annotated genomes of Saccharomycetaceae, we carried out a systematic search for HGT candidates amidst genes present in only one species within conserved synteny blocks. Out of 255 species-specific genes, we discovered 11 candidates for HGT, based on their similarity with bacterial proteins and on reconstructed phylogenies. This corresponds to a minimum of six transfer events because some horizontally acquired genes appear to rapidly duplicate in yeast genomes (e. g. YwqG genes in Kluyveromyces thermotolerans and serine recombinase genes of the IS607 family in Saccharomyces kluyveri). We show that the resulting copies are submitted to a strong functional selective pressure. The mechanisms of DNA transfer and integration are discussed, in relation with the generally small size of HGT candidates. Our results on a limited set of species expand by 50% the number of previously published HGT cases in hemiascomycetous yeasts, suggesting that this type of event is more frequent than usually thought. Our restrictive method does not exclude the possibility that additional HGT events exist. Actually, ancestral events common to several yeast species must have been overlooked, and the absence of homologs in present databases leaves open the question of the origin of the 244 remaining species-specific genes inserted within conserved synteny blocks.	[Rolland, Thomas; Sacerdot, Christine; Dujon, Bernard] Univ Paris 06, UFR927, Unite Genet Mol Levures, Dept Genomes & Genet,Inst Pasteur,CNRS,URA 2171, Paris, France; [Neuveglise, Cecile] AgroParisTech, INRA UMR1238, CNRS UMR2585, Lab Microbiol & Genet Mol, F-78850 Thiverval Grignon, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rolland, T (corresponding author), Univ Paris 06, UFR927, Unite Genet Mol Levures, Dept Genomes & Genet,Inst Pasteur,CNRS,URA 2171, Paris, France.	thomas.rolland@pasteur.fr	Dujon, Bernard A/F-4971-2010	Sacerdot, Christine/0000-0002-7402-3411; Rolland, Thomas/0000-0001-6468-8391				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Andersson JO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-14; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; Borneman AR, 2008, FEMS YEAST RES, V8, P1185, DOI 10.1111/j.1567-1364.2008.00434.x; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Campbell A, 2007, ANNU REV GENET, V41, P1, DOI 10.1146/annurev.genet.41.110306.130240; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cohan FM, 2008, CURR BIOL, V18, pR1024, DOI 10.1016/j.cub.2008.09.014; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Durand F, 2008, YEAST, V25, P563, DOI 10.1002/yea.1608; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; Hellborg L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-164; Huang JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r88; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Khaldi N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003036; KONDRASHOV FA, 2006, BIOL DIRECT, P1; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Muller LAH, 2009, FEMS YEAST RES, V9, P143, DOI 10.1111/j.1567-1364.2008.00464.x; Nakashima K, 2004, DEV GENES EVOL, V214, P81, DOI 10.1007/s00427-003-0379-8; Naumova ES, 2005, YEAST, V22, P1099, DOI 10.1002/yea.1298; NOVO M, 2009, GENOME SEQUENC UNPUB; PAYEN C, 2009, GENOME RES UNPUB; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Sacerdot C, 2008, FEMS YEAST RES, V8, P846, DOI 10.1111/j.1567-1364.2008.00409.x; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; SERET ML, 2007, THESIS U LOUVAIN; SHERMAN DJ, 2009, NUCL ACIDS RES, V37; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; STACHEL SE, 1989, NATURE, V340, P190, DOI 10.1038/340190a0; Temporini ED, 2004, CURR GENET, V46, P29, DOI 10.1007/s00294-004-0506-8; Vandamme P, 2003, RES MICROBIOL, V154, P91, DOI 10.1016/S0923-2508(03)00026-3; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	63	45	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6515	10.1371/journal.pone.0006515	http://dx.doi.org/10.1371/journal.pone.0006515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654869	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739100010
J	Ermonval, M; Baudry, A; Baychelier, F; Pradines, E; Pietri, M; Oda, K; Schneider, BT; Mouillet-Richard, S; Launay, JM; Kellermann, O				Ermonval, Myriam; Baudry, Anne; Baychelier, Florence; Pradines, Elodie; Pietri, Mathea; Oda, Kimimitsu; Schneider, Benoi T.; Mouillet-Richard, Sophie; Launay, Jean-Marie; Kellermann, Odile			The Cellular Prion Protein Interacts with the Tissue Non-Specific Alkaline Phosphatase in Membrane Microdomains of Bioaminergic Neuronal Cells	PLOS ONE			English	Article								Background: The cellular prion protein, PrPC, is GPI anchored and abundant in lipid rafts. The absolute requirement of PrPC in neurodegeneration associated to prion diseases is well established. However, the function of this ubiquitous protein is still puzzling. Our previous work using the 1C11 neuronal model, provided evidence that PrPC acts as a cell surface receptor. Besides a ubiquitous signaling function of PrPC, we have described a neuronal specificity pointing to a role of PrPC in neuronal homeostasis. 1C11 cells, upon appropriate induction, engage into neuronal differentiation programs, giving rise either to serotonergic (1C11(5-HT)) or noradrenergic (1C11(NE)) derivatives. Methodology/Principal Findings: The neuronal specificity of PrPC signaling prompted us to search for PrPC partners in 1C11-derived bioaminergic neuronal cells. We show here by immunoprecipitation an association of PrPC with an 80 kDa protein identified by mass spectrometry as the tissue non-specific alkaline phosphatase (TNAP). This interaction occurs in lipid rafts and is restricted to 1C11-derived neuronal progenies. Our data indicate that TNAP is implemented during the differentiation programs of 1C11(5-HT) and 1C11(NE) cells and is active at their cell surface. Noteworthy, TNAP may contribute to the regulation of serotonin or catecholamine synthesis in 1C11(5-HT) and 1C11(NE) bioaminergic cells by controlling pyridoxal phosphate levels. Finally, TNAP activity is shown to modulate the phosphorylation status of laminin and thereby its interaction with PrP. Conclusion/Significance: The identification of a novel PrPC partner in lipid rafts of neuronal cells favors the idea of a role of PrP in multiple functions. Because PrPC and laminin functionally interact to support neuronal differentiation and memory consolidation, our findings introduce TNAP as a functional protagonist in the PrPC-laminin interplay. The partnership between TNAP and PrPC in neuronal cells may provide new clues as to the neurospecificity of PrPC function.			Ermonval, M (corresponding author), Inst Pasteur, Dept Virol, Paris, France.	myriam.ermonval@pasteur.fr; odile.kellermann@parisdescartes.fr	Baudry, Anne/O-2624-2017; Mouillet, Sophie/E-4960-2017; Schneider, Benoit/AAF-3850-2019	Mouillet, Sophie/0000-0002-8950-1949; PIETRI, Mathea/0000-0002-1819-2878; Schneider, Benoit/0000-0002-1377-2670; Baudry, Anne/0000-0002-7729-1753; Ermonval, Myriam/0000-0002-9685-9826				Azzalin A, 2006, BIOCHEM BIOPH RES CO, V346, P108, DOI 10.1016/j.bbrc.2006.05.097; Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019; BECQ F, 1994, P NATL ACAD SCI USA, V91, P9160, DOI 10.1073/pnas.91.19.9160; BOSSI M, 1993, J BIOL CHEM, V268, P25409; Capellari S, 1999, J BIOL CHEM, V274, P34846, DOI 10.1074/jbc.274.49.34846; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Clausse B, 1997, VIROLOGY, V228, P285, DOI 10.1006/viro.1996.8380; Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x; Ermonval M, 2003, BIOCHIMIE, V85, P33, DOI 10.1016/S0300-9084(03)00040-3; ERMONVAL M, 2008, GLYCOCONJ J IN PRESS; Fonta C, 2004, CEREB CORTEX, V14, P595, DOI 10.1093/cercor/bhh021; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2001, ADV PROTEIN CHEM, V57, P229; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Graner E, 2000, FEBS LETT, V482, P257, DOI 10.1016/S0014-5793(00)02070-6; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Keshet GI, 2000, J NEUROCHEM, V75, P1889, DOI 10.1046/j.1471-4159.2000.0751889.x; Krebs B, 2006, BIOCHEM BIOPH RES CO, V340, P13, DOI 10.1016/j.bbrc.2005.11.158; Langer D, 2007, NEUROSCIENCE, V150, P863, DOI 10.1016/j.neuroscience.2007.07.064; Langer D, 2008, CELL TISSUE RES, V334, P199, DOI 10.1007/s00441-008-0681-x; Lasmezas CI, 2003, BRIT MED BULL, V66, P61, DOI 10.1093/bmb/66.1.61; Ledoux JM, 2005, MED HYPOTHESES, V64, P910, DOI 10.1016/j.mehy.2004.11.020; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Loberto N, 2005, J NEUROCHEM, V95, P771, DOI 10.1111/j.1471-4159.2005.03397.x; Mattei V, 2002, NEUROCHEM RES, V27, P743, DOI 10.1023/A:1020244621373; MATTEI V, 2004, PRION PROTEIN IS COM; Meggio F, 2000, BIOCHEM J, V352, P191, DOI 10.1042/0264-6021:3520191; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; Mouillet-Richard S, 2008, J BIOL CHEM, V283, P23782, DOI 10.1074/jbc.M802433200; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Nakano Y, 2004, BONE, V35, P1077, DOI 10.1016/j.bone.2004.07.009; NARISAWA S, 1994, DEV DYNAM, V201, P227, DOI 10.1002/aja.1002010306; Oda K, 1999, J BIOCHEM, V126, P694, DOI 10.1093/oxfordjournals.jbchem.a022505; Ohkubo S, 2000, BRIT J PHARMACOL, V131, P1667, DOI 10.1038/sj.bjp.0703750; Pereira GS, 2001, NEUROSCI LETT, V301, P72; Pradines E, 2008, CELL SIGNAL, V20, P2050, DOI 10.1016/j.cellsig.2008.07.016; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Scheibe RJ, 2000, J CELL BIOCHEM, V76, P420, DOI 10.1002/(SICI)1097-4644(20000301)76:3<420::AID-JCB10>3.0.CO;2-F; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; SCHMITTULMS G, 2004, NAT BIOTECHNOL, V16, P16; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spielhaupter C, 2001, J BIOL CHEM, V276, P44604, DOI 10.1074/jbc.M103289200; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Trachana V, 2005, INT J BIOCHEM CELL B, V37, P478, DOI 10.1016/j.biocel.2004.08.001; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zimmermann H, 1999, PROG BRAIN RES, V120, P371	60	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6497	10.1371/journal.pone.0006497	http://dx.doi.org/10.1371/journal.pone.0006497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652718	Green Submitted, gold, Green Published			2022-12-25	WOS:000268637800009
J	Ivankov, DN; Bogatyreva, NS; Lobanov, MY; Galzitskaya, OV				Ivankov, Dmitry N.; Bogatyreva, Natalya S.; Lobanov, Michail Yu; Galzitskaya, Oxana V.			Coupling between Properties of the Protein Shape and the Rate of Protein Folding	PLOS ONE			English	Article								There are several important questions on the coupling between properties of the protein shape and the rate of protein folding. We have studied a series of structural descriptors intended for describing protein shapes (the radius of gyration, the radius of cross-section, and the coefficient of compactness) and their possible connection with folding behavior, either rates of folding or the emergence of folding intermediates, and compared them with classical descriptors, protein chain length and contact order. It has been found that when a descriptor is normalized to eliminate the influence of the protein size (the radius of gyration normalized to the radius of gyration of a ball of equal volume, the coefficient of compactness defined as the ratio of the accessible surface area of a protein to that of an ideal ball of equal volume, and relative contact order) it completely looses its ability to predict folding rates. On the other hand, when a descriptor correlates well with protein size (the radius of cross-section and absolute contact order in our consideration) then it correlates well with the logarithm of folding rates and separates reasonably well two-state folders from multi-state ones. The critical control for the performance of new descriptors demonstrated that the radius of cross-section has a somewhat higher predictive power (the correlation coefficient is -0.74) than size alone (the correlation coefficient is -0.65). So, we have shown that the numerical descriptors of the overall shape-geometry of protein structures are one of the important determinants of the protein-folding rate and mechanism.			Ivankov, DN (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia.	ogalzit@vega.protres.ru	Bogatyreva, Natalya S/B-9598-2017; GALZITSKAYA, OXANA V/L-2664-2015; Ivankov, Dmitry/AAD-8104-2019	Ivankov, Dmitry/0000-0002-8224-4118; Bogatyreva, Natalya/0000-0002-1719-1136				Bogatyreva NS, 2009, NUCLEIC ACIDS RES, V37, pD342, DOI 10.1093/nar/gkn696; Capriotti E, 2007, BIOINFORMATICS, V23, P385, DOI 10.1093/bioinformatics/btl610; Cota E, 2000, PROTEIN SCI, V9, P112; De Sancho D, 2009, J AM CHEM SOC, V131, P2074, DOI 10.1021/ja808843h; Dinner AR, 2001, NAT STRUCT BIOL, V8, P21; DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6; Finkelstein AV, 2004, PHYS LIFE REV, V1, P23, DOI 10.1016/j.plrev.2004.03.001; Finkelstein AV, 1997, FOLD DES, V2, P115, DOI 10.1016/S1359-0278(97)00016-3; Galzitskaya OV, 2006, PROTEINS, V63, P144, DOI 10.1002/prot.20851; Galzitskaya OV, 2003, PROTEINS, V51, P162, DOI 10.1002/prot.10343; Galzitskaya OV, 2001, FEBS LETT, V489, P113, DOI 10.1016/S0014-5793(01)02092-0; Galzitskaya OV, 2008, PROTEINS, V70, P329, DOI 10.1002/prot.21619; Galzitskaya Oxana V., 2008, Journal of Bioinformatics and Computational Biology, V6, P667, DOI 10.1142/S0219720008003618; Gong HP, 2003, J MOL BIOL, V327, P1149, DOI 10.1016/S0022-2836(03)00211-0; Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043; Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775; Guijarro JI, 1998, J MOL BIOL, V276, P657, DOI 10.1006/jmbi.1997.1553; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Ivankov DN, 2004, P NATL ACAD SCI USA, V101, P8942, DOI 10.1073/pnas.0402659101; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jones K, 2003, J AM CHEM SOC, V125, P9606, DOI 10.1021/ja0358807; Koga N, 2001, J MOL BIOL, V313, P171, DOI 10.1006/jmbi.2001.5037; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kuznetsov IB, 2004, PROTEINS, V54, P333, DOI 10.1002/prot.10518; Ma BG, 2007, J MOL BIOL, V370, P439, DOI 10.1016/j.jmb.2007.04.051; Makarov DE, 2002, P NATL ACAD SCI USA, V99, P3535, DOI 10.1073/pnas.052713599; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229; Plaxco KW, 1998, BIOCHEMISTRY-US, V37, P2529, DOI 10.1021/bi972075u; Plaxco KW, 1997, J MOL BIOL, V270, P763, DOI 10.1006/jmbi.1997.1148; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Prabhu NP, 2006, BIOCHEMISTRY-US, V45, P3805, DOI 10.1021/bi0521137; Punta M, 2005, J MOL BIOL, V348, P507, DOI 10.1016/j.jmb.2005.02.068; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Shakhnovich EI, 1998, FOLD DES, V3, pR45, DOI 10.1016/S1359-0278(98)00021-2; Sivukhin D V, 1989, GEN COURSE PHYS, V1; THIRUMALAI D, 1995, J PHYS I, V5, P1457, DOI 10.1051/jp1:1995209; Tsai CJ, 1997, PROTEIN SCI, V6, P1426, DOI 10.1002/pro.5560060707; van Nuland NAJ, 1998, J MOL BIOL, V283, P883, DOI 10.1006/jmbi.1998.2009; Voelz VA, 2007, PROTEINS, V66, P877, DOI 10.1002/prot.21234; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; WODAK SJ, 1981, BIOCHEMISTRY-US, V20, P6544, DOI 10.1021/bi00526a005; ZEHFUS MH, 1986, BIOCHEMISTRY-US, V25, P5759, DOI 10.1021/bi00367a062; Zerovnik E, 1998, PROTEINS, V32, P296; Zhang LX, 2003, POLYMER, V44, P1751, DOI 10.1016/S0032-3861(03)00021-1; Zhou HY, 2002, BIOPHYS J, V82, P458, DOI 10.1016/S0006-3495(02)75410-6	47	53	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6476	10.1371/journal.pone.0006476	http://dx.doi.org/10.1371/journal.pone.0006476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649298	gold, Green Submitted, Green Published			2022-12-25	WOS:000268637700003
J	Clay, CA; Lehmer, EM; Jeor, SS; Dearing, MD				Clay, Christine A.; Lehmer, Erin M.; Jeor, Stephen St.; Dearing, M. Denise			Sin Nombre Virus and Rodent Species Diversity: A Test of the Dilution and Amplification Hypotheses	PLOS ONE			English	Article								Background: Species diversity is proposed to greatly impact the prevalence of pathogens. Two predominant hypotheses, the "Dilution Effect'' and the "Amplification Effect'', predict divergent outcomes with respect to the impact of species diversity. The Dilution Effect predicts that pathogen prevalence will be negatively correlated with increased species diversity, while the Amplification Effect predicts that pathogen prevalence will be positively correlated with diversity. For many host-pathogen systems, the relationship between diversity and pathogen prevalence has not be empirically examined. Methodology/Principal Findings: We tested the Dilution and Amplification Effect hypotheses by examining the prevalence of Sin Nombre virus (SNV) with respect to diversity of the nocturnal rodent community. SNV is directly transmitted primarily between deer mice (Peromyscus maniculatus). Using mark-recapture sampling in the Spring and Fall of 2003-2005, we measured SNV prevalence in deer mice at 16 landscape level sites (3.1 hectares each) that varied in rodent species diversity. We explored several mechanisms by which species diversity may affect SNV prevalence, including reduced host density, reduced host persistence, the presence of secondary reservoirs and community composition. We found a negative relationship between species diversity and SNV prevalence in deer mice, thereby supporting the Dilution Effect hypothesis. Deer mouse density and persistence were lower at sites with greater species diversity; however, only deer mouse persistence was positively correlated with SNV prevalence. Pinyon mice (P. truei) may serve as dilution agents, having a negative effect on prevalence, while kangaroo rats (Dipodomys ordii), may have a positive effect on the prevalence of SNV, perhaps through effects on deer mouse behavior. Conclusions/Significance: While previous studies on host-pathogen systems have found patterns of diversity consistent with either the Dilution or Amplification Effects, the mechanisms by which species diversity influences prevalence have not been investigated. Our study indicates that changes in host persistence, coupled with interspecific interactions, are important mechanisms through which diversity may influence patterns of pathogens. Our results reveal the complexity of rodent community interactions with respect to SNV dynamics.			Clay, CA (corresponding author), Westminster Coll, Dept Biol, Salt Lake City, UT USA.	cclay@westminstercollege.edu			NIAID NIH HHS [AI055434-01A1, T32 AI055434] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055434] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbott KD, 1999, EMERG INFECT DIS, V5, P102, DOI 10.3201/eid0501.990112; Alain B, 2006, LANDSCAPE ECOL, V21, P449, DOI 10.1007/s10980-005-4118-6; AMBROSE RF, 1977, J MAMMAL, V58, P665, DOI 10.2307/1380017; Boone JD, 1998, AM J TROP MED HYG, V59, P445, DOI 10.4269/ajtmh.1998.59.445; Borucki MK, 2000, J VIROL, V74, P2426, DOI 10.1128/JVI.74.5.2426-2429.2000; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; BROWN JH, 1985, ECOLOGY, V66, P1545, DOI 10.2307/1938017; BROWN JH, 1973, ECOLOGY, V54, P775, DOI 10.2307/1935672; Calisher CH, 1999, EMERG INFECT DIS, V5, P126, DOI 10.3201/eid0501.990115; Calisher CH, 2001, J WILDLIFE DIS, V37, P280, DOI 10.7589/0090-3558-37.2.280; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cui Qinghu, 2005, Acta Theriologica Sinica, V25, P45; Dearing MD, 1998, J MAMMAL, V79, P1254, DOI 10.2307/1383016; Douglass RJ, 2001, AM J TROP MED HYG, V65, P33, DOI 10.4269/ajtmh.2001.65.33; Doyle TJ, 1998, INFECT DIS CLIN N AM, V12, P95, DOI 10.1016/S0891-5520(05)70411-6; Ernest SKM, 2001, SCIENCE, V292, P101; Falkenberg JC, 1998, J MAMMAL, V79, P558, DOI 10.2307/1382986; Flowerdew JR, 2001, FORESTRY, V74, P277, DOI 10.1093/forestry/74.3.277; Gilbert L, 2001, J ANIM ECOL, V70, P1053, DOI 10.1046/j.0021-8790.2001.00558.x; GINI C, 1912, STUDI ECONOMICOGIU 2, V3; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; HJELLE B, 1994, J VIROL, V68, P592, DOI 10.1128/JVI.68.2.592-596.1994; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick ED, 2004, J IMMUNOL, V172, P3297, DOI 10.4049/jimmunol.172.5.3297; Klein SL, 2004, ANIM BEHAV, V67, P421, DOI 10.1016/j.anbehav.2003.03.022; Klein SL, 2002, J MAMMAL, V83, P478, DOI 10.1644/1545-1542(2002)083&lt;0478:EAPFAW&gt;2.0.CO;2; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; KRITZMAN EB, 1974, J MAMMAL, V55, P172, DOI 10.2307/1379265; Kuenzi AJ, 1999, EMERG INFECT DIS, V5, P113, DOI 10.3201/eid0501.990113; LARSEN E, 1986, OECOLOGIA, V69, P231, DOI 10.1007/BF00377627; Lehmer EM, 2008, OECOLOGIA, V155, P429, DOI 10.1007/s00442-007-0922-9; LLEWELLYN JB, 1987, AM NAT, V129, P365, DOI 10.1086/284642; LLEWELLYN JB, 1980, J MAMMAL, V61, P341, DOI 10.2307/1380062; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Mackelprang R, 2001, EMERG INFECT DIS, V7, P480, DOI 10.3201/eid0703.017328; Mills J. N., 1995, METHODS TRAPPING SAM; Mills JN, 2005, ARCH VIROL, P45; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Mills JN, 1998, AM J TROP MED HYG, V58, P525; Mills JN, 1997, AM J TROP MED HYG, V56, P273; Mills JN, 1999, EMERG INFECT DIS, V5, P95, DOI 10.3201/eid0501.990111; MITCHELL CA, 2003, GLOBAL CHANGE BIOL, V9; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; MUNGER JC, 1981, SCIENCE, V211, P510, DOI 10.1126/science.211.4481.510; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Otteson EW, 1996, AM J TROP MED HYG, V54, P127, DOI 10.4269/ajtmh.1996.54.127; Ovadia O, 2005, OECOLOGIA, V142, P480, DOI 10.1007/s00442-004-1726-9; Peixoto ID, 2006, ECOLOGY, V87, P873, DOI 10.1890/0012-9658(2006)87[873:TEOBOT]2.0.CO;2; RAFFAELLI D, 2002, MULTITROPHIC DYNAMIC; Rogovin KA, 1996, IZV AKAD NAUK BIOL+, P743; Ruedas LA, 2004, J VECTOR ECOL, V29, P177; Smith MD, 1999, OECOLOGIA, V120, P605, DOI 10.1007/s004420050896; Thomas L., 2004, DISTANCE 4 1 RELEASE; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Valone TJ, 2005, J ARID ENVIRON, V61, P161, DOI 10.1016/j.jaridenv.2004.07.011; Yahnke CJ, 2001, AM J TROP MED HYG, V65, P768, DOI 10.4269/ajtmh.2001.65.768; YAMADA T, 1995, J VIROL, V69, P1939, DOI 10.1128/JVI.69.3.1939-1943.1995	59	68	72	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6467	10.1371/journal.pone.0006467	http://dx.doi.org/10.1371/journal.pone.0006467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649283	Green Published, gold			2022-12-25	WOS:000268637600015
J	Van Kerkhove, MD; Ly, S; Guitian, J; Holl, D; San, S; Mangtani, P; Ghani, A; Vong, S				Van Kerkhove, Maria D.; Ly, Sowath; Guitian, Javier; Holl, Davun; San, Sorn; Mangtani, Punam; Ghani, Azra; Vong, Sirenda			Changes in Poultry Handling Behavior and Poultry Mortality Reporting among Rural Cambodians in Areas Affected by HPAI/H5N1	PLOS ONE			English	Article								Background: Since 2004, 21 highly pathogenic avian influenza H5N1 outbreaks in domestic poultry and eight human cases have been confirmed in Cambodia. As a result, a large number of avian influenza education campaigns have been ongoing in provinces in which H5N1 outbreaks have occurred in humans and/or domestic poultry. Methodology/Principal Findings: Data were collected from 1,252 adults >15 years old living in two southern provinces in Cambodia where H5N1 has been confirmed in domestic poultry and human populations using two cross-sectional surveys conducted in January 2006 and in November/December 2007. Poultry handling behaviors, poultry mortality occurrence and self-reported notification of suspect H5N1 poultry cases to animal health officials in these two surveys were evaluated. Our results demonstrate that although some at risk practices have declined since the first study, risky contact with poultry is still frequent. Improved rates of reporting poultry mortality were observed overall, but reporting to trained village animal health workers decreased by approximately 50%. Conclusions/Significance: Although some improvements in human behavior have occurred, there are still areas particularly with respect to the handling of poultry among children and the proper treatment of poultry and the surrounding household environment-that need to be addressed in public health campaigns. Though there were some differences in the sampling methods of the 2006 and 2007 surveys, our results illustrate the potential to induce considerable, potentially very relevant, behavioral changes over a short period of time.			Van Kerkhove, MD (corresponding author), Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia.	m.vankerkhove@imperial.ac.uk	Guitian, Javier/C-3022-2009; Guitian, Javier/O-1185-2019; Guitian, Javier/O-5744-2019; Ghani, Azra/B-8560-2009	Guitian, Javier/0000-0003-0799-0476; Guitian, Javier/0000-0003-0799-0476; Guitian, Javier/0000-0003-0799-0476; Van Kerkhove, Maria/0000-0002-6135-0018; Ghani, Azra/0000-0002-0007-4910; Mangtani, Punam/0000-0001-7074-2999	MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719B] Funding Source: researchfish; Medical Research Council [G0600719] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; LY S, 2007, EMERG INFECT DIS, V13; *OIE, 2009, WHO ORG AN HLTH; *UNICEF, 2008, UNICEF AV PAND INFL; Van Kerkhove MD, 2008, INFLUENZA OTHER RESP, V2, P155, DOI 10.1111/j.1750-2659.2008.00052.x; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; *WHO, 2006, AV INFL SIT CAMB	8	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6466	10.1371/journal.pone.0006466	http://dx.doi.org/10.1371/journal.pone.0006466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649287	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000268637600014
J	Morales, MEP; Gereau, RW				Morales, Maria Elena P.; Gereau, Robert W.			The Effects of Tail Biopsy for Genotyping on Behavioral Responses to Nociceptive Stimuli	PLOS ONE			English	Article								Removal of a small segment of tail at weaning is a common method used to obtain tissue for the isolation of genomic DNA to identify genetically modified mice. When genetically manipulated mice are used for pain research, this practice could result in confounding changes to the animals' responses to noxious stimuli. In this study, we sought to systematically investigate whether tail biopsy representative of that used in standard genotyping methods affects behavioral responses to a battery of tests of nociception. Wild- type littermate C57BL/6J and 129S6 female and male mice received either tail biopsies or control procedural handling at Day 21 after birth and were then tested at 6-9 weeks for mechanical and thermal sensitivity. C57BL/6J mice were also tested in the formalin model of inflammatory pain. In all tests performed (von Frey, Hargreaves, modified Randall Selitto, and formalin), C57BL/6J tail-biopsied animals' behavioral responses were not significantly different from control animals. In 129S6 animals, tail biopsy did not have a significant effect on behavioral responses in either sex to the von Frey and the modified Randall- Selitto tests of mechanical sensitivity. Interestingly, however, both sexes exhibited small but significant differences between tail biopsied and control responses to a radiant heat stimulus. These results indicate that tail biopsy for genotyping purposes has no effect on nocifensive behavioral responses of C57BL/6J mice, and in 129S6 mice, causes only a minor alteration in response to a radiant heat stimulus while other nocifensive behavioral responses are unchanged. The small effect seen is modality-and strain-specific.			Morales, MEP (corresponding author), Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63130 USA.	gereaur@wustl.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS048602, R01NS042595, R56NS048602, F31NS061615] Funding Source: NIH RePORTER; NINDS NIH HHS [NS42595, P30 NS057105, NS48602, F31 NS061615, R56 NS048602, R01 NS042595, R01 NS048602, 1F31NS061615] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bhave G, 2001, NAT NEUROSCI, V4, P417, DOI 10.1038/86075; Bhutta AT, 2001, PHYSIOL BEHAV, V73, P51, DOI 10.1016/S0031-9384(01)00432-2; Blom JMC, 2006, J NEUROSCI RES, V84, P1789, DOI 10.1002/jnr.21077; Carrasquillo Y, 2007, J NEUROSCI, V27, P1543, DOI 10.1523/JNEUROSCI.3536-06.2007; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; Karim F, 2001, MOL PSYCHIATR, V6, P615, DOI 10.1038/sj.mp.4000961; Kest B, 2002, PHARMACOL BIOCHEM BE, V73, P821, DOI 10.1016/S0091-3057(02)00908-5; KITA T, 1979, JPN J PHARMACOL, V29, P479, DOI 10.1254/jjp.29.479; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lidow MS, 2001, NEUROREPORT, V12, P399, DOI 10.1097/00001756-200102120-00042; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mogil JS, 2001, METH NE FRO NEUROSCI, P11; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; Sternberg WF, 2005, PAIN, V113, P347, DOI 10.1016/j.pain.2004.11.013; Yang DN, 2003, PAIN, V106, P411, DOI 10.1016/j.pain.2003.08.011; Young EE, 2008, BEHAV NEUROSCI, V122, P589, DOI 10.1037/0735-7044.122.3.589; Zhuo M, 1998, EUR J PHARMACOL, V349, P211, DOI 10.1016/S0014-2999(98)00197-6	26	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6457	10.1371/journal.pone.0006457	http://dx.doi.org/10.1371/journal.pone.0006457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649248	Green Published, gold			2022-12-25	WOS:000268494600020
J	He, L; Kim, JA; Whistler, JL				He, Li; Kim, Joseph A.; Whistler, Jennifer L.			Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor	FASEB JOURNAL			English	Article						adenylyl cyclase; c-fos; glucocorticoid receptor; NMDA receptor; trafficking	INDUCED DOWN-REGULATION; VENTRAL TEGMENTAL AREA; NMDA RECEPTORS; GLUCOCORTICOID-RECEPTORS; OPIATE WITHDRAWAL; RAT-BRAIN; C-FOS; REDUCES TOLERANCE; NUCLEUS-ACCUMBENS; INDUCED ANALGESIA	Growing evidence shows that trafficking of the mu-opioid receptor (MOR) is a critical process in functional recovery from desensitization following activation and plays important roles in morphine tolerance and dependence largely because of the failure of morphine to promote such trafficking. However, morphine tolerance and dependence are believed to be mediated by multiple mechanisms, including well-documented biochemical changes in cAMP activity, N-methyl-D-aspartate receptors (NMDARs), glucocorticoid receptors (GRs), and c-fos. Here, we assess the consequences of promoting morphine-induced endocytosis on these biochemical changes utilizing a knock-in mouse model, RMOR, in which MORs undergo morphine-induced endocytosis. Chronic morphine treatment of wild-type (WT) mice promoted superactivation of adenylyl cyclase, alterations in NMDARs, and up-regulation of GR and c-fos in distinct brain regions. Notably, none of these biochemical changes occurred in the RMOR-knock-in mice. Together, these data demonstrate that morphine tolerance and dependence are mediated by multiple biochemical mechanisms and that MOR endocytosis plays a critical role in each of these mechanisms.-He, L., Kim, J. A., Whistler, J. L. Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor. FASEB J. 23, 4327-4334 (2009). www.fasebj.org	[Whistler, Jennifer L.] Univ Calif San Francisco, Ernest Gallo Clin, Dept Neurol, Emeryville, CA 94608 USA; Univ Calif San Francisco, Res Ctr, Dept Neurol, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, Dept Neurol, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	jwhistler@gallo.ucsf.edu			National Institute on Drug Abuse [R01 DA015232, DA19958]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015232, R01DA019958] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Drs. Anuradha Madhavan, Dawn Thompson, and Johan Enquist for critical reading of the manuscript. We thank Stacy Taylor and Madeline Ferwerda for maintenance and genotyping of the mouse colony. This work was supported by National Institute on Drug Abuse grant R01 DA015232 and DA19958 to J.L.W., and funds were provided by the state of California for medical research on alcohol and substance abuse through the University of California- San Francisco to J.L.W.	AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; Bajo M, 2006, J NEUROSCI RES, V83, P532, DOI 10.1002/jnr.20756; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; David V, 2008, NEUROPSYCHOPHARMACOL, V33, P1746, DOI 10.1038/sj.npp.1301529; de Kloet ER, 2008, EUR J PHARMACOL, V585, P473, DOI 10.1016/j.ejphar.2008.03.011; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Erdtmann-Vourliotis M, 1999, MOL BRAIN RES, V72, P1, DOI 10.1016/S0169-328X(99)00184-9; Erdtmann-Vourliotis M, 1998, MOL BRAIN RES, V61, P51, DOI 10.1016/S0169-328X(98)00197-1; Ferguson SM, 2004, NEUROPSYCHOPHARMACOL, V29, P1664, DOI 10.1038/sj.npp.1300465; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Grecksch G, 2006, PSYCHOPHARMACOLOGY, V186, P177, DOI 10.1007/s00213-006-0365-8; He L, 2005, CURR BIOL, V15, P1028, DOI 10.1016/j.cub.2005.04.052; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Inoue M, 2003, J NEUROSCI, V23, P6529; IZENWASSER S, 1993, J PHARMACOL EXP THER, V267, P145; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; Kolber BJ, 2008, STRESS, V11, P321, DOI 10.1080/10253890701821081; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Lim G, 2005, ANESTHESIOLOGY, V102, P832, DOI 10.1097/00000542-200504000-00020; Lim G, 2005, PAIN, V114, P81, DOI 10.1016/j.pain.2004.11.019; Lim GW, 2005, J NEUROSCI, V25, P11145, DOI 10.1523/JNEUROSCI.3768-05.2005; LIU JL, 1994, P NATL ACAD SCI USA, V91, P8537, DOI 10.1073/pnas.91.18.8537; Mao JR, 2002, J NEUROSCI, V22, P8312; Marinelli M, 1998, P NATL ACAD SCI USA, V95, P7742, DOI 10.1073/pnas.95.13.7742; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Nestler EJ, 1996, NEURON, V16, P897, DOI 10.1016/S0896-6273(00)80110-5; Nye HE, 1996, MOL PHARMACOL, V49, P636; Pasternak GW, 2007, J CLIN INVEST, V117, P3185, DOI 10.1172/JCI34035; Pawar M, 2007, EUR J PHARMACOL, V563, P92, DOI 10.1016/j.ejphar.2007.01.059; RASMUSSEN K, 1990, J NEUROSCI, V10, P2308; Resink A, 1996, J NEUROCHEM, V66, P369; RESINK A, 1995, EUR J NEUROSCI, V7, P1700, DOI 10.1111/j.1460-9568.1995.tb00691.x; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Thomson F, 2008, NEUROCHEM RES, V33, P691, DOI 10.1007/s11064-007-9518-3; Trafton JA, 2000, J NEUROSCI, V20, P8578; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Trujillo KA, 2000, PSYCHOPHARMACOLOGY, V151, P121, DOI 10.1007/s002130000416; WANG YH, 1995, J NEUROCHEM, V65, P176; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Yang Y, 2004, J NEUROSCI, V24, P2412, DOI 10.1523/JNEUROSCI.5544-03.2004; Zeng JS, 2006, J NEUROSCI, V26, P12033, DOI 10.1523/JNEUROSCI.2530-06.2006; Zollner C, 2008, J CLIN INVEST, V118, P1065, DOI 10.1172/JCI25911	50	32	32	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4327	4334		10.1096/fj.09-133223	http://dx.doi.org/10.1096/fj.09-133223			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19679639	Green Published			2022-12-25	WOS:000272193700027
J	Feng, YJ; Cronan, JE				Feng, Youjun; Cronan, John E.			Escherichia coli Unsaturated Fatty Acid Synthesis COMPLEX TRANSCRIPTION OF THE fabA GENE AND IN VIVO IDENTIFICATION OF THE ESSENTIAL REACTION CATALYZED BY FabB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-ACP THIOESTERASES; CARRIER PROTEIN THIOESTERASE; SUBSTRATE-SPECIFICITY; BIOSYNTHESIS; PLANT; EXPRESSION; DEHYDRASE; CLONING; FADR; PHOSPHOLIPIDS	Although the unsaturated fatty acid (UFA) synthetic pathway of Escherichia coli is the prototype of such pathways, several unresolved issues have accumulated over the years. The key players are the fabA and fabB genes. Earlier studies of fabA transcription showed that the gene was transcribed from two promoters, with one being positively regulated by the FadR protein. The other weaker promoter (which could not be mapped with the technology then available) was considered constitutive because its function was independent of FadR. However, the FabR negative regulator was recently shown to represses fabA transcription. We report that the weak promoter overlaps the FadR-dependent promoter and is regulated by FabR. This promoter is strictly conserved in all E. coli and Salmonella enterica genomes sequenced to date and is thought to provide insurance against inappropriate regulation of fabA transcription by exogenous saturated fatty acids. Also, the fabAup promoter, a mutant promoter previously isolated by selection for increased FabA activity, was shown to be a promoter created de novo by a four-base deletion within the gene located immediately upstream of fabA. Demonstration of the key UFA synthetic reaction catalyzed by FabB has been elusive, although it was known to catalyze an elongation reaction. Strains lacking FabB are UFA auxotrophs indicating that the enzyme catalyzes an essential step in UFA synthesis. Using thioesterases specific for hydrolysis of short chain acyl-ACPs, the intermediates of the UFA synthetic pathway have been followed in vivo for the first time. These experiments showed that a fabB mutant strain accumulated less cis-5-dodecenoic acid than the parental wild-type strain. These data indicate that the key reaction in UFA synthesis catalyzed by FabB is elongation of the cis-3-decenoyl-ACP produced by FabA.	[Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, B103,Chem & Life Sci Lab,601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019; Feng, Youjun/I-4134-2012; Feng, Youjun/E-8386-2010		National Institutes of Health, NIAID [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650 from the NIAID.	[Anonymous], 2003, LIPID ANAL; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BATCHELOR JG, 1973, BIOCHEM BIOPH RES CO, V52, P1374, DOI 10.1016/0006-291X(73)90653-0; BLOCH K, 1971, ENZYMES, P441; Cho BK, 2006, MICROBIOL-SGM, V152, P2207, DOI 10.1099/mic.0.28912-0; Clark D. P., 2005, ECOSAL ESCHERICHIA C; CLARK DP, 1983, BIOCHEMISTRY-US, V22, P5897, DOI 10.1021/bi00294a032; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; CRONAN JE, 1988, J BIOL CHEM, V263, P4641; CRONAN JE, 1973, J BIOL CHEM, V248, P1188; CRONAN JE, 1969, J BACTERIOL, V100, P601, DOI 10.1128/JB.100.2.601-604.1969; Cronan Jr. JE, 2008, ECOSAL ESCHERICHIA C; DAGNOLO G, 1975, J BIOL CHEM, V250, P5289; DIRUSSO CC, 1993, MOL MICROBIOL, V7, P311, DOI 10.1111/j.1365-2958.1993.tb01122.x; DORMANN P, 1995, ARCH BIOCHEM BIOPHYS, V316, P612, DOI 10.1006/abbi.1995.1081; Edwards P, 1997, FEBS LETT, V402, P62, DOI 10.1016/S0014-5793(96)01437-8; Feng YJ, 2008, J BACTERIOL, V190, P7567, DOI 10.1128/JB.01532-07; GARWIN JL, 1980, J BIOL CHEM, V255, P3263; GARWIN JL, 1980, J BIOL CHEM, V255, P1949; GELMANN EP, 1972, J BACTERIOL, V112, P381, DOI 10.1128/JB.112.1.381-387.1972; Ghosh SK, 2007, PLANT PHYSIOL BIOCH, V45, P887, DOI 10.1016/j.plaphy.2007.09.003; GUERRA DJ, 1990, ARCH BIOCHEM BIOPHYS, V280, P336, DOI 10.1016/0003-9861(90)90339-Z; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; HENRY MF, 1991, J MOL BIOL, V222, P843, DOI 10.1016/0022-2836(91)90574-P; Ismail IA., 1967, CHEM PHYS LIPIDS, V1, P376, DOI [10.1016/0009-3084(67)90015-1, DOI 10.1016/0009-3084(67)90015-1]; Jha JK, 2006, PLANT PHYSIOL BIOCH, V44, P645, DOI 10.1016/j.plaphy.2006.09.017; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Mayer KM, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-1; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; Miller J.H., 1972, EXPT MOL GENETICS; MORRIS LJ, 1965, J CHROMATOGR, V20, P27, DOI 10.1016/S0021-9673(01)97362-5; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; SILBERT DF, 1967, P NATL ACAD SCI USA, V58, P1579, DOI 10.1073/pnas.58.4.1579; SINGER M, 1989, MICROBIOL REV, V53, P1; Voelker T, 1996, Genet Eng (N Y), V18, P111; VOELKER TA, 1994, J BACTERIOL, V176, P7320, DOI 10.1128/JB.176.23.7320-7327.1994; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang HH, 2003, J BACTERIOL, V185, P4930, DOI 10.1128/JB.185.16.4930-4937.2003; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; YOSHIKAWA W, 1985, BIOCHIM BIOPHYS ACTA, V821, P277, DOI 10.1016/0005-2736(85)90097-5; YUAN L, 1995, P NATL ACAD SCI USA, V92, P10639, DOI 10.1073/pnas.92.23.10639; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhao MZ, 1998, TETRAHEDRON LETT, V39, P5323, DOI 10.1016/S0040-4039(98)00987-3	49	139	154	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29526	29535		10.1074/jbc.M109.023440	http://dx.doi.org/10.1074/jbc.M109.023440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19679654	Green Published, hybrid			2022-12-25	WOS:000270896800035
J	Maghzal, GJ; Leck, MC; Collinson, E; Li, C; Stocker, R				Maghzal, Ghassan J.; Leck, Meng-Choo; Collinson, Emma; Li, Cheng; Stocker, Roland			Limited Role for the Bilirubin-Biliverdin Redox Amplification Cycle in the Cellular Antioxidant Protection by Biliverdin Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR PHYSIOLOGICAL CYTOPROTECTANT; ALBUMIN-BOUND BILIRUBIN; HUMAN-BLOOD-PLASMA; OXIDATIVE STRESS; HEME OXYGENASE-1; SACCHAROMYCES-CEREVISIAE; CONJUGATED BILIRUBIN; LIPID-PEROXIDATION; BILE-PIGMENTS; METABOLISM	In mammalian cells, heme is degraded by heme oxygenase to biliverdin, which is then reduced to bilirubin by biliverdin reductase (BVR). Both bile pigments have reducing properties, and bilirubin is now generally considered to be a potent antioxidant, yet it remains unclear how it protects cells against oxidative damage. A presently popular explanation for the antioxidant function of bilirubin is a redox cycle in which bilirubin is oxidized to biliverdin and then recycled by BVR. Here, we re-examined this putative BVR-mediated redox cycle. We observed that lipid peroxidation-mediated oxidation of bilirubin in chloroform, a model of cell membrane-bound bilirubin, did not yield biliverdin, a prerequisite for the putative redox cycle. Similarly, H2O2 did not oxidize albumin-bound bilirubin to biliverdin, and in vitro oxidation of albumin or ligandin-bound bilirubin by peroxyl radicals gave modest yields of biliverdin. In addition, decreasing cellular BVR protein and activity in HeLa cells using RNA interference did not alter H2O2-mediated cell death, just as BVR overexpression failed to enhance protection of these cells against H2O2-mediated damage, irrespective of whether bilirubin or biliverdin were added to the cells as substrate for the putative redox cycle. Similarly, transformation of human BVR into hmx1 (heme oxygenase) mutant yeast did not provide protection against H2O2 toxicity above that seen in hmx1 mutant yeast expressing human heme oxygenase-1. Together, these results argue against the BVR-mediated redox cycle playing a general or important role as cellular antioxidant defense mechanism.	[Stocker, Roland] Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Camperdown, NSW 2006, Australia; Univ Sydney, Sydney Med Sch, Bosch Inst, Camperdown, NSW 2006, Australia	University of Sydney; University of Sydney	Stocker, R (corresponding author), Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Med Fdn Bldg K25,92-94 Parramatta Rd, Camperdown, NSW 2006, Australia.	rstocker@med.usyd.edu.au	Stocker, Roland/AAV-4489-2021; maghzal, ghassan/A-9692-2015		National Health and Medical Research Council (NHMRC) [570861]; Australian Research Council Discovery Project [DP 0344964]; University of Sydney Professorial Fellowship; University of Sydney Medical Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Project(Australian Research Council); University of Sydney Professorial Fellowship(University of Sydney); University of Sydney Medical Foundation(University of Sydney)	This work was supported by National Health and Medical Research Council (NHMRC) Program Grant 570861 (to R. S.) and, in part, by Australian Research Council Discovery Project Grant DP 0344964 (to R. S.).; Supported by a NHMRC postgraduate scholarship.; Supported by a NHMRC Senior Principal Research Fellowship, a University of Sydney Professorial Fellowship, and the University of Sydney Medical Foundation.	ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T; Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BERNHARD K, 1954, HELV CHIM ACTA, V37, P306, DOI 10.1002/hlca.19540370139; BONNETT R, 1978, PROC R SOC SER B-BIO, V202, P249, DOI 10.1098/rspb.1978.0066; BRODERSEN R, 1979, CRC CR REV CL LAB SC, V11, P305; Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5; De Matteis F, 2006, RAPID COMMUN MASS SP, V20, P1209, DOI 10.1002/rcm.2431; DENNERY PA, 1995, FREE RADICAL BIO MED, V19, P395, DOI 10.1016/0891-5849(95)00032-S; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; FEVERY J, 1977, BIOCHEM J, V164, P737, DOI 10.1042/bj1640737; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; GOLLAN JL, 1982, PROG LIVER DIS, V7, P261; HSIEH YZ, 1988, J AM CHEM SOC, V110, P62, DOI 10.1021/ja00209a009; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; KAUFMANN HP, 1961, FETT SEIFEN ANSTR, V63, P334; Kim D, 2006, BIOCHEMISTRY-US, V45, P14772, DOI 10.1021/bi061429r; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; KUTTY RK, 1984, BIOCHEM BIOPH RES CO, V122, P40, DOI 10.1016/0006-291X(84)90436-4; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Liu YR, 2006, FREE RADICAL BIO MED, V40, P960, DOI 10.1016/j.freeradbiomed.2005.07.021; Maines MD, 2007, ANTIOXID REDOX SIGN, V9, P2187, DOI 10.1089/ars.2007.1805; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; May JM, 2001, FREE RADICAL BIO MED, V31, P117, DOI 10.1016/S0891-5849(01)00566-4; McDonagh A. F., 1979, PORPHYRINS, VVI; MCDONAGH AF, 1971, BIOCHEM BIOPH RES CO, V44, P1306, DOI 10.1016/S0006-291X(71)80228-0; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; Minetti M, 1998, ARCH BIOCHEM BIOPHYS, V352, P165, DOI 10.1006/abbi.1998.0584; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; NEUZIL J, 1994, J BIOL CHEM, V269, P16712; NOGALES D, 1995, J BIOL CHEM, V270, P73, DOI 10.1074/jbc.270.1.73; OSTROW JD, 1961, J CLIN INVEST, V40, P1442, DOI 10.1172/JCI104375; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; REED GA, 1985, PROSTAGLANDINS, V30, P153, DOI 10.1016/S0090-6980(85)80019-8; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; SINGLETON JW, 1965, J BIOL CHEM, V240, P4780; STOCKER R, 1990, METHOD ENZYMOL, V186, P301; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; STOCKER R, 1989, FREE RADICAL RES COM, V6, P57, DOI 10.3109/10715768909073428; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P8130, DOI 10.1073/pnas.84.22.8130; STOCKER R, 1988, MED BIOCH CHEM ASPEC, P465; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0	47	80	81	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29251	29259		10.1074/jbc.M109.037119	http://dx.doi.org/10.1074/jbc.M109.037119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19690164	hybrid, Green Published			2022-12-25	WOS:000270896800004
J	Baron, D; LaBelle, E; Coursolle, D; Gralnick, JA; Bond, DR				Baron, Daniel; LaBelle, Edward; Coursolle, Dan; Gralnick, Jeffrey A.; Bond, Daniel R.			Electrochemical Measurement of Electron Transfer Kinetics by Shewanella oneidensis MR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CYTOCHROMES MTRC; METAL-REDUCING BACTERIUM; C-TYPE CYTOCHROMES; ANAEROBIC RESPIRATION; PUTREFACIENS MR-1; IRON REDUCTION; FE(III)-REDUCING BACTERIUM; DISSIMILATORY FE(III); OMCA; PROTEIN	Shewanella oneidensis strain MR-1 can respire using carbon electrodes and metal oxyhydroxides as electron acceptors, requiring mechanisms for transferring electrons from the cell interior to surfaces located beyond the cell. Although purified outer membrane cytochromes will reduce both electrodes and metals, S. oneidensis also secretes flavins, which accelerate electron transfer to metals and electrodes. We developed techniques for detecting direct electron transfer by intact cells, using turnover and single turnover voltammetry. Metabolically active cells attached to graphite electrodes produced thin (submonolayer) films that demonstrated both catalytic and reversible electron transfer in the presence and absence of flavins. In the absence of soluble flavins, electron transfer occurred in a broad potential window centered at similar to 0 V (versus standard hydrogen electrode), and was altered in single (Delta omcA, Delta mtrC) and double deletion (Delta omcA/Delta mtrC) mutants of outer membrane cytochromes. The addition of soluble flavins at physiological concentrations significantly accelerated electron transfer and allowed catalytic electron transfer to occur at lower applied potentials (- 0.2 V). Scan rate analysis indicated that rate constants for direct electron transfer were slower than those reported for pure cytochromes (similar to 1 s(-1)). These observations indicated that anodic current in the higher (> 0 V) window is due to activation of a direct transfer mechanism, whereas electron transfer at lower potentials is enabled by flavins. The electrochemical dissection of these activities in living cells into two systems with characteristic midpoint potentials and kinetic behaviors explains prior observations and demonstrates the complementary nature of S. oneidensis electron transfer strategies.	[Bond, Daniel R.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Coursolle, Dan] Univ Minnesota, Dept Biochem Biophys & Mol Biol, St Paul, MN 55108 USA; [Gralnick, Jeffrey A.; Bond, Daniel R.] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bond, DR (corresponding author), Univ Minnesota, Inst Biotechnol, 140 Gortner,1479 Gortner Ave, St Paul, MN 55108 USA.	dbond@umn.edu		Bond, Daniel/0000-0001-8083-7107	National Institutes of Health [2T32-GM008347-16]; Office of Naval Research [N000140810166, N000140810162]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2T32-GM008347-16 (to D. C.). This work was also supported by Office of Naval Research Grants N000140810166 (to J. A. G.) and N000140810162 (to D. R. B.).	Armstrong FA, 2005, CURR OPIN CHEM BIOL, V9, P110, DOI 10.1016/j.cbpa.2005.02.011; Armstrong FA, 1999, BIOCHEM SOC T, V27, P206, DOI 10.1042/bst0270206; Armstrong FA, 2000, FARADAY DISCUSS, V116, P191, DOI 10.1039/b002290j; Armstrong FA, 1997, CHEM SOC REV, V26, P169, DOI 10.1039/cs9972600169; Bard A. J., 2001, ELECTROCHEMICAL METH; Baymann F, 2003, FEBS LETT, V539, P91, DOI 10.1016/S0014-5793(03)00206-0; Blanford CF, 2006, J SOLID STATE ELECTR, V10, P826, DOI 10.1007/s10008-006-0183-2; Bonneville S, 2006, GEOCHIM COSMOCHIM AC, V70, P5842, DOI 10.1016/j.gca.2006.04.029; Busalmen JP, 2008, ANGEW CHEM INT EDIT, V47, P4874, DOI 10.1002/anie.200801310; Busalmen JP, 2008, ENVIRON SCI TECHNOL, V42, P2445, DOI 10.1021/es702569y; Dumas C, 2008, ELECTROCHIM ACTA, V53, P5235, DOI 10.1016/j.electacta.2008.02.056; Eggleston CM, 2008, INORG CHIM ACTA, V361, P769, DOI 10.1016/j.ica.2007.07.015; El-Naggar MY, 2008, BIOPHYS J, V95, pL10, DOI 10.1529/biophysj.108.134411; Firer-Sherwood M, 2008, J BIOL INORG CHEM, V13, P849, DOI 10.1007/s00775-008-0398-z; Fourmond V, 2009, BIOELECTROCHEMISTRY, V76, P141, DOI 10.1016/j.bioelechem.2009.02.010; Fricke K, 2008, ENERG ENVIRON SCI, V1, P144, DOI 10.1039/b802363h; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Haas JR, 2002, ENVIRON SCI TECHNOL, V36, P373, DOI 10.1021/es0109287; Hartshorne RS, 2007, J BIOL INORG CHEM, V12, P1083, DOI 10.1007/s00775-007-0278-y; Hau HH, 2008, APPL ENVIRON MICROB, V74, P6880, DOI 10.1128/AEM.00840-08; Heering HA, 1998, J PHYS CHEM B, V102, P6889, DOI 10.1021/jp981023r; Heering HA, 1997, J AM CHEM SOC, V119, P11628, DOI 10.1021/ja9723242; Hirst J, 1996, J AM CHEM SOC, V118, P5031, DOI 10.1021/ja9534361; Hirst J, 1998, J AM CHEM SOC, V120, P7085, DOI 10.1021/ja980380c; Jeuken LJC, 2002, J AM CHEM SOC, V124, P5702, DOI 10.1021/ja012638w; Kerisit S, 2007, J PHYS CHEM C, V111, P11363, DOI 10.1021/jp072060y; Kim BH, 1999, BIOTECHNOL TECH, V13, P475, DOI 10.1023/A:1008993029309; Kim BH, 1999, J MICROBIOL BIOTECHN, V9, P127; Kim HJ, 1999, J MICROBIOL BIOTECHN, V9, P365; Kim HJ, 2002, ENZYME MICROB TECH, V30, P145, DOI 10.1016/S0141-0229(01)00478-1; LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3; Lies DP, 2005, APPL ENVIRON MICROB, V71, P4414, DOI 10.1128/AEM.71.8.4414-4426.2005; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Lower BH, 2007, J BACTERIOL, V189, P4944, DOI 10.1128/JB.01518-06; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Marsili E, 2008, APPL ENVIRON MICROB, V74, P7329, DOI 10.1128/AEM.00177-08; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; Myers JM, 1998, BBA-BIOMEMBRANES, V1373, P237, DOI 10.1016/S0005-2736(98)00111-4; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; Nealson KH, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P1133, DOI 10.1007/0-387-30746-x_45; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Richter H, 2009, ENERG ENVIRON SCI, V2, P506, DOI 10.1039/b816647a; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Ross DE, 2009, APPL ENVIRON MICROB, V75, P5218, DOI 10.1128/AEM.00544-09; Ruebush SS, 2006, APPL ENVIRON MICROB, V72, P2925, DOI 10.1128/AEM.72.4.2925-2935.2006; Shi L, 2006, J BACTERIOL, V188, P4705, DOI 10.1128/JB.01966-05; Shi L, 2008, J BACTERIOL, V190, P5512, DOI 10.1128/JB.00514-08; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Srikanth S, 2008, BIOTECHNOL BIOENG, V99, P1065, DOI 10.1002/bit.21671; Taillefert M, 2007, J INORG BIOCHEM, V101, P1760, DOI 10.1016/j.jinorgbio.2007.07.020; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08; Wigginton NS, 2007, J PHYS CHEM B, V111, P12857, DOI 10.1021/jp0718698; Xing DF, 2008, ENVIRON SCI TECHNOL, V42, P4146, DOI 10.1021/es800312v; Xiong YJ, 2006, J AM CHEM SOC, V128, P13978, DOI 10.1021/ja063526d; Zhang HZ, 2008, J PROTEOME RES, V7, P1712, DOI 10.1021/pr7007658	61	212	216	7	158	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28865	28873		10.1074/jbc.M109.043455	http://dx.doi.org/10.1074/jbc.M109.043455			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19661057	Green Published, hybrid			2022-12-25	WOS:000270678900043
J	Ousingsawat, J; Martins, JR; Schreiber, R; Rock, JR; Harfe, BD; Kunzelmann, K				Ousingsawat, Jiraporn; Martins, Joana R.; Schreiber, Rainer; Rock, Jason R.; Harfe, Brian D.; Kunzelmann, Karl			Loss of TMEM16A Causes a Defect in Epithelial Ca2+-dependent Chloride Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-DEPENDENT DIARRHEA; CYSTIC-FIBROSIS; MOUSE AIRWAYS; CHANNEL; CELLS; SECRETION; MEMBRANE; GLANDS; CA2+; HEPATOCYTES	Molecular identification of the Ca2+-dependent chloride channel TMEM16A (ANO1) provided a fundamental step in understanding Ca2+-dependent Cl- secretion in epithelia. TMEM16A is an intrinsic constituent of Ca2+-dependent Cl- channels in cultured epithelia and may control salivary output, but its physiological role in native epithelial tissues remains largely obscure. Here, we demonstrate that Cl- secretion in native epithelia activated by Ca2+-dependent agonists is missing in mice lacking expression of TMEM16A. Ca2+-dependent Cl- transport was missing or largely reduced in isolated tracheal and colonic epithelia, as well as hepatocytes and acinar cells from pancreatic and submandibular glands of TMEM16A(-/-) animals. Measurement of particle transport on the surface of tracheas ex vivo indicated largely reduced mucociliary clearance in TMEM16A(-/-) mice. These results clearly demonstrate the broad physiological role of TMEM16A(-/-) for Ca2+-dependent Cl- secretion and provide the basis for novel treatments in cystic fibrosis, infectious diarrhea, and Sjoegren syndrome.	[Ousingsawat, Jiraporn; Martins, Joana R.; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Rock, Jason R.; Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	University of Regensburg; State University System of Florida; University of Florida	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@vkl.uni-regensburg.de	Martins, Joana/L-2965-2016	Martins, Joana/0000-0002-3784-9775; Kunzelmann, Karl/0000-0002-4583-7037	DFG [SFB699, KU 756/8-2]; Target-Screen2 [EU-FP6-2005-LH-037365]; Else Kroner-Fresenius-Stiftung [P36/05//A44/05]	DFG(German Research Foundation (DFG)); Target-Screen2; Else Kroner-Fresenius-Stiftung	This work was supported by DFG SFB699, DFG KU 756/8-2, Target-Screen2 (EU-FP6-2005-LH-037365), and Else Kroner-Fresenius-Stiftung P36/05//A44/05.	Aromataris EC, 2006, J PHYSIOL-LONDON, V573, P611, DOI 10.1113/jphysiol.2006.109819; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Barro-Soria R, 2008, BBA-MOL CELL RES, V1783, P1993, DOI 10.1016/j.bbamcr.2008.06.016; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Faria D, 2009, PFLUG ARCH EUR J PHY, V457, P1373, DOI 10.1007/s00424-008-0606-2; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; GREGER R, 1991, PFLUG ARCH EUR J PHY, V419, P209, DOI 10.1007/BF00373009; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; KOUMI SI, 1994, J GEN PHYSIOL, V104, P357, DOI 10.1085/jgp.104.2.357; Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1; Kunzelmann K, 2002, PFLUG ARCH EUR J PHY, V444, P220, DOI 10.1007/s00424-002-0796-y; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Milenkovic VM, 2009, PFLUG ARCH EUR J PHY, V458, P431, DOI 10.1007/s00424-008-0626-y; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; PETERSEN OH, 1986, AM J PHYSIOL, V251, pG1, DOI 10.1152/ajpgi.1986.251.1.G1; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Soria RB, 2009, J BIOL CHEM, V284, P29405, DOI 10.1074/jbc.M605716200; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	31	183	190	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28698	28703		10.1074/jbc.M109.012120	http://dx.doi.org/10.1074/jbc.M109.012120			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679661	Green Published, hybrid			2022-12-25	WOS:000270678900025
J	Deng, S; Zhang, GF; Kasumov, T; Roe, CR; Brunengraber, H				Deng, Shuang; Zhang, Guo-Fang; Kasumov, Takhar; Roe, Charles R.; Brunengraber, Henri			Interrelations between C-4 Ketogenesis, C-5 Ketogenesis, and Anaplerosis in the Perfused Rat Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA ACETYLTRANSFERASE; KETONE-BODY PRODUCTION; FATTY ACID METABOLISM; GLUCONEOGENESIS INVIVO; MAMMALIAN-TISSUES; MASS ISOTOPOMER; COENZYME-A; MITOCHONDRIAL; ENZYMES; DEFICIENCY	We investigated the interrelations between C, ketogenesis (production of beta-hydroxybutyrate + acetoacetate), C-5 ketogenesis (production of beta-hydroxypentanoate + beta-ketopentanoate), and anaplerosis in isolated rat livers perfused with C-13-labeled octanoate, heptanoate, or propionate. Mass isotopomer analysis of C-4 and C-5 ketone bodies and of related acyl-CoA esters reveal that C-4 and C-5 ketogenesis share the same pool of acetyl-CoA. Although the uptake of octanoate and heptanoate by the liver are similar, the rate of C-5 ketogenesis from heptanoate is much lower than the rate of C-4 ketogenesis from octanoate. This results from the channeling of the propionyl moiety of heptanoate into anaplerosis of the citric acid cycle. C-5 ketogenesis from propionate is virtually nil because acetoacyl-CoA thiolase does not favor the formation of beta-ketopentanoyl-CoA from propionyl-CoA and acetyl-CoA. Anaplerosis and gluconeogenesis from heptanoate are inhibited by octanoate. The data have implications for the design of diets for the treatment of long chain fatty acid oxidation disorders, such as the triheptanoin-based diet.	[Deng, Shuang; Zhang, Guo-Fang; Kasumov, Takhar; Brunengraber, Henri] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Roe, Charles R.] Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX 75226 USA	Case Western Reserve University; Baylor University; Baylor University Medical Center	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, WG 48,10900 Euclid Ave, Cleveland, OH 44106 USA.	hxb8@case.edu			National Institutes of Health [5R33DK070291, 5ROIDK069752]; Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291, R01DK069752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant Road Map Grant 5R33DK070291 and Grant 5ROIDK069752. This work was also supported by the Cleveland Mt. Sinai Health Care Foundation.	BAKER FC, 1981, BIOCHIM BIOPHYS ACTA, V664, P356, DOI 10.1016/0005-2760(81)90058-8; BALASSE EO, 1989, DIABETES METAB REV, V5, P247, DOI 10.1002/dmr.5610050304; BALZER I, 1986, BIOCHIM BIOPHYS ACTA, V870, P350, DOI 10.1016/0167-4838(86)90239-6; BERGMEYER HU, 1967, BIOCHEM J, V102, P423, DOI 10.1042/bj1020423; BOUGNERES PF, 1981, J PEDIATR-US, V98, P742, DOI 10.1016/S0022-3476(81)80834-7; BRASS EP, 1988, BIOCHEM J, V250, P819, DOI 10.1042/bj2500819; DURAN M, 1978, CLIN CHIM ACTA, V82, P93, DOI 10.1016/0009-8981(78)90030-X; ENDEMANN G, 1987, BIOCHEM CELL BIOL, V65, P989, DOI 10.1139/o87-129; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; HETENYI G, 1982, FED PROC, V41, P104; HOMMES FA, 1968, PEDIATR RES, V2, P519, DOI 10.1203/00006450-196811000-00010; HUTH W, 1973, H-S Z PHYSIOL CHEM, V354, P635, DOI 10.1515/bchm2.1973.354.1.635; HUTH W, 1985, BIOCHIM BIOPHYS ACTA, V830, P274, DOI 10.1016/0167-4838(85)90283-3; HUTH W, 1974, BIOCHEM BIOPH RES CO, V56, P1069, DOI 10.1016/S0006-291X(74)80297-4; HUTH W, 1982, EUR J BIOCHEM, V128, P413; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kasumov T, 2007, ARCH BIOCHEM BIOPHYS, V463, P110, DOI 10.1016/j.abb.2007.02.022; KATZ J, 1985, AM J PHYSIOL, V248, pR391, DOI 10.1152/ajpregu.1985.248.4.R391; KREBS HA, 1970, BIOCHEM J, V119, P525, DOI 10.1042/bj1190525; KUHARA T, 1983, BIOMED MASS SPECTROM, V10, P629, DOI 10.1002/bms.1200101202; LECLERC J, 1995, AM J PHYSIOL-ENDOC M, V268, pE446, DOI 10.1152/ajpendo.1995.268.3.E446; MCGARRY JD, 1971, J BIOL CHEM, V246, P1149; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Roe CR, 2008, NEUROLOGY, V71, P260, DOI 10.1212/01.wnl.0000318283.42961.e9; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; ROSIERS CD, 1991, J BIOL CHEM, V266, P1574; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; STERN JR, 1956, J BIOL CHEM, V221, P1; SWEETMAN L, 1978, BIOMED MASS SPECTROM, V5, P198, DOI 10.1002/bms.1200050307; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041	35	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27799	27807		10.1074/jbc.M109.048744	http://dx.doi.org/10.1074/jbc.M109.048744			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666922	Green Published, hybrid			2022-12-25	WOS:000270676300006
J	Mastroianni, JR; Ouellette, AJ				Mastroianni, Jennifer R.; Ouellette, Andre J.			alpha-Defensins in Enteric Innate Immunity FUNCTIONAL PANETH CELL alpha-DEFENSINS IN MOUSE COLONIC LUMEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; ANTIMICROBIAL PEPTIDES; BETA-DEFENSINS; CATHELICIDIN LL-37; MESSENGER-RNA; EXPRESSION; ACTIVATION; CRYPTDIN-4; SECRETION; BETA-DEFENSIN-3	Paneth cells are a secretory epithelial lineage that release dense core granules rich in host defense peptides and proteins from the base of small intestinal crypts. Enteric alpha-defensins, termed cryptdins (Crps) in mice, are highly abundant in Paneth cell secretions and inherently resistant to proteolysis. Accordingly, we tested the hypothesis that enteric alpha-defensins of Paneth cell origin persist in a functional state in the mouse large bowel lumen. To test this idea, putative Crps purified from mouse distal colonic lumen were characterized biochemically and assayed in vitro for bactericidal peptide activities. The peptides comigrated with cryptdin control peptides in acid-urea-PAGE and SDS-PAGE, providing identification as putative Crps. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry experiments showed that the molecular masses of the putative alpha-defensins matched those of the six most abundant known Crps, as well as N-terminally truncated forms of each, and that the peptides contain six Cys residues, consistent with identities as alpha-defensins. N-terminal sequencing definitively revealed peptides with N termini corresponding to full-length, (des-Leu)-truncated, and (des-Leu-Arg)-truncated N termini of Crps 1-4 and 6. Crps from mouse large bowel lumen were bactericidal in the low micromolar range. Thus, Paneth cell alpha-defensins secreted into the small intestinal lumen persist as intact and functional forms throughout the intestinal tract, suggesting that the peptides may mediate enteric innate immunity in the colonic lumen, far from their upstream point of secretion in small intestinal crypts.	[Mastroianni, Jennifer R.; Ouellette, Andre J.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Ouellette, Andre J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ouellette, AJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Norris Canc Ctr, 1450 Biggy St,NRT 7514,Mail Code 9601, Los Angeles, CA 90033 USA.	andre.ouellette@keck.usc.edu			National Institutes of Health [DK044632, AI059346]; Human Frontiers Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044632, R55DK044632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK044632 and AI059346. This work was also supported by the Human Frontiers Science Program.	ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Boulton RA, 2003, WORLD J SURG, V27, P1014, DOI 10.1007/s00268-003-7054-0; Carlisle MD, 2009, J INNATE IMMUN, V1, P118, DOI 10.1159/000181015; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Fahlgren A, 2004, CLIN EXP IMMUNOL, V137, P379, DOI 10.1111/j.1365-2249.2004.02543.x; Fernandez MI, 2008, J IMMUNOL, V180, P4924, DOI 10.4049/jimmunol.180.7.4924; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hadjicharalambous C, 2008, BIOCHEMISTRY-US, V47, P12626, DOI 10.1021/bi800335e; HARWIG SSL, 1995, ADV EXP MED BIOL, V371, P251; HARWIG SSL, 1995, J CLIN INVEST, V95, P603, DOI 10.1172/JCI117704; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; OUELLETTE AJ, 1992, FEBS LETT, V304, P146, DOI 10.1016/0014-5793(92)80606-H; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; Ouellette AJ, 2005, SPRINGER SEMIN IMMUN, V27, P133, DOI 10.1007/s00281-005-0202-x; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; OUELLETTE AJ, 1988, GASTROENTEROLOGY, V94, P114, DOI 10.1016/0016-5085(88)90618-X; OUELLETTE AJ, 1989, J CELL BIOL, V108, P1687, DOI 10.1083/jcb.108.5.1687; Patil A, 2004, PHYSIOL GENOMICS, V20, P1, DOI 10.1152/physiolgenomics.00150.2004; PEETERS T, 1975, GUT, V16, P553, DOI 10.1136/gut.16.7.553; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Qu XD, 1996, INFECT IMMUN, V64, P5161, DOI 10.1128/IAI.64.12.5161-5165.1996; Rodenburg W, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-84; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Selsted M E, 1993, Genet Eng (N Y), V15, P131; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1995, TRENDS CELL BIOL, V5, P114, DOI 10.1016/S0962-8924(00)88961-8; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; SOMMERS SC, 1966, GASTROENTEROLOGY, V51, P841; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Takahashi A, 2001, FEBS LETT, V508, P484, DOI 10.1016/S0014-5793(01)03088-5; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tarver AP, 1998, INFECT IMMUN, V66, P1045, DOI 10.1128/IAI.66.3.1045-1056.1998; TRIER JS, 1966, GASTROENTEROLOGY, V51, P560; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	66	76	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27848	27856		10.1074/jbc.M109.050773	http://dx.doi.org/10.1074/jbc.M109.050773			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19687006	Green Published, hybrid			2022-12-25	WOS:000270676300011
J	Richard, B; Swanson, R; Olson, ST				Richard, Benjamin; Swanson, Richard; Olson, Steven T.			The Signature 3-O-Sulfo Group of the Anticoagulant Heparin Sequence Is Critical for Heparin Binding to Antithrombin but Is Not Required for Allosteric Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL CHANGE; HIGH-AFFINITY HEPARIN; PROTEINASE REACTIONS; RAPID INHIBITION; BETA-SHEET; FACTOR-IXA; FACTOR-XA; PENTASACCHARIDE; MECHANISM; RESIDUES	Heparin and heparan sulfate glycosaminoglycans allosterically activate the serpin, antithrombin, by binding through a specific pentasaccharide sequence containing a critical 3-O-sulfo group. To elucidate the role of the 3-O-sulfo group in the activation mechanism, we compared the effects of deleting the 3-O-sulfo group or mutating the Lys(114) binding partner of this group on antithrombin-pentasaccharide interactions by equilibrium binding and rapid kinetic analyses. Binding studies over a wide range of ionic strength and pH showed that loss of the 3-O-sulfo group caused a massive similar to 60% loss in binding energy for the antithrombin-pentasaccharide interaction due to the disruption of a cooperative network of ionic and nonionic interactions. Despite this affinity loss, the 3-O-desulfonated pentasaccharide retained the ability to induce tryptophan fluorescence changes and to enhance factor Xa reactivity in antithrombin, indicative of normal conformational activation. Rapid kinetic studies showed that loss of the 3-O-sulfo group affected both the ability of the pentasaccharide to recognize native antithrombin and its ability to preferentially bind and stabilize activated antithrombin. By contrast, mutation of Lys(114) solely affected the preferential interaction of the pentasaccharide with activated antithrombin. These findings demonstrate that the 3-O-sulfo group functions as a key determinant of heparin pentasaccharide activation of antithrombin both by contributing to the Lys(114)-independent recognition of native antithrombin and by triggering a Lys(114)-dependent induced fit interaction with activated antithrombin that locks the serpin in the activated state.	[Richard, Benjamin; Swanson, Richard; Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, Rm 530C Dent M-C 860,801 S Paulina St, Chicago, IL 60612 USA.	stolson@uic.edu		Richard, Benjamin/0000-0003-4531-1905	National Institutes of Health [HL-39888]; American Heart Association Fellowship [0920118G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL039888, R37HL039888, R01HL039888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-39888 (to S. T. O.). This work was also supported by American Heart Association Fellowship 0920118G (to B. R.).	Arocas V, 1999, BIOCHEMISTRY-US, V38, P10196, DOI 10.1021/bi990686b; Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200; Arocas V, 2000, BIOCHEMISTRY-US, V39, P8512, DOI 10.1021/bi9928243; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; ATHA DH, 1987, BIOCHEMISTRY-US, V26, P6454, DOI 10.1021/bi00394a024; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Church F. C., 2007, MOL CELLULAR ASPECTS, P509; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Desai U, 2000, J BIOL CHEM, V275, P18976, DOI 10.1074/jbc.M001340200; Desai UR, 1998, BIOCHEMISTRY-US, V37, P13033, DOI 10.1021/bi981426h; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FERRO DR, 1986, J AM CHEM SOC, V108, P6773, DOI 10.1021/ja00281a052; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GETTINS PGW, 1996, SERPINS STRUCTURE FU, P40; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Ishiguro K, 2000, J CLIN INVEST, V106, P873, DOI 10.1172/JCI10489; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Jairajpuri MA, 2003, J BIOL CHEM, V278, P15941, DOI 10.1074/jbc.M212319200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; NORDENMAN B, 1978, BIOCHEMISTRY-US, V17, P3339, DOI 10.1021/bi00609a026; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1981, J BIOL CHEM, V256, P1073; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P198, DOI 10.1016/S1050-1738(02)00160-3; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; PETERSON CB, 1985, J BIOL CHEM, V260, P610; Petitou M, 2003, BIOCHIMIE, V85, P83, DOI 10.1016/S0300-9084(03)00078-6; PETITOU M, 1988, CARBOHYD RES, V179, P163, DOI 10.1016/0008-6215(88)84116-8; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; vanBoven HH, 1997, SEMIN HEMATOL, V34, P188; WALENGA JM, 1988, THROMB RES, V52, P553, DOI 10.1016/0049-3848(88)90128-4	47	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27054	27064		10.1074/jbc.M109.029892	http://dx.doi.org/10.1074/jbc.M109.029892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661062	hybrid, Green Published			2022-12-25	WOS:000270232300007
J	Li, C; Iida, M; Dunn, EF; Ghia, AJ; Wheeler, DL				Li, C.; Iida, M.; Dunn, E. F.; Ghia, A. J.; Wheeler, D. L.			Nuclear EGFR contributes to acquired resistance to cetuximab	ONCOGENE			English	Article						EGFR; nuclear; cetuximab; resistance; src-family kinases; dasatinib	GROWTH-FACTOR RECEPTOR; DEPENDENT PROTEIN-KINASE; PROGNOSTIC VALUE; TYROSINE KINASE; IN-VIVO; CANCER; LOCALIZATION; ACTIVATION; MECHANISMS; EXPRESSION	Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine kinase involved in the etiology of several human cancers. Cetuximab is an EGFR-blocking antibody that has been approved for the treatment of patients with head and neck squamous cell carcinoma and metastatic colorectal cancer. Previous reports have shown that EGFR translocation to the nucleus is associated with cell proliferation. Here we investigated mechanisms of acquired resistance to cetuximab using a model derived from the non-small cell lung cancer line H226. We demonstrated that cetuximab-resistant cells overexpress HER family ligands including epidermal growth factor (EGF), amphiregulin, heparin-binding EGF and beta-cellulin. Overexpression of these ligands is associated with the nuclear translocation of the EGFR and this process was mediated by the Src family kinases (SFK). Treatment of cetuximab-resistant cells with the SFK inhibitor, dasatinib, resulted in loss of nuclear EGFR, increased membrane expression of the EGFR and resensitization to cetuximab. In addition, expression of a nuclear localization sequence-tagged EGFR in cetuximab-sensitive cells increased resistance to cetuximab both in vitro and in mouse xenografts. Collectively, these data suggest that nuclear expression of EGFR may be an important molecular determinant of resistance to cetuximab therapy and provides a rationale for investigating nuclear EGFR as a biomarker for cetuximab response. Further, these data suggest a rationale for the design of clinical trials that examine the value of treating patients with cetuximab-resistant tumors with inhibitors of SFKs in combination with cetuximab. Oncogene (2009) 28, 3801-3813; doi:10.1038/onc.2009.234; published online 17 August 2009	[Wheeler, D. L.] Univ Wisconsin, Dept Human Oncol, Ctr Comprehens Canc, Sch Med & Publ Hlth, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Wheeler, DL (corresponding author), Univ Wisconsin, Dept Human Oncol, Ctr Comprehens Canc, Sch Med & Publ Hlth, 600 Highland Ave K4-364 CSC, Madison, WI 53792 USA.	dlwheeler@wisc.edu	Li, Chunrong/F-6955-2011; Wheeler, Deric/B-7175-2013	Wheeler, Deric/0000-0001-5915-3675	NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014520-30, P30 CA014520] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arteaga CL, 2003, J CLIN ONCOL, V21, p289S, DOI 10.1200/JCO.2003.10.523; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bianco R, 2005, ENDOCR-RELAT CANCER, V12, pS159, DOI 10.1677/erc.1.00999; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Camp ER, 2005, CLIN CANCER RES, V11, P397; CAO H, 1995, ENDOCRINOLOGY, V136, P3163, DOI 10.1210/en.136.7.3163; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Gupta AK, 2002, CLIN CANCER RES, V8, P885; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; MARTI U, 1991, HEPATOLOGY, V13, P15, DOI 10.1016/0270-9139(91)90210-M; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Psyrri A, 2008, CANCER EPIDEM BIOMAR, V17, P1486, DOI 10.1158/1055-9965.EPI-07-2684; Rajput A, 2007, CANCER RES, V67, P665, DOI 10.1158/0008-5472.CAN-06-2773; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Viloria-Petit A, 2001, CANCER RES, V61, P5090; Viloria-Petit AM, 2004, INT J RADIAT ONCOL, V58, P914, DOI 10.1016/j.ijrobp.2003.09.091; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wheeler DL, 2009, CANCER BIOL THER, V8, P696, DOI 10.4161/cbt.8.8.7903; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	42	229	237	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	43					3801	3813		10.1038/onc.2009.234	http://dx.doi.org/10.1038/onc.2009.234			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	512KT	19684613	Bronze, Green Accepted			2022-12-25	WOS:000271248400004
J	Hornemann, T; Penno, A; Rutti, MF; Ernst, D; Kivrak-Pfiffner, F; Rohrer, L; von Eckardstein, A				Hornemann, Thorsten; Penno, Anke; Ruetti, Markus F.; Ernst, Daniela; Kivrak-Pfiffner, Fatma; Rohrer, Lucia; von Eckardstein, Arnold			The SPTLC3 Subunit of Serine Palmitoyltransferase Generates Short Chain Sphingoid Bases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; SPHINGOMYELIN SYNTHESIS; LIQUID-CHROMATOGRAPHY; KNOCKOUT MICE; SPHINGOLIPIDS; METABOLISM; IDENTIFICATION; INHIBITION; DISEASE; ELECTROSPRAY	The enzyme serine palmitoyltransferase (SPT) catalyzes the rate-limiting step in the de novo synthesis of sphingolipids. Previously the mammalian SPT was described as a heterodimer composed of two subunits, SPTLC1 and SPTLC2. Recently we identified a novel third SPT subunit (SPTLC3). SPTLC3 shows about 68% identity to SPTLC2 and also includes a pyridoxal phosphate consensus motif. Here we report that the overexpression of SPTLC3 in HEK293 cells leads to the formation of two new sphingoid base metabolites, namely C-16-sphinganine and C-16-sphingosine. SPTLC3-expressing cells have higher in vitro SPT activities with lauryl-and myristoyl-CoA than SPTLC2-expressing cells, and SPTLC3 mRNA expression levels correlate closely with the C-16-sphinganine synthesis rates in various human and murine cell lines. Approximately 15% of the total sphingolipids in human plasma contain a C-16 backbone and are found in the high density and low density but not the very low density lipoprotein fraction. In conclusion, we show that the SPTLC3 subunit generates C-16-sphingoid bases and that sphingolipids with a C-16 backbone constitute a significant proportion of human plasma sphingolipids.	[Hornemann, Thorsten; Penno, Anke; Ruetti, Markus F.; Ernst, Daniela; Kivrak-Pfiffner, Fatma; Rohrer, Lucia; von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Hornemann, T (corresponding author), Univ Zurich Hosp, Inst Clin Chem, Ramistr 100, CH-8091 Zurich, Switzerland.	thorsten.hornemann@usz.ch			Foundation for Scientific Research (Forschungskommission, University of Zurich); Hartmann Muller Foundation; German Society for Clinical Chemistry and Laboratory Medicine (DGKL); EMDO Foundation; European Commission [LSHM-CT-2006-037631]	Foundation for Scientific Research (Forschungskommission, University of Zurich); Hartmann Muller Foundation; German Society for Clinical Chemistry and Laboratory Medicine (DGKL); EMDO Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Foundation for Scientific Research (Forschungskommission, University of Zurich), the Hartmann Muller Foundation, the German Society for Clinical Chemistry and Laboratory Medicine (DGKL), the EMDO Foundation, and European Commission Grant LSHM-CT-2006-037631.	Byrdwell WC, 2007, J CHROMATOGR A, V1146, P164, DOI 10.1016/j.chroma.2007.01.108; DUGGLEBY RG, 1981, ANAL BIOCHEM, V110, P9, DOI 10.1016/0003-2697(81)90104-4; Fyrst H, 2004, J LIPID RES, V45, P54, DOI 10.1194/jlr.M300005-JLR200; Fyrst H, 2008, J LIPID RES, V49, P597, DOI 10.1194/jlr.M700414-JLR200; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Karlsson AA, 1998, J MASS SPECTROM, V33, P1192, DOI 10.1002/(SICI)1096-9888(199812)33:12<1192::AID-JMS735>3.0.CO;2-J; KATSIKAS H, 1995, BBA-LIPID LIPID MET, V1258, P95, DOI 10.1016/0005-2760(95)00104-K; KELLEY JL, 1986, METHOD ENZYMOL, V128, P170; Merrill AH, 2005, GLYCOBIOLOGY, V15, p15G, DOI 10.1093/glycob/cwi070; MERRILL AH, 1985, J LIPID RES, V26, P617; MERRILL AH, 1984, J LIPID RES, V25, P185; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Riley RT, 1999, NAT TOXINS, V7, P407, DOI 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; SAMUELSSON B, 1969, J LIPID RES, V10, P47; Schissel SL, 1996, J CLIN INVEST, V98, P1455, DOI 10.1172/JCI118934; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; WONG JTF, 1962, CAN J BIOCHEM PHYS, V40, P763; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yunoki K, 2008, LIPIDS, V43, P151, DOI 10.1007/s11745-007-3145-2; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	33	114	115	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26322	26330		10.1074/jbc.M109.023192	http://dx.doi.org/10.1074/jbc.M109.023192			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648650	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000269969600012
J	Teytelman, L; Ozaydin, B; Zill, O; Lefrancois, P; Snyder, M; Rine, J; Eisen, MB				Teytelman, Leonid; Oezaydin, Bilge; Zill, Oliver; Lefrancois, Philippe; Snyder, Michael; Rine, Jasper; Eisen, Michael B.			Impact of Chromatin Structures on DNA Processing for Genomic Analyses	PLOS ONE			English	Article								Chromatin has an impact on recombination, repair, replication, and evolution of DNA. Here we report that chromatin structure also affects laboratory DNA manipulation in ways that distort the results of chromatin immunoprecipitation (ChIP) experiments. We initially discovered this effect at the Saccharomyces cerevisiae HMR locus, where we found that silenced chromatin was refractory to shearing, relative to euchromatin. Using input samples from ChIP-Seq studies, we detected a similar bias throughout the heterochromatic portions of the yeast genome. We also observed significant chromatin-related effects at telomeres, protein binding sites, and genes, reflected in the variation of input-Seq coverage. Experimental tests of candidate regions showed that chromatin influenced shearing at some loci, and that chromatin could also lead to enriched or depleted DNA levels in prepared samples, independently of shearing effects. Our results suggested that assays relying on immunoprecipitation of chromatin will be biased by intrinsic differences between regions packaged into different chromatin structures - biases which have been largely ignored to date. These results established the pervasiveness of this bias genome- wide, and suggested that this bias can be used to detect differences in chromatin structures across the genome.			Teytelman, L (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@lbl.gov	Teytelman, Lenny/AAX-2835-2021; Lefrancois, Philippe/J-1440-2019	Teytelman, Lenny/0000-0001-8573-8351; Lefrancois, Philippe/0000-0003-2939-7956; Zill, Oliver/0000-0002-4329-2790; Eisen, Michael/0000-0002-7528-738X; Snyder, Michael/0000-0003-0784-7987	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031105, R37GM031105] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002779, HG002779] Funding Source: Medline; NIGMS NIH HHS [R37 GM031105, GM31105, R01 GM031105] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Barton AB, 2006, GENETICS, V173, P1169, DOI 10.1534/genetics.106.058420; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Diaz-Castillo C, 2007, GENETICS, V177, P359, DOI 10.1534/genetics.107.077081; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; R Development Core Team, 2005, R LANG ENV STAT COMP; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Teytelman L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000247; Vega-Palas MA, 2000, MOL GEN GENET, V263, P287, DOI 10.1007/s004380051170; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zill OA, 2008, GENE DEV, V22, P1704, DOI 10.1101/gad.1640008	36	89	92	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6700	10.1371/journal.pone.0006700	http://dx.doi.org/10.1371/journal.pone.0006700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693276	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267400008
J	Wang, XH; Song, YJ; Ren, JS; Qu, XG				Wang, Xiaohui; Song, Yujun; Ren, Jinsong; Qu, Xiaogang			Knocking-Down Cyclin A(2) by siRNA Suppresses Apoptosis and Switches Differentiation Pathways in K562 Cells upon Administration with Doxorubicin	PLOS ONE			English	Article								Cyclin A(2) is critical for the initiation of DNA replication, transcription and cell cycle regulation. Cumulative evidences indicate that the deregulation of cyclin A(2) is tightly linked to the chromosomal instability, neoplastic transformation and tumor proliferation. Here we report that treatment of chronic myelogenous leukaemia K562 cells with doxorubicin results in an accumulation of cyclin A(2) and follows by induction of apoptotic cell death. To investigate the potential preclinical relevance, K562 cells were transiently transfected with the siRNA targeting cyclin A(2) by functionalized single wall carbon nanotubes. Knocking down the expression of cyclin A(2) in K562 cells suppressed doxorubicin-induced growth arrest and cell apoptosis. Upon administration with doxorubicin, K562 cells with reduced cyclin A(2) showed a significant decrease in erythroid differentiation, and a small fraction of cells were differentiated along megakaryocytic and monocyte-macrophage pathways. The results demonstrate the pro-apoptotic role of cyclin A(2) and suggest that cyclin A(2) is a key regulator of cell differentiation. To the best of our knowledge, this is the first report that knocking down expression of one gene switches differentiation pathways of human myeloid leukemia K562 cells.			Wang, XH (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Div Biol Inorgan Chem, State Key Lab Rare Earth Resources Utilizat,Grad, Changchun 130022, Jilin, Peoples R China.	xqu@ciac.jl.cn	Qu, xiaogang/M-9472-2016; Wang, Xiaohui/B-8126-2011; Song, Yujun/I-2120-2012; song, Yujun/A-3770-2010	Wang, Xiaohui/0000-0002-3415-5612; song, Yujun/0000-0001-6311-5364				BUI KC, 1993, AM J RESP CELL MOL, V9, P115; Chao Y, 1998, CANCER RES, V58, P985; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Czyz M, 2005, BIOCHEM PHARMACOL, V70, P1431, DOI 10.1016/j.bcp.2005.08.010; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Grzanka A, 2005, NEOPLASMA, V52, P489; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hiromura K, 2002, ONCOGENE, V21, P1750, DOI 10.1038/sj.onc.1205238; HOANG AT, 1994, P NATL ACAD SCI USA, V91, P6875, DOI 10.1073/pnas.91.15.6875; HORIGUCHIYAMADA J, 1994, MOL CELL BIOCHEM, V132, P31, DOI 10.1007/BF00925672; Huuhtanen RL, 1999, CANCER RES, V59, P2885; Huuhtanen RL, 1999, BRIT J CANCER, V81, P1017, DOI 10.1038/sj.bjc.6690801; Ito Y, 2000, ONCOLOGY-BASEL, V59, P68, DOI 10.1159/000012140; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; Karlsson M, 1996, INT J CANCER, V65, P1, DOI 10.1002/(SICI)1097-0215(19960103)65:1<1::AID-IJC1>3.0.CO;2-6; Kawashima R, 2004, INT J ONCOL, V24, P273; KIYOKAWA H, 1994, MOL CELL BIOL, V14, P7195, DOI 10.1128/MCB.14.11.7195; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; Li JQ, 2002, HUM PATHOL, V33, P1006, DOI 10.1053/hupa.2002.125774; Li X, 2006, P NATL ACAD SCI USA, V103, P19658, DOI 10.1073/pnas.0607245103; Li X, 2006, NUCLEIC ACIDS RES, V34, P3670, DOI 10.1093/nar/gkl513; Liao C, 2004, INT J CANCER, V108, P654, DOI 10.1002/ijc.11573; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Liu Z, 2007, ANGEW CHEM INT EDIT, V46, P2023, DOI 10.1002/anie.200604295; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Meikrantz W, 1996, J BIOL CHEM, V271, P10205, DOI 10.1074/jbc.271.17.10205; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mrena J, 2006, INT J CANCER, V119, P1897, DOI 10.1002/ijc.21944; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PATERLINI P, 1993, CANCER RES, V53, P235; Peng YH, 2007, CHEM COMMUN, P5176, DOI 10.1039/b710950d; Poikonen P, 2005, BRIT J CANCER, V93, P515, DOI 10.1038/sj.bjc.6602735; RIEBER M, 1994, CELL GROWTH DIFFER, V5, P1339; Rodriguez-Pinilla M, 2004, CLIN CANCER RES, V10, P8486, DOI 10.1158/1078-0432.CCR-04-0771; SOBCZAKTHEPOT J, 1993, EXP CELL RES, V206, P43, DOI 10.1006/excr.1993.1118; STAL O, 1994, BRIT J CANCER, V70, P1258, DOI 10.1038/bjc.1994.483; Volm M, 1997, BRIT J CANCER, V75, P1774, DOI 10.1038/bjc.1997.302; Wang SJ, 2003, AM J PHYSIOL-HEART C, V284, pH1917, DOI 10.1152/ajpheart.00861.2002; Wang XH, 2008, CHEMMEDCHEM, V3, P940, DOI 10.1002/cmdc.200700329; Wolowiec D, 1999, LEUKEMIA LYMPHOMA, V35, P147, DOI 10.3109/10428199909145714; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; YONG PR, 1989, J VIROL METHODS, V24, P227; YOSHIZUMI M, 1995, J CLIN INVEST, V95, P2275, DOI 10.1172/JCI117918; Zhao C, 2008, CHEM-EUR J, V14, P5435, DOI 10.1002/chem.200800280; Zhao C, 2008, SMALL, V4, P656, DOI 10.1002/smll.200701054; Zuryn A, 2007, ONCOL REP, V17, P1013	50	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6665	10.1371/journal.pone.0006665	http://dx.doi.org/10.1371/journal.pone.0006665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684852	gold, Green Published, Green Submitted			2022-12-25	WOS:000269075600002
J	Vazin, T; Becker, KG; Chen, J; Spivak, CE; Lupica, CR; Zhang, YQ; Worden, L; Freed, WJ				Vazin, Tandis; Becker, Kevin G.; Chen, Jia; Spivak, Charles E.; Lupica, Carl R.; Zhang, Yongqing; Worden, Lila; Freed, William J.			A Novel Combination of Factors, Termed SPIE, which Promotes Dopaminergic Neuron Differentiation from Human Embryonic Stem Cells	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; GENE-EXPRESSION PROFILE; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; NEUROTROPHIC FACTOR; PROGENITOR CELLS; IN-VIVO; SUBSTANTIA-NIGRA; RAT-BRAIN; ES CELLS	Background: Stromal-Derived Inducing Activity (SDIA) is one of the most efficient methods of generating dopaminergic (DA) neurons from embryonic stem cells (ESC). DA neuron induction can be achieved by co-culturing ESC with the mouse stromal cell lines PA6 or MS5. The molecular nature of this effect, which has been termed "SDIA" is so far unknown. Recently, we found that factors secreted by PA6 cells provided lineage-specific instructions to induce DA differentiation of human ESC (hESC). Methodology/Principal Findings: In the present study, we compared PA6 cells to various cell lines lacking the SDIA effect, and employed genome expression analysis to identify differentially-expressed signaling molecules. Among the factors highly expressed by PA6 cells, and known to be associated with CNS development, were stromal cell-derived factor 1 (SDF1/CXCL12), pleiotrophin (PTN), insulin-like growth factor 2 (IGF2), and ephrin B1 (EFNB1). When these four factors, the combination of which was termed SPIE, were applied to hESC, they induced differentiation to TH-positive neurons in vitro. RT-PCR and western blot analysis confirmed the expression of midbrain specific markers, including engrailed 1, Nurr1, Pitx3, and dopamine transporter (DAT) in cultures influenced by these four molecules. Electrophysiological recordings showed that treatment of hESC with SPIE induced differentiation of neurons that were capable of generating action potentials and forming functional synaptic connections. Conclusions/Significance: The combination of SDF-1, PTN, IGF2, and EFNB1 mimics the DA phenotype-inducing property of SDIA and was sufficient to promote differentiation of hESC to functional midbrain DA neurons. These findings provide a method for differentiating hESC to form DA neurons, without a requirement for the use of animal-derived cell lines or products.	[Vazin, Tandis; Chen, Jia; Spivak, Charles E.; Lupica, Carl R.; Worden, Lila; Freed, William J.] NIDA, Cellular Neurobiol Res Branch, Intramural Res Program, NIH,DHHS, Baltimore, MD USA; [Becker, Kevin G.; Zhang, Yongqing] NIA, Gene Express & Genom Unit, Intramural Res Program, DHHS, Baltimore, MD 21224 USA; [Vazin, Tandis] AlbaNova Univ Ctr, KTH Royal Inst Technol, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Royal Institute of Technology	Vazin, T (corresponding author), NIDA, Cellular Neurobiol Res Branch, Intramural Res Program, NIH,DHHS, Baltimore, MD USA.	vazint@mail.nih.gov	Lupica, Carl/AAY-3193-2021	Lupica, Carl/0000-0002-5375-3263; Becker, Kevin/0000-0002-6794-6656	IRPs of NIDA; NIA; NIH; DHHS; NATIONAL INSTITUTE ON AGING [ZICAG000616, Z01AG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000472, ZIADA000472, ZIADA000457] Funding Source: NIH RePORTER	IRPs of NIDA; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research was supported by the IRPs of NIDA and NIA, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BERGER B, 1982, NEUROSCIENCE, V7, P193, DOI 10.1016/0306-4522(82)90160-9; Bhattacharya B, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-22; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BRAR AK, 1993, J NEUROSCI RES, V35, P103, DOI 10.1002/jnr.490350112; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Buytaert-Hoefen KA, 2004, STEM CELLS, V22, P669, DOI 10.1634/stemcells.22-5-669; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Castelo-Branco G, 2006, NEURODEGENER DIS, V3, P5, DOI 10.1159/000092086; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chiba S, 2008, STEM CELLS, V26, P2810, DOI 10.1634/stemcells.2008-0085; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Edman LC, 2008, STEM CELLS, V26, P1891, DOI 10.1634/stemcells.2007-0753; Farkas LM, 2003, J NEUROSCI, V23, P5178; Feldman EL, 1997, NEUROBIOL DIS, V4, P201, DOI 10.1006/nbdi.1997.0156; Freed WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001422; Hayashi H, 2008, EUR J NEUROSCI, V27, P261, DOI 10.1111/j.1460-9568.2008.06027.x; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jung CG, 2004, FASEB J, V18, P1237, DOI 10.1096/fj.03-0927fje; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; KELEOLOVSSON JMV, 2007, REGULATION MIDBRAIN; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; Klein RS, 2001, DEVELOPMENT, V128, P1971; Lau T, 2006, NEUROREPORT, V17, P975, DOI 10.1097/01.wnr.0000223395.66951.01; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; Luo YQ, 2002, J NEUROCHEM, V83, P1481, DOI 10.1046/j.1471-4159.2002.01260.x; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MANSUY IM, 1993, DEVELOPMENT, V119, P1119; Marchionini DM, 2007, BRAIN RES, V1147, P77, DOI 10.1016/j.brainres.2007.02.028; Morizane A, 2002, J NEUROSCI RES, V69, P934, DOI 10.1002/jnr.10363; MURASE K, 1989, NEUROSCI LETT, V103, P56, DOI 10.1016/0304-3940(89)90485-0; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; PINTAR JE, 1994, INT CONGR SER, V1056, P253; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Santiago A, 2002, DEVELOPMENT, V129, P3621; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Schulz TC, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-27; Schwartz CM, 2005, STEM CELLS DEV, V14, P517, DOI 10.1089/scd.2005.14.517; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Tham TN, 2001, EUR J NEUROSCI, V13, P845, DOI 10.1046/j.0953-816x.2000.01451.x; TRUPP M, 1996, NATURE, V381, P789; Vazin T, 2008, STEM CELLS, V26, P1517, DOI 10.1634/stemcells.2008-0039; Vazin T, 2008, RESTOR NEUROL NEUROS, V26, P447; Yamazoe H, 2005, BIOMATERIALS, V26, P5746, DOI 10.1016/j.biomaterials.2005.02.021; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yu S, 2006, NEUROSCIENCE, V141, P817, DOI 10.1016/j.neuroscience.2006.02.080; Yue FM, 2006, STEM CELLS, V24, P1695, DOI 10.1634/stemcells.2005-0409; Yue Y, 1999, J NEUROSCI, V19, P2090; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	70	61	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6606	10.1371/journal.pone.0006606	http://dx.doi.org/10.1371/journal.pone.0006606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672298	Green Submitted, Green Published, gold			2022-12-25	WOS:000268935900017
J	Rosenfeld, JA; Ballif, BC; Lucas, A; Spence, EJ; Powell, C; Aylsworth, AS; Torchia, BA; Shaffer, LG				Rosenfeld, Jill A.; Ballif, Blake C.; Lucas, Ann; Spence, Edward J.; Powell, Cynthia; Aylsworth, Arthur S.; Torchia, Beth A.; Shaffer, Lisa G.			Small Deletions of SATB2 Cause Some of the Clinical Features of the 2q33.1 Microdeletion Syndrome	PLOS ONE			English	Article								Recurrent deletions of 2q32q33 have recently been reported as a new microdeletion syndrome. Clinical features of this syndrome include severe mental retardation, growth retardation, dysmorphic features, thin and sparse hair, feeding difficulties and cleft or high palate. The commonly deleted region contains at least seven genes. Haploinsufficiency of one of these genes, SATB2, a DNA-binding protein that regulates gene expression, has been implicated as causative in the cleft or high palate of individuals with 2q32q33 microdeletion syndrome. In this study we describe three individuals with smaller microdeletions of this region, within 2q33.1. The deletions ranged in size from 173.1 kb to 185.2 kb and spanned part of SATB2. Review of clinical records showed similar clinical features among these individuals, including severe developmental delay and tooth abnormalities. Two of the individuals had behavioral problems. Only one of the subjects presented here had a cleft palate, suggesting reduced penetrance for this feature. Our results suggest that deletion of SATB2 is responsible for several of the clinical features associated with 2q32q33 microdeletion syndrome.			Rosenfeld, JA (corresponding author), Signature Genom Labs LLC, Spokane, WA USA.	shaffer@signaturegenomics.com						ALAWADI SA, 1983, J MED GENET, V20, P464, DOI 10.1136/jmg.20.6.464; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; BENSON K, 1986, AM J MED GENET, V25, P405, DOI 10.1002/ajmg.1320250302; Brewer CM, 1999, AM J HUM GENET, V65, P387, DOI 10.1086/302498; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; BUCHANAN PD, 1983, AM J MED GENET, V15, P121, DOI 10.1002/ajmg.1320150116; DALLAPICCOLA B, 1988, HUM GENET, V79, P92, DOI 10.1007/BF00291721; DERAVEL TJ, 2009, EUR J MED GENET; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; FRANCESCHINI P, 1983, HUM GENET, V64, P98, DOI 10.1007/BF00289489; GLASS IA, 1989, J MED GENET, V26, P127, DOI 10.1136/jmg.26.2.127; HIROYAMA Y, 1990, Acta Paediatrica Japonica, V32, P563; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; MARKOVIC S, 1985, J MED GENET, V22, P154, DOI 10.1136/jmg.22.2.154-a; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mencarelli MA, 2007, AM J MED GENET A, V143A, P858, DOI 10.1002/ajmg.a.31602; MIYAZAKI K, 1988, J MED GENET, V25, P850, DOI 10.1136/jmg.25.12.850; PALMER CG, 1990, AM J MED GENET, V36, P214, DOI 10.1002/ajmg.1320360215; RAMER JC, 1990, AM J MED GENET, V37, P392, DOI 10.1002/ajmg.1320370320; RAMER JC, 1989, AM J MED GENET, V32, P359, DOI 10.1002/ajmg.1320320318; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; SUMI S, 1988, JPN J HUM GENET, V33, P461, DOI 10.1007/BF01897787; TAYSI K, 1981, ANN GENET-PARIS, V24, P245; Tegay DH, 2009, CLIN GENET, V75, P259, DOI 10.1111/j.1399-0004.2008.01145.x; Van Buggenhout G, 2005, EUR J MED GENET, V48, P276, DOI 10.1016/j.ejmg.2005.05.005; Vogels A, 1997, GENET COUNSEL, V8, P249; YOUNG RS, 1983, J MED GENET, V20, P199, DOI 10.1136/jmg.20.3.199	32	71	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6568	10.1371/journal.pone.0006568	http://dx.doi.org/10.1371/journal.pone.0006568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668335	Green Published, gold, Green Submitted			2022-12-25	WOS:000268773300010
J	Zhao, M; Duan, XF; Zhao, XY; Zhang, B; Lu, Y; Liu, W; Cheng, JK; Chen, GQ				Zhao, Meng; Duan, Xu-Fang; Zhao, Xu-Yun; Zhang, Bo; Lu, Ying; Liu, Wei; Cheng, Jin-Ke; Chen, Guo-Qiang			Protein Kinase C delta Stimulates Proteasome-Dependent Degradation of C/EBP alpha during Apoptosis Induction of Leukemic Cells	PLOS ONE			English	Article								Background: The precise regulation and maintenance of balance between cell proliferation, differentiation and death in metazoan are critical for tissue homeostasis. CCAAT/enhancer-binding protein alpha (C/EBP alpha) has been implicated as a key regulator of differentiation and proliferation in various cell types. Here we investigated the potential dynamic change and role of C/EBP alpha protein during apoptosis induction. Methodology/Principal Findings: Upon onset of apoptosis induced by various kinds of inducers such as NSC606985, etoposide and others, C/EBP alpha expression presented a profound down-regulation in leukemic cell lines and primary cells via induction of protein degradation and inhibition of transcription, as assessed respectively by cycloheximide inhibition test, real-time quantitative RT-PCR and luciferase reporter assay. Applying chemical inhibition, forced expression of dominant negative mutant and catalytic fragment (CF) of protein kinase Cdelta (PKC delta), which was proteolytically activated during apoptosis induction tested, we showed that the active PKC delta protein contributed to the increased degradation of C/EBP alpha protein. Three specific proteasome inhibitors antagonized C/EBP alpha degradation during apoptosis induction. More importantly, ectopic expression of PKC delta-CF stimulated the ubiquitination of C/EBP alpha protein, while the chemical inhibition of PKC delta action significantly inhibited the enhanced ubiquitination of C/EBP alpha protein under NSC606985 treatment. Additionally, silencing of C/EBP alpha expression by small interfering RNAs enhanced, while inducible expression of C/EBP alpha inhibited NSC606985/etoposide-induced apoptosis in leukemic cells. Conclusions/Significance: These observations indicate that the activation of PKC delta upon apoptosis results in the increased proteasome-dependent degradation of C/EBP alpha, which partially contributes to PKC delta-mediated apoptosis.			Zhao, M (corresponding author), Chinese Acad Sci, SIBS, Inst Hlth Sci, Shanghai, Peoples R China.	chengq@shsmu.edu.cn		Zhao, Meng/0000-0001-7909-7594				Adams J, 1999, CANCER RES, V59, P2615; Basu A, 2003, J CELL MOL MED, V7, P341, DOI 10.1111/j.1582-4934.2003.tb00237.x; Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Droin N, 2008, BIOCHIMIE, V90, P416, DOI 10.1016/j.biochi.2007.08.007; Emoto Y, 1996, BLOOD, V87, P1990; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Hamada M, 2006, APOPTOSIS, V11, P47, DOI 10.1007/s10495-005-3348-z; Iturrioz X, 2006, BIOCHEM J, V397, P109, DOI 10.1042/BJ20060354; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; Kockar FT, 2001, NUCLEIC ACIDS RES, V29, P362, DOI 10.1093/nar/29.2.362; LANOTTE M, 1991, BLOOD, V77, P1080; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; LEGRAVEREND C, 1993, NUCLEIC ACIDS RES, V21, P1735, DOI 10.1093/nar/21.8.1735; Leitges M, 2001, LAB INVEST, V81, P1087, DOI 10.1038/labinvest.3780321; Leverrier S, 2002, BIOCHEM J, V368, P905, DOI 10.1042/BJ20021253; Lin KI, 1998, CELL DEATH DIFFER, V5, P577, DOI 10.1038/sj.cdd.4400384; Liu JH, 2003, CANCER RES, V63, P1153; Liu ZJ, 2007, LEUKEMIA RES, V31, P1156, DOI 10.1016/j.leukres.2006.09.014; Lu QL, 1996, HUM PATHOL, V27, P102, DOI 10.1016/S0046-8177(96)90362-7; Lu Y, 2008, LEUKEMIA, V22, P378, DOI 10.1038/sj.leu.2405020; Lu Y, 2006, LEUKEMIA, V20, P987, DOI 10.1038/sj.leu.2404218; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Paz-Priel I, 2005, MOL CANCER RES, V3, P585, DOI 10.1158/1541-7786.MCR-05-0111; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rapisarda A, 2002, CANCER RES, V62, P4316; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Shim M, 2003, J BIOL CHEM, V278, P19674, DOI 10.1074/jbc.M301356200; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Song MG, 2005, BLOOD, V105, P3714, DOI 10.1182/blood-2004-10-4011; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Walker JL, 2006, J BIOL CHEM, V281, P38127, DOI 10.1074/jbc.M609622200; Wang L, 2007, CELL DEATH DIFFER, V14, P306, DOI 10.1038/sj.cdd.4401996; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027; Yu Y, 2007, J PROTEOME RES, V6, P3808, DOI 10.1021/pr0700100; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zheng Y, 2009, PROTEOMICS, V9, P2064, DOI 10.1002/pmic.200800031	61	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6552	10.1371/journal.pone.0006552	http://dx.doi.org/10.1371/journal.pone.0006552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662097	Green Submitted, Green Published, gold			2022-12-25	WOS:000268739600009
J	Tietzel, I; El-Haibi, C; Carabeo, RA				Tietzel, Illya; El-Haibi, Christelle; Carabeo, Rey A.			Human Guanylate Binding Proteins Potentiate the Anti-Chlamydia Effects of Interferon-gamma	PLOS ONE			English	Article								Chlamydiae are obligate intracellular pathogens that are sensitive to pro-inflammatory cytokine interferon-c. IFN-gamma-inducible murine p47 GTPases have been demonstrated to function in resistance to chlamydia infection in vivo and in vitro. Because the human genome does not encode IFN-gamma-inducible homologues of these proteins, the significance of the p47 GTPase findings to chlamydia pathogenesis in humans is unclear. Here we report a pair of IFN-gamma-inducible proteins, the human guanylate binding proteins (hGBPs) 1 and 2 that potentiate the anti-chlamydial properties of IFN-gamma. hGBP1 and 2 localize to the inclusion membrane, and their anti-chlamydial functions required the GTPase domain. Alone, hGBP1 or 2 have mild, but statistically significant and reproducible negative effects on the growth of Chlamydia trachomatis, whilst having potent antichlamydial activity in conjunction with treatment with a sub-inhibitory concentration of IFN-gamma. Thus, hGBPs appear to potentiate the anti-chlamydial effects of IFN-gamma. Indeed, depletion of hGBP1 and 2 in cells treated with IFN-gamma led to an increase in inclusion size, indicative of better growth. Interestingly, chlamydia species/strains harboring the full-length version of the putative cytotoxin gene, which has been suggested to confer resistance to IFN-gamma was not affected by hGBP overexpression. These findings identify the guanylate binding proteins as potentiators of IFN-gamma inhibition of C. trachomatis growth, and may be the targets of the chlamydial cytotoxin.			Tietzel, I (corresponding author), So Univ New Orleans, Dept Nat Sci, New Orleans, LA USA.	r.carabeo@imperial.ac.uk		Tietzel, Illya/0000-0003-0966-4498; CARABEO, REY/0000-0002-5708-5493	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI052252, R01AI065545] Funding Source: NIH RePORTER; NIAID NIH HHS [AI065545, K22 AI052252, AI052252, R01 AI065545-02, R01 AI065545] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; BALLARD FJ, 1973, BIOCHEM J, V136, P259, DOI 10.1042/bj1360259; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Bernstein-Hanley I, 2006, GENES IMMUN, V7, P122, DOI 10.1038/sj.gene.6364285; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Brusic V, 2003, GENOME RES, V13, P1307, DOI 10.1101/gr.1016503; BYRNE GI, 1986, J INTERFERON RES, V6, P389, DOI 10.1089/jir.1986.6.389; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; CARLIN JM, 1989, J INTERFERON RES, V9, P329, DOI 10.1089/jir.1989.9.329; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CHENG YSE, 1985, J BIOL CHEM, V260, P5834; CHENG YSE, 1988, J INTERFERON RES, V8, P385, DOI 10.1089/jir.1988.8.385; CHENG YSE, 1991, MOL CELL BIOL, V11, P4717, DOI 10.1128/MCB.11.9.4717; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Kane CD, 1999, INFECT IMMUN, V67, P1666; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; PAGUIRIGAN AM, 1994, INFECT IMMUN, V62, P1131, DOI 10.1128/IAI.62.4.1131-1136.1994; Pammer J, 2006, LAB INVEST, V86, P997, DOI 10.1038/labinvest.3700461; Perry LL, 1997, J IMMUNOL, V158, P3344; Perry LL, 1999, INFECT IMMUN, V67, P1379, DOI 10.1128/IAI.67.3.1379-1385.1999; Perry LL, 1999, J IMMUNOL, V162, P3541; Persano L, 2009, CARCINOGENESIS, V30, P851, DOI 10.1093/carcin/bgp052; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; SAKURAI T, 1974, BIOCHIM BIOPHYS ACTA, V360, P275, DOI 10.1016/0005-2760(74)90057-5; Schwemmle M, 1996, J BIOL CHEM, V271, P10304, DOI 10.1074/jbc.271.17.10304; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; STREHLOW I, 1994, GENE, V144, P295, DOI 10.1016/0378-1119(94)90393-X; Su H, 2000, INFECT IMMUN, V68, P192, DOI 10.1128/IAI.68.1.192-196.2000; THOMAS SM, 1993, J IMMUNOL, V150, P5529; TREADOW BR, 1972, NATURE-NEW BIOL, V239, P131, DOI 10.1038/newbio239131a0; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Yang X, 2001, MICROSC RES TECHNIQ, V53, P273, DOI 10.1002/jemt.1093	45	77	81	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6499	10.1371/journal.pone.0006499	http://dx.doi.org/10.1371/journal.pone.0006499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652711	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637800011
J	Boscia, F; Esposito, CL; Di Crisci, A; de Franciscis, V; Annunziato, L; Cerchia, L				Boscia, Francesca; Esposito, Carla Lucia; Di Crisci, Antonella; de Franciscis, Vittorio; Annunziato, Lucio; Cerchia, Laura			GDNF Selectively Induces Microglial Activation and Neuronal Survival in CA1/CA3 Hippocampal Regions Exposed to NMDA Insult through Ret/ERK Signalling	PLOS ONE			English	Article								The glial cell line-derived neurotrophic factor (GDNF) is a potent survival factor for several neuronal populations in different brain regions, including the hippocampus. However, no information is available on the: (1) hippocampal subregions involved in the GDNF-neuroprotective actions upon excitotoxicity, (2) identity of GDNF-responsive hippocampal cells, (3) transduction pathways involved in the GDNF-mediated neuroprotection in the hippocampus. We addressed these questions in organotypic hippocampal slices exposed to GDNF in presence of N-methyl-D-aspartate (NMDA) by immunoblotting, immunohistochemistry, and confocal analysis. In hippocampal slices GDNF acts through the activation of the tyrosine kinase receptor, Ret, without involving the NCAM-mediated pathway. Both Ret and ERK phosphorylation mainly occurred in the CA3 region where the two activated proteins co-localized. GDNF protected in a greater extent CA3 rather than CA1 following NMDA exposure. This neuroprotective effect targeted preferentially neurons, as assessed by NeuN staining. GDNF neuroprotection was associated with a significant increase of Ret phosphorylation in both CA3 and CA1. Interestingly, confocal images revealed that upon NMDA exposure, Ret activation occurred in microglial cells in the CA3 and CA1 following GDNF exposure. Collectively, this study shows that CA3 and CA1 hippocampal regions are highly responsive to GDNF-induced Ret activation and neuroprotection, and suggest that, upon excitotoxicity, such neuroprotection involves a GDNF modulation of microglial cell activity.			Boscia, F (corresponding author), Univ Naples Federico 2, Fac Med & Chirurg, Sez Farmacol, Dipartimento Neurosci, Naples, Italy.	lannunzi@unina.it; cerchia@unina.it	Esposito, Carla L/K-5246-2016	Esposito, Carla L/0000-0003-0624-6821; Cerchia, Laura/0000-0002-7633-7932; BOSCIA, Francesca/0000-0003-1572-0484; ANNUNZIATO, LUCIO/0000-0002-8534-8270	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; Boscia F, 2008, NEUROPHARMACOLOGY, V55, P428, DOI 10.1016/j.neuropharm.2008.04.024; Boscia F, 2006, NEUROPHARMACOLOGY, V51, P283, DOI 10.1016/j.neuropharm.2006.03.024; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Chang YP, 2006, J CELL BIOCHEM, V97, P501, DOI 10.1002/jcb.20646; ColucciDAmato GL, 1996, CELL GROWTH DIFFER, V7, P1081; Evans JR, 2008, EXPERT OPIN THER TAR, V12, P437, DOI 10.1517/14728222.12.4.437 ; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Honda S, 1999, NEUROSCI LETT, V275, P203, DOI 10.1016/S0304-3940(99)00769-7; HUMPEL C, 1994, NEUROSCIENCE, V59, P791, DOI 10.1016/0306-4522(94)90284-4; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; MARTIN D, 1995, BRAIN RES, V683, P172, DOI 10.1016/0006-8993(95)00369-2; Marty S, 1996, J NEUROSCI, V16, P675; Matsutani S, 2004, NEUROSCIENCE, V123, P695, DOI 10.1016/j.neuroscience.2003.10.030; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; Nicole O, 2001, J NEUROSCI, V21, P3024, DOI 10.1523/JNEUROSCI.21-09-03024.2001; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Remy S, 2001, J NEUROSCI RES, V64, P242, DOI 10.1002/jnr.1072; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; SCHMIDTKASTNER R, 1994, MOL BRAIN RES, V26, P325, DOI 10.1016/0169-328X(94)90106-6; Serra MP, 2005, INT J DEV NEUROSCI, V23, P425, DOI 10.1016/j.ijdevneu.2005.05.003; STREIT WJ, 1990, J HISTOCHEM CYTOCHEM, V38, P1683, DOI 10.1177/38.11.2212623; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1997, J NEUROSCI, V17, P3554; Wang Y, 1997, J NEUROSCI, V17, P4341; Williams LR, 1996, J PHARMACOL EXP THER, V277, P1140; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; Yu T, 1998, J NEUROSCI, V18, P4684; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	39	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6486	10.1371/journal.pone.0006486	http://dx.doi.org/10.1371/journal.pone.0006486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649251	Green Submitted, Green Published, gold			2022-12-25	WOS:000268637700011
J	Quan, JY; Tian, JD				Quan, Jiayuan; Tian, Jingdong			Circular Polymerase Extension Cloning of Complex Gene Libraries and Pathways	PLOS ONE			English	Article							RECOMBINANT-DNA; RAPID CONSTRUCTION; LARGE NUMBERS; IN-VITRO; PCR; PLASMID	High-throughput genomics and the emerging field of synthetic biology demand ever more convenient, economical, and efficient technologies to assemble and clone genes, gene libraries and synthetic pathways. Here, we describe the development of a novel and extremely simple cloning method, circular polymerase extension cloning (CPEC). This method uses a single polymerase to assemble and clone multiple inserts with any vector in a one- step reaction in vitro. No restriction digestion, ligation, or single-stranded homologous recombination is required. In this study, we elucidate the CPEC reaction mechanism and demonstrate its usage in demanding synthetic biology applications such as one- step assembly and cloning of complex combinatorial libraries and multi-component pathways.			Quan, JY (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	jtian@duke.edu	Feng, Miao/B-8220-2012					ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; DANNA K, 1971, P NATL ACAD SCI USA, V68, P2913, DOI 10.1073/pnas.68.12.2913; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kranz RG, 1997, APPL ENVIRON MICROB, V63, P3010, DOI 10.1128/AEM.63.8.3010-3013.1997; Kung SS, 2007, LETT APPL MICROBIOL, V44, P364, DOI 10.1111/j.1472-765X.2006.02090.x; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Marsischky G, 2004, GENOME RES, V14, P2020, DOI 10.1101/gr.2528804; Nisson P E, 1991, PCR Methods Appl, V1, P120; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; Rashtchian Ayoub, 1995, Current Opinion in Biotechnology, V6, P30, DOI 10.1016/0958-1669(95)80006-9; SHULDINER AR, 1990, NUCLEIC ACIDS RES, V18, P1920, DOI 10.1093/nar/18.7.1920; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X	21	319	371	11	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6441	10.1371/journal.pone.0006441	http://dx.doi.org/10.1371/journal.pone.0006441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649325	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494600011
J	Xiao, LQ; Eto, M; Kazanietz, MG				Xiao, Liqing; Eto, Masumi; Kazanietz, Marcelo G.			ROCK Mediates Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via p21(Cip1) Up-regulation and JNK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; LIGHT-CHAIN PHOSPHORYLATION; RHO-ASSOCIATED KINASE; PKC-DELTA; BARRIER FUNCTION; GENE-EXPRESSION; EXCHANGE FACTOR; ACTIVATION; PATHWAY; GTPASES	It is established that androgen-dependent prostate cancer cells undergo apoptosis upon treatment with phorbol esters and related analogs, an effect primarily mediated by PKC delta. Treatment of LNCaP prostate cancer cells with phorbol 12-myristate 13-acetate (PMA) causes a strong and sustained activation of RhoA and its downstream effector ROCK(Rho kinase) as well as the formation of stress fibers. These effects are impaired in cells subjected to PKC delta RNA interference depletion. Functional studies revealed that expression of a dominant negative RhoA mutant or treatment with the ROCK inhibitor Y-27632 inhibits the apoptotic effect of PMA in LNCaP cells. Remarkably, the cytoskeleton inhibitors cytochalasin B and blebbistatin blocked not only PMA-induced apoptosis but also the activation of JNK, a mediator of the cell death effect by the phorbol ester. In addition, we found that up-regulation of the cell cycle inhibitor p21(Cip1) is required for PMA-induced apoptosis and that inhibitors of ROCK or the cytoskeleton organization prevent p21(Cip1) induction. Real time PCR analysis and reporter gene assay revealed thatPMAinduces p21(Cip1) transcriptionally in a ROCK- and cytoskeleton-dependent manner. p21(Cip1) promoter analysis revealed that PMA induction is dependent on Sp1 elements in the p21(Cip1) promoter but independent of p53. Taken together, our studies implicate ROCK-mediated up-regulation of p21(Cip1) and the cytoskeleton in PKC delta-dependent apoptosis in prostate cancer cells.	[Xiao, Liqing; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Eto, Masumi] Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA	University of Pennsylvania; Jefferson University	Kazanietz, MG (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Eto, Masumi/ABE-4700-2020	Eto, Masumi/0000-0002-0651-5836	National Institutes of Health [RO1-CA89202, RO1-HL083261]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA89202 (to M. G. K.) and RO1-HL083261 (to M. E.).	Afrasiabi E, 2008, MOL CELL ENDOCRINOL, V292, P26, DOI 10.1016/j.mce.2008.04.018; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; Berenjeno IM, 2008, CLIN TRANSL ONCOL, V10, P726, DOI 10.1007/s12094-008-0279-5; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Cen B, 2008, CANCER RES, V68, P5355, DOI 10.1158/0008-5472.CAN-07-6869; Chaigne-Delalande B, 2008, ARCH IMMUNOL THER EX, V56, P9, DOI 10.1007/s00005-008-0002-9; Chang YC, 2006, CELL DEATH DIFFER, V13, P2023, DOI 10.1038/sj.cdd.4401901; Chang ZF, 2006, J BIOMED SCI, V13, P173, DOI 10.1007/s11373-005-9056-4; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Cohen O, 1999, J CELL BIOL, V146, P141; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Coleman ML, 2006, ONCOGENE, V25, P2708, DOI 10.1038/sj.onc.1209322; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; De Siervi A, 2004, CANCER RES, V64, P743, DOI 10.1158/0008-5472.CAN-03-2505; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; EL DW, 1993, CELL, V75, P817; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FOJAS DB, 2001, EMBO J, V20, P5737; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Harrington EO, 2005, EXP CELL RES, V308, P407, DOI 10.1016/j.yexcr.2005.05.005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jin YJ, 2001, J BIOL CHEM, V276, P30342, DOI 10.1074/jbc.M102404200; Kim CG, 2007, CELL SIGNAL, V19, P1290, DOI 10.1016/j.cellsig.2007.01.008; Lai JM, 2003, J CELL SCI, V116, P3491, DOI 10.1242/jcs.00660; Lai JM, 2002, MOL CELL BIOL, V22, P7581, DOI 10.1128/MCB.22.21.7581-7592.2002; Lashinger LM, 2005, CANCER RES, V65, P4902, DOI 10.1158/0008-5472.CAN-04-3701; Lee HH, 2004, J CELL SCI, V117, P5579, DOI 10.1242/jcs.01482; Liu PY, 2008, METHOD ENZYMOL, V439, P181, DOI 10.1016/S0076-6879(07)00414-4; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Meacci E, 2000, FEBS LETT, V482, P97, DOI 10.1016/S0014-5793(00)02039-1; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Miralles F, 2006, CURR OPIN CELL BIOL, V18, P261, DOI 10.1016/j.ceb.2006.04.009; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Orlando KA, 2006, EXP CELL RES, V312, P3298, DOI 10.1016/j.yexcr.2006.06.033; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Papadopoulou N, 2008, EXP CELL RES, V314, P3162, DOI 10.1016/j.yexcr.2008.07.012; Park JW, 2001, BIOCHEM BIOPH RES CO, V280, P244, DOI 10.1006/bbrc.2000.4105; Potin S, 2007, FEBS LETT, V581, P118, DOI 10.1016/j.febslet.2006.12.016; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; Slater SJ, 2003, BIOCHEMISTRY-US, V42, P12105, DOI 10.1021/bi034860e; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Truman JP, 2005, J BIOL CHEM, V280, P23262, DOI 10.1074/jbc.M503701200; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200; Xiao LQ, 2009, MOL CARCINOGEN, V48, P187, DOI 10.1002/mc.20476; Yanazume T, 2002, J BIOL CHEM, V277, P8618, DOI 10.1074/jbc.M107924200; Yin LH, 2005, J BIOL CHEM, V280, P5533, DOI 10.1074/jbc.M405266200; Zhao X, 1997, J BIOL CHEM, V272, P22751, DOI 10.1074/jbc.272.36.22751	64	38	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29365	29375		10.1074/jbc.M109.007971	http://dx.doi.org/10.1074/jbc.M109.007971			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19667069	hybrid, Green Published			2022-12-25	WOS:000270896800017
J	Ishida, H; Rainaldi, M; Vogel, HJ				Ishida, Hiroaki; Rainaldi, Mario; Vogel, Hans J.			Structural Studies of Soybean Calmodulin Isoform 4 Bound to the Calmodulin-binding Domain of Tobacco Mitogen-activated Protein Kinase Phosphatase-1 Provide Insights into a Sequential Target Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-DECARBOXYLASE; PEPTIDE INTERACTION; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; NITRIC-OXIDE; CALCIUM; COMPLEX; RECOGNITION; REVEALS; PROGRAM	The calcium regulatory protein calmodulin (CaM) binds in a calcium-dependent manner to numerous target proteins. The calmodulin-binding domain (CaMBD) region of Nicotiana tabacum MAPK phosphatase has an amino acid sequence that does not resemble the CaMBD of any other known Ca2+-CaM-binding proteins. Using a unique fusion protein strategy, we have been able to obtain a high resolution solution structure of the complex of soybean Ca2+-CaM4 (SCaM4) and this CaMBD. Complete isotope labeling of both parts of the complex in the fusion protein greatly facilitated the structure determination by NMR. The 12-residue CaMBD region was found to bind exclusively to the C-lobe of SCaM4. A specific Trp and Leu side chain are utilized to facilitate strong binding through a novel "double anchor" motif. Moreover, the orientation of the helical peptide on the surface of Ca2+-SCaM4 is distinct from other known complexes. The N-lobe of Ca2+-SCaM4 in the complex remains free for additional interactions and could possibly act as a calcium-dependent adapter protein. Signaling through the MAPK pathway and increases in intracellular Ca2+ are both hallmarks of the plant stress response, and our data support the notion that coordination of these responses may occur through the formation of a unique CaM-MAPK phosphatase multiprotein complex.	[Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Chem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Chem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research; University of Calgary	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of Calgary	This work was supported by a discovery grant from the Natural Sciences and Engineering Research Council of Canada. The Bio-NMR Centre in Calgary was supported by the Canadian Institutes for Health Research and the University of Calgary.	Ataman ZA, 2007, STRUCTURE, V15, P1603, DOI 10.1016/j.str.2007.10.012; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Baum G, 1996, EMBO J, V15, P2988, DOI 10.1002/j.1460-2075.1996.tb00662.x; BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Bhattacharya N, 2007, J MOL BIOL, V374, P977, DOI 10.1016/j.jmb.2007.09.063; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Heo WD, 1999, P NATL ACAD SCI USA, V96, P766, DOI 10.1073/pnas.96.2.766; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ishida H, 2008, J BIOL CHEM, V283, P14619, DOI 10.1074/jbc.M801398200; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee K, 2008, J BIOL CHEM, V283, P23581, DOI 10.1074/jbc.M801549200; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Yamakawa H, 2004, J BIOL CHEM, V279, P928, DOI 10.1074/jbc.M310277200; Yamakawa H, 2001, EUR J BIOCHEM, V268, P3916, DOI 10.1046/j.1432-1327.2001.02301.x; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yamniuk AP, 2007, PLANT SIGNAL BEHAV, V2, P354, DOI 10.4161/psb.2.5.4155; Yamniuk AP, 2005, BIOCHEMISTRY-US, V44, P3101, DOI 10.1021/bi047770y; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Ye QL, 2006, BIOCHEMISTRY-US, V45, P738, DOI 10.1021/bi0521801; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; Zielinski RE, 2002, PLANTA, V214, P446, DOI 10.1007/s004250100636; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	59	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28292	28305		10.1074/jbc.M109.025080	http://dx.doi.org/10.1074/jbc.M109.025080			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19667066	Green Published, hybrid			2022-12-25	WOS:000270676300056
J	Loiarro, M; Gallo, G; Fanto, N; De Santis, R; Carminati, P; Ruggiero, V; Sette, C				Loiarro, Maria; Gallo, Grazia; Fanto, Nicola; De Santis, Rita; Carminati, Paolo; Ruggiero, Vito; Sette, Claudio			Identification of Critical Residues of the MyD88 Death Domain Involved in the Recruitment of Downstream Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; ADAPTER PROTEIN; TNF RECEPTOR; IRAK FAMILY; INTERLEUKIN-1; ACTIVATION; COMPLEX; MEMBER; DIFFERENTIATION	MyD88 couples the activation of the Toll-like receptors and interleukin-1 receptor superfamily with intracellular signaling pathways. Upon ligand binding, activated receptors recruit MyD88 via its Toll-interleukin-1 receptor domain. MyD88 then allows the recruitment of the interleukin-1 receptor-associated kinases (IRAKs). We performed a site-directed mutagenesis of MyD88 residues, conserved in death domains of the homologous FADD and Pelle proteins, and analyzed the effect of the mutations on MyD88 signaling. Our studies revealed that mutation of residues 52 (MyD88(E52A)) and 58 (MyD88(Y58A)) impaired recruitment of both IRAK1 and IRAK4, whereas mutation of residue 95 (MyD88(K95A)) only affected IRAK4 recruitment. Since all MyD88 mutants were defective in signaling, recruitment of both IRAKs appeared necessary for activation of the pathway. Moreover, overexpression of a green fluorescent protein (GFP)-tagged mini-MyD88 protein (GFP-MyD88-(27-72)), comprising the Glu(52) and Tyr(58) residues, interfered with recruitment of both IRAK1 and IRAK4 by MyD88 and suppressed NF-kappa B activation by the interleukin-1 receptor but not by the MyD88-independent TLR3. GFP-MyD88-(27-72) exerted its effect by titrating IRAK1 and suppressing IRAK1-dependent NF-kappa B activation. These experiments identify novel residues of MyD88 that are crucially involved in the recruitment of IRAK1 and IRAK4 and in downstream propagation of MyD88 signaling.	[Loiarro, Maria; Sette, Claudio] Fdn Santa Lucia Roma & Uno, Ist Ricovero & Cura Carattere Sci, Lab Neuroembryol, I-00143 Rome, Italy; [Gallo, Grazia; Fanto, Nicola; De Santis, Rita; Carminati, Paolo; Ruggiero, Vito] Sigma Tau Ind Farmaceutiche Riunite SpA, Dept Immunol Bldg LABIO, I-00040 Pomezia, RM, Italy; [Loiarro, Maria; Sette, Claudio] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, I-00133 Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata	Sette, C (corresponding author), Sigma Tau Ind Farmaceutiche Riunite SpA, Dept Immunol Bldg LABIO, Via Pontina Km 30-400, I-00040 Pomezia, RM, Italy.	vito.ruggiero@sigma-tau.it; claudio.sette@uniroma2.it	Sette, Claudio/S-4307-2019	Sette, Claudio/0000-0003-2864-8266; DE SANTIS, Rita/0000-0002-5037-0611	Istituto Superiore della Sanita [527/B/3A/5]; Association for International Cancer Research; Fondazione Italiana Sclerosi Multipla; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Istituto Superiore della Sanita; Association for International Cancer Research; Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Istituto Superiore della Sanita (ISS Project 527/B/3A/5), the Association for International Cancer Research, and the Fondazione Italiana Sclerosi Multipla.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Fischer M, 2008, ANN NY ACAD SCI, V1143, P21, DOI 10.1196/annals.1443.012; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Gearing AJH, 2007, IMMUNOL CELL BIOL, V85, P490, DOI 10.1038/sj.icb.7100102; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hardiman G, 1996, ONCOGENE, V13, P2467; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; Hong-Geller Elizabeth, 2008, Curr Drug Discov Technol, V5, P29, DOI 10.2174/157016308783769441; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; LORD KA, 1990, ONCOGENE, V5, P387; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	41	59	74	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28093	28103		10.1074/jbc.M109.004465	http://dx.doi.org/10.1074/jbc.M109.004465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679662	Green Published, hybrid			2022-12-25	WOS:000270676300036
J	Park, KM; Yule, DI; Bowers, WJ				Park, Keigan M.; Yule, David I.; Bowers, William J.			Tumor Necrosis Factor-alpha-mediated Regulation of the Inositol 1,4,5-Trisphosphate Receptor Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SMOOTH-MUSCLE-CELLS; CORTICAL-NEURONS; TRANSCRIPTIONAL REGULATION; SYNAPTIC PLASTICITY; GENE-TRANSCRIPTION; PROTEIN-KINASE; CA2+ RELEASE; KAPPA-B; C-JUN	Tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine, has been implicated as a central mediator in multiple homeostatic and pathologic processes. Signaling cascades downstream of its cellular cognate receptors, as well as the resultant transcriptional responses have received intense interest in regards to how such signals impact cellular physiology. Notably, TNF-alpha was shown to potentiate neuronal Ca2+ signaling by enhancing type-1 inositol 1,4,5-trisphosphate receptor (IP3R) steady-state mRNA levels. In the present study, we sought to determine the promoter region ultimately responsive to TNF-alpha exposure. We report that a sequence encompassing a specificity protein 1 (SP-1) binding site is necessary for TNF-alpha regulation. Electrophoretic mobility shift analysis demonstrated specific binding to this sequence, while site-directed mutagenesis of this site abrogated both JNK-mediated regulation as well as transcription factor binding. Expression of a dominant-negative SP-1 eliminated both the enhanced promoter activity and the elevated IP3R-mediated Ca2+ signals observed with TNF-alpha exposure. Overall, these data delineate a key pathway by which TNF-alpha in a neuronal environment modulates IP3R expression and intracellular Ca2+ homeostasis.	[Bowers, William J.] Univ Rochester, Med Ctr, Dept Neurol, Sch Med & Dent, Rochester, NY 14642 USA; [Park, Keigan M.; Bowers, William J.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Sch Med & Dent, Rochester, NY 14642 USA; [Park, Keigan M.; Yule, David I.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Bowers, WJ (corresponding author), 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	william_bowers@urmc.rochester.edu			National Institutes of Health [F31-NS056731, T32-DE07202, R01-DK54588, R01-DE14756, R01-AG023593, R01-AG026328]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK054588, R43DK054588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023593, R01AG026328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant F31-NS056731, Oral Biology Training Grant T32-DE07202 (to K. M. P.), Grants R01-DK54588 and R01-DE14756 (to D.I.Y.), and Grants R01-AG023593 and R01-AG026328 (to W.J.B.).	Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Albensi BC, 2000, SYNAPSE, V35, P151; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; BRADFORD PG, 1991, BIOCHEM J, V280, P205, DOI 10.1042/bj2800205; BROWN PH, 1994, ONCOGENE, V9, P791; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Deelman LE, 1998, GENE, V207, P219, DOI 10.1016/S0378-1119(97)00630-6; Di Filippo M, 2008, TRENDS PHARMACOL SCI, V29, P402, DOI 10.1016/j.tips.2008.06.005; DieckmannSchuppert A, 1997, CELL TISSUE RES, V288, P119, DOI 10.1007/s004410050799; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; Furutama D, 1996, J NEUROCHEM, V66, P1793; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Giovannucci DR, 2002, J PHYSIOL-LONDON, V540, P469, DOI 10.1113/jphysiol.2001.013453; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; JOLLIFF K, 1991, NUCLEIC ACIDS RES, V19, P2267, DOI 10.1093/nar/19.9.2267; Kavurma MM, 2003, J BIOL CHEM, V278, P32537, DOI 10.1074/jbc.M305650200; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; Koga T, 2007, AM J PHYSIOL-LUNG C, V293, pL693, DOI 10.1152/ajplung.00491.2006; Konishi Y, 1997, J NEUROCHEM, V69, P476; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; Mackrill JJ, 1996, BIOCHEM J, V318, P871, DOI 10.1042/bj3180871; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Park KM, 2008, J BIOL CHEM, V283, P33069, DOI 10.1074/jbc.M802209200; Puebla C, 2008, J CELL PHYSIOL, V215, P645, DOI 10.1002/jcp.21347; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Ramirez SH, 2001, J NEUROCHEM, V78, P874, DOI 10.1046/j.1471-4159.2001.00467.x; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sneyd J, 2003, BIOPHYS J, V85, P1392, DOI 10.1016/S0006-3495(03)74572-X; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2003, J NEUROSCI, V23, P758; TAKEI N, 1994, BRAIN RES, V652, P65, DOI 10.1016/0006-8993(94)90317-4; Wu DY, 2006, CELL RES, V16, P319, DOI 10.1038/sj.cr.7310040; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200	49	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27557	27566		10.1074/jbc.M109.034504	http://dx.doi.org/10.1074/jbc.M109.034504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666470	Green Published, hybrid			2022-12-25	WOS:000270232300057
J	Sasaki, N; Ogasawara, M; Sekiguchi, T; Kusumoto, S; Satake, H				Sasaki, Naoko; Ogasawara, Michio; Sekiguchi, Toshio; Kusumoto, Shoichi; Satake, Honoo			Toll-like Receptors of the Ascidian Ciona intestinalis PROTOTYPES WITH HYBRID FUNCTIONALITIES OF VERTEBRATE TOLL-LIKE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE GENE REPERTOIRE; PURPLE SEA-URCHIN; INFLAMMATORY RESPONSE; EVOLUTIONARY ORIGIN; EXPRESSION PATTERNS; SIGNALING PATHWAY; GENOMIC ANALYSIS; STRUCTURAL BASIS; HOST-DEFENSE; RECOGNITION	Key transmembrane proteins in the innate immune system, Toll-like receptors (TLRs), have been suggested to occur in the genome of non-mammalian organisms including invertebrates. However, authentic invertebrate TLRs have been neither structurally nor functionally investigated. In this paper, we originally present the structures, localization, ligand recognition, activities, and inflammatory cytokine production of all TLRs of the ascidian Ciona intestinalis, designated as Ci-TLR1 and Ci-TLR2. The amino acid sequence of Ci-TLR1 and Ci-TLR2 were found to possess unique structural organization with moderate sequence similarity to functionally characterized vertebrate TLRs. ci-tlr1 and ci-tlr2 genes were expressed predominantly in the stomach and intestine as well as in hemocytes. Ci-TLR1 and Ci-TLR2 expressed in HEK293 cells, unlike vertebrate TLRs, were localized to both the plasma membrane and endosomes. Intriguingly, both Ci-TLR1 and Ci-TLR2 stimulate NF-kappa B induction in response to multiple pathogenic ligands such as double-stranded RNA, and bacterial cell wall components that are differentially recognized by respective vertebrate TLRs, revealing that Ci-TLRs recognize broader pathogen-associated molecular patterns than vertebrate TLRs. The Ci-TLR-stimulating pathogenic ligands also induced the expression of Ci-TNF alpha in the intestine and stomach where Ci-TLRs are expressed. These results provide evidence that the TLR-triggered innate immune systems are essentially conserved in ascidians, and that Ci-TLRs possess "hybrid" biological and immunological functions, compared with vertebrate TLRs. Moreover, it is presumed that chordate TLR ancestors also acquired the Ci-TLR-like multiple cellular localization and pathogen-associated molecular pattern recognition.	[Sasaki, Naoko; Sekiguchi, Toshio; Kusumoto, Shoichi; Satake, Honoo] Suntory Inst Bioorgan Res, Osaka 6188503, Japan; [Ogasawara, Michio] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan	Suntory Holdings Ltd; Chiba University	Satake, H (corresponding author), Suntory Inst Bioorgan Res, 1-1-1 Wakayamadai, Osaka 6188503, Japan.	satake@sunbor.or.jp			MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Kazuko Hirayama and all members of Maizuru Fisheries Research Station for cultivation of the ascidians. All ascidians were provided by Kyoto University through the National Bio-Resource Project of the MEXT, Japan.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aoyama M, 2008, ENDOCRINOLOGY, V149, P4346, DOI 10.1210/en.2008-0323; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Lettinga KD, 2002, J INFECT DIS, V186, P570, DOI 10.1086/341780; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Ogasawara M, 2002, DEV GENES EVOL, V212, P173, DOI 10.1007/s00427-002-0230-7; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parrinello N, 2008, CELL TISSUE RES, V334, P305, DOI 10.1007/s00441-008-0695-4; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Satake H, 2004, J BIOL CHEM, V279, P53798, DOI 10.1074/jbc.M408161200; SATAKE H, 2006, NEUROPEPTIDES HORMON; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Satoh N, 2009, ZOOL SCI, V26, P97, DOI 10.2108/zsj.26.97; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Wu H, 2008, ENDOCRINOLOGY, V149, P4402, DOI 10.1210/en.2007-1776; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhao HM, 2004, MOL THER, V9, P241, DOI 10.1016/j.ymthe.2003.11.012	44	66	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27336	27343		10.1074/jbc.M109.032433	http://dx.doi.org/10.1074/jbc.M109.032433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651780	hybrid, Green Published			2022-12-25	WOS:000270232300034
J	Tiwari, A; Liba, A; Sohn, SH; Seetharaman, SV; Bilsel, O; Matthews, CR; Hart, PJ; Valentine, JS; Hayward, LJ				Tiwari, Ashutosh; Liba, Amir; Sohn, Se Hui; Seetharaman, Sai V.; Bilsel, Osman; Matthews, C. Robert; Hart, P. John; Valentine, Joan Selverstone; Hayward, Lawrence J.			Metal Deficiency Increases Aberrant Hydrophobicity of Mutant Superoxide Dismutases That Cause Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; COPPER-BINDING-SITE; CU,ZN-SUPEROXIDE DISMUTASE; TRANSGENIC MICE; FAMILIAL ALS; 1-ANILINO-8-NAPHTHALENE SULFONATE; FOLDING MECHANISM; DISULFIDE STATUS; DIMER STABILITY; SOD1 MUTANTS	The mechanisms by which mutant variants of Cu/Zn-superoxide dismutase (SOD1) cause familial amyotrophic lateral sclerosis are not clearly understood. Evidence to date suggests that altered conformations of amyotrophic lateral sclerosis mutant SOD1s trigger perturbations of cellular homeostasis that ultimately cause motor neuron degeneration. In this study we correlated the metal contents and disulfide bond status of purified wild-type (WT) and mutant SOD1 proteins to changes in electrophoretic mobility and surface hydrophobicity as detected by 1-anilinonaphthalene-8-sulfonic acid (ANS) fluorescence. As-isolated WT and mutant SOD1s were copper-deficient and exhibited mobilities that correlated with their expected negative charge. However, upon disulfide reduction and demetallation at physiological pH, both WT and mutant SOD1s underwent a conformational change that produced a slower mobility indicative of partial unfolding. Furthermore, although ANS did not bind appreciably to the WT holoenzyme, incubation of metal-deficient WT or mutant SOD1s with ANS increased the ANS fluorescence and shifted its peak toward shorter wavelengths. This increased interaction with ANS was greater for the mutant SOD1s and could be reversed by the addition of metal ions, especially Cu2+, even for SOD1 variants incapable of forming the disulfide bond. Overall, our findings support the notion that misfolding associated with metal deficiency may facilitate aberrant interactions of SOD1 with itself or with other cellular constituents and may thereby contribute to neuronal toxicity.	[Tiwari, Ashutosh; Hayward, Lawrence J.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [Liba, Amir; Sohn, Se Hui; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Seetharaman, Sai V.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Bilsel, Osman; Matthews, C. Robert] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; University of Texas System; University of Texas Health San Antonio; University of Massachusetts System; University of Massachusetts Worcester	Hayward, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA.	tiwari@mtu.edu; Lawrence.Hayward@umassmed.edu	Tiwari, Ashutosh/A-7458-2008; Valentine, Joan S/B-6665-2008	Tiwari, Ashutosh/0000-0001-7373-349X; Valentine, Joan S/0000-0002-7174-925X; Bilsel, Osman/0000-0003-0414-3060; Hayward, Lawrence/0000-0003-0579-0358	National Institutes of Health [NS44170, NS049134, NS39112, GM54836]; NINDS; ALS Association; ALS Therapy Alliance; Angel Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039112, R01NS044170, P01NS049134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association; ALS Therapy Alliance; Angel Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS44170 (to L.J.H.), NS049134 (to J. S. V.), NS39112 (to P. J. H.), and GM54836 (to C. R. M.) from NINDS. This work was also supported by grants from the ALS Association (to A. T. and L. J. H.), the ALS Therapy Alliance (to A. T. and L. J. H.), and The Angel Fund (to A. T.).	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2000, BIOCHEMISTRY-US, V39, P9108, DOI 10.1021/bi000067z; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2005, J BIOL CHEM, V280, P35815, DOI 10.1074/jbc.M506637200; Banci L, 2002, PROTEIN SCI, V11, P2479, DOI 10.1110/ps.0210802; Banci L, 2002, EUR J BIOCHEM, V269, P1905, DOI 10.1046/j.1432-1033.2002.02840.x; Banci L, 2007, BIOCHEMISTRY-US, V46, P9953, DOI 10.1021/bi700620r; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Bilsel O, 1999, BIOCHEMISTRY-US, V38, P1018, DOI 10.1021/bi982365q; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Crow JP, 1997, J NEUROCHEM, V69, P1936; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; GOLDBERG M, 1974, P NATL ACAD SCI USA, V71, P4684, DOI 10.1073/pnas.71.12.4684; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Hart PJ, 1998, PROTEIN SCI, V7, P545; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; ICHIMURA S, 1977, BIOPOLYMERS, V16, P1449, DOI 10.1002/bip.1977.360160706; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kabashi E, 2006, BBA-MOL BASIS DIS, V1762, P1038, DOI 10.1016/j.bbadis.2006.06.006; LEHRER SS, 1969, J BIOL CHEM, V244, P3613; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Lyons TJ, 2000, J BIOL INORG CHEM, V5, P189, DOI 10.1007/s007750050363; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Matulis D, 1999, BIOPOLYMERS, V49, P451, DOI 10.1002/(SICI)1097-0282(199905)49:6<451::AID-BIP3>3.0.CO;2-6; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Ricchelli F, 2005, CELL MOL LIFE SCI, V62, P1724, DOI 10.1007/s00018-005-5141-0; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROE JA, 1988, BIOCHEMISTRY-US, V27, P950, DOI 10.1021/bi00403a017; Schafer BW, 2000, J BIOL CHEM, V275, P30623, DOI 10.1074/jbc.M002260200; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Strange RW, 2007, P NATL ACAD SCI USA, V104, P10040, DOI 10.1073/pnas.0703857104; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Wang J, 2007, J BIOL CHEM, V282, P345, DOI 10.1074/jbc.M604503200; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042	83	51	53	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27746	27758		10.1074/jbc.M109.043729	http://dx.doi.org/10.1074/jbc.M109.043729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651777	hybrid, Green Published			2022-12-25	WOS:000270232300075
J	Xi, XY; Guo, Y; Chen, H; Xu, CP; Zhang, HY; Hu, HB; Cui, LX; Ba, DN; He, W				Xi, Xueyan; Guo, Yang; Chen, Hui; Xu, Chunping; Zhang, Huiyuan; Hu, Hongbo; Cui, Lianxian; Ba, Denian; He, Wei			Antigen Specificity of gamma delta T Cells Depends Primarily on the Flanking Sequences of CDR3 delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDR3 LENGTH; RECEPTOR; REPERTOIRES; LYMPHOCYTES; REGION	The structural basis that determines the specificity of gamma delta T cell receptor (TCR) recognition remains undefined. Our previous data show that the complementary determining region of human TCR delta (CDR3 delta) is critical to ligand binding. Here we used linear and configurational approaches to examine the roles of V, N-D-N, or J regions in CDR3 delta-mediated antigen recognition. Surprisingly, we found that the binding activities of CDR3 delta from different gamma delta TCRs to their target tissues and ligands depend on the conserved flanking sequences (V and J) but not as much on the D region of CDR3 delta fragment. We further defined the key residues in the V and J regions of CDR3 delta fragments, including the cysteine residue in the V fragment and the leucine residue in the J fragment that determine their ligand binding specificity. Our results demonstrate that TCR delta primarily uses conserved flanking regions to bind ligands. This finding may provide an explanation for the limited number of gamma delta TCR ligands that have as yet been identified.	[He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; Sch Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	heweiimu@public.bta.net.cn	Zhang, Huiyuan/J-2784-2016; Hu, Hongbo/J-8059-2016	Hu, Hongbo/0000-0002-8177-7641; Zhang, Huiyuan/0000-0002-1532-2462	Ministry of Science and Technology, China PR [2001CB510009, 2004CB518706, 2007CB512405]; National Natural Science Foundation of China PR [30490244]; National Program for Biomedical Hightech, the Ministry of Science and Technology, China [2006AA02Z480, 2006AA02A245, 2007AA021109]	Ministry of Science and Technology, China PR(National High Technology Research and Development Program of China); National Natural Science Foundation of China PR(National Natural Science Foundation of China (NSFC)); National Program for Biomedical Hightech, the Ministry of Science and Technology, China	This work was sponsored in part by Grants 2001CB510009, 2004CB518706, and 2007CB512405 from the National Program for Key Basic Research Projects, Ministry of Science and Technology, China PR Grant 30490244 from the National Natural Science Foundation of China PR, and three Grants (No. 2006AA02Z480, No. 2006AA02A245, and No. 2007AA021109) from the National Program for Biomedical Hightech, the Ministry of Science and Technology, China.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Brawley JV, 1999, J IMMUNOL, V163, P4946; Cao W, 2004, IMMUNOBIOLOGY, V209, P283, DOI 10.1016/j.imbio.2004.04.008; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; Chien YH, 2000, SPRINGER SEMIN IMMUN, V22, P239, DOI 10.1007/PL00006752; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Koohsari H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-21; Koralov SB, 2006, IMMUNITY, V25, P43, DOI 10.1016/j.immuni.2006.04.016; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; McVay LD, 1998, J IMMUNOL, V160, P5851; Moser B, 2006, TRENDS IMMUNOL, V27, P112, DOI 10.1016/j.it.2006.01.002; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yao XS, 2007, CELL MOL IMMUNOL, V4, P215; Xu CP, 2007, MOL IMMUNOL, V44, P302, DOI 10.1016/j.molimm.2006.03.010; Zocchi MR, 2004, FRONT BIOSCI-LANDMRK, V9, P2588, DOI 10.2741/1419	20	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27449	27455		10.1074/jbc.M109.011684	http://dx.doi.org/10.1074/jbc.M109.011684			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666468	Green Published, hybrid			2022-12-25	WOS:000270232300047
J	Brown, RM; Robertson, EM; Press, DZ				Brown, Rachel M.; Robertson, Edwin M.; Press, Daniel Z.			Sequence Skill Acquisition and Off-Line Learning in Normal Aging	PLOS ONE			English	Article							MEMORY-SYSTEMS; SERIAL PATTERNS; AGE-DIFFERENCES; CONSOLIDATION; SLEEP; BRAIN	It is well known that certain cognitive abilities decline with age. The ability to form certain new declarative memories, particularly memories for facts and events, has been widely shown to decline with advancing age. In contrast, the effects of aging on the ability to form new procedural memories such as skills are less well known, though it appears that older adults are able to acquire some new procedural skills over practice. The current study examines the effects of normal aging on procedural memory more closely by comparing the effects of aging on the encoding or acquisition stage of procedural learning versus its effects on the consolidation, or between-session stage of procedural learning. Twelve older and 14 young participants completed a sequence-learning task (the Serial Reaction Time Task) over a practice session and at a re-test session 24 hours later. Older participants actually demonstrated more sequence skill during acquisition than the young. However, older participants failed to show skill improvement at re-test as the young participants did. Age thus appears to have a differential effect upon procedural learning stages such that older adults' skill acquisition remains relatively intact, in some cases even superior, compared to that of young adults, while their skill consolidation may be poorer than that of young adults. Although the effect of normal aging on procedural consolidation remains unclear, aging may actually enhance skill acquisition on some procedural tasks.			Brown, RM (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	dpress@bidmc.harvard.edu		Brown, Rachel M./0000-0002-4851-8429	NIMH NIH HHS [MH 65434, K23 MH065434] Funding Source: Medline; NINDS NIH HHS [R01 NS051446] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH065434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051446] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albert MS, 1997, PHILOS T ROY SOC B, V352, P1703, DOI 10.1098/rstb.1997.0152; Curran T, 1997, PSYCHOL RES-PSYCH FO, V60, P24, DOI 10.1007/BF00419678; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; HOWARD DV, 1991, J EXP PSYCHOL LEARN, V17, P779, DOI 10.1037/0278-7393.17.4.779; HOWARD DV, 1989, PSYCHOL AGING, V4, P357, DOI 10.1037/0882-7974.4.3.357; HOWARD DV, 1992, PSYCHOL AGING, V7, P232, DOI 10.1037/0882-7974.7.2.232; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; MITCHELL DB, 1989, J EXP PSYCHOL LEARN, V15, P31, DOI 10.1037/0278-7393.15.1.31; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Schroeder JP, 2002, HIPPOCAMPUS, V12, P280, DOI 10.1002/hipo.10024; Smith CD, 2005, NEUROBIOL AGING, V26, P883, DOI 10.1016/j.neurobiolaging.2004.08.014; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031	17	86	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6683	10.1371/journal.pone.0006683	http://dx.doi.org/10.1371/journal.pone.0006683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487IY	19690610	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000269267300004
J	Kuwayama, H; Kubohara, Y				Kuwayama, Hidekazu; Kubohara, Yuzuru			Differentiation-Inducing Factor-1 and-2 Function also as Modulators for Dictyostelium Chemotaxis	PLOS ONE			English	Article								Background: In the early stages of development of the cellular slime mold Dictyostelium discoideum, chemotaxis toward cAMP plays a pivotal role in organizing discrete cells into a multicellular structure. In this process, a series of signaling molecules, such as G-protein-coupled cell surface receptors for cAMP, phosphatidylinositol metabolites, and cyclic nucleotides, function as the signal transducers for controlling dynamics of cytoskeleton. Differentiation-inducing factor-1 and -2 (DIF-1 and DIF-2) were originally identified as the factors (chlorinated alkylphenones) that induce Dictyostelium stalk cell differentiation, but it remained unknown whether the DIFs had any other physiologic functions. Methodology/Principal Findings: To further elucidate the functions of DIFs, in the present study we investigated their effects on chemotaxis under various conditions. Quite interestingly, in shallow cAMP gradients, DIF-1 suppressed chemotaxis whereas DIF-2 promoted it greatly. Analyses with various mutants revealed that DIF-1 may inhibit chemotaxis, at least in part, via GbpB ( a phosphodiesterase) and a decrease in the intracellular cGMP concentration ([cGMP](i)). DIF-2, by contrast, may enhance chemotaxis, at least in part, via RegA (another phosphodiesterase) and an increase in [cGMP](i). Using null mutants for DimA and DimB, the transcription factors that are required for DIF-dependent prestalk differentiation, we also showed that the mechanisms for the modulation of chemotaxis by DIFs differ from those for the induction of cell differentiation by DIFs, at least in part. Conclusions/Significance: Our findings indicate that DIF-1 and DIF-2 function as negative and positive modulators for Dictyostelium chemotaxis, respectively. To our knowledge, this is the first report in any organism of physiologic modulators (small molecules) for chemotaxis having differentiation-inducing activity.			Kuwayama, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	kubohara@showa.gunma-u.ac.jp						Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Bosgraaf L, 2002, MOL BIOL CELL, V13, P3878, DOI 10.1091/mbc.E02-05-0302; Bosgraaf L, 2006, EUR J CELL BIOL, V85, P969, DOI 10.1016/j.ejcb.2006.04.004; BROOKMAN JJ, 1982, DEV BIOL, V91, P191, DOI 10.1016/0012-1606(82)90022-7; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; DARMON M, 1975, P NATL ACAD SCI USA, V72, P3163, DOI 10.1073/pnas.72.8.3163; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Goldberg JM, 2002, P NATL ACAD SCI USA, V99, P6749, DOI 10.1073/pnas.102167299; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Kay RR, 1999, SEMIN CELL DEV BIOL, V10, P577, DOI 10.1006/scdb.1999.0341; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; Kortholt A, 2007, MOL BIOL CELL, V18, P4772, DOI 10.1091/mbc.E07-05-0407; Kubohara Y, 1999, EUR J PHARMACOL, V381, P57, DOI 10.1016/S0014-2999(99)00548-8; Kubohara Y, 1999, BIOCHEM BIOPH RES CO, V263, P790, DOI 10.1006/bbrc.1999.1468; KUWAYAMA H, 1993, J CELL BIOL, V123, P1453, DOI 10.1083/jcb.123.6.1453; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; LIU G, 1993, SYM SOC EXP BIOL, V47, P283; MASENTO MS, 1988, BIOCHEM J, V256, P23, DOI 10.1042/bj2560023; MORRIS HR, 1988, BIOCHEM J, V249, P903, DOI 10.1042/bj2490903; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Roelofs J, 2002, MOL BIOL EVOL, V19, P2239, DOI 10.1093/oxfordjournals.molbev.a004047; Saito T, 2006, BBA-GEN SUBJECTS, V1760, P754, DOI 10.1016/j.bbagen.2005.12.006; Shaulsky G, 1998, DEVELOPMENT, V125, P691; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; Shimizu K, 2004, CANCER RES, V64, P2568, DOI 10.1158/0008-5472.CAN-03-3551; SOBOLEWSKI A, 1983, DIFFERENTIATION, V25, P93; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; TOWN CD, 1976, NATURE, V262, P717, DOI 10.1038/262717a0; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; VETLMAN DM, 2008, J CELL BIOL, V180, P747; WANG M, 1986, DIFFERENTIATION, V33, P24, DOI 10.1111/j.1432-0436.1986.tb00406.x; Wardlaw AJ, 2000, BRIT MED BULL, V56, P985, DOI 10.1258/0007142001903490; Willard SS, 2006, EUR J CELL BIOL, V85, P897, DOI 10.1016/j.ejcb.2006.06.003; WURSTER B, 1990, DEV BIOL, V140, P189, DOI 10.1016/0012-1606(90)90066-R; Zhukovskaya NV, 2006, DEVELOPMENT, V133, P439, DOI 10.1242/dev.02190	42	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6658	10.1371/journal.pone.0006658	http://dx.doi.org/10.1371/journal.pone.0006658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684855	Green Submitted, Green Published, gold			2022-12-25	WOS:000269075600007
J	Berthonneche, C; Peter, B; Schupfer, F; Hayoz, P; Kutalik, Z; Abriel, H; Pedrazzini, T; Beckmann, JS; Bergmann, S; Maurer, F				Berthonneche, Corinne; Peter, Bastian; Schuepfer, Fanny; Hayoz, Pamela; Kutalik, Zoltan; Abriel, Hugues; Pedrazzini, Thierry; Beckmann, Jacques S.; Bergmann, Sven; Maurer, Fabienne			Cardiovascular Response to Beta-Adrenergic Blockade or Activation in 23 Inbred Mouse Strains	PLOS ONE			English	Article							FALSE DISCOVERY RATE; BLOOD-PRESSURE; DRUG-THERAPY; SUSCEPTIBILITY GENES; CARDIAC-HYPERTROPHY; IN-SILICO; SYSTEM; PHARMACOKINETICS; PHARMACOGENETICS; HERITABILITY	We report the characterisation of 27 cardiovascular-related traits in 23 inbred mouse strains. Mice were phenotyped either in response to chronic administration of a single dose of the beta-adrenergic receptor blocker atenolol or under a low and a high dose of the beta-agonist isoproterenol and compared to baseline condition. The robustness of our data is supported by high trait heritabilities (typically H-2>0.7) and significant correlations of trait values measured in baseline condition with independent multistrain datasets of the Mouse Phenome Database. We then focused on the drug-, dose-, and strain-specific responses to beta-stimulation and beta-blockade of a selection of traits including heart rate, systolic blood pressure, cardiac weight indices, ECG parameters and body weight. Because of the wealth of data accumulated, we applied integrative analyses such as comprehensive bi-clustering to investigate the structure of the response across the different phenotypes, strains and experimental conditions. Information extracted from these analyses is discussed in terms of novelty and biological implications. For example, we observe that traits related to ventricular weight in most strains respond only to the high dose of isoproterenol, while heart rate and atrial weight are already affected by the low dose. Finally, we observe little concordance between strain similarity based on the phenotypes and genotypic relatedness computed from genomic SNP profiles. This indicates that cardiovascular phenotypes are unlikely to segregate according to global phylogeny, but rather be governed by smaller, local differences in the genetic architecture of the various strains.	[Berthonneche, Corinne; Schuepfer, Fanny; Hayoz, Pamela; Beckmann, Jacques S.; Maurer, Fabienne] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Berthonneche, Corinne; Peter, Bastian; Kutalik, Zoltan; Beckmann, Jacques S.; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Peter, Bastian; Kutalik, Zoltan; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Abriel, Hugues] CHU Vaudois, Dept Pharmacol, CH-1011 Lausanne, Switzerland; [Abriel, Hugues] CHU Vaudois, Serv Cardiol, CH-1011 Lausanne, Switzerland; [Abriel, Hugues] Univ Bern, Dept Clin Res, Bern, Switzerland; [Pedrazzini, Thierry] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Berthonneche, C (corresponding author), CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland.	fabienne.maurer@chuv.ch	Abriel, Hugues/B-9800-2009; Kutalik, Zoltan/HHZ-5697-2022; Beckmann, Jacques S/A-9772-2008	Abriel, Hugues/0000-0003-0465-5138; Kutalik, Zoltan/0000-0001-8285-7523; Beckmann, Jacques S/0000-0002-9741-1900; Bergmann, Sven/0000-0002-6785-9034	Centre Hospitalier Universitaire Vaudois; University of Lausanne, Switzerland; Swiss National Science Foundation [310000-112552, 3100AO-116323/1]; Giorgi-Cavaglieri Foundation; European Framework Project	Centre Hospitalier Universitaire Vaudois; University of Lausanne, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Giorgi-Cavaglieri Foundation; European Framework Project	This work was supported by the Centre Hospitalier Universitaire Vaudois and the University of Lausanne, Switzerland, the Swiss National Science Foundation (grants nb 310000-112552, JSB, HA, TP, and FM and nb 3100AO-116323/1, SB), the Giorgi-Cavaglieri Foundation (SB) and the European Framework Project 6 (through the EuroDia, AnEuploidy and Hypergenes projects, SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochud M, 2005, HYPERTENSION, V45, P445, DOI 10.1161/01.HYP.0000156538.59873.86; Chrysant SG, 2008, CLIN CARDIOL, V31, P249, DOI 10.1002/clc.20249; Chu V, 2001, BMC Physiol, V1, P6, DOI 10.1186/1472-6793-1-6; Cotsapas C, 2008, PHARMACOGENOMICS, V9, P1323, DOI 10.2217/14622416.9.9.1323; Deschepper CF, 2004, J APPL PHYSIOL, V97, P369, DOI 10.1152/japplphysiol.00073.2004; Errami M, 2008, J PHARMACOL EXP THER, V324, P1196, DOI 10.1124/jpet.107.133975; Faulx MD, 2005, AM J PHYSIOL-HEART C, V289, pH30, DOI 10.1152/ajpheart.00636.2004; Faulx MD, 2007, CLIN EXP PHARMACOL P, V34, P77, DOI 10.1111/j.1440-1681.2007.04531.x; Fenske TS, 2006, CANCER RES, V66, P5029, DOI 10.1158/0008-5472.CAN-05-3404; FITZ GERALD JD, 1978, EUR J CLIN PHARMACOL, V13, P81, DOI 10.1007/BF00609750; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gillies M, 2005, CRIT CARE, V9, P266, DOI 10.1186/cc3024; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Guo Y, 2007, P NATL ACAD SCI USA, V104, P17735, DOI 10.1073/pnas.0700724104; Guo YY, 2006, NAT BIOTECHNOL, V24, P531, DOI 10.1038/nbt1195; Hollenberg NK, 2005, AM J HYPERTENS, V18, p165S, DOI 10.1016/j.amjhyper.2005.09.010; Howden R, 2008, AM J PHYSIOL-HEART C, V295, pH59, DOI 10.1152/ajpheart.00941.2007; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kirstein SL, 2004, PHARMACOL REV, V56, P31, DOI 10.1124/pr.56.1.2; Kudej RK, 1997, J MOL CELL CARDIOL, V29, P2735, DOI 10.1006/jmcc.1997.0508; Liang DY, 2006, ANESTHESIOLOGY, V104, P1054, DOI 10.1097/00000542-200605000-00023; Liu PY, 2006, NAT GENET, V38, P888, DOI 10.1038/ng1849; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; MORGAN DJ, 1990, CLIN PHARMACOKINET, V18, P270, DOI 10.2165/00003088-199018040-00002; Muszkat M, 2005, CLIN PHARMACOL THER, V77, P123, DOI 10.1016/j.clpt.2004.10.007; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Prenner BM, 2008, CURR OPIN PULM MED, V14, P57; REEVES PR, 1978, XENOBIOTICA, V8, P305, DOI 10.3109/00498257809060955; Seidlerova J, 2008, J HYPERTENS, V26, P721, DOI 10.1097/HJH.0b013e3282f4d1e7; Shizukuda Y, 1998, AM J PHYSIOL-HEART C, V275, pH961, DOI 10.1152/ajpheart.1998.275.3.H961; Shusterman V, 2002, AM J PHYSIOL-HEART C, V282, pH2076, DOI 10.1152/ajpheart.00917.2001; Smith SB, 2008, PHARMACOGENET GENOM, V18, P231, DOI 10.1097/FPC.0b013e3282f55ab2; Szatkiewicz JP, 2008, MAMM GENOME, V19, P199, DOI 10.1007/s00335-008-9098-9; Tsukahara C, 2004, MAMM GENOME, V15, P943, DOI 10.1007/s00335-004-2411-3; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang JM, 2005, TRENDS GENET, V21, P526, DOI 10.1016/j.tig.2005.06.010; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5	44	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6610	10.1371/journal.pone.0006610	http://dx.doi.org/10.1371/journal.pone.0006610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672458	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900021
J	Boussetta, T; Raad, H; Letteron, P; Gougerot-Pocidalo, MA; Marie, JC; Driss, F; El-Benna, J				Boussetta, Tarek; Raad, Houssam; Letteron, Philippe; Gougerot-Pocidalo, Marie-Anne; Marie, Jean-Claude; Driss, Fathi; El-Benna, Jamel			Punicic Acid a Conjugated Linolenic Acid Inhibits TNF alpha-Induced Neutrophil Hyperactivation and Protects from Experimental Colon Inflammation in Rats	PLOS ONE			English	Article							RESPIRATORY BURST OXIDASE; TUMOR-NECROSIS-FACTOR; DEPENDENT OXIDATIVE STRESS; POMEGRANATE SEED OIL; NADPH OXIDASE; FATTY-ACIDS; PARTIAL PHOSPHORYLATION; BOWEL-DISEASE; KINASE-C; ACTIVATION	Background: Neutrophils play a major role in inflammation by releasing large amounts of ROS produced by NADPH-oxidase and myeloperoxidase (MPO). The proinflammatory cytokine TNF alpha primes ROS production through phosphorylation of the NADPH-oxidase subunit p47phox on Ser345. Conventional anti-inflammatory therapies remain partially successful and may have side effects. Therefore, regulation of neutrophil activation by natural dietary components represents an alternative therapeutic strategy in inflammatory diseases such as inflammatory bowel diseases. The aim of this study was to assess the effect of punicic acid, a conjugated linolenic fatty acid from pomegranate seed oil on TNF alpha-induced neutrophil hyperactivation in vitro and on colon inflammation in vivo. Methodology and Principal Findings: We analyzed the effect of punicic acid on TNF alpha-induced neutrophil upregulation of ROS production in vitro and on TNBS-induced rat colon inflammation. Results show that punicic acid inhibited TNF alpha-induced priming of ROS production in vitro while preserving formyl-methionyl-leucyl-phenylalanine (fMLP)-induced response. This effect was mediated by the inhibition of Ser345-p47phox phosphorylation and upstream kinase p38MAPK. Punicic acid also inhibited fMLP-and TNF alpha+ fMLP-induced MPO extracellular release from neutrophils. In vivo experiments showed that punicic acid and pomegranate seed oil intake decreased neutrophil-activation and ROS/MPO-mediated tissue damage as measured by F2-isoprostane release and protected rats from TNBS-induced colon inflammation. Conclusions/Significance: These data show that punicic acid exerts a potent anti-inflammatory effect through inhibition of TNF alpha-induced priming of NADPH oxidase by targeting the p38MAPKinase/Ser345-p47phox-axis and MPO release. This natural dietary compound may provide a novel alternative therapeutic strategy in inflammatory diseases such as inflammatory bowel diseases.			Boussetta, T (corresponding author), Univ Paris, Fac Med, INSERM, U773, F-75252 Paris, France.	fathi.driss@bch.ap-hop-paris.fr; jamel.elbenna@inserm.fr						Arao Keisuke, 2004, Lipids Health Dis, V3, P24, DOI 10.1186/1476-511X-3-24; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; BABIOR BM, 1984, BLOOD, V64, P959; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Barrett EG, 1999, AM J PHYSIOL-LUNG C, V276, pL979, DOI 10.1152/ajplung.1999.276.6.L979; Bartelt S, 2008, BRIT J NUTR, V99, P1230, DOI 10.1017/S0007114507853451; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; D'Odorico A, 2000, DIGEST DIS SCI, V45, P1594, DOI 10.1023/A:1005521212948; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dang PMC, 1999, J BIOL CHEM, V274, P20704, DOI 10.1074/jbc.274.29.20704; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; Feldmann M, 2008, J CLIN INVEST, V118, P3533, DOI 10.1172/JCI37346; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Ginzberg HH, 2001, AM J PHYSIOL-GASTR L, V281, pG705, DOI 10.1152/ajpgi.2001.281.3.G705; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Handa O, 2004, J PHARMACOL EXP THER, V309, P670, DOI 10.1124/jpet.103.062216; Harbige LS, 2003, LIPIDS, V38, P323, DOI 10.1007/s11745-003-1067-z; HARDY SJ, 1994, J IMMUNOL, V153, P1754; Hashimoto S, 2001, BRIT J PHARMACOL, V132, P270, DOI 10.1038/sj.bjp.0703787; Hatanaka E, 2006, FREE RADICAL BIO MED, V41, P1124, DOI 10.1016/j.freeradbiomed.2006.06.014; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Hwang DM, 2007, CARCINOGENESIS, V28, P363, DOI 10.1093/carcin/bgl151; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kew S, 2003, AM J CLIN NUTR, V77, P1287, DOI 10.1093/ajcn/77.5.1287; Kim ND, 2002, BREAST CANCER RES TR, V71, P203, DOI 10.1023/A:1014405730585; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kohno H, 2004, CANCER SCI, V95, P481, DOI 10.1111/j.1349-7006.2004.tb03236.x; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YQ, 1996, J CLIN INVEST, V97, P1605, DOI 10.1172/JCI118585; Luostarinen R, 1996, PROSTAG LEUKOTR ESS, V55, P167, DOI 10.1016/S0952-3278(96)90093-9; MacLean C H, 2004, Evid Rep Technol Assess (Summ), P1; Murakami Akira, 2005, Asian Pac J Cancer Prev, V6, P437; Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; Naito Y, 2007, J GASTROENTEROL, V42, P787, DOI 10.1007/s00535-007-2096-y; Naito Y, 2007, J CLIN BIOCHEM NUTR, V41, P18, DOI 10.3164/jcbn.2007003; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN CF, 1989, BLOOD, V73, P301; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Omori K, 2008, J LEUKOCYTE BIOL, V84, P292, DOI 10.1189/jlb.1207832; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tatsukawa M, 2004, ATHEROSCLEROSIS, V172, P337, DOI 10.1016/j.atherosclerosis.2003.10.007; Thies F, 2001, LIPIDS, V36, P1183, DOI 10.1007/s11745-001-0831-4; THOMPSON PJ, 1991, LIPIDS, V26, P1223, DOI 10.1007/BF02536536; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109; Tsuzuki T, 2006, J NUTR, V136, P2153, DOI 10.1093/jn/136.8.2153; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Yamasaki M, 2006, NUTRITION, V22, P54, DOI 10.1016/j.nut.2005.03.009; YONEMARU M, 1989, J LAB CLIN MED, V114, P674	66	89	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6458	10.1371/journal.pone.0006458	http://dx.doi.org/10.1371/journal.pone.0006458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649246	Green Submitted, Green Published, gold			2022-12-25	WOS:000268637600008
J	Okamura, E; Matsuzaki, H; Campbell, AD; Engel, JD; Fukamizu, A; Tanimoto, K				Okamura, Eiichi; Matsuzaki, Hitomi; Campbell, Andrew D.; Engel, James Douglas; Fukamizu, Akiyoshi; Tanimoto, Keiji			All of the human beta-type globin genes compete for LCR enhancer activity in embryonic erythroid cells of yeast artificial chromosome transgenic mice	FASEB JOURNAL			English	Article						hemoglobin; gene switching; chromosome conformation capture; 3C	LOCUS-CONTROL REGION; INTERGENIC TRANSCRIPTION; DEVELOPMENTAL REGULATION; HYPERSENSITIVE SITES; GAMMA-GLOBIN; EXPRESSION; DISTANCE; DIFFERENTIATION; ELEMENTS; LINKING	In primitive erythroid cells of human beta-globin locus transgenic mice (TgM), the locus control region (LCR)-proximal epsilon- and gamma-globin genes are transcribed, whereas the distal delta- and beta-globin genes are silent. It is generally accepted that the beta-globin gene is competitively suppressed by gamma-globin gene expression at this developmental stage. Previously, however, we observed that epsilon-globin gene expression was severely attenuated when its distance from the LCR was extended, implying that beta-globin gene might also be silenced because of its great distance from the LCR. Here, to clarify the beta-globin gene silencing mechanism, we established TgM lines carrying either gamma- or epsilon- plus gamma-globin promoter deletions, without significantly altering the distance between the beta-globin gene and the LCR. Precocious expression of delta- and beta-globin genes was observed in primitive erythroid cells of mutant, but not wild-type TgM, which was most evident when both the epsilon and gamma promoters were deleted. Thus, we clearly demonstrated that the repression of the delta- and beta-globin genes in primitive erythroid cells is dominated by competitive silencing by the epsilon- and gamma-globin gene promoters, and that epsilon- and the other beta-like globin genes might be activated by two distinct mechanisms by the LCR.-Okamura, E., Matsuzaki, H., Campbell, A. D., Engel, J. D., Fukamizu, A., Tanimoto, K. All of the human beta-type globin genes compete for LCR enhancer activity in embryonic erythroid cells of yeast artificial chromosome transgenic mice. FASEB J. 23, 4335-4343 (2009). www.fasebj.org	[Okamura, Eiichi; Matsuzaki, Hitomi; Fukamizu, Akiyoshi; Tanimoto, Keiji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Campbell, Andrew D.; Engel, James Douglas] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Tsukuba; University of Michigan System; University of Michigan	Tanimoto, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tennoudai 1-1-1, Tsukuba, Ibaraki 3058577, Japan.	keiji@tara.tsukuba.ac.jp	Tanimoto, Keiji/B-2600-2014; fukamizu, akiyoshi/J-5350-2012; Campbell, Andrew/AAX-8590-2020	fukamizu, akiyoshi/0000-0002-8786-6020; Campbell, Andrew/0000-0002-8829-0043; Okamura, Eiichi/0000-0002-1713-9290; Tanimoto, Keiji/0000-0003-1971-6546; Matsuzaki, Hitomi/0000-0002-8890-5933	U.S. National Institutes of Health [HL24415]; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024415] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	thank Y. Tanimoto for technical assistance in generating TgM. This work was partially supported by research grants from the U.S. National Institutes of Health (HL24415 to J. D. E.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for Scientific Research (A) and for Young Scientists (S) (to K. T.).	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; CLOUSTON W M, 1988, Genomics, V2, P240, DOI 10.1016/0888-7543(88)90008-0; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Hardison R, 1998, J EXP BIOL, V201, P1099; Hu X, 2007, BLOOD, V109, P2210, DOI 10.1182/blood-2006-06-029868; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Plant KE, 2001, MOL CELL BIOL, V21, P6507, DOI 10.1128/MCB.21.19.6507-6514.2001; RAICH N, 1990, SCIENCE, V250, P1147, DOI 10.1126/science.2251502; Shimotsuma M, 2007, MOL CELL BIOL, V27, P5664, DOI 10.1128/MCB.00602-07; STAMATOYANNOPOU.G, 1994, MOL BASIS BLOOD DIS; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Tanimoto K, 2000, GENE DEV, V14, P2778, DOI 10.1101/gad.822500; Tanimoto K, 1999, NUCLEIC ACIDS RES, V27, P3130, DOI 10.1093/nar/27.15.3130; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Yu M, 2006, MOL CELL BIOL, V26, P4775, DOI 10.1128/MCB.00406-06; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zhu XG, 2007, NUCLEIC ACIDS RES, V35, P5532, DOI 10.1093/nar/gkm595	35	5	5	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4335	4343		10.1096/fj.09-137778	http://dx.doi.org/10.1096/fj.09-137778			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19690216	Green Published, Green Submitted			2022-12-25	WOS:000272193700028
J	Deng, Z; Wan, M; Cao, P; Rao, A; Cramer, SD; Sui, G				Deng, Z.; Wan, M.; Cao, P.; Rao, A.; Cramer, S. D.; Sui, G.			Yin Yang 1 regulates the transcriptional activity of androgen receptor	ONCOGENE			English	Article						androgen receptor; Yin Yang 1; prostate cancer; PSA promoter; transcription	PROSTATE-SPECIFIC ANTIGEN; GENE-EXPRESSION; CANCER CELLS; FACTOR YY1; FACTOR YIN-YANG-1; RESPONSE ELEMENT; RNAI TECHNOLOGY; IN-VIVO; P53; REPRESSION	The multifunctional protein Yin Yang 1 (YY1) has an important role in epigenetic regulation of gene expression. YY1 is highly expressed in various types of cancers, including prostate cancer. Currently, the mechanism underlying the functional role of YY1 in prostate tumorigenesis remains unclear. In this report, we investigated the functional interplay between YY1 and androgen receptor (AR), and the effect of YY1 on AR-mediated transcription. We found that YY1 physically interacts with AR both in a cell-free system and in cultured cells. YY1 is required for the optimal transcriptional activity of AR in promoting the transcription of the prostate-specific antigen (PSA) promoter. However, ectopic YY1 expression in LNCaP cells did not further enhance the reporter driven by the PSA promoter, suggesting that an optimal level of YY1 is already established in prostate tumor cells. Consistently, YY1 depletion in LNCaP cells reduced endogenous PSA levels, but overexpressed YY1 did not significantly increase PSA expression. We also observed that YY1-AR interaction is essential to YY1-mediated transcription activity of AR and YY1 is a necessary component in the complex binding to the androgen response element. Thus, our study demonstrates that YY1 interacts with AR and regulates its transcriptional activity. Oncogene (2009) 28, 3746-3757; doi: 10.1038/onc.2009.231; published online 10 August 2009	[Sui, G.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Sui, G (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 1 Med Ctr Blvd,Hanes 4052, Winston Salem, NC 27157 USA.	gsui@wfubmc.edu	Deng, Zhiyong/D-4656-2012	Sui, Guangchao/0000-0002-8164-5585	Department of Cancer Biology and Comprehensive Cancer Center of Wake Forest University; NCI training [5T32CA079448-09]; NATIONAL CANCER INSTITUTE [T32CA079448] Funding Source: NIH RePORTER	Department of Cancer Biology and Comprehensive Cancer Center of Wake Forest University; NCI training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Purnima Dubey and Ms Karen Klein for critical reading of the article. We also thank Dr Suzy Torti and Dr Wei Wang for providing the access to some equipment, and Dr Kazushi Inoue for the EMSA protocol. The support for the work came from the grant of American Cancer Society (RSG09-082-01-MGO) and the startup fund from the Department of Cancer Biology and Comprehensive Cancer Center of Wake Forest University to GS. PC is supported by NCI training Grant 5T32CA079448-09.	Bain M, 2005, EUR J CELL BIOL, V84, P543, DOI 10.1016/j.ejcb.2004.12.024; Baritaki S, 2007, INT J ONCOL, V31, P69; Begon DY, 2005, J BIOL CHEM, V280, P24428, DOI 10.1074/jbc.M503790200; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Craft N, 1999, CANCER RES, V59, P5030; de Nigris F, 2006, EUR J CANCER, V42, P2420, DOI 10.1016/j.ejca.2006.06.008; Dehm SM, 2005, EXPERT REV ANTICANC, V5, P63, DOI 10.1586/14737140.5.1.63; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gregory CW, 2001, CANCER RES, V61, P2892; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hirawat S, 2003, CANCER INVEST, V21, P400, DOI 10.1081/CNV-120018232; Joshi B, 2007, BIOCHEM J, V401, P155, DOI 10.1042/BJ20060364; Koivisto P, 1997, CANCER RES, V57, P314; Lapouge G, 2007, INT J CANCER, V121, P1238, DOI 10.1002/ijc.22830; Rao A, 2003, UROLOGY, V61, P864, DOI 10.1016/S0090-4295(02)02414-7; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Rylski M, 2008, J BIOL CHEM, V283, P35140, DOI 10.1074/jbc.M804540200; Santiago FS, 2007, CIRC RES, V101, P146, DOI 10.1161/CIRCRESAHA.106.145235; Seligson D, 2005, INT J ONCOL, V27, P131; Sharifi Nima, 2006, Am J Ther, V13, P166, DOI 10.1097/00045391-200603000-00013; Shenk JL, 2001, J BIOL CHEM, V276, P38472, DOI 10.1074/jbc.M103652200; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Sui G, 2005, METH MOL B, V309, P205; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Taplin ME, 1999, CANCER RES, V59, P2511; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001	43	52	59	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2009	28	42					3746	3757		10.1038/onc.2009.231	http://dx.doi.org/10.1038/onc.2009.231			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	509MY	19668226	Green Accepted			2022-12-25	WOS:000271023200007
J	Almaca, J; Tian, YM; Aldehni, F; Ousingsawat, J; Kongsuphol, P; Rock, JR; Harfe, BD; Schreiber, R; Kunzelmann, K				Almaca, Joana; Tian, Yuemin; Aldehni, Fadi; Ousingsawat, Jiraporn; Kongsuphol, Patthara; Rock, Jason R.; Harfe, Brian D.; Schreiber, Rainer; Kunzelmann, Karl			TMEM16 Proteins Produce Volume-regulated Chloride Currents That Are Reduced in Mice Lacking TMEM16A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCITES TUMOR-CELLS; ANION CHANNELS; DECREASE; CALCIUM; CONDUCTANCE; CAMP; PROLIFERATION; STIMULATION; INHIBITION; ACTIVATION	All vertebrate cells regulate their cell volume by activating chloride channels of unknown molecular identity, thereby activating regulatory volume decrease. We show that the Ca2+-activated Cl- channel TMEM16A together with other TMEM16 proteins are activated by cell swelling through an autocrine mechanism that involves ATP release and binding to purinergic P2Y(2) receptors. TMEM16A channels are activated by ATP through an increase in intracellular Ca2+ and a Ca2+-independent mechanism engaging extracellular-regulated protein kinases (ERK1/2). The ability of epithelial cells to activate a Cl-conductance upon cell swelling, and to decrease their cell volume (regulatory volume decrease) was dependent on TMEM16 proteins. Activation of I-Cl,I-swell was reduced in the colonic epithelium and in salivary acinar cells from mice lacking expression of TMEM16A. Thus TMEM16 proteins appear to be a crucial component of epithelial volume-regulated Cl-channels and may also have a function during proliferation and apoptotic cell death.	[Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Rock, Jason R.; Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	University of Regensburg; State University System of Florida; University of Florida	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@vkl.uni-regensburg.de	Tian, Yuemin/AAE-8827-2021	Almaca, Joana/0000-0002-9316-712X; Kunzelmann, Karl/0000-0002-4583-7037	Deutsche Forschungsgemeinschaft [SFB699, KU 756/8-2]; TargetScreen2 [EU-FP6-2005-LH-037365]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TargetScreen2	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB699 and KU 756/8-2 and TargetScreen2 Grant EU-FP6-2005-LH-037365.	Adam G, 2005, PFLUG ARCH EUR J PHY, V449, P470, DOI 10.1007/s00424-004-1356-4; Altamirano J, 1998, J GEN PHYSIOL, V112, P145, DOI 10.1085/jgp.112.2.145; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Chen B, 2007, J MEMBRANE BIOL, V215, P1, DOI 10.1007/s00232-007-9000-9; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; DIENER M, 1992, PFLUG ARCH EUR J PHY, V421, P530, DOI 10.1007/BF00375048; Franco R, 2008, J CELL PHYSIOL, V216, P14, DOI 10.1002/jcp.21406; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; HOFFMANN EK, 1984, J MEMBRANE BIOL, V78, P211, DOI 10.1007/BF01925969; Hoffmann EK, 2000, CELL PHYSIOL BIOCHEM, V10, P273, DOI 10.1159/000016356; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Katoh M, 2004, INT J MOL MED, V14, P759; KUNZELMANN K, 1994, PFLUG ARCH EUR J PHY, V428, P76, DOI 10.1007/BF00374754; Lan WZ, 2005, AM J PHYSIOL-GASTR L, V288, pG221, DOI 10.1152/ajpgi.00226.2004; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2000, CELL PHYSIOL BIOCHEM, V10, P417, DOI 10.1159/000016367; Lang F, 2000, PFLUG ARCH EUR J PHY, V440, P902, DOI 10.1007/s004240000358; Okada Y, 2004, PFLUG ARCH EUR J PHY, V448, P287, DOI 10.1007/s00424-004-1276-3; Pedersen SF, 1998, J MEMBRANE BIOL, V163, P97, DOI 10.1007/s002329900374; PIFFERI S, 2009, PFLUGERS AR IN PRESS; RAFUNDO DF, 2004, AM J PHYSIOL-REG I, V287, pR833; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stutzin A, 2006, ACTA PHYSIOL, V187, P27, DOI 10.1111/j.1748-1716.2006.01537.x; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; VALVERDE MA, 1995, P NATL ACAD SCI USA, V92, P9038, DOI 10.1073/pnas.92.20.9038; VALVERDE MA, 1993, PFLUG ARCH EUR J PHY, V425, P434, DOI 10.1007/BF00374869; van der Wijk T, 1999, BIOCHEM J, V343, P579, DOI 10.1042/0264-6021:3430579; Vennekens R, 1999, J PHYSIOL-LONDON, V515, P75, DOI 10.1111/j.1469-7793.1999.075ad.x; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	31	138	143	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28571	28578		10.1074/jbc.M109.010074	http://dx.doi.org/10.1074/jbc.M109.010074			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19654323	Green Published, hybrid			2022-12-25	WOS:000270678900011
J	Koslowski, M; Tureci, O; Biesterfeld, S; Seitz, G; Huber, C; Sahin, U				Koslowski, Michael; Tuereci, Oezlem; Biesterfeld, Stefan; Seitz, Gerhard; Huber, Christoph; Sahin, Ugur			Selective Activation of Trophoblast-specific PLAC1 in Breast Cancer by CCAAT/Enhancer-binding Protein beta (C/EBP beta) Isoform 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PROLACTIN RECEPTOR; PLACENTAL CELLS; NUCLEAR FACTOR; MESSENGER-RNA; ALPHA; DIFFERENTIATION; PREGNANCY	The trophoblast-specific gene PLAC1 (placenta-specific 1) is ectopically expressed in a wide range of human malignancies, most frequently in breast cancer, and is essentially involved in cancer cell proliferation, migration, and invasion. Here we show that basal activity of the PLAC1 promoter is selectively controlled by ubiquitous transcription factor SP1 and isoform 2 of CCAAT/enhancer-binding protein beta that we found to be selectively expressed in placental tissue and cancer cells. Binding of both factors to their respective elements within the PLAC1 promoter was essential to attain full promoter activity. Estrogen receptor alpha (ER alpha) signaling further augmented transcription and translation of PLAC1 and most likely accounts for the positive correlation between PLAC1 expression levels and the ER alpha status we observed in primary breast cancer specimens. DNA affinity precipitation and chromatin immunoprecipitation assays revealed that transactivation of the PLAC1 promoter by ligand-activated ER alpha is based on a nonclassical pathway independent of estrogen-response elements, by tethering of ER alpha to DNA-bound CCAAT/enhancer-binding protein beta-2, and SP1. Our findings provide first insight into a novel and hitherto unknown regulatory mechanism governing selective activation of trophoblast-specific gene expression in breast cancer.	[Koslowski, Michael; Huber, Christoph; Sahin, Ugur] Johannes Gutenberg Univ Mainz, Dept Internal Med Expt & Translat Oncol 3, D-55131 Mainz, Germany; [Tuereci, Oezlem] Ganymed Pharmaceut AG, D-55131 Mainz, Germany; [Biesterfeld, Stefan] Johannes Gutenberg Univ Mainz, Inst Pathol, D-55131 Mainz, Germany; [Seitz, Gerhard] Bamberg Hosp, Inst Pathol, D-96049 Bamberg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Dept Internal Med Expt & Translat Oncol 3, Zahlbacherstr 63, D-55131 Mainz, Germany.	sahin@uni-mainz.de	Sahin, Ugur/L-4818-2017	Sahin, Ugur/0000-0003-0363-1564	Forschungsfond and the Center for Natural Sciences and Medicine of the Johannes Gutenberg University [SFB 432]; Federal Ministry of Education and Research	Forschungsfond and the Center for Natural Sciences and Medicine of the Johannes Gutenberg University; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Combined Project Grant SFB 432, by the Forschungsfond and the Center for Natural Sciences and Medicine of the Johannes Gutenberg University, and by the GO-Bio funding of the Federal Ministry of Education and Research.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Bamberger AM, 2004, VIRCHOWS ARCH, V444, P149, DOI 10.1007/s00428-003-0935-7; Beard J, 1902, LANCET, V1, P1758; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bundy L, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-43; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Caldon CE, 2006, J CELL BIOCHEM, V97, P261, DOI 10.1002/jcb.20690; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chakrabarty A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-14; CHEN HW, 1995, DNA CELL BIOL, V14, P681, DOI 10.1089/dna.1995.14.681; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; CLARKE R, 1992, CRIT REV ONCOL HEMAT, V12, P1, DOI 10.1016/1040-8428(92)90062-U; Cross JC, 2002, MOL CELL ENDOCRINOL, V187, P207, DOI 10.1016/S0303-7207(01)00703-1; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dirnhofer S, 1998, HUM PATHOL, V29, P377, DOI 10.1016/S0046-8177(98)90119-8; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Fant M, 2002, MOL REPROD DEV, V63, P430, DOI 10.1002/mrd.10200; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; Holland MP, 2004, ENDOCRINOLOGY, V145, P1096, DOI 10.1210/en.2003-0777; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; HORNE CHW, 1976, LANCET, V2, P279; Hu ZZ, 1998, J BIOL CHEM, V273, P26225, DOI 10.1074/jbc.273.40.26225; ILES RK, 1991, J UROLOGY, V145, P453, DOI 10.1016/S0022-5347(17)38367-2; Koslowski M, 2007, CANCER RES, V67, P9528, DOI 10.1158/0008-5472.CAN-07-1350; Koslowski M, 2006, HUM MOL GENET, V15, P2392, DOI 10.1093/hmg/ddl163; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kreiter S, 2008, J IMMUNOL, V180, P309, DOI 10.4049/jimmunol.180.1.309; Kreiter S, 2007, CANCER IMMUNOL IMMUN, V56, P1577, DOI 10.1007/s00262-007-0302-7; LAURENCE DJ, 1972, BRIT J CANCER, V26, P335, DOI 10.1038/bjc.1972.45; LEE YH, 1994, MOL CELL BIOL, V14, P1383, DOI 10.1128/MCB.14.2.1383; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Massabbal E, 2005, MOL REPROD DEV, V71, P299, DOI 10.1002/mrd.20272; Omoto Y, 2003, ONCOGENE, V22, P5011, DOI 10.1038/sj.onc.1206787; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Rama S, 2001, MOL CELL ENDOCRINOL, V182, P233, DOI 10.1016/S0303-7207(01)00550-0; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; STEPHANOU A, 1995, BIOCHEM BIOPH RES CO, V206, P215, DOI 10.1006/bbrc.1995.1030; STRICKLAND S, 1992, CELL, V71, P355, DOI 10.1016/0092-8674(92)90503-5; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; TODA K, 1995, J STEROID BIOCHEM, V53, P181, DOI 10.1016/0960-0760(95)00032-U; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Weier JF, 2005, DEV BIOL, V279, P420, DOI 10.1016/j.ydbio.2004.12.035; Wilczynski JR, 2006, CHEMOTHERAPY, V52, P107, DOI 10.1159/000092537; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428	50	24	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28607	28615		10.1074/jbc.M109.031120	http://dx.doi.org/10.1074/jbc.M109.031120			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19652226	Green Published, hybrid			2022-12-25	WOS:000270678900015
J	Martin-Visscher, LA; Gong, XD; Duszyk, M; Vederas, JC				Martin-Visscher, Leah A.; Gong, Xiandi; Duszyk, Marek; Vederas, John C.			The Three-dimensional Structure of Carnocyclin A Reveals That Many Circular Bacteriocins Share a Common Structural Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE PREDICTION SERVER; PEPTIDE ANTIBIOTIC AS-48; LACTIC-ACID BACTERIA; BACILLUS-SUBTILIS; NK-LYSIN; ANTIBACTERIAL PEPTIDES; ANTIMICROBIAL PEPTIDE; CYCLIC BACTERIOCINS; LIPID-BILAYERS; CHEMICAL-SHIFT	Carnocyclin A (CclA) is a potent antimicrobial peptide from Carnobacterium maltaromaticum UAL307 that displays a broad spectrum of activity against numerous Gram-positive organisms. An amide bond links the N and C termini of this bacteriocin, imparting stability and structural integrity to this 60-amino acid peptide. CclA interacts with lipid bilayers in a voltage-dependent manner and forms anion selective pores. Several other circular bacteriocins have been reported, yet only one (enterocin AS-48) has been structurally characterized. We have now determined the solution structure of CclA by NMR and further examined its anion binding and membrane channel properties. The results reveal that CclA preferentially binds halide anions and has a structure that is surprisingly similar to that of AS-48 despite low sequence identity, different oligomeric state, and disparate function. CclA folds into a compact globular bundle, comprised of four helices surrounding a hydrophobic core. NMR studies show two fluoride ion binding modes for CclA. Our findings suggest that although other circular bacteriocins are likely to have diverse mechanisms of action, many may have a common structural motif. This shared three-dimensional arrangement resembles the fold of mammalian saposins, peptides that either directly lyse membranes or serve as activators of lipid-degrading enzymes.	[Martin-Visscher, Leah A.; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Gong, Xiandi; Duszyk, Marek] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2G2, Canada	University of Alberta; University of Alberta	Vederas, JC (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	john.vederas@ualberta.ca		Vederas, John/0000-0002-2996-0326	Natural Sciences and Engineering Research Council of Canada; Advanced Foods and Materials Network; Canada Research Chair in Bioorganic and Medicinal Chemistry	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Advanced Foods and Materials Network; Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Advanced Foods and Materials Network, and the Canada Research Chair in Bioorganic and Medicinal Chemistry.	Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; BABASAKI K, 1985, J BIOCHEM, V98, P585, DOI 10.1093/oxfordjournals.jbchem.a135315; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Craik DJ, 2003, J BACTERIOL, V185, P4011, DOI 10.1128/JB.185.14.4011-4021.2003; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GALVEZ A, 1991, J BACTERIOL, V173, P886, DOI 10.1128/jb.173.2.886-892.1991; Gong XD, 2009, BBA-BIOMEMBRANES, V1788, P1797, DOI 10.1016/j.bbamem.2009.05.008; Gonzalez C, 2000, P NATL ACAD SCI USA, V97, P11221, DOI 10.1073/pnas.210301097; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hecht O, 2004, J BIOL CHEM, V279, P17834, DOI 10.1074/jbc.M312978200; Hille B., 1992, IONIC CHANNELS EXCIT; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jimenez MA, 2005, J PEPT SCI, V11, P29, DOI 10.1002/psc.589; John M, 2006, BIOCHEMISTRY-US, V45, P5206, DOI 10.1021/bi051944+; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalmokoff ML, 2003, CAN J MICROBIOL, V49, P763, DOI 10.1139/W03-101; Kawai Y, 1998, BIOSCI BIOTECH BIOCH, V62, P2438, DOI 10.1271/bbb.62.2438; Kawai Y, 2004, APPL ENVIRON MICROB, V70, P2906, DOI 10.1128/AEM.70.5.2906-2911.2004; Kawulka K, 2003, J AM CHEM SOC, V125, P4726, DOI 10.1021/ja029654t; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Kemperman R, 2003, APPL ENVIRON MICROB, V69, P1589, DOI 10.1128/AEM.69.3.1589-1597.2003; Lai CZ, 2009, J AM CHEM SOC, V131, P1598, DOI 10.1021/ja808047x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEER RJ, 1995, MICROBIOL-SGM, V141, P1629, DOI 10.1099/13500872-141-7-1629; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Maqueda M, 2004, CURR PROTEIN PEPT SC, V5, P399, DOI 10.2174/1389203043379567; Maqueda M, 2008, FEMS MICROBIOL REV, V32, P2, DOI 10.1111/j.1574-6976.2007.00087.x; Martin-Visscher LA, 2008, APPL ENVIRON MICROB, V74, P4756, DOI 10.1128/AEM.00817-08; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miteva M, 1999, FEBS LETT, V462, P155, DOI 10.1016/S0014-5793(99)01520-3; Nes IF, 2007, FOOD SCI BIOTECHNOL, V16, P675; SAMYN B, 1994, FEBS LETT, V352, P87, DOI 10.1016/0014-5793(94)00925-2; Sanchez-Barrena MJ, 2003, J MOL BIOL, V334, P541, DOI 10.1016/j.jmb.2003.09.060; Sawa N, 2009, APPL ENVIRON MICROB, V75, P1552, DOI 10.1128/AEM.02299-08; van Belkum MJ, 2000, NAT PROD REP, V17, P323, DOI 10.1039/a801347k; Wirawan RE, 2007, MICROBIOL-SGM, V153, P1619, DOI 10.1099/mic.0.2006/005967-0; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109; ZERBE O, 2003, BIONMR DRUG RES, P79; Zheng GL, 1999, J BACTERIOL, V181, P7346, DOI 10.1128/JB.181.23.7346-7355.1999	46	68	70	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28674	28681		10.1074/jbc.M109.036459	http://dx.doi.org/10.1074/jbc.M109.036459			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692336	Green Published, hybrid			2022-12-25	WOS:000270678900022
J	Wang, ZA; van der Wel, H; Vohra, Y; Buskas, T; Boons, GJ; West, CM				Wang, Zhuo A.; van der Wel, Hanke; Vohra, Yusuf; Buskas, Therese; Boons, Geert-Jan; West, Christopher M.			Role of a Cytoplasmic Dual-function Glycosyltransferase in O-2 Regulation of Development in Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; CYTOSOLIC GLYCOPROTEIN; UBIQUITIN LIGASES; MODIFIES SKP1; SPORE COAT; HYDROXYPROLINE; GLYCOSYLATION; DISCOIDEUM; FP21; HYDROXYLASE	In the social amoeba Dictyostelium, a terminal step in development is regulated by environmental O-2. Prolyl 4-hydroxylase- 1 (P4H1) was previously implicated in mediating the O-2 signal, and P4H1-null cells require elevated O-2 to culminate. The E3-ubiquitin ligase adaptor Skp1 is a P4H1 substrate, and here we investigate the function of PgtA, a dual function beta 3-galactosyltransferase/alpha 2-fucosyltransferase that contributes the 2nd and 3rd sugars of the pentasaccharide cap formed on Skp1 hydroxyproline. Although pgtA-null cells, whose Skp1 contains only a single sugar (N-acetylglucosamine or GlcNAc), show wild-type O-2 dependence of culmination, cells lacking AgtA, an alpha 3-galactosyltransferase required to extend the trisaccharide, require elevated O-2 as for P4H1-null cells. Skp1 is the only detectable protein modified by purified PgtA added to pgtA-null extracts. The basis for specificity of PgtA was investigated using native Skp1 acceptor glycoforms and a novel synthetic peptide containing GlcNAc alpha 1,4-hydroxy(trans) proline. Cysteine-alkylation of Skp1 strongly inhibited modification by the PgtA galactosyltransferase but not the fucosyltransferase. Furthermore, native and synthetic Skp1 glycopeptides were poorly galactosylated, not processively fucosylated, and negligibly inhibitory, whereas the fucosyltransferase was active toward small substrates. In addition, the galactosyltransferase exhibited an atypical concentration dependence on UDP-galactose. The results provide the first evidence that Skp1 is the functional target of P4H1 in O-2 regulation, indicate a gatekeeper function for the alpha 3-galactosyltransferase in the PgtA dual reaction, and identify an unexpected P4H1-dependent yet antagonistic function for PgtA that is reversed by AgtA.	[West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Vohra, Yusuf; Buskas, Therese; Boons, Geert-Jan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Vohra, Yusuf; Buskas, Therese; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	West, CM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 975 NE 10th St,BRC 417, Oklahoma City, OK 73104 USA.	Cwest2@ouhsc.edu	Wang, Zhuo/L-6912-2019; Boons, Geert-Jan P H/J-3211-2016; Vohra, Yusuf/C-6004-2014	Wang, Zhuo/0000-0002-4707-036X; Boons, Geert-Jan P H/0000-0003-3111-5954; Vohra, Yusuf/0000-0003-0385-2965	National Institutes of Health [R01-GM84383, 2R01-GM37539, 2R01CA088986]; NATIONAL CANCER INSTITUTE [R01CA088986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539, R01GM084383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM84383 and 2R01-GM37539 (to C. M. W.) and 2R01CA088986 (to G. J. B.)	Banerjee S, 2009, GLYCOBIOLOGY, V19, P331, DOI 10.1093/glycob/cwn107; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Funakoshi Y, 2009, BBA-GEN SUBJECTS, V1790, P81, DOI 10.1016/j.bbagen.2008.09.009; GONZALEZYANES B, 1992, J BIOL CHEM, V267, P9595; GONZALEZYANES B, 1989, DEV BIOL, V133, P576, DOI 10.1016/0012-1606(89)90060-2; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Ketcham C, 2004, J BIOL CHEM, V279, P29050, DOI 10.1074/jbc.M313858200; KOZAROV E, 1995, J BIOL CHEM, V270, P3022, DOI 10.1074/jbc.270.7.3022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Sassi S, 2001, GLYCOBIOLOGY, V11, P283, DOI 10.1093/glycob/11.4.283; SCHILLER B, 2009, BIOCH J IN PRESS; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; TELSER A, 1971, J BIOL CHEM, V246, P2252; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; Teng-umnuay P, 1999, J BIOL CHEM, V274, P36392, DOI 10.1074/jbc.274.51.36392; van der Wel H, 2005, J BIOL CHEM, V280, P14645, DOI 10.1074/jbc.M500600200; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; van der Wel H, 2001, J BIOL CHEM, V276, P33952, DOI 10.1074/jbc.M102555200; West CM, 2006, METHOD ENZYMOL, V417, P389, DOI 10.1016/S0076-6879(06)17023-8; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2009, EUKARYOT CELL, V8, P27, DOI 10.1128/EC.00398-07; West CM, 1996, J BIOL CHEM, V271, P12024, DOI 10.1074/jbc.271.20.12024; West CM, 2004, BBA-GEN SUBJECTS, V1673, P29, DOI 10.1016/j.bbagen.2004.04.007; West CM, 1997, GENE, V200, P1, DOI 10.1016/S0378-1119(97)00194-7; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027	25	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28896	28904		10.1074/jbc.M109.022574	http://dx.doi.org/10.1074/jbc.M109.022574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19687007	Green Published, hybrid			2022-12-25	WOS:000270678900046
J	Komatsu, S; Takenobu, H; Ozaki, T; Ando, K; Koida, N; Suenaga, Y; Ichikawa, T; Hishiki, T; Chiba, T; Iwama, A; Yoshida, H; Ohnuma, N; Nakagawara, A; Kamijo, T				Komatsu, S.; Takenobu, H.; Ozaki, T.; Ando, K.; Koida, N.; Suenaga, Y.; Ichikawa, T.; Hishiki, T.; Chiba, T.; Iwama, A.; Yoshida, H.; Ohnuma, N.; Nakagawara, A.; Kamijo, T.			Plk1 regulates liver tumor cell death by phosphorylation of TAp63	ONCOGENE			English	Article						p63; phosphorylation; Plk1; apoptosis	POLO-LIKE KINASE-1; DNA-DAMAGE; HEPATOCELLULAR-CARCINOMA; P73-DEPENDENT APOPTOSIS; EPIDERMAL DEVELOPMENT; PHYSICAL INTERACTION; P63 EXPRESSION; P53 HOMOLOG; CANCER; GENE	We previously found that Plk1 inhibited the p53/p73 activity through its direct phosphorylation. In this study, we investigated the functional role of Plk1 in modulating the p53 family member TAp63, resulting in the control of apoptotic cell death in liver tumor cells. Immunoprecipitation and in vitro pull-down assay showed that p63 binds to the kinase domain of Plk1 through its DNA-binding region. in vitro kinase assay indicated that p63 is phosphorylated by Plk1 at Ser-52 of the transactivating (TA) domain. Plk1 decreased the protein stability of TAp63 by its phosphorylation and suppressed TAp63-induced cell death. Furthermore, Plk1 knockdown in p53-mutated liver tumor cells transactivated p53 family downstream effectors, PUMA, p21(Cip1/WAF1) and 14-3-3 sigma, and induced apoptotic cell death. Double knockdown of Plk1/p63 attenuated Plk1 knockdown-induced apoptotic cell death and transactivation. Intriguingly, both Plk1 and p63 are highly expressed in the side population (SP) fraction of liver tumor cells compared to non-SP fraction cells, suggesting the significance of Plk1/TAp63 in the control of cell death in tumor-initiating SP fraction cells. Thus, Plk1 controls TAp63 by its phosphorylation and regulates apoptotic cell death in liver tumor cells. Plk1/TAp63 may be a suitable candidate as a molecular target of liver tumor treatments. Oncogene (2009) 28, 3631-3641; doi: 10.1038/onc.2009.216; published online 10 August 2009	[Kamijo, T.] Chiba Canc Ctr, Res Inst, Div Biochem, Chuo Ku, Chiba 2608717, Japan; [Komatsu, S.; Hishiki, T.; Yoshida, H.; Ohnuma, N.] Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chiba, Japan; [Chiba, T.; Iwama, A.] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan	Chiba Cancer Center; Chiba University; Chiba University	Kamijo, T (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	tkamijo@chiba-cc.jp		Suenaga, Yusuke/0000-0001-6902-5386; Takenobu, Hisanori/0000-0001-7355-1565	Ministry of Health, Labor, and Welfare; Ministry of Health, Labor, and Welfare of Japan [20-13]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K Sakurai for technical assistance and Daniel Mrozek, Medical English Service, for editorial assistance. This work was supported, in part, by a grant-in-aid from the Ministry of Health, Labor, and Welfare for Third Term Comprehensive Control Research for Cancer; a grant-in-aid for Cancer Research (20-13) from the Ministry of Health, Labor, and Welfare of Japan; and a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Blandino G, 2004, CELL CYCLE, V3, P886; Bruix J, 2002, HEPATOLOGY, V35, P519, DOI 10.1053/jhep.2002.32089; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Candi E, 2006, J CELL SCI, V119, P4617, DOI 10.1242/jcs.03265; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Eckerdt F, 2006, CANCER RES, V66, P6895, DOI 10.1158/0008-5472.CAN-06-0358; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; Ichikawa T, 2008, ONCOGENE, V27, P409, DOI 10.1038/sj.onc.1210658; Kato S, 1999, CANCER RES, V59, P5908; Koga F, 2003, CLIN CANCER RES, V9, P5501; Koida N, 2008, J BIOL CHEM, V283, P8555, DOI 10.1074/jbc.M710608200; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; MacPartlin M, 2008, J BIOL CHEM, V283, P15754, DOI 10.1074/jbc.M801394200; Massion PP, 2003, CANCER RES, V63, P7113; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Montesano R, 1997, JNCI-J NATL CANCER I, V89, P1844, DOI 10.1093/jnci/89.24.1844; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Petitjean A, 2005, ONCOGENE, V24, P512, DOI 10.1038/sj.onc.1208215; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Shen HM, 1996, MUTAT RES-REV GENET, V366, P23, DOI 10.1016/S0165-1110(96)90005-6; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; van Vugt MATM, 2001, J BIOL CHEM, V276, P41656, DOI 10.1074/jbc.M101831200; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Westfall MD, 2005, CELL CYCLE, V4, P710, DOI 10.4161/cc.4.5.1685; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Yamada S, 2004, ONCOGENE, V23, P5901, DOI 10.1038/sj.onc.1207782; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhou JB, 2008, CELL CYCLE, V7, P1360, DOI 10.4161/cc.7.10.5953	44	21	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2009	28	41					3631	3641		10.1038/onc.2009.216	http://dx.doi.org/10.1038/onc.2009.216			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KJ	19668228				2022-12-25	WOS:000270851800004
J	Bernal-Bayard, J; Ramos-Morales, F				Bernal-Bayard, Joaquin; Ramos-Morales, Francisco			Salmonella Type III Secretion Effector SlrP Is an E3 Ubiquitin Ligase for Mammalian Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INTESTINAL EPITHELIAL-CELLS; EARLY EMBRYONIC LETHALITY; UP-REGULATED PROTEIN-1; NF-KAPPA-B; PATHOGENICITY ISLAND-2; ESCHERICHIA-COLI; PEYERS-PATCHES; HOST-CELLS; APOPTOSIS	Salmonella enterica encodes two virulence-related type III secretion systems in Salmonella pathogenicity islands 1 and 2, respectively. These systems mediate the translocation of protein effectors into the eukaryotic host cell, where they alter cell signaling and manipulate host cell functions. However, the precise role of most effectors remains unknown. Using a genetic screen, we identified the small, reduction/oxidation-regulatory protein thioredoxin as a mammalian binding partner of the Salmonella effector SlrP. The interaction was confirmed by affinity chromatography and coimmunoprecipitation. In vitro, SlrP was able to mediate ubiquitination of ubiquitin and thioredoxin. A Cys residue conserved in other effectors of the same family that also possess E3 ubiquitin ligase activity was essential for this catalytic function. Stable expression of SlrP in HeLa cells resulted in a significant decrease of thioredoxin activity and in an increase of cell death. The physiological significance of these results was strengthened by the finding that Salmonella was able to trigger cell death and inhibit thioredoxin activity in HeLa cells several hours post-infection. This study assigns a functional role to the Salmonella effector SlrP as a binding partner and an E3 ubiquitin ligase for mammalian thioredoxin.	[Bernal-Bayard, Joaquin; Ramos-Morales, Francisco] Univ Seville, Dept Genet, Fac Biol, E-41080 Seville, Spain	University of Sevilla	Ramos-Morales, F (corresponding author), Univ Seville, Dept Genet, Fac Biol, Apartado 1095, E-41080 Seville, Spain.	framos@us.es	Bayard, Joaquin Bernal/E-9836-2016; Ramos-Morales, Francisco/C-5734-2008	Bayard, Joaquin Bernal/0000-0003-1199-3629; Ramos-Morales, Francisco/0000-0002-1151-4547	Spanish Ministry of Science and Innovation; ConsejerIa de Innovacion [SAF2007-60738, P08-CVI-03487]; Ciencia y Empresa; Junta de Andalucia	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ConsejerIa de Innovacion; Ciencia y Empresa; Junta de Andalucia(Junta de Andalucia)	This work was supported by Spanish Ministry of Science and Innovation and the European Regional Development Fund Grant SAF2007-60738 and Grant P08-CVI-03487 from ConsejerIa de Innovacion, Ciencia y Empresa, of the Junta de Andalucia.	Andersen JF, 1997, BIOCHEMISTRY-US, V36, P13979, DOI 10.1021/bi971004s; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bello RI, 2003, J BIOENERG BIOMEMBR, V35, P169, DOI 10.1023/A:1023702321148; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Bizzarri C, 2005, ANTIOXID REDOX SIGN, V7, P1189, DOI 10.1089/ars.2005.7.1189; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Coombes BK, 2005, J MOL BIOL, V348, P817, DOI 10.1016/j.jmb.2005.03.024; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Galan JE, 1996, CURR TOP MICROBIOL, V209, P43; Geddes K, 2005, INFECT IMMUN, V73, P6260, DOI 10.1128/IAI.73.10.6260-6271.2005; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; HARPER JW, 1993, CELL, V75, P805; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Johnson ES, 2002, NAT CELL BIOL, V4, pE295, DOI 10.1038/ncb1202-e295; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Lundberg U, 1999, J BACTERIOL, V181, P3433, DOI 10.1128/JB.181.11.3433-3437.1999; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Ly KT, 2007, CELL MICROBIOL, V9, P2103, DOI 10.1111/j.1462-5822.2007.00992.x; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; OBERLEY TD, 1995, FREE RADICAL BIO MED, V19, P53, DOI 10.1016/0891-5849(95)00012-M; Paesold G, 2002, CELL MICROBIOL, V4, P771, DOI 10.1046/j.1462-5822.2002.00233.x; Pekkari K, 2005, BLOOD, V105, P1598, DOI 10.1182/blood-2004-04-1577; Penheiter KL, 1997, MOL MICROBIOL, V24, P697, DOI 10.1046/j.1365-2958.1997.3741745.x; Philpott DJ, 2001, CURR OPIN IMMUNOL, V13, P410; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Ramsden AE, 2007, TRENDS MICROBIOL, V15, P516, DOI 10.1016/j.tim.2007.10.002; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sherman F., 1986, METHODS YEAST GENETI; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Spielberger JC, 2008, J CELL BIOCHEM, V104, P1879, DOI 10.1002/jcb.21762; Stavrinides J, 2008, CELL MICROBIOL, V10, P285, DOI 10.1111/j.1462-5822.2007.01078.x; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	63	70	74	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27587	27595		10.1074/jbc.M109.010363	http://dx.doi.org/10.1074/jbc.M109.010363			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19690162	hybrid, Green Published			2022-12-25	WOS:000270232300060
J	Fujimoto, K; Hanson, PT; Tran, H; Ford, EL; Han, ZQ; Johnson, JD; Schmidt, RE; Green, KG; Wice, BM; Polonsky, KS				Fujimoto, Kei; Hanson, Piia T.; Tran, Hung; Ford, Eric L.; Han, Zhiqiang; Johnson, James D.; Schmidt, Robert E.; Green, Karen G.; Wice, Burton M.; Polonsky, Kenneth S.			Autophagy Regulates Pancreatic Beta Cell Death in Response to Pdx1 Deficiency and Nutrient Deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-FAT DIET; MICE; APOPTOSIS; TUMORIGENESIS; BECLIN-1; DISEASE; FUSION; ISLETS; GENE; MASS	There are three types of cell death; apoptosis, necrosis, and autophagy. The possibility that activation of the macroautophagy (autophagy) pathway may increase beta cell death is addressed in this study. Increased autophagy was present in pancreatic islets from Pdx1(+/-) mice with reduced insulin secretion and beta cell mass. Pdx1 expression was reduced in mouse insulinoma 6 (MIN6) cells by delivering small hairpinRNAsusing a lentiviral vector. The MIN6 cells died after 7 days of Pdx1 deficiency, and autophagy was evident prior to the onset of cell death. Inhibition of autophagy prolonged cell survival and delayed cell death. Nutrient deprivation increased autophagy in MIN6 cells and mouse and human islets after starvation. Autophagy inhibition partly prevented amino acid starvation-induced MIN6 cell death. The in vivo effects of reduced autophagy were studied by crossing Pdx1(+/-) mice to Becn1(+/-) mice. After 1 week on a high fat diet, 4-week-old Pdx1(+/-) Becn1(+/-) mice showed normal glucose tolerance, preserved beta cell function, and increased beta cell mass compared with Pdx1(+/-) mice. This protective effect of reduced autophagy had worn off after 7 weeks on a high fat diet. Increased autophagy contributes to pancreatic beta cell death in Pdx1 deficiency and following nutrient deprivation. The role of autophagy should be considered in studies of pancreatic beta cell death and diabetes and as a target for novel therapeutic intervention.	[Fujimoto, Kei; Hanson, Piia T.; Tran, Hung; Ford, Eric L.; Han, Zhiqiang; Johnson, James D.; Wice, Burton M.; Polonsky, Kenneth S.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Internal Med,Barnes Jewish Hosp, St Louis, MO 63110 USA; [Schmidt, Robert E.; Green, Karen G.] Washington Univ, Sch Med, Div Neuropathol, Dept Pathol & Immunol,Barnes Jewish Hosp, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Polonsky, KS (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8066,660 S Euclid Ave, St Louis, MO 63110 USA.	Polonsky@im.wustl.edu		Johnson, James/0000-0002-7523-9433	Radioimmunoassay and Morphology Cores of the Diabetes Research and Training Center of Washington University [P60 DK-20579, DK-31842]; Washington University Digestive Diseases Research Center Morphology Core [5P30 DK052574]; Washington University [UL1RR024992]; Blum Kovler Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031842, P30DK052574, R01DK088126, R01DK031842, P60DK020579] Funding Source: NIH RePORTER	Radioimmunoassay and Morphology Cores of the Diabetes Research and Training Center of Washington University; Washington University Digestive Diseases Research Center Morphology Core; Washington University; Blum Kovler Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Radioimmunoassay and Morphology Cores of the Diabetes Research and Training Center of Washington University Grants P60 DK-20579 and DK-31842 ( to K. S. P.), Washington University Digestive Diseases Research Center Morphology Core Grant 5P30 DK052574, Clinical and Translational Science Award to Washington University Grant UL1RR024992, and the Blum Kovler Foundation.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; GREIDER MH, 1969, J CELL BIOL, V41, P162, DOI 10.1083/jcb.41.1.162; Hwang SO, 2008, BIOTECHNOL BIOENG, V99, P678, DOI 10.1002/bit.21589; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sadasivan S, 2006, APOPTOSIS, V11, P1573, DOI 10.1007/s10495-006-7690-6; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shvets E, 2008, AUTOPHAGY, V4, P1054, DOI 10.4161/auto.6823; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang HY, 2002, DIABETES, V51, pS333, DOI 10.2337/diabetes.51.2007.S333; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	33	94	98	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27664	27673		10.1074/jbc.M109.041616	http://dx.doi.org/10.1074/jbc.M109.041616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654319	Green Published, hybrid			2022-12-25	WOS:000270232300068
J	Uchida, Y; Ohshima, T; Yamashita, N; Ogawara, M; Sasaki, Y; Nakamura, F; Goshima, Y				Uchida, Yutaka; Ohshima, Toshio; Yamashita, Naoya; Ogawara, Miyuki; Sasaki, Yukio; Nakamura, Fumio; Goshima, Yoshio			Semaphorin3A Signaling Mediated by Fyn-dependent Tyrosine Phosphorylation of Collapsin Response Mediator Protein 2 at Tyrosine 32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-CONE COLLAPSE; ALZHEIMERS-DISEASE; RHO-KINASE; CRMP-2; MIGRATION; TRANSPORT; TUBULIN; NEURONS; COMPLEX; UNC-33	Collapsin response mediator protein 2 (CRMP2) is an intracellular protein that mediates signaling of Semaphorin3A (Sema3A), a repulsive axon guidance molecule. Fyn, a Src-type tyrosine kinase, is involved in the Sema3A signaling. However, the relationship between CRMP2 and Fyn in this signaling pathway is still unknown. In our research, we demonstrated that Fyn phosphorylated CRMP2 at Tyr(32) residues in HEK293T cells. Immunohistochemical analysis using a phospho-specific antibody at Tyr(32) of CRMP showed that Tyr(32)-phosphorylated CRMP was abundant in the nervous system, including dorsal root ganglion neurons, the molecular and Purkinje cell layer of adult cerebellum, and hippocampal fimbria. Overexpression of a nonphosphorylated mutant (Tyr(32) to Phe(32)) of CRMP2 in dorsal root ganglion neurons interfered with Sema3A-induced growth cone collapse response. These results suggest that Fyn-dependent phosphorylation of CRMP2 at Tyr(32) is involved in Sema3A signaling.	[Uchida, Yutaka; Yamashita, Naoya; Ogawara, Miyuki; Sasaki, Yukio; Nakamura, Fumio; Goshima, Yoshio] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1698555, Japan; [Uchida, Yutaka; Ohshima, Toshio] RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Goshima, Yoshio] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Yokohama City University; Waseda University; RIKEN; Japan Science & Technology Agency (JST)	Goshima, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan.	goshima@med.yokohama-cu.ac.jp	Sasaki, Yukio/P-7662-2015	Sasaki, Yukio/0000-0001-6143-7001	Ministry of Education, Culture, Sports, Science, and Technology; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported by grants-in-aid for scientific research on priority areas and targeted proteins research program from the Ministry of Education, Culture, Sports, Science, and Technology (to Y. G.) and Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (to Y. G.).	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li CX, 2004, J NEUROSCI, V24, P6161, DOI 10.1523/JNEUROSCI.1476-04.2004; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Mitsui N, 2002, EMBO J, V21, P3274, DOI 10.1093/emboj/cdf328; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shapovalova Z, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-133; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Varrin-Doyer M, 2009, J BIOL CHEM, V284, P13265, DOI 10.1074/jbc.M807664200; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	27	46	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27393	27401		10.1074/jbc.M109.000240	http://dx.doi.org/10.1074/jbc.M109.000240			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19652227	Green Published, hybrid			2022-12-25	WOS:000270232300041
J	Wu, CY; Roje, S; Sandoval, FJ; Bird, AJ; Winge, DR; Eide, DJ				Wu, Chang-Yi; Roje, Sanja; Sandoval, Francisco J.; Bird, Amanda J.; Winge, Dennis R.; Eide, David J.			Repression of Sulfate Assimilation Is an Adaptive Response of Yeast to the Oxidative Stress of Zinc Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR MET4; SACCHAROMYCES-CEREVISIAE; HOMOCYSTEINE TOXICITY; S-ADENOSYLMETHIONINE; GENE-EXPRESSION; REGULATED GENES; DNA-BINDING; SCFMET30; ZAP1; PROTEIN	The Zap1 transcription factor is a central player in the response of yeast to changes in zinc status. Previous studies identified over 80 genes activated by Zap1 in zinc-limited cells. In this report, we identified 36 genes repressed in a zinc-and Zap1-responsive manner. As a result, we have identified a new mechanism of Zap1-mediated gene repression whereby transcription of the MET3, MET14, and MET16 genes is repressed in zinc-limited cells. These genes encode the first three enzymes of the sulfate assimilation pathway. We found that MET30, encoding a component of the SCFMet30 ubiquitin ligase, is a direct Zap1 target gene. MET30 expression is increased in zinc-limited cells, and this leads to degradation of Met4, a transcription factor responsible for MET3, MET14, and MET16 expression. Thus, Zap1 is responsible for a decrease in sulfate assimilation in zinc-limited cells. We further show that cells that are unable to down-regulate sulfate assimilation under zinc deficiency experience increased oxidative stress. This increased oxidative stress is associated with an increase in the NADP(+)/NADPH ratio and may result from a decrease in NADPH-dependent antioxidant activities. These studies have led to new insights into how cells adapt to nutrient-limiting growth conditions.	[Wu, Chang-Yi; Eide, David J.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Roje, Sanja; Sandoval, Francisco J.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Bird, Amanda J.; Winge, Dennis R.] Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA	University of Wisconsin System; University of Wisconsin Madison; Washington State University; Utah System of Higher Education; University of Utah	Eide, DJ (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	deide@wisc.edu	Bird, Amanda Jane/ABD-2295-2021	Bird, Amanda Jane/0000-0002-1846-7050; Roje, Sanja/0000-0002-6302-5382	National Institutes of Health [GM56285]; National Science Foundation [MCB-0429968]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083292, R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56285 (to D.J.E.). This work was also supported by National Science Foundation Grant MCB-0429968 (to S. R.).	Ames BN, 2002, NAT REV CANCER, V2, P694, DOI 10.1038/nrc886; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Avram D, 1999, YEAST, V15, P473, DOI 10.1002/(SICI)1097-0061(199904)15:6<473::AID-YEA388>3.0.CO;2-Y; Barbey R, 2005, EMBO J, V24, P521, DOI 10.1038/sj.emboj.7600556; Bird A, 2000, J BIOL CHEM, V275, P16160, DOI 10.1074/jbc.M000664200; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; BURKE JP, 1985, P SOC EXP BIOL MED, V179, P187; Cai L, 2005, CURR MED CHEM, V12, P2753, DOI 10.2174/092986705774462950; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Chandrasekaran S, 2006, MOL CELL, V24, P689, DOI 10.1016/j.molcel.2006.10.028; Chiang DY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-16; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; De Nicola R, 2007, APPL ENVIRON MICROB, V73, P7680, DOI 10.1128/AEM.01445-07; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; Higgins VJ, 2003, APPL ENVIRON MICROB, V69, P7535, DOI 10.1128/AEM.69.12.7535-7540.2003; Ho E, 2003, J NUTR, V133, P2543, DOI 10.1093/jn/133.8.2543; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; OTEIZA PI, 1995, J NUTR, V125, P823; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Powell SR, 2000, J NUTR, V130, p1447S, DOI 10.1093/jn/130.5.1447S; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Smothers DB, 2000, MOL CELL BIOL, V20, P7845, DOI 10.1128/MCB.20.21.7845-7852.2000; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1995, MOL CELL BIOL, V15, P6526; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Yen JL, 2005, MOL BIOL CELL, V16, P1872, DOI 10.1091/mbc.E04-12-1130; Yuan DS, 2000, GENETICS, V156, P45; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; Zhou ZHS, 1999, BIOCHEMISTRY-US, V38, P15915, DOI 10.1021/bi992062b; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	65	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27544	27556		10.1074/jbc.M109.042036	http://dx.doi.org/10.1074/jbc.M109.042036			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656949	hybrid, Green Published			2022-12-25	WOS:000270232300056
J	Schanzer, DL; Garner, MJ; Hatchette, TF; Langley, JM; Aziz, S; Tam, TWS				Schanzer, Dena L.; Garner, Michael J.; Hatchette, Todd F.; Langley, Joanne M.; Aziz, Samina; Tam, Theresa W. S.			Estimating Sensitivity of Laboratory Testing for Influenza in Canada through Modelling	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; HUMAN METAPNEUMOVIRUS INFECTION; REAL-TIME PCR; RESPIRATORY VIRUSES; VIRAL CULTURE; DIAGNOSIS; HOSPITALIZATION; CHILDREN; DEATHS; ADULTS	Background: The weekly proportion of laboratory tests that are positive for influenza is used in public health surveillance systems to identify periods of influenza activity. We aimed to estimate the sensitivity of influenza testing in Canada based on results of a national respiratory virus surveillance system. Methods and Findings: The weekly number of influenza-negative tests from 1999 to 2006 was modelled as a function of laboratory-confirmed positive tests for influenza, respiratory syncytial virus (RSV), adenovirus and parainfluenza viruses, seasonality, and trend using Poisson regression. Sensitivity was calculated as the number of influenza positive tests divided by the number of influenza positive tests plus the model-estimated number of false negative tests. The sensitivity of influenza testing was estimated to be 33% (95% CI 32-34%), varying from 30-40% depending on the season and region. Conclusions: The estimated sensitivity of influenza tests reported to this national laboratory surveillance system is considerably less than reported test characteristics for most laboratory tests. A number of factors may explain this difference, including sample quality and specimen procurement issues as well as test characteristics. Improved diagnosis would permit better estimation of the burden of influenza.			Schanzer, DL (corresponding author), Publ Hlth Agcy Canada, Infect Dis & Emergency Preparedness Branch, Ottawa, ON, Canada.	Dena_Schanzer@phac-aspc.gc.ca	Schanzer, Dena/G-1593-2011	Schanzer, Dena/0000-0001-7093-4309; Langley, Joanne/0000-0003-3270-7345; Hatchette, Todd/0000-0002-5377-2528				[Anonymous], 2005, Can Commun Dis Rep, V31, P1; ARENS MQ, 1986, DIAGN MICR INFEC DIS, V5, P307, DOI 10.1016/0732-8893(86)90033-7; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Cooper DL, 2007, J INFECTION, V55, P240, DOI 10.1016/j.jinf.2007.04.353; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; Erdman DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Falsey AR, 2008, PEDIATR INFECT DIS J, V27, pS80, DOI 10.1097/INF.0b013e3181684dac; GARNER M, 2008, CAN IMM C TOR ONT CA; Grijalva CG, 2007, EPIDEMIOL INFECT, V135, P951, DOI 10.1017/S095026880600762X; Grijalva CG, 2007, PEDIATRICS, V119, pE6, DOI 10.1542/peds.2006-1694; Hatchette TF, 2009, CAN J PUBLIC HEALTH, V100, P204, DOI 10.1007/BF03405541; Heikkinen T, 2002, J CLIN MICROBIOL, V40, P4337, DOI 10.1128/JCM.40.11.4337-4339.2002; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Leitmeyer K, 2002, Euro Surveill, V7, P180; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; *PUBL HLTH AG CAN, FLUWATCH REP; RACHLIS ML, 2004, PRESCRIPTION EXCELLE; Reyes F, 2007, Can Commun Dis Rep, V33, P21; Robinson JL, 2008, CLIN INFECT DIS, V46, pE61, DOI 10.1086/529386; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; *SAS I INC, 2002, SAS STAT 9 US GUID, V1; *SAS I INC, 2002, SAS STAT 9 US GUID, V3; *SAS I INC, 2002, SAS STAT 9 US GUID, V2; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2008, VACCINE, V26, P4697, DOI 10.1016/j.vaccine.2008.06.087; Schanzer DL, 2007, J OBSTET GYNAECOL CA, V29, P622, DOI 10.1016/S1701-2163(16)32559-2; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Steininger C, 2002, J CLIN MICROBIOL, V40, P2051, DOI 10.1128/JCM.40.6.2051-2056.2002; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Upfold J, 2002, CAN MED ASSOC J, V166, P445; van de Pol AC, 2007, J CLIN MICROBIOL, V45, P2260, DOI 10.1128/JCM.00848-07; Wallace LA, 2004, J CLIN VIROL, V31, P40, DOI 10.1016/j.jcv.2003.12.003; Walsh EE, 2008, ARCH INTERN MED, V168, P2489, DOI 10.1001/archinte.168.22.2489; Weinberg A, 2005, J CLIN VIROL, V33, P172, DOI 10.1016/j.jcv.2004.12.013; Weinberg A, 2005, CLIN DIAGN LAB IMMUN, V12, P367, DOI 10.1128/CDLI.12.3.367-370.2005; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6681	10.1371/journal.pone.0006681	http://dx.doi.org/10.1371/journal.pone.0006681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688094	Green Published, gold, Green Submitted			2022-12-25	WOS:000269075800016
J	Sharma, D; Martineau, CN; Le Dall, MT; Reidy, M; Masison, DC; Kabani, M				Sharma, Deepak; Martineau, Celine N.; Le Dall, Marie-Therese; Reidy, Michael; Masison, Daniel C.; Kabani, Mehdi			Function of SSA Subfamily of Hsp70 Within and Across Species Varies Widely in Complementing Saccharomyces cerevisiae Cell Growth and Prion Propagation	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE EXCHANGE FACTORS; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; TRANSGENIC MICE; CYTOSOLIC HSP70; YEAST PRIONS; PSI+ PRION; IN-VITRO	Background: The cytosol of most eukaryotic cells contains multiple highly conserved Hsp70 orthologs that differ mainly by their spatio-temporal expression patterns. Hsp70s play essential roles in protein folding, transport or degradation, and are major players of cellular quality control processes. However, while several reports suggest that specialized functions of Hsp70 orthologs were selected through evolution, few studies addressed systematically this issue. Methodology/Principal Findings: We compared the ability of Ssa1p-Ssa4p from Saccharomyces cerevisiae and Ssa5p-Ssa8p from the evolutionary distant yeast Yarrowia lipolytica to perform Hsp70-dependent tasks when expressed as the sole Hsp70 for S. cerevisiae in vivo. We show that Hsp70 isoforms (i) supported yeast viability yet with markedly different growth rates, (ii) influenced the propagation and stability of the [PSI+] and [URE3] prions, but iii) did not significantly affect the proteasomal degradation rate of CFTR. Additionally, we show that individual Hsp70 orthologs did not induce the formation of different prion strains, but rather influenced the aggregation properties of Sup35 in vivo. Finally, we show that [URE3] curing by the overexpression of Ydj1p is Hsp70-isoform dependent. Conclusion/Significance: Despite very high homology and overlapping functions, the different Hsp70 orthologs have evolved to possess distinct activities that are required to cope with different types of substrates or stress situations. Yeast prions provide a very sensitive model to uncover this functional specialization and to explore the intricate network of chaperone/co-chaperone/substrates interactions.	[Sharma, Deepak; Reidy, Michael; Masison, Daniel C.] Natl Inst Diabet Digest & Kidney Dis, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA; [Martineau, Celine N.; Kabani, Mehdi] Ctr Natl Rech Sci, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Le Dall, Marie-Therese] AgroParisTech, Lab Microbiol & Genet Mol, Ctr Natl Rech Sci, Inst Natl Rech Agron, Thiverval Grignon, France	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Centre National de la Recherche Scientifique (CNRS); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Sharma, D (corresponding author), Natl Inst Diabet Digest & Kidney Dis, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.	masisond@helix.nih.gov; Mehdi.Kabani@lebs.cnrs-gif.fr	Kabani, Mehdi/G-7456-2012	Kabani, Mehdi/0000-0001-7440-6394; Reidy, Michael/0000-0002-9290-7595	Centre National de la Recherche Scientifique; National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health; French Cystic Fibrosis Foundation 'Vaincre la Mucoviscidose' [FC0518]; French Ministry of National Education, Research and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK024946, ZIADK024946] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); French Cystic Fibrosis Foundation 'Vaincre la Mucoviscidose'; French Ministry of National Education, Research and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Centre National de la Recherche Scientifique (M. K.), the intramural program of the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health (D. C. M.), and by the French Cystic Fibrosis Foundation 'Vaincre la Mucoviscidose' research grant FC0518 (M. K.). C.N.M. is the beneficiary of a doctoral grant from the French Ministry of National Education, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELIDIS CE, 1996, TRANSGENICS, V2, P111; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Bousset L, 2008, CURR ALZHEIMER RES, V5, P251, DOI 10.2174/156720508784533303; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DOEL SM, 1994, GENETICS, V137, P659; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; HE F, 1992, J BIOL CHEM, V267, P1932; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; JAATTELA M, 1992, EMBO J, V11, P3507, DOI 10.1002/j.1460-2075.1992.tb05433.x; Jones GW, 2003, GENETICS, V163, P495; Jung G, 2000, GENETICS, V156, P559; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280; Kabani Mehdi, 2003, Current Genomics, V4, P465, DOI 10.2174/1389202033490268; Kabani M, 2009, PROTEIN PEPTIDE LETT, V16, P623, DOI 10.2174/092986609788490186; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; LANDRY J, 1982, CANCER RES, V42, P2457; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; LI GC, 1992, P NATL ACAD SCI USA, V89, P2036, DOI 10.1073/pnas.89.6.2036; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Martineau CN, 2007, GENETICS, V177, P1679, DOI 10.1534/genetics.107.081141; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Monje-Casas F, 2004, BIOCHEM J, V383, P139, DOI 10.1042/BJ20040851; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Park KW, 2006, GENETICS, V173, P35, DOI 10.1534/genetics.105.054221; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; PLUMIER JCL, 1995, J CLIN INVEST, V95, P1854, DOI 10.1172/JCI117865; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Rikhvanov EG, 2007, PRION, V1, P217, DOI 10.4161/pri.1.4.5058; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roberts BT, 2004, YEAST, V21, P107, DOI 10.1002/yea.1062; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; Sharma D, 2009, GENETICS, V181, P129, DOI 10.1534/genetics.108.098699; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tutar Y, 2006, GENETICS, V172, P851, DOI 10.1534/genetics.105.048926; Umebayashi K, 1997, YEAST, V13, P1009; Uppuluri P, 2007, FEMS YEAST RES, V7, P110, DOI 10.1111/j.1567-1364.2006.00143.x; WARD CL, 1994, J BIOL CHEM, V269, P25710; WENZEL TJ, 1995, NUCLEIC ACIDS RES, V23, P883, DOI 10.1093/nar/23.5.883; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	81	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6644	10.1371/journal.pone.0006644	http://dx.doi.org/10.1371/journal.pone.0006644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680550	gold, Green Submitted, Green Published			2022-12-25	WOS:000268936200010
J	Ahamed, J; Janczak, CA; Wittkowski, KM; Coller, BS				Ahamed, Jasimuddin; Janczak, Christin A.; Wittkowski, Knut M.; Coller, Barry S.			In Vitro and In Vivo Evidence that Thrombospondin-1 (TSP-1) Contributes to Stirring- and Shear-Dependent Activation of Platelet-Derived TGF-beta 1	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; LATENT TGF-BETA; THIOL-DISULFIDE EXCHANGE; ENDOTHELIAL-CELLS; TYPE-1 REPEATS; GROWTH-FACTOR-BETA-1; RELEASE; ABSENCE; FORMS; ISOMERIZATION	Thrombospondin 1 (TSP-1), which is contained in platelet alpha-granules and released with activation, has been shown to activate latent TGF-beta 1 in vitro, but its in vivo role is unclear as TSP-1-null (Thbs1(-/-)) mice have a much less severe phenotype than TGF-beta 1-null (Tgfb1(-/-)) mice. We recently demonstrated that stirring and/or shear could activate latent TGF-beta 1 released from platelets and have now studied these methods of TGF-beta 1 activation in samples from Thbs1(-/-) mice, which have higher platelet counts and higher levels of total TGF-beta 1 in their serum than wild type mice. After either two hours of stirring or shear, Thbs1(-/-) samples demonstrated less TGF-beta 1 activation (31% and 54% lower levels of active TGF-beta 1 in serum and platelet releasates, respectively). TGF-beta 1 activation in Thbs1(-/-) mice samples was normalized by adding recombinant human TSP-1 (rhTSP-1). Exposure of platelet releasates to shear for one hour led to near depletion of TSP-1, but this could be prevented by preincubating samples with thiol-reactive agents. Moreover, replenishing rhTSP-1 to human platelet releasates after one hour of stirring enhanced TGF-beta 1 activation. In vivo TGF-beta 1 activation in carotid artery thrombi was also partially impaired in Thbs1(-/-) mice. These data indicate that TSP-1 contributes to shear-dependent TGF-beta 1 activation, thus providing a potential explanation for the inconsistent in vitro data previously reported as well as for the differences in phenotypes of Thbs1(-/-) and Tgfb1(-/-) mice.	[Ahamed, Jasimuddin; Janczak, Christin A.; Wittkowski, Knut M.; Coller, Barry S.] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA	Rockefeller University	Ahamed, J (corresponding author), Rockefeller Univ, Lab Blood & Vasc Biol, 1230 York Ave, New York, NY 10021 USA.	jahamed@rockefeller.edu			National Heart, Lung and Blood Institute [19278]; National Center for Research Resources (NIH) [5UL1RR024143]; New York City Community Trust Career Development Grant Award; Monique Weill-Caulier Trust New Faculty Research Award; Stony Brook University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019278] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); New York City Community Trust Career Development Grant Award; Monique Weill-Caulier Trust New Faculty Research Award; Stony Brook University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants 19278 from the National Heart, Lung and Blood Institute (B.S.C.), a Clinical and Translational Science Award (CTSA; 5UL1RR024143) from the National Center for Research Resources (NIH), a New York City Community Trust Career Development Grant Award for Young Faculty (JA), a Monique Weill-Caulier Trust New Faculty Research Award (J.A.), and funds from Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouahed M, 2000, J BIOL CHEM, V275, P17933, DOI 10.1074/jbc.275.24.17933; ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; AHAMED J, 2008, BLOOD; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Blakytny R, 2004, J CELL PHYSIOL, V199, P67, DOI 10.1002/jcp.10454; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; CHOI H, 2007, J BIOL CHEM; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DETWILER TC, 1987, SEMIN THROMB HEMOST, V13, P276, DOI 10.1055/s-2007-1003502; DETWILER TC, 1978, THROMB HAEMOSTASIS, V40, P207; Frangogiannis NG, 2005, CIRCULATION, V111, P2935, DOI 10.1161/CIRCULATIONAHA.104.510354; FRAZIER WA, 1987, J CELL BIOL, V105, P625, DOI 10.1083/jcb.105.2.625; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Grainger DJ, 2000, BIOCHEM J, V350, P291, DOI 10.1042/0264-6021:3500291; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; GRINSTEIN S, 1983, J BIOL CHEM, V258, P7876; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Huang EM, 1997, BLOOD, V89, P3205, DOI 10.1182/blood.V89.9.3205; Jirouskova M, 2004, BLOOD, V103, P1995, DOI 10.1182/blood-2003-10-3401; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; LAWLER J, 1986, BLOOD, V67, P1197; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MOSHER DF, 1990, ANNU REV MED, V41, P85; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; SchiniKerth VB, 1997, CIRCULATION, V96, P3888; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26775; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Shet AS, 2008, BLOOD CELL MOL DIS, V41, P109, DOI 10.1016/j.bcmd.2008.01.008; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SLIVKA SR, 1991, BLOOD, V77, P1013; SOUCHELNITSKIY S, 1995, ENDOCRINOLOGY, V136, P5118, DOI 10.1210/en.136.11.5118; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; TURK JL, 1986, ARCH BIOCHEM BIOPHYS, V245, P446, DOI 10.1016/0003-9861(86)90236-5; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341; YEE KO, 2003, CURR PROTOC CELL BIO, pCH10; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Zhou Y, 2006, BIOCHEM BIOPH RES CO, V339, P633, DOI 10.1016/j.bbrc.2005.11.060	54	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6608	10.1371/journal.pone.0006608	http://dx.doi.org/10.1371/journal.pone.0006608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672301	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900019
J	Piech, RM; Lewis, J; Parkinson, CH; Owen, AM; Roberts, AC; Downing, PE; Parkinson, JA				Piech, Richard M.; Lewis, Jade; Parkinson, Caroline H.; Owen, Adrian M.; Roberts, Angela C.; Downing, Paul E.; Parkinson, John A.			Neural Correlates of Appetite and Hunger-Related Evaluative Judgments	PLOS ONE			English	Article							PRIMATE ORBITOFRONTAL CORTEX; HUMAN AMYGDALA; REWARD PREDICTION; HUMAN BRAIN; FOOD; RESPONSES; REPRESENTATION; MOTIVATION; INTENSITY; STIMULI	How much we desire a meal depends on both the constituent foods and how hungry we are, though not every meal becomes more desirable with increasing hunger. The brain therefore needs to be able to integrate hunger and meal properties to compute the correct incentive value of a meal. The present study investigated the functional role of the amygdala and the orbitofrontal cortex in mediating hunger and dish attractiveness. Furthermore, it explored neural responses to dish descriptions particularly susceptible to value-increase following fasting. We instructed participants to rate how much they wanted food menu items while they were either hungry or sated, and compared the rating differences in these states. Our results point to the representation of food value in the amygdala, and to an integration of attractiveness with hunger level in the orbitofrontal cortex. Dishes particularly desirable during hunger activated the thalamus and the insula. Our results specify the functions of evaluative structures in the context of food attractiveness, and point to a complex neural representation of dish qualities which contribute to state-dependent value.	[Piech, Richard M.; Lewis, Jade; Parkinson, Caroline H.; Downing, Paul E.; Parkinson, John A.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Owen, Adrian M.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Roberts, Angela C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Bangor University; University of Cambridge	Piech, RM (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	r.piech@vanderbilt.edu	Roberts, Angela C/C-1313-2012; Owen, Adrian M/B-4997-2015	Roberts, Angela C/0000-0003-2873-157X; Downing, Paul/0000-0002-5046-2858	School of Psychology, Bangor University; MRC [MC_U105559847] Funding Source: UKRI; Medical Research Council [G0001354, MC_U105559847, G0001354B] Funding Source: researchfish	School of Psychology, Bangor University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the School of Psychology, Bangor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; [Anonymous], 1998, NEURAL NETWORKS BRAI; Arana FS, 2003, J NEUROSCI, V23, P9632; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; de Araujo IE, 2004, J NEUROSCI, V24, P3086, DOI 10.1523/JNEUROSCI.0130-04.2004; deCastro JM, 1997, NUTR RES, V17, P807, DOI 10.1016/S0271-5317(97)00050-X; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Erlanson-Albertsson C, 2005, BASIC CLIN PHARMACOL, V97, P61, DOI 10.1111/j.1742-7843.2005.pto_179.x; Flint A, 2006, AM J CLIN NUTR, V84, P1365, DOI 10.1093/ajcn/84.6.1365; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; HILL AJ, 1984, APPETITE, V5, P361, DOI 10.1016/S0195-6663(84)80008-2; Hinton EC, 2004, EUR J NEUROSCI, V20, P1411, DOI 10.1111/j.1460-9568.2004.03589.x; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Holsen LM, 2005, NEUROIMAGE, V27, P669, DOI 10.1016/j.neuroimage.2005.04.043; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; LANG PJ, 1993, STRUCTURE EMOTION, P243; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Rolls E. T., 1995, NEUROL DIS, P549; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Smeets AJPG, 2006, PHYSIOL BEHAV, V89, P281, DOI 10.1016/j.physbeh.2006.06.011; Talairach J., 1988, COPLANAR STEREOTAXIC; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	41	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6581	10.1371/journal.pone.0006581	http://dx.doi.org/10.1371/journal.pone.0006581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672296	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900006
J	Fallahi-Sichani, M; Linderman, JJ				Fallahi-Sichani, Mohammad; Linderman, Jennifer J.			Lipid Raft-Mediated Regulation of G-Protein Coupled Receptor Signaling by Ligands which Influence Receptor Dimerization: A Computational Study	PLOS ONE			English	Article							PLASMA-MEMBRANE MICRODOMAINS; HETEROTRIMERIC G-PROTEINS; RESONANCE ENERGY-TRANSFER; BETA(2)-ADRENERGIC RECEPTOR; OPIOID RECEPTOR; MONTE-CARLO; NANOSCALE ORGANIZATION; CHOLESTEROL REDUCTION; CARDIAC MYOCYTES; ADENYLYL-CYCLASE	G-protein coupled receptors (GPCRs) are the largest family of cell surface receptors; they activate heterotrimeric G-proteins in response to ligand stimulation. Although many GPCRs have been shown to form homo-and/or heterodimers on the cell membrane, the purpose of this dimerization is not known. Recent research has shown that receptor dimerization may have a role in organization of receptors on the cell surface. In addition, microdomains on the cell membrane termed lipid rafts have been shown to play a role in GPCR localization. Using a combination of stochastic (Monte Carlo) and deterministic modeling, we propose a novel mechanism for lipid raft partitioning of GPCRs based on reversible dimerization of receptors and then demonstrate that such localization can affect GPCR signaling. Modeling results are consistent with a variety of experimental data indicating that lipid rafts have a role in amplification or attenuation of G-protein signaling. Thus our work suggests a new mechanism by which dimerization-inducing or inhibiting characteristics of ligands can influence GPCR signaling by controlling receptor organization on the cell membrane.	[Fallahi-Sichani, Mohammad; Linderman, Jennifer J.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fallahi-Sichani, M (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	linderma@umich.edu			NIH [R01 LM009027, R33 HL092844]; Merck Research Laboratories; Rackham International Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL092844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062930] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Rackham International Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We acknowledge support from NIH R01 LM009027, R33 HL092844, Merck Research Laboratories and Rackham International Fellowship (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Baker A, 2007, EUR BIOPHYS J BIOPHY, V36, P849, DOI 10.1007/s00249-007-0214-7; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Brinkerhoff CJ, 2008, J THEOR BIOL, V251, P561, DOI 10.1016/j.jtbi.2008.01.002; Brinkerhoff CJ, 2008, J THEOR BIOL, V255, P278, DOI 10.1016/j.jtbi.2008.08.003; Cameron PL, 1997, J NEUROSCI, V17, P9520; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Claasen B, 2005, J AM CHEM SOC, V127, P916, DOI 10.1021/ja044434w; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Flaherty P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000185; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gomes I, 2001, J MOL MED, V79, P226, DOI 10.1007/s001090100219; Harding PJ, 2009, BIOPHYS J, V96, P964, DOI 10.1016/j.bpj.2008.09.054; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hsieh MY, 2008, IET SYST BIOL, V2, P256, DOI 10.1049/iet-syb:20070073; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; Huang P, 2007, BRAIN RES, V1184, P46, DOI 10.1016/j.brainres.2007.09.096; Huang P, 2007, BIOCHEM PHARMACOL, V73, P534, DOI 10.1016/j.bcp.2006.10.032; Ishizaka N, 1998, HYPERTENSION, V32, P459, DOI 10.1161/01.HYP.32.3.459; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Keil ML, 2003, BIOCHEM BIOPH RES CO, V301, P862, DOI 10.1016/S0006-291X(03)00057-3; Kinzer-Ursem TL, 2007, PLOS COMPUT BIOL, V3, P84, DOI 10.1371/journal.pcbi.0030006; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Linderman JJ, 2009, J BIOL CHEM, V284, P5427, DOI 10.1074/jbc.R800028200; MAHAMA PA, 1994, BIOPHYS J, V67, P1345, DOI 10.1016/S0006-3495(94)80606-X; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Maurya MR, 2007, BIOPHYS J, V93, P709, DOI 10.1529/biophysj.106.097469; Mayawala K, 2006, BIOPHYS CHEM, V121, P194, DOI 10.1016/j.bpc.2006.01.008; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Nicolau DV, 2007, BIOPHYS J, V92, P1975, DOI 10.1529/biophysj.105.076869; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ostasov P, 2007, J RECEPT SIG TRANSD, V27, P335, DOI 10.1080/10799890701684142; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Riccobene TA, 1999, J THEOR BIOL, V200, P207, DOI 10.1006/jtbi.1999.0988; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sautel M, 2000, CURR MED CHEM, V7, P889, DOI 10.2174/0929867003374570; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Schroeder F, 2001, EXP BIOL MED, V226, P873, DOI 10.1177/153537020122601002; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shea LD, 1997, BIOPHYS J, V73, P2949, DOI 10.1016/S0006-3495(97)78323-1; Shea LD, 1998, J THEOR BIOL, V191, P249, DOI 10.1006/jtbi.1997.0571; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sitrin RG, 2006, J IMMUNOL, V177, P8177, DOI 10.4049/jimmunol.177.11.8177; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smith SML, 2006, ENDOCRINOLOGY, V147, P1789, DOI 10.1210/en.2005-1046; Turcotte M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000148; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Woolf PJ, 2004, J THEOR BIOL, V229, P157, DOI 10.1016/j.jtbi.2004.03.012; Woolf PJ, 2003, BIOPHYS CHEM, V104, P217, DOI 10.1016/S0301-4622(02)00369-1; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Xue M, 2004, J BIOL CHEM, V279, P45175, DOI 10.1074/jbc.M407053200; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	77	68	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6604	10.1371/journal.pone.0006604	http://dx.doi.org/10.1371/journal.pone.0006604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668374	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935600021
J	Daude, N; Wohlgemuth, S; Rogaeva, E; Farid, AH; Heaton, M; Westaway, D				Daude, Nathalie; Wohlgemuth, Serene; Rogaeva, Ekaterina; Farid, A. Hossein; Heaton, Mike; Westaway, David			Frequent Missense and Insertion/Deletion Polymorphisms in the Ovine Shadoo Gene Parallel Species-Specific Variation in PrP	PLOS ONE			English	Article								Background: The cellular prion protein PrP(C) is encoded by the Prnp gene. This protein is expressed in the central nervous system (CNS) and serves as a precursor to the misfolded PrP(Sc) isoform in prion diseases. The prototype prion disease is scrapie in sheep, and whereas Prnp exhibits common missense polymorphisms for V136A, R154H and Q171R in ovine populations, genetic variation in mouse Prnp is limited. Recently the CNS glycoprotein Shadoo (Sho) has been shown to resemble PrP(C) both in a central hydrophobic domain and in activity in a toxicity assay performed in cerebellar neurons. Sho protein levels are reduced in prion infections in rodents. Prompted by these properties of the Sho protein we investigated the extent of natural variation in SPRN. Principal Findings: Paralleling the case for ovine versus human and murine PRNP, we failed to detect significant coding polymorphisms that alter the mature Sho protein in a sample of neurologically normal humans, or in diverse strains of mice. However, ovine SPRN exhibited 4 missense mutations and expansion/contraction in a series of 5 tandem Ala/Gly-containing repeats R1-R5 encoding Sho's hydrophobic domain. A Val71Ala polymorphism and polymorphic expansion of wt 67(Ala)(3)Gly70 to 67(Ala)(5)Gly72 reached frequencies of 20%, with other alleles including Delta 67-70 and a 67(Ala)(6)Gly73 expansion. Sheep V71, A71, Delta 67-70 and 67(Ala)(6)Gly73 SPRN alleles encoded proteins with similar stability and posttranslational processing in transfected neuroblastoma cells. Significance: Frequent coding polymorphisms are a hallmark of the sheep PRNP gene and our data indicate a similar situation applies to ovine SPRN. Whether a common selection pressure balances diversity at both loci remains to be established.			Daude, N (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	david.westaway@ualberta.ca		Heaton, Michael/0000-0003-1386-1208; Wohlgemuth, Serene/0000-0001-7287-0935				Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; BECK JA, 2008, J MED GENET; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Caburet S, 2004, J MED GENET, V41, P932, DOI 10.1136/jmg.2004.024356; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Dickinson A. G., 1976, Slow virus diseases of animals and man,, P209; DRISALDI B, 2004, J BIOL CHEM; FERRIS SD, 1983, GENETICS, V105, P681; Flechsig E., 2004, VVolume 41, P373; Giri K, 2007, BIOPHYS J, V92, P293, DOI 10.1529/biophysj.106.091769; GOLDMANN W, 1990, P NATL ACAD SCI USA, V87, P2476, DOI 10.1073/pnas.87.7.2476; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Holter J, 2005, J MOL NEUROSCI, V25, P37, DOI 10.1385/JMN:25:1:037; Kreitman M, 2004, TRENDS GENET, V20, P300, DOI 10.1016/j.tig.2004.05.002; Lampo E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-138; LAPLANCHE JL, 1993, GENOMICS, V15, P30, DOI 10.1006/geno.1993.1006; Lenzmeier BA, 2003, CYTOGENET GENOME RES, V100, P7, DOI 10.1159/000072836; LLOYD SE, 2009, MAMM GENOME; Ma BY, 2002, PROTEIN SCI, V11, P2335, DOI 10.1110/ps.4270102; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Premzl M, 2003, GENE, V314, P89, DOI 10.1016/S0378-1119(03)00707-8; PREMZL M, 2004, MOL BIOL EVOL; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sawalha RM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001236; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Soldevila M, 2006, GENOME RES, V16, P231, DOI 10.1101/gr.4345506; Soldevila M, 2005, TRENDS GENET, V21, P389, DOI 10.1016/j.tig.2005.05.001; STEWART P, 2009, J GEN VIROL; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959	35	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6538	10.1371/journal.pone.0006538	http://dx.doi.org/10.1371/journal.pone.0006538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657386	Green Submitted, gold, Green Published			2022-12-25	WOS:000268739300009
J	Wimpenny, JH; Weir, AAS; Clayton, L; Rutz, C; Kacelnik, A				Wimpenny, Joanna H.; Weir, Alex A. S.; Clayton, Lisa; Rutz, Christian; Kacelnik, Alex			Cognitive Processes Associated with Sequential Tool Use in New Caledonian Crows	PLOS ONE			English	Article							CORVUS-MONEDULOIDES; RHESUS-MONKEYS; CEBUS; TASK; INSTRUMENTATION; CHIMPANZEES; BEHAVIOR; WILD; SET	Background: Using tools to act on non-food objects-for example, to make other tools-is considered to be a hallmark of human intelligence, and may have been a crucial step in our evolution. One form of this behaviour, 'sequential tool use', has been observed in a number of non-human primates and even in one bird, the New Caledonian crow (Corvus moneduloides). While sequential tool use has often been interpreted as evidence for advanced cognitive abilities, such as planning and analogical reasoning, the behaviour itself can be underpinned by a range of different cognitive mechanisms, which have never been explicitly examined. Here, we present experiments that not only demonstrate new tool-using capabilities in New Caledonian crows, but allow examination of the extent to which crows understand the physical interactions involved. Methodology/Principal Findings: In two experiments, we tested seven captive New Caledonian crows in six tasks requiring the use of up to three different tools in a sequence to retrieve food. Our study incorporated several novel features: (i) we tested crows on a three-tool problem (subjects were required to use a tool to retrieve a second tool, then use the second tool to retrieve a third one, and finally use the third one to reach for food); (ii) we presented tasks of different complexity in random rather than progressive order; (iii) we included a number of control conditions to test whether tool retrieval was goal-directed; and (iv) we manipulated the subjects' pre-testing experience. Five subjects successfully used tools in a sequence (four from their first trial), and four subjects repeatedly solved the three-tool condition. Sequential tool use did not require, but was enhanced by, pre-training on each element in the sequence ('chaining'), an explanation that could not be ruled out in earlier studies. By analyzing tool choice, tool swapping and improvement over time, we show that successful subjects did not use a random probing strategy. However, we find no firm evidence to support previous claims that sequential tool use demonstrates analogical reasoning or human-like planning. Conclusions/Significance: While the ability of subjects to use three tools in sequence reveals a competence beyond that observed in any other species, our study also emphasises the importance of parsimony in comparative cognitive science: seemingly intelligent behaviour can be achieved without the involvement of high-level mental faculties, and detailed analyses are necessary before accepting claims for complex cognitive abilities.			Wimpenny, JH (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	alex.kacelnik@zoo.ox.ac.uk		Rutz, Christian/0000-0001-5187-7417	Biotechnology and Biological Sciences Research Council [BB/C517392/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANDERSON JR, 1994, MAMMALIA, V58, P351, DOI 10.1515/mamm.1994.58.3.351; Beck B. B., 1980, ANIMAL TOOL BEHAV US; Birch HG, 1945, J COMP PSYCHOL, V38, P295, DOI 10.1037/h0059937; BIRD CD, 2009, P NATL ACAD SCI ADV; Bluff LA, 2007, COMP COGN BEHAV REV, V2, P1; BREWER SM, 1990, FOLIA PRIMATOL, V54, P100, DOI 10.1159/000156429; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Clayton N, 2007, CURR BIOL, V17, pR894, DOI 10.1016/j.cub.2007.08.028; Deblauwe I, 2006, AM J PRIMATOL, V68, P1191, DOI 10.1002/ajp.20318; EPSTEIN R, 1984, NATURE, V308, P61, DOI 10.1038/308061a0; Hansell M, 2008, TRENDS ECOL EVOL, V23, P73, DOI 10.1016/j.tree.2007.10.006; Hihara S, 2003, PHYSIOL BEHAV, V78, P427, DOI 10.1016/S0031-9384(02)01006-5; Hood BM, 2006, DEVELOPMENTAL SCI, V9, P303, DOI 10.1111/j.1467-7687.2006.00493.x; Hunt G.R., 2006, ACTA ZOOL SINICA, V52, P622; Hunt GR, 2006, ANIM COGN, V9, P307, DOI 10.1007/s10071-006-0047-2; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; Kenward B, 2006, ANIM BEHAV, V72, P1329, DOI 10.1016/j.anbehav.2006.04.007; Kitahara-Frisch J., 1993, USE TOOLS HUMAN NONH, P1; Kluver H., 1933, BEHAV MECH MONKEYS; Kohler W., 1925, MENTALITY APES; MATSUZAWA T, 1991, BEHAV BRAIN SCI, V14, P570, DOI 10.1017/S0140525X00071417; Matsuzawa Tetsuro, 1994, P351; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; Mulcahy NJ, 2005, J COMP PSYCHOL, V119, P23, DOI 10.1037/0735-7036.119.1.23; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Santos LR, 2005, ANIM COGN, V8, P236, DOI 10.1007/s10071-004-0246-7; SANZ C, 2004, AM NAT, V164, P562; SCHILLER P, 1952, PSYCHOL REV, V58, P177; SHESKIN D, 2004, HDB PARAMETRIC NONPA, P525; St Amant R, 2008, ANIM BEHAV, V75, P1199, DOI 10.1016/j.anbehav.2007.09.028; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Sugiyama Y, 1997, EVOL ANTHROPOL, V6, P23, DOI 10.1002/(SICI)1520-6505(1997)6:1<23::AID-EVAN7>3.0.CO;2-X; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Warden CJ, 1941, J PSYCHOL, V11, P3, DOI 10.1080/00223980.1941.9917016; Warden CJ, 1940, PEDAGOG SEMIN J GEN, V56, P297; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433	39	85	87	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6471	10.1371/journal.pone.0006471	http://dx.doi.org/10.1371/journal.pone.0006471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480MN	19654861	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000268739100002
J	Dostert, C; Guarda, G; Romero, JF; Menu, P; Gross, O; Tardivel, A; Suva, ML; Stehle, JC; Kopf, M; Stamenkovic, I; Corradin, G; Tschopp, J				Dostert, Catherine; Guarda, Greta; Romero, Jackeline F.; Menu, Philippe; Gross, Olaf; Tardivel, Aubry; Suva, Mario-Luca; Stehle, Jean-Christophe; Kopf, Manfred; Stamenkovic, Ivan; Corradin, Giampietro; Tschopp, Jurg			Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal	PLOS ONE			English	Article								Background: Characteristic symptoms of malaria include recurrent fever attacks and neurodegeneration, signs that are also found in patients with a hyperactive Nalp3 inflammasome. Plasmodium species produce a crystal called hemozoin that is generated by detoxification of heme after hemoglobin degradation in infected red blood cells. Thus, we hypothesized that hemozoin could activate the Nalp3 inflammasome, due to its particulate nature reminiscent of other inflammasome-activating agents. Methodology/Principal Findings: We found that hemozoin acts as a proinflammatory danger signal that activates the Nalp3 inflammasome, causing the release of IL-1 beta. Similar to other Nalp3-activating particles, hemozoin activity is blocked by inhibiting phagocytosis, K(+) efflux and NADPH oxidase. In vivo, intraperitoneal injection of hemozoin results in acute peritonitis, which is impaired in Nalp3-, caspase-1- and IL-1R-deficient mice. Likewise, the pathogenesis of cerebral malaria is dampened in Nalp3-deficient mice infected with Plasmodium berghei sporozoites, while parasitemia remains unchanged. Significance/Conclusions: The potent pro-inflammatory effect of hemozoin through inflammasome activation may possibly be implicated in plasmodium-associated pathologies such as cerebral malaria.			Dostert, C (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Gross, Olaf/E-4570-2010; Suva, Mario/AAY-7798-2020; Guarda, Greta/G-1921-2011; Kopf, Manfred/B-6907-2009; Dostert, Catherine/AAJ-5473-2020	Gross, Olaf/0000-0001-8660-3619; Suva, Mario/0000-0001-9898-5351; Kopf, Manfred/0000-0002-0628-7140; Guarda, Greta/0000-0001-9243-6116				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Coban C, 2007, TRENDS MICROBIOL, V15, P271, DOI 10.1016/j.tim.2007.04.003; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Hanscheid T, 2007, LANCET INFECT DIS, V7, P675, DOI 10.1016/S1473-3099(07)70238-4; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jaramillo M, 2004, J IMMUNOL, V172, P3101, DOI 10.4049/jimmunol.172.5.3101; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Labow M, 1997, J IMMUNOL, V159, P2452; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Sanni Latifu A, 2002, Methods Mol Med, V72, P57, DOI 10.1385/1-59259-271-6:57; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; SUTTERWALA FS, 2008, CLIN IMMUNOL; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; Weissbuch I, 2008, CHEM REV, V108, P4899, DOI 10.1021/cr078274t; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	28	282	294	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6510	10.1371/journal.pone.0006510	http://dx.doi.org/10.1371/journal.pone.0006510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652710	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637800016
J	Schmidt, T; Mewes, HW; Stumpflen, V				Schmidt, Thorsten; Mewes, Hans-Werner; Stuempflen, Volker			A Novel Putative miRNA Target Enhancer Signal	PLOS ONE			English	Article								It is known that miRNA target sites are very short and the effect of miRNA-target site interaction alone appears as being unspecific. Recent experiments suggest further context signals involved in miRNA target site recognition and regulation. Here, we present a novel GC-rich RNA motif downstream of experimentally supported miRNA target sites in human mRNAs with no similarity to previously reported functional motifs. We demonstrate that the novel motif can be found in at least one third of all transcripts regulated by miRNAs. Furthermore, we show that motif occurrence and the frequency of miRNA target sites as well as the stability of their duplex structures correlate. The finding, that the novel motif is significantly associated with miRNA target sites, suggests a functional role of the motif in miRNA target site biology. Beyond, the novel motif has the impact to improve prediction of miRNA target sites significantly.			Schmidt, T (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol MIPS, Neuherberg, Germany.	v.stuempflen@helmholtz-muenchen.de	; Mewes, Hans-Werner/A-8204-2019	Schmidt, Thorsten/0000-0002-6719-0633; Mewes, Hans-Werner/0000-0002-9713-6398				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Inouchi A, 2007, COMPUT BIOL CHEM, V31, P207, DOI 10.1016/j.compbiolchem.2007.03.011; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040; Rajewsky N, 2006, NAT STRUCT MOL BIOL, V13, P754, DOI 10.1038/nsmb0906-754; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Roepcke S, 2005, NUCLEIC ACIDS RES, V33, pW438, DOI 10.1093/nar/gki590; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wingender Edgar, 2004, In Silico Biology, V4, P55; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yousef M, 2007, BIOINFORMATICS, V23, P2987, DOI 10.1093/bioinformatics/btm484	39	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6473	10.1371/journal.pone.0006473	http://dx.doi.org/10.1371/journal.pone.0006473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649282	Green Published, gold, Green Submitted			2022-12-25	WOS:000268637600020
J	Garcia, MA; Gallego, P; Campagna, M; Gonzalez-Santamaria, J; Martinez, G; Marcos-Villar, L; Vidal, A; Esteban, M; Rivas, C				Garcia, Maria A.; Gallego, Pedro; Campagna, Michela; Gonzalez-Santamaria, Jose; Martinez, Gloria; Marcos-Villar, Laura; Vidal, Anxo; Esteban, Mariano; Rivas, Carmen			Activation of NF-kB Pathway by Virus Infection Requires Rb Expression	PLOS ONE			English	Article								The retinoblastoma protein Rb is a tumor suppressor involved in cell cycle control, differentiation, and inhibition of oncogenic transformation. Besides these roles, additional functions in the control of immune response have been suggested. In the present study we investigated the consequences of loss of Rb in viral infection. Here we show that virus replication is increased by the absence of Rb, and that Rb is required for the activation of the NF-kB pathway in response to virus infection. These results reveal a novel role for tumor suppressor Rb in viral infection surveillance and further extend the concept of a link between tumor suppressors and antiviral activity.			Garcia, MA (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma, Madrid, Spain.	crivas@cnb.csic.es	Santamaria, Jose Gonzalez/AAN-1044-2020; Santamaría, José González/Q-2439-2015; MARCOS-VILLAR, LAURA/L-8444-2014; Esteban, Mariano/ABG-5375-2020; Rivas, Carmen/L-3162-2017; Vidal, Anxo/B-5010-2015; Rivas, Carmen/AAB-6278-2019; Garcia, Maria Angel MA/I-5116-2016	Santamaría, José González/0000-0003-1244-3477; MARCOS-VILLAR, LAURA/0000-0002-8635-6432; Esteban, Mariano/0000-0003-0846-2827; Rivas, Carmen/0000-0002-0518-7199; Vidal, Anxo/0000-0002-0866-4202; Rivas, Carmen/0000-0002-0518-7199; Garcia, Maria Angel MA/0000-0003-2003-3769; Gonzalez Santamaria, Jose/0000-0001-7855-4749				Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Cook JL, 2002, P NATL ACAD SCI USA, V99, P9966, DOI 10.1073/pnas.162082999; Eason DD, 2001, CANCER LETT, V171, P209, DOI 10.1016/S0304-3835(01)00603-6; Garcia MA, 2002, ONCOGENE, V21, P8379, DOI 10.1038/sj.onc.1206036; Garcia MA, 2006, EMBO J, V25, P4284, DOI 10.1038/sj.emboj.7601302; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kundu M, 1997, J BIOL CHEM, V272, P29468, DOI 10.1074/jbc.272.47.29468; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LU YM, 1994, ONCOGENE, V9, P1015; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Munoz-Fontela C, 2005, ONCOGENE, V24, P3059, DOI 10.1038/sj.onc.1208477; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Osborne A, 1997, NUCLEIC ACIDS RES, V25, P5095, DOI 10.1093/nar/25.24.5095; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; RESNITZKY D, 1992, P NATL ACAD SCI USA, V89, P402, DOI 10.1073/pnas.89.1.402; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sangfelt O, 1999, ONCOGENE, V18, P2798, DOI 10.1038/sj.onc.1202609; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Xin H, 2003, ONCOGENE, V22, P4775, DOI 10.1038/sj.onc.1206780; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhu X, 1999, ONCOGENE, V18, P4940, DOI 10.1038/sj.onc.1202876	44	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6422	10.1371/journal.pone.0006422	http://dx.doi.org/10.1371/journal.pone.0006422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649275	gold, Green Published			2022-12-25	WOS:000268494600001
J	Lee, MH; Koria, P; Qu, J; Andreadis, ST				Lee, Meng-Horng; Koria, Piyush; Qu, Jun; Andreadis, Stelios T.			JNK phosphorylates beta-catenin and regulates adherens junctions	FASEB JOURNAL			English	Article						cell adhesion; E-cadherin; epithelial development; cell invasion; SP600125; okadaic acid	N-TERMINAL KINASE; SIGNAL-TRANSDUCTION; PROTEIN; MORPHOGENESIS; LOCALIZATION; ACTIVATION; EXPRESSION; ADHESION; PATHWAY; TARGET	The c-Jun amino-terminal kinase (JNK) is an important player in inflammation, proliferation, and apoptosis. More recently, JNK was found to regulate cell migration by phosphorylating paxillin. Here, we report a novel role of JNK in cell adhesion. Specifically, we provide evidence that JNK binds to E-cadherin/beta-catenin complex and phosphorylates beta-catenin at serine 37 and threonine 41, the sites also phosphorylated by GSK-3 beta. Inhibition of JNK kinase activity using dominant-negative constructs reduces phosphorylation of beta-catenin and promotes localization of E-cadherin/beta-catenin complex to cell-cell contact sites. Conversely, activation of JNK induces beta-catenin phosphorylation and disruption of cell contacts, which are prevented by JNK siRNA. We propose that JNK binds to beta-catenin and regulates formation of adherens junctions, ultimately controlling cell-to-cell adhesion.-Lee, M.-H., Koria, P., Qu, J., Andreadis, S. T. JNK phosphorylates beta-catenin and regulates adherens junctions. FASEB J. 23, 3874-3883 (2009). www.fasebj.org	[Lee, Meng-Horng; Koria, Piyush; Andreadis, Stelios T.] SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, Amherst, NY 14260 USA; [Qu, Jun] SUNY Buffalo, Dept Pharmaceut Sci, Amherst, NY 14260 USA; [Qu, Jun; Andreadis, Stelios T.] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Amherst, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Andreadis, ST (corresponding author), SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, 908 Furnas Hall, Amherst, NY 14260 USA.	sandread@buffalo.edu			National Institutes of Health (NIH) [R01 EB 000876-01]; National Science Foundation [BES-0354626]; National Center for Research Resources, NIH [S10-RR14592, S10-RR021221]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021221, S10RR014592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000876] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the National Institutes of Health (NIH; R01 EB 000876-01) and the National Science Foundation (BES-0354626) to S. T. A. We thank the Pharmaceutical Sciences Instrumentation Facility at the University at Buffalo (UB) for the use of the liquid chromatography/mass spectrometry systems. The MS instruments were obtained from shared instrumentation grants S10-RR14592 and S10-RR021221 from the National Center for Research Resources, NIH. We also thank Dr. Wade J. Sigurdson (Confocal Microscopy and Flow Cytometry Facility, UB) for his help with confocal microscopy.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Altan ZM, 2004, BIOCHEM BIOPH RES CO, V322, P56, DOI 10.1016/j.bbrc.2004.07.079; Avdi NJ, 2002, J BIOL CHEM, V277, P40687, DOI 10.1074/jbc.M204455200; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Dietrich C, 2002, BIOCHEM BIOPH RES CO, V292, P195, DOI 10.1006/bbrc.2002.6625; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Iordanov Mihail S., 2000, Molecular Cell Biology Research Communications, V4, P122, DOI 10.1006/mcbr.2000.0266; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Koria P, 2006, J INVEST DERMATOL, V126, P1834, DOI 10.1038/sj.jid.5700325; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lallemand D, 1998, EMBO J, V17, P5615, DOI 10.1093/emboj/17.19.5615; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Liu JY, 2008, CARDIOVASC RES, V79, P24, DOI 10.1093/cvr/cvn059; Qu J, 2005, RAPID COMMUN MASS SP, V19, P2857, DOI 10.1002/rcm.2138; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Sadot E, 2002, J CELL SCI, V115, P2771; Serres M, 1997, EXP CELL RES, V231, P163, DOI 10.1006/excr.1996.3443; Sharma M, 2006, J BIOL CHEM, V281, P17140, DOI 10.1074/jbc.M513027200; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Steen H, 2006, MOL CELL PROTEOMICS, V5, P172, DOI 10.1074/mcp.M500135-MCP200; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; Tian J, 2008, MOL THER, V16, P1146, DOI 10.1038/mt.2008.79; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	39	83	85	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3874	3883		10.1096/fj.08-117804	http://dx.doi.org/10.1096/fj.08-117804			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19667122	Green Published			2022-12-25	WOS:000271272500023
J	Ang, SK; Lu, H				Ang, Swee Kim; Lu, Hui			Deciphering Structural and Functional Roles of Individual Disulfide Bonds of the Mitochondrial Sulfhydryl Oxidase Erv1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE SPACE; PROTEIN IMPORT; RELAY SYSTEM; GENERATING DISULFIDES; PRECURSOR OXIDATION; REDOX ENVIRONMENT; CYTOCHROME-C; IN-VIVO; PATHWAYS; SHUTTLE	Erv1p is a FAD-dependent sulfhydryl oxidase of the mitochondrial intermembrane space. It contains three conserved disulfide bonds arranged in two CXXC motifs and one CX16C motif. Experimental evidence for the specific roles of the individual disulfide bonds is lacking. In this study, structural and functional roles of the disulfides were dissected systematically using a wide range of biochemical and biophysical methods. Three double cysteine mutants with each pair of cysteines mutated to serines were generated. All of the mutants were purified with the normal FAD binding properties as the wild type Erv1p, showing that none of the three disulfides are essential for FAD binding. Thermal denaturation and trypsin digestion studies showed that the CX16C disulfide plays an important role in stabilizing the folding of Erv1p. To understand the functional role of each disulfide, small molecules and the physiological substrate protein Mia40 were used as electron donors in oxygen consumption assays. We show that both CXXC disulfides are required for Erv1 oxidase activity. The active site disulfide is well protected thus requires the shuttle disulfide for its function. Although both mutants of the CXXC motifs were individually inactive, Erv1p activity was partially recovered by mixing these two mutants together, and the recovery was rapid. Thus, we provided the first experimental evidence of electron transfer between the shuttle and active site disulfides of Erv1p, and we propose that both intersubunit and intermolecular electron transfer can occur.	[Ang, Swee Kim; Lu, Hui] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Lu, H (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	hui.lu@manchester.ac.uk	Lu, Hui/AAB-5476-2021	Ang, Swee Kim/0000-0003-3058-6105; Lu, Hui/0000-0002-7029-2681	Royal Society; Biotechnology and Biological Sciences Research Council [BB/C514323]	Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Royal Society and by Biotechnology and Biological Sciences Research Council Grant BB/C514323.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Koehler CM, 2009, BBA-MOL CELL RES, V1793, P139, DOI 10.1016/j.bbamcr.2008.08.002; Krezel A, 2003, INORG CHEM, V42, P1994, DOI 10.1021/ic025969y; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Morgan B, 2009, J BIOL CHEM, V284, P6818, DOI 10.1074/jbc.M808691200; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Stojanovski D, 2008, BBA-MOL CELL RES, V1783, P610, DOI 10.1016/j.bbamcr.2007.10.004; Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200	35	45	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28754	28761		10.1074/jbc.M109.021113	http://dx.doi.org/10.1074/jbc.M109.021113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679655	Green Published, hybrid			2022-12-25	WOS:000270678900032
J	Inder, KL; Lau, C; Loo, D; Chaudhary, N; Goodall, A; Martin, S; Jones, A; van der Hoeven, D; Parton, RG; Hill, MM; Hancock, JF				Inder, Kerry L.; Lau, Chiyan; Loo, Dorothy; Chaudhary, Natasha; Goodall, Andrew; Martin, Sally; Jones, Alun; van der Hoeven, Dharini; Parton, Robert G.; Hill, Michelle M.; Hancock, John F.			Nucleophosmin and Nucleolin Regulate K-Ras Plasma Membrane Interactions and MAPK Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-RAS; PROTEIN B23; SINGLE-MOLECULE; RIBOSOMAL-RNA; CELL-SURFACE; LIVING CELLS; HUMAN CANCER; NANOCLUSTERS; ASSOCIATION; ACTIVATION	The spatial organization of Ras proteins into nanoclusters on the inner leaflet of the plasma membrane is essential for high fidelity signaling through the MAPK pathway. Here we identify two selective regulators of K-Ras nanoclustering from a proteomic screen for K-Ras interacting proteins. Nucleophosmin (NPM) and nucleolin are predominantly localized to the nucleolus but also have extranuclear functions. We show that a subset of NPM and nucleolin localizes to the inner leaflet of plasma membrane and forms specific complexes with K-Ras but not other Ras isoforms. Active GTP-loaded and inactive GDP-loaded K-Ras both interact with NPM, although NPM-K-Ras binding is increased by growth factor receptor activation. NPM and nucleolin both stabilize K-Ras levels on the plasma membrane, but NPM concurrently increases the clustered fraction of GTP-K-Ras. The increase in nanoclustered GTP-K-Ras in turn enhances signal gain in the MAPK pathway. In summary these results reveal novel extranucleolar functions for NPM and nucleolin as regulators of K-Ras nanocluster formation and activation of the MAPK pathway. The study also identifies a new class of K-Ras nanocluster regulator that operates independently of the structural scaffold galectin-3.	[Inder, Kerry L.; Lau, Chiyan; Loo, Dorothy; Chaudhary, Natasha; Goodall, Andrew; Martin, Sally; Jones, Alun; Parton, Robert G.; Hill, Michelle M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [van der Hoeven, Dharini; Hancock, John F.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Loo, Dorothy; Hill, Michelle M.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4702, Australia	University of Queensland; University of Texas System; University of Texas Health Science Center Houston; University of Queensland; University of Queensland	Hill, MM (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	m.hill2@uq.edu.au; john.f.hancock@uth.tmc.edu	Parton, Robert G/C-5673-2009; Martin, Sally/A-7150-2010; Inder, Kerry/K-3769-2012; Hill, Michelle Mei Chih/G-4417-2010	Parton, Robert G/0000-0002-7494-5248; Martin, Sally/0000-0001-9294-5404; Inder, Kerry/0000-0002-7648-2398; Hill, Michelle Mei Chih/0000-0003-1134-0951; Lau, Chiyan/0000-0002-9129-8783; Hancock, John/0000-0003-0542-4710	National Institutes of Health [GM066717]; Australian Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066717. This work was also supported by the Australian Cancer Research Foundation.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; BESAG J, 1977, APPL STAT, V26, P329; Birchenall-Roberts MC, 2006, BIOCHEM BIOPH RES CO, V348, P540, DOI 10.1016/j.bbrc.2006.07.094; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BOS JL, 1989, CANCER RES, V49, P4682; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; DIGGLE PJ, 1986, J NEUROSCI METH, V18, P115, DOI 10.1016/0165-0270(86)90115-9; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Harding A, 2003, J BIOL CHEM, V278, P16747, DOI 10.1074/jbc.M301015200; Harding A, 2008, CELL CYCLE, V7, P127, DOI 10.4161/cc.7.2.5237; Harding AS, 2008, TRENDS CELL BIOL, V18, P364, DOI 10.1016/j.tcb.2008.05.006; Hibino K, 2003, CHEMPHYSCHEM, V4, P748, DOI 10.1002/cphc.200300731; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Lim MJ, 2006, CANCER DETECT PREV, V30, P481, DOI 10.1016/j.cdp.2006.10.008; Liu HT, 1999, CANCER LETT, V144, P45, DOI 10.1016/S0304-3835(99)00184-6; LIU QR, 1991, EUR J BIOCHEM, V200, P715, DOI 10.1111/j.1432-1033.1991.tb16236.x; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Szebeni A, 1999, PROTEIN SCI, V8, P905; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168	41	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28410	28419		10.1074/jbc.M109.001537	http://dx.doi.org/10.1074/jbc.M109.001537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19661056	Green Published, hybrid			2022-12-25	WOS:000270676300066
J	Pioszak, AA; Parker, NR; Gardella, TJ; Xu, HE				Pioszak, Augen A.; Parker, Naomi R.; Gardella, Thomas J.; Xu, H. Eric			Structural Basis for Parathyroid Hormone-related Protein Binding to the Parathyroid Hormone Receptor and Design of Conformation-selective Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE; LIGAND-BINDING; FRAGMENT; PTH; IDENTIFICATION; HYPERCALCEMIA; REFINEMENT; MECHANISMS; DOMAIN	Parathyroid hormone (PTH) and PTH-related protein (PTHrP) are two related peptides that control calcium/phosphate homeostasis and bone development, respectively, through activation of the PTH/PTHrP receptor (PTH1R), a class B G protein-coupled receptor. Both peptides hold clinical interest for their capacities to stimulate bone formation. PTH and PTHrP display different selectivity for two distinct PTH1R conformations, but how their binding to the receptor differs is unclear. The high resolution crystal structure of PTHrP bound to the extracellular domain (ECD) of PTH1R reveals that PTHrP binds as an amphipathic a-helix to the same hydrophobic groove in the ECD as occupied by PTH, but in contrast to a straight, continuous PTH helix, the PTHrP helix is gently curved and C-terminally "unwound." The receptor accommodates the altered binding modes by shifting the side chain conformations of two residues within the binding groove: Leu-41 and Ile-115, the former acting as a rotamer toggle switch to accommodate PTH/PTHrP sequence divergence, and the latter adapting to the PTHrP curvature. Binding studies performed with PTH/PTHrP hybrid ligands having reciprocal exchanges of residues involved in different contacts confirmed functional consequences for the altered interactions and enabled the design of altered PTH and PTHrP peptides that adopt the ECD-binding mode of the opposite peptide. Hybrid peptides that bound the ECD poorly were selective for the G protein-coupled PTH1R conformation. These results establish a molecular model for better understanding of how two biologically distinct ligands can act through a single receptor and provide a template for designing better PTH/PTHrP therapeutics.	[Pioszak, Augen A.; Parker, Naomi R.; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Gardella, Thomas J.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02144 USA	Van Andel Institute; Harvard University; Massachusetts General Hospital	Pioszak, AA (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA.	augie.pioszak@vai.org; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301, DK-11794]; Jay and Betty Van Andel Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794, R01DK071662, R01DK066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662, DK066202, and HL089301 (to H. E. X.), and DK-11794 (toT. J. G.).This work was also supported by the Jay and Betty Van Andel Foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURTIS WJ, 1987, J BIOL CHEM, V262, P7151; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Delano W.L., 2002, DELANO SCI; Gardella T J, 2000, Rev Endocr Metab Disord, V1, P317, DOI 10.1023/A:1026522619828; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Hoare SRJ, 2000, J BIOL CHEM, V275, P27274; Hoare SRJ, 2001, J BIOL CHEM, V276, P7741, DOI 10.1074/jbc.M009395200; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; KLEIN RF, 1987, ENDOCRINOLOGY, V120, P504, DOI 10.1210/endo-120-2-504; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Luck MD, 1999, MOL ENDOCRINOL, V13, P670, DOI 10.1210/me.13.5.670; Mann R, 2008, MOL PHARMACOL, V74, P605, DOI 10.1124/mol.108.048017; Marx UC, 2000, BIOCHEM BIOPH RES CO, V267, P213, DOI 10.1006/bbrc.1999.1958; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSELEY JM, 1987, P NATL ACAD SCI USA, V84, P5048, DOI 10.1073/pnas.84.14.5048; Murray TM, 2005, ENDOCR REV, V26, P78, DOI 10.1210/er.2003-0024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Penel S, 2001, J MOL BIOL, V305, P961, DOI 10.1006/jmbi.2000.4339; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Plotkin H, 1998, J CLIN ENDOCR METAB, V83, P2786, DOI 10.1210/jc.83.8.2786; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Weidler M, 1999, FEBS LETT, V444, P239, DOI 10.1016/S0014-5793(98)01658-5; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	44	96	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28382	28391		10.1074/jbc.M109.022905	http://dx.doi.org/10.1074/jbc.M109.022905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674967	Green Published, hybrid			2022-12-25	WOS:000270676300063
J	Beach, JR; Egelhoff, TT				Beach, Jordan R.; Egelhoff, Thomas T.			Myosin II Recruitment during Cytokinesis Independent of Centralspindlin-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY LIGHT-CHAIN; SMOOTH-MUSCLE MYOSIN; CONTRACTILE RING FORMATION; PROTEIN-KINASE-C; HEAVY-CHAIN; CORTICAL FLOW; CITRON-KINASE; HELA-CELLS; NONMUSCLE; ISOFORMS	During cell division, the mechanisms by which myosin II is recruited to the contractile ring are not fully understood. Much recent work has focused on a model in which spatially restricted de novo filament assembly occurs at the cell equator via localized myosin II regulatory light chain (RLC) phosphorylation, stimulated by the RhoA-activating centralspindlin complex. Here, we show that a recombinant myosin IIA protein that assembles constitutively and is incapable of binding RLC still displays strong localization to the furrow in mammalian cells. Furthermore, this RLC-deficient myosin II efficiently drives cytokinesis, demonstrating that centralspindlin-based RLC phosphorylation is not necessary for myosin II localization during furrowing. Myosin II truncation analysis further reveals two distinct myosin II tail properties that contribute to furrow localization: a central tail domain mediating cortical furrow binding to heterologous binding partners and a carboxyl-terminal region mediating co-assembly with existing furrow myosin IIA or IIB filaments.	[Beach, Jordan R.; Egelhoff, Thomas T.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Beach, Jordan R.; Egelhoff, Thomas T.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Egelhoff, TT (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, NC10,9500 Euclid Ave, Cleveland, OH 44195 USA.	Egelhot@ccf.org		Beach, Jordan/0000-0003-0633-4928	National Institutes of Health [GM 077224]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 077224 (to T. T. E.).	Bao JJ, 2007, J BIOL CHEM, V282, P22102, DOI 10.1074/jbc.M702731200; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; CONTI MA, 1991, BIOCHEMISTRY-US, V30, P966, DOI 10.1021/bi00218a012; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; Dean SO, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000131; DeBiasio RL, 1996, MOL BIOL CELL, V7, P1259, DOI 10.1091/mbc.7.8.1259; Eda M, 2001, J CELL SCI, V114, P3273; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kolega J, 1998, J CELL SCI, V111, P2085; Madaule P, 2000, MICROSC RES TECHNIQ, V49, P123, DOI 10.1002/(SICI)1097-0029(20000415)49:2<123::AID-JEMT3>3.0.CO;2-R; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; Marini M, 2006, INT J MOL MED, V17, P729; Miyauchi K, 2006, BIOCHEM BIOPH RES CO, V350, P543, DOI 10.1016/j.bbrc.2006.09.065; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; SELLERS JR, 1985, J CELL BIOL, V101, P1897, DOI 10.1083/jcb.101.5.1897; SELLERS JR, 1981, J BIOL CHEM, V256, P3137; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Totsukawa G, 1996, CELL STRUCT FUNCT, V21, P475, DOI 10.1247/csf.21.475; UYEDA TQP, 1993, SCIENCE, V262, P1867, DOI 10.1126/science.8266074; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Werner M, 2008, BIOCHEM SOC T, V36, P371, DOI 10.1042/BST0360371; Wong KCY, 2002, CURR BIOL, V12, P724, DOI 10.1016/S0960-9822(02)00790-X; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; Yumura S, 2008, TRAFFIC, V9, P2089, DOI 10.1111/j.1600-0854.2008.00837.x; Zang JH, 1998, P NATL ACAD SCI USA, V95, P13652, DOI 10.1073/pnas.95.23.13652; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783	41	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27377	27383		10.1074/jbc.M109.028316	http://dx.doi.org/10.1074/jbc.M109.028316			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661065	Green Published, hybrid			2022-12-25	WOS:000270232300039
J	Fereidouni, SR; Starick, E; Beer, M; Wilking, H; Kalthoff, D; Grund, C; Hauslaigner, R; Breithaupt, A; Lange, E; Harder, TC				Fereidouni, Sasan R.; Starick, Elke; Beer, Martin; Wilking, Hendrik; Kalthoff, Donata; Grund, Christian; Haeuslaigner, Rafaela; Breithaupt, Angele; Lange, Elke; Harder, Timm C.			Highly Pathogenic Avian Influenza Virus Infection of Mallards with Homo- and Heterosubtypic Immunity Induced by Low Pathogenic Avian Influenza Viruses	PLOS ONE			English	Article							TIME RT-PCR; WILD BIRDS; H5N1; DUCKS; SUSCEPTIBILITY; GERMANY; SPREAD; GULLS	The potential role of wild birds as carriers of highly pathogenic avian influenza virus (HPAIV) subtype H5N1 is still a matter of debate. Consecutive or simultaneous infections with different subtypes of influenza viruses of low pathogenicity (LPAIV) are very common in wild duck populations. To better understand the epidemiology and pathogenesis of HPAIV H5N1 infections in natural ecosystems, we investigated the influence of prior infection of mallards with homo- (H5N2) and heterosubtypic (H4N6) LPAIV on exposure to HPAIV H5N1. In mallards with homosubtypic immunity induced by LPAIV infection, clinical disease was absent and shedding of HPAIV from respiratory and intestinal tracts was grossly reduced compared to the heterosubtypic and control groups (mean GEC/100 mu l at 3 dpi: 3.0 x 10(2) vs. 2.3x10(4) vs. 8.7x10(4); p < 0.05). Heterosubtypic immunity induced by an H4N6 infection mediated a similar but less pronounced effect. We conclude that the epidemiology of HPAIV H5N1 in mallards and probably other aquatic wild bird species is massively influenced by interfering immunity induced by prior homo- and heterosubtypic LPAIV infections.			Fereidouni, SR (corresponding author), FLI, Insel Riems, Germany.	sasan.fereidouni@fli.bund.de	Breithaupt, Angele/GON-7227-2022; Breithaupt, Angele/B-6155-2013; Harder, Timm/AAE-2932-2019	Breithaupt, Angele/0000-0002-6373-5923; Harder, Timm/0000-0003-2387-378X; Wilking, Hendrik/0000-0002-8574-5831; Fereidouni, Sasan/0000-0002-3508-991X; Hoffmann, Donata/0000-0003-4552-031X				Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Commission of European Communities (CEC), 2006, OFF J EUR COMMUN, V237, P1; Feare CJ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-96; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; HARDER T, 2007, EMERG INFECT DIS, V15, P272; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1132, DOI 10.3201/eid1407.071468; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Pantin-Jackwood MJ, 2007, VIRUS RES, V130, P151, DOI 10.1016/j.virusres.2007.06.006; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Perkins LEL, 2003, AVIAN DIS, V47, P956, DOI 10.1637/0005-2086-47.s3.956; Perkins LEL, 2002, AVIAN DIS, V46, P877, DOI 10.1637/0005-2086(2002)046[0877:SOLGLA]2.0.CO;2; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319	26	88	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6706	10.1371/journal.pone.0006706	http://dx.doi.org/10.1371/journal.pone.0006706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693268	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267400014
J	Kong, QR; Wu, ML; Huan, YJ; Zhang, L; Liu, HY; Bou, G; Luo, YB; Mu, YS; Liu, ZH				Kong, Qingran; Wu, Meiling; Huan, Yanjun; Zhang, Li; Liu, Haiyan; Bou, Gerelchimeg; Luo, Yibo; Mu, Yanshuang; Liu, Zhonghua			Transgene Expression Is Associated with Copy Number and Cytomegalovirus Promoter Methylation in Transgenic Pigs	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IMMEDIATE-EARLY PROMOTER; GENE-EXPRESSION; DNA METHYLATION; INTEGRATION SITES; GENOME; PATTERNS; STABILITY; CELLS; REACTIVATION	Transgenic animals have been used for years to study gene function, produce important proteins, and generate models for the study of human diseases. However, inheritance and expression instability of the transgene in transgenic animals is a major limitation. Copy number and promoter methylation are known to regulate gene expression, but no report has systematically examined their effect on transgene expression. In the study, we generated two transgenic pigs by somatic cell nuclear transfer ( SCNT) that express green fluorescent protein (GFP) driven by cytomegalovirus (CMV). Absolute quantitative real-time PCR and bisulfite sequencing were performed to determine transgene copy number and promoter methylation level. The correlation of transgene expression with copy number and promoter methylation was analyzed in individual development, fibroblast cells, various tissues, and offspring of the transgenic pigs. Our results demonstrate that transgene expression is associated with copy number and CMV promoter methylation in transgenic pigs.			Kong, QR (corresponding author), NE Agr Univ China, Coll life Sci, Harbin, Peoples R China.	liu086@yahoo.com	Liu, Zhunghua/F-2485-2010	Liu, Zhunghua/0000-0002-9199-6493; , Yanjun/0000-0001-7334-4582				Bacharach E, 2000, J VIROL, V74, P4755, DOI 10.1128/JVI.74.10.4755-4764.2000; Balko JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-289; BALOW D, 1995, SCIENCE, V270, P1610; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; BURDON TG, 1992, MOL REPROD DEV, V33, P436, DOI 10.1002/mrd.1080330410; CHAN AW, 1999, MOL REPROD DEV, V33, P436; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; DOERFLER W, 1992, MICROB PATHOGENESIS, V12, P1, DOI 10.1016/0882-4010(92)90060-2; EDUARDO OM, 2007, J APPL GENET, V48, P47; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GAVALLI G, 1998, CELL, V93, P505; Grassi G, 2003, CARCINOGENESIS, V24, P1625, DOI 10.1093/carcin/bgg118; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Gubin AN, 1997, BIOCHEM BIOPH RES CO, V236, P347, DOI 10.1006/bbrc.1997.6963; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Houdebine LM, 2000, TRANSGENIC RES, V9, P305, DOI 10.1023/A:1008934912555; Houdebine LM, 2002, J BIOTECHNOL, V98, P145, DOI 10.1016/S0168-1656(02)00129-3; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kearns M, 2000, NUCLEIC ACIDS RES, V28, P3301, DOI 10.1093/nar/28.17.3301; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Liu WM, 2006, J MOL MED, V84, P57, DOI 10.1007/s00109-005-0711-z; Liu ZH, 2008, CHINESE SCI BULL, V53, P1035, DOI 10.1007/s11434-008-0168-x; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Meier JL, 2001, J VIROL, V75, P1581, DOI 10.1128/JVI.75.4.1581-1593.2001; Migliaccio AR, 2000, GENE, V256, P197, DOI 10.1016/S0378-1119(00)00353-X; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; MULLER U, 1987, J VIROL, V61, P3710; Nakanishi T, 2002, GENOMICS, V80, P564, DOI 10.1006/geno.2002.7008; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Park KW, 2002, BIOL REPROD, V66, P1001, DOI 10.1095/biolreprod66.4.1001; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Pillai MM, 2008, TRANSGENIC RES, V17, P749, DOI 10.1007/s11248-007-9161-4; Prosch S, 1996, BIOL CHEM H-S, V377, P195, DOI 10.1515/bchm3.1996.377.3.195; Pupecka Malgorzata, 2006, Postepy Biochem, V52, P247; Robertson G, 1996, NUCLEIC ACIDS RES, V24, P1465, DOI 10.1093/nar/24.8.1465; Schulz TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001013; Schumacher A, 2000, J BIOL CHEM, V275, P37915, DOI 10.1074/jbc.M004839200; Strathdee D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000004; Sutherland HGE, 2000, MAMM GENOME, V11, P347, DOI 10.1007/s003350010066; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang W, 2007, J EXP BOT, V58, P545, DOI 10.1093/jxb/erl228; TOTH M, 1989, P NATL ACAD SCI USA, V86, P3728, DOI 10.1073/pnas.86.10.3728; van den Pol AN, 1998, J NEUROSCI, V18, P10640; Villuendas G, 2001, INT J ANDROL, V24, P300, DOI 10.1046/j.1365-2605.2001.00302.x; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Yamauchi Y, 2007, BIOL REPROD, V77, P803, DOI 10.1095/biolreprod.107.063040; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	55	80	100	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6679	10.1371/journal.pone.0006679	http://dx.doi.org/10.1371/journal.pone.0006679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688097	Green Published, Green Submitted, gold			2022-12-25	WOS:000269075800014
J	Rajan, I; Savelieva, KV; Ye, GL; Wang, CY; Malbari, MM; Friddle, C; Lanthorn, TH; Zhang, WD				Rajan, Indrani; Savelieva, Katerina V.; Ye, Gui-Lan; Wang, Ching-yun; Malbari, Murtaza M.; Friddle, Carl; Lanthorn, Thomas H.; Zhang, Wandong			Loss of the Putative Catalytic Domain of HDAC4 Leads to Reduced Thermal Nociception and Seizures while Allowing Normal Bone Development	PLOS ONE			English	Article							II HISTONE DEACETYLASES; CONTROLS CHONDROCYTE HYPERTROPHY; MEF2 TRANSCRIPTION FACTOR; INTRACELLULAR TRAFFICKING; MUSCLE DIFFERENTIATION; CBFA1-DEFICIENT MICE; NUCLEAR EXPORT; RUNX FAMILY; CELL-DEATH; BINDING	Histone deacetylase 4 (HDAC4) has been associated with muscle & bone development [1-6]. N-terminal MEF2 and RUNX2 binding domains of HDAC4 have been shown to mediate these effects in vitro. A complete gene knockout has been reported to result in premature ossification and associated defects resulting in postnatal lethality [6]. We report a viral insertion mutation that deletes the putative deacetylase domain, while preserving the N-terminal portion of the protein. Western blot and immuno-precipitation analysis confirm expression of truncated HDAC4 containing N-terminal amino acids 1-747. These mutant mice are viable, living to at least one year of age with no gross defects in muscle or bone. At 2-4 months of age no behavioral or physiological abnormalities were detected except for an increased latency to respond to a thermal nociceptive stimulus. As the mutant mice aged past 5 months, convulsions appeared, often elicited by handling. Our findings confirm the sufficiency of the N-terminal domain for muscle and bone development, while revealing other roles of HDAC4.	[Rajan, Indrani; Savelieva, Katerina V.; Ye, Gui-Lan; Wang, Ching-yun; Malbari, Murtaza M.; Friddle, Carl; Lanthorn, Thomas H.; Zhang, Wandong] Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA	Lexicon Pharmaceuticals	Rajan, I (corresponding author), Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA.	zhangw96@gmail.com			Lexicon Pharmaceuticals	Lexicon Pharmaceuticals	The study was conducted at and financially supported by Lexicon Pharmaceuticals. All authors were employees of Lexicon Pharmaceuticals when conducting the research of this manuscript. Authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon Pharmaceuticals approved the decision to publish this manuscript.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Baraban SC, 2007, CURR OPIN NEUROL, V20, P164, DOI 10.1097/WCO.0b013e328042bae0; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hoshi K, 1999, BONE, V25, P639, DOI 10.1016/S8756-3282(99)00223-9; Hug BA, 2004, CELL, V119, P448, DOI 10.1016/j.cell.2004.10.023; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Martin JR, 1998, J PHARMACOL EXP THER, V286, P913; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Weiergraber M, 2005, BRAIN RES PROTOC, V14, P154, DOI 10.1016/j.brainresprot.2004.12.006; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	42	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6612	10.1371/journal.pone.0006612	http://dx.doi.org/10.1371/journal.pone.0006612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672313	Green Submitted, Green Published, gold			2022-12-25	WOS:000268935900022
J	Bradley, RK; Uzilov, AV; Skinner, ME; Bendana, YR; Barquist, L; Holmes, I				Bradley, Robert K.; Uzilov, Andrew V.; Skinner, Mitchell E.; Bendana, Yuri R.; Barquist, Lars; Holmes, Ian			Evolutionary Modeling and Prediction of Non-Coding RNAs in Drosophila	PLOS ONE			English	Article							DNA-SEQUENCES; GENOMES; ELEMENTS; IDENTIFICATION; SUBSTITUTION; BIOGENESIS; ALIGNMENT; GENES	We performed benchmarks of phylogenetic grammar-based ncRNA gene prediction, experimenting with eight different models of structural evolution and two different programs for genome alignment. We evaluated our models using alignments of twelve Drosophila genomes. We find that ncRNA prediction performance can vary greatly between different gene predictors and subfamilies of ncRNA gene. Our estimates for false positive rates are based on simulations which preserve local islands of conservation; using these simulations, we predict a higher rate of false positives than previous computational ncRNA screens have reported. Using one of the tested prediction grammars, we provide an updated set of ncRNA predictions for D. melanogaster and compare them to previously-published predictions and experimental data. Many of our predictions show correlations with protein-coding genes. We found significant depletion of intergenic predictions near the 39 end of coding regions and furthermore depletion of predictions in the first intron of protein-coding genes. Some of our predictions are colocated with larger putative unannotated genes: for example, 17 of our predictions showing homology to the RFAM family snoR28 appear in a tandem array on the X chromosome; the 4.5 Kbp spanned by the predicted tandem array is contained within a FlyBase-annotated cDNA.	[Bradley, Robert K.; Holmes, Ian] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Uzilov, Andrew V.; Skinner, Mitchell E.; Bendana, Yuri R.; Barquist, Lars; Holmes, Ian] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bradley, RK (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	ihh@berkeley.edu	Barquist, Lars/H-6529-2019	Barquist, Lars/0000-0003-4732-2667; Holmes, Ian/0000-0001-7639-5369; Bradley, Robert/0000-0002-8046-1063	NIH/NHGRI [GM076705]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076705] Funding Source: NIH RePORTER	NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH/NHGRI grant GM076705. RKB was partially supported by an NSF Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Babak T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-33; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bendana YR, 2008, BIOINFORMATICS, V24, P579, DOI 10.1093/bioinformatics/btm635; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bradley RK, 2007, BIOINFORMATICS, V23, P3258, DOI 10.1093/bioinformatics/btm402; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bruno WJ, 1996, MOL BIOL EVOL, V13, P1368, DOI 10.1093/oxfordjournals.molbev.a025583; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; D Dowell R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-400; Dewey Colin N., 2007, V395, P221; Dowell RD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-71; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; Gesell T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-248; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Klosterman PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-428; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; McGuire G, 2001, MOL BIOL EVOL, V18, P481, DOI 10.1093/oxfordjournals.molbev.a003827; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Parker D. Stott, 2003, OMICS A Journal of Integrative Biology, V7, P37, DOI 10.1089/153623103322006580; PATEN B, 2008, PECAN LARGE IN PRESS; PEDERSEN J, 2008, COMP SCREEN ST UNPUB; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pedersen JS, 2004, NUCLEIC ACIDS RES, V32, P4925, DOI 10.1093/nar/gkh839; Pedersen JS, 2003, BIOINFORMATICS, V19, P219, DOI 10.1093/bioinformatics/19.2.219; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; RIJK PD, 1998, NUCLEIC ACIDS RES, V26, P183; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Rose D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-406; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; THORNE JL, 1992, J MOL EVOL, V34, P3, DOI 10.1007/BF00163848; Torarinsson E, 2008, GENOME RES, V18, P242, DOI 10.1101/gr.6887408; Varadarajan A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r147; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396	52	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6478	10.1371/journal.pone.0006478	http://dx.doi.org/10.1371/journal.pone.0006478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668382	gold, Green Published, Green Submitted			2022-12-25	WOS:000268935600002
J	Ropars, V; Despouy, G; Stern, MH; Benichou, S; Roumestand, C; Arold, ST				Ropars, Virginie; Despouy, Gilles; Stern, Marc-Henri; Benichou, Serge; Roumestand, Christian; Arold, Stefan T.			The TCL1A Oncoprotein Interacts Directly with the NF-kappa B Inhibitor I kappa B	PLOS ONE			English	Article								The T cell leukaemia/lymphoma 1A (TCL1A) oncoprotein plays key roles in several B and T cell malignancies. Lacking enzymatic activity, TCL1A's transforming action was linked to its capacity to co-activate the protein kinase AKT via binding to its pleckstrin homology (PH) domain. However, perturbation of AKT signalling alone was recently shown insufficient to explain TCL1A oncogenesis, suggesting that TCL1A has additional cellular partners. Searching for such additional targets, we found that TCL1A binds specifically and directly to the ankyrin domain of I kappa B, the inhibitor of the NF-kappa B transcription factors. Through binding assays and a structural analysis by small angle X-ray scattering, we show that TCL1A and I kappa B interact in yeast-two-hybrid systems, when transiently overexpressed in 293 cells, and as recombinant proteins in vitro. We further establish that the association between TCL1A and I kappa B is compatible with AKT binding to TCL1A, but incompatible with I kappa B binding to NF-kappa B. By interfering with the inhibition of NF-kappa B by I kappa B, TCL1A may increase the concentration of free NF-kappa B molecules sufficiently to trigger expression of anti-apoptotic genes. Thus our data suggest an additional route by which TCL1A might cause cancer.			Ropars, V (corresponding author), Ctr Biochim Struct, UMR5048, CNRS, Montpellier, France.	Stefan.Arold@cbs.cnrs.fr	Arold, Stefan/T-2612-2019; Stern, Marc-Henri/A-2728-2011; Despouy, Gilles/ABE-1702-2021	Stern, Marc-Henri/0000-0002-8100-2272; Arold, Stefan T/0000-0001-5278-0668; ROUMESTAND, Christian/0000-0002-4082-3293; Benichou, Serge/0000-0003-3602-3530; Ropars, Virginie/0000-0002-3372-6030; Gilles, Despouy/0000-0001-9250-9821				Auguin D, 2004, J BIOL CHEM, V279, P35890, DOI 10.1074/jbc.M400364200; Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Bergqvist S, 2006, J MOL BIOL, V360, P421, DOI 10.1016/j.jmb.2006.05.014; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; Despouy G, 2003, J BIOL CHEM, V278, P6355, DOI 10.1074/jbc.M210697200; Despouy G, 2007, BLOOD, V110, P4406, DOI 10.1182/blood-2006-11-059501; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoh F, 1998, STRUCTURE, V6, P147, DOI 10.1016/S0969-2126(98)00017-3; Huxford T, 2000, J BIOL CHEM, V275, P32800, DOI 10.1074/jbc.M006037200; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Noguchi M, 2007, FASEB J, V21, P2273, DOI 10.1096/fj.06-7684com; Ozes ON, 1999, NATURE, V401, P82; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Pekarsky Y, 2007, J CELL BIOCHEM, V100, P1109, DOI 10.1002/jcb.21147; Pekarsky Y, 2008, P NATL ACAD SCI USA, V105, P19643, DOI 10.1073/pnas.0810965105; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Teitell MA, 2005, NAT REV CANCER, V5, P640, DOI 10.1038/nrc1672; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	28	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6567	10.1371/journal.pone.0006567	http://dx.doi.org/10.1371/journal.pone.0006567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668332	Green Published, gold, Green Submitted			2022-12-25	WOS:000268773300009
J	Davies, PS; Powell, AE; Swain, JR; Wong, MH				Davies, Paige S.; Powell, Anne E.; Swain, John R.; Wong, Melissa H.			Inflammation and Proliferation Act Together to Mediate Intestinal Cell Fusion	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MARROW-DERIVED CELLS; PURKINJE NEURONS; IN-VIVO; INTERLEUKIN-10-DEFICIENT MICE; SKELETAL-MUSCLE; BETA-CATENIN; KAPPA-B; CANCER; EXPRESSION	Cell fusion between circulating bone marrow-derived cells (BMDCs) and non-hematopoietic cells is well documented in various tissues and has recently been suggested to occur in response to injury. Here we illustrate that inflammation within the intestine enhanced the level of BMDC fusion with intestinal progenitors. To identify important microenvironmental factors mediating intestinal epithelial cell fusion, we performed bone marrow transplantation into mouse models of inflammation and stimulated epithelial proliferation. Interestingly, in a non-injury model or in instances where inflammation was suppressed, an appreciable baseline level of fusion persisted. This suggests that additional mediators of cell fusion exist. A rigorous temporal analysis of early post-transplantation cellular dynamics revealed that GFP-expressing donor cells first trafficked to the intestine coincident with a striking increase in epithelial proliferation, advocating for a required fusogenic state of the host partner. Directly supporting this hypothesis, induction of augmented epithelial proliferation resulted in a significant increase in intestinal cell fusion. Here we report that intestinal inflammation and epithelial proliferation act together to promote cell fusion. While the physiologic impact of cell fusion is not yet known, the increased incidence in an inflammatory and proliferative microenvironment suggests a potential role for cell fusion in mediating the progression of intestinal inflammatory diseases and cancer.			Davies, PS (corresponding author), Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Knight Canc Inst, Dept Dermatol, Portland, OR 97201 USA.	wongme@ohsu.edu		Zemper, Anne/0000-0001-8238-1406	NATIONAL CANCER INSTITUTE [T32CA106195, R01CA118235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068326] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA106195, T32CA106195, R01 CA118235-03, R01 CA118235, R01CA118235] Funding Source: Medline; NICHD NIH HHS [T32HD409309] Funding Source: Medline; NIDDK NIH HHS [R01DK068326, R01 DK068326-04, R01 DK068326] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Anderson DA, 2005, STEM CELLS, V23, P638, DOI 10.1634/stemcells.2004-0325; AZADKHAN AK, 1977, LANCET, V2, P892; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Battaile KP, 1999, BLOOD, V94, P2151; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Camargo FD, 2004, J CLIN INVEST, V113, P1266, DOI 10.1172/JCI200421301; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; CHENG H, 1969, AM J ANAT, V126, P507, DOI 10.1002/aja.1001260409; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; Dionne S, 1997, DIGEST DIS SCI, V42, P1557, DOI 10.1023/A:1018895500721; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Karin M, 2005, NAT MED, V11, P20, DOI 10.1038/nm0105-20; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kokkotou E, 2008, P NATL ACAD SCI USA, V105, P10613, DOI 10.1073/pnas.0804536105; KOVACS L, 1973, CELL TISSUE KINET, V6, P125, DOI 10.1111/j.1365-2184.1973.tb01601.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Molla M, 2007, WORLD J GASTROENTERO, V13, P3043, DOI 10.3748/wjg.v13.i22.3043; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakanishi T, 2002, GENOMICS, V80, P564, DOI 10.1006/geno.2002.7008; Nelson D, 2006, J LEUKOCYTE BIOL, V80, P685, DOI 10.1189/jlb.1105646; Nern C, 2009, J NEUROSCI, V29, P3799, DOI 10.1523/JNEUROSCI.5848-08.2009; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; RENNICK D, 1995, CLIN IMMUNOL IMMUNOP, V76, pS174, DOI 10.1016/S0090-1229(95)90144-2; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	50	67	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6530	10.1371/journal.pone.0006530	http://dx.doi.org/10.1371/journal.pone.0006530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657387	Green Submitted, gold, Green Published			2022-12-25	WOS:000268739300003
J	Pastorino, R; Menni, C; Barca, M; Foco, L; Saddi, V; Gazzaniga, G; Ferrai, R; Mascaretti, L; Dudbridge, F; Berzuini, C; Murgia, SB; Piras, ML; Ticca, A; Bitti, PP; Bernardinelli, L				Pastorino, Roberta; Menni, Cristina; Barca, Monserrata; Foco, Luisa; Saddi, Valeria; Gazzaniga, Giovanna; Ferrai, Raffaela; Mascaretti, Luca; Dudbridge, Frank; Berzuini, Carlo; Murgia, Salvatore Bruno; Piras, Maria Luisa; Ticca, Anna; Bitti, Pier Paolo; Bernardinelli, Luisa			Association between Protective and Deleterious HLA Alleles with Multiple Sclerosis in Central East Sardinia	PLOS ONE			English	Article							CLASS-I REGION; GENETIC SUSCEPTIBILITY; LINKAGE DISEQUILIBRIUM; HAPLOTYPE; POPULATION; RISK; MHC; COMPLEX; LOCUS; MECHANISMS	The human leukocyte antigen (HLA) complex on chromosome 6p21 has been unambiguously associated with multiple sclerosis (MS). The complex features of the HLA region, especially its high genic content, extreme polymorphism, and extensive linkage disequilibrium, has prevented to resolve the nature of HLA association in MS. We performed a family based association study on the isolated population of the Nuoro province (Sardinia) to clarify the role of HLA genes in MS. The main stage of our study involved an analysis of the ancestral haplotypes A2Cw7B58DR2DQ1 and A30Cw5B18DR3DQ2. On the basis of a multiplicative model, the effect of the first haplotype is protective with an odds ratio (OR) = 0.27 (95% confidence interval CI 0.13-0.57), while that of the second is deleterious, OR 1.78 (95% CI 1.26-2.50). We found both class I (A, Cw, B) and class II (DR, DQ) loci to have an effect on MS susceptibility, but we saw that they act independently from each other. We also performed an exploratory analysis on a set of 796 SNPs in the same HLA region. Our study supports the claim that Class I and Class II loci act independently on MS susceptibility and this has a biological explanation. Also, the analysis of SNPs suggests that there are other HLA genes involved in MS, but replication is needed. This opens up new perspective on the study of MS.			Pastorino, R (corresponding author), Univ Pavia, Dipartimento Sci Sanitarie Applicate & Psicocompo, Via Palestro 3, I-27100 Pavia, Italy.	roberta.pastorino@unipv.it	Mascaretti, Luca Giovanni/AAL-3170-2020; PASTORINO, Roberta/AAC-1866-2022; Mascaretti, Luca/AAS-2022-2020; Bernardinelli, Luisa/AAL-5750-2021; Berzuini, Carlo/AAA-7023-2019	PASTORINO, Roberta/0000-0001-5013-0733; Berzuini, Carlo/0000-0001-6056-0489; Menni, Cristina/0000-0001-9790-0571	Medical Research Council [MC_U105292688, G0802320] Funding Source: Medline; MRC [MC_U105292688, G0802320] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alves-Leon SV, 2007, ACTA NEUROL SCAND, V115, P306, DOI 10.1111/j.1600-0404.2006.00750.x; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Bernardinelli L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000480; Bitti PP, 2001, GENET EPIDEMIOL, V20, P271, DOI 10.1002/1098-2272(200102)20:2<271::AID-GEPI9>3.0.CO;2-L; Brum DG, 2007, J NEUROIMMUNOL, V189, P118, DOI 10.1016/j.jneuroim.2007.06.009; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Burfoot RK, 2008, TISSUE ANTIGENS, V71, P42, DOI 10.1111/j.1399-0039.2007.00962.x; Caballero A, 1999, TISSUE ANTIGENS, V54, P524, DOI 10.1034/j.1399-0039.1999.540511.x; CONTU L, 1992, TISSUE ANTIGENS, V40, P165, DOI 10.1111/j.1399-0039.1992.tb02041.x; CONTU L, 1992, TISSUE ANTIGENS, V39, P58, DOI 10.1111/j.1399-0039.1992.tb01908.x; Cordell HJ, 2006, GENET EPIDEMIOL, V30, P259, DOI 10.1002/gepi.20142; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Duvefelt K, 2004, TISSUE ANTIGENS, V63, P13, DOI 10.1111/j.1399-0039.2004.00135.x; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Gardiner CM, 2008, INT J IMMUNOGENET, V35, P1, DOI 10.1111/j.1744-313X.2007.00739.x; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; JERSILD C, 1972, LANCET, V1, P1240; JERSILD C, 1972, ACTA NEUROL SCAND, V48, P377; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Marrosu MG, 1997, AM J HUM GENET, V61, P454; Marrosu MG, 1998, HUM MOL GENET, V7, P1235, DOI 10.1093/hmg/7.8.1235; McElroy JP, 2008, CURR TOP MICROBIOL, V318, P45; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Modin H, 2004, AM J HUM GENET, V74, P1321, DOI 10.1086/420977; Montomoli C, 2002, GENET EPIDEMIOL, V22, P265, DOI 10.1002/gepi.0173; Morandi B, 2008, PHARMACOL RES, V57, P1, DOI 10.1016/j.phrs.2007.11.003; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Oksenberg JR, 2001, J NEUROIMMUNOL, V113, P171, DOI 10.1016/S0165-5728(00)00444-6; OLERUP O, 1987, TISSUE ANTIGENS, V30, P135; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Osterhout DJ, 2002, J NEUROSCI RES, V69, P24, DOI 10.1002/jnr.10230; Poser CM, 2001, CLIN NEUROL NEUROSUR, V103, P1, DOI 10.1016/S0303-8467(00)00125-6; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Ramagopalan SV, 2008, LANCET, V371, P283, DOI 10.1016/S0140-6736(08)60145-2; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Sawcer S, 2006, EUR J HUM GENET, V14, P257, DOI 10.1038/sj.ejhg.5201561; Sawcer S, 2005, AM J HUM GENET, V77, P454; SERCARZ EE, 1994, CURR OPIN IMMUNOL, V6, P875, DOI 10.1016/0952-7915(94)90007-8; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stewart GJ, 1997, EUR J IMMUNOGENET, V24, P81, DOI 10.1046/j.1365-2370.1997.00252.x; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thorsby E, 1997, HUM IMMUNOL, V53, P1, DOI 10.1016/S0198-8859(97)00024-4; Traherne JA, 2006, HUM MOL GENET, V15, P155, DOI 10.1093/hmg/ddi436; VARTDAL F, 1989, HUM IMMUNOL, V25, P103, DOI 10.1016/0198-8859(89)90074-8; Willer CJ, 2007, J HUM GENET, V52, P955, DOI 10.1007/s10038-007-0194-6; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zipp F, 2000, CELL TISSUE RES, V301, P163, DOI 10.1007/s004410000179	60	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6526	10.1371/journal.pone.0006526	http://dx.doi.org/10.1371/journal.pone.0006526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654877	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000268739100018
J	Wu, WL; Wang, CH; Huang, EYK; Chen, CC				Wu, Wei-Li; Wang, Chih-Hung; Huang, Eagle Yi-Kung; Chen, Chih-Cheng			Asic3(-/-) Female Mice with Hearing Deficit Affects Social Development of Pups	PLOS ONE			English	Article							SENSING ION CHANNELS; ULTRASONIC VOCALIZATIONS; MOUSE PUPS; MATERNAL RESPONSIVENESS; AFFILIATIVE BEHAVIOR; SOUND COMMUNICATION; MUS-MUSCULUS; ACID; INFANT; SEROTONIN	Background: Infant crying is an important cue for mothers to respond adequately. Inappropriate response to infant crying can hinder social development in infants. In rodents, the pup-mother interaction largely depends on pup's calls. Mouse pups emit high frequency to ultrasonic vocalization (2-90 kHz) to communicate with their dam for maternal care. However, little is known about how the maternal response to infant crying or pup calls affects social development over the long term. Methodology/Principal Findings: Here we used mice lacking acid-sensing ion channel 3 (Asic3(-/-)) to create a hearing deficit to probe the effect of caregiver hearing on maternal care and adolescent social development. Female Asic3(-/-) mice showed elevated hearing thresholds for low to ultrasonic frequency (4-32 kHz) on auditory brain stem response, which thus hindered their response to their pups' wriggling calls and ultrasonic vocalization, as well as their retrieval of pups. In adolescence, pups reared by Asic3(-/-) mice showed a social deficit in juvenile social behaviors as compared with those reared by wild-type or heterozygous dams. The social-deficit phenotype in juvenile mice reared by Asic3(-/-) mice was associated with the reduced serotonin transmission of the brain. However, Asic3(-/-) pups cross-fostered to wild-type dams showed rescued social deficit. Conclusions/Significance: Inadequate response to pups' calls as a result of ASIC3-dependent hearing loss confers maternal deficits in caregivers and social development deficits in their young.			Wu, WL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	chih@ibms.sinica.edu.tw	Chen, Chih-Cheng/AAT-1062-2021; Wu, Wei-Li/ADY-3311-2022; Wang, Chih-Hung/AAR-9766-2020; Chen, Chih-Cheng/S-7015-2018	Chen, Chih-Cheng/0000-0003-4768-5660; Chen, Chih-Cheng/0000-0003-4768-5660				Ainsworth M., 1978, PATTERNS ATTACHMENT; AINSWORTH MDS, 1991, AM PSYCHOL, V46, P331; BELL SM, 1972, CHILD DEV, V43, P1171, DOI 10.1111/j.1467-8624.1972.tb02075.x; Branchi I, 2006, BIOL PSYCHIAT, V60, P690, DOI 10.1016/j.biopsych.2006.01.005; Champagne FA, 2005, CURR OPIN NEUROBIOL, V15, P704, DOI 10.1016/j.conb.2005.10.001; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; EHRET G, 1975, BEHAVIOUR, V52, P38; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Hager R, 2003, NATURE, V421, P533, DOI 10.1038/nature01239; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Hildebrand MS, 2004, HEARING RES, V190, P149, DOI 10.1016/S0378-5955(04)00015-2; Hruska-Hageman AM, 2004, J BIOL CHEM, V279, P46962, DOI 10.1074/jbc.M405874200; Insel TR, 1998, BIOL PSYCHIAT, V44, P207, DOI 10.1016/S0006-3223(98)00094-8; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Leavitt L A, 1998, Pediatrics, V102, P1247; Leigh Irene W, 2004, J Deaf Stud Deaf Educ, V9, P176, DOI 10.1093/deafed/enh019; Lesch KP, 2007, EMBO REP, V8, pS24, DOI 10.1038/sj.embor.7401008; LEVINE S, 1957, SCIENCE, V126, P405, DOI 10.1126/science.126.3270.405; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Maubaret C, 2002, DNA CELL BIOL, V21, P781, DOI 10.1089/104454902320908432; Meaney MJ, 2000, J NEUROSCI, V20, P3926, DOI 10.1523/JNEUROSCI.20-10-03926.2000; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Peng BG, 2004, J NEUROSCI, V24, P10167, DOI 10.1523/JNEUROSCI.3196-04.2004; Prakash P, 2006, BRAIN RES, V1111, P122, DOI 10.1016/j.brainres.2006.06.089; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; Sapolsky RM, 2004, NAT NEUROSCI, V7, P791, DOI 10.1038/nn0804-791; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schneider T, 2006, NEUROPSYCHOPHARMACOL, V31, P36, DOI 10.1038/sj.npp.1300767; Shih Hsi-Te, 2000, Acta Zoologica Taiwanica, V11, P47; Stern JM, 1997, DEV PSYCHOBIOL, V31, P19, DOI 10.1002/(SICI)1098-2302(199707)31:1<19::AID-DEV3>3.0.CO;2-X; Storm EE, 2005, NEURON, V47, P483, DOI 10.1016/j.neuron.2005.08.004; van der Veen R, 2008, GENES BRAIN BEHAV, V7, P184, DOI 10.1111/j.1601-183X.2007.00337.x; VAN IMH, 2000, ATTACH HUM DEV, V2, P371; Wade Kerri, 2005, J Pediatr Health Care, V19, P347, DOI 10.1016/j.pedhc.2005.06.003; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weller A, 2003, DEV PSYCHOBIOL, V42, P194, DOI 10.1002/dev.10079; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wohr M, 2008, BEHAV GENET, V38, P579, DOI 10.1007/s10519-008-9221-4; Wohr M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001365; Yen YT, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-1; Zhang M, 2008, NEUROSCIENCE, V154, P461, DOI 10.1016/j.neuroscience.2008.03.040	53	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6508	10.1371/journal.pone.0006508	http://dx.doi.org/10.1371/journal.pone.0006508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479CW	19652708	Green Published, gold, Green Submitted			2022-12-25	WOS:000268637800015
J	Glass, D; Lens, M; Swaminathan, R; Spector, TD; Bataille, V				Glass, Daniel; Lens, Marko; Swaminathan, Ramasamyiyer; Spector, Tim D.; Bataille, Veronique			Pigmentation and Vitamin D Metabolism in Caucasians: Low Vitamin D Serum Levels in Fair Skin Types in the UK	PLOS ONE			English	Article							BONE-MINERAL DENSITY; D INSUFFICIENCY; CUTANEOUS SYNTHESIS; UNITED-STATES; PREVALENCE; CANCER; 25-HYDROXYVITAMIN-D; EXPOSURE; DETERMINANTS; POPULATION	Background: Vitamin D may play a protective role in many diseases. Public health messages are advocating sun avoidance to reduce skin cancer risk but the potential deleterious effects of these recommendations for vitamin D metabolism have been poorly investigated. Methodology/Principal Findings: We investigated the association between 25-hydroxy-vitamin D (25(OH)D), skin type and ultraviolet exposure in 1414 Caucasian females in the UK. Mean age of the cohort was 47 years (18-79) and mean 25(OH)D levels were 77 nmol/L (6-289). 25( OH) D levels were strongly associated with season of sampling with higher levels in the spring and summer months (p<0.0001). Light skin types ( skin type 1 and 2) have lower levels of 25(OH)D (mean 71 nmol/L) compared to darker skin types (skin type 3 and 4) (mean 82 nmol/L) after adjusting for multiple confounders (p<0.0001). The trend for increasing risk of low vitamin D with fairer skin types was highly significant despite adjustment for all confounders (p=0.001). Conclusions/Significance: Contrary to previous studies across different ethnic backgrounds, this study within Caucasian UK females shows that fair skin types have lower levels of 25(OH)D compared to darker skin types with potential detrimental health effects. Public health campaigns advocating sun avoidance in fair skinned individuals may need to be revised in view of their risk of vitamin D deficiency.			Glass, D (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, St Thomas Hosp Campus, London WC2R 2LS, England.	bataille@doctors.org.uk			Arthritis Research UK Funding Source: Medline; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0900339] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G0900339] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Berwick M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1261, DOI 10.1562/2005-02-18-IR-445; Bohm M, 2006, J INVEST DERMATOL, V126, P1966, DOI 10.1038/sj.jid.5700421; Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014; Bruyere O, 2007, CURR MED RES OPIN, V23, P1939, DOI 10.1185/030079907X219562; CHANG YM, 2009, INT J EPIDEMIOL; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; CLEMENS TL, 1982, LANCET, V1, P74; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Dealberto MJ, 2007, MED HYPOTHESES, V68, P259, DOI 10.1016/j.mehy.2006.07.040; Egan KM, 2008, CANCER CAUSE CONTROL, V19, P527, DOI 10.1007/s10552-008-9115-z; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; LIPS P, 1988, J CLIN ENDOCR METAB, V67, P644, DOI 10.1210/jcem-67-4-644; Malvy DJM, 2000, PHOTOCHEM PHOTOBIOL, V71, P466, DOI 10.1562/0031-8655(2000)071&lt;0466:RBVDSA&gt;2.0.CO;2; MATSUOKA LY, 1991, ARCH DERMATOL, V127, P536, DOI 10.1001/archderm.127.4.536; MAY H, 1995, EUR J CLIN INVEST, V25, P85, DOI 10.1111/j.1365-2362.1995.tb01531.x; Moan J, 2008, P NATL ACAD SCI USA, V105, P668, DOI 10.1073/pnas.0710615105; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Park S, 2005, NUTR REV, V63, P203, DOI [10.1301/nr.2005.Jun.203-209, 10.1111/j.1753-4887.2005.tb00138.x]; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Rockell JE, 2005, J NUTR, V135, P2602, DOI 10.1093/jn/135.11.2602; ROCKELL JE, 2008, OSTEOPOROS INT; Tangpricha V, 2004, AM J CLIN NUTR, V80, P1645, DOI 10.1093/ajcn/80.6.1645; van der Mei IAF, 2007, ENVIRON HEALTH PERSP, V115, P1132, DOI 10.1289/ehp.9937; Webb AR, 2008, ADV EXP MED BIOL, V624, P72, DOI 10.1007/978-0-387-77574-6_6	33	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6477	10.1371/journal.pone.0006477	http://dx.doi.org/10.1371/journal.pone.0006477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649299	gold, Green Submitted, Green Published			2022-12-25	WOS:000268637700004
J	Cai, KQ; Caslini, C; Capo-chichi, CD; Slater, C; Smith, ER; Wu, H; Klein-Szanto, AJ; Godwin, AK; Xu, XX				Cai, Kathy Qi; Caslini, Corrado; Capo-chichi, Callinice D.; Slater, Carolyn; Smith, Elizabeth R.; Wu, Hong; Klein-Szanto, Andres J.; Godwin, Andrew K.; Xu, Xiang-Xi			Loss of GATA4 and GATA6 Expression Specifies Ovarian Cancer Histological Subtypes and Precedes Neoplastic Transformation of Ovarian Surface Epithelia	PLOS ONE			English	Article								Background: The family of zinc finger-containing GATA transcription factors plays critical roles in cell lineage specification during early embryonic development and organ formation. GATA4 and GATA6 were found to be frequently lost in ovarian cancer, and the loss is proposed to account for dedifferentiation of the cancer cells. Methodology/Principal Findings: We further investigated the expression of GATA4 and GATA6 in ovarian surface epithelial lesions and histological subtypes of ovarian carcinomas by immunostaining. GATA4 and GATA6 were found to be absent in high percentages (80 to 90%) of serous, clear cell, and endometrioid ovarian cancer examined. In contrast, both were found positive in 11 out of 12 cases of mucinous carcinomas, suggesting the expression of the GATA factors can distinguish mucinous cancer from other histological subtypes. GATA4 was frequently lost in preneoplastic lesions such as morphologically normal inclusion cysts and epithelial hyperplasia adjacent to malignant cells. The loss of GATA6 correlates closely with neoplastic morphological transformation of ovarian surface epithelia. In culture, GATA4 expression was progressively reduced upon passaging primary ovarian surface epithelial cells, which correlated with changes in histone modification of the GATA4 locus. A reduced GATA6 gene dosage as in GATA6 (+/-) mice led to an increased pre-neoplastic changes and inclusion cysts in the ovaries, suggesting the loss of GATA6 contributes to ovarian cancer development. Conclusions/Significance: This study suggests that the expression status of GATA4 and GATA6 may dictate distinct pathologic pathways leading to serous or mucinous ovarian carcinomas. The readily loss of GATA4 expression through changes in chromatin conformation suggests a potential non-phenotypic initiating event, leading to subsequent loss of GATA6, morphological transformation, and ultimate tumorigenesis.			Cai, KQ (corresponding author), Fox Chase Canc Ctr, Ovarian Canc Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	xxu2@med.miami.edu	Caslini, Corrado/W-6123-2019; Capo-chichi, Deylosse Callinice/AAP-4937-2020; Caslini, Corrado/A-1689-2012	Caslini, Corrado/0000-0001-8326-8368; Caslini, Corrado/0000-0001-8326-8368; CAPO-CHICHI, D. Callinice/0000-0003-4941-7301	NCI NIH HHS [R01 CA079716-10, R01 CA095071-06, R01 CA079716, CA75389, P30 CA006927, CA79716, R01 CA095071, P50CA83638, P50 CA083638, #CA006927] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA083638, P30CA006927, R01CA079716, R01CA075389, R01CA095071] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aoki Y, 2000, J REPROD MED, V45, P159; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; BERCHUCK A, 1994, AM J OBSTET GYNECOL, V170, P246; Boyd JA, 2000, PRINCIPLES PRACTICE, P103; Boyd J, 2008, GYNECOL ONCOL, V109, P161, DOI 10.1016/j.ygyno.2008.03.016; Cai KQ, 2008, DEV DYNAM, V237, P2820, DOI 10.1002/dvdy.21703; Cai KQ, 2006, GYNECOL ONCOL, V103, P719, DOI 10.1016/j.ygyno.2006.03.053; Capo-chichi CD, 2005, DEV BIOL, V286, P574, DOI 10.1016/j.ydbio.2005.07.037; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Caslini C, 2006, ONCOGENE, V25, P5446, DOI 10.1038/sj.onc.1209533; Dubeau L, 1999, GYNECOL ONCOL, V72, P437, DOI 10.1006/gyno.1998.5275; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Fusenig N E, 1995, Recent Results Cancer Res, V139, P1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee Y, 2007, J PATHOL, V213, P116, DOI 10.1002/path.2212; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; LYNCH RG, 1995, P NATL ACAD SCI USA, V92, P647, DOI 10.1073/pnas.92.3.647; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrisey EE, 2000, J BIOL CHEM, V275, P19949, DOI 10.1074/jbc.M001331200; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; PULS LE, 1992, GYNECOL ONCOL, V47, P53, DOI 10.1016/0090-8258(92)90075-T; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; RICHARDSON GS, 1985, NEW ENGL J MED, V312, P474, DOI 10.1056/NEJM198502213120804; Salazar H, 1996, JNCI-J NATL CANCER I, V88, P1810, DOI 10.1093/jnci/88.24.1810; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Scully RE, 1995, J CELL BIOCHEM, P208; Seidman JD, 2002, BLAUSTEINS PATHOLOGY, P791; Sheng ZJ, 2000, ONCOGENE, V19, P4847, DOI 10.1038/sj.onc.1203853; Wakana K, 2006, CANCER LETT, V241, P281, DOI 10.1016/j.canlet.2005.10.039; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yang DH, 2002, CANCER-AM CANCER SOC, V94, P2380, DOI 10.1002/cncr.10497; Yang DH, 2007, J BIOL CHEM, V282, P13114, DOI 10.1074/jbc.M611356200; Yang DH, 2006, AM J PATHOL, V169, P258, DOI 10.2353/ajpath.2006.060036	44	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6454	10.1371/journal.pone.0006454	http://dx.doi.org/10.1371/journal.pone.0006454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649254	Green Submitted, gold, Green Published			2022-12-25	WOS:000268637600006
J	Macey, PM; Richard, CA; Kumar, R; Woo, MA; Ogren, JA; Avedissian, C; Thompson, PM; Harper, RM				Macey, Paul M.; Richard, Christopher A.; Kumar, Rajesh; Woo, Mary A.; Ogren, Jennifer A.; Avedissian, Christina; Thompson, Paul M.; Harper, Ronald M.			Hippocampal Volume Reduction in Congenital Central Hypoventilation Syndrome	PLOS ONE			English	Article								Children with congenital central hypoventilation syndrome (CCHS), a genetic disorder characterized by diminished drive to breathe during sleep and impaired CO(2) sensitivity, show brain structural and functional changes on magnetic resonance imaging (MRI) scans, with impaired responses in specific hippocampal regions, suggesting localized injury. We assessed total volume and regional variation in hippocampal surface morphology to identify areas affected in the syndrome. We studied 18 CCHS (mean age +/- std: 15.1 +/- 2.2 years; 8 female) and 32 healthy control (age 15.2 +/- 2.4 years; 14 female) children, and traced hippocampi on 1 mm(3) resolution T1-weighted scans, collected with a 3.0 Tesla MRI scanner. Regional hippocampal volume variations, adjusted for cranial volume, were compared between groups based on t- tests of surface distances to the structure midline, with correction for multiple comparisons. Significant tissue losses emerged in CCHS patients on the left side, with a trend for loss on the right; however, most areas affected on the left also showed equivalent right-sided volume reductions. Reduced regional volumes appeared in the left rostral hippocampus, bilateral areas in mid and mid-to caudal regions, and a dorsal-caudal region, adjacent to the fimbria. The volume losses may result from hypoxic exposure following hypoventilation during sleep-disordered breathing, or from developmental or vascular consequences of genetic mutations in the syndrome. The sites of change overlap regions of abnormal functional responses to respiratory and autonomic challenges. Affected hippocampal areas have roles associated with memory, mood, and indirectly, autonomic regulation; impairments in these behavioral and physiological functions appear in CCHS.			Macey, PM (corresponding author), Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA.	rharper@ucla.edu	Thompson, Paul M/C-4194-2018; Ogren, Jennifer/B-1944-2010; Macey, Paul M./B-5037-2008	Thompson, Paul M/0000-0002-4720-8867; Macey, Paul M./0000-0003-4093-7458	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022695] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD022695, R01 HD-22695] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN GV, 1989, J COMP NEUROL, V286, P311, DOI 10.1002/cne.902860303; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Banzett RB, 2000, NEUROREPORT, V11, P2117, DOI 10.1097/00001756-200007140-00012; Bassett JP, 2007, J NEUROSCI, V27, P7564, DOI 10.1523/JNEUROSCI.0268-07.2007; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bonne O, 2008, J CLIN PSYCHIAT, V69, P1087, DOI 10.4088/JCP.v69n0707; Brisch R, 2008, PSYCHIAT RES-NEUROIM, V164, P265, DOI 10.1016/j.pscychresns.2007.12.007; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; FISCHETTE CT, 1980, BRAIN RES, V195, P373, DOI 10.1016/0006-8993(80)90073-6; Goodridge JP, 1997, J NEUROSCI, V17, P9315; HADDAD GG, 1978, MEDICINE, V57, P517, DOI 10.1097/00005792-197811000-00003; Harper RM, 2005, J NEUROPHYSIOL, V93, P1647, DOI 10.1152/jn.00863.2004; Henderson LA, 2006, RESP PHYSIOL NEUROBI, V150, P87, DOI 10.1016/j.resp.2005.08.007; Hernandez SAR, 2003, HYPERTENSION, V42, P56, DOI 10.1161/01.HYP.0000077983.66161.6F; Hopkins DA, 2005, HEAD DIRECTION CELLS, P17; Hufner K, 2007, HIPPOCAMPUS, V17, P471, DOI 10.1002/hipo.20283; Kumar R, 2005, J COMP NEUROL, V487, P361, DOI 10.1002/cne.20565; KUMAR R, PEDIAT RES IN PRESS; KUMAR R, 2009, SOC NEUROSCI ABS; Kumar R, 2008, PEDIATR RES, V64, P275, DOI 10.1203/PDR.0b013e31817da10a; Kumar R, 2006, J MAGN RESON IMAGING, V24, P1252, DOI 10.1002/jmri.20759; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Macey KE, 2004, J APPL PHYSIOL, V97, P1897, DOI 10.1152/japplphysiol.00359.2004; Macey PM, 2005, PEDIATR RES, V57, P500, DOI 10.1203/01.PDR.0000155757.98389.53; Macey PM, 2005, J APPL PHYSIOL, V98, P958, DOI 10.1152/japplphysiol.00969.2004; Macey PM, 2003, RESP PHYSIOL NEUROBI, V139, P41, DOI 10.1016/j.resp.2003.09.006; MacQueen GM, 2008, BIOL PSYCHIAT, V64, P880, DOI 10.1016/j.biopsych.2008.06.027; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Brien LM, 2005, CHEST, V128, P2478, DOI 10.1378/chest.128.4.2478; Pae EK, 2005, NEUROSCI LETT, V375, P123, DOI 10.1016/j.neulet.2004.10.091; PATON JY, 1989, AM REV RESPIR DIS, V140, P368, DOI 10.1164/ajrccm/140.2.368; Peiffer C, 2001, AM J RESP CRIT CARE, V163, P951, DOI 10.1164/ajrccm.163.4.2005057; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Ruof H, 2008, J CHILD NEUROL, V23, P1254, DOI 10.1177/0883073808318048; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; SWANSON LW, 1975, SCIENCE, V189, P303, DOI 10.1126/science.49928; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Van Asselen M, 2005, J CLIN EXP NEUROPSYC, V27, P645, DOI 10.1081/13803390490919281; Vanderlaan M, 2004, PEDIATR PULM, V37, P217, DOI 10.1002/ppul.10438; Vann SD, 2004, NAT REV NEUROSCI, V5, P35, DOI 10.1038/nrn1299; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Weese-Mayer DE, 1999, AM J RESP CRIT CARE, V160, P368; Weese-Mayer DE, 2001, AM J MED GENET, V100, P237, DOI 10.1002/ajmg.1249; Woo MA, 2005, PEDIATR RES, V57, P510, DOI 10.1203/01.PDR.0000155763.93819.46; WOO MS, 1992, PEDIATR RES, V31, P291, DOI 10.1203/00006450-199203000-00020	49	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6436	10.1371/journal.pone.0006436	http://dx.doi.org/10.1371/journal.pone.0006436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649271	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494600006
J	Catalgol, B; Ziaja, I; Breusing, N; Jung, T; Hohn, A; Alpertunga, B; Schroeder, P; Chondrogianni, N; Gonos, ES; Petropoulos, I; Friguet, B; Klotz, LO; Krutmann, J; Grune, T				Catalgol, Betul; Ziaja, Isabella; Breusing, Nicolle; Jung, Tobias; Hoehn, Annika; Alpertunga, Buket; Schroeder, Peter; Chondrogianni, Niki; Gonos, Efstathios S.; Petropoulos, Isabelle; Friguet, Bertrand; Klotz, Lars-Oliver; Krutmann, Jean; Grune, Tilman			The Proteasome Is an Integral Part of Solar Ultraviolet A Radiation-induced Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SULFOXIDE REDUCTASE; HUMAN DERMAL FIBROBLASTS; NF-KAPPA-B; SINGLET OXYGEN; C-JUN; OXIDIZED PROTEINS; OXIDATIVE STRESS; 26S PROTEASOME; UVA IRRADIATION; DEGRADATION	Solar ultraviolet (UV) A radiation is a well known trigger of signaling responses in human skin fibroblasts. One important consequence of this stress response is the increased expression of matrix metalloproteinase-1 (MMP-1), which causes extracellular protein degradation and thereby contributes to photoaging of human skin. In the present study we identify the proteasome as an integral part of the UVA-induced, intracellular signaling cascade in human dermal fibroblasts. UVA-induced singlet oxygen formation was accompanied by protein oxidation, the cross-linking of oxidized proteins, and an inhibition of the proteasomal system. This proteasomal inhibition subsequently led to an accumulation of c-Jun and phosphorylated c-Jun and activation of activator protein-1, i.e. transcription factors known to control MMP-1 expression. Increased transcription factor activation was also observed if the proteasome was inhibited by cross-linked proteins or lactacystin, indicating a general mechanism. Most importantly, inhibition of the proteasome was of functional relevance for UVA-induced MMP-1 expression, because overexpression of the proteasome or the protein repair enzyme methionine sulfoxide reductase prevented the UVA-induced induction of MMP-1. These studies show that an environmentally relevant stimulus can trigger a signaling pathway, which links intracellular and extracellular protein degradation. They also identify the proteasome as an integral part of the UVA stress response.	[Catalgol, Betul; Breusing, Nicolle; Jung, Tobias; Hoehn, Annika; Grune, Tilman] Univ Hohenheim, Inst Biol Chem & Nutr, D-70593 Stuttgart, Germany; [Catalgol, Betul; Alpertunga, Buket] Istanbul Univ, Fac Pharm, Dept Pharmaceut Toxicol, TR-34116 Istanbul, Turkey; [Ziaja, Isabella; Jung, Tobias; Schroeder, Peter; Klotz, Lars-Oliver; Krutmann, Jean; Grune, Tilman] Environm Med Res Inst, D-40225 Dusseldorf, Germany; [Chondrogianni, Niki; Gonos, Efstathios S.] Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, Athens 11635, Greece; [Petropoulos, Isabelle; Friguet, Bertrand] Univ Paris 06, CNRS Physiol & Physiopathol 7079, F-75005 Paris, France	University Hohenheim; Istanbul University; National Hellenic Research Foundation; UDICE-French Research Universities; Sorbonne Universite	Krutmann, J (corresponding author), IUF, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.	krutmann@rz.uni-duesseldorf.de	Klotz, Lars Oliver/AAC-5051-2019; Yilmaz, Betul/AAH-9806-2021; Alpertunga, Buket/AAD-6135-2020	Klotz, Lars Oliver/0000-0002-1261-8911; Yilmaz, Betul/0000-0003-1762-0284; Hohn, Annika/0000-0003-1306-2668; Petropoulos, Isabelle/0000-0001-9205-7458; Grune, Tilman/0000-0003-4775-9973; Friguet, Bertrand/0000-0001-8085-1961; Jung, Tobias/0000-0002-9159-8444	Henkel AG; CoKGaA, Dursseldorf, Germany; Scientific and Technological Research Council of Turkey (TUBITAK); Eliteprogramme for Postdocs.; Deutsche Forschungsgemeinschaft [GK1033, SFB728/B4, SFB728/C1]; European Cooperation in Science and Technology [B35]	Henkel AG; CoKGaA, Dursseldorf, Germany; Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Eliteprogramme for Postdocs.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST))	This work was supported by Henkel AG and CoKGaA, Dursseldorf, Germany. Supported by The Scientific and Technological Research Council of Turkey (TUBITAK). This work represents, in part, a Ph. D. thesis.; Recipient of LANDESSTIFTUNG Baden-Wurttemberg financial support of this research project by the Eliteprogramme for Postdocs.; Supported by Deutsche Forschungsgemeinschaft Grants GK1033, SFB728/B4, and SFB728/C1.; Supported by Deutsche Forschungsgemeinschaft, Bundesministerium fur r Umwelt (German Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety), and by European Cooperation in Science and Technology B35.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Davies KJA, 2006, NEUROLOGY, V66, pS93, DOI 10.1212/01.wnl.0000192308.43151.63; Dean RT, 1997, BIOCHEM J, V324, P1; Demasi M, 2003, FEBS LETT, V542, P89, DOI 10.1016/S0014-5793(03)00353-3; DjavaheriMergny M, 1996, FEBS LETT, V384, P92, DOI 10.1016/0014-5793(96)00294-3; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504; Grune T, 2001, FREE RADICAL BIO MED, V30, P1243, DOI 10.1016/S0891-5849(01)00515-9; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Hantke B, 2002, PHOTOCH PHOTOBIO SCI, V1, P826, DOI 10.1039/b207731k; Herrmann G, 1993, Exp Dermatol, V2, P92, DOI 10.1111/j.1600-0625.1993.tb00015.x; HOUGH R, 1987, J BIOL CHEM, V262, P8303; JarielEncontre I, 1997, MOL BIOL REP, V24, P51, DOI 10.1023/A:1006804723722; JARIELENCONTRE I, 1995, J BIOL CHEM, V270, P11623, DOI 10.1074/jbc.270.19.11623; Jung T, 2006, FREE RADICAL BIO MED, V40, P1303, DOI 10.1016/j.freeradbiomed.2005.11.023; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klotz LO, 2003, PHOTOCH PHOTOBIO SCI, V2, P88, DOI 10.1039/b210750c; Klotz LO, 2002, BIOL CHEM, V383, P443, DOI 10.1515/BC.2002.047; Klotz LO, 1997, FEBS LETT, V408, P289, DOI 10.1016/S0014-5793(97)00440-7; Klotz LO, 2001, CURR PROBL DERMATOL, V29, P95; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Krutmann J, 2005, SKIN AGING, P33; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUY H, 1994, PHOTODERMATOL PHOTO, V10, P126; McDuffee AT, 1997, J CELL PHYSIOL, V171, P143, DOI 10.1002/(SICI)1097-4652(199705)171:2<143::AID-JCP4>3.0.CO;2-O; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Naru E, 2005, BRIT J DERMATOL, V153, P6, DOI 10.1111/j.1365-2133.2005.06964.x; Ogawa F, 2006, J INVEST DERMATOL, V126, P1128, DOI 10.1038/sj.jid.5700116; Ortega Z, 2007, CELL MOL LIFE SCI, V64, P2245, DOI 10.1007/s00018-007-7222-8; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Picot CR, 2007, EXP GERONTOL, V42, P859, DOI 10.1016/j.exger.2007.02.006; Picot CR, 2005, FREE RADICAL BIO MED, V39, P1332, DOI 10.1016/j.freeradbiomed.2005.06.017; Picot CR, 2004, FEBS LETT, V558, P74, DOI 10.1016/S0014-5793(03)01530-8; Polte T, 2004, FREE RADICAL BIO MED, V36, P1566, DOI 10.1016/j.freeradbiomed.2004.04.003; Powell SR, 2005, FREE RADICAL BIO MED, V38, P1093, DOI 10.1016/j.freeradbiomed.2005.01.003; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Rittie L, 2005, SKIN AGING, P143; Salvat C, 1999, MOL BIOL REP, V26, P45, DOI 10.1023/A:1006960021281; Sander CS, 2002, J INVEST DERMATOL, V118, P618, DOI 10.1046/j.1523-1747.2002.01708.x; SCHARFFETTER K, 1991, ARCH DERMATOL RES, V283, P506, DOI 10.1007/BF00371923; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; SCHARFFETTERKOCHANEK K, 1993, FEBS LETT, V331, P304, DOI 10.1016/0014-5793(93)80357-Z; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8; Sommerburg O, 1998, FREE RADICAL BIO MED, V24, P1369, DOI 10.1016/S0891-5849(98)00012-4; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; Tyrrell RM, 2004, ANTIOXID REDOX SIGN, V6, P835, DOI 10.1089/1523086041798033; Tyrrell RM, 1996, BIOESSAYS, V18, P139, DOI 10.1002/bies.950180210; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; VILE GF, 1995, PHOTOCHEM PHOTOBIOL, V62, P463, DOI 10.1111/j.1751-1097.1995.tb02369.x; von Montfort C, 2006, BIOL CHEM, V387, P1399, DOI 10.1515/BC.2006.175; Voss P, 2006, FREE RADICAL RES, V40, P673, DOI 10.1080/10715760500419357; Wan YS, 2001, CELL SIGNAL, V13, P139, DOI 10.1016/S0898-6568(00)00146-7; Wang XY, 2006, CHINESE MED J-PEKING, V119, P827, DOI 10.1097/00029330-200605020-00006; Wlaschek M, 1997, FEBS LETT, V413, P239, DOI 10.1016/S0014-5793(97)00919-8; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100	73	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30076	30086		10.1074/jbc.M109.044503	http://dx.doi.org/10.1074/jbc.M109.044503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19690165	hybrid, Green Published			2022-12-25	WOS:000271090000010
J	Wang, LW; Leonhard-Melief, C; Haltiwanger, RS; Apte, SS				Wang, Lauren W.; Leonhard-Melief, Christina; Haltiwanger, Robert S.; Apte, Suneel S.			Post-translational Modification of Thrombospondin Type-1 Repeats in ADAMTS-like 1/Punctin-1 by C-Mannosylation of Tryptophan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-FUCOSYLATION; CARTILAGE DEGRADATION; EXTRACELLULAR-MATRIX; RNASE 2; PROTEIN; FAMILY; AGGRECANASE; METALLOPROTEASES; GLYCOSYLATION; GLYCOPROTEIN	Protein C-mannosylation is the attachment of alpha-mannopyranose to tryptophan via a C-C linkage. This post-translational modification typically occurs within the sequence motif WXXW, which is frequently present in thrombospondin type-1 repeats (TSRs). TSRs are especially numerous in and a defining feature of the ADAMTS superfamily. We investigated the presence and functional significance of C-mannosylation of ADAMTS-like 1/punctin-1, which contains four TSRs (two with predicted C-mannosylation sites), using mass spectrometry, metabolic labeling, site-directed mutagenesis, and expression in C-mannosylation-defective Chinese hamster ovary cell variants. Analysis of tryptic fragments of recombinant human punctin-1 by mass spectrometry identified a peptide derived from TSR1 containing the (36)WDAWGPWSECSRTC(49) sequence of interest modified with two mannose residues and a Glc-Fuc disaccharide (O-fucosylation). Tandem mass spectrometry (MS/MS) and MS/MS/MS analysis demonstrated the characteristic cross-ring cleavage of C-mannose and identified the modified residues as Trp(39) and Trp(42). C-Mannosylation of TSR1 of the related protease ADAMTS5 was also identified. Metabolic labeling of CHO-K1 cells or Lec35.1 cells demonstrated incorporation of D-[2,6-H-3] mannose in secreted punctin-1 from CHO-K1 cells but not Lec35.1 cells. Quantitation of punctin-1 secretion in Lec35.1 cells versus CHO-K1 cells suggested decreased secretion in Lec35.1 cells. Replacement of mannosylated Trp residues in TSR1 with either Ala or Phe affected punctin secretion efficiency. These data demonstrate that TSR1 from punctin-1 carries C-mannosylation in close proximity to O-linked fucose. Together, these modifications appear to provide a quality control mechanism for punctin-1 secretion.	[Wang, Lauren W.; Apte, Suneel S.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Leonhard-Melief, Christina; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cleveland Clinic Foundation; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Apte, SS (corresponding author), Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org		Apte, Suneel/0000-0001-8441-1226	National Institutes of Health [AR49930, AR53890]; NATIONAL CANCER INSTITUTE [R01CA123071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049930, R56AR049930, R01AR053890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR49930 and AR53890 ( to S. S. A.) and CA12307101 ( to R. S. H.).	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Arner EC, 2002, CURR OPIN PHARMACOL, V2, P322, DOI 10.1016/S1471-4892(02)00148-0; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; Doucey MA, 1999, GLYCOBIOLOGY, V9, P435, DOI 10.1093/glycob/9.5.435; Doucey MA, 1998, MOL BIOL CELL, V9, P291, DOI 10.1091/mbc.9.2.291; Furmanek A, 2003, BIOCHEMISTRY-US, V42, P8452, DOI 10.1021/bi034112p; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Krieg J, 1998, MOL BIOL CELL, V9, P301, DOI 10.1091/mbc.9.2.301; Krieg J, 1997, J BIOL CHEM, V272, P26687, DOI 10.1074/jbc.272.42.26687; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Perez-Vilar J, 2004, GLYCOBIOLOGY, V14, P325, DOI 10.1093/glycob/cwh041; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stone K. L., 1993, PRACTICAL GUIDE PROT, P43; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	34	70	73	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30004	30015		10.1074/jbc.M109.038059	http://dx.doi.org/10.1074/jbc.M109.038059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19671700	Green Published, hybrid			2022-12-25	WOS:000271090000002
J	Dela Cruz, CS; Viswanathan, SR; El-Guindy, AS; Shedd, D; Miller, G				Dela Cruz, Charles S.; Viswanathan, Srinivas R.; El-Guindy, Ayman S.; Shedd, Duane; Miller, George			Complex N-Linked Glycans on Asn-89 of Kaposi Sarcoma Herpes Virus-encoded Interleukin-6 Mediate Optimal Function by Affecting Cytokine Protein Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL INTERLEUKIN-6; GP130; CELLS; HOMOLOG; MIMICRY; GLYCOSYLATION; ACTIVATION; EXPRESSION; GENES; ROLES	Kaposi sarcoma-associated herpesvirus-encoded interleukin-6 (vIL-6) and its human cellular homologue (huIL-6) share similar biological functions. Our previous work showed that N-linked glycosylation was required for optimal function of vIL6 but not huIL-6 (1). Here we describe heterogeneity in the composition of the glycans of the two N-linked sites of vIL-6. The Asn-89 site of vIL-6, found to be required for optimal cytokine function, is composed of complex glycans. The Asn-78 site is composed of high mannose glycans, which are dispensable for cytokine function. N-Linked glycosylation at the Asn-89 site was required for intracellular production of functional vIL-6, but endoglycosidase-mediated removal of N-linked glycans from secreted vIL-6 did not impair protein function. With the use of a conformation-specific antibody and tryptic digestion assays, we showed that glycosylation at the Asn-89 site of vIL-6 affected protein conformation. Human IL-6, but not vIL-6, requires IL-6R alpha for binding to gp130. We tested the hypothesis that the Asn-89 complex glycan of vIL-6 alone was sufficient to confer binding to gp130 independently of IL-6R alpha. Two mutants of huIL-6, made to contain additional complex N-linked glycans in the region that interacts with IL-6R alpha, did not confer binding to gp130 independently of IL-6R alpha. Our findings support the conclusion that complex glycans on Asn-89 of vIL-6 specifically promote a protein conformation that allows the viral cytokine to bind gp130 independently of IL-6R alpha.	[Shedd, Duane; Miller, George] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Viswanathan, Srinivas R.; El-Guindy, Ayman S.; Miller, George] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Miller, George] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Dela Cruz, Charles S.] Yale Univ, Sch Med, Dept Pulm & Crit Care Internal Med, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Miller, G (corresponding author), Yale Univ, Sch Med, Dept Pediat, Rm 420 LSOG,333 Cedar St, New Haven, CT 06520 USA.	george.miller@yale.edu	Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023	National Institutes of Health [CA16038, CA12055]; NATIONAL CANCER INSTITUTE [R37CA012055, P01CA016038, R01CA012055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA16038 and CA12055 (to G. M.).	ADAM N, 2009, J VIROLOGY; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Aoki Y, 2001, BLOOD, V98, P3042, DOI 10.1182/blood.V98.10.3042; Boulanger MJ, 2004, J MOL BIOL, V335, P641, DOI 10.1016/j.jmb.2003.10.070; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Burger R, 1998, BLOOD, V91, P1858, DOI 10.1182/blood.V91.6.1858.1858_1858_1863; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; Chen DM, 2006, J VIROL, V80, P9811, DOI 10.1128/JVI.00872-06; Chen DM, 2009, J VIROL, V83, P722, DOI 10.1128/JVI.01517-08; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Dela Cruz CS, 2004, J EXP MED, V199, P503, DOI 10.1084/jem.20031205; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; El-Guindy AS, 2002, J VIROL, V76, P11199, DOI 10.1128/JVI.76.22.11199-11208.2002; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Hideshima T, 2000, CLIN CANCER RES, V6, P1180; High S, 2000, FEBS LETT, V476, P38, DOI 10.1016/S0014-5793(00)01666-5; Hoischen SH, 2000, EUR J BIOCHEM, V267, P3604, DOI 10.1046/j.1432-1327.2000.01389.x; Jones KD, 1999, BLOOD, V94, P2871; Meads MB, 2004, J BIOL CHEM, V279, P51793, DOI 10.1074/jbc.M407382200; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Nicholas J, 1997, NAT MED, V3, P287, DOI 10.1038/nm0397-287; Nicholas J, 2007, FRONT BIOSCI-LANDMRK, V12, P265, DOI 10.2741/2063; Osborne J, 1999, HUM IMMUNOL, V60, P921, DOI 10.1016/S0198-8859(99)00083-X; Papanicolaou DA, 1998, ANN INTERN MED, V128, P127, DOI 10.7326/0003-4819-128-2-199801150-00009; Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797	31	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29269	29282		10.1074/jbc.M109.039115	http://dx.doi.org/10.1074/jbc.M109.039115			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19690161	Green Published, hybrid			2022-12-25	WOS:000270896800006
J	Lee, DW; Rajagopalan, S; Siddiq, A; Gwiazda, R; Yang, LC; Beal, MF; Ratan, RR; Andersen, JK				Lee, Donna W.; Rajagopalan, Subramanian; Siddiq, Ambreena; Gwiazda, Roberto; Yang, Lichuan; Beal, M. Flint; Ratan, Rajiv R.; Andersen, Julie K.			Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity MODEL FOR THE POTENTIAL INVOLVEMENT OF THE HYPOXIA-INDUCIBLE FACTOR PATHWAY IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; DOPAMINERGIC-NEURONS; CEREBRAL-ISCHEMIA; HEME OXYGENASE-1; GENE-EXPRESSION; KYNURENIC ACID; BASAL GANGLIA; IRON CONTENT	Hypoxia-inducible factor (HIF) plays an important role in cell survival by regulating iron, antioxidant defense, and mitochondrial function. Pharmacological inhibitors of the iron-dependent enzyme class prolyl hydroxylases (PHD), which target alpha subunits of HIF proteins for degradation, have recently been demonstrated to alleviate neurodegeneration associated with stroke and hypoxic-ischemic injuries. Here we report that inhibition of PHD by 3,4-dihydroxybenzoate (DHB) protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigral dopaminergic cell loss and up-regulates HIF-1 alpha within these neurons. Elevations in mRNA and protein levels of HIF-dependent genes heme oxygenase-1 (Ho-1) and manganese superoxide dismutase (Mnsod) following DHB pretreatment alone are also maintained in the presence of MPTP. MPTP-induced reductions in ferroportin and elevations in nigral and striatal iron levels were reverted to levels comparable with that of untreated controls with DHB pretreatment. Reductions in pyruvate dehydrogenase mRNA and activity resulting from MPTP were also found to be attenuated by DHB. In vitro, the HIF pathway was activated in N27 cells grown at 3% oxygen treated with either PHD inhibitors or an iron chelator. Concordant with our in vivo data, the MPP+-elicited increase in total iron as well as decreases in cell viability were attenuated in the presence of DHB. Taken together, these data suggest that protection against MPTP neurotoxicity may be mediated by alterations in iron homeostasis and defense against oxidative stress and mitochondrial dysfunction brought about by cellular HIF-1 alpha induction. This study provides novel data extending the possible therapeutic utility of HIF induction to a Parkinson disease model of neurodegeneration, which may prove beneficial not only in this disorder itself but also in other diseases associated with metal-induced oxidative stress.	[Lee, Donna W.; Rajagopalan, Subramanian; Andersen, Julie K.] Buck Inst Age Res, Novato, CA 94945 USA; [Siddiq, Ambreena; Ratan, Rajiv R.] Burke Cornell Med Res Inst, White Plains, NY 10605 USA; [Gwiazda, Roberto] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Yang, Lichuan; Beal, M. Flint] Cornell Univ, Weill Med Coll, New York, NY 10065 USA	Buck Institute for Research on Aging; University of California System; University of California Santa Cruz; Cornell University	Andersen, JK (corresponding author), 8001 Redwood Blvd, Novato, CA 94945 USA.	jandersen@buckinstitute.org		Andersen, Julie/0000-0003-1324-4875	National Institutes of Health [NS041264]; American Parkinson's Disease Association; Larry L. Hillblom Foundation fellowships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson's Disease Association; Larry L. Hillblom Foundation fellowships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS041264 (to J. K. A.). This work was also supported by the American Parkinson's Disease Association and Larry L. Hillblom Foundation fellowships (to D. W. L.).	AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; BEAL MF, 1992, J NEUROL SCI, V108, P80; BEAL MF, 1990, J NEUROCHEM, V55, P1327, DOI 10.1111/j.1471-4159.1990.tb03143.x; Callapina M, 2005, EXP CELL RES, V306, P274, DOI 10.1016/j.yexcr.2005.02.018; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; Connor JR, 1995, J NEUROL SCI, V134, P33, DOI 10.1016/0022-510X(95)00206-H; Cosi C, 1998, BRAIN RES, V809, P58, DOI 10.1016/S0006-8993(98)00829-4; Deudero JJP, 2008, J BIOL CHEM, V283, P11435, DOI 10.1074/jbc.M703875200; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; GRAHAM DG, 1978, MOL PHARMACOL, V14, P644; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Greenberg DA, 2004, TRENDS MOL MED, V10, P1, DOI 10.1016/j.molmed.2003.11.006; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haavik J, 1997, J NEUROCHEM, V68, P328; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; He Y, 2003, FREE RADICAL BIO MED, V35, P540, DOI 10.1016/S0891-5849(03)00385-X; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang E, 2004, NEUROSCIENCE, V128, P487, DOI 10.1016/j.neuroscience.2004.06.055; HURN PD, 1995, STROKE, V26, P688, DOI 10.1161/01.STR.26.4.688; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klivenyi P, 1998, NEUROBIOL DIS, V5, P253, DOI 10.1006/nbdi.1998.0191; Lan J, 1997, J NEURAL TRANSM, V104, P469, DOI 10.1007/BF01277665; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Luo G, 1997, GENE EXPRESSION, V6, P287; MAJAMAA K, 1986, J BIOL CHEM, V261, P7819; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Martin-Puig S, 2004, J BIOL CHEM, V279, P9504, DOI 10.1074/jbc.M310658200; Molina-Holgado F, 2008, J NEUROCHEM, V105, P2466, DOI 10.1111/j.1471-4159.2008.05332.x; Mu DZ, 2003, NEUROBIOL DIS, V14, P524, DOI 10.1016/j.nbd.2003.08.020; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pichiule P, 2003, ADV EXP MED BIOL, V530, P611; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Ratan RR, 2004, STROKE, V35, P2687, DOI 10.1161/01.STR.0000143216.85349.9e; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; SMITH DR, 1992, TOXICOL APPL PHARM, V116, P85, DOI 10.1016/0041-008X(92)90148-L; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; TANAKA M, 1991, J NEUROL SCI, V101, P198, DOI 10.1016/0022-510X(91)90046-A; TETRUD JW, 1989, NEUROLOGY, V39, P1483, DOI 10.1212/WNL.39.11.1483; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tian Youyong, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P670, DOI 10.1007/s11596-006-0611-7; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; Viatte L, 2005, BLOOD, V105, P4861, DOI 10.1182/blood-2004-12-4608; WANG GL, 1993, BLOOD, V82, P3610; Wang J, 2009, NEUROCHEM INT, V54, P43, DOI 10.1016/j.neuint.2008.10.003; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; WARD RJ, 1995, BIOCHEM PHARMACOL, V49, P1821, DOI 10.1016/0006-2952(94)00521-M; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wright WE, 2006, NAT PROTOC, V1, P2088, DOI 10.1038/nprot.2006.374; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Xu HM, 2008, NEUROCHEM INT, V52, P1044, DOI 10.1016/j.neuint.2007.10.019; Yasuhara T, 2005, BRAIN RES, V1053, P10, DOI 10.1016/j.brainres.2005.05.027; Yasuhara T, 2004, EUR J NEUROSCI, V19, P1494, DOI 10.1111/j.1460-9568.2004.03254.x; Youdim MBH, 2004, ANN NY ACAD SCI, V1012, P306, DOI 10.1196/annals.1306.025; Zhang SZ, 2009, NEUROBIOL AGING, V30, P1466, DOI 10.1016/j.neurobiolaging.2007.11.025	67	84	94	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29065	29076		10.1074/jbc.M109.000638	http://dx.doi.org/10.1074/jbc.M109.000638			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679656	Green Published, hybrid			2022-12-25	WOS:000270678900063
J	Polzien, L; Baljuls, A; Rennefahrt, UEE; Fischer, A; Schmitz, W; Zahedi, RP; Sickmann, A; Metz, R; Albert, S; Benz, R; Hekman, M; Rapp, UR				Polzien, Lisa; Baljuls, Angela; Rennefahrt, Ulrike E. E.; Fischer, Andreas; Schmitz, Werner; Zahedi, Rene P.; Sickmann, Albert; Metz, Renate; Albert, Stefan; Benz, Roland; Hekman, Mirko; Rapp, Ulf R.			Identification of Novel in Vivo Phosphorylation Sites of the Human Proapoptotic Protein BAD PORE-FORMING ACTIVITY OF BAD IS REGULATED BY PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; OUTER MITOCHONDRIAL-MEMBRANE; PROGRAMMED CELL-DEATH; BCL-2 FAMILY; GROWTH-FACTOR; PERMEABILITY TRANSITION; CYTOCHROME-C; ION-CHANNEL; POLYACRYLAMIDE-GELS; STRUCTURAL BIOLOGY	BAD is a proapoptotic member of the Bcl-2 protein family that is regulated by phosphorylation in response to survival factors. Although much attention has been devoted to the identification of phosphorylation sites in murine BAD, little data are available with respect to phosphorylation of human BAD protein. Using mass spectrometry, we identified here besides the established phosphorylation sites at serines 75, 99, and 118 several novel in vivo phosphorylation sites within human BAD (serines 25, 32/34, 97, and 124). Furthermore, we investigated the quantitative contribution of BAD targeting kinases in phosphorylating serine residues 75,99, and 118. Our results indicate that RAF kinases represent, besides protein kinase A, PAK, and Akt/protein kinase B, in vivo BAD-phosphorylating kinases. RAF-induced phosphorylation of BAD was reduced to control levels using the RAF inhibitor BAY 43-9006. This phosphorylation was not prevented by MEK inhibitors. Consistently, expression of constitutively active RAF suppressed apoptosis induced by BAD and the inhibition of colony formation caused by BAD could be prevented by RAF. In addition, using the surface plasmon resonance technique, we analyzed the direct consequences of BAD phosphorylation by RAF with respect to association with 14-3-3 and Bcl-2/Bcl-X-L proteins. Phosphorylation of BAD by active RAF promotes 14-3-3 protein association, in which the phosphoserine 99 represented the major binding site. Finally, we show here that BAD forms channels in planar bilayer membranes in vitro. This pore-forming capacity was dependent on phosphorylation status and interaction with 14-3-3 proteins. Collectively, our findings provide new insights into the regulation of BAD function by phosphorylation.	[Polzien, Lisa; Baljuls, Angela; Rennefahrt, Ulrike E. E.; Fischer, Andreas; Metz, Renate; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Inst Med Radiat & Cell Res, D-97078 Wurzburg, Germany; [Schmitz, Werner] Univ Wurzburg, Inst Physiol Chem, D-97078 Wurzburg, Germany; [Albert, Stefan] Univ Wurzburg, Julius von Sachs Inst Biosci, D-97078 Wurzburg, Germany; [Benz, Roland] Univ Wurzburg, Inst Biotechnol, D-97078 Wurzburg, Germany; [Zahedi, Rene P.; Sickmann, Albert] Inst Sci Anal, Dept Bioanalyt, D-44139 Dortmund, Germany; [Sickmann, Albert] Ruhr Univ Bochum, Med Proteome Ctr, D-44801 Bochum, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Ruhr University Bochum	Rapp, UR (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Versbacher Str 5, D-97078 Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de	Zahedi, René/A-9148-2012; Sickmann, Albert/A-1010-2011; Zahedi, Rene/HGU-5710-2022	Zahedi, René/0000-0002-4960-5460; Sickmann, Albert/0000-0002-2388-5265; Benz, Roland/0000-0002-9510-9265	Ministerium fur Innovation, Wissenschaft, Forschung, und Technologie des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [SFB 487, C3]	Ministerium fur Innovation, Wissenschaft, Forschung, und Technologie des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Ministerium fur Innovation, Wissenschaft, Forschung, und Technologie des Landes Nordrhein-Westfalen and by the Bundesministerium fur Bildung und Forschung. This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB 487, Project C3.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Baljuls A, 2008, J BIOL CHEM, V283, P27239, DOI 10.1074/jbc.M801782200; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BENZ R, 1992, BIOL CHEM H-S, V373, P295, DOI 10.1515/bchm3.1992.373.1.295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Fleischer A, 2004, MOL CANCER RES, V2, P674; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fueller J, 2008, BIOCHEM BIOPH RES CO, V370, P552, DOI 10.1016/j.bbrc.2008.03.141; Galmiche A, 2008, J BIOL CHEM, V283, P14857, DOI 10.1074/jbc.M709098200; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; HOSANG M, 1985, J CELL BIOCHEM, V29, P265, DOI 10.1002/jcb.240290310; HUANG RRC, 1990, MOL PHARMACOL, V37, P304; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Jonas EA, 2005, J BIOL CHEM, V280, P4491, DOI 10.1074/jbc.M410661200; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Jonas EA, 2003, J NEUROSCI, V23, P8423; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kebache S, 2007, J BIOL CHEM, V282, P21873, DOI 10.1074/jbc.M611066200; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Klumpp S, 2004, NEUROCHEM INT, V45, P747, DOI 10.1016/j.neuint.2004.02.006; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Le Mellay V, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-14; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Manich M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003764; Martinez-Senac MD, 2002, BIOPHYS J, V82, P233, DOI 10.1016/S0006-3495(02)75390-3; Martinez-Senac MD, 2001, BIOCHEMISTRY-US, V40, P9983; Martinez-Senac MD, 2000, BIOCHEMISTRY-US, V39, P7744, DOI 10.1021/bi000256h; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; Rapp UR, 2004, BBA-MOL CELL RES, V1644, P149, DOI 10.1016/j.bbamcr.2003.10.015; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Troppmair J, 2003, BIOCHEM PHARMACOL, V66, P1341, DOI 10.1016/S0006-2952(03)00483-0; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wei MC, 2000, GENE DEV, V14, P2060; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533; Zamzami N, 2003, CURR BIOL, V13, pR71, DOI 10.1016/S0960-9822(02)01433-1; Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang JY, 2005, CANCER RES, V65, P8372, DOI 10.1158/0008-5472.CAN-05-0576; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	100	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28004	28020		10.1074/jbc.M109.010702	http://dx.doi.org/10.1074/jbc.M109.010702			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19667065	Green Published, hybrid			2022-12-25	WOS:000270676300029
J	Niiya, D; Egawa, N; Sakamoto, T; Kikkawa, Y; Shinkawa, T; Isobe, T; Koshikawa, N; Seiki, M				Niiya, Daigo; Egawa, Nagayasu; Sakamoto, Takeharu; Kikkawa, Yamato; Shinkawa, Takashi; Isobe, Toshiaki; Koshikawa, Naohiko; Seiki, Motoharu			Identification and Characterization of Lutheran Blood Group Glycoprotein as a New Substrate of Membrane-type 1 Matrix Metalloproteinase 1 (MT1-MMP) A SYSTEMIC WHOLE CELL ANALYSIS OF MT1-MMP-ASSOCIATING PROTEINS IN A431 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; EXTRACELLULAR-MATRIX; MASS-SPECTROMETRY; LAMININ; BINDING; INVASION; PROTEIN; CD44; PROTEOMICS; INHIBITOR	Membrane-type 1 matrix metalloproteinase 1 (MT1-MMP) is a potent modulator of the pericellular microenvironment and regulates cellular functions in physiological and pathological settings in mammals. MT1-MMP mediates its biological effects through cleavage of specific substrate proteins. However, our knowledge of MT1-MMP substrates remains limited. To identify new substrates of MT1-MMP, we purified proteins associating with MT1-MMP in human epidermoid carcinoma A431 cells and analyzed them by mass spectrometry. We identified 163 proteins, including membrane proteins, cytoplasmic proteins, and functionally unknown proteins. Sixty-four membrane proteins were identified, and they included known MT1-MMP substrates. Of these, eighteen membrane proteins were selected, and we confirmed their association with MT1-MMP using an immunoprecipitation assay. Co-expression of each protein together with MT1-MMP revealed that nine proteins were cleaved by MT1-MMP. Lutheran blood group glycoprotein (Lu) is one of the proteins cleaved by MT1-MMP, and we confirmed the cleavage of the endogenous Lu protein by endogenous MT1-MMP in A431 cells. Mutation of the cleavage site of Lu abrogated processing by MT1-MMP. Luprotein expressed in A431 cells bound to laminin-511, and knock down of MT1-MMP in these cells increased both their binding to laminin-511 and the amount of Lu protein on the cell surface. Thus, the identified membrane proteins associated with MT1-MMP are an enriched source of physiological MT1-MMP substrates.	[Niiya, Daigo; Egawa, Nagayasu; Sakamoto, Takeharu; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan; [Egawa, Nagayasu] Natl Canc Ctr, Res Inst, Div Virol, Chuo Ku, Tokyo 1040045, Japan; [Kikkawa, Yamato] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan; [Shinkawa, Takashi; Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Tokyo 1920397, Japan	University of Tokyo; National Cancer Center - Japan; Tokyo University of Pharmacy & Life Sciences; Tokyo Metropolitan University	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Kikkawa, Yamato/D-1503-2010; Isobe, Toshiaki/Q-9279-2017; Koshikawa, Naohiko/S-7306-2017; Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Koshikawa, Naohiko/0000-0002-4539-888X; Sakamoto, Takeharu/0000-0002-1225-1902; 	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas "Integrative Research Toward the Conquest of Cancer" and was supported in part by Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology.	Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Nemer W, 1998, J BIOL CHEM, V273, P16686; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hwang IK, 2004, BBA-PROTEINS PROTEOM, V1702, P79, DOI 10.1016/j.bbapap.2004.08.001; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	33	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27360	27369		10.1074/jbc.M109.029124	http://dx.doi.org/10.1074/jbc.M109.029124			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19667067	hybrid, Green Published			2022-12-25	WOS:000270232300037
J	Scholz, R; Suter, M; Weimann, T; Polge, C; Konarev, PV; Thali, RF; Tuerk, RD; Viollet, B; Wallimann, T; Schlattner, U; Neumann, D				Scholz, Roland; Suter, Marianne; Weimann, Theodore; Polge, Cecile; Konarev, Petr V.; Thali, Ramon F.; Tuerk, Roland D.; Viollet, Benoit; Wallimann, Theo; Schlattner, Uwe; Neumann, Dietbert			Homo-oligomerization and Activation of AMP-activated Protein Kinase Are Mediated by the Kinase Domain alpha G-Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; METABOLIC SYNDROME; INSULIN-RECEPTOR; STRUCTURAL BASIS; TYROSINE KINASE; CELL-GROWTH; RAT-LIVER; IN-VITRO; PHOSPHORYLATION; MECHANISM	AMP-activated protein kinase (AMPK) is a heterotrimeric complex playing a crucial role in maintaining cellular energy homeostasis. Recently, homodimerization of mammalian AMPK and yeast ortholog SNF1 was shown by us and others. In SNF1, it involved specific hydrophobic residues in the kinase domain alpha G-helix. Mutation of the corresponding AMPK alpha-subunit residues (Val-219 and Phe-223) to glutamate reduced the tendency of the kinase to form higher order homo-oligomers, as was determined by the following three independent techniques in vitro: (i) small angle x-ray scattering, (ii) surface plasmon resonance spectroscopy, and (iii) two-dimensional blue native/SDS-PAGE. Recombinant protein as well as AMPK in cell lysates of primary cells revealed distinct complexes of various sizes. In particular, the assembly of very high molecular mass complexes was dependent on both the alpha G-helix-mediated hydrophobic interactions and kinase activation. In vitro and when overexpressed in double knock-out (alpha 1(-/-), alpha 2(-/-)) mouse embryonic fibroblast cells, activation of mutant AMPK was impaired, indicating a critical role of the alpha G-helix residues for AMPK activation via its upstream kinases. Also inactivation by protein phosphatase 2C alpha was affected in mutant AMPK. Importantly, activation of mutant AMPK by LKB1 was restored by exchanging the corresponding and conserved hydrophobic alpha G-helix residues of LKB1 (Ile-260 and Phe-264) to positively charged amino acids. These mutations functionally rescued LKB1-dependent activation of mutant AMPK in vitro and in cell culture. Our data suggest a physiological role for the hydrophobic alpha G-helix residues in homo-oligomerization of heterotrimers and cellular interactions, in particular with upstream kinases, indicating an additional level of AMPK regulation.	[Scholz, Roland; Suter, Marianne; Thali, Ramon F.; Tuerk, Roland D.; Wallimann, Theo; Neumann, Dietbert] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Weimann, Theodore; Polge, Cecile; Schlattner, Uwe] Univ Grenoble 1, Lab Fundamental & Appl Bioenerget, INSERM, U884, F-38041 Grenoble, France; [Konarev, Petr V.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia; [Konarev, Petr V.] DESY, EMBL, D-22603 Hamburg, Germany; [Viollet, Benoit] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, F-75014 Paris, France; [Viollet, Benoit] INSERM, U567, Inst Cochin IC, F-75014 Paris, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Neumann, D (corresponding author), ETH, Inst Cell Biol, Dept Biol, Schafmattstr 18,HPM D23, CH-8093 Zurich, Switzerland.	dietbert.neumann@cell.biol.ethz.ch	Scholz, Roland W./AAH-8385-2020; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Wallimann, Theo/C-6047-2008; Polge, Cécile/AAM-2467-2020; Konarev, Petr V/W-1380-2017; Schlattner, Uwe/D-1267-2009	Scholz, Roland W./0000-0003-2506-3254; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Wallimann, Theo/0000-0003-4957-5836; Polge, Cécile/0000-0002-8730-5776; Schlattner, Uwe/0000-0003-1159-5911; Neumann, Dietbert/0000-0002-4316-684X; Konarev, Petr/0000-0002-5606-1596	Swiss National Science Foundation [3100A0114137]; ETH; Krebsliga Zentralschweiz; FP-6 European Union Framework Programme Project [LSHM-CT-2004-005272]; French Agence Nationale de Recherche	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH(ETH Zurich); Krebsliga Zentralschweiz; FP-6 European Union Framework Programme Project(European Commission); French Agence Nationale de Recherche(French National Research Agency (ANR))	This work was supported by Swiss National Science Foundation Grant 3100A0114137, ETH graduate student grants (to R. F. T. and R. S.), the Krebsliga Zentralschweiz (to D. N.), FP-6 European Union Framework Programme Project LSHM-CT-2004-005272 EXGENESIS, INSERM, and the French Agence Nationale de Recherche ("Chaire d'Excellence" given to U.S.).	Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1999, BIOCHEM SOC SYMP, P13; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HJERTEN S, 1962, ARCH BIOCHEM BIOPHYS, V99, P466, DOI 10.1016/0003-9861(62)90295-3; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Huang JH, 2003, BIOCHEM BIOPH RES CO, V303, P532, DOI 10.1016/S0006-291X(03)00387-5; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Klumpp S, 2006, BIOCHEM SOC T, V34, P1370, DOI 10.1042/BST0341370; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Neumann D, 2003, BIOCHEM SOC T, V31, P169, DOI 10.1042/bst0310169; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Riek Uwe, 2009, Biotechniques, V46, pix, DOI 10.2144/000113130; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Saks V, 2008, INT J MOL SCI, V9, P751, DOI 10.3390/ijms9050751; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Tu Z, 2003, CELL SIGNAL, V15, P65, DOI 10.1016/S0898-6568(02)00056-6; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	90	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27425	27437		10.1074/jbc.M109.047670	http://dx.doi.org/10.1074/jbc.M109.047670			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651772	hybrid, Green Published			2022-12-25	WOS:000270232300045
J	Kikuchi, K; Abdel-Aziz, HI; Taniguchi, Y; Yamazoe, M; Takeda, S; Hirota, K				Kikuchi, Koji; Abdel-Aziz, H. Ismail; Taniguchi, Yoshihito; Yamazoe, Mitsuyoshi; Takeda, Shunichi; Hirota, Kouji			Bloom DNA Helicase Facilitates Homologous Recombination between Diverged Homologous Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; SISTER-CHROMATID EXCHANGES; V GENE CONVERSION; CHROMOSOMAL INTEGRITY; RECQ HELICASES; SGS1 HELICASE; DEAMINASE AID; RESECT DNA; BLM; ROLES	Bloom syndrome caused by inactivation of the Bloom DNA helicase (Blm) is characterized by increases in the level of sister chromatid exchange, homologous recombination (HR) associated with cross-over. It is therefore believed that Blm works as an anti-recombinase. Meanwhile, in Drosophila, DmBlm is required specifically to promote the synthesis-dependent strand anneal (SDSA), a type of HR not associating with cross-over. However, conservation of Blm function in SDSA through higher eukaryotes has been a matter of debate. Here, we demonstrate the function of Blm in SDSA type HR in chicken DT40 B lymphocyte line, where Ig gene conversion diversifies the immunoglobulin V gene through intragenic HR between diverged homologous segments. This reaction is initiated by the activation-induced cytidine deaminase enzyme-mediated uracil formation at the V gene, which in turn converts into abasic site, presumably leading to a single strand gap. Ig gene conversion frequency was drastically reduced in BLM-/- cells. In addition, BLM-/- cells used limited donor segments harboring higher identity compared with other segments in Ig gene conversion event, suggesting that Blm can promote HR between diverged sequences. To further understand the role of Blm in HR between diverged homologous sequences, we measured the frequency of gene targeting induced by an I-SceI-endonuclease-mediated double-strand break. BLM-/- cells showed a severer defect in the gene targeting frequency as the number of heterologous sequences increased at the double-strand break site. Conversely, the overexpression of Blm, even an ATPase-defective mutant, strongly stimulated gene targeting. In summary, Blm promotes HR between diverged sequences through a novel ATPase-independent mechanism.	[Kikuchi, Koji; Abdel-Aziz, H. Ismail; Taniguchi, Yoshihito; Yamazoe, Mitsuyoshi; Takeda, Shunichi; Hirota, Kouji] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan.	khirota@rg.med.kyoto-u.ac.jp	Kikuchi, Koji/W-1048-2017; Taniguchi, Yoshihito/L-5746-2013	Kikuchi, Koji/0000-0002-7616-8200; Takeda, Shunichi/0000-0002-7924-7991; Manhi, Hoida/0000-0003-3503-211X	Program for Promotion of Basic Research Activities for Innovative Biosciences; Uehara Memorial Foundation; Naito Foundation; Kanae Foundation; NATIONAL CANCER INSTITUTE [R01CA100839, R56CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH084119] Funding Source: NIH RePORTER	Program for Promotion of Basic Research Activities for Innovative Biosciences; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Kanae Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by funds from the Program for Promotion of Basic Research Activities for Innovative Biosciences (to S. T.), grants from the Uehara Memorial Foundation and the Naito Foundation (to S. T.), and grants from the Kanae Foundation (to K. K.).	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Bugreev DV, 2009, J BIOL CHEM, V284, P26349, DOI 10.1074/jbc.M109.029371; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cobb JA, 2006, NUCLEIC ACIDS RES, V34, P4106, DOI 10.1093/nar/gkl557; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Imamura O, 2002, ONCOGENE, V21, P954, DOI 10.1038/sj.onc.1205143; Inbar O, 1999, MOL CELL BIOL, V19, P4134; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kikuchi K, 2005, MOL CELL BIOL, V25, P6948, DOI 10.1128/MCB.25.16.6948-6955.2005; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kohzaki M, 2007, MOL CELL BIOL, V27, P2812, DOI 10.1128/MCB.02043-06; Lanning D, 2000, IMMUNOL REV, V175, P214, DOI 10.1034/j.1600-065X.2000.017516.x; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakahara M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000356; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Otsuki M, 2007, J CELL BIOL, V179, P53, DOI 10.1083/jcb.200702183; Otsuki M, 2007, BIOCHEM BIOPH RES CO, V355, P477, DOI 10.1016/j.bbrc.2007.01.175; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Saberi A, 2008, MOL CELL BIOL, V28, P6113, DOI 10.1128/MCB.00156-08; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; So S, 2006, GENES CELLS, V11, P363, DOI 10.1111/j.1365-2443.2006.00944.x; So S, 2004, J BIOL CHEM, V279, P55433, DOI 10.1074/jbc.M409827200; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	52	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26360	26367		10.1074/jbc.M109.029348	http://dx.doi.org/10.1074/jbc.M109.029348			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19661064	Green Published, hybrid			2022-12-25	WOS:000269969600016
J	Stiffler, JD; Nguyen, M; Sohn, JA; Liu, C; Kaplan, D; Seeger, C				Stiffler, J. David; Nguyen, Minhhuyen; Sohn, Ji A.; Liu, Chen; Kaplan, David; Seeger, Christoph			Focal Distribution of Hepatitis C Virus RNA in Infected Livers	PLOS ONE			English	Article								Background: Hepatitis C virus (HCV) is a plus-strand RNA virus that replicates by amplification of genomic RNA from minus strands leading to accumulation of almost one thousand copies per cell under in vitro cell culture conditions. In contrast, HCV RNA copy numbers in livers of infected patients appear to be much lower, estimated at a few copies per cell. Methodology/Principal Findings: To gain insights into mechanisms that control HCV replication in vivo, we analyzed HCV RNA levels as well as expression of interferon beta (IFN beta) and several interferon stimulated genes (ISGs) from whole liver sections and micro-dissected subpopulations of hepatocytes in biopsy samples from 21 HCV-infected patients. The results showed that intrahepatic HCV RNA levels range form less than one copy per hepatocyte to a maximum of about eight. A correlation existed between viral RNA levels and IFN beta expression, but not between viral RNA and ISG levels. Also, IFN beta expression did not correlate with ISGs levels. Replication of HCV RNA occurred in focal areas in the liver in the presence of a general induction of ISGs. Conclusion/Significance: The low average levels of HCV RNA in biopsy samples can be explained by focal distribution of infected hepatocytes. HCV replication directly induces IFN beta, which then activates ISGs. The apparent lack of a correlation between levels of IFN beta and ISG expression indicates that control of the innate immune response during HCV infections depends on multiple factors.			Stiffler, JD (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	seeger@fccc.edu		Kaplan, David/0000-0002-3839-336X				Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; Evans Jared D, 2006, Hepatology, V43, P615, DOI 10.1002/hep.21096; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Frese M, 2002, HEPATOLOGY, V35, P694, DOI 10.1053/jhep.2002.31770; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Gosalvez J, 1998, HEPATOLOGY, V27, P1428, DOI 10.1002/hep.510270534; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Jo J, 2009, GASTROENTEROLOGY, V136, P1391, DOI 10.1053/j.gastro.2008.12.034; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; KATO T, 1992, VIROLOGY, V190, P856, DOI 10.1016/0042-6822(92)90925-F; LANFORD RE, 1995, J VIROL, V69, P8079, DOI 10.1128/JVI.69.12.8079-8083.1995; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pal S, 2006, J VIROL, V80, P2280, DOI 10.1128/JVI.80.5.2280-2290.2006; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; SELL S, 1997, LIVER STEM CELLS, P83; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Vona G, 2004, J HEPATOL, V40, P682, DOI 10.1016/j.jhep.2003.12.012; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	31	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6661	10.1371/journal.pone.0006661	http://dx.doi.org/10.1371/journal.pone.0006661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688046	Green Published, Green Submitted, gold			2022-12-25	WOS:000269075800004
J	Tee, KK; Kusagawa, S; Li, XJ; Onogi, N; Isogai, M; Hase, S; Uenishi, R; Liao, HN; Kamarulzaman, A; Takebe, Y				Tee, Kok Keng; Kusagawa, Shigeru; Li, Xiao-Jie; Onogi, Narumi; Isogai, Maya; Hase, Saiki; Uenishi, Rie; Liao, Huanan; Kamarulzaman, Adeeba; Takebe, Yutaka			Isolation and Characterization of a Replication-Competent Molecular Clone of an HIV-1 Circulating Recombinant Form (CRF33_01B)	PLOS ONE			English	Article							SUBTYPE-B; CONSTRUCTION; IDENTIFICATION; CRF15-01B; CRF01-AE	A growing number of emerging HIV-1 recombinants classified as circulating recombinant forms (CRFs) have been identified in Southeast Asia in recent years, establishing a molecular diversity of increasing complexity in the region. Here, we constructed a replication-competent HIV-1 clone for CRF33_01B (designated p05MYKL045.1), a newly identified recombinant comprised of CRF01_AE and subtype B. p05MYKL045.1 was reconstituted by cloning of the near full-length HIV-1 sequence from a newly-diagnosed individual presumably infected heterosexually in Kuala Lumpur, Malaysia. The chimeric clone, which contains the 59 LTR (long terminal repeat) region of p93JP-NH1 (a previously isolated CRF01_AE infectious clone), showed robust viral replication in the human peripheral blood mononuclear cells. This clone demonstrated robust viral propagation and profound syncytium formation in CD4(+), CXCR4-expressing human glioma NP-2 cells, indicating that p05MYKL045.1 is a CXCR4-using virus. Viral propagation, however, was not detected in various human T cell lines including MT-2, M8166, Sup-T1, H9, Jurkat, Molt-4 and PM1.p05MYKL045.1 appears to proliferate only in restricted host range, suggesting that unknown viral and/or cellular host factors may play a role in viral infectivity and replication in human T cell lines. Availability of a CRF33_01B molecular clone will be useful in facilitating the development of vaccine candidates that match the HIV-1 strains circulating in Southeast Asia.			Tee, KK (corresponding author), Natl Inst Infect Dis, Lab Mol Virol & Epidemiol, AIDS Res Ctr, Shinjuku Ku, Tokyo, Japan.	takebe@nih.go.jp	Tee, Kok Keng/A-8148-2008	Tee, Kok Keng/0000-0002-7923-5448				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; [Anonymous], AIDS EP UPD DEC 2007; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Kato K, 1999, J VIROL, V73, P5520, DOI 10.1128/JVI.73.7.5520-5526.1999; Kusagawa S, 2002, AIDS RES HUM RETROV, V18, P115, DOI 10.1089/08892220252779656; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mukai T, 2002, AIDS RES HUM RETROV, V18, P585, DOI 10.1089/088922202753747932; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Salminen MO, 2000, VIROLOGY, V278, P103, DOI 10.1006/viro.2000.0640; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Takebe Y, 2008, ADV PHARMACOL, V56, P1, DOI 10.1016/S1054-3589(07)56001-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tebit DM, 2007, AIDS REV, V9, P75; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2007, AIDS RES HUM RETROV, V23, P829, DOI 10.1089/aid.2006.0300; Wang Z, 2008, AIDS RES HUM RETROV, V24, P251, DOI 10.1089/aid.2007.0226; LOS ALAMOS HIV SEQUE	22	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6666	10.1371/journal.pone.0006666	http://dx.doi.org/10.1371/journal.pone.0006666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688091	Green Published, Green Submitted, gold			2022-12-25	WOS:000269075800005
J	Barnes, A; Bullmore, ET; Suckling, J				Barnes, Anna; Bullmore, Edward T.; Suckling, John			Endogenous Human Brain Dynamics Recover Slowly Following Cognitive Effort	PLOS ONE			English	Article							FLUCTUATIONS; OSCILLATIONS; NOISE	Background: In functional magnetic resonance imaging, the brain's response to experimental manipulation is almost always assumed to be independent of endogenous oscillations. To test this, we addressed the possible interaction between cognitive task performance and endogenous fMRI oscillations in an experiment designed to answer two questions: 1) Does performance of a cognitively effortful task significantly change fractal scaling properties of fMRI time series compared to their values before task performance? 2) If so, can we relate the extent of task-related perturbation to the difficulty of the task? Methodology/Principal Findings: Using a novel continuous acquisition "rest-task-rest'' design, we found that endogenous dynamics tended to recover their pre-task parameter values relatively slowly, over the course of several minutes, following completion of one of two versions of the n-back working memory task and that the rate of recovery was slower following completion of the more demanding (n = 2) version of the task. Conclusion/Significance: This result supports the model that endogenous low frequency oscillatory dynamics are relevant to the brain's response to exogenous stimulation. Moreover, it suggests that large-scale neurocognitive systems measured using fMRI, like the heart and other physiological systems subjected to external demands for enhanced performance, can take a considerable period of time to return to a stable baseline state.	[Barnes, Anna; Bullmore, Edward T.; Suckling, John] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Behav & Clin Neurosci Inst, Cambridge, England	University of Cambridge	Barnes, A (corresponding author), Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Behav & Clin Neurosci Inst, Cambridge, England.	ab369@cam.ac.uk	Bullmore, Ed/C-1706-2012; Barnes, Anna/AAV-8780-2021; Suckling, John/ABD-7246-2021	Bullmore, Ed/0000-0002-8955-8283; Barnes, Anna/0000-0002-6902-214X; Suckling, John/0000-0002-5098-1527	National Institute of Mental Health; National Institute of Biomedical Imaging and Bioengineering [5RO1EB001518-05]; Medical Research Council [G0001354, G0001354B] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001518] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by a Human Brain Project grant from the National Institute of Mental Health and the National Institute of Biomedical Imaging and Bioengineering (Grant Number: 5RO1EB001518-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bullmore ET, 2004, NEUROIMAGE, V23, pS234, DOI 10.1016/j.neuroimage.2004.07.012; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Suckling J, 2006, HUM BRAIN MAPP, V27, P425, DOI 10.1002/hbm.20252; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Wink AM, 2006, NEUROBIOL AGING, V27, P1395, DOI 10.1016/j.neurobiolaging.2005.08.011	18	134	135	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6626	10.1371/journal.pone.0006626	http://dx.doi.org/10.1371/journal.pone.0006626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680553	Green Published, gold, Green Submitted			2022-12-25	WOS:000268936200002
J	Jodoin, J; Misiewicz, M; Makhijani, P; Giannopoulos, PN; Hammond, J; Goodyer, CG; LeBlanc, AC				Jodoin, Julie; Misiewicz, Micheal; Makhijani, Priya; Giannopoulos, Paresa N.; Hammond, Jennifer; Goodyer, Cynthia G.; LeBlanc, Andrea C.			Loss of Anti-Bax Function in Gerstmann-Straussler-Scheinker Syndrome-Associated Prion Protein Mutants	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNALS; STRESS-INDUCIBLE PROTEIN-1; FATAL FAMILIAL INSOMNIA; MEDIATED CELL-DEATH; SPONGIFORM ENCEPHALOPATHIES; NEUROPROTECTIVE FUNCTION; THERMODYNAMIC STABILITY; PROTEASOMAL DEGRADATION; NUCLEOCAPSID PROTEIN; GASTRIC-CANCER	Previously, we have shown the loss of anti-Bax function in Creutzfeldt Jakob disease (CJD)-associated prion protein (PrP) mutants that are unable to generate cytosolic PrP (CyPrP). To determine if the anti-Bax function of PrP modulates the manifestation of prion diseases, we further investigated the anti-Bax function of eight familial Gerstmann-Straussler-Scheinker Syndrome (GSS)-associated PrP mutants. These PrP mutants contained their respective methionine ((M)) or valine ((V)) at codon 129. All of the mutants lost their ability to prevent Bax-mediated chromatin condensation or DNA fragmentation in primary human neurons. In the breast carcinoma MCF-7 cells, the F198S(V), D202N(V), P102L(V) and Q217R(V) retained, whereas the P102L(M), P105L(V), Y145stop(M) and Q212P(M) PrP mutants lost their ability to inhibit Bax-mediated condensed chromatin. The inhibition of Bax-mediated condensed chromatin depended on the ability of the mutants to generate cytosolic PrP. However, except for the P102L(V), none of the mutants significantly inhibited Bax-mediated caspase activation. These results show that the cytosolic PrP generated from the GSS mutants is not as efficient as wild type PrP in inhibiting Bax-mediated cell death. Furthermore, these results indicate that the anti-Bax function is also disrupted in GSS-associated PrP mutants and is not associated with the difference between CJD and GSS.	[Jodoin, Julie; Misiewicz, Micheal; Makhijani, Priya; Giannopoulos, Paresa N.; Hammond, Jennifer; LeBlanc, Andrea C.] Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Jodoin, Julie; LeBlanc, Andrea C.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Goodyer, Cynthia G.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Jodoin, J (corresponding author), Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ, Canada.	andrea.leblanc@mcgill.ca		Makhijani, Priya/0000-0002-1775-3303	National Institutes for Health [1RO1 NS-40431]; Canadian Institutes of Health Research [MOP 89376]; Fonds de Recherche en Sante du Quebec; NIH [HD 000836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040431] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes for Health (1RO1 NS-40431), the Canadian Institutes of Health Research (MOP 89376), and the Fonds de Recherche en Sante du Quebec. The Birth Defects Research Laboratory (University of Washington, Seattle, WA, USA) is funded by NIH HD 000836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Bugiani O, 2000, MICROSC RES TECHNIQ, V50, P10, DOI 10.1002/1097-0029(20000701)50:1<10::AID-JEMT3>3.3.CO;2-Y; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Collins S, 2001, J CLIN NEUROSCI, V8, P387, DOI 10.1054/jocn.2001.0919; Coulpier M, 2006, NEUROSCIENCE, V141, P1827, DOI 10.1016/j.neuroscience.2006.05.037; Crozet C, 2006, MOL CELL NEUROSCI, V32, P315, DOI 10.1016/j.mcn.2006.05.004; Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Du JP, 2005, INT J CANCER, V113, P213, DOI 10.1002/ijc.20570; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; GHETTI B, 1995, BRAIN PATHOL, V5, P61, DOI 10.1111/j.1750-3639.1995.tb00578.x; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; GOLDFARB LG, 1995, ANNU REV MED, V46, P57; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Hachiya NS, 2005, BIOCHEM BIOPH RES CO, V327, P894, DOI 10.1016/j.bbrc.2004.12.079; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; Jodoin J, 2007, J NEUROSCI, V27, P5081, DOI 10.1523/JNEUROSCI.0957-07.2007; Juanes ME, 2009, J BIOL CHEM, V284, P2787, DOI 10.1074/jbc.M804051200; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kiachopoulos S, 2005, J BIOL CHEM, V280, P9320, DOI 10.1074/jbc.M412525200; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Laroche-Pierre S, 2009, J NEUROCHEM, V108, P1019, DOI 10.1111/j.1471-4159.2008.05851.x; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; LeBlanc AC, 1997, J NEUROCHEM, V68, P1183; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liang J, 2006, TUMOR BIOL, V27, P84, DOI 10.1159/000092488; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lin DTS, 2008, BBA-MOL CELL RES, V1783, P2001, DOI 10.1016/j.bbamcr.2008.05.022; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Mange A, 2004, J CELL SCI, V117, P2411, DOI 10.1242/jcs.01094; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Meslin F, 2007, CANCER RES, V67, P10910, DOI 10.1158/0008-5472.CAN-07-0512; Mishra RS, 2003, J ALZHEIMERS DIS, V5, P15, DOI 10.3233/JAD-2003-5103; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Nikles D, 2008, BBA-MOL BASIS DIS, V1782, P335, DOI 10.1016/j.bbadis.2008.02.003; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; White FA, 1998, J NEUROSCI, V18, P1428; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zaidi SIA, 2005, J ALZHEIMERS DIS, V7, P159; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	65	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6647	10.1371/journal.pone.0006647	http://dx.doi.org/10.1371/journal.pone.0006647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680558	Green Submitted, Green Published, gold			2022-12-25	WOS:000268936200013
J	Serino, A; Annella, L; Avenanti, A				Serino, Andrea; Annella, Laura; Avenanti, Alessio			Motor Properties of Peripersonal Space in Humans	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; TRANSCRANIAL MAGNETIC STIMULATION; PREMOTOR CORTEX; POSTERIOR PARIETAL; FUNCTIONAL INTERPLAY; RESPONSE PROPERTIES; MULTISENSORY SPACE; BRAIN-STIMULATION; COIL ORIENTATION; HUMAN FMRI	Background: A stimulus approaching the body requires fast processing and appropriate motor reactions. In monkeys, fronto-parietal networks are involved both in integrating multisensory information within a limited space surrounding the body (i.e. peripersonal space, PPS) and in action planning and execution, suggesting an overlap between sensory representations of space and motor representations of action. In the present study we investigate whether these overlapping representations also exist in the human brain. Methodology/Principal Findings: We recorded from hand muscles motor-evoked potentials (MEPs) induced by single-pulse of transcranial magnetic stimulation (TMS) after presenting an auditory stimulus either near the hand or in far space. MEPs recorded 50 ms after the near-sound onset were enhanced compared to MEPs evoked after far sounds. This near-far modulation faded at longer inter-stimulus intervals, and reversed completely for MEPs recorded 300 ms after the sound onset. At that time point, higher motor excitability was associated with far sounds. Such auditory modulation of hand motor representation was specific to a hand-centred, and not a body-centred reference frame. Conclusions/Significance: This pattern of corticospinal modulation highlights the relation between space and time in the PPS representation: an early facilitation for near stimuli may reflect immediate motor preparation, whereas, at later time intervals, motor preparation relates to distant stimuli potentially approaching the body.	[Serino, Andrea; Avenanti, Alessio] Univ Bologna, Dipartimento Psicol, Bologna, Italy; [Serino, Andrea; Annella, Laura; Avenanti, Alessio] CsrNC, Bologna, Italy	University of Bologna	Serino, A (corresponding author), Univ Bologna, Dipartimento Psicol, Bologna, Italy.	andrea.serino@unibo.it; alessio.avenanti@unibo.it	Avenanti, Alessio/K-5250-2012	Avenanti, Alessio/0000-0003-1139-9996; Annella, Laura/0000-0003-2465-9291	University of Bologna	University of Bologna	The study was funded by the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Cerri G, 2003, J NEUROPHYSIOL, V90, P832, DOI 10.1152/jn.01026.2002; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Classen J, 2000, EXP BRAIN RES, V130, P48, DOI 10.1007/s002210050005; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2004, J NEUROPHYSIOL, V91, P1648, DOI 10.1152/jn.00955.2003; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; Davare M, 2008, J PHYSIOL-LONDON, V586, P2735, DOI 10.1113/jphysiol.2008.152603; diPellegrino G, 1997, NATURE, V388, P730, DOI 10.1038/41921; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; Facchini S, 2002, CLIN NEUROPHYSIOL, V113, P367, DOI 10.1016/S1388-2457(02)00009-3; Fisher RJ, 2004, EXP BRAIN RES, V157, P1, DOI 10.1007/s00221-003-1809-6; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Hallett M, 1999, EEG CL N SU, P183; JEANNEROD M, 1997, COGNITIVE NEUROSCIEN, P256; Keselman HJ, 2001, BRIT J MATH STAT PSY, V54, P1, DOI 10.1348/000711001159357; Koch G, 2008, J NEUROSCI, V28, P5944, DOI 10.1523/JNEUROSCI.0957-08.2008; Koch G, 2009, BEHAV BRAIN RES, V202, P147, DOI 10.1016/j.bbr.2009.03.023; Kuhn AA, 2004, EXP BRAIN RES, V155, P48, DOI 10.1007/s00221-003-1707-y; Ladavas E, 2008, COGN NEUROPSYCHOL, V25, P1099, DOI 10.1080/02643290802359113; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; MAKIN TR, 2008, CODING MULTISENSORY; Manganotti P, 1997, ELECTROMYOGR MOTOR C, V105, P280, DOI 10.1016/S0924-980X(97)00018-0; Matelli M, 2000, ADV NEUROL, V84, P51; Matelli M, 2001, NEUROIMAGE, V14, pS27, DOI 10.1006/nimg.2001.0835; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sambo CF, 2009, J COGNITIVE NEUROSCI, V21, P1550, DOI 10.1162/jocn.2009.21109; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Serino A, 2007, PSYCHOL SCI, V18, P642, DOI 10.1111/j.1467-9280.2007.01952.x; SPENCE C, 2008, HAPTIC RENDERING FDN, P21, DOI DOI 10.1201/B10636-4; Terao Y, 1995, ELECTROMYOGR MOTOR C, V97, P375, DOI 10.1016/0924-980X(95)00179-O	49	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6582	10.1371/journal.pone.0006582	http://dx.doi.org/10.1371/journal.pone.0006582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668366	Green Submitted, Green Published, gold			2022-12-25	WOS:000268935600010
J	Lacraz, G; Figeac, F; Movassat, J; Kassis, N; Coulaud, J; Galinier, A; Leloup, C; Bailbe, D; Homo-Delarche, F; Portha, B				Lacraz, Gregory; Figeac, Florence; Movassat, Jamileh; Kassis, Nadim; Coulaud, Josiane; Galinier, Anne; Leloup, Corinne; Bailbe, Danielle; Homo-Delarche, Francoise; Portha, Bernard			Diabetic beta-Cells Can Achieve Self-Protection against Oxidative Stress through an Adaptive Up-Regulation of Their Antioxidant Defenses	PLOS ONE			English	Article								Background: Oxidative stress (OS), through excessive and/or chronic reactive oxygen species (ROS), is a mediator of diabetes-related damages in various tissues including pancreatic beta-cells. Here, we have evaluated islet OS status and beta-cell response to ROS using the GK/Par rat as a model of type 2 diabetes. Methodology/Principal Findings: Localization of OS markers was performed on whole pancreases. Using islets isolated from 7-day-old or 2.5-month-old male GK/Par and Wistar control rats, 1) gene expression was analyzed by qRT-PCR; 2) insulin secretion rate was measured; 3) ROS accumulation and mitochondrial polarization were assessed by fluorescence methods; 4) antioxidant contents were quantified by HPLC. After diabetes onset, OS markers targeted mostly peri-islet vascular and inflammatory areas, and not islet cells. GK/Par islets revealed in fact protected against OS, because they maintained basal ROS accumulation similar or even lower than Wistar islets. Remarkably, GK/Par insulin secretion also exhibited strong resistance to the toxic effect of exogenous H(2)O(2) or endogenous ROS exposure. Such adaptation was associated to both high glutathione content and overexpression (mRNA and/or protein levels) of a large set of genes encoding antioxidant proteins as well as UCP2. Finally, we showed that such a phenotype was not innate but spontaneously acquired after diabetes onset, as the result of an adaptive response to the diabetic environment. Conclusions: The GK/Par model illustrates the effectiveness of adaptive response to OS by beta-cells to achieve self-tolerance. It remains to be determined to what extend such islet antioxidant defenses upregulation might contribute to GK/Par beta-cell secretory dysfunction.			Lacraz, G (corresponding author), Univ Paris Diderot, Unite BFA Biol Fonct & Adaptat, Equipe Biol & Pathol Pancreas Endocrine B2PE, Paris, France.	portha@univ-paris-diderot.fr	leloup, corinne/T-3769-2017; Portha, Bernard/AAW-3021-2021	leloup, corinne/0000-0003-0900-4991; Galinier, Anne/0000-0003-2454-5681				Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Choe SS, 2007, DIABETES, V56, P1534, DOI 10.2337/db06-1059; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dolz M, 2005, DIABETES, V54, P3229, DOI 10.2337/diabetes.54.11.3229; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; EHSES JA, PNAS IN PRESS; Ehses Jan A., 2007, Current Immunology Reviews, V3, P216; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Galinier A, 2006, FEBS LETT, V580, P6391, DOI 10.1016/j.febslet.2006.10.052; GIROIX MH, 1993, DIABETOLOGIA, V36, P305, DOI 10.1007/BF00400232; GIROIX MH, 1993, ENDOCRINOLOGY, V132, P815, DOI 10.1210/en.132.2.815; GIROIX MH, 1993, BIOCHEM MED METAB B, V50, P301, DOI 10.1006/bmmb.1993.1072; Hayden MR, 2007, ANTIOXID REDOX SIGN, V9, P891, DOI 10.1089/ars.2007.1610; HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; HOMODELARCHE F, 2008, DIABETOLOGIA S1, V51, pS771; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; Hughes SJ, 1998, DIABETES, V47, P73, DOI 10.2337/diabetes.47.1.73; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; Kajimoto Y, 1999, DIABETOLOGIA, V42, P1417, DOI 10.1007/s001250051313; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Li XY, 2006, DIABETES, V55, P1592, DOI 10.2337/db05-1357; Ling ZC, 1998, ENDOCRINOLOGY, V139, P2670; Lortz S, 2003, FREE RADICAL BIO MED, V34, P683, DOI 10.1016/S0891-5849(02)01371-0; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Mysore TB, 2005, DIABETES, V54, P2109, DOI 10.2337/diabetes.54.7.2109; Pascal SMA, 2008, AM J PHYSIOL-ENDOC M, V295, pE92, DOI 10.1152/ajpendo.90235.2008; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P1; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Seo YJ, 2004, FREE RADICAL BIO MED, V37, P1272, DOI 10.1016/j.freeradbiomed.2004.07.012; Shao JQ, 2006, BIOCHEM BIOPH RES CO, V344, P1224, DOI 10.1016/j.bbrc.2006.04.011; Sies H, 1997, J BIOL CHEM, V272, P27812, DOI 10.1074/jbc.272.44.27812; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tiedge M, 1998, DIABETES, V47, P1578, DOI 10.2337/diabetes.47.10.1578; Tran POT, 2004, J BIOL CHEM, V279, P53988, DOI 10.1074/jbc.M404809200; Uzan B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004734; Ye J, 1998, ENDOCRINOLOGY, V139, P4155, DOI 10.1210/en.139.10.4155; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	59	51	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6500	10.1371/journal.pone.0006500	http://dx.doi.org/10.1371/journal.pone.0006500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654863	gold, Green Submitted, Green Published			2022-12-25	WOS:000268739100006
J	Jeong, YI; Jung, ID; Lee, CM; Chang, JH; Chun, SH; Noh, KT; Jeong, SK; Shin, YK; Lee, WS; Kang, MS; Lee, SY; Lee, JD; Park, YM				Jeong, Young-Il; Jung, In Duk; Lee, Chang-Min; Chang, Jeong Hyun; Chun, Sung Hak; Noh, Kyung Tae; Jeong, Soo Kyung; Shin, Yong Kyoo; Lee, Won Suk; Kang, Mi Sun; Lee, Sang-Yull; Lee, Jae-Dong; Park, Yeong-Min			The Novel Role of Platelet-Activating Factor in Protecting Mice against Lipopolysaccharide-Induced Endotoxic Shock	PLOS ONE			English	Article							SEPSIS; ANTAGONIST; SURVIVAL; MEDIATOR; FAILURE	Background: Platelet-activating factor (PAF) has been long believed to be associated with many pathophysiological processes during septic shock. Here we present novel activities for PAF in protecting mice against LPS-mediated endotoxic shock. Principal Findings: In vivo PAF treatment immediately after LPS challenge markedly improved the survival rate against mortality from endotoxic shock. Administration of PAF prominently attenuated LPS-induced organ injury, including profound hypotension, excessive polymorphonuclear neutrophil infiltration, and severe multiple organ failure. In addition, PAF treatment protects against LPS-induced lymphocytes apoptosis. These protective effects of PAF was correlated with significantly decreases in the production of the inflammatory mediators such as TNF-alpha, IL-1b, IL-12, and IFN-gamma, while increasing production of the anti-inflammatory cytokine IL-10 in vivo and in vitro. Conclusions: Taken together, these results suggest that PAF may protect mice against endotoxic shock via a complex mechanism involving modulation of inflammatory and anti-inflammatory mediators.			Jeong, YI (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan, South Korea.	immunpym@pusan.ac.kr						Angus DC, 2001, AM J RESP CRIT CARE, V164, P1154, DOI 10.1164/ajrccm.164.7.2012126; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; Beishuizen A, 1999, ADV CLIN CHEM, V33, P55; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CASALSSTENZEL J, 1987, EUR J PHARMACOL, V135, P117, DOI 10.1016/0014-2999(87)90602-9; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Doughty L, 1998, CHEST, V113, P1625, DOI 10.1378/chest.113.6.1625; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Giral M, 1996, BRIT J PHARMACOL, V118, P1223, DOI 10.1111/j.1476-5381.1996.tb15527.x; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; IMAIZUMI TA, 1995, J INTERN MED, V238, P5, DOI 10.1111/j.1365-2796.1995.tb00894.x; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; KUBIN M, 1994, J EXP MED, V180, P211, DOI 10.1084/jem.180.1.211; Lopez-Bojorquez L, 2004, ARCH MED RES, V35, P465, DOI 10.1016/j.arcmed.2004.07.006; Mathiak G, 1997, SHOCK, V7, P391, DOI 10.1097/00024382-199706000-00001; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Sawyer D W, 1989, Rev Infect Dis, V11 Suppl 7, pS1532; Steinhauser ME, 1999, J IMMUNOL, V162, P392; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; Walterscheid JP, 2002, J EXP MED, V195, P171, DOI 10.1084/jem.20011450	25	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6503	10.1371/journal.pone.0006503	http://dx.doi.org/10.1371/journal.pone.0006503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652714	Green Submitted, Green Published, gold			2022-12-25	WOS:000268637800013
J	Pan, WH; Bodempudi, V; Esfandyari, T; Farassati, F				Pan, Weihong; Bodempudi, Vidya; Esfandyari, Tuba; Farassati, Faris			Utilizing Ras Signaling Pathway to Direct Selective Replication of Herpes Simplex Virus-1	PLOS ONE			English	Article								Re-engineering the tropism of viruses is an attractive translational strategy for targeting cancer cells. The Ras signal transduction pathway is a central hub for a variety of pro-oncogenic events with a fundamental role in normal and neoplastic physiology. In this work we were interested in linking Ras activation to HSV-1 replication in a direct manner in order to generate a novel oncolytic herpes virus which can target cancer cells. To establish such link, we developed a mutant HSV-1 in which the expression of ICP4 (infected cell protein-4, a viral protein necessary for replication) is controlled by activation of ELK, a transcription factor down-stream of the Ras pathway and mainly activated by ERK (extracellular signal-regulated kinase, an important Ras effector pathway). This mutant HSV-1 was named as Signal-Smart 1 (SS1). A series of prostate cells were infected with the SS1 virus. Cells with elevated levels of ELK activation were preferentially infected by the SS1 virus, as demonstrated by increased levels of viral progeny, herpetic glycoprotein C and overall SS1 viral protein production. Upon exposure to SS1, the proliferation, invasiveness and colony formation capabilities of prostate cancer cells with increased ELK activation were significantly decreased (p < 0.05), while the rate of apoptosis/necrosis in these cells was increased. Additionally, high Ras signaling cells infected with SS1 showed a prominent arrest in the G1 phase of the cell cycle as compared to cells exposed to parental HSV-1. The results of this study reveal the potential for re-modeling the hostherpes interaction to specifically interfere with the life of cancer cells with increased Ras signaling. SS1 also serves as a "prototype'' for development of a family of signal-smart viruses which can target cancer cells on the basis of their signaling portfolio.			Pan, WH (corresponding author), Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.	ffarassati@kumc.edu						Alvarado Y, 2007, EXPERT OPIN EMERG DR, V12, P271, DOI 10.1517/14728214.12.2.271; BROWN SM, 1998, HERPES SIMPLEX VIRUS; BUDAY L, 2008, MANY FACES RAS ACTIV; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; Farassati F, 2001, NAT CELL BIOL, V3, P745, DOI 10.1038/35087061; Farassati Faris, 2003, ScientificWorldJournal, V3, P533; Gavrilov D, 2001, EUR J CANCER, V37, P1033, DOI 10.1016/S0959-8049(01)00077-6; Kyosseva SV, 2004, INT REV NEUROBIOL, V59, P201; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee CYF, 2007, CANCER GENE THER, V14, P652, DOI 10.1038/sj.cgt.7701052; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Molina JR, 2006, J THORAC ONCOL, V1, P7, DOI 10.1097/01243894-200601000-00004; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Ricote M, 2006, J PATHOL, V208, P401, DOI 10.1002/path.1910; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shelton JG, 2003, ONCOGENE, V22, P2478, DOI 10.1038/sj.onc.1206321; Song B, 2000, VIROLOGY, V267, P326, DOI 10.1006/viro.1999.0146; Song BW, 2001, VIROLOGY, V290, P320, DOI 10.1006/viro.2001.1175; SUNDARAM MV, 2006, RTK RAS MAPK SIGNALI, P1, DOI DOI 10.1895/WORMBOOK.1.80.1; White CM, 2000, BIOCHEMISTRY-US, V39, P12262, DOI 10.1021/bi001427l; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Wu NX, 1996, J VIROL, V70, P6358, DOI 10.1128/JVI.70.9.6358-6369.1996; Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670	28	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6514	10.1371/journal.pone.0006514	http://dx.doi.org/10.1371/journal.pone.0006514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652721	Green Published, gold, Green Submitted			2022-12-25	WOS:000268637800020
J	Warner, JM; Karatekin, E; O'Shaughnessy, B				Warner, Jason M.; Karatekin, Erdem; O'Shaughnessy, Ben			Model of SNARE-Mediated Membrane Adhesion Kinetics	PLOS ONE			English	Article								SNARE proteins are conserved components of the core fusion machinery driving diverse membrane adhesion and fusion processes in the cell. In many cases micron-sized membranes adhere over large areas before fusion. Reconstituted in vitro assays have helped isolate SNARE mechanisms in small membrane adhesion-fusion and are emerging as powerful tools to study large membrane systems by use of giant unilamellar vesicles (GUVs). Here we model SNARE-mediated adhesion kinetics in SNARE-reconstituted GUV-GUV or GUV-supported bilayer experiments. Adhesion involves many SNAREs whose complexation pulls apposing membranes into contact. The contact region is a tightly bound rapidly expanding patch whose growth velocity nu(patch) increases with SNARE density Gamma(snare). We find three patch expansion regimes: slow, intermediate, fast. Typical experiments belong to the fast regime where nu(patch)similar to(Gamma(snare))(2/3) depends on SNARE diffusivities and complexation binding constant. The model predicts growth velocities similar to 10-300 mu m/s. The patch may provide a close contact region where SNAREs can trigger fusion. Extending the model to a simple description of fusion, a broad distribution of fusion times is predicted. Increasing SNARE density accelerates fusion by boosting the patch growth velocity, thereby providing more complexes to participate in fusion. This quantifies the notion of SNAREs as dual adhesion-fusion agents.			Warner, JM (corresponding author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.	bo8@columbia.edu						Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Bakker AC, 1997, J CELL SCI, V110, P2227; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; Boulbitch A, 2001, BIOPHYS J, V81, P2743, DOI 10.1016/S0006-3495(01)75917-6; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; CHAMARAUX F, 2005, PHYS REV LETT, V94; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Coorssen JR, 1998, J CELL BIOL, V143, P1845, DOI 10.1083/jcb.143.7.1845; CUVELIER D, 2004, PHYS REV LETT, V93; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; de Gennes PG, 2003, LANGMUIR, V19, P7112, DOI 10.1021/la034421g; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Duman JG, 2003, AM J PHYSIOL-CELL PH, V285, pC237, DOI 10.1152/ajpcell.00091.2003; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; EVANS E, 1991, LANGMUIR, V7, P1900, DOI 10.1021/la00057a014; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; HELFRICH W, 1984, NUOVO CIMENTO D, V3, P137, DOI 10.1007/BF02452208; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JAMIESON BGM, 1995, ANAT RECORD, V241, P461, DOI 10.1002/ar.1092410404; Karatekin E, 2003, BIOPHYS J, V84, P1734, DOI 10.1016/S0006-3495(03)74981-9; Karatekin E, 2008, BIOPHYS J, V94, P2891, DOI 10.1529/biophysj.107.116756; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Lee JY, 2007, BIOPHYS J, V92, P3938, DOI 10.1529/biophysj.106.097063; Liu TT, 2005, BIOPHYS J, V89, P2458, DOI 10.1529/biophysj.105.062539; Luini A, 2005, CURR OPIN CELL BIOL, V17, P353, DOI 10.1016/j.ceb.2005.06.012; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Puech PH, 2004, EUR PHYS J E, V15, P127, DOI 10.1140/epje/i2003-10157-8; RADLER JO, 1995, PHYS REV E, V51, P4526, DOI 10.1103/PhysRevE.51.4526; RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5; Reister-Gottfried E, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.208103; Schwarz U, 2007, SOFT MATTER, V3, P263, DOI 10.1039/b606409d; Smith AS, 2008, P NATL ACAD SCI USA, V105, P6906, DOI 10.1073/pnas.0801706105; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Wagner ML, 2001, BIOPHYS J, V81, P266, DOI 10.1016/S0006-3495(01)75697-4; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wessel GM, 2001, INT REV CYTOL, V209, P117; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wolfel M, 2003, J NEUROSCI, V23, P7059, DOI 10.1523/JNEUROSCI.23-18-07059.2003; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	53	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6375	10.1371/journal.pone.0006375	http://dx.doi.org/10.1371/journal.pone.0006375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649266	Green Submitted, Green Published, gold			2022-12-25	WOS:000268637700001
J	Yu, J; Mller, H; Hehn, S; Koschmieder, S; Schonig, K; Berdel, WE; Serve, H; Muller-Tidow, C				Yu, Jun; Mller, Helena; Hehn, Sina; Koschmieder, Steffen; Schoenig, Kai; Berdel, Wolfgang E.; Serve, Hubert; Mueller-Tidow, Carsten			Construction and Application of an Inducible System for Homogenous Expression Levels in Bulk Cell Lines	PLOS ONE			English	Article								Stringently controlled conditional expressing systems are crucial for the functional characterization of genes. Currently, screening of multiple clones to identify the tightly controlled ones is necessary but time-consuming. Here, we describe a system fusing Tet (tetracycline)-inducible elements, BAC (bacterial artificial chromosome) and Gateway technology together to allow tight control of gene expression in BAC-transfected eukaryotic bulk cell cultures. Recombinase cloning into the shuttle vector and the BAC facilitates vector construction. An EGFP (enhanced green fluorescent protein) allows FACS (fluorescence activated cell sorting) and the BAC technology ensures tight control of gene expression that is independent of the integrating site. In the current first application, our gene of interest encodes a beta-catenin-ER alpha fusion protein. Tested by luciferase assay and western blotting, in HTB56 lung cancer cells the final BAC E11-IGR-beta-catenin-ER alpha vector demonstrated sensitive inducibility by Tet or Dox (doxycycline)in a dose-dependent manner with low background, and the EGFP was an effective selection marker by FACS in bulk culture HTB56 and myeloblastic 32D cells. This is a highly efficient tool for the rapid generation of stringently controlled Tet-inducible systems in cell lines.			Yu, J (corresponding author), Univ Munster, Dept Med Hematol & Oncol, Munster, Germany.	muellerc@uni-muenster.de	Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014	Müller-Tidow, Carsten/0000-0002-7166-5232; Serve, Hubert/0000-0001-8472-5516; Koschmieder, Steffen/0000-0002-1011-8171				Aurisicchio L, 2005, J VIROL, V79, P6772, DOI 10.1128/JVI.79.11.6772-6780.2005; Chenuaud P, 2004, MOL THER, V9, P410, DOI 10.1016/j.ymthe.2003.12.015; Ebert AD, 2005, EXP NEUROL, V191, pS80, DOI 10.1016/j.expneurol.2004.08.024; Georgievska B, 2004, HUM GENE THER, V15, P934, DOI 10.1089/hum.2004.15.934; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hong YK, 2001, ANAL BIOCHEM, V291, P142, DOI 10.1006/abio.2001.5010; Iida A, 1996, J VIROL, V70, P6054, DOI 10.1128/JVI.70.9.6054-6059.1996; Jiang L, 2004, GENE THER, V11, P1057, DOI 10.1038/sj.gt.3302245; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Koponen JK, 2003, GENE THER, V10, P459, DOI 10.1038/sj.gt.3301889; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Lee YB, 2005, J GENE MED, V7, P576, DOI 10.1002/jgm.694; Magdaleno SM, 1999, NAT GENET, V22, P319, DOI 10.1038/11882; Mizuguchi H, 2003, HUM GENE THER, V14, P1265, DOI 10.1089/104303403767740803; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Rendahl KG, 2002, HUM GENE THER, V13, P335, DOI 10.1089/10430340252769842; Rubinchik S, 2005, GENE THER, V12, P504, DOI 10.1038/sj.gt.3302437; Salucci V, 2002, GENE THER, V9, P1415, DOI 10.1038/sj.gt.3301813; Smith-Arica JR, 2000, MOL THER, V2, P579, DOI 10.1006/mthe.2000.0215; Tickenbrock L, 2005, BLOOD, V105, P3699, DOI 10.1182/blood-2004-07-2924; Umana P, 2001, NAT BIOTECHNOL, V19, P582, DOI 10.1038/89349; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang L, 2004, GASTROENTEROLOGY, V126, P278, DOI 10.1053/j.gastro.2003.10.075; Zerby D, 2003, HUM GENE THER, V14, P749, DOI 10.1089/104303403765255147	26	5	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6445	10.1371/journal.pone.0006445	http://dx.doi.org/10.1371/journal.pone.0006445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649290	gold, Green Published, Green Submitted			2022-12-25	WOS:000268494600014
J	Wang, CH; Xin, XB; Xiang, RH; Ramos, FJ; Liu, ML; Lee, HJ; Chen, HZ; Mao, XM; Kikani, CK; Liu, F; Dong, LQ				Wang, Changhua; Xin, Xiaoban; Xiang, Ruihua; Ramos, Fresnida J.; Liu, Meilian; Lee, Hak Joo; Chen, Hongzhi; Mao, Xuming; Kikani, Chintan K.; Liu, Feng; Dong, Lily Q.			Yin-Yang Regulation of Adiponectin Signaling by APPL Isoforms in Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; PROTEIN APPL1; ACTIVATION; RECEPTORS; AKT; INTERACTS; PATHWAY; MICE	APPL1 is a newly identified adiponectin receptor-binding protein that positively mediates adiponectin signaling in cells. Here we report that APPL2, an isoform of APPL1 that forms a dimer with APPL1, can interacts with both AdipoR1 and AdipoR2 and acts as a negative regulator of adiponectin signaling in muscle cells. Overexpression of APPL2 inhibits the interaction between APPL1 and AdipoR1, leading to down-regulation of adiponectin signaling in C2C12 myotubes. In contrast, suppressing APPL2 expression by RNAi significantly enhances adiponectin-stimulated glucose uptake and fatty acid oxidation. In addition to targeting directly to and competing with APPL1 in binding with the adiponectin receptors, APPL2 also suppresses adiponectin and insulin signaling by sequestrating APPL1 from these two pathways. In addition to adiponectin, metformin also induces APPL1-APPL2 dissociation. Taken together, our results reveal that APPL isoforms function as an integrated Yin-Yang regulator of adiponectin signaling and mediate the crosstalk between adiponectin and insulin signaling pathways in muscle cells.	[Xin, Xiaoban; Xiang, Ruihua; Lee, Hak Joo; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Mao, Xuming; Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Chen, Hongzhi; Kikani, Chintan K.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Dong, LQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	dongq@uthscsa.edu	Xin, Xiaoban/D-2338-2012	Chen, Hongzhi/0000-0001-6060-3776; Kikani, Chintan/0000-0003-1140-0192	National Institutes of Health [R01 DK69930, R01 DK080344, R01 DK76902]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080344, R01DK076902, R01DK069930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK69930 and R01 DK080344 (to L. Q. D.) and R01 DK76902 (to F. L.). This work was also supported by a Career Development Award from the American Diabetes Association (to L. Q. D.).	Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mao XM, 2006, MINI-REV MED CHEM, V6, P1331, DOI 10.2174/138955706778992978; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Mullen KL, 2009, AM J PHYSIOL-REG I, V296, pR243, DOI 10.1152/ajpregu.90774.2008; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200	20	105	113	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31608	31615		10.1074/jbc.M109.010355	http://dx.doi.org/10.1074/jbc.M109.010355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19661063	hybrid, Green Published			2022-12-25	WOS:000271572700015
J	Lin, CP; Ban, Y; Lyu, YL; Liu, LF				Lin, Chao-Po; Ban, Yi; Lyu, Yi Lisa; Liu, Leroy F.			Proteasome-dependent Processing of Topoisomerase I-DNA Adducts into DNA Double Strand Breaks at Arrested Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT COMPLEXES; CLEAVABLE COMPLEXES; DRUG CAMPTOTHECIN; MULTIPLE-MYELOMA; PROSTATE-CANCER; CARCINOMA CELLS; TUMOR-CELLS; REPAIR; DEGRADATION; PROTEIN	Reversible topoisomerase I (Top1)-DNA cleavage complexes are the key DNA lesion induced by anticancer camptothecins (CPTs) (e.g. topotecan and irinotecan) as well as structurally perturbed DNAs (e.g. oxidatively damaged, UV-irradiated, or alkylated DNA). It has been proposed that Top1 cleavage complexes arrest advancing replication forks, triggering the formation of DNA double strand breaks (DSBs) because of replication fork runoff at the Top1 cleavage complex sites on the leading strand. In this study, we show that the formation of replication-dependent DSBs requires the ubiquitin-proteasome pathway in CPT-treated cells. First, the proteasome inhibitor MG-132 specifically inhibited CPT-induced but not ionizing radiation- or hydroxyurea-induced DSBs as revealed by both the neutral comet assay and measurements of the specific DNA damage signals (e.g. gamma-H2AX, phosphorylated ataxia telangiectasia mutated (Ser-1981), and phosphorylated Chk2 (Ser-33/35)) that are characteristic for DSBs. Knocking down the 20 S proteasome maturation protein also supported the requirement of the proteasome activity for CPT-induced DSBs. Second, CPT-induced DSB signals were shown to require ubiquitin, ubiquitin-activating enzyme (E1), a CUL-3-based ubiquitin ligase (E3), and the formation of Lys-48-finked polyubiquitin chains on Top1. Third, immunocytochemical studies revealed that the CPT-induced formation of gamma-H2AX foci occurred at the replication forks and was attenuated by co-treatment with the proteasome inhibitor MG-132. In the aggregate, these results support a replication fork collision model in which Top1 cleavage complexes at the arrested replication forks are degraded by proteasome prior to replication fork runoff on the leading strand to generate DSBs.	[Lin, Chao-Po; Ban, Yi; Lyu, Yi Lisa; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Liu, LF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	lliu@umdnj.edu		Lin, Chao-Po/0000-0002-1457-1635; Liu, Leroy/0000-0001-9396-763X	National Institutes of Health [CA39662]; Department of Defense Idea [W81XWH-07-1-0407]; New Jersey Commission on Cancer Research [08-1079-CCR-EO]; NATIONAL CANCER INSTITUTE [R01CA039662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Idea(United States Department of Defense); New Jersey Commission on Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA39662 (to L. F. L.). This work was also supported by a Department of Defense Idea Award W81XWH-07-1-0407 (to Y. L. L.) and a New Jersey Commission on Cancer Research Grant 08-1079-CCR-EO (to Y. L. L.).	Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Andersen JB, 2006, BRIT J CANCER, V94, P1465, DOI 10.1038/sj.bjc.6603099; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; DARPA P, 1990, CANCER RES, V50, P6919; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gudmundsdottir K, 2007, ONCOGENE, V26, P7601, DOI 10.1038/sj.onc.1210579; HOLM C, 1989, CANCER RES, V49, P6365; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Kiessling A, 2009, ONCOGENE, V28, P2606, DOI 10.1038/onc.2009.115; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Mateos MV, 2006, BLOOD, V108, P2165, DOI 10.1182/blood-2006-04-019778; Mimnaugh EG, 2000, BIOCHEM PHARMACOL, V60, P1343, DOI 10.1016/S0006-2952(00)00455-X; Mitsiades N, 2003, BLOOD, V101, P2377, DOI 10.1182/blood-2002-06-1768; Moreau S, 1999, MOL CELL BIOL, V19, P556; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; Pajonk F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-76; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Reid RJD, 1999, P NATL ACAD SCI USA, V96, P11440, DOI 10.1073/pnas.96.20.11440; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; TSAO YP, 1993, CANCER RES, V53, P5908; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; ZHANG H, 1990, CANCER CELL-MON REV, V2, P23; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	49	51	51	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28084	28092		10.1074/jbc.M109.030601	http://dx.doi.org/10.1074/jbc.M109.030601			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666469	hybrid, Green Published			2022-12-25	WOS:000270676300035
J	Sherwood, T; Franke, R; Conneely, S; Joyner, J; Arumugan, P; Askwith, C				Sherwood, Thomas; Franke, Ruthie; Conneely, Shannon; Joyner, Jeffrey; Arumugan, Prakash; Askwith, Candice			Identification of Protein Domains That Control Proton and Calcium Sensitivity of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; TARANTULA TOXIN PSALMOTOXIN-1; HIPPOCAMPAL-NEURONS; SENSORY NEURONS; BINDING-SITES; NA+ CHANNEL; ACID; CA2+; H+; CURRENTS	The acid-sensing ion channels (ASICs) open in response to extracellular acidic pH, and individual subunits display differential sensitivity to protons and calcium. ASIC1a acts as a high affinity proton sensor, whereas ASIC2a requires substantially greater proton concentrations to activate. Using chimeras composed of ASIC1a and ASIC2a, we determined that two regions of the extracellular domain (residues 87-197 and 323-431) specify the high affinity proton response of ASIC1a. These two regions appear to undergo intersubunit interactions within the multimeric channel to specify proton sensitivity. Single amino acid mutations revealed that amino acids around Asp(357) play a prominent role in determining the pH dose response of ASIC1a. Within the same region, mutation F352L abolished PcTx1 modulation of ASIC1a. Surprisingly, we determined that another area of the extracellular domain was required for calcium-dependent regulation of ASIC1a activation, and this region functioned independently of high affinity proton sensing. These results indicate that specific regions play overlapping roles in pH-dependent gating and PcTx1-dependent modulation of ASIC1a activity, whereas a distinct region determines the calcium dependence of ASIC1a activation.	[Sherwood, Thomas; Franke, Ruthie; Conneely, Shannon; Joyner, Jeffrey; Arumugan, Prakash; Askwith, Candice] Ohio State Univ, Dept Neurosci, Sch Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Askwith, C (corresponding author), Ohio State Univ, Dept Neurosci, Sch Med, 4197 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	askwith.1@osu.edu		Conneely, Shannon/0000-0001-9076-3973	National Science Foundation [IBN-0416920]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062967] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation Grant IBN-0416920.	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Berdiev BK, 2001, J BIOL CHEM, V276, P38755, DOI 10.1074/jbc.M107266200; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Cho JH, 2008, J NEUROPHYSIOL, V99, P426, DOI 10.1152/jn.00940.2007; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Qadri YJ, 2009, J BIOL CHEM, V284, P17625, DOI 10.1074/jbc.M109.003913; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Todorovic NA, 2005, ANN NY ACAD SCI, V1048, P331, DOI 10.1196/annals.1342.030; Voilley Nicolas, 2004, Current Drug Targets - Inflammation and Allergy, V3, P71, DOI 10.2174/1568010043483980; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2007, FRONT BIOSCI-LANDMRK, V12, P1376, DOI 10.2741/2154; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	41	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27899	27907		10.1074/jbc.M109.029009	http://dx.doi.org/10.1074/jbc.M109.029009			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654327	Green Published, hybrid			2022-12-25	WOS:000270676300017
J	Whittle, JRR; Schwartz, TU				Whittle, James R. R.; Schwartz, Thomas U.			Architectural Nucleoporins Nup157/170 and Nup133 Are Structurally Related and Descend from a Second Ancestral Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; MULTIPLE SEQUENCE ALIGNMENT; MESSENGER-RNA EXPORT; CRYSTAL-STRUCTURE; POLY(A)(+) RNA; FUNCTIONALLY INTERACTS; VERTEBRATE HOMOLOG; PROTEIN; ORGANIZATION; ACCUMULATION	The nuclear pore complex (NPC) constitutes one of the largest protein assemblies in the eukaryotic cell and forms the exclusive gateway to the nucleus. The stable, similar to 15-20-MDa scaffold ring of the NPC is built from two multiprotein complexes arranged around a central 8-fold axis. Here we present crystal structures of two large architectural units, yNup170(979-1502) and hNup107(658-925).hNup133(517-156), each a constituent of one of the two multiprotein complexes. Conservation of domain arrangement and of tertiary structure suggests that Nup157/170 and Nup133 derived from a common ancestor. Together with the previously established ancestral coatomer element (ACE1), these two elements constitute the major a-helical building blocks of the NPC scaffold and define its branched, lattice-like architecture, similar to vesicle coats like COPII. We hypothesize that the extant NPC evolved early during eukaryotic evolution from a rudimentary structure composed of several identical copies of a few ancestral elements, later diversified and specified by gene duplication.	[Whittle, James R. R.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,Rm 68-480, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512	National Institutes of Health [GM77537]; Pew Scholar Award; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM77537 (to T. U.S.). This work was also supported by a Pew Scholar Award (to T. U. S.) and a National Science Foundation Graduate Research Fellowship (to J. R. R. W.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Bai SW, 2004, MOL CELL BIOL, V24, P6379, DOI 10.1128/MCB.24.14.6379-6392.2004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; BROHAWN SG, 2009, COMMUN INTEGR BIOL, V2, P1; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brunger AT, 2009, ACTA CRYSTALLOGR D, V65, P128, DOI 10.1107/S0907444908043795; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESWAR N, 2007, CURR PROTOC PROTEIN, V50; Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Flemming D, 2009, J CELL BIOL, V185, P387, DOI 10.1083/jcb.200810016; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gao HH, 2003, J BIOL CHEM, V278, P25331, DOI 10.1074/jbc.M301607200; GRANDI P, 1995, J CELL BIOL, V130, P1263, DOI 10.1083/jcb.130.6.1263; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Handa N, 2006, J MOL BIOL, V363, P114, DOI 10.1016/j.jmb.2006.07.089; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hawryluk-Gara LA, 2008, MOL BIOL CELL, V19, P1753, DOI 10.1091/mbc.E07-08-0820; Heath CV, 1995, J CELL BIOL, V131, P1677, DOI 10.1083/jcb.131.6.1677; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Jeudy S, 2007, J BIOL CHEM, V282, P34904, DOI 10.1074/jbc.M705479200; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Kosova B, 1999, J BIOL CHEM, V274, P22646, DOI 10.1074/jbc.274.32.22646; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leksa NC, 2009, STRUCTURE, V17, P1082, DOI 10.1016/j.str.2009.06.003; LI O, 1995, MOL BIOL CELL, V6, P401, DOI 10.1091/mbc.6.4.401; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Mans BJ, 2004, CELL CYCLE, V3, P1612; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Weis K, 2007, CELL, V130, P405, DOI 10.1016/j.cell.2007.07.029; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141	81	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28442	28452		10.1074/jbc.M109.023580	http://dx.doi.org/10.1074/jbc.M109.023580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674973	Green Published, hybrid			2022-12-25	WOS:000270676300069
J	Faucher, S; Crawley, AM; Decker, W; Sherring, A; Bogdanovic, D; Ding, T; Bergeron, M; Angel, JB; Sandstrom, P				Faucher, Sylvie; Crawley, Angela M.; Decker, Wendy; Sherring, Alice; Bogdanovic, Dragica; Ding, Tao; Bergeron, Michele; Angel, Jonathan B.; Sandstrom, Paul			Development of a Quantitative Bead Capture Assay for Soluble IL-7 Receptor Alpha in Human Plasma	PLOS ONE			English	Article							T-CELL DEVELOPMENT; INTERLEUKIN-7 RECEPTOR; CD127 EXPRESSION; IL-7R-ALPHA EXPRESSION; DOWN-REGULATION; HIV-INFECTION; CHAIN CD127; DISEASE; MURINE; IDENTIFICATION	Background: IL-7 is an essential cytokine in T-cell development and homeostasis. It binds to the IL-7R receptor, a complex of the IL-7R alpha (CD127) and common gamma (CD132) chains. There is significant interest in evaluating the expression of CD127 on human T-cells as it often decreased in medical conditions leading to lymphopenia. Previous reports showed the usefulness of CD127 as a prognostic marker in viral infections such as HIV, CMV, EBV and HCV. A soluble CD127 (sCD127) is released in plasma and may contribute to disease pathogenesis through its control on IL-7 activities. Measuring sCD127 is important to define its role and may complement existing markers used in lymphopenic disease management. We describe a new quantitative assay for the measurement of sCD127 in plasma and report sCD127 concentrations in healthy adults. Methodology/Principal Findings: We developed a quantitative bead-based sCD127 capture assay. Polyclonal CD127-specific antibodies were chosen for capture and a biotinylated monoclonal anti-CD127 antibody was selected for detection. The assay can detect native sCD127 and recombinant sCD127 which served as the calibrator. The analytical performance of the assay was characterized and the concentration and stability of plasma sCD127 in healthy adults was determined. The assay's range was 3.2-1000 ng/mL. The concentration of plasma sCD127 was 164 +/- 104 ng/mL with over a log variation between subjects. Individual sCD127 concentrations remained stable when measured serially during a period of up to one year. Conclusions/Significance: This is the first report on the quantification of plasma sCD127 in a population of healthy adults. Soluble CD127 plasma concentrations remained stable over time in a given individual and sCD127 immunoreactivity was resistant to repeated freeze-thaw cycles. This quantitative sCD127 assay is a valuable tool for defining the potential role of sCD127 in lymphopenic diseases.			Faucher, S (corresponding author), Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada.	sylvie_faucher@phac-aspc.gc.ca		Crawley, Angela/0000-0002-7453-7922; Angel, Jonathan B/0000-0003-3102-4462				Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Benito JM, 2008, J INFECT DIS, V198, P1466, DOI 10.1086/592716; Blom-Potar MC, 2009, JAIDS-J ACQ IMM DEF, V51, P104, DOI 10.1097/QAI.0b013e31819d8a20; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; CARINI C, 1994, EUR J IMMUNOL, V24, P2927, DOI 10.1002/eji.1830241202; Colle JH, 2007, AIDS, V21, P101, DOI 10.1097/QAD.0b013e3280115b6a; Faucher S, 2004, CLIN CHEM, V50, P1250, DOI 10.1373/clinchem.2004.032995; Fernandez-Botran R, 2002, TRANSPLANTATION, V74, P623, DOI 10.1097/00007890-200209150-00007; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Giliani S, 2005, IMMUNOL REV, V203, P110, DOI 10.1111/j.0105-2896.2005.00234.x; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Gotoh Y, 1999, CLIN CHIM ACTA, V289, P89, DOI 10.1016/S0009-8981(99)00161-8; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; Korte A, 2000, CYTOKINE, V12, P1597, DOI 10.1006/cyto.2000.0777; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Mckay FC, 2008, GENES IMMUN, V9, P1, DOI 10.1038/sj.gene.6364436; Mckay FC, 2008, J AUTOIMMUN, V31, P52, DOI 10.1016/j.jaut.2008.02.003; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; PLEIMAN CM, 1991, MOL CELL BIOL, V11, P3052, DOI 10.1128/MCB.11.6.3052; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Read SW, 2006, JAIDS-J ACQ IMM DEF, V42, P537, DOI 10.1097/01.qai.0000223027.47456.d0; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; RICHARDS JM, 1990, BLOOD, V76, P1941; Roifman CM, 2000, BLOOD, V96, P2803; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Sasson SC, 2006, CURR DRUG TARGETS, V7, P1571, DOI 10.2174/138945006779025365; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Selinsky CL, 2000, CELL IMMUNOL, V200, P81, DOI 10.1006/cimm.2000.1622; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Tonozuka Y, 2001, CYTOGENET CELL GENET, V93, P23, DOI 10.1159/000056941; Vingerhoets J, 1998, IMMUNOL LETT, V61, P53, DOI 10.1016/S0165-2478(97)00162-4; Viviani S, 1998, BRIT J CANCER, V77, P992, DOI 10.1038/bjc.1998.163; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Wang Y, 2006, AM J TRANSPLANT, V6, P2851, DOI 10.1111/j.1600-6143.2006.01550.x; Witkowska AM, 2005, MEDIAT INFLAMM, P121, DOI 10.1155/MI.2005.121; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	49	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6690	10.1371/journal.pone.0006690	http://dx.doi.org/10.1371/journal.pone.0006690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690616	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267300008
J	Selbo, PK; Rosenblum, MG; Cheung, LH; Zhang, W; Berg, K				Selbo, Pal K.; Rosenblum, Michael G.; Cheung, Lawrence H.; Zhang, Wendy; Berg, Kristian			Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGel	PLOS ONE			English	Article								Background: There is a need for drug delivery systems (DDS) that can enhance cytosolic delivery of anti-cancer drugs trapped in the endo-lysosomal compartments. Exposure of cells to specific photosensitizers followed by light exposure (photochemical internalization, PCI) results in transfer of agents from the endocytic compartment into the cytosol. Methodology and Principal Findings: The recombinant single-chain fusion construct scFvMEL/rGel is composed of an antibody targeting the progenitor marker HMW-MAA/NG2/MGP/gp240 and the highly effective toxin gelonin (rGel). Here we demonstrate enhanced tumor cell selectivity, cytosolic delivery and anti-tumor activity by applying PCI of scFvMEL/rGel. PCI performed by light activation of cells co-incubated with scFvMEL/rGel and the endo-lysosomal targeting photosensitizers AlPcS2a or TPPS2a resulted in enhanced cytotoxic effects against antigen-positive cell lines, while no differences in cytotoxicity between the scFvMEL/rGel and rGel were observed in antigen-negative cells. Mice bearing well-developed melanoma (A-375) xenografts (50-100 mm(3)) were treated with PCI of scFvMEL/rGel. By 30 days after injection, similar to 100% of mice in the control groups had tumors>800 mm(3). In contrast, by day 40, 50% of mice in the PCI of scFvMEL/rGel combination group had tumors<800 mm(3) with no increase in tumor size up to 110 days. PCI of scFvMEL/rGel resulted in a synergistic effect (p<0.05) and complete regression (CR) in 33% of tumor-bearing mice (n = 12). Conclusions/Significance: This is a unique demonstration that a non-invasive multi-modality approach combining a recombinant, targeted therapeutic such as scFvMEL/rGel and PCI act in concert to provide potent in vivo efficacy without sacrificing selectivity or enhancing toxicity. The present DDS warrants further evaluation of its clinical potential.			Selbo, PK (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Radiat Biol, Oslo, Norway.	selbo@rr-research.no	Selbo, Pål Kristian/B-4638-2009	Selbo, Pål Kristian/0000-0002-5310-057X; Berg, Kristian/0000-0002-7816-7543				Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Bababeygy SR, 2008, STEM CELLS DEV, V17, P11, DOI 10.1089/scd.2007.0117; Baumstark-Khan C, 1999, J FLUORESC, V9, P37, DOI 10.1023/A:1020583623407; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Berg K, 1999, CANCER RES, V59, P1180; BERG K, 1994, INT J CANCER, V59, P814, DOI 10.1002/ijc.2910590618; Berg K, 2005, CLIN CANCER RES, V11, P8476, DOI 10.1158/1078-0432.CCR-05-1245; Berg K., 2006, MED LASER APPL, V21, P239; Campoli MR, 2004, CRIT REV IMMUNOL, V24, P267, DOI 10.1615/CritRevImmunol.v24.i4.40; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Chetty NC, 2008, CLIN EXP DERMATOL, V33, P204, DOI 10.1111/j.1365-2230.2007.02600.x; Dell'Erba L, 2001, ANTICANCER RES, V21, P925; Dietrich J, 2008, NAT CLIN PRACT ONCOL, V5, P393, DOI 10.1038/ncponc1132; Dietze A, 2005, BRIT J CANCER, V92, P2004, DOI 10.1038/sj.bjc.6602600; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Golab J, 2003, J BIOL CHEM, V278, P407, DOI 10.1074/jbc.M209125200; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Hogset A, 2004, ADV DRUG DELIVER REV, V56, P95, DOI 10.1016/j.addr.2003.08.016; Hopper C, 2000, Lancet Oncol, V1, P212; Jones AT, 2003, ADV DRUG DELIVER REV, V55, P1353, DOI 10.1016/j.addr.2003.07.002; Liu YY, 2006, NEOPLASIA, V8, P384, DOI 10.1593/neo.06121; Liu YY, 2006, NEOPLASIA, V8, P125, DOI 10.1593/neo.05556; Lu YJ, 2006, AAPS J, V8, pE466, DOI 10.1208/aapsj080355; Luo W, 2006, J IMMUNOL, V176, P6046, DOI 10.4049/jimmunol.176.10.6046; Ndoye A, 2006, MOL THER, V13, P1156, DOI 10.1016/j.ymthe.2006.02.003; NETTI PA, 1995, CANCER RES, V55, P5451; Nishiyama N, 2005, NAT MATER, V4, P934, DOI 10.1038/nmat1524; Oliveira S, 2008, CURR PHARM DESIGN, V14, P3686, DOI 10.2174/138161208786898789; Prasmickaite L, 2002, BRIT J CANCER, V86, P652, DOI 10.1038/sj.bjc.6600138; Riesenberg R, 1996, EUR J CANCER, V32A, P328, DOI 10.1016/0959-8049(95)00548-X; ROSENBLUM MG, 1987, CANCER CHEMOTH PHARM, V20, P41; Rosenblum MG, 2003, CANCER RES, V63, P3995; Rye PD, 1996, INT J CANCER, V68, P682, DOI 10.1002/(SICI)1097-0215(19961127)68:5<682::AID-IJC20>3.0.CO;2-2; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Selbo PK, 2006, J PHARMACOL EXP THER, V319, P604, DOI 10.1124/jpet.106.109165; Selbo PK, 2001, INT J CANCER, V92, P761, DOI 10.1002/1097-0215(20010601)92:5<761::AID-IJC1238>3.0.CO;2-4; Smith FO, 1996, BLOOD, V87, P1123, DOI 10.1182/blood.V87.3.1123.bloodjournal8731123; Steff AM, 2001, CYTOMETRY, V45, P237, DOI 10.1002/1097-0320(20011201)45:4<237::AID-CYTO10024>3.0.CO;2-J; Thong PSP, 2007, LANCET ONCOL, V8, P950, DOI 10.1016/S1470-2045(07)70318-2; Ulukaya E, 2004, CHEMOTHERAPY, V50, P43, DOI 10.1159/000077285; Veenendaal LM, 2002, P NATL ACAD SCI USA, V99, P7866, DOI [10.1073/pnas.122157899, 10.1073/pnas.162346299]; Weyergang A, 2006, J CONTROL RELEASE, V111, P165, DOI 10.1016/j.jconrel.2005.12.002; Weyergang A, 2009, MOL PHARMACEUT, V6, P255, DOI 10.1021/mp800156e; Weyeyang A, 2007, BIOCHEM PHARMACOL, V74, P226, DOI 10.1016/j.bcp.2007.04.018; Wiranowska M, 2006, BRAIN CELL BIOL, V35, P159, DOI 10.1007/s11068-007-9009-0; Yip WL, 2007, MOL PHARM, V4, P241, DOI 10.1021/mp060105u	50	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6691	10.1371/journal.pone.0006691	http://dx.doi.org/10.1371/journal.pone.0006691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690617	gold, Green Submitted, Green Published			2022-12-25	WOS:000269267300009
J	Baertschiger, RM; Serre-Beinier, V; Morel, P; Bosco, D; Peyrou, M; Clement, S; Sgroi, A; Kaelin, A; Buhler, LH; Gonelle-Gispert, C				Baertschiger, Reto M.; Serre-Beinier, Veronique; Morel, Philippe; Bosco, Domenico; Peyrou, Marion; Clement, Sophie; Sgroi, Antonino; Kaelin, Andre; Buhler, Leo H.; Gonelle-Gispert, Carmen			Fibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver	PLOS ONE			English	Article								Multipotent mesenchymal stromal cells ( MSC) are currently investigated clinically as cellular therapy for a variety of diseases. Differentiation of MSC toward endodermal lineages, including hepatocytes and their therapeutic effect on fibrosis has been described but remains controversial. Recent evidence attributed a fibrotic potential to MSC. As differentiation potential might be dependent of donor age, we studied MSC derived from adult and pediatric human bone marrow and their potential to differentiate into hepatocytes or myofibroblasts in vitro and in vivo. Following characterization, expanded adult and pediatric MSC were co-cultured with a human hepatoma cell line, Huh-7, in a hepatogenic differentiation medium containing Hepatocyte growth factor, Fibroblast growth factor 4 and oncostatin M. In vivo, MSC were transplanted into spleen or liver of NOD/SCID mice undergoing partial hepatectomy and retrorsine treatment. Expression of mesenchymal and hepatic markers was analyzed by RT-PCR, Western blot and immunohistochemistry. In vitro, adult and pediatric MSC expressed characteristic surface antigens of MSC. Expansion capacity of pediatric MSC was significantly higher when compared to adult MSC. In co-culture with Huh-7 cells in hepatogenic differentiation medium, albumin expression was more frequently detected in pediatric MSC (5/8 experiments) when compared to adult MSC (2/10 experiments). However, in such condition pediatric MSC expressed alpha smooth muscle more strongly than adult MSC. Stable engraftment in the liver was not achieved after intrasplenic injection of pediatric or adult MSC. After intrahepatic injection, MSC permanently remained in liver tissue, kept a mesenchymal morphology and expressed vimentin and alpha smooth muscle actin, but no hepatic markers. Further, MSC localization merges with collagen deposition in transplanted liver and no difference was observed using adult or pediatric MSC. In conclusion, when transplanted into an injured or regenerating liver, MSC differentiated into myofibroblasts with development of fibrous tissue, regardless of donor age. These results indicate that MSC in certain circumstances might be harmful due to their fibrogenic potential and this should be considered before potential use of MSC for cell therapy.			Baertschiger, RM (corresponding author), Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland.	carmen.gonelle@unige.ch	Kaelin, Andre/AAU-2577-2021; Peyrou, Marion/A-7190-2015; Baertschiger, Reto/AAA-3299-2021; Serre-Beinier, Véronique/T-8064-2019	Peyrou, Marion/0000-0002-1210-6094; Baertschiger, Reto/0000-0002-6284-1994; Serre-Beinier, Véronique/0000-0002-6016-1645; Bosco, Domenico/0000-0003-3453-9613; Buhler, Leo/0000-0002-9461-8498				Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Badillo AT, 2007, BIOL BLOOD MARROW TR, V13, P412, DOI 10.1016/j.bbmt.2006.12.447; Baertschiger RM, 2008, PANCREAS, V37, P75, DOI 10.1097/MPA.0b013e31815fcb1e; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Campard D, 2008, GASTROENTEROLOGY, V134, P833, DOI 10.1053/j.gastro.2007.12.024; Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chamberlain JR, 2008, MOL THER, V16, P187, DOI 10.1038/sj.mt.6300339; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Di Bonzo LV, 2008, GUT, V57, P223, DOI 10.1136/gut.2006.111617; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; GABBIANI G, 1983, P NATL ACAD SCI-BIOL, V80, P2361, DOI 10.1073/pnas.80.8.2361; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Hong SH, 2005, BIOCHEM BIOPH RES CO, V330, P1153, DOI 10.1016/j.bbrc.2005.03.086; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ishikawa T, 2007, CELL TISSUE RES, V327, P463, DOI 10.1007/s00441-006-0334-x; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange C, 2005, WORLD J GASTROENTERO, V11, P4497, DOI 10.3748/wjg.v11.i29.4497; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Martin CA, 2007, PROTEIN SCI, V16, P2531, DOI 10.1110/ps.073007207; Meyerrose TE, 2007, STEM CELLS, V25, P220, DOI 10.1634/stemcells.2006-0243; Nguyen TH, 2005, J HEPATOL, V43, P1031, DOI 10.1016/j.jhep.2005.05.036; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Popp FC, 2007, STEM CELLS, V25, P639, DOI 10.1634/stemcells.2006-0515; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; SATO Y, 2005, BLOOD; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Tsai JH, 2008, J VIRAL HEPATITIS, V15, P508, DOI 10.1111/j.1365-2893.2008.00971.x; Wasser S, 2001, J GASTROEN HEPATOL, V16, P1244, DOI 10.1046/j.1440-1746.2001.02621.x; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186	49	95	106	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6657	10.1371/journal.pone.0006657	http://dx.doi.org/10.1371/journal.pone.0006657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684854	Green Published, gold, Green Submitted			2022-12-25	WOS:000269075600006
J	Jung, SC; Hoffman, DA				Jung, Sung-Cherl; Hoffman, Dax A.			Biphasic Somatic A-Type K+ Channel Downregulation Mediates Intrinsic Plasticity in Hippocampal CA1 Pyramidal Neurons	PLOS ONE			English	Article								Since its original description, the induction of synaptic long-term potentiation (LTP) has been known to be accompanied by a lasting increase in the intrinsic excitability (intrinsic plasticity) of hippocampal neurons. Recent evidence shows that dendritic excitability can be enhanced by an activity-dependent decrease in the activity of A-type K+ channels. In the present manuscript, we examined the role of A-type K+ channels in regulating intrinsic excitability of CA1 pyramidal neurons of the hippocampus after synapse-specific LTP induction. In electrophysiological recordings we found that LTP induced a potentiation of excitability which was accompanied by a two-phased change in A-type K+ channel activity recorded in nucleated patches from organotypic slices of rat hippocampus. Induction of LTP resulted in an immediate but short lasting hyperpolarization of the voltage-dependence of steady-state A-type K+ channel inactivation along with a progressive, long-lasting decrease in peak A-current density. Blocking clathrin-mediated endocytosis prevented the A-current decrease and most measures of intrinsic plasticity. These results suggest that two temporally distinct but overlapping mechanisms of A-channel downregulation together contribute to the plasticity of intrinsic excitability. Finally we show that intrinsic plasticity resulted in a global enhancement of EPSP-spike coupling.			Jung, SC (corresponding author), Jeju Natl Univ, Coll Med, Dept Physiol, Cheju, South Korea.	hoffmand@mail.nih.gov	Hoffman, Dax A/E-5155-2011	Hoffman, Dax A/0000-0001-6999-2157	Intramural NIH HHS [Z99 HD999999] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008755] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ALKON DL, 1985, BEHAV NEURAL BIOL, V44, P278, DOI 10.1016/S0163-1047(85)90296-1; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BAYLISS DA, 1994, J NEUROPHYSIOL, V71, P119, DOI 10.1152/jn.1994.71.1.119; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Cash S, 1998, J NEUROSCI, V18, P10; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; HESS G, 1990, NEUROSCIENCE, V37, P61, DOI 10.1016/0306-4522(90)90192-7; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Jung SC, 2008, NEURON, V60, P657, DOI 10.1016/j.neuron.2008.08.029; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim J, 2008, NEUROSCIENTIST, V14, P276, DOI 10.1177/1073858408315041; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; STORM JF, 1990, PROG BRAIN RES, V83, P161; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	28	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6549	10.1371/journal.pone.0006549	http://dx.doi.org/10.1371/journal.pone.0006549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662093	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739600007
J	Roe, OD; Anderssen, E; Helge, E; Pettersen, CH; Olsen, KS; Sandeck, H; Haaverstad, R; Lundgren, S; Larsson, E				Roe, Oluf Dimitri; Anderssen, Endre; Helge, Eli; Pettersen, Caroline Hild; Olsen, Karina Standahl; Sandeck, Helmut; Haaverstad, Rune; Lundgren, Steinar; Larsson, Erik			Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; FALSE DISCOVERY RATE; MALIGNANT MESOTHELIOMA; AURORA KINASES; TRANSCRIPTION FACTORS; THYMIDYLATE SYNTHASE; KAPPA-B; EXPRESSION; SUSCEPTIBILITY; MICROARRAY	Background: Malignant pleural mesothelioma is considered an almost incurable tumour with increasing incidence worldwide. It usually develops in the parietal pleura, from mesothelial lining or submesothelial cells, subsequently invading the visceral pleura. Chromosomal and genomic aberrations of mesothelioma are diverse and heterogenous. Genome-wide profiling of mesothelioma versus parietal and visceral normal pleural tissue could thus reveal novel genes and pathways explaining its aggressive phenotype. Methodology and Principal Findings: Well-characterised tissue from five mesothelioma patients and normal parietal and visceral pleural samples from six non-cancer patients were profiled by Affymetrix oligoarray of 38 500 genes. The lists of differentially expressed genes tested for overrepresentation in KEGG PATHWAYS (Kyoto Encyclopedia of Genes and Genomes) and GO (gene ontology) terms revealed large differences of expression between visceral and parietal pleura, and both tissues differed from mesothelioma. Cell growth and intrinsic resistance in tumour versus parietal pleura was reflected in highly overexpressed cell cycle, mitosis, replication, DNA repair and anti-apoptosis genes. Several genes of the "salvage pathway" that recycle nucleobases were overexpressed, among them TYMS, encoding thymidylate synthase, the main target of the antifolate drug pemetrexed that is active in mesothelioma. Circadian rhythm genes were expressed in favour of tumour growth. The local invasive, non-metastatic phenotype of mesothelioma, could partly be due to overexpression of the known metastasis suppressors NME1 and NME2. Down-regulation of several tumour suppressor genes could contribute to mesothelioma progression. Genes involved in cell communication were down-regulated, indicating that mesothelioma may shield itself from the immune system. Similarly, in non-cancer parietal versus visceral pleura signal transduction, soluble transporter and adhesion genes were down-regulated. This could represent a genetical platform of the parietal pleura propensity to develop mesothelioma. Conclusions: Genome-wide microarray approach using complex human tissue samples revealed novel expression patterns, reflecting some important features of mesothelioma biology that should be further explored.			Roe, OD (corresponding author), Univ Trondheim Hosp, Dept Oncol, St Olavs Hosp, N-7006 Trondheim, Norway.	olufdroe@yahoo.no		Roe, Oluf Dimitri/0000-0002-4870-5822				Acevedo-Duncan M, 2002, CELL PROLIFERAT, V35, P23, DOI 10.1046/j.1365-2184.2002.00220.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baas P, 2005, LUNG CANCER-J IASLC, V49, pS61, DOI 10.1016/j.lungcan.2005.03.013; Belogubova EV, 2004, LUNG CANCER, V43, P259, DOI 10.1016/j.lungcan.2003.08.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Boquest AC, 2006, METH MOL B, V325, P35; BOUTIN C, 1993, CANCER, V72, P389, DOI 10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V; Briassouli P, 2007, CANCER RES, V67, P1689, DOI 10.1158/0008-5472.CAN-06-2272; Bridda Alessio, 2007, MedGenMed, V9, P32; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; De Angelis PM, 2004, INT J ONCOL, V24, P1279; Dejmek A, 1997, APMIS, V105, P889, DOI 10.1111/j.1699-0463.1997.tb05099.x; FitzGerald LM, 2009, EUR J HUM GENET, V17, P368, DOI 10.1038/ejhg.2008.171; Gery S, 2007, COLD SPRING HARB SYM, V72, P459, DOI 10.1101/sqb.2007.72.004; Gery S, 2007, CLIN CANCER RES, V13, P1399, DOI 10.1158/1078-0432.CCR-06-1730; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gidskehaug L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-346; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Ha SA, 2004, CLIN CANCER RES, V10, P8386, DOI 10.1158/1078-0432.CCR-04-1029; Hartsough MT, 2001, CANCER RES, V61, P2320; Hashimoto K, 2004, PATHOBIOLOGY, V71, P193, DOI 10.1159/000078673; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hoang CD, 2004, CHEST, V125, P1843, DOI 10.1378/chest.125.5.1843; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Kamrul HM, 2007, ANN NY ACAD SCI, V1100, P312, DOI 10.1196/annals.1395.033; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Kettunen E, 2005, CARCINOGENESIS, V26, P17, DOI 10.1093/carcin/bgh276; Kettunen E, 2001, INT J CANCER, V91, P492, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1094>3.0.CO;2-M; KINSELLA AR, 1991, CANCER RES, V51, P1855; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Langsenlehner U, 2006, BREAST CANCER RES TR, V97, P67, DOI 10.1007/s10549-005-9089-4; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Lindholm PM, 2007, CYTOGENET GENOME RES, V119, P46, DOI 10.1159/000109618; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Lugli A, 2003, HUM PATHOL, V34, P994, DOI 10.1053/S0046-8177(03)00339-3; Malard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-147; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Mohr S, 2004, BIOCHIMIE, V86, P13, DOI 10.1016/j.biochi.2003.11.008; Mohr S, 2004, BBA-MOL BASIS DIS, V1688, P43, DOI 10.1016/j.bbadis.2003.10.007; Mountzios G, 2008, CANCER TREAT REV, V34, P175, DOI 10.1016/j.ctrv.2007.09.005; Musti M, 2006, CANCER GENET CYTOGEN, V170, P9, DOI 10.1016/j.cancergencyto.2006.04.011; Ogiso Y, 2000, CANCER RES, V60, P2429; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Ozdemir F, 2006, J EXP CLIN CANC RES, V25, P83; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Reimer D, 2006, ANN NY ACAD SCI, V1091, P270, DOI 10.1196/annals.1378.073; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rihn BH, 2000, FEBS LETT, V480, P95, DOI 10.1016/S0014-5793(00)01913-X; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; ROE OD, 2008, LUNG CANC; ROE OD, 2009, LUNG CANC; Rustum Y M, 1980, Antibiot Chemother (1971), V28, P86; SALABAT MR, 2008, MOL CARCINOG; Singh M, 2008, MUTAT RES-FUND MOL M, V638, P184, DOI 10.1016/j.mrfmmm.2007.10.003; Singhal S, 2003, CLIN CANCER RES, V9, P3080; Soling A, 2005, CLIN CANCER RES, V11, P249; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Sun XJ, 2005, J PATHOL, V207, P91, DOI 10.1002/path.1810; Teboul M, 2008, MOL ENDOCRINOL, V22, P2573, DOI 10.1210/me.2007-0521; Thickett DR, 1999, THORAX, V54, P707, DOI 10.1136/thx.54.8.707; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Toziu-Kara S, 2007, J MOL ENDOCRINOL, V39, P305, DOI 10.1677/JME-07-0001; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Vivo C, 2001, ONCOGENE, V20, P1085, DOI 10.1038/sj.onc.1204199; Wang JC, 2007, GENE CHROMOSOME CANC, V46, P192, DOI 10.1002/gcc.20400; WANG NS, 1985, CLIN CHEST MED, V6, P3; Warner SL, 2006, SEMIN ONCOL, V33, P436, DOI 10.1053/j.seminoncol.2006.04.007; Wei Tao, 2007, BMC Womens Health, V7, P5, DOI 10.1186/1472-6874-7-5; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wood PA, 2006, MOL CANCER THER, V5, P2023, DOI 10.1158/1535-7163.MCT-06-0177; Xiang Shulin, 2008, J Circadian Rhythms, V6, P4, DOI 10.1186/1740-3391-6-4; Xu JG, 2007, J NEURO-ONCOL, V83, P183, DOI 10.1007/s11060-006-9284-0; Xu LJ, 2006, J BIOL CHEM, V281, P35567, DOI 10.1074/jbc.M607702200; Yu J, 2007, CARCINOGENESIS, V28, P632, DOI 10.1093/carcin/bgl168; Zanazzi C, 2007, GENE CHROMOSOME CANC, V46, P895, DOI 10.1002/gcc.20475	86	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6554	10.1371/journal.pone.0006554	http://dx.doi.org/10.1371/journal.pone.0006554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662092	Green Published, gold			2022-12-25	WOS:000268739600010
J	Hu, GH; Agarwal, P				Hu, Guanghui; Agarwal, Pankaj			Human Disease-Drug Network Based on Genomic Expression Profiles	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CONNECTIVITY MAP; SMALL MOLECULES; CANCER; TARGET; IDENTIFICATION; ENDOMETRIOSIS; MECHANISMS; DISCOVERY; TAMOXIFEN	Background: Drug repositioning offers the possibility of faster development times and reduced risks in drug discovery. With the rapid development of high-throughput technologies and ever-increasing accumulation of whole genome-level datasets, an increasing number of diseases and drugs can be comprehensively characterized by the changes they induce in gene expression, protein, metabolites and phenotypes. Methodology/Principal Findings: We performed a systematic, large-scale analysis of genomic expression profiles of human diseases and drugs to create a disease-drug network. A network of 170,027 significant interactions was extracted from the similar to 24.5 million comparisons between similar to 7,000 publicly available transcriptomic profiles. The network includes 645 disease-disease, 5,008 disease-drug, and 164,374 drug-drug relationships. At least 60% of the disease-disease pairs were in the same disease area as determined by the Medical Subject Headings (MeSH) disease classification tree. The remaining can drive a molecular level nosology by discovering relationships between seemingly unrelated diseases, such as a connection between bipolar disorder and hereditary spastic paraplegia, and a connection between actinic keratosis and cancer. Among the 5,008 disease-drug links, connections with negative scores suggest new indications for existing drugs, such as the use of some antimalaria drugs for Crohn's disease, and a variety of existing drugs for Huntington's disease; while the positive scoring connections can aid in drug side effect identification, such as tamoxifen's undesired carcinogenic property. From the similar to 37K drug-drug relationships, we discover relationships that aid in target and pathway deconvolution, such as 1) KCNMA1 as a potential molecular target of lobeline, and 2) both apoptotic DNA fragmentation and G2/M DNA damage checkpoint regulation as potential pathway targets of daunorubicin. Conclusions/Significance: We have automatically generated thousands of disease and drug expression profiles using GEO datasets, and constructed a large scale disease-drug network for effective and efficient drug repositioning as well as drug target/pathway identification.	[Hu, Guanghui; Agarwal, Pankaj] GlaxoSmithKline, Computat Biol, King Of Prussia, PA USA	GlaxoSmithKline	Hu, GH (corresponding author), GlaxoSmithKline, Computat Biol, King Of Prussia, PA USA.	guanghui.2.hu@gsk.com	Agarwal, Pankaj/N-2147-2019	Agarwal, Pankaj/0000-0002-4165-9990				Ackerman Z, 2000, AM J GASTROENTEROL, V95, P319; Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Augen J, 2002, DRUG DISCOV TODAY, V7, pS157, DOI 10.1016/S1359-6446(02)02484-4; Baldi A, 2008, ONCOL REP, V19, P843; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bebchuk JM, 2000, ARCH GEN PSYCHIAT, V57, P95, DOI 10.1001/archpsyc.57.1.95; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Buchhalter AR, 2008, DRUGS, V68, P1067, DOI 10.2165/00003495-200868080-00005; Burke Catherine, 2005, Clin J Oncol Nurs, V9, P247, DOI 10.1188/05.CJON.247-249; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Butte AJ, 2008, SCIENCE, V320, P325, DOI 10.1126/science.1158343; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carthew P, 2001, ARCH TOXICOL, V75, P375, DOI 10.1007/s002040100244; Chen ES, 2008, J AM MED INFORM ASSN, V15, P87, DOI 10.1197/jamia.M2401; Fielden MR, 2005, TOXICOL PATHOL, V33, P675, DOI 10.1080/01926230500321213; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; FRIEDMAN E, 1993, BIOL PSYCHIAT, V33, P520, DOI 10.1016/0006-3223(93)90006-Y; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hahn CG, 2005, J PSYCHIATR RES, V39, P355, DOI 10.1016/j.jpsychires.2004.10.007; Hengstler JG, 2006, CURR CANCER DRUG TAR, V6, P603, DOI 10.2174/156800906778742488; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jarvinen TAH, 2006, CURR CANCER DRUG TAR, V6, P579, DOI 10.2174/156800906778742497; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kulkarni J, 2006, PSYCHONEUROENDOCRINO, V31, P543, DOI 10.1016/j.psyneuen.2005.11.001; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Laurent G, 2001, BLOOD, V98, P913, DOI 10.1182/blood.V98.4.913; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Meier CR, 1999, JAMA-J AM MED ASSOC, V281, P427, DOI 10.1001/jama.281.5.427; Ness RB, 2003, AM J OBSTET GYNECOL, V189, P280, DOI 10.1067/mob.2003.408; Neugebauer NM, 2007, EUR J PHARMACOL, V571, P33, DOI 10.1016/j.ejphar.2007.06.003; Panes J, 2007, DRUGS, V67, P2511, DOI 10.2165/00003495-200767170-00005; Phillips DH, 2001, CARCINOGENESIS, V22, P839, DOI 10.1093/carcin/22.6.839; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Polston JE, 2006, LIFE SCI, V79, P981, DOI 10.1016/j.lfs.2006.05.006; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P18, DOI 10.1111/j.1365-2133.2007.08267.x; Rossi R, 2007, INT J DERMATOL, V46, P895, DOI 10.1111/j.1365-4632.2007.03166.x; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanner SW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-348; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Vazza G, 2000, AM J HUM GENET, V67, P504, DOI 10.1086/303017; VLIAGOFTIS H, 1992, INT ARCH ALLERGY IMM, V98, P398, DOI 10.1159/000236217; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yan Albert C, 2005, Adv Dermatol, V21, P65, DOI 10.1016/j.yadr.2005.05.001; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yildiz A, 2008, ARCH GEN PSYCHIAT, V65, P255, DOI 10.1001/archgenpsychiatry.2007.43; Zemke D, 2007, DRUG NEWS PERSPECT, V20, P495, DOI 10.1358/dnp.2007.20.8.1157618	63	215	222	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6536	10.1371/journal.pone.0006536	http://dx.doi.org/10.1371/journal.pone.0006536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657382	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739300007
J	Vaucheret, H				Vaucheret, Herve			AGO1 Homeostasis Involves Differential Production of 21-nt and 22-nt miR168 Species by MIR168a and MIR168b	PLOS ONE			English	Article								Background AGO1 associates with microRNAs (miRNAs) and regulates mRNAs through cleavage and translational repression. AGO1 homeostasis entails DCL1-dependent production of miR168 from MIR168a and MIR168b transcripts, post-transcriptional stabilization of miR168 by AGO1, and AGO1-catalyzed miR168-guided cleavage of AGO1 mRNA. Principal Findings: This study reveals that MIR168a is highly expressed and predominantly produces a 21-nt miR168 species. By contrast, MIR168b is expressed at low levels and produces an equal amount of 21- and 22-nt miR168 species. Only the 21-nt miR168 is preferentially stabilized by AGO1, and consequently, the accumulation of the 22-nt but not the 21-nt miR168 is reduced when DCL1 activity is impaired. mir168a mutants with strongly reduced levels of 21-nt miR168 are viable but exhibit developmental defects, particularly during environmentally challenging conditions. Conclusions/Significance: These results suggest that 22-nt miR168 ensures basal cleavage of AGO1 mRNA whereas 21-nt miR168 permits an effective response to endogenous or environmental fluctuations owing to its preferential stabilization by AGO1.	INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Vaucheret, H (corresponding author), INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	herve.vaucheret@versailles.inra.fr		VAUCHERET, HERVE/0000-0002-9986-0988				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cartolano M, 2007, NAT GENET, V39, P901, DOI 10.1038/ng2056; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gazzani S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-62; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mallory AC, 2009, EMBO REP, V10, P521, DOI 10.1038/embor.2009.32; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	36	76	77	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6442	10.1371/journal.pone.0006442	http://dx.doi.org/10.1371/journal.pone.0006442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649244	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494600012
J	Han, JY; Liu, GQ; Profirovic, J; Niu, JX; Voyno-Yasenetskaya, T				Han, Jingyan; Liu, Guoquan; Profirovic, Jasmina; Niu, Jiaxin; Voyno-Yasenetskaya, Tatyana			Zyxin is involved in thrombin signaling via interaction with PAR-1 receptor	FASEB JOURNAL			English	Article						endothelium; G-protein-coupled receptors; actin cytoskeleton; heterotrimeric G proteins	SERUM RESPONSE FACTOR; STIMULATED PHOSPHOPROTEIN FAMILY; HUMAN ENDOTHELIAL-CELLS; STRESS FIBER FORMATION; ACTIN-POLYMERIZATION; FOCAL ADHESIONS; CYTOSKELETAL REORGANIZATION; PROTEIN; ACTIVATION; G-ALPHA(12)	Protease-activated receptor 1 (PAR-1) mediates thrombin signaling in human endothelial cells. As a G-protein-coupled receptor, PAR-1 transmits thrombin signal through activation of the heterotrimeric G proteins, Gi, Gq, and G12/13. In this study, we demonstrated that zyxin, a LIM-domain-containing protein, is involved in thrombin-mediated actin cytoskeleton remodeling and serum response element (SRE)dependent gene transcription. We determined that zyxin binds to the C-terminal domain of PAR-1, providing a possible mechanism of involvement of zyxin as a signal transducer in PAR-1 signaling. Data showing that disruption of PAR-1-zyxin interaction inhibited thrombin-induced stress fiber formation and SRE activation supports this hypothesis. Similarly, depletion of zyxin using siRNA inhibited thrombin-induced actin stress fiber formation and SRE-dependent gene transcription. In addition, depletion of zyxin resulted in delay of endothelial barrier restoration after thrombin treatment. Notably, down-regulation of zyxin did not affect thrombin-induced activation of RhoA or Gi, Gq, and G12/13 heterotrimeric G proteins, implicating a novel signaling pathway regulated by PAR-1 that is not mediated by G-proteins. The observation that zyxin targets VASP, a partner of zyxin in regulation of actin assembly and dynamics, to focal adhesions and along stress fibers on thrombin stimulation suggests that zyxin may participate in thrombin-induced cytoskeletal remodeling through recruitment of VASP. In summary, this study establishes a crucial role of zyxin in thrombin signaling in endothelial cells and provides evidence for a novel PAR-1 signaling pathway mediated by zyxin.-Han, J., Liu, G., Profirovic, J., Niu, J., Voyno-Yasenetskaya, T. Zyxin is involved in thrombin signaling via interaction with PAR-1 receptor. FASEB J. 23, 4193-4206 (2009). www.fasebj.org	[Han, Jingyan; Liu, Guoquan; Profirovic, Jasmina; Niu, Jiaxin; Voyno-Yasenetskaya, Tatyana] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Voyno-Yasenetskaya, Tatyana] Univ Illinois, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Voyno-Yasenetskaya, T (corresponding author), Univ Illinois, Dept Pharmacol MC 868, 909 S Wolcott Ave, Chicago, IL 60612 USA.	tvy@uic.edu			National Institutes of Health [GM56159, P01 HL60678]; American Heart Association [0710113Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056159, R55GM056159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grants GM56159 and P01 HL60678 and by American Heart Association predoctoral fellowship 0710113Z to J. H.	Andreeva AV, 2005, J BIOL CHEM, V280, P30376, DOI 10.1074/jbc.M502844200; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; GARCIA JGN, 1995, J INVEST MED, V43, P117; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Gorovoy M, 2005, J BIOL CHEM, V280, P26533, DOI 10.1074/jbc.M502921200; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hobert O, 1996, ONCOGENE, V12, P1577; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; KATADA T, 1984, J BIOL CHEM, V259, P3578; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Li B, 2001, J BIOL CHEM, V276, P33328, DOI 10.1074/jbc.M100789200; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; Macalma T, 1996, J BIOL CHEM, V271, P31470, DOI 10.1074/jbc.271.49.31470; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Narayanan S, 1999, ANN CLIN LAB SCI, V29, P275; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Pai KS, 2001, J BIOL CHEM, V276, P32642, DOI 10.1074/jbc.M104212200; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rajagopal K, 2005, J CLIN INVEST, V115, P2971, DOI 10.1172/JCI26950; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Schaphorst KL, 1997, AM J RESP CELL MOL, V17, P443, DOI 10.1165/ajrcmb.17.4.2502; Schmeichel KL, 1998, BIOCHEM J, V331, P885, DOI 10.1042/bj3310885; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Vaiskunaite R, 2001, J BIOL CHEM, V276, P46088, DOI 10.1074/jbc.M108711200; Vanhauwe JF, 2002, J BIOL CHEM, V277, P34143, DOI 10.1074/jbc.M204477200; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Yi JS, 2002, J BIOL CHEM, V277, P9580, DOI 10.1074/jbc.M106922200; Yi JS, 1998, GENOMICS, V49, P314, DOI 10.1006/geno.1998.5248; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330	60	17	17	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4193	4206		10.1096/fj.09-131862	http://dx.doi.org/10.1096/fj.09-131862			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19690217	Green Published			2022-12-25	WOS:000272193700015
J	Wartosch, L; Fuhrmann, JC; Schweizer, M; Stauber, T; Jentsch, TJ				Wartosch, Lena; Fuhrmann, Jens C.; Schweizer, Michaela; Stauber, Tobias; Jentsch, Thomas J.			Lysosomal degradation of endocytosed proteins depends on the chloride transport protein ClC-7	FASEB JOURNAL			English	Article						neurodegeneration; neuronal ceroid lipofuscinosis; NCL; lysosomal storage disease	AUTOSOMAL RECESSIVE OSTEOPETROSIS; DENTS-DISEASE; STORAGE DISEASE; LATE ENDOSOMES; BETA-SUBUNIT; PROTON PUMP; CHANNEL; DISRUPTION; PATHWAY; MOUSE	Mutations in either ClC-7, a late endosomal/lysosomal member of the CLC family of chloride channels and transporters, or in its beta-subunit Ostm1 cause osteopetrosis and lysosomal storage disease in mice and humans. The severe phenotype of mice globally deleted for ClC-7 or Ostm1 and the absence of storage material in cultured cells hampered investigations of the mechanism leading to lysosomal pathology in the absence of functional ClC-7/Ostm1 transporters. Tissue-specific ClC-7-knockout mice now reveal that accumulation of storage material occurs cell-autonomously in neurons or renal proximal tubular cells lacking ClC-7. Almost all ClC-7-deficient neurons die. The activation of glia is restricted to brain regions where ClC-7 has been inactivated. The effect of ClC-7 disruption on lysosomal function was investigated in renal proximal tubular cells, which display high endocytotic activity. Pulse-chase endocytosis experiments in vivo with mice carrying chimeric deletion of ClC-7 in proximal tubules allowed a direct comparison of the handling of endocytosed protein between cells expressing or lacking ClC-7. Whereas protein was endocytosed similarly in cells of either genotype, its half-life increased significantly in ClC-7-deficient cells. These experiments demonstrate that lysosomal pathology is a cell-autonomous consequence of ClC-7 disruption and that ClC-7 is important for lysosomal protein degradation.-Wartosch, L., Fuhrmann, J. C., Schweizer, M., Stauber, T., Jentsch, T. J. Lysosomal degradation of endocytosed proteins depends on the chloride transport protein ClC-7. FASEB J. 23, 4056-4068 (2009). www.fasebj.org	[Wartosch, Lena; Fuhrmann, Jens C.; Stauber, Tobias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmacol, FMP, D-13125 Berlin, Germany; [Wartosch, Lena; Fuhrmann, Jens C.; Stauber, Tobias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, MDC, Berlin, Germany; [Wartosch, Lena] Free Univ Berlin, D-1000 Berlin, Germany; [Schweizer, Michaela] Univ Hamburg, Zentrum Mol Neurobiol ZMNH, Hamburg, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; University of Hamburg	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmacol, FMP, Robert Rossle Str 10, D-13125 Berlin, Germany.	jentsch@fmp-berlin.de	Stauber, Tobias/E-4005-2010	Stauber, Tobias/0000-0003-0727-6109; Jentsch, Thomas/0000-0002-3509-2553; Fuhrmann, Jens/0000-0001-5730-381X	Deutsche Forschungsgemeinschaft; European Union (Euregene); Boehringer Ingelheim fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (Euregene)(European Commission); Boehringer Ingelheim fellowship(Boehringer Ingelheim)	We thank the following colleagues for generously making material available: Takuji Iwasato and Shigeyoshi Itohara (Brain Science Institute, RIKEN, Saitama, Japan) for EMX1-cre mice, Thomas Willnow (MDC, Berlin, Germany) for ApoE-cre mice, and Jean Gruenberg (University of Geneva, Geneva, Switzerland) for the LBPA antibody. We thank Sebastian Bachmann for helpful discussions; Irm Hermans-Borgmeyer and Tina Koppelmann for help in generating Clcn7lox/lox mice; Nicole Kronke, Patrick Seidler, and Stephanie Wernick for technical assistance; York Rudhard for EMX1-Z/AP reporter staining; and Gunter Delling for help with X-ray analysis. This work was supported by grants of the Deutsche Forschungsgemeinschaft and the European Union (Euregene) to T. J. J. and a Boehringer Ingelheim fellowship to L. W.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Cigic B, 1999, EUR J BIOCHEM, V264, P944, DOI 10.1046/j.1432-1327.1999.00697.x; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Cooper JD, 2006, BBA-MOL BASIS DIS, V1762, P873, DOI 10.1016/j.bbadis.2006.08.002; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Leheste JR, 2002, FASEB J, V16, P247, DOI 10.1096/fj.02-0578fje; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Nielsen R, 2007, P NATL ACAD SCI USA, V104, P5407, DOI 10.1073/pnas.0700330104; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; ZEUZEM S, 1992, P NATL ACAD SCI USA, V89, P6619, DOI 10.1073/pnas.89.14.6619	45	53	56	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4056	4068		10.1096/fj.09-130880	http://dx.doi.org/10.1096/fj.09-130880			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19661288				2022-12-25	WOS:000272193700003
J	Muller, B; Anders, M; Akiyama, H; Welsch, S; Glass, B; Nikovics, K; Clavel, F; Tervo, HM; Keppler, OT; Krausslich, HG				Mueller, Barbara; Anders, Maria; Akiyama, Hisashi; Welsch, Sonja; Glass, Baerbel; Nikovics, Krisztina; Clavel, Francois; Tervo, Hanna-Mari; Keppler, Oliver T.; Kraeusslich, Hans-Georg			HIV-1 Gag Processing Intermediates Trans-dominantly Interfere with HIV-1 Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TERMINAL CAPSID MUTANTS; VIRAL PROTEASE; T-CELLS; PARTICLE MATURATION; BLOCK INFECTIVITY; VIRION MATURATION; CLEAVAGE SITES; INFECTED-CELLS; TYPE-1	Protease inhibitors (PI) act by blocking human immunodeficiency virus (HIV) polyprotein processing, but there is no direct quantitative correlation between the degree of impairment of Gag processing and virion infectivity at low PI concentrations. To analyze the consequences of partial processing, virus particles were produced in the presence of limiting PI concentrations or by co-transfection of wild-type proviral plasmids with constructs carrying mutations in one or more cleavage sites. Low PI concentrations caused subtle changes in polyprotein processing associated with a pronounced reduction of particle infectivity. Dissection of individual stages of viral entry indicated a block in accumulation of reverse transcriptase products, whereas virus entry, enzymatic reverse transcriptase activity, and replication steps following reverse transcription were not affected. Co-expression of low amounts of partially processed forms of Gag together with wild-type HIV generally exerted a trans-dominant effect, which was most prominent for a construct carrying mutations at both cleavage sites flanking the CA domain. Interestingly, co-expression of low amounts of Gag mutated at the CA-SP1 cleavage site also affected processing activity at this site in the wild-type virus. The results indicate that low amounts (<5%) of Gag processing intermediates can display a trans-dominant effect on HIV particle maturation, with the maturation cleavage between CA and SP1 being of particular importance. These effects are likely to be important for the strong activity of PI at concentrations achieved in vivo and also bear relevance for the mechanism of action of the antiviral drug bevirimat.	[Mueller, Barbara; Tervo, Hanna-Mari; Keppler, Oliver T.; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Virol, D-69120 Heidelberg, Germany; [Welsch, Sonja] EMBL, D-69117 Heidelberg, Germany; [Nikovics, Krisztina; Clavel, Francois] Hop St Louis, Inst Univ Hematol, INSERM, U941, F-75475 Paris, France	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Muller, B (corresponding author), Univ Klinikum Heidelberg, Dept Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	barbara_mueller@med.uni-heidelberg.de	Muller, Barbara/AAC-4483-2020	Muller, Barbara/0000-0001-5726-5585; Akiyama, Hisashi/0000-0001-9228-0465; Welsch, Sonja/0000-0002-6049-6664	European Union [LSHP-CT-2007-036793]; Deutsche Forschungsgemeinschaft [MU885/4-2]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by European Union FP6 Grant LSHP-CT-2007-036793 (HIV PI resistance) and by Deutsche Forschungsgemeinschaft Grant MU885/4-2.	Accola MA, 2000, J VIROL, V74, P6198, DOI 10.1128/JVI.74.13.6198-6202.2000; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Anderson N, 2009, FOREST CHRON, V85, P110, DOI 10.5558/tfc85110-1; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Bohne J, 2004, FEBS LETT, V563, P113, DOI 10.1016/S0014-5793(04)00277-7; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Coren LV, 2007, J VIROL, V81, P10047, DOI 10.1128/JVI.02496-06; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Goffinet C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-53; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Jiang JY, 2006, VIROLOGY, V346, P460, DOI 10.1016/j.virol.2005.11.008; Justesen US, 2008, DAN MED BULL, V55, P165; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; KRAUSSLICH HG, 1992, J VIROL, V66, P567; LAMBERT DM, 1992, ANTIMICROB AGENTS CH, V36, P982, DOI 10.1128/AAC.36.5.982; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; MEEK TD, 1990, NATURE, V343, P90, DOI 10.1038/343090a0; Moore MD, 2008, VIROLOGY, V379, P152, DOI 10.1016/j.virol.2008.06.030; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; PARK J, 1993, VIROLOGY, V194, P843, DOI 10.1006/viro.1993.1328; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pettit SC, 2002, J VIROL, V76, P10226, DOI 10.1128/JVI.76.20.10226-10233.2002; Race E, 1999, AIDS, V13, P2061, DOI 10.1097/00002030-199910220-00008; ROSE JR, 1995, J VIROL, V69, P2751; Rulli SJ, 2006, VIROLOGY, V347, P364, DOI 10.1016/j.virol.2005.12.012; Salzwedel K, 2007, AIDS REV, V9, P162; Sham HL, 1998, ANTIMICROB AGENTS CH, V42, P3218, DOI 10.1128/AAC.42.12.3218; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tang SX, 2003, J VIROL, V77, P12592, DOI 10.1128/JVI.77.23.12592-12602.2003; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; Tervo HM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-58; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Zhou J, 2004, J VIROL, V78, P922, DOI 10.1128/JVI.78.2.922-929.2004	47	78	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29692	29703		10.1074/jbc.M109.027144	http://dx.doi.org/10.1074/jbc.M109.027144			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19666477	Green Published, hybrid			2022-12-25	WOS:000270896800051
J	Snow, JW; Orkin, SH				Snow, Jonathan W.; Orkin, Stuart H.			Translational Isoforms of FOG1 Regulate GATA1-interacting Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ZINC-FINGER PROTEIN; ERYTHROID-CELLS; CO-REPRESSOR; NORMAL ERYTHROPOIESIS; MAMMALIAN-CELLS; BINDING-PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; ACTIVATION	Erythropoietic and megakaryocytic programs are directed by the transcription factor GATA1. Friend of GATA1 (FOG1), a protein interaction partner of GATA1, is critical for GATA1 function in multiple contexts. Previous work has shown that FOG1 recruits two multi-protein complexes, the nucleosome remodeling domain (NuRD) complex and a C-terminal binding protein (CTBP)-containing complex, into association with GATA1 to mediate activation and repression of target genes. To elucidate mechanisms that might differentially regulate the association of FOG1, as well as GATA1, with these two complexes, we characterized a previously unrecognized translational isoform of FOG1. We found that an N-terminally truncated version of FOG1 is produced from an internal ATG and that this isoform, designated FOG1S, lacks the nucleosome remodeling domain-binding domain, altering the complexes with which it interacts. Both isoforms interact with the C-terminal binding protein complex, which we show also contains lysine-specific demethylase 1 (LSD1). FOG1S is preferentially excluded from the nucleus by unknown mechanisms. These data reveal two novel mechanisms for the regulation of GATA1 interaction with FOG1-dependent protein complexes through the production of two translational isoforms with differential interaction profiles and independent nuclear localization controls.	[Snow, Jonathan W.; Orkin, Stuart H.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Snow, Jonathan W.; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Snow, Jonathan W.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu			National Institutes of Health [HL32259, HL32262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL032259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL32259 and HL32262 (to S. H. O.).	Calkhoven CF, 2000, GENE DEV, V14, P1920; Calkhoven CF, 2003, GENE DEV, V17, P959, DOI 10.1101/gad.251903; Calkhoven CF, 2002, TRENDS MOL MED, V8, P577, DOI 10.1016/S1471-4914(02)02424-3; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Dale RM, 2007, BIOCHEM BIOPH RES CO, V357, P683, DOI 10.1016/j.bbrc.2007.04.008; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Gobert S, 1996, EMBO J, V15, P2434, DOI 10.1002/j.1460-2075.1996.tb00601.x; GREGORY GD, 2008, BLOOD ASH ANN M; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Katz SG, 2002, MOL CELL BIOL, V22, P3121, DOI 10.1128/MCB.22.9.3121-3128.2002; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lackner DH, 2008, INT REV CEL MOL BIO, V271, P199, DOI 10.1016/S1937-6448(08)01205-7; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; ORKIN SH, 1992, BLOOD, V80, P575; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Quadrini KJ, 2008, EXP CELL RES, V314, P1595, DOI 10.1016/j.yexcr.2008.01.033; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Tan JS, 2006, BLOOD, V107, P2557, DOI 10.1182/blood-2005-07-2957; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Vyas P, 1999, BLOOD, V93, P2867; Vyas P, 2007, CURR OPIN PEDIATR, V19, P9, DOI 10.1097/MOP.0b013e328013e7b2; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29310	29319		10.1074/jbc.M109.043497	http://dx.doi.org/10.1074/jbc.M109.043497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19654328	hybrid, Green Published			2022-12-25	WOS:000270896800010
J	Zheng, HQ; Zhou, Z; Huang, J; Chaudhury, L; Dong, JT; Chen, C				Zheng, H-Q; Zhou, Z.; Huang, J.; Chaudhury, L.; Dong, J-T; Chen, C.			Kruppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of broblast growth factor binding protein 1	ONCOGENE			English	Article						KLF5; FGF-BP; proliferation; transcription factor; breast cancer	EPITHELIAL-CELLS; FGF-BP; CANCER-CELLS; SKIN CARCINOGENESIS; TUMOR-GROWTH; LIGASE WWP1; KLF5; EXPRESSION; KRUPPEL-LIKE-FACTOR-5; ACTIVATION	The Kruppel-like factor 5 (KLF5) is a zinc-finger transcription factor promoting cell proliferation, cell-cycle progression and survival. A high expression level of KLF5 mRNA has been shown to be associated with shorter breast cancer patient survival. However, the mechanism of KLF5 action in breast cancer is still not clear. In this study, we found that both KLF5 and its downstream gene. broblast growth factor binding protein 1 (FGF-BP) are co-expressed in breast cell lines and primary tumors. Manipulation of the KLF5 expression can positively regulate the FGF-BP mRNA and protein levels in multiple breast cell lines. In addition, the secreted FGF-BP protein in the conditional medium is also regulated by KLF5. Furthermore, we demonstrated that KLF5 binds and activates the FGF-BP promoter through a GC box by luciferase reporter, oligo pull down and chromatin immunoprecipitation (ChIP) assays. When FGF-BP is depleted by siRNA, KLF5 fails to promote cell proliferation in MCF10A, SW527 and TSU-Pr1. We further demonstrated that overexpression or addition of FGF-BP rescues the KLF5-knockdown-induced growth arrest in MCF10A cells. Finally, KLF5 significantly promotes MCF7 breast cancer cell xenograft growth in athymic nude mice. These findings suggest that KLF5 may promote breast cancer cell proliferation at least partially through directly activating the FGF-BP mRNA transcription. Understanding the mechanism of KLF5 action in breast cancer may result in useful diagnostic and therapeutic targets. Oncogene (2009) 28, 3702-3713; doi: 10.1038/onc.2009.235; published online 10 August 2009	[Zheng, H-Q; Zhou, Z.; Chaudhury, L.; Chen, C.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Huang, J.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Dong, J-T] Emory Univ, Sch Med, Dept Hematol & Oncol, Winship Canc Inst, Atlanta, GA USA	Albany Medical College; Baylor College of Medicine; Emory University	Chen, C (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MS355,Mail Code 165,47 New Scotland Ave, Albany, NY 12208 USA.	chenc@mail.amc.edu		Zheng, Hanqiu/0000-0002-8062-1215; Dong, Jin-Tang/0000-0003-2349-5782	Susan G Komen Breast Cancer Foundation [BCTR0503705]; American Cancer Society; Department of Defense [W81XWH-07-1-0191]	Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense)	This work was supported in part by a grant (BCTR0503705) from the Susan G Komen Breast Cancer Foundation, a grant from the American Cancer Society and a grant from the Department of Defense (W81XWH-07-1-0191). We thank Dr Chunhong Yan and Dr Jihe Zhao for providing the pRL-bactin construct and the pBabe-puro retroviral system.	Abuharbeid S, 2006, INT J BIOCHEM CELL B, V38, P1463, DOI 10.1016/j.biocel.2005.10.017; Aigner A, 2001, INT J CANCER, V92, P510, DOI 10.1002/1097-0215(20010515)92:4<510::AID-IJC1227>3.0.CO;2-H; Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2007, INT J CANCER, V121, P2834; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; CZUBAYKO F, 1994, J BIOL CHEM, V269, P21358; Czubayko F, 1997, NAT MED, V3, P1137, DOI 10.1038/nm1097-1137; CZUBAYKO F, 1994, J BIOL CHEM, V269, P28243; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Harris VK, 1998, J BIOL CHEM, V273, P19130, DOI 10.1074/jbc.273.30.19130; Harris VK, 2001, ONCOGENE, V20, P1730, DOI 10.1038/sj.onc.1204249; Kagan BL, 2003, CANCER RES, V63, P1696; Kojima S, 1997, J BIOCHEM, V121, P389; Kurtz A, 1997, ONCOGENE, V14, P2671, DOI 10.1038/sj.onc.1201117; Kurtz A, 2004, NEOPLASIA, V6, P595, DOI 10.1593/neo.04214; Kwak MK, 2008, J CANCER RES CLIN, V134, P163, DOI 10.1007/s00432-007-0265-2; Li WM, 2004, CHINESE MED J-PEKING, V117, P621; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Ray PE, 2006, AM J PHYSIOL-REG I, V290, pR105, DOI 10.1152/ajpregu.00492.2005; Ray R, 2003, CANCER RES, V63, P8085; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Sur I, 2002, EUR J CELL BIOL, V81, P323, DOI 10.1078/0171-9335-00257; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Tassi E, 2006, CANCER RES, V66, P1191, DOI 10.1158/0008-5472.CAN-05-2926; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; WU DQ, 1991, J BIOL CHEM, V266, P16778; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310; Zhao Y, 2008, ONCOGENE, V27, P1, DOI 10.1038/sj.onc.1210625	45	79	80	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2009	28	42					3702	3713		10.1038/onc.2009.235	http://dx.doi.org/10.1038/onc.2009.235			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	509MY	19668233				2022-12-25	WOS:000271023200003
J	Campa, F; Yoon, HY; Ha, VL; Szentpetery, Z; Balla, T; Randazzo, PA				Campa, Fanny; Yoon, Hye-Young; Ha, Vi Luan; Szentpetery, Zsofia; Balla, Tamas; Randazzo, Paul A.			A PH Domain in the Arf GTPase-activating Protein (GAP) ARAP1 Binds Phosphatidylinositiol 3,4,5-Trisphosphate and Regulates Arf GAP Activity Independently of Recruitment to the Plasma Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; INOSITOL-LIPID-BINDING; MYRISTOYLATED ARF1; STRUCTURAL BASIS; ASAP1; ADAPTER; FAMILY; ROLES; GGA; IDENTIFICATION	ARAP1 is a phosphatidylinositol 3,4,5-trisphosphate (PtdIns-(3,4,5)P-3)-dependent Arf GTPase-activating protein (GAP) with five PH domains that regulates endocytic trafficking of the epidermal growth factor receptor (EGFR). Two tandem PH domains are immediately N-terminal of the Arf GAP domain, and one of these fits the consensus sequence for PtdIns(3,4,5)P-3 binding. Here, we tested the hypothesis that PtdIns(3,4,5)P-3-dependent recruitment mediated by the first PH domain of ARAP1 regulates the in vivo and in vitro function of ARAP1. We found that PHI of ARAP1 specifically bound to PtdIns(3,4,5)P-3, but with relatively low affinity (approximate to 1.6 mu M), and the PH domains did not mediate PtdIns(3,4,5)P-3-dependent recruitment to membranes in cells. However, PtdIns(3,4,5)P-3 binding to the PH domain stimulated GAP activity and was required for in vivo function of ARAP1 as a regulator of endocytic trafficking of the EGFR. Based on these results, we propose a variation on the model for the function of phosphoinositide-binding PH domains. In our model, ARAP1 is recruited to membranes independently of PtdIns(3,4,5)P-3, the subsequent production of which triggers enzymatic activity.	[Campa, Fanny; Yoon, Hye-Young; Ha, Vi Luan; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA; [Szentpetery, Zsofia; Balla, Tamas] NICHD, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, NIH, Bldg 37,Rm 2042, Bethesda, MD 20892 USA.	randazzo@helix.nih.gov		Balla, Tamas/0000-0002-9077-3335	National Institutes of Health; NICHID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants from the NCI Intramural Program and NICHID.	Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Che MM, 2005, METHOD ENZYMOL, V404, P147, DOI 10.1016/S0076-6879(05)04015-2; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Gervais V, 2004, NAT STRUCT MOL BIOL, V11, P616, DOI 10.1038/nsmb782; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hirsch DS, 2003, TRAFFIC, V4, P26, DOI 10.1034/j.1600-0854.2003.40105.x; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jacques KM, 2002, J BIOL CHEM, V277, P47235, DOI 10.1074/jbc.M208875200; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Krugmann S, 2006, J CELL SCI, V119, P425, DOI 10.1242/jcs.02755; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 1998, CURR TOP MICROBIOL, V228, P39; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Logsdon JM, 2003, PROTEINS CELL REG, V1, P1; Luo R, 2008, CELL SIGNAL, V20, P1968, DOI 10.1016/j.cellsig.2008.07.007; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Nie ZZ, 2005, J CELL SCI, V118, P3555, DOI 10.1242/jcs.02486; Nie ZZ, 2003, DEV CELL, V5, P513, DOI 10.1016/S1534-5807(03)00234-X; Oda A, 2003, J BIOL CHEM, V278, P6456, DOI 10.1074/jbc.M210817200; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; RANDAZZO PA, 1992, METHOD ENZYMOL, V219, P362; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Randazzo PA, 2001, METHOD ENZYMOL, V329, P343; RANDAZZO PA, 2000, SCI STKE, V59, pRE1; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Randazzo Paul A, 2002, Methods Mol Biol, V189, P169; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Stacey TTI, 2004, J CELL SCI, V117, P6071, DOI 10.1242/jcs.01526; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Thomas CC, 2001, BIOCHEM J, V358, P287, DOI 10.1042/0264-6021:3580287; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	60	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28069	28083		10.1074/jbc.M109.028266	http://dx.doi.org/10.1074/jbc.M109.028266			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666464	hybrid, Green Published			2022-12-25	WOS:000270676300034
J	Hayashi, I; Takatori, S; Urano, Y; Iwanari, H; Isoo, N; Osawa, S; Fukuda, MA; Kodama, T; Hamakubo, T; Li, T; Wong, PC; Tomita, T; Iwatsubo, T				Hayashi, Ikuo; Takatori, Sho; Urano, Yasuomi; Iwanari, Hiroko; Isoo, Noriko; Osawa, Satoko; Fukuda, Maiko A.; Kodama, Tatsuhiko; Hamakubo, Takao; Li, Tong; Wong, Philip C.; Tomita, Taisuke; Iwatsubo, Takeshi			Single Chain Variable Fragment against Nicastrin Inhibits the gamma-Secretase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ANTIBODY FRAGMENTS; COMPLEX-FORMATION; CATALYTIC PORE; BETA-SECRETASE; C-TERMINUS; PRESENILIN; TRAFFICKING; PATHWAY; STABILIZATION	gamma-Secretase is a membrane protein complex that catalyzes intramembrane proteolysis of a variety of substrates including the amyloid beta precursor protein of Alzheimer disease. Nicastrin (NCT), a single-pass membrane glycoprotein that harbors a large extracellular domain, is an essential component of the gamma-secretase complex. Here we report that overexpression of a single chain variable fragment (scFv) against NCT as an intrabody suppressed the gamma-secretase activity. Biochemical analyses revealed that the scFv disrupted the proper folding and the appropriate glycosyl maturation of the endogenous NCT, which are required for the stability of the gamma-secretase complex and the intrinsic proteolytic activity, respectively, implicating the dual role of NCT in the gamma-secretase complex. Our results also highlight the importance of the calnexin cycle in the functional maturation of the gamma-secretase complex. The engineered intrabodies may serve as rationally designed, molecular targeting tools for the discovery of novel actions of the membrane proteins.	[Hayashi, Ikuo; Takatori, Sho; Isoo, Noriko; Osawa, Satoko; Fukuda, Maiko A.; Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Urano, Yasuomi; Iwanari, Hiroko; Kodama, Tatsuhiko; Hamakubo, Takao] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Iwanari, Hiroko] Perseus Prote Inc, Meguro Ku, Tokyo 1530041, Japan; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Bunkyo Ku, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Johns Hopkins University; Japan Science & Technology Agency (JST); University of Tokyo	Tomita, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Takatori, Sho/0000-0002-3925-4011; Urano, Yasuomi/0000-0002-4901-1937	Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institute of Biomedical Innovation; Japan Science and Technology Corporation (EST); Core Research for Evolutional Science and Technology of EST, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Science and Technology Corporation (EST)(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology of EST, Japan(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants-in-aid for Young Scientists (S) from the Japan Society for the Promotion of Science, Scientific Research on Priority Areas Research on Pathomechanisms of Brain Disorders from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, by Targeted Proteins Research Program of the Japan Science and Technology Corporation (EST), and by Core Research for Evolutional Science and Technology of EST, Japan.	Arbel M, 2005, P NATL ACAD SCI USA, V102, P7718, DOI 10.1073/pnas.0502427102; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; de Armas HN, 2007, STRUCTURE, V15, P1105, DOI 10.1016/j.str.2007.07.009; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Farady CJ, 2007, J MOL BIOL, V369, P1041, DOI 10.1016/j.jmb.2007.03.078; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Gal-Tanamy M, 2005, J MOL BIOL, V347, P991, DOI 10.1016/j.jmb.2005.02.020; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kato K, 2007, GLYCOBIOLOGY, V17, P1031, DOI 10.1093/glycob/cwm046; Keller SH, 1998, J BIOL CHEM, V273, P17064, DOI 10.1074/jbc.273.27.17064; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kimberly WT, 2002, J BIOL CHEM, V277, P35113, DOI 10.1074/jbc.M204446200; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li T, 2003, J NEUROSCI, V23, P3272; Marcus NY, 2000, J BIOL CHEM, V275, P1987, DOI 10.1074/jbc.275.3.1987; Mikkelsen JH, 2008, J BIOL CHEM, V283, P16772, DOI 10.1074/jbc.M802429200; Miller TW, 2005, MOL THER, V12, P394, DOI 10.1016/j.ymthe.2005.04.003; Morais VA, 2006, BBA-MOL BASIS DIS, V1762, P802, DOI 10.1016/j.bbadis.2006.06.018; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Saitoh R, 2007, J IMMUNOL METHODS, V322, P104, DOI 10.1016/j.jim.2007.02.005; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; SAUL R, 1983, ARCH BIOCHEM BIOPHYS, V221, P593, DOI 10.1016/0003-9861(83)90181-9; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 2002, FEBS LETT, V520, P117, DOI 10.1016/S0014-5793(02)02802-8; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Verbeke K, 2004, J THROMB HAEMOST, V2, P298, DOI 10.1111/j.1538-7933.2004.00583.x; Walker ES, 2006, J NEUROCHEM, V98, P300, DOI 10.1111/j.1471-4159.2006.03881.x; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	57	20	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27838	27847		10.1074/jbc.M109.055061	http://dx.doi.org/10.1074/jbc.M109.055061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684016	Green Published, hybrid			2022-12-25	WOS:000270676300010
J	Kriegs, M; Burckstummer, T; Himmelsbach, K; Bruns, M; Frelin, L; Ahlen, G; Sallberg, M; Hildt, E				Kriegs, Malte; Buerckstuemmer, Tilmann; Himmelsbach, Kyoshi; Bruns, Michael; Frelin, Lars; Ahlen, Gustaf; Sallberg, Matti; Hildt, Eberhard			The Hepatitis C Virus Non-structural NS5A Protein Impairs Both the Innate and Adaptive Hepatic Immune Response in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; TRANSGENIC MICE; GENE-EXPRESSION; 5A PROTEIN; INTERFERON; CLEARANCE; INFECTION; KINASE; LIVER; REPLICATION	The role of hepatitis C virus (HCV) protein non-structural (NS) 5A in HCV-associated pathogenesis is still enigmatic. To investigate the in vivo role of NS5A for viral persistence and virus-associated pathogenesis a transgenic (Tg) mouse model was established. Mice with liver-targeted NS5A transgene expression were generated using the albumin promoter. Alterations in the hepatic immune response were determined by Western blot, infection by lymphocytic choriomeningitis virus (LCMV), and using transient NS3/4A Tg mice generated by hydrodynamic injection. Cytotoxic T lymphocyte (CTL) activity was investigated by the Cr-release assay. The stable NS5A Tg mice did not reveal signs of spontaneous liver disease. The intrahepatic immunity was disrupted in the NS5A Tg mice as determined by clearance of LCMV infection or transiently NS3/4A Tg hepatocytes in vivo. This impaired immunity was explained by a reduced induction of interferon beta, 2',5'-OAS, and PKR after LCMV infection and an impairment of the CTL-mediated elimination of NS3-expressing hepatocytes. In conclusion, these data indicate that in the present transgenic mouse model, NS5A does not cause spontaneous liver disease. However, we discovered that NS5A could impair both the innate and the adaptive immune response to promote chronic HCV infection.	[Himmelsbach, Kyoshi; Hildt, Eberhard] Univ Kiel, Inst Infect Med, D-24105 Kiel, Germany; [Kriegs, Malte; Himmelsbach, Kyoshi; Hildt, Eberhard] Univ Freiburg, Dept Internal Med 2, D-79106 Freiburg, Germany; [Kriegs, Malte; Bruns, Michael] Heinrich Pette Inst Expt Virol & Immunol, D-20251 Homburg, Germany; [Kriegs, Malte; Buerckstuemmer, Tilmann] Robert Koch Inst, D-13353 Berlin, Germany; [Kriegs, Malte; Frelin, Lars; Ahlen, Gustaf; Sallberg, Matti] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Microbiol F68, S-14186 Stockholm, Sweden	University of Kiel; University of Freiburg; Heinrich Pette Institute; Robert Koch Institute; Karolinska Institutet; Karolinska University Hospital	Hildt, E (corresponding author), Univ Kiel, Inst Infect Med, Brunswiker Str 4, D-24105 Kiel, Germany.	hildt@infmed.uni-kiel.de	Hildt, Eberhard/A-1040-2015; Ahlén, Gustaf/GLN-2986-2022	Frelin, Lars/0000-0001-7452-1667; Burckstummer, Tilmann/0000-0001-5681-8045; Buerckstuemmer, Tilmann/0000-0002-5961-0829; Himmelsbach, Kiyoshi/0000-0002-1840-6012; Ahlen, Gustaf/0000-0002-2681-6433	Swedish Society of Medical Research; Swedish Society of Medicine; Royal Swedish Academy of Sciences; Goljes Memorial Fund; Ruth and Richard Juhlin Foundation; Karolinska Institutet; DFG-excellence cluster	Swedish Society of Medical Research; Swedish Society of Medicine; Royal Swedish Academy of Sciences; Goljes Memorial Fund; Ruth and Richard Juhlin Foundation; Karolinska Institutet(Karolinska Institutet); DFG-excellence cluster(German Research Foundation (DFG))	This work was supported in part by grants from the Swedish Society of Medical Research, the Swedish Society of Medicine, the Royal Swedish Academy of Sciences, Goljes Memorial Fund, the Ruth and Richard Juhlin Foundation, and the Karolinska Institutet (to L. F.). This work was also supported by a grant from the DFG-excellence cluster (to E. H.).	Ahlen G, 2005, J INFECT DIS, V192, P2112, DOI 10.1086/498218; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; ASSMANNWISCHER U, 1985, MED MICROBIOL IMMUN, V174, P249, DOI 10.1007/BF02124809; Blindenbacher A, 2003, GASTROENTEROLOGY, V124, P1465, DOI 10.1016/S0016-5085(03)00290-7; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; BRUNS M, 1988, VIROLOGY, V166, P133, DOI 10.1016/0042-6822(88)90154-7; Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; CHISARI FV, 1989, MOL BIOL MED, V6, P143; Disson O, 2004, GASTROENTEROLOGY, V126, P859, DOI 10.1053/j.gastro.2003.12.005; Donauer J, 2003, TRANSPLANTATION, V76, P539, DOI 10.1097/01.TP.0000079459.89608.B7; Frelin L, 2004, GENE THER, V11, P522, DOI 10.1038/sj.gt.3302184; Frelin L, 2003, GENE THER, V10, P686, DOI 10.1038/sj.gt.3301933; Gale M, 1999, J VIROL, V73, P6506, DOI 10.1128/JVI.73.8.6506-6516.1999; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Ghosh AK, 1999, J GEN VIROL, V80, P1179, DOI 10.1099/0022-1317-80-5-1179; Girard S, 2004, HEPATOLOGY, V40, P708, DOI 10.1002/hep.20371; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; Hildt E, 2002, EMBO J, V21, P525, DOI 10.1093/emboj/21.4.525; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Jorns J, 2003, ANAT EMBRYOL, V207, P85, DOI 10.1007/s00429-003-0331-8; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; LAUER U, 1992, J VIROL, V66, P5284, DOI 10.1128/JVI.66.9.5284-5289.1992; LEHMANNGRUBE F, 1985, J IMMUNOL, V134, P608; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Majumder M, 2003, FEBS LETT, V555, P528, DOI 10.1016/S0014-5793(03)01337-1; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Malmgaard L, 2002, J VIROL, V76, P4520, DOI 10.1128/JVI.76.9.4520-4525.2002; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Qadri I, 2002, BBA-MOL CELL RES, V1592, P193, DOI 10.1016/S0167-4889(02)00315-4; Saher G, 1999, J BIOL CHEM, V274, P27651, DOI 10.1074/jbc.274.39.27651; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Stobart MJ, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-5; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; WERNER S, 1993, EMBO J, V12, P2635, DOI 10.1002/j.1460-2075.1993.tb05924.x	43	29	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28343	28351		10.1074/jbc.M109.038877	http://dx.doi.org/10.1074/jbc.M109.038877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674968	Green Published, hybrid			2022-12-25	WOS:000270676300060
J	Leonardi, R; Frank, MW; Jackson, PD; Rock, CO; Jackowski, S				Leonardi, Roberta; Frank, Matthew W.; Jackson, Pamela D.; Rock, Charles O.; Jackowski, Suzanne			Elimination of the CDP-ethanolamine Pathway Disrupts Hepatic Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOETHANOLAMINE CYTIDYLYLTRANSFERASE; FAT-SPECIFIC PROTEIN-27; PLASMA HIGH-DENSITY; PPAR-GAMMA; PHOSPHATIDYLSERINE DECARBOXYLATION; IN-VIVO; GENE; BIOSYNTHESIS; PHOSPHATIDYLETHANOLAMINE; EXPRESSION	Phosphoethanolamine cytidylyltransferase (ECT) catalyzes the rate-controlling step in a major pathway for the synthesis of phosphatidylethanolamine (PtdEtn). Hepatocyte-specific deletion of the ECT gene in mice resulted in normal appearing animals without overt signs of liver injury or inflammation. The molecular species of PtdEtn in the ECT-deficient livers were significantly altered compared with controls and matched the composition of the phosphatidylserine (PtdSer) pool, illustrating the complete reliance on the PtdSer decarboxylase pathway for PtdEtn synthesis. PtdSer structure was controlled by the substrate specificity of PtdSer synthase that selectively converted phosphatidylcholine molecular species containing stearate paired with a polyunsaturated fatty acid to PtdSer. There was no evidence for fatty acid remodeling of PtdEtn. The elimination of diacylglycerol utilization by the CDP-ethanolamine pathway led to a 10-fold increase in triacylglycerols in the ECT-deficient hepatocytes that became engorged with lipid droplets. Triacylglycerol accumulation was associated with a significant elevation in the expression of the transcription factors and target genes that drive de novo lipogenesis. The absence of the ECT pathway for diacylglycerol utilization at the endoplasmic reticulum triggers increased fatty acid synthesis to support the formation of triacylglycerols leading to liver steatosis.	[Leonardi, Roberta; Frank, Matthew W.; Jackson, Pamela D.; Rock, Charles O.; Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Jackowski, S (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429; Frank, Matthew/0000-0002-4914-1440	National Institutes of Health [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health CORE Support Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Agren JJ, 2005, BBA-MOL CELL BIOL L, V1734, P34, DOI 10.1016/j.bbalip.2005.02.001; ALVAREZ JG, 1992, J CHROMATOGR-BIOMED, V577, P142, DOI 10.1016/0378-4347(92)80609-T; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Bergo MO, 2002, J BIOL CHEM, V277, P47701, DOI 10.1074/jbc.M207734200; Bladergroen BA, 1999, BIOCHEM J, V343, P107, DOI 10.1042/0264-6021:3430107; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; DEMANT EJF, 1982, ARCH BIOCHEM BIOPHYS, V213, P186, DOI 10.1016/0003-9861(82)90454-4; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Fullerton MD, 2009, J BIOL CHEM, V284, P25704, DOI 10.1074/jbc.M109.023846; GOLDBERG DM, 1981, BIOCHEM J, V196, P337, DOI 10.1042/bj1960337; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Hunt MC, 1999, BIOCHEM SOC T, V27, P378, DOI 10.1042/bst0270378; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jacobs RL, 2008, J BIOL CHEM, V283, P2147, DOI 10.1074/jbc.M706628200; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kevala JH, 2001, ANAL BIOCHEM, V292, P130, DOI 10.1006/abio.2001.5076; Krank J, 2007, METHOD ENZYMOL, V432, P1, DOI 10.1016/S0076-6879(07)32001-6; Kuge O, 1998, P NATL ACAD SCI USA, V95, P4199, DOI 10.1073/pnas.95.8.4199; Kuge O, 1999, J BIOL CHEM, V274, P23844, DOI 10.1074/jbc.274.34.23844; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; MUDRA DR, 2001, CURRENT PROTOCOLS TO; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nakashima A, 1997, J BIOL CHEM, V272, P9567; Poloumienko A, 2004, GENE, V325, P145, DOI 10.1016/j.gene.2003.10.005; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; Sasaki H, 1997, P NATL ACAD SCI USA, V94, P7320, DOI 10.1073/pnas.94.14.7320; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; SCHMID PC, 1995, ARCH BIOCHEM BIOPHYS, V319, P168, DOI 10.1006/abbi.1995.1279; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; SUNDLER R, 1973, BIOCHIM BIOPHYS ACTA, V306, P218, DOI 10.1016/0005-2760(73)90227-0; SUNDLER R, 1974, FEBS LETT, V43, P303, DOI 10.1016/0014-5793(74)80667-8; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	65	64	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27077	27089		10.1074/jbc.M109.031336	http://dx.doi.org/10.1074/jbc.M109.031336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666474	hybrid, Green Published			2022-12-25	WOS:000270232300009
J	Liu, P; Li, HL; Cepeda, J; Xia, Y; Kempf, JA; Ye, H; Zhang, LQ; Ye, SQ				Liu, Peng; Li, Hailong; Cepeda, Javier; Xia, Yue; Kempf, Jessica A.; Ye, Hong; Zhang, Li Qin; Ye, Shui Qing			Regulation of Inflammatory Cytokine Expression in Pulmonary Epithelial Cells by Pre-B-cell Colony-enhancing Factor via a Nonenzymatic and AP-1-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE RESPIRATORY-DISTRESS; ACUTE LUNG INJURY; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; BIOSYNTHETIC ENZYME; NAD BIOSYNTHESIS; KAPPA-B; GENE; NAMPT/PBEF/VISFATIN; IDENTIFICATION; TRANSCRIPTION	Although our previous studies found Pre-B-cell colony-enhancing factor (PBEF) as a highly up-regulated gene in acute lung injury that could stimulate expressions of other inflammatory cytokines, the underlying molecular mechanisms remain to be fully elucidated. Growing evidence indicates that PBEF is a nicotinamide phosphoribosyltransferase involved in the mammalian salvage pathway of NAD synthesis. This study was designed to determine whether the effect of PBEF to stimulate expressions of inflammatory cytokines depends on its enzymatic activity. We prepared two human PBEF mutant (H247E and H247A) recombinant proteins and overexpressing constructs for their overexpressions in A549 cells and confirmed that enzymatic activities of both mutants were nearly or completely abolished. Two mutants stimulated interleukin-8 (IL-8) expression at both the mRNA level and protein level just as equally effective as the wild-type PBEF did. These effects were due to the increased transcription, not the mRNA stability, of the IL-8 gene. Reporter gene assays and gel shift experiments indicated that AP-1 transcription factor is required to mediate these effects. SB203580, a p38 MAPK pathway inhibitor, and JNK inhibitor 1 can attenuate these effects. Both PBEF mutants similarly stimulated the expression of two other inflammatory cytokines: IL-16 and CCR3. These results indicate that PBEF stimulated expression of IL-8, IL-16, and CCR3 via its non-enzymatic activity. This effect is AP-1-dependent, in part via the p38 MAPK pathway and the JNK pathway. This finding reveals a new insight, which may manifest a novel role of PBEF in the pathogenesis of acute lung injury and other inflammatory disorders.	[Liu, Peng; Li, Hailong; Xia, Yue; Kempf, Jessica A.; Ye, Hong; Zhang, Li Qin; Ye, Shui Qing] Univ Missouri, Dept Surg, Columbia, MO 65212 USA; [Liu, Peng; Li, Hailong; Xia, Yue; Kempf, Jessica A.; Ye, Hong; Zhang, Li Qin; Ye, Shui Qing] Univ Missouri, Dept Mol Biol & Immunol, Columbia, MO 65212 USA; [Liu, Peng] Dalian Med Univ, Affiliated Hosp 1, Sino UK Ctr Regenerat Med, Dalian, Peoples R China; [Cepeda, Javier] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06511 USA; [Xia, Yue] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan 430072, Peoples R China; [Ye, Hong] China Three Gorges Univ, Med Sci Coll, Dept Gynecol & Obstet, Yichang, Peoples R China	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Dalian Medical University; Yale University; Wuhan University; China Three Gorges University	Ye, SQ (corresponding author), Univ Missouri, Dept Surg, Med Sci Bldg,N512,DC097-00,1 Hosp Dr, Columbia, MO 65212 USA.	yes@health.missouri.edu			National Institutes of Health [HL 080042]; University of Missouri-Columbia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri-Columbia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 080042 (to S. Q. Y.). This work was also supported by a University of Missouri-Columbia Start-up fund.	ASHBAUGH DG, 1967, LANCET, V2, P319; Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Casola A, 2002, VIROLOGY, V298, P8, DOI 10.1006/viro.2002.1475; Casola A, 2000, J IMMUNOL, V164, P5944, DOI 10.4049/jimmunol.164.11.5944; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; De Lucca GV, 2006, CURR OPIN DRUG DISC, V9, P516; Frank JA, 2003, CRIT CARE, V7, P233, DOI 10.1186/cc1829; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Li HL, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-15; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Martin PR, 2001, J BACTERIOL, V183, P1168, DOI 10.1128/JB.183.4.1168-1174.2001; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Pilz S, 2007, J ENDOCRINOL INVEST, V30, P138, DOI 10.1007/BF03347412; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang S, 2008, KIDNEY INT, V73, P318, DOI 10.1038/sj.ki.5002692; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Wang YL, 1998, J BIOL CHEM, V273, P34623, DOI 10.1074/jbc.273.51.34623; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware Lorraine B, 2005, Crit Care Med, V33, pS217, DOI 10.1097/01.CCM.0000155788.39101.7E; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Ye SQ, 2005, MICROVASC RES, V70, P142, DOI 10.1016/j.mvr.2005.08.003; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhu YM, 2003, J BIOL CHEM, V278, P29366, DOI 10.1074/jbc.M301785200	36	34	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27344	27351		10.1074/jbc.M109.002519	http://dx.doi.org/10.1074/jbc.M109.002519			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654329	Green Published, hybrid			2022-12-25	WOS:000270232300035
J	Dudley, DD; Wang, HC; Sun, XH				Dudley, Darryll D.; Wang, Hong-Cheng; Sun, Xiao-Hong			Hes1 Potentiates T Cell Lymphomagenesis by Up-Regulating a Subset of Notch Target Genes	PLOS ONE			English	Article								Background: Hairy/Enhancer of Split (Hes) proteins are targets of the Notch signaling pathway and make up a class of basic helix-loop-helix (bHLH) proteins that function to repress transcription. Data from Hes1 deficient mice suggested that Hes1, like Notch1, is necessary for the progression of early T cell progenitors. Constitutive activation of Notch is known to cause T cell leukemia or lymphoma but whether Hes1 has any oncogenic activity is not known. Methodology/Principal Findings: We generated mice carrying a Hes1 transgene under control of the proximal promote of the lck gene. Hes1 expression led to a reduction in numbers of total thymocytes, concomitant with the increased percentage and number of immature CD8(+) (ISP) T cells and sustained CD25 expression in CD4(+)CD8(+) double positive (DP) thymocytes. Hes1 transgenic mice develop thymic lymphomas at about 20 weeks of age with a low penetrance. However, expression of Hes1 significantly shortens the latency of T cell lymphoma developed in Id1 transgenic mice, where the function of bHLH E proteins is inhibited. Interestingly, Hes1 increased expression of a subset of Notch target genes in premalignant ISP and DP thymocytes, which include Notch1, Notch3 and c-myc, thus suggesting a possible mechanism for lymphomagenesis. Conclusions/Significance: We have demonstrated for the first time that Hes1 potentiates T cell lymphomagenesis, by upregulating a subset of Notch target genes and by causing an accumulation of ISP thymocytes particularly vulnerable to oncogenic transformation.			Dudley, DD (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sunx@omrf.org			NCI NIH HHS [R01 CA077553, CA77553] Funding Source: Medline; NIAID NIH HHS [T32 AI007633, F32-AI07633, R01 AI056129, AI56129] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007633, R01AI056129] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Aster JC, 2001, CURR OPIN HEMATOL, V8, P237, DOI 10.1097/00062752-200107000-00010; BAER R, 1993, SEMIN CANCER BIOL, V4, P341; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; CEREDIG R, 1988, J IMMUNOL, V141, P355; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fowlkes BJ, 2002, J IMMUNOL, V169, P1817, DOI 10.4049/jimmunol.169.4.1817; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Kim D, 1999, MOL CELL BIOL, V19, P8240; Kim DS, 2002, IMMUNITY, V16, P9, DOI 10.1016/S1074-7613(02)00264-9; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; LEWIS WH, 1985, NATURE, V317, P544, DOI 10.1038/317544a0; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Nie L, 2008, MOL CELL BIOL, V28, P2078, DOI 10.1128/MCB.00844-07; Nuthall HN, 2002, MOL CELL BIOL, V22, P389, DOI 10.1128/MCB.22.2.389-399.2002; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; O'Neil J, 2001, ONCOGENE, V20, P3897, DOI 10.1038/sj.onc.1204519; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; PATERSON DJ, 1987, J EXP MED, V166, P1603, DOI 10.1084/jem.166.5.1603; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Qi ZB, 2004, MOL CELL BIOL, V24, P7313, DOI 10.1128/MCB.24.17.7313-7323.2004; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reschly EJ, 2006, BLOOD, V107, P4115, DOI 10.1182/blood-2005-09-3551; Reynaud-Deonauth S, 2002, DIFFERENTIATION, V69, P198, DOI 10.1046/j.1432-0436.2002.690413.x; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SELTEN G, 1984, EMBO J, V3, P3215, DOI 10.1002/j.1460-2075.1984.tb02281.x; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; Weerkamp F, 2006, LEUKEMIA, V20, P1967, DOI 10.1038/sj.leu.2404396; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317	54	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6678	10.1371/journal.pone.0006678	http://dx.doi.org/10.1371/journal.pone.0006678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688092	Green Published, Green Submitted, gold			2022-12-25	WOS:000269075800013
J	Smolders, J; Thewissen, M; Peelen, E; Menheere, P; Tervaert, JWC; Damoiseaux, J; Hupperts, R				Smolders, Joost; Thewissen, Marielle; Peelen, Evelyn; Menheere, Paul; Tervaert, Jan Willem Cohen; Damoiseaux, Jan; Hupperts, Raymond			Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis	PLOS ONE			English	Article							FOXP3 EXPRESSION; RISK; AUTOIMMUNITY; SUPPRESSION; CHILDHOOD; T(H)17	Background: In several autoimmune diseases, including multiple sclerosis (MS), a compromised regulatory T cell (Treg) function is believed to be critically involved in the disease process. In vitro, the biologically active metabolite of vitamin D has been shown to promote Treg development. A poor vitamin D status has been linked with MS incidence and MS disease activity. In the present study, we assess a potential in vivo correlation between vitamin D status and Treg function in relapsing remitting MS (RRMS) patients. Methodology/Principal Findings: Serum levels of 25-hydroxyvitamin D (25(OH) D) were measured in 29 RRMS patients. The number of circulating Tregs was assessed by flow-cytometry, and their functionality was tested in vitro in a CFSE-based proliferation suppression assay. Additionally, the intracellular cytokine profile of T helper cells was determined directly ex-vivo by flow-cytometry. Serum levels of 25(OH) D correlated positively with the ability of Tregs to suppress T cell proliferation (R = 0.590, P = 0.002). No correlation between 25(OH) D levels and the number of Tregs was found. The IFN-gamma/IL-4 ratio (Th1/Th2-balance) was more directed towards IL-4 in patients with favourable 25(OH) D levels (R = -0.435, P = 0.023). Conclusions/Significance: These results show an association of high 25(OH) D levels with an improved Treg function, and with skewing of the Th1/Th2 balance towards Th2. These findings suggest that vitamin D is an important promoter of T cell regulation in vivo in MS patients. It is tempting to speculate that our results may not only hold for MS, but also for other autoimmune diseases. Future intervention studies will show whether modulation of vitamin D status results in modulation of the T cell response and subsequent amelioration of disease activity.	[Smolders, Joost; Peelen, Evelyn; Tervaert, Jan Willem Cohen; Hupperts, Raymond] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Smolders, Joost; Thewissen, Marielle; Peelen, Evelyn; Tervaert, Jan Willem Cohen; Damoiseaux, Jan] Maastricht Univ, Med Ctr, Dept Internal Med, Div Clin & Expt Immunol, Maastricht, Netherlands; [Menheere, Paul] Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands; [Hupperts, Raymond] Orbis Med Ctr, Dept Neurol, Sittard, Netherlands	Maastricht University; Maastricht University; Maastricht University; Orbis Medical Center	Smolders, J (corresponding author), Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	j.smolders@mumc.nl	Smolders, Joost/B-7658-2009; Thewissen, Marielle/G-3545-2014; tervaert, jan willem cohen/AAB-1111-2019; Peelen, Evelyn/H-9955-2012; Damoiseaux, Jan/B-8993-2009	Smolders, Joost/0000-0001-9766-8661; Damoiseaux, Jan/0000-0003-4007-6985				[Anonymous], NEUROLOGY; Arnson Y, 2007, ANN RHEUM DIS, V66, P1137, DOI 10.1136/ard.2007.069831; Balashov KE, 1998, ANN NEUROL, V44, P824, DOI 10.1002/ana.410440519; Bar-Or A, 2008, SEMIN NEUROL, V28, P29, DOI 10.1055/s-2007-1019124; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Costantino CM, 2008, EUR J IMMUNOL, V38, P921, DOI 10.1002/eji.200738104; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/s002239900002; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Islam T, 2007, NEUROLOGY, V69, P381, DOI 10.1212/01.wnl.0000268266.50850.48; Kampman MT, 2007, J NEUROL, V254, P471, DOI 10.1007/s00415-006-0395-5; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kimlin MG, 2008, MOL ASPECTS MED, V29, P453, DOI 10.1016/j.mam.2008.08.005; Kragt JJ, 2009, MULT SCLER J, V15, P9, DOI 10.1177/1352458508095920; KURTZKE JF, 1967, ACTA NEUROL SCAND, V43, P257, DOI 10.1111/j.1600-0404.1967.tb05733.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Ordonez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005287; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Royal W, 2009, J NEUROIMMUNOL, V213, P135, DOI 10.1016/j.jneuroim.2009.05.012; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stewart N, 2007, J NEUROIMMUNOL, V188, P181, DOI 10.1016/j.jneuroim.2007.06.012; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	36	217	221	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6635	10.1371/journal.pone.0006635	http://dx.doi.org/10.1371/journal.pone.0006635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675671	gold, Green Submitted, Green Published			2022-12-25	WOS:000268936100010
J	Daoud, F; Candelario-Martinez, A; Billard, JM; Avital, A; Khelfaoui, M; Rozenvald, Y; Guegan, M; Mornet, D; Jaillard, D; Nudel, U; Chelly, J; Martinez-Rojas, D; Laroche, S; Yaffe, D; Vaillend, C				Daoud, Fatma; Candelario-Martinez, Aurora; Billard, Jean-Marie; Avital, Avi; Khelfaoui, Malik; Rozenvald, Yael; Guegan, Maryvonne; Mornet, Dominique; Jaillard, Danielle; Nudel, Uri; Chelly, Jamel; Martinez-Rojas, Dalila; Laroche, Serge; Yaffe, David; Vaillend, Cyrille			Role of Mental Retardation-Associated Dystrophin-Gene Product Dp71 in Excitatory Synapse Organization, Synaptic Plasticity and Behavioral Functions	PLOS ONE			English	Article								Background:Duchenne muscular dystrophy (DMD) is caused by deficient expression of the cytoskeletal protein, dystrophin. One third of DMD patients also have mental retardation (MR), likely due to mutations preventing expression of dystrophin and other brain products of the DMD gene expressed from distinct internal promoters. Loss of Dp71, the major DMD-gene product in brain, is thought to contribute to the severity of MR; however, the specific function of Dp71 is poorly understood. Methodology/Principal Findings: Complementary approaches were used to explore the role of Dp71 in neuronal function and identify mechanisms by which Dp71 loss may impair neuronal and cognitive functions. Besides the normal expression of Dp71 in a subpopulation of astrocytes, we found that a pool of Dp71 colocalizes with synaptic proteins in cultured neurons and is expressed in synaptic subcellular fractions in adult brains. We report that Dp71-associated protein complexes interact with specialized modular scaffolds of proteins that cluster glutamate receptors and organize signaling in postsynaptic densities. We then undertook the first functional examination of the brain and cognitive alterations in the Dp71-null mice. We found that these mice display abnormal synapse organization and maturation in vitro, altered synapse density in the adult brain, enhanced glutamatergic transmission and reduced synaptic plasticity in CA1 hippocampus. Dp71-null mice show selective behavioral disturbances characterized by reduced exploratory and novelty-seeking behavior, mild retention deficits in inhibitory avoidance, and impairments in spatial learning and memory. Conclusions/Significance: Results suggest that Dp71 expression in neurons play a regulatory role in glutamatergic synapse organization and function, which provides a new mechanism by which inactivation of Dp71 in association with that of other DMD-gene products may lead to increased severity of MR.	[Daoud, Fatma; Khelfaoui, Malik; Chelly, Jamel] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Daoud, Fatma; Khelfaoui, Malik; Chelly, Jamel] INSERM, U567, Paris, France; [Candelario-Martinez, Aurora; Martinez-Rojas, Dalila] CINVESTAV, Mexico City 14000, DF, Mexico; [Billard, Jean-Marie] Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR 894,Fac Med Rene Descartes, Paris, France; [Avital, Avi] Yezreel Valley Coll, Dept Psychol, Emek Yezreel, Israel; [Avital, Avi] Yezreel Valley Coll, Ctr Psychobiol Res, Emek Yezreel, Israel; [Avital, Avi; Rozenvald, Yael; Nudel, Uri; Yaffe, David] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Guegan, Maryvonne; Laroche, Serge; Vaillend, Cyrille] CNRS, UMR 8620, F-91405 Orsay, France; [Jaillard, Danielle] Univ Paris 11, CNRS, UMR 8080, CCME, F-91405 Orsay, France; [Jaillard, Danielle] Univ Montpellier I, INSERM, Equipe ESPRI Muscle & Pathol 25, UFR Med,EA 4202, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Daoud, F (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	cyrille.vaillend@u-psud.fr	Vaillend, Cyrille/K-4626-2012; Chelly, Jamel/J-7528-2015; Billard, Jean-Marie/ABD-4987-2020; Avital, Avraham/I-2163-2016	Vaillend, Cyrille/0000-0002-8783-8185; Chelly, Jamel/0000-0002-0939-8719; Avital, Avraham/0000-0002-0691-153X	AFM (Association Francaise contre les Myopathies, France); FRM (Fondation pour la Recherche Medicate, France); ANR (Agence Nationale de Recherche, France) [ANR 05-Neuro-040-01]; MDA (Muscular Dystrophy Association); ISF (Israel Science Foundation); Nella and Leon Benoziyo Center for Neurosciences; CNRS (Centre National de la Recherche Scientifique, France); INSERM (Institut National de la Sante et de la Recherche Medicate, France); Institut Francais de Cooperation (Tunisie)	AFM (Association Francaise contre les Myopathies, France)(Association Francaise contre les Myopathies); FRM (Fondation pour la Recherche Medicate, France)(Fondation pour la Recherche Medicale); ANR (Agence Nationale de Recherche, France)(French National Research Agency (ANR)); MDA (Muscular Dystrophy Association)(Muscular Dystrophy Association); ISF (Israel Science Foundation)(Israel Science Foundation); Nella and Leon Benoziyo Center for Neurosciences; CNRS (Centre National de la Recherche Scientifique, France)(Centre National de la Recherche Scientifique (CNRS)); INSERM (Institut National de la Sante et de la Recherche Medicate, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Francais de Cooperation (Tunisie)	This work was supported by grants from AFM (Association Francaise contre les Myopathies, France) to CV., to D.Y and U.N., and to J.C., from FRM (Fondation pour la Recherche Medicate, France), ANR (Agence Nationale de Recherche, ANR 05-Neuro-040-01, France) and FJL to J.C., from MDA (Muscular Dystrophy Association), ISF (Israel Science Foundation) and the Nella and Leon Benoziyo Center for Neurosciences to U.N. and D.Y., and by CNRS (Centre National de la Recherche Scientifique, France) and INSERM (Institut National de la Sante et de la Recherche Medicate, France). F.D. had a fellowship from Institut Francais de Cooperation (Tunisie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Aleman V, 2001, HISTOCHEM CELL BIOL, V115, P243; AUSTIN RC, 1995, HUM MOL GENET, V4, P1475; Banks GB, 2003, J NEUROCYTOL, V32, P709, DOI 10.1023/B:NEUR.0000020619.24681.2b; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Cavaldesi M, 1999, J NEUROCHEM, V72, P1648, DOI 10.1046/j.1471-4159.1999.721648.x; CHEUNG HH, 2000, J CEREB BLOOD FLOW M, V20, P305; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; COTREKI DC, 1995, NEUROREPORT, V6, P893; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; DESMOND XL, 1986, J COMP NEUROL, V253, P176; DONDERS J, 2009, CHILD NEUROPSYCHOL, V22, P1; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; ELHUSEINI AE, 2000, SCIENCE, V200, P1361; FABBRIZIO E, 1993, FEBS LETT, V322, P10, DOI 10.1016/0014-5793(93)81100-E; FABBRIZIO E, 1994, BIOCHEM J, V299, P359, DOI 10.1042/bj2990359; Fritschy JM, 2003, BIOCHEM SOC T, V31, P889, DOI 10.1042/bst0310889; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gee SH, 1998, J NEUROSCI, V18, P128; Gorecki DC, 1997, EUR J NEUROSCI, V9, P965, DOI 10.1111/j.1460-9568.1997.tb01447.x; GRANGER R, 1993, SYNAPSE, V15, P326, DOI 10.1002/syn.890150409; HAEUGGI T, 2001, NEUROSCIENCE, V129, P403; Hendriksen JGM, 2008, J CHILD NEUROL, V23, P477, DOI 10.1177/0883073807309775; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JULIG D, 1993, NEUROMUSCULAR DISORD, V3, P515; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Knuesel I, 2000, J COMP NEUROL, V422, P594, DOI 10.1002/1096-9861(20000710)422:4<594::AID-CNE8>3.0.CO;2-Q; KOYIAKH I, 2005, J NEUROSCI, V25, P11468; Lauri SE, 2000, NEUROREPORT, V11, P997, DOI 10.1097/00001756-200004070-00020; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Lidov HGW, 1996, BRAIN PATHOL, V6, P63, DOI 10.1111/j.1750-3639.1996.tb00783.x; Lin Y, 2006, P NATL ACAD SCI USA, V103, P19902, DOI 10.1073/pnas.0609924104; Martone ME, 2000, HIPPOCAMPUS, V10, P610, DOI 10.1002/1098-1063(2000)10:5<610::AID-HIPO12>3.0.CO;2-E; Mayhew TM, 1996, J NEUROCYTOL, V25, P793, DOI 10.1007/BF02284842; Miranda R, 2009, CEREB CORTEX, V19, P876, DOI 10.1093/cercor/bhn135; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; Poirier R, 2007, BEHAV GENET, V37, P31, DOI 10.1007/s10519-006-9116-1; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; Stein V, 2003, J NEUROSCI, V23, P5503; Vaillend C, 1998, NEUROSCIENCE, V86, P53, DOI 10.1016/S0306-4522(98)00023-2; Vaillend C, 1999, NEUROMUSCULAR DISORD, V9, P296, DOI 10.1016/S0960-8966(99)00029-2; Vaillend C, 2002, HIPPOCAMPUS, V12, P713, DOI 10.1002/hipo.10068; Vaillend C, 2004, NEUROBIOL DIS, V17, P10, DOI 10.1016/j.nbd.2004.05.004; VAILLEND C, 1995, BEHAV GENET, V25, P569, DOI 10.1007/BF02327580; Vaillend C, 2008, BEHAV BRAIN RES, V192, P88, DOI 10.1016/j.bbr.2008.01.009	56	84	85	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6574	10.1371/journal.pone.0006574	http://dx.doi.org/10.1371/journal.pone.0006574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YK	19649270	Green Published, Green Submitted, gold			2022-12-25	WOS:000207566700001
J	Hogslund, N; Radutoiu, S; Krusell, L; Voroshilova, V; Hannah, MA; Goffard, N; Sanchez, DH; Lippold, F; Ott, T; Sato, S; Tabata, S; Liboriussen, P; Lohmann, GV; Schauser, L; Weiller, GF; Udvardi, MK; Stougaard, J				Hogslund, Niels; Radutoiu, Simona; Krusell, Lene; Voroshilova, Vera; Hannah, Matthew A.; Goffard, Nicolas; Sanchez, Diego H.; Lippold, Felix; Ott, Thomas; Sato, Shusei; Tabata, Satoshi; Liboriussen, Poul; Lohmann, Gitte V.; Schauser, Leif; Weiller, Georg F.; Udvardi, Michael K.; Stougaard, Jens			Dissection of Symbiosis and Organ Development by Integrated Transcriptome Analysis of Lotus japonicus Mutant and Wild-Type Plants	PLOS ONE			English	Article								Genetic analyses of plant symbiotic mutants has led to the identification of key genes involved in Rhizobium-legume communication as well as in development and function of nitrogen fixing root nodules. However, the impact of these genes in coordinating the transcriptional programs of nodule development has only been studied in limited and isolated studies. Here, we present an integrated genome-wide analysis of transcriptome landscapes in Lotus japonicus wild-type and symbiotic mutant plants. Encompassing five different organs, five stages of the sequentially developed determinate Lotus root nodules, and eight mutants impaired at different stages of the symbiotic interaction, our data set integrates an unprecedented combination of organ-or tissue-specific profiles with mutant transcript profiles. In total, 38 different conditions sampled under the same well-defined growth regimes were included. This comprehensive analysis unravelled new and unexpected patterns of transcriptional regulation during symbiosis and organ development. Contrary to expectations, none of the previously characterized nodulins were among the 37 genes specifically expressed in nodules. Another surprise was the extensive transcriptional response in whole root compared to the susceptible root zone where the cellular response is most pronounced. A large number of transcripts predicted to encode transcriptional regulators, receptors and proteins involved in signal transduction, as well as many genes with unknown function, were found to be regulated during nodule organogenesis and rhizobial infection. Combining wild type and mutant profiles of these transcripts demonstrates the activation of a complex genetic program that delineates symbiotic nitrogen fixation. The complete data set was organized into an indexed expression directory that is accessible from a resource database, and here we present selected examples of biological questions that can be addressed with this comprehensive and powerful gene expression data set.			Hogslund, N (corresponding author), Aarhus Univ, Ctr Carbohydrate Recognit & Signalling, MBI, Aarhus C, Denmark.	stougaard@mb.au.dk	Ott, Thomas/G-7056-2011; Ott, Thomas/H-8192-2013; Udvardi, Michael/GPX-4653-2022; Goffard, Nicolas/A-1759-2011; Sato, Shusei/A-3616-2015	Ott, Thomas/0000-0002-4494-9811; Udvardi, Michael/0000-0001-9850-0828; Sato, Shusei/0000-0002-0293-5366; Hannah, Matthew/0000-0002-4889-490X; Stougaard, Jens/0000-0002-9312-2685				Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Chen CY, 2008, NEW PHYTOL, V180, P311, DOI 10.1111/j.1469-8137.2008.02612.x; Cohn JR, 2001, PLANT PHYSIOL, V125, P2104, DOI 10.1104/pp.125.4.2104; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; CULLEY DE, 1995, PLANT PHYSIOL, V107, P301, DOI 10.1104/pp.107.1.301; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Deguchi Y, 2007, DNA RES, V14, P117, DOI 10.1093/dnares/dsm014; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Fudali S, 2008, PHYSIOL PLANTARUM, V132, P370, DOI 10.1111/j.1399-3054.2007.01017.x; Fukai E, 2008, PLANT MOL BIOL, V68, P653, DOI 10.1007/s11103-008-9397-2; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Goffard N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-87; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; Govindarajulu M, 2009, PLANT PHYSIOL, V149, P994, DOI 10.1104/pp.108.128728; Hala M, 2008, PLANT CELL, V20, P1330, DOI 10.1105/tpc.108.059105; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kanamori N, 2006, P NATL ACAD SCI USA, V103, P359, DOI 10.1073/pnas.0508883103; Kim SY, 2006, PLANT PHYSIOL, V142, P984, DOI 10.1104/pp.106.085670; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Krusell L, 2005, PLANT CELL, V17, P1625, DOI 10.1105/tpc.104.030106; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Leidi EO, 2000, NEW PHYTOL, V147, P337, DOI 10.1046/j.1469-8137.2000.00703.x; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Liu X, 2006, AMINO ACIDS, V30, P113, DOI 10.1007/s00726-005-0248-z; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; LOPEZLARA IM, 1995, MOL MICROBIOL, V15, P627, DOI 10.1111/j.1365-2958.1995.tb02372.x; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen LH, 2005, PLANT J, V44, P372, DOI 10.1111/j.1365-313X.2005.02534.x; Marsh JF, 2007, PLANT PHYSIOL, V144, P324, DOI 10.1104/pp.106.093021; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Messinese E, 2007, MOL PLANT MICROBE IN, V20, P912, DOI 10.1094/MPMI-20-8-0912; Miller AJ, 2008, J EXP BOT, V59, P111, DOI 10.1093/jxb/erm208; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Miwa H, 2006, MOL PLANT MICROBE IN, V19, P914, DOI 10.1094/MPMI-19-0914; Moreau S, 2002, J BIOL CHEM, V277, P4738, DOI 10.1074/jbc.M106754200; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Navarro-Gochicoa MT, 2003, PLANT PHYSIOL, V131, P1124, DOI 10.1104/pp.102.010926; Nukui N, 2000, PLANT CELL PHYSIOL, V41, P893, DOI 10.1093/pcp/pcd011; Oldroyd GED, 2001, PLANT CELL, V13, P1835, DOI 10.1105/tpc.13.8.1835; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Saito K, 2007, PLANT CELL, V19, P610, DOI 10.1105/tpc.106.046938; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; SMYTH GK, 2005, BIOINFORMATICS COMPU; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Suganuma N, 2004, MOL PLANT MICROBE IN, V17, P1223, DOI 10.1094/MPMI.2004.17.11.1223; Suganuma N, 2003, MOL GENET GENOMICS, V269, P312, DOI 10.1007/s00438-003-0840-4; Tirichine L, 2006, MOL PLANT MICROBE IN, V19, P373, DOI 10.1094/MPMI-19-0373; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Wieczorek K, 2008, PLANT J, V53, P336, DOI 10.1111/j.1365-313X.2007.03340.x; WU Z, 2004, J HOPKINS U WORKING, V1; Yano K, 2008, P NATL ACAD SCI USA, V105, P20540, DOI 10.1073/pnas.0806858105; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869	76	107	109	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6556	10.1371/journal.pone.0006556	http://dx.doi.org/10.1371/journal.pone.0006556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662091	Green Published, gold			2022-12-25	WOS:000268739600012
J	Chae, YK; Huang, HY; Strickland, P; Hoffman, SC; Helzlsouer, K				Chae, Young Kwang; Huang, Han-Yao; Strickland, Paul; Hoffman, Sandra C.; Helzlsouer, Kathy			Genetic Polymorphisms of Estrogen Receptors alpha and beta and the Risk of Developing Prostate Cancer	PLOS ONE			English	Article								Estrogen may be involved in the development of prostate cancer. The association between genetic polymorphisms of estrogen receptors alpha (ESR1) and beta (ESR2) and prostate cancer risk was examined in a nested case-control study in Washington County, Maryland. Incident prostate cancer cases (n = 269) were matched to one or two controls (n = 440) by age, sex, race, and date of blood donation. Associations between estrogen receptor genotypes or dietary intake and the development of prostate cancer were examined in conditional logistic regression models. Results from this study showed that six single base-pair polymorphisms (SNPs) of ESR1 (rs1801132, rs2077647, rs746432, rs2273206, rs851982, rs2228480) and four SNPs of ESR2 (rs4986938, rs928554, rs8018687, rs number not available for ESR2 5696 bp 3' of STP A>G) were not significantly associated with prostate cancer risk, either by allelic or genotypic frequencies. However, an interactive association with BMI was observed in the relationship between prostate cancer risk and genotypes of ESR2 38 bp 39 of STP G. A (rs4986938) (p = 0.031). An interaction between intake level of phytoestrogen and genotypes of ESR1 Ex1-192G>C (rs746432) and between intake level of phytoestrogen and genotypes of ESR1 Ex8+229G>A (rs2228480) and risk of prostate cancer was observed (p = 0.0009 and p = 0.044, respectively). In conclusion, selected genetic polymorphisms of ESR1 and ESR2, overall, were not associated with prostate cancer risk. However, a variation in risk by BMI and phytoestrogen intake was implicated.			Chae, YK (corresponding author), Albert Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA.	youngkwang.chae@gmail.com			NIA NIH HHS [1U01AG18033, U01 AG018033] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [U01AG018033] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Bashirelahi N, 1979, Prog Clin Biol Res, V33, P65; Cancel-Tassin G, 2003, EUR UROL, V44, P487, DOI 10.1016/S0302-2838(03)00319-1; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Ekman P, 2000, PROSTATE, P14; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; GEORGE W, 2002, COMSTOCK CTR PUBLIC; Hedelin M, 2006, PROSTATE, V66, P1512, DOI 10.1002/pros.20487; Hernandez J, 2006, J UROLOGY, V175, P523, DOI 10.1016/S0022-5347(05)00240-5; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; Kuiper GGJM, 1997, FEBS LETT, V410, P87, DOI 10.1016/S0014-5793(97)00413-4; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Lai JS, 2004, UROLOGY, V64, P814, DOI 10.1016/j.urology.2004.05.036; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Lee MM, 2003, CANCER EPIDEM BIOMAR, V12, P665; Low YL, 2006, NUTR CANCER, V56, P31, DOI 10.1207/s15327914nc5601_5; McIntyre MH, 2007, CANCER EPIDEM BIOMAR, V16, P2233, DOI 10.1158/1055-9965.EPI-07-0481; Medeiros R, 2003, CANCER GENET CYTOGEN, V141, P91, DOI 10.1016/S0165-4608(02)00660-X; Modugno F, 2001, CLIN CANCER RES, V7, P3092; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nicolaiew N, 2009, EUR J ENDOCRINOL, V160, P101, DOI 10.1530/EJE-08-0321; NOBLE RL, 1977, CANCER RES, V37, P1929; Packer BR, 2004, NUCLEIC ACIDS RES, V32, pD528, DOI 10.1093/nar/gkh005; Prins GS, 1998, ENDOCRINOLOGY, V139, P874, DOI 10.1210/en.139.3.874; Prins GS, 2001, CANCER RES, V61, P6089; Ricke WA, 2007, DIFFERENTIATION, V75, P871, DOI 10.1111/j.1432-0436.2007.00224.x; Risbridger G, 2001, DEV BIOL, V229, P432, DOI 10.1006/dbio.2000.9994; SCHNEIDER G, 1979, J CLIN ENDOCR METAB, V48, P633, DOI 10.1210/jcem-48-4-633; Signoretti S, 2001, AM J PATHOL, V159, P13, DOI 10.1016/S0002-9440(10)61666-5; Singer EA, 2008, EXPERT OPIN PHARMACO, V9, P211, DOI 10.1517/14656566.9.2.211 ; Sobti RC, 2008, CANCER GENET CYTOGEN, V185, P78, DOI 10.1016/j.cancergencyto.2008.04.022; Southey MC, 1998, J NATL CANCER I, V90, P532, DOI 10.1093/jnci/90.7.532; Sun Ying-hao, 2005, Zhonghua Wai Ke Za Zhi, V43, P948; Suzuki K, 2003, CANCER-AM CANCER SOC, V98, P1411, DOI 10.1002/cncr.11639; Tanaka Y, 2003, MOL CARCINOGEN, V37, P202, DOI 10.1002/mc.10138; THELLENBERGKARL.C, 2006, CLIN CANCER RES, V15, P306; *USDA, IOW STAT U DAT IS CO; Yager J D, 2000, J Natl Cancer Inst Monogr, P67; Zhu XG, 2004, AM J PATHOL, V164, P2003, DOI 10.1016/S0002-9440(10)63760-1	44	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6523	10.1371/journal.pone.0006523	http://dx.doi.org/10.1371/journal.pone.0006523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654868	Green Submitted, gold, Green Published			2022-12-25	WOS:000268739100016
J	Gill, A; Kidd, J; Vieira, F; Thompson, K; Perrin, S				Gill, Alan; Kidd, Joshua; Vieira, Fernando; Thompson, Kenneth; Perrin, Steven			No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS	PLOS ONE			English	Article								Background: In any animal model of human disease a positive control therapy that demonstrates efficacy in both the animal model and the human disease can validate the application of that animal model to the discovery of new therapeutics. Such a therapy has recently been reported by Fornai et al. using chronic lithium carbonate treatment and showing therapeutic efficacy in both the high-copy SOD1G93A mouse model of familial amyotrophic lateral sclerosis (ALS), and in human ALS patients. Methodology/Principal Findings: Seeking to verify this positive control therapy, we tested chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using the high-copy ( average 23 copies) SOD1G93A mouse (n = 27-28/group). Lithium-treated mice received single daily 36.9 mg/kg i.p. injections from 50 days of age through death. This dose delivered 1 mEq/kg (6.94 mg/kg/day lithium ions). Neurological disease severity score and body weight were determined daily during the dosing period. Age at onset of definitive disease and survival duration were recorded. Summary measures from individual body weight changes and neurological score progression, age at disease onset, and age at death were compared using Kaplan-Meier and Cox proportional hazards analysis. Our study did not show lithium efficacy by any measure. Conclusions/Significance: Rigorous survival study design that includes sibling matching, gender balancing, investigator blinding, and transgene copy number verification for each experimental subject minimized the likelihood of attaining a false positive therapeutic effect in this standard animal model of familial ALS. Results from this study do not support taking lithium carbonate into human clinical trials for ALS.			Gill, A (corresponding author), ALS Therapy Dev Inst, Cambridge, MA USA.	agill@als.net	Vieira, Fernando/ABG-9082-2020; Vieira, Fernando/L-6246-2013	Vieira, Fernando/0000-0003-2996-6418; Vieira, Fernando/0000-0003-2996-6418				Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Chuang DM, 2007, BIOL PSYCHIAT, V62, P4, DOI 10.1016/j.biopsych.2007.04.008; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Fornai F, 2008, AUTOPHAGY, V4, P527, DOI 10.4161/auto.5923; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; [Institute of Laboratory Animal Research Commission on Life Sciences National Research Council], 1996, GUID CAR US LAB AN; Koh SH, 2007, EXP NEUROL, V205, P336, DOI 10.1016/j.expneurol.2007.03.004; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Nciri R, 2008, CR BIOL, V331, P23, DOI 10.1016/j.crvi.2007.11.004; PIZZASEGOLA C, 2009, AMYOTROPH LATERAL SC, V23, P1; Quiroz JA, 2004, MOL INTERV, V4, P259, DOI 10.1124/mi.4.5.6; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Shin JH, 2007, MOL PHARMACOL, V71, P965, DOI 10.1124/mol.106.030676; Stam NC, 2008, EUR J NEUROSCI, V28, P717, DOI 10.1111/j.1460-9568.2008.06374.x; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182; WOOD AJ, 1986, NEUROPHARMACOLOGY, V25, P1285, DOI 10.1016/0028-3908(86)90149-8	19	77	80	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6489	10.1371/journal.pone.0006489	http://dx.doi.org/10.1371/journal.pone.0006489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649300	Green Published, gold, Green Submitted			2022-12-25	WOS:000268637700013
J	Flores-Valdez, MA; Morris, RP; Laval, F; Daffe, M; Schoolnik, GK				Alberto Flores-Valdez, Mario; Morris, Rowan P.; Laval, Francoise; Daffe, Mamadou; Schoolnik, Gary K.			Mycobacterium tuberculosis modulates its cell surface via an oligopeptide permease (Opp) transport system	FASEB JOURNAL			English	Article						lipid virulence factors; cell wall modulation; chronic infection; surface interaction	ALTERNATIVE SIGMA-FACTOR; STREPTOMYCES-COELICOLOR; MYCOLIC ACIDS; STREPTOCOCCUS-PNEUMONIAE; STRINGENT RESPONSE; BINDING-PROTEIN; AERIAL MYCELIUM; MUTANT LACKING; GENE-CLUSTER; BOVIS BCG	Bacterial species utilize a vast repertoire of surface structures to interact with their surroundings and employ a number of strategies to reconfigure the cellular envelope according to specific stimuli. Gram-positive bacteria, exemplified by Streptomyces and Bacillus species, control production of some exposed molecules by importing oligopeptide signals via permeases (Opp). Such oligopeptides modulate intracellular signaling pathways. In this work, we functionally characterized an Opp of the human pathogen Mycobacterium tuberculosis (Mtb) and propose its reannotation. Using genome-wide transcriptional profiling, we found that Opp was required to modulate (fold-change ranging from -3.5 to 2.0) the expression of several genes, most of them encoding surface-exposed molecules. These included the virulence-associated lipids mycolic acids and phthiocerol dimycocerosates (PDIMs) as well as PE-family proteins. By thin-layer chromatography and MALDI-TOF-MS we confirmed changes in the lipid profile, including an altered accumulation of triacylglycerides and an affected ratio of mycolic acids to PDIMs. An Opp loss of function mutant showed no in vitro growth defect, but had diminished burden during chronic infection and produced a slightly delayed time to death of animals when compared to WT Mtb infection.-Flores-Valdez, M. A., Morris, R. P., Laval, F., Daffe, M., Schoolnik, G. K. Mycobacterium tuberculosis modulates its cell surface via an oligopeptide permease (Opp) transport system. FASEB J. 23, 4091-4104 (2009). www.fasebj.org	[Alberto Flores-Valdez, Mario; Schoolnik, Gary K.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Morris, Rowan P.] Novartis Pharma AG, Novartis Inst Biomed Res, Nat Prod Unit, Basel, Switzerland; [Laval, Francoise; Daffe, Mamadou] CNRS, Inst Pharmacol & Biol Struct, Dept Mecanismes Mol Infect Mycobacteriennes, Toulouse, France; [Laval, Francoise; Daffe, Mamadou] Univ Toulouse 3, F-31062 Toulouse, France	Stanford University; Novartis; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Flores-Valdez, MA (corresponding author), Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Normalistas 800, Guadalajara 44270, Jalisco, Mexico.	floresv@ciatej.net.mx	Flores-Valdez, Mario Alberto/D-4139-2018; Morris, Rowan/HGU-9105-2022; LAUZERAL-VIZCAINO, Françoise/W-8898-2019	Flores-Valdez, Mario Alberto/0000-0002-4125-1370; LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252	NIH [N01-AI30036]; Stanford University School of Medicine	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University School of Medicine	The support of NIH contract N01-AI30036 is gratefully acknowledged. Within this group, our especial appreciation to Dr. Gyanu Lamichhane, who designed animal infection experiments, Dr. Paul Converse for his advice and data analysis, and Scott Nolan for superior technical assistance. The authors thank Dr. Jeannette Barba for her assistance in exporting microarray data to GEO and ArrayExpress. M. A. F. V. was a recipient of the Stanford University School of Medicine Dean's Fellowship.	Agarwal N, 2007, INFECT IMMUN, V75, P452, DOI 10.1128/IAI.01395-06; Ando M, 2003, INFECT IMMUN, V71, P7170, DOI 10.1128/IAI.71.12.7170-7172.2003; ASHBRIDGE KR, 1990, J IMMUNOL, V144, P3137; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Borezee E, 2000, INFECT IMMUN, V68, P7069, DOI 10.1128/IAI.68.12.7069-7077.2000; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Calamita H, 2005, CELL MICROBIOL, V7, P233, DOI 10.1111/j.1462-5822.2004.00454.x; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chater KF, 2003, MOL MICROBIOL, V48, P9, DOI 10.1046/j.1365-2958.2003.03476.x; Chen P, 2000, INFECT IMMUN, V68, P5575, DOI 10.1128/IAI.68.10.5575-5580.2000; Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; CUNDELL DR, 1995, INFECT IMMUN, V63, P2493, DOI 10.1128/IAI.63.7.2493-2498.1995; Dainese E, 2006, INFECT IMMUN, V74, P2457, DOI 10.1128/IAI.74.4.2457-2461.2006; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; ENGELBRE.HL, 1972, J BACTERIOL, V11, P33; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Ghosh J, 2009, P NATL ACAD SCI USA, V106, P10781, DOI 10.1073/pnas.0904104106; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; Green RM, 2000, INFECT IMMUN, V68, P429, DOI 10.1128/IAI.68.2.429-436.2000; GUILHOT CAD, 2008, HDB TUBERCULOSIS MOL, V1, P21; Hahn MY, 2005, J BACTERIOL, V187, P7062, DOI 10.1128/JB.187.20.7062-7071.2005; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; LAMB JR, 1988, EUR J IMMUNOL, V18, P973, DOI 10.1002/eji.1830180623; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Lazazzera BA, 1997, CELL, V89, P917, DOI 10.1016/S0092-8674(00)80277-9; Lazazzera BA, 2001, PEPTIDES, V22, P1519, DOI 10.1016/S0196-9781(01)00488-0; Leonard BAB, 1996, P NATL ACAD SCI USA, V93, P260, DOI 10.1073/pnas.93.1.260; Lorenzana LM, 2004, J BACTERIOL, V186, P3431, DOI 10.1128/JB.186.11.3431-3438.2004; Manca C, 1999, J IMMUNOL, V162, P6740; Marrakchi H, 2008, MYCOBACTERIAL CELL ENVELOPE, P41; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x; Nodwell JR, 1998, J BACTERIOL, V180, P1334, DOI 10.1128/JB.180.5.1334-1337.1998; OCHI K, 1987, J BACTERIOL, V169, P3608, DOI 10.1128/jb.169.8.3608-3616.1987; OCHI K, 1981, J BIOL CHEM, V256, P6866; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Perego M, 1996, P NATL ACAD SCI USA, V93, P1549, DOI 10.1073/pnas.93.4.1549; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Piette A, 2005, J PROTEOME RES, V4, P1699, DOI 10.1021/pr050155b; Pope MK, 1996, MOL MICROBIOL, V19, P747, DOI 10.1046/j.1365-2958.1996.414933.x; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Raman S, 2004, J BACTERIOL, V186, P6605, DOI 10.1128/JB.186.19.6605-6616.2004; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Samen U, 2004, J BACTERIOL, V186, P1398, DOI 10.1128/JB.186.5.1398-1408.2004; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schwartz D, 2004, APPL ENVIRON MICROB, V70, P7093, DOI 10.1128/AEM.70.12.7093-7102.2004; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Smirnova GV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1199, DOI 10.1007/s10541-005-0248-3; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sun RG, 2004, MOL MICROBIOL, V52, P25, DOI 10.1111/j.1365-2958.2003.03958.x; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wang CH, 2005, INFECT IMMUN, V73, P2881, DOI 10.1128/IAI.73.5.2881-2890.2005; Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18	77	32	33	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4091	4104		10.1096/fj.09-132407	http://dx.doi.org/10.1096/fj.09-132407			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19671666	Green Published			2022-12-25	WOS:000272193700006
J	Murray, AJ; Knight, NS; Cochlin, LE; McAleese, S; Deacon, RMJ; Rawlins, JNP; Clarke, K				Murray, Andrew J.; Knight, Nicholas S.; Cochlin, Lowri E.; McAleese, Sara; Deacon, Robert M. J.; Rawlins, J. Nicholas P.; Clarke, Kieran			Deterioration of physical performance and cognitive function in rats with short-term high-fat feeding	FASEB JOURNAL			English	Article						exercise; cognition; nutrition; mitochondria; metabolism	ACTIVATED-RECEPTOR-ALPHA; MITOCHONDRIAL UNCOUPLING PROTEINS; INDUCED CARDIAC-HYPERTROPHY; DECREASED EFFICIENCY; ENDURANCE EXERCISE; MUSCLE GLYCOGEN; ACIDS; DIET; METABOLISM; EXPRESSION	Efficiency, defined as the amount of work produced for a given amount of oxygen consumed, is a key determinant of endurance capacity, and can be altered by metabolic substrate supply, in that fatty acid oxidation is less efficient than glucose oxidation. It is unclear, however, whether consumption of a high-fat diet would be detrimental or beneficial for endurance capacity, due to purported glycogen-sparing properties. In addition, a high-fat diet over several months leads to cognitive impairment. Here, we tested the hypothesis that short-term ingestion of a high-fat diet (55% kcal from fat) would impair exercise capacity and cognitive function in rats, compared with a control chow diet (7.5% kcal from fat) via mitochondrial uncoupling and energy deprivation. We found that rats ran 35% less far on a treadmill and showed cognitive impairment in a maze test with 9 d of high-fat feeding, with respiratory uncoupling in skeletal muscle mitochondria, associated with increased uncoupling protein (UCP3) levels. Our results suggest that high-fat feeding, even over short periods of time, alters skeletal muscle UCP3 expression, affecting energy production and physical performance. Optimization of nutrition to maximize the efficiency of mitochondrial ATP production could improve energetics in athletes and patients with metabolic abnormalities.-Murray, A. J., Knight, N. S., Cochlin, L. E., McAleese, S., Deacon, R. M. J., Rawlins, J. N. P., Clarke, K. Deterioration of physical performance and cognitive function in rats with short-term high-fat feeding. FASEB J. 23, 4353-4360 (2009). www.fasebj.org	[Murray, Andrew J.; Knight, Nicholas S.; Cochlin, Lowri E.; McAleese, Sara; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Deacon, Robert M. J.; Rawlins, J. Nicholas P.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Murray, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	ajm267@cam.ac.uk	Murray, Andrew/B-3130-2010	Murray, Andrew/0000-0002-0929-9315	Wellcome Trust; British Heart Foundation [RG/02/009/13631]; British Heart Foundation [RG/07/004/22659, PS/02/002/14893] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	We thank Emma Carter for her invaluable technical assistance and Dr. Charles L. Hoppel and his research group for their generous help in teaching us their mitochondrial isolation and respiration protocols. We thank Stefan Alexson (Karolinska Institutet, Stockholm, Sweden) for his generous gift of the MTE-1 antibody. S. M. thanks the Wellcome Trust for her Undergraduate Vacation Studentship. This study was supported by the British Heart Foundation (grant RG/02/009/13631).	AMIEL SA, 1995, P NUTR SOC, V54, P151, DOI 10.1079/PNS19950044; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Erlenbusch M, 2005, INT J SPORT NUTR EXE, V15, P1, DOI 10.1123/ijsnem.15.1.1; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Gilde AJ, 2003, ACTA PHYSIOL SCAND, V178, P425, DOI 10.1046/j.1365-201X.2003.01161.x; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Hart G, 2003, EXP PHYSIOL, V88, P639, DOI 10.1113/eph8802619; Helge JW, 1996, J PHYSIOL-LONDON, V492, P293, DOI 10.1113/jphysiol.1996.sp021309; Helge JW, 2001, J PHYSIOL-LONDON, V537, P1009, DOI 10.1113/jphysiol.2001.012933; Helge JW, 1998, J APPL PHYSIOL, V85, P1342, DOI 10.1152/jappl.1998.85.4.1342; HERMANSE.L, 1967, ACTA PHYSIOL SCAND, V71, P129, DOI 10.1111/j.1748-1716.1967.tb03719.x; HICKSON RC, 1979, AM J PHYSIOL, V236, pH268, DOI 10.1152/ajpheart.1979.236.2.H268; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; How O. -J., 2007, Archives of Physiology and Biochemistry, V113, P211, DOI 10.1080/13813450701783281; HULTMAN E, 1967, ACTA MED SCAND, V182, P109; HULTMAN E, 1967, SCAND J CLIN LAB INV, VS 19, P11; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33, DOI 10.1093/oxfordjournals.aje.a009029; Kalmijn S, 2004, NEUROLOGY, V62, P275, DOI 10.1212/01.WNL.0000103860.75218.A5; Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054; King KL, 2007, J LIPID RES, V48, P1511, DOI 10.1194/jlr.M600364-JLR200; MILLER WC, 1984, J APPL PHYSIOL, V56, P78, DOI 10.1152/jappl.1984.56.1.78; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Priego T, 2008, OBESITY, V16, P819, DOI 10.1038/oby.2007.117; Roriz JS, 2009, BBA-MOL BASIS DIS, V1792, P432, DOI 10.1016/j.bbadis.2008.12.003; Sienkiewicz ZJ, 2000, BIOELECTROMAGNETICS, V21, P151, DOI 10.1002/(SICI)1521-186X(200004)21:3<151::AID-BEM1>3.0.CO;2-Q; SIMI B, 1991, J APPL PHYSIOL, V71, P197, DOI 10.1152/jappl.1991.71.1.197; Stavinoha MA, 2004, AM J PHYSIOL-ENDOC M, V287, pE888, DOI 10.1152/ajpendo.00190.2004; Winocur G, 2005, NEUROBIOL AGING, V26, pS46, DOI 10.1016/j.neurobiolaging.2005.09.003; WISNESKI JA, 1987, J CLIN INVEST, V79, P359, DOI 10.1172/JCI112820; Young ME, 2001, FASEB J, V15, P833, DOI 10.1096/fj.00-0351com; Zackova M, 2003, J BIOL CHEM, V278, P20761, DOI 10.1074/jbc.M212850200	36	108	109	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4353	4360		10.1096/fj.09-139691	http://dx.doi.org/10.1096/fj.09-139691			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19667117				2022-12-25	WOS:000272193700030
J	O'Boyle, G; Mellor, P; Kirby, JA; Ali, S				O'Boyle, Graeme; Mellor, Paul; Kirby, John A.; Ali, Simi			Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12	FASEB JOURNAL			English	Article						chemokine; glycosaminoglycan; G-protein-coupled receptors; integrin adhesion; receptor desensitization	CHEMOKINE-MEDIATED INFLAMMATION; BREAST-CANCER METASTASIS; GLYCOSAMINOGLYCAN-BINDING; RHEUMATOID-ARTHRITIS; RECEPTOR; CXCR4; CHEMOATTRACTANT; INHIBITION; CELLS; CC	Interaction between chemokines and heparan sulfate (HS) is essential for leukocyte recruitment during inflammation. Previous studies have shown that a non-HS-binding mutant form of the inflammatory chemokine CCL7 can block inflammation produced by wild-type chemokines. This study examined the anti-inflammatory mechanism of a non-HS-binding mutant of the homeostatic chemokine CXCL12. Initial experiments demonstrated that mutant CXCL12 was an effective CXCR4 agonist. However, this mutant chemokine failed to promote transendothelial migration in vitro and inhibited the haptotactic response to wild-type CCL7, CXCL12, and CXCL8, and naturally occurring chemoattractants in synovial fluid from the rheumatoid synovium, including CCL2, CCL7, and CXCL8. Notably, intravenous administration of mutant CXCL12 also inhibited the recruitment of leukocytes to murine air pouches filled with wild-type CXCL12. Following intravenous administration, wild-type CXCL12 was cleared from the circulation rapidly, while the mutant chemokine persisted for >24 h. Chronic exposure to mutant CXCL12 in the circulation reduced leukocyte-surface expression of CXCR4, reduced the chemotactic response of these cells to CXCL12, and inhibited normal chemokine-mediated induction of adhesion between the alpha 4 beta 1 integrin, VLA-4, and VCAM-1. These data demonstrate that systemic administration of non-HS-binding variants of CXCL12 can mediate a powerful anti-inflammatory effect through chemokine receptor desensitization.-O'Boyle, G., Mellor, P., Kirby, J. A., Ali, S. Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12. FASEB J. 23, 3906-3916 (2009). www.fasebj.org	[O'Boyle, Graeme; Mellor, Paul; Kirby, John A.; Ali, Simi] Univ Newcastle, Appl Immunobiol & Transplantat Res Grp, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Kirby, JA (corresponding author), Univ Newcastle, Appl Immunobiol & Transplantat Res Grp, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	j.a.kirby@ncl.ac.uk		Kirby, John/0000-0003-2543-4131; O'Boyle, Graeme/0000-0002-0472-8061	Wellcome Trust [078892]; Roche Organ Transplantation Research Fund [884289934]	Wellcome Trust(Wellcome TrustEuropean Commission); Roche Organ Transplantation Research Fund	The authors thank J. D. Issacs (University of Newcastle) for assistance with the synovial fluid study; Drs. H. Walden, C. Wilson, M. Baker, and M. Kirkley for technical support; and the Wellcome Trust (grant 078892) and the Roche Organ Transplantation Research Fund (grant 884289934) for financial support.	Al-Hamidi A, 2008, MOL IMMUNOL, V45, P4000, DOI 10.1016/j.molimm.2008.06.011; Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Ali S, 2002, GLYCOBIOLOGY, V12, P535, DOI 10.1093/glycob/cwf069; Ali S, 2007, MOL IMMUNOL, V44, P1477, DOI 10.1016/j.molimm.2006.08.011; AlMughales J, 1996, CLIN EXP IMMUNOL, V106, P230, DOI 10.1046/j.1365-2249.1996.d01-836.x; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bursill CA, 2009, GENE THER, V16, P93, DOI 10.1038/gt.2008.141; Chigaev A, 2007, J IMMUNOL, V178, P6828, DOI 10.4049/jimmunol.178.11.6828; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Comerford L, 2005, IMMUNOL LETT, V96, P163, DOI 10.1016/j.imlet.2004.08.018; Culley FJ, 2003, EUR J IMMUNOL, V33, P1302, DOI 10.1002/eji.200323509; Dowsland MH, 2003, CURR MED CHEM, V10, P579, DOI 10.2174/0929867033457944; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Fricker SP, 2008, EXPERT OPIN INV DRUG, V17, P1749, DOI 10.1517/13543784.17.11.1749 ; Glynn PC, 2001, EUR RESPIR J, V18, P522, DOI 10.1183/09031936.01.00057901; Gouwy M, 2008, MOL PHARMACOL, V74, P485, DOI 10.1124/mol.108.045146; Hardy LA, 2004, LAB INVEST, V84, P81, DOI 10.1038/labinvest.3700007; Harvey JR, 2007, CLIN CANCER RES, V13, P1562, DOI 10.1158/1078-0432.CCR-06-1987; Hecht I, 2003, INT IMMUNOL, V15, P29, DOI 10.1093/intimm/dxg002; Iwamoto T, 2008, FEBS J, V275, P4448, DOI 10.1111/j.1742-4658.2008.06580.x; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Johnson Z, 2004, BIOCHEM SOC T, V32, P366, DOI 10.1042/BST0320366; Konstandin MH, 2006, J IMMUNOL METHODS, V310, P67, DOI 10.1016/j.jim.2005.12.005; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Lenoir M, 2004, J IMMUNOL, V172, P7136, DOI 10.4049/jimmunol.172.11.7136; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; O'Boyle G, 2007, MOL IMMUNOL, V44, P1944, DOI 10.1016/j.molimm.2006.09.033; Potzinger H, 2006, BIOCHEM SOC T, V34, P435, DOI 10.1042/BST0340435; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2008, ARTHRITIS RHEUM, V58, P1889, DOI 10.1002/art.23590; Rueda P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002543; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; SIN YM, 1986, ANN RHEUM DIS, V45, P873, DOI 10.1136/ard.45.10.873; Sweeney EA, 2002, BLOOD, V99, P44, DOI 10.1182/blood.V99.1.44; Van Coillie E, 1999, CYTOKINE GROWTH F R, V10, P61, DOI 10.1016/S1359-6101(99)00005-2; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714	41	39	39	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3906	3916		10.1096/fj.09-134643	http://dx.doi.org/10.1096/fj.09-134643			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19667120	Green Published			2022-12-25	WOS:000271272500026
J	Kress, D; Brugel, D; Schall, I; Linder, D; Buckel, W; Essen, LO				Kress, Daniel; Bruegel, Daniela; Schall, Iris; Linder, Dietmar; Buckel, Wolfgang; Essen, Lars-Oliver			An Asymmetric Model for Na+-translocating Glutaconyl-CoA Decarboxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACIDAMINOCOCCUS-FERMENTANS; CARBOXYLTRANSFERASE DOMAIN; ESCHERICHIA-COLI; SODIUM-PUMP; PURIFICATION; COENZYME; TRANSFERASE; NUCLEATUM; SUBUNIT	Glutaconyl-CoA decarboxylase (Gcd) couples the biotin-dependent decarboxylation of glutaconyl-CoA with the generation of an electrochemical Na+ gradient. Sequencing of the genes encoding all subunits of the Clostridium symbiosum decarboxylase membrane complex revealed that it comprises two distinct biotin carrier subunits, GcdC(1) and GcdC(2), which differ in the length of a central alanine- and proline-rich linker domain. Co-crystallization of the decarboxylase subunit GcdA with the substrate glutaconyl-CoA, the product crotonyl-CoA, and the substrate analogue glutaryl-CoA, respectively, resulted in a high resolution model for substrate binding and catalysis revealing remarkable structural changes upon substrate binding. Unlike the GcdA structure from Acidaminococcus fermentans, these data suggest that in intact Gcd complexes, GcdA is associated as a tetramer crisscrossed by a network of solvent-filled tunnels.	[Buckel, Wolfgang] Univ Marburg, Mikrobiol Lab, Fachbereich Biol, D-35032 Marburg, Germany; [Kress, Daniel; Essen, Lars-Oliver] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany; [Linder, Dietmar] Univ Giessen, Fachbereich Med, D-35392 Giessen, Germany; [Buckel, Wolfgang] Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen; Max Planck Society	Buckel, W (corresponding author), Univ Marburg, Mikrobiol Lab, Fachbereich Biol, D-35032 Marburg, Germany.	buckel@staff.uni-marburg.de; essen@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026	Deutsche Forschungsgemeinschaft [1070]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Priority Program 1070) (to L.-O.E. and W.B.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEATRIX B, 1990, ARCH MICROBIOL, V154, P362, DOI 10.1007/BF00276532; BENDRAT K, 1993, EUR J BIOCHEM, V211, P697, DOI 10.1111/j.1432-1033.1993.tb17598.x; Berger S, 1996, ANGEW CHEM INT EDIT, V35, P2132, DOI 10.1002/anie.199621321; Bilder P, 2006, BIOCHEMISTRY-US, V45, P1712, DOI 10.1021/bi0520479; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Braune A, 1999, MOL MICROBIOL, V31, P473, DOI 10.1046/j.1365-2958.1999.01189.x; BUCKEL W, 1986, METHOD ENZYMOL, V125, P547; BUCKEL W, 1981, EUR J BIOCHEM, V118, P315, DOI 10.1111/j.1432-1033.1981.tb06404.x; Buckel W, 2001, APPL MICROBIOL BIOT, V57, P263, DOI 10.1007/s002530100773; BUCKEL W, 1983, EUR J BIOCHEM, V136, P427, DOI 10.1111/j.1432-1033.1983.tb07760.x; BUCKEL W, 1986, EUR J BIOCHEM, V156, P251, DOI 10.1111/j.1432-1033.1986.tb09575.x; Buckel W, 2001, BBA-BIOENERGETICS, V1505, P15, DOI 10.1016/S0005-2728(00)00273-5; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diacovich L, 2004, BIOCHEMISTRY-US, V43, P14027, DOI 10.1021/bi049065v; Dimroth P, 1998, ARCH MICROBIOL, V170, P69, DOI 10.1007/s002030050616; DIMROTH P, 1984, BIOCHEMISTRY-US, V23, P5360, DOI 10.1021/bi00317a039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Hall PR, 2003, EMBO J, V22, P2334, DOI 10.1093/emboj/cdg244; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hans M, 1999, EUR J BIOCHEM, V265, P404, DOI 10.1046/j.1432-1327.1999.00748.x; HARTEL U, 1993, ARCH MICROBIOL, V159, P174, DOI 10.1007/BF00250279; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; Hwang IT, 2003, BIOTECHNIQUES, V35, P1180, DOI 10.2144/03356st03; KANEUCHI C, 1976, INT J SYST BACTERIOL, V26, P195, DOI 10.1099/00207713-26-2-195; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; MACK M, 1994, EUR J BIOCHEM, V226, P41, DOI 10.1111/j.1432-1033.1994.tb20024.x; MEAD GC, 1971, J GEN MICROBIOL, V67, P47, DOI 10.1099/00221287-67-1-47; MICHEL C, 1991, J CHROMATOGR, V587, P93, DOI 10.1016/0021-9673(91)85202-Q; Mouttaki H, 2007, APPL ENVIRON MICROB, V73, P930, DOI 10.1128/AEM.02227-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novy R., 2001, INNOVATIONS, V12, P1; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Ponstingl H, 2003, J APPL CRYSTALLOGR, V36, P1116, DOI 10.1107/S0021889803012421; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Sambrook J, 2001, MOL CLONING LAB MANU; Selmer T, 1999, J BIOL CHEM, V274, P20772, DOI 10.1074/jbc.274.30.20772; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wendt KS, 2003, EMBO J, V22, P3493, DOI 10.1093/emboj/cdg358; Yaffe E, 2008, NUCLEIC ACIDS RES, V36, pW210, DOI 10.1093/nar/gkn223; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366; ZIEGENHORN J, 1976, CLIN CHEM, V22, P151	58	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28401	28409		10.1074/jbc.M109.037762	http://dx.doi.org/10.1074/jbc.M109.037762			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654317	Green Published, hybrid			2022-12-25	WOS:000270676300065
J	Mielgo, A; Torres, VA; Clair, K; Barbero, S; Stupack, DG				Mielgo, A.; Torres, V. A.; Clair, K.; Barbero, S.; Stupack, D. G.			Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules	ONCOGENE			English	Article						caspase; microtubule-organizing center; centrosome; cell survival; death effector domain	INDUCED CELL-DEATH; CANCER-CELLS; PROTEASOME INHIBITOR; IN-VIVO; PROTEIN FAMILY; LEUKEMIA-CELLS; LYMPHOID-CELLS; LUNG-CANCER; ACTIVATION; RECEPTOR	Microtubule-perturbing drugs have become front-line chemotherapeutics, inducing cell-cycle crisis as a major mechanism of action. However, these agents show pleiotropic effects on cells and can induce apoptosis through other means. Paclitaxel, a microtubule-stabilizing agent, induces a caspase-dependent apoptosis, although the precise mechanism(s) remain unclear. Here, we used genetic approaches to evaluate the role of caspase 8 in paclitaxel-mediated apoptosis. We observed that caspase 8-expressing cells are more sensitive to paclitaxel than caspase 8-deficient cells. Mechanistically, caspase 8 was found associated with microtubules, and this interaction increased after paclitaxel treatment. The prodomains death effector domains (DEDs) of caspase 8 were sufficient for interaction with microtubules, but the caspase 8 holoprotein was required for apoptosis. DED-only forms of caspase 8 were found in both primary and tumor cell lines, associating with perinuclear microtubules and the centrosome. Microtubule association, and paclitaxel sensitivity, depends on a critical lysine (K156) within a microtubule-binding motif (KLD) in DED-b of caspase 8. The results show an unexpected pathway of apoptosis mediated by caspase 8. Oncogene (2009) 28, 3551-3562; doi: 10.1038/onc.2009.210; published online 10 August 2009	[Stupack, D. G.] Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, Sch Med, La Jolla, CA 92093 USA; [Mielgo, A.; Torres, V. A.; Clair, K.; Barbero, S.; Stupack, D. G.] Univ Calif San Diego, Sch Med, Moores Comprehens Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Stupack, DG (corresponding author), Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, Sch Med, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	dstupack@ucsd.edu	Torres, Vicente/I-2437-2013	Torres, Vicente A/0000-0002-5973-7248	NIH/NCI [CA107263]; Swiss National Foundation; Novartis Foundation; Caja Madrid Foundation; NATIONAL CANCER INSTITUTE [R01CA107263] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); Caja Madrid Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH/NCI Grant CA107263 to DGS and by grants from the Swiss National Foundation, the Novartis Foundation and the Caja Madrid Foundation to AM. The authors thank Drs S Zeitlin and M Hogan for helpful comments and Drs Marcus Peter (Ben May Institute), Jill Lahti (St Jude Children's Research Hospital), Mark Ginsberg (UCSD) and Guy Salvesen (The Burnham Institute) for the kind gift of reagents.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Al-Bassam J, 2003, J CELL BIOL, V163, P743, DOI 10.1083/jcb.200308020; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Barnhart BC, 2003, ONCOGENE, V22, P8634, DOI 10.1038/sj.onc.1207103; Bayless KJ, 2004, J BIOL CHEM, V279, P11686, DOI 10.1074/jbc.M308373200; Beisner DR, 2003, J IMMUNOL, V171, P247, DOI 10.4049/jimmunol.171.1.247; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Calvaruso G, 2006, MOL CELL BIOCHEM, V287, P13, DOI 10.1007/s11010-005-9016-3; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chauhan D, 2008, BLOOD, V111, P1654, DOI 10.1182/blood-2006-10-050476; Feng GP, 2000, J CLIN INVEST, V105, P329, DOI 10.1172/JCI7398; Garvey TL, 2002, VIROLOGY, V300, P217, DOI 10.1006/viro.2002.1518; Garvey TL, 2002, J VIROL, V76, P697, DOI 10.1128/JVI.76.2.697-706.2002; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gdynia G, 2007, MOL CANCER RES, V5, P1232, DOI 10.1158/1541-7786.MCR-07-0343; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Kabore AF, 2006, APOPTOSIS, V11, P1175, DOI 10.1007/s10495-006-8048-9; Kasibhatla S, 2007, CANCER RES, V67, P5865, DOI 10.1158/0008-5472.CAN-07-0127; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kim M, 2008, CANCER RES, V68, P3440, DOI 10.1158/0008-5472.CAN-08-0014; Kretschmar CS, 2004, J CLIN ONCOL, V22, P4119, DOI 10.1200/JCO.2004.08.174; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; Mitsui C, 2001, J NEUROSCI RES, V66, P601, DOI 10.1002/jnr.10008; Nimmanapalli R, 2001, CANCER RES, V61, P759; Odoux C, 2002, INT J CANCER, V97, P458, DOI 10.1002/ijc.1640; Odoux C, 2004, VITAM HORM, V67, P385; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Pellegrini M, 2005, BLOOD, V106, P1581, DOI 10.1182/blood-2005-01-0284; Petit I, 2008, BLOOD, V111, P1951, DOI 10.1182/blood-2007-05-089219; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Shikama Y, 2002, BIOCHEM BIOPH RES CO, V291, P484, DOI 10.1006/bbrc.2002.6482; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Singh TR, 2003, CANCER RES, V63, P5390; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; Teitz T, 2002, ONCOGENE, V21, P1848, DOI 10.1038/sj.onc.1205180; Teitz T, 2001, J MOL MED, V79, P428, DOI 10.1007/s001090100233; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Voortman J, 2007, MOL CANCER THER, V6, P2103, DOI 10.1158/1535-7163.MCT-07-0167; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Yao Z, 2007, EMBO J, V26, P1068, DOI 10.1038/sj.emboj.7601571; Zhu HB, 2004, MOL THER, V9, P666, DOI 10.1016/j.ymthe.2004.02.007	55	42	45	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2009	28	40					3551	3562		10.1038/onc.2009.210	http://dx.doi.org/10.1038/onc.2009.210			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KI	19668227	Green Accepted			2022-12-25	WOS:000270851700004
J	Nedumaran, B; Hong, S; Xie, YB; Kim, YH; Seo, WY; Lee, MW; Lee, CH; Koo, SH; Choi, HS				Nedumaran, Balachandar; Hong, Sungpyo; Xie, Yuan-Bin; Kim, Yong-Hoon; Seo, Woo-Young; Lee, Min-Woo; Lee, Chul Ho; Koo, Seung-Hoi; Choi, Hueng-Sik			DAX-1 Acts as a Novel Corepressor of Orphan Nuclear Receptor HNF4 alpha and Negatively Regulates Gluconeogenic Enzyme Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL HYPOPLASIA CONGENITA; HORMONE-RECEPTOR; DNA-BINDING; HEPATIC GLUCONEOGENESIS; TRANSCRIPTION FACTOR; COACTIVATOR TORC2; PROTEIN-KINASE; INSULIN; TRANSACTIVATION; SHP	DAX-1 (dosage-sensitive sex reversal adrenal hypoplasia congenital critical region on X chromosome, gene 1) is an atypical member of the nuclear receptor family and acts as a corepressor of a number of nuclear receptors. HNF4 alpha (hepatocyte nuclear factor 4 alpha) is a liver-enriched transcription factor that controls the expression of a variety of genes involved in cholesterol, fatty acid, and glucose metabolism. Here we show that DAX-1 inhibits transcriptional activity of HNF4 alpha and modulates hepatic gluconeogenic gene expression. Hepatic DAX-1 expression is increased by insulin and SIK1 (salt-inducible kinase 1), whereas it is decreased in high fat diet-fed and diabetic mice. Coimmunoprecipitation assay from mouse liver samples depicts that endogenous DAX-1 interacts with HNF4 alpha in vivo. In vivo chromatin immunoprecipitation assay affirms that the recruitment of DAX-1 on the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter is inversely correlated with the recruitment of PGC-1 alpha and HNF4 alpha under fasting and refeeding, showing that DAX-1 could compete with the coactivator PGC-1 alpha for binding to HNF4 alpha. Adenovirus-mediated expression of DAX-1 decreased both HNF4 alpha- and forskolin-mediated gluconeogenic gene expressions. In addition, knockdown of DAX-1 partially reverses the insulin-mediated inhibition of gluconeogenic gene expression in primary hepatocytes. Finally, DAX-1 inhibits PEPCK and glucose-6-phosphatase gene expression and significantly lowers fasting blood glucose level in high fat diet-fed mice, suggesting that DAX-1 can modulate hepatic gluconeogenesis in vivo. Overall, this study demonstrates that DAX-1 acts as a corepressor of HNF4 alpha to negatively regulate hepatic gluconeogenic gene expression in liver.	[Nedumaran, Balachandar; Xie, Yuan-Bin; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Hong, Sungpyo; Seo, Woo-Young; Lee, Min-Woo; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Kim, Yong-Hoon; Lee, Chul Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Sungkyunkwan University (SKKU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Nedumaran, Balachandar/V-9958-2019; Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	Ministry of Science and Technology [M10500000047-06J0000-04710]; Korea Research Foundation [2006-005-J03003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Research Foundation(National Research Foundation of Korea)	This study was supported by the Korea Science and Engineering Foundation through the National Research Laboratory Program funded by Ministry of Science and Technology Grant M10500000047-06J0000-04710 and Korea Research Foundation Grant 2006-005-J03003.	Agoulnik IU, 2003, J BIOL CHEM, V278, P31136, DOI 10.1074/jbc.M305153200; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Drewes T, 1996, MOL CELL BIOL, V16, P925; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hattersley AT, 1998, DIABETIC MED, V15, P15, DOI 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; Iyer AK, 2006, MOL ENDOCRINOL, V20, P2326, DOI 10.1210/me.2005-0383; JIANG GQ, 1995, MOL CELL BIOL, V15, P5131; Jiang YW, 2001, P NATL ACAD SCI USA, V98, P10102, DOI 10.1073/pnas.131200398; Kim GS, 2008, BIOCHEM BIOPH RES CO, V370, P264, DOI 10.1016/j.bbrc.2008.03.098; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lalli E, 2000, MOL CELL BIOL, V20, P4910, DOI 10.1128/MCB.20.13.4910-4921.2000; Lausen J, 2000, NUCLEIC ACIDS RES, V28, P430, DOI 10.1093/nar/28.2.430; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Li TG, 2008, J LIPID RES, V49, P1981, DOI 10.1194/jlr.M800140-JLR200; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsumoto M, 2006, NAT MED, V12, P33, DOI 10.1038/nm0106-33; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Ruse MD, 2002, MOL CELL BIOL, V22, P1626, DOI 10.1128/MCB.22.6.1626-1638.2002; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Smith CA, 2000, J MOL ENDOCRINOL, V24, P23, DOI 10.1677/jme.0.0240023; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Sugita J, 2001, GENE, V280, P67, DOI 10.1016/S0378-1119(01)00739-9; Suzuki T, 2003, MOL CELL BIOL, V23, P238, DOI 10.1128/MCB.23.1.238-249.2003; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Wang DS, 2002, BIOCHEM BIOPH RES CO, V297, P632, DOI 10.1016/S0006-291X(02)02252-0; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yoshida E, 1997, BIOCHEM BIOPH RES CO, V241, P664, DOI 10.1006/bbrc.1997.7871; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zazopoulos E, 1997, NATURE, V390, P311, DOI 10.1038/36899; Zhang H, 2000, J BIOL CHEM, V275, P39855, DOI 10.1074/jbc.C000567200	53	37	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27511	27523		10.1074/jbc.M109.034660	http://dx.doi.org/10.1074/jbc.M109.034660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651776	Green Published, hybrid			2022-12-25	WOS:000270232300053
J	Perkins, DI; Trudell, JR; Crawford, DK; Asatryan, L; Alkana, RL; Davies, DL				Perkins, Daya I.; Trudell, James R.; Crawford, Daniel K.; Asatryan, Liana; Alkana, Ronald L.; Davies, Daryl L.			Loop 2 Structure in Glycine and GABA(A) Receptors Plays a Key Role in Determining Ethanol Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; EXTRACELLULAR DOMAIN; GENERAL-ANESTHETICS; ALCOHOL DEPENDENCE; ACTIVATED CURRENT; CRYSTAL-STRUCTURE; TONIC INHIBITION; AGONIST BINDING; 5-HT3 RECEPTORS; P2X RECEPTORS	The present study tests the hypothesis that the structure of extracellular domain Loop 2 can markedly affect ethanol sensitivity in glycine receptors (GlyRs) and gamma-aminobutyric acid type A receptors (GABA(A)Rs). To test this, we mutated Loop 2 in the alpha 1 subunit of GlyRs and in the gamma subunit of alpha 1 beta 2 gamma 2GABA(A)Rs and measured the sensitivity of wild type and mutant receptors expressed in Xenopus oocytes to agonist, ethanol, and other agents using two-electrode voltage clamp. Replacing Loop 2 of alpha 1GlyR subunits with Loop 2 from the delta GABA(A)R (delta L2), but not the gamma GABA(A)R subunit, reduced ethanol threshold and increased the degree of ethanol potentiation without altering general receptor function. Similarly, replacing Loop 2 of the gamma subunit of GABAARs with delta L2 shifted the ethanol threshold from 50 mM in WT to 1 mM in the GABA(A) gamma-delta L2 mutant. These findings indicate that the structure of Loop 2 can profoundly affect ethanol sensitivity in GlyRs and GABAARs. The delta L2 mutations did not affect GlyR or GABA(A)R sensitivity, respectively, to Zn2+ or diazepam, which suggests that these delta L2-induced changes in ethanol sensitivity do not extend to all allosteric modulators and may be specific for ethanol or ethanol-like agents. To explore molecular mechanisms underlying these results, we threaded the WT and delta L2 GlyR sequences onto the x-ray structure of the bacterial Gloeobacter violaceus pentameric ligand-gated ion channel homologue (GLIC). In addition to being the first GlyR model threaded on GLIC, the juxtaposition of the two structures led to a possible mechanistic explanation for the effects of ethanol on GlyR-based on changes in Loop 2 structure.	[Perkins, Daya I.; Alkana, Ronald L.] Univ So Calif, Sch Pharm, Alcohol & Brain Res Labs, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Asatryan, Liana; Davies, Daryl L.] Univ So Calif, Sch Pharm, Alcohol & Brain Res Labs, Titus Family Dept Clin Pharm & Pharmaceut Econ &, Los Angeles, CA 90089 USA; [Trudell, James R.] Stanford Sch Med, Dept Anesthesia, Palo Alto, CA 94305 USA; [Trudell, James R.] Stanford Sch Med, Beckman Program Mol & Genet Med, Palo Alto, CA 94305 USA; [Crawford, Daniel K.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; Stanford University; Stanford University; University of California System; University of California Los Angeles	Alkana, RL (corresponding author), Univ So Calif, Sch Pharm, Alcohol & Brain Res Labs, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave,PSC 506, Los Angeles, CA 90089 USA.	alkana@usc.edu	Davies, Daryl L/P-1137-2016	Davies, Daryl L/0000-0003-2940-7739; Crawford, Daniel/0000-0002-0169-8645	National Institutes of Health (NIH), NIAAA [AA017569, AA03972, AA013890, AA013922, AA017293, AA013378]; NIH, NIGMS [G64371]; USC School of Pharmacy; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013922, F31AA017569, R01AA013378, R01AA003972, R21AA013890] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USC School of Pharmacy; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIAAA, Grants AA017569 (to D. I. P), AA03972 (to R. L. A.), AA013890 and AA013922 (to D. L. D.), AA017293 (to L. A.), and AA013378 (to J. R. T.) and NIH, NIGMS, Grant G64371 (to J. R. T.). This work was also supported by the USC School of Pharmacy. This work was conducted as partial fulfillment of the requirements for the Ph. D. degree in Molecular Pharmacology and Toxicology, University of Southern California (D. I. P.).	Asatryan L, 2008, NEUROPHARMACOLOGY, V55, P835, DOI 10.1016/j.neuropharm.2008.06.044; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Borghese CM, 2007, ALCOHOL, V41, P155, DOI 10.1016/j.alcohol.2007.03.006; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cardoso RA, 1999, J PHARMACOL EXP THER, V289, P774; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Chen ZW, 2005, MOL PHARMACOL, V68, P152, DOI 10.1124/mol.104.009878; Cheng MH, 2008, PROTEINS, V71, P972, DOI 10.1002/prot.21784; Crawford DK, 2008, J BIOL CHEM, V283, P27698, DOI 10.1074/jbc.M802384200; Crawford DK, 2007, J NEUROCHEM, V102, P2097, DOI 10.1111/j.1471-4159.2007.04680.x; Davies DL, 2005, NEUROPHARMACOLOGY, V49, P243, DOI 10.1016/j.neuropharm.2005.03.015; Davies DL, 2004, J NEUROCHEM, V89, P1175, DOI 10.1111/j.1471-4159.2004.02390.x; Davies DL, 2003, ALCOHOL CLIN EXP RES, V27, P743, DOI 10.1097/01.ALC.0000065722.31109.A1; Davies DL, 2002, ALCOHOL CLIN EXP RES, V26, P773, DOI 10.1111/j.1530-0277.2002.tb02604.x; Davies DL, 2001, ALCOHOL CLIN EXP RES, V25, P1098; DEITRICH RA, 1989, PHARMACOL REV, V41, P489; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; GRANT KA, 1995, DRUG ALCOHOL DEPEN, V38, P155, DOI 10.1016/0376-8716(95)01120-N; Hanchar HJ, 2006, P NATL ACAD SCI USA, V103, P8546, DOI 10.1073/pnas.0509903103; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; Heilig M, 2006, PHARMACOL THERAPEUT, V111, P855, DOI 10.1016/j.pharmthera.2006.02.001; HONIG BH, 1984, P NATL ACAD SCI-BIOL, V81, P5412, DOI 10.1073/pnas.81.17.5412; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2004, NEUROSCI LETT, V371, P230, DOI 10.1016/j.neulet.2004.09.002; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Koski A, 2002, ALCOHOL CLIN EXP RES, V26, P956, DOI 10.1097/01.ALC.0000021337.78063.67; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Krasowski MD, 2000, BRIT J PHARMACOL, V129, P731, DOI 10.1038/sj.bjp.0703087; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Liang J, 2006, J NEUROSCI, V26, P1749, DOI 10.1523/JNEUROSCI.4702-05.2006; Lobo IA, 2008, J NEUROCHEM, V104, P1649, DOI 10.1111/j.1471-4159.2007.05090.x; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; Mascia MP, 1996, MOL PHARMACOL, V50, P402; McGinnis JM, 1999, P ASSOC AM PHYSICIAN, V111, P109, DOI 10.1046/j.1525-1381.1999.09256.x; Mihic SJ, 1996, J PHARMACOL EXP THER, V277, P411; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Mody I, 2007, ALCOHOL, V41, P145, DOI 10.1016/j.alcohol.2007.03.009; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; O'Mara M, 2003, P NATL ACAD SCI USA, V100, P4310, DOI 10.1073/pnas.0630652100; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Olsen RW, 2007, ALCOHOL, V41, P201, DOI 10.1016/j.alcohol.2007.04.006; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Perkins DI, 2008, J NEUROCHEM, V106, P1337, DOI 10.1111/j.1471-4159.2008.05476.x; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Santhakumar V, 2007, ALCOHOL, V41, P211, DOI 10.1016/j.alcohol.2007.04.011; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Valenzuela CF, 1998, ALCOHOL CLIN EXP RES, V22, P1132, DOI 10.1097/00000374-199808000-00023; Volpicelli JR, 2001, J CLIN PSYCHIAT, V62, P4; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Weight FF, 1999, NEUROCHEM INT, V35, P143, DOI 10.1016/S0197-0186(99)00056-X; Weiner JL, 1997, J NEUROPHYSIOL, V77, P1306, DOI 10.1152/jn.1997.77.3.1306; WHITE G, 1990, BRAIN RES, V507, P332, DOI 10.1016/0006-8993(90)90292-J; Woodward JJ, 2004, MOL BRAIN RES, V125, P86, DOI 10.1016/j.molbrainres.2004.03.005; Ye JH, 2002, NEUROPHARMACOLOGY, V43, P788, DOI 10.1016/S0028-3908(02)00179-X; Ye Q, 1998, J BIOL CHEM, V273, P3314, DOI 10.1074/jbc.273.6.3314; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Zhou Q, 1996, J PHARMACOL EXP THER, V278, P732	73	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27304	27314		10.1074/jbc.M109.023598	http://dx.doi.org/10.1074/jbc.M109.023598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656948	Green Published, hybrid			2022-12-25	WOS:000270232300031
J	Sporn, JC; Kustatscher, G; Hothorn, T; Collado, M; Serrano, M; Muley, T; Schnabel, P; Ladurner, AG				Sporn, J. C.; Kustatscher, G.; Hothorn, T.; Collado, M.; Serrano, M.; Muley, T.; Schnabel, P.; Ladurner, A. G.			Histone macroH2A isoforms predict the risk of lung cancer recurrence	ONCOGENE			English	Article						Epigenetics; chromatin; metabolism; PARP; proliferation; cancer	ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; MARKERS; P53	Lung cancer is the leading cause of cancer deaths. Despite optimal diagnosis and early treatment, many patients die of recurrent disease. There are no sufficiently useful biomarkers to predict the risk of tumor recurrence. Here, we show that expression of histone macroH2A1.1 and macroH2A2 predicts lung cancer recurrence, identifying these histone variants as a novel tool for an improved risk stratification of cancer patients. Moreover, macroH2A isoforms are highly expressed in cells undergoing senescence, a known antitumor mechanism, suggesting macroH2A1.1 may be a useful biomarker for senescent cells in tumors. Oncogene (2009) 28, 3423-3428; doi: 10.1038/onc.2009.26; published online 3 August 2009	[Sporn, J. C.; Kustatscher, G.; Ladurner, A. G.] EMBL, Gene Express Unit, D-69117 Heidelberg, Germany; [Hothorn, T.] Univ Munich, Inst Stat, Munich, Germany; [Collado, M.; Serrano, M.] Spanish Natl Canc Ctr, Madrid, Spain; [Muley, T.] Univ Heidelberg, Thoraxklin, Heidelberg, Germany; [Schnabel, P.] Univ Heidelberg, Dept Pathol, D-6900 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); University of Munich; Centro Nacional de Investigaciones Oncologicas (CNIO); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Ladurner, AG (corresponding author), EMBL, Gene Express Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	ladurner@embl.de	Serrano, Manuel/H-2634-2015; Hothorn, Torsten/A-3639-2010; Collado, Manuel/K-8140-2014	Serrano, Manuel/0000-0001-7177-9312; Hothorn, Torsten/0000-0001-8301-0471; Collado, Manuel/0000-0002-0330-0880; Kustatscher, Georg/0000-0001-8955-0866; Ladurner, Andreas/0000-0003-3835-232X	EMBL; NoE The Epigenome and the Marie Curie RTN Chromatin Plasticity	EMBL; NoE The Epigenome and the Marie Curie RTN Chromatin Plasticity	We thank Dr Esther Herpel for lung cancer tissue microarrays. AGL is supported by the EMBL, the NoE The Epigenome and the Marie Curie RTN Chromatin Plasticity.	Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; D'Amico TA, 2008, ANN THORAC SURG, V85, pS737, DOI 10.1016/j.athoracsur.2007.11.047; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhu CQ, 2006, J CLIN PATHOL, V59, P790, DOI 10.1136/jcp.2005.031351	18	133	139	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2009	28	38					3423	3428		10.1038/onc.2009.26	http://dx.doi.org/10.1038/onc.2009.26			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	497ZD	19648962				2022-12-25	WOS:000270103300009
J	Leschner, S; Westphal, K; Dietrich, N; Viegas, N; Jablonska, J; Lyszkiewicz, M; Lienenklaus, S; Falk, W; Gekara, N; Loessner, H; Weiss, S				Leschner, Sara; Westphal, Kathrin; Dietrich, Nicole; Viegas, Nuno; Jablonska, Jadwiga; Lyszkiewicz, Marcin; Lienenklaus, Stefan; Falk, Werner; Gekara, Nelson; Loessner, Holger; Weiss, Siegfried			Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-alpha	PLOS ONE			English	Article								Background: Several facultative anaerobic bacteria with potential therapeutic abilities are known to preferentially colonize solid tumors after systemic administration. How they efficiently find and invade the tumors is still unclear. However, this is an important issue to be clarified when bacteria should be tailored for application in cancer therapy. Methodology/Principal Findings: We describe the initial events of colonization of an ectopic transplantable tumor by Salmonella enterica serovar Typhimurium. Initially, after intravenous administration, bacteria were found in blood, spleen, and liver. Low numbers were also detected in tumors associated with blood vessels as could be observed by immunohistochemistry. A rapid increase of TNF-alpha in blood was observed at that time, in addition to other pro-inflammatory cytokines. This induced a tremendous influx of blood into the tumors by vascular disruption that could be visualized in H&E stainings and quantified by hemoglobin measurements of tumor homogenate. Most likely, together with the blood, bacteria were flushed into the tumor. In addition, blood influx was followed by necrosis formation, bacterial growth, and infiltration of neutrophilic granulocytes. Depletion of TNF-alpha retarded blood influx and delayed bacterial tumor-colonization. Conclusion: Our findings emphasize similarities between Gram-negative tumor-colonizing bacteria and tumor vascular disrupting agents and show the involvement of TNF-alpha in the initial phase of tumor-colonization by bacteria.			Leschner, S (corresponding author), HZI Helmholtz Ctr Infect Res, Braunschweig, Germany.	sara.leschner@helmholtz-hzi.de	Jablonska, Jadwiga/S-8278-2019; Gekara, Nelson/AAG-7944-2020; Gekara, Nelson/P-9208-2019; Lienenklaus, Stefan/HIK-0899-2022	Jablonska, Jadwiga/0000-0003-1490-2542; Gekara, Nelson O./0000-0002-1269-8288; Lienenklaus, Stefan/0000-0003-4790-3445				Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Avogadri F, 2005, CANCER RES, V65, P3920, DOI 10.1158/0008-5472.CAN-04-3002; Bereta M, 2007, VACCINE, V25, P4183, DOI 10.1016/j.vaccine.2007.03.008; Bettegowda C, 2003, P NATL ACAD SCI USA, V100, P15083, DOI 10.1073/pnas.2036598100; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; ECHTENACHER B, 1990, J IMMUNOL, V145, P3762; ENGELHARDT R, 1991, CANCER RES, V51, P2524; Forbes NS, 2003, CANCER RES, V63, P5188; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; Heimann DM, 2003, J IMMUNOTHER, V26, P179, DOI 10.1097/00002371-200303000-00011; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jia LJ, 2007, INT J CANCER, V121, P666, DOI 10.1002/ijc.22688; Jia LJ, 2005, CANCER BIOL THER, V4, P840, DOI 10.4161/cbt.4.8.1891; Kasinskas RW, 2006, BIOTECHNOL BIOENG, V94, P710, DOI 10.1002/bit.20883; KIMURA NT, 1980, CANCER RES, V40, P2061; King I, 2002, HUM GENE THER, V13, P1225, DOI 10.1089/104303402320139005; Lee CH, 2005, MOL THER, V11, P707, DOI 10.1016/j.ymthe.2005.01.008; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; LESS JR, 1991, CANCER RES, V51, P265; Mengesha A, 2007, FRONT BIOSCI-LANDMRK, V12, P3880, DOI 10.2741/2357; Otto F, 1996, EUR J CANCER, V32A, P1712, DOI 10.1016/0959-8049(96)00186-4; Pawelek JM, 1997, CANCER RES, V57, P4537; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; Platt J, 2000, EUR J CANCER, V36, P2397, DOI 10.1016/S0959-8049(00)00336-1; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; Tozer GM, 1999, CANCER RES, V59, P1626; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Tozer GM, 2005, ADV DRUG DELIVER REV, V57, P135, DOI 10.1016/j.addr.2004.07.015; Van Mellaert L, 2006, TRENDS MICROBIOL, V14, P190, DOI 10.1016/j.tim.2006.02.002; VOSIKA GJ, 1984, CANCER IMMUNOL IMMUN, V18, P107; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716	40	146	153	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6692	10.1371/journal.pone.0006692	http://dx.doi.org/10.1371/journal.pone.0006692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693266	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267400004
J	Kring, SII; Werge, T; Holst, C; Toubro, S; Astrup, A; Hansen, T; Pedersen, O; Sorensen, TIA				Kring, Sofia I. I.; Werge, Thomas; Holst, Claus; Toubro, Soren; Astrup, Arne; Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.			Polymorphisms of Serotonin Receptor 2A and 2C Genes and COMT in Relation to Obesity and Type 2 Diabetes	PLOS ONE			English	Article							ASSOCIATION; WEIGHT; ENVIRONMENT; DOPAMINE; INSULIN; DISEASE	Background: Candidate genes of psychological importance include 5HT2A, 5HT2C, and COMT, implicated in the serotonin, noradrenaline and dopamine pathways, which also may be involved in regulation of energy balance. We investigated the associations of single nucleotide polymorphisms (SNPs) of these genes with obesity and metabolic traits. Methodology/Principal Findings: In a population of 166 200 young men examined at the draft boards, obese men (n = 726, BMI >= 31.0 kg/m(2)) and a randomly selected group (n = 831) were re-examined at two surveys at mean ages 46 and 49 years (S-46, S-49). Anthropometric, physiological and biochemical measures were available. Logistic regression analyses were used to assess age-adjusted odds ratios. No significant associations were observed of 5HT2A rs6311, 5HT2C rs3813929 and COMT rs4680 with obesity, except that COMT rs4680 GG-genotype was associated with fat-BMI (OR = 1.08, CI = 1.01-1.16). The SNPs were associated with a number of physiological variables; most importantly 5HT2C rs3813929 T-allele was associated with glucose (OR = 4.56, CI = 1.13-18.4) and acute insulin response (OR = 0.65, CI = 0.44-0.94) in S-49. COMT rs4680 GG-genotype was associated with glucose (OR = 1.04, CI = 1.00-1.09). Except for an association between 5HT2A rs6311 and total-cholesterol at both surveys, significant in S-46 (OR = 2.66, CI = 1.11-6.40), no significant associations were observed for the other phenotypes. Significant associations were obtained when combined genotype of 5HT2C rs3813929 and COMT rs4680 were examined in relation to BMI (OR = 1.12, CI = 1.03-1.21), fat-BMI (OR = 1.22, CI = 1.08-1.38), waist (OR = 1.13, CI = 1.04-1.22), and cholesterol (OR = 5.60, CI = 0.99-31.4). Analyses of impaired glucose tolerance (IGT) and type 2 diabetes (T2D) revealed, a 12.3% increased frequency of 5HT2C rs3813929 T-allele and an 11.6% increased frequency of COMT rs4680 GG-genotype in individuals with IGT or T2D (chi(2), p = 0.05 and p = 0.06, respectively). Examination of the combined genotypes of 5HT2C and COMT showed a 34.0% increased frequency of IGT or T2D (chi(2), p = 0.01). Conclusions: The findings lend further support to the involvement of serotonin, noradrenaline and dopamine pathways on obesity and glucose homeostasis, in particular when combined genotype associations are explored.			Kring, SII (corresponding author), Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark.	SI@ipm.regionh.dk	Palmer, David/E-6824-2010; Werge, Thomas/G-7263-2012; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Astrup, Arne/B-1407-2015	Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Astrup, Arne/0000-0001-8968-8996				ANNERBRINK K, 2008, METABOLISM 2008, P708; Arranz MJ, 2007, MOL PSYCHIATR, V12, P707, DOI 10.1038/sj.mp.4002009; Astrup A, 2008, OBESITY, V16, P1363, DOI 10.1038/oby.2008.56; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; BUEMANN B, 2005, INT J OBESITY, P624; CLEMENT K, 2007, OBESITY GENOMICS POS; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Halford JCG, 2005, CURR DRUG TARGETS, V6, P201, DOI 10.2174/1389450053174550; Halford JCG, 2004, CURR DRUG TARGETS, V5, P221, DOI 10.2174/1389450043490541; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Huang XF, 2004, MOL BRAIN RES, V127, P39, DOI 10.1016/j.molbrainres.2004.05.008; IORDANIDOU M, 2008, PHARMACOGENET GENOM, P153; KAHN SE, 2006, DIABETOLOGIA, P3; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Malhotra AK, 2007, INT REV PSYCHIATR, V19, P523, DOI 10.1080/09540260701563460; MANNISTO PT, 1999, PHARMACOL REV, P593; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Messa C, 2003, PSYCHOPHARMACOLOGY, V167, P72, DOI 10.1007/s00213-002-1379-5; Meyer JH, 2003, AM J PSYCHIAT, V160, P90, DOI 10.1176/appi.ajp.160.1.90; Need AC, 2006, ANN HUM GENET, V70, P293, DOI 10.1111/j.1469-1809.2005.00228.x; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; PARKINSON WL, 1990, AM J PHYSIOL-REG I, pR829; Pinborg LH, 2008, NEUROIMAGE, V40, P1175, DOI 10.1016/j.neuroimage.2007.09.019; Pooley EC, 2004, AM J MED GENET B, V126B, P124, DOI 10.1002/ajmg.b.20143; PRENTICE R, 1976, BIOMETRICS, V32, P599, DOI 10.2307/2529748; Reynolds GP, 2005, PROG NEURO-PSYCHOPH, V29, P1021, DOI 10.1016/j.pnpbp.2005.03.019; Reynolds GP, 2002, LANCET, V359, P2086, DOI 10.1016/S0140-6736(02)08913-4; Rosmond R, 2004, MED HYPOTHESES, V62, P976, DOI 10.1016/j.mehy.2003.12.030; Rosmond R, 2002, OBES RES, V10, P585, DOI 10.1038/oby.2002.79; ROSMOND R, 2002, ANN NY ACAD SCI, P571; SCHNOHR P, 2001, J EUROPEAN SOC CA SH, V3; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; SONNEHOLM S, 1989, BRIT MED J, V299, P767, DOI 10.1136/bmj.299.6702.767; Tan QH, 2005, GENET RES, V86, P223, DOI 10.1017/S0016672305007792; Tan QH, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-70; Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004; Waldman ID, 1999, ANN HUM GENET, V63, P329, DOI 10.1046/j.1469-1809.1999.6340329.x; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wang SS, 2007, HUM GENET, V122, P41, DOI 10.1007/s00439-007-0374-7; *WHO, 2003, PHYS STAT US INT ANT; Yuan X, 2000, DIABETOLOGIA, V43, P373, DOI 10.1007/s001250050056; Zimmermann U, 2003, J PSYCHIATR RES, V37, P193, DOI 10.1016/S0022-3956(03)00018-9; Zou GY, 2006, ANN HUM GENET, V70, P262, DOI 10.1111/j.1529-8817.2005.00213.x	50	56	59	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6696	10.1371/journal.pone.0006696	http://dx.doi.org/10.1371/journal.pone.0006696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690620	gold, Green Submitted, Green Published			2022-12-25	WOS:000269267300012
J	Hamann, S; Schorderet, DF; Cottet, S				Hamann, Severine; Schorderet, Daniel F.; Cottet, Sandra			Bax-Induced Apoptosis in Leber's Congenital Amaurosis: A Dual Role in Rod and Cone Degeneration	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; SEVERE RETINAL DYSTROPHY; RPE65(-/-) MOUSE MODEL; NIGHT BLINDNESS; VISUAL CYCLE; CELL-DEATH; BINDING-PROTEIN; DEFICIENT MICE; GATED CHANNEL; ALPHA-SUBUNIT	Pathogenesis in the Rpe65(-/-) mouse model of Leber's congenital amaurosis (LCA) is characterized by a slow and progressive degeneration of the rod photoreceptors. On the opposite, cones degenerate rapidly at early ages. Retinal degeneration in Rpe65(-/-) mice, showing a null mutation in the gene encoding the retinal pigment epithelium 65-kDa protein (Rpe65), was previously reported to depend on continuous activation of a residual transduction cascade by unliganded opsin. However, the mechanisms of apoptotic signals triggered by abnormal phototransduction remain elusive. We previously reported that activation of a Bcl-2-dependent pathway was associated with apoptosis of rod photoreceptors in Rpe65(-/-) mice during the course of the disease. In this study we first assessed whether activation of Bcl-2-mediated apoptotic pathway was dependent on constitutive activation of the visual cascade through opsin apoprotein. We then challenged the direct role of pro-apoptotic Bax protein in triggering apoptosis of rod and cone photoreceptors. Quantitative PCR analysis showed that increased expression of pro-apoptotic Bax and decreased level of anti-apoptotic Bcl-2 were restored in Rpe65(-/-)/Gnat1(-/-) mice lacking the Gnat1 gene encoding rod transducin. Moreover, photoreceptor apoptosis was prevented as assessed by TUNEL assay. These data indicate that abnormal activity of opsin apoprotein induces retinal cell apoptosis through the Bcl-2-mediated pathway. Following immunohistological and real-time PCR analyses, we further observed that decreased expression of rod genes in Rpe65-deficient mice was rescued in Rpe65(-/-)/ Bax(-/-) mice. Histological and TUNEL studies confirmed that rod cell demise and apoptosis in diseased Rpe65(-/-) mice were dependent on Bax-induced pathway. Surprisingly, early loss of cones was not prevented in Rpe65(-/-)/Bax(-/-) mice, indicating that proapoptotic Bax was not involved in the pathogenesis of cone cell death in Rpe65-deficient mice. This is the first report, to our knowledge, that a single genetic mutation can trigger two independent apoptotic pathways in rod and cone photoreceptors in Rpe65-dependent LCA disease. These results highlight the necessity to investigate and understand the specific death signaling pathways committed in rods and cones to develop effective therapeutic approaches to treat RP diseases.	[Hamann, Severine; Schorderet, Daniel F.; Cottet, Sandra] Inst Res Ophthalmol, IRO, Sion, Switzerland; [Schorderet, Daniel F.; Cottet, Sandra] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Hamann, Severine; Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hamann, S (corresponding author), Inst Res Ophthalmol, IRO, Sion, Switzerland.	sandra.cottet@irovision.ch		Schorderet, Daniel/0000-0002-1331-504X	The Swiss National Science Foundation (SNSF) [3100A0-118336]	The Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This research was supported by The Swiss National Science Foundation (SNSF) Grant 3100A0-118336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Cottet S, 2008, APOPTOSIS, V13, P329, DOI 10.1007/s10495-008-0180-2; Cottet S, 2006, FASEB J, V20, P2036, DOI 10.1096/fj.06-6211com; Cottet S, 2009, CURR MOL MED, V9, P375, DOI 10.2174/156652409787847155; DOWLING JE, 1960, P NATL ACAD SCI USA, V46, P587, DOI 10.1073/pnas.46.5.587; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; El Matri L, 2006, GRAEF ARCH CLIN EXP, V244, P1104, DOI 10.1007/s00417-005-0096-2; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Galvin JA, 2005, OPHTHALMOLOGY, V112, P349, DOI 10.1016/j.ophtha.2004.08.023; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P11824, DOI 10.1021/bi035227w; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hahn P, 2004, CELL DEATH DIFFER, V11, P1192, DOI 10.1038/sj.cdd.4401486; Hahn P, 2003, INVEST OPHTH VIS SCI, V44, P3598, DOI 10.1167/iovs.02-1113; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jacobson SG, 2008, INVEST OPHTH VIS SCI, V49, P4573, DOI 10.1167/iovs.08-2121; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; Kaneda K, 1999, BRAIN RES, V815, P11, DOI 10.1016/S0006-8993(98)01074-9; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Lai Chooi-May, 2004, Genet Vaccines Ther, V2, P3, DOI 10.1186/1479-0556-2-3; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Ogilvie JM, 1998, INVEST OPHTH VIS SCI, V39, P1713; Pequignot MO, 2003, DEV DYNAM, V228, P231, DOI 10.1002/dvdy.10376; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Saliba RS, 2002, J CELL SCI, V115, P2907; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Sieving PA, 2001, J NEUROSCI, V21, P5449, DOI 10.1523/JNEUROSCI.21-15-05449.2001; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Yang L, 2004, INVEST OPHTH VIS SCI, V45, P648, DOI 10.1167/iovs.03-0827; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhang Y, 2005, INVEST OPHTH VIS SCI, V46, P2133, DOI 10.1167/iovs.04-1235; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	54	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6616	10.1371/journal.pone.0006616	http://dx.doi.org/10.1371/journal.pone.0006616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672311	Green Submitted, Green Published, gold			2022-12-25	WOS:000268935900025
J	Yau, TO; Leung, THY; Lam, S; Cheung, OF; Tung, EKK; Khong, PL; Lam, A; Chung, S; Ng, IOL				Yau, Tai On; Leung, Thomas Ho Yin; Lam, Sandra; Cheung, Oi Fung; Tung, Edmund Kwok Kwan; Khong, Pek Lan; Lam, Amy; Chung, Sookja; Ng, Irene Oi Lin			Deleted in Liver Cancer 2 (DLC2) Was Dispensable for Development and Its Deficiency Did Not Aggravate Hepatocarcinogenesis	PLOS ONE			English	Article								DLC2 (deleted in liver cancer 2), a Rho GTPase-activating protein, was previously shown to be underexpressed in human hepatocellular carcinoma and has tumor suppressor functions in cell culture models. We generated DLC2-deficient mice to investigate the tumor suppressor role of DLC2 in hepatocarcinogenesis and the function of DLC2 in vivo. In this study, we found that, unlike homologous DLC1, which is essential for embryonic development, DLC2 was dispensable for embryonic development and DLC2-deficient mice could survive to adulthood. We also did not observe a higher incidence of liver tumor formation or diethylnitrosamine (DEN)-induced hepatocarcinogenesis in DLC2-deficient mice. However, we observed that DLC2-deficient mice were smaller and had less adipose tissue than the wild type mice. These phenotypes were not due to reduction of cell size or defect in adipogenesis, as observed in the 190B RhoGAP-deficient mouse model. Together, these results suggest that deficiency in DLC2 alone does not enhance hepatocarcinogenesis.			Yau, TO (corresponding author), Univ Hong Kong, Liver Canc & Hepatitis Res Lab, Hong Kong, Hong Kong, Peoples R China.	iolng@hkucc.hku.hk		Ng, Irene Oi-lin/0000-0001-7532-2029				Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Kawai K, 2007, BIOCHEM BIOPH RES CO, V364, P783, DOI 10.1016/j.bbrc.2007.10.052; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; Klocke R, 2001, FASEB J, V15, P1404, DOI 10.1096/fj.00-0487fje; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Li HY, 2007, PROTEINS, V67, P1154, DOI 10.1002/prot.21361; Li XR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-205; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; Manley NR, 1997, DEV BIOL, V192, P274, DOI 10.1006/dbio.1997.8765; Ng DCH, 2006, FEBS LETT, V580, P191, DOI 10.1016/j.febslet.2005.11.073; Ng IOL, 2000, CANCER RES, V60, P6581; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Roux P, 1997, CURR BIOL, V7, P629, DOI 10.1016/S0960-9822(06)00289-2; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Santoni-Rugiu E, 1999, AM J PATHOL, V154, P1693, DOI 10.1016/S0002-9440(10)65425-9; Schultz J, 1997, PROTEIN SCI, V6, P249; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Wei L, 2001, DEVELOPMENT, V128, P2953; Wong CCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002779; Wong CM, 2003, CANCER RES, V63, P7646; Yuan BZ, 1998, CANCER RES, V58, P2196; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao ZY, 2003, DEV DYNAM, V226, P24, DOI 10.1002/dvdy.10212	33	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6566	10.1371/journal.pone.0006566	http://dx.doi.org/10.1371/journal.pone.0006566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668331	Green Submitted, gold, Green Published			2022-12-25	WOS:000268773300008
J	Chen, HF				Chen, Hai-Feng			Molecular Dynamics Simulation of Phosphorylated KID Post-Translational Modification	PLOS ONE			English	Article								Background: Kinase-inducible domain (KID) as transcriptional activator can stimulate target gene expression in signal transduction by associating with KID interacting domain (KIX). NMR spectra suggest that apo-KID is an unstructured protein. After post-translational modification by phosphorylation, KID undergoes a transition from disordered to well folded protein upon binding to KIX. However, the mechanism of folding coupled to binding is poorly understood. Methodology: To get an insight into the mechanism, we have performed ten trajectories of explicit-solvent molecular dynamics (MD) for both bound and apo phosphorylated KID (pKID). Ten MD simulations are sufficient to capture the average properties in the protein folding and unfolding. Conclusions: Room-temperature MD simulations suggest that pKID becomes more rigid and stable upon the KIX-binding. Kinetic analysis of high-temperature MD simulations shows that bound pKID and apo-pKID unfold via a three-state and a two-state process, respectively. Both kinetics and free energy landscape analyses indicate that bound pKID folds in the order of KIX access, initiation of pKID tertiary folding, folding of helix alpha(B), folding of helix alpha(A), completion of pKID tertiary folding, and finalization of pKID-KIX binding. Our data show that the folding pathways of apo-pKID are different from the bound state: the foldings of helices alpha(A) and alpha(B) are swapped. Here we also show that Asn139, Asp140 and Leu141 with large Phi-values are key residues in the folding of bound pKID. Our results are in good agreement with NMR experimental observations and provide significant insight into the general mechanisms of binding induced protein folding and other conformational adjustment in post-translational modification.			Chen, HF (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	haifengchen@sjtu.edu.cn	Chen, Haifeng/AAT-7444-2020					Akanuma S, 2005, PROTEINS, V58, P538, DOI 10.1002/prot.20349; Baker D, 1998, NAT STRUCT BIOL, V5, P1021, DOI 10.1038/4130; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; CAFLISCH A, 1995, J MOL BIOL, V252, P672, DOI 10.1006/jmbi.1995.0528; CAFLISCH A, 1994, P NATL ACAD SCI USA, V91, P1746, DOI 10.1073/pnas.91.5.1746; Campbell KM, 2002, BIOCHEMISTRY-US, V41, P13956, DOI 10.1021/bi026222m; CASE DA, 2004, 8 AMBER U CAL; Chen HF, 2008, J CHEM THEORY COMPUT, V4, P1360, DOI 10.1021/ct800030s; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Chen HF, 2009, COMPUT BIOL CHEM, V33, P41, DOI 10.1016/j.compbiolchem.2008.07.023; Chong LT, 2005, J MOL BIOL, V345, P869, DOI 10.1016/j.jmb.2004.10.083; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Daggett V, 1996, J MOL BIOL, V257, P430, DOI 10.1006/jmbi.1996.0173; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2005, P NATL ACAD SCI USA, V102, P13445, DOI 10.1073/pnas.0501773102; Day R, 2005, PROTEIN SCI, V14, P1242, DOI 10.1110/ps.041226005; Day R, 2007, J MOL BIOL, V366, P677, DOI 10.1016/j.jmb.2006.11.043; Esposito L, 2005, BIOCHEMISTRY-US, V44, P3358, DOI 10.1021/bi0488350; Fernandez-Escamilla AM, 2004, P NATL ACAD SCI USA, V101, P2834, DOI 10.1073/pnas.0304180101; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Geiger TR, 2008, MOL CELL BIOL, V28, P1383, DOI 10.1128/MCB.01657-07; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gsponer J, 2002, P NATL ACAD SCI USA, V99, P6719, DOI 10.1073/pnas.092686399; Gsponer J, 2001, J MOL BIOL, V309, P285, DOI 10.1006/jmbi.2001.4552; Henkels CH, 2001, BIOCHEMISTRY-US, V40, P2777, DOI 10.1021/bi002078y; Henkels CH, 2006, J AM CHEM SOC, V128, P7772, DOI 10.1021/ja057279+; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kumar S, 2000, PROTEIN SCI, V9, P10; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Ladurner AG, 1998, P NATL ACAD SCI USA, V95, P8473, DOI 10.1073/pnas.95.15.8473; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; McCully ME, 2008, BIOCHEMISTRY-US, V47, P7079, DOI 10.1021/bi800118b; Oard S, 2006, BIOPHYS CHEM, V121, P30, DOI 10.1016/j.bpc.2005.12.004; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Parker D, 1996, MOL CELL BIOL, V16, P694; PETSKO GA, 2003, PROTEIN STRUCTURE FU, pCH2; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Sato S, 2007, J MOL BIOL, V372, P254, DOI 10.1016/j.jmb.2007.06.043; Scott KA, 2006, J MOL BIOL, V359, P159, DOI 10.1016/j.jmb.2006.03.011; Solt I, 2006, PROTEINS, V64, P749, DOI 10.1002/prot.21032; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Tsai J, 1999, J MOL BIOL, V291, P215, DOI 10.1006/jmbi.1999.2949; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	61	46	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6516	10.1371/journal.pone.0006516	http://dx.doi.org/10.1371/journal.pone.0006516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654879	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739100011
J	Garofalo, M; Nieus, T; Massobrio, P; Martinoia, S				Garofalo, Matteo; Nieus, Thierry; Massobrio, Paolo; Martinoia, Sergio			Evaluation of the Performance of Information Theory-Based Methods and Cross-Correlation to Estimate the Functional Connectivity in Cortical Networks	PLOS ONE			English	Article							NEURONS; SYNCHRONIZATION; DYNAMICS; PATTERNS; MODEL	Functional connectivity of in vitro neuronal networks was estimated by applying different statistical algorithms on data collected by Micro-Electrode Arrays (MEAs). First we tested these "connectivity methods'' on neuronal network models at an increasing level of complexity and evaluated the performance in terms of ROC (Receiver Operating Characteristic) and PPC (Positive Precision Curve), a new defined complementary method specifically developed for functional links identification. Then, the algorithms better estimated the actual connectivity of the network models, were used to extract functional connectivity from cultured cortical networks coupled to MEAs. Among the proposed approaches, Transfer Entropy and Joint-Entropy showed the best results suggesting those methods as good candidates to extract functional links in actual neuronal networks from multi-site recordings.			Garofalo, M (corresponding author), Italian Inst Technol, Neurosci & Brain Technol Dept, Genoa, Italy.	sergio.martinoia@unige.it	Martinoia, Sergio/H-1863-2011; Massobrio, Paolo/AAB-9161-2019	Martinoia, Sergio/0000-0002-0058-9519; Massobrio, Paolo/0000-0001-8335-3407; Nieus, Thierry/0000-0001-8708-1015				Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; BORST A, 1999, INFORM THEORY NEURAL; BRADLEY AP, 1997, PATTERN RECOGN, V30, P15; Braitenberg V, 1991, ANATOMY CORTEX STAT; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BUCHMANN J, 1987, BIOL CYBERN, V56, P313; Cadotte AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003355; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Dayan P., 2001, THEORETICAL NEUROSCI; Dockendorf KP, 2009, BIOSYSTEMS, V95, P90, DOI 10.1016/j.biosystems.2008.08.001; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friston K. J., 1993, Human Brain Mapping, V1, P69, DOI 10.1002/hbm.460010108; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hahnloser RHR, 2007, BIOL CYBERN, V96, P497, DOI [10.1007/s00422-007-0143-7, 10.1007/S00422-007-0143-7]; HULATA E, 2004, PHYS REV LETT, V92; Imfeld K, 2008, IEEE T BIO-MED ENG, V55, P2064, DOI 10.1109/TBME.2008.919139; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jimbo Y, 1998, IEEE T BIO-MED ENG, V45, P1297, DOI 10.1109/10.725326; KNOX CK, 1981, TRENDS NEUROSCI, V4, P222, DOI 10.1016/0166-2236(81)90070-9; LI W, 1990, STAT PHYS, V60, P15; LUNGARELLA M, 2006, METHODS QUANTIFYING; Lungarella M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056117; Maccione A, 2009, J NEUROSCI METH, V177, P241, DOI 10.1016/j.jneumeth.2008.09.026; Marom S, 2005, PROG BRAIN RES, V147, P189, DOI 10.1016/S0079-6123(04)47014-9; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Rolston JD, 2007, NEUROSCIENCE, V148, P294, DOI 10.1016/j.neuroscience.2007.05.025; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Sporns Olaf, 2001, Complexity, V7, P28, DOI 10.1002/cplx.10015; Tam DC, 1998, BIOL CYBERN, V78, P95, DOI 10.1007/s004220050417; Teramae JN, 2007, J COMPUT NEUROSCI, V22, P301, DOI 10.1007/s10827-006-0014-6; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; vanVreeswijk C, 1996, PHYS REV E, V54, P5522, DOI 10.1103/PhysRevE.54.5522; VANVREESWIJK C, 1994, J COMPUT NEUROSCI, V1, P303; Xu JH, 1997, PHYSICA D, V106, P363, DOI 10.1016/S0167-2789(97)00042-0; Yamada S, 1996, J NEUROSCI METH, V66, P35, DOI 10.1016/0165-0270(95)00152-2	46	120	121	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6482	10.1371/journal.pone.0006482	http://dx.doi.org/10.1371/journal.pone.0006482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652720	Green Submitted, Green Published, gold			2022-12-25	WOS:000268637800004
J	Othumpangat, S; Gibson, LF; Samsell, L; Piedimonte, G				Othumpangat, Sreekumar; Gibson, Laura F.; Samsell, Lennie; Piedimonte, Giovanni			NGF Is an Essential Survival Factor for Bronchial Epithelial Cells during Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; MAST-CELLS; BRONCHIOLITIS; APOPTOSIS; INFLAMMATION; MECHANISMS; EXPRESSION; RECEPTORS; INFANTS; RISK	Background: Overall expression of neurotrophins in the respiratory tract is upregulated in infants infected by the respiratory syncytial virus (RSV), but it is unclear where (structural vs. inflammatory cells, upper vs. lower airways) and why, these changes occur. We analyzed systematically the expression of neurotrophic factors and receptors following RSV infection of human nasal, tracheal, and bronchial epithelial cells, and tested the hypothesis that neurotrophins work as innate survival factors for infected respiratory epithelia. Methodology: Expression of neurotrophic factors (nerve growth factor, NGF; brain-derived neurotrophic factor, BDNF) and receptors (trkA, trkB, p75) was analyzed at the protein level by immunofluorescence and flow cytometry and at the mRNA level by real-time PCR. Targeted siRNA was utilized to blunt NGF expression, and its effect on virus-induced apoptosis/necrosis was evaluated by flow cytometry following annexin V/7-AAD staining. Principal Findings: RSV infection was more efficient in cells from more distal (bronchial) vs. more proximal origin. In bronchial cells, RSV infection induced transcript and protein overexpression of NGF and its high-affinity receptor trkA, with concomitant downregulation of the low-affinity p75(NTR). In contrast, tracheal cells exhibited an increase in BDNF, trkA and trkB, and nasal cells increased only trkA. RSV-infected bronchial cells transfected with NGF-specific siRNA exhibited decreased trkA and increased p75(NTR) expression. Furthermore, the survival of bronchial epithelial cells was dramatically decreased when their endogenous NGF supply was depleted prior to RSV infection. Conclusions/Significance: RSV infection of the distal airway epithelium, but not of the more proximal sections, results in overexpression of NGF and its trkA receptor, while the other p75(NTR) receptor is markedly downregulated. This pattern of neurotrophin expression confers protection against virus-induced apoptosis, and its inhibition amplifies programmed cell death in the infected bronchial epithelium. Thus, pharmacologic modulation of NGF expression may offer a promising new approach for management of common respiratory infections.			Othumpangat, S (corresponding author), W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA.	gpiedimonte@hsc.wvu.edu		Gibson, Laura/0000-0002-7291-9046; Othumpangat, Sreekumar/0000-0002-6563-611X	NCI NIH HHS [R01 CA134573, R01CA134573] Funding Source: Medline; NCRR NIH HHS [P20RR016440, P20 RR016440] Funding Source: Medline; NHLBI NIH HHS [R01HL056888, R01 HL061007, R01 HL056888, R01HL61007] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA134573] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056888, R01HL061007] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; ANTONI BA, 1995, J VIROL, V69, P2384, DOI 10.1128/JVI.69.4.2384-2392.1995; Bredesen DE, 1998, CELL DEATH DIFFER, V5, P365, DOI 10.1038/sj.cdd.4400378; Coppola V, 2004, DEVELOPMENT, V131, P5185, DOI 10.1242/dev.01383; Falsey AR, 2008, J INFECT DIS, V198, P1317, DOI 10.1086/592168; Fiedler MA, 1996, AM J PHYSIOL-LUNG C, V271, pL963, DOI 10.1152/ajplung.1996.271.6.L963; Folkerts G, 1998, AM J RESP CRIT CARE, V157, P1708, DOI 10.1164/ajrccm.157.6.9707163; Freund-Michel V, 2008, PHARMACOL THERAPEUT, V117, P52, DOI 10.1016/j.pharmthera.2007.07.003; Garaci E, 1999, P NATL ACAD SCI USA, V96, P14013, DOI 10.1073/pnas.96.24.14013; GROSKREUTZ DJ, 2009, AM J RESP CELL MOL B; Haeberle HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003352; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Hashem M, 2003, J CLIN VIROL, V27, P14, DOI 10.1016/S1386-6532(03)00047-7; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; KAWAMOTO K, 1995, BLOOD, V86, P4638, DOI 10.1182/blood.V86.12.4638.bloodjournal86124638; la Sala A, 2000, J LEUKOCYTE BIOL, V68, P104; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Mellow TE, 2004, EXP LUNG RES, V30, P43, DOI 10.1080/01902140490252812; NOAH TL, 1993, AM J PHYSIOL, V265, pL472, DOI 10.1152/ajplung.1993.265.5.L472; Openshaw PJM, 2003, PEDIATR INFECT DIS J, V22, pS58, DOI 10.1097/00006454-200302001-00009; Ott L., 1977, INTRO STAT METHODS D; Panitch HB, 2001, CURR OPIN PEDIATR, V13, P256, DOI 10.1097/00008480-200106000-00008; PATEL JA, 1995, AM J RESP CELL MOL, V13, P602, DOI 10.1165/ajrcmb.13.5.7576697; Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010; Piedimonte G, 2002, PEDIATR INFECT DIS J, V21, P462, DOI 10.1097/00006454-200205000-00034; Piedimonte G, 2001, AM J RESP CRIT CARE, V163, pS18, DOI 10.1164/ajrccm.163.supplement_1.2011113; Psarras Stelios, 2004, Paediatr Respir Rev, V5 Suppl A, pS179, DOI 10.1016/S1526-0542(04)90034-6; Schauer U, 2002, EUR RESPIR J, V20, P1277, DOI 10.1183/09031936.02.00019902; Sikkel MB, 2008, PEDIATR INFECT DIS J, V27, pS63, DOI 10.1097/INF.0b013e3181684d67; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Soilu-Hanninen M, 1999, J NEUROSCI, V19, P4828; Steiner RWP, 2004, AM FAM PHYSICIAN, V69, P325; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zar J. H., 2009, BIOSTATISTICAL ANAL	43	50	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6444	10.1371/journal.pone.0006444	http://dx.doi.org/10.1371/journal.pone.0006444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649262	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637600001
J	Peerani, R; Onishi, K; Mahdavi, A; Kumacheva, E; Zandstra, PW				Peerani, Raheem; Onishi, Kento; Mahdavi, Alborz; Kumacheva, Eugenia; Zandstra, Peter W.			Manipulation of Signaling Thresholds in "Engineered Stem Cell Niches'' Identifies Design Criteria for Pluripotent Stem Cell Screens	PLOS ONE			English	Article								In vivo, stem cell fate is regulated by local microenvironmental parameters. Governing parameters in this stem cell niche include soluble factors, extra-cellular matrix, and cell-cell interactions. The complexity of this in vivo niche limits analyses into how individual niche parameters regulate stem cell fate. Herein we use mouse embryonic stem cells (mESC) and microcontact printing (mu CP) to investigate how niche size controls endogenous signaling thresholds. mu CP is used to restrict colony diameter, separation, and degree of clustering. We show, for the first time, spatial control over the activation of the Janus kinase/signal transducer and activator of transcription pathway (Jak-Stat). The functional consequences of this niche-size-dependent signaling control are confirmed by demonstrating that direct and indirect transcriptional targets of Stat3, including members of the Jak-Stat pathway and pluripotency-associated genes, are regulated by colony size. Modeling results and empirical observations demonstrate that colonies less than 100 mu m in diameter are too small to maximize endogenous Stat3 activation and that colonies separated by more than 400 mu m can be considered independent from each other. These results define parameter boundaries for the use of ESCs in screening studies, demonstrate the importance of context in stem cell responsiveness to exogenous cues, and suggest that niche size is an important parameter in stem cell fate control.			Peerani, R (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	Peter.zandstra@utoronto.ca	Kumacheva, Eugenia/U-7612-2019					Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Batsilas L, 2003, BIOPHYS J, V85, P3659, DOI 10.1016/S0006-3495(03)74783-3; Berezhkovskii AM, 2004, BIOPHYS CHEM, V107, P221, DOI 10.1016/j.bpc.2003.09.006; Blanchard F, 2000, J BIOL CHEM, V275, P28793, DOI 10.1074/jbc.M003986200; Carnegie JA, 1999, J REPROD FERTIL, V117, P41, DOI 10.1530/jrf.0.1170041; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085; Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015; Goodhill GJ, 1997, EUR J NEUROSCI, V9, P1414, DOI 10.1111/j.1460-9568.1997.tb01496.x; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Jinno S, 2008, J BIOMED MATER RES A, V86A, P278, DOI 10.1002/jbm.a.32030; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Ko SY, 2006, CELL STRUCT FUNCT, V31, P53, DOI 10.1247/csf.31.53; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Parekkadan B, 2008, NEUROSCI LETT, V438, P190, DOI 10.1016/j.neulet.2008.03.094; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365; Viswanathan S, 2002, STEM CELLS, V20, P119, DOI 10.1634/stemcells.20-2-119; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang Q, 2006, BLOOD, V108, P1058, DOI 10.1182/blood-2005-08-007377; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	48	60	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6438	10.1371/journal.pone.0006438	http://dx.doi.org/10.1371/journal.pone.0006438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649273	Green Submitted, gold, Green Published			2022-12-25	WOS:000268494600008
J	Welsh, M; Saunders, PTK; Atanassova, N; Sharpe, RM; Smith, LB				Welsh, Michelle; Saunders, Philippa T. K.; Atanassova, Nina; Sharpe, Richard M.; Smith, Lee B.			Androgen action via testicular peritubular myoid cells is essential for male fertility	FASEB JOURNAL			English	Article						spermatogenesis; stromal-epithelial interactions; testosterone; steroid receptors	FOLLICLE-STIMULATING-HORMONE; SEMINIFEROUS TUBULE FLUID; MALE-MICE LACKING; SERTOLI-CELL; POSTNATAL-DEVELOPMENT; SELECTIVE KNOCKOUT; GENE-EXPRESSION; GERM-CELLS; RECEPTOR; RAT	Androgens are essential for normal spermatogenesis and male fertility, but how androgens exert this effect remains uncertain. Androgen receptors (ARs) are expressed in several testicular cell types, but continuing uncertainty exists over which cell type mediates androgen control of spermatogenesis. Androgen signaling via Sertoli cells (SCs) is essential for complete spermatogenesis, but the role for androgen signaling via peritubular myoid (PTM) cells is contentious. To address this controversy, we generated PTM-specific AR-knockout (PTM-ARKO) mice in which gross reproductive development was normal, but all PTM-ARKO males were azoospermic and infertile. Testis weight was reduced beyond puberty, and in adulthood there was an 86% reduction in germ cells, compared with wild-type littermates. These changes were not explained by any deficits in testosterone, luteinizing hormone, or follicle-stimulating hormone concentrations. SC function was impaired in PTM-ARKO males, indicated by reduced seminiferous tubule fluid production and reduced expression of some androgen-dependent SC genes. Androgen action via PTM cells is therefore essential for normal testis function, spermatogenesis, and fertility in males. This study also provides the first direct evidence for the importance of androgen-driven stromal-epithelial interactions underpinning the regulation of spermatogenesis; PTM-ARKO mice will enable identification of the new molecular pathways involved.-Welsh, M., Saunders, P. T. K., Atanassova, N., Sharpe, R. M., Smith, L. B. Androgen action via testicular peritubular myoid cells is essential for male fertility. FASEB J. 23, 4218-4230 (2009). www.fasebj.org	[Welsh, Michelle; Saunders, Philippa T. K.; Sharpe, Richard M.; Smith, Lee B.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Ctr Reprod Biol, Edinburgh EH16 4TJ, Midlothian, Scotland; [Atanassova, Nina] Bulgarian Acad Sci, Inst Expt Morphol & Anthropol Museum, Sofia, Bulgaria	University of Edinburgh; Bulgarian Academy of Sciences	Smith, LB (corresponding author), Queens Med Res Inst, MRC, Human Reprod Sci Unit, Ctr Reprod Biol, Edinburgh EH16 4TJ, Midlothian, Scotland.	l.smith@hrsu.mrc.ac.uk	Smith, Lee B/J-4861-2013; welsh, michelle/G-2261-2010; Sharpe, Richard M/D-2725-2013; Atanassova, Nina/AAH-2722-2021; Saunders, Philippa TK/C-7489-2013	Sharpe, Richard M/0000-0003-1686-8085; Atanassova, Nina/0000-0002-9032-3588; Saunders, Philippa TK/0000-0001-9051-9380; Smith, Lee/0000-0002-4103-3074	UK Medical Research Council [WBS U.1276.00.002.0003.01]; MRC [MC_U127684422, MC_U127685844, MC_U127685841] Funding Source: UKRI; Medical Research Council [MC_U127685841, MC_U127684422, MC_U127685844] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Karel De Gendt and Guido Verhoeven (Catholic University of Leuven, Leuven, Belgium) for providing the AR<SUP>flox</SUP> mice, The Jackson Laboratory (Bar Harbor, ME, USA) for SM22-Cre mice, and Michael Kotlikoff (Cornell University, Ithaca, NY, USA) for smMHC-Cre mice. We thank the UK Medical Research Council for funding (WBS U.1276.00.002.0003.01). We also thank Ian Swanston, Mark Fisken, Lindsey Moffat, Lindsay Rutherford, Nancy Nelson, and the members of the histology department for technical assistance.	Andersson AM, 2008, INT J ANDROL, V31, P74, DOI 10.1111/j.1365-2605.2007.00853.x; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; CORKER CS, 1978, J STEROID BIOCHEM, V9, P373, DOI 10.1016/0022-4731(78)90634-9; CUNHA GR, 1976, INT REV CYTOL, V47, P137, DOI 10.1016/S0074-7696(08)60088-1; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; DEFRANCA LR, 1994, ANAT REC, V240, P225; Denolet E, 2006, MOL ENDOCRINOL, V20, P321, DOI 10.1210/me.2005-0113; FARR CH, 1980, J REPROD FERTIL, V58, P37, DOI 10.1530/jrf.0.0580037; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Franca LR, 2000, BIOL REPROD, V63, P1403, DOI 10.1095/biolreprod63.5.1403; Frutkin AD, 2006, J MOL CELL CARDIOL, V41, P724, DOI 10.1016/j.yjmcc.2006.06.067; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Jeanes A, 2005, REPRODUCTION, V130, P509, DOI 10.1530/rep.1.00718; JEGOU B, 1983, INT J ANDROL, V6, P249, DOI 10.1111/j.1365-2605.1983.tb00539.x; Johnston DS, 2001, ENDOCRINOLOGY, V142, P2405, DOI 10.1210/en.142.6.2405; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; KOTITE NJ, 1978, BIOL REPROD, V18, P65, DOI 10.1095/biolreprod18.1.65; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; McNeilly JR, 2000, ENDOCRINOLOGY, V141, P4284, DOI 10.1210/en.141.11.4284; Meistrich ML, 2003, J ANDROL, V24, P135; ODONNELL L, 1994, ENDOCRINOLOGY, V135, P2608, DOI 10.1210/en.135.6.2608; Patek CE, 2005, TRANSGENIC RES, V14, P691, DOI 10.1007/s11248-005-7216-y; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; RICHARDSON LL, 1995, BIOL REPROD, V52, P320, DOI 10.1095/biolreprod52.2.320; Romano F, 2005, CONTRACEPTION, V72, P294, DOI 10.1016/j.contraception.2005.03.009; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Sharpe Richard M., 1994, P1363; SHARPE RM, 1994, J REPROD FERTIL, V101, P193, DOI 10.1530/jrf.0.1010193; SHARPE RM, 2004, SERTOLI CELL BIOL, P199; SKINNER MK, 1985, J CELL BIOL, V100, P1941, DOI 10.1083/jcb.100.6.1941; SKINNER MK, 1985, P NATL ACAD SCI USA, V82, P114, DOI 10.1073/pnas.82.1.114; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Verhoeven G, 2000, ANDROLOGIA, V32, P42; Wang GS, 2009, J ANDROL, V30, P338, DOI 10.2164/jandrol.108.006890; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Welsh M, 2006, ENDOCRINOLOGY, V147, P4820, DOI 10.1210/en.2006-0149; Welsh M, 2009, ENDOCRINOLOGY, V150, P2472, DOI 10.1210/en.2008-0529; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103	45	164	172	1	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4218	4230		10.1096/fj.09-138347	http://dx.doi.org/10.1096/fj.09-138347			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19692648	Green Published			2022-12-25	WOS:000272193700017
J	Zheng, W; Xin, N; Chi, ZH; Zhao, BL; Zhang, J; Li, JY; Wang, ZY				Zheng, Wei; Xin, Na; Chi, Zhi-Hong; Zhao, Bo-Lu; Zhang, Jie; Li, Jia-Yi; Wang, Zhan-You			Divalent metal transporter 1 is involved in amyloid precursor protein processing and A beta generation	FASEB JOURNAL			English	Article						beta-amyloid peptide; RNA interference; APP/PS1 transgenic mouse; Alzheimer's disease; divalent cation transporter 1	IRON-RESPONSIVE ELEMENT; ALZHEIMERS-DISEASE; MESSENGER-RNA; 5'-UNTRANSLATED REGION; TRANSGENIC MICE; UP-REGULATION; BELGRADE RAT; EXPRESSION; COPPER; CELLS	The amyloid-beta precursor protein (APP) and its pathogenic byproduct beta-amyloid peptide (A beta) play central roles in the pathogenesis of Alzheimer's disease (AD). Reduction in levels of the potentially toxic A beta is one of the most important therapeutic goals in AD. Recent studies have shown that bivalent metals such as iron, copper, and zinc are involved in APP expression, A beta deposition, and senile plaque formation in the AD brain. However, the underlying mechanisms involved in abnormal homeostasis of bivalent metals in AD brain remain unclear. In the present study, we found that two isoforms of the divalent metal transporter 1 (DMT1), DMT1-IRE, and DMT1-nonIRE, were colocalized with A beta in the plaques of postmortem AD brain. Using the APP/PS1 transgenic mouse model, we found that the levels of both DMT1-IRE and DMT1-nonIRE were significantly increased in the cortex and hippocampus compared with wild type-control. We further verified the proposed mechanisms by which DMT1 might be involved in APP processing and A beta secretion by using the SH-SY5Y cell line stably overexpressing human APP Swedish mutation (APPsw) as a cell model. We found that overexpression of APPsw resulted in increased expression levels of both DMT1-IRE and DMT1-nonIRE in SH-SY5Y cells. Interestingly, silencing of endogenous DMT1 by RNA interference, which reduced bivalent ion influx, led to reductions of APP expression and A beta secretion. These findings suggest both that DMT1 plays a critical role in ion-mediated neuropathogenesis in AD and that pharmacological blockage of DMT1 may provide novel therapeutic strategies against AD.-Zheng, W., Xin, N., Chi, Z.-H., Zhao, B.-L., Zhang, J., Li, J.-Y., Wang, Z.-Y. Divalent metal transporter 1 (DMT1) is involved in amyloid precursor protein processing and A beta generation. FASEB J. 23, 4207-4217 (2009). www.fasebj.org	[Zheng, Wei; Xin, Na; Chi, Zhi-Hong; Wang, Zhan-You] China Med Univ, Lab Cell Engn & Cell Therapy, Minist Publ Hlth China, Key Lab Cell Biol, Shenyang 110001, Peoples R China; [Zhao, Bo-Lu; Zhang, Jie] Acad Sinica, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Li, Jia-Yi] Lund Univ, Dept Expt Med Sci, S-22100 Lund, Sweden	China Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Lund University	Wang, ZY (corresponding author), China Med Univ, Lab Cell Engn & Cell Therapy, Minist Publ Hlth China, Key Lab Cell Biol, Shenyang 110001, Peoples R China.	zhanyouw@hotmail.com	Zhang, Jie/A-5426-2010	Wang, Zhan-You/0000-0003-0807-9916; Li, Jia-Yi/0000-0002-7770-7376	Natural Science Foundation of China [30770680]; Program for New Century Excellent Talents in University [NCET-04-0288]; China Postdoctoral Science Foundation [2005037008]; Specialized Research Fund for the Doctoral Program of Higher Education [SRFDP-20060159001]; National Grand Fundamental Research 973 Program of China [2006CB500700]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Grand Fundamental Research 973 Program of China(National Basic Research Program of China)	We are grateful to Dr. Rong Liu for statistical analysis. The study was supported by the Natural Science Foundation of China (30770680), the Program for New Century Excellent Talents in University (NCET-04-0288), the China Postdoctoral Science Foundation (2005037008), the Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP-20060159001), and the National Grand Fundamental Research 973 Program of China (2006CB500700).	Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Aracena P, 2006, BIOL RES, V39, P157, DOI 10.4067/S0716-97602006000100017; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Bandyopadhyay S, 2006, J NEURAL TRANSM-SUPP, P237; Bandyopadhyay S, 2006, J NEUROSCI RES, V84, P106, DOI 10.1002/jnr.20864; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Burdo JR, 2004, J CEREBR BLOOD F MET, V24, P67, DOI 10.1097/01.WCB.0000095800.98378.03; Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs; Burdo JR, 1999, NEUROSCIENCE, V93, P1189, DOI 10.1016/S0306-4522(99)00207-9; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Ci WM, 2003, CELL CALCIUM, V33, P257, DOI 10.1016/S0143-4160(02)00240-3; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Conrad ME, 2000, AM J PHYSIOL-GASTR L, V279, pG767, DOI 10.1152/ajpgi.2000.279.4.G767; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P277; Devirgiliis C, 2007, MUTAT RES-FUND MOL M, V622, P84, DOI 10.1016/j.mrfmmm.2007.01.013; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Erikson KM, 2006, NEUROTOXICOLOGY, V27, P125, DOI 10.1016/j.neuro.2005.07.003; Falangola MF, 2005, NEUROCHEM RES, V30, P201, DOI 10.1007/s11064-004-2442-x; Finefrock AE, 2003, J AM GERIATR SOC, V51, P1143, DOI 10.1046/j.1532-5415.2003.51368.x; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang E, 2006, EXP BRAIN RES, V170, P376, DOI 10.1007/s00221-005-0220-x; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Jamieson SE, 2005, NEUROSCI LETT, V374, P124, DOI 10.1016/j.neulet.2004.10.038; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Ke Y, 2005, NEUROBIOL AGING, V26, P739, DOI 10.1016/j.neurobiolaging.2004.06.002; Ke Y, 2007, PROG NEUROBIOL, V83, P149, DOI 10.1016/j.pneurobio.2007.07.009; Knutson M, 2004, J NEUROSCI RES, V76, P633, DOI 10.1002/jnr.20113; Lee JY, 2004, NEUROBIOL AGING, V25, P1315, DOI 10.1016/j.neurobiolaging.2004.01.005; Lee PL, 1998, BLOOD CELL MOL DIS, V24, P199, DOI 10.1006/bcmd.1998.0186; Li HY, 2003, BIOCHEM J, V372, P757, DOI 10.1042/BJ20030075; Liu GJ, 2006, J STRUCT BIOL, V155, P45, DOI 10.1016/j.jsb.2005.12.011; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Macreadie IG, 2008, EUR BIOPHYS J BIOPHY, V37, P295, DOI 10.1007/s00249-007-0235-2; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Nevo Y, 2004, J BIOL CHEM, V279, P53056, DOI 10.1074/jbc.M408398200; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Paradkar PN, 2006, J NEUROCHEM, V96, P1768, DOI 10.1111/j.1471-4159.2006.03702.x; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Rogers JT, 2008, BIOCHEM SOC T, V36, P1282, DOI 10.1042/BST0361282; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Venti A, 2004, ANN NY ACAD SCI, V1035, P34, DOI 10.1196/annals.1332.003; Wang XC, 2005, AM J PHYSIOL-LUNG C, V289, pL24, DOI 10.1152/ajplung.00428.2003; Wardrop SL, 2000, EUR J BIOCHEM, V267, P6586, DOI 10.1046/j.1432-1327.2000.01752.x; Xu HM, 2008, NEUROCHEM INT, V52, P1044, DOI 10.1016/j.neuint.2007.10.019; Zhang J, 2006, NEUROSCIENCE, V143, P63, DOI 10.1016/j.neuroscience.2006.07.023; Zhang J, 2006, FASEB J, V20, P1212, DOI 10.1096/fj.05-5214fje; Zhang LH, 2008, BRAIN RES BULL, V77, P55, DOI 10.1016/j.brainresbull.2008.03.014; Zhang LH, 2010, NEUROBIOL AGING, V31, P74, DOI 10.1016/j.neurobiolaging.2008.02.018; ZHANG S, 2008, NEUROBIOL AGING, V32, pS12	60	73	80	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4207	4217		10.1096/fj.09-135749	http://dx.doi.org/10.1096/fj.09-135749			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19679638				2022-12-25	WOS:000272193700016
J	Bui, LC; Tomkiewicz, C; Chevallier, A; Pierre, S; Bats, AS; Mota, S; Raingeaud, J; Pierre, J; Diry, M; Transy, C; Garlatti, M; Barouki, R; Coumoul, X				Bui, L-C; Tomkiewicz, C.; Chevallier, A.; Pierre, S.; Bats, A-S; Mota, S.; Raingeaud, J.; Pierre, J.; Diry, M.; Transy, C.; Garlatti, M.; Barouki, R.; Coumoul, X.			Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity	ONCOGENE			English	Article						PAHs; cellular plasticity; toxicology; xenobiotics; metastasis marker	DOCKING PROTEIN HEF1; HYDROCARBON RECEPTOR; GENE-EXPRESSION; AH RECEPTOR; CANCER; ACTIVATION; DIOXIN; IDENTIFICATION; METASTASIS; NETWORKS	Aryl hydrocarbon receptor (AhR), or dioxin receptor, is a transcription factor that induces adaptive metabolic pathways in response to environmental pollutants. Recently, other pathways were found to be altered by AhR and its ligands. Indeed, developmental defects elicited by AhR ligands suggest that additional cellular functions may be targeted by this receptor, including cell migration and plasticity. Here, we show that dioxin-mediated activation of Ahr induces Nedd9/Hef1/Cas-L, a member of the Cas protein family recently identified as a metastasis marker. The Hef1 gene induction is mediated by two xenobiotic responsive elements present in this gene promoter. Moreover, using RNA interference, we show that Nedd9/Hef1/Cas-L mediates the dioxin-elicited changes related to cell plasticity, including alterations of cellular adhesion and shape, cytoskeleton reorganization, and increased cell migration. Furthermore, we show that both E-cadherin repression and Jun N-terminal kinases activation by dioxin and AhR also depend on the expression of Nedd9/Hef1/Cas-L. Our study unveils, for the first time, a link between pollutants exposure and the induced expression of a metastasis marker and shows that cellular migration and plasticity markers are regulated by AhR and its toxic ligands. Oncogene (2009) 28, 3642-3651; doi:10.1038/onc.2009.224; published online 3 August 2009	[Bui, L-C; Tomkiewicz, C.; Chevallier, A.; Pierre, S.; Bats, A-S; Mota, S.; Garlatti, M.; Barouki, R.; Coumoul, X.] INSERM, UMR S 747, Paris, France; [Bui, L-C; Tomkiewicz, C.; Chevallier, A.; Pierre, S.; Bats, A-S; Mota, S.; Diry, M.; Transy, C.; Garlatti, M.; Barouki, R.; Coumoul, X.] Univ Paris 05, Ctr Univ Saints Peres, Paris, France; [Raingeaud, J.; Pierre, J.] Univ Paris 11, Fac Pharm, INSERM, U461, F-92290 Chatenay Malabry, France; [Diry, M.; Transy, C.] INSERM, U490, Paris, France; [Barouki, R.] Hop Necker Enfants Malad, APHP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Barouki, R (corresponding author), Univ Paris 05, INSERM, Fac Med Saints Peres, UMR Toxicol Pharmacol & Signalisat Cellulaire S 7, 45 Rue Saints Peres, F-75006 Paris, Ile De France, France.	robert.barouki@univ-paris5.fr; xavier.coumoul@parisdescartes.fr	COUMOUL, Xavier/AAR-3649-2020; Chevallier, Aline/O-5939-2014; Mota, Sandra/AAB-6073-2019	COUMOUL, Xavier/0000-0003-2928-9648; Mota, Sandra/0000-0001-9623-5012; BATS, Anne-Sophie/0000-0001-5333-3296	AFSSET (Agence Francaise de Securite Sanitaire de l'Environnement et du Travail); ANR (Agence Nationale de la Recherche) [06SEST26]; ARC (Association pour la Recherche sur le Cancer) [3927]; Fondation pour la Recherche Medicale (Bourse postdoctorale, Linh-Chi Bui); INSERM (Institut National de la Sante et de la Recherche Medicale); Ligue contre le Cancer; Ministere de l'enseignement superieur et de la recherche; Region Ile de France; Universite Paris Descartes	AFSSET (Agence Francaise de Securite Sanitaire de l'Environnement et du Travail); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (Bourse postdoctorale, Linh-Chi Bui)(Fondation pour la Recherche Medicale); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue contre le Cancer(Ligue nationale contre le cancer); Ministere de l'enseignement superieur et de la recherche; Region Ile de France(Region Ile-de-France); Universite Paris Descartes	This work was supported by AFSSET (Agence Francaise de Securite Sanitaire de l'Environnement et du Travail; all authors); ANR (Agence Nationale de la Recherche, 06SEST26, Oncopop; all authors); ARC (Association pour la Recherche sur le Cancer, 3927; all authors); Fondation pour la Recherche Medicale (Bourse postdoctorale, Linh-Chi Bui); INSERM (Institut National de la Sante et de la Recherche Medicale; all authors); Ligue contre le Cancer (Bourse postdoctorale, Linh-Chi Bui); Ministere de l'enseignement superieur et de la recherche (Bourse doctorale, Aline Chevallier); Region Ile de France (bourse doctorale, Stephane Pierre); Universite Paris Descartes.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Crews ST, 2006, GENE DEV, V20, P2773, DOI 10.1101/gad.1487706; Diry M, 2006, ONCOGENE, V25, P5570, DOI 10.1038/sj.onc.1209553; Downie D, 2005, CLIN CANCER RES, V11, P7369, DOI 10.1158/1078-0432.CCR-05-0466; Frueh FW, 2001, TOXICOL LETT, V122, P189, DOI 10.1016/S0378-4274(01)00364-2; Haas S, 2006, INT J CANCER, V119, P1785, DOI 10.1002/ijc.21915; Huang C, 2004, CELL CYCLE, V3, P4, DOI 10.4161/cc.3.1.601; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Kumarakulasingham M, 2005, CLIN CANCER RES, V11, P3758, DOI 10.1158/1078-0432.CCR-04-1848; Law SF, 1996, MOL CELL BIOL, V16, P3327; Law SF, 2000, MOL CELL BIOL, V20, P5184, DOI 10.1128/MCB.20.14.5184-5195.2000; Ma Q, 1996, MOL CELL BIOL, V16, P2144; Marchand A, 2005, MOL PHARMACOL, V67, P444, DOI 10.1124/mol.104.004010; McMillan BJ, 2007, P NATL ACAD SCI USA, V104, P1412, DOI 10.1073/pnas.0607296104; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; O'Neill GM, 2001, MOL CELL BIOL, V21, P5094, DOI 10.1128/MCB.21.15.5094-5108.2001; Puga A, 2005, BIOCHEM PHARMACOL, V69, P199, DOI 10.1016/j.bcp.2004.06.043; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Pugacheva EN, 2006, CELL CYCLE, V5, P384, DOI 10.4161/cc.5.4.2439; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Qin HT, 2006, DEV BIOL, V298, P606, DOI 10.1016/j.ydbio.2006.07.017; Regelmann AG, 2006, IMMUNITY, V25, P907, DOI 10.1016/j.immuni.2006.09.014; Seo S, 2006, CRIT REV IMMUNOL, V26, P391, DOI 10.1615/CritRevImmunol.v26.i5.20; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	29	63	68	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2009	28	41					3642	3651		10.1038/onc.2009.224	http://dx.doi.org/10.1038/onc.2009.224			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KJ	19648964				2022-12-25	WOS:000270851800005
J	Morita, T; Sobue, K				Morita, Tsuyoshi; Sobue, Kenji			Specification of Neuronal Polarity Regulated by Local Translation of CRMP2 and Tau via the mTOR-p70S6K Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; NERVOUS-SYSTEM; RHEB GTPASE; MTOR; RAPAMYCIN; MECHANISMS; PROTEIN; S6K1	Mammalian target of rapamycin (mTOR) is an important regulator of neuronal development and functions. Although it was reported recently that mTOR signaling is critical for neuronal polarity, the underlying mechanism remains unclear. Here, we describe the molecular pathway of mTOR-dependent axon specification, in which the collapsing response mediator protein 2 (CRMP2) and Tau are major downstream targets. The activity of mTOR effector 70-kDa ribosomal protein S6 kinase (p70S6K) specifically increases in the axon during neuronal polarity formation. The mTOR inhibitor rapamycin suppresses the translation of some neuronal polarity proteins, including CRMP2 and Tau, thereby inhibiting axon formation. In contrast, constitutively active p70S6K up-regulates the translation of these molecules, thus inducing multiple axons. Exogenous CRMP2 and Tau facilitate axon formation, even in the presence of rapamycin. In the 5'-untranslated region of Tau and CRMP2 mRNAs, we identified a 5'-terminal oligopyrimidine tract, which mediates mTOR-governed protein synthesis. The 5'-terminal oligopyrimidine tract sequences of CRMP2 and Tau mRNAs strongly contribute to the up-regulation of their translation in the axon in response to the axonal activation of the mTOR-p70S6K pathway. Taken together, we conclude that the local translation of CRMP2 and Tau, regulated by mTOR-p70S6K, is critical for the specification of neuronal polarity.	[Morita, Tsuyoshi; Sobue, Kenji] Osaka Univ, Dept Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Sobue, Kenji] Osaka Univ, Res Ctr Child Mental Dev, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Sobue, K (corresponding author), Osaka Univ, Dept Neurosci, Grad Sch Med, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	sobue@nbiochem.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [20240038]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research 20240038 from the Japan Society for the Promotion of Science ( to K. S.).	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Li YH, 2008, J BIOL CHEM, V283, P33784, DOI 10.1074/jbc.M802431200; LITMAN P, 1993, NEURON, V10, P627, DOI 10.1016/0896-6273(93)90165-N; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Zhang WG, 2006, PROTEIN EXPRES PURIF, V46, P414, DOI 10.1016/j.pep.2005.08.012	26	96	106	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27734	27745		10.1074/jbc.M109.008177	http://dx.doi.org/10.1074/jbc.M109.008177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648118	hybrid, Green Published			2022-12-25	WOS:000270232300074
J	Swee, LK; Ingold-Salamin, K; Tardivel, A; Willen, L; Gaide, O; Favre, M; Demotz, S; Mikkola, M; Schneider, P				Swee, Lee Kim; Ingold-Salamin, Karine; Tardivel, Aubry; Willen, Laure; Gaide, Olivier; Favre, Manuel; Demotz, Stephane; Mikkola, Marja; Schneider, Pascal			Biological Activity of Ectodysplasin A Is Conditioned by Its Collagen and Heparan Sulfate Proteoglycan-binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; ECTODERMAL DYSPLASIA; TNF; EXPRESSION; LIGAND; FORM; SHH; IDENTIFICATION; REQUIREMENT	Mutations in the TNF family ligand EDA1 cause X-linked hypohidrotic ectodermal dysplasia (XLHED), a condition characterized by defective development of skin appendages. The EDA1 protein displays a proteolytic processing site responsible for its conversion to a soluble form, a collagen domain, and a trimeric TNF homology domain (THD) that binds the receptor EDAR. In-frame deletions in the collagen domain reduced the thermal stability of EDA1. Removal of the collagen domain decreased its activity about 100-fold, as measured with natural and engineered EDA1-responsive cell lines. The collagen domain could be functionally replaced by multimerization domains or by cross-linking antibodies, suggesting that it functions as an oligomerization unit. Surprisingly, mature soluble EDA1 containing the collagen domain was poorly active when administered in newborn, EDA-deficient (Tabby) mice. This was due to a short stretch of basic amino acids located at the N terminus of the collagen domain that confers EDA1 with proteoglycan binding ability. In contrast to wild-type EDA1, EDA1 with mutations in this basic sequence was a potent inducer of tail hair development in vivo. Thus, the collagen domain activates EDA1 by multimerization, whereas the proteoglycan-binding domain may restrict the distribution of endogeneous EDA1 in vivo.	[Swee, Lee Kim; Ingold-Salamin, Karine; Tardivel, Aubry; Willen, Laure; Gaide, Olivier; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Mikkola, Marja] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Favre, Manuel; Demotz, Stephane] Apoxis SA, CH-1004 Lausanne, Switzerland	University of Lausanne; University of Helsinki	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch		Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; NCCR Molecular Oncology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Swiss National Science Foundation and the NCCR Molecular Oncology.	Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hammerschmidt B, 2007, DEV BIOL, V305, P246, DOI 10.1016/j.ydbio.2007.02.010; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Holler N, 2000, J IMMUNOL METHODS, V237, P159, DOI 10.1016/S0022-1759(99)00239-2; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Pummila M, 2007, DEVELOPMENT, V134, P117, DOI 10.1242/dev.02708; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Srivastava AK, 2001, HUM MOL GENET, V10, P2973, DOI 10.1093/hmg/10.26.2973; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	36	43	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27567	27576		10.1074/jbc.M109.042259	http://dx.doi.org/10.1074/jbc.M109.042259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19657145	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000270232300058
J	Fu, Y; Sun, WJ; Shi, YZ; Shi, RY; Cheng, JX				Fu, Yan; Sun, Wenjing; Shi, Yunzhou; Shi, Riyi; Cheng, Ji-Xin			Glutamate Excitotoxicity Inflicts Paranodal Myelin Splitting and Retraction	PLOS ONE			English	Article								Paranodal myelin damage is observed in white matter injury. However the culprit for such damage remains unknown. By coherent anti-Stokes Raman scattering imaging of myelin sheath in fresh tissues with sub-micron resolution, we observed significant paranodal myelin splitting and retraction following glutamate application both ex vivo and in vivo. Multimodal multiphoton imaging further showed that glutamate application broke axo-glial junctions and exposed juxtaparanodal K(+) channels, resulting in axonal conduction deficit that was demonstrated by compound action potential measurements. The use of 4-aminopyridine, a broad-spectrum K(+) channel blocker, effectively recovered both the amplitude and width of compound action potentials. Using CARS imaging as a quantitative readout of nodal length to diameter ratio, the same kind of paranodal myelin retraction was observed with applications of Ca(2+) ionophore A23187. Moreover, exclusion of Ca(2+) from the medium or application of calpain inhibitor abolished paranodal myelin retraction during glutamate exposure. Examinations of glutamate receptor agonists and antagonists further showed that the paranodal myelin damage was mediated by NMDA and kainate receptors. These results suggest that an increased level of glutamate in diseased white matter could impair paranodal myelin through receptor-mediated Ca(2+) overloading and subsequent calpain activation.			Fu, Y (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	riyi@purdue.edu; jcheng@purdue.edu	Shi, Yunzhou/C-7500-2013		NIBIB NIH HHS [R01 EB007243] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007243] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Baltan S, 2008, J NEUROSCI, V28, P1479, DOI 10.1523/JNEUROSCI.5137-07.2008; BANIK NL, 1992, CRIT REV NEUROBIOL, V6, P257; Bever Jr CT, 1995, CNS DRUG REV, V1, P261; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; Brand-Schieber E, 2003, GLIA, V42, P12, DOI 10.1002/glia.10136; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Cheng JX, 2007, APPL SPECTROSC, V61, p197A, DOI 10.1366/000370207781746044; CHOI DW, 1987, J NEUROSCI, V7, P357; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Fu Y, 2007, BIOPHYS J, V92, P3251, DOI 10.1529/biophysj.106.089011; Hayes KC, 2004, CNS DRUG REV, V10, P295; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Jatzke C, 2002, J PHYSIOL-LONDON, V538, P25, DOI 10.1113/jphysiol.2001.012897; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Li SX, 2000, J NEUROPHYSIOL, V84, P1116; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Luo J, 2002, SPINAL CORD, V40, P656, DOI 10.1038/sj.sc.3101363; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Matsuo A, 1997, AM J PATHOL, V150, P1253; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Matute C, 2006, TRENDS MOL MED, V12, P289, DOI 10.1016/j.molmed.2006.05.004; McCarran WJ, 2007, J NEUROSCI, V27, P4220, DOI 10.1523/JNEUROSCI.5542-06.2007; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Morell P., 1999, BASIC NEUROCHEMISTRY, V6th ed.; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Platt SR, 2007, VET J, V173, P278, DOI 10.1016/j.tvjl.2005.11.007; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Ray SK, 2003, J CHEM NEUROANAT, V26, P119, DOI 10.1016/S0891-0618(03)00044-9; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schabitz WR, 2000, STROKE, V31, P1709, DOI 10.1161/01.STR.31.7.1709; Schaecher KE, 2001, NEUROCHEM RES, V26, P731, DOI 10.1023/A:1010903823668; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Shields DC, 1998, P NATL ACAD SCI USA, V95, P5768, DOI 10.1073/pnas.95.10.5768; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; STYS PK, 1992, J CEREBR BLOOD F MET, V12, P977, DOI 10.1038/jcbfm.1992.135; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Tekkok SB, 2007, J CEREBR BLOOD F MET, V27, P1540, DOI 10.1038/sj.jcbfm.9600455; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; WAXMAN SG, 1994, BRAIN RES, V644, P197, DOI 10.1016/0006-8993(94)91680-2; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Yam PS, 2000, J CEREBR BLOOD F MET, V20, P772, DOI 10.1097/00004647-200005000-00003	56	65	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6705	10.1371/journal.pone.0006705	http://dx.doi.org/10.1371/journal.pone.0006705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693274	gold, Green Published, Green Submitted			2022-12-25	WOS:000269267400013
J	Scharstuhl, A; Mutsaers, HAM; Pennings, SWC; Russel, FGM; Wagener, FADTG				Scharstuhl, Alwin; Mutsaers, Henricus A. M.; Pennings, Sebastiaan W. C.; Russel, Frans G. M.; Wagener, Frank A. D. T. G.			Involvement of VDAC, Bax and Ceramides in the Efflux of AIF from Mitochondria during Curcumin-Induced Apoptosis	PLOS ONE			English	Article								Background: We previously identified curcumin as a potent inducer of fibroblast apoptosis, which could be used to treat hypertrophic scar formation. Here we investigated the underlying mechanism of this process. Principal Findings: Curcumin-induced apoptosis could not be blocked by caspase-inhibitors and we could not detect any caspase-3/7 activity. Curcumin predominantly induced mitochondria-mediated ROS formation and stimulated the expression of the redox-sensitive pro-apoptotic factor p53. Inhibition of the pro-apoptotic signaling enzyme glycogen synthase kinase-3 beta (GSK-3 beta) blocked curcumin-induced apoptosis. Apoptosis was associated with high molecular weight DNA damage, a possible indicator of apoptosis-inducing factor (AIF) activity. Indeed, curcumin caused nuclear translocation of AIF, which could be blocked by the antioxidant N-acetyl cysteine. We next investigated how AIF is effluxed from mitochondria in more detail. The permeability transition pore complex (PTPC), of which the voltage-dependent anion channel (VDAC) is a component, could be involved since the VDAC-inhibitor DIDS (4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid) efficiently blocked AIF translocation. However, PTPC is not involved in AIF release since cyclosporine A, a specific inhibitor of the complex did not block apoptosis. Alternatively, the pro-apoptotic protein Bax could have formed mitochondrial channels and interacted with VDAC. Curcumin caused mitochondrial translocation of Bax, which was blocked by DIDS, suggesting a Bax-VDAC interaction. Interestingly, ceramide channels can also release apoptogenic factors from mitochondria and we found that addition of ceramide induced caspase-independent apoptosis. Surprisingly, this process could also be blocked by DIDS, suggesting the concerted action of Bax, VDAC and ceramide in the efflux of AIF from the mitochondrion. Conclusions: Curcumin-induced fibroblast apoptosis is totally caspase-independent and relies on the mitochondrial formation of ROS and the subsequent nuclear translocation of AIF, which is released from a mitochondrial pore that involves VDAC, Bax and possibly ceramides. The composition of the AIF-releasing channel seems to be much more complex than previously thought.			Scharstuhl, A (corresponding author), Radboud Univ Nijmegen, Dept Pharmacol & Toxicol, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	f.wagener@ncmls.ru.nl	Russel, Frans G.M./B-3184-2014; Pennings, Bas/AAE-3107-2019; Mutsaers, Henricus/AAK-6321-2020; Wagener, Frank/O-6225-2014	Russel, Frans G.M./0000-0002-7959-2314; Mutsaers, Henricus/0000-0002-9553-8860; Wagener, Frank/0000-0003-4837-1559				Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Crompton M, 2000, CURR OPIN CELL BIOL, V12, P414, DOI 10.1016/S0955-0674(00)00110-1; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu AH, 2008, CELL PHYSIOL BIOCHEM, V22, P177, DOI 10.1159/000149795; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; MIYASHITA T, 1995, CELL, V80, P293; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Moussavi M, 2006, CARCINOGENESIS, V27, P1636, DOI 10.1093/carcin/bgi371; Penninger JM, 2003, NAT CELL BIOL, V5, P97, DOI 10.1038/ncb0203-97; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Piwocka K, 2001, FREE RADICAL BIO MED, V31, P670, DOI 10.1016/S0891-5849(01)00629-3; Piwocka K, 1999, EXP CELL RES, V249, P299, DOI 10.1006/excr.1999.4480; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Scarlatti F, 2003, FASEB J, V17, P2339, DOI 10.1096/fj.03-0292fje; Scharstuhl A, 2009, J CELL MOL MED, V13, P712, DOI 10.1111/j.1582-4934.2008.00339.x; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Sikora E, 2006, MOL CANCER THER, V5, P927, DOI 10.1158/1535-7163.MCT-05-0360; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; THAYYULLATHIL F, 2008, FREE RADIC BIOL MED; Thon L, 2005, FASEB J, V19, P1945, DOI 10.1096/fj.05-3726com; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; Watcharasit P, 2008, J APPL TOXICOL, V28, P466, DOI 10.1002/jat.1296; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	46	60	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6688	10.1371/journal.pone.0006688	http://dx.doi.org/10.1371/journal.pone.0006688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693275	Green Submitted, Green Published, gold			2022-12-25	WOS:000269267400002
J	Campeau, E; Ruhl, VE; Rodier, F; Smith, CL; Rahmberg, BL; Fuss, JO; Campisi, J; Yaswen, P; Cooper, PK; Kaufmann, PD				Campeau, Eric; Ruhl, Victoria E.; Rodier, Francis; Smith, Corey L.; Rahmberg, Brittany L.; Fuss, Jill O.; Campisi, Judith; Yaswen, Paul; Cooper, Priscilla K.; Kaufmann, Paul D.			A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells	PLOS ONE			English	Article							EFFICIENT GENE DELIVERY; EMBRYONIC STEM-CELLS; TYPE-1 TAT PROTEIN; RNA-POLYMERASE-II; IN-VIVO; LENTIVIRAL VECTOR; HIV-1 TAT; TRANSGENE EXPRESSION; TRANSCRIPTIONAL REPRESSION; NUCLEAR ANTIGEN	The ability to express or deplete proteins in living cells is crucial for the study of biological processes. Viral vectors are often useful to deliver DNA constructs to cells that are difficult to transfect by other methods. Lentiviruses have the additional advantage of being able to integrate into the genomes of non-dividing mammalian cells. However, existing viral expression systems generally require different vector backbones for expression of cDNA, small hairpin RNA (shRNA) or microRNA (miRNA) and provide limited drug selection markers. Furthermore, viral backbones are often recombinogenic in bacteria, complicating the generation and maintenance of desired clones. Here, we describe a collection of 59 vectors that comprise an integrated system for constitutive or inducible expression of cDNAs, shRNAs or miRNAs, and use a wide variety of drug selection markers. These vectors are based on the Gateway technology (Invitrogen) whereby the cDNA, shRNA or miRNA of interest is cloned into an Entry vector and then recombined into a Destination vector that carries the chosen viral backbone and drug selection marker. This recombination reaction generates the desired product with >95% efficiency and greatly reduces the frequency of unwanted recombination in bacteria. We generated Destination vectors for the production of both retroviruses and lentiviruses. Further, we characterized each vector for its viral titer production as well as its efficiency in expressing or depleting proteins of interest. We also generated multiple types of vectors for the production of fusion proteins and confirmed expression of each. We demonstrated the utility of these vectors in a variety of functional studies. First, we show that the FKBP12 Destabilization Domain system can be used to either express or deplete the protein of interest in mitotically-arrested cells. Also, we generate primary fibroblasts that can be induced to senesce in the presence or absence of DNA damage. Finally, we determined that both isoforms of the AT-Rich Interacting Domain 4B (ARID4B) protein could induce G1 arrest when overexpressed. As new technologies emerge, the vectors in this collection can be easily modified and adapted without the need for extensive recloning.			Campeau, E (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	Eric.Campeau@umassmed.edu	Classen, Scott/AAY-8176-2020	Smith, Corey/0000-0002-9716-2545; Rodier, Francis/0000-0003-2523-309X; Kaufman, Paul/0000-0003-3089-313X	NATIONAL CANCER INSTITUTE [U54CA112970, P01CA092584, R01CA063503, F32CA108393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055712, F32GM076863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA108393, U54 CA112970, P01 CA092584, R01 CA063503, 1F32CA108393] Funding Source: Medline; NIA NIH HHS [AG017242, P01 AG017242] Funding Source: Medline; NIGMS NIH HHS [5 F32 GM076863-03, R01 GM055712, R01 GM055712-11, R01 GM557, F32 GM076863] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albini A, 1998, P NATL ACAD SCI USA, V95, P13153, DOI 10.1073/pnas.95.22.13153; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Antoszczyk Slawomir, 2006, Nucleic Acids Symp Ser (Oxf), P295; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Binda O, 2008, ONCOGENE, V27, P3384, DOI 10.1038/sj.onc.1211014; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; BLOSE SH, 1984, J CELL BIOL, V98, P847, DOI 10.1083/jcb.98.3.847; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cao JN, 2001, J NATL CANCER I, V93, P1159, DOI 10.1093/jnci/93.15.1159; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chakiath CS, 2007, BIOTECHNIQUES, V43, P466, DOI 10.2144/000112585; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Cheng N, 2002, MOL CANCER RES, V1, P2; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; CONE RD, 1984, P NATL ACAD SCI-BIOL, V81, P6349, DOI 10.1073/pnas.81.20.6349; Cui DX, 2004, CANCER EPIDEM BIOMAR, V13, P1136; Cujec TP, 1997, MOL CELL BIOL, V17, P1817, DOI 10.1128/MCB.17.4.1817; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; Darbinian N, 2008, J CELL PHYSIOL, V216, P128, DOI 10.1002/jcp.21382; DASGUPTA U, 1987, GENETICS, V115, P41; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; El-Hage N, 2006, GLIA, V53, P132, DOI 10.1002/glia.20262; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; FISCHERFANTUZZI L, 1988, MOL CELL BIOL, V8, P5495, DOI 10.1128/MCB.8.12.5495; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; FREDERICK M, 2003, CURRENT PROTOCOLS MO, P4648; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Gerolami R, 2000, CANCER GENE THER, V7, P1286, DOI 10.1038/sj.cgt.7700225; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; *INV, 2006, NATIVEPURE LENT EXPR; JAFFE A, 1985, J BACTERIOL, V163, P841; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; JUNKER U, 1995, GENE THER, V2, P639; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim SH, 2008, J CELL BIOL, V181, P447, DOI 10.1083/jcb.200710028; KRUDE T, 1995, EXP CELL RES, V220, P304, DOI 10.1006/excr.1995.1320; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; LIU J, 2008, MOL REPROD DEV; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lotti Francesco, 2003, Methods Mol Biol, V229, P17; Manganini M, 2002, HUM GENE THER, V13, P1793, DOI 10.1089/104303402760372909; Mitta B, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh104; Mitta B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf112; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Pocernich CB, 2005, BRAIN RES REV, V50, P14, DOI 10.1016/j.brainresrev.2005.04.002; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RODIER F, 2009, NAT CELL BI IN PRESS; Sano M, 2005, METHOD ENZYMOL, V392, P97, DOI 10.1016/S0076-6879(04)92006-X; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Scherr M, 2003, CELL CYCLE, V2, P251, DOI 10.4161/cc.2.3.376; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sirven A, 2000, BLOOD, V96, P4103; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SMITH S, 1991, J BIOL CHEM, V266, P12041; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; STUHLMANN H, 1984, P NATL ACAD SCI-BIOL, V81, P7151, DOI 10.1073/pnas.81.22.7151; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vigna E, 2002, MOL THER, V5, P252, DOI 10.1006/mthe.2002.0542; Villani GRD, 2002, BIOCHEM J, V364, P747, DOI 10.1042/BJ20011872; WASEEM NH, 1990, J CELL SCI, V96, P121; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	93	571	601	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6529	10.1371/journal.pone.0006529	http://dx.doi.org/10.1371/journal.pone.0006529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657394	Green Published, Green Submitted, gold			2022-12-25	WOS:000268739300002
J	Ceribelli, M; Benatti, P; Imbriano, C; Mantovani, R				Ceribelli, Michele; Benatti, Paolo; Imbriano, Carol; Mantovani, Roberto			NF-YC Complexity Is Generated by Dual Promoters and Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; 3RD SUBUNIT; B-SUBUNIT; CBF-C; BINDING; GENES; DOMAINS; IDENTIFICATION; RECRUITMENT	The CCAAT box is a DNA element present in the majority of human promoters, bound by the trimeric NF-Y, composed of NF-YA, NF-YB, and NF-YC subunits. We describe and characterize novel isoforms of one of the two histone-like subunits, NF-YC. The locus generates a minimum of four splicing products, mainly located within the Q-rich activation domain. The abundance of each isoform is cell-dependent; only one major NF-YC isoform is present in a given cell type. The 37- and 50-kDa isoforms are mutually exclusive, and preferential pairings with NF-YA isoforms possess different transcriptional activities, with specific combinations being more active on selected promoters. The transcriptional regulation of the NF-YC locus is also complex, and mRNAs arise from the two promoters P1 and P2. Transient transfections, chromatin immunoprecipitations, and reverse transcription-PCRs indicate that P1 has a robust housekeeping activity; P2 possesses a lower basal activity, but it is induced in response to DNA damage in a p53-dependent way. Alternative promoter usage directly affects NF-YC splicing, with the 50-kDa transcript being excluded from P2. Specific functional inactivation of the 37- kDa isoform affects the basal levels of G(1)/S blocking and proapoptotic genes but not G(2)/M promoters. In summary, our data highlight an unexpected degree of complexity and regulation of the NF-YC gene, demonstrating the existence of a discrete cohort of NF-Y trimer subtypes resulting from the functional diversification of Q-rich transactivating subunits and a specific role of the 37- kDa isoform in suppression of the DNA damage-response under growing conditions.	Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Benatti, Paolo; Imbriano, Carol] Univ Modena & Reggio Emilia, Dipartimento Biol Anim, I-41100 Modena, Italy	University of Milan; Universita di Modena e Reggio Emilia		mantor@unimi.it	Imbriano, Carol/C-9376-2015; Imbriano, Carol/ABD-8204-2021	Imbriano, Carol/0000-0003-2864-4820; Imbriano, Carol/0000-0003-2864-4820	Associazione Italiana per la Ricerca sul Cancro; CARIPLO-Nobel	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); CARIPLO-Nobel(Fondazione Cariplo)	Supported by My First AIRC Grant from the Associazione Italiana per la Ricerca sul Cancro.; Supported by AIRC and CARIPLO-Nobel grants. To whom correspondence should be addressed. Fax: 390250315044; E-mail: mantor@unimi.it.	Bellorini M, 1997, GENE, V193, P119, DOI 10.1016/S0378-1119(97)00109-1; Bellorini M, 1997, NUCLEIC ACIDS RES, V25, P2174, DOI 10.1093/nar/25.11.2174; Benatti P, 2008, NUCLEIC ACIDS RES, V36, P1415, DOI 10.1093/nar/gkm1046; Bhattacharya A, 2003, CANCER RES, V63, P8167; Borrelli S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-85; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Chen FF, 2002, BIOCHEM J, V364, P571, DOI 10.1042/BJ20011703; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Ge YB, 2002, BBA-GENE STRUCT EXPR, V1579, P73, DOI 10.1016/S0167-4781(02)00509-2; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Kabe Y, 2005, MOL CELL BIOL, V25, P512, DOI 10.1128/MCB.25.1.512-522.2005; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; LI XY, 1992, J BIOL CHEM, V267, P8984; Liberati C, 1999, J MOL BIOL, V285, P1441, DOI 10.1006/jmbi.1998.2384; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Singer GAC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-349; Sinha S, 1996, GENOMICS, V37, P260, DOI 10.1006/geno.1996.0555; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Suzuki Yutaka, 2004, In Silico Biology, V4, P429; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Yang J, 2005, NEW PHYTOL, V165, P623, DOI 10.1111/j.1469-8137.2004.01260.x; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102; Zhu Z, 2005, GENOME RES, V15, P848, DOI 10.1101/gr.3394405	49	26	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34189	34200		10.1074/jbc.M109.008417	http://dx.doi.org/10.1074/jbc.M109.008417			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19690168	Green Published, hybrid			2022-12-25	WOS:000272165200051
J	Allington, TM; Galliher-Beckley, AJ; Schiemann, WP				Allington, Tressa M.; Galliher-Beckley, Amy J.; Schiemann, William P.			Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors	FASEB JOURNAL			English	Article						EMT; matrix metalloproteinases; organotypic cultures; Imatinib; signal transduction	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; PHASE-II TRIAL; MATRIX-METALLOPROTEINASE INHIBITORS; IMATINIB MESYLATE; TGF-BETA; C-ABL; TYROSINE KINASE; PROSTATE-CANCER; BIOCHEMICAL RELAPSE	Transforming growth factor-beta (TGF-beta) is a ubiquitous cytokine with dual roles in tumor suppression and promotion, and these dichotomous functions have frustrated the development of therapies targeting oncogenic signaling by TGF-beta. In comparison, Abl is well established as an initiator of hematopoietic cancers; however, a clear role for Abl in regulating solid tumor development remains elusive. Here, we investigated the role of Abl in TGF-beta-mediated epithelial-mesenchymal transition (EMT) in normal and metastatic mammary epithelial cells (MECs). In doing so, we identified Abl as an essential regulator of MEC morphology and showed that Abl inactivation was sufficient to induce phenotypic and transcriptional EMT in normal MECs. Increasing Abl activity in metastatic MECs resulted in their complete morphological reversion, restored their cytostatic response to TGF-beta, and blocked their secretion of matrix metalloproteinases induced by TGF-beta. Constitutively active Abl expression blocked TGF-beta-responsive mammary tumor growth in mice, while Imatinib therapy afforded no clinical benefit in mice bearing mammary tumors. Collectively, this investigation establishes Abl as a potent mediator of MEC identity, and as a suppressor of oncogenic TGF-beta signaling during mammary tumorigenesis. Notably, our findings strongly caution against the use of pharmacological Abl antagonists in the treatment of developing and progressing mammary tumors.-Allington, T. M., Galliher-Beckley, A. J., Schiemann, W. P. Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors. FASEB J. 23, 4231-4243 (2009). www.fasebj.org	[Allington, Tressa M.; Galliher-Beckley, Amy J.; Schiemann, William P.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Schiemann, WP (corresponding author), Univ Colorado Denver, Dept Pharmacol, MS-8303,Anschutz Med Campus,RC1 S Tower,Rm L18-61, Aurora, CO 80045 USA.	bill.schiemann@ucdenver.edu			National Institutes of Health [CA129359]; Komen Foundation [BCTR0706967]; Department of Defense Predoctoral Training Fellowship [BC083323]; NATIONAL CANCER INSTITUTE [R01CA129359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense Predoctoral Training Fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Tony Hunter (Salk Institute, La Jolla, CA, USA) for providing wild-type, kinase-dead, and constitutively-active murine c-Abl (type IV) constructs. We also thank members of the W. P. S. laboratory for critical comments and reading of the manuscript. Research support was provided in part by the National Institutes of Health (CA129359) and the Komen Foundation (BCTR0706967) to W. P. S., and by the Department of Defense Predoctoral Training Fellowship (BC083323) to T. M. A.	ALBINI A, 1987, CANCER RES, V47, P3239; Bajaj GK, 2007, UROLOGY, V69, P526, DOI 10.1016/j.urology.2006.12.006; Benson JR, 2004, LANCET ONCOL, V5, P229, DOI 10.1016/S1470-2045(04)01426-3; Bhattacharyya S, 2009, ONCOGENE, V28, P1285, DOI 10.1038/onc.2008.479; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chen J, 2006, CANCER LETT, V233, P328, DOI 10.1016/j.canlet.2005.03.027; Chew HK, 2008, CLIN BREAST CANCER, V8, P511, DOI 10.3816/CBC.2008.n.062; Cristofanilli M, 2008, ANN ONCOL, V19, P1713, DOI 10.1093/annonc/mdn352; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Dumont N, 2000, BREAST CANCER RES, V2, P125, DOI 10.1186/bcr44; Echarri A, 2001, CURR BIOL, V11, P1759, DOI 10.1016/S0960-9822(01)00538-3; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Frasca F, 2001, ONCOGENE, V20, P3845, DOI 10.1038/sj.onc.1204531; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Gharibo M, 2008, PANCREAS, V36, P341, DOI 10.1097/MPA.0b013e31815d50f9; Hamer G, 2001, ONCOGENE, V20, P4298, DOI 10.1038/sj.onc.1204568; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Kominsky SL, 2008, CLIN EXP METASTAS, V25, P865, DOI 10.1007/s10585-008-9202-2; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Li LS, 2008, J BIOL CHEM, V283, P21394, DOI 10.1074/jbc.M709954200; Lin AM, 2007, CLIN GENITOURIN CANC, V5, P323, DOI 10.3816/CGC.2007.n.011; Lin AM, 2006, BJU INT, V98, P763, DOI 10.1111/j.1464-410X.2006.06396.x; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Modi S, 2005, BREAST CANCER RES TR, V90, P157, DOI 10.1007/s10549-004-3974-0; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Neil JR, 2008, CANCER RES, V68, P1462, DOI 10.1158/0008-5472.CAN-07-3094; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Ongkeko WM, 2006, LARYNGOSCOPE, V116, P1390, DOI 10.1097/01.mlg.0000225941.60901.0f; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pendergast AM, 1996, CURR OPIN CELL BIOL, V8, P174, DOI 10.1016/S0955-0674(96)80063-9; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Przybylo JA, 2007, INT J BIOCHEM CELL B, V39, P1082, DOI 10.1016/j.biocel.2007.03.002; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Radisky Derek C, 2008, Proc Am Thorac Soc, V5, P316, DOI 10.1513/pats.200711-166DR; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Schiemann WP, 2007, EXPERT REV ANTICANC, V7, P609, DOI 10.1586/14737140.7.5.609; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Sinpitaksakul SN, 2008, BIOCHEM BIOPH RES CO, V371, P713, DOI 10.1016/j.bbrc.2008.04.128; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; Skiles JW, 2001, CURR MED CHEM, V8, P425, DOI 10.2174/0929867013373417; Soverini S, 2008, EXPERT REV ANTICANC, V8, P853, DOI 10.1586/14737140.8.6.853; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Wagner MW, 2008, J BIOL CHEM, V283, P21382, DOI 10.1074/jbc.M709953200; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wakefield LM, 2001, J MAMMARY GLAND BIOL, V6, P67, DOI 10.1023/A:1009568532177; Wang JYJ, 2006, NAT CELL BIOL, V8, P785, DOI 10.1038/ncb0806-785; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452	68	48	51	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4231	4243		10.1096/fj.09-138412	http://dx.doi.org/10.1096/fj.09-138412			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19690215	Green Published			2022-12-25	WOS:000272193700018
J	Jivan, A; Earnest, S; Juang, YC; Cobb, MH				Jivan, Arif; Earnest, Svetlana; Juang, Yu-Chi; Cobb, Melanie H.			Radial Spoke Protein 3 Is a Mammalian Protein Kinase A-anchoring Protein That Binds ERK1/2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; IN-VITRO; CHLAMYDOMONAS FLAGELLA; SEQUENCE MOTIFS; DOCKING MOTIF; IDENTIFICATION; ACTIVATION; ERK2; PHOSPHORYLATION; ASSOCIATION	Initially identified in Chlamydomonas, RSP3 (radial spoke protein 3) is 1 of more than 20 identified radial spoke structural components of motile cilia and is required for axonemal sliding and flagellar motility. The mammalian orthologs for this and other radial spoke proteins, however, remain to be characterized. We found mammalian RSP3 to bind to the MAPK ERK2 through a yeast two-hybrid screen designed to identify interacting proteins that have a higher affinity for the phosphorylated, active form of the protein kinase. Consistent with the screening result, the human homolog, RSPH3, interacts with and is a substrate for ERK1/2. Moreover, RSPH3 is a protein kinase A-anchoring protein (AKAP) that scaffolds the cAMP-dependent protein kinase holoenzyme. The binding of RSPH3 to the regulatory subunits of cAMP-dependent protein kinase, RII alpha and RII beta, is regulated by ERK1/2 activity and phosphorylation. Here we describe an ERK1/2-interacting AKAP and suggest a mechanism by which cAMP-dependent protein kinase-AKAP binding can be modulated by the activity of other enzymes.	[Jivan, Arif; Earnest, Svetlana; Juang, Yu-Chi; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Melanie.Cobb@UTSouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [R37 DK34128]; THECB Advanced Research Program; Welch Foundation [I1243]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); THECB Advanced Research Program; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 DK34128. This work was also supported by a grant from the THECB Advanced Research Program and Grant I1243 from the Welch Foundation (to M. H. C.).	Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Beavo J A, 1975, Adv Cyclic Nucleotide Res, V5, P241; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Elion EA, 2001, J CELL SCI, V114, P3967; Gaillard AR, 2006, MOL BIOL CELL, V17, P2626, DOI 10.1091/mbc.E06-02-0095; Gaillard AR, 2001, J CELL BIOL, V153, P443, DOI 10.1083/jcb.153.2.443; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; GREGORY JS, 1989, J BIOL CHEM, V264, P18397; Hausken ZE, 1996, J BIOL CHEM, V271, P29016, DOI 10.1074/jbc.271.46.29016; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lee HY, 2000, J BIOL CHEM, V275, P32193, DOI 10.1074/jbc.M005490200; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; LUCK D, 1977, P NATL ACAD SCI USA, V74, P3456, DOI 10.1073/pnas.74.8.3456; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PIPERNO G, 1981, J CELL BIOL, V88, P73, DOI 10.1083/jcb.88.1.73; Polychronopoulos S, 2006, J BIOL CHEM, V281, P25601, DOI 10.1074/jbc.M605185200; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; REIMANN EM, 1983, METHOD ENZYMOL, V99, P51; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Wirschell M, 2008, CELL MOTIL CYTOSKEL, V65, P238, DOI 10.1002/cm.20257; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; XU SC, 1995, P NATL ACAD SCI USA, V92, P6808, DOI 10.1073/pnas.92.15.6808; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	46	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29437	29445		10.1074/jbc.M109.048181	http://dx.doi.org/10.1074/jbc.M109.048181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19684019	Green Published, hybrid			2022-12-25	WOS:000270896800025
J	Blasingame, E; Tuton-Blasingame, T; Larkin, L; Falick, AM; Zhao, L; Fong, J; Vaidyanathan, V; Visperas, A; Geurts, P; Hu, XY; La Mattina, C; Vierra, C				Blasingame, Eric; Tuton-Blasingame, Tiffany; Larkin, Leah; Falick, Arnold M.; Zhao, Liang; Fong, Justine; Vaidyanathan, Veena; Visperas, Anabelle; Geurts, Paul; Hu, Xiaoyi; La Mattina, Coby; Vierra, Craig			Pyriform Spidroin 1, a Novel Member of the Silk Gene Family That Anchors Dragline Silk Fibers in Attachment Discs of the Black Widow Spider, Latrodectus hesperus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG CASE SILK; FINE-STRUCTURAL ASPECTS; COB WEAVER; PROTEIN EVOLUTION; WRAPPING SILK; FIBROIN; GLANDS; MODEL; SUBSTITUTION; SECRETION	Spiders spin high performance threads that have diverse mechanical properties for specific biological applications. To better understand the molecular mechanism by which spiders anchor their threads to a solid support, we solubilized the attachment discs from black widow spiders and performed in-solution tryptic digests followed by MS/MS analysis to identify novel peptides derived from glue silks. Combining matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry and cDNA library screening, we isolated a novel member of the silk gene family called pysp1 and demonstrate that its protein product is assembled into the attachment disc silks. Alignment of the PySp1 amino acid sequence to other fibroins revealed conservation in the non-repetitive C-terminal region of the silk family. MS/MS analysis also confirmed the presence of MaSp1 and MaSp2, two important components of dragline silks, anchored within the attachment disc materials. Characterization of the ultrastructure of attachment discs using scanning electron microscopy studies support the localization of PySp1 to small diameter fibers embedded in a glue-like cement, which network with large diameter dragline silk threads, producing a strong, adhesive material. Consistent with elevated PySp1 mRNA levels detected in the pyriform gland, MS analysis of the luminal contents extracted from the pyriform gland after tryptic digestion support the assertion that PySp1 represents one of the major constituents manufactured in the pyriform gland. Taken together, our data demonstrate that PySp1 is spun into attachment disc silks to help affix dragline fibers to substrates, a critical function during spider web construction for prey capture and locomotion.	[Blasingame, Eric; Tuton-Blasingame, Tiffany; Larkin, Leah; Fong, Justine; Vaidyanathan, Veena; Visperas, Anabelle; Geurts, Paul; La Mattina, Coby; Vierra, Craig] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA; [Zhao, Liang] Univ Pacific, Dept Chem, Stockton, CA 95211 USA; [Hu, Xiaoyi] Abbott Labs, Santa Clara, CA 95054 USA; [Falick, Arnold M.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of the Pacific; University of the Pacific; Abbott Laboratories; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Vierra, C (corresponding author), 3601 Pacific Ave, Stockton, CA 95211 USA.	cvierra@pacific.edu	Zhao, Liang/I-4777-2015	Zhao, Liang/0000-0002-2126-6778	National Science Foundation RUI [MCB-0544087]	National Science Foundation RUI(National Science Foundation (NSF))	This work was supported by National Science Foundation RUI Grant MCB-0544087.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Casem ML, 1999, INT J BIOL MACROMOL, V24, P103, DOI 10.1016/S0141-8130(98)00078-6; Challis RJ, 2006, INSECT MOL BIOL, V15, P45, DOI 10.1111/j.1365-2583.2005.00606.x; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foelix R. F., 2011, BIOL SPIDERS; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e; Hu XY, 2005, BIOCHEMISTRY-US, V44, P10020, DOI 10.1021/bi050494i; Hu XY, 2005, J BIOL CHEM, V280, P21220, DOI 10.1074/jbc.M412316200; KOVOOR J, 1980, TISSUE CELL, V12, P547, DOI 10.1016/0040-8166(80)90044-0; KOVOOR J, 1982, TISSUE CELL, V14, P519, DOI 10.1016/0040-8166(82)90044-1; La Mattina C, 2008, BIOCHEMISTRY-US, V47, P4692, DOI 10.1021/bi800140q; Maddison W.P., 1986, MACCLADE VERSION 10; Mitchell B, 2000, BBA-GENE STRUCT EXPR, V1492, P320, DOI 10.1016/S0167-4781(00)00109-3; Moon Myung-Jin, 2006, Entomological Research, V36, P133, DOI 10.1111/j.1748-5967.2006.00023.x; Nguyen L, 2001, NUCLEIC ACIDS RES, V29, P4423, DOI 10.1093/nar/29.21.4423; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b; Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vasanthavada K, 2007, J BIOL CHEM, V282, P35088, DOI 10.1074/jbc.M705791200; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g; Zwickl D., 2006, GARLI GENETIC ALGORI	40	72	78	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29097	29108		10.1074/jbc.M109.021378	http://dx.doi.org/10.1074/jbc.M109.021378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19666476	hybrid, Green Published			2022-12-25	WOS:000270678900066
J	Bruck, I; Kaplan, D				Bruck, Irina; Kaplan, Daniel			Dbf4-Cdc7 Phosphorylation of Mcm2 Is Required for Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; KINASE REGULATORY SUBUNIT; CDC7 PROTEIN-KINASE; S-PHASE; ATP HYDROLYSIS; BUDDING YEAST; HELICASE; INITIATION; CDC7-DBF4; COMPLEX	The Dbf4-Cdc7 kinase (DDK) is required for the activation of the origins of replication, and DDK phosphorylates Mcm2 in vitro. We find that budding yeast Cdc7 alone exists in solution as a weakly active multimer. Dbf4 forms a likely heterodimer with Cdc7, and this species phosphorylates Mcm2 with substantially higher specific activity. Dbf4 alone binds tightly to Mcm2, whereas Cdc7 alone binds weakly to Mcm2, suggesting that Dbf4 recruits Cdc7 to phosphorylate Mcm2. DDK phosphorylates two serine residues of Mcm2 near the N terminus of the protein, Ser-164 and Ser-170. Expression of mcm2-S170A is lethal to yeast cells that lack endogenous MCM2 (mcm2 Delta); however, this lethality is rescued in cells harboring the DDK bypass mutant mcm5-bob1. We conclude thatDDKphosphorylation of Mcm2 is required for cell growth.	[Bruck, Irina; Kaplan, Daniel] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, D (corresponding author), Vanderbilt Univ, Dept Biol Sci, Stn B,Box 35-1634, Nashville, TN 37235 USA.	Daniel.Kaplan@Vanderbilt.Edu		Kaplan, Daniel/0000-0003-2760-7745	American Cancer Society Research Scholar [RSG-08-124-01-CCG]; Vanderbilt Ingram Cancer Center; Vanderbilt University	American Cancer Society Research Scholar(American Cancer Society); Vanderbilt Ingram Cancer Center; Vanderbilt University	This work was supported by American Cancer Society Research Scholar Grant RSG-08-124-01-CCG (to D. K. and I. B.), a pilot grant from the Vanderbilt Ingram Cancer Center (to D. K.), and a Discovery Grant from Vanderbilt University (to D. K.).	Barry ER, 2007, NUCLEIC ACIDS RES, V35, P988, DOI 10.1093/nar/gkl1117; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Jares P, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-5; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Shellman YG, 1998, MOL GEN GENET, V259, P429, DOI 10.1007/s004380050833; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	36	52	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28823	28831		10.1074/jbc.M109.039123	http://dx.doi.org/10.1074/jbc.M109.039123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692334	Green Published, hybrid			2022-12-25	WOS:000270678900039
J	Montanez-Wiscovich, ME; Seachrist, DD; Landis, MD; Visvader, J; Andersen, B; Keri, RA				Montanez-Wiscovich, M. E.; Seachrist, D. D.; Landis, M. D.; Visvader, J.; Andersen, B.; Keri, R. A.			LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression	ONCOGENE			English	Article						breast cancer; cullin-3; ErbB2; HER2; LMO4	MAMMARY EPITHELIAL-CELLS; DOMAIN PROTEIN LMO4; MESSENGER-RNA STABILITY; ADJUVANT CHEMOTHERAPY; TRANSGENIC MICE; ERBB RECEPTORS; IN-VITRO; GENE; EXPRESSION; KINASE	ErbB2/HER2/Neu-overexpressing breast cancers are characterized by poor survival due to high proliferation and metastasis rates and identifying downstream targets of ErbB2 should facilitate developing novel therapies for this disease. Gene expression pro. ling revealed the transcriptional regulator LIM-only protein 4 (LMO4) is upregulated during ErbB2-induced mouse mammary gland tumorigenesis. Although LMO4 is frequently overexpressed in breast cancer and LMO4-overexpressing mice develop mammary epithelial tumors, the mechanisms involved are unknown. In this study, we report that LMO4 is a downstream target of ErbB2 and PI3K in ErbB2-dependent breast cancer cells. Furthermore, LMO4 silencing reduces proliferation of these cells, inducing a G2/M arrest that was associated with decreased cullin-3, an E3-ubiquitin ligase component important for mitosis. Loss of LMO4 subsequently results in reduced Cyclin D1 and Cyclin E. Further supporting a role for LMO4 in modulating proliferation by regulating cullin-3 expression, we found that LMO4 expression oscillates throughout the cell cycle with maximum expression occurring during G2/M and these changes precede oscillations in cullin-3 levels. LMO4 levels are also highest in high-grade/less differentiated breast cancers, which are characteristically highly proliferative. We conclude that LMO4 is a novel cell cycle regulator with a key role in mediating ErbB2-induced proliferation, a hallmark of ErbB2-positive disease. Oncogene (2009) 28, 3608-3618; doi:10.1038/onc.2009.221; published online 3 August 2009	[Keri, R. A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Visvader, J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Victorian Breast Canc Res Consortium Lab, Parkville, Vic 3050, Australia; [Andersen, B.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Andersen, B.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Keri, R. A.] Case Western Reserve Univ, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of California System; University of California Irvine; University of California System; University of California Irvine; Case Western Reserve University	Keri, RA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	keri@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	CURE [RO1-CA090398]; NIH [AR44882, T32-GM007250, F31-CA123642]; NATIONAL CANCER INSTITUTE [R01CA090398, F31CA123642, P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	CURE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jonathan Mosley for help with statistical analyses, Meredith Sorenson for technical support and members of the Keri laboratory, especially Gina Bernardo and Emhonta Johnson, for useful discussions. We are grateful for assistance from the Case Comprehensive Cancer Center core facilities (P30 CA43703). This work was supported by: RO1-CA090398 (RAK), CURE supplementary grant to RO1-CA090398 (RAK), NIH AR44882 (BA), T32-GM007250 (MEMW) and F31-CA123642 (MEMW).	Andrechek ER, 2005, ONCOGENE, V24, P932, DOI 10.1038/sj.onc.1208230; Beerli RR, 1996, J BIOL CHEM, V271, P6071, DOI 10.1074/jbc.271.11.6071; BENLEVY R, 1994, EMBO J, V13, P3302, DOI 10.1002/j.1460-2075.1994.tb06632.x; CAPOROSSI D, 1995, HUM GENET, V96, P269; Chen HH, 2007, BIOCHEM BIOPH RES CO, V357, P56, DOI 10.1016/j.bbrc.2007.03.113; Dankort DL, 2000, ONCOGENE, V19, P1038, DOI 10.1038/sj.onc.1203272; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Ismail IA, 2007, EUR J PHARMACOL, V575, P12, DOI 10.1016/j.ejphar.2007.07.039; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Junaid A, 2007, AM J PHYSIOL-CELL PH, V292, pC919, DOI 10.1152/ajpcell.00477.2006; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Kuraguchi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000367; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Landis MD, 2005, ONCOGENE, V24, P5173, DOI 10.1038/sj.onc.1208712; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lenferink AEG, 2001, CANCER RES, V61, P6583; Lewis GD, 1996, CANCER RES, V56, P1457; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Mousses S, 2002, CANCER RES, V62, P1256; PELES E, 1991, EMBO J, V10, P2077, DOI 10.1002/j.1460-2075.1991.tb07739.x; PELES E, 1992, J BIOL CHEM, V267, P12266; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; SANCHEZMARGALET V, 1994, BIOCHEM BIOPH RES CO, V204, P446, DOI 10.1006/bbrc.1994.2480; Seidman A, 2002, J CLIN ONCOL, V20, P1215, DOI 10.1200/JCO.20.5.1215; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stern DF, 2003, EXP CELL RES, V284, P89, DOI 10.1016/S0014-4827(02)00103-9; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Sum EYM, 2005, J HISTOCHEM CYTOCHEM, V53, P475, DOI 10.1369/jhc.4A6553.2005; Sum EYM, 2005, ONCOGENE, V24, P4820, DOI 10.1038/sj.onc.1208638; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Sutherland KD, 2003, INT J CANCER, V107, P155, DOI 10.1002/ijc.11343; Taniwaki M, 2006, INT J ONCOL, V29, P567; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465; Wang N, 2004, ONCOGENE, V23, P1507, DOI 10.1038/sj.onc.1207288; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wittlin S, 2003, GENOMICS, V82, P280, DOI 10.1016/S0888-7543(03)00147-2; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yakes FM, 2002, CANCER RES, V62, P4132; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	53	33	33	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2009	28	41					3608	3618		10.1038/onc.2009.221	http://dx.doi.org/10.1038/onc.2009.221			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KJ	19648968	Green Accepted, Green Submitted			2022-12-25	WOS:000270851800002
J	Brelidze, TI; Carlson, AE; Zagotta, WN				Brelidze, Tinatin I.; Carlson, Anne E.; Zagotta, William N.			Absence of Direct Cyclic Nucleotide Modulation of mEAG1 and hERG1 Channels Revealed with Fluorescence and Electrophysiological Methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; AMP RECEPTOR PROTEIN; HUMAN INWARD RECTIFIER; LONG QT SYNDROME; EAG K+ CHANNELS; POTASSIUM CHANNEL; ESCHERICHIA-COLI; BINDING DOMAIN; CARDIAC-ARRHYTHMIA; PACEMAKER CHANNELS	Similar to CNG and HCN channels, EAG and ERG channels contain a cyclic nucleotide binding domain (CNBD) in their C terminus. While cyclic nucleotides have been shown to facilitate opening of CNG and HCN channels, their effect on EAG and ERG channels is less clear. Here we explored cyclic nucleotide binding and modulation of mEAG1 and hERG1 channels with fluorescence and electrophysiology. Binding of cyclic nucleotides to the isolated CNBD of mEAG1 and hERG1 channels was examined with two independent fluorescence-based methods: changes in tryptophan fluorescence and fluorescence of an analog of cAMP, 8-NBD-cAMP. As a positive control for cyclic nucleotide binding we used changes in the fluorescence of the isolated CNBD of mHCN2 channels. Our results indicated that cyclic nucleotides do not bind to the isolated CNBD domain of mEAG1 channels and bind with low affinity (K-d >= 51 mu M) to the isolated CNBD of hERG1 channels. Consistent with the results on the isolated CNBD, application of cyclic nucleotides to inside-out patches did not affect currents recorded from mEAG1 channels. Surprisingly, despite its low affinity binding to the isolated CNBD, cAMP also had no effect on currents from hERG1 channels even at high concentrations. Our results indicate that cyclic nucleotides do not directly modulate mEAG1 and hERG1 channels. Further studies are necessary to determine if the CNBD in the EAG family of K+ channels might harbor a binding site for a ligand yet to be uncovered.	[Brelidze, Tinatin I.; Carlson, Anne E.; Zagotta, William N.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Brelidze, Tinatin I.; Zagotta, William N.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu		Brelidze, Tinatin/0000-0003-3046-8184	National Institutes of Health [2R01EY010329-16, F32 HL095241]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01EY010329-16 (to W.N.Z.) and F32 HL095241 (to A. E.Q. This work was also supported by the Howard Hughes Medical Institute.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Altieri SL, 2008, J MOL BIOL, V381, P655, DOI 10.1016/j.jmb.2008.06.011; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; BELDUZ AO, 1993, NUCLEIC ACIDS RES, V21, P1827, DOI 10.1093/nar/21.8.1827; Berthet M, 1999, CIRCULATION, V99, P1464, DOI 10.1161/01.CIR.99.11.1464; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; BUBIS J, 1988, J BIOL CHEM, V263, P9668; Cayabyab FS, 2002, J BIOL CHEM, V277, P13673, DOI 10.1074/jbc.M108211200; Chen GQ, 1997, PROTEIN ENG, V10, P1061, DOI 10.1093/protein/10.9.1061; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; Cui J, 2001, J BIOL CHEM, V276, P17244, DOI 10.1074/jbc.M010904200; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Cukkemane A, 2007, EMBO REP, V8, P749, DOI 10.1038/sj.embor.7401025; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; GRONENBORN AM, 1988, BIOCHEM J, V253, P801, DOI 10.1042/bj2530801; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Herzberg IM, 1998, J PHYSIOL-LONDON, V511, P3, DOI 10.1111/j.1469-7793.1998.003bi.x; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kiehn J, 1998, J BIOL CHEM, V273, P25285, DOI 10.1074/jbc.273.39.25285; Kiehn J, 1996, CIRCULATION, V94, P2572, DOI 10.1161/01.CIR.94.10.2572; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Meyer R, 1998, J PHYSIOL-LONDON, V508, P49, DOI 10.1111/j.1469-7793.1998.049br.x; MOORE J, 1992, J BACTERIOL, V174, P8030, DOI 10.1128/JB.174.24.8030-8035.1992; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nimigean CM, 2007, J MOL BIOL, V371, P1325, DOI 10.1016/j.jmb.2007.06.030; OGREID D, 1988, J BIOL CHEM, V263, P17397; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1991, CIRC RES, V68, P77, DOI 10.1161/01.RES.68.1.77; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Thomas D, 1999, J BIOL CHEM, V274, P27457, DOI 10.1074/jbc.274.39.27457; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZHONG Y, 1993, J NEUROSCI, V13, P4669; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	70	85	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27989	27997		10.1074/jbc.M109.016337	http://dx.doi.org/10.1074/jbc.M109.016337			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19671703	Green Published, hybrid			2022-12-25	WOS:000270676300027
J	Helmbold, H; Komm, N; Deppert, W; Bohn, W				Helmbold, H.; Koemm, N.; Deppert, W.; Bohn, W.			Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence	ONCOGENE			English	Article						Rb2/p130; p53; DNA-damage; senescence	ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; FAMILY-MEMBERS; IN-VIVO; ANTICANCER AGENTS; HUMAN FIBROBLASTS; TUMOR-CELLS; S PHASE; GENE; RETINOBLASTOMA	The different pocket proteins are established as negative cell cycle regulators. With regard to the repressor functions of pocket proteins in cellular senescence, studies so far have mainly focused on pRb/p105. Here, we show that in a broad range of wild-type p53-expressing human tumor cells, and in human diploid fibroblasts, Rb2/p130 is the dominating pocket protein in replicative and in accelerated senescence. Senescent cells are arrested at the transition from late G1- to early S-phase, as indicated by the absence of S- and G2-phase cyclins A and B. Expression of cyclin A and entry into S- phase resumed after RNA interference-mediated knockdown of Rb2/p130. Activation of different upstream pathways by overexpression of either p21 or p16 converged on Rb2/p130 accumulation and induced senescence. In contrast, p53- or p21-negative cells treated with DNA-damaging agents failed to accumulate Rb2/p130 and to enter senescence. Our data suggest that Rb2/p130 is a member of the p53-p21 DNA damage signaling cascade, and represents the essential pocket protein family member needed for the induction of any type of senescence. Oncogene (2009) 28, 3456-3467; doi: 10.1038/onc.2009.222; published online 3 August 2009	[Helmbold, H.; Koemm, N.; Deppert, W.; Bohn, W.] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Dept Tumorvirol, D-20251 Hamburg, Germany	Heinrich Pette Institute; University of Hamburg	Helmbold, H (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Dept Tumorvirol, Martinistr 52, D-20251 Hamburg, Germany.	heike.helmbold@hpi.uni-hamburg.de			Deutsche Krebshilfe; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	Deutsche Krebshilfe(Deutsche Krebshilfe); Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	This work was supported by a grant from Deutsche Krebshilfe (German Cancer Aid) to WB. The Heinrich-Pette-Institute is financially supported by Freie und Hansestadt Hamburg and Bundesministerium fur Gesundheit.	Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Caterina C, 2005, ONCOGENE, V24, P5821, DOI 10.1038/sj.onc.1208880; Chang BD, 1999, CANCER RES, V59, P3761; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; CLAUDIO PP, 1994, CANCER RES, V54, P5556; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Helmbold H, 2006, ONCOGENE, V25, P5257, DOI 10.1038/sj.onc.1209613; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Kapic A, 2006, CELL DEATH DIFFER, V13, P324, DOI 10.1038/sj.cdd.4401756; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; Lacy S, 1997, ONCOGENE, V14, P2395, DOI 10.1038/sj.onc.1201085; Li Qiang, 2004, Brain Tumor Pathol, V21, P121, DOI 10.1007/BF02482187; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; SHAN B, 1994, MOL CELL BIOL, V14, P299, DOI 10.1128/MCB.14.1.299; Susini T, 2001, HUM PATHOL, V32, P360, DOI 10.1053/hupa.2001.23514; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Takahashi Y, 2000, GENE DEV, V14, P804; te Poele RH, 2002, CANCER RES, V62, P1876; Tosi GM, 2005, ONCOGENE, V24, P5827, DOI 10.1038/sj.onc.1208630; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800; Zhang BY, 2006, P NATL ACAD SCI USA, V103, P437, DOI 10.1073/pnas.0510012103; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	40	38	39	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	39					3456	3467		10.1038/onc.2009.222	http://dx.doi.org/10.1038/onc.2009.222			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	502RR	19648966				2022-12-25	WOS:000270478300003
J	Chheng, K; Tarquinio, S; Wuthiekanun, V; Sin, L; Thaipadungpanit, J; Amornchai, P; Chanpheaktra, N; Tumapa, S; Putchhat, H; Day, NPJ; Peacock, SJ				Chheng, Kheng; Tarquinio, Sarah; Wuthiekanun, Vanaporn; Sin, Lina; Thaipadungpanit, Janjira; Amornchai, Premjit; Chanpheaktra, Ngoun; Tumapa, Sarinna; Putchhat, Hor; Day, Nicholas P. J.; Peacock, Sharon J.			Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Associated with Pediatric Infection in Cambodia	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; SOFT-TISSUE INFECTIONS; SINGLE CLONE; GENES; SKIN; PNEUMONIA; STRAINS; TRENDS; MRSA; MEC	Background: The incidence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection is rising in the developed world but appears to be rare in developing countries. One explanation for this difference is that resource poor countries lack the diagnostic microbiology facilities necessary to detect the presence of CA-MRSA carriage and infection. Methodology and Principal Findings: We developed diagnostic microbiology capabilities at the Angkor Hospital for Children, Siem Reap, western Cambodia in January 2006 and in the same month identified a child with severe community-acquired impetigo caused by CA-MRSA. A study was undertaken to identify and describe additional cases presenting between January 2006 and December 2007. Bacterial isolates underwent molecular characterization using multilocus sequence typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for the presence of the genes encoding Panton-Valentine Leukocidin (PVL). Seventeen children were identified with CA-MRSA infection, of which 11 had skin and soft tissue infection and 6 had invasive disease. The majority of cases were unrelated in time or place. Molecular characterization identified two independent MRSA clones; fifteen isolates were sequence type (ST) 834, SCCmec type IV, PVL gene-negative, and two isolates were ST 121, SCCmec type V, PVL gene-positive. Conclusions: This represents the first ever report of MRSA in Cambodia, spread of which would pose a significant threat to public health. The finding that cases were mostly unrelated in time or place suggests that these were sporadic infections in persons who were CA-MRSA carriers or contacts of carriers, rather than arising in the context of an outbreak.	[Chheng, Kheng; Tarquinio, Sarah; Sin, Lina; Chanpheaktra, Ngoun; Putchhat, Hor] Angkor Hosp Children, Siem Reap, Cambodia; [Wuthiekanun, Vanaporn; Thaipadungpanit, Janjira; Amornchai, Premjit; Tumapa, Sarinna; Day, Nicholas P. J.; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Day, Nicholas P. J.; Peacock, Sharon J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chheng, K (corresponding author), Angkor Hosp Children, Siem Reap, Cambodia.	sharon@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021	Thaipadungpanit, Janjira/0000-0002-6184-3381; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust; Li Kha Shing Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Li Kha Shing Foundation	Financial support was provided by the Wellcome Trust and the Li Kha Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2002, J ANTIMICROB CHEMOTH, V50, P825, DOI 10.1093/jac/dkf242; BENNEJMA M, 2009, DIAGN MICROBIOL 0402; *CDC, 1998, JAMA-J AM MED ASSOC, V282, P1123; Clinical and Laboratory Standards Institute, 2006, M2A9 CLIN LAB STAND; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fiebelkorn KR, 2003, J CLIN MICROBIOL, V41, P4740, DOI 10.1128/JCM.41.10.4740-4744.2003; Fishbain Joel T, 2002, Hawaii Med J, V61, P231; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gupta K, 2007, J CLIN MICROBIOL, V45, P3930, DOI 10.1128/JCM.01510-07; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Karden-Lilja M, 2007, EUR J CLIN MICROBIOL, V26, P729, DOI 10.1007/s10096-007-0334-0; Kim ES, 2007, J ANTIMICROB CHEMOTH, V60, P1108, DOI 10.1093/jac/dkm309; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Liassine N, 2004, J CLIN MICROBIOL, V42, P825, DOI 10.1128/JCM.42.2.825-828.2004; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lo WT, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-51; Mekviwattanawong Sripetcharat, 2006, J Med Assoc Thai, V89 Suppl 5, pS106; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Sam IC, 2008, DIAGN MICR INFEC DIS, V62, P437, DOI 10.1016/j.diagmicrobio.2008.07.016; Tang CT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000822; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978	28	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6630	10.1371/journal.pone.0006630	http://dx.doi.org/10.1371/journal.pone.0006630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675670	Green Published, gold, Green Submitted			2022-12-25	WOS:000268936100007
J	Boulais, N; Pereira, U; Lebonvallet, N; Gobin, E; Dorange, G; Rougier, N; Chesne, C; Misery, L				Boulais, Nicholas; Pereira, Ulysse; Lebonvallet, Nicolas; Gobin, Eric; Dorange, Germaine; Rougier, Nathalie; Chesne, Christophe; Misery, Laurent			Merkel Cells as Putative Regulatory Cells in Skin Disorders: An In Vitro Study	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; IMMUNOHISTOCHEMICAL LOCALIZATION; PALATINE MUCOSA; SENSORY NEURONS; MET-ENKEPHALIN; VIP; MECHANORECEPTORS; IMMUNOREACTIVITY; PROLIFERATION; DEPENDENCY	Merkel cells (MCs) are involved in mechanoreception, but several lines of evidence suggest that they may also participate in skin disorders through the release of neuropeptides and hormones. In addition, MC hyperplasias have been reported in inflammatory skin diseases. However, neither proliferation nor reactions to the epidermal environment have been demonstrated. We established a culture model enriched in swine MCs to analyze their proliferative capability and to discover MC survival factors and modulators of MC neuroendocrine properties. In culture, MCs reacted to bFGF by extending outgrowths. Conversely, neurotrophins failed to induce cell spreading, suggesting that they do not act as a growth factor for MCs. For the first time, we provide evidence of proliferation in culture through Ki-67 immunoreactivity. We also found that MCs reacted to histamine or activation of the proton gated/osmoreceptor TRPV4 by releasing vasoactive intestinal peptide (VIP). Since VIP is involved in many pathophysiological processes, its release suggests a putative regulatory role for MCs in skin disorders. Moreover, in contrast to mechanotransduction, neuropeptide exocytosis was Ca(2+)-independent, as inhibition of Ca(2+) channels or culture in the absence of Ca(2+) failed to decrease the amount of VIP released. We conclude that neuropeptide release and neurotransmitter exocytosis may be two distinct pathways that are differentially regulated.	[Boulais, Nicholas; Pereira, Ulysse; Lebonvallet, Nicolas; Dorange, Germaine; Misery, Laurent] Univ Brest, EA4326, Brest, France; [Gobin, Eric] Univ Hosp, Pathol Lab, Brest, France; [Boulais, Nicholas; Rougier, Nathalie; Chesne, Christophe] BIOPREDIC Int, Rennes, France; [Misery, Laurent] Univ Hosp, Dept Dermatol, Brest, France	Universite de Bretagne Occidentale; CHU Brest; CHU Brest	Boulais, N (corresponding author), Univ Brest, EA4326, Brest, France.	laurent.misery@chu-brest.fr	Misery, Laurent/I-1186-2019; Pereira, Ulysse/ABF-6922-2020	Lebonvallet, Nicolas/0000-0001-7263-1408; Pereira, Ulysse/0000-0001-5677-6906	Socite Francaise de Dermatologie	Socite Francaise de Dermatologie	This work was helped by a grant from the Socite Francaise de Dermatologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTFAI T, 1988, ANNU REV PHARMACOL, V28, P285, DOI 10.1146/annurev.pa.28.040188.001441; Botchkarev VA, 1999, J INVEST DERMATOL, V113, P691; Boulais N, 2008, EUR J DERMATOL, V18, P119, DOI 10.1684/ejd.2008.0348; Boulais N, 2007, J AM ACAD DERMATOL, V57, P147, DOI 10.1016/j.jaad.2007.02.009; BROSIUS DC, 1992, J NEUROPHYSIOL, V68, P1229, DOI 10.1152/jn.1992.68.4.1229; Cahusac PMB, 2006, SYNAPSE, V59, P235, DOI 10.1002/syn.20236; Cannon KE, 2007, PAIN, V129, P76, DOI 10.1016/j.pain.2006.09.039; Chateau Y, 2007, J INVEST DERMATOL, V127, P979, DOI 10.1038/sj.jid.5700646; CHEW SBC, 1994, J ANAT, V185, P511; DALLOS A, 2006, NEUROPEPTIDES; Delgado M, 1999, J IMMUNOL, V162, P4685; EISPERT AC, 2009, HISTOCHEM CELL BIOL; Fantini F, 1992, Exp Dermatol, V1, P127; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fernandez-Martin A, 2006, ANN NY ACAD SCI, V1070, P276, DOI 10.1196/annals.1317.026; Fradette J, 2003, J INVEST DERMATOL, V120, P313, DOI 10.1046/j.1523-1747.2003.12024.x; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; GALLEGO R, 1995, VIRCHOWS ARCH, V426, P317; GAUDILLERE A, 1994, ANN DERMATOL VENER, V121, P909; GOTTSCHALDT KM, 1982, EXP BRAIN RES, V45, P459, DOI 10.1007/BF01208608; Granoth R, 2000, FEBS LETT, V475, P78, DOI 10.1016/S0014-5793(00)01628-8; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Haeberle H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001750; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HARTSCHUH W, 1984, PEPTIDES, V5, P239, DOI 10.1016/0196-9781(84)90213-4; HARTSCHUH W, 1989, ARCH HISTOL CYTOL, V52, P423, DOI 10.1679/aohc.52.Suppl_423; HARTSCHUH W, 1983, J INVEST DERMATOL, V81, P361, DOI 10.1111/1523-1747.ep12519966; Ichikawa H, 2001, MOL BRAIN RES, V88, P171, DOI 10.1016/S0169-328X(01)00035-3; Kakurai M, 2001, J INVEST DERMATOL, V116, P743, DOI 10.1046/j.1523-1747.2001.01306.x; Kanitakis J, 1998, DERMATOLOGY, V196, P208, DOI 10.1159/000017900; Kim DK, 2001, YONSEI MED J, V42, P311, DOI 10.3349/ymj.2001.42.3.311; Krimm RF, 2004, J COMP NEUROL, V471, P352, DOI 10.1002/cne.20041; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; McNiff JM, 2005, J CUTAN PATHOL, V32, P541, DOI 10.1111/j.0303-6987.2005.00378.x; MEROT Y, 1988, ACTA DERM-VENEREOL, V68, P366; MEROT Y, 1989, DERMATOLOGICA, V178, P189, DOI 10.1159/000248425; Misery L, 2003, ANN DERMATOL VENER, V130, P195; Moll I, 1996, J INVEST DERMATOL, V106, P281, DOI 10.1111/1523-1747.ep12340714; Moll I, 2005, EUR J CELL BIOL, V84, P259, DOI 10.1016/j.ejcb.2004.12.023; Moll I, 1996, ARCH DERMATOL RES, V288, P184, DOI 10.1007/s004030050044; NARISAWA Y, 1994, J INVEST DERMATOL, V102, P506, DOI 10.1111/1523-1747.ep12373164; Ogawa H, 1996, PROG NEUROBIOL, V49, P317, DOI 10.1016/0301-0082(96)00018-4; PISKOROWSKI R, 2008, PFLUGERS ARCH; REGAZZINI R, 1995, EUR J DERMATOL, V5, P326; Reich A, 2008, G Ital Dermatol Venereol, V143, P289; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Senok SS, 1997, J PHYSIOL-LONDON, V500, P29, DOI 10.1113/jphysiol.1997.sp021996; Shimohira-Yamasaki M, 2006, CELL STRUCT FUNCT, V31, P39, DOI 10.1247/csf.31.39; Szeder V, 2003, DEV DYNAM, V228, P623, DOI 10.1002/dvdy.10403; Szeder V, 2003, DEV BIOL, V253, P258, DOI 10.1016/S0012-1606(02)00015-5; Tachibana T, 1998, ARCH HISTOL CYTOL, V61, P115, DOI 10.1679/aohc.61.115; Tachibana T, 2000, ANAT EMBRYOL, V202, P359, DOI 10.1007/s004290000124; Tachibana T, 1997, ARCH HISTOL CYTOL, V60, P379, DOI 10.1679/aohc.60.379; TACHIBANA T, 1995, ARCH HISTOL CYTOL, V58, P379, DOI 10.1679/aohc.58.379; VAIGOT P, 1987, ACTA DERM-VENEREOL, V67, P517; VOS P, 1991, DEV BIOL, V144, P281, DOI 10.1016/0012-1606(91)90422-Y; YAMASHITA Y, 1992, J PHYSIOL-LONDON, V450, P143, DOI 10.1113/jphysiol.1992.sp019120	59	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6528	10.1371/journal.pone.0006528	http://dx.doi.org/10.1371/journal.pone.0006528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668696	gold, Green Published, Green Submitted			2022-12-25	WOS:000268935600003
J	Mattiussi, S; Lazzari, C; Truffa, S; Antonini, A; Soddu, S; Capogrossi, MC; Gaetano, C				Mattiussi, Stefania; Lazzari, Chiara; Truffa, Silvia; Antonini, Annalisa; Soddu, Silvia; Capogrossi, Maurizio C.; Gaetano, Carlo			Homeodomain Interacting Protein Kinase 2 Activation Compromises Endothelial Cell Response to Laminar Flow: Protective Role of p21waf1,cip1,sdi1	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FLUID SHEAR-STRESS; VASCULAR INFLAMMATION; APOPTOSIS; INJURY; P53; INHIBITION; CANCER	Background: In the cardiovascular system, laminar shear stress (SS) is one of the most important source of endothelial protecting signals. Physical and chemical agents, however, including ionising radiations and anticancer drugs, may injure endothelial cells determining an increase in oxidative stress and genotoxic damage. Whether the SS protective function remains intact in the presence of strong oxidants or DNA damage is currently unclear. Methods and Results: To investigate this aspect a series of experiments were performed in which HUVEC were exposed to sub-lethal doses of the radio-mimetic compound Bleomycin (Bleo; 10 mu g/ml) which generated free radicals (ROS) without significantly compromising cell survival. Remarkably, the application of a SS of 12 dyne/cm(2) did not protect endothelial cells but markedly accelerated apoptosis compared to controls kept in static culture and in the presence of Bleo. Experiments with the inducible nitric oxide synthase (iNOS) inhibitor GW274150 significantly reduced the SS-dependent apoptosis indicating that the production of NO was relevant for this effect. At molecular level, the ataxia-telangectasia-mutated (ATM) kinase, the homeodomain-interacting protein kinase-2 (HIPK2) and p53 were found activated along a pro-apoptotic signalling pathway while p21(waf1,cip1,sdi1) was prevented from its protective action. RNA interference experiments revealed that HIPK2 and p53 were both important for this process, however, only the forced expression p21(waf1,cip1,sdi1) fully restored the SS-dependent pro-survival function. Conclusions: This study provides the first evidence that, in the presence of genotoxic damage, laminar flow contributes to endothelial toxicity and death and identifies molecular targets potentially relevant in endothelial dysfunction and cardiovascular disease pathogenesis.	[Mattiussi, Stefania; Truffa, Silvia; Antonini, Annalisa; Capogrossi, Maurizio C.; Gaetano, Carlo] Ist Dermopat Immacolata, Lab Patol Vasc, Rome, Italy; [Lazzari, Chiara; Soddu, Silvia] Ist Regina Elena, Lab Oncogenesi Mol, Dipartimento Oncol Sperimentale, I-00161 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Mattiussi, S (corresponding author), Ist Dermopat Immacolata, Lab Patol Vasc, Rome, Italy.	gaetano@idi.it	Gaetano, Carlo/P-9997-2019; Soddu, Silvia/ABH-6774-2020; Soddu, Silvia/K-2467-2018	Gaetano, Carlo/0000-0002-5238-1832; Soddu, Silvia/0000-0001-8526-0044; Soddu, Silvia/0000-0001-8526-0044	FIRB [RBLA035A4X-1-FIRB]; UE FP6 [UE-LHSB-CT-04-502988]	FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); UE FP6(European Commission)	This work has been partially supported by: grant FIRB # RBLA035A4X-1-FIRB to M.C.C., UE FP6 grant # UE-LHSB-CT-04-502988 to M. C. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto S, 2000, CIRC RES, V86, P185, DOI 10.1161/01.RES.86.2.185; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bartling B, 2000, BIOCHEM BIOPH RES CO, V278, P740, DOI 10.1006/bbrc.2000.3873; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Colman MS, 2000, MUTAT RES-REV MUTAT, V462, P179, DOI 10.1016/S1383-5742(00)00035-1; COLUSSI C, 2009, FASEB J; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Das Undurti, 2002, Med Sci Monit, V8, pRA79; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Dimmeler S, 1996, FEBS LETT, V399, P71, DOI 10.1016/S0014-5793(96)01289-6; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Eiserich Jason P., 1998, Molecular Aspects of Medicine, V19, P221, DOI 10.1016/S0098-2997(99)00002-3; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; FRAGKOS M, 2009, MOL CELL BIOL; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Genovese T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-58; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Hall MC, 2000, J UROLOGY, V163, P1033, DOI 10.1016/S0022-5347(05)67877-9; Harrison DG, 2006, J INTERN MED, V259, P351, DOI 10.1111/j.1365-2796.2006.01621.x; Hermann C, 1997, ARTERIOSCL THROM VAS, V17, P3588, DOI 10.1161/01.ATV.17.12.3588; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; LAZO JS, 1986, BIOCHEM PHARMACOL, V35, P1919, DOI 10.1016/0006-2952(86)90720-3; Lin K, 2000, P NATL ACAD SCI USA, V97, P9385, DOI 10.1073/pnas.170282597; Mailloux A, 2001, EUR J CELL BIOL, V80, P442, DOI 10.1078/0171-9335-00171; MARTIN WJ, 1987, J LAB CLIN MED, V110, P153; Mattiussi S, 2004, CARDIOVASC RES, V61, P693, DOI 10.1016/j.cardiores.2003.12.008; Mattiussi S, 2006, CARDIOVASC RES, V70, P578, DOI 10.1016/j.cardiores.2006.02.008; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Moncada S., 2006, V176, P213; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Sullivan R, 2008, CURR PHARM DESIGN, V14, P1113, DOI 10.2174/138161208784246225; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001	33	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6603	10.1371/journal.pone.0006603	http://dx.doi.org/10.1371/journal.pone.0006603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668373	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935600020
J	Jin, J; Sturgeon, T; Weisz, OA; Mothes, W; Montelaro, RC				Jin, Jing; Sturgeon, Timothy; Weisz, Ora A.; Mothes, Walther; Montelaro, Ronald C.			HIV-1 Matrix Dependent Membrane Targeting Is Regulated by Gag mRNA Trafficking	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTIOUS-ANEMIA VIRUS; TYPE-1 GAG; PLASMA-MEMBRANE; BINDING; CELLS; RETROVIRUS; LOCALIZATION; MACROPHAGES; REV	Retroviral Gag polyproteins are necessary and sufficient for virus budding. Productive HIV-1 Gag assembly takes place at the plasma membrane. However, little is known about the mechanisms by which thousands of Gag molecules are targeted to the plasma membrane. Using a bimolecular fluorescence complementation (BiFC) assay, we recently reported that the cellular sites and efficiency of HIV-1 Gag assembly depend on the precise pathway of Gag mRNA export from the nucleus, known to be mediated by Rev. Here we describe an assembly deficiency in human cells for HIV Gag whose expression depends on hepatitis B virus (HBV) post-transcriptional regulatory element (PRE) mediated-mRNA nuclear export. PRE-dependent HIV Gag expressed well in human cells, but assembled with slower kinetics, accumulated intracellularly, and failed to associate with a lipid raft compartment where the wild-type Rev-dependent HIV-1 Gag efficiently assembles. Surprisingly, assembly and budding of PRE-dependent HIV Gag in human cells could be rescued in trans by co-expression of Rev-dependent Gag that provides correct membrane targeting signals, or in cis by replacing HIV matrix (MA) with other membrane targeting domains. Taken together, our results demonstrate deficient membrane targeting of PRE-dependent HIV-1 Gag and suggest that HIV MA function is regulated by the trafficking pathway of the encoding mRNA.			Jin, J (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	rmont@pitt.edu		Jin, Jing/0000-0003-3994-8600	NCI NIH HHS [R01 CA098727, R01 CA49296, R01 CA049296] Funding Source: Medline; NIAID NIH HHS [R56 AI073261] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098727, R01CA049296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073261] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Bieniasz PD, 2000, J VIROL, V74, P9868, DOI 10.1128/JVI.74.21.9868-9877.2000; BLOM J, 1993, APMIS, V101, P672, DOI 10.1111/j.1699-0463.1993.tb00164.x; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; Cook RF, 1998, J VIROL, V72, P1383, DOI 10.1128/JVI.72.2.1383-1393.1998; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Ding LM, 2003, J VIROL, V77, P1916, DOI 10.1128/JVI.77.3.1916-1926.2003; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Gomez CY, 2006, J VIROL, V80, P8796, DOI 10.1128/JVI.02159-05; Hatziioannou T, 2005, J VIROL, V79, P15586, DOI 10.1128/JVI.79.24.15586-15589.2005; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hubner W, 2006, VIROLOGY, V352, P27, DOI 10.1016/j.virol.2006.04.024; Jager S, 2007, J VIROL, V81, P9193, DOI 10.1128/JVI.00044-07; Jin J, 2007, J VIROL, V81, P11226, DOI 10.1128/JVI.00431-07; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lindwasser OW, 2002, P NATL ACAD SCI USA, V99, P13037, DOI 10.1073/pnas.212409999; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Lochrie MA, 1997, NUCLEIC ACIDS RES, V25, P2902, DOI 10.1093/nar/25.14.2902; Mariani R, 2001, J VIROL, V75, P3141, DOI 10.1128/JVI.75.7.3141-3151.2001; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; NASIOULAS G, 1995, P NATL ACAD SCI USA, V92, P11940, DOI 10.1073/pnas.92.25.11940; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Ono A, 2005, ADV VIRUS RES, V64, P311, DOI 10.1016/S0065-3527(05)64010-9; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Ono A, 2007, VIROLOGY, V360, P27, DOI 10.1016/j.virol.2006.10.011; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Ott DE, 2005, J VIROL, V79, P13839, DOI 10.1128/JVI.79.22.13839-13847.2005; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perez-Caballero D, 2004, J VIROL, V78, P9560, DOI 10.1128/JVI.78.17.9560-9563.2004; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; Spearman P, 1997, J VIROL, V71, P6582, DOI 10.1128/JVI.71.9.6582-6592.1997; Swanson CM, 2006, TRAFFIC, V7, P1440, DOI 10.1111/j.1600-0854.2006.00488.x; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036	51	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6551	10.1371/journal.pone.0006551	http://dx.doi.org/10.1371/journal.pone.0006551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662089	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000268739600008
J	Ravel, C; Chantot-Bastaraud, S; Chalmey, C; Barreiro, L; Aknin-Seifer, I; Pfeffer, J; Berthaut, I; Mathieu, EE; Mandelbaum, J; Siffroi, JP; McElreavey, K; Bashamboo, A				Ravel, Celia; Chantot-Bastaraud, Sandra; Chalmey, Clementine; Barreiro, Luis; Aknin-Seifer, Isabelle; Pfeffer, Jerome; Berthaut, Isabelle; Mathieu, E. Emmanuelle; Mandelbaum, Jacqueline; Siffroi, Jean-Pierre; McElreavey, Ken; Bashamboo, Anu			Lack of Association between Genetic Polymorphisms in Enzymes Associated with Folate Metabolism and Unexplained Reduced Sperm Counts	PLOS ONE			English	Article								Background: The metabolic pathway of folate is thought to influence DNA stability either by inducing single/double stranded breaks or by producing low levels of S-adenosyl-methionine leading to abnormal gene expression and chromosome segregation. Polymorphisms in the genes encoding enzymes in the folate metabolism pathway show distinct geographic and/or ethnic variations and in some cases have been linked to disease. Notably, the gene Methylenetetrahydrofolate reductase (MTHFR) in which the homozygous (TT) state of the polymorphism c.665C>T (p.A222V) is associated with reduced specific activity and increased thermolability of the enzyme causing mild hyperhomocysteinemia. Recently several studies have suggested that men carrying this polymorphism may be at increased risk to develop infertility. Methodology/Principal Findings: We have tested this hypothesis in a case/control study of ethnic French individuals. We examined the incidence of polymorphisms in the genes MTHFR (R68Q, A222V and E429A), Methionine synthase reductase MTRR; (I22M and S175L) and Cystathionine beta-synthase (CBS; G307S). The case population consisted of DNA samples from men with unexplained azoospermia (n = 70) or oligozoospermia (n = 182) and the control population consisted of normospermic and fertile men (n = 114). We found no evidence of an association between the incidence of any of these variants and reduced sperm counts. In addition haplotype analysis did not reveal differences between the case and control populations. Conclusions/Significance: We could find no evidence for an association between reduced sperm counts and polymorphisms in enzymes involved in folate metabolism in the French population.			Ravel, C (corresponding author), Inst Pasteur, Paris, France.	kenmce@pasteur.fr	Barreiro, Luis/I-7772-2015; RAVEL, Celia/F-2702-2015	RAVEL, Celia/0000-0001-5013-6932; Chalmey, Clementine/0000-0002-1874-2876; Barreiro, Luis/0000-0001-9456-367X				A ZC, 2007, ASIAN J ANDROL, V9, P57, DOI 10.1111/j.1745-7262.2007.00225.x; BENTIVOGLIO G, 1993, FERTIL STERIL, V60, P698; Bezold G, 2001, NEW ENGL J MED, V344, P1172, DOI 10.1056/NEJM200104123441517; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Dhillon VS, 2007, MOL HUM REPROD, V13, P213, DOI 10.1093/molehr/gal118; Donnelly JG, 2001, CRIT REV CL LAB SCI, V38, P183, DOI 10.1080/20014091084209; Ebisch IMW, 2003, FERTIL STERIL, V80, P1190, DOI 10.1016/S0015-0282(03)02157-5; Fowler Brian, 2005, Semin Vasc Med, V5, P77; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GALLAGHER PM, 1995, HUM MUTAT, V6, P177, DOI 10.1002/humu.1380060211; Gaughan DJ, 2001, ATHEROSCLEROSIS, V157, P451, DOI 10.1016/S0021-9150(00)00739-5; HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857; Kelly TLJ, 2005, BIOL REPROD, V72, P667, DOI 10.1095/biolreprod.104.035238; KRAUS JP, 1994, J INHERIT METAB DIS, V17, P383, DOI 10.1007/BF00711354; Krausz C, 2001, HUM MOL GENET, V10, P1873, DOI 10.1093/hmg/10.18.1873; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Lee HC, 2006, HUM REPROD, V21, P3162, DOI 10.1093/humrep/del280; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; McElreavey K, 2000, Results Probl Cell Differ, V28, P211; O'Leary VB, 2005, MOL GENET METAB, V85, P220, DOI 10.1016/j.ymgme.2005.02.003; O'Leary VB, 2002, AM J MED GENET, V107, P151, DOI 10.1002/ajmg.10121; Park JH, 2005, J ASSIST REPROD GEN, V22, P361, DOI 10.1007/s10815-005-6795-0; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Singh K, 2005, INT J ANDROL, V28, P115, DOI 10.1111/j.1365-2605.2004.00513.x; Stevenson RE, 1997, AM J HUM GENET, V60, P229; Stuppia L, 2003, J ENDOCRINOL INVEST, V26, P620, DOI 10.1007/BF03347018; Toffoli G, 2008, PHARMACOGENOMICS, V9, P1195, DOI 10.2217/14622416.9.9.1195; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; vanderPut NMJ, 1996, J MOL MED, V74, P691, DOI 10.1007/s001090050073; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Wong WY, 2002, FERTIL STERIL, V77, P491, DOI 10.1016/S0015-0282(01)03229-0	37	46	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6540	10.1371/journal.pone.0006540	http://dx.doi.org/10.1371/journal.pone.0006540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657388	gold, Green Published, Green Submitted			2022-12-25	WOS:000268739300011
J	Yadav, UCS; Ramana, KV; Aguilera-Aguirre, L; Boldogh, I; Boulares, HA; Srivastava, SK				Yadav, Umesh C. S.; Ramana, Kota V.; Aguilera-Aguirre, Leopoldo; Boldogh, Istvan; Boulares, Hamid A.; Srivastava, Satish K.			Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice	PLOS ONE			English	Article							FACTOR-KAPPA-B; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; MONOCLONAL-ANTIBODY; CYCLOOXYGENASE-2 EXPRESSION; EOSINOPHIL RECRUITMENT; ASTHMATIC SUBJECTS; N-ACETYLCYSTEINE; MURINE MODEL	Background: The bronchial asthma, a clinical complication of persistent inflammation of the airway and subsequent airway hyper-responsiveness, is a leading cause of morbidity and mortality in critically ill patients. Several studies have shown that oxidative stress plays a key role in initiation as well as amplification of inflammation in airways. However, still there are no good anti-oxidant strategies available for therapeutic intervention in asthma pathogenesis. Most recent studies suggest that polyol pathway enzyme, aldose reductase (AR), contributes to the pathogenesis of oxidative stress-induced inflammation by affecting the NF-kappa B-dependent expression of cytokines and chemokines and therefore inhibitors of AR could be antiinflammatory. Since inhibitors of AR have already gone through phase-III clinical studies for diabetic complications and found to be safe, our hypothesis is that AR inhibitors could be novel therapeutic drugs for the prevention and treatment of asthma. Hence, we investigated the efficacy of AR inhibition in the prevention of allergic responses to a common natural airborne allergen, ragweed pollen that leads to airway inflammation and hyper-responsiveness in a murine model of asthma. Methods and Findings: Primary Human Small Airway Epithelial Cells (SAEC) were used to investigate the in vitro effects of AR inhibition on ragweed pollen extract (RWE)-induced cytotoxic and inflammatory signals. Our results indicate that inhibition of AR prevents RWE-induced apoptotic cell death as measured by annexin-v staining, increase in the activation of NF-kappa B and expression of inflammatory markers such as inducible nitric oxide synthase (iNOS), cycloxygenase (COX)-2, Prostaglandin (PG) E-2, IL-6 and IL-8. Further, BALB/c mice were sensitized with endotoxin-free RWE in the absence and presence of AR inhibitor and followed by evaluation of perivascular and peribronchial inflammation, mucin production, eosinophils infiltration and airway hyperresponsiveness. Our results indicate that inhibition of AR prevents airway inflammation and production of inflammatory cytokines, accumulation of eosinophils in airways and sub-epithelial regions, mucin production in the bronchoalveolar lavage fluid and airway hyperresponsiveness in mice. Conclusions: These results suggest that airway inflammation due to allergic response to RWE, which subsequently activates oxidative stress-induced expression of inflammatory cytokines via NF-kappa B-dependent mechanism, could be prevented by AR inhibitors. Therefore, inhibition of AR could have clinical implications, especially for the treatment of airway inflammation, a major cause of asthma pathogenesis.			Yadav, UCS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	ssrivast@utmb.edu	Ramana, Kota/C-5460-2012; Yadav, Umesh/C-7858-2012; Aguilera-Aguirre, Leopoldo/B-9864-2012	Ramana, Kota/0000-0001-6502-7800; Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI062885] Funding Source: Medline; NIEHS NIH HHS [P30 ES006676] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Awasthi YC, 2008, FREE RADICAL BIO MED, V45, P111, DOI 10.1016/j.freeradbiomed.2008.04.007; Awasthi Yogesh C., 2003, Molecular Aspects of Medicine, V24, P219; Bacsi A, 2005, J ALLERGY CLIN IMMUN, V116, P836, DOI 10.1016/j.jaci.2005.06.002; Bacsi A, 2006, J ALLERGY CLIN IMMUN, V118, P844, DOI 10.1016/j.jaci.2006.07.006; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Casillas AM, 1999, ANN ALLERG ASTHMA IM, V83, P624, DOI 10.1016/S1081-1206(10)62884-0; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Cho HY, 2001, AM J PHYSIOL-LUNG C, V280, pL537, DOI 10.1152/ajplung.2001.280.3.L537; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; De Benedetto F, 2005, PULM PHARMACOL THER, V18, P41, DOI 10.1016/j.pupt.2004.09.030; Dekhuijzen PNR, 2004, EUR RESPIR J, V23, P629, DOI 10.1183/09031936.04.00016804; Dharajiya N, 2007, J ALLERGY CLIN IMMUN, V119, P646, DOI 10.1016/j.jaci.2006.11.634; Dworski R, 2000, THORAX, V55, pS51, DOI 10.1136/thorax.55.suppl_2.S51; Ebtekar Massoumeh, 2006, Iran J Allergy Asthma Immunol, V5, P47; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; Hamada Yoji, 2004, Treat Endocrinol, V3, P245, DOI 10.2165/00024677-200403040-00006; HAMID Q, 1993, LANCET, V342, P1510, DOI 10.1016/S0140-6736(05)80083-2; Hauber Hans-Peter, 2008, Inflammation & Allergy Drug Targets, V7, P30, DOI 10.2174/187152808784165153; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; KAY AB, 1992, BRIT MED BULL, V48, P51, DOI 10.1093/oxfordjournals.bmb.a072541; Kierstein S, 2008, ALLERGY, V63, P438, DOI 10.1111/j.1398-9995.2007.01587.x; KING TP, 1976, ADV IMMUNOL, V23, P77, DOI 10.1016/S0065-2776(08)60319-3; Kirkham P, 2006, PHARMACOL THERAPEUT, V111, P476, DOI 10.1016/j.pharmthera.2005.10.015; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Liu TS, 2004, J BIOL CHEM, V279, P2461, DOI 10.1074/jbc.M307251200; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Pantano C, 2008, AM J RESP CRIT CARE, V177, P959, DOI 10.1164/rccm.200707-1096OC; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pladzyk A, 2006, INVEST OPHTH VIS SCI, V47, P5395, DOI 10.1167/iovs.06-0469; Pourazar J, 2005, AM J PHYSIOL-LUNG C, V289, pL724, DOI 10.1152/ajplung.00055.2005; Profita M, 2003, J ALLERGY CLIN IMMUN, V112, P709, DOI 10.1016/S0091-6749(03)01889-X; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; RAFNAR T, 1991, J BIOL CHEM, V266, P1229; Rahman I, 2001, BIOCHEM PHARMACOL, V62, P787, DOI 10.1016/S0006-2952(01)00702-X; Ramana KV, 2006, J BIOL CHEM, V281, P33019, DOI 10.1074/jbc.M603819200; Ramana KV, 2006, J BIOL CHEM, V281, P17652, DOI 10.1074/jbc.M600270200; Ramana KV, 2004, DIABETES, V53, P2910, DOI 10.2337/diabetes.53.11.2910; Ramana KV, 2004, FEBS LETT, V570, P189, DOI 10.1016/j.febslet.2004.06.046; Ramana KV, 2002, FASEB J, V16, P315, DOI 10.1096/fj.02-0568fje; Ramana KV, 2002, J BIOL CHEM, V277, P32063, DOI 10.1074/jbc.M202126200; Ramis I, 2000, EUR RESPIR J, V15, P582, DOI 10.1034/j.1399-3003.2000.15.26.x; Redington AE, 2001, THORAX, V56, P351, DOI 10.1136/thorax.56.5.351; ROBINSON D, 1993, J ALLERGY CLIN IMMUN, V92, P313, DOI 10.1016/0091-6749(93)90175-F; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Sadowska AM, 2005, RESP MED, V99, P241, DOI 10.1016/j.rmed.2004.07.005; Schunemann HJ, 1997, AM J EPIDEMIOL, V146, P939; SCHWARTZ J, 1994, AM J CLIN NUTR, V59, P110, DOI 10.1093/ajcn/59.1.110; Shardonofsky FR, 1999, J ALLERGY CLIN IMMUN, V104, P215, DOI 10.1016/S0091-6749(99)70138-7; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Tammali R, 2006, CANCER RES, V66, P9705, DOI 10.1158/0008-5472.CAN-06-2105; Wang CC, 2005, AM J PHYSIOL-LUNG C, V288, pL227, DOI 10.1152/ajplung.00224.2004; Yadav UCS, 2007, INVEST OPHTH VIS SCI, V48, P4634, DOI 10.1167/iovs.07-0485; Yadav UCS, 2009, INVEST OPHTH VIS SCI, V50, P752, DOI 10.1167/iovs.08-2322; Yamashita M, 2007, CRIT REV IMMUNOL, V27, P539, DOI 10.1615/CritRevImmunol.v27.i6.40; Yang GY, 2005, J PHARMACOL EXP THER, V313, P8, DOI 10.1124/jpet.104.076133; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Zhao Y, 2009, AM J RESP CELL MOL, V40, P19, DOI 10.1165/rcmb.2008-0105OC	64	46	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6535	10.1371/journal.pone.0006535	http://dx.doi.org/10.1371/journal.pone.0006535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657391	Green Submitted, gold, Green Published			2022-12-25	WOS:000268739300006
J	Raghavachari, N; Xu, XL; Munson, PJ; Gladwin, MT				Raghavachari, Nalini; Xu, Xiuli; Munson, Peter J.; Gladwin, Mark T.			Characterization of Whole Blood Gene Expression Profiles as a Sequel to Globin mRNA Reduction in Patients with Sickle Cell Disease	PLOS ONE			English	Article								Global transcriptome analysis of whole blood RNA using microarrays has been proven to be challenging due to the high abundance of globin transcripts that constitute 70% of whole blood mRNA. This is a particular problem in patients with sickle cell disease, secondary to the high abundance of globin-expressing nucleated red blood cells and reticulocytes in the circulation. In order to accurately measure the steady state blood transcriptome in sickle cell patients we evaluated the efficacy of reducing globin transcripts in PAXgene stabilized RNA for genome-wide transcriptome analyses using microarrays. We demonstrate here by both microarrays and Q-PCR that the globin mRNA depletion method resulted in 5565 fold reduction in globin transcripts in whole blood collected from healthy volunteers and sickle cell disease patients. This led to an improvement in microarray data quality by reducing data variability, with increased detection rate of expressed genes and improved overlap with the expression signatures of isolated peripheral blood mononuclear (PBMC) preparations. Analysis of differences between the whole blood transcriptome and PBMC transcriptome revealed important erythrocyte genes that participate in sickle cell pathogenesis and compensation. The combination of globin mRNA reduction after whole-blood RNA stabilization represents a robust clinical research methodology for the discovery of biomarkers for hematologic diseases.			Raghavachari, N (corresponding author), NHLBI, NIH, Pulm & Vasc Med Branch, Bldg 10, Bethesda, MD 20892 USA.	nraghavachari@nhlbi.nih.gov			CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266, Z01CT000266] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006018] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AFF, 2003, AN BLOOD PROC METH P; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; DePrimo SE, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-3; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Locati M, 2002, J IMMUNOL, V168, P3557, DOI 10.4049/jimmunol.168.7.3557; McPhail S, 2005, DRUG DISCOV TODAY, V10, P1485, DOI 10.1016/S1359-6446(05)03644-5; Pahl A, 2002, BLOOD, V100, P1094, DOI 10.1182/blood-2002-03-0813; Rainen L, 2002, CLIN CHEM, V48, P1883; WHITLEY PMS, 2005, IMPROVED MICROARRAY, P20	13	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6484	10.1371/journal.pone.0006484	http://dx.doi.org/10.1371/journal.pone.0006484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649296	Green Accepted, Green Published, gold			2022-12-25	WOS:000268637700009
J	Millington, M; Arndt, A; Boyd, M; Applegate, T; Shen, S				Millington, Michelle; Arndt, Allison; Boyd, Maureen; Applegate, Tanya; Shen, Sylvie			Towards a Clinically Relevant Lentiviral Transduction Protocol for Primary Human CD34(+) Hematopoietic Stem/Progenitor Cells	PLOS ONE			English	Article							EX-VIVO EXPANSION; INTEGRATION SITE SELECTION; RETROVIRAL GENE-TRANSFER; STEM-CELLS; BONE-MARROW; ALDEHYDE DEHYDROGENASE; IN-VITRO; INSERTIONAL MUTAGENESIS; TRANSGENE EXPRESSION; HUMAN GENOME	Background: Hematopoietic stem cells (HSC), in particular mobilized peripheral blood stem cells, represent an attractive target for cell and gene therapy. Efficient gene delivery into these target cells without compromising self-renewal and multipotency is crucial for the success of gene therapy. We investigated factors involved in the ex vivo transduction of CD34(+) HSCs in order to develop clinically relevant transduction protocol for gene delivery. Specifically sought was a protocol that allows for efficient transduction with minimal ex vivo manipulation without serum or other reagents of animal origin. Methodology/Principal Findings: Using commercially available G-CSF mobilized peripheral blood (PB) CD34(+) cells as the most clinically relevant target, we systematically examined factors including the use of serum, cytokine combinations, pre-stimulation time, multiplicity of infection (MOI), transduction duration and the use of spinoculation and/or retronectin. A self-inactivating lentiviral vector (SIN-LV) carrying enhanced green fluorescent protein (GFP) was used as the gene delivery vehicle. HSCs were monitored for transduction efficiency, surface marker expression and cellular function. We were able to demonstrate that efficient gene transduction can be achieved with minimal ex vivo manipulation while maintaining the cellular function of transduced HSCs without serum or other reagents of animal origin. Conclusions/Significance: This study helps to better define factors relevant towards developing a standard clinical protocol for the delivery of SIN-LV into CD34(+) cells.			Millington, M (corresponding author), Johnson & Johnson Res Pty Ltd, Eveleigh, NSW, Australia.	swshen@optusnet.com.au		Applegate, Tanya/0000-0002-8657-4261				Ailles L, 2002, MOL THER, V6, P615, DOI 10.1006/mthe.2002.0720; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Barquinero J, 2000, BLOOD, V95, P3085, DOI 10.1182/blood.V95.10.3085.010k01_3085_3093; Barrette S, 2000, BLOOD, V96, P3385; Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314; Bokhoven M, 2009, J VIROL, V83, P283, DOI 10.1128/JVI.01865-08; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Champlin RE, 2000, BLOOD, V95, P3702; Charrier S, 2007, GENE THER, V14, P415, DOI 10.1038/sj.gt.3302863; Christ O, 2007, HAEMATOLOGICA, V92, P1165, DOI 10.3324/haematol.11366; Cohen-Haguenauer O, 2006, P NATL ACAD SCI USA, V103, P2340, DOI 10.1073/pnas.0510613103; Cui Y, 2002, BLOOD, V99, P399, DOI 10.1182/blood.V99.2.399; Dando JS, 2001, J GENE MED, V3, P219, DOI 10.1002/1521-2254(200105/06)3:3<219::AID-JGM184>3.0.CO;2-E; De Palma M, 2005, BLOOD, V105, P2307, DOI 10.1182/blood-2004-03-0798; de Sio FRS, 2006, BLOOD, V107, P4257, DOI 10.1182/blood-2005-10-4047; Di Nunzio F, 2007, HUM GENE THER, V18, P811, DOI 10.1089/hum.2006.138; Donaldson C, 2001, BONE MARROW TRANSPL, V27, P365, DOI 10.1038/sj.bmt.1702810; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunbar CE, 2005, ANN NY ACAD SCI, V1044, P178, DOI 10.1196/annals.1349.023; Even MS, 2006, TRENDS BIOTECHNOL, V24, P105, DOI 10.1016/j.tibtech.2006.01.001; Gammaitoni L, 2003, EXP HEMATOL, V31, P261, DOI 10.1016/S0301-472X(02)01077-9; Glimm H, 2000, BLOOD, V96, P4185, DOI 10.1182/blood.V96.13.4185.h8004185_4185_4193; Kim VN, 1998, J VIROL, V72, P811, DOI 10.1128/JVI.72.1.811-816.1998; Kurre P, 2006, GENE THER, V13, P369, DOI 10.1038/sj.gt.3302659; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Lee CI, 2004, MOL THER, V9, P112, DOI 10.1016/j.ymthe.2003.09.019; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; Modlich U, 2009, J CLIN INVEST, V119, P755, DOI 10.1172/JCI38831; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nayak SK, 1996, CANCER GENE THER, V3, P143; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Pawelec G, 1998, J LEUKOCYTE BIOL, V64, P733, DOI 10.1002/jlb.64.6.733; Peters SO, 1996, BLOOD, V87, P30; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; Pike-Overzet K, 2007, MOL THER, V15, P1910, DOI 10.1038/sj.mt.6300297; Prus E, 2004, LEUKEMIA LYMPHOMA, V45, P1025, DOI 10.1080/10428190310001645924; ROBART F D, 1990, Photochemistry and Photobiology, V51, p92S; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Storms RW, 2005, BLOOD, V106, P95, DOI 10.1182/blood-2004-09-3652; Sutton RE, 1999, J VIROL, V73, P3649, DOI 10.1128/JVI.73.5.3649-3660.1999; Tesio M, 2008, STEM CELLS, V26, P1620, DOI 10.1634/stemcells.2008-0161; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tuschong L, 2002, HUM GENE THER, V13, P1605, DOI 10.1089/10430340260201699; Vigna E, 2000, J GENE MED, V2, P308; Ward WW., 1981, BIOLUMINESCENCE CHEM, DOI 10.1016/b978-0-12-208820-9.50035-5; Williams SF, 1996, BLOOD, V87, P1687; Wilpshaar J, 2000, BLOOD, V96, P2100; Wu MH, 2001, STEM CELLS, V19, P492, DOI 10.1634/stemcells.19-6-492; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	62	41	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6461	10.1371/journal.pone.0006461	http://dx.doi.org/10.1371/journal.pone.0006461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649289	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494600021
J	El Firar, A; Voisin, T; Rouyer-Fessard, C; Ostuni, MA; Couvineau, A; Laburthe, M				El Firar, Aadil; Voisin, Thierry; Rouyer-Fessard, Christiane; Ostuni, Mariano A.; Couvineau, Alain; Laburthe, Marc			Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis	FASEB JOURNAL			English	Article						neuropeptide; G protein-coupled receptor; tyrosine-based motifs; protein tyrosine phosphatase; SHP-2	PROTEIN-COUPLED-RECEPTOR; SRC HOMOLOGY-2 DOMAINS; CRYSTAL-STRUCTURE; INHIBITORY RECEPTORS; PHOSPHATASE SH-PTP1; CELL-PROLIFERATION; PERIPHERAL-TISSUES; SH2 DOMAINS; ACTIVATION; SHP-2	The orexin neuropeptides promote robust apoptosis in cancer cells. We have recently shown that the 7-transmembrane-spanning orexin receptor OX1R mediates apoptosis through an original mechanism. OX1R is equipped with a tyrosine-based inhibitory motif ITIM, which is tyrosine-phosphorylated on receptor activation, allowing the recruitment and activation of the tyrosine phosphatase SHP-2, leading to apoptosis. We show here that another motif, immunoreceptor tyrosine-based switch motif (ITSM), is present in OX1R and is mandatory for OX1R-mediated apoptosis. This conclusion is based on the following observations: 1) a canonical ITSM sequence is present in the first intracellular loop of OX1R; 2) mutation of Y-83 to F within ITSM abolished OX1R-mediated apoptosis but did not alter orexin-induced inositol phosphate formation or calcium transient via coupling of OX1R to G(q) protein; 3) mutation of Y-83 to F further abolished orexin-induced tyrosine phosphorylation in ITSM and subsequent recruitment of SHP-2 by the receptor. Finally, we developed a structural model of OX1R showing that the spatial localization of phosphotyrosines in ITSM and ITIM in OX1R is compatible with their interaction with the two SH2 domains of SHP-2. These data represent the first evidence for a functional role of an ITSM in a 7-transmembrane-spanning receptor.-El Firar, A., Voisin, T., Rouyer-Fessard, C., Ostuni, M. A., Couvineau, A., Laburthe, M. Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis. FASEB J. 23, 4069-4080 (2009). www.fasebj.org	[Voisin, Thierry] INSERM, U773, CRB3, F-75018 Paris, France; Univ Paris 07, UMR S773, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Voisin, T (corresponding author), INSERM, U773, CRB3, F-75018 Paris, France.	thierry.voisin@inserm.fr; marc.laburthe@inserm.fr	couvineau, alain/G-3641-2013; couvineau, alain/T-3466-2019; voisin, thierry/R-1241-2017; LABURTHE, Marc/C-1875-2012; OSTUNI, Mariano/J-2930-2015	couvineau, alain/0000-0003-2912-5168; couvineau, alain/0000-0003-2912-5168; voisin, thierry/0000-0002-4320-5183; OSTUNI, Mariano/0000-0001-6769-3786	Ministere de la Recherche et de l'Enseignement Superieur; Universite Paris-Sud 11	Ministere de la Recherche et de l'Enseignement Superieur; Universite Paris-Sud 11	A. E. F. is supported by Ministere de la Recherche et de l'Enseignement Superieur and Universite Paris-Sud 11. We thank N. Rivard (University of Sherbrooke, Sherbrooke, QC, Canada) for supplying us with the SHP-1 and SHP-2 dominant-negative constructions.	Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; Boutrel B, 2008, PHYSIOL BEHAV, V93, P947, DOI 10.1016/j.physbeh.2007.11.022; Bruhns P, 1999, J IMMUNOL, V162, P3168; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Couvineau A, 1996, BIOCHEMISTRY-US, V35, P1745, DOI 10.1021/bi952022h; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Duchene J, 2002, J BIOL CHEM, V277, P40375, DOI 10.1074/jbc.M202744200; Duchesne C, 2003, J BIOL CHEM, V278, P14274, DOI 10.1074/jbc.M300425200; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Ferjoux G, 2003, MOL BIOL CELL, V14, P3911, DOI 10.1091/mbc.E03-02-0069; Gentili C, 2006, J ENDOCRINOL, V188, P69, DOI 10.1677/joe.1.06397; Gether U, 2002, PHARMACOL TOXICOL, V91, P304, DOI 10.1034/j.1600-0773.2002.910607.x; Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002; Heinonen MV, 2008, ACTA PHYSIOL, V192, P471, DOI 10.1111/j.1748-1716.2008.01836.x; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Imhof D, 2006, J BIOL CHEM, V281, P20271, DOI 10.1074/jbc.M601047200; Kukkonen JP, 2001, NEUROREPORT, V12, P2017, DOI 10.1097/00001756-200107030-00046; Kumaresan PR, 2002, MOL IMMUNOL, V39, P1, DOI 10.1016/S0161-5890(02)00094-9; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Magga J, 2006, BIOCHEM PHARMACOL, V71, P827, DOI 10.1016/j.bcp.2005.12.021; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nishino S, 2007, SLEEP MED, V8, P373, DOI 10.1016/j.sleep.2007.03.008; Ostrakhovitch EA, 2006, BIOCHEM CELL BIOL, V84, P832, DOI 10.1139/O06-191; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pei DH, 1996, P NATL ACAD SCI USA, V93, P1141, DOI 10.1073/pnas.93.3.1141; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rouet-Benzineb P, 2004, J BIOL CHEM, V279, P45875, DOI 10.1074/jbc.M404136200; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Vatinel S, 2006, BBA-MOL CELL RES, V1763, P1098, DOI 10.1016/j.bbamcr.2006.07.003; Voisin T, 2003, CELL MOL LIFE SCI, V60, P72, DOI 10.1007/s000180300005; Voisin T, 2008, FASEB J, V22, P1993, DOI 10.1096/fj.07-098723; Voisin T, 2006, ENDOCRINOLOGY, V147, P4977, DOI 10.1210/en.2006-0201; Williams Rhiannan H., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000823; Zhu Y, 2003, J PHARMACOL SCI, V92, P259	45	36	44	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4069	4080		10.1096/fj.09-131367	http://dx.doi.org/10.1096/fj.09-131367			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19661287				2022-12-25	WOS:000272193700004
J	Frase, H; Shi, QC; Testero, SA; Mobashery, S; Vakulenko, SB				Frase, Hilary; Shi, Qicun; Testero, Sebastian A.; Mobashery, Shahriar; Vakulenko, Sergei B.			Mechanistic Basis for the Emergence of Catalytic Competence against Carbapenem Antibiotics by the GES Family of beta-Lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; SUBSTRATE PROFILE; RESISTANCE; TURNOVER; IMIPENEM; SUBSTITUTIONS; EVOLUTION; BACTERIA; LOOP	A major mechanism of bacterial resistance to beta-lactam antibiotics (penicillins, cephalosporins, carbapenems, etc.) is the production of beta-lactamases. A handful of class A beta-lactamases have been discovered that have acquired the ability to turn over carbapenem antibiotics. This is a disconcerting development, as carbapenems are often considered last resort antibiotics in the treatment of difficult infections. The GES family of beta-lactamases constitutes a group of extended spectrum resistance enzymes that hydrolyze penicillins and cephalosporins avidly. A single amino acid substitution at position 170 has expanded the breadth of activity to include carbapenems. The basis for this expansion of activity is investigated in this first report of detailed steady-state and pre-steady-state kinetics of carbapenem hydrolysis, performed with a class A carbapenemase. Monitoring the turnover of imipenem (a carbapenem) by GES-1 (Gly-170) revealed the acylation step as rate-limiting. GES-2 (Asn-170) has an enhanced rate of acylation, compared with GES-1, and no longer has a single rate-determining step. Both the acylation and deacylation steps are of equal magnitude. GES-5 (Ser-170) exhibits an enhancement of the rate constant for acylation by a remarkable 5000-fold, whereby the enzyme acylation event is no longer rate-limiting. This carbapenemase exhibits k(cat)/K-m of 3 x 10(5) M-1 s(-1), which is sufficient for manifestation of resistance against imipenem.	[Frase, Hilary; Shi, Qicun; Testero, Sebastian A.; Mobashery, Shahriar; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Vakulenko, SB (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	svakulen@nd.edu	Testero, Sebastian A./AAF-6532-2019	Testero, Sebastian A./0000-0002-0185-5751	NIAID NIH HHS [R01 AI089726] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089726] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Babic M, 2006, DRUG RESIST UPDATE, V9, P142, DOI 10.1016/j.drup.2006.05.005; Bae IK, 2007, DIAGN MICR INFEC DIS, V58, P465, DOI 10.1016/j.diagmicrobio.2007.02.013; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Giakkoupi P, 2000, ANTIMICROB AGENTS CH, V44, P2247, DOI 10.1128/AAC.44.9.2247-2253.2000; Kim SY, 2007, DIAGN MICR INFEC DIS, V57, P85, DOI 10.1016/j.diagmicrobio.2006.05.008; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Mavroidi A, 2001, J ANTIMICROB CHEMOTH, V48, P627, DOI 10.1093/jac/48.5.627; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Mourey L, 1998, J AM CHEM SOC, V120, P9382, DOI 10.1021/ja9817996; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Page MGP, 2008, CLIN MICROBIOL INFEC, V14, P63, DOI 10.1111/j.1469-0691.2007.01863.x; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P2598, DOI 10.1128/AAC.45.9.2598-2603.2001; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; RATCLIFFE RW, 1989, J ORG CHEM, V54, P653, DOI 10.1021/jo00264a028; Smith CA, 2007, ACTA CRYSTALLOGR D, V63, P982, DOI 10.1107/S0907444907036955; TAIBI P, 1995, J AM CHEM SOC, V117, P7600, DOI 10.1021/ja00134a003; TaibiTronche P, 1996, J AM CHEM SOC, V118, P7441, DOI 10.1021/ja9529753; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; Vourli S, 2004, FEMS MICROBIOL LETT, V234, P209, DOI 10.1016/j.femsle.2004.03.028; Wachino J, 2004, ANTIMICROB AGENTS CH, V48, P2905, DOI 10.1128/AAC.48.8.2905-2910.2004; Wachino J, 2004, ANTIMICROB AGENTS CH, V48, P1960, DOI 10.1128/AAC.48.6.1960-1967.2004; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016	30	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29509	29513		10.1074/jbc.M109.011262	http://dx.doi.org/10.1074/jbc.M109.011262			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19656947	Green Published, hybrid			2022-12-25	WOS:000270896800033
J	Schichl, YM; Resch, U; Hofer-Warbinek, R; de Martin, R				Schichl, Yvonne M.; Resch, Ulrike; Hofer-Warbinek, Renate; de Martin, Rainer			Tristetraprolin Impairs NF-kappa B/p65 Nuclear Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; AU-RICH ELEMENT; MESSENGER-RNA TARGETS; NECROSIS-FACTOR-ALPHA; ZINC-FINGER PROTEINS; SWISS 3T3 CELLS; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; NUCLEOTIDE-SEQUENCE; GROWTH-FACTOR	Tristetraprolin (TTP) is a prototypic family member of CCCH-type tandem zinc-finger domain proteins that regulate mRNA destabilization in eukaryotic cells. TTP binds to AU-rich elements (AREs) in the 3'-untranslated region of certain mRNAs, including tumor necrosis factor alpha, granulocyte macrophage colony-stimulating factor, and immediate early response 3, thereby facilitating their ARE-mediated decay. Expression of TTP is up-regulated by a variety of agents, including inflammatory mediators such as tumor necrosis factor alpha, a prominent activator of the nuclear factor kappa B (NF-kappa B) family of transcription factors. Accordingly, TTP is involved in the negative feedback regulation of NF-kappa B through promoting mRNA degradation. We describe here a novel, ARE-mediated decay-independent function of TTP on the termination of NF-kappa B response: TTP suppresses the transcriptional activity of NF-kappa B-dependent promoters independent of its mRNA-destabilizing property. In TTP knockout mouse embryonic fibroblasts, lack of TTP leads to enhanced nuclear p65 levels, which is associated with the up-regulation of specific, ARE-less NF-kappa B target genes. We find that attenuation of NF-kappa B activity is at least in part due to an interference of TTP with the nuclear import of the p65 subunit of the transcription factor. This novel role of TTP may synergize with its mRNA-degrading function to contribute to the efficient regulation of proinflammatory gene expression.	[Schichl, Yvonne M.; Resch, Ulrike; Hofer-Warbinek, Renate; de Martin, Rainer] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria	Medical University of Vienna	Schichl, YM (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Lazarettg 19, A-1090 Vienna, Austria.	yvonne.schichl@gmx.net; rainer.demartin@meduniwien.ac.at		Resch, Ulrike/0000-0002-8380-9555	Austrian Science Foundation [P19217-B13]	Austrian Science Foundation(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Foundation, Project P19217-B13 (to R. d. M.).	Baker A, 1997, GENE THER, V4, P773, DOI 10.1038/sj.gt.3300471; Beutler B, 1995, J CARDIOVASC PHARM, V25, pS1, DOI 10.1097/00005344-199500252-00002; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; BLANK V, 1991, EMBO J, V10, P4159, DOI 10.1002/j.1460-2075.1991.tb04994.x; Campbell KJ, 2004, BIOCHEM SOC T, V32, P1087, DOI 10.1042/BST0321087; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carman JA, 2004, BIOCHEM BIOPH RES CO, V315, P445, DOI 10.1016/j.bbrc.2004.01.080; Carrick DM, 2006, J AUTOIMMUN, V26, P182, DOI 10.1016/j.jaut.2006.01.004; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Harant H, 1996, J BIOL CHEM, V271, P26954, DOI 10.1074/jbc.271.43.26954; Harhaj EW, 1999, MOL CELL BIOL, V19, P7088; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Heximer SP, 1998, DNA CELL BIOL, V17, P249, DOI 10.1089/dna.1998.17.249; HEXIMER SP, 1993, DNA CELL BIOL, V12, P73, DOI 10.1089/dna.1993.12.73; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; KANEDA N, 1992, GENE, V118, P289, DOI 10.1016/0378-1119(92)90202-Z; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Li Q, 2007, ONCOGENE, V26, P7885, DOI 10.1038/sj.onc.1210597; LIM RW, 1987, ONCOGENE, V1, P263; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; MA QF, 1991, ONCOGENE, V6, P1277; Moroianu J, 1999, J CELL BIOCHEM, P76; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schabbauer G, 2007, THROMB HAEMOSTASIS, V97, P988, DOI 10.1160/TH07-01-0037; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; VARNUM BC, 1989, ONCOGENE, V4, P119; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Xylourgidis N, 2006, J CELL SCI, V119, P4409, DOI 10.1242/jcs.03201; Zhang WJ, 1997, ARTERIOSCL THROM VAS, V17, P465, DOI 10.1161/01.ATV.17.3.465	52	70	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29571	29581		10.1074/jbc.M109.031237	http://dx.doi.org/10.1074/jbc.M109.031237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19654331	Green Published, hybrid			2022-12-25	WOS:000270896800039
J	Kirschbaum, K; Kriebel, M; Kranz, EU; Potz, O; Volkmer, H				Kirschbaum, Katja; Kriebel, Martin; Kranz, Eva Ursula; Poetz, Oliver; Volkmer, Hansjuergen			Analysis of Non-canonical Fibroblast Growth Factor Receptor 1 (FGFR1) Interaction Reveals Regulatory and Activating Domains of Neurofascin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE L1; DEPENDENT NEURITE OUTGROWTH; ANKYRIN-BINDING-ACTIVITY; CELL-ADHESION; CHICK NEUROFASCIN; AXONAL SURFACE; RPTP-ALPHA; N-CAM; NCAM; PHOSPHORYLATION	Fibroblast growth factor receptors (FGFRs) are important for many different mechanisms, including cell migration, proliferation, differentiation, and survival. Here, we show a new link between FGFR1 and the cell adhesion molecule neurofascin, which is important for neurite outgrowth. After overexpression in HEK293 cells, embryonal neurofascin isoform NF166 was able to associate with FGFR1, whereas the adult isoform NF186, differing from NF166 in additional extracellular sequences, was deficient. Pharmacological inhibitors and overexpression of dominant negative components of the FGFR signaling pathway pointed to the activation of FGFR1 after association with neurofascin in neurite outgrowth assays in chick tectal neurons and rat PC12-E2 cells. Both extra- and intracellular domains of embryonal neurofascin isoform NF166 were able to form complexes with FGFR1 independently. However, the cytosolic domain was both necessary and sufficient for the activation of FGFR1. Cytosolic serine residues 56 and 100 were shown to be essential for the neurite outgrowth-promoting activity of neurofascin, whereas both amino acid residues were dispensable for FGFR1 association. In conclusion, the data suggest a neurofascin intracellular domain, which activates FGFR1 for neurite outgrowth, whereas the extracellular domain functions as an additional, regulatory FGFR1 interaction domain in the course of development.	[Kirschbaum, Katja; Kriebel, Martin; Kranz, Eva Ursula; Volkmer, Hansjuergen] Univ Tubingen, Dept Mol Biol, D-72770 Reutlingen, Germany; [Poetz, Oliver] Univ Tubingen, Dept Biochem Nat Wissensch, D-72770 Reutlingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Volkmer, H (corresponding author), Univ Tubingen, Dept Mol Biol, Markwiesenstr 55, D-72770 Reutlingen, Germany.	volkmer@nmi.de	Volkmer, Hansjuergen/AAU-9641-2021	Volkmer, Hansjuergen/0000-0002-3867-0603	European Union 6th Framework Program [LSHM-CT-2005-512012]; Bundesministerium fur Bildung und Forschung [0312114]	European Union 6th Framework Program(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by European Union 6th Framework Program Grant LSHM-CT-2005-512012 and by Bundesministerium fur Bildung und Forschung Grant 0312114.	Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Boget S, 2001, EUR J ENDOCRINOL, V145, P303, DOI 10.1530/eje.0.1450303; Burkarth N, 2007, MOL CELL NEUROSCI, V36, P59, DOI 10.1016/j.mcn.2007.06.001; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Groth C, 2002, INT J DEV BIOL, V46, P393; Hansen RK, 2007, J NEUROCHEM, V103, P1396, DOI 10.1111/j.1471-4159.2007.04894.x; Hassel B, 1997, J BIOL CHEM, V272, P28742, DOI 10.1074/jbc.272.45.28742; Heiland PC, 1998, EUR J CELL BIOL, V75, P97, DOI 10.1016/S0171-9335(98)80052-6; HILDEBRANDT H, 2008, NEUROCHEM R IN PRESS; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Jessen U, 2001, J NEUROCHEM, V79, P1149, DOI 10.1046/j.1471-4159.2001.00636.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kolkova K, 2005, J NEUROCHEM, V92, P886, DOI 10.1111/j.1471-4159.2004.02919.x; Kolkova K, 2000, J NEUROSCI, V20, P2238; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Koticha D, 2005, MOL CELL NEUROSCI, V30, P137, DOI 10.1016/j.mcn.2005.06.007; Krushel LA, 1999, J BIOL CHEM, V274, P2432, DOI 10.1074/jbc.274.4.2432; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Little EB, 1998, CELL ADHES COMMUN, V6, P415, DOI 10.3109/15419069809109150; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Ornitz DM, 2001, GENOME BIOL, V2; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Pruss T, 2006, MOL CELL NEUROSCI, V31, P354, DOI 10.1016/j.mcn.2005.10.009; Pruss T, 2004, EUR J NEUROSCI, V20, P3184, DOI 10.1111/j.1460-9568.2004.03773.x; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; Ren Q, 1998, J NEUROCHEM, V70, P1839; Ronn LCB, 2000, J NEUROCHEM, V75, P665, DOI 10.1046/j.1471-4159.2000.0750665.x; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schmid RS, 2000, J NEUROSCI, V20, P4177; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; VOLKMER H, 2001, CELL ADHESION, P1; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785	57	14	15	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28533	28542		10.1074/jbc.M109.004440	http://dx.doi.org/10.1074/jbc.M109.004440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19666467	hybrid, Green Published			2022-12-25	WOS:000270678900007
J	Song, HH; Suehiro, J; Kanki, Y; Kawai, Y; Inoue, K; Daida, H; Yano, K; Ohhashi, T; Oettgen, P; Aird, WC; Kodama, T; Minami, T				Song, Haihua; Suehiro, Jun-ichi; Kanki, Yasuharu; Kawai, Yoshiko; Inoue, Kenji; Daida, Hiroyuki; Yano, Kiichiro; Ohhashi, Toshio; Oettgen, Peter; Aird, William C.; Kodama, Tatsuhiko; Minami, Takashi			Critical Role for GATA3 in Mediating Tie2 Expression and Function in Large Vessel Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-2; ADHESION MOLECULE-1 EXPRESSION; SYNDROME CRITICAL REGION-1; GENE-EXPRESSION; TRANSGENIC MICE; IN-VITRO; THROMBIN STIMULATION; PROMOTER; ANGIOPOIETIN-1; DIFFERENTIATION	Endothelial phenotypes are highly regulated in space and time by both transcriptional and post-transcriptional mechanisms. There is increasing evidence that the GATA family of transcription factors function as signal transducers, coupling changes in the extracellular environment to changes in downstream target gene expression. Here we show that human primary endothelial cells derived from large blood vessels express GATA2, -3, and -6. Of these factors, GATA3 was expressed at the highest levels. In DNA microarrays of human umbilical vein endothelial cells (HUVEC), small interfering RNA-mediated knockdown of GATA3 resulted in reduced expression of genes associated with angiogenesis, including Tie2. At a functional level, GATA3 knockdown inhibited angiopoietin (Ang)-1-mediated but not vascular endothelial cell growth factor (VEGF)-mediated AKT signaling, cell migration, survival, and tube formation. In electrophoretic gel mobility shift assays and chromatin immunoprecipitation, GATA3 was shown to bind to regulatory regions within the 5'-untranslated region of the Tie2 gene. In co-immunoprecipitation and co-transfection assays, GATA3 and the Ets transcription factor, ELF1, physically interacted and synergized to transactivate the Tie2 promoter. GATA3 knockdown blocked the ability of Ang-1 to attenuate vascular endothelial cell growth factor stimulation of vascular cell adhesion molecule-1 expression and monocytic cell adhesion. Moreover, exposure of human umbilical vein endothelial cells to tumor necrosis factor-alpha resulted in marked down-regulation of GATA3 expression and reduction in Tie2 expression. Together, these findings suggest that GATA3 is indispensable for Ang-1-Tie2-mediated signaling in large vessel endothelial cells.	[Yano, Kiichiro; Aird, William C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Mol & Vasc Med, Boston, MA 02215 USA; [Kodama, Tatsuhiko; Minami, Takashi] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Kodama, Tatsuhiko; Minami, Takashi] Univ Tokyo, Translat Syst Biol & Med Initiat, Tokyo 1138655, Japan; [Kawai, Yoshiko; Ohhashi, Toshio] Shinshu Univ, Sch Med, Dept Physiol, Matsumoto, Nagano 3908621, Japan; [Inoue, Kenji; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Med Dis Old Ages, Sch Med, Tokyo 1138421, Japan; [Oettgen, Peter] Harvard Inst Med, Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Tokyo; University of Tokyo; Shinshu University; Juntendo University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Aird, WC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Mol & Vasc Med, 330 Brookline Ave, Boston, MA 02215 USA.	waird@bidmc.harvard.edu; minami@med.rcast.u-tokyo.ac.jp	Oettgen, Peter/AAF-5026-2021		National Institutes of Health [PO1 HL76540, R01HL082927]; NHLBI; Ministry of Education, Culture, Sports, Science, and Technology in Japan; Takeda Science Foundation in Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082927, P01HL076540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation in Japan(Takeda Science Foundation (TSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL76540 (to W. C. A. and P. O.) and R01HL082927 (to W. C. A.) from NHLBI. This work was also supported by the fund for Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and in part by Takeda Science Foundation in Japan (to T. M.).	Abid MR, 2008, ARTERIOSCL THROM VAS, V28, P2042, DOI 10.1161/ATVBAHA.108.175109; Adryan B, 2004, BIOINFORMATICS, V20, P2851, DOI 10.1093/bioinformatics/bth289; BROCK TG, 1994, J BIOL CHEM, V269, P22059; Cowan PJ, 1998, J BIOL CHEM, V273, P11737, DOI 10.1074/jbc.273.19.11737; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Fadel BM, 1999, J BIOL CHEM, V274, P20376, DOI 10.1074/jbc.274.29.20376; Fadel BM, 1998, BIOCHEM J, V330, P335; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Fujikawa K, 1999, EXP CELL RES, V253, P663, DOI 10.1006/excr.1999.4693; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; Kawai Yoshiko, 2007, Lymphatic Research and Biology, V5, P115, DOI 10.1089/lrb.2007.1003; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Lin JHC, 1996, ATHEROSCLEROSIS, V127, P185, DOI 10.1016/S0021-9150(96)05951-5; Maeda M, 2005, DEV GROWTH DIFFER, V47, P591; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Minami T, 2003, ARTERIOSCL THROM VAS, V23, P2041, DOI 10.1161/01.ATV.0000089326.63053.9A; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Minami T, 2001, J BIOL CHEM, V276, P5395, DOI 10.1074/jbc.M008798200; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; MINAMI T, 2007, ENDOTHELIAL BIOMEDIC, P806; Minami T, 2006, J BIOL CHEM, V281, P20503, DOI 10.1074/jbc.M513112200; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Sharifi BG, 2006, ARTERIOSCL THROM VAS, V26, P1273, DOI 10.1161/01.ATV.0000222017.05085.8e; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Tomi M, 2004, MOL VIS, V10, P537; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Umetani M, 2001, ARTERIOSCL THROM VAS, V21, P917, DOI 10.1161/01.ATV.21.6.917; Velazquez OC, 2002, FASEB J, V16, P1316, DOI 10.1096/fj.01-1011fje; WEISS MJ, 1995, EXP HEMATOL, V23, P99; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320	49	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29109	29124		10.1074/jbc.M109.041145	http://dx.doi.org/10.1074/jbc.M109.041145			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19674970	Green Published, hybrid			2022-12-25	WOS:000270678900067
J	Wakita, C; Maeshima, T; Yamazaki, A; Shibata, T; Ito, S; Akagawa, M; Ojika, M; Yodoi, J; Uchida, K				Wakita, Chika; Maeshima, Takuya; Yamazaki, Atsushi; Shibata, Takahiro; Ito, Sohei; Akagawa, Mitsugu; Ojika, Makoto; Yodoi, Junji; Uchida, Koji			Stereochemical Configuration of 4-Hydroxy-2-nonenal-Cysteine Adducts and Their Stereoselective Formation in a Redox-regulated Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN REDUCTASE; POSSIBLE INVOLVEMENT; LIPID-PEROXIDATION; REACTIVE ALDEHYDE; GLUTATHIONE; INHIBITION; MECHANISMS; DISEASES; PEPTIDE; SYSTEMS	4-Hydroxy-2-nonenal (HNE), a major racemic product of lipid peroxidation, preferentially reacts with cysteine residues to form a stable HNE-cysteine Michael addition adduct possessing three chiral centers. Here, to gain more insight into sulfhydryl modification by HNE, we characterized the stereochemical configuration of the HNE-cysteine adducts and investigated their stereoselective formation in redox-regulated proteins. To characterize the HNE-cysteine adducts by NMR, the authentic (R)-HNE- and (S)-HNE-cysteine adducts were prepared by incubating N-acetylcysteine with each HNE enantiomer, both of which provided two peaks in reversed-phase high performance liquid chromatography (HPLC). The NMR analysis revealed that each peak was a mixture of anomeric isomers. In addition, mutarotation at the anomeric center was also observed in the analysis of the nuclear Overhauser effect. To analyze these adducts in proteins, we adapted a pyridylamination-based approach, using 2-aminopyridine in the presence of sodium cyanoborohydride, which enabled analyzing the individual (R)-HNE-and (S)-HNE-cysteine adducts by reversed-phase HPLC following acid hydrolysis. Using the pyridylamination method along with mass spectrometry, we characterized the stereoselective formation of the HNE-cysteine adducts in human thioredoxin and found that HNE preferentially modifies Cys(73) and, to the lesser extent, the active site Cys(32). More interestingly, the (R)-HNE-and (S)-HNE-cysteine adducts were almost equally formed at Cys(73), whereas Cys(32) exhibited a remarkable preference for the adduct formation with (R)-HNE. Finally, the utility of the method for the determination of the HNE-cysteine adducts was confirmed by an in vitro study using HeLa cells. The present results not only offer structural insight into sulfhydryl modification by lipid peroxidation products but also provide a platform for the chemical analysis of protein S-associated aldehydes in vitro and in vivo.	[Wakita, Chika; Maeshima, Takuya; Yamazaki, Atsushi; Shibata, Takahiro; Ojika, Makoto; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ito, Sohei] Univ Shizuoka, Sch Food & Nutr Sci, Shizuoka 4228526, Japan; [Akagawa, Mitsugu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 5998531, Japan; [Yodoi, Junji] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Kyoto 6068507, Japan	Nagoya University; University of Shizuoka; Osaka Metropolitan University; Kyoto University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Ito, Sohei/M-5930-2019; Ito, Sohei/A-4266-2010; Shibata, Takahiro/I-6872-2014	Ito, Sohei/0000-0002-9937-3100; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on innovative areas (Research in a Proposed Research Area) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K. U.).	ALLEVI P, 1993, J ORG CHEM, V58, P5000, DOI 10.1021/jo00070a043; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Balogh LM, 2008, J BIOL CHEM, V283, P16702, DOI 10.1074/jbc.M801725200; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; DEMONTARBY L, 1988, TETRAHEDRON LETT, V29, P3937, DOI 10.1016/S0040-4039(00)80387-1; Deneke SM, 2000, CURR TOP CELL REGUL, V36, P151; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Hartley DP, 1997, CHEM RES TOXICOL, V10, P895, DOI 10.1021/tx960181b; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; Hashimoto M, 2003, J BIOL CHEM, V278, P5044, DOI 10.1074/jbc.M210129200; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jordan BF, 2005, CLIN CANCER RES, V11, P529; Kirkpatrick DL, 1998, BIOCHEM PHARMACOL, V55, P987, DOI 10.1016/S0006-2952(97)00597-2; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Sasada T, 1999, FREE RADICAL BIO MED, V27, P504, DOI 10.1016/S0891-5849(99)00101-X; SCHAUENSTEIN E, 1971, MONATSH CHEM, V102, P517, DOI 10.1007/BF00909348; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SZWEDA LI, 1993, J BIOL CHEM, V268, P3342; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P5611, DOI 10.1073/pnas.89.12.5611; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; YODOI J, 1992, IMMUNOL TODAY, V13, P405, DOI 10.1016/0167-5699(92)90091-K	36	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28810	28822		10.1074/jbc.M109.019927	http://dx.doi.org/10.1074/jbc.M109.019927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692331	Green Published, hybrid			2022-12-25	WOS:000270678900038
J	Isobe, T; Hattori, T; Kitagawa, K; Uchida, C; Kotake, Y; Kosugi, I; Oda, T; Kitagawa, M				Isobe, Tomoyasu; Hattori, Takayuki; Kitagawa, Kyoko; Uchida, Chiharu; Kotake, Yojiro; Kosugi, Isao; Oda, Toshiaki; Kitagawa, Masatoshi			Adenovirus E1A Inhibits SCFFbw7 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; PHOSPHORYLATION-DEPENDENT UBIQUITINATION; TUMOR-SUPPRESSOR; CYCLIN-E; CONJUGATING ENZYME; NEDD8 MODIFICATION; RING FINGER; C-MYC; DEGRADATION; PROTEIN	The SCFFbw7 ubiquitin ligase complex plays important roles in cell growth, survival, and differentiation via the ubiquitin-proteasome-mediated regulation of protein stability. Fbw7 (also known as Fbxw7, Sel-10, hCdc4, or hAgo), a substrate recognition subunit of SCFFbw7 ubiquitin ligase, facilitates the degradation of several proto-oncogene products by the proteasome. Given that mutations in Fbw7 are found in various types of human cancers, Fbw7 is considered to be a potent tumor suppressor. In the present study, we show that E1A, an oncogene product derived from adenovirus, interferes with the activity of the SCFFbw7 ubiquitin ligase. E1A interacted with SCFFbw7 and attenuated the ubiquitylation of its target proteins in vivo. Furthermore, using in vitro purified SCFFbw7 component proteins, we found that E1A directly bound to Roc1/Rbx1 and CUL1 and that E1A inhibited the ubiquitin ligase activity of the Roc1/Rbx1-CUL1 complex but not that of another RING-type ubiquitin ligase, Mdm2. Ectopically expressed E1A interacted with cellular endogenous Roc1/Rbx1 and CUL1 and decelerated the degradation of several protooncogene products that were degraded by SCFFbw7 ubiquitin ligase. Moreover, after wild-type adenovirus infection, adenovirus-derived E1A interacted with endogenous Roc1/Rbx1 and decelerated degradation of the endogenous target protein of SCFFbw7. These observations demonstrated that E1A perturbs protein turnover regulated by SCFFbw7 through the inhibition of SCFFbw7 ubiquitin ligase. Our findings may help to explain the mechanism whereby adenovirus infection induces unregulated proliferation.	[Isobe, Tomoyasu; Hattori, Takayuki; Kitagawa, Kyoko; Uchida, Chiharu; Kotake, Yojiro; Oda, Toshiaki; Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kosugi, Isao] Hamamatsu Univ Sch Med, Dept Pathol 2, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Kitagawa, M (corresponding author), Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kitamasa@hama-med.ac.jp			Ministry of Education, Science, Sports, Culture, and Technology of Japan	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Science, Sports, Culture, and Technology of Japan (to M. K. and K. K.) and by the Centers of Excellence Program of Hamamatsu University School of Medicine from the Ministry of Education, Science, Sports, Culture, and Technology of Japan (to M. K.).	Brockmann D, 2003, CURR TOP MICROBIOL, V272, P97; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Chinnadurai G, 2004, CURR TOP MICROBIOL, V273, P139; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; EGAN C, 1987, VIROLOGY, V160, P292, DOI 10.1016/0042-6822(87)90077-8; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Isobe T, 2006, BIOCHEM BIOPH RES CO, V339, P367, DOI 10.1016/j.bbrc.2005.11.028; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Nakajima T, 1998, J BIOL CHEM, V273, P20036, DOI 10.1074/jbc.273.32.20036; Nakajima T, 1996, J BIOL CHEM, V271, P24842, DOI 10.1074/jbc.271.40.24842; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Samuelson AV, 2005, J BIOL CHEM, V280, P21915, DOI 10.1074/jbc.M414564200; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Tworkowski KA, 2008, P NATL ACAD SCI USA, V105, P6103, DOI 10.1073/pnas.0802095105; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Welcker M, 2005, J BIOL CHEM, V280, P7654, DOI 10.1074/jbc.M413377200; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu JT, 2006, TRENDS CELL BIOL, V16, P362, DOI 10.1016/j.tcb.2006.05.001; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	69	24	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27766	27779		10.1074/jbc.M109.006809	http://dx.doi.org/10.1074/jbc.M109.006809			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679664	Green Published, hybrid			2022-12-25	WOS:000270676300003
J	Xu, L; Kappler, CS; Mani, SK; Shepherd, NR; Renaud, L; Snider, P; Conway, SJ; Menick, DR				Xu, Lin; Kappler, Christiana S.; Mani, Santhosh K.; Shepherd, Neal R.; Renaud, Ludivine; Snider, Paige; Conway, Simon J.; Menick, Donald R.			Chronic Administration of KB-R7943 Induces Up-regulation of Cardiac NCX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; NA-CA EXCHANGE; RABBIT VENTRICULAR MYOCYTES; SIGNAL-TRANSDUCING FUNCTION; FAILING HUMAN HEART; NA+-CA2+ EXCHANGER; GENE-EXPRESSION; NA+/CA2+ EXCHANGE; REPERFUSION INJURY; CYCLING PROTEINS	The NCX1 (sodium-calcium exchanger) is up-regulated in human heart failure and in many animal models of heart failure. The potential benefits and risks of therapeutically blocking NCX1 in heart failure and during ischemia-reperfusion are being actively investigated. In this study, we demonstrate that prolonged administration of the NCX1 inhibitor KB-R7943 resulted in the up-regulation of Ncx1 gene expression in both isolated adult cardiomyocytes and intact mouse hearts. Ncx1 up-regulation is mediated by the activation of p38. Importantly, p38 is not activated by KB-R7943 treatment in heart tubes from Ncx1(-/-) mice at 9.5 days postcoitum but is activated in heart tubes from Ncx1(+/+) mice. p38 activation does not appear to be in response to changes in cytosolic calcium concentration, [Ca2+](i). Interestingly, chronic KB-R7943 treatment in mice leads to the formation of an NCX1-p38 complex. Our study demonstrates for the first time that the electrogenic sarcolemma membrane cardiac NCX1 can act as a regulator of "activity-dependent signal transduction" leading to changes in gene expression.	[Xu, Lin; Kappler, Christiana S.; Mani, Santhosh K.; Shepherd, Neal R.; Renaud, Ludivine; Menick, Donald R.] Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, Charleston, SC 29425 USA; [Snider, Paige; Conway, Simon J.] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN 46202 USA	Medical University of South Carolina; Indiana University System; Indiana University-Purdue University Indianapolis	Menick, DR (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, 114 Doughty St,Box 250773, Charleston, SC 29425 USA.	menickd@musc.edu	Renaud, Ludivine/T-1209-2019		National Institutes of Health [P01 HL085098, R01 HL066223, P01 HL48788, RR16434, T32HL07260, T32HL079995]; The Riley Children's Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066223, T32HL007260, P01HL048788, P01HL085098, T32HL079995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Riley Children's Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL085098 (to S. J. C.) and Grants R01 HL066223 and P01 HL48788, Project 3 (to D. R. M.). This work was also supported by The Riley Children's Foundation, Indiana University Department of Pediatrics/Cardiology. Supported in part by National Institutes of Health Grant RR16434.; Supported in part by National Institutes of Health Grant T32HL07260.; Supported in part by National Institutes of Health Grant T32HL079995.	AARONS RD, 1980, J CLIN INVEST, V65, P949, DOI 10.1172/JCI109781; AdachiAkahane S, 1997, J GEN PHYSIOL, V109, P717, DOI 10.1085/jgp.109.6.717; Ahmmed GU, 2000, CIRC RES, V86, P558, DOI 10.1161/01.RES.86.5.558; Andrews C, 2003, CARDIOVASC RES, V59, P46, DOI 10.1016/S0008-6363(03)00329-8; BASSANI RA, 1994, J MOL CELL CARDIOL, V26, P1335, DOI 10.1006/jmcc.1994.1152; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BERS DM, 1990, AM J PHYSIOL, V258, pC944, DOI 10.1152/ajpcell.1990.258.5.C944; BERS DM, 1989, CIRC RES, V65, P334, DOI 10.1161/01.RES.65.2.334; Birinyi P, 2008, CARDIOVASC RES, V78, P476, DOI 10.1093/cvr/cvn031; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; de Hurtado MCC, 2002, J MOL CELL CARDIOL, V34, P1539, DOI 10.1006/jmcc.2002.2107; DIAZ RG, 1973, LANCET, V1, P1068; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Haas M, 2000, J BIOL CHEM, V275, P27832; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Hasenfuss G, 1996, BASIC RES CARDIOL, V91, P17, DOI 10.1007/BF00795357; Hasenfuss G, 1997, BASIC RES CARDIOL, V92, P87, DOI 10.1007/BF00794072; Hobai IA, 2000, CIRC RES, V87, P690, DOI 10.1161/01.RES.87.8.690; Hobai IA, 2004, CIRC RES, V95, P292, DOI 10.1161/01.RES.0000136817.28691.2d; Kang JX, 1997, P NATL ACAD SCI USA, V94, P2724, DOI 10.1073/pnas.94.6.2724; KENT RL, 1989, AM J PHYSIOL, V257, pH1717, DOI 10.1152/ajpheart.1989.257.5.H1717; KENT RL, 1993, AM J PHYSIOL, V265, pH1024, DOI 10.1152/ajpheart.1993.265.3.H1024; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Lee C, 2005, CAN J CARDIOL, V21, P509; Liang QR, 2003, J MOL CELL CARDIOL, V35, P1385, DOI 10.1016/j.yjmcc.2003.10.001; Litwin SE, 1997, CIRC RES, V81, P1083; MacDonald AC, 2008, EUR J PHARMACOL, V580, P214, DOI 10.1016/j.ejphar.2007.10.055; Menick DR, 1996, ANN NY ACAD SCI, V779, P489, DOI 10.1111/j.1749-6632.1996.tb44823.x; MILLER RR, 1975, NEW ENGL J MED, V293, P416, DOI 10.1056/NEJM197508282930902; Mohammadi K, 2001, J BIOL CHEM, V276, P42050, DOI 10.1074/jbc.M107892200; Morgan PE, 1999, J MOL CELL CARDIOL, V31, P1873, DOI 10.1006/jmcc.1999.1019; Muller JG, 2002, CIRC RES, V90, P158, DOI 10.1161/hh0202.103231; Nagy ZA, 2004, BRIT J PHARMACOL, V143, P827, DOI 10.1038/sj.bjp.0706026; Niu CF, 2007, EUR J PHARMACOL, V573, P161, DOI 10.1016/j.ejphar.2007.06.033; O'Rourke B, 2008, CIRC RES, V102, P1301, DOI 10.1161/CIRCRESAHA.108.178095; Ozdemir S, 2008, CIRC RES, V102, P1398, DOI 10.1161/CIRCRESAHA.108.173922; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Pogwizd SM, 1999, CIRC RES, V85, P1009; PORZIG H, 1993, AM J PHYSIOL, V265, pC748, DOI 10.1152/ajpcell.1993.265.3.C748; Ranu HK, 2002, J MOL CELL CARDIOL, V34, P389, DOI 10.1006/jmcc.2001.1521; Reuter H, 2004, J PHYSIOL-LONDON, V554, P779, DOI 10.1113/jphysiol.2003.055046; Satoh H, 2000, CIRCULATION, V101, P1441, DOI 10.1161/01.CIR.101.12.1441; Schillinger W, 2000, CIRC RES, V87, P581, DOI 10.1161/01.RES.87.7.581; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Smajilovic S, 2007, CARDIOVASC RES, V75, P457, DOI 10.1016/j.cardiores.2007.03.015; Studer R, 1997, BASIC RES CARDIOL, V92, P53, DOI 10.1007/BF00794068; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Tanaka H, 2002, BRIT J PHARMACOL, V135, P1096, DOI 10.1038/sj.bjp.0704574; Tfelt-Hansen J, 2006, AM J PHYSIOL-HEART C, V290, pH1165, DOI 10.1152/ajpheart.00821.2005; Tian J, 2001, AM J PHYSIOL-HEART C, V281, pH1899, DOI 10.1152/ajpheart.2001.281.5.H1899; Xu L, 2005, J MOL CELL CARDIOL, V38, P735, DOI 10.1016/j.yjmcc.2005.03.002; Xu L, 2006, J BIOL CHEM, V281, P34430, DOI 10.1074/jbc.M607446200; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	55	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27265	27272		10.1074/jbc.M109.022855	http://dx.doi.org/10.1074/jbc.M109.022855			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661061	Green Published, hybrid			2022-12-25	WOS:000270232300027
J	Younce, CW; Azfer, A; Kolattukudy, PE				Younce, Craig W.; Azfer, Asim; Kolattukudy, Pappachan E.			MCP-1 (Monocyte Chemotactic Protein-1)-induced Protein, a Recently Identified Zinc Finger Protein, Induces Adipogenesis in 3T3-L1 Pre-adipocytes without Peroxisome Proliferator-activated Receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ADIPOSE-TISSUE; INSULIN-RESISTANCE; PPAR-GAMMA; TRANSCRIPTION FACTOR; C/EBP-ALPHA; OBESITY; ANGIOGENESIS; PATHWAY; DIFFERENTIATION	Adipogenesis is a key differentiation process relevant to obesity and associated diseases such as type 2 diabetes. This process involves temporally regulated genes controlled by a set of transcription factors, CCAAT/enhancer-binding proteins (C/EBP) beta, C/EBP delta, and C/EBP alpha and peroxisome proliferator-activated receptor gamma (PPAR gamma). Currently, PPAR gamma is universally accepted as the master regulator that is necessary and sufficient to induce adipogenesis as no known factor can induce adipogenesis without PPAR gamma. We present evidence that a novel zinc finger protein, MCP-1-induced protein (MCPIP), can induce adipogenesis without PPAR gamma. Classical adipogenesis-inducing medium induces MCP-1 production and expression of MCPIP in 3T3-L1 cells before the induction of the C/EBP family of transcription factors and PPAR gamma. Knockdown of MCPIP prevents their expression and adipogenesis as measured by expression of adipocyte markers and lipid droplet accumulation. Treatment of 3T3-L1 cells with MCP-1 or forced expression of MCPIP induces expression of C/EBP beta, C/EBP delta, C/EBP alpha, and PPAR gamma and adipogenesis without any other inducer. Forced expression of MCPIP induces expression of the C/EBP family of transcription factors and adipogenesis in PPAR gamma(-/-) mouse embryonic fibroblasts. Thus, MCPIP is a newly identified protein that can induce adipogenesis without PPAR gamma.	[Younce, Craig W.; Azfer, Asim; Kolattukudy, Pappachan E.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Kolattukudy, PE (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	pk@mail.ucf.edu	kolattukudy, pappachan e/A-1350-2012		National Institutes of Health [HL-69458]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069458, R56HL069458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-69458.	Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hemmrich K, 2007, OBESITY, V15, P2951, DOI 10.1038/oby.2007.352; Hogaboam GM, 1999, J IMMUNOL, V163, P2193; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kobara M, 2008, J APPL PHYSIOL, V104, P601, DOI 10.1152/japplphysiol.00254.2007; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang BH, 2005, AM J PHYSIOL-ENDOC M, V288, pE731, DOI 10.1152/ajpendo.00475.2004; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	28	51	56	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27620	27628		10.1074/jbc.M109.025320	http://dx.doi.org/10.1074/jbc.M109.025320			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666473	Green Published, hybrid			2022-12-25	WOS:000270232300063
J	Agrawal, N; Padmanabhan, N; Hasan, G				Agrawal, Neha; Padmanabhan, Nisha; Hasan, Gaiti			Inositol 1,4,5-Trisphosphate Receptor Function in Drosophila Insulin Producing Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; SIGNALING PATHWAYS; GENE-EXPRESSION; BODY-SIZE; SEROTONIN; MELANOGASTER; CALCIUM; NEURONS; GROWTH; HOMEOSTASIS	The Inositol 1,4,5-trisphosphate receptor (InsP3R) is an intracellular ligand gated channel that releases calcium from intracellular stores in response to extracellular signals. To identify and understand physiological processes and behavior that depends on the InsP(3) signaling pathway at a systemic level, we are studying Drosophila mutants for the InsP(3)R (itpr) gene. Here, we show that growth defects precede larval lethality and both are a consequence of the inability to feed normally. Moreover, restoring InsP(3)R function in insulin producing cells (IPCs) in the larval brain rescues the feeding deficit, growth and lethality in the itpr mutants to a significant extent. We have previously demonstrated a critical requirement for InsP(3)R activity in neuronal cells, specifically in aminergic interneurons, for larval viability. Processes from the IPCs and aminergic domain are closely apposed in the third instar larval brain with no visible cellular overlap. Ubiquitous depletion of itpr by dsRNA results in feeding deficits leading to larval lethality similar to the itpr mutant phenotype. However, when itpr is depleted specifically in IPCs or aminergic neurons, the larvae are viable. These data support a model where InsP(3)R activity in non-overlapping neuronal domains independently rescues larval itpr phenotypes by non-cell autonomous mechanisms.	[Agrawal, Neha; Padmanabhan, Nisha; Hasan, Gaiti] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Agrawal, N (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	gaiti@ncbs.res.in	Padmanabhan, Nisha/ABE-4879-2020; Hasan, Gaiti/I-5851-2015; Hasan, Gaiti/P-4107-2019	Padmanabhan, Nisha/0000-0003-1253-2162; Hasan, Gaiti/0000-0001-7194-383X; Hasan, Gaiti/0000-0001-7194-383X; Agrawal, Neha/0000-0002-3916-5844	Department of Biotechnology, Govt. of India; National Centre for Biological Sciences; Tata Institute of Fundamental Research; NCBS; Wellcome Trust, UK [NLO-056727/Z/99/B]; Department of Science and Technology, Govt. of India [SR/S5/NM-36/2005]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); National Centre for Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); NCBS; Wellcome Trust, UK(Wellcome Trust); Department of Science and Technology, Govt. of India(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, Govt. of India and National Centre for Biological Sciences, Tata Institute of Fundamental Research. The NCBS imaging facilities used for this work were supported by the NCBS Central Image-Flow Facility, Wellcome Trust, UK (NLO-056727/Z/99/B) and Department of Science and Technology, Govt. of India (No. SR/S5/NM-36/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Banerjee S, 2004, J NEUROSCI, V24, P7869, DOI 10.1523/JNEUROSCI.0656-04.2004; BARKER CJ, 1994, BIOCHEM J, V297, P265, DOI 10.1042/bj2970265; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BIDEN TJ, 1984, BIOCHEM J, V223, P467, DOI 10.1042/bj2230467; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Bunin MA, 1999, TRENDS NEUROSCI, V22, P377, DOI 10.1016/S0166-2236(99)01410-1; Cherradi N, 1998, ENDOCR RES, V24, P355, DOI 10.3109/07435809809032615; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fellner SK, 2005, INSECT BIOCHEM MOLEC, V35, P263, DOI 10.1016/j.ibmb.2004.11.006; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Gates J, 2004, DEVELOPMENT, V131, P25, DOI 10.1242/dev.00920; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Hagar RE, 2000, CELL MOL LIFE SCI, V57, P1938, DOI 10.1007/PL00000674; Janning W, 1997, SEMIN CELL DEV BIOL, V8, P469, DOI 10.1006/scdb.1997.0172; Joshi R, 2004, GENETICS, V166, P225, DOI 10.1534/genetics.166.1.225; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaplan DD, 2008, GENE DEV, V22, P1877, DOI 10.1101/gad.1670508; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lorentzos P, 2003, GENET TEST, V7, P135, DOI 10.1089/109065703322146821; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Matsumoto M, 1999, J MOL MED, V77, P406, DOI 10.1007/s001090050370; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; Nichols CD, 2007, DEV NEUROBIOL, V67, P752, DOI 10.1002/dneu.20370; PRENTKI M, 1985, J BIOL CHEM, V260, P9185; Ruaud AF, 2008, GENE DEV, V22, P1851, DOI 10.1101/gad.1700708; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Srikanth S, 2004, BIOPHYS J, V86, P3634, DOI 10.1529/biophysj.104.040121; Street VA, 1997, J NEUROSCI, V17, P635; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Sykes PA, 2005, DEV BIOL, V286, P207, DOI 10.1016/j.ydbio.2005.07.025; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Tecott LH, 2007, CELL METAB, V6, P352, DOI 10.1016/j.cmet.2007.09.012; Venkatesh K, 1997, CURR BIOL, V7, P500, DOI 10.1016/S0960-9822(06)00221-1; Venkatesh K, 2001, GENETICS, V158, P309; Walker DS, 2002, MOL BIOL CELL, V13, P1329, DOI 10.1091/mbc.01-08-0422; WON JGS, 1995, ENDOCRINOLOGY, V136, P5399, DOI 10.1210/en.136.12.5399; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600; Zinke I, 1999, DEVELOPMENT, V126, P5275	58	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6652	10.1371/journal.pone.0006652	http://dx.doi.org/10.1371/journal.pone.0006652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680544	Green Published, Green Submitted, gold			2022-12-25	WOS:000268936200016
J	Hajri, A; Brin, C; Hunault, G; Lardeux, F; Lemaire, C; Manceau, C; Boureau, T; Poussier, S				Hajri, Ahmed; Brin, Chrystelle; Hunault, Gilles; Lardeux, Frederic; Lemaire, Christophe; Manceau, Charles; Boureau, Tristan; Poussier, Stephane			A "Repertoire for Repertoire" Hypothesis: Repertoires of Type Three Effectors are Candidate Determinants of Host Specificity Xanthomonas	PLOS ONE			English	Article							III SECRETION SYSTEM; CAMPESTRIS PV. VESICATORIA; SEPTICEMIC ESCHERICHIA-COLI; PLANT PATHOGEN XANTHOMONAS; BACTERIAL SPOT DISEASE; PHASEOLI VAR. FUSCANS; PSEUDOMONAS-SYRINGAE; GENETIC DIVERSITY; SEQUENCE-ANALYSIS; TOMATO DC3000	Background: The genetic basis of host specificity for animal and plant pathogenic bacteria remains poorly understood. For plant pathogenic bacteria, host range is restricted to one or a few host plant species reflecting a tight adaptation to specific hosts. Methodology/Principal Findings: Two hypotheses can be formulated to explain host specificity: either it can be explained by the phylogenetic position of the strains, or by the association of virulence genes enabling a pathological convergence of phylogenically distant strains. In this latter hypothesis, host specificity would result from the interaction between repertoires of bacterial virulence genes and repertoires of genes involved in host defences. To challenge these two hypotheses, we selected 132 Xanthomonas axonopodis strains representative of 18 different pathovars which display different host range. First, the phylogenetic position of each strain was determined by sequencing the housekeeping gene rpoD. This study showed that many pathovars of Xanthomonas axonopodis are polyphyletic. Second, we investigated the distribution of 35 type III effector genes (T3Es) in these strains by both PCR and hybridization methods. Indeed, for pathogenic bacteria T3Es were shown to trigger and to subvert host defences. Our study revealed that T3E repertoires comprise core and variable gene suites that likely have distinct roles in pathogenicity and different evolutionary histories. Our results showed a correspondence between composition of T3E repertoires and pathovars of Xanthomonas axonopodis. For polyphyletic pathovars, this suggests that T3E genes might explain a pathological convergence of phylogenetically distant strains. We also identified several DNA rearrangements within T3E genes, some of which correlate with host specificity of strains. Conclusions/Significance: These data provide insight into the potential role played by T3E genes for pathogenic bacteria and support a "repertoire for repertoire'' hypothesis that may explain host specificity. Our work provides resources for functional and evolutionary studies aiming at understanding host specificity of pathogenic bacteria, functional redundancy between T3Es and the driving forces shaping T3E repertoires.	[Hajri, Ahmed; Brin, Chrystelle; Manceau, Charles] INRA, Dept Sante Plantes & Environm, Beaucouze, France; [Hunault, Gilles; Lardeux, Frederic] Univ Angers, Dept Informat, Angers, Beaucouze, France; [Lemaire, Christophe; Boureau, Tristan] Univ Angers, Dept Biol, Angers, Beaucouze, France; [Poussier, Stephane] INHP, Dept Sci Biol, Agrocampus Ouest Ctr Angers, Beaucouze, France	INRAE; Universite d'Angers; Universite d'Angers; Institut Agro; Agrocampus Ouest	Hajri, A (corresponding author), INRA, Dept Sante Plantes & Environm, Beaucouze, France.	tristan.boureau@univ-angers.fr; stephane.poussier@agrocampus-ouest.fr	Manceau, Charles/AAS-8130-2021; Hajri, Ahmed/F-7603-2011; , AGROCAMPUS OUEST/O-6651-2016	Hajri, Ahmed/0000-0002-1516-3852; Poussier, Stephane/0000-0003-0273-3518; Manceau, Charles/0000-0003-3590-6454; , AGROCAMPUS OUEST/0000-0002-1800-4558; Lardeux, Frederic/0000-0001-8636-3870	Region Pays de la Loire; INRA; Tunisian Government; Conseil General du Maine-et-Loire	Region Pays de la Loire(Region Pays de la Loire); INRA; Tunisian Government; Conseil General du Maine-et-Loire(Region Pays de la Loire)	This study is part of programs funded by the Region Pays de la Loire and by the Plant Health and Environment Department of INRA. AH is supported by a grant from the Tunisian Government, from the Conseil General du Maine-et-Loire and from INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-You N, 2007, PHYTOPATHOLOGY, V97, P1568, DOI 10.1094/PHYTO-97-12-1568; Alavi SM, 2008, APPL ENVIRON MICROB, V74, P3295, DOI 10.1128/AEM.02507-07; Alavi SM, 2007, APPL ENVIRON MICROB, V73, P1678, DOI 10.1128/AEM.02031-06; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arnold DL, 2007, TRENDS GENET, V23, P293, DOI 10.1016/j.tig.2007.03.017; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P1346, DOI 10.1094/MPMI.2000.13.12.1346; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; Ausubel FM, 1991, CURRENT PROTOCOLS MO; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Badel JL, 2003, MOL MICROBIOL, V49, P1239, DOI 10.1046/j.1365-2958.2003.03647.x; BERTHIER Y, 1993, APPL ENVIRON MICROB, V59, P851, DOI 10.1128/AEM.59.3.851-859.1993; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Ciesiolka LD, 1999, MOL PLANT MICROBE IN, V12, P35, DOI 10.1094/MPMI.1999.12.1.35; Comas I, 2006, MOL BIOL EVOL, V23, P2049, DOI 10.1093/molbev/msl075; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Da Cunha L, 2007, CURR OPIN PLANT BIOL, V10, P349, DOI 10.1016/j.pbi.2007.04.018; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Darsonval A, 2008, APPL ENVIRON MICROB, V74, P2669, DOI 10.1128/AEM.02906-07; Darsonval A, 2009, MOL PLANT MICROBE IN, V22, P747, DOI 10.1094/MPMI-22-6-0747; DEFEYTER R, 1991, MOL PLANT MICROBE IN, V4, P423, DOI 10.1094/MPMI-4-423; Demuth A, 2008, INFECT GENET EVOL, V8, P386, DOI 10.1016/j.meegid.2008.01.005; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Dye D. W., 1980, Review of Plant Pathology, V59, P153; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; FARGIER E, 2007, THESIS U ANGERS; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fujikawa T, 2006, MOL PLANT MICROBE IN, V19, P342, DOI 10.1094/MPMI-19-0342; Fujikawa Takashi, 2006, Journal of General Plant Pathology, V72, P176, DOI 10.1007/s10327-005-0268-2; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; Gent DH, 2005, PHYTOPATHOLOGY, V95, P918, DOI 10.1094/PHYTO-95-0918; Gillings MR, 2005, P NATL ACAD SCI USA, V102, P4419, DOI 10.1073/pnas.0406620102; Gonzalez AI, 1998, MOL PLANT MICROBE IN, V11, P423, DOI 10.1094/MPMI.1998.11.5.423; Gonzalez C, 2002, FEMS MICROBIOL LETT, V215, P23, DOI 10.1111/j.1574-6968.2002.tb11365.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guidot A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06; Gurlebeck D, 2006, J PLANT PHYSIOL, V163, P233, DOI 10.1016/j.jplph.2005.11.011; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Ham JH, 2007, PLANT J, V51, P604, DOI 10.1111/j.1365-313X.2007.03165.x; Hayward A. C., 1993, Xanthomonas., P1; He YQ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r218; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Jacques MA, 2005, APPL ENVIRON MICROB, V71, P2008, DOI 10.1128/AEM.71.4.2008-2015.2005; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Jiang BL, 2008, RES MICROBIOL, V159, P216, DOI 10.1016/j.resmic.2007.12.004; Jones JB, 1998, ANNU REV PHYTOPATHOL, V36, P41, DOI 10.1146/annurev.phyto.36.1.41; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kariyawasam S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-81; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; KEARNEY B, 1988, NATURE, V332, P541, DOI 10.1038/332541a0; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; KEARNEY B, 1990, J BACTERIOL, V172, P143, DOI 10.1128/JB.172.1.143-148.1990; Khatri-Chhetri GB, 2003, EUR J PLANT PATHOL, V109, P851, DOI 10.1023/A:1026104716650; Kim JF, 1998, MOL PLANT MICROBE IN, V11, P1247, DOI 10.1094/MPMI.1998.11.12.1247; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Lavie M, 2004, MOL PLANT MICROBE IN, V17, P931, DOI 10.1094/MPMI.2004.17.8.931; Leach JE, 2001, ANNU REV PHYTOPATHOL, V39, P187, DOI 10.1146/annurev.phyto.39.1.187; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Lima WC, 2005, OMICS, V9, P160, DOI 10.1089/omi.2005.9.160; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lindeberg M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S4; Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x; LORANG JM, 1994, MOL PLANT MICROBE IN, V7, P508, DOI 10.1094/MPMI-7-0508; Lu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003828; Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209; Maddison, 2019, MESQUITE MODULAR SYS; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Metz M, 2005, PLANT J, V41, P801, DOI 10.1111/j.1365-313X.2005.02338.x; Meyer Damien F., 2009, P147; Mkandawire ABC, 2004, PHYTOPATHOLOGY, V94, P593, DOI 10.1094/PHYTO.2004.94.6.593; Mokady D, 2005, INT J MED MICROBIOL, V295, P455, DOI 10.1016/j.ijmm.2005.07.007; Mokady D, 2005, J CLIN MICROBIOL, V43, P66, DOI 10.1128/JCM.43.1.66-73.2005; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Noel L, 2003, J BACTERIOL, V185, P7092, DOI 10.1128/JB.185.24.7092-7102.2003; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rademaker JLW, 2005, PHYTOPATHOLOGY, V95, P1098, DOI 10.1094/PHYTO-95-1098; Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665, DOI 10.1099/00207713-50-2-665; Reboutier D, 2007, J CELL SCI, V120, P3271, DOI 10.1242/jcs.011098; Restrepo S, 2000, PHYTOPATHOLOGY, V90, P683, DOI 10.1094/PHYTO.2000.90.7.683; Rivas LA, 2005, APPL ENVIRON MICROB, V71, P3778, DOI 10.1128/AEM.71.7.3778-3785.2005; Robene-Soustrade I, 2006, APPL ENVIRON MICROB, V72, P1072, DOI 10.1128/AEM.72.2.1072-1078.2006; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; Rohmer L, 2004, GENETICS, V167, P1341, DOI 10.1534/genetics.103.019638; Ron EZ, 2006, CURR OPIN MICROBIOL, V9, P28, DOI 10.1016/j.mib.2005.12.001; Roumagnac P, 2004, INT J SYST EVOL MICR, V54, P15, DOI 10.1099/ijs.0.02714-0; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Staden R, 2000, Methods Mol Biol, V132, P115; Stavrinides J, 2008, CELL MICROBIOL, V10, P285, DOI 10.1111/j.1462-5822.2007.01078.x; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Torto-Alalibo T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S1; Triplett LR, 2006, APPL ENVIRON MICROB, V72, P7359, DOI 10.1128/AEM.01159-06; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vauterin L, 2000, PHYTOPATHOLOGY, V90, P677, DOI 10.1094/PHYTO.2000.90.7.677; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Wichmann G, 2005, APPL ENVIRON MICROB, V71, P2418, DOI 10.1128/AEM.71.5.2418-2432.2005; Xu RQ, 2008, J BACTERIOL, V190, P343, DOI 10.1128/JB.00978-07; Yang B, 2005, MOL PLANT MICROBE IN, V18, P142, DOI 10.1094/MPMI-18-0142; YANG YO, 1995, J BACTERIOL, V177, P4963, DOI 10.1128/jb.177.17.4963-4968.1995; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zhou HB, 2009, MOL PLANT MICROBE IN, V22, P176, DOI 10.1094/MPMI-22-2-0176; ZOMORODIAN A, 1993, XANTHOMONAS, P25	127	103	110	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6632	10.1371/journal.pone.0006632	http://dx.doi.org/10.1371/journal.pone.0006632			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680562	Green Published, gold			2022-12-25	WOS:000268936200004
J	Krahe, TE; Wang, WL; Medina, AE				Krahe, Thomas E.; Wang, Weili; Medina, Alexandre E.			Phosphodiesterase Inhibition Increases CREB Phosphorylation and Restores Orientation Selectivity in a Model of Fetal Alcohol Spectrum Disorders	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; POSTNATAL ETHANOL EXPOSURE; EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; LONG-TERM POTENTIATION; CATS STRIATE CORTEX; SPINAL-CORD NEURONS; SYNAPTIC PLASTICITY; RECEPTIVE-FIELDS; CORTICAL PLASTICITY	Background: Fetal alcohol spectrum disorders (FASD) are the leading cause of mental retardation in the western world and children with FASD present altered somatosensory, auditory and visual processing. There is growing evidence that some of these sensory processing problems may be related to altered cortical maps caused by impaired developmental neuronal plasticity. Methodology/Principal Findings: Here we show that the primary visual cortex of ferrets exposed to alcohol during the third trimester equivalent of human gestation have decreased CREB phosphorylation and poor orientation selectivity revealed by western blotting, optical imaging of intrinsic signals and single-unit extracellular recording techniques. Treating animals several days after the period of alcohol exposure with a phosphodiesterase type 1 inhibitor (Vinpocetine) increased CREB phosphorylation and restored orientation selectivity columns and neuronal orientation tuning. Conclusions/Significance: These findings suggest that CREB function is important for the maturation of orientation selectivity and that plasticity enhancement by vinpocetine may play a role in the treatment of sensory problems in FASD.	[Krahe, Thomas E.; Wang, Weili; Medina, Alexandre E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Ctr, Richmond, VA 23284 USA	Virginia Commonwealth University	Krahe, TE (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Ctr, Richmond, VA 23284 USA.	amedina@vcu.edu	Krahe, Thomas E/H-1695-2013	Krahe, Thomas E/0000-0002-4686-9284; Medina, Alexandre/0000-0003-0517-7756	NIH(NIAAA) [AA-13023]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R56AA013023, R01AA013023] Funding Source: NIH RePORTER	NIH(NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH(NIAAA) grant AA-13023 to A. E. M.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; BEAR MF, 1990, J NEUROSCI, V10, P909; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 1996, J NEUROSCI, V16, P6443; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Coles CD, 2002, ALCOHOL CLIN EXP RES, V26, P263, DOI 10.1111/j.1530-0277.2002.tb02533.x; Constantinescu A, 1999, J BIOL CHEM, V274, P26985, DOI 10.1074/jbc.274.38.26985; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Costa ET, 2000, ALCOHOL CLIN EXP RES, V24, P706, DOI 10.1097/00000374-200005000-00016; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; DURAND D, 1984, SCIENCE, V224, P1359, DOI 10.1126/science.6328654; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Galindo R, 2005, J NEUROCHEM, V94, P1500, DOI 10.1111/j.1471-4159.2005.03294.x; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; HARRIS SR, 1995, ALCOHOL CLIN EXP RES, V19, P660, DOI 10.1111/j.1530-0277.1995.tb01564.x; Hebb Donald O., 1949, ORG BEHAV; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x; Hsiao SH, 1999, BRAIN RES, V832, P124, DOI 10.1016/S0006-8993(99)01480-8; Hsiao SH, 1998, BRAIN RES, V810, P100, DOI 10.1016/S0006-8993(98)00891-9; Hsiao SH, 2002, DEV BRAIN RES, V138, P177, DOI 10.1016/S0165-3806(02)00470-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Johnston MV, 2003, EUR J PAEDIATR NEURO, V7, P105, DOI 10.1016/S1090-3798(03)00039-4; Johnston MV, 2001, BRAIN DEV-JPN, V23, pS206, DOI 10.1016/S0387-7604(01)00351-5; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kemeny V, 2005, J CLIN PHARMACOL, V45, P1048, DOI 10.1177/0091270005279363; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Klug MG, 2003, NEUROTOXICOL TERATOL, V25, P763, DOI 10.1016/j.ntt.2003.07.012; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Krahe TE, 2005, NEURON, V48, P329, DOI 10.1016/j.neuron.2005.09.016; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Lamprecht R, 1999, CELL MOL LIFE SCI, V55, P554, DOI 10.1007/s000180050314; Lee YH, 1996, ALCOHOL CLIN EXP RES, V20, P921, DOI 10.1111/j.1530-0277.1996.tb05272.x; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Lowel S, 1998, EUR J NEUROSCI, V10, P2629, DOI 10.1046/j.1460-9568.1998.t01-1-00274.x; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Margret CP, 2006, EXP BRAIN RES, V172, P387, DOI 10.1007/s00221-005-0339-9; Mattson SN, 1996, CHILD NEUROPSYCHOL, V2, P165, DOI 10.1080/09297049608402249; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Medina AE, 2006, J NEUROSCI, V26, P1057, DOI 10.1523/JNEUROSCI.4177-05.2006; Medina AE, 2005, J NEUROPHYSIOL, V93, P1317, DOI 10.1152/jn.00714.2004; Medina AE, 2003, J NEUROSCI, V23, P10002; Medina AE, 2008, J NEUROSCI RES, V86, P256, DOI 10.1002/jnr.21447; Miller MW, 2006, NEUROSCIENCE, V138, P97, DOI 10.1016/j.neuroscience.2005.10.060; MISKOLCZI P, 1990, EUR J DRUG METAB PH, V15, P1; Monti B, 2006, NEUROPSYCHOPHARMACOL, V31, P278, DOI 10.1038/sj.npp.1300813; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Pandey SC, 2001, J PHARMACOL EXP THER, V296, P857; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; Powrozek TA, 2005, DEV BRAIN RES, V155, P135, DOI 10.1016/j.devbrainres.2005.01.003; Ramoa AS, 2001, J NEUROSCI, V21, P4299, DOI 10.1523/JNEUROSCI.21-12-04299.2001; Rao SC, 1997, J COMP NEUROL, V387, P358; Rao VR, 2007, TRENDS NEUROSCI, V30, P284, DOI 10.1016/j.tins.2007.03.012; Rasmussen C, 2006, CHILD NEUROPSYCHOL, V12, P453, DOI 10.1080/09297040600646854; Rema V, 1999, J NEUROSCI, V19, P10993, DOI 10.1523/JNEUROSCI.19-24-10993.1999; Rose GM, 2005, CURR PHARM DESIGN, V11, P3329, DOI 10.2174/138161205774370799; SAVAGE DD, 1992, ALCOHOL, V9, P37, DOI 10.1016/0741-8329(92)90007-W; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Servais L, 2007, P NATL ACAD SCI USA, V104, P9858, DOI 10.1073/pnas.0607037104; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Uecker A, 1996, NEUROPSYCHOLOGIA, V34, P209, DOI 10.1016/0028-3932(95)00096-8; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; YANG X, 1988, J NEUROCHEM, V70, P224; Yang XO, 1998, ALCOHOL CLIN EXP RES, V22, P382, DOI 10.1097/00000374-199804000-00014	93	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6643	10.1371/journal.pone.0006643	http://dx.doi.org/10.1371/journal.pone.0006643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680548	Green Published, gold, Green Submitted			2022-12-25	WOS:000268936200009
J	Fino, E; Deniau, JM; Venance, L				Fino, Elodie; Deniau, Jean-Michel; Venance, Laurent			Brief Subthreshold Events Can Act as Hebbian Signals for Long-Term Plasticity	PLOS ONE			English	Article								Background: Action potentials are thought to be determinant for the induction of long-term synaptic plasticity, the cellular basis of learning and memory. However, neuronal activity does not lead systematically to an action potential but also, in many cases, to synaptic depolarizing subthreshold events. This is particularly exemplified in corticostriatal information processing. Indeed, the striatum integrates information from the whole cerebral cortex and, due to the membrane properties of striatal medium spiny neurons, cortical inputs do not systematically trigger an action potential but a wide range of subthreshold postsynaptic depolarizations. Accordingly, we have addressed the following question: does a brief subthreshold event act as a Hebbian signal and induce long-term synaptic efficacy changes? Methodology/Principal Findings: Here, using perforated patch-clamp recordings on rat brain corticostriatal slices, we demonstrate, that brief (30 ms) subthreshold depolarizing events in quasi-coincidence with presynaptic activity can act as Hebbian signals and are sufficient to induce long-term synaptic plasticity at corticostriatal synapses. This "subthreshold-depolarization dependent plasticity" (SDDP) induces strong, significant and bidirectional long-term synaptic efficacy changes at a very high occurrence (81%) for time intervals between pre- and postsynaptic stimulations (Delta t) of -110<Delta t<+110 ms. Such subthreshold depolarizations are able to induce robust long-term depression (cannabinoid type-1 receptor-activation dependent) as well as long-term potentiation (NMDA receptor-activation dependent). Conclusion/Significance: Our data show the existence of a robust, reliable and timing-dependent bidirectional long-term plasticity induced by brief subthreshold events paired with presynaptic activity. The existence of a subthreshold-depolarization dependent plasticity extends considerably, beyond the action potential, the neuron's capabilities to express long-term synaptic efficacy changes.			Fino, E (corresponding author), Univ Paris 06, INSERM, U667, Dynam Neuronal Network,Coll France, Paris, France.	laurent.venance@college-de-france.fr	Fino, Elodie/M-6586-2014; Venance, Laurent/E-5840-2016	Fino, Elodie/0000-0003-1453-7784; Venance, Laurent/0000-0003-0738-1662				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; CALABRESI P, 1987, NEUROSCIENCE, V20, P293, DOI 10.1016/0306-4522(87)90021-2; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CHANG HT, 1982, J COMP NEUROL, V208, P107, DOI 10.1002/cne.902080202; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fino E, 2009, NEUROSCIENCE, V160, P744, DOI 10.1016/j.neuroscience.2009.03.015; Fino E, 2005, J NEUROSCI, V25, P11279, DOI 10.1523/JNEUROSCI.4476-05.2005; Fino E, 2008, J PHYSIOL-LONDON, V586, P265, DOI 10.1113/jphysiol.2007.144501; Fino E, 2007, NEUROSCI RES, V58, P305, DOI 10.1016/j.neures.2007.04.002; Fitzpatrick JS, 2001, J NEUROPHYSIOL, V85, P2088, DOI 10.1152/jn.2001.85.5.2088; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Narushima M, 2006, NEUROSCI RES, V54, P159, DOI 10.1016/j.neures.2005.12.004; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; NISENBAUM ES, 1995, J NEUROSCI, V15, P4449; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2004, J NEUROPHYSIOL, V92, P3338, DOI 10.1152/jn.00376.2004; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Staubli UV, 1996, BRAIN RES, V714, P169, DOI 10.1016/0006-8993(95)01523-X; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Venance L, 2003, NEUROSCIENCE, V122, P77, DOI 10.1016/S0306-4522(03)00553-0; Venance L, 2004, J PHYSIOL-LONDON, V559, P215, DOI 10.1113/jphysiol.2004.065672; Wilson C., 1995, MODELS INFORMATION P, V1, P29; WILSON CJ, 1984, J NEUROSCI, V4, P281; Xu NL, 2006, J NEUROSCI, V26, P3002, DOI 10.1523/JNEUROSCI.5220-05.2006; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	45	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6557	10.1371/journal.pone.0006557	http://dx.doi.org/10.1371/journal.pone.0006557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19675683	Green Published, Green Submitted, gold			2022-12-25	WOS:000268739600013
J	Blais, C; Fiset, D; Arguin, M; Jolicoeur, P; Bub, D; Gosselin, F				Blais, Caroline; Fiset, Daniel; Arguin, Martin; Jolicoeur, Pierre; Bub, Daniel; Gosselin, Frederic			Reading between Eye Saccades	PLOS ONE			English	Article							SPATIOTEMPORAL DYNAMICS; CLASSIFICATION IMAGES; WORD RECOGNITION; INFORMATION; MOVEMENTS; BUBBLES; PERCEPTION; ATTENTION; DISCRETE; FEATURES	Background: Skilled adult readers, in contrast to beginners, show no or little increase in reading latencies as a function of the number of letters in words up to seven letters. The information extraction strategy underlying such efficiency in word identification is still largely unknown, and methods that allow tracking of the letter information extraction through time between eye saccades are needed to fully address this question. Methodology/Principal Findings: The present study examined the use of letter information during reading, by means of the Bubbles technique. Ten participants each read 5,000 five-letter French words sampled in space-time within a 200 ms window. On the temporal dimension, our results show that two moments are especially important during the information extraction process. On the spatial dimension, we found a bias for the upper half of words. We also show for the first time that letter positions four, one, and three are particularly important for the identification of five-letter words. Conclusions/Significance: Our findings are consistent with either a partially parallel reading strategy or an optimal serial reading strategy. We show using computer simulations that this serial reading strategy predicts an absence of a word-length effect for words from four-to seven letters in length. We believe that the Bubbles technique will play an important role in further examining the nature of reading between eye saccades.			Blais, C (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	martin.arguin@umontreal.ca; frederic.gosselin@umontreal.ca	Fiset, Daniel/Y-7799-2019	Arguin, Martin/0000-0002-1036-2932				Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; CONTENT A, 1990, ANN PSYCHOL, V90, P551; Eckstein MP, 2002, J VISION, V2, pI, DOI 10.1167/2.1.i; Fiset D, 2006, COGN NEUROPSYCHOL, V23, P240, DOI 10.1080/02643290442000437; Fiset D, 2008, PSYCHOL SCI, V19, P1161, DOI 10.1111/j.1467-9280.2008.02218.x; Fiset D, 2009, COGN NEUROPSYCHOL, V26, P23, DOI 10.1080/02643290802421160; Geisler W, 2003, NATURE, V423, P696, DOI 10.1038/423696a; Gold JM, 2006, J VISION, V6, P356, DOI 10.1167/6.4.5; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Gosselin F, 2004, VISION RES, V44, P471, DOI 10.1016/j.visres.2003.10.007; Gosselin F, 2003, PSYCHOL SCI, V14, P505, DOI 10.1111/1467-9280.03452; Gosselin F, 2002, TRENDS COGN SCI, V6, P70, DOI 10.1016/S1364-6613(00)01838-6; Hertz JA, 2018, INTRO THEORY NEURAL; Huey E.B., 1908, PSYCHOL PEDAGOGY REA; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Murray RF, 2004, VISION RES, V44, P461, DOI 10.1016/j.visres.2003.10.006; Neri P, 2002, NAT NEUROSCI, V5, P812, DOI 10.1038/nn886; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1978, PSYCHOL BULL, V85, P618, DOI 10.1037/0033-2909.85.3.618; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Sereno SC, 2000, BRAIN COGNITION, V42, P78, DOI 10.1006/brcg.1999.1167; SLOWIACZEK ML, 1987, B PSYCHONOMIC SOC, V25, P175; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Watson Andrew B., 1997, Investigative Ophthalmology and Visual Science, V38, pS1; Watson Andrew B., 1998, IOVS, V39, pS912; Weekes BS, 1997, Q J EXP PSYCHOL-A, V50, P439, DOI 10.1080/027249897392170; Wolfe JM, 2000, NATURE, V406, P691, DOI 10.1038/35021132; Wolfs GGMC, 1998, EUR UROL, V33, P1, DOI 10.1159/000019527	35	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6448	10.1371/journal.pone.0006448	http://dx.doi.org/10.1371/journal.pone.0006448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CG	19649292	Green Published, gold			2022-12-25	WOS:000268494600016
J	Garbarino, J; Padamsee, M; Wilcox, L; Oelkers, PM; D'Ambrosio, D; Ruggles, KV; Ramsey, N; Jabado, O; Turkish, A; Sturley, SL				Garbarino, Jeanne; Padamsee, Mahajabeen; Wilcox, Lisa; Oelkers, Peter M.; D'Ambrosio, Diana; Ruggles, Kelly V.; Ramsey, Nicole; Jabado, Omar; Turkish, Aaron; Sturley, Stephen L.			Sterol and Diacylglycerol Acyltransferase Deficiency Triggers Fatty Acid-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; INDUCED INSULIN-RESISTANCE; GRAPHICAL USER-INTERFACE; GENE-EXPRESSION DATA; LIPID PARTICLES; TRIGLYCERIDE-METABOLISM; ENDOPLASMIC-RETICULUM; INDUCED APOPTOSIS; MICROARRAY DATA; ACYL-COENZYME	Deletion of the acyltransferases responsible for triglyceride and steryl ester synthesis in Saccharomyces cerevisiae serves as a genetic model of diseases where lipid overload is a component. The yeast mutants lack detectable neutral lipids and cytoplasmic lipid droplets and are strikingly sensitive to unsaturated fatty acids. Expression of human diacylglycerol acyltransferase 2 in the yeast mutants was sufficient to reverse these phenotypes. Similar to mammalian cells, fatty acid-mediated death in yeast is apoptotic and presaged by transcriptional induction of stress-response pathways, elevated oxidative stress, and activation of the unfolded protein response. To identify pathways that protect cells from lipid excess, we performed genetic interaction and transcriptional profiling screens with the yeast acyltransferase mutants. We thus identified diacylglycerol kinase-mediated phosphatidic acid biosynthesis and production of phosphatidylcholine via methylation of phosphatidylethanolamine as modifiers of lipotoxicity. Accordingly, the combined ablation of phospholipid and triglyceride biosynthesis increased sensitivity to saturated fatty acids. Similarly, normal sphingolipid biosynthesis and vesicular transport were required for optimal growth upon denudation of triglyceride biosynthesis and also mediated resistance to exogenous fatty acids. In metazoans, many of these processes are implicated in insulin secretion thus linking lipotoxicity with early aspects of pancreatic beta-cell dysfunction, diabetes, and the metabolic syndrome.	[D'Ambrosio, Diana; Turkish, Aaron; Sturley, Stephen L.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Jabado, Omar] Columbia Univ, Dept Epidemiol, Med Ctr, New York, NY 10032 USA; [Ruggles, Kelly V.; Ramsey, Nicole; Sturley, Stephen L.] Columbia Univ, Inst Human Nutr, Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Sturley, SL (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, 630 W 168th St, New York, NY 10032 USA.	sls37@columbia.edu		Ruggles, Kelly/0000-0002-0152-0863; Padamsee, Mahajabeen/0000-0002-0741-3014	National Institutes of Health [DK54320, T32 HL007343, K12HD043389]; NIDDK [2P30-DK63608-07]; American Diabetes Association; American Heart Association; Heart and Stroke Foundation of Canada; American Liver Foundation; Children's Digestive Health and Nutrition Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043389] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320, P30DK063608, T32DK007647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); American Liver Foundation; Children's Digestive Health and Nutrition Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54320 (to S. L. S.) and Grant 2P30-DK63608-07 from NIDDK (pilot award from Diabetes and Endocrinology Research Center to Columbia University). This work was also supported by the American Diabetes Association and the American Heart Association.; Supported by the Heart and Stroke Foundation of Canada.; Supported in part by National Institutes of Health Grant T32 HL007343 (fellowship in arteriosclerosis research).; Supported in part by National Institutes of Health Child Health Research Career Development Award K12HD043389, the American Liver Foundation, American Association for the Study of Liver Diseases Sheila Sherlock Award, and the Young Investigator Development Award of the Children's Digestive Health and Nutrition Foundation.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Cartwright I J, 1993, Methods Mol Biol, V19, P153; Chang BHJ, 2007, AM J PHYSIOL-GASTR L, V292, pG1465, DOI 10.1152/ajpgi.00566.2006; Cury-Boaventura MF, 2005, CLIN SCI, V108, P245, DOI 10.1042/CS20040281; Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Garbarino J, 2005, BIOCHEM SOC T, V33, P1182, DOI 10.1042/BST20051182; Garbarino J, 2009, CURR OPIN CLIN NUTR, V12, P110, DOI 10.1097/MCO.0b013e32832182ee; GAYNOR PM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P326, DOI 10.1016/0167-4781(91)90197-T; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hartz CS, 2006, J NUTR, V136, P3005, DOI 10.1093/jn/136.12.3005; HENRY SA, 1973, J BACTERIOL, V114, P1158, DOI 10.1128/JB.114.3.1158-1163.1973; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HULTIN M, 1994, J LIPID RES, V35, P1850; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kudo T, 2006, J PHARMACOL EXP THER, V318, P1203, DOI 10.1124/jpet.106.105759; LAW SWT, 1976, CAN J MICROBIOL, V22, P1710, DOI 10.1139/m76-252; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Mo C, 2003, BBA-MOL CELL BIOL L, V1633, P68, DOI 10.1016/S1388-1981(03)00088-X; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Packter NM, 1995, ARCH MICROBIOL, V164, P420, DOI 10.1007/BF02529740; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sandager L, 2000, BIOCHEM SOC T, V28, P700; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Walkey CJ, 1996, J LIPID RES, V37, P2341; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	64	114	116	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30994	31005		10.1074/jbc.M109.050443	http://dx.doi.org/10.1074/jbc.M109.050443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19690167	Green Published, hybrid			2022-12-25	WOS:000271378400029
J	Blaauw, B; Canato, M; Agatea, L; Toniolo, L; Mammucari, C; Masiero, E; Abraham, R; Sandri, M; Schiaffino, S; Reggiani, C				Blaauw, Bert; Canato, Marta; Agatea, Lisa; Toniolo, Luana; Mammucari, Cristina; Masiero, Eva; Abraham, Reimar; Sandri, Marco; Schiaffino, Stefano; Reggiani, Carlo			Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation	FASEB JOURNAL			English	Article						BrdU; angiogenesis; skinned fibers; nuclear domain	MYONUCLEAR DOMAIN SIZE; ADDITION IS/IS; HYPERTROPHY; EXPRESSION; FIBERS; GROWTH; COUNTERPOINT; PREVENTS; PATHWAY; VELOCITY	A better understanding of the signaling pathways that control muscle growth is required to identify appropriate countermeasures to prevent or reverse the loss of muscle mass and force induced by aging, disuse, or neuromuscular diseases. However, two major issues in this field have not yet been fully addressed. The first concerns the pathways involved in leading to physiological changes in muscle size. Muscle hypertrophy based on perturbations of specific signaling pathways is either characterized by impaired force generation, e. g., myostatin knockout, or incompletely studied from the physiological point of view, e. g., IGF-1 overexpression. A second issue is whether satellite cell proliferation and incorporation into growing muscle fibers is required for a functional hypertrophy. To address these issues, we used an inducible transgenic model of muscle hypertrophy by short-term Akt activation in adult skeletal muscle. In this model, Akt activation for 3 wk was followed by marked hypertrophy (similar to 50% of muscle mass) and by increased force generation, as determined in vivo by ankle plantar flexor stimulation, ex vivo in intact isolated diaphragm strips, and in single-skinned muscle fibers. No changes in fiber-type distribution and resistance to fatigue were detectable. Bromodeoxyuridine incorporation experiments showed that Akt-dependent muscle hypertrophy was accompanied by proliferation of interstitial cells but not by satellite cell activation and new myonuclei incorporation, pointing to an increase in myonuclear domain size. We can conclude that during a fast hypertrophic growth myonuclear domain can increase without compromising muscle performance.-Blaauw, B., Canato, M., Agatea, L., Toniolo, L., Mammucari, C., Masiero, E., Abraham, R., Sandri, M., Schiaffino, S., Reggiani, C. Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation. FASEB J. 23, 3896-3905 (2009). www.fasebj.org	[Blaauw, Bert; Agatea, Lisa; Masiero, Eva; Abraham, Reimar; Sandri, Marco; Schiaffino, Stefano] Venetian Inst Mol Med, I-35126 Padua, Italy; [Canato, Marta; Toniolo, Luana; Reggiani, Carlo] Univ Padua, Dept Human Anat & Physiol, CNR, Inst Neurosci, Padua, Italy; [Agatea, Lisa; Mammucari, Cristina; Masiero, Eva; Sandri, Marco; Schiaffino, Stefano; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, CNR, Inst Neurosci, Padua, Italy; [Sandri, Marco] Dulbecco Telethon Inst, Rome, Italy	Veneto Institute Molecular Medicine; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI)	Blaauw, B (corresponding author), Venetian Inst Mol Med, Via Orus 2, I-35126 Padua, Italy.	bertblaauw@yahoo.com	Toniolo, Luana/B-9647-2014; blaauw, bert/A-7614-2014; agatea, lisa/L-8267-2016	Toniolo, Luana/0000-0001-7160-5638; blaauw, bert/0000-0002-3893-1463; agatea, lisa/0000-0002-8380-9619; Schiaffino, Stefano/0000-0002-5607-6421; BLAAUW, BERT/0000-0002-4167-5106	Italian Ministry of University; Italian Space Agency; European Commission [LSHG-CT-2004-511978, LSHM-CT-2004-005272]; Fondazione Telethon Funding Source: Custom	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Telethon(Fondazione Telethon)	The authors thank Tom Sato (University of Texas, Houston, TX, USA) for the transgenic line expressing silent Akt and Steven Burden (University of New York, New York, NY, USA) for the transgenic line expressing Cre recombinase. The technical assistance of A. Picard, C. Argentini, T. Zaglia, and K. Dyar is gratefully acknowledged. This work was supported by grants from the Italian Ministry of University and the Italian Space Agency (OSMA project) to S. S. and C. R., and by grants from the European Commission to S. S. (Network of Excellence MYORES, contract LSHG-CT-2004-511978, and Integrated Project EXGENESIS, contract LSHM-CT-2004-005272). The authors declare no conflicts of interest.	Adams GR, 2002, AM J PHYSIOL-CELL PH, V283, pC1182, DOI 10.1152/ajpcell.00173.2002; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Amthor H, 2009, P NATL ACAD SCI USA, V106, P7479, DOI 10.1073/pnas.0811129106; Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Blough ER, 1996, ANAL BIOCHEM, V233, P31, DOI 10.1006/abio.1996.0003; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Bruusgaard JC, 2005, ACTA PHYSIOL SCAND, V185, P141, DOI 10.1111/j.1365-201X.2005.01462.x; D'Antona G, 2006, J PHYSIOL-LONDON, V570, P611, DOI 10.1113/jphysiol.2005.101642; Defranchi E, 2005, MICROSC RES TECHNIQ, V67, P27, DOI 10.1002/jemt.20177; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; GODT RE, 1977, BIOPHYS J, V19, P103, DOI 10.1016/S0006-3495(77)85573-2; Herbst KL, 2004, CURR OPIN CLIN NUTR, V7, P271, DOI 10.1097/00075197-200405000-00006; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hudon-David F, 2007, J MOL CELL CARDIOL, V42, P991, DOI 10.1016/j.yjmcc.2007.02.009; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kim YK, 2003, J BIOL CHEM, V278, P47622, DOI 10.1074/jbc.M305909200; Kroll J, 2003, GENESIS, V35, P160, DOI 10.1002/gene.10180; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Liu JX, 2009, EXP PHYSIOL, V94, P117, DOI 10.1113/expphysiol.2008.043877; Lowe DA, 1999, CELL TISSUE RES, V296, P531, DOI 10.1007/s004410051314; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mantilla CB, 2008, J APPL PHYSIOL, V104, P787, DOI 10.1152/japplphysiol.00347.2007; McCarthy JJ, 2007, J APPL PHYSIOL, V103, P1102; McCarthy JJ, 2007, J APPL PHYSIOL, V103, P1100, DOI 10.1152/japplphysiol.00101.2007a; METZGER JM, 1987, BIOPHYS J, V52, P127, DOI 10.1016/S0006-3495(87)83197-1; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420; Nader GA, 2005, INT J BIOCHEM CELL B, V37, P1985, DOI 10.1016/j.biocel.2005.02.026; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1107, DOI 10.1152/japplphysiol.00502.2007; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; PAVLATH GK, 1989, NATURE, V337, P570, DOI 10.1038/337570a0; Rehfeldt C, 2007, J APPL PHYSIOL, V103, P1104, DOI 10.1152/japplphysiol.00466.2007; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Roy RR, 1999, J APPL PHYSIOL, V87, P634, DOI 10.1152/jappl.1999.87.2.634; Sakamoto K, 2002, J BIOL CHEM, V277, P11910, DOI 10.1074/jbc.M112410200; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHIAFFINO S, 1976, VIRCHOWS ARCH B, V21, P113; Sonnet C, 2006, J CELL SCI, V119, P2497, DOI 10.1242/jcs.02988; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; TSIKA RW, 1987, J APPL PHYSIOL, V63, P2111, DOI 10.1152/jappl.1987.63.5.2111	49	176	179	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3896	3905		10.1096/fj.09-131870	http://dx.doi.org/10.1096/fj.09-131870			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19661286				2022-12-25	WOS:000271272500025
J	Yamaguchi, Y; Park, JH; Inouye, M				Yamaguchi, Yoshihiro; Park, Jung-Ho; Inouye, Masayori			MqsR, a Crucial Regulator for Quorum Sensing and Biofilm Formation, Is a GCU-specific mRNA Interferase in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-ANTITOXIN MODULE; GENE-EXPRESSION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA GYRASE; CELL-DEATH; C QSEBC; MECHANISM; CLEAVAGE; SYSTEM	The mqsR gene has been shown to be positively regulated by the quorum-sensing autoinducer AI-2, which in turn activates a two-component system, the qseB-qseC operon. This operon plays an important role in biofilm formation in Escherichia coli. However, its cellular function has remained unknown. Here, we found that 1 base downstream of mqsR there is a gene, ygiT, that is co-transcribed with mqsR. Induction of mqsR caused cell growth arrest, whereas ygiT co-induction recovered cell growth. We demonstrate that MqsR (98 amino acid residues), which has no homology to the well characterized mRNA interferase MazF, is a potent inhibitor of protein synthesis that functions by degrading cellular mRNAs. In vivo and in vitro primer extension experiments showed that MqsR is an mRNA interferase specifically cleaving mRNAs at GCU. The mRNA interferase activity of purified MqsR was inhibited by purified YgiT (131 residues). MqsR forms a stable 2: 1 complex with YgiT, and the complex likely functions as a repressor for the mqsR-ygiT operon by specifically binding to two different palindromic sequences present in the 5'-untranslated region of this operon.	[Yamaguchi, Yoshihiro; Park, Jung-Ho; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	inouye@umdnj.edu		Yamaguchi, Yoshihiro/0000-0003-4663-6963; Park, Jung-Ho/0000-0003-0441-4457	National Institutes of Health [1RO1 GM081567]; Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 GM081567. This work was also supported by Takara Bio Inc.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bahassi EM, 1999, J BIOL CHEM, V274, P10936, DOI 10.1074/jbc.274.16.10936; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Brown JM, 2003, J BACTERIOL, V185, P6600, DOI 10.1128/JB.185.22.6600-6608.2003; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Clarke MB, 2005, MOL MICROBIOL, V58, P441, DOI 10.1111/j.1365-2958.2005.04819.x; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Inouye M, 2006, J CELL PHYSIOL, V209, P670, DOI 10.1002/jcp.20801; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; LIU YC, 1990, BIOTECHNIQUES, V9, P558; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; MIZUNO T, 1984, P NATL ACAD SCI-BIOL, V81, P1966, DOI 10.1073/pnas.81.7.1966; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Puerta-Fernandez E, 2003, FEMS MICROBIOL REV, V27, P75, DOI 10.1016/S0168-6445(03)00020-2; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Wang XX, 2009, ISME J, V3, P1164, DOI 10.1038/ismej.2009.59; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	57	130	149	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28746	28753		10.1074/jbc.M109.032904	http://dx.doi.org/10.1074/jbc.M109.032904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690171	hybrid, Green Published			2022-12-25	WOS:000270678900031
J	Kelly-Spratt, KS; Philipp-Staheli, J; Gurley, KE; Hoon-Kim, K; Knoblaugh, S; Kemp, CJ				Kelly-Spratt, K. S.; Philipp-Staheli, J.; Gurley, K. E.; Hoon-Kim, K.; Knoblaugh, S.; Kemp, C. J.			Inhibition of PI-3K restores nuclear p27(Kip1) expression in a mouse model of Kras-driven lung cancer	ONCOGENE			English	Article						kras; p27; Akt; lung cancer; tumor suppressor	CYCLIN-DEPENDENT KINASES; CELL-CYCLE; TUMOR SUPPRESSION; BREAST-CANCER; MICE LACKING; P53 RESTORATION; P27; PHOSPHORYLATION; GROWTH; DEGRADATION	Reduced expression of the CDK inhibitor p27(Kip1) (p27) in human lung cancer correlates with tumor aggressiveness and poor prognosis. However, the regulation of p27 expression and the role of p27 during lung cancer are poorly understood. Urethane-induced lung tumors in mice frequently harbor mutations in the Kras oncogene, and in this study, we use this model to address the regulation of p27 during tumorigenesis. The Ras effector Akt is known to regulate p27 mRNA abundance by phosphorylating and inactivating the FOXO transcription factors. Phosphorylated Akt and FOXO proteins were both increased in lung tumors, correlating with a reduction in p27 mRNA transcript. Akt also directly phosphorylates p27 and regulates its nuclear/cytoplasmic localization. Tumors showed a reduced nuclear/cytoplasmic ratio of p27 protein, together with an increase in phosphorylated Thr197 p27 in the cytoplasmic pool. Treatment of lung tumor-bearing mice with the phosphoinositol-3 kinase inhibitor LY294002 induced a rapid decrease in phosphorylated Akt and phosphorylated p27, concomitant with an increase in nuclear p27. Germline p27 deficiency accelerated both the growth and malignant progression of urethane-induced lung tumors, and did so in a cell autonomous manner, confirming a causal role of p27 in tumor suppression. These results show that p27 is a potent barrier to the growth and malignant progression of Kras-initiated lung tumors. Further, the reduction of nuclear p27 in tumors is mediated by oncogene signaling pathways, which can be reversed by pharmacological agents. Oncogene (2009) 28, 3652-3662; doi:10.1038/onc.2009.226; published online 3 August 2009	[Kemp, C. J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Kemp, CJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, C1-015,1100 Fairview Ave N, Seattle, WA 98109 USA.	cjkemp@fhcrc.org			NIH [T32 CA8046, R01]; ACS; NATIONAL CANCER INSTITUTE [R01CA099517] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a NIH T32 CA8046 Interdisciplinary Training Grant in Cancer Research (KSK-S), and an ACS Research Scholar Award and a NIH R01 Research Grant (CJK).	Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Blain SW, 2002, NAT MED, V8, P1076, DOI 10.1038/nm1002-1076; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Catzavelos C, 1999, CANCER RES, V59, P684; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Inui N, 2003, BIOCHEM BIOPH RES CO, V303, P978, DOI 10.1016/S0006-291X(03)00469-8; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KAWAMATA N, 1995, CANCER RES, V55, P2266; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Malkinson AM, 2001, LUNG CANCER, V32, P265, DOI 10.1016/S0169-5002(00)00232-4; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Motti ML, 2004, CELL CYCLE, V3, P1074; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; Philipp-Staheli J, 2004, ONCOGENE, V23, P905, DOI 10.1038/sj.onc.1207220; Philipp-Staheli J, 2002, CANCER CELL, V1, P355, DOI 10.1016/S1535-6108(02)00054-5; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; PONCECASTANEDA MV, 1995, CANCER RES, V55, P1211; Sa G, 2004, EXP CELL RES, V300, P427, DOI 10.1016/j.yexcr.2004.07.032; Schiappacassi M, 2008, MOL CANCER THER, V7, P1164, DOI 10.1158/1535-7163.MCT-07-2154; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shaffer DR, 2005, P NATL ACAD SCI USA, V102, P210, DOI 10.1073/pnas.0407362102; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Susaki E, 2007, CELL CYCLE, V6, P3015, DOI 10.4161/cc.6.24.5087; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tong W, 1998, CELL GROWTH DIFFER, V9, P787; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Yuan YH, 2007, CANCER RES, V67, P8032, DOI 10.1158/0008-5472.CAN-07-0083; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462	55	37	37	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 15	2009	28	41					3652	3662		10.1038/onc.2009.226	http://dx.doi.org/10.1038/onc.2009.226			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KJ	19648963	Green Accepted			2022-12-25	WOS:000270851800006
J	Singh, P; Salih, M; Tuana, BS				Singh, Puneet; Salih, Maysoon; Tuana, Balwant S.			alpha-Kinase Anchoring Protein alpha KAP Interacts with SERCA2A to Spatially Position Ca2+/Calmodulin-dependent Protein Kinase II and Modulate Phospholamban Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; AKAP SIGNALING COMPLEXES; SKELETAL-MUSCLE; RYANODINE RECEPTOR; CAM KINASE; CARDIAC-HYPERTROPHY; CA2+ RELEASE; CALMODULIN; HEART; CHANNELS	The sarco-endoplasmic reticulum calcium ATPase 2a (SERCA2a) is critical for sequestering cytosolic calcium into the sarco-endoplasmic reticulum (SR) and regulating cardiac muscle relaxation. Protein-protein interactions indicated that it exists in complex with Ca2+/calmodulin-dependent protein kinase II (CaMKII) and its anchoring protein alpha KAP. Confocal imaging of isolated cardiomyocytes revealed the colocalization of CAMKII and alpha KAP with SERCA2a at the SR. Deletion analysis indicated that SERCA2a and CaMKII bind to different regions in the association domain of alpha KAP but not with each other. Although deletion of the putative N-terminal hydrophobic amino acid stretch in alpha KAP prevented its membrane targeting, it did not influence binding to SERCA2a or CaMKII. Both CaMKII delta(C) and the novel CaMKII beta(4) isoforms were found to exist in complex with alpha KAP and SERCA2a at the SR and were able to phosphorylate Thr-17 on phospholamban (PLN), an accessory subunit and known regulator of SERCA2a activity. Interestingly, the presence of alpha KAP was also found to significantly modulate the Ca2+/calmodulin-dependent phosphorylation of Thr-17 on PLN. These data demonstrate that aKAP exhibits a novel interaction with SERCA2a and may serve to spatially position CaMKII isoforms at the SR and to uniquely modulate the phosphorylation of PLN.	[Singh, Puneet; Salih, Maysoon; Tuana, Balwant S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Tuana, BS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	btuana@uottawa.ca			Canadian Institute of Health Research [9596]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grant 9596 (to B. S. T.).	Alto N, 2002, DIABETES, V51, pS385, DOI 10.2337/diabetes.51.2007.S385; Bayer KU, 1998, EMBO J, V17, P5598, DOI 10.1093/emboj/17.19.5598; Bayer KU, 1996, MOL CELL BIOL, V16, P29; Bkaily G, 1997, MOL CELL BIOCHEM, V172, P171, DOI 10.1023/A:1006840228104; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; Catterall WA, 2006, J RECEPT SIG TRANSD, V26, P577, DOI 10.1080/10799890600915100; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kennedy DJ, 2006, AM J PHYSIOL-HEART C, V291, pH3003, DOI 10.1152/ajpheart.00603.2006; Kim YK, 2003, J BIOL CHEM, V278, P47622, DOI 10.1074/jbc.M305909200; Kolb SJ, 1998, J BIOL CHEM, V273, P31555, DOI 10.1074/jbc.273.47.31555; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MACLENNAN DH, 1984, ADV CYCLIC NUCL PROT, V17, P393; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Nori A, 2003, BIOCHEM J, V370, P873, DOI 10.1042/BJ20021624; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Singh P, 2005, MOL CELL BIOCHEM, V270, P215, DOI 10.1007/s11010-005-5234-y; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; TUANA BS, 1988, FEBS LETT, V235, P219, DOI 10.1016/0014-5793(88)81266-3; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Yamaguchi N, 2007, J CLIN INVEST, V117, P1344, DOI 10.1172/JCI29515; Yamaguchi N, 2007, CIRC RES, V100, P293, DOI 10.1161/01.RES.0000259327.56377.55; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200	36	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28212	28221		10.1074/jbc.M109.044990	http://dx.doi.org/10.1074/jbc.M109.044990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19671701	Green Published, hybrid			2022-12-25	WOS:000270676300049
J	Watanabe, M; Wake, H; Moorhouse, AJ; Nabekura, J				Watanabe, Miho; Wake, Hiroaki; Moorhouse, Andrew J.; Nabekura, Junichi			Clustering of Neuronal K+-Cl- Cotransporters in Lipid Rafts by Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; GABA(A) RECEPTOR; EXCITATORY ACTIONS; CREATINE-KINASE; KCC2 EXPRESSION; STRUCTURAL UNIT; DOWN-REGULATION; GNRH NEURONS; LOCALIZATION; CHLORIDE	The neuronal K+-Cl- cotransporter (KCC2) is a membrane transport protein that extrudes Cl- from neurons and helps maintain low intracellular [Cl-] and hyperpolarizing GABAergic synaptic potentials. Depolarizing gamma-aminobutyric acid (GABA) responses in neonatal neurons and following various forms of neuronal injury are associated with reduced levels of KCC2 expression. Despite the importance for plasticity of inhibitory transmission, less is known about cellular mechanisms involved in more dynamic changes in KCC2 function. In this study, we investigated the role of tyrosine phosphorylation in KCC2 localization and function in hippocampal neurons and in cultured GT1-7 cells. Mutation to the putative tyrosine phosphorylation site within the long intracellular carboxyl terminus of KCC2(Y1087D) or application of the tyrosine kinase inhibitor genistein shifted the GABA reversal potential (E-GABA) to more depolarized values, indicating reduced KCC2 function. This was associated with a change in the expression pattern of KCC2 from a punctate distribution to a more uniform distribution, suggesting that functional tyrosine-phosphorylated KCC2 forms clusters in restricted membrane domains. Sodium vanadate, a tyrosine phosphatase inhibitor, increased the proportion of KCC2 associated with lipid rafts membrane domains. Loss of tyrosine phosphorylation also reduced oligomerization of KCC2. A loss of the punctuate distribution and oligomerization of KCC2 and a more depolarized E-GABA Were seen when the 28-amino-acid carboxyl terminus of KCC2 was deleted. These results indicate that direct tyrosine phosphorylation of KCC2 results in membrane clusters and functional transport activity, suggesting a mechanism by which intracellular Cl- concentrations and GABA responses can be rapidly modulated.	[Watanabe, Miho; Wake, Hiroaki; Nabekura, Junichi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Wake, Hiroaki; Nabekura, Junichi] Japan Sci & Technol Corp, Core Res Evolutionary Sci & Technol, Saitama 3330012, Japan; [Moorhouse, Andrew J.] Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW 2052, Australia; [Nabekura, Junichi] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Hayama 2400193, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); University of New South Wales Sydney; Graduate University for Advanced Studies - Japan	Nabekura, J (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan.	nabekura@nips.ac.jp	Moorhouse, Andrew J/B-8526-2011	Moorhouse, Andrew J/0000-0001-7957-2498; WAKE, Hiroaki/0000-0002-8543-4590	The Ministry of Education, Culture, Sports, Science and Technology, Japan [19040030, 18077009, 21790234]; Japan Science and Technology Agency and Core Research for the Evolutionary Science and Technology, Japan Science and Technology Corporation	The Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency and Core Research for the Evolutionary Science and Technology, Japan Science and Technology Corporation(Japan Science & Technology Agency (JST))	This work was supported by Grant-in-Aids for Scientific Research on Priority Areas 19040030 (to M. W.) and 18077009 (to J. N.) and Grant-in-Aids for Young Scientists (B) 21790234 (to M. W.) from The Ministry of Education, Culture, Sports, Science and Technology, Japan and by grants from the Japan Science and Technology Agency and Core Research for the Evolutionary Science and Technology, Japan Science and Technology Corporation (to J. N.).	Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Dalskov SM, 2005, NEUROCHEM INT, V46, P489, DOI 10.1016/j.neuint.2004.11.010; Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; de la Escalera GM, 2001, ARCH MED RES, V32, P486, DOI 10.1016/S0188-4409(01)00320-4; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Garbarini N, 2008, CELL PHYSIOL BIOCHEM, V22, P31, DOI 10.1159/000149781; Hering H, 2003, J NEUROSCI, V23, P3262; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kitamura A, 2008, NEUROSCI RES, V62, P270, DOI 10.1016/j.neures.2008.09.002; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Reid KH, 2000, BRAIN RES, V864, P134, DOI 10.1016/S0006-8993(00)02121-1; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P3039, DOI 10.1097/01.ASN.0000097370.29737.5B; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; Ueno T, 2002, J BIOL CHEM, V277, P4945, DOI 10.1074/jbc.M109439200; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Watanabe M, 2004, ENDOCRINOLOGY, V145, P2375, DOI 10.1210/en.2003-1257; WETSEL WC, 1992, P NATL ACAD SCI USA, V89, P4149, DOI 10.1073/pnas.89.9.4149; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200	40	72	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27980	27988		10.1074/jbc.M109.043620	http://dx.doi.org/10.1074/jbc.M109.043620			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679663	hybrid, Green Published			2022-12-25	WOS:000270676300026
J	Hughes, KJ; Meares, GP; Chambers, KT; Corbett, JA				Hughes, Katherine J.; Meares, Gordon P.; Chambers, Kari T.; Corbett, John A.			Repair of Nitric Oxide-damaged DNA in beta-Cells Requires JNK-dependent GADD45 alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PANCREATIC-ISLETS; BASE EXCISION-REPAIR; C-JUN; INSULIN-SECRETION; KINASE PATHWAY; P53-REGULATED PROTEIN; GENE-TRANSCRIPTION; DIABETES-MELLITUS; TERMINAL KINASE; P53 ACTIVATION	Proinflammatory cytokines induce nitric oxide-dependent DNA damage and ultimately beta-cell death. Not only does nitric oxide cause beta-cell damage, it also activates a functional repair process. In this study, the mechanisms activated by nitric oxide that facilitate the repair of damaged beta-cell DNA are examined. JNK plays a central regulatory role because inhibition of this kinase attenuates the repair of nitric oxide-induced DNA damage. p53 is a logical target of JNK-dependent DNA repair; however, nitric oxide does not stimulate p53 activation or accumulation in beta-cells. Further, knockdown of basal p53 levels does not affect DNA repair. In contrast, expression of growth arrest and DNA damage (GADD) 45 alpha, a DNA repair gene that can be regulated by p53-dependent and p53-independent pathways, is stimulated by nitric oxide in a JNK-dependent manner, and knockdown of GADD45 alpha expression attenuates the repair of nitric oxide-induced beta-cell DNA damage. These findings show that beta-cells have the ability to repair nitric oxide-damaged DNA and that JNK and GADD45 alpha mediate the p53-independent repair of this DNA damage.	[Meares, Gordon P.; Corbett, John A.] Univ Alabama, Comprehens Diabet Ctr, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Hughes, Katherine J.; Chambers, Kari T.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Alabama System; University of Alabama Birmingham; Saint Louis University	Corbett, JA (corresponding author), Univ Alabama, Comprehens Diabet Ctr, Dept Med, Div Endocrinol Diabet & Metab, 1206 Shelby,1530 3rd Ave S, Birmingham, AL 35294 USA.	corbettj@UAB.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155	National Institutes of Health [DK52194, AI44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported, in whole or in part, by National Institutes of Health Grants DK52194 and AI44458 (to J. A. C.).	Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; Andreka P, 2001, CIRC RES, V88, P305, DOI 10.1161/01.RES.88.3.305; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; CARRIER F, 1994, J BIOL CHEM, V269, P32672; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; Eizirik DL, 1996, MOL CELL ENDOCRINOL, V118, P71, DOI 10.1016/0303-7207(96)03768-9; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gjerset RA, 1999, CELL GROWTH DIFFER, V10, P545; Graziewicz M, 1996, CARCINOGENESIS, V17, P2501, DOI 10.1093/carcin/17.11.2501; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; HUGHES JH, 1990, J CLIN INVEST, V86, P856, DOI 10.1172/JCI114785; Jaiswal M, 2001, CANCER RES, V61, P6388; Jin SQ, 2001, ONCOGENE, V20, P2683, DOI 10.1038/sj.onc.1204390; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Kow YW, 2002, FREE RADICAL BIO MED, V33, P886, DOI 10.1016/S0891-5849(02)00902-4; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; MESSMER UK, 1994, FEBS LETT, V355, P23; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; Niles JC, 2006, NITRIC OXIDE-BIOL CH, V14, P109, DOI 10.1016/j.niox.2005.11.001; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Rosales AL, 2004, FREE RADICAL RES, V38, P665, DOI 10.1080/10715760410001697609; Scarim AL, 2003, ENDOCRINOLOGY, V144, P3415, DOI 10.1210/en.2002-0112; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Tamir S, 1996, CHEM RES TOXICOL, V9, P821, DOI 10.1021/tx9600311; Tong T, 2001, EXP CELL RES, V269, P64, DOI 10.1006/excr.2001.5312; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; White BH, 1997, J NEUROSCI, V17, P1582; Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914	52	32	33	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27402	27408		10.1074/jbc.M109.046912	http://dx.doi.org/10.1074/jbc.M109.046912			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648647	Green Published, hybrid			2022-12-25	WOS:000270232300042
J	Qian, SB; Waldron, L; Choudhary, N; Klevit, RE; Chazin, WJ; Patterson, C				Qian, Shu-Bing; Waldron, Lauren; Choudhary, Neelima; Klevit, Rachel E.; Chazin, Walter J.; Patterson, Cam			Engineering a Ubiquitin Ligase Reveals Conformational Flexibility Required for Ubiquitin Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 LIGASE; PROTEIN; CHIP; COMPLEX; DOMAIN; UBIQUITYLATION; MECHANISMS; P53; ACTIVATION; CHAPERONE	Protein ubiquitination regulates numerous cellular functions in eukaryotes. The prevailing view about the role of RING or U-box ubiquitin ligases (E3) is to provide precise positioning between the attached substrate and the ubiquitin-conjugating enzyme (E2). However, the mechanism of ubiquitin transfer remains obscure. Using the carboxyl terminus of Hsc70-interacting protein as a model E3, we show herein that although U-box binding is required, it is not sufficient to trigger the transfer of ubiquitin onto target substrates. Furthermore, additional regions of the E3 protein that have no direct contact with E2 play critical roles in mediating ubiquitin transfer from E2 to attached substrates. By combining computational structure modeling and protein engineering approaches, we uncovered a conformational flexibility of E3 that is required for substrate ubiquitination. Using an engineered version of the carboxyl terminus of Hsc70-interacting protein ubiquitin ligase as a research tool, we demonstrate a striking flexibility of ubiquitin conjugation that does not affect substrate specificity. Our results not only reveal conformational changes of E3 during ubiquitin transfer but also provide a promising approach to custom-made E3 for targeted proteolysis.	[Qian, Shu-Bing] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Qian, Shu-Bing; Waldron, Lauren; Choudhary, Neelima; Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Struct Biol Ctr, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Struct Biol Ctr, Nashville, TN 37232 USA	Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University	Qian, SB (corresponding author), Cornell Univ, Div Nutr Sci, 301 Biotech Bldg, Ithaca, NY 14853 USA.	sq38@cornell.edu; cpatters@med.unc.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; Wasson, Lauren/0000-0002-5193-5215	National Institutes of Health [GM61728, HL65619, AG024282, GM75156]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL065619, R01HL065619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061728, R01GM075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61728, HL65619, and AG024282 ( to C. P.) and GM75156 ( to W. J. C.).	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Paltoglou S, 2007, ONCOGENE, V26, P604, DOI 10.1038/sj.onc.1209818; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou PB, 2005, CURR OPIN CHEM BIOL, V9, P51, DOI 10.1016/j.cbpa.2004.10.012	32	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26797	26802		10.1074/jbc.M109.032334	http://dx.doi.org/10.1074/jbc.M109.032334			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648119	Green Published, hybrid			2022-12-25	WOS:000269969600061
J	Alaux, C; Duong, N; Schneider, SS; Southey, BR; Rodriguez-Zas, S; Robinson, GE				Alaux, Cedric; Duong, Nhi; Schneider, Stanley S.; Southey, Bruce R.; Rodriguez-Zas, Sandra; Robinson, Gene E.			Modulatory Communication Signal Performance Is Associated with a Distinct Neurogenomic State in Honey Bees	PLOS ONE			English	Article								Studies of animal communication systems have revealed that the perception of a salient signal can cause large-scale changes in brain gene expression, but little is known about how communication affects the neurogenomic state of the sender. We explored this issue by studying honey bees that produce a vibratory modulatory signal. We chose this system because it represents an extreme case of animal communication; some bees perform this behavior intensively, effectively acting as communication specialists. We show large differences in patterns of brain gene expression between individuals producing vibratory signal as compared with carefully matched non-senders. Some of the differentially regulated genes have previously been implicated in the performance of other motor activities, including courtship behavior in Drosophila melanogaster and Parkinson's Disease in humans. Our results demonstrate for the first time a neurogenomic brain state associated with sending a communication signal and provide suggestive glimpses of molecular roots for motor control.			Alaux, C (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	generobi@illinois.edu	Alaux, Cedric/B-4667-2013	Alaux, Cedric/0000-0002-3045-2599; Southey, Bruce/0000-0002-8959-7709; Rodriguez-Zas, Sandra/0000-0003-1122-4758	NIDCD NIH HHS [DC 006395, R01 DC006395] Funding Source: Medline; NIGMS NIH HHS [R01 GM068946] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006395] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Brennan PA, 1999, NEUROSCIENCE, V90, P1463, DOI 10.1016/S0306-4522(98)00556-9; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Cersosimo MG, 2006, NEUROTOXICOLOGY, V27, P340, DOI 10.1016/j.neuro.2005.10.006; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Duong N, 2008, ETHOLOGY, V114, P646, DOI 10.1111/j.1439-0310.2008.01504.x; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; FIBER JM, 1993, NEUROREPORT, V4, P871, DOI 10.1097/00001756-199307000-00008; GIERER A, 1983, NATURWISSENSCHAFTEN, V70, P282, DOI 10.1007/BF00404834; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; Hyland KM, 2007, ANIM BEHAV, V73, P541, DOI 10.1016/j.anbehav.2006.10.006; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jin H, 1997, NEUROBIOL LEARN MEM, V68, P271, DOI 10.1006/nlme.1997.3795; Kelliher KR, 1998, BIOL REPROD, V59, P1454, DOI 10.1095/biolreprod59.6.1454; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kurusu M, 2002, DEVELOPMENT, V129, P409; Kyriacou CP, 2005, NATURE, V436, P334, DOI 10.1038/436334a; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Painter-Kurt S, 1998, ETHOLOGY, V104, P457, DOI 10.1111/j.1439-0310.1998.tb00083.x; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Schneider SS, 2004, APIDOLOGIE, V35, P117, DOI 10.1051/apido:2004006; Sen Sarma M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-202; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Waddell S, 2001, DEV CELL, V1, P8, DOI 10.1016/S1534-5807(01)00012-0; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103	43	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6694	10.1371/journal.pone.0006694	http://dx.doi.org/10.1371/journal.pone.0006694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693278	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267400005
J	Roe, BE; Tilley, MR; Gu, HH; Beversdorf, DQ; Sadee, W; Haab, TC; Papp, AC				Roe, Brian E.; Tilley, Michael R.; Gu, Howard H.; Beversdorf, David Q.; Sadee, Wolfgang; Haab, Timothy C.; Papp, Audrey C.			Financial and Psychological Risk Attitudes Associated with Two Single Nucleotide Polymorphisms in the Nicotine Receptor (CHRNA4) Gene	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; PERSONALITY-TRAITS; NOVELTY-SEEKING; DECISION-MAKING; HARM AVOIDANCE; ANXIETY; PROMOTER; DISORDERS; TEMPERAMENT; ACTIVATION	With recent advances in understanding of the neuroscience of risk taking, attention is now turning to genetic factors that may contribute to individual heterogeneity in risk attitudes. In this paper we test for genetic associations with risk attitude measures derived from both the psychology and economics literature. To develop a long-term prospective study, we first evaluate both types of risk attitudes and find that the economic and psychological measures are poorly correlated, suggesting that different genetic factors may underlie human response to risk faced in different behavioral domains. We then examine polymorphisms in a spectrum of candidate genes that affect neurotransmitter systems influencing dopamine regulation or are thought to be associated with risk attitudes or impulsive disorders. Analysis of the genotyping data identified two single nucleotide polymorphisms (SNPs) in the gene encoding the alpha 4 nicotine receptor (CHRNA4, rs4603829 and rs4522666) that are significantly associated with harm avoidance, a risk attitude measurement drawn from the psychology literature. Novelty seeking, another risk attitude measure from the psychology literature, is associated with several COMT (catechol-O-methyl transferase) SNPs while economic risk attitude measures are associated with several VMAT2 (vesicular monoamine transporter) SNPs, but the significance of these associations did not withstand statistical adjustment for multiple testing and requires larger cohorts. These exploratory results provide a starting point for understanding the genetic basis of risk attitudes by considering the range of methods available for measuring risk attitudes and by searching beyond the traditional direct focus on dopamine and serotonin receptor and transporter genes.			Roe, BE (corresponding author), Ohio State Univ, Dept Agr Environm & Dev Econ, Columbus, OH 43210 USA.	roe.30@osu.edu	Roe, Brian E/A-7386-2009; Haab, Tim/N-4392-2013; Beversdorf, David Q./M-2786-2016	Roe, Brian E/0000-0003-4228-2889; Haab, Tim/0000-0002-2381-0087; Beversdorf, David Q./0000-0002-0298-0634	NCRR NIH HHS [UL1 RR025755, UL1RR025755] Funding Source: Medline; NIDA NIH HHS [DA022199, R01 DA020124, R01 DA022199, DA020124] Funding Source: Medline; NINDS NIH HHS [K23 NS043222, K23 NS43222] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020124, R01DA022199] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alvarez-Moya EM, 2007, COMPR PSYCHIAT, V48, P452, DOI 10.1016/j.comppsych.2007.03.008; Andersen S, 2008, INT ECON REV, V49, P1091, DOI 10.1111/j.1468-2354.2008.00507.x; Barry D, 2008, BRAIN COGNITION, V66, P243, DOI 10.1016/j.bandc.2007.09.001; Barsky RB, 1997, Q J ECON, V112, P537, DOI 10.1162/003355397555280; BECHARA A, 2001, DECISION MALTING DEF, P376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blairy S, 2000, AM J MED GENET, V96, P360, DOI 10.1002/1096-8628(20000612)96:3<360::AID-AJMG24>3.0.CO;2-E; CESARINI D, Q J EC IN PRESS; Chien AJ, 1996, J PSYCHIAT RES, V30, P21, DOI 10.1016/0022-3956(95)00041-0; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Comings DE, 2000, CLIN GENET, V58, P375, DOI 10.1034/j.1399-0004.2000.580508.x; DOHMEN TJ, INDIVIDUAL RISK ATTI; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Eisen SA, 1998, ADDICTION, V93, P1375; Ekelund J, 2005, LABOUR ECON, V12, P649, DOI 10.1016/j.labeco.2004.02.009; Forbush KT, 2008, CNS SPECTRUMS, V13, P306, DOI 10.1017/S1092852900016424; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7, DOI DOI 10.1016/J.JRP.2014.05.003; Goudriaan AE, 2006, DRUG ALCOHOL DEPEN, V84, P231, DOI 10.1016/j.drugalcdep.2006.02.007; Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437; Hansenne M, 2003, PERS INDIV DIFFER, V34, P1039, DOI 10.1016/S0191-8869(02)00088-0; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Hutchison KE, 2007, ARCH GEN PSYCHIAT, V64, P1078, DOI 10.1001/archpsyc.64.9.1078; Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kazantseva AV, 2008, PSYCHIAT GENET, V18, P167, DOI 10.1097/YPG.0b013e328304deb8; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Kusunoki K, 2000, ACTA PSYCHIAT SCAND, V101, P403, DOI 10.1034/j.1600-0447.2000.101005403.x; Laine TPJ, 2001, J ADDICT DIS, V20, P91; Lang UE, 2007, NEUROPSYCHOPHARMACOL, V32, P1950, DOI 10.1038/sj.npp.1301335; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Le Strat Y, 2008, ALCOHOL CLIN EXP RES, V32, P27, DOI 10.1111/j.1530-0277.2007.00552.x; Lin ZC, 2005, HUM MOL GENET, V14, P1393, DOI 10.1093/hmg/ddi148; Ling DJ, 2004, J HUM GENET, V49, P35, DOI 10.1007/s10038-003-0104-5; LITTLE KY, 2003, LOSS STRIATAL VESICU, P47; Martin SB, 2007, NEUROPSYCHOLOGIA, V45, P2874, DOI 10.1016/j.neuropsychologia.2007.05.009; Martinotti G, 2006, COMPR PSYCHIAT, V47, P350, DOI 10.1016/j.comppsych.2005.12.005; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; Nordin C, 2007, J GAMBL STUD, V23, P113, DOI 10.1007/s10899-006-9049-x; Ouellet-Morin I, 2008, AM J MED GENET B, V147B, P1442, DOI 10.1002/ajmg.b.30677; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; *POOL IPI, 2001, SCI COLL DEV ADV MEA; Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020; Rigbi A, 2008, GENES BRAIN BEHAV, V7, P164, DOI 10.1111/j.1601-183X.2007.00329.x; ROE BE, J EC PSYCHO IN PRESS; Ronai Z, 2001, MOL PSYCHIATR, V6, P35, DOI 10.1038/sj.mp.4000832; Rosenberg S, 2006, HUM GENET, V120, P447, DOI 10.1007/s00439-006-0198-x; Roussos P, 2008, NEUROPSYCHOLOGIA, V46, P757, DOI 10.1016/j.neuropsychologia.2007.10.009; Schwab SG, 2005, NEUROPSYCHOPHARMACOL, V30, P2263, DOI 10.1038/sj.npp.1300809; Starcevic V, 1996, J AFFECT DISORDERS, V37, P75, DOI 10.1016/0165-0327(95)00058-5; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strobel A, 2003, J NEURAL TRANSM, V110, P1445, DOI 10.1007/s00702-003-0072-0; Sullivan PF, 1997, BIOL PSYCHIAT, V42, P1070, DOI 10.1016/S0006-3223(97)00346-6; Takeuchi H, 2009, J NEUROSCI RES, V87, P576, DOI 10.1002/jnr.21869; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V50, P153, DOI 10.1159/000079107; Voineskos S, 2007, J PSYCHIATR NEUROSCI, V32, P412; Voon V, 2007, CURR OPIN NEUROL, V20, P484, DOI 10.1097/WCO.0b013e32826fbc8f; Voon V, 2007, ARCH NEUROL-CHICAGO, V64, P212, DOI 10.1001/archneur.64.2.212; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Westberg L, 2003, MOL PSYCHIATR, V8, P118, DOI 10.1038/sj.mp.4001192; Yamasue H, 2008, CEREB CORTEX, V18, P46, DOI 10.1093/cercor/bhm030; Yang TT, 2009, NEUROREPORT, V20, P19, DOI 10.1097/WNR.0b013e328317f3cb; ZHONG S, 2009, TWIN RES HUM GENET, V12, P5	66	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6704	10.1371/journal.pone.0006704	http://dx.doi.org/10.1371/journal.pone.0006704			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693267	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267400012
J	Zardi, GI; Nicastro, KR; McQuaid, CD; Gektidis, M				Zardi, Gerardo Ivan; Nicastro, Katy Rebecca; McQuaid, Christopher David; Gektidis, Marcos			Effects of Endolithic Parasitism on Invasive and Indigenous Mussels in a Variable Physical Environment	PLOS ONE			English	Article							PERNA-PERNA; MYTILUS-GALLOPROVINCIALIS; SHELL STRENGTH; WAVE ACTION; MARINE; COMMUNITIES; POPULATION; GROWTH; REEF; CONSEQUENCES	Biotic stress may operate in concert with physical environmental conditions to limit or facilitate invasion processes while altering competitive interactions between invaders and native species. Here, we examine how endolithic parasitism of an invasive and an indigenous mussel species acts in synergy with abiotic conditions of the habitat. Our results show that the invasive Mytilus galloprovincialis is more infested than the native Perna perna and this difference is probably due to the greater thickness of the protective outer-layer of the shell of the indigenous species. Higher abrasion due to waves on the open coast could account for dissimilarities in degree of infestation between bays and the more wave-exposed open coast. Also micro-scale variations of light affected the level of endolithic parasitism, which was more intense at non-shaded sites. The higher levels of endolithic parasitism in Mytilus mirrored greater mortality rates attributed to parasitism in this species. Condition index, attachment strength and shell strength of both species were negatively affected by the parasites suggesting an energy trade-off between the need to repair the damaged shell and the other physiological parameters. We suggest that, because it has a lower attachment strength and a thinner shell, the invasiveness of M. galloprovincialis will be limited at sun and wave exposed locations where endolithic activity, shell scouring and risk of dislodgement are high. These results underline the crucial role of physical environment in regulating biotic stress, and how these physical-biological interactions may explain site-to-site variability of competitive balances between invasive and indigenous species.			Zardi, GI (corresponding author), Univ Algarve, CCMAR CIMAR Lab Associado, Faro, Portugal.	katynicastro@yahoo.it	Zardi, Gerardo/M-4026-2013; Nicastro, Katy R/ABI-1531-2020; Nicastro, Katy/D-2259-2012; McQuaid, Christopher/AAT-3725-2020; Nicastro, Katy/AAY-3692-2021	Zardi, Gerardo/0000-0001-8798-5794; Nicastro, Katy R/0000-0002-7071-141X; Nicastro, Katy/0000-0002-7071-141X; McQuaid, Christopher/0000-0002-3473-8308; 				Alfaro AC, 2008, MAR BIOL RES, V4, P376, DOI 10.1080/17451000802022879; AMBARIYANTO, 1991, J MOLLUS STUD, V57, P413, DOI 10.1093/mollus/57.4.413; Bentis CJ, 2000, BIOL BULL, V198, P254, DOI 10.2307/1542528; Bownes SJ, 2006, J EXP MAR BIOL ECOL, V338, P140, DOI 10.1016/j.jembe.2006.07.006; Byers JE, 2000, ECOLOGY, V81, P1225, DOI 10.2307/177203; Calvo-Ugarteburu G, 1998, J EXP MAR BIOL ECOL, V220, P47, DOI 10.1016/S0022-0981(97)00083-X; Calvo-Ugarteburu G, 1998, MAR ECOL PROG SER, V169, P149, DOI 10.3354/meps169149; Darwin C., 1859, ORIGIN SPECIES MEANS; DAVENPORT J, 1987, J MOLLUS STUD, V53, P293, DOI 10.1093/mollus/53.3.293; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DENNY MW, 1987, J EXP MAR BIOL ECOL, V113, P231, DOI 10.1016/0022-0981(87)90103-1; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; DOBSON A P, 1988, Conservation Biology, V2, P31, DOI 10.1111/j.1523-1739.1988.tb00333.x; DOBSON AP, 1986, TRENDS ECOL EVOL, V1, P11, DOI 10.1016/0169-5347(86)90060-1; Dove ADM, 2000, PARASITOLOGY, V120, P609, DOI 10.1017/S0031182099005958; Dunphy BJ, 2001, MAR FRESHWATER RES, V52, P781, DOI 10.1071/MF99189; Ehrlich P.R., 1989, BIOL INVASIONS GLOBA, P315; Ford SE, 1996, J SHELLFISH RES, V15, P45; GARDNER JPA, 1987, MAR ECOL PROG SER, V39, P31, DOI 10.3354/meps039031; Gektidis M, 2007, FACIES, V53, P43, DOI 10.1007/s10347-006-0091-z; GELLER JB, 1990, J EXP MAR BIOL ECOL, V136, P77, DOI 10.1016/0022-0981(90)90101-H; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Glaub Ingrid, 1994, Courier Forschungsinstitut Senckenberg, V174, P1; Golubic S, 2003, FOSSIL AND RECENT BIOFILMS, P249; Golubic S., 1975, STUDY TRACE FOSSILS, P229; GRIFFITHS CL, 1979, MAR BIOL, V53, P217, DOI 10.1007/BF00952429; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Kaehler S, 1999, MAR BIOL, V135, P505, DOI 10.1007/s002270050651; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; LAWTON JH, 1986, PHILOS T ROY SOC B, V314, P607, DOI 10.1098/rstb.1986.0076; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAY JA, 1982, SMITHSONIAN CONTRIBU, V12, P93; Mitchell CE, 2003, GLOBAL CHANGE BIOL, V9, P438, DOI 10.1046/j.1365-2486.2003.00602.x; Nicastro KR, 2008, MAR ECOL PROG SER, V368, P189, DOI 10.3354/meps07607; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Pantazidou A, 2006, EUR J PHYCOL, V41, P189, DOI 10.1080/09670260600649420; Perry CT, 2002, PALAEOGEOGR PALAEOCL, V186, P101, DOI 10.1016/S0031-0182(02)00446-7; Piculell BJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-23; Pimm SL, 1989, BIOL INVASIONS GLOBA, P351; Radtke G, 1996, ALGOLOGICAL STUDIES, V83, P469; RAGHUKUMAR C, 1991, PHYCOLOGIA, V30, P303, DOI 10.2216/i0031-8884-30-3-303.1; RAUBENHEIMER D, 1990, Journal of Shellfish Research, V9, P87; RIUS M, 2009, BASIC APPL IN PRESS; Rius M, 2006, MAR BIOL, V150, P69, DOI 10.1007/s00227-006-0322-4; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; SCHNEIDER J, 1983, Marine Ecology, V4, P45, DOI 10.1111/j.1439-0485.1983.tb00287.x; Schneider J, 1999, EUR J PHYCOL, V34, P417, DOI 10.1017/S0967026299002280; SCHURINK CV, 1993, AQUACULTURE, V109, P257; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Suchanek T.H., 1992, MUSSEL MYTILUS ECOLO, P87; Thompson J. N., 2005, INTERSPEC INTERACT; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Torchin ME, 2004, FRONT ECOL ENVIRON, V2, P183, DOI 10.1890/1540-9295(2004)002[0183:PPAIBP]2.0.CO;2; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; TORUNSKI H, 1979, Senckenbergiana Maritima, V11, P193; Vogel K, 2000, LETHAIA, V33, P190; von der Meden CEO, 2008, MAR ECOL PROG SER, V372, P135, DOI 10.3354/meps07731; Waite J.H., 1992, Results and Problems in Cell Differentiation, V19, P27; WEBB SC, 1994, J SHELLFISH RES, V13, P11; Zardi GI, 2007, MAR ECOL PROG SER, V334, P155, DOI 10.3354/meps334155; Zuschin M, 2001, PALAIOS, V16, P161, DOI 10.2307/3515527	63	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6560	10.1371/journal.pone.0006560	http://dx.doi.org/10.1371/journal.pone.0006560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668334	Green Published, gold, Green Submitted			2022-12-25	WOS:000268773300002
J	Hattori, RS; Fernandino, JI; Kishii, A; Kimura, H; Kinno, T; Oura, M; Somoza, GM; Yokota, M; Strussmann, CA; Watanabe, S				Hattori, Ricardo S.; Fernandino, Juan I.; Kishii, Ai; Kimura, Hiroyuki; Kinno, Tomomi; Oura, Miho; Somoza, Gustavo M.; Yokota, Masashi; Strussmann, Carlos A.; Watanabe, Seiichi			Cortisol-Induced Masculinization: Does Thermal Stress Affect Gonadal Fate in Pejerrey, a Teleost Fish with Temperature-Dependent Sex Determination?	PLOS ONE			English	Article							ODONTESTHES-BONARIENSIS; RAINBOW-TROUT; EXPRESSION PROFILE; SENSITIVE PERIOD; LIFE-HISTORY; COMMON CARP; DIFFERENTIATION; ANDROGENS; AROMATASE; HORMONE	Background: Gonadal fate in many reptiles, fish, and amphibians is modulated by the temperature experienced during a critical period early in life (temperature-dependent sex determination; TSD). Several molecular processes involved in TSD have been described but how the animals "sense" environmental temperature remains unknown. We examined whether the stress-related hormone cortisol mediates between temperature and sex differentiation of pejerrey, a gonochoristic teleost fish with marked TSD, and the possibility that it involves glucocorticoid receptor- and/or steroid biosynthesis-modulation. Methodology/Principal Findings: Larvae maintained during the period of gonadal sex differentiation at a masculinizing temperature (29 degrees C; 100% males) consistently had higher cortisol, 11-ketotestoterone (11-KT), and testosterone (T) titres than those at a feminizing temperature (17 degrees C; 100% females). Cortisol-treated animals had elevated 11-KT and T, and showed a typical molecular signature of masculinization including amh upregulation, cyp19a1a downregulation, and higher incidence of gonadal apoptosis during sex differentiation. Administration of cortisol and a non-metabolizable glucocorticoid receptor (GR) agonist (Dexamethasone) to larvae at a "sexually neutral" temperature (24 degrees C) caused significant increases in the proportion of males. Conclusions/Significance: Our results suggest a role of cortisol in the masculinization of pejerrey and provide a possible link between stress and testicular differentiation in this gonochoristic TSD species. Cortisol role or roles during TSD of pejerrey seem(s) to involve both androgen biosynthesis-and GR-mediated processes. These findings and recent reports of cortisol effects on sex determination of sequential hermaphroditic fishes, TSD reptiles, and birds provide support to the notion that stress responses might be involved in various forms of environmental sex determination.			Hattori, RS (corresponding author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan.	carlos@kaiyodai.ac.jp	Hattori, Ricardo S/K-2870-2012; Strussmann, Carlos A/O-1932-2014; YOKOTA, Masashi/O-1947-2014; Somoza, Gustavo Manuel/A-1642-2012	YOKOTA, Masashi/0000-0002-4121-4115; Somoza, Gustavo Manuel/0000-0002-3638-702X; Fernandino, Juan/0000-0003-1754-2802				Auperin B, 2008, GEN COMP ENDOCR, V158, P234, DOI 10.1016/j.ygcen.2008.07.002; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Bull JJ, 2008, J BIOSCIENCES, V33, P5, DOI 10.1007/s12038-008-0016-9; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Fernandino JI, 2008, SEX DEV, V2, P316, DOI 10.1159/000195681; FRANCIS RC, 1992, Q REV BIOL, V67, P1, DOI 10.1086/417445; Frisch AJ, 2007, HORM BEHAV, V52, P540, DOI 10.1016/j.yhbeh.2007.07.008; Gardner L, 2005, J STEROID BIOCHEM, V94, P395, DOI 10.1016/j.jsbmb.2004.12.045; Geley S, 1996, REV PHYSIOL BIOCH P, V128, P1; GODWIN JR, 1993, GEN COMP ENDOCR, V91, P144, DOI 10.1006/gcen.1993.1114; Goos HJT, 2002, MOL CELL ENDOCRINOL, V197, P105, DOI 10.1016/S0303-7207(02)00284-8; Hardy MP, 2005, CELL TISSUE RES, V322, P147, DOI 10.1007/s00441-005-0006-2; Fernandino JI, 2008, DEV DYNAM, V237, P3192, DOI 10.1002/dvdy.21731; Karube M, 2007, J EXP ZOOL PART A, V307A, P625, DOI 10.1002/jez.416; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; Lance VA, 2009, J EXP ZOOL PART A, V311A, P314, DOI 10.1002/jez.465; Lokman PM, 2002, GEN COMP ENDOCR, V129, P1, DOI 10.1016/S0016-6480(02)00562-2; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; McMaster A, 2008, NAT CLIN PRACT ENDOC, V4, P91, DOI 10.1038/ncpendmet0745; Miranda LA, 2003, GEN COMP ENDOCR, V132, P444, DOI 10.1016/S0016-6480(03)00117-5; Miranda LA, 2001, GEN COMP ENDOCR, V124, P45, DOI 10.1006/gcen.2001.7687; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Ozaki Y, 2006, ENDOCRINOLOGY, V147, P5139, DOI 10.1210/en.2006-0391; Perry AN, 2003, HORM BEHAV, V43, P31, DOI 10.1016/S0018-506X(02)00036-3; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; Ruane NM, 2005, GEN COMP ENDOCR, V143, P66, DOI 10.1016/j.ygcen.2005.02.024; Saillant E, 2003, J EXP MAR BIOL ECOL, V287, P103, DOI 10.1016/S0022-0981(02)00502-6; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Shoemaker CM, 2009, SEMIN CELL DEV BIOL, V20, P293, DOI 10.1016/j.semcdb.2008.10.010; Stouthart AJHX, 1998, J ENDOCRINOL, V157, P127, DOI 10.1677/joe.0.1570127; Strobl-Mazzulla PH, 2008, GEN COMP ENDOCR, V158, P191, DOI 10.1016/j.ygcen.2008.07.006; Strussmann CA, 2008, CYBIUM, V32, P77; Strussmann C.A., 1999, ENCY REPROD; Strussmann CA, 1996, J FISH BIOL, V48, P643, DOI 10.1111/j.1095-8649.1996.tb01459.x; Strussmann CA, 2002, FISH PHYSIOL BIOCHEM, V26, P13, DOI 10.1023/A:1023343023556; Strussmann CA, 1997, J EXP ZOOL, V278, P167, DOI 10.1002/(SICI)1097-010X(19970615)278:3&lt;167::AID-JEZ6&gt;3.0.CO;2-M; Uller T, 2009, J EXP BIOL, V212, P1087, DOI 10.1242/jeb.024257; VANDENHURK R, 1985, GEN COMP ENDOCR, V57, P216, DOI 10.1016/0016-6480(85)90266-7; Warner DA, 2009, PHYSIOL BIOCHEM ZOOL, V82, P363, DOI 10.1086/588491; Wood AW, 2002, MOL REPROD DEV, V61, P511, DOI 10.1002/mrd.10108	42	137	145	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6548	10.1371/journal.pone.0006548	http://dx.doi.org/10.1371/journal.pone.0006548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662094	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739600006
J	Cerniglia, GJ; Pore, N; Tsai, JH; Schultz, S; Mick, R; Choe, R; Xing, XM; Durduran, T; Yodh, AG; Evans, SM; Koch, CJ; Hahn, SM; Quon, H; Sehgal, CM; Lee, WMF; Maity, A				Cerniglia, George J.; Pore, Nabendu; Tsai, Jeff H.; Schultz, Susan; Mick, Rosemarie; Choe, Regine; Xing, Xiaoman; Durduran, Turgut; Yodh, Arjun G.; Evans, Sydney M.; Koch, Cameron J.; Hahn, Stephen M.; Quon, Harry; Sehgal, Chandra M.; Lee, William M. F.; Maity, Amit			Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy	PLOS ONE			English	Article								Background: Epidermal growth factor receptor (EGFR) inhibitors have shown only modest clinical activity when used as single agents to treat cancers. They decrease tumor cell expression of hypoxia-inducible factor 1-alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF). Hypothesizing that this might normalize tumor vasculature, we examined the effects of the EGFR inhibitor erlotinib on tumor vascular function, tumor microenvironment (TME) and chemotherapy and radiotherapy sensitivity. Methodology/Principal Findings: Erlotinib treatment of human tumor cells in vitro and mice bearing xenografts in vivo led to decreased HIF-1 alpha and VEGF expression. Treatment altered xenograft vessel morphology assessed by confocal microscopy (following tomato lectin injection) and decreased vessel permeability (measured by Evan's blue extravasation), suggesting vascular normalization. Erlotinib increased tumor blood flow measured by Power Doppler ultrasound and decreased hypoxia measured by EF5 immunohistochemistry and tumor O(2) saturation measured by optical spectroscopy. Predicting that these changes would improve drug delivery and increase response to chemotherapy and radiation, we performed tumor regrowth studies in nude mice with xenografts treated with erlotinib and either radiotherapy or the chemotherapeutic agent cisplatin. Erlotinib therapy followed by cisplatin led to synergistic inhibition of tumor growth compared with either treatment by itself (p<0.001). Treatment with erlotinib before cisplatin led to greater tumor growth inhibition than did treatment with cisplatin before erlotinib (p = 0.006). Erlotinib followed by radiation inhibited tumor regrowth to a greater degree than did radiation alone, although the interaction between erlotinib and radiation was not synergistic. Conclusions/Significance: EGFR inhibitors have shown clinical benefit when used in combination with conventional cytotoxic therapy. Our studies show that targeting tumor cells with EGFR inhibitors may modulate the TME via vascular normalization to increase response to chemotherapy and radiotherapy. These studies suggest ways to assess the response of tumors to EGFR inhibition using non-invasive imaging of the TME.			Cerniglia, GJ (corresponding author), Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	maity@xrt.upenn.edu	Durduran, Turgut/N-7768-2015	Durduran, Turgut/0000-0001-5838-1027; Maity, Amit/0000-0001-7151-2845; Choe, Regine/0000-0001-5851-4504; Evans, Sydney M/0000-0002-0216-1014	NATIONAL CANCER INSTITUTE [R01CA093638] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA093638] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali MALS, 2008, CANCER SCI, V99, P1589, DOI 10.1111/j.1349-7006.2008.00861.x; Barcellos-Hoff MH, 2007, INT J RADIAT BIOL, V83, P723, DOI 10.1080/09553000701799928; BASELGA J, 1993, J NATL CANCER I, V85, P1327, DOI 10.1093/jnci/85.16.1327; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Busch TM, 2003, ADV EXP MED BIOL, V510, P37; Cai WB, 2008, J NUCL MED, V49, p113S, DOI 10.2967/jnumed.107.045922; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chinnaiyan P, 2005, CANCER RES, V65, P3328, DOI 10.1158/0008-5472.CAN-04-3547; Ciardiello F, 2001, CLIN CANCER RES, V7, P1459; Ciardiello F, 1999, CLIN CANCER RES, V5, P909; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; DOUPLE E B, 1988, NCI (National Cancer Institute) Monographs, P129; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Evans H, 2000, JAVA REP, V5, P60; Evans SM, 2006, J INVEST DERMATOL, V126, P2596, DOI 10.1038/sj.jid.5700451; FAN Z, 1993, CANCER RES, V53, P4637; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121, DOI 10.1091/mbc.4.1.121; Huang SM, 2002, CANCER RES, V62, P4300; Huang SM, 2000, CLIN CANCER RES, V6, P2166; Huang SM, 1999, CANCER RES, V59, P1935; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang ZB, 2007, CANCER RES, V67, P4467, DOI 10.1158/0008-5472.CAN-06-3398; KOCH CJ, 1995, BRIT J CANCER, V72, P869, DOI 10.1038/bjc.1995.426; Krause M, 2005, RADIOTHER ONCOL, V76, P162, DOI 10.1016/j.radonc.2005.06.032; Krause M, 2008, CANCER METAST REV, V27, P387, DOI 10.1007/s10555-008-9141-z; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maity A, 2000, CANCER RES, V60, P5879; MASUI H, 1984, CANCER RES, V44, P1002; Milas L, 2000, CLIN CANCER RES, V6, P701; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Penet MF, 2008, J NUCL MED, V49, P687, DOI 10.2967/jnumed.107.043349; Perrotte P, 1999, CLIN CANCER RES, V5, P257; Petit AMV, 1997, AM J PATHOL, V151, P1523; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Pore N, 2003, CANCER RES, V63, P236; Prewett MC, 2002, CLIN CANCER RES, V8, P994; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Sehgal CM, 2001, RADIOLOGY, V219, P419, DOI 10.1148/radiology.219.2.r01ma13419; Sehgal CM, 2000, J ULTRAS MED, V19, P427, DOI 10.7863/jum.2000.19.7.427; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Solomon B, 2005, MOL CANCER THER, V4, P1417, DOI 10.1158/1535-7163.MCT-05-0066; Solonenko M, 2002, PHYS MED BIOL, V47, P857, DOI 10.1088/0031-9155/47/6/301; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang HW, 2004, CANCER RES, V64, P7553, DOI 10.1158/0008-5472.CAN-03-3632; Warburton C, 2004, CLIN CANCER RES, V10, P2512, DOI 10.1158/1078-0432.CCR-03-0244; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wood AKW, 2007, ULTRASOUND MED BIOL, V33, P1901, DOI 10.1016/j.ultrasmedbio.2007.06.013; Zakarija A, 2005, CURR OPIN ONCOL, V17, P578, DOI 10.1097/01.cco.0000183672.15133.ab; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	57	101	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6539	10.1371/journal.pone.0006539	http://dx.doi.org/10.1371/journal.pone.0006539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657384	Green Published, Green Submitted, gold			2022-12-25	WOS:000268739300010
J	Kroener, S; Chandler, LJ; Phillips, PEM; Seamans, JK				Kroener, Sven; Chandler, L. Judson; Phillips, Paul E. M.; Seamans, Jeremy K.			Dopamine Modulates Persistent Synaptic Activity and Enhances the Signal-to-Noise Ratio in the Prefrontal Cortex	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; DELAY-PERIOD ACTIVITY; D1 RECEPTOR ACTIONS; STOCHASTIC RESONANCE; PYRAMIDAL NEURONS; NETWORK MODEL; ELECTROPHYSIOLOGICAL PROPERTIES; CORTICAL-NEURONS; STRIATAL NEURONS; IN-VIVO	Background: The importance of dopamine (DA) for prefrontal cortical (PFC) cognitive functions is widely recognized, but its mechanisms of action remain controversial. DA is thought to increase signal gain in active networks according to an inverted U dose-response curve, and these effects may depend on both tonic and phasic release of DA from midbrain ventral tegmental area (VTA) neurons. Methodology/Principal Findings: We used patch-clamp recordings in organotypic co-cultures of the PFC, hippocampus and VTA to study DA modulation of spontaneous network activity in the form of Up-states and signals in the form of synchronous EPSP trains. These cultures possessed a tonic DA level and stimulation of the VTA evoked DA transients within the PFC. The addition of high (>= 1 mu M) concentrations of exogenous DA to the cultures reduced Up-states and diminished excitatory synaptic inputs (EPSPs) evoked during the Down-state. Increasing endogenous DA via bath application of cocaine also reduced Up-states. Lower concentrations of exogenous DA (0.1 mu M) had no effect on the up-state itself, but they selectively increased the efficiency of a train of EPSPs to evoke spikes during the Up-state. When the background DA was eliminated by depleting DA with reserpine and alpha-methyl-p-tyrosine, or by preparing corticolimbic co-cultures without the VTA slice, Up-states could be enhanced by low concentrations (0.1-1 mu M) of DA that had no effect in the VTA containing cultures. Finally, in spite of the concentration-dependent effects on Up-states, exogenous DA at all but the lowest concentrations increased intracellular current-pulse evoked firing in all cultures underlining the complexity of DA's effects in an active network. Conclusions/Significance: Taken together, these data show concentration-dependent effects of DA on global PFC network activity and they demonstrate a mechanism through which optimal levels of DA can modulate signal gain to support cognitive functioning.			Kroener, S (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kroener@musc.edu	Phillips, Paul E. M./A-4463-2008; Phillips, Paul/E-7813-2013; Kroener, Sven/F-4561-2012; Chandler, Lawrence/N-8569-2017	Phillips, Paul E. M./0000-0002-8749-7026; Phillips, Paul/0000-0002-8749-7026; Kroener, Sven/0000-0003-1728-8111; Chandler, Lawrence/0000-0002-1468-7320	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010983, R29AA010983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA015369] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR015455, RR015455] Funding Source: Medline; NIAAA NIH HHS [R29 AA010983, AA10983, R01 AA010983] Funding Source: Medline; NIDA NIH HHS [P50 DA015369, DA015369] Funding Source: Medline; NINDS NIH HHS [NS056124, R21 NS056124-01A1, R21 NS056124-02, R21 NS056124] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Azouz R, 1999, J NEUROSCI, V19, P2209; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Chen NNH, 1997, NEUROSCI LETT, V225, P197, DOI 10.1016/S0304-3940(97)00222-X; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Del Arco A, 2000, BRAIN RES BULL, V53, P339, DOI 10.1016/S0361-9230(00)00353-1; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 1999, J NEUROSCI, V19, P2807; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Durstewitz D, 2007, CEREB CORTEX, V17, P894, DOI 10.1093/cercor/bhk044; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Franke H, 2003, NEUROCHEM INT, V42, P431, DOI 10.1016/S0197-0186(02)00134-1; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V94, P4168, DOI 10.1152/jn.00698.2005; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gulledge AT, 1998, J NEUROSCI, V18, P9139; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Kroner S, 2007, CEREB CORTEX, V17, P1020, DOI 10.1093/cercor/bhl012; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Lavin A, 2001, NEUROSCIENCE, V104, P335, DOI 10.1016/S0306-4522(01)00096-3; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Muller UU, 2000, PHYS REV E, V61, P4286, DOI 10.1103/PhysRevE.61.4286; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Nestler E.J., 2015, MOL NEUROPHARMACOLOG; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Peters Y, 2004, SYNAPSE, V52, P143, DOI 10.1002/syn.20015; Plenz D, 1996, NEUROSCIENCE, V70, P893, DOI 10.1016/0306-4522(95)00405-X; Reynolds JNJ, 2000, NEUROSCIENCE, V99, P199, DOI 10.1016/S0306-4522(00)00273-6; ROLLS ET, 1984, NEUROSCIENCE, V12, P1201, DOI 10.1016/0306-4522(84)90014-9; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sawaguchi T, 2001, NEUROSCI RES, V41, P115, DOI 10.1016/S0168-0102(01)00270-X; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2003, CEREB CORTEX, V13, P1242, DOI 10.1093/cercor/bhg094; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shu YS, 2003, J NEUROSCI, V23, P10388; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Timofeev I, 1996, J PHYSIOL-LONDON, V494, P265, DOI 10.1113/jphysiol.1996.sp021489; Trantham H, 2002, NEUROSCIENCE, V113, P749, DOI 10.1016/S0306-4522(02)00246-4; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Trantham-Davidson H, 2004, NEUROPSYCHOPHARMACOL, V29, P2046, DOI 10.1038/sj.npp.1300482; Tseng KY, 2007, PSYCHOPHARMACOLOGY, V191, P627, DOI 10.1007/s00213-006-0439-7; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Tseng KY, 2005, CEREB CORTEX, V15, P49, DOI 10.1093/cercor/bhh107; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tu Y, 2007, J NEUROSCI, V27, P4765, DOI 10.1523/JNEUROSCI.5378-06.2007; Venton BJ, 2006, J NEUROSCI, V26, P3206, DOI 10.1523/JNEUROSCI.4901-04.2006; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Ward LM, 2006, CAN J EXP PSYCHOL, V60, P319, DOI 10.1037/cjep2006029; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Winterer G, 1999, CLIN NEUROPHYSIOL, V110, P1193, DOI 10.1016/S1388-2457(99)00059-0; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Yang CR, 1996, J NEUROSCI, V16, P1922; Zheng P, 1999, NEUROSCIENCE, V91, P527, DOI 10.1016/S0306-4522(98)00604-6	76	115	116	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6507	10.1371/journal.pone.0006507	http://dx.doi.org/10.1371/journal.pone.0006507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654866	Green Published, gold			2022-12-25	WOS:000268739100008
J	Sauna, ZE; Okunji, C; Hunt, RC; Gupta, T; Allen, CE; Plum, E; Blaisdell, A; Grigoryan, V; Geetha, S; Fathke, R; Soejima, K; Kimchi-Sarfaty, C				Sauna, Zuben E.; Okunji, Chinyere; Hunt, Ryan C.; Gupta, Tanvi; Allen, Courtni E.; Plum, Elizabeth; Blaisdell, Adam; Grigoryan, Vahan; Geetha, S.; Fathke, Robert; Soejima, Kenji; Kimchi-Sarfaty, Chava			Characterization of Conformation-Sensitive Antibodies to ADAMTS13, the von Willebrand Cleavage Protease	PLOS ONE			English	Article								Background: The zinc metalloprotease ADAMTS13 is a multidomain protein that cleaves von Willebrand Factor (VWF) and is implicated in Thrombotic Thrombocytopenic Purpura (TTP) pathogenesis. Understanding the mechanism of this protein is an important goal. Conformation sensitive antibodies have been used to monitor protein conformation and to decipher the molecular mechanism of proteins as well as to distinguish functional and non-functional mutants. Methodology/Principal Findings: We have characterized several antibodies against ADAMTS13, both monoclonal and polyclonal. We have used flow cytometry to estimate the binding of these antibodies to ADAMTS13 and demonstrate that antibodies raised against the TSP and disintegrin domains detect conformation changes in the ADAMTS13. Thus for example, increased binding of these antibodies was detected in the presence of the substrate (VWF), mainly at 37 degrees C and not at 4 degrees C. These antibodies could also detect differences between wild-type ADAMTS13 and the catalytically deficient mutant (P475S). The flow cytometry approach also allows us to estimate the reactivity of the antibody as well as its apparent affinity. Conclusions/Significance: Our results suggest that these antibodies may serve as useful reagents to distinguish functional and non-functional ADAMTS13 and analyze conformational transitions to understand the catalytic mechanism.			Sauna, ZE (corresponding author), US FDA, Lab Hemostasis, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	Zuben.sauna@fda.hhs.gov; Chava.kimchi-sarfaty@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019	Kimchi-Sarfaty, Chava/0000-0002-9355-8585				Ai JH, 2005, J BIOL CHEM, V280, P29428, DOI 10.1074/jbc.M505513200; CORNISH VW, 1994, P NATL ACAD SCI USA, V91, P2910, DOI 10.1073/pnas.91.8.2910; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Fanucci GE, 2006, CURR OPIN STRUC BIOL, V16, P644, DOI 10.1016/j.sbi.2006.08.008; FERSHT A, 2003, STRUCTURE MECH PROTE; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Fujiwara N, 2005, J BIOL CHEM, V280, P5061, DOI 10.1074/jbc.M406106200; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 1998, BLOOD, V91, P2839, DOI 10.1182/blood.V91.8.2839.2839_2839_2846; GEETHA S, 2009, CYTOMETRY A IN PRESS; Hovinga JAK, 2006, J THROMB HAEMOST, V4, P1146, DOI 10.1111/j.1538-7836.2006.01904.x; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Jacquemin MG, 1998, HAEMOPHILIA, V4, P552, DOI 10.1046/j.1365-2516.1998.440552.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Knobe KE, 2008, HAEMOPHILIA, V14, P723, DOI 10.1111/j.1365-2516.2008.01753.x; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Leonard BJN, 2000, J BIOL CHEM, V275, P34894, DOI 10.1074/jbc.M001166200; Levy GG, 2005, BLOOD, V106, P11, DOI 10.1182/blood-2004-10-4097; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Liu CT, 2005, INTERMETALLICS, V13, P3, DOI 10.1016/j.intermet.2004.09.005; Luken BM, 2005, THROMB HAEMOSTASIS, V93, P267, DOI 10.1160/TH04-05-0301; Majerus EM, 2003, J BIOL CHEM, V278, P46643, DOI 10.1074/jbc.M309872200; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Pfund WP, 1996, J BIOL CHEM, V271, P14055, DOI 10.1074/jbc.271.24.14055; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Rieger M, 2005, BLOOD, V106, P1262, DOI 10.1182/blood-2004-11-4490; Scheiflinger F, 2003, BLOOD, V102, P3241, DOI 10.1182/blood-2003-05-1616; Shida Y, 2008, BLOOD, V111, P1295, DOI 10.1182/blood-2007-09-110700; Soejima K, 2006, J BIOCHEM, V139, P147, DOI 10.1093/jb/mvj013; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; Sukumvanich P, 2004, CELL MOTIL CYTOSKEL, V59, P141, DOI 10.1002/cm.20030; Suzuki M, 2004, BIOCHEM BIOPH RES CO, V313, P212, DOI 10.1016/j.bbrc.2003.11.111; Tsai HM, 2006, THROMB HAEMOSTASIS, V95, P886, DOI 10.1160/TH06-02-0100; TSAI HM, 1994, BLOOD, V83, P2171; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Turner N, 2006, J THROMB HAEMOST, V4, P1396, DOI 10.1111/j.1538-7836.2006.01959.x; Uemura M, 2005, BLOOD, V106, P922, DOI 10.1182/blood-2005-01-0152; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zhou WH, 2005, J BIOL CHEM, V280, P39934, DOI 10.1074/jbc.M504919200; Zhou WH, 2005, LAB INVEST, V85, P780, DOI 10.1038/labinvest.3700275	45	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6506	10.1371/journal.pone.0006506	http://dx.doi.org/10.1371/journal.pone.0006506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654870	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739100007
J	Sarugaser, R; Hanoun, L; Keating, A; Stanford, WL; Davies, JE				Sarugaser, Rahul; Hanoun, Lorraine; Keating, Armand; Stanford, William L.; Davies, John E.			Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy	PLOS ONE			English	Article							HUMAN-BONE-MARROW; UMBILICAL-CORD; IN-VITRO; STROMAL CELLS; TUMOR STROMA; PRECURSORS; TRANSPLANTATION; FIBROBLASTS; EXPRESSION; GENERATION	Background: Mesenchymal progenitor cells (MPCs) have been isolated from a variety of connective tissues, and are commonly called "mesenchymal stem cells'' (MSCs). A stem cell is defined as having robust clonal self-renewal and multilineage differentiation potential. Accordingly, the term "MSC'' has been criticised, as there is little data demonstrating self-renewal of definitive single-cell-derived (SCD) clonal populations from a mesenchymal cell source. Methodology/Principal Findings: Here we show that a tractable MPC population, human umbilical cord perivascular cells (HUCPVCs), was capable of multilineage differentiation in vitro and, more importantly, contributed to rapid connective tissue healing in vivo by producing bone, cartilage and fibrous stroma. Furthermore, HUCPVCs exhibit a high clonogenic frequency, allowing us to isolate definitive SCD parent and daughter clones from mixed gender suspensions as determined by Y-chromosome fluorescent in situ hybridization. Conclusions/Significance: Analysis of the multilineage differentiation capacity of SCD parent clones and daughter clones enabled us to formulate a new hierarchical schema for MSC self-renewal and differentiation in which a self-renewing multipotent MSC gives rise to more restricted self-renewing progenitors that gradually lose differentiation potential until a state of complete restriction to the fibroblast is reached.			Sarugaser, R (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	jed.davies@utoronto.ca		Stanford, William/0000-0002-5813-8016				Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Ennis J, 2008, CYTOTHERAPY, V10, P174, DOI 10.1080/14653240801891667; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; GRONTHOS S, 1995, BLOOD, V85, P929, DOI 10.1182/blood.V85.4.929.bloodjournal854929; Halleux C., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P71; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim JW, 2004, ANN HEMATOL, V83, P733, DOI 10.1007/s00277-004-0918-z; Kobayashi K, 1998, EARLY HUM DEV, V51, P223, DOI 10.1016/S0378-3782(97)00123-0; Kuznetsov SA, 1997, BRIT J HAEMATOL, V97, P561, DOI 10.1046/j.1365-2141.1997.902904.x; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Muraglia A, 2000, J CELL SCI, V113, P1161; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sarugaser Rahul, 2009, V482, P269, DOI 10.1007/978-1-59745-060-7_17; SCHOR AM, 1990, J CELL SCI, V97, P449; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Seruya M, 2004, CELL TRANSPLANT, V13, P93, DOI 10.3727/000000004773301762; SHAHDADFAR A, 2005, STEM CELLS; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Takahashi K, 2004, CELL TRANSPLANT, V13, P337, DOI 10.3727/000000004783983918; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TAKECHI K, 1993, PLACENTA, V14, P235, DOI 10.1016/S0143-4004(05)80264-4; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Turner NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1147, DOI 10.1016/j.bbrc.2008.10.131; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	54	169	179	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6498	10.1371/journal.pone.0006498	http://dx.doi.org/10.1371/journal.pone.0006498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652709	Green Published, gold			2022-12-25	WOS:000268637800010
J	Natividad, JM; Huang, XX; Slack, E; Jury, J; Sanz, Y; David, C; Denou, E; Yang, PC; Murray, J; McCoy, KD; Verdu, EF				Natividad, Jane M.; Huang, Xianxi; Slack, Emma; Jury, Jennifer; Sanz, Yolanda; David, Chella; Denou, Emmanuel; Yang, Pinchang; Murray, Joseph; McCoy, Kathy D.; Verdu, Elena F.			Host Responses to Intestinal Microbial Antigens in Gluten-Sensitive Mice	PLOS ONE			English	Article								Background and Aims: Excessive uptake of commensal bacterial antigens through a permeable intestinal barrier may influence host responses to specific antigen in a genetically predisposed host. The aim of this study was to investigate whether intestinal barrier dysfunction induced by indomethacin treatment affects the host response to intestinal microbiota in gluten-sensitized HLA-DQ8/HCD4 mice. Methodology/Principal Findings: HLA-DQ8/HCD4 mice were sensitized with gluten, and gavaged with indomethacin plus gluten. Intestinal permeability was assessed by Ussing chamber; epithelial cell (EC) ultra-structure by electron microscopy; RNA expression of genes coding for junctional proteins by Q-real-time PCR; immune response by in-vitro antigen-specific T-cell proliferation and cytokine analysis by cytometric bead array; intestinal microbiota by fluorescence in situ hybridization and analysis of systemic antibodies against intestinal microbiota by surface staining of live bacteria with serum followed by FACS analysis. Indomethacin led to a more pronounced increase in intestinal permeability in gluten-sensitized mice. These changes were accompanied by severe EC damage, decreased E-cadherin RNA level, elevated IFN-gamma in splenocyte culture supernatant, and production of significant IgM antibody against intestinal microbiota. Conclusion: Indomethacin potentiates barrier dysfunction and EC injury induced by gluten, affects systemic IFN-gamma production and the host response to intestinal microbiota antigens in HLA-DQ8/HCD4 mice. The results suggest that environmental factors that alter the intestinal barrier may predispose individuals to an increased susceptibility to gluten through a bystander immune activation to intestinal microbiota.			Natividad, JM (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8S 4L8, Canada.	verdue@mcmaster.ca	McCoy, Kathy/ABD-5814-2021; Slack, Emma/B-1612-2016; Slack, Emma/AAD-5837-2019; Sanz, Yolanda/H-5498-2012	Slack, Emma/0000-0002-2473-1145; Slack, Emma/0000-0002-2473-1145; Sanz, Yolanda/0000-0002-1615-1976; murray, joseph/0000-0003-1941-9090	NIDDK NIH HHS [R01 DK71003, R01 DK071003] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071003] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Ashorn S, 2008, J CLIN IMMUNOL, V28, P486, DOI 10.1007/s10875-008-9200-9; Barshack I, 2001, J CLIN PATHOL, V54, P684, DOI 10.1136/jcp.54.9.684; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; BJARNASON I, 1985, GUT, V26, P1214, DOI 10.1136/gut.26.11.1214; BJARNASON I, 1984, GUT, V25, P145, DOI 10.1136/gut.25.2.145; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Cheng S, 2003, J AUTOIMMUN, V21, P195, DOI 10.1016/S0896-8411(03)00120-3; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Cronin CC, 2003, AM J GASTROENTEROL, V98, P518; D'Arienzo R, 2008, IMMUNOL LETT, V119, P78, DOI 10.1016/j.imlet.2008.04.006; Dalby AB, 2006, APPL ENVIRON MICROB, V72, P6707, DOI 10.1128/AEM.00378-06; Dieterich W, 2006, GUT, V55, P478, DOI 10.1136/gut.2005.069385; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; Ford AC, 2008, AM J GASTROENTEROL, V103, P1229, DOI 10.1111/j.1572-0241.2007.01740.x; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Furst Sylvia M, 2005, J Immunotoxicol, V1, P149, DOI 10.1080/15476910490916828; Green PHR, 2006, ANNU REV MED, V57, P207, DOI 10.1146/annurev.med.57.051804.122404; Guo X, 2003, AM J PHYSIOL-CELL PH, V285, pC1174, DOI 10.1152/ajpcell.00015.2003; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kaukinen K, 2001, DIGEST DIS SCI, V46, P879, DOI 10.1023/A:1010729207320; Lindfors K, 2008, CLIN EXP IMMUNOL, V152, P552, DOI 10.1111/j.1365-2249.2008.03635.x; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Mallant-Hent RC, 2006, EUR J GASTROEN HEPAT, V18, P75, DOI 10.1097/00042737-200601000-00013; Marietta E, 2004, J CLIN INVEST, V114, P1090, DOI 10.1172/JCI200421055; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mino M, 2003, AM J SURG PATHOL, V27, P1237, DOI 10.1097/00000478-200309000-00007; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Newberry RD, 1999, NAT MED, V5, P900, DOI 10.1038/11341; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinier M, 2009, GASTROENTEROLOGY, V136, P288, DOI 10.1053/j.gastro.2008.09.016; Porras M, 2004, AM J PHYSIOL-GASTR L, V287, pG58, DOI 10.1152/ajpgi.00513.2003; Porras M, 2006, INFLAMM BOWEL DIS, V12, P843, DOI 10.1097/01.mib.0000231571.88806.62; ROBERT A, 1977, PROSTAGLANDINS, V14, P333, DOI 10.1016/0090-6980(77)90178-2; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; Sanz Y, 2007, FEMS IMMUNOL MED MIC, V51, P562, DOI 10.1111/j.1574-695X.2007.00337.x; Senger S, 2005, J IMMUNOL, V175, P8087, DOI 10.4049/jimmunol.175.12.8087; Sigthorsson G, 2002, GASTROENTEROLOGY, V122, P1913, DOI 10.1053/gast.2002.33647; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Sollid LM, 2004, AM J GASTROENTEROL, V99, P905, DOI 10.1111/j.1572-0241.2004.04158.x; Sollid Ludvig M, 2005, J Pediatr Gastroenterol Nutr, V40 Suppl 1, pS41, DOI 10.1097/00005176-200504001-00025; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Troncone R, 2003, AM J GASTROENTEROL, V98, P590, DOI 10.1111/j.1572-0241.2003.07301.x; VANELBURG RM, 1993, GUT, V34, P354, DOI 10.1136/gut.34.3.354; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Yu LCH, 2000, ANN NY ACAD SCI, V915, P247	56	52	55	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6472	10.1371/journal.pone.0006472	http://dx.doi.org/10.1371/journal.pone.0006472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649259	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637600019
J	Xing, B; Yin, XB				Xing, Bo; Yin, Xue-Bo			Novel Poly-Dopamine Adhesive for a Halloysite Nanotube-Ru(bpy)(3)(2+) Electrochemiluminescent Sensor	PLOS ONE			English	Article								Herein, for the first time, the electrochemiluminescent sensor based on Ru(bpy)(3)(2+)-modified electrode using dopamine as an adhesive was successfully developed. After halloysite nanotube slurry was cast on a glassy carbon electrode and dried, an alkaline dopamine solution was added on the electrode surface. Initially, polydopamine belts with dimensions of tens to hundreds of nanometers formed via oxidization of the dopamine by ambient oxygen. As the incubation time increased, the nanobelts became broader and then united with each other to form a polydopamine film. The halloysite nanotubes were embedded within the polydopamine film. The above electrode was soaked in Ru(bpy)(3)(2+) aqueous solution to adsorb Ru(bpy)(3)(2+) into the active sites of the halloysite nanotubes via cation-exchange procedure. Through this simple procedure, a Ru(bpy)(3)(2+)-modified electrode was obtained using only 6.25 mg Ru(bpy)(3)(2+), 15.0 mu g dopamine, and 9.0 mu g halloysite nanotubes. The electrochemistry and electrochemiluminescence (ECL) of the modified electrode was investigated using tripropylamine (TPA) and nitrilotriacetic acid (NTA) as co-reactants. The different ECL behaviors of the modified electrode using NTA and TPA as well as the contact angle measurements reflected the hydrophilic character of the electrode. The results indicate that halloysite nanotubes have a high loading capacity for Ru(bpy)(3)(2+) and that dopamine is suitable for the preparation of modified electrodes.			Yin, XB (corresponding author), Nankai Univ, Res Ctr Analyt Sci, Coll Chem, Tianjin 300071, Peoples R China.	xbyin@nankai.edu.cn	Yin, Xue-Bo/G-2305-2011	Yin, Xue-Bo/0000-0002-7954-163X				Alexander CJ, 1999, ANAL CHIM ACTA, V402, P105, DOI 10.1016/S0003-2670(99)00535-8; Bertoncello P, 2007, ANAL CHEM, V79, P7549, DOI 10.1021/ac070811m; Bruce D, 2002, ANALYST, V127, P125, DOI 10.1039/b108072p; Choi HN, 2007, ELECTROANAL, V19, P459, DOI 10.1002/elan.200603747; Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963; Du Y, 2006, J PHYS CHEM B, V110, P21662, DOI 10.1021/jp064948c; Factor B, 2001, ANAL CHEM, V73, P4621, DOI 10.1021/ac010698e; Guo ZH, 2004, ANALYST, V129, P657, DOI 10.1039/b314645f; Guo ZH, 2004, ANAL CHEM, V76, P2683, DOI 10.1021/ac035276e; Guo ZH, 2004, ANAL CHEM, V76, P184, DOI 10.1021/ac034759f; Kanoufi F, 2001, J PHYS CHEM B, V105, P210, DOI 10.1021/jp002880+; Khramov AN, 2000, ANAL CHEM, V72, P2943, DOI 10.1021/ac9914519; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee JK, 2003, CHEM COMMUN, P1602, DOI 10.1039/b303766e; LELAND JK, 1990, J ELECTROCHEM SOC, V137, P73131; Li J, 2007, ANAL CHEM, V79, P5439, DOI 10.1021/ac0706224; Liang PY, 2003, J ELECTROANAL CHEM, V560, P151, DOI 10.1016/j.jelechem.2003.07.010; Miao WJ, 2002, J AM CHEM SOC, V124, P14478, DOI 10.1021/ja027532v; Miao WJ, 2008, CHEM REV, V108, P2506, DOI 10.1021/cr068083a; NOFFSINGER JB, 1987, ANAL CHEM, V59, P865, DOI 10.1021/ac00133a017; Ouyang RZ, 2008, CHEM COMMUN, P5761, DOI 10.1039/b810248a; Podsiadlo P, 2007, ADV MATER, V19, P949, DOI 10.1002/adma.200602706; Pyati R., 2007, ANNU REP PROG CHEM C, V103, P12; Qian L, 2007, ADV FUNCT MATER, V17, P1353, DOI 10.1002/adfm.200600253; Sun XP, 2005, ANAL CHEM, V77, P8166, DOI 10.1021/ac051476+; Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087; Wang HY, 2003, ANAL CHIM ACTA, V480, P285, DOI 10.1016/S0003-2670(03)00049-7; Wang HY, 2002, ELECTROANAL, V14, P853, DOI 10.1002/1521-4109(200206)14:12<853::AID-ELAN853>3.0.CO;2-D; Wang HY, 2001, ANALYST, V126, P1095, DOI 10.1039/b100376n; Wang HY, 2001, TALANTA, V55, P61, DOI 10.1016/S0039-9140(01)00406-4; Wei H, 2008, TRAC-TREND ANAL CHEM, V27, P447, DOI 10.1016/j.trac.2008.02.009; Workman S, 2000, ANAL CHEM, V72, P5556, DOI 10.1021/ac000800s; Xing B, 2009, BIOSENS BIOELECTRON, V24, P2939, DOI 10.1016/j.bios.2009.02.011; Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802; Ye YP, 2007, POLYMER, V48, P6426, DOI 10.1016/j.polymer.2007.08.035; Yin XB, 2008, ELECTROANAL, V20, P1085, DOI 10.1002/elan.200704156; Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y; Zhang LH, 2007, BIOSENS BIOELECTRON, V22, P1097, DOI 10.1016/j.bios.2006.03.026; Zhang LH, 2006, ANAL CHEM, V78, P5119, DOI 10.1021/ac060451n; Zu YB, 2001, ANAL CHEM, V73, P3960, DOI 10.1021/ac010230b; Zurcher S, 2006, J AM CHEM SOC, V128, P1064, DOI 10.1021/ja056256s	41	24	25	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6451	10.1371/journal.pone.0006451	http://dx.doi.org/10.1371/journal.pone.0006451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649294	gold, Green Published, Green Submitted			2022-12-25	WOS:000268494600018
J	Armanet, M; Wojtusciszyn, A; Morel, P; Parnaud, G; Rousselle, P; Sinigaglia, C; Berney, T; Bosco, D				Armanet, Mathieu; Wojtusciszyn, Anne; Morel, Philippe; Parnaud, Geraldine; Rousselle, Patricia; Sinigaglia, Corinne; Berney, Thierry; Bosco, Domenico			Regulated laminin-332 expression in human islets of Langerhans	FASEB JOURNAL			English	Article						extracellular matrix; cytokines; PI3-K	NF-KAPPA-B; BASEMENT-MEMBRANE; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; EXTRACELLULAR-MATRIX; CELL-PROLIFERATION; PANCREATIC-ISLETS; GAMMA-2 CHAIN; BETA-CELLS; INTERLEUKIN-1	Laminin-332 (LN-332) is a basement membrane component known to exert a beneficial effect on rat pancreatic beta cells in vitro. In this work, we analyzed the expression of LN-332 in human islets, its expression after inflammatory insults by cytokines, and the molecular mechanisms responsible for this effect. By Western blotting and RT-PCR, we showed that LN-332 was expressed in isolated human islets. By immunofluorescence on pancreas sections, we observed that labeling was confined to endocrine cells in islets. Confocal microscopy analysis on isolated islet cells revealed that labeling was granular but did not colocalize with hormone secretory granules. LN-332 was most abundant in cultured islets compared to freshly isolated islets and was found in culture medium, which suggests that it was secreted by islets. When islets were exposed to interleukin (IL)-1 beta, expression and secretion of LN-332 increased as compared to control. No effect was observed with tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma. LY294002, an inhibitor of phosphatidylinositol 3-kinase (PI3-K) activity, inhibited culture- and IL-1 beta-induced LN-332 expression in islets. These results show that LN-332, known to have some beneficial effect on beta cells in vitro, is produced and secreted by endocrine islet cells and is up-regulated by stressing conditions such as culture and IL-1 beta-exposure.-Armanet, M., Wojtusciszyn, A., Morel, P., Parnaud, G., Rousselle, P., Sinigaglia, C., Berney, T., Bosco, D. Regulated laminin-332 expression in human islets of Langerhans. FASEB J. 23, 4046-4055 (2009). www.fasebj.org	[Armanet, Mathieu; Wojtusciszyn, Anne; Morel, Philippe; Parnaud, Geraldine; Sinigaglia, Corinne; Berney, Thierry; Bosco, Domenico] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, CH-1211 Geneva 4, Switzerland; [Armanet, Mathieu; Wojtusciszyn, Anne; Morel, Philippe; Parnaud, Geraldine; Sinigaglia, Corinne; Berney, Thierry; Bosco, Domenico] Univ Geneva, Geneva, Switzerland; [Rousselle, Patricia] CNRS, Inst Biol & Chim Prot, Lyon, France; [Rousselle, Patricia] Univ Lyon 1, F-69365 Lyon, France	University of Geneva; University of Geneva; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bosco, D (corresponding author), Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, CH-1211 Geneva 4, Switzerland.	domenico.bosco@unige.ch	Berney, Thierry/ABE-9450-2021; Rousselle, Patricia/J-5290-2019; Rousselle, Patricia/CAF-3915-2022	Berney, Thierry/0000-0002-4230-9378; Rousselle, Patricia/0000-0003-0275-4562; Rousselle, Patricia/0000-0003-0275-4562; Wojtusciszyn, Anne/0000-0002-9410-9909; Bosco, Domenico/0000-0003-3453-9613	Swiss National Science Foundation [3200BO-116562]; Juvenile Diabetes Research Foundation [31-2008416]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by grants from the Swiss National Science Foundation (3200BO-116562 to P. M., D. B., and T. B.) and the Juvenile Diabetes Research Foundation (31-2008416). We thank Dr. Didier Cholet and Christelle Barraclough (Genomics Platform, National Centers of Competence in Research, University of Geneva School of Medicine) as well as Florentina Naville for their excellent technical assistance.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Amano S, 2004, BRIT J DERMATOL, V151, P961, DOI 10.1111/j.1365-2133.2004.06175.x; Baba Y, 2008, BRIT J CANCER, V98, P974, DOI 10.1038/sj.bjc.6604252; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Christiano AM, 1996, J INVEST DERMATOL, V106, P775, DOI 10.1111/1523-1747.ep12346246; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; EIZIRIK DL, 1991, AUTOIMMUNITY, V10, P107, DOI 10.3109/08916939109004814; Ekblom P, 1996, CURR OPIN CELL BIOL, V8, P700, DOI 10.1016/S0955-0674(96)80112-8; Francoeur C, 2004, AM J PHYSIOL-GASTR L, V287, pG592, DOI 10.1152/ajpgi.00535.2003; Gentilini D, 2007, MOL HUM REPROD, V13, P317, DOI 10.1093/molehr/gam001; Ghosh S, 2000, MICROSC RES TECHNIQ, V51, P238, DOI 10.1002/1097-0029(20001101)51:3<238::AID-JEMT4>3.0.CO;2-3; Giannelli G, 2001, CLIN EXP METASTAS, V18, P439; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Grassi M, 1999, J CELL SCI, V112, P2511; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Hoorens A, 2001, DIABETES, V50, P551, DOI 10.2337/diabetes.50.3.551; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kantengwa S, 1997, EXP CELL RES, V237, P394, DOI 10.1006/excr.1997.3803; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Kingsley K, 2002, BIOCHEM BIOPH RES CO, V294, P1017, DOI 10.1016/S0006-291X(02)00592-2; Kingsley K, 2002, BIOCHEM BIOPH RES CO, V293, P1000, DOI 10.1016/S0006-291X(02)00331-5; KORANG K, 1995, FEBS LETT, V368, P556, DOI 10.1016/0014-5793(95)00740-Z; Koshikawa N, 1999, CANCER RES, V59, P5596; Koshikawa N, 2008, CANCER RES, V68, P530, DOI 10.1158/0008-5472.CAN-07-5269; Larsen CM, 1998, J BIOL CHEM, V273, P15294, DOI 10.1074/jbc.273.24.15294; Mandrup-Poulsen T R, 2001, Ugeskr Laeger, V163, P4176; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MATSUI C, 1995, J BIOL CHEM, V270, P23496, DOI 10.1074/jbc.270.40.23496; MATSUI C, 1995, J INVEST DERMATOL, V105, P648, DOI 10.1111/1523-1747.ep12324108; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Montolio M, 2007, J ENDOCRINOL, V192, P169, DOI 10.1677/joe.1.06968; MORITA A, 1985, BIOCHEM J, V229, P259, DOI 10.1042/bj2290259; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; PETERS BP, 1985, J BIOL CHEM, V260, P4732; Pousset F, 2000, EUR CYTOKINE NETW, V11, P427; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; Ribaux P, 2007, ENDOCRINOLOGY, V148, P5582, DOI 10.1210/en.2007-0325; Roggia C, 2007, EXP CELL RES, V313, P921, DOI 10.1016/j.yexcr.2006.12.009; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Salo T, 1999, J ORAL PATHOL MED, V28, P337; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Virtanen I, 2008, DIABETOLOGIA, V51, P1181, DOI 10.1007/s00125-008-0997-9; Yamaoka T, 1999, INT J MOL MED, V3, P247; Yao K, 2008, OPHTHALMIC RES, V40, P69, DOI 10.1159/000113884	64	16	17	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4046	4055		10.1096/fj.08-127142	http://dx.doi.org/10.1096/fj.08-127142			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19667121				2022-12-25	WOS:000272193700002
J	Telci, D; Collighan, RJ; Basaga, H; Griffin, M				Telci, Dilek; Collighan, Russell John; Basaga, Huveyda; Griffin, Martin			Increased TG2 Expression Can Result in Induction of Transforming Growth Factor beta 1, Causing Increased Synthesis and Deposition of Matrix Proteins, Which Can Be Regulated by Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; TUBULAR EPITHELIAL-CELLS; SWISS 3T3 FIBROBLASTS; TISSUE TRANSGLUTAMINASE; EXTRACELLULAR-MATRIX; CROSS-LINKING; CANCER-CELLS; BINDING-PROTEIN; ENDOTHELIAL-CELLS; BETA(1) INTEGRIN	In fibrotic conditions increases in TG2 activity has been linked to an increase in the deposition of extracellular matrix proteins. Using TG2 transfected Swiss 3T3 fibroblasts expressing TG2 under the control of the tetracycline-regulated inducible promoter, we demonstrate that induction of TG2 not only stimulates an increase in collagen and fibronectin deposition but also an increase in the expression of these proteins. Increased TG2 expression in these fibroblasts led to NF-kappa B activation, resulting in the increased expression of transforming growth factor (TGF) beta(1). In addition, cells overexpressing TG2 demonstrated an increase in biologically active TGF beta(1) in the extracellular environment. A specific site-directed inhibitor of TG abolished the NF-kappa B and TGF beta 1 activation and the subsequent elevation in the synthesis and deposition of extracellular matrix proteins, confirming that this process depends on the induction of transglutaminase activity. Treatment of TG2-induced fibroblasts with nontoxic doses of nitric oxide donor S-nitroso-N-acetylpenicillamine resulted in decreased TG2 activity and apprehension of the inactive enzyme on the cell surface. This was paralleled by a reduction in activation of NF-kappa B and TGF beta(1) production with a subsequent decrease in collagen expression and deposition. These findings support a role for NO in the regulation of TG2 function in the extracellular environment.	[Telci, Dilek; Collighan, Russell John; Griffin, Martin] Aston Univ, Sch Life & Hlth, Birmingham B4 7ET, W Midlands, England; [Telci, Dilek] Yeditepe Univ, Dept Genet & Bioengn, TR-34755 Istanbul, Turkey; [Basaga, Huveyda] Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey	Aston University; Yeditepe University; Sabanci University	Griffin, M (corresponding author), Aston Univ, Sch Life & Hlth, Aston Triangle, Birmingham B4 7ET, W Midlands, England.	M.Griffin@aston.ac.uk	Telci, Dilek/N-5053-2019; Telci, Dilek/B-5880-2017	Telci, Dilek/0000-0002-2793-6533; Telci, Dilek/0000-0002-2793-6533; Griffin, Martin/0000-0003-3824-306X	Aston University; European Union [MRTN-CT-2006-036032]; Scientific & Technological Research Council of Turkey Health Sciences Division [104S606]	Aston University; European Union(European Commission); Scientific & Technological Research Council of Turkey Health Sciences Division(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported in part by Aston University, Grant MRTN-CT-2006-036032 from the European Union, and Grant 104S606 from the Scientific & Technological Research Council of Turkey Health Sciences Division.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; ANDO T, 1995, KIDNEY INT, V47, P733, DOI 10.1038/ki.1995.112; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Caccamo D, 2005, J NEUROSCI RES, V82, P858, DOI 10.1002/jnr.20683; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Cho BR, 2008, CORONARY ARTERY DIS, V19, P459, DOI 10.1097/MCA.0b013e3283108fc3; Craven PA, 1997, DIABETES, V46, P671, DOI 10.2337/diabetes.46.4.671; Ferrero R, 1999, BRIT J PHARMACOL, V127, P779, DOI 10.1038/sj.bjp.0702607; Fisher M, 2009, MATRIX BIOL, V28, P20, DOI 10.1016/j.matbio.2008.10.003; FREUND KF, 1994, BIOCHEMISTRY-US, V33, P10109, DOI 10.1021/bi00199a039; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; Gaudry CA, 1999, EXP CELL RES, V252, P104, DOI 10.1006/excr.1999.4633; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Gross SR, 2003, J INVEST DERMATOL, V121, P412, DOI 10.1046/j.1523-1747.2003.12353.x; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Johnson TS, 2007, J AM SOC NEPHROL, V18, P3078, DOI 10.1681/ASN.2006070690; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; Johnson TS, 1999, J AM SOC NEPHROL, V10, P2146; Kalk P, 2006, BRIT J PHARMACOL, V148, P853, DOI 10.1038/sj.bjp.0706792; Kang DH, 2002, AM J PATHOL, V161, P239, DOI 10.1016/S0002-9440(10)64175-2; Kelley TJ, 1998, J CLIN INVEST, V102, P1200, DOI 10.1172/JCI2357; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kutuk O, 2003, TRENDS MOL MED, V9, P549, DOI 10.1016/j.molmed.2003.10.007; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; Le M, 2001, CONNECT TISSUE RES, V42, P245, DOI 10.3109/03008200109016839; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; Leon L, 2008, NITRIC OXIDE-BIOL CH, V19, P77, DOI 10.1016/j.niox.2008.04.014; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Niculescu-Duvaz I, 2007, NEPHRON EXP NEPHROL, V105, pE108, DOI 10.1159/000100492; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; PEREZ JR, 1994, MOL CELL BIOL, V14, P5326, DOI 10.1128/MCB.14.8.5326; Pistea A, 2008, J VASC RES, V45, P10, DOI 10.1159/000109073; Prabhakar S, 2007, J AM SOC NEPHROL, V18, P2945, DOI 10.1681/ASN.2006080895; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Rameshwar P, 2000, J IMMUNOL, V165, P2271, DOI 10.4049/jimmunol.165.4.2271; Ritter SJ, 1998, J BIOL CHEM, V273, P12798, DOI 10.1074/jbc.273.21.12798; Saura M, 2005, CIRC RES, V97, P1115, DOI 10.1161/01.RES.0000191538.76771.66; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Studer RK, 1999, ARTHRITIS RHEUM-US, V42, P248, DOI 10.1002/1529-0131(199902)42:2<248::AID-ANR6>3.0.CO;2-S; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Wani J, 2007, BIOL CHEM, V388, P497, DOI 10.1515/BC.2007.056; Zhu JL, 1999, GASTROENTEROLOGY, V117, P1198, DOI 10.1016/S0016-5085(99)70406-3	56	55	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29547	29558		10.1074/jbc.M109.041806	http://dx.doi.org/10.1074/jbc.M109.041806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19657147	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000270896800037
J	Liao, MC; Ahmed, M; Smith, SO; Van Nostrand, WE				Liao, Mei-Chen; Ahmed, Mahiuddin; Smith, Steven O.; Van Nostrand, William E.			Degradation of Amyloid beta Protein by Purified Myelin Basic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIN-CONVERTING ENZYME; A-BETA; ALZHEIMERS-DISEASE; GELATINASE-A; IN-VITRO; PEPTIDE; BRAIN; MATTER; AGGREGATION; CLEAVAGE	The progressive accumulation of beta-amyloid (A beta) in senile plaques and in the cerebral vasculature is the hallmark of Alzheimer disease and related disorders. Impaired clearance of A beta from the brain likely contributes to the prevalent sporadic form of Alzheimer disease. Several major pathways for A beta clearance include receptor-mediated cellular uptake, blood-brain barrier transport, and direct proteolytic degradation. Myelin basic protein (MBP) is the major structural protein component of myelin and plays a functional role in the formation and maintenance of the myelin sheath. MBP possesses endogenous serine proteinase activity and can undergo autocatalytic cleavage liberating distinct fragments. Recently, we showed that MBP binds A beta and inhibits A beta fibril formation (Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2007) J. Biol. Chem. 282, 9952-9961; Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2009) Biochemistry 48, 4720-4727). Here we show that A beta 40 and A beta 42 peptides are degraded by purified human brain MBP and recombinant human MBP, but not an MBP fragment that lacks autolytic activity. MBP-mediated A beta degradation is inhibited by serine proteinase inhibitors. Similarly, Cos-1 cells expressing MBP degrade exogenous A beta 40 and A beta 42. In addition, we demonstrate that purified MBP also degrades assembled fibrillar A beta in vitro. Mass spectrometry analysis identified distinct degradation products generated from A beta digestion by MBP. Lastly, we demonstrate in situ that purified MBP can degrade parenchymal amyloid plaques as well as cerebral vascular amyloid that form in brain tissue of A beta precursor protein transgenic mice. Together, these findings indicate that purified MBP possesses A beta degrading activity in vitro.	[Van Nostrand, William E.] SUNY Stony Brook, Dept Neurosurg, Stony Brook, NY 11794 USA; [Liao, Mei-Chen; Van Nostrand, William E.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Ahmed, Mahiuddin; Smith, Steven O.] SUNY Stony Brook, Struct Biol Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Nostrand, WE (corresponding author), SUNY Stony Brook, Dept Neurosurg, HSC T-12-080, Stony Brook, NY 11794 USA.	William.VanNostrand@stonybrook.edu	Smith, Steven/HDM-9496-2022		National Institutes of Health [RO1-NS035781, RO1-AG027317]; Alzheimer's Association [IIRG-06-26805]; Cure Alzheimer's Fund; Stony Brook University; Collaborative Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Fund; Stony Brook University; Collaborative Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-NS035781 (to W. E. V. N.) and RO1-AG027317 (to S. O. S.). This work was also supported by Alzheimer's Association Grant IIRG-06-26805, the Cure Alzheimer's Fund (to W. E. V. N.), the proteomics center at Stony Brook University and a Collaborative Research Center grant.	Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; BURDICK D, 1992, J BIOL CHEM, V267, P546; CHEIFETZ S, 1985, BIOCHEMISTRY-US, V24, P1909, DOI 10.1021/bi00329a016; D'Souza CA, 2005, BIOCHEMISTRY-US, V44, P12905, DOI 10.1021/bi051152f; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Evin G, 2002, PEPTIDES, V23, P1285, DOI 10.1016/S0196-9781(02)00063-3; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Givogri MI, 2000, J NEUROSCI RES, V59, P153, DOI 10.1002/(SICI)1097-4547(20000115)59:2<153::AID-JNR1>3.3.CO;2-6; Hoos MD, 2007, J BIOL CHEM, V282, P9952, DOI 10.1074/jbc.M603494200; Hoos MD, 2009, BIOCHEMISTRY-US, V48, P4720, DOI 10.1021/bi900037s; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Korneck B, 2003, BRAIN RES BULL, V61, P321, DOI 10.1016/S0361-9230(03)00095-9; Ledesma MD, 2000, EMBO REP, V1, P530; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; OMLIN FX, 1982, J CELL BIOL, V95, P242, DOI 10.1083/jcb.95.1.242; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Staugaitis SM, 1996, BIOESSAYS, V18, P13, DOI 10.1002/bies.950180106; Stout JC, 1996, ARCH NEUROL-CHICAGO, V53, P742, DOI 10.1001/archneur.1996.00550080056013; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Wang DS, 2004, NEUROSCI RES, V48, P93, DOI 10.1016/j.neures.2003.10.002; WISNIEWSKI HM, 1989, ACTA NEUROPATHOL, V78, P337, DOI 10.1007/BF00688170; WOOD DD, 1989, J BIOL CHEM, V264, P5121; YAMADA T, 1995, ACTA NEUROPATHOL, V89, P199; Yamin R, 2007, J NEUROCHEM, V100, P458, DOI 10.1111/j.1471-4159.2006.04251.x; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c	38	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28917	28925		10.1074/jbc.M109.050856	http://dx.doi.org/10.1074/jbc.M109.050856			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692707	Green Published, hybrid			2022-12-25	WOS:000270678900048
J	Tschumi, A; Nai, C; Auchli, Y; Hunziker, P; Gehrig, P; Keller, P; Grau, T; Sander, P				Tschumi, Andreas; Nai, Corrado; Auchli, Yolanda; Hunziker, Peter; Gehrig, Peter; Keller, Peter; Grau, Thomas; Sander, Peter			Identification of Apolipoprotein N-Acyltransferase (Lnt) in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE LIPOPROTEIN; LIPID-MODIFIED PROTEINS; ESCHERICHIA-COLI; TUBERCULOSIS; PHOSPHATIDYLETHANOLAMINE; PROLIPOPROTEIN; GLYCOSYLATION; INACTIVATION; SYNTHASE; MANNOSE	Lipoproteins of Gram-negative and Gram-positive bacteria carry a thioether-bound diacylglycerol but differ by a fatty acid amide bound to the alpha-amino group of the universally conserved cysteine. In Escherichia coli the N-terminal acylation is catalyzed by the N-acyltransferase Lnt. Using E. coli Lnt as a query in a BLASTp search, we identified putative lnt genes also in Gram-positive mycobacteria. The Mycobacterium tuberculosis lipoprotein LppX, heterologously expressed in Mycobacterium smegmatis, was N-acylated at the N-terminal cysteine, whereas LppX expressed in a M. smegmatis lnt::aph knock-out mutant was accessible for N-terminal sequencing. Western blot analyses of a truncated and tagged form of LppX indicated a smaller size of about 0.3 kDa in the lnt::aph mutant compared with the parental strain. Matrix-assisted laser desorption ionization time-of-flight/time-of-flight analyses of a trypsin digest of LppX proved the presence of the diacylglycerol modification in both strains, the parental strain and lnt:: aph mutant. N-Acylation was found exclusively in the M. smegmatis parental strain. Complementation of the lnt:: aph mutant with M. tuberculosis ppm1 restored N-acylation. The substrate for N-acylation is a C16 fatty acid, whereas the two fatty acids of the diacylglycerol residue were identified as C16 and C19:0 fatty acid, the latter most likely tuberculostearic acid. We demonstrate that mycobacterial lipoproteins are triacylated. For the first time to our knowledge, we identify Lnt activity in Gram-positive bacteria and assigned the responsible genes. In M. smegmatis and M. tuberculosis the open reading frames are annotated as MSMEG_3860 and M. tuberculosis ppm1, respectively.	[Tschumi, Andreas; Nai, Corrado; Keller, Peter; Grau, Thomas; Sander, Peter] Univ Zurich, Inst Med Mikrobiol, CH-8006 Zurich, Switzerland; [Auchli, Yolanda; Hunziker, Peter; Gehrig, Peter] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Sander, Peter] Natl Zentrum Mykobakterien, CH-8006 Zurich, Switzerland	University of Zurich	Sander, P (corresponding author), Gloriastr 30-32, CH-8006 Zurich, Switzerland.	psander@imm.uzh.ch	Sander, Peter/D-2548-2009; Keller, Peter M/D-8675-2013; Tschumi, Andreas/D-3721-2009; Keller, Peter M/C-6876-2012	Sander, Peter/0000-0003-1581-0682; Keller, Peter M/0000-0002-2890-5384; Keller, Peter M/0000-0002-2890-5384; Nai, Corrado/0000-0002-6232-6634	Swiss National Science Foundation [3100A0-120326]; European Union [LSHP-CT-2006-037217]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	This work was supported in part by the Swiss National Science Foundation Grant 3100A0-120326 and the European Union TB-Drug Grant LSHP-CT-2006-037217.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baulard AR, 2003, J BIOL CHEM, V278, P2242, DOI 10.1074/jbc.M207922200; Baumgartner M, 2007, J BACTERIOL, V189, P313, DOI 10.1128/JB.00976-06; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dobos KM, 1996, J BACTERIOL, V178, P2498, DOI 10.1128/jb.178.9.2498-2506.1996; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Goren M. B., 1979, TUBERCULOSIS, P63; GUPTA SD, 1993, J BIOL CHEM, V268, P16551; GUPTA SD, 1991, J BIOL CHEM, V266, P9983; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; HAYASHI S, 1985, J BIOL CHEM, V260, P5753; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Isaacs RCA, 2006, BIOORG MED CHEM LETT, V16, P338, DOI 10.1016/j.bmcl.2005.09.083; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; LAI JS, 1980, J BACTERIOL, V144, P451, DOI 10.1128/JB.144.1.451-453.1980; LIN JJC, 1980, J BIOL CHEM, V255, P1160; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Navarre WW, 1996, J BACTERIOL, V178, P441, DOI 10.1128/jb.178.2.441-446.1996; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Rampini SK, 2008, MICROBIOL-SGM, V154, P2991, DOI 10.1099/mic.0.2008/018895-0; Rezwan M, 2007, MICROBIOL-SGM, V153, P652, DOI 10.1099/mic.0.2006/000216-0; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Robichon C, 2003, MOL MICROBIOL, V49, P1145, DOI 10.1046/j.1365-2958.2003.03654.x; Sander P, 2004, MOL MICROBIOL, V52, P1543, DOI 10.1111/j.1365-2958.2004.04041.x; SANDER P, 1995, MOL MICROBIOL, V16, P991, DOI 10.1111/j.1365-2958.1995.tb02324.x; Sander P, 2001, Methods Mol Med, V54, P93, DOI 10.1385/1-59259-147-7:093; Sander P, 1997, MOL MICROBIOL, V26, P469, DOI 10.1046/j.1365-2958.1997.5811946.x; SANKARAN K, 1995, METHOD ENZYMOL, V248, P169; Sartain MJ, 2009, GLYCOBIOLOGY, V19, P38, DOI 10.1093/glycob/cwn102; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Sutcliffe IC, 2004, FEMS MICROBIOL REV, V28, P645, DOI 10.1016/j.femsre.2004.06.002; Tawaratsumida K, 2009, J BIOL CHEM, V284, P9147, DOI 10.1074/jbc.M900429200; Ujihara T, 2008, ANAL BIOCHEM, V374, P429, DOI 10.1016/j.ab.2007.11.014; Venema R, 2003, J BIOL CHEM, V278, P14739, DOI 10.1074/jbc.M209857200; Vidal-Ingigliardi D, 2007, J BACTERIOL, V189, P4456, DOI 10.1128/JB.00099-07; Wu HC, 1996, ESCHERICHIA COLI SAL, V1, P1005; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; YOUNG DB, 1991, RES MICROBIOL, V142, P55, DOI 10.1016/0923-2508(91)90097-T; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	48	57	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27146	27156		10.1074/jbc.M109.022715	http://dx.doi.org/10.1074/jbc.M109.022715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661058	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000270232300015
J	Yang, JQ; Kong, XY; Martins-Santos, MES; Aleman, G; Chaco, E; Liu, GE; Wu, SY; Samols, D; Hakimi, P; Chiang, CM; Hanson, RW				Yang, Jianqi; Kong, Xiaoying; Martins-Santos, Maria Emilia S.; Aleman, Gabriela; Chaco, Ernestine; Liu, George E.; Wu, Shwu-Yuan; Samols, David; Hakimi, Parvin; Chiang, Cheng-Ming; Hanson, Richard W.			Activation of SIRT1 by Resveratrol Represses Transcription of the Gene for the Cytosolic Form of Phosphoenolpyruvate Carboxykinase (GTP) by Deacetylating Hepatic Nuclear Factor 4 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; IN-VIVO; INSULIN; EXPRESSION; GLYCERONEOGENESIS; INDUCTION; GLUCONEOGENESIS; GLUCOCORTICOIDS; IDENTIFICATION; ACETYLATION	The SIRT1 activators isonicotinamide (IsoNAM), resveratrol, fisetin, and butein repressed transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) (PEPCK-C). An evolutionarily conserved binding site for hepatic nuclear factor (HNF) 4 alpha (-272/-252) was identified, which was required for transcriptional repression of the PEPCK-C gene promoter caused by these compounds. This site contains an overlapping AP-1 binding site and is adjacent to the C/EBP binding element (-248/-234); the latter is necessary for hepatic transcription of PEPCK-C. AP-1 competed with HNF4 alpha for binding to this site and also decreased HNF4 alpha stimulation of transcription from the PEPCK-C gene promoter. Chromatin immunoprecipitation experiments demonstrated that HNF4 alpha and AP-1, but not C/EBP beta, reciprocally bound to this site prior to and after treating HepG2 cells with IsoNAM. IsoNAM treatment resulted in deacetylation of HNF4 alpha, which decreased its binding affinity to the PEPCK-C gene promoter. In HNF4 alpha-null Chinese hamster ovary cells, IsoNAM and resveratrol failed to repress transcription from the PEPCK-C gene promoter; overexpression of HNF4 alpha in Chinese hamster ovary cells re-established transcriptional inhibition. Exogenous SIRT1 expression repressed transcription, whereas knockdown of SIRT1 by RNA interference reversed this effect. IsoNAM decreased the level of mRNA for PEPCK-C but had no effect on mRNA for glucose-6-phosphatase in AML12 mouse hepatocytes. We conclude that SIRT1 activation inhibited transcription of the gene for PEPCK-C in part by deacetylation of HNF4 alpha. However, SIRT1 deacetylation of other key regulatory proteins that control PEPCK-C gene transcription also likely contributed to the inhibitory effect.	[Yang, Jianqi; Kong, Xiaoying; Martins-Santos, Maria Emilia S.; Aleman, Gabriela; Chaco, Ernestine; Samols, David; Hakimi, Parvin; Hanson, Richard W.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Liu, George E.] USDA ARS, ANRI, Bovine Funct Genom Lab, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	Case Western Reserve University; United States Department of Agriculture (USDA); University of Texas System; University of Texas Southwestern Medical Center Dallas	Hanson, RW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	rwh@case.edu	ALEMAN, GABRIELA/AAB-6484-2020; Hakimi, Parvin/AAB-1643-2021; Alemán, Gabriela/AAR-1781-2021; Liu, George/K-3371-2019	Liu, George/0000-0003-0192-6705; Aleman, Gabriela/0000-0003-0755-2302	National Institutes of Health [DK058620, DK025541, CA103867, CA124760]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025541, R01DK058620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK058620 and DK025541 (to R. W. H.) and CA103867 and CA124760 (to C-M. C.).	Ahmad F, 1999, J IMMUNOL, V162, P4864; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; Croniger CM, 2001, J BIOL CHEM, V276, P629, DOI 10.1074/jbc.M007576200; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Dey S, 2008, CARCINOGENESIS, V29, P1920, DOI 10.1093/carcin/bgn175; EISENBERGER CL, 1992, MOL CELL BIOL, V12, P1396, DOI 10.1128/MCB.12.3.1396; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Franckhauser S, 2006, DIABETES, V55, P273, DOI 10.2337/diabetes.55.02.06.db05-0482; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; GURNEY AL, 1992, J BIOL CHEM, V267, P18133; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; HANSON RW, 1994, P ENOLPYRUVATE CARBO; IMAI E, 1993, J BIOL CHEM, V268, P5353; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Leahy P, 1999, J BIOL CHEM, V274, P8813, DOI 10.1074/jbc.274.13.8813; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; LIU JS, 1991, J BIOL CHEM, V266, P19095; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MEYUHAS O, 1976, BIOCHEM J, V158, P9, DOI 10.1042/bj1580009; MEYUHAS O, 1976, BIOCHEM J, V158, P1; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; MOHN KL, 1991, MOL CELL BIOL, V11, P381, DOI 10.1128/MCB.11.1.381; NECHUSHTAN H, 1987, NUCLEIC ACIDS RES, V15, P6405, DOI 10.1093/nar/15.16.6405; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; PATEL YM, 1994, J BIOL CHEM, V269, P5619; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; RESHEF L, 1972, BIOCHEM J, V127, P809, DOI 10.1042/bj1270809; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; RESHEFF L, 1970, J BIOL CHEM, V245, P5979; Roden M, 2004, NEWS PHYSIOL SCI, V19, P92, DOI 10.1152/nips.01459.2003; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Sauve AA, 2004, CURR MED CHEM, V11, P807, DOI 10.2174/0929867043455675; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; SQUINTO SP, 1989, MOL ENDOCRINOL, V3, P433, DOI 10.1210/mend-3-3-433; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	63	57	59	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27042	27053		10.1074/jbc.M109.047340	http://dx.doi.org/10.1074/jbc.M109.047340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651778	hybrid, Green Published			2022-12-25	WOS:000270232300006
J	Zhong, N; Ramaswamy, G; Weisgraber, KH				Zhong, Ning; Ramaswamy, Gayathri; Weisgraber, Karl H.			Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CEREBRAL GLUCOSE-METABOLISM; E TYPE-4 ALLELE; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; THERAPEUTIC TARGET; BRAIN; PATHWAYS; HEALTH; ROLES	Domain interaction, a structural property of apolipoprotein E4 (apoE4), is predicted to contribute to the association of apoE4 with Alzheimer disease. Arg-61 apoE mice, a gene-targeted mouse model specific for domain interaction, have lower brain apoE levels and synaptic, functional, and cognitive deficits. We hypothesized that domain interaction elicits an endoplasmic reticulum (ER) stress in astrocytes and an unfolded protein response that targets Arg-61 apoE for degradation. Primary Arg-61 apoE astrocytes had less intracellular apoE than wildtype astrocytes, and unfolded protein response markers OASIS (old astrocyte specifically induced substance), ATF4, and XBP-1 and downstream effectors were up-regulated. ER stress appears to cause global astrocyte dysfunction as glucose uptake was decreased in Arg-61 apoE astrocytes, and astrocyte-conditioned medium promoted neurite outgrowth less efficiently than wildtype medium in Neuro-2a cell cultures. We showed age-dependent up-regulation of brain OASIS levels and processing in Arg-61 apoE mice. ER stress and astrocyte dysfunction represent a new paradigm underlying the association of apoE4 with neurodegeneration.	[Zhong, Ning; Ramaswamy, Gayathri; Weisgraber, Karl H.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weisgraber, KH (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	kweisgraber@gladstone.ucsf.edu		Zhong, Ning/0000-0002-3696-5301	National Institutes of Health [PO1 AG022074, RO1 AG20235]; National Center for Research Resources [CO6 RR0118928]; American Health Assistance Foundation [A2006-231]; Alzheimer's Association Zenith Award [AG028793]; NATIONAL INSTITUTE ON AGING [P01AG022074, R01AG020235, R01AG028793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Health Assistance Foundation(BrightFocus Foundation); Alzheimer's Association Zenith Award(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 AG022074 (to K. W.), RO1 AG20235 (to K. W.), and CO6 RR0118928 from the National Center for Research Resources. This work was also supported in part by American Health Assistance Foundation Pilot Grant for Alzheimer's Disease Research A2006-231 (to N. Z.), Alzheimer's Association Zenith Award AG028793 (to K. W.).	Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bredesen DE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-27; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; Hol EM, 2008, J MOL NEUROSCI, V34, P23, DOI 10.1007/s12031-007-0013-8; Huang Y, 2006, CURR OPIN DRUG DISC, V9, P627; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Lee KU, 2003, J NEUROPSYCH CLIN N, V15, P78, DOI 10.1176/appi.neuropsych.15.1.78; Leira F, 2002, TOXICOL IN VITRO, V16, P267, DOI 10.1016/S0887-2333(02)00002-4; Lin DT, 2007, NEUROBIOL AGING, V28, P99, DOI 10.1016/j.neurobiolaging.2005.11.004; Loaiza A, 2003, J NEUROSCI, V23, P7337; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; Mahley RW, 2007, CURR ALZHEIMER RES, V4, P537, DOI 10.2174/156720507783018334; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Markowitz Alison J B, 2007, Cellscience, V4, P111; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Ramaswamy G, 2005, J NEUROSCI, V25, P10658, DOI 10.1523/JNEUROSCI.1922-05.2005; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200	51	56	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27273	27280		10.1074/jbc.M109.014464	http://dx.doi.org/10.1074/jbc.M109.014464			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666463	Green Published, hybrid			2022-12-25	WOS:000270232300028
J	Du, W; Wu, JF; Walsh, EM; Zhang, YJ; Chen, CY; Xiao, ZXJ				Du, Wei; Wu, Junfeng; Walsh, Erica M.; Zhang, Yujun; Chen, Chang Yan; Xiao, Zhi-Xiong Jim			Nutlin-3 Affects Expression and Function of Retinoblastoma Protein ROLE OF RETINOBLASTOMA PROTEIN IN CELLULAR RESPONSE TO NUTLIN-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; MDM2 ANTAGONISTS; TUMOR-CELLS; P53; INHIBITION; ACTIVATION; RB; CANCER; E2F; PHOSPHORYLATION	The retinoblastoma protein (Rb) plays a pivotal role in regulating cell proliferation and apoptosis. Nutlin-3, a small molecule MDM2 antagonist blocking interaction between MDM2 and p53, activates p53 resulting in cell growth arrest or apoptosis in various cancer cells. However, the molecular basis for the different cellular responses upon nutlin-3 treatment is not fully understood. In this study, we show that nutlin-3 activates p53 resulting in a dramatic increase in MDM2 expression and a marked reduction in total Rb protein levels. Interestingly, nutlin-3 reduces the levels of hypophosphorylated Rb and induces massive apoptosis in SJSA-1 cells, which can be largely rescued by knockdown of MDM2 or by expression of constitutively active Rb. By contrast, nutlin-3 treatment of several human cancer cells, including A549, U2-OS, and HCT116, results in an accumulation of hypophosphorylated Rb and cell cycle arrest but not apoptosis. Furthermore, we show that down-regulation of Rb by nutlin-3 does not lead to E2F1 activation nor does E2F1 play a critical role for nutlin-3-induced apoptosis in SJSA-1 cells. Taken together, these results suggest that Rb plays a critical role in influencing cellular response to activation of p53 pathway by nutlin-3.	[Du, Wei; Wu, Junfeng; Walsh, Erica M.; Xiao, Zhi-Xiong Jim] Boston Univ, Sch Med, Grad Program Cellular & Mol Biol, Boston, MA 02118 USA; [Du, Wei; Wu, Junfeng; Walsh, Erica M.; Xiao, Zhi-Xiong Jim] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Zhang, Yujun; Xiao, Zhi-Xiong Jim] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Chen, Chang Yan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Xiao, ZXJ (corresponding author), K423 715 Albany St, Boston, MA 02118 USA.	jxiao@bu.edu			National Institutes of Health [CA79804, GM70017]; NATIONAL CANCER INSTITUTE [R01CA079804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA79804 and GM70017 (to Z.X.X.).	Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; ARVA NC, 2008, ETHN DIS S2, V18; Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576; Chang DLF, 2007, ONCOGENE, V26, P4627, DOI 10.1038/sj.onc.1210254; Cheok CF, 2007, MOL CANCER RES, V5, P1133, DOI 10.1158/1541-7786.MCR-07-0161; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; HSICH JK, 1999, MOL CELL, V3, P181; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Kan CE, 2007, CANCER RES, V67, P9862, DOI 10.1158/0008-5472.CAN-07-0259; Kitagawa M, 2008, ONCOGENE, V27, P5303, DOI 10.1038/onc.2008.164; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Kojima K, 2006, BLOOD, V108, P993, DOI 10.1182/blood-2005-12-5148; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Maimets T, 2008, ONCOGENE, V27, P5277, DOI 10.1038/onc.2008.166; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; XIAO ZX, 1995, J MOL BIOL, V248, P255, DOI 10.1006/jmbi.1995.0219; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	31	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26315	26321		10.1074/jbc.M109.046904	http://dx.doi.org/10.1074/jbc.M109.046904			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648117	hybrid, Green Published			2022-12-25	WOS:000269969600011
J	Darash-Yahana, M; Gillespie, JW; Hewitt, SM; Chen, YYK; Maeda, S; Stein, I; Singh, SP; Bedolla, RB; Peled, A; Troyer, DA; Pikarsky, E; Karin, M; Farber, JM				Darash-Yahana, Merav; Gillespie, John W.; Hewitt, Stephen M.; Chen, Yun-Yun K.; Maeda, Shin; Stein, Ilan; Singh, Satya P.; Bedolla, Roble B.; Peled, Amnon; Troyer, Dean A.; Pikarsky, Eli; Karin, Michael; Farber, Joshua M.			The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers	PLOS ONE			English	Article							PROSTATE-CANCER; SCAVENGER RECEPTOR; LIGAND CXCL16; INFILTRATING LYMPHOCYTES; EXPRESSION CLONING; CELL RECRUITMENT; BREAST-CANCER; LIVER-INJURY; TUMOR-GROWTH; CXCL16/SR-PSOX	Clinical observations and mouse models have suggested that inflammation can be pro-tumorigenic. Since chemokines are critical in leukocyte trafficking, we hypothesized that chemokines play essential roles in inflammation-associated cancers. Screening for 37 chemokines in prostate cancer cell lines and xenografts revealed CXCL16, the ligand for the receptor CXCR6, as the most consistently expressed chemokine. Immunohistochemistry and/or immunofluorescence and confocal imaging of 121 human prostate specimens showed that CXCL16 and CXCR6 were co-expressed, both on prostate cancer cells and adjacent T cells. Expression levels of CXCL16 and CXCR6 on cancer cells correlated with poor prognostic features including high-stage and high-grade, and expression also correlated with post-inflammatory changes in the cancer stroma as revealed by loss of alpha-smooth muscle actin. Moreover, CXCL16 enhanced the growth of CXCR6-expressing cancer and primary CD4 T cells. We studied expression of CXCL16 in an additional 461 specimens covering 12 tumor types, and found that CXCL16 was expressed in multiple human cancers associated with inflammation. Our study is the first to describe the expression of CXCL16/CXCR6 on both cancer cells and adjacent T cells in humans, and to demonstrate correlations between CXCL16 and CXCR6 vs. poor both prognostic features and reactive changes in cancer stoma. Taken together, our data suggest that CXCL16 and CXCR6 may mark cancers arising in an inflammatory milieu and mediate pro-tumorigenic effects of inflammation through direct effects on cancer cell growth and by inducing the migration and proliferation of tumor-associated leukocytes.			Darash-Yahana, M (corresponding author), NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	meravd@hadassah.org.il; jfarber@niaid.nih.gov	pikarsky, eli/GXV-7099-2022	Hewitt, Stephen/0000-0001-8283-1788; pikarsky, eli/0000-0003-4186-7105	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZICBC010923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000749, Z01AI000749] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini C, 2005, AM J RESP CRIT CARE, V172, P1290, DOI 10.1164/rccm.200501-142OC; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Condon MS, 2005, SEMIN CANCER BIOL, V15, P132, DOI 10.1016/j.semcancer.2004.08.002; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Dong H, 2002, BIOCHEM BIOPH RES CO, V298, P675, DOI 10.1016/S0006-291X(02)02528-7; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Hojo S, 2007, CANCER RES, V67, P4725, DOI 10.1158/0008-5472.CAN-06-3424; Hu WD, 2008, CANCER SCI, V99, P1362, DOI 10.1111/j.1349-7006.2008.00833.x; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kita T, 2001, ANN NY ACAD SCI, V947, P199; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2008, MOL CANCER RES, V6, P546, DOI 10.1158/1541-7786.MCR-07-0277; Ludwig A, 2005, J NEUROCHEM, V93, P1293, DOI 10.1111/j.1471-4159.2005.03123.x; Lundberg GA, 2005, J INTERN MED, V257, P415, DOI 10.1111/j.1365-2796.2005.01469.x; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Meijer J, 2008, CANCER RES, V68, P4701, DOI 10.1158/0008-5472.CAN-08-0482; Morgan AJ, 2005, CLIN EXP ALLERGY, V35, P1572, DOI 10.1111/j.1365-2222.2005.02383.x; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nanki T, 2005, ARTHRITIS RHEUM, V52, P3004, DOI 10.1002/art.21301; Nomura T, 2000, ANTICANCER RES, V20, P4073; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ou DL, 2006, J PATHOL, V210, P363, DOI 10.1002/path.2053; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Ruth JH, 2006, ARTHRITIS RHEUM-US, V54, P765, DOI 10.1002/art.21662; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; SEIDL H, 2007, HUM PATHOL; Sheikine Y, 2004, ANN MED, V36, P98, DOI 10.1080/07853890310019961; SHEIKINE Y, 2005, ATHEROSCLEROSIS; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Tenger C, 2005, ARTERIOSCL THROM VAS, V25, P791, DOI 10.1161/01.ATV.0000153516.02782.65; Wagsater D, 2004, BIOCHEM BIOPH RES CO, V325, P1187, DOI 10.1016/j.bbrc.2004.10.160; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Wuttge DM, 2004, ARTERIOSCL THROM VAS, V24, P750, DOI 10.1161/01.ATV.0000124102.11472.36; Xu HB, 2005, INFECT IMMUN, V73, P4007, DOI 10.1128/IAI.73.7.4007-4016.2005; Xu HB, 2005, WORLD J GASTROENTERO, V11, P4979, DOI 10.3748/wjg.v11.i32.4979	53	96	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6695	10.1371/journal.pone.0006695	http://dx.doi.org/10.1371/journal.pone.0006695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690611	Green Submitted, gold, Green Published			2022-12-25	WOS:000269267300011
J	Sander, AF; Salanti, A; Lavstsen, T; Nielsen, MA; Magistrado, P; Lusingu, J; Ndam, NT; Arnot, DE				Sander, Adam F.; Salanti, Ali; Lavstsen, Thomas; Nielsen, Morten A.; Magistrado, Pamela; Lusingu, John; Ndam, Nicaise Tuikue; Arnot, David E.			Multiple var2csa-Type PfEMP1 Genes Located at Different Chromosomal Loci Occur in Many Plasmodium falciparum Isolates	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; VARIANT SURFACE-ANTIGEN; INFECTED ERYTHROCYTES; ALLELIC DIMORPHISM; STRUCTURAL BASIS; IMMUNE EVASION; MALARIA; PREGNANCY; BINDING; IDENTIFICATION	Background: The var2csa gene encodes a Plasmodium falciparum adhesion receptor which binds chondroitin sulfate A (CSA). This var gene is more conserved than other PfEMP1/var genes and is found in all P. falciparum isolates. In isolates 3D7, FCR3/It4 and HB3, var2csa is transcribed from a sub-telomeric position on the left arm of chromosome 12, but it is not known if this location is conserved in all parasites. Genome sequencing indicates that the var2csa gene is duplicated in HB3, but whether this is true in natural populations is uncertain. Methodology/Principal Findings: To assess global variation in the VAR2CSA protein, sequence variation in the DBL2X region of var2csa genes in 54 P. falciparum samples was analyzed. Chromosome mapping of var2csa loci was carried out and a quantitative PCR assay was developed to estimate the number of var2csa genes in P. falciparum isolates from the placenta of pregnant women and from the peripheral circulation of other malaria patients. Sequence analysis, gene mapping and copy number quantitation in P. falciparum isolates indicate that there are at least two loci and that both var2csa-like genes can be transcribed. All VAR2CSA DBL2X domains fall into one of two distinct phylogenetic groups possessing one or the other variant of a large (similar to 26 amino acid) dimorphic motif, but whether either motif variant is linked to a specific locus is not known. Conclusions/Significance: Two or more related but distinct var2csa-type PfEMP1/var genes exist in many P. falciparum isolates. One gene is on chromosome 12 but additional var2csa-type genes are on different chromosomes in different isolates. Multiplicity of var2csa genes appears more common in infected placentae than in samples from non-pregnant donors indicating a possible advantage of this genotype in pregnancy associated malaria.			Sander, AF (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	dearnot@sund.ku.dk	Lusingu, John P. A./GSJ-3228-2022; Arnot, David/S-1984-2019	Arnot, David/0000-0002-3027-1130; Lavstsen, Thomas/0000-0002-3044-4249; Nielsen, Morten Agertoug/0000-0003-2668-4992; Tuikue Ndam, Nicaise/0000-0003-2646-2513; Salanti, Ali/0000-0003-2207-5575; Bertelsen, Adam Frederik Sander/0000-0002-8782-7830; Lusingu, John P. A./0000-0002-9407-0602				Arnot David E, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS131, DOI 10.1016/S0035-9203(02)90064-7; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; Bengtsson D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-101; Bentley GA, 2008, NAT STRUCT MOL BIOL, V15, P895, DOI 10.1038/nsmb0908-895; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; CORCORAN LM, 1986, CELL, V44, P87, DOI 10.1016/0092-8674(86)90487-3; Creasey AM, 2003, INFECT IMMUN, V71, P4767, DOI 10.1128/IAI.71.8.4767-4771.2003; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Duffy MF, 2009, J MOL BIOL, V389, P453, DOI 10.1016/j.jmb.2009.04.032; Duffy PE, 2003, CURR OPIN MICROBIOL, V6, P371, DOI 10.1016/S1369-5274(03)00090-0; Ferreira MU, 2004, CLIN DIAGN LAB IMMUN, V11, P987, DOI 10.1128/CDLI.11.6.987-995.2004; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gamain B, 2004, MOL MICROBIOL, V53, P445, DOI 10.1111/j.1365-2958.2004.04145.x; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghumra A, 2009, EUR J IMMUNOL, V39, P1147, DOI 10.1002/eji.200839184; Gowda ASP, 2007, J BIOL CHEM, V282, P916, DOI 10.1074/jbc.M604741200; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hviid L, 2007, PARASITOLOGY, V134, P1871, DOI 10.1017/S0031182007000121; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; McColl DJ, 1997, MOL BIOCHEM PARASIT, V90, P21, DOI 10.1016/S0166-6851(97)00130-8; McKenzie FE, 2001, EVOLUTION, V55, P1299, DOI 10.1111/j.0014-3820.2001.tb00652.x; Ndam NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001855; NIELSEN MA, 2009, INFECT IMMUN; Pearce JA, 2004, INFECT IMMUN, V72, P2321, DOI 10.1128/IAI.72.4.2321-2328.2004; Resende M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-104; Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; Rowe JA, 2004, MOL MICROBIOL, V53, P1011, DOI 10.1111/j.1365-2958.2004.04256.x; Roy SW, 2008, HEREDITY, V100, P103, DOI 10.1038/sj.hdy.6800887; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Semblat JP, 2006, MOL BIOCHEM PARASIT, V146, P192, DOI 10.1016/j.molbiopara.2005.12.007; Sharling L, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-31; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; SMYTHE JA, 1991, P NATL ACAD SCI USA, V88, P1751, DOI 10.1073/pnas.88.5.1751; Soerli J, 2009, PARASITE IMMUNOL, V31, P341, DOI 10.1111/j.1365-3024.2009.01097.x; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Tuikue NN, 2008, PARASITE, V15, P515, DOI 10.1051/parasite/2008153515; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Ward CP, 1999, MOL BIOCHEM PARASIT, V102, P167, DOI 10.1016/S0166-6851(99)00106-1; WARE LA, 1993, MOL BIOCHEM PARASIT, V60, P105, DOI 10.1016/0166-6851(93)90033-T	49	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6667	10.1371/journal.pone.0006667	http://dx.doi.org/10.1371/journal.pone.0006667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690615	gold, Green Submitted, Green Published			2022-12-25	WOS:000269267300001
J	Martins, A; Spengler, G; Rodrigues, L; Viveiros, M; Ramos, J; Martins, M; Couto, I; Fanning, S; Pages, JM; Bolla, JM; Molnar, J; Amaral, L				Martins, Ana; Spengler, Gabriella; Rodrigues, Liliana; Viveiros, Miguel; Ramos, Jorge; Martins, Marta; Couto, Isabel; Fanning, Seamus; Pages, Jean-Marie; Bolla, Jean Michel; Molnar, Joseph; Amaral, Leonard			pH Modulation of Efflux Pump Activity of Multi-Drug Resistant Escherichia coli: Protection During Its Passage and Eventual Colonization of the Colon	PLOS ONE			English	Article								Background: Resistance Nodulation Division (RND) efflux pumps of Escherichia coli extrude antibiotics and toxic substances before they reach their intended targets. Whereas these pumps obtain their energy directly from the proton motive force (PMF), ATP-Binding Cassette (ABC) transporters, which can also extrude antibiotics, obtain energy from the hydrolysis of ATP. Because E. coli must pass through two pH distinct environments of the gastrointestinal system of the host, it must be able to extrude toxic agents at very acidic and at near neutral pH (bile salts in duodenum and colon for example). The herein described study examines the effect of pH on the extrusion of ethidium bromide (EB). Methodology/Principal Findings: E. coli AG100 and its tetracycline induced progeny AG100(TET) that over-expresses the acrAB efflux pump were evaluated for their ability to extrude EB at pH 5 and 8, by our recently developed semi-automated fluorometric method. At pH 5 the organism extrudes EB without the need for metabolic energy (glucose), whereas at pH 8 extrusion of EB is dependent upon metabolic energy. Phe-Arg beta-naphtylamide (PA beta N), a commonly assumed inhibitor of RND efflux pumps has no effect on the extrusion of EB as others claim. However, it does cause accumulation of EB. Competition between EB and PA beta N was demonstrated and suggested that PA beta N was preferentially extruded. A K-m representing competition between PA beta N and EB has been calculated. Conclusions/Significance: The results suggest that E. coli has two general efflux systems (not to be confused with a distinct efflux pump) that are activated at low and high pH, respectively, and that the one at high pH is probably a putative ABC transporter coded by msbA, which has significant homology to the ABC transporter coded by efrAB of Enterococcus faecalis, an organism that faces similar challenges as it makes its way through the toxic intestinal system of the host.			Martins, A (corresponding author), Univ Nova Lisboa, Unit Mycobacteriol, IHMT, P-1200 Lisbon, Portugal.	lamaral@ihmt.unl.pt	Couto, Isabel/I-2640-2012; Viveiros, Miguel/A-7326-2008; Bolla, Jean Michel/D-3885-2014; MARTINS, MARTA/I-3015-2012; Amaral, Leonard/I-2112-2012; Spengler, Gabriella/I-6433-2012; Rodrigues, Liliana/N-2463-2014; Martins, Ana/I-6432-2012; PAGES, jean-marie/F-2555-2013	Couto, Isabel/0000-0003-3536-2733; Viveiros, Miguel/0000-0001-9676-6251; Bolla, Jean Michel/0000-0003-3892-4340; Amaral, Leonard/0000-0003-3127-1295; Rodrigues, Liliana/0000-0002-2094-2666; PAGES, jean-marie/0000-0001-7092-7977; Martins, Marta/0000-0002-0323-2857; Spengler, Gabriella/0000-0001-8085-0950; Martins, Ana/0000-0002-8541-7440; Fanning, Seamus/0000-0002-1922-8836; Ramos, Jorge/0000-0001-6419-5351				Cherepanov DA, 2004, BIOPHYS J, V86, P665, DOI 10.1016/S0006-3495(04)74146-6; COLE CB, 1984, BRIT POULTRY SCI, V25, P227, DOI 10.1080/00071668408454861; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Deckers-Hebestreit G, 2000, BBA-BIOENERGETICS, V1458, P364, DOI 10.1016/S0005-2728(00)00087-6; Elkins CA, 2003, DRUG RESIST UPDATE, V6, P9, DOI 10.1016/S1368-7646(03)00004-9; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; GUFFANTI AA, 1984, J BACTERIOL, V159, P448, DOI 10.1128/JB.159.2.448-452.1984; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Krulwich TA, 1996, BBA-BIOENERGETICS, V1275, P21, DOI 10.1016/0005-2728(96)00044-8; Lee EW, 2003, ANTIMICROB AGENTS CH, V47, P3733, DOI 10.1128/AAC.47.12.3733-3738.2003; Lee EW, 2003, BIOL PHARM BULL, V26, P266, DOI 10.1248/bpb.26.266; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lomovskaya O, 2007, NAT REV DRUG DISCOV, V6, P56, DOI 10.1038/nrd2200; Martins M, 2006, IN VIVO, V20, P657; MICHELL P, 1966, PHYSIOL REV, V41, P445; Mulkidjanian AY, 2006, BBA-BIOENERGETICS, V1757, P913, DOI 10.1016/j.bbabio.2006.02.015; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nikaido H, 1998, CURR OPIN MICROBIOL, V1, P516, DOI 10.1016/S1369-5274(98)80083-0; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Pietras Z, 2008, CURR DRUG TARGETS, V9, P719, DOI 10.2174/138945008785747743; Ponte-Sucre A, 2007, APPL MICROBIOL BIOT, V76, P279, DOI 10.1007/s00253-007-1017-6; Rodrigues L, 2008, J ANTIMICROB CHEMOTH, V61, P1076, DOI 10.1093/jac/dkn070; Russell JB, 1998, ADV MICROB PHYSIOL, V39, P205; Saier MH, 1998, FASEB J, V12, P265, DOI 10.1096/fasebj.12.3.265; Seeger MA, 2008, CURR DRUG TARGETS, V9, P729, DOI 10.2174/138945008785747789; Simon J, 2008, BBA-BIOENERGETICS, V1777, P1480, DOI 10.1016/j.bbabio.2008.09.008; Su CC, 2007, FEBS LETT, V581, P4972, DOI 10.1016/j.febslet.2007.09.035; Thota N, 2008, BIOORGAN MED CHEM, V16, P6535, DOI 10.1016/j.bmc.2008.05.030; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Turina P, 2006, BBA-BIOENERGETICS, V1757, P320, DOI 10.1016/j.bbabio.2006.04.018; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Viveiros M, 2005, ANTIMICROB AGENTS CH, V49, P3578, DOI 10.1128/AAC.49.8.3578-3582.2005; Viveiros M, 2008, INT J ANTIMICROB AG, V31, P458, DOI 10.1016/j.ijantimicag.2007.12.015; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365	36	48	48	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6656	10.1371/journal.pone.0006656	http://dx.doi.org/10.1371/journal.pone.0006656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684858	Green Published, Green Submitted, gold			2022-12-25	WOS:000269075600005
J	Schutte, M; Thullier, P; Pelat, T; Wezler, X; Rosenstock, P; Hinz, D; Kirsch, MI; Hasenberg, M; Frank, R; Schirrmann, T; Gunzer, M; Hust, M; Dubel, S				Schuette, Mark; Thullier, Philippe; Pelat, Thibaut; Wezler, Xenia; Rosenstock, Philip; Hinz, Dominik; Kirsch, Martina Inga; Hasenberg, Mike; Frank, Ronald; Schirrmann, Thomas; Gunzer, Matthias; Hust, Michael; Duebel, Stefan			Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; INVASIVE FUNGAL-INFECTIONS; PHAGE DISPLAY; HIGH-AFFINITY; BACILLUS-ANTHRACIS; SPOT-SYNTHESIS; DIAGNOSIS; GALACTOMANNAN; EPIDEMIOLOGY; CONSTRUCTION	Background: Aspergillus fumigatus is a common airborne fungal pathogen for humans. It frequently causes an invasive aspergillosis (IA) in immunocompromised patients with poor prognosis. Potent antifungal drugs are very expensive and cause serious adverse effects. Their correct application requires an early and specific diagnosis of IA, which is still not properly achievable. This work aims to a specific detection of A. fumigatus by immunofluorescence and the generation of recombinant antibodies for the detection of A. fumigatus by ELISA. Results: The A. fumigatus antigen Crf2 was isolated from a human patient with proven IA. It is a novel variant of a group of surface proteins (Crf1, Asp f9, Asp f16) which belong to the glycosylhydrolase family. Single chain fragment variables (scFvs) were obtained by phage display from a human naive antibody gene library and an immune antibody gene library generated from a macaque immunized with recombinant Crf2. Two different selection strategies were performed and shown to influence the selection of scFvs recognizing the Crf2 antigen in its native conformation. Using these antibodies, Crf2 was localized in growing hyphae of A. fumigatus but not in spores. In addition, the antibodies allowed differentiation between A. fumigatus and related Aspergillus species or Candida albicans by immunofluorescence microscopy. The scFv antibody clones were further characterized for their affinity, the nature of their epitope, their serum stability and their detection limit of Crf2 in human serum. Conclusion: Crf2 and the corresponding recombinant antibodies offer a novel approach for the early diagnostics of IA caused by A. fumigatus.	[Schuette, Mark; Wezler, Xenia; Rosenstock, Philip; Hinz, Dominik; Kirsch, Martina Inga; Schirrmann, Thomas; Hust, Michael; Duebel, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-3300 Braunschweig, Germany; [Thullier, Philippe; Pelat, Thibaut] Serv Sante Armees, Ctr Rech, Dept Biol Agents Transmissibles, Grp Biotechnol Anticorps, La Tronche, France; [Hasenberg, Mike; Gunzer, Matthias] Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, D-39016 Magdeburg, Germany; [Frank, Ronald] Helmholtz Ctr Infect Res, Braunschweig, Germany	Braunschweig University of Technology; Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research	Schutte, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-3300 Braunschweig, Germany.	s.dubel@tu-bs.de	Gunzer, Matthias/AAW-7026-2021	Gunzer, Matthias/0000-0002-5534-6055; Pelat, thibaut/0000-0003-4312-1032; Hust, Michael/0000-0003-3418-6045; Dubel, Stefan/0000-0001-8811-7390	Land Niedersachsen; German ministry of education and research (BMBF); European Commission	Land Niedersachsen; German ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We gratefully acknowledge the financial support by the Land Niedersachsen, the German ministry of education and research (BMBF, SMP "Antibody Factory'' in the NGFN2 program) and the European Commission ("Proteome Binders'' program). The funders in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo J, 2007, YEAST, V24, P289, DOI 10.1002/yea.1480; Banerjee B, 2001, CLIN EXP ALLERGY, V31, P761, DOI 10.1046/j.1365-2222.2001.01076.x; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bowyer P, 2007, MED MYCOL, V45, P17, DOI 10.1080/13693780600972907; Bozza S, 2002, MICROBES INFECT, V4, P1281, DOI 10.1016/S1286-4579(02)00007-2; Bruneau JM, 2001, ELECTROPHORESIS, V22, P2812, DOI 10.1002/1522-2683(200108)22:13&lt;2812::AID-ELPS2812&gt;3.0.CO;2-Q; Chowdhury PS, 1998, P NATL ACAD SCI USA, V95, P669, DOI 10.1073/pnas.95.2.669; Cloutier SM, 2000, MOL IMMUNOL, V37, P1067, DOI 10.1016/S0161-5890(01)00023-2; Cordonnier C, 2005, MED MYCOL, V43, pS243, DOI 10.1080/13693780400020022; Crameri R, 2001, INT ARCH ALLERGY IMM, V124, P43, DOI 10.1159/000053664; Denikus N, 2005, INFECT IMMUN, V73, P4704, DOI 10.1128/IAI.73.8.4704-4713.2005; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Diederich S, 1998, EUR RADIOL, V8, P306, DOI 10.1007/s003300050386; Dona MG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-25; Fenelon LE, 1999, J CLIN MICROBIOL, V37, P1221, DOI 10.1128/JCM.37.4.1221-1223.1999; Florent M, 2006, J INFECT DIS, V193, P741, DOI 10.1086/500466; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; FRANK R, 2005, PROTEIN PROTEIN INTE, P591; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Hachem RY, 2009, J CLIN MICROBIOL, V47, P129, DOI 10.1128/JCM.00506-08; HIDALGO A, EUR J RADIO IN PRESS; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Howard SJ, 2006, INT J ANTIMICROB AG, V28, P450, DOI 10.1016/j.ijantimicag.2006.08.017; Hust M, 2004, TRENDS BIOTECHNOL, V22, P8, DOI 10.1016/j.tibtech.2003.10.011; Hust M, 2007, HDB THERAPEUTIC ANTI; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Ikemoto H, 2000, INTERNAL MED, V39, P191, DOI 10.2169/internalmedicine.39.191; Kanu A, 2008, PEDIATR PULM, V43, P1249, DOI 10.1002/ppul.20907; Kawazu M, 2004, J CLIN MICROBIOL, V42, P2733, DOI 10.1128/JCM.42.6.2733-2741.2004; Kirsch MI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-66; Kodzius R, 2003, COMB CHEM HIGH T SCR, V6, P147, DOI 10.2174/1386207033329751; Krauss J, 2003, PROTEIN ENG, V16, P753, DOI 10.1093/protein/gzg096; Laffly E, 2005, ANTIMICROB AGENTS CH, V49, P3414, DOI 10.1128/AAC.49.8.3414-3420.2005; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Loset GA, 2005, J IMMUNOL METHODS, V299, P47, DOI 10.1016/j.jim.2005.01.014; Lundquist R, 2006, INFECT IMMUN, V74, P3222, DOI 10.1128/IAI.00928-05; Mabey JE, 2004, NUCLEIC ACIDS RES, V32, pD401, DOI 10.1093/nar/gkh009; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; Maschmeyer G, 2007, DRUGS, V67, P1567, DOI 10.2165/00003495-200767110-00004; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Nadkarni T, 2005, J Postgrad Med, V51 Suppl 1, pS37; Nepomuceno IB, 1999, CHEST, V115, P364, DOI 10.1378/chest.115.2.364; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Ramadan G, 2005, CLIN EXP IMMUNOL, V139, P257, DOI 10.1111/j.1365-2249.2005.02699.x; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Ruping MJGT, 2008, DRUGS, V68, P1941, DOI 10.2165/00003495-200868140-00002; Sambrook J, 2001, MOL CLONING LAB MANU; Sanglard D, 2002, CURR OPIN MICROBIOL, V5, P379, DOI 10.1016/S1369-5274(02)00344-2; Skov M, 2002, ALLERGY, V57, P723, DOI 10.1034/j.1398-9995.2002.23583.x; Slobbe L, 2008, CLIN INFECT DIS, V47, P1507, DOI 10.1086/591531; STAIB F, 1980, ZBL BAKT-INT J MED M, V247, P530, DOI 10.1016/S0172-5599(80)80059-9; Thie H, 2008, CURR PHARM BIOTECHNO, V9, P439, DOI 10.2174/138920108786786349; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Van Campenhout H, 2008, CLIN DRUG INVEST, V28, P509, DOI 10.2165/00044011-200828080-00006; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0	62	51	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6625	10.1371/journal.pone.0006625	http://dx.doi.org/10.1371/journal.pone.0006625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675673	gold, Green Published, Green Submitted			2022-12-25	WOS:000268936100005
J	Jafar-Mohammadi, B; Groves, CJ; Owen, KR; Frayling, TM; Hattersley, AT; McCarthy, MI; Gloyn, AL				Jafar-Mohammadi, Bahram; Groves, Christopher J.; Owen, Katharine R.; Frayling, Timothy M.; Hattersley, Andrew T.; McCarthy, Mark I.; Gloyn, Anna L.			Low Frequency Variants in the Exons Only Encoding Isoform A of HNF1A Do Not Contribute to Susceptibility to Type 2 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIATION; HNF1-ALPHA GENE; RISK LOCI; OJI-CREE; ONSET; REPLICATION; POPULATION; YOUNG; MUTATIONS	Background: There is considerable interest in the hypothesis that low frequency, intermediate penetrance variants contribute to the proportion of Type 2 Diabetes (T2D) susceptibility not attributable to the common variants uncovered through genome-wide association approaches. Genes previously implicated in monogenic and multifactorial forms of diabetes are obvious candidates in this respect. In this study, we focussed on exons 8-10 of the HNF1A gene since rare, penetrant mutations in these exons (which are only transcribed in selected HNF1A isoforms) are associated with a later age of diagnosis of Maturity onset diabetes of the young (MODY) than mutations in exons 1-7. The age of diagnosis in the subgroup of HNF1A-MODY individuals with exon 8-10 mutations overlaps with that of early multifactorial T2D, and we set out to test the hypothesis that these exons might also harbour low-frequency coding variants of intermediate penetrance that contribute to risk of multifactorial T2D. Methodology and Principal Findings: We performed targeted capillary resequencing of HNF1A exons 8-10 in 591 European T2D subjects enriched for genetic aetiology on the basis of an early age of diagnosis (<= 45 years) and/or family history of T2D (>= 1 affected sibling). PCR products were sequenced and compared to the published HNF1A sequence. We identified several variants (rs735396 [IVS9224T > C], rs1169304 [IVS8+29T > C], c.1768+44C > T [IVS9+44C > T] and rs61953349 [c.1545G > A, p.T515T] but no novel non-synonymous coding variants were detected. Conclusions and Significance: We conclude that low frequency, nonsynonymous coding variants in the terminal exons of HNF1A are unlikely to contribute to T2D-susceptibility in European samples. Nevertheless, the rationale for seeking low-frequency causal variants in genes known to contain rare, penetrant mutations remains strong and should motivate efforts to screen other genes in a similar fashion.	[Jafar-Mohammadi, Bahram; Groves, Christopher J.; Owen, Katharine R.; McCarthy, Mark I.; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Jafar-Mohammadi, Bahram; Owen, Katharine R.; McCarthy, Mark I.; Gloyn, Anna L.] Churchill Hosp, Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Frayling, Timothy M.; Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; University of Exeter; University of Oxford; Wellcome Centre for Human Genetics	Jafar-Mohammadi, B (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	anna.gloyn@drl.ox.ac.uk	; McCarthy, Mark/M-3763-2015	Gloyn, Anna/0000-0003-1205-1844; Hattersley, Andrew/0000-0001-5620-473X; McCarthy, Mark/0000-0002-4393-0510	Oxford; Medical Research Council (MRC) [G0601261, 81696, G0000934]; Wellcome Trust [068545/Z/02]; Diabetes UK; MRC [G0000934, G0700222, G0601261] Funding Source: UKRI; Medical Research Council [G0700222, G0601261, G0000934] Funding Source: researchfish; National Institute for Health Research [DHCS/07/07/008] Funding Source: researchfish	Oxford; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded in Oxford by the NIHR Oxford Biomedical Research Centre Programme and the Medical Research Council (MRC) award G0601261. BJM is a Diabetes UK Clinical Training Fellow, KRO is an NIHR Clinician Scientist, ALG is an MRC New Investigator (Grant Reference 81696). The British 1958 Birth Cohort was funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Diabetes UK funded the Warren 2 resource utilised in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Bellanne-Chantelot C, 2005, DIABETES, V54, P3126, DOI 10.2337/diabetes.54.11.3126; Bingley PJ, 1997, DIABETES, V46, P1701, DOI 10.2337/diabetes.46.11.1701; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Ellard S, 2009, GENET TEST MOL BIOMA, V13, P381, DOI 10.1089/gtmb.2008.0096; Frayling TM, 2001, DIABETES, V50, pS94, DOI 10.2337/diabetes.50.2007.S94; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Harries LW, 2006, HUM MOL GENET, V15, P2216, DOI 10.1093/hmg/ddl147; Hegele RA, 1999, J CLIN ENDOCR METAB, V84, P1077, DOI 10.1210/jc.84.3.1077; Hugot JP, 2006, ANN NY ACAD SCI, V1072, P9, DOI 10.1196/annals.1326.011; LANGO H, 2008, DIABETES; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Triggs-Raine BL, 2002, P NATL ACAD SCI USA, V99, P4614, DOI 10.1073/pnas.062059799; Weedon MN, 2005, DIABETES, V54, P2487, DOI 10.2337/diabetes.54.8.2487; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Winckler W, 2005, DIABETES, V54, P2336, DOI 10.2337/diabetes.54.8.2336; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6615	10.1371/journal.pone.0006615	http://dx.doi.org/10.1371/journal.pone.0006615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672314	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935900024
J	Dasgupta, S; Yung, RC; Westra, WH; Rini, DA; Brandes, J; Sidransky, D				Dasgupta, Santanu; Yung, Rex C.; Westra, William H.; Rini, David A.; Brandes, Johann; Sidransky, David			Following Mitochondrial Footprints through a Long Mucosal Path to Lung Cancer	PLOS ONE			English	Article							DNA MUTATIONS; EPITHELIUM; INCREASE; CELLS; P53	Background: Mitochondrial DNA (mtDNA) mutations are reported in different tumors. However, there is no information on the temporal development of the mtDNA mutations/content alteration and their extent in normal and abnormal mucosa continuously exposed to tobacco smoke in lung cancer patients. Methodology: We examined the pattern of mtDNA alteration (mtDNA mutation and content index) in 25 airway mucosal biopsies, corresponding tumors and normal lymph nodes obtained from three patients with primary lung cancers. In addition, we examined the pattern of mtDNA mutation in corresponding tumors and normal lymph nodes obtained from eight other patients with primary lung cancers. The entire 16.5 kb mitochondrial genome was sequenced on Affymetrix Mitochip v2.0 sequencing platform in every sample. To examine mtDNA content index, we performed real-time PCR analysis. Principal Findings: The airway mucosal biopsies obtained from three lung cancer patients were histopathologically negative but exhibited multiple clonal mtDNA mutations detectable in the corresponding tumors. One of the patients was operated twice for the removal of tumor from the right upper and left lower lobe respectively within a span of two years. Both of these tumors exhibited twenty identical mtDNA mutations. MtDNA content increased significantly (P<0.001) in the lung cancer and all the histologically negative mucosal biopsies except one compared to the control lymph node. Conclusions/Significance:: Our results document the extent of massive clonal patches that develop in lifetime smokers and ultimately give rise to clinically significant cancers. These observations shed light on the extent of disease in the airway of smokers traceable through mtDNA mutation. MtDNA mutation could be a reliable tool for molecular assessment of respiratory epithelium exposed to continuous smoke as well as disease detection and monitoring. Functional analysis of the pathogenic mtDNA mutations may be useful to understand their role in lung tumorigenesis.			Dasgupta, S (corresponding author), Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21218 USA.	dsidrans@jhmi.edu		Brandes, Johann/0000-0002-1815-8311	NCI NIH HHS [UO1CA084986, U01 CA084986] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084986] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Franklin WA, 1997, J CLIN INVEST, V100, P2133, DOI 10.1172/JCI119748; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gochhait S, 2008, INT J CANCER, V123, P2580, DOI 10.1002/ijc.23817; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jakupciak JP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-285; Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147; Jones JB, 2001, CANCER RES, V61, P1299; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Mao L, 1997, J NATL CANCER I, V89, P857, DOI 10.1093/jnci/89.12.857; Maragh S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-7; Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Sui GP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-73; Suzuki M, 2003, CLIN CANCER RES, V9, P5636; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wistuba II, 1997, JNCI-J NATL CANCER I, V89, P1366, DOI 10.1093/jnci/89.18.1366; Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008; ZHUO S, 2007, P NATL ACAD SCI USA, V104, P7540	26	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6533	10.1371/journal.pone.0006533	http://dx.doi.org/10.1371/journal.pone.0006533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657397	Green Published, gold, Green Submitted			2022-12-25	WOS:000268739300004
J	Guzman, B; Lledo, MD; Vargas, P				Guzman, Beatriz; Lledo, Maria Dolores; Vargas, Pablo			Adaptive Radiation in Mediterranean Cistus (Cistaceae)	PLOS ONE			English	Article							CHARACTER EVOLUTION; MOLECULAR EVIDENCE; DIVERGENCE TIMES; DNA-SEQUENCES; LEAF SIZE; CHLOROPLAST; BIOGEOGRAPHY; RATES; DIVERSIFICATION; AMPLIFICATION	Background: Adaptive radiation in Mediterranean plants is poorly understood. The white-flowered Cistus lineage consists of 12 species primarily distributed in Mediterranean habitats and is herein subject to analysis. Methodology/Principal Findings: We conducted a "total evidence" analysis combining nuclear (ncpGS, ITS) and plastid (trnL-trnF, trnK-matK, trnS-trnG, rbcL) DNA sequences and using MP and BI to test the hypothesis of radiation as suggested by previous phylogenetic results. One of the five well-supported lineages of the Cistus-Halimium complex, the white-flowered Cistus lineage, comprises the higher number of species (12) and is monophyletic. Molecular dating estimates a Mid Pleistocene (1.04+/-0.25 Ma) diversification of the white-flowered lineage into two groups (C. clusii and C. salviifolius lineages), which display asymmetric characteristics: number of species (2 vs. 10), leaf morphologies (linear vs. linear to ovate), floral characteristics (small, three-sepalled vs. small to large, three- or five-sepalled flowers) and ecological attributes (low-land vs. low-land to mountain environments). A positive phenotype-environment correlation has been detected by historical reconstructions of morphological traits (leaf shape, leaf labdanum content and leaf pubescence). Ecological evidence indicates that modifications of leaf shape and size, coupled with differences in labdanum secretion and pubescence density, appear to be related to success of new species in different Mediterranean habitats. Conclusions/Significance: The observation that radiation in the Cistus salviifolius lineage has been accompanied by the emergence of divergent leaf traits (such as shape, pubescence and labdanum secretion) in different environments suggets that radiation in the group has been adaptive. Here we argued that the diverse ecological conditions of Mediterranean habitats played a key role in directing the evolution of alternative leaf strategies in this plant group. Key innovation of morphological characteristics is supported by our dated phylogeny, in which a Mediterranean climate establishment (2.8 Ma) predated the adaptive radiation of the white- flowered Cistus.			Guzman, B (corresponding author), CSIC, Real Jardin Botan, Madrid, Spain.	bguzmanasenjo@gmail.com						Ackerly DD, 2004, AM NAT, V163, P654, DOI 10.1086/383062; Ackerly DD, 2002, OECOLOGIA, V130, P449, DOI 10.1007/s004420100805; Arrington JM, 2003, FA GE VAS P, V5, P62; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baldwin B. G., 1998, MOL SYSTEMATICS PLAN, P410, DOI DOI 10.1007/978-1-4615-5419-6_14; BALDWIN BG, 1995, HAWAIIAN BIOGEOGRAPH, P257; Bell CD, 2005, ORG DIVERS EVOL, V5, P147, DOI 10.1016/j.ode.2004.10.014; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CUNNINGHAM GL, 1969, ECOLOGY, V50, P400, DOI 10.2307/1933890; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; DAGET P, 1977, VEGETATIO, V34, P1, DOI 10.1007/BF00119883; DANSEREAU P, 1958, C R SEANCES SOC BIOG, V304, P22; Demoly J.P., 1993, FLORA IB RICA, V3, P319; Ehleringer JR., 1988, PLANT EVOLUTIONARY B, P221; Emshwiller E, 1999, MOL PHYLOGENET EVOL, V12, P310, DOI 10.1006/mpev.1999.0613; Endler J.A., 1986, Monographs in Population Biology, pviii; ERIKSSON O, 1992, EVOLUTION, V46, P258, DOI [10.2307/2409820, 10.1111/j.1558-5646.1992.tb02000.x]; GATES DM, 1968, SCIENCE, V159, P994, DOI 10.1126/science.159.3818.994; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Givnish T., 1979, Topics in plant population biology., P375; Givnish T. J., 1984, Physiological ecology of plants in the wet tropics. Proceedings of an international symposium held in Oxatepec and Los Tuxtlas, Mexico, June 29 to July 6, 1983, P51; Givnish Thomas J., 1995, P288; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; GIVNISH TJ, 1976, AM NAT, V110, P743, DOI 10.1086/283101; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; GIVNISH TJ, 1987, NEW PHYTOL, V106, P131, DOI 10.1111/j.1469-8137.1987.tb04687.x; Greuter Werner, 1996, Taxon, V45, P715, DOI 10.2307/1224270; GROSSER W, 1903, PFLANZENREICH; Gulz PG, 1996, FLORA, V191, P85; Guzman B, 2005, MOL PHYLOGENET EVOL, V37, P644, DOI 10.1016/j.ympev.2005.04.026; GUZMAN B, 2008, THESIS U COMPLUTENSE; Guzman B, 2009, ORG DIVERS EVOL, V9, P83, DOI 10.1016/j.ode.2009.01.001; Guzman B, 2009, J BIOGEOGR, V36, P954, DOI 10.1111/j.1365-2699.2008.02040.x; Hamilton MB, 1999, MOL ECOL, V8, P521; HERRERA CM, 1992, AM NAT, V140, P421, DOI 10.1086/285420; Hodges Scott A., 1997, P391; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KENDALL DG, 1949, J R STAT SOC B, V11, P230; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Lowrey Timothy K., 1995, P195; MAC ARTHUR ROBERT H., 1967; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Meimberg H, 2006, MOL PHYLOGENET EVOL, V41, P566, DOI 10.1016/j.ympev.2006.05.037; MENKE B, 1976, GEOL JB A, V32, P3; MOONEY HA, 1970, AM NAT, V104, P447, DOI 10.1086/282679; MORAN PA, 2000, J R STAT SOC B, V13, P141; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; NAHAL I, 1981, ECOSYSTEMS WORLD, V11, P63; NAUD G, 1975, B SOC GEOL FR, V17, P820; NunezOlivera E, 1996, FUNCT ECOL, V10, P636, DOI 10.2307/2390174; Nylander J.A.A., 2002, MRMODELTEST V1 0B; PAGEL M, 2007, BAYES TRAITS VERSION; PARKHURST DF, 1972, J ECOL, V60, P505, DOI 10.2307/2258359; Pausas JG, 2005, OIKOS, V109, P196, DOI 10.1111/j.0030-1299.2005.13596.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Read J, 2003, NEW PHYTOL, V160, P81, DOI 10.1046/j.1469-8137.2003.00855.x; Reinthal Peter N., 1997, P375; ROBICHAUX RH, 1990, ANN MO BOT GARD, V77, P64, DOI 10.2307/2399626; Ruber L, 2003, EVOLUTION, V57, P1584; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Save R, 2000, BIOL PLANTARUM, V43, P239, DOI 10.1023/A:1002704327076; Savolainen V, 2000, SYST BIOL, V49, P306, DOI 10.1093/sysbio/49.2.306; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Suc Jean-Pierre, 1995, Acta Zoologica Cracoviensia, V38, P3; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; SZWARCBAUM I, 1982, PLANT SCI LETT, V26, P47, DOI 10.1016/0304-4211(82)90041-4; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verboom GA, 2004, AM J BOT, V91, P1364, DOI 10.3732/ajb.91.9.1364; Warburg E.F., 1968, FLORA EUROPAEA, V2, P282; White T., 1990, PCR PROTOCOLS GUIDE, P315; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; [No title captured]	79	68	71	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6362	10.1371/journal.pone.0006362	http://dx.doi.org/10.1371/journal.pone.0006362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19668338	Green Published, gold, Green Submitted			2022-12-25	WOS:000268260200008
J	Choi, Y; Seeliger, MA; Panjarian, SB; Kim, H; Deng, X; Sim, T; Couch, B; Koleske, AJ; Smithgall, TE; Gray, NS				Choi, Yongmun; Seeliger, Markus A.; Panjarian, Shoghag B.; Kim, Hakjoong; Deng, Xianming; Sim, Taebo; Couch, Brian; Koleske, Anthony J.; Smithgall, Thomas E.; Gray, Nathanael S.			N-Myristoylated c-Abl Tyrosine Kinase Localizes to the Endoplasmic Reticulum upon Binding to an Allosteric Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; BCR-ABL; GENE-PRODUCT; PROTEIN; ACTIN; PROLIFERATION; TRANSLOCATION; ACTIVATION; EXPRESSION; LEUKEMIA	Allosteric kinase inhibitors hold promise for revealing unique features of kinases that may not be apparent using conventional ATP-competitive inhibitors. Here we explore the activity of a previously reported allosteric inhibitor of BCR-Abl kinase, GNF-2, against two cellular isoforms of Abl tyrosine kinase: one that carries a myristate in the N terminus and the other that is deficient in N-myristoylation. Our results show that GNF-2 inhibits the kinase activity of non-myristoylated c-Abl more potently than that of myristoylated c-Abl by binding to the myristate-binding pocket in the C-lobe of the kinase domain. Unexpectedly, indirect immunofluorescence reveals a translocation of myristoylated c-Abl to the endoplasmic reticulum in GNF-2-treated cells, whereas GNF-2 has no detectable effect on the localization of non-myristoylated c-Abl. These results indicate that GNF-2 competes with the NH2-terminal myristate for binding to the c-Abl kinase myristate-binding pocket and that the exposed myristoyl group accounts for the localization to the endoplasmic reticulum. We also demonstrate that GNF-2 can inhibit enzymatic and cellular kinase activity of Arg, a kinase highly homologous to c-Abl, which is also likely to be regulated through intramolecular binding of an NH2-terminal myristate lipid. These results suggest that non-ATP-competitive inhibitors, such as GNF-2, can serve as chemical tools that can discriminate between c-Abl isoform-specific behaviors.	[Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Choi, Yongmun; Deng, Xianming; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Seeliger, Markus A.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Seeliger, Markus A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Panjarian, Shoghag B.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Couch, Brian; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University	Gray, NS (corresponding author), AGM 628A,250 Longwood Ave, Boston, MA 02115 USA.	nathanael_gray@dfci.harvard.edu	Kim, Hak/AAI-5399-2020; Seeliger, Markus A/D-6409-2013	Kim, Hak/0000-0002-9265-9181; Seeliger, Markus/0000-0003-0990-1756; Deng, Xianming/0000-0002-9354-5864	National Institutes of Health [R01 CA130876-01A1, NS39475, MH77306, R01 CA101828]; Novartis Institute of Biomedical Research; NATIONAL CANCER INSTITUTE [R01CA101828, R01CA130876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH077306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institute of Biomedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA130876-01A1; NS39475 and MH77306 (to A. J. K.); and R01 CA101828 (to T. E. S.). This work was also supported by the Novartis Institute of Biomedical Research (to N. S. G.).	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; FOULKES JG, 1985, J BIOL CHEM, V260, P8070; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Ito Y, 2001, MOL CELL BIOL, V21, P6233, DOI 10.1128/MCB.21.18.6233-6242.2001; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Zhou V, 2009, ANAL BIOCHEM, V385, P300, DOI 10.1016/j.ab.2008.11.015	31	42	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29005	29014		10.1074/jbc.M109.026633	http://dx.doi.org/10.1074/jbc.M109.026633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679652	hybrid, Green Published			2022-12-25	WOS:000270678900058
J	Solyakov, L; Sayan, E; Riley, J; Pointon, A; Tobin, AB				Solyakov, L.; Sayan, E.; Riley, J.; Pointon, A.; Tobin, A. B.			Regulation of p53 expression, phosphorylation and subcellular localization by a G-protein-coupled receptor	ONCOGENE			English	Article						apoptosis; p53; G-protein-coupled receptor; M-3-muscarinic; mitochondria; SH-SY5Y	DAMAGE-INDUCED PHOSPHORYLATION; DNA-DAMAGE; INDUCED APOPTOSIS; CELL-DEATH; M-3-MUSCARINIC RECEPTOR; RHO-KINASE; IN-VIVO; ACTIVATION; MITOCHONDRIA; CANCER	G-protein-coupled receptors (GPCRs) have been extremely successful drug targets for a multitude of diseases from heart failure to depression. This superfamily of cell surface receptors have not, however, been widely considered as a viable target in cancer treatment. In this study we show that a classical G(q/11)-coupled GPCR, the M-3-muscarinic receptor, was able to regulate apoptosis through receptors that are endogenously expressed in the human neuroblastoma cell line, SH-SY5Y, and when ectopically expressed in Chinese hamster ovary (CHO) cells. Stimulation of the M-3-muscarinic receptor was shown to inhibit the ability of the DNA-damaging chemotherapeutic agent, etoposide, from mediating apoptosis. This protective response in CHO cells correlated with the ability of the receptor to regulate the expression levels of p53. In contrast, stimulation of endogenous muscarinic receptors in SH-SY5Y cells did not regulate p53 expression but rather was able to inhibit p53 translocation to the mitochondria and p53 phosphorylation at serine 15 and 37. This study suggests the possibility that a GPCR can regulate the apoptotic properties of a chemotherapeutic DNA-damaging agent by regulating the expression, subcellular traf. cking and modi. cation of p53 in a manner that is, in part, dependent on the cell type. Oncogene (2009) 28, 3619-3630; doi:10.1038/onc.2009.225; published online 3 August 2009	[Solyakov, L.; Tobin, A. B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Sayan, E.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 9HN, Leics, England; [Riley, J.; Pointon, A.] MRC Toxicol Unit, Leicester, Leics, England	University of Leicester; University of Leicester	Tobin, AB (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	tba@le.ac.uk	SAYAN, A. EMRE/H-7330-2012	SAYAN, A. EMRE/0000-0002-5291-1485	Wellcome Trust [073480, 047600]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the Wellcome Trust for their support (Grants 073480 and 047600).	Bean LJH, 2001, ONCOGENE, V20, P1076, DOI 10.1038/sj.onc.1204204; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Budd DC, 2004, BIOCHEM J, V381, P43, DOI 10.1042/BJ20031705; Budd DC, 2003, J BIOL CHEM, V278, P19565, DOI 10.1074/jbc.M211670200; Chao C, 2000, P NATL ACAD SCI USA, V97, P11936, DOI 10.1073/pnas.220252297; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; Chitaley K, 2001, NAT MED, V7, P119, DOI 10.1038/83258; Courtois S, 2004, ONCOGENE, V23, P631, DOI 10.1038/sj.onc.1206929; Cui HJ, 2002, MOL CANCER THER, V1, P679; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; De Sarno L, 2005, BRAIN RES, V1041, P112, DOI 10.1016/j.brainres.2005.01.081; De Sarno P, 2003, J BIOL CHEM, V278, P11086, DOI 10.1074/jbc.M212157200; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Diao CTM, 2000, BBA-MOL CELL RES, V1499, P49, DOI 10.1016/S0167-4889(00)00107-5; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Haupt S, 2006, ANTI-CANCER DRUG, V17, P725, DOI 10.1097/01.cad.0000217422.52208.fa; Hu T, 1999, MUTAT RES-FUND MOL M, V426, P51, DOI 10.1016/S0027-5107(99)00077-9; Kakudo Y, 2005, CANCER RES, V65, P2108, DOI 10.1158/0008-5472.CAN-04-2935; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; KOH JY, 1991, P NATL ACAD SCI USA, V88, P9431, DOI 10.1073/pnas.88.21.9431; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kwon YG, 2001, J BIOL CHEM, V276, P10627, DOI 10.1074/jbc.M011449200; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Murph MM, 2007, MOL CANCER RES, V5, P1201, DOI 10.1158/1541-7786.MCR-06-0338; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nemajerova A, 2005, CELL DEATH DIFFER, V12, P197, DOI 10.1038/sj.cdd.4401526; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Park BS, 2005, APOPTOSIS, V10, P193, DOI 10.1007/s10495-005-6074-7; Paulsen MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-25; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sayan BS, 2006, J BIOL CHEM, V281, P13566, DOI 10.1074/jbc.M512467200; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Song P, 2007, CANCER RES, V67, P3936, DOI 10.1158/0008-5472.CAN-06-2484; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tobin AB, 2003, BIOCHEM SOC T, V31, P1182; ULLRICH SJ, 1992, ONCOGENE, V7, P1635; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; van Koppen CJ, 2003, PHARMACOL THERAPEUT, V98, P197, DOI 10.1016/S0163-7258(03)00032-9; Vichalkovski A, 2005, CELL SIGNAL, V17, P447, DOI 10.1016/j.cellsig.2004.09.010; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; YAN GM, 1995, MOL PHARMACOL, V47, P248; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	62	11	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2009	28	41					3619	3630		10.1038/onc.2009.225	http://dx.doi.org/10.1038/onc.2009.225			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KJ	19648965	Green Accepted			2022-12-25	WOS:000270851800003
J	Bonten, EJ; Campos, Y; Zaitsev, V; Nourse, A; Waddell, B; Lewis, W; Taylor, G; d'Azzo, A				Bonten, Erik J.; Campos, Yvan; Zaitsev, Viateslav; Nourse, Amanda; Waddell, Brett; Lewis, William; Taylor, Garry; d'Azzo, Alessandra			Heterodimerization of the Sialidase NEU1 with the Chaperone Protective Protein/Cathepsin A Prevents Its Premature Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL BETA-GALACTOSIDASE; SIZE-DISTRIBUTION ANALYSIS; NEURAMINIDASE; PROTEIN; BINDING; MODEL; GALACTOSIALIDOSIS; SIALIDOSIS; MEMBRANE; DOMAIN	Lysosomal neuraminidase-1 (NEU1) forms a multienzyme complex with beta-galactosidase and protective protein/cathepsin A (PPCA). Because of its association with PPCA, which acts as a molecular chaperone, NEU1 is transported to the lysosomal compartment, catalytically activated, and stabilized. However, the mode(s) of association between these two proteins both en route to the lysosome and in the multienzyme complex has remained elusive. Here, we have analyzed the hydrodynamic properties of PPCA, NEU1, and a complex of the two proteins and identified multiple binding sites on both proteins. One of these sites on NEU1 that is involved in binding to PPCA can also bind to other NEU1 molecules, albeit with lower affinity. Therefore, in the absence of PPCA, as in the lysosomal storage disease galactosialidosis, NEU1 self-associates into chain-like oligomers. Binding of PPCA can reverse self-association of NEU1 by causing the disassembly of NEU1-oligomers and the formation of a PPCA-NEU1 heterodimeric complex. The identification of binding sites between the two proteins allowed us to create innovative structural models of the NEU1 oligomer and the PPCA-NEU1 heterodimeric complex. The proposed mechanism of interaction between NEU1 and its accessory protein PPCA provides a rationale for the secondary deficiency of NEU1 in galactosialidosis.	[Bonten, Erik J.; Campos, Yvan; d'Azzo, Alessandra] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Nourse, Amanda; Waddell, Brett; Lewis, William] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Zaitsev, Viateslav; Taylor, Garry] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9UA, Fife, Scotland	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of St Andrews	Bonten, EJ (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA.	erik.bonten@stjude.org; alessandra.dazzo@stjude.org	Taylor, Garry/G-3017-2014	Nourse, Amanda/0000-0003-4595-5321	National Institutes of Health [GM60905, DK52025]; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060950, R13GM060905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60905 and DK52025. This work was also supported by the Assisi Foundation of Memphis and the American Lebanese Syrian Associated Charities.	Ando K, 1996, J BIOCHEM-TOKYO, V119, P639; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2000, J BIOL CHEM, V275, P37657, DOI 10.1074/jbc.M007380200; BONTEN EJ, 1995, J BIOL CHEM, V270, P26441, DOI 10.1074/jbc.270.44.26441; Bonten EJ, 2004, FASEB J, V18, P971, DOI 10.1096/fj.03-0941fje; Brown CJ, 2008, S AFR J BUS MANAG, V39, P1; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chaudhury S, 2007, PROTEINS, V69, P793, DOI 10.1002/prot.21731; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; d'Azzo A., 2001, METABOLIC MOL BASES, V3, P3811; de Geest N, 2002, HUM MOL GENET, V11, P1455, DOI 10.1093/hmg/11.12.1455; DOMINGUES RMCP, 1992, ZBL BAKT-INT J MED M, V277, P340, DOI 10.1016/S0934-8840(11)80912-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FISHER KJ, 1991, J BIOL CHEM, V266, P12105; GALJAARD H, 1979, ANN CLIN BIOCHEM, V16, P343, DOI 10.1177/000456327901600192; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; HADDAD EB, 1992, EUR J PHARMACOL, V211, P273, DOI 10.1016/0014-2999(92)90540-K; Harding S. E., 2001, PROTEIN LIGAND INTER; HECHLER V, 1990, MOL CELL BIOCHEM, V93, P87; IGARASHI M, 1990, J IMMUNOL METHODS, V135, P91, DOI 10.1016/0022-1759(90)90260-3; Johansson A, 1999, CANCER RES, V59, P48; KARASUNO T, 1992, EUR J IMMUNOL, V22, P2003, DOI 10.1002/eji.1830220808; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Laune D, 1997, J BIOL CHEM, V272, P30937, DOI 10.1074/jbc.272.49.30937; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Monti E, 2004, GENOMICS, V83, P445, DOI 10.1016/j.ygeno.2003.08.019; NAKAMURA M, 1991, CANCER RES, V51, P1940; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILSSON J, 1982, EXP CELL RES, V142, P333, DOI 10.1016/0014-4827(82)90375-5; OHYASHIKI T, 1987, BIOCHIM BIOPHYS ACTA, V905, P57, DOI 10.1016/0005-2736(87)90008-3; POTIER M, 1990, BIOCHEM J, V267, P197, DOI 10.1042/bj2670197; PURI A, 1992, BIOCHEMISTRY-US, V31, P10108, DOI 10.1021/bi00156a034; Rottier RJ, 1998, HUM MOL GENET, V7, P313, DOI 10.1093/hmg/7.2.313; RUDENKO G, 1995, STRUCTURE, V3, P1249, DOI 10.1016/S0969-2126(01)00260-X; Rudenko G, 1998, P NATL ACAD SCI USA, V95, P621, DOI 10.1073/pnas.95.2.621; Saito M., 1995, BIOL SIALIC ACIDS; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato K, 1996, BIOCHEM BIOPH RES CO, V221, P826, DOI 10.1006/bbrc.1996.0681; SCHEIBE R, 1990, BIOMED BIOCHIM ACTA, V49, P547; SCHENKMAN S, 1994, J BIOL CHEM, V269, P7970; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; STENBERG PE, 1991, J CELL PHYSIOL, V147, P7, DOI 10.1002/jcp.1041470103; Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474; Thomas G.H., METABOLIC MOL BASES, V3, P3507; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; van der Spoel A, 2000, J BIOL CHEM, V275, P10035, DOI 10.1074/jbc.275.14.10035; van der Spoel A, 1998, EMBO J, V17, P1588, DOI 10.1093/emboj/17.6.1588; VANDONGEN JM, 1985, EUR J CELL BIOL, V39, P179; Vinogradova MV, 1998, BIOCHEM J, V330, P641; Wang DN, 2005, MOL GENET METAB, V85, P181, DOI 10.1016/j.ymgme.2005.03.007; Wang D, 2009, BBA-GEN SUBJECTS, V1790, P275, DOI 10.1016/j.bbagen.2009.01.006; WU GS, 1991, J NEUROCHEM, V56, P95, DOI 10.1111/j.1471-4159.1991.tb02567.x; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; YAMAMOTO Y, 1987, INT J BIOCHEM, V19, P435, DOI 10.1016/0020-711X(87)90064-4; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; ZHOU XY, 1995, GENE DEV, V9, P2623, DOI 10.1101/gad.9.21.2623	64	55	56	6	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28430	28441		10.1074/jbc.M109.031419	http://dx.doi.org/10.1074/jbc.M109.031419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666471	Green Published, hybrid			2022-12-25	WOS:000270676300068
J	Park, SY; Choi, JH; Ryu, HS; Pak, YK; Park, KS; Lee, HK; Lee, W				Park, Seung-Yoon; Choi, Jung Hyun; Ryu, Hyun Su; Pak, Youngmi Kim; Park, Kyong Soo; Lee, Hong Kyu; Lee, Wan			C1q Tumor Necrosis Factor alpha-related Protein Isoform 5 Is Increased in Mitochondrial DNA-depleted Myocytes and Activates AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; GLUCOSE-TRANSPORT; INSULIN-RESISTANCE; CONTRACTION; CELLS; GENE; ACRP30/ADIPONECTIN	Depletion of mtDNA in myocytes causes insulin resistance and alters nuclear gene expression that may be involved in rescuing processes against cellular stress. Here we show that the expression of C1q tumor necrosis factor a-related protein isoform 5 (C1QTNF5) is drastically increased following depletion of mtDNA in myocytes. C1QTNF5 is homologous to adiponectin in respect to domain structure, and its expression and secretion from myocytes correlated negatively with the cellular mtDNA content. Similar to adiponectin, C1QTNF5 induced the phosphorylation of AMP-activated protein kinase (AMPK), leading to increased cell surface recruitment of GLUT4 and increased glucose uptake. Treatment of cells with purified recombinant C1QTNF5 increased the phosphorylation of acetyl-CoA carboxylase and stimulated fatty acid oxidation. C1QTNF5-mediated phosphorylation of AMPK or acetyl-CoA carboxylase was unaffected by depletion of adiponectin receptors such as AdipoR1 or AdipoR2, which indicated that adiponectin receptors do not participate in C1QTNF5-induced activation of AMPK. Serum C1QTNF5 levels were significantly higher in obese/diabetic animals (OLETF rats, ob/ob mice, and db/db mice). These results highlight C1QTNF5 as a putative biomarker for mitochondrial dysfunction and a potent activator of AMPK.	[Park, Seung-Yoon; Choi, Jung Hyun; Ryu, Hyun Su; Lee, Wan] Dongguk Univ, Coll Med, Dept Biochem, Kyungju 780714, South Korea; [Pak, Youngmi Kim] Kyung Hee Univ, Dept Nanopharmaceut & Life Sci, Age Related & Brain Dis Res Ctr, Seoul 130701, South Korea; [Park, Kyong Soo; Lee, Hong Kyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea	Dongguk University; Kyung Hee University; Seoul National University (SNU)	Lee, W (corresponding author), Dongguk Univ, Coll Med, Dept Biochem, Kyungju 780714, South Korea.	wanlee@dongguk.ac.kr	Pak, Youngmi Kim/AAI-1091-2020; Park, Kyong Soo/C-2265-2008; Lee, Wan/B-6252-2013	Pak, Youngmi Kim/0000-0001-7424-3484; Park, Kyong Soo/0000-0003-3597-342X; Lee, Wan/0000-0002-5181-2135	Korea Health 21 RD Project [00-PJ3-PG6-GN07-0001]; Korea Healthcare Technology RD Project [A080151]; Ministry of Health and Welfare [MI 08KMOI 0008-08KI 301-00810]; Ministryof Education, Science and Technology, KOSEF, Republic of Korea [M10642140004-06N4214-00410]	Korea Health 21 RD Project; Korea Healthcare Technology RD Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministryof Education, Science and Technology, KOSEF, Republic of Korea(Korea Science and Engineering Foundation)	This work was supported by Grant 00-PJ3-PG6-GN07-0001 of the Korea Health 21 R&D Project (to W. L.) and Grant A080151 of the Korea Healthcare Technology R&D Project (to S. Y. P.) from the Ministry of Health and Welfare, by Grant MI 08KMOI 0008-08KI 301-00810 of 21 C Frontier Functional Proteomics Project from Ministryof Education, Science and Technology (to W.L.), and by Grant M10642140004-06N4214-00410 from KOSEF (to Y. K. P.), Republic of Korea.	Akiyama H, 2006, FEBS J, V273, P2257, DOI 10.1111/j.1742-4658.2006.05240.x; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Fang X, 2005, J MOL ENDOCRINOL, V35, P465, DOI 10.1677/jme.1.01877; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; KANAI F, 1993, J BIOL CHEM, V268, P14523; KAWANO K, 1994, DIABETES RES CLIN PR, V24, pS317, DOI 10.1016/0168-8227(94)90269-0; Kim JY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1014, DOI 10.1152/ajpendo.00233.2001; Kottom TJ, 2004, INFECT IMMUN, V72, P4628, DOI 10.1128/IAI.72.8.4628-4636.2004; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Somwar R, 2002, J BIOL CHEM, V277, P50386, DOI 10.1074/jbc.M205277200; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	30	82	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27780	27789		10.1074/jbc.M109.005611	http://dx.doi.org/10.1074/jbc.M109.005611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19651784	hybrid, Green Published			2022-12-25	WOS:000270676300004
J	Geiss-Friedlander, R; Parmentier, N; Moller, U; Urlaub, H; Van den Eynde, BJ; Melchior, F				Geiss-Friedlander, Ruth; Parmentier, Nicolas; Moeller, Ulrike; Urlaub, Henning; Van den Eynde, Benoit J.; Melchior, Frauke			The Cytoplasmic Peptidase DPP9 Is Rate-limiting for Degradation of Proline-containing Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANTIGEN PRESENTATION; THIMET OLIGOPEPTIDASE; ENDOPLASMIC-RETICULUM; DRUG DISCOVERY; AMINOPEPTIDASE; PROTEASOMES; GENERATION; INHIBITORS; ERAP1	Protein degradation is an essential process that continuously takes place in all living cells. Regulated degradation of most cellular proteins is initiated by proteasomes, which produce peptides of varying length. These peptides are rapidly cleaved to single amino acids by cytoplasmic peptidases. Proline-containing peptides pose a specific problem due to structural constrains imposed by the pyrrolidine ring that prevents most peptidases from cleavage. Here we show that DPP9, a poorly characterized cytoplasmic prolyl-peptidase, is rate-limiting for destruction of proline-containing substrates both in cell extracts and in intact cells. We identified the first natural substrate for DPP9, the RU1(34-42) antigenic peptide (VPYGSFKHV). RU1(34-42) is degraded in vitro by DPP9, and down-regulation of DPP9 in intact cells results in increased presentation of this antigen. Together our findings demonstrate an important role for DPP9 in peptide turnover and antigen presentation.	[Geiss-Friedlander, Ruth; Moeller, Ulrike; Melchior, Frauke] Univ Gottingen, Fac Med, Dept Biochem 1, D-37073 Gottingen, Germany; [Parmentier, Nicolas; Van den Eynde, Benoit J.] Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Parmentier, Nicolas; Van den Eynde, Benoit J.] Univ Catholique Louvain, Cellular Genet Unit, B-1200 Brussels, Belgium; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Melchior, Frauke] Univ Heidelberg, ZMBH, D-69120 Heidelberg, Germany	University of Gottingen; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Max Planck Society; Ruprecht Karls University Heidelberg	Geiss-Friedlander, R (corresponding author), Univ Gottingen, Fac Med, Dept Biochem 1, Humboldtallee 23, D-37073 Gottingen, Germany.	rgeiss@gwdg.de; f.melchior@zmbh.uni-heidelberg.de	Geiss-Friedlander, Ruth/AAT-8768-2020; Melchior, Frauke/E-2014-2014; Geiss-Friedlander, Ruth/G-3569-2013	Geiss-Friedlander, Ruth/0000-0002-1720-3440; Melchior, Frauke/0000-0001-9546-8797; Geiss-Friedlander, Ruth/0000-0002-1720-3440	European Union [LSHC-CT-2006-518234]; Fonds J. Maisin (Belgium); Fondation contre le Cancer (Belgium); Fonds National de la Recherche Scientifique (Belgium)	European Union(European Commission); Fonds J. Maisin (Belgium); Fondation contre le Cancer (Belgium); Fonds National de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the European Union (Rubicon NoE and LSHC-CT-2006-518234), the Fonds J. Maisin (Belgium), and the Fondation contre le Cancer (Belgium).; Supported by a Televie grant from the Fonds National de la Recherche Scientifique (Belgium).	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Connolly BA, 2008, J MED CHEM, V51, P6005, DOI 10.1021/jm800390n; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Daniel S, 1998, J IMMUNOL, V161, P617; DE MI, 2003, ADV EXP MED BIOL, V524, P3; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Levy F, 2002, J IMMUNOL, V169, P4161, DOI 10.4049/jimmunol.169.8.4161; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; McIntosh CHS, 2008, FRONT BIOSCI-LANDMRK, V13, P1753, DOI 10.2741/2797; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; MORTZ E, 1994, BIOL MASS SPECTROM, V23, P249, DOI 10.1002/bms.1200230503; NEISIG A, 1995, J IMMUNOL, V154, P1273; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; Van der Veken P, 2007, CURR TOP MED CHEM, V7, P621, DOI 10.2174/156802607780091046; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; Wu JJ, 2009, BIOCHEM PHARMACOL, V78, P203, DOI 10.1016/j.bcp.2009.03.032; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	44	69	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27211	27219		10.1074/jbc.M109.041871	http://dx.doi.org/10.1074/jbc.M109.041871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19667070	hybrid, Green Published			2022-12-25	WOS:000270232300021
J	Esper, RM; Loeb, JA				Esper, Raymond M.; Loeb, Jeffrey A.			Neurotrophins Induce Neuregulin Release through Protein Kinase C delta Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PERIPHERAL NERVOUS-SYSTEM; ACETYLCHOLINE-RECEPTOR SYNTHESIS; NEU DIFFERENTIATION FACTOR; NECROSIS-FACTOR-ALPHA; GLIAL GROWTH-FACTOR; PKC-DELTA; IN-VIVO; MULTIPLE-SCLEROSIS; CANCER-CELLS	Proper, graded communication between different cell types is essential for normal development and function. In the nervous system, heart, and for some cancer cells, part of this communication requires signaling by soluble and membrane-bound factors produced by the NRG1 gene. We have previously shown that glial-derived neurotrophic factors activate a rapid, localized release of soluble neuregulin from neuronal axons that can, in turn promote proper axoglial development (Esper, R. M., and Loeb, J. A. (2004) J. Neurosci. 24, 6218-6227). Here we elucidate the mechanism of this localized, regulated release by implicating the delta isoform of protein kinase C (PKC). Blocking the PKC delta isoform with either rottlerin, a selective antagonist, or small interference RNA blocks the regulated release of neuregulin from both transfected cells and primary neuronal cultures. PKC activation also leads to the rapid phosphorylation of the pro-NRG1 cytoplasmic tail on serine residues adjacent to the membrane-spanning segment, that, when mutated markedly reduce the rate of NRG1 activity release. These findings implicate this specific PKC isoform as an important factor for the cleavage and neurotrophin-regulated release of soluble NRG1 forms that have important effects in nervous system development and disease.	[Loeb, Jeffrey A.] Wayne State Univ, Dept Neurol, Detroit, MI 48201 USA; [Esper, Raymond M.; Loeb, Jeffrey A.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Loeb, JA (corresponding author), Wayne State Univ, Dept Neurol, Elliman 3122,421 E Canfield Ave, Detroit, MI 48201 USA.	jloeb@med.wayne.edu			National Multiple Sclerosis Society [RG-3410-A-2, RG-3410B3]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by National Multiple Sclerosis Society Grants RG-3410-A-2 and RG-3410B3 (to J.A.L.).	Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; ARIS JP, 1993, BIOCHIM BIOPHYS ACTA, V1174, P171, DOI 10.1016/0167-4781(93)90111-P; ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; Atlas E, 2003, MOL CANCER RES, V1, P165; BANKER G, 1998, CULTURING NERVE CELL; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Cannella B, 1998, P NATL ACAD SCI USA, V95, P10100, DOI 10.1073/pnas.95.17.10100; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Corbit KC, 1999, MOL CELL BIOL, V19, P4209; CORFAS G, 1993, P NATL ACAD SCI USA, V90, P1624, DOI 10.1073/pnas.90.4.1624; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Ernfors P, 2001, CELL MOL LIFE SCI, V58, P1036, DOI 10.1007/PL00000918; Esper RM, 2006, BRAIN RES REV, V51, P161, DOI 10.1016/j.brainresrev.2005.11.006; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Farinas I, 1999, MICROSC RES TECHNIQ, V45, P233, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<233::AID-JEMT7>3.0.CO;2-Y; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gilmour LMR, 2002, CLIN CANCER RES, V8, P3933; Goekjian PG, 1999, CURR MED CHEM, V6, P877; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Han B, 1999, J BIOL CHEM, V274, P26407, DOI 10.1074/jbc.274.37.26407; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; Hinkle CL, 2003, BIOCHEMISTRY-US, V42, P2127, DOI 10.1021/bi026709v; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Ishiguro H, 1998, Nihon Shinkei Seishin Yakurigaku Zasshi, V18, P137; Isohara T, 1999, BIOCHEM BIOPH RES CO, V258, P300, DOI 10.1006/bbrc.1999.0637; JAYASURIYA H, 1989, J NAT PROD, V52, P325, DOI 10.1021/np50062a018; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Lanni C, 2004, EUR J BIOCHEM, V271, P3068, DOI 10.1111/j.1432-1033.2004.04240.x; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Li QF, 2001, J BIOL CHEM, V276, P38068; LI WQ, 1995, J BIOL CHEM, V270, P8311, DOI 10.1074/jbc.270.14.8311; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; Loeb JA, 1998, MOL CELL NEUROSCI, V11, P77, DOI 10.1006/mcne.1998.0676; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; Loeb JA, 1997, J NEUROSCI, V17, P1416; Loeb JA, 2002, J NEUROSCI, V22, P2206, DOI 10.1523/JNEUROSCI.22-06-02206.2002; Loeb JA, 1999, DEVELOPMENT, V126, P781; LOEB JA, 2003, J NEUROCYTO IN PRESS; Loeb JA, 2007, NEUROLOGY, V68, pS38, DOI 10.1212/01.wnl.0000275231.97764.43; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; ODRISCOLL KR, 1995, MOL BIOL CELL, V6, P449, DOI 10.1091/mbc.6.4.449; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Pankonin MS, 2009, BRAIN RES, V1258, P1, DOI 10.1016/j.brainres.2008.12.047; Pankonin MS, 2005, J BIOL CHEM, V280, P383, DOI 10.1074/jbc.M402645200; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Plo I, 2004, J NEUROSCI RES, V77, P465, DOI 10.1002/jnr.20189; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steinthorsdottir V, 2004, GENE, V342, P97, DOI 10.1016/j.gene.2004.07.029; Susarla BTS, 2003, J NEUROCHEM, V86, P635, DOI 10.1046/j.1471-4159.2003.01886.x; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Thabard W, 2001, BIOCHEM J, V358, P193, DOI 10.1042/0264-6021:3580193; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Winseck AK, 2002, J NEUROSCI, V22, P4509, DOI 10.1523/JNEUROSCI.22-11-04509.2002; Wooten MW, 1998, CELL SIGNAL, V10, P265, DOI 10.1016/S0898-6568(97)00127-7; Zhan Wen-Zhi, 2003, Shengli Xuebao, V55, P617; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; ZIRRGIEBEL U, 1995, J NEUROCHEM, V65, P2241	88	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26251	26260		10.1074/jbc.M109.002915	http://dx.doi.org/10.1074/jbc.M109.002915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648576	Green Published, hybrid			2022-12-25	WOS:000269969600005
J	Chen, P; Abacherli, LE; Nadler, ST; Wang, Y; Li, QL; Parks, WC				Chen, Peter; Abacherli, Laura E.; Nadler, Samuel T.; Wang, Ying; Li, Qinglang; Parks, William C.			MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting alpha(2)beta(1) Integrin Activation	PLOS ONE			English	Article							BREAST-CARCINOMA CELLS; SMOOTH-MUSCLE-CELLS; EPITHELIAL-CELLS; REGULATES ALPHA(V)BETA(3); KERATINOCYTE MIGRATION; ENDOTHELIAL-CELLS; WOUND REPAIR; I COLLAGEN; MATRILYSIN; MATRIX	Background: Lung injury promotes the expression of matrix metalloproteinase-7 (MMP7, matrilysin), which is required for neutrophil recruitment and re-epithelialization. MMP7 governs the lung inflammatory response through the shedding of syndecan-1. Because inflammation and repair are related events, we evaluated the role of syndecan-1 shedding in lung re-epithelialization. Methodology/Principal Finding: Epithelial injury induced syndecan-1 shedding from wild-type epithelium but not from Mmp7(-/-) mice in vitro and in vivo. Moreover, cell migration and wound closure was enhanced by MMP7 shedding of syndecan-1. Additionally, we found that syndecan-1 augmented cell adhesion to collagen by controlling the affinity state of the alpha(2)beta(1) integrin. Conclusion/Significance: MMP7 shedding of syndecan-1 facilitates wound closure by causing the alpha(2)beta(1) integrin to assume a less active conformation thereby removing restrictions to migration. MMP7 acts in the lungs to regulate inflammation and repair, and our data now show that both these functions are controlled through the shedding of syndecan-1.			Chen, P (corresponding author), Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA 98195 USA.	petechen@u.washington.edu	Parks, William C./AAH-6786-2021	Chen, Peter/0000-0002-5330-1718	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008396, R01HL077555, K08HL084396, P01HL029594] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL084396, HL08396, HL029594, R01 HL077555, P01 HL029594, HL077555] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adamczyk John J. Jr., 2001, Journal of Insect Science (Tucson), V1, P1; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Block ER, 2004, J BIOL CHEM, V279, P24307, DOI 10.1074/jbc.M401058200; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Burbach BJ, 2004, EXP CELL RES, V300, P234, DOI 10.1016/j.yexcr.2004.07.001; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; Chen P, 2008, AM J PATHOL, V172, P1256, DOI 10.2353/ajpath.2008.070891; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; GRUSHKINLERNER LS, 1991, CURR EYE RES, V10, P75, DOI 10.3109/02713689109007612; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; Hangan D, 1996, CANCER RES, V56, P3142; Hayashida K, 2008, J BIOL CHEM, V283, P35435, DOI 10.1074/jbc.M804172200; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jurjus RA, 2008, WOUND REPAIR REGEN, V16, P649, DOI 10.1111/j.1524-475X.2008.00423.x; KAHN ML, 1992, CIRC RES, V71, P1508, DOI 10.1161/01.RES.71.6.1508; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Lebakken CS, 2000, EXP CELL RES, V259, P315, DOI 10.1006/excr.2000.4981; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Leppa S, 1996, J CELL SCI, V109, P1393; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liu Y, 2002, ARTERIOSCL THROM VAS, V22, P76, DOI 10.1161/hq0102.101822; Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; MASUR SK, 1995, INVEST OPHTH VIS SCI, V36, P1837; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; MENDRICK DL, 1995, LAB INVEST, V72, P367; MENDRICK DL, 1993, LAB INVEST, V69, P690; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785; Pal-Ghosh S, 2008, EXP EYE RES, V87, P478, DOI 10.1016/j.exer.2008.08.013; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SaarialhoKere UK, 1996, AM J PATHOL, V148, P519; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Small JV, 1999, CURR OPIN CELL BIOL, V11, P54, DOI 10.1016/S0955-0674(99)80007-6; STAATZ WD, 1991, J BIOL CHEM, V266, P7363; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Su G, 2008, CANCER RES, V68, P9558, DOI 10.1158/0008-5472.CAN-08-1645; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Swee M, 2008, J LEUKOCYTE BIOL, V83, P1404, DOI 10.1189/jlb.0108016; vanWinkle LS, 1995, AM J PHYSIOL-LUNG C, V269, pL800, DOI 10.1152/ajplung.1995.269.6.L800; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Wang XQ, 1998, MOL BIOL CELL, V9, P865, DOI 10.1091/mbc.9.4.865; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; WILSON CL, 1995, MOL BIOL CELL, V86, P113; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; ZAHM JM, 1991, AM J RESP CELL MOL, V5, P242, DOI 10.1165/ajrcmb/5.3.242	76	93	93	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6565	10.1371/journal.pone.0006565	http://dx.doi.org/10.1371/journal.pone.0006565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668337	Green Submitted, Green Published, gold			2022-12-25	WOS:000268773300007
J	De Francesco, F; Tirino, V; Desiderio, V; Ferraro, G; D'Andrea, F; Giuliano, M; Libondi, G; Pirozzi, G; De Rosa, A; Papaccio, G				De Francesco, Francesco; Tirino, Virginia; Desiderio, Vincenzo; Ferraro, Giuseppe; D'Andrea, Francesco; Giuliano, Mariateresa; Libondi, Guido; Pirozzi, Giuseppe; De Rosa, Alfredo; Papaccio, Gianpaolo			Human CD34(+)/CD90(+) ASCs Are Capable of Growing as Sphere Clusters, Producing High Levels of VEGF and Forming Capillaries	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; STROMAL CELLS; POSTNATAL NEOVASCULARIZATION; PROGENITOR CELLS; BONE-MARROW; UMBILICAL-CORD; LINEAGE CELLS; IN-VITRO	Background: Human adult adipose tissue is an abundant source of mesenchymal stem cells (MSCs). Moreover, it is an easily accessible site producing a considerable amount of stem cells. Methodology/Principal Findings: In this study, we have selected and characterized stem cells within the stromal vascular fraction (SVF) of human adult adipose tissue with the aim of understanding their differentiation capabilities and performance. We have found, within the SVF, different cell populations expressing MSC markers - including CD34, CD90, CD29, CD44, CD105, and CD117 - and endothelial-progenitor-cell markers - including CD34, CD90, CD44, and CD54. Interestingly, CD34(+)/CD90(+) cells formed sphere clusters, when placed in non-adherent growth conditions. Moreover, they showed a high proliferative capability, a telomerase activity that was significantly higher than that found in differentiated cells, and contained a fraction of cells displaying the phenotype of a side population. When cultured in adipogenic medium, CD34(+)/CD90(+) quickly differentiated into adipocytes. In addition, they differentiated into endothelial cells (CD31(+)/VEGF(+)/Flk-1(+)) and, when placed in methylcellulose, were capable of forming capillary-like structures producing a high level of VEGF, as substantiated with ELISA tests. Conclusions/Significance: Our results demonstrate, for the first time, that CD34(+)/CD90(+) cells of human adipose tissue are capable of forming sphere clusters, when grown in free-floating conditions, and differentiate in endothelial cells that form capillary-like structures in methylcellulose. These cells might be suitable for tissue reconstruction in regenerative medicine, especially when patients need treatments for vascular disease.			De Francesco, F (corresponding author), Univ Naples 2, TERM Lab, Dipartimento Med Sperimentale, Sez Istol & Embriol, Naples, Italy.	gianpaolo.papaccio@unina2.it	Grella, Roberto/J-1748-2012; De Francesco, Francesco/D-8080-2016; desiderio, vincenzo/K-4244-2018; Papaccio, Gianpaolo/B-7150-2014	De Francesco, Francesco/0000-0003-2977-7828; desiderio, vincenzo/0000-0003-1819-6083; Papaccio, Gianpaolo/0000-0002-4014-5306; D'andrea, Francesco/0000-0002-3518-0406; Tirino, Virginia/0000-0003-2731-5718; Giuliano, Mariateresa/0000-0002-7338-9200				Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; D'Andrea F, 2008, TISSUE ENG PART C-ME, V14, P233, DOI 10.1089/ten.tec.2008.0108; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; DEROSA A, 2009, TISSUE ENG C; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; FINA L, 1990, BLOOD, V75, P2417; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; GREAVES MF, 1992, LEUKEMIA, V6, P31; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; Isner J M, 1996, Vasc Med, V1, P79; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Maruyama K, 1999, J MOL CELL CARDIOL, V31, P607, DOI 10.1006/jmcc.1998.0895; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Niknejad H, 2008, EUR CELLS MATER, V15, P88; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Ryden M, 2003, BIOCHEM BIOPH RES CO, V311, P391, DOI 10.1016/j.bbrc.2003.10.010; Schilling T, 2007, MOL CELL ENDOCRINOL, V271, P1, DOI 10.1016/j.mce.2007.03.004; Sengenes C, 2007, STEM CELLS, V25, P2269, DOI 10.1634/stemcells.2007-0180; Verfaillie Catherine M, 2002, Hematology Am Soc Hematol Educ Program, P369; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	33	132	136	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6537	10.1371/journal.pone.0006537	http://dx.doi.org/10.1371/journal.pone.0006537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657392	gold, Green Published, Green Submitted			2022-12-25	WOS:000268739300008
J	Yamano, Y; Araya, N; Sato, T; Utsunomiya, A; Azakami, K; Hasegawa, D; Izumi, T; Fujita, H; Aratani, S; Yagishita, N; Fujii, R; Nishioka, K; Jacobson, S; Nakajima, T				Yamano, Yoshihisa; Araya, Natsumi; Sato, Tomoo; Utsunomiya, Atae; Azakami, Kazuko; Hasegawa, Daisuke; Izumi, Toshihiko; Fujita, Hidetoshi; Aratani, Satoko; Yagishita, Naoko; Fujii, Ryoji; Nishioka, Kusuki; Jacobson, Steven; Nakajima, Toshihiro			Abnormally High Levels of Virus-Infected IFN-gamma(+)CCR4(+)CD4(+)CD25(+) T Cells in a Retrovirus-Associated Neuroinflammatory Disorder	PLOS ONE			English	Article								Background: Human T-lymphotropic virus type 1 (HTLV-1) is a human retrovirus associated with both HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), which is a chronic neuroinflammatory disease, and adult T-cell leukemia (ATL). The pathogenesis of HAM/TSP is known to be as follows: HTLV-1-infected T cells trigger a hyperimmune response leading to neuroinflammation. However, the HTLV-1-infected T cell subset that plays a major role in the accelerated immune response has not yet been identified. Principal Findings: Here, we demonstrate that CD4(+)CD25(+)CCR4(+) T cells are the predominant viral reservoir, and their levels are increased in HAM/TSP patients. While CCR4 is known to be selectively expressed on T helper type 2 (Th2), Th17, and regulatory T (Treg) cells in healthy individuals, we demonstrate that IFN-gamma production is extraordinarily increased and IL-4, IL-10, IL-17, and Foxp3 expression is decreased in the CD4(+)CD25(+)CCR4(+) T cells of HAM/TSP patients as compared to those in healthy individuals, and the alteration in function is specific to this cell subtype. Notably, the frequency of IFN-gamma-producing CD4(+)CD25(+)CCR4(+) T Foxp3 2 T cells is dramatically increased in HAM/TSP patients, and this was found to be correlated with disease activity and severity. Conclusions: We have defined a unique T cell subset-IFN-gamma(+)CCR4(+)CD4(+)CD25(+) T cells-that is abnormally increased and functionally altered in this retrovirus-associated inflammatory disorder of the central nervous system.			Yamano, Y (corresponding author), St Marianna Univ, Sch Med, Inst Med Sci, Dept Mol Med Sci, Kawasaki, Kanagawa, Japan.	yyamano@marianna-u.ac.jp	Sato, Tomoo/E-3262-2010; Yamano, Yoshihisa/AAG-3955-2020	Sato, Tomoo/0000-0001-8439-3128; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002817, ZIANS002817] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20249052] Funding Source: KAKEN	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Chen SM, 2006, INT IMMUNOL, V18, P269, DOI 10.1093/intimm/dxh366; Enose-Akahata Y, 2008, BLOOD, V112, P2400, DOI 10.1182/blood-2008-02-138529; Furuya T, 1999, J NEUROIMMUNOL, V95, P185, DOI 10.1016/S0165-5728(98)00263-X; GESSAIN A, 1985, LANCET, V2, P407; Hanon E, 2001, BLOOD, V98, P721, DOI 10.1182/blood.V98.3.721; Hayashi D, 2008, J NEUROIMMUNOL, V200, P115, DOI 10.1016/j.jneuroim.2008.06.005; Hieshima K, 2008, J IMMUNOL, V180, P931, DOI 10.4049/jimmunol.180.2.931; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; ITOYAMA Y, 1988, NEUROLOGY, V38, P1302, DOI 10.1212/WNL.38.8.1302; Izumo Shuji, 1997, Leukemia (Basingstoke), V11, P82; Jacobson S, 2002, J INFECT DIS, V186, pS187, DOI 10.1086/344269; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Kannagi M, 2007, INT J HEMATOL, V86, P113, DOI 10.1532/IJH97.07092; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Karube K, 2004, BRIT J HAEMATOL, V126, P81, DOI 10.1111/j.1365-2141.2004.04999.x; Kohno T, 2005, CANCER SCI, V96, P527, DOI 10.1111/j.1349-7006.2005.00080.x; KOYANAGI Y, 1993, VIROLOGY, V196, P25, DOI 10.1006/viro.1993.1451; Kubota R, 2000, AIDS RES HUM RETROV, V16, P1705, DOI 10.1089/08892220050193182; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27; Michaelsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-41; Nagai M, 2001, BLOOD, V98, P1858, DOI 10.1182/blood.V98.6.1858; Nagai M, 2001, ANN NEUROL, V50, P807, DOI 10.1002/ana.10065; Nagai M, 2001, J INFECT DIS, V183, P197, DOI 10.1086/317932; NAKAGAWA M, 1995, J NEUROVIROL, V1, P50, DOI 10.3109/13550289509111010; NISHIOKA K, 1989, LANCET, V1, P441; NOMOTO M, 1991, NEUROLOGY, V41, P457, DOI 10.1212/WNL.41.3.457; Oh U, 2006, J INFECT DIS, V193, P1557, DOI 10.1086/503874; Okayama A, 2004, INT J CANCER, V110, P621, DOI 10.1002/ijc.20144; OSAME M, 1986, LANCET, V1, P1031; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Shimizu Y, 2009, CANCER SCI, V100, P481, DOI 10.1111/j.1349-7006.2008.01054.x; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Toulza F, 2008, BLOOD, V111, P5047, DOI 10.1182/blood-2007-10-118539; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vine AM, 2002, J INFECT DIS, V186, P932, DOI 10.1086/342953; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamano Y, 2005, J CLIN INVEST, V115, P1361, DOI [10.1172/JCI200523913, 10.1172/JCI23913]; Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88; Yamano Y, 2004, J EXP MED, V199, P1367, DOI 10.1084/jem.20032042; Yoshida Y, 1999, INTERNAL MED, V38, P133, DOI 10.2169/internalmedicine.38.133; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9	46	79	83	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6517	10.1371/journal.pone.0006517	http://dx.doi.org/10.1371/journal.pone.0006517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654865	Green Submitted, gold, Green Published			2022-12-25	WOS:000268739100012
J	Martino, AT; Nayak, S; Hoffman, BE; Cooper, M; Liao, GX; Markusic, DM; Byrne, BJ; Terhorst, C; Herzog, RW				Martino, Ashley T.; Nayak, Sushrusha; Hoffman, Brad E.; Cooper, Mario; Liao, Gongxian; Markusic, David M.; Byrne, Barry J.; Terhorst, Cox; Herzog, Roland W.			Tolerance Induction to Cytoplasmic beta-Galactosidase by Hepatic AAV Gene Transfer - Implications for Antigen Presentation and Immunotoxicity	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; ADENOVIRUS-INFECTED HEPATOCYTES; REGULATORY T-CELLS; HUMORAL IMMUNE-RESPONSE; COAGULATION-FACTOR-IX; TRANSGENE PRODUCT; SKELETAL-MUSCLE; HEMOPHILIA-B; EXPRESSION; INJECTION	Background: Hepatic gene transfer, in particular using adeno-associated viral (AAV) vectors, has been shown to induce immune tolerance to several protein antigens. This approach has been exploited in animal models of inherited protein deficiency for systemic delivery of therapeutic proteins. Adequate levels of transgene expression in hepatocytes induce a suppressive T cell response, thereby promoting immune tolerance. This study addresses the question of whether AAV gene transfer can induce tolerance to a cytoplasmic protein. Major Findings: AAV-2 vector-mediated hepatic gene transfer for expression of cytoplasmic beta-galactosidase ( beta-gal) was performed in immune competent mice, followed by a secondary b-gal gene transfer with E1/E3-deleted adenoviral Ad-LacZ vector to provoke a severe immunotoxic response. Transgene expression from the AAV-2 vector in similar to 2% of hepatocytes almost completely protected from inflammatory T cell responses against b-gal, eliminated antibody formation, and significantly reduced adenovirus-induced hepatotoxicity. Consequently, similar to 10% of hepatocytes continued to express beta-gal 45 days after secondary Ad-LacZ gene transfer, a time point when control mice had lost all Ad-LacZ derived expression. Suppression of inflammatory T cell infiltration in the liver and liver damage was linked to specific transgene expression and was not seen for secondary gene transfer with Ad-GFP. A combination of adoptive transfer studies and flow cytometric analyses demonstrated induction of Treg that actively suppressed CD8(+) T cell responses to b-gal and that was amplified in liver and spleen upon secondary Ad-LacZ gene transfer. Conclusions: These data demonstrate that tolerance induction by hepatic AAV gene transfer does not require systemic delivery of the transgene product and that expression of a cytoplasmic neo-antigen in few hepatocytes can induce Treg and provide long-term suppression of inflammatory responses and immunotoxicity.			Martino, AT (corresponding author), Univ Florida, Dept Pediat, Gainesville, FL 32610 USA.	rherzog@ufl.edu	Hoffman, Brad E/E-8363-2010	Hoffman, Brad E/0000-0002-5560-9580; nayak, sushrusha/0000-0003-1243-5792; Markusic, David/0000-0002-3774-0825; Byrne, Barry J./0000-0002-7302-1756	NHLBI NIH HHS [P01 HL078810] Funding Source: Medline; NIAID NIH HHS [R01 AI051390, AI/HL51390] Funding Source: Medline; NIDDK NIH HHS [T32 DK074367] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK074367] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arruda VR, 2005, BLOOD, V105, P3458, DOI 10.1182/blood-2004-07-2908; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Cao O, 2007, CURR GENE THER, V7, P381, DOI 10.2174/156652307782151506; Cao O, 2007, BLOOD, V110, P1132, DOI 10.1182/blood-2007-02-073304; COOPER M, 2009, HUM GENE TH IN PRESS; Cresawn KO, 2005, HUM GENE THER, V16, P68, DOI 10.1089/hum.2005.16.68; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; De Geest BR, 2003, BLOOD, V101, P2551, DOI 10.1182/blood-2002-07-2146; Dobrzynski E, 2004, BLOOD, V104, P969, DOI 10.1182/blood-2004-03-0847; Dobrzynski E, 2006, P NATL ACAD SCI USA, V103, P4592, DOI 10.1073/pnas.0508685103; Dobrzynski E, 2005, CLIN MED RES, V3, P234, DOI 10.3121/cmr.3.4.234; Fields PA, 2000, MOL THER, V1, P225, DOI 10.1006/mthe.2000.0032; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; Hoffman BE, 2007, HUM GENE THER, V18, P603, DOI 10.1089/hum.2007.042; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Jooss K, 1998, J VIROL, V72, P4212, DOI 10.1128/JVI.72.5.4212-4223.1998; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Le Guiner C, 2007, CURR GENE THER, V7, P334; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; Liu YL, 2003, BIOTECHNIQUES, V34, P184, DOI 10.2144/03341dd07; LoDuca PA, 2009, CURR GENE THER, V9, P104, DOI 10.2174/156652309787909490; Luth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Mingozzi F, 2007, BLOOD, V110, P2334, DOI 10.1182/blood-2007-03-080093; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Overwijk WW, 1997, METHODS, V12, P117, DOI 10.1006/meth.1997.0461; Passini MA, 2007, P NATL ACAD SCI USA, V104, P9505, DOI 10.1073/pnas.0703509104; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sarukhan A, 2001, J GENE MED, V3, P260, DOI 10.1002/jgm.175; Snyder RO, 1999, NAT MED, V5, P64, DOI 10.1038/4751; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; Sun B, 2007, AM J HUM GENET, V81, P1042, DOI 10.1086/522236; Walter J, 1996, P NATL ACAD SCI USA, V93, P3056, DOI 10.1073/pnas.93.7.3056; Wang L, 2005, GENE THER, V12, P1453, DOI 10.1038/sj.gt.3302539; Xiao WD, 2000, MOL THER, V1, P323, DOI 10.1006/mthe.2000.0045; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; Yang Y, 1996, GENE THER, V3, P137; Yang YP, 1996, HUM MOL GENET, V5, P1703, DOI 10.1093/hmg/5.11.1703; YANG YP, 1995, J IMMUNOL, V155, P2564; YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257; Yuasa K, 2007, GENE THER, V14, P1249, DOI 10.1038/sj.gt.3302984	47	51	54	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6376	10.1371/journal.pone.0006376	http://dx.doi.org/10.1371/journal.pone.0006376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652717	Green Published, gold, Green Submitted			2022-12-25	WOS:000268637800002
J	Innes-Brown, H; Crewther, D				Innes-Brown, Hamish; Crewther, David			The Impact of Spatial Incongruence on an Auditory-Visual Illusion	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; SUPERIOR COLLICULUS; TEMPORAL FACTORS; ILLUSORY-FLASH; GANGLION-CELLS; HUMAN V1; CORTEX; SOUND; PERCEPTION; RESPONSES	Background: The sound-induced flash illusion is an auditory-visual illusion-when a single flash is presented along with two or more beeps, observers report seeing two or more flashes. Previous research has shown that the illusion gradually disappears as the temporal delay between auditory and visual stimuli increases, suggesting that the illusion is consistent with existing temporal rules of neural activation in the superior colliculus to multisensory stimuli. However little is known about the effect of spatial incongruence, and whether the illusion follows the corresponding spatial rule. If the illusion occurs less strongly when auditory and visual stimuli are separated, then integrative processes supporting the illusion must be strongly dependant on spatial congruence. In this case, the illusion would be consistent with both the spatial and temporal rules describing response properties of multisensory neurons in the superior colliculus. Methodology/Principal Findings: The main aim of this study was to investigate the importance of spatial congruence in the flash-beep illusion. Selected combinations of one to four short flashes and zero to four short 3.5 KHz tones were presented. Observers were asked to count the number of flashes they saw. After replication of the basic illusion using centrally-presented stimuli, the auditory and visual components of the illusion stimuli were presented either both 10 degrees to the left or right of fixation (spatially congruent) or on opposite (spatially incongruent) sides, for a total separation of 20 degrees. Conclusions/Significance: The sound-induced flash fission illusion was successfully replicated. However, when the sources of the auditory and visual stimuli were spatially separated, perception of the illusion was unaffected, suggesting that the "spatial rule'' does not extend to describing behavioural responses in this illusion. We also find no evidence for an associated "fusion'' illusion reportedly occurring when multiple flashes are accompanied by a single beep.			Innes-Brown, H (corresponding author), Swinburne Univ Technol, Brain Sci Inst, Hawthorn, Vic 3122, Australia.	dcrewther@swin.edu.au	Innes-Brown, Hamish/H-3298-2019	Innes-Brown, Hamish/0000-0002-1512-2823				ALTSHULER M W, 1975, Journal of Auditory Research, V15, P262; Andersen TS, 2004, COGNITIVE BRAIN RES, V21, P301, DOI 10.1016/j.cogbrainres.2004.06.004; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Bhattacharya J, 2002, NEUROREPORT, V13, P1727, DOI 10.1097/00001756-200210070-00007; Bolognini N, 2005, NEUROPSYCHOLOGIA, V43, P1655, DOI 10.1016/j.neuropsychologia.2005.01.015; Brugge JF, 2001, AUDIOL NEURO-OTOL, V6, P173, DOI 10.1159/000046827; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; DEMONASTERIO FM, 1978, J NEUROPHYSIOL, V41, P1435, DOI 10.1152/jn.1978.41.6.1435; Driver J, 1998, PHILOS T R SOC B, V353, P1319, DOI 10.1098/rstb.1998.0286; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Falchier A, 2002, J NEUROSCI, V22, P5749; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Frassinetti F, 2002, J COGNITIVE NEUROSCI, V14, P62, DOI 10.1162/089892902317205320; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Harrington LK, 1998, EXP BRAIN RES, V122, P247, DOI 10.1007/s002210050512; Jiang W, 2002, J COGNITIVE NEUROSCI, V14, P1240, DOI 10.1162/089892902760807230; MACDONALD J, 1978, PERCEPT PSYCHOPHYS, V24, P253, DOI 10.3758/BF03206096; MACLEOD A, 1987, British Journal of Audiology, V21, P131, DOI 10.3109/03005368709077786; Maravita A, 2008, NEUROREPORT, V19, P271, DOI 10.1097/WNR.0b013e3282f4f04e; McCormick D, 2008, VISION RES, V48, P63, DOI 10.1016/j.visres.2007.10.010; McDonald JJ, 2003, J COGNITIVE NEUROSCI, V15, P10, DOI 10.1162/089892903321107783; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MEREDITH MA, 1986, BRAIN RES, V365, P350; Meylan RV, 2007, NEUROIMAGE, V35, P244, DOI 10.1016/j.neuroimage.2006.11.033; MILLER LM, 2009, P NATL ACAD SCI US; Mishra J, 2007, J NEUROSCI, V27, P4120, DOI 10.1523/JNEUROSCI.4912-06.2007; Mishra J, 2008, BRAIN RES, V1242, P102, DOI 10.1016/j.brainres.2008.05.023; Mrsic-Flogel TD, 2005, J NEUROPHYSIOL, V93, P3489, DOI 10.1152/jn.00748.2004; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; PERROTT DR, 1990, J ACOUST SOC AM, V87, P1728, DOI 10.1121/1.399421; SCHILLER PH, 1977, J NEUROPHYSIOL, V40, P428, DOI 10.1152/jn.1977.40.2.428; Senkowski D, 2007, NEUROPSYCHOLOGIA, V45, P561, DOI 10.1016/j.neuropsychologia.2006.01.013; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2005, NEUROSCI LETT, V378, P76, DOI 10.1016/j.neulet.2004.12.035; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; STEIN BE, 1993, PROG BRAIN RES, V95, P79, DOI 10.1016/S0079-6123(08)60359-3; Stein BE., 1993, MERGING SENSES; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; WALLACE MT, 1994, J NEUROPHYSIOL, V71, P429, DOI 10.1152/jn.1994.71.1.429; Watkins S, 2007, NEUROIMAGE, V37, P572, DOI 10.1016/j.neuroimage.2007.05.027; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Zhang NY, 2006, EXP BRAIN RES, V172, P57, DOI 10.1007/s00221-005-0304-7	49	45	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6450	10.1371/journal.pone.0006450	http://dx.doi.org/10.1371/journal.pone.0006450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479CU	19649293	Green Published, gold			2022-12-25	WOS:000268637600003
J	Ashley, N; Poulton, J				Ashley, N.; Poulton, J.			Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling	ONCOGENE			English	Article						anthracyclines; mtDNA; mitochondria; nucleoids; doxorubicin; mitofusin	HUMAN-CELLS; DOXORUBICIN; P53; ADRIAMYCIN; MUTATIONS; DEPLETION; FUSION; DRUGS; OPA1; CARDIOMYOPATHY	Many anticancer drugs, such as doxorubicin (DXR), intercalate into nuclear DNA of cancer cells, thereby inhibiting their growth. However, it is not well understood how such drugs interact with mitochondrial DNA (mtDNA). Using cell and molecular studies of cultured cells, we show that DXR and other DNA intercalators, such as ethidium bromide, can rapidly intercalate into mtDNA within living cells, causing aggregation of mtDNA nucleoids and altering the distribution of nucleoid proteins. Remodelled nucleoids excluded DXR and maintained mtDNA synthesis, whereas non-remodelled nucleoids became heavily intercalated with DXR, which inhibited their replication, thus leading to mtDNA depletion. Remodelling was accompanied by extensive mitochondrial elongation or interconnection, and was suppressed in cells lacking mitofusin 1 and optic atrophy 1 (OPA1), the key proteins for mitochondrial fusion. In contrast, remodelling was significantly increased by p53 or ataxia telangiectasia mutated inhibition (ATM), indicating a link between nucleoid dynamics and the genomic DNA damage response. Collectively, our results show that DNA intercalators can trigger a common mitochondrial response, which likely contributes to the marked clinical toxicity associated with these drugs. Oncogene (2009) 28, 3880-3891; doi:10.1038/onc.2009.242; published online 17 August 2009	[Ashley, N.; Poulton, J.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Womens Ctr, John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford	Ashley, N (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Womens Ctr, John Radcliffe Hosp, Level 3, Oxford OX3 9DU, England.	Neil.Ashley@clin-pharm.ox.ac.uk; Joanna.Poulton@obs-gyn.ox.ac.uk	Poulton, Joanna/AAB-4828-2021	Poulton, Joanna/0000-0002-2460-5587; Ashley, Neil/0000-0002-1655-5137	MRC/Wellcome Trust; MRC [G0500695] Funding Source: UKRI; Medical Research Council [G0500695] Funding Source: researchfish	MRC/Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank I Sargent for providing the equipment; E Brampton, M Zeviani, I Holt, B Roques, A Trifunovic, P Cook and D Chan for materials; and K Morten and F Brook for technical support. This work was funded by the MRC/Wellcome Trust.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150; Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090; Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; Bakhanashvili M, 2009, AIDS, V23, P779, DOI 10.1097/QAD.0b013e328329c74e; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Conklin Kenneth A, 2005, Integr Cancer Ther, V4, P110, DOI 10.1177/1534735405276191; Cullinane C, 2000, NUCLEIC ACIDS RES, V28, P1019, DOI 10.1093/nar/28.4.1019; ELLIS CN, 1987, BIOCHEM J, V245, P309, DOI 10.1042/bj2450309; Emmerson CF, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.2.e1; FELIX CA, 1992, CANCER RES, V52, P2243; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Hande KR, 1998, BBA-GENE STRUCT EXPR, V1400, P173, DOI 10.1016/S0167-4781(98)00134-1; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; HIXON SC, 1981, J MOL CELL CARDIOL, V13, P855, DOI 10.1016/0022-2828(81)90242-X; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jung K, 2001, ADV DRUG DELIVER REV, V49, P87, DOI 10.1016/S0169-409X(01)00128-4; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lebrecht D, 2005, J PATHOL, V207, P436, DOI 10.1002/path.1863; Lebrecht D, 2004, NEPHROL DIAL TRANSPL, V19, P329, DOI 10.1093/ndt/gfg564; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0; Martinez LA, 2002, P NATL ACAD SCI USA, V99, P14849, DOI 10.1073/pnas.222406899; McKenzie PP, 2002, MOL CANCER THER, V1, P1097; Nithipongvanitch R, 2007, J HISTOCHEM CYTOCHEM, V55, P629, DOI 10.1369/jhc.6A7146.2007; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; STEINHERZ L, 1991, Pediatrician, V18, P49; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Tokarska-Schlattner M, 2006, CR BIOL, V329, P657, DOI 10.1016/j.crvi.2005.08.007; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; von Wurmb-Schwark N, 2006, MUTAT RES-FUND MOL M, V596, P57, DOI 10.1016/j.mrfmmm.2005.12.003; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0	45	42	42	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2009	28	44					3880	3891		10.1038/onc.2009.242	http://dx.doi.org/10.1038/onc.2009.242			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	515LJ	19684617	Green Accepted			2022-12-25	WOS:000271471900003
J	Hardy, AB; Fox, JEM; Giglou, PR; Wijesekara, N; Bhattacharjee, A; Sultan, S; Gyulkhandanyan, AV; Gaisano, HY; MacDonald, PE; Wheeler, MB				Hardy, Alexandre B.; Fox, Jocelyn E. Manning; Giglou, Pejman Raeisi; Wijesekara, Nadeeja; Bhattacharjee, Alpana; Sultan, Sobia; Gyulkhandanyan, Armen V.; Gaisano, Herbert Y.; MacDonald, Patrick E.; Wheeler, Michael B.			Characterization of Erg K+ Channels in alpha- and beta-Cells of Mouse and Human Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCORPION BUTHUS-EUPEUS; INSULIN-SECRETION; ELECTRICAL-ACTIVITY; POTASSIUM CHANNEL; ION CHANNELS; ELECTROPHYSIOLOGICAL CHARACTERIZATION; GLUCAGON-SECRETION; NERVOUS-SYSTEM; RAT PANCREAS; ATP-CHANNELS	Voltage-gated eag-related gene (Erg) K+ channels regulate the electrical activity of many cell types. Data regarding Erg channel expression and function in electrically excitable glucagon and insulin producing cells of the pancreas is limited. In the present study Erg1 mRNA and protein were shown to be highly expressed in human and mouse islets and in alpha-TC6 and Min6 cells alpha- and beta-cell lines, respectively. Whole cell patch clamp recordings demonstrated the functional expression of Erg1 in alpha- and beta-cells, with rBeKm1, an Erg1 antagonist, blocking inward tail currents elicited by a double pulse protocol. Additionally, a small interference RNA approach targeting the kcnh2 gene (Erg1) induced a significant decrease of Erg1 inward tail current in Min6 cells. To investigate further the role of Erg channels in mouse and human islets, ratiometric Fura-2 AM Ca2+-imaging experiments were performed on isolated alpha- and beta-cells. Blocking Erg channels with rBeKm1 induced a transient cytoplasmic Ca2+ increase in both alpha- and beta-cells. This resulted in an increased glucose-dependent insulin secretion, but conversely impaired glucagon secretion under low glucose conditions. Together, these data present Erg1 channels as new mediators of alpha- and beta-cell repolarization. However, antagonism of Erg1 has divergent effects in these cells; to augment glucose-dependent insulin secretion and inhibit low glucose stimulated glucagon secretion.	[Hardy, Alexandre B.; Fox, Jocelyn E. Manning; Giglou, Pejman Raeisi; Wijesekara, Nadeeja; Bhattacharjee, Alpana; Sultan, Sobia; Gyulkhandanyan, Armen V.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Fox, Jocelyn E. Manning; MacDonald, Patrick E.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2E1, Canada; [Fox, Jocelyn E. Manning; MacDonald, Patrick E.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada; [Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Alberta; University of Alberta; University of Toronto	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle,Rm 3352, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Wijesekara, Nadeeja/AAW-7230-2021	Wheeler, Michael B./0000-0002-7480-7267; MacDonald, Patrick/0000-0002-5439-6288	Canadian Institutes of Health [MOP 49521]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP 49521 to M. B. W.).	Ammala Carina, 1997, Digestion, V58, P81; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Bauer CK, 2003, PFLUG ARCH EUR J PHY, V445, P589, DOI 10.1007/s00424-002-0980-0; Berts A, 1996, ENDOCRINOLOGY, V137, P693, DOI 10.1210/en.137.2.693; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Filippov AK, 1996, FEBS LETT, V384, P277, DOI 10.1016/0014-5793(96)00333-X; Gomis A, 1998, BRIT J PHARMACOL, V123, P443, DOI 10.1038/sj.bjp.0701628; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P497, DOI 10.1111/j.1469-7793.2000.00497.x; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; Gurrola GB, 1999, FASEB J, V13, P953, DOI 10.1096/fasebj.13.8.953; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; HENQUIN JC, 1979, BIOCHIM BIOPHYS ACTA, V587, P579, DOI 10.1016/0304-4165(79)90010-2; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Korolkova YV, 2001, J BIOL CHEM, V276, P9868, DOI 10.1074/jbc.M005973200; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lecchi M, 2002, J NEUROSCI, V22, P3414; Leung YM, 2005, ENDOCRINOLOGY, V146, P4766, DOI 10.1210/en.2005-0803; Liu SG, 1996, BIOPHYS J, V70, P2704, DOI 10.1016/S0006-3495(96)79840-5; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; Muhlbauer E, 2007, CELL MOL LIFE SCI, V64, P768, DOI 10.1007/s00018-007-6478-3; O'Gorman D, 2005, TRANSPLANTATION, V80, P801, DOI 10.1097/01.tp.0000172216.47547.d5; Pessia M, 2008, J PHYSIOL-LONDON, V586, P4877, DOI 10.1113/jphysiol.2008.155762; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; RAJAN AS, 1990, DIABETES CARE, V13, P340, DOI 10.2337/diacare.13.3.340; Restano-Cassulini R, 2006, MOL PHARMACOL, V69, P1673, DOI 10.1124/mol.105.019729; RORSMAN P, 1994, DIABETES METAB, V20, P138; Rorsman P, 2008, TRENDS ENDOCRIN MET, V19, P277, DOI 10.1016/j.tem.2008.07.003; Rosati B, 2000, FASEB J, V14, P2601, DOI 10.1096/fj.00-0077com; Royer A, 2005, CARDIOVASC RES, V65, P128, DOI 10.1016/j.cardiores.2004.09.030; Salehi A, 1999, J PHYSIOL-LONDON, V514, P579, DOI 10.1111/j.1469-7793.1999.579ae.x; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, AM J PHYSIOL, V259, pH1881, DOI 10.1152/ajpheart.1990.259.6.H1881; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Schledermann W, 2001, J PHYSIOL-LONDON, V532, P143, DOI 10.1111/j.1469-7793.2001.0143g.x; Schwarz JR, 2004, J CELL MOL MED, V8, P22, DOI 10.1111/j.1582-4934.2004.tb00256.x; Sher E, 2003, J BIOENERG BIOMEMBR, V35, P687, DOI 10.1023/B:JOBB.0000008032.49504.48; Shi WM, 1997, J NEUROSCI, V17, P9423; VALDEOLMILLOS M, 1992, J PHYSIOL-LONDON, V455, P173, DOI 10.1113/jphysiol.1992.sp019295; WETTWER E, 1991, J CARDIOVASC PHARM, V17, P480, DOI 10.1097/00005344-199103000-00018; Yeung SYM, 2007, AM J PHYSIOL-CELL PH, V292, pC468, DOI 10.1152/ajpcell.00142.2006; Zaza A, 1997, J PHYSIOL-LONDON, V505, P677, DOI 10.1111/j.1469-7793.1997.677ba.x; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	51	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30441	30452		10.1074/jbc.M109.040659	http://dx.doi.org/10.1074/jbc.M109.040659			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19690348	Green Published, hybrid			2022-12-25	WOS:000271090000047
J	Li, H; Dong, B; Park, SW; Lee, HS; Chen, W; Liu, JW				Li, Hai; Dong, Bin; Park, Sahng Wook; Lee, Hyun-Sook; Chen, Wei; Liu, Jingwen			Hepatocyte Nuclear Factor 1 alpha Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; CONVERTASE SUBTILISIN/KEXIN TYPE-9; CORONARY-ARTERY-DISEASE; ELEMENT-BINDING PROTEIN; LDL CHOLESTEROL; PLASMA-CHOLESTEROL; TARGETING PCSK9; HEPG2 CELLS; EXPRESSION	PCSK9 is a natural inhibitor of LDL receptor (LDLR) that binds the extracellular domain of LDLR and triggers its intracellular degradation. PCSK9 and LDLR are coordinately regulated at the transcriptional level by sterols through their promoter-imbedded sterol response elements (SRE) and co-induced by statins. Identification of regulatory networks modulating PCSK9 transcription is important for developing selective repressors of PCSK9 to improve statin efficacy by prolonging the up-regulation of LDLR. Interestingly, the plant-derived hypocholesterolemic compound berberine (BBR) up-regulates LDLR expression while down-regulating PCSK9. In our investigations to define mechanisms underlying the transcriptional suppression of PCSK9 by BBR in HepG2 cells, we have identified a highly conserved hepatocyte nuclear factor 1 (HNF1) binding site residing 28 bp upstream from SRE as a critical sequence motif for PCSK9 transcription and its regulation by BBR. Mutation of the HNF1 site reduced PCSK9 promoter activity > 90%. A battery of functional assays identified HNF1 alpha as the predominant trans-activator for PCSK9 gene working through this sequence motif. We further provide evidence suggesting that HNF1 site works cooperatively with SRE as HNF1 mutation significantly attenuated the activity of nuclear SREBP2 to transactivate PCSK9 promoter. Finally, we show that a coordinate modest reduction of HNF1 alpha and nuclear SREBP2 by BBR led to a strong suppression of PCSK9 transcription through these two critical regulatory sequences. This is the first described example of SREBP pairing with HNF1 to control an important regulatory pathway in cholesterol homeostasis. This work also provides a mechanism for how BBR suppresses PCSK9 transcription.	[Li, Hai; Dong, Bin; Chen, Wei; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Park, Sahng Wook; Lee, Hyun-Sook] Yonsei Univ, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, Ctr Chron Metab Dis Res,Inst Genet Sci,Coll Med, Seoul 120752, South Korea	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Yonsei University; Yonsei University Health System	Liu, JW (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Jingwen.Liu@med.va.gov		Park, Sahng Wook/0000-0002-9594-7074	National Institutes of Health, NCCAM [1RO1 AT002543-01A1, 1R21AT003195-01A2]; Department of Veterans Affairs; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002543, R21AT003195] Funding Source: NIH RePORTER	National Institutes of Health, NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1 AT002543-01A1 and 1R21AT003195-01A2 from NCCAM. This work was also supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service).	Abidi P, 2005, ARTERIOSCL THROM VAS, V25, P2170, DOI 10.1161/01.ATV.0000181761.16341.2b; Abidi P, 2006, J LIPID RES, V47, P2134, DOI 10.1194/jlr.M600195-JLR200; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Attie AD, 2005, CELL METAB, V1, P290, DOI 10.1016/j.cmet.2005.04.006; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Cao Guoqing, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P238, DOI 10.2174/187153008786848286; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Egea M, 2008, GEN COMP ENDOCR, V155, P359, DOI 10.1016/j.ygcen.2007.06.018; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kong WJ, 2009, METABOLISM, V58, P109, DOI 10.1016/j.metabol.2008.08.013; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kourimate S, 2008, J BIOL CHEM, V283, P9666, DOI 10.1074/jbc.M705831200; Langhi C, 2008, FEBS LETT, V582, P949, DOI 10.1016/j.febslet.2008.02.038; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Li H, 2009, J LIPID RES, V50, P820, DOI 10.1194/jlr.M800375-JLR200; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Qadri I, 2009, TOXICOL APPL PHARM, V234, P281, DOI 10.1016/j.taap.2008.10.005; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; REYCAMPOS J, 1991, EMBO J, V10, P1445, DOI 10.1002/j.1460-2075.1991.tb07665.x; Rowley CW, 2006, AM J PHYSIOL-GASTR L, V290, pG466, DOI 10.1152/ajpgi.00431.2005; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	46	240	259	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28885	28895		10.1074/jbc.M109.052407	http://dx.doi.org/10.1074/jbc.M109.052407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19687008	Green Published, hybrid			2022-12-25	WOS:000270678900045
J	Wethkamp, N; Klempnauer, KH				Wethkamp, Nils; Klempnauer, Karl-Heinz			Daxx Is a Transcriptional Repressor of CCAAT/Enhancer-binding Protein beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PML-RAR-ALPHA; C/EBP-BETA; INTERACTING PROTEIN; SUMO MODIFICATION; FAMILY-MEMBERS; NF-M; ACTIVATION; APOPTOSIS; CELLS	CCAAT/enhancer-binding Protein beta (C/EBP beta) is a member of the bZIP transcription factor family that is expressed in various tissues, including cells of the hematopoietic system. C/EBP beta is involved in tissue-specific gene expression and thereby takes part in fundamental cellular processes such as proliferation and differentiation. Here, we show that the activity of C/EBP beta is negatively regulated by the transcriptional co-repressor Daxx. C/EBP beta was found to directly interact with Daxx after overexpression as well as on the endogenous level. Glutathione S-transferase pulldown assays showed that Daxx binds via amino acids 190-400 to the C-terminal part of C/EBP beta. Coexpression of C/EBP beta changed the sub-nuclear Daxx distribution pattern from predominantly POD-localized to nucleoplasmic. Daxx suppressed basal and p300-enhanced transcriptional activity of C/EBP beta. Furthermore, Daxx decreased the C/EBP beta dependent phosphorylation of p300, which in turn was associated with a diminished level of p300-mediated C/EBP beta acetylation. Co-expression of promyelocytic leukemia protein abrogated the repressive effect of Daxx on C/EBP beta as well as the direct interaction of Daxx and C/EBP beta, presumably by re-recruiting Daxx to PML-oncogenic domains. In acute promyelocytic leukemia (APL) cells, C/EBP beta activity is known to be required for all-trans-retinoic acid-induced cell differentiation and disease remission. We show that all-trans-retinoic acid as well as arsenic trioxide treatment leads to a reduced C/EBP beta fraction associated with Daxx suggesting a relief of Daxx-dependent C/EBP beta repression as an important molecular event leading to APL cell differentiation. Overall, our data identify Daxx as a new negative regulator of C/EBP beta and provide first clues for a link between abrogation of Daxx-C/EBP beta complex formation and APL remission.	[Wethkamp, Nils; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de			Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Deutsche Krebshilfe.	Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Amin HM, 2001, BRIT J HAEMATOL, V115, P287, DOI 10.1046/j.1365-2141.2001.03123.x; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chayka O, 2005, MOL CELL BIOL, V25, P499, DOI 10.1128/MCB.25.1.499-511.2005; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Hofmann TG, 2003, CANCER RES, V63, P8271; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Ko YG, 2001, J BIOL CHEM, V276, P39103, DOI 10.1074/jbc.M105928200; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin DY, 2002, J BIOL CHEM, V277, P25446, DOI 10.1074/jbc.M200633200; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lin DY, 2003, J BIOL CHEM, V278, P15958, DOI 10.1074/jbc.M300387200; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Mistry AR, 2003, BLOOD REV, V17, P71, DOI 10.1016/S0268-960X(02)00075-9; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Park J, 2007, J MOL BIOL, V368, P388, DOI 10.1016/j.jmb.2007.02.047; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	61	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28783	28794		10.1074/jbc.M109.041186	http://dx.doi.org/10.1074/jbc.M109.041186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690170	Green Published, hybrid			2022-12-25	WOS:000270678900035
J	Hasdemir, B; Murphy, JE; Cottrell, GS; Bunnett, NW				Hasdemir, Burcu; Murphy, Jane E.; Cottrell, Graeme S.; Bunnett, Nigel W.			Endosomal Deubiquitinating Enzymes Control Ubiquitination and Down-regulation of Protease-activated Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ARRESTIN-DEPENDENT ENDOCYTOSIS; BETA-ARRESTIN; COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; MEDIATES UBIQUITINATION; EPITHELIAL-CELLS; SUBSTANCE-P; UBPY; TRAFFICKING	The E3 ubiquitin ligase c-Cbl ubiquitinates the G protein-coupled receptor protease-activated receptor 2 (PAR(2)), which is required for postendocytic sorting of activated receptors to lysosomes, where degradation terminates signaling. The mechanisms of PAR(2) deubiquitination and its importance in trafficking and signaling of endocytosed PAR(2) are unknown. We report that receptor deubiquitination occurs between early endosomes and lysosomes and involves the endosomal deubiquitinating proteases AMSH and UBPY. Expression of the catalytically inactive mutants, AMSH(D348A) and UBPY(C786S), caused an increase in PAR(2) ubiquitination and trapped the receptor in early endosomes, thereby preventing lysosomal trafficking and degradation. Small interfering RNA knockdown of AMSH or UBPY also impaired deubiquitination, lysosomal trafficking, and degradation of PAR(2). Trapping PAR(2) in endosomes through expression of AMSH(D348A) or UBPY(C786S) did not prolong the association of PAR(2) with beta-arrestin2 or the duration of PAR(2)-induced ERK2 activation. Thus, AMSH and UBPY are essential for trafficking and down-regulation of PAR(2) but not for regulating PAR(2) dissociation from beta-arrestin2 or PAR(2)-mediated ERK2 activation.	[Bunnett, Nigel W.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bunnett, NW (corresponding author), Univ Calif San Francisco, Dept Surg, 513 Parnassus Ave, San Francisco, CA 94143 USA.	nigel.bunnett@ucsf.edu		Bunnett, Nigel W./0000-0003-3367-0644; Cottrell, Graeme/0000-0001-9098-7627	National Institutes of Health [DK43207, DK57480, DK39957]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043207, R01DK039957, R37DK039957, R56DK043207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43207, DK57480, and DK39957.	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Chen LY, 2002, TRAFFIC, V3, P110, DOI 10.1034/j.1600-0854.2002.030204.x; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; GARLAND AM, 1994, BIOCHEM J, V303, P177, DOI 10.1042/bj3030177; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li HS, 2005, TRAFFIC, V6, P324, DOI 10.1111/j.1600-0854.2005.00274.x; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Tanaka N, 1999, J BIOL CHEM, V274, P19129, DOI 10.1074/jbc.274.27.19129; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154	48	71	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28453	28466		10.1074/jbc.M109.025692	http://dx.doi.org/10.1074/jbc.M109.025692			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684015	hybrid, Green Published			2022-12-25	WOS:000270676300070
J	Li, ZQ; Li, Y; Chakraborty, M; Fan, YF; Bui, HH; Peake, DA; Kuo, MS; Xiao, X; Cao, GQ; Jiang, XC				Li, Zhiqiang; Li, Yan; Chakraborty, Mahua; Fan, Yifan; Bui, Hai H.; Peake, David A.; Kuo, Ming-Shang; Xiao, Xiao; Cao, Guoqing; Jiang, Xian-Cheng			Liver-specific Deficiency of Serine Palmitoyltransferase Subunit 2 Decreases Plasma Sphingomyelin and Increases Apolipoprotein E Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; RICH MEMBRANE RAFTS; CHOLESTEROL ACYLTRANSFERASE REACTION; PALMITOYL-COA TRANSFERASE; CORONARY-ARTERY-DISEASE; ATHEROGENIC LIPOPROTEINS; SPHINGOLIPID SYNTHESIS; LIPID EMULSIONS; RISK-FACTOR; MICE	Sphingomyelin (SM) is one of the major lipid components of plasma lipoproteins. Serine palmitoyltransferase (SPT) is the key enzyme in SM biosynthesis. Mice totally lacking in SPT are embryonic lethal. The liver is the major site for plasma lipoprotein biosynthesis, secretion, and degradation, and in this study we utilized a liver-specific knock-out approach for evaluating liver SPT activity and also its role in plasma SM and lipoprotein metabolism. We found that a deficiency of liver-specific Sptlc2 (a subunit of SPT) decreased liver SPT protein mass and activity by 95 and 92%, respectively, but had no effect on other tissues. Liver Sptlc2 deficiency decreased plasma SM levels (in both high density lipoprotein and non-high density lipoprotein fractions) by 36 and 35% (p<0.01), respectively, and increased phosphatidylcholine levels by 19% (p<0.05), thus increasing the phosphatidylcholine/SM ratio by 77% (p<0.001),compared with controls. This deficiency also decreased SM levels in the liver by 38% (p<0.01) and in the hepatocyte plasma membranes (based on a lysenin-mediated cell lysis assay). Liver-specific Sptlc2 deficiency significantly increased hepatocyte apoE secretion and thus increased plasma apoE levels 3.5-fold (p<0.0001). Furthermore, plasma from Sptlc2 knock-out mice had a significantly stronger potential for promoting cholesterol efflux from macrophages than from wild-type mice (p<0.01) because of a greater amount of apoE in the circulation. As a result of these findings, we believe that the ability to control liver SPT activity could result in regulation of lipoprotein metabolism and might have an impact on the development of atherosclerosis.	[Li, Zhiqiang; Li, Yan; Chakraborty, Mahua; Fan, Yifan; Jiang, Xian-Cheng] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Bui, Hai H.; Peake, David A.; Kuo, Ming-Shang; Cao, Guoqing] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Xiao, Xiao] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Eli Lilly; University of North Carolina; University of North Carolina Chapel Hill	Jiang, XC (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	XJiang@downstate.edu	fan, yi/GYU-1036-2022	Chakraborty, Mahua/0000-0003-1598-0665	National Institutes of Health [HL-64735, HL-69817]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064735, R01HL069817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-64735 and HL-69817 (to X.- C. J.). This work was also supported by an American Heart Association grant-in-aid (to X.- C. J.).	Arimoto I, 1998, LIPIDS, V33, P773, DOI 10.1007/s11745-998-0269-8; Arimoto I, 1998, J LIPID RES, V39, P143; Bolin DJ, 1996, J BIOL CHEM, V271, P19152, DOI 10.1074/jbc.271.32.19152; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; GORDON V, 1983, J BIOL CHEM, V258, P6202; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; GRONBERG L, 1991, BIOCHEMISTRY-US, V30, P10746, DOI 10.1021/bi00108a020; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hoekstra D, 2000, CURR OPIN CELL BIOL, V12, P496, DOI 10.1016/S0955-0674(00)00122-8; HOFF HF, 1985, ANN NY ACAD SCI, V454, P183, DOI 10.1111/j.1749-6632.1985.tb11857.x; Hojjati MR, 2006, J LIPID RES, V47, P673, DOI 10.1194/jlr.D500040-JLR200; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; INNERARITY TL, 1982, ARTERIOSCLEROSIS, V2, P114, DOI 10.1161/01.ATV.2.2.114; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Jeong TS, 1998, J CLIN INVEST, V101, P905, DOI 10.1172/JCI870; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Jones Jr, 2005, METH MOLEC MED, V103, P245; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Lucic D, 2007, BIOCHEMISTRY-US, V46, P11196, DOI 10.1021/bi701106v; MCINTOSH TJ, 1992, BIOCHEMISTRY-US, V31, P2020, DOI 10.1021/bi00122a018; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; PLUMP AS, 1995, ANNU REV NUTR, V15, P495, DOI 10.1146/annurev.nu.15.070195.002431; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; RODRIGUEZ JL, 1976, ATHEROSCLEROSIS, V23, P73, DOI 10.1016/0021-9150(76)90119-2; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rye KA, 1996, J BIOL CHEM, V271, P4243; Saito H, 2000, BBA-MOL CELL BIOL L, V1486, P312, DOI 10.1016/S1388-1981(00)00071-8; Schissel SL, 1996, J CLIN INVEST, V98, P1455, DOI 10.1172/JCI118934; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; Schlitt A, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-5; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Subbaiah PV, 2005, J LIPID RES, V46, P2699, DOI 10.1194/jlr.M500263-JLR200; SUBBAIAH PV, 1993, J BIOL CHEM, V268, P20156; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Xian-Cheng J, 2005, J BIOL CHEM, V280, P18336, DOI 10.1074/jbc.M500007200; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	53	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					27010	27019		10.1074/jbc.M109.042028	http://dx.doi.org/10.1074/jbc.M109.042028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648608	Green Published, hybrid			2022-12-25	WOS:000269969600080
J	Egami, Y; Araki, N				Egami, Youhei; Araki, Nobukazu			Dynamic Changes in the Spatiotemporal Localization of Rab21 in Live RAW264 Cells during Macropinocytosis	PLOS ONE			English	Article								Rab21, a member of the Rab GTPase family, is known to be involved in membrane trafficking, but its implication in macropinocytosis is unclear. We analyzed the spatiotemporal localization of Rab21 in M-CSF-stimulated RAW264 macrophages by the live-cell imaging of fluorescent protein-fused Rab21. It was demonstrated that wild- type Rab21 was transiently associated with macropinosomes. Rab21 was recruited to the macropinosomes after a decrease in PI(4,5)P(2) and PI(3,4,5)P(3) levels. Although Rab21 was largely colocalized with Rab5, the recruitment of Rab21 to the macropinosomes lagged a minute behind that of Rab5, and preceded that of Rab7. Then, Rab21 was dissociated from the macropinosomes prior to the accumulation of Lamp1, a late endosomal/lysosomal marker. Our analysis of Rab21 mutants revealed that the GTP-bound mutant, Rab21-Q78L, was recruited to the macropinosomes, similarly to wild- type Rab21. However, the GDP-bound mutant, Rab21-T33N, did not localize on the formed macropinosomes, suggesting that the binding of GTP to Rab21 is required for the proper recruitment of Rab21 onto the macropinosomes. However, neither mutation of Rab21 significantly affected the rate of macropinosome formation. These data indicate that Rab21 is a transient component of early and intermediate stages of macropinocytosis, and probably functions in macropinosome maturation before fusing with lysosomal compartments.			Egami, Y (corresponding author), Kagawa Univ, Dept Histol & Cell Biol, Sch Med, Kagawa, Japan.	naraki@med.kagawa-u.ac.jp	King, Jason S/D-6228-2011	King, Jason S/0000-0003-0596-4506; Araki, Nobukazu/0000-0001-6160-210X				ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; Araki N, 2003, J CELL SCI, V116, P247, DOI 10.1242/jcs.00235; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Egami Y, 2008, EXP CELL RES, V314, P729, DOI 10.1016/j.yexcr.2007.11.018; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Khurana T, 2005, EMBO J, V24, P2254, DOI 10.1038/sj.emboj.7600716; Kunita R, 2007, J BIOL CHEM, V282, P16599, DOI 10.1074/jbc.M610682200; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Li GP, 1997, J BIOL CHEM, V272, P10337; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; MERESSE S, 1995, J CELL SCI, V108, P3349; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Nobes C, 2000, CURR BIOL, V10, pR739, DOI 10.1016/S0960-9822(00)00736-3; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Opdam FJM, 2000, EUR J CELL BIOL, V79, P308, DOI 10.1078/S0171-9335(04)70034-5; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; RACOOSIN EL, 1992, J CELL SCI, V102, P867; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rodman JS, 2000, J CELL SCI, V113, P183; Sansonetti PJ, 2001, AM J PHYSIOL-GASTR L, V280, pG319, DOI 10.1152/ajpgi.2001.280.3.G319; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Stenmark H, 2001, GENOME BIOL, V2; Sun P, 2003, J BIOL CHEM, V278, P4063, DOI 10.1074/jbc.M208699200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang Q, 1999, MOL CELL BIOL, V19, P8158; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	44	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6689	10.1371/journal.pone.0006689	http://dx.doi.org/10.1371/journal.pone.0006689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693279	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267400003
J	Li, YQ; Roy, A; Zhang, Y				Li, Yunqi; Roy, Ambrish; Zhang, Yang			HAAD: A Quick Algorithm for Accurate Prediction of Hydrogen Atoms in Protein Structures	PLOS ONE			English	Article							DYNAMICS; REFINEMENT; POSITIONS; CRYSTALLOGRAPHY; CONFORMATION; SIMULATIONS; PRINCIPLES; CONTACTS; LIGAND	Hydrogen constitutes nearly half of all atoms in proteins and their positions are essential for analyzing hydrogen-bonding interactions and refining atomic-level structures. However, most protein structures determined by experiments or computer prediction lack hydrogen coordinates. We present a new algorithm, HAAD, to predict the positions of hydrogen atoms based on the positions of heavy atoms. The algorithm is built on the basic rules of orbital hybridization followed by the optimization of steric repulsion and electrostatic interactions. We tested the algorithm using three independent data sets: ultra-high-resolution X-ray structures, structures determined by neutron diffraction, and NOE proton-proton distances. Compared with the widely used programs CHARMM and REDUCE, HAAD has a significantly higher accuracy, with the average RMSD of the predicted hydrogen atoms to the X-ray and neutron diffraction structures decreased by 26% and 11%, respectively. Furthermore, hydrogen atoms placed by HAAD have more matches with the NOE restraints and fewer clashes with heavy atoms. The average CPU cost by HAAD is 18 and 8 times lower than that of CHARMM and REDUCE, respectively. The significant advantage of HAAD in both the accuracy and the speed of the hydrogen additions should make HAAD a useful tool for the detailed study of protein structure and function. Both an executable and the source code of HAAD are freely available at http://zhang.bioinformatics.ku.edu/HAAD.			Li, YQ (corresponding author), Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA.	yzhang@ku.edu	YZ, YZ/B-3243-2011; Roy, Ambrish/H-8550-2013		NIGMS NIH HHS [R01 GM083107, GM-083107, R01 GM084222, GM-084222] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083107, R01GM084222] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; BAUD F, 1993, J MOL BIOL, V231, P877, DOI 10.1006/jmbi.1993.1334; Bickelhaupt FM, 2003, ANGEW CHEM INT EDIT, V42, P4183, DOI 10.1002/anie.200350947; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen JH, 2007, PROTEINS, V67, P922, DOI 10.1002/prot.21345; Cohen M, 2008, PROTEINS, V72, P741, DOI 10.1002/prot.21960; DILL KA, 1995, PROTEIN SCI, V4, P561; Engler N, 2003, P NATL ACAD SCI USA, V100, P10243, DOI 10.1073/pnas.1834279100; Forrest LR, 2005, PROTEINS, V61, P296, DOI 10.1002/prot.20601; GOCHIN M, 1995, PROTEIN SCI, V4, P296; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kimura SR, 2008, PROTEINS, V71, P1919, DOI 10.1002/prot.21906; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; KOSSIAKOFF AA, 1983, ANNU REV BIOPHYS BIO, V12, P159, DOI 10.1146/annurev.bb.12.060183.001111; KOSSIAKOFF AA, 1982, NATURE, V296, P713, DOI 10.1038/296713a0; Li Y, 2008, J PHYS CHEM B, V112, P3797, DOI 10.1021/jp077392h; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nilges M, 1997, FOLD DES, V2, pS53, DOI 10.1016/S1359-0278(97)00064-3; Pauling L., 1931, J AM CHEM SOC, V53, P1367, DOI [10.1021/ja01355a027, DOI 10.1021/JA01355A027]; Pophristic V, 2001, NATURE, V411, P565, DOI 10.1038/35079036; Read RJ, 2007, PROTEINS, V69, P27, DOI 10.1002/prot.21662; Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103; Rowland RS, 1996, J PHYS CHEM-US, V100, P7384, DOI 10.1021/jp953141+; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seeliger D, 2007, PROTEINS, V68, P595, DOI 10.1002/prot.21447; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Verma A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-12; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wallin S, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/28/283101; Wang W, 2001, ANNU REV BIOPH BIOM, V30, P211, DOI 10.1146/annurev.biophys.30.1.211; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; ZHANG Y, 2009, CORR OPIN STRUCT BIO, DOI DOI 10.1016/J.SBI.2009.1002.1005	40	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6701	10.1371/journal.pone.0006701	http://dx.doi.org/10.1371/journal.pone.0006701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693270	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267400009
J	Harper, JT; Gile, GH; James, ER; Carpenter, KJ; Keeling, PJ				Harper, James T.; Gile, Gillian H.; James, Erick R.; Carpenter, Kevin J.; Keeling, Patrick J.			The Inadequacy of Morphology for Species and Genus Delineation in Microbial Eukaryotes: An Example from the Parabasalian Termite Symbiont Coronympha	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; COSPECIATION; PSEUDOTRICHONYMPHA; REPRODUCTION; TAXONOMY; GUT	Background: For the majority of microbial eukaryotes (protists, algae), there is no clearly superior species concept that is consistently applied. In the absence of a practical biological species concept, most species and genus level delineations have historically been based on morphology, which may lead to an underestimate of the diversity of microbial eukaryotes. Indeed, a growing body of molecular evidence, such as barcoding surveys, is beginning to support the conclusion that significant cryptic species diversity exists. This underestimate of diversity appears to be due to a combination of using morphology as the sole basis for assessing diversity and our inability to culture the vast majority of microbial life. Here we have used molecular markers to assess the species delineations in two related but morphologically distinct genera of uncultivated symbionts found in the hindgut of termites. Methodology/Principal Findings: Using single-cell isolation and environmental PCR, we have used a barcoding approach to characterize the diversity of Coronympha and Metacoronympha symbionts in four species of Incisitermes termites, which were also examined using scanning electron microscopy and light microcopy. Despite the fact that these genera are significantly different in morphological complexity and structural organisation, we find they are two life history stages of the same species. At the same time, we show that the symbionts from different termite hosts show an equal or greater level of sequence diversity than do the hosts, despite the fact that the symbionts are all classified as one species. Conclusions/Significance: The morphological information used to describe the diversity of these microbial symbionts is misleading at both the genus and species levels, and led to an underestimate of species level diversity as well as an overestimate of genus level diversity. The genus 'Metacoronympha' is invalid and appears to be a life history stage of Coronympha, while the single recognized species of Coronympha octonaria inhabiting these four termites is better described as four distinct species.	[Harper, James T.; Gile, Gillian H.; James, Erick R.; Carpenter, Kevin J.; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Harper, James T.] Douglas Coll, Dept Biol, New Westminster, BC, Canada	University of British Columbia	Harper, JT (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	pkeeling@interchange.ubc.ca	James, Erick R/D-4725-2012	Keeling, Patrick/0000-0002-7644-0745	Natural Sciences and Engineering Research Council of Canada [227301]; Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (227301). GHG is supported by a postgraduate doctoral fellowship from the Natural Sciences and Engineering Research Council of Canada. PJK is a Fellow of the Canadian Institute for Advanced Research and a Senior Investigator of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell G., 1988, SEX DEATH PROTOZOA, P199; Brugerolle Guy, 2002, P1196; Carpenter KJ, 2007, J EUKARYOT MICROBIOL, V54, P325, DOI 10.1111/j.1550-7408.2007.00263.x; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; CLEVELAND LR, 1934, MEM AM ACAD ARTS, V17, P1; Coleman AW, 2002, SCIENCE, V297, P337; DOERDER FP, 1995, P NATL ACAD SCI USA, V92, P8715, DOI 10.1073/pnas.92.19.8715; Dolan M, 1997, SYMBIOSIS, V22, P229; Dolan MF, 2000, ACTA PROTOZOOL, V39, P275; Doolittle WF, 1999, TRENDS CELL BIOL, V15, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; Finlay BJ, 2002, SCIENCE, V297, P337; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Gerbod D, 2002, MOL PHYLOGENET EVOL, V25, P545, DOI 10.1016/S1055-7903(02)00300-7; Gibson W, 2007, INT J PARASITOL, V37, P829, DOI 10.1016/j.ijpara.2007.03.002; GIBSON W, 1991, MOL BIOCHEM PARASIT, V45, P77, DOI 10.1016/0166-6851(91)90029-6; GUNDERSON J, 1995, J EUKARYOT MICROBIOL, V42, P411, DOI 10.1111/j.1550-7408.1995.tb01604.x; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Hoef-Emden K, 2003, PROTIST, V154, P371, DOI 10.1078/143446103322454130; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kirby H., 1941, University of California Publications in Zoology, V45, P1; Kirby H. Jr., 1939, Proceedings of the California Academy of Science (4th Series), V22, P207; Kirby H. jr., 1932, University of California Publications in Zoology, V37, P349; Kirby Harold, 1942, UNIV CALIFORNIA PUBL ZOOL, V45, P167; KIRBY HAROLD, 1929, UNIV CALIFORNIA PUBL ZOOL, V31, P417; KIRBY HAROLD, 1931, UNIV CALIFORNIA PUBL ZOOL, V36, P171; Kofoid C. A, 1919, U CALIF PUBL ZOOL, V20, P21; Lawrence JG, 2003, MOL MICROBIOL, V50, P739, DOI 10.1046/j.1365-2958.2003.03778.x; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; Ohkuma M, 2000, J EUKARYOT MICROBIOL, V47, P249, DOI 10.1111/j.1550-7408.2000.tb00044.x; Ohkuma M, 2009, P ROY SOC B-BIOL SCI, V276, P239, DOI 10.1098/rspb.2008.1094; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Slamovits CH, 2004, J EUKARYOT MICROBIOL, V51, P207, DOI 10.1111/j.1550-7408.2004.tb00547.x; Sokolova YY, 2003, J INVERTEBR PATHOL, V84, P159, DOI 10.1016/j.jip.2003.10.004; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWAFFORD DL, 1993, PAUP PHYLOGENETIC AN; TENTER AM, 1995, INT J PARASITOL, V25, P1311, DOI 10.1016/0020-7519(95)00068-D; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thompson RCA, 2004, ADV PARASIT, V58, P69, DOI 10.1016/S0065-308X(04)58002-8; Trager W, 1934, BIOL BULL-US, V66, P182, DOI 10.2307/1537331; VRIJENHOEK RC, 2009, DEEP SEA RE IN PRESS; WEST JA, 1972, BRIT PHYCOL J, V7, P299, DOI DOI 10.1080/00071617200650311; YAMIN MA, 1979, SOCIOBIOLOGY, V4, P3	46	43	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6577	10.1371/journal.pone.0006577	http://dx.doi.org/10.1371/journal.pone.0006577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668363	Green Published, Green Submitted, gold			2022-12-25	WOS:000268935600006
J	Piette, BMAG; Liu, JL; Peeters, K; Smertenko, A; Hawkins, T; Deeks, M; Quinlan, R; Zakrzewski, WJ; Hussey, PJ				Piette, Bernard M. A. G.; Liu, Junli; Peeters, Kasper; Smertenko, Andrei; Hawkins, Timothy; Deeks, Michael; Quinlan, Roy; Zakrzewski, Wojciech J.; Hussey, Patrick J.			A Thermodynamic Model of Microtubule Assembly and Disassembly	PLOS ONE			English	Article							INDIVIDUAL MICROTUBULES; DYNAMIC INSTABILITY; GTP CAP; MICROSCOPY; LATTICE	Microtubules are self-assembling polymers whose dynamics are essential for the normal function of cellular processes including chromosome separation and cytokinesis. Therefore understanding what factors effect microtubule growth is fundamental to our understanding of the control of microtubule based processes. An important factor that determines the status of a microtubule, whether it is growing or shrinking, is the length of the GTP tubulin microtubule cap. Here, we derive a Monte Carlo model of the assembly and disassembly of microtubules. We use thermodynamic laws to reduce the number of parameters of our model and, in particular, we take into account the contribution of water to the entropy of the system. We fit all parameters of the model from published experimental data using the GTP tubulin dimer attachment rate and the lateral and longitudinal binding energies of GTP and GDP tubulin dimers at both ends. Also we calculate and incorporate the GTP hydrolysis rate. We have applied our model and can mimic published experimental data, which formerly suggested a single layer GTP tubulin dimer microtubule cap, to show that these data demonstrate that the GTP cap can fluctuate and can be several microns long.	[Piette, Bernard M. A. G.; Liu, Junli; Peeters, Kasper; Smertenko, Andrei; Hawkins, Timothy; Deeks, Michael; Quinlan, Roy; Zakrzewski, Wojciech J.; Hussey, Patrick J.] Univ Durham, Biophys Sci Inst, Durham, England; [Piette, Bernard M. A. G.; Peeters, Kasper; Zakrzewski, Wojciech J.] Univ Durham, Dept Math Sci, Durham, England; [Liu, Junli; Smertenko, Andrei; Hawkins, Timothy; Deeks, Michael; Quinlan, Roy; Hussey, Patrick J.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Durham University; Durham University; Durham University	Piette, BMAG (corresponding author), Univ Durham, Biophys Sci Inst, Durham, England.	b.m.a.g.piette@durham.ac.uk; p.j.hussey@durham.ac.uk	Quinlan, Roy/A-1348-2012	Quinlan, Roy/0000-0003-0644-4123; Smertenko, Andrei/0000-0002-5078-4881; Hussey, Patrick/0000-0002-7349-8722; Deeks, Michael/0000-0001-5487-5732; Piette, Bernard/0000-0001-9777-603X; Liu, Junli/0000-0001-8264-2450	BBSRC [BB/F010788/1]; Biotechnology and Biological Sciences Research Council [BB/F010788/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in part by the BBSRC Grant No. BB/F010788/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOS LA, 1979, NATURE, V279, P607, DOI 10.1038/279607a0; BAYLEY PM, 1990, J CELL SCI, V95, P33; CHEN YD, 1985, P NATL ACAD SCI USA, V82, P1131, DOI 10.1073/pnas.82.4.1131; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; FERMI E, 1932, THERMODYNAMICS; GIBSON M, 2000, THESIS CALTECH; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; HILL TL, 1984, P NATL ACAD SCI-BIOL, V81, P5772, DOI 10.1073/pnas.81.18.5772; LEACH AR, 2001, MOL MODELING; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Pollard T.D., 2017, CELL BIOL, P543; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; WALKER RA, 1991, J CELL BIOL, V114, P73, DOI 10.1083/jcb.114.1.73; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	17	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6378	10.1371/journal.pone.0006378	http://dx.doi.org/10.1371/journal.pone.0006378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668378	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000268935600001
J	Sequeira, A; Mamdani, F; Ernst, C; Vawter, MP; Bunney, WE; Lebel, V; Rehal, S; Klempan, T; Gratton, A; Benkelfat, C; Rouleau, GA; Mechawar, N; Turecki, G				Sequeira, Adolfo; Mamdani, Firoza; Ernst, Carl; Vawter, Marquis P.; Bunney, William E.; Lebel, Veronique; Rehal, Sonia; Klempan, Tim; Gratton, Alain; Benkelfat, Chawki; Rouleau, Guy A.; Mechawar, Naguib; Turecki, Gustavo			Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression	PLOS ONE			English	Article							CHRONIC ETHANOL TREATMENT; MESSENGER-RNA EXPRESSION; GAMMA-AMINOBUTYRIC-ACID; FALSE DISCOVERY RATE; POSTMORTEM BRAIN; HIPPOCAMPAL VOLUME; LOCUS-COERULEUS; PREFRONTAL CORTEX; RECEPTOR-BINDING; FRONTAL-CORTEX	Background: Most studies investigating the neurobiology of depression and suicide have focused on the serotonergic system. While it seems clear that serotonergic alterations play a role in the pathogenesis of these major public health problems, dysfunction in additional neurotransmitter systems and other molecular alterations may also be implicated. Microarray expression studies are excellent screening tools to generate hypotheses about additional molecular processes that may be at play. In this study we investigated brain regions that are known to be implicated in the neurobiology of suicide and major depression are likely to represent valid global molecular alterations. Methodology/Principal Findings: We performed gene expression analysis using the HG-U133AB chipset in 17 cortical and subcortical brain regions from suicides with and without major depression and controls. Total mRNA for microarray analysis was obtained from 663 brain samples isolated from 39 male subjects, including 26 suicide cases and 13 controls diagnosed by means of psychological autopsies. Independent brain samples from 34 subjects and animal studies were used to control for the potential confounding effects of comorbidity with alcohol. Using a Gene Ontology analysis as our starting point, we identified molecular pathways that may be involved in depression and suicide, and performed follow-up analyses on these possible targets. Methodology included gene expression measures from microarrays, Gene Score Resampling for global ontological profiling, and semi-quantitative RT-PCR. We observed the highest number of suicide specific alterations in prefrontal cortical areas and hippocampus. Our results revealed alterations of synaptic neurotransmission and intracellular signaling. Among these, Glutamatergic (GLU) and GABAergic related genes were globally altered. Semi-quantitative RT-PCR results investigating expression of GLU and GABA receptor subunit genes were consistent with microarray data. Conclusions/Significance: The observed results represent the first overview of global expression changes in brains of suicide victims with and without major depression and suggest a global brain alteration of GLU and GABA receptor subunit genes in these conditions.	[Sequeira, Adolfo; Vawter, Marquis P.; Bunney, William E.] Univ Calif Irvine, Dept Psychiat & Human Behav, Sch Med, Irvine, CA 92717 USA; [Sequeira, Adolfo; Mamdani, Firoza; Ernst, Carl; Lebel, Veronique; Rehal, Sonia; Klempan, Tim; Gratton, Alain; Mechawar, Naguib; Turecki, Gustavo] McGill Univ, McGill Grp Suicide Studies, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Benkelfat, Chawki] McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Rouleau, Guy A.] Univ Montreal, Ste Justine Hosp, Montreal, PQ, Canada	University of California System; University of California Irvine; McGill University; McGill University; Royal Victoria Hospital; Universite de Montreal	Sequeira, A (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Sch Med, Irvine, CA 92717 USA.	gustavo.turecki@mcgill.ca	Sequeira, Adolfo/K-7278-2015; Turecki, Gustavo/K-5100-2015	Sequeira, Adolfo/0000-0003-3040-1190; Mamdani, Firoza/0000-0001-8238-2492; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institute of Health Research (CIHR) [53321, 79253]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded in part by Canadian Institute of Health Research (CIHR) grants MOP# 53321 and MOP#79253. In addition, microarray studies in this study were carried out as part of a collaboration with Gene Logic Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; ALTSHULER LL, 1990, ARCH GEN PSYCHIAT, V47, P1029; ARANGO V, 1993, BRAIN RES, V630, P271, DOI 10.1016/0006-8993(93)90666-B; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auer DP, 2000, BIOL PSYCHIAT, V47, P305, DOI 10.1016/S0006-3223(99)00159-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergquist J, 2002, EUR NEUROPSYCHOPHARM, V12, P153, DOI 10.1016/S0924-977X(02)00002-0; Berk M, 2001, CLIN NEUROPHARMACOL, V24, P129, DOI 10.1097/00002826-200105000-00002; BOURNE HR, 1968, LANCET, V2, P805; Bowden C, 1997, BRAIN RES, V752, P227, DOI 10.1016/S0006-8993(96)01460-6; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Bunney WE, 2003, AM J PSYCHIAT, V160, P657, DOI 10.1176/appi.ajp.160.4.657; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; CHEETHAM SC, 1988, BRAIN RES, V460, P114, DOI 10.1016/0006-8993(88)91211-5; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; DeArmond SJ, 1989, STRUCTURE HUMAN BRAI; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DISCENNA PG, 1994, BRAIN RES, V647, P353, DOI 10.1016/0006-8993(94)91335-8; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Dwivedi Y, 2006, MOL PSYCHIATR, V11, P86, DOI 10.1038/sj.mp.4001744; Dwivedi Y, 2004, BIOL PSYCHIAT, V55, P234, DOI 10.1016/j.biopsych.2003.11.003; Dwivedi Y, 2002, NEUROPSYCHOPHARMACOL, V27, P499; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Escriba PV, 2004, NEUROPSYCHOPHARMACOL, V29, P1512, DOI 10.1038/sj.npp.1300459; Fujita M, 2000, BIOL PSYCHIAT, V48, P801, DOI 10.1016/S0006-3223(00)00960-4; GARLOW S, 1999, NEUROBIOLOGY MENTAL; George MS, 2001, ARCH GEN PSYCHIAT, V58, P345, DOI 10.1001/archpsyc.58.4.345; Gross-Isseroff R, 1998, NEUROSCI BIOBEHAV R, V22, P653, DOI 10.1016/S0149-7634(97)00061-4; Gwadry FG, 2005, AM J MED GENET C, V133C, P48, DOI 10.1002/ajmg.c.30046; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; HOLEMANS S, 1993, BRAIN RES, V616, P138, DOI 10.1016/0006-8993(93)90202-X; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; KIM C, 2004, AM J PSYCHI IN PRESS; Klimek V, 1997, J NEUROSCI, V17, P8451; Krystal JH, 2002, MOL PSYCHIATR, V7, pS71, DOI 10.1038/sj.mp.4001021; Kupfer, 1990, SUICIDE LIFE CYCLE R; Laje G, 2007, AM J PSYCHIAT, V164, P1530, DOI 10.1176/appi.ajp.2007.06122018; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; MANJI HK, 1992, AM J PSYCHIAT, V149, P746; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Mann JJ, 2001, NEUROPSYCHOPHARMACOL, V24, P467, DOI 10.1016/S0893-133X(00)00228-1; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; MEANA JJ, 1992, BIOL PSYCHIAT, V31, P471; MEANA JJ, 1987, J NEURAL TRANSM, V70, P377, DOI 10.1007/BF01253612; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Milak MS, 2005, ARCH GEN PSYCHIAT, V62, P397, DOI 10.1001/archpsyc.62.4.397; Nemeroff Charles B, 2002, Psychopharmacol Bull, V36 Suppl 2, P6; Noga JT, 1997, SYNAPSE, V27, P168, DOI 10.1002/(SICI)1098-2396(199711)27:3<168::AID-SYN2>3.3.CO;2-#; NOWAK G, 1995, BRAIN RES, V675, P157, DOI 10.1016/0006-8993(95)00057-W; Ordway GA, 1997, ANN NY ACAD SCI, V836, P233, DOI 10.1111/j.1749-6632.1997.tb52363.x; Pandey GN, 2004, ARCH GEN PSYCHIAT, V61, P685, DOI 10.1001/archpsyc.61.7.685; PANDEY GN, 2005, NEUROPSYCHOPHARMACOL; PARE CMB, 1969, LANCET, V2, P133; Pawitan Y, 2005, BIOINFORMATICS, V21, P3865, DOI 10.1093/bioinformatics/bti626; Pellegrini-Giampietro DE, 2003, TRENDS NEUROSCI, V26, P9, DOI 10.1016/S0166-2236(02)00004-8; Petroff OAC, 2002, NEUROSCIENTIST, V8, P562, DOI 10.1177/1073858402238515; Ragnarsson L, 2002, J NEUROCHEM, V81, P765, DOI 10.1046/j.1471-4159.2002.00872.x; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; ROMANO C, 1991, J NEUROCHEM, V57, P811, DOI 10.1111/j.1471-4159.1991.tb08223.x; ROY A, 1989, BIOL PSYCHIAT, V25, P341, DOI 10.1016/0006-3223(89)90181-9; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Samson HH, 1999, ALCOHOL, V19, P151, DOI 10.1016/S0741-8329(99)00032-4; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHULZ R, 1980, PSYCHOPHARMACOLOGY, V68, P221, DOI 10.1007/BF00428107; SEIZINGER BR, 1983, PHARMACOL BIOCHEM BE, V18, P361, DOI 10.1016/0091-3057(83)90200-9; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; Sheline YI, 2000, BIOL PSYCHIAT, V48, P791, DOI 10.1016/S0006-3223(00)00994-X; Sheline YI, 2002, EUR PSYCHIAT, V17, p300S; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; SIMARD LR, 1994, HUM MOL GENET, V3, P459, DOI 10.1093/hmg/3.3.459; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Stewart CA, 2002, MOL PSYCHIATR, V7, pS15, DOI 10.1038/sj.mp.4001014; Storey John D, 2003, Methods Mol Biol, V224, P149; Turecki G, 1999, AM J PSYCHIAT, V156, P1456; Turecki G, 2001, BIPOLAR DISORD, V3, P335, DOI 10.1034/j.1399-5618.2001.30608.x; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; World Health Organization, 2000, WORLD HLTH REP 2000; Zalsman G, 2004, J NEURAL TRANSM, V111, P1593, DOI 10.1007/s00702-004-0182-3; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhu MY, 1999, BIOL PSYCHIAT, V46, P1275, DOI 10.1016/S0006-3223(99)00135-3	96	249	257	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6585	10.1371/journal.pone.0006585	http://dx.doi.org/10.1371/journal.pone.0006585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668376	Green Published, gold			2022-12-25	WOS:000268935600012
J	Sainz, B; Barretto, N; Uprichard, SL				Sainz, Bruno, Jr.; Barretto, Naina; Uprichard, Susan L.			Hepatitis C Virus Infection in Phenotypically Distinct Huh7 Cell Lines	PLOS ONE			English	Article								In 2005, the first robust hepatitis C virus (HCV) infectious cell culture system was developed based on the HCV genotype 2a JFH-1 molecular clone and the human-derived hepatoma cell line Huh7. Although much effort has been made to dissect and expand the repertoire of JFH-1-derived clones, less attention has been given to the host cell despite the intriguing facts that thus far only Huh7 cells have been found to be highly permissive for HCV infection and furthermore only a limited number of Huh7 cell lines/stocks appear to be fully permissive. As such, we compiled a panel of Huh7 lines from disparate sources and evaluated their permissiveness for HCV infection. We found that although Huh7 lines from different laboratories do vary in morphology and cell growth, the majority (8 out of 9) were highly permissive for infection, as demonstrated by robust HCV RNA and de novo infectious virion production following infection. While HCV RNA levels achieved in the 8 permissive cell lines were relatively equivalent, three Huh7 lines demonstrated higher infectious virion production suggesting these cell lines more efficiently support post-replication event(s) in the viral life cycle. Consistent with previous studies, the single Huh7 line found to be relatively resistant to infection demonstrated a block in HCV entry. These studies not only suggest that the majority of Huh7 cell lines in different laboratories are in fact highly permissive for HCV infection, but also identify phenotypically distinct Huh7 lines, which may facilitate studies investigating the cellular determinants of HCV infection.			Sainz, B (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	sluprich@uic.edu	Anding, Bruno Sainz/ABH-5365-2020	Anding, Bruno Sainz/0000-0003-4829-7651	NCI NIH HHS [R21 CA133266, R21 CA133266-01A1] Funding Source: Medline; NIAID NIH HHS [R01 AI070827, AI070827, R01 AI070827-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA133266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070827] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Bartenschlager R, 2005, P NATL ACAD SCI USA, V102, P9739, DOI 10.1073/pnas.0504296102; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; CHANG CM, 1987, EMBO J, V6, P675, DOI 10.1002/j.1460-2075.1987.tb04807.x; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Choi S, 2009, XENOBIOTICA, V39, P205, DOI 10.1080/00498250802613620; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moradpour D, 2004, J VIROL, V78, P13278, DOI 10.1128/JVI.78.23.13278-13284.2004; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	32	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6561	10.1371/journal.pone.0006561	http://dx.doi.org/10.1371/journal.pone.0006561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668344	Green Published, Green Submitted, gold			2022-12-25	WOS:000268773300003
J	Pergams, ORW; Lawler, JJ				Pergams, Oliver R. W.; Lawler, Joshua J.			Recent and Widespread Rapid Morphological Change in Rodents	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; CLIMATE-CHANGE; BODY-SIZE; EVOLUTION; TIME; EXPRESSION; RESPONSES; RATES; LIFE	In general, rapid morphological change in mammals has been infrequently documented. Examples that do exist are almost exclusively of rodents on islands. Such changes are usually attributed to selective release or founder events related to restricted gene flow in island settings. Here we document rapid morphological changes in rodents in 20 of 28 museum series collected on four continents, including 15 of 23 mainland sites. Approximately 17,000 measurements were taken of 1302 rodents. Trends included both increases and decreases in the 15 morphological traits measured, but slightly more trends were towards larger size. Generalized linear models indicated that changes in several of the individual morphological traits were associated with changes in human population density, current temperature gradients, and/or trends in temperature and precipitation. When we restricted these analyses to samples taken in the US (where data on human population trends were presumed to be more accurate), we found changes in two additional traits to be positively correlated with changes in human population density. Principle component analysis revealed general trends in cranial and external size, but these general trends were uncorrelated with climate or human population density. Our results indicate that over the last 100+ years, rapid morphological change in rodents has occurred quite frequently, and that these changes have taken place on the mainland as well as on islands. Our results also suggest that these changes may be driven, at least in part, by human population growth and climate change.			Pergams, ORW (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	pergams@uic.edu						Afifi A., 2003, COMPUTER AIDED MULTI; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Allen JA, 1877, RADICAL REV, V1, P108, DOI DOI 10.1038/SCIENTIFICAMERICAN05251907-26247SUPP; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Both C, 2006, ARDEA, V94, P511; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; DAVISON AW, 1995, NEW PHYTOL, V131, P337, DOI 10.1111/j.1469-8137.1995.tb03069.x; Dayan T, 1998, MAMMAL REV, V28, P99, DOI 10.1046/j.1365-2907.1998.00029.x; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Garant D, 2004, EVOLUTION, V58, P634, DOI 10.1111/j.0014-3820.2004.tb01685.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; Hammond KA, 1999, PHYSIOL BIOCHEM ZOOL, V72, P613, DOI 10.1086/316697; Hartl D., 2007, PRINCIPLES POPULATIO; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Hegyi G, 2006, J EVOLUTION BIOL, V19, P228, DOI 10.1111/j.1420-9101.2005.00970.x; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hendry AP, 2006, P R SOC B, V273, P1887, DOI 10.1098/rspb.2006.3534; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; HOLM S, 1979, SCAND J STAT, V6, P65; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MITCHELL TD, 2004, 55 TYND CTR CLIM CHG; Moller AP, 2005, J EVOLUTION BIOL, V18, P481, DOI 10.1111/j.1420-9101.2004.00807.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Palkovacs EP, 2003, OIKOS, V103, P37, DOI 10.1034/j.1600-0706.2003.12502.x; Pergams ORW, 2008, MOL ECOL, V17, P450, DOI 10.1111/j.1365-294X.2007.03517.x; Pergams ORW, 1999, EVOLUTION, V53, P1573, DOI 10.1111/j.1558-5646.1999.tb05420.x; Pergams ORW, 2003, NATURE, V423, P397, DOI 10.1038/423397a; Pergams ORW, 2001, GENETICA, V112, P245, DOI 10.1023/A:1013343923155; Pergams ORW, 2009, PRINCETON GUIDE ECOL; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; Serrat MA, 2008, P NATL ACAD SCI USA, V105, P19348, DOI 10.1073/pnas.0803319105; Svensson EI, 2007, FUNCT ECOL, V21, P422, DOI 10.1111/j.1365-2435.2007.01265.x; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wright S, 2006, P NATL ACAD SCI USA, V103, P7718, DOI 10.1073/pnas.0510383103; ZAKHAROV EV, 2009, MOL ECOL IN PRESS; [No title captured]; [No title captured]	51	53	53	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6452	10.1371/journal.pone.0006452	http://dx.doi.org/10.1371/journal.pone.0006452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649284	Green Published, gold, Green Submitted			2022-12-25	WOS:000268637600004
J	Kingsley, EP; Manceau, M; Wiley, CD; Hoekstra, HE				Kingsley, Evan P.; Manceau, Marie; Wiley, Christopher D.; Hoekstra, Hopi E.			Melanism in Peromyscus Is Caused by Independent Mutations in Agouti	PLOS ONE			English	Article								Identifying the molecular basis of phenotypes that have evolved independently can provide insight into the ways genetic and developmental constraints influence the maintenance of phenotypic diversity. Melanic (darkly pigmented) phenotypes in mammals provide a potent system in which to study the genetic basis of naturally occurring mutant phenotypes because melanism occurs in many mammals, and the mammalian pigmentation pathway is well understood. Spontaneous alleles of a few key pigmentation loci are known to cause melanism in domestic or laboratory populations of mammals, but in natural populations, mutations at one gene, the melanocortin-1 receptor (Mc1r), have been implicated in the vast majority of cases, possibly due to its minimal pleiotropic effects. To investigate whether mutations in this or other genes cause melanism in the wild, we investigated the genetic basis of melanism in the rodent genus Peromyscus, in which melanic mice have been reported in several populations. We focused on two genes known to cause melanism in other taxa, Mc1r and its antagonist, the agouti signaling protein (Agouti). While variation in the Mc1r coding region does not correlate with melanism in any population, in a New Hampshire population, we find that a 125-kb deletion, which includes the upstream regulatory region and exons 1 and 2 of Agouti, results in a loss of Agouti expression and is perfectly associated with melanic color. In a second population from Alaska, we find that a premature stop codon in exon 3 of Agouti is associated with a similar melanic phenotype. These results show that melanism has evolved independently in these populations through mutations in the same gene, and suggest that melanism produced by mutations in genes other than Mc1r may be more common than previously thought.			Kingsley, EP (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	ekingsley@oeb.harvard.edu	Hoekstra, Hopi E/I-6690-2012	Hoekstra, Hopi E/0000-0003-1431-1769; Kingsley, Evan/0000-0002-4351-2300; Wiley, Christopher/0000-0002-7699-6866				Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Baiao PC, 2007, J HERED, V98, P287, DOI 10.1093/jhered/esm030; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Baxter SW, 2008, GENETICS, V180, P1567, DOI 10.1534/genetics.107.082982; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bronson RT, 2001, J NEUROPATH EXP NEUR, V60, P724, DOI 10.1093/jnen/60.7.724; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen YR, 1996, GENETICS, V144, P265; Cott H.B., 1940, ADAPTIVE COLORATION; COTTLE CA, 1987, J COMP PSYCHOL, V101, P390, DOI 10.1037/0735-7036.101.4.390; DICKIE MM, 1969, J HERED, V60, P20, DOI 10.1093/oxfordjournals.jhered.a107920; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Gunn TM, 1999, NATURE, V398, P152, DOI 10.1038/18217; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Hayssen V, 1997, J COMP PSYCHOL, V111, P419, DOI 10.1037/0735-7036.111.4.419; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hiragaki T, 2008, GENETICS, V178, P771, DOI 10.1534/genetics.107.077040; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Hoekstra HE, 2003, MOL ECOL, V12, P1185, DOI 10.1046/j.1365-294X.2003.01788.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HOGAN KM, 1993, J MAMMAL, V74, P819, DOI 10.2307/1382420; HORNER BE, 1980, J HERED, V71, P49, DOI 10.1093/oxfordjournals.jhered.a109310; Howard W. E., 1957, Journal of Mammalogy, V38, P417; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kijas JMH, 1998, GENETICS, V150, P1177; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; KORNEGAY JR, 1994, MOL BIOL EVOL, V11, P921; Kuramoto T, 2001, MAMM GENOME, V12, P469, DOI 10.1007/s003350020010; Ling MK, 2003, EUR J BIOCHEM, V270, P1441, DOI 10.1046/j.1432-1033.2003.03506.x; Lu DS, 1998, MOL ENDOCRINOL, V12, P592, DOI 10.1210/me.12.4.592; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; MAJERUS MEN, 1998, MELANISM EVOLUTION A; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Miltenberger RJ, 2002, GENETICS, V160, P659; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nadeau NJ, 2006, ANIM GENET, V37, P287, DOI 10.1111/j.1365-2052.2006.01442.x; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Ollmann MM, 1999, J BIOL CHEM, V274, P15837, DOI 10.1074/jbc.274.22.15837; Orr HA, 2001, GENETICS, V157, P875; Osgood W. H., 1909, REVISION MICE AM GEN; Perry WL, 1996, GENETICS, V144, P255; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Steiner CC, 2009, MOL BIOL EVOL, V26, P35, DOI 10.1093/molbev/msn218; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1308, P164, DOI 10.1016/0167-4781(96)00100-5; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Vage DI, 2005, PEPTIDES, V26, P1814, DOI 10.1016/j.peptides.2004.11.040; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Vage DI, 1999, MAMM GENOME, V10, P39, DOI 10.1007/s003359900939; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wlasiuk G, 2007, J HERED, V98, P567, DOI 10.1093/jhered/esm059	76	85	91	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6435	10.1371/journal.pone.0006435	http://dx.doi.org/10.1371/journal.pone.0006435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649329	gold, Green Published, Green Submitted			2022-12-25	WOS:000268494600005
J	Bang, ML; Caremani, M; Brunello, E; Littlefield, R; Lieber, RL; Chen, J; Lombardi, V; Linari, M				Bang, Marie-Louise; Caremani, Marco; Brunello, Elisabetta; Littlefield, Ryan; Lieber, Richard L.; Chen, Ju; Lombardi, Vincenzo; Linari, Marco			Nebulin plays a direct role in promoting strong actin-myosin interactions	FASEB JOURNAL			English	Article						muscle performance; muscle force generation; cytoskeletal proteins	THIN FILAMENT LENGTHS; RABBIT PSOAS MUSCLE; SKELETAL-MUSCLE; STRIATED-MUSCLE; NEMALINE MYOPATHY; FORCE DEVELOPMENT; ATP HYDROLYSIS; POINTED ENDS; FIBERS; PHOSPHATE	The role of the actin filament-associated protein nebulin on mechanical and kinetic properties of the actomyosin motor was investigated in skeletal muscle of wild-type (wt) and nebulin-deficient (nebulin(-/-)) mice that were 1 d old, an age at which sarcomeric structure is still well preserved. In Ca(2+)-activated skinned fibers from psoas muscle, we determined the Ca(2+) dependence of isometric force and stiffness, the rate of force redevelopment after unloaded shortening (k(TR)), the power during isotonic shortening, and the unloaded shortening velocity (V(0)). Our results show a 65% reduction in isometric force in nebulin(-/-) fibers at saturating [Ca(2+)], whereas neither thin-filament length nor the Ca(2+) sensitivity of the contractile system is affected. Stiffness measurements indicate that the reduction in isometric force is due to a reduction in the number of actin-attached myosin motors, whereas the force of the motor is unchanged. Furthermore, in nebulin(-/-) fibers, kTR is decreased by 57%, V(0) is increased by 63%, and the maximum power is decreased by 80%. These results indicate that, in the absence of nebulin, the attachment probability of the myosin motors to actin is decreased, revealing a direct role for nebulin in promoting strong actomyosin interactions responsible for force and power production.-Bang, M.-L., Caremani, M., Brunello, E., Littlefield, R., Lieber, R. L., Chen, J., Lombardi, V., Linari, M. Nebulin plays a direct role in promoting strong actin-myosin interactions. FASEB J. 23, 4117-4125 (2009). www.fasebj.org	[Bang, Marie-Louise] CNR, ITB, Dulbecco Telethon Inst, I-20090 Milan, Italy; [Bang, Marie-Louise] Ist Ricovero & Cura Carattere Sci Multimed, Milan, Italy; [Caremani, Marco; Brunello, Elisabetta; Lombardi, Vincenzo; Linari, Marco] Univ Florence, Dipartimento Biol Evoluzionist, Lab Fisiol, Florence, Italy; [Caremani, Marco; Linari, Marco] Univ Florence, Consorzio Nazl Interuniv Sci Fis Mat, Florence, Italy; [Littlefield, Ryan] Univ Washington, Friday Harbor Labs, Ctr Cell Dynam, Friday Harbor, WA 98250 USA; [Lieber, Richard L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lieber, Richard L.] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lieber, Richard L.] Vet Affairs Med Ctr, La Jolla, CA USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Florence; University of Florence; University of Washington; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bang, ML (corresponding author), CNR, ITB, Dulbecco Telethon Inst, Via Fratelli Cervi 93, I-20090 Milan, Italy.	m.bang@itb.cnr.it; marco.linari@unifi.it	Bang, Marie-Louise/B-5683-2015; Chen, Ju/E-5579-2011	Bang, Marie-Louise/0000-0001-8859-5034; Brunello, Elisabetta/0000-0003-3167-4828; Lieber, Richard/0000-0002-7203-4520; Caremani, Marco/0000-0001-9128-7227; LINARI, MARCO/0000-0001-6512-4897	U. S. National Institutes of Health [R01 AR49033]; Ministero dell'Universitae della Ricerca [MiUR-Cofin 2006]; Ministero del Lavoro, della Salute e delle Politiche Sociali [RF-MUL-2007-666195]; Telethon-Italy [TCP07006]; Fondazione Cariplo [2007.5812]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049033] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Universitae della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero del Lavoro, della Salute e delle Politiche Sociali; Telethon-Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors acknowledge the Telethon Electron Microscopy core facility (directed by R. S. Polishchuk) for the preparation and analysis of electron microscopic specimens and thank Mario Dolfi for skilled technical assistance. This research was supported by the U. S. National Institutes of Health (grant R01 AR49033), Ministero dell'Universitae della Ricerca (MiUR-Cofin 2006), and Ministero del Lavoro, della Salute e delle Politiche Sociali (grant RF-MUL-2007-666195). M.-L. B. is an Assistant Telethon Scientist supported by Telethon-Italy (grant TCP07006) and Fondazione Cariplo (grant 2007.5812).	Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Bang ML, 2002, J STRUCT BIOL, V137, P119, DOI 10.1006/jsbi.2002.4457; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Brunello E, 2006, J PHYSIOL-LONDON, V577, P971, DOI 10.1113/jphysiol.2006.115394; CASELLA JF, 1987, J CELL BIOL, V105, P371, DOI 10.1083/jcb.105.1.371; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; FINK RHA, 1986, J PHYSIOL-LONDON, V373, P513, DOI 10.1113/jphysiol.1986.sp016060; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V354, P577, DOI 10.1113/jphysiol.1984.sp015394; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; Huxley AF, 1980, J PHYSL, V305, P15; JIN JP, 1991, FEBS LETT, V281, P93, DOI 10.1016/0014-5793(91)80366-B; KAWAI M, 1987, PFLUG ARCH EUR J PHY, V408, P1, DOI 10.1007/BF00581833; Kohler J, 2002, P NATL ACAD SCI USA, V99, P3557, DOI 10.1073/pnas.062415899; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; Linari M, 2004, J PHYSIOL-LONDON, V554, P335, DOI 10.1113/jphysiol.2003.051748; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; Littlefield R, 2002, BIOPHYS J, V82, P2548, DOI 10.1016/S0006-3495(02)75598-7; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; Ma K, 2002, FEBS LETT, V532, P273, DOI 10.1016/S0014-5793(02)03655-4; McElhinny AS, 2001, J BIOL CHEM, V276, P583, DOI 10.1074/jbc.M005693200; MILLAR NC, 1990, J BIOL CHEM, V265, P20234; Ottenheijm CAC, 2008, FASEB J, V22, P2912, DOI 10.1096/fj.07-104372; PFUHL M, 1994, EMBO J, V13, P1782, DOI 10.1002/j.1460-2075.1994.tb06446.x; Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045; Regnier M, 1995, AM J PHYSIOL-CELL PH, V269, pC1532, DOI 10.1152/ajpcell.1995.269.6.C1532; ROOT DD, 1994, BIOCHEMISTRY-US, V33, P12581, DOI 10.1021/bi00208a008; Root DD, 2001, BIOCHEMISTRY-US, V40, P1171, DOI 10.1021/bi0015010; SCHAFER DA, 1995, J CELL BIOL, V128, P61, DOI 10.1083/jcb.128.1.61; Simmons RM, 1974, RECENT ADV PHYSIOL, V31, P87; Sleep J, 2005, J PHYSIOL-LONDON, V563, P671, DOI 10.1113/jphysiol.2004.078873; Stehle R, 2000, BIOPHYS J, V78, P1458, DOI 10.1016/S0006-3495(00)76699-9; Wallgren-Pettersson C, 1999, NEUROMUSCULAR DISORD, V9, P564, DOI 10.1016/S0960-8966(99)00061-9; Wallgren-Pettersson C, 2002, NEUROMUSCULAR DISORD, V12, P674, DOI 10.1016/S0960-8966(02)00065-2; Wang K, 1996, J BIOL CHEM, V271, P4304; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242	43	54	54	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2009	23	12					4117	4125		10.1096/fj.09-137729	http://dx.doi.org/10.1096/fj.09-137729			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19679637	Green Published			2022-12-25	WOS:000272193700008
J	Du, XL; Yang, H; Liu, SG; Luo, ML; Hao, JJ; Zhang, Y; Lin, DC; Xu, X; Cai, Y; Zhan, QM; Wang, MR				Du, X-L; Yang, H.; Liu, S-G; Luo, M-L; Hao, J-J; Zhang, Y.; Lin, D-C; Xu, X.; Cai, Y.; Zhan, Q-M; Wang, M-R			Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma	ONCOGENE			English	Article						Calreticulin; Cortactin; anoikis; motility; STAT3	2-DIMENSIONAL ELECTROPHORESIS; ENDOPLASMIC-RETICULUM; PROTEOMIC ANALYSIS; INDUCED APOPTOSIS; DUCTAL CARCINOMA; CORTACTIN; EXPRESSION; GENE; OVEREXPRESSION; PROTEIN	We have shown earlier that overexpression of Calreticulin (CRT) contributed to a poor prognosis for patients with esophageal squamous cell carcinoma (ESCC). Here, we have shown an important role of CRT in tumorigenesis through enhancing cell motility and anoikis resistance. SiRNA-mediated knockdown of CRT caused impaired cell migration, invasion and resistance to anoikis. Notably, CRT downregulation decreased the expression of Cortactin (CTTN), which has been previously reported as a candidate oncogene associated with anoikis through the PI3K-Akt pathway. In addition, Akt phosphorylation was abolished after CRT downregulation and its activation can be refreshed by CRT upregulation, suggesting that CRT-enhanced cell resistance to anoikis through the CRT-CTTN-PI3K-Akt pathway. Moreover, the CTTN mRNA level was decreased in CRT-siRNA cells, coupled with the inactivation of STAT3. Expression of both CTTN and p-STAT3 was reduced in tumor cells following incubation with the JAK-specific inhibitor, AG490. Chromatin immunoprecipitation assay showed direct binding of p-STAT3 to the conservative STAT3-binding sequences in CTTN promoter. Furthermore, overexpression of CTTN in CRT-downregulated ESCC cells restored its motility and resistance to anoikis. This study not only reveals a role of CRT in motility promotion and anoikis resistance in ESCC cells, but also identifies CRT as an upstream regulator in the CRT-STAT3-CTTN Akt pathway. Oncogene (2009) 28, 3714-3722; doi: 10.1038/onc.2009.237; published online 17 August 2009	[Wang, M-R] Chinese Acad Med Sci, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Wang, MR (corresponding author), Chinese Acad Med Sci, Canc Inst Hosp, State Key Lab Mol Oncol, 17 Pan Jia Yuan, Beijing 100021, Peoples R China.	wangmr04@126.com	Luo, Man/GWQ-4789-2022; luo, man/HGC-7868-2022; LIN, DECHEN/K-9457-2014		National Basic Research Program of China [2004CB518705]; National High-tech R&D Program of China [2006AA02A403]; National Key Technologies R&D Program of China [2006BAI02A14]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20060023003]; National Natural Science Foundation [30872936, 30721001]	National Basic Research Program of China(National Basic Research Program of China); National High-tech R&D Program of China(National High Technology Research and Development Program of China); National Key Technologies R&D Program of China(National Key Technology R&D Program); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	We thank Professor Simon J Harris for the English revision of the article. This study was supported by National Basic Research Program of China (2004CB518705), National High-tech R&D Program of China (2006AA02A403), National Key Technologies R&D Program of China (2006BAI02A14), Specialized Research Fund for the Doctoral Program of Higher Education of China (20060023003) and National Natural Science Foundation (30872936, 30721001).	Alaiya A, 2000, ANAL CELL PATHOL, V21, P1, DOI 10.1155/2000/351963; Bini L, 1997, ELECTROPHORESIS, V18, P2832, DOI 10.1002/elps.1150181519; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Chahed K, 2005, INT J ONCOL, V27, P1425; Chen DQ, 2005, J BIOL CHEM, V280, P22425, DOI 10.1074/jbc.M413380200; Chuma M, 2004, J HEPATOL, V41, P629, DOI 10.1016/j.jhep.2004.06.018; Clark ES, 2009, ONCOGENE, V28, P431, DOI 10.1038/onc.2008.389; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Du XL, 2007, J MOL MED, V85, P863, DOI 10.1007/s00109-007-0159-4; Eric A, 2009, PATHOL ONCOL RES, V15, P89, DOI 10.1007/s12253-008-9112-2; Gold LI, 2006, J INVEST DERM SYMP P, V11, P57, DOI 10.1038/sj.jidsymp.5650011; Hayashida Y, 2006, J BIOL CHEM, V281, P32469, DOI 10.1074/jbc.M607240200; Helbling D, 2004, P NATL ACAD SCI USA, V101, P13312, DOI 10.1073/pnas.0404731101; Huang YH, 2002, PROTEOMICS, V2, P1220, DOI 10.1002/1615-9861(200209)2:9<1220::AID-PROT1220>3.0.CO;2-3; Kageyama K, 2002, J BIOL CHEM, V277, P19255, DOI 10.1074/jbc.M112377200; Kim YM, 2004, MOL CELL BIOCHEM, V259, P23, DOI 10.1023/B:MCBI.0000021341.38630.52; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Li YS, 2001, CANCER RES, V61, P6906; Lim S, 2008, MOL CELLS, V25, P390; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Luo ML, 2006, CANCER RES, V66, P11690, DOI 10.1158/0008-5472.CAN-06-1484; Mesaeli N, 2004, MOL BIOL CELL, V15, P1862, DOI 10.1091/mbc.E03-04-0251; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 1996, J BIOL CHEM, V271, P29436, DOI 10.1074/jbc.271.46.29436; Nishimori T, 2006, PROTEOMICS, V6, P1011, DOI 10.1002/pmic.200500262; Okunaga T, 2006, CANCER RES, V66, P8662, DOI 10.1158/0008-5472.CAN-05-4256; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Shago M, 1997, EXP CELL RES, V230, P50, DOI 10.1006/excr.1996.3408; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Vougas K, 2008, J BUON, V13, P101; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388	37	60	69	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2009	28	42					3714	3722		10.1038/onc.2009.237	http://dx.doi.org/10.1038/onc.2009.237			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	509MY	19684620				2022-12-25	WOS:000271023200004
J	Farrall, AL; Whitelaw, ML				Farrall, A. L.; Whitelaw, M. L.			The HIF1 alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element	ONCOGENE			English	Article						SIM2; BNIP3; HIF1 alpha; hypoxia; cell death; cancer	DRUG-THERAPY TARGET; SINGLE-MINDED GENE; PANCREATIC-CANCER; PROSTATE-CANCER; COLORECTAL-CANCER; UP-REGULATION; EXPRESSION; AUTOPHAGY; PROTEIN; APOPTOSIS	The short isoform of single-minded 2 (SIM2s), a basic helix-loop-helix/PAS (bHLH/PAS) transcription factor, is upregulated in pancreatic and prostate tumours; however, a mechanistic role for SIM2s in these cancers is unknown. Microarray studies in prostate DU145 cells identified the pro-cell death gene, BNIP3 (Bcl-2/adenovirus E1B 19 kDa interacting protein 3), as a novel putative target of SIM2s repression. Further validation showed BNIP3 repression in several prostate and pancreatic carcinoma-derived cell lines with ectopic expression of human SIM2s. BNIP3 levels are enhanced in prostate carcinoma cells upon short interfering (si) RNA-mediated knockdown of endogenous SIM2s. Chromatin immunoprecipitation and promoter studies show that SIM2s represses BNIP3 through its activities at the proximal promoter hypoxia response element (HRE), the site through which the bHLH/PAS family member, hypoxia-inducible factor 1 alpha (HIF1 alpha), induces BNIP3. SIM2s attenuates BNIP3 hypoxic induction via the HRE, and increased hypoxic induction of BNIP3 occurs with siRNA knockdown of endogenous SIM2s in prostate PC3AR+ cells. BNIP3 is implicated in hypoxia-induced cell death processes. Prolonged treatment of PC3AR+ cells with hypoxia mimetics, DP and DMOG, confers hypoxia-induced autophagy, measured by enhanced LC3-II levels and SQSTM1/p62 turnover. We show that PC3AR+ cells expressing ectopic SIM2s have enhanced survival in these conditions. Induction of LC3-II and turnover of SQSTM1/p62 are attenuated in PC3AR+/SIM2s DMOG and hypoxia-treated cells, suggesting that SIM2s may attenuate autophagic cell death processes, perhaps through BNIP3 repression. These data show, for the first time, SIM2s cross-talk on an endogenous HRE. SIM2s' functional interference with HIF1 alpha activities on BNIP3 may indicate a novel role for SIM2s in promoting tumourigenesis. Oncogene (2009) 28, 3671-3680; doi: 10.1038/onc.2009.228; published online 10 August 2009	[Farrall, A. L.; Whitelaw, M. L.] Univ Adelaide, Discipline Biochem, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Farrall, A. L.; Whitelaw, M. L.] Ctr Mol Genet Dev, Adelaide, SA, Australia	University of Adelaide	Farrall, AL (corresponding author), Univ Adelaide, Discipline Biochem, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	alexandra.farrall@adelaide.edu.au	Farrall, Alexandra/ABD-2079-2020	Farrall, Alexandra/0000-0002-0909-8978	Australian Cancer Research Foundation; Australian Research Council; Cancer Council South Australia	Australian Cancer Research Foundation; Australian Research Council(Australian Research Council); Cancer Council South Australia(Cancer Council South Australia)	We thank M van Bekkum and C Bindloss for their kind technical assistance, and Dr S Woods for reagents and critical reading of the manuscript. PC3AR+ cells were a kind gift from Prof W Tilley, Hanson Research Institute, Adelaide, Australia. Tet-inducible lentiviral vectors were a kind gift from Dr S Barry, Children's Health Research Institute, SA, Australia (Drabsch et al., 2007). Anti-HIF1 alpha-CAD antibody was obtained from the laboratory of Prof J Pouyssegur, CNRS UMR6543, University of Nice, France (Richard et al., 1999). We acknowledge the contribution of the Australian Cancer Research Foundation for their support of the Adelaide Microarray Facility, Adelaide, Australia, which supplied, processed and analysed the microarrays. This work was supported by grants from the Australian Research Council and the Cancer Council South Australia.	Abe T, 2005, J GASTROENTEROL, V40, P504, DOI 10.1007/s00535-005-1576-1; Akada M, 2005, CLIN CANCER RES, V11, P3094, DOI 10.1158/1078-0432.CCR-04-1785; Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Bacon AL, 2007, ONCOGENE, V26, P132, DOI 10.1038/sj.onc.1209761; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Chrast R, 1997, GENOME RES, V7, P615, DOI 10.1101/gr.7.6.615; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; De Angelis PM, 2004, INT J ONCOL, V24, P1279; DeYoung MP, 2003, CANCER LETT, V200, P25, DOI 10.1016/S0304-3835(03)00409-9; DeYoung MP, 2003, P NATL ACAD SCI USA, V100, P4760, DOI 10.1073/pnas.0831000100; Deyoung MP, 2002, ANTICANCER RES, V22, P3149; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Ema M, 1996, MOL CELL BIOL, V16, P5865; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Goshu E, 2002, MOL CELL BIOL, V22, P4147, DOI 10.1128/MCB.22.12.4147-4157.2002; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; Ishiguro M, 2007, ANN SURG ONCOL, V14, P1752, DOI 10.1245/s10434-006-9285-4; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Laffin B, 2008, MOL CELL BIOL, V28, P1936, DOI 10.1128/MCB.01701-07; Lee H, 2006, MOL CELLS, V21, P1; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Mahon PC, 2007, CANCER RES, V67, P6786, DOI 10.1158/0008-5472.CAN-07-0440; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mellor HR, 2007, CANCER METAST REV, V26, P553, DOI 10.1007/s10555-007-9080-0; Metz RP, 2006, J BIOL CHEM, V281, P10839, DOI 10.1074/jbc.M508858200; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moffett P, 1997, MOL CELL BIOL, V17, P4933, DOI 10.1128/MCB.17.9.4933; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Murai M, 2005, CLIN CANCER RES, V11, P1021; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Probst MR, 1997, J BIOL CHEM, V272, P4451, DOI 10.1074/jbc.272.7.4451; Pursiheimo JP, 2009, ONCOGENE, V28, P334, DOI 10.1038/onc.2008.392; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; RICHTER JE, 1999, CLIN PRACTICE GASTRO, V1, P1; Semenza GL, 2000, GENE DEV, V14, P1983; Shamblott MJ, 2002, DEV DYNAM, V224, P373, DOI 10.1002/dvdy.10116; Sowter HM, 2001, CANCER RES, V61, P6669; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; Woods S, 2008, NUCLEIC ACIDS RES, V36, P3716, DOI 10.1093/nar/gkn247; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	51	36	38	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2009	28	41					3671	3680		10.1038/onc.2009.228	http://dx.doi.org/10.1038/onc.2009.228			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KJ	19668230				2022-12-25	WOS:000270851800008
J	Bouzakri, K; Ribaux, P; Halban, PA				Bouzakri, Karim; Ribaux, Pascale; Halban, Philippe A.			Silencing Mitogen-activated Protein 4 Kinase 4 (MAP4K4) Protects Beta Cells from Tumor Necrosis Factor-alpha-induced Decrease of IRS-2 and Inhibition of Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; HUMAN SKELETAL-MUSCLE; C-REACTIVE PROTEIN; TNF-ALPHA; SYSTEMIC INFLAMMATION; SIGNALING PATHWAY; INDUCED APOPTOSIS; GENE-EXPRESSION; ISLET CELLS; RESISTANCE	Obesity and type 2 diabetes present partially overlapping phenotypes with systemic inflammation as a common feature, raising the hypothesis that elevated cytokine levels may contribute to peripheral insulin resistance as well as the decreased beta cell functional mass observed in type 2 diabetes. In healthy humans, TNF-alpha infusion induces skeletal muscle insulin resistance. We now explore the impact of TNF-alpha on primary beta cell function and the underlying signaling pathways. Human and rat primary beta cells were sorted by FACS and cultured for 24 h +/- 20 ng/ml TNF-alpha to explore the impact on apoptosis, proliferation, and short-term insulin secretion (1 h, 2.8 mM glucose followed by 1 h, 16.7 mM glucose at the end of the 24-h culture period) as well as key signaling protein phosphorylation and expression. Prior exposure to TNF-alpha for 24 It inhibits glucose-stimulated insulin secretion from primary beta cells. This is associated with a decrease in glucose-stimulated phosphorylation of key proteins in the insulin signaling pathway including Akt, AS160, and other Akt substrates, ERK as well as the insulin receptor. Strikingly, TNF-alpha treatment decreased IRS-2 protein level by 46 +/- 7% versus control, although mRNA expression was unchanged. While TNF-alpha treatment increased MAP4K4 mRNA expression by 33 +/- 5%, knockdown of MAP4K4 by siRNA-protected beta cells against the detrimental effects of TNF-alpha on both insulin secretion and signaling. We thus identify MAP4K4 as a key upstream mediator of TNF-alpha action on the beta cell, making it a potential therapeutic target for preservation of beta cell function in type 2 diabetes.	[Bouzakri, Karim; Ribaux, Pascale; Halban, Philippe A.] Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	University of Geneva	Bouzakri, K (corresponding author), Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	karim.bouzakri@unige.ch			Investigator-initiated Studies Program	Investigator-initiated Studies Program	This work was supported in part by a research grant from the Investigator-initiated Studies Program of MSD.	Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bertazza L, 2008, FRONT BIOSCI-LANDMRK, V13, P2736, DOI 10.2741/2881; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Bouzakri K, 2008, DIABETES, V57, P1195, DOI 10.2337/db07-1469; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; Deshmukh A, 2006, DIABETES, V55, P1776, DOI 10.2337/db05-1419; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; Ferrannini E, 2007, J CLIN ENDOCR METAB, V92, P396, DOI 10.1210/jc.2006-0944; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Gual P, 2003, DIABETES METAB, V29, P566, DOI 10.1016/S1262-3636(07)70071-X; Hagerkvist R, 2005, ANN NY ACAD SCI, V1040, P114, DOI 10.1196/annals.1327.014; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim HE, 2008, J ENDOCRINOL, V198, P549, DOI 10.1677/JOE-08-0131; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Kwon G, 1999, J BIOL CHEM, V274, P18702, DOI 10.1074/jbc.274.26.18702; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; Ohsugi M, 2005, J BIOL CHEM, V280, P4992, DOI 10.1074/jbc.M411727200; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ribaux P, 2007, ENDOCRINOLOGY, V148, P5582, DOI 10.1210/en.2007-0325; ROUILLER DG, 1991, DEV BIOL, V148, P233, DOI 10.1016/0012-1606(91)90332-W; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Winkler G, 1998, DIABETES RES CLIN PR, V42, P169, DOI 10.1016/S0168-8227(98)00109-0; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yermen B, 2007, DIABETES, V56, P80, DOI 10.2337/db06-0769; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	53	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27892	27898		10.1074/jbc.M109.048058	http://dx.doi.org/10.1074/jbc.M109.048058			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690174	hybrid, Green Published			2022-12-25	WOS:000270676300016
J	Kawai-Yamada, M; Hori, Z; Ogawa, T; Ihara-Ohori, Y; Tamura, K; Nagano, M; Ishikawa, T; Uchimiya, H				Kawai-Yamada, Maki; Hori, Zenta; Ogawa, Taro; Ihara-Ohori, Yuri; Tamura, Katsunori; Nagano, Minoru; Ishikawa, Toshiki; Uchimiya, Hirofumi			Loss of Calmodulin Binding to Bax Inhibitor-1 Affects Pseudomonas-mediated Hypersensitive Response-associated Cell Death in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PLANT HOMOLOG; SUPPRESSOR; OVEREXPRESSION; RESISTANCE; YEAST; GENE; ISOFORMS; KINASE; RICE	Bax inhibitor-1 (BI-1) is a cell death suppressor protein conserved across a variety of organisms. The Arabidopsis atbi1-1 plant is a mutant in which the C-terminal 6 amino acids of the expressed BI-1 protein have been replaced by T-DNA insertion. This mutant BI-1 protein (AtBI-CM) produced in Escherichia coli can no longer bind to calmodulin. A promoter-reporter assay demonstrated compartmentalized expression of BI-1 during hypersensitive response, introduced by the inoculation of Pseudomonas syringae possessing the avrRTP2 gene, Pst(avr-RPT2). In addition, both BI-1 knockdown plants and atbi1-1 showed increased sensitivity to Pst(avrRPT2)-induced cell death. The results indicated that the loss of calmodulin binding reduces the cell death suppressor activity of BI-1 in planta.	[Kawai-Yamada, Maki; Ishikawa, Toshiki] Saitama Univ, Dept Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Kawai-Yamada, Maki] Saitama Univ, Inst Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Uchimiya, Hirofumi] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Kawai-Yamada, Maki; Hori, Zenta; Ogawa, Taro; Ihara-Ohori, Yuri; Tamura, Katsunori; Nagano, Minoru; Ishikawa, Toshiki; Uchimiya, Hirofumi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kawai-Yamada, Maki; Ishikawa, Toshiki] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Saitama University; Saitama University; Iwate Biotechnology Research Center; University of Tokyo; Japan Science & Technology Agency (JST)	Kawai-Yamada, M (corresponding author), Saitama Univ, Dept Environm Sci & Technol, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	mkawai@mail.saitama-u.ac.jp	Ishikawa, Toshiki/F-6970-2018; Uchimiya, Hirofumi/B-3813-2012; Kawai-Yamada, Maki/B-2739-2012	Ishikawa, Toshiki/0000-0001-8083-6542; Kawai-Yamada, Maki/0000-0002-8732-052X	Ministry of Agriculture, Forestry and Fisheries of Japan; CREST, EST, Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); CREST, EST, Japan	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan and a grant from CREST, EST, Japan.	Bolduc N, 2002, FEBS LETT, V532, P111, DOI 10.1016/S0014-5793(02)03650-5; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; DONG XN, 1991, PLANT CELL, V3, P61, DOI 10.1105/tpc.3.1.61; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Heath MC, 1998, NEW PHYTOL, V138, P251, DOI 10.1046/j.1469-8137.1998.00897.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Huckelhoven R, 2004, APOPTOSIS, V9, P299, DOI 10.1023/B:APPT.0000025806.71000.1c; Huckelhoven R, 2003, P NATL ACAD SCI USA, V100, P5555, DOI 10.1073/pnas.0931464100; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Kawai M, 1999, FEBS LETT, V464, P143, DOI 10.1016/S0014-5793(99)01695-6; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; Kohler C, 2000, FEBS LETT, V471, P133, DOI 10.1016/S0014-5793(00)01383-1; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Liao BR, 1996, ARCH BIOCHEM BIOPHYS, V327, P53, DOI 10.1006/abbi.1996.0092; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Nagano M, 2009, PLANT J, V58, P122, DOI 10.1111/j.1365-313X.2008.03765.x; Oshima R, 2007, FEBS LETT, V581, P4627, DOI 10.1016/j.febslet.2007.08.054; Pan L, 2000, PLANT PHYSIOL, V122, P447, DOI 10.1104/pp.122.2.447; Pike SM, 2005, PLANT PHYSIOL, V138, P1009, DOI 10.1104/pp.104.047142; Reddy VS, 1999, J BIOL CHEM, V274, P31727, DOI 10.1074/jbc.274.44.31727; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yu IC, 2000, MOL PLANT MICROBE IN, V13, P277, DOI 10.1094/MPMI.2000.13.3.277	32	30	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27998	28003		10.1074/jbc.M109.037234	http://dx.doi.org/10.1074/jbc.M109.037234			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674971	hybrid, Green Published			2022-12-25	WOS:000270676300028
J	Muniandy, PA; Thapa, D; Thazhathveetil, AK; Liu, ST; Seidman, MM				Muniandy, Parameswary A.; Thapa, Dennis; Thazhathveetil, Arun Kalliat; Liu, Su-ting; Seidman, Michael M.			Repair of Laser-localized DNA Interstrand Cross-links in G(1) Phase Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; UV-DAMAGED DNA; CYCLOBUTANE PYRIMIDINE DIMERS; COMPLEMENTATION GROUP-E; PIGMENTOSUM GROUP-E; IN-VIVO; ESCHERICHIA-COLI; BINDING PROTEIN; MITOMYCIN-C	Interstrand cross-links (ICLs) are absolute blocks to transcription and replication and can provoke genomic instability and cell death. Studies in bacteria define a two-stage repair scheme, the first involving recognition and incision on either side of the cross-link on one strand (unhooking), followed by recombinational repair or lesion bypass synthesis. The resultant monoadduct is removed in a second stage by nucleotide excision repair. In mammalian cells, there are multiple, but poorly defined, pathways, with much current attention on repair in S phase. However, many questions remain, including the efficiency of repair in the absence of replication, the factors involved in cross-link recognition, and the timing and demarcation of the first and second repair cycles. We have followed the repair of laser-localized lesions formed by psoralen (cross-links/monoadducts) and angelicin (only monoadducts) in mammalian cells. Both were repaired in G, phase by nucleotide excision repair-dependent pathways. Removal of psoralen adducts was blocked in XPC-deficient cells but occurred with wild type kinetics in cells deficient in DDB2 protein (XPE). XPC protein was rapidly recruited to psoralen adducts. However, accumulation of DDB2 was slow and XPC-dependent. Inhibition of repair DNA synthesis did not interfere with DDB2 recruitment to angelicin but eliminated recruitment to psoralen. Our results demonstrate an efficient ICL repair pathway in G, phase cells dependent on XPC, with entry of DDB2 only after repair synthesis that completes the first repair cycle. DDB2 accumulation at sites of cross-link repair is a marker for the start of the second repair cycle.	[Muniandy, Parameswary A.; Thapa, Dennis; Seidman, Michael M.] NIA, LMG, NIH, Baltimore, MD 21224 USA; [Thazhathveetil, Arun Kalliat] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Liu, Su-ting] BASF Co, Hong Kong, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Northwestern University; BASF	Seidman, MM (corresponding author), NIA, LMG, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	seidmanm@grc.nia.nih.gov			National Institutes of Health, NIA; Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING [Z01AG000746, ZIAAG000746] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health, NIA, Intramural Research Program. This work was also supported by the Fanconi Anemia Research Fund.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Barber LJ, 2005, MOL CELL BIOL, V25, P2297, DOI 10.1128/MCB.25.6.2297-2309.2005; Berardini M, 1999, J BACTERIOL, V181, P2878, DOI 10.1128/JB.181.9.2878-2882.1999; Bergstralh DT, 2008, TRENDS GENET, V24, P70, DOI 10.1016/j.tig.2007.11.003; BREDBERG A, 1985, BIOCHIM BIOPHYS ACTA, V824, P268, DOI 10.1016/0167-4781(85)90058-2; COLE RS, 1976, J MOL BIOL, V103, P39, DOI 10.1016/0022-2836(76)90051-6; COLE RS, 1973, P NATL ACAD SCI USA, V70, P1064, DOI 10.1073/pnas.70.4.1064; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Derheimer FA, 2009, MOL PHARMACOL, V75, P599, DOI 10.1124/mol.108.051698; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; Dip R, 2004, DNA REPAIR, V3, P1409, DOI 10.1016/j.dnarep.2004.05.005; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Eichman BF, 2001, J MOL BIOL, V308, P15, DOI 10.1006/jmbi.2001.4567; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Emmert S, 2000, P NATL ACAD SCI USA, V97, P2151, DOI 10.1073/pnas.040559697; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Grompe M, 2001, HUM MOL GENET, V10, P2253, DOI 10.1093/hmg/10.20.2253; Grossmann KF, 2001, MUTAT RES-DNA REPAIR, V487, P73, DOI 10.1016/S0921-8777(01)00106-9; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; ISLAS AL, 1994, BIOCHEMISTRY-US, V33, P10794, DOI 10.1021/bi00201a029; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; JOHNSTON BH, 1977, SCIENCE, V197, P906, DOI 10.1126/science.887929; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Kruhlak MJ, 2006, CELL CYCLE, V5, P1910, DOI 10.4161/cc.5.17.3169; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Kusumoto R, 2001, MUTAT RES-DNA REPAIR, V485, P219, DOI 10.1016/S0921-8777(00)00082-3; Lai CF, 2008, ANAL CHEM, V80, P8790, DOI 10.1021/ac801520m; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lan L, 2004, DNA REPAIR, V3, P135, DOI 10.1016/j.dnarep.2003.10.005; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Maillard O, 2008, MUTAT RES-REV MUTAT, V658, P271, DOI 10.1016/j.mrrev.2008.01.007; Maillard O, 2007, PLOS BIOL, V5, P717, DOI 10.1371/journal.pbio.0050079; Maillard O, 2007, TRENDS BIOCHEM SCI, V32, P494, DOI 10.1016/j.tibs.2007.08.008; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; McHugh PJ, 2006, CELL CYCLE, V5, P1044, DOI 10.4161/cc.5.10.2763; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Mocquet V, 2007, EMBO J, V26, P2923, DOI 10.1038/sj.emboj.7601730; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Mu D, 2000, MOL CELL BIOL, V20, P2446, DOI 10.1128/MCB.20.7.2446-2454.2000; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; Noronha AM, 2002, BIOCHEMISTRY-US, V41, P760, DOI 10.1021/bi011610u; Palom Y, 2002, CHEM RES TOXICOL, V15, P1398, DOI 10.1021/tx020044g; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Reynolds MF, 2009, CANCER RES, V69, P1071, DOI 10.1158/0008-5472.CAN-08-2306; Richards S, 2005, NUCLEIC ACIDS RES, V33, P5382, DOI 10.1093/nar/gki851; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Saffran WA, 2004, J BIOL CHEM, V279, P36462, DOI 10.1074/jbc.M402323200; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; SARTORELLI AC, 1994, ONCOL RES, V6, P501; Scharer OD, 2009, NAT STRUCT MOL BIOL, V16, P102, DOI 10.1038/nsmb0209-102; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; SLADEK FM, 1989, P NATL ACAD SCI USA, V86, P3982, DOI 10.1073/pnas.86.11.3982; SLADEK FM, 1989, J BIOL CHEM, V264, P6755; Smeaton MB, 2008, BIOCHEMISTRY-US, V47, P9920, DOI 10.1021/bi800925e; SPIELMANN HP, 1995, P NATL ACAD SCI USA, V92, P2345, DOI 10.1073/pnas.92.6.2345; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Thazhathveetil AK, 2007, BIOCONJUGATE CHEM, V18, P431, DOI 10.1021/bc060309t; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Wu Q, 2005, EMBO REP, V6, P551, DOI 10.1038/sj.embor.7400418; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zhang NX, 2007, DNA REPAIR, V6, P1670, DOI 10.1016/j.dnarep.2007.06.002; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng HY, 2003, MOL CELL BIOL, V23, P754, DOI 10.1128/MCB.23.2.754-761.2003	88	72	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27908	27917		10.1074/jbc.M109.029025	http://dx.doi.org/10.1074/jbc.M109.029025			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684342	hybrid, Green Published			2022-12-25	WOS:000270676300018
J	Nemes, Z; Petrovski, G; Aerts, M; Sergeant, K; Devreese, B; Fesus, L				Nemes, Zoltan; Petrovski, Goran; Aerts, Maarten; Sergeant, Kjell; Devreese, Bart; Fesus, Laszlo			Transglutaminase-mediated Intramolecular Cross-linking of Membrane-bound alpha-Synuclein Promotes Amyloid Formation in Lewy Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; PARKINSONS-DISEASE; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; FIBRIL FORMATION; CALCIUM-IONS; AGGREGATION; PROTEIN; MECHANISMS; SUBSTRATE	The alpha-synuclein immunopositive and chaotrope-insoluble material from human brains with Lewy body pathology was analyzed by mass spectrometry. From the proteinase K-cleavable peripheral fraction of Lewy bodies, which was densely crosslinked by gamma-glutamyl-epsilon-lysine bonds between HspB1 and ubiquitin in a pattern similar to neurofibrillary tangles (Nemes, Z., Devreese, B., Steinert, P. M., Van Beeumen, J., and Fesus, L. (2004) FASEB J. 18, 1135-1137), 53 proteins were identified. In the core of Lewy bodies only alpha-synuclein was found, and it contained a low amount of intramolecular cross-links between Gln-99 and Lys-58. In vitro cross-linking of alpha-synuclein by transglutaminases 1-3 and 5 produced a heterogeneous population of variably cross-linked alpha-synucleins in solution, which inhibited the aggregation of the protein into amyloid. However, in the presence of phosphatidylserine-rich membranes and micromolar calcium concentrations, the cross-linking by transglutaminases 1, 2, and 5 showed specificity toward the utilization of Gln-99 and Lys-58. As shown by thioflavin T fluorescence monitoring, the formation of this cross-link accelerated the aggregation of native alpha-synuclein. Chemical cross-linking of residues 58-99 triggered amyloid formation, whereas such bonding of residues 99 to 10 was inhibitory. Our findings reveal the pivotal role of membrane attachment and transglutaminase-mediated intermolecular cross-linking for the propagative misfolding and aggregation of alpha-synuclein.	[Nemes, Zoltan] Univ Debrecen, Res Ctr Mol Med, Hungarian Acad Sci, Signaling & Apoptosis Res Grp,Dept Psychiat, H-4012 Debrecen, Hungary; [Petrovski, Goran; Fesus, Laszlo] Univ Debrecen, Signaling & Apoptosis Res Grp, Hungarian Acad Sci, Res Ctr Mol Med,Dept Biochem & Mol Biol, H-4012 Debrecen, Hungary; [Aerts, Maarten; Sergeant, Kjell; Devreese, Bart] Univ Ghent, Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium	Hungarian Academy of Sciences; University of Debrecen; Hungarian Academy of Sciences; University of Debrecen; Ghent University	Nemes, Z (corresponding author), 98 Nagyerdei Krt, H-4012 Debrecen, Hungary.	znemes@dote.hu	Devreese, Bart/B-2011-2009; Aerts, Maarten/O-6194-2014; sergeant, kjell/M-9789-2015; Petrovski, Goran/A-8983-2012; Devreese, Bart/K-2841-2019; Sergeant, Kjell/E-5419-2012	Devreese, Bart/0000-0002-9764-2581; Aerts, Maarten/0000-0003-0125-6721; sergeant, kjell/0000-0003-2071-3510; Devreese, Bart/0000-0002-9764-2581; Sergeant, Kjell/0000-0003-2071-3510; Petrovski, Goran/0000-0003-2905-9252	Hungarian Scientific Research Fund OTKA TS [044798]; Hungarian Ministry of Health [ETT115/03]; Hungarian Ministry of Education [OM00427/04]; Flemish-Hungarian Intergovernmental Research [B33/04, B/06093]; Fund for Scientific Research/Flanders [G0422.98]; European Union [MRTNCT2006- 036032, MRTN-CT-2006-035624, LSHB-CT-2007-037730]	Hungarian Scientific Research Fund OTKA TS(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; Hungarian Ministry of Education; Flemish-Hungarian Intergovernmental Research; Fund for Scientific Research/Flanders(FWO); European Union(European Commission)	This work was supported in part by the Hungarian Scientific Research Fund OTKA TS 044798, the Hungarian Ministry of Health Grant ETT115/03, the Hungarian Ministry of Education Grant OM00427/04, the Flemish-Hungarian Intergovernmental Research Grants B33/04 and B/06093, the Fund for Scientific Research/Flanders G0422.98, and European Union Grants MRTNCT2006- 036032, MRTN-CT-2006-035624, and LSHB-CT-2007-037730.	Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Beyer K, 2007, J NEUROPATH EXP NEUR, V66, P965, DOI 10.1097/nen.0b013e3181587d64; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Candi E, 1998, J BIOL CHEM, V273, P13693, DOI 10.1074/jbc.273.22.13693; Candi E, 2004, BIOCHEM J, V381, P313, DOI 10.1042/BJ20031474; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Candi E, 1999, J BIOL CHEM, V274, P7226, DOI 10.1074/jbc.274.11.7226; Casadio R, 1999, EUR J BIOCHEM, V262, P672, DOI 10.1046/j.1432-1327.1999.00437.x; Citron BA, 2001, J BIOL CHEM, V276, P3295, DOI 10.1074/jbc.M004776200; Colosimo C, 2003, J NEUROL NEUROSUR PS, V74, P852, DOI 10.1136/jnnp.74.7.852; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Csosz E, 2008, J MOL BIOL, V383, P390, DOI 10.1016/j.jmb.2008.08.026; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; HARSFALVI J, 1987, BIOCHIM BIOPHYS ACTA, V923, P42, DOI 10.1016/0304-4165(87)90123-1; Hashimoto M, 2004, J MOL NEUROSCI, V24, P343, DOI 10.1385/JMN:24:3:343; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kim HC, 2001, J STRUCT BIOL, V135, P73, DOI 10.1006/jsbi.2001.4384; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Konno T, 2005, BIOCHEMISTRY-US, V44, P2072, DOI 10.1021/bi047722d; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Muma NA, 2007, J NEUROPATH EXP NEUR, V66, P258, DOI 10.1097/nen.0b013e31803d3b02; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nemes Z, 2005, ANAL BIOCHEM, V342, P1, DOI 10.1016/j.ab.2004.10.015; Nemes Z, 2004, FASEB J, V18, P1135, DOI 10.1096/fj.04-1493fje; Nemes Z, 1999, J BIOL CHEM, V274, P11013, DOI 10.1074/jbc.274.16.11013; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Schmid AW, 2009, J BIOL CHEM, V284, P13128, DOI 10.1074/jbc.M809067200; Segers-Nolten IMJ, 2008, PROTEIN SCI, V17, P1395, DOI 10.1110/ps.036103.108; Signorini M, 1996, BIOL CHEM H-S, V377, P167, DOI 10.1515/bchm3.1996.377.3.167; SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Steinert PM, 1996, J BIOL CHEM, V271, P26242, DOI 10.1074/jbc.271.42.26242; Suh MD, 2004, ARCH PHARM RES, V27, P850, DOI 10.1007/BF02980178; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje	42	25	25	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27252	27264		10.1074/jbc.M109.033969	http://dx.doi.org/10.1074/jbc.M109.033969			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651786	hybrid, Green Published			2022-12-25	WOS:000270232300026
J	Takahashi, Y; Forrest, ARR; Maeno, E; Hashimoto, T; Daub, CO; Yasuda, J				Takahashi, Yukari; Forrest, Alistair R. R.; Maeno, Emi; Hashimoto, Takehiro; Daub, Carsten O.; Yasuda, Jun			MiR-107 and MiR-185 Can Induce Cell Cycle Arrest in Human Non Small Cell Lung Cancer Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; GASTRIC-CANCER; MICRORNAS; MIRNA; P53; MIR-34A; TARGET; PROLIFERATION; ACTIVATION; PREDICTION	Background: MicroRNAs (miRNAs) are short single stranded noncoding RNAs that suppress gene expression through either translational repression or degradation of target mRNAs. The annealing between messenger RNAs and 59 seed region of miRNAs is believed to be essential for the specific suppression of target gene expression. One miRNA can have several hundred different targets in a cell. Rapidly accumulating evidence suggests that many miRNAs are involved in cell cycle regulation and consequentially play critical roles in carcinogenesis. Methodology/Principal Findings: Introduction of synthetic miR-107 or miR-185 suppressed growth of the human non-small cell lung cancer cell lines. Flow cytometry analysis revealed these miRNAs induce a G1 cell cycle arrest in H1299 cells and the suppression of cell cycle progression is stronger than that by Let-7 miRNA. By the gene expression analyses with oligonucleotide microarrays, we find hundreds of genes are affected by transfection of these miRNAs. Using miRNA-target prediction analyses and the array data, we listed up a set of likely targets of miR-107 and miR-185 for G1 cell cycle arrest and validate a subset of them using real-time RT-PCR and immunoblotting for CDK6. Conclusions/Significance: We identified new cell cycle regulating miRNAs, miR-107 and miR-185, localized in frequently altered chromosomal regions in human lung cancers. Especially for miR-107, a large number of down-regulated genes are annotated with the gene ontology term 'cell cycle'. Our results suggest that these miRNAs may contribute to regulate cell cycle in human malignant tumors.			Takahashi, Y (corresponding author), RIKEN, Yokohama Inst, RNA Funct Res Team, Omics Sci Ctr, Yokohama, Kanagawa, Japan.	yasuda-jun@umin.ac.jp	Daub, Carsten O/A-7436-2010; Forrest, Alistair/A-6597-2008	Daub, Carsten O/0000-0002-3295-8729; Forrest, Alistair/0000-0003-4543-1675; Yasuda, Jun/0000-0002-3887-6871				Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li KY, 2003, CANCER RES, V63, P3593; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saeki N, 2000, MAMM GENOME, V11, P718, DOI 10.1007/s003350010138; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Yasuda J, 2008, ADV CANCER RES, V99, P77, DOI 10.1016/S0065-230X(07)99003-X; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	37	182	205	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6677	10.1371/journal.pone.0006677	http://dx.doi.org/10.1371/journal.pone.0006677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688090	Green Published, gold			2022-12-25	WOS:000269075800012
J	Battaglia, G; Molinaro, G; Riozzi, B; Storto, M; Busceti, CL; Spinsanti, P; Bucci, D; Di Liberto, V; Mudo, G; Corti, C; Corsi, M; Nicoletti, F; Belluardo, N; Bruno, V				Battaglia, Giuseppe; Molinaro, Gemma; Riozzi, Barbara; Storto, Marianna; Busceti, Carla L.; Spinsanti, Paola; Bucci, Domenico; Di Liberto, Valentina; Mudo, Giuseppina; Corti, Corrado; Corsi, Mauro; Nicoletti, Ferdinando; Belluardo, Natale; Bruno, Valeria			Activation of mGlu3 Receptors Stimulates the Production of GDNF in Striatal Neurons	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; MIDBRAIN DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR GDNF; GROWTH-FACTOR-BETA; PARKINSONS-DISEASE; IN-VIVO; MGLUR2/3 AGONIST; ANTAGONIST MPEP; AMINO-ACIDS; MOUSE MODEL	Metabotropic glutamate (mGlu) receptors have been considered potential targets for the therapy of experimental parkinsonism. One hypothetical advantage associated with the use of mGlu receptor ligands is the lack of the adverse effects typically induced by ionotropic glutamate receptor antagonists, such as sedation, ataxia, and severe learning impairment. Low doses of the mGlu2/3 metabotropic glutamate receptor agonist, LY379268 (0.25-3 mg/kg, i.p.) increased glial cell line-derived neurotrophic factor (GDNF) mRNA and protein levels in the mouse brain, as assessed by in situ hybridization, real-time PCR, immunoblotting, and immunohistochemistry. This increase was prominent in the striatum, but was also observed in the cerebral cortex. GDNF mRNA levels peaked at 3 h and declined afterwards, whereas GDNF protein levels progressively increased from 24 to 72 h following LY379268 injection. The action of LY379268 was abrogated by the mGlu2/3 receptor antagonist, LY341495 (1 mg/kg, i. p.), and was lost in mGlu3 receptor knockout mice, but not in mGlu2 receptor knockout mice. In pure cultures of striatal neurons, the increase in GDNF induced by LY379268 required the activation of the mitogen-activated protein kinase and phosphatidylinositol-3-kinase pathways, as shown by the use of specific inhibitors of the two pathways. Both in vivo and in vitro studies led to the conclusion that neurons were the only source of GDNF in response to mGlu3 receptor activation. Remarkably, acute or repeated injections of LY379268 at doses that enhanced striatal GDNF levels (0.25 or 3 mg/kg, i.p.) were highly protective against nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, as assessed by stereological counting of tyrosine hydroxylase-positive neurons in the pars compacta of the substantia nigra. We speculate that selective mGlu3 receptor agonists or enhancers are potential candidates as neuroprotective agents in Parkinson's disease, and their use might circumvent the limitations associated with the administration of exogenous GDNF.	[Battaglia, Giuseppe; Molinaro, Gemma; Riozzi, Barbara; Storto, Marianna; Busceti, Carla L.; Bucci, Domenico; Nicoletti, Ferdinando; Bruno, Valeria] Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy; [Spinsanti, Paola; Nicoletti, Ferdinando; Bruno, Valeria] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy; [Di Liberto, Valentina; Mudo, Giuseppina; Belluardo, Natale] Univ Palermo, DIMES, Human Physiol Sect, Palermo, Italy; [Corti, Corrado; Corsi, Mauro] GlaxoSmithKline Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, Verona, Italy	IRCCS Neuromed; Sapienza University Rome; University of Palermo; GlaxoSmithKline	Battaglia, G (corresponding author), Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy.	valeria.bruno@uniroma1.it	Bucci, Domenico/AAA-5475-2019; Storto, Marianna/G-8745-2012; Busceti, Carla Letizia/F-9941-2011; Nicoletti, Ferdinando/K-4410-2016; Di+Liberto, Valentina/ACL-0264-2022; Nicoletti, Ferdinando/T-4898-2019; bruno, Valeria/F-3146-2012; Busceti, Carla Letizia/K-6485-2016; Bucci, Domenico/G-6747-2011; Mudo', Giuseppa/G-7408-2011; Molinaro, Gemma/G-8822-2011; Riozzi, Barbara/A-8737-2013; Battaglia, Giuseppe/A-7709-2010; Nicoletti, Ferdinando/A-2446-2010	Bucci, Domenico/0000-0003-3239-2435; bruno, Valeria/0000-0003-4231-0739; Busceti, Carla Letizia/0000-0002-1417-1893; Mudo', Giuseppa/0000-0002-3275-9981; Riozzi, Barbara/0000-0003-2050-1489; Battaglia, Giuseppe/0000-0001-7571-3417; Corti, Corrado/0000-0002-7876-9114; marianna, storto/0000-0002-0159-7449; Di Liberto, Valentina/0000-0002-8574-0061; Nicoletti, Ferdinando/0000-0003-0917-443X; NICOLETTI, Ferdinando/0000-0003-3366-7269	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Funding for this work came from the Italian Ministry of Health as "Ricerca Corrente" for the year 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JA, 2005, BRAIN RES, V1033, P216, DOI 10.1016/j.brainres.2004.11.040; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Battaglia G, 1997, NEUROSCI LETT, V229, P161, DOI 10.1016/S0304-3940(97)00442-4; Battaglia G, 2003, NEUROPHARMACOLOGY, V45, P155, DOI 10.1016/S0028-3908(03)00146-1; Battaglia G, 2002, J NEUROSCI, V22, P2135, DOI 10.1523/JNEUROSCI.22-06-02135.2002; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; Batten JA, 2006, INT FINANCE REVIEW, V6, P1; Belluardo N, 2005, NEUROSCIENCE, V133, P787, DOI 10.1016/j.neuroscience.2005.01.061; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Bruno V, 1998, J NEUROSCI, V18, P9594; Bruno V, 1997, J NEUROSCI, V17, P1891; Ciccarelli R, 1999, GLIA, V27, P275, DOI 10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0; Conn PJ, 2005, NAT REV NEUROSCI, V6, P787, DOI 10.1038/nrn1763; Corti C, 2007, J NEUROSCI, V27, P8297, DOI 10.1523/JNEUROSCI.1889-07.2007; Cozzi A, 1997, EUR J NEUROSCI, V9, P1350, DOI 10.1111/j.1460-9568.1997.tb01489.x; D'Onofrio M, 2001, J NEUROCHEM, V78, P435, DOI 10.1046/j.1471-4159.2001.00435.x; Dawson L, 2000, BRIT J PHARMACOL, V129, P541, DOI 10.1038/sj.bjp.0703105; Eslamboli A, 2005, REV NEUROSCIENCE, V16, P303; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gash DM, 1998, ANN NEUROL, V44, pS121, DOI 10.1002/ana.410440718; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Greco B, 2005, PSYCHOPHARMACOLOGY, V179, P68, DOI 10.1007/s00213-004-2127-9; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Konieczny J, 1998, N-S ARCH PHARMACOL, V358, P500, DOI 10.1007/PL00005284; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LEHMANN A, 1974, ATLAS STEREOTAXIQUE; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LOVINGER DM, 1991, NEUROSCI LETT, V129, P17, DOI 10.1016/0304-3940(91)90710-B; LOVINGER DM, 1995, J NEUROPHYSIOL, V73, P1076, DOI 10.1152/jn.1995.73.3.1076; Mandel SA, 2007, NEUROCHEM RES, V32, P1694, DOI 10.1007/s11064-007-9351-8; Matarredona ER, 2001, J NEUROCHEM, V76, P351, DOI 10.1046/j.1471-4159.2001.00056.x; Mayhew TM, 1996, J ANAT, V188, P1; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; Nosrat CA, 1996, CELL TISSUE RES, V286, P191, DOI 10.1007/s004410050688; Olive MF, 2008, ALCOHOL, V42, P191, DOI 10.1016/j.alcohol.2008.01.007; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P1, DOI 10.1111/j.1365-2818.1988.tb04582.x; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; Rose K., 1992, METHODS TOXICOLOGY, V1, P46, DOI DOI 10.1371/J0URNAL.P0NE.0006591; Schlefer J, 2004, BRAIN RES, V1019, P246, DOI 10.1016/j.brainres.2004.06.005; SCHMIDTKASTNER R, 1994, MOL BRAIN RES, V26, P325, DOI 10.1016/0169-328X(94)90106-6; Schober A, 1999, J NEUROSCI, V19, P2008; Schober A, 2007, NEUROBIOL DIS, V25, P378, DOI 10.1016/j.nbd.2006.10.005; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Trupp M, 1997, J NEUROSCI, V17, P3554; Venero JL, 2002, NEUROSCIENCE, V113, P857, DOI 10.1016/S0306-4522(02)00232-4; Visanji NP, 2008, FASEB J, V22, P2488, DOI 10.1096/fj.07-095398; Weinreb O, 2007, ANN NY ACAD SCI, V1122, P155, DOI 10.1196/annals.1403.011; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645	61	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6591	10.1371/journal.pone.0006591	http://dx.doi.org/10.1371/journal.pone.0006591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672295	Green Published, gold, Green Submitted			2022-12-25	WOS:000268935900007
J	Pluskota, A; Horzowski, E; Bossinger, O; von Mikecz, A				Pluskota, Adam; Horzowski, Eva; Bossinger, Olaf; von Mikecz, Anna			In Caenorhabditis elegans Nanoparticle-Bio-Interactions Become Transparent: Silica-Nanoparticles Induce Reproductive Senescence	PLOS ONE			English	Article							IN-VIVO; MODEL	While expectations and applications of nanotechnologies grow exponentially, little is known about interactions of engineered nanoparticles with multicellular organisms. Here we propose the transparent roundworm Caenorhabditis elegans as a simple but anatomically and biologically well defined animal model that allows for whole organism analyses of nanoparticle-bio-interactions. Microscopic techniques showed that fluorescently labelled nanoparticles are efficiently taken up by the worms during feeding, and translocate to primary organs such as epithelial cells of the intestine, as well as secondary organs belonging to the reproductive tract. The life span of nanoparticle- fed Caenorhabditis elegans remained unchanged, whereas a reduction of progeny production was observed in silica-nanoparticle exposed worms versus untreated controls. This reduction was accompanied by a significant increase of the 'bag of worms' phenotype that is characterized by failed egg-laying and usually occurs in aged wild type worms. Experimental exclusion of developmental defects suggests that silica-nanoparticles induce an age-related degeneration of reproductive organs, and thus set a research platform for both, detailed elucidation of molecular mechanisms and high throughput screening of different nanomaterials by analyses of progeny production.	[Pluskota, Adam; von Mikecz, Anna] Univ Dusseldorf, IUF, Dusseldorf, Germany; [Horzowski, Eva; Bossinger, Olaf] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Aachen, Germany	Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); RWTH Aachen University	Pluskota, A (corresponding author), Univ Dusseldorf, IUF, Dusseldorf, Germany.	olaf.bossinger@rwth-aachen.de; mikecz@tec-source.de			"Forschungsforderungsfonds'' of the University of Dusseldorf; Federal Ministry of the Environment (BMU); DFG; GIF	"Forschungsforderungsfonds'' of the University of Dusseldorf; Federal Ministry of the Environment (BMU); DFG(German Research Foundation (DFG)); GIF(German-Israeli Foundation for Scientific Research and Development)	This work was supported by "Forschungsforderungsfonds'' of the University of Dusseldorf and the Federal Ministry of the Environment (BMU) granted to A.v.M. Work in the laboratory of O.B. is sponsored by the DFG and GIF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; CHAPLEAU RR, 2009, TOXICOLOGY IN PRESS; Chen M, 2005, EXP CELL RES, V305, P51, DOI 10.1016/j.yexcr.2004.12.021; Chen M, 2008, J CELL BIOL, V180, P697, DOI 10.1083/jcb.200708131; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Fynewever TL, 2007, J ASSIST REPROD GEN, V24, P61, DOI 10.1007/s10815-006-9084-7; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Hall DH., 2008, C ELEGANS ATLAS; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kiontke Karin, 2005, P1; Komatsu T, 2008, CATAL SURV ASIA, V12, P6, DOI 10.1007/s10563-007-9031-3; LARSEN PL, 1995, GENETICS, V139, P1567; Lee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001213; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lim SF, 2006, NANO LETT, V6, P169, DOI 10.1021/nl0519175; McKinney W, 2009, INHAL TOXICOL, V21, P1053, DOI 10.1080/08958370802712713; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Sanvicens N, 2008, TRENDS BIOTECHNOL, V26, P425, DOI 10.1016/j.tibtech.2008.04.005; Schafer William R, 2005, WormBook, P1; SCOTTFORDSMAND JJ, 2008, ECOTOXICOL ENV SAF; Slotkin JR, 2007, DEV DYNAM, V236, P3393, DOI 10.1002/dvdy.21235; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Wang HH, 2009, ENVIRON POLLUT, V157, P1171, DOI 10.1016/j.envpol.2008.11.004	32	105	108	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6622	10.1371/journal.pone.0006622	http://dx.doi.org/10.1371/journal.pone.0006622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672302	gold, Green Submitted, Green Published			2022-12-25	WOS:000268935900029
J	Matsagas, K; Lim, DB; Horwitz, M; Rizza, CL; Mueller, LD; Villeponteau, B; Rose, MR				Matsagas, Kennedy; Lim, David B.; Horwitz, Marc; Rizza, Cristina L.; Mueller, Laurence D.; Villeponteau, Bryant; Rose, Michael R.			Long-Term Functional Side-Effects of Stimulants and Sedatives in Drosophila melanogaster	PLOS ONE			English	Article							LIFE-SPAN; CAFFEINE; ETHANOL; EVOLUTION; ALCOHOL; CONSUMPTION; FERTILITY	Background: Small invertebrate animals, such as nematodes and fruit flies, are increasingly being used to test candidate drugs both for specific therapeutic purposes and for long-term health effects. Some of the protocols used in these experiments feature such experimental design features as lifelong virginity and very low densities. By contrast, the ability of both fruit flies and nematodes to resist stress is frequently correlated with their longevity and other functional measures, suggesting that low-stress assays are not necessarily the only useful protocol for testing the long-term effects of drugs. Methodology/Principal Findings: Here we report an alternative protocol for fruit fly drug-testing that maximizes reproductive opportunities and other types of interaction, with moderately high population densities. We validate this protocol using two types of experimental tests: 1. We show that this protocol detects previously well-established genetic differences between outbred fruit fly populations. 2. We show that this protocol is able to distinguish among the long-term effects of similar types of drugs within two broad categories, stimulants and tranquilizers. Conclusions: Large-scale fly drug testing can be conducted using mixed-sex high-density cage assays. We find that the commonly-used stimulants caffeine and theobromine differ dramatically in their chronic functional effects, theobromine being more benign. Likewise, we find that two generic pharmaceutical tranquilizers, lithium carbonate and valproic acid, differ dramatically in their chronic effects, lithium being more benign. However, these findings do not necessarily apply to human subjects, and we thus do not recommend the use of any one substance over any other.	[Matsagas, Kennedy; Lim, David B.; Horwitz, Marc; Rizza, Cristina L.; Mueller, Laurence D.; Villeponteau, Bryant; Rose, Michael R.] Genescient Corp, Corona Del Mar, CA USA		Matsagas, K (corresponding author), Genescient Corp, Corona Del Mar, CA USA.	science@genescient.com			Genescient Corporation (Genescient)	Genescient Corporation (Genescient)	This study was funded in whole by Genescient Corporation (Genescient). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The authors recommended and received approval from Genescient for publication.	Araque P, 2007, J AGR FOOD CHEM, V55, P6918, DOI 10.1021/jf071052b; Barbieri RL, 2001, AM J OBSTET GYNECOL, V185, P1168, DOI 10.1067/mob.2001.117667; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Belleville J, 2002, NUTRITION, V18, P173, DOI 10.1016/S0899-9007(01)00721-3; Bielecka AM, 2008, PHARMACOL REP, V60, P771; Bishop YM., 2007, DISCRETE MULTIVARIAT; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; *EP, 2009, LITH; *EP, 2009, VALP AC; Giles S, 2008, REPROD TOXICOL, V25, P224, DOI 10.1016/j.reprotox.2007.11.014; HAGEN DR, 1981, J REPROD FERTIL, V63, P11; Hakim RB, 1998, FERTIL STERIL, V70, P632, DOI 10.1016/S0015-0282(98)00257-X; Hannuksela Minna L, 2004, Pathophysiology, V10, P93, DOI 10.1016/j.pathophys.2003.10.009; Jafari M, 2006, AGING CELL, V5, P17, DOI 10.1111/j.1474-9726.2006.00195.x; Jafari M, 2007, BIOGERONTOLOGY, V8, P639, DOI 10.1007/s10522-007-9105-7; Jafari M, 2006, CURR DRUG TARGETS, V7, P1479, DOI 10.2174/1389450110607011479; Kennedy BK, 2008, J INTERN MED, V263, P142, DOI 10.1111/j.1365-2796.2007.01903.x; Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Mueller LD, 1995, EXP GERONTOL, V30, P553, DOI 10.1016/0531-5565(95)00029-1; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rose MR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-30; Rose MR, 2002, EVOLUTION, V56, P1982; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; ROSE MR, 1991, EVOLUTIONARY BIOL AG, P14; Sampayo JN, 2003, BIOCHEM SOC T, V31, P1305; Singletary K, 1997, ALCOHOL CLIN EXP RES, V21, P334; Smith ED, 2008, GENOME RES, V18, P564, DOI 10.1101/gr.074724.107; Williams PL, 2000, J TOXICOL ENV HEAL A, V61, P641, DOI 10.1080/00984100050195125; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	34	12	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6578	10.1371/journal.pone.0006578	http://dx.doi.org/10.1371/journal.pone.0006578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668379	Green Published, gold			2022-12-25	WOS:000268935600007
J	Kim, M; Min, HJ; Won, HY; Park, H; Lee, JC; Park, HW; Chung, J; Hwang, ES; Lee, K				Kim, Miyoung; Min, Hyun Jung; Won, Hee Yeon; Park, Heejin; Lee, Ji-Chul; Park, Heung-Woo; Chung, Junho; Hwang, Eun Sook; Lee, Kyunglim			Dimerization of Translationally Controlled Tumor Protein Is Essential For Its Cytokine-Like Activity	PLOS ONE			English	Article								Background: Translationally Controlled Tumor Protein (TCTP) found in nasal lavage fluids of allergic patients was named IgE-dependent histamine-releasing factor (HRF). Human recombinant HRF (HrHRF) has been recently reported to be much less effective than HRF produced from activated mononuclear cells (HRFmn). Methods and Findings: We found that only NH2-terminal truncated, but not C-terminal truncated, TCTP shows cytokine releasing activity compared to full-length TCTP. Interestingly, only NH2-terminal truncated TCTP, unlike full-length TCTP, forms dimers through intermolecular disulfide bonds. We tested the activity of dimerized full-length TCTP generated by fusing it to rabbit Fc region. The untruncated-full length protein (Fc-HrTCTP) was more active than HrTCTP in BEAS-2B cells, suggesting that dimerization of TCTP, rather than truncation, is essential for the activation of TCTP in allergic responses. We used confocal microscopy to evaluate the affinity of TCTPs to its putative receptor. We detected stronger fluorescence in the plasma membrane of BEAS-2B cells incubated with Del-N11TCTP than those incubated with rat recombinant TCTP (RrTCTP). Allergenic activity of Del-N11TCTP prompted us to see whether the NH2-terminal truncated TCTP can induce allergic airway inflammation in vivo. While RrTCTP had no influence on airway inflammation, Del-N11TCTP increased goblet cell hyperplasia in both lung and rhinal cavity. The dimerized protein was found in sera from allergic patients, and bronchoalveolar lavage fluids from airway inflamed mice. Conclusions: Dimerization of TCTP seems to be essential for its cytokine-like activity. Our study has potential to enhance the understanding of pathogenesis of allergic disease and provide a target for allergic drug development.			Kim, M (corresponding author), Ewha Womans Univ, Ctr Cell Signaling Res & Drug Discovery Res, Coll Pharm, Seoul, South Korea.	klyoon@ewha.ac.kr	Min, Hyunjung/ABA-8709-2020; Park, Heung-Woo/AAW-7690-2020; Chung, Junho/J-2792-2012	Park, Heung-Woo/0000-0002-6970-3228; 				Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Bhisutthibhan J, 2001, ANTIMICROB AGENTS CH, V45, P2397, DOI 10.1128/AAC.45.8.2397-2399.2001; BOHM H, 1989, BIOCHEM INT, V19, P277; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Budde IK, 2003, CLIN EXP ALLERGY, V33, P1175, DOI 10.1046/j.1365-2222.2003.01767.x; Budde IK, 2002, ANN ALLERG ASTHMA IM, V89, P606, DOI 10.1016/S1081-1206(10)62109-6; Cairns JA, 1996, J IMMUNOL, V156, P275; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; CHITPATIMA ST, 1988, NUCLEIC ACIDS RES, V16, P2350, DOI 10.1093/nar/16.5.2350; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; ELLERSON JR, 1976, J IMMUNOL, V116, P510; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; IMBODEN JB, 1985, J IMMUNOL, V134, P663; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; LIU MC, 1986, J IMMUNOL, V136, P2588; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; MOQBEL R, 1994, J ALLERGY CLIN IMMUN, V94, P1183, DOI 10.1016/0091-6749(94)90330-1; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mosmann TR, 1986, J IMMUNOL, P5; NAKAMURA H, 1992, J CLIN INVEST, V89, P1478, DOI 10.1172/JCI115738; Oikawa K, 2002, BIOCHEM BIOPH RES CO, V290, P984, DOI 10.1006/bbrc.2001.6302; PASMANS SGMA, 1994, INT ARCH ALLERGY IMM, V103, P44, DOI 10.1159/000236604; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Schroeder JT, 1997, J IMMUNOL, V159, P447; Sower LE, 1996, CELL IMMUNOL, V171, P159, DOI 10.1006/cimm.1996.0187; Teshima S, 1998, J IMMUNOL, V161, P6356; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Vonakis BM, 2003, J IMMUNOL, V171, P3742, DOI 10.4049/jimmunol.171.7.3742; WARNER JA, 1986, J IMMUNOL, V136, P2583; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; YASUEDA H, 1993, CLIN EXP ALLERGY, V23, P384, DOI 10.1111/j.1365-2222.1993.tb00343.x; Yoneda K, 2004, AM J PHYSIOL-LUNG C, V286, pL174, DOI 10.1152/ajplung.00118.2003; Yoon T, 2000, ARCH BIOCHEM BIOPHYS, V384, P379, DOI 10.1006/abbi.2000.2108	42	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6464	10.1371/journal.pone.0006464	http://dx.doi.org/10.1371/journal.pone.0006464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649253	Green Published, Green Submitted, gold			2022-12-25	WOS:000268637600012
J	Willemssen, R; Muller, T; Schwarz, M; Falkenstein, M; Beste, C				Willemssen, Rita; Mueller, Thomas; Schwarz, Michael; Falkenstein, Michael; Beste, Christian			Response Monitoring in De Novo Patients with Parkinson's Disease	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; COGNITIVE IMPAIRMENT; HUNTINGTONS-DISEASE; PREFRONTAL CORTEX; ERROR NEGATIVITY; DOPAMINE; TASK; SCHIZOPHRENIA; COMPENSATION; ATROPHY	Background: Parkinson's disease (PD) is accompanied by dysfunctions in a variety of cognitive processes. One of these is error processing, which depends upon phasic decreases of medial prefrontal dopaminergic activity. Until now, there is no study evaluating these processes in newly diagnosed, untreated patients with PD ("de novo PD''). Methodology/Principal Findings: Here we report large changes in performance monitoring processes using event-related potentials (ERPs) in de novo PD-patients. The results suggest that increases in medial frontal dopaminergic activity after an error (Ne) are decreased, relative to age-matched controls. In contrast, neurophysiological processes reflecting general motor response monitoring (Nc) are enhanced in de novo patients. Conclusions/Significance: It may be hypothesized that the Nc-increase is at costs of dopaminergic activity after an error; on a functional level errors may not always be detected and correct responses sometimes be misinterpreted as errors. This pattern differs from studies examining patients with a longer history of PD and may reflect compensatory processes, frequently occurring in pre-manifest stages of PD. From a clinical point of view the clearly attenuated Ne in the de novo PD patients may prove a useful additional tool for the early diagnosis of basal ganglia dysfunction in PD.	[Willemssen, Rita; Falkenstein, Michael; Beste, Christian] WHO Collaborating Res Ctr Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Mueller, Thomas] St Joseph Hosp, Klin Weissensee, Dept Neurol, Berlin, Germany; [Schwarz, Michael] Klin Dortmund, Dept Neurol, Dortmund, Germany; [Beste, Christian] Ruhr Univ Bochum, Inst Cognitive Neurosci Biopsychol, Bochum, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Klinikum Dortmund; Ruhr University Bochum	Willemssen, R (corresponding author), WHO Collaborating Res Ctr Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	willemssen@ifado.de	Falkenstein, Michael/ABA-7497-2020; Müller, Thomas/C-9317-2011; Ferrari, Davide/F-5644-2015; Di Virgilio, Francesco/J-3754-2018	Muller, Tobias/0000-0002-9801-3496; Ferrari, Davide/0000-0002-5727-9204; Di Virgilio, Francesco/0000-0003-3566-1362	Deutsche Forschungsgemeinschaft (DFG) [FA 211/16-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant FA 211/16-1 to 3 from the Deutsche Forschungsgemeinschaft (DFG). No other financial and material support for this research and work was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2002, CEREB CORTEX, V12, P840, DOI 10.1093/cercor/12.8.840; Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; BEST C, 2004, PLOS ONE, V1, pE86; Beste C, 2008, HUM BRAIN MAPP, V29, P121, DOI 10.1002/hbm.20374; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Brenneis C, 2003, MOVEMENT DISORD, V18, P1132, DOI 10.1002/mds.10502; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Eppinger B, 2007, BIOL PSYCHOL, V75, P52, DOI 10.1016/j.biopsycho.2006.12.001; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; Gehring W. J., 1990, PSYCHOPHYSIOLOGY, V27, pS34, DOI DOI 10.1111/J.1469-8986.1990.TB02175.X; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Hautzinger M., 1995, BECK DEPRESSIONS INV; Heaton R., 2003, WCST CV4 WISCONSIN C; Holroyd CB, 2002, NEUROPSYCHOLOGIA, V40, P2116, DOI 10.1016/S0028-3932(02)00052-0; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kopp B, 1996, ELECTROEN CLIN NEURO, V99, P19, DOI 10.1016/0921-884X(96)95617-9; Lehrl S., 1977, MEHRFACHWAHL WORTSCH; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Mathewson KJ, 2005, BIOL PSYCHOL, V70, P88, DOI 10.1016/j.biopsycho.2004.12.005; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Muller T, 2000, J NEUROL SCI, V181, P98, DOI 10.1016/S0022-510X(00)00436-6; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Stemmer B, 2007, CLIN NEUROPHYSIOL, V118, P1223, DOI 10.1016/j.clinph.2007.02.019; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Willemssen R, 2008, J NEURAL TRANSM, V115, P461, DOI 10.1007/s00702-007-0842-1; Willemssen R, 2004, PSYCHOPHYSIOLOGY, V41, P762, DOI 10.1111/j.1469-8986.2004.00201.x; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040	38	163	173	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e4898	10.1371/journal.pone.0004898	http://dx.doi.org/10.1371/journal.pone.0004898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PO	19325909	Green Published, gold			2022-12-25	WOS:000265499600002
J	Nickerson, EK; Wuthiekanun, V; Wongsuvan, G; Limmathurosakul, D; Srisamang, P; Mahavanakul, W; Thaipadungpanit, J; Shah, KR; Arayawichanont, A; Amornchai, P; Thanwisai, A; Day, NP; Peacock, SJ				Nickerson, Emma K.; Wuthiekanun, Vanaporn; Wongsuvan, Gumphol; Limmathurosakul, Direk; Srisamang, Pramot; Mahavanakul, Weera; Thaipadungpanit, Janjira; Shah, Krupal R.; Arayawichanont, Arkhom; Amornchai, Premjit; Thanwisai, Aunchalee; Day, Nicholas P.; Peacock, Sharon J.			Factors Predicting and Reducing Mortality in Patients with Invasive Staphylococcus aureus Disease in a Developing Country	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; BACTEREMIA; GENES; COMMUNITY; IDENTIFICATION; DETERMINANTS; ASSOCIATION; INFECTIONS; EXPERIENCE	Background: Invasive Staphylococcus aureus infection is increasingly recognised as an important cause of serious sepsis across the developing world, with mortality rates higher than those in the developed world. The factors determining mortality in developing countries have not been identified. Methods: A prospective, observational study of invasive S. aureus disease was conducted at a provincial hospital in northeast Thailand over a 1-year period. All-cause and S. aureus-attributable mortality rates were determined, and the relationship was assessed between death and patient characteristics, clinical presentations, antibiotic therapy and resistance, drainage of pus and carriage of genes encoding Panton-Valentine Leukocidin (PVL). Principal Findings: A total of 270 patients with invasive S. aureus infection were recruited. The range of clinical manifestations was broad and comparable to that described in developed countries. All-cause and S. aureus-attributable mortality rates were 26% and 20%, respectively. Early antibiotic therapy and drainage of pus were associated with a survival advantage (both p < 0.001) on univariate analysis. Patients infected by a PVL gene-positive isolate (122/248 tested, 49%) had a strong survival advantage compared with patients infected by a PVL gene-negative isolate (all-cause mortality 11% versus 39% respectively, p < 0.001). Multiple logistic regression analysis using all variables significant on univariate analysis revealed that age, underlying cardiac disease and respiratory infection were risk factors for all-cause and S. aureus-attributable mortality, while one or more abscesses as the presenting clinical feature and procedures for infectious source control were associated with survival. Conclusions: Drainage of pus and timely antibiotic therapy are key to the successful management of S. aureus infection in the developing world. Defining the presence of genes encoding PVL provides no practical bedside information and draws attention away from identifying verified clinical risk factors and those interventions that save lives.			Nickerson, EK (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	emma@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021; Chierakul, Wirongrong/AAC-3226-2020; Fowler, Vance/AAW-2017-2021; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	Thaipadungpanit, Janjira/0000-0002-6184-3381; Chierakul, Wirongrong/0000-0003-2103-9425; White, Nick/0000-0002-1897-1978; West, T Eoin/0000-0001-5503-7204; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	NIAID NIH HHS [U54 AI057141, R01 AI068804, R01-AI068804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Afroz S, 2008, JPN J INFECT DIS, V61, P393; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Korownyk C, 2007, CAN FAM PHYSICIAN, V53, P1680; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LAUTENSCHLAGER S, 1993, CLIN INFECT DIS, V16, P567, DOI 10.1093/clind/16.4.567; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Melles DC, 2006, EMERG INFECT DIS, V12, P1174, DOI 10.3201/eid1207.050865; *NCCLS, 2004, M100S14  S, V24, P40; NEELA V, 2008, INT J INFECT DIS; Nickerson EK, 2006, LANCET INFECT DIS, V6, P70, DOI 10.1016/S1473-3099(06)70363-2; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Nickerson EK, 2009, LANCET INFECT DIS, V9, P130, DOI 10.1016/S1473-3099(09)70022-2; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; Renwick L, 2008, EUR J CLIN MICROBIOL, V27, P791, DOI 10.1007/s10096-008-0503-9; Tang YW, 2007, J CLIN MICROBIOL, V45, P1867, DOI 10.1128/JCM.02100-06; Topeli A, 2000, INT J ANTIMICROB AG, V14, P57, DOI 10.1016/S0924-8579(99)00147-8; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; WILSON R, 1957, AM J MED, V22, P437, DOI 10.1016/0002-9343(57)90099-2; Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004	32	88	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6512	10.1371/journal.pone.0006512	http://dx.doi.org/10.1371/journal.pone.0006512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652705	Green Submitted, Green Published, gold			2022-12-25	WOS:000268637800018
J	Nickerson, EK; Hongsuwan, M; Limmathurotsakul, D; Wuthiekanun, V; Shah, KR; Srisomang, P; Mahavanakul, W; Wacharaprechasgul, T; Fowler, VG; West, TE; Teerawatanasuk, N; Becher, H; White, NJ; Chierakul, W; Day, NP; Peacock, SJ				Nickerson, Emma K.; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Wuthiekanun, Vanaporn; Shah, Krupal R.; Srisomang, Pramot; Mahavanakul, Weera; Wacharaprechasgul, Therapon; Fowler, Vance G., Jr.; West, T. Eoin; Teerawatanasuk, Nitaya; Becher, Harald; White, Nicholas J.; Chierakul, Wirongrong; Day, Nicholas P.; Peacock, Sharon J.			Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; MEDICAL PROGRESS; EPIDEMIOLOGY; POPULATION; MORTALITY; CHILDREN	Background: Most information on invasive Staphylococcus aureus infections comes from temperate countries. There considerable knowledge gaps in epidemiology, treatment, drug resistance and outcome of invasive S. aureus infection in the tropics. Methods: A prospective, observational study of S. aureus bacteraemia was conducted in a 1000-bed regional hospital in northeast Thailand over 1 year. Detailed clinical data were collected and final outcomes determined at 12 weeks, and correlated with antimicrobial susceptibility profiles of infecting isolates. Principal Findings: Ninety-eight patients with S. aureus bacteraemia were recruited. The range of clinical manifestations was similar to that reported from temperate countries. The prevalence of endocarditis was 14%. The disease burden was highest at both extremes of age, whilst mortality increased with age. The all-cause mortality rate was 52%, with a mortality attributable to S. aureus of 44%. Methicillin-resistant S. aureus (MRSA) was responsible for 28% of infections, all of which were healthcare-associated. Mortality rates for MRSA and methicillin-susceptible S. aureus (MSSA) were 67% (18/27) and 46% (33/71), respectively (p = 0.11). MRSA isolates were multidrug resistant. Only vancomycin or fusidic acid would be suitable as empirical treatment options for suspected MRSA infection. Conclusions: S. aureus is a significant pathogen in northeast Thailand, with comparable clinical manifestations and a similar endocarditis prevalence but higher mortality than industrialised countries. S. aureus bacteraemia is frequently associated with exposure to healthcare settings with MRSA causing a considerable burden of disease. Further studies are required to define setting-specific strategies to reduce mortality from S. aureus bacteraemia, prevent MRSA transmission, and to define the burden of S. aureus disease and emergence of drug resistance throughout the developing world.	[Nickerson, Emma K.; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Wuthiekanun, Vanaporn; White, Nicholas J.; Chierakul, Wirongrong; Day, Nicholas P.; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Nickerson, Emma K.; White, Nicholas J.; Day, Nicholas P.; Peacock, Sharon J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Shah, Krupal R.; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Durham, NC USA; [Srisomang, Pramot] Sappasithiprasong Hosp, Dept Pediat, Ubon Ratchathani, Thailand; [Mahavanakul, Weera] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Wacharaprechasgul, Therapon] Sappasithiprasong Hosp, Dept Radiol, Ubon Ratchathani, Thailand; [West, T. Eoin] Univ Washington, Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; [Teerawatanasuk, Nitaya] Sappasithiprasong Hosp, Dept Microbiol, Ubon Ratchathani, Thailand; [Becher, Harald] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Duke University; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Oxford	Nickerson, EK (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	emma@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021; Chierakul, Wirongrong/AAC-3226-2020; Fowler, Vance/AAW-2017-2021; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	Thaipadungpanit, Janjira/0000-0002-6184-3381; Chierakul, Wirongrong/0000-0003-2103-9425; White, Nick/0000-0002-1897-1978; West, T Eoin/0000-0001-5503-7204; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust; National Institutes of Health [R01-AI068804, U54 AI057141]; Parker B. Francis Fellowship in Pulmonary Research; NIAID NIH HHS [U54 AI057141, R01 AI068804, R01-AI068804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship in Pulmonary Research; NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust. EKN, MH, DL, VW, NJW, WC, NPD and SJP are funded by the Wellcome Trust. VGF is funded by National Institutes of Health award R01-AI068804. TEW is funded by National Institutes of Health award U54 AI057141 and by a Parker B. Francis Fellowship in Pulmonary Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; DHAWAN A, 1993, ANN TROP PAEDIATR, V13, P189, DOI 10.1080/02724936.1993.11747644; Feil EJ, 2008, J CLIN MICROBIOL, V46, P1520, DOI 10.1128/JCM.02238-07; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Frederiksen MS, 2007, PEDIATR INFECT DIS J, V26, P398, DOI 10.1097/01.inf.0000261112.53035.4c; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; Karunakaran Rina, 2007, Journal of Microbiology Immunology and Infection, V40, P432; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; *NCCLS, 2004, M100S14  S, V24, P40; Nkomo VT, 2007, HEART, V93, P1510, DOI 10.1136/hrt.2007.118810; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Powell JP, 2008, EXPERT REV ANTI-INFE, V6, P299, DOI 10.1586/14787210.6.3.299; Singhi S, 2008, INDIAN J PEDIATR, V75, P25, DOI 10.1007/s12098-008-0002-0; Wallin TR, 2008, EMERG MED CLIN N AM, V26, P431, DOI 10.1016/j.emc.2008.01.010; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wyllie DH, 2007, J HOSP INFECT, V67, P301, DOI 10.1016/j.jhin.2007.08.018	25	88	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4308	10.1371/journal.pone.0004308	http://dx.doi.org/10.1371/journal.pone.0004308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19652705	Green Published, gold			2022-12-25	WOS:000274089700007
